<SEC-DOCUMENT>0001493152-21-006756.txt : 20210325
<SEC-HEADER>0001493152-21-006756.hdr.sgml : 20210325
<ACCEPTANCE-DATETIME>20210325060425
ACCESSION NUMBER:		0001493152-21-006756
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		91
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210325
DATE AS OF CHANGE:		20210325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protagenic Therapeutics, Inc.\new
		CENTRAL INDEX KEY:			0001022899
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				061390025
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51353
		FILM NUMBER:		21770012

	BUSINESS ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 994-8200

	MAIL ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atrinsic, Inc.
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEW MOTION, INC.
		DATE OF NAME CHANGE:	20070504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MPLC, Inc.
		DATE OF NAME CHANGE:	20050608
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNUAL
    REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
fiscal year ended: December 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSITION
    REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from _______________ to _______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number: 000-51353</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Protagenic
    Therapeutics, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>06-1390025</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>149
    Fifth Avenue</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, New York</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10010</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <B><U>(212) 994-8200</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered under Section 12(b) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of exchange on which registered</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered under Section 12(g) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock, $0.0001 par value</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
of class)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
[&nbsp;&nbsp;] No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes [&nbsp;&nbsp;]
No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes [X] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted posted
pursuant to Rule 405 of Regulation S-T (&sect; 232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit and post such files).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
[X] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated file, smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer [&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company [X]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company [&nbsp;&nbsp;]</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report and attestation to its management&rsquo;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. Yes [&nbsp;&nbsp;] No [X]</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
[&nbsp;&nbsp;] No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant on June 30, 2020, based
on a closing price as reported on the OTCQB of $1.17 was approximately $12,005,860.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 17, 2021, there were 10,521,506 shares of the registrant&rsquo;s common stock, par value $0.0001, issued and outstanding,
and 872,766 shares of the registrant&rsquo;s Series B Preferred Stock, par value $0.000001, issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOCUMENTS
INCORPORATED BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROTAGENIC
THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANNUAL
REPORT ON FORM 10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEAR ENDED DECEMBER 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A HREF="#d_001">PART
    I</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_002"><FONT STYLE="font-size: 10pt">Business</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_003"><FONT STYLE="font-size: 10pt">Risk
    Factors</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_004"><FONT STYLE="font-size: 10pt">Unresolved
    Staff Comments</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_005"><FONT STYLE="font-size: 10pt">Properties</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_006"><FONT STYLE="font-size: 10pt">Legal
    Proceedings</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_007"><FONT STYLE="font-size: 10pt">Mine
    Safety Disclosures</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_008"><FONT STYLE="font-size: 10pt"><B>PART
    II</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_009"><FONT STYLE="font-size: 10pt">Market
    for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_010"><FONT STYLE="font-size: 10pt">Selected
    Financial Data</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_011"><FONT STYLE="font-size: 10pt">Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_012"><FONT STYLE="font-size: 10pt">Quantitative
    and Qualitative Disclosures About Market Risk</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_013"><FONT STYLE="font-size: 10pt">Financial
    Statements and Supplementary Data</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_014"><FONT STYLE="font-size: 10pt">Changes
    in and Disagreements with Accountants on Accounting and Financial Disclosure</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_015"><FONT STYLE="font-size: 10pt">Controls
    and Procedures</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_016"><FONT STYLE="font-size: 10pt">Other
    Information</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_017"><FONT STYLE="font-size: 10pt"><B>PART
    III</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_018"><FONT STYLE="font-size: 10pt">Directors,
    Executive Officers and Corporate Governance</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_019"><FONT STYLE="font-size: 10pt">Executive
    Compensation</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_020"><FONT STYLE="font-size: 10pt">Security
    Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_021"><FONT STYLE="font-size: 10pt">Certain
    Relationships and Related Transactions, and Director Independence</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_022"><FONT STYLE="font-size: 10pt">Principal
    Accountant Fees and Services</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_023"><FONT STYLE="font-size: 10pt"><B>PART
    IV</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_024"><FONT STYLE="font-size: 10pt">Exhibits
    and Financial Statement Schedules</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#d_025"><FONT STYLE="font-size: 10pt">SIGNATURES</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
report on Form 10-K contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals,
expectations, anticipations, assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties
and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be
materially different from future results, performance or achievements expressed or implied by such forward-looking statements.
All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify
these forward-looking statements through our use of words such as &ldquo;may,&rdquo; &ldquo;can,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;assume,&rdquo; &ldquo;should,&rdquo; &ldquo;indicate,&rdquo; &ldquo;would,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;seek,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;plan,&rdquo; &ldquo;point to,&rdquo;
&ldquo;project,&rdquo; &ldquo;predict,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;target,&rdquo; &ldquo;potential&rdquo;
and other similar words and expressions of the future. The matters discussed in these forward-looking statements are subject to
risks, uncertainties and other factors that could cause our actual results to differ materially from those projected, anticipated
or implied in the forward-looking statements. As a result, you should not place undue reliance on any forward-looking statements.
Except to the limited extent required by applicable law, we undertake no obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Risk Factors Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Below is a summary
of material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address
all of the risks and uncertainties that we face. Additional discussion of the risks and uncertainties summarized in this risk
factor summary, as well as other risks and uncertainties that we face, can be found under &ldquo;Risk Factors&rdquo; in Part I,
Item 1A of this Annual Report on Form 10-K. The below summary is qualified in its entirety by that more complete discussion of
such risks and uncertainties. You should consider carefully the risks and uncertainties described under &ldquo;Risk Factors&rdquo;
in Part I, Item 1A of this Annual Report on Form 10-K as part of your evaluation of the risks associated with an investment in
our securities.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Condition and Capital Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&rsquo;s financial statements have been prepared on a going concern basis, and do not include adjustments that might
    be necessary if the Company is unable to continue as a going concern.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we continue to incur operating losses and fail to obtain the capital necessary to fund our operations, we will be unable to
    advance our development programs, complete our clinical trials, or bring products to market, or may be forced to reduce or
    cease operations entirely. In addition, any capital obtained by us may be obtained on terms that are unfavorable to us, our
    investors, or both.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unstable
    market and economic conditions may have serious adverse consequences on our ability to raise funds, which may cause us to
    cease or delay our operations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covid-19
    could adversely impact our business, including our clinical trials, and financial condition.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Clinical Development and Regulatory Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    results to date provide no basis for predicting whether any of our product candidates will be safe or effective, or receive
    regulatory approval.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to initiate and complete preclinical studies and clinical trials for our product candidates which could adversely
    affect our business.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we experience delays or difficulties in the enrollment of subjects to our clinical trials, our receipt of necessary regulatory
    approvals could be delayed or prevented, which could materially affect our financial condition.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the market opportunities for our current and potential future drug candidates are smaller than we believe they are, our ability
    to generate product revenues will be adversely affected and our business may suffer.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Reliance on Third Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have no experience in sales, marketing and distribution and may have to enter into agreements with third parties to perform
    these functions, which could prevent us from successfully commercializing our product candidates.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
    provided by collaborators and other parties upon which we rely have not been independently verified and could turn out to
    be inaccurate, misleading, or incomplete.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on third parties to conduct our non-clinical studies and our clinical trials. If these third parties do not successfully
    carry out their contractual duties or meet expected deadlines, we may be unable to obtain regulatory approval for or commercialize
    our current product candidates or any future products, on a timely basis or at all, and our financial condition will be adversely
    affected.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Commercialization of Our Product Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have no experience as a company in commercializing any product. If we fail to obtain commercial expertise, upon product approval
    by regulatory agencies, our product launch and revenues could be delayed.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to gain market acceptance of our product candidates, which would prevent us from becoming profitable.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to manufacture our product candidates in clinical or commercial quantities, which would prevent us from commercializing
    our product candidates.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disputes
    under key agreements or conflicts of interest with our scientific advisors or clinical investigators could delay or prevent
    development or commercialization of our product candidates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to maintain our exclusive worldwide license to use and develop PT00114 which could materially affect our business
    plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Business Operations and Industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are not able to retain our current senior management team and our scientific advisors or continue to attract and retain
    qualified scientific, technical and business personnel, our business will suffer.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may encounter difficulties in managing our growth, which could adversely affect our operations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
    reform measures could adversely affect our business.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business and operations are vulnerable to computer system failures, cyber-attacks or deficiencies in our cyber-security, which
    could increase our expenses, divert the attention of our management and key personnel away from our business operations and
    adversely affect our results of operations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
    to comply with health and data protection laws and regulations could lead to government enforcement actions (which could include
    civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and
    business.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we, our CROs or our IT vendors experience security or data privacy breaches or other unauthorized or improper access to, use
    of, or destruction of personal data, we may face costs, significant liabilities, harm to our brand and business disruption.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we do not comply with laws regulating the protection of the environment and health and human safety, our business could be
    adversely affected.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Associated to our Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is a &ldquo;Penny Stock&rdquo; subject to specific rules governing its sale to investors that could impact its
    liquidity.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    is no recent trading activity in our common stock and there is no assurance that an active market will develop in the future.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    ability to list on Nasdaq will require raising significant capital; failure to qualify to trade on Nasdaq will make it more
    difficult to raise capital.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our common stock may be volatile, which could lead to losses by investors and costly securities litigation.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results
    or detect fraud. Consequently, investors could lose confidence in our financial reporting and this may decrease the trading
    price of our stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
    may experience dilution of their ownership interests because of the future issuance of additional shares of our common stock.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is controlled by insiders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    do not intend to pay dividends for the foreseeable future and may never pay dividends.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    certificate of incorporation allows for our board to create new series of preferred stock without further approval by our
    stockholders, which could adversely affect the rights of the holders of our common stock.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_001"></A>PART
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_002"></A>Item
1. Business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protagenic
Therapeutic, Inc. (together with its subsidiary, &ldquo;Protagenic,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo;
or &ldquo;us&rdquo;) are a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related
neuropsychiatric and mood disorders. Our proprietary, patent-protected, first-in-class lead compound, PT00114, is a synthetic
form of Teneurin Carboxy-terminal Associated Peptide (&ldquo;TCAP&rdquo;), an endogenous brain signaling peptide that can dampen
overactive stress responses. Our preclinical models have demonstrated efficacy of PT00114 in animal models of depression, anxiety,
substance abuse &amp; addiction, and PTSD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
leverages a completely novel mechanism of action. Protagenic owns exclusive, worldwide rights to PT00114 through its license agreement
with the University of Toronto and has an exclusive right to license additional intellectual property generated by Dr. David Lovejoy&rsquo;s
lab at University of Toronto. Additionally, the company is engaged in the research &amp; development of follow-on compounds in
the TCAP family. Extensive publications in peer-reviewed scientific journals underline the central role stress plays in the onset
and proliferation of neuropsychiatric disorders like depression, anxiety, substance abuse &amp; addiction, and PTSD. The mechanism
of action of TCAP suggests that it counterbalances stress overdrive at the cellular level within the brain&rsquo;s stress response
cascade. TCAP works to alleviate the harmful behavioral, biochemical, and physiological effects of these disorders, while simultaneously
restoring brain health. This mechanism has been corroborated in preclinical animal models of the psychiatric disorders listed
above. Preclinical experiments required for IND filing have been completed, and the company will seek to prove the safety and
efficacy of PT00114 in humans through its initial clinical studies to commence by midyear 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Protagenic transitions into a clinical-stage company, we aim to complete certain key strategic and tactical milestones over the
coming two years;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rapidly
    advance our lead product candidate, PT00114, through clinical trials in treatment resistant depression, substance use disorder,
    generalized anxiety disorder, and/or post-traumatic stress disorder.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Develop
    additional product candidates from the TCAP family to build out a broad pipeline of assets with differentiated features using
    our unique expertise with this mechanism.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Explore
    efficacy in additional stress-related neuropsychiatric and mood disorders beyond initially targeted indications.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facilitate
    long-term growth by building a nimble R&amp;D, operational, clinical and commercial team.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proactively
    assess strategic partnership opportunities including in important international markets</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
with our strategy of strengthening our IP position in this important novel field of neuropsychiatry</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IND
Submission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate submitting an investigational new drug (IND) application in early 2021 to evaluate the safety, tolerability, and early
activity of PT100114 (TCAP) in healthy volunteers and patients with psychiatric illnesses. The IND enabling studies, including
the preclinical efficacy data generated, as well as the GLP toxicology study, and a summary of the Phase I clinical trial plan,
will be among the components of this key regulatory submission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
clinical development program will be led by Dr. Maurizio Fava, MD, PhD, a world-leader in psychiatric disorders, the Psychiatrist-in-Chief
of the Massachusetts General Hospital and Slater Family Professor of Psychiatry at Harvard Medical School. Dr. Fava was co-principal
investigator of STAR*D, the largest research study ever conducted in depression, has coauthored more than 800 medical journal
publications, and is one of the top enrolling psychiatry clinicians in the US. Protagenic&rsquo;s Phase I/II clinical study was
designed by Dr. Fava, who will be the trial&rsquo;s principal investigator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will launch our clinical program with a basket trial designed first to evaluate the safety of TCAP in a small cohort of healthy
volunteers, immediately followed by the evaluation of safety, pharmacological and clinical activity in cohorts of patients with
stress-related neuropsychiatric disorders including, but not limited to depression, addiction, anxiety, and Post-Traumatic Stress
Disorder (PTSD). We will be using this study for both safety and preliminary efficacy to prioritize indications for later phase
development that would ultimately support a New Drug Application (NDA) and registration. The four indications were chosen for
multiple reasons, including the mechanism of TCAP in reducing biological stress signals, preclinical evidence of efficacy in animal
models of these disorders and the high unmet need in these patient populations, which creates significant market opportunity.
We believe the basket trial structure offers the most efficient use of capital in early-stage development and will give us insights
into which indication we should focus on in advanced clinical trials. Healthy volunteers will be the first cohort and subsequent
parallel cohorts will include patients with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
    Depressive Disorder (MDD) who have suboptimal response to or poorly tolerated two prior SSRIs / SNRIs</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generalized
    Anxiety Disorder (GAD) who have suboptimal response to or poorly tolerated two prior SSRIs /SNRIs</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opioid
    Use Disorder (OUD) who are on treatment with Suboxone and have suboptimal response</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Traumatic
    Stress Disorder (PTSD) who have suboptimal response to or intolerance of sertraline and paroxetine</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trial will use a classic sequential dose escalation design using cohort replication with initial doses estimated from non-clinical
data. The study will assess dose ranging through standard and small cohorts with a rules-based approach for dose, safety, efficacy,
and biomarkers. Trial participants will have a maximal 28-day exposure. As this will be the first in human study of TCAP, safety
and adverse events will be the primary endpoint. Key secondary endpoints were chosen to ascertain efficacy in individual conditions
and compare drug impact across disparate diseases. All disease cohorts will be measured for Strengths and Difficulties Questionnaire
(SDQ), which is a validated broad self-rated outcome measure that has outperformed the clinician-rated Montgomery&ndash;&Aring;sberg
Depression Rating Scale (MADRS) scale in previous trials. Patients will also be assessed for stress biomarkers <I>via</I> pre-
and post-treatment systemic cortisol levels and skin conductance. Each disease cohort (anxiety, depression, PTSD and addiction)
will also have disease specific assessments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
although patient populations and their responses to CNS agents can be highly variable in clinical studies, we attempt to mitigate
this by stratifying the initial series of cohorts to select for and control for corticosterone levels to enable the broadest window
of effect detection. Preclinical studies of TCAP demonstrate that its beneficial actions are most easily observed in stressed
animals, which show elevations of plasma corticosterone levels at baseline before TCAP treatment. Anxious or depressed patients
have elevated corticosterone levels, providing an opportunity to identify patients more likely to benefit pharmacologically and
potentially clinically. This also provides a useful translational bridge between preclinical behavioral models and human clinical
studies and enables flexibility in evaluating routes of administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Market
for Stress-Related Neuropsychiatric Disorders: Depression, Addiction, Anxiety, and PTSD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Humans
living in our modern world, in both developed and developing nations, are being exposed to a multitude of life stressors that
are progressively taking a toll on our mental health. The recent COVID-19 has exacerbated both near-term and long-term global
impacts of stress-induced disorders on modern society. Stress-related mental, mood and behavioral disorders include, but are not
limited to: treatment resistant depression (TRD), which is a subgroup of major depressive disorder (MDD); addiction or substance
use disorder (SUD); and anxiety, including generalized anxiety disorder (GAD) and post-traumatic stress disorder (PTSD). These
disorders are a leading cause of disability worldwide and also a major contributor to suicide. Yet, a majority of these patients
are inadequately served by current therapeutic options, which can have limited efficacy, significant side effects and high treatment
burden. We believe these stress-related disorders are suitable indications for the use of Protagenic Therapeutics neuropeptide-based
drug candidates.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
depressive disorder (MDD) is highly prevalent and disabling. The lifetime prevalence is approximately 12% with a past year prevalence
of 7.8% of adults in the United States in 2019, translating to over 19 million adults each year. The World Health Organization
estimates 264 million people globally suffer from depression, which ranks depression as one of the highest causes of disability
and mortality in the world. Stress plays a significant role in this illness and affects as many as half of people diagnosed with
depression. MDD is characterized by multiple symptoms, potentially including depressed mood, loss of interest or pleasure, change
in appetite or weight, sleep disturbance, fatigue or loss of energy, neurocognitive dysfunction, psychomotor agitation or retardation,
feelings of worthlessness or excessive guilt, and suicidal ideation and behavior. MDD is highly treatment resistant, with 45-50%
of patients who receive initial treatment for MDD not achieving long term remission, generally referred to as Treatment Resistant
Depression (TRD). Patients suffering with TRD are at greater risk of hospitalization for their psychiatric illness and are more
likely to abuse drugs and alcohol. These patients have a lower long-term quality of life and are at increased risk of attempting
suicide. MDD is also highly recurrent and the estimated rate of recurrence over two years is over 40%, which rises to 75% after
two episodes within five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treatment
guidelines recommend the combination of pharmacotherapy plus psychotherapy, but pharmacotherapy alone and psychotherapy alone
are frequently used. For initial pharmacotherapy with antidepressants, selective serotonin reuptake inhibitors (SSRIs) are recommended.
However, several classes of antidepressants are available, including serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical
antidepressants, and serotonin modulators, with efficacy generally comparable across and within classes. Drug choice is based
on multiple factors, including side effect profile, comorbid illnesses, concurrent medications, patient preference, and cost.
Physicians typically cycle through multiple generics if the initial response is suboptimal or patients experience AEs. Efficacy
of therapy is challenged by non-compliance during the weeks to months required to achieve therapeutic benefit in combination with
daily dosing requirements. However, SSRIs can produce significant quality of life side effects that interfere with medication
adherence, including sexual dysfunction, gastrointestinal nausea and diarrhea, insomnia and weight gain. As a last resort, this
disease is currently managed by invasive treatment, primarily electroconvulsive therapy (ECT). However, the side effects and high
cost prevent widespread adoption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
drugs that have launched in recent years validate the market for branded agents in this field, in spite of their marginal improvements
in safety or efficacy. Takeda&rsquo;s Trintellix (vortioxetine hydrobromide) launched in 2014 and has grown to $837M 2019 sales,
largely due to studies added to the label after original approval showing cognitive function improvement and reduced incidence
of treatment emergent sexual dysfunction (TESD). Despite these label additions, sales have lagged original consensus analyst forecasts,
which at launch estimated 2019 worldwide sales of ~$1.1B.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generalized
anxiety disorder (GAD) is one of the most common mental disorders in both community and clinical settings. In the United States,
the estimated lifetime prevalence of GAD is 5.7% with a past year prevalence of 2.7%, corresponding to 18 million and 9 million
individuals, respectively. GAD is characterized by excessive and persistent worrying that causes significant distress or impairment
on most days and is hard to control. Other symptoms can include apprehensiveness, irritability, increased fatigue and muscular
tension. GAD is also associated with increased rates of substance abuse, posttraumatic stress disorder, and obsessive-compulsive
disorder. GAD is a potentially chronic illness, with symptom severity fluctuating over time. A 12-year study of treated patients
showed approximately 60% of patients had symptoms resolve, but around one-half of those subsequently relapsed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacotherapy
for GAD is primarily selective-serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs),
which are mildly efficacious. Clinical trials for different SSRIs and SNRIs have shown approximately the same effectiveness, with
response rates of approximately 60- 70% for the drug and 40% for placebo. However, SSRIs can produce significant quality of life
side effects that interfere with medication adherence, including sexual dysfunction, gastrointestinal nausea and diarrhea, insomnia
and weight gain. Thus, choice of agent is often dependent on the patient&rsquo;s side effect profile for individual drugs. Benzodiazepines
are efficacious and can reduce emotional and somatic symptoms within hours. However, concerns about dependence risk has contributed
to a decline in their use. Buspirone has similar efficacy to benzodiazepines without the risk of dependence but has a time to
onset of approximately four weeks. As the majority of these agents are now available as generics, the worldwide market for GAD
therapies was only $483M in 2019 and consensus analyst forecasts expect it to decline to $222M in 2026.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-traumatic
stress disorder (PTSD) is one of the most common psychiatric disorders, with an estimated past-year and lifetime prevalence of
4.7% and 6.1 %, translating to 11.5M adults in the US each year. PTSD develops in some patients following exposure to a traumatic
event involving actual or threatened injury to themselves or others, such as war, natural disasters, rape or assault. Symptoms
can be severe, chronic and disabling, which can include intrusive thoughts, nightmares and flashbacks of past traumatic events,
avoidance of reminders of trauma, hypervigilance, and sleep disturbance, all of which lead to significant occupational and social
impairment. Currently, PTSD is treated with psychotherapy and/or pharmacotherapy, with psychotherapy as the recommended primary
intervention. Logistics and cost often limit access to psychotherapy, which results in many patients needing to rely on pharmacotherapy.
Guidelines for pharmacotherapy recommend first-line treatment with sertraline and paroxetine, selective serotonin reuptake inhibitors
(SSRI) antidepressants, as these are the only approved medications for PTSD. However, these only treat one aspect of symptomology
and efficacy is limited, with fewer than 30% of patients experiencing remission. The side effect profile of these agents results
in significant rates of discontinuation, particularly the severe effects such as suicidality and sexual dysfunction. Serotonin-norepinephrine
reuptake inhibitors (SNRI) and second-generation antipsychotics are used off-label in some patients, but efficacy is sporadic,
and side-effects can make these undesirable therapeutic options. As all of these options are currently generic, branded commercial
sales for PTSD is almost non-existent. Given the size of the potential addressable population and limited therapeutic options
available, a therapy with a superior therapeutic index could achieve significant market penetration and sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substance
use disorders (SUDs) are highly prevalent, with ~7.2% of individuals age 12 or over having a diagnosable SUD in 2017, translating
to ~20 million people in the United States. The majority of SUDs involve alcohol use disorder (14 million), followed by illicit
drug use disorder (8 million). Illicit drug use and nonmedical use of medications alone or in combination with alcohol are associated
with a substantial proportion of emergency department visits in the United States. Pharmacologic options to treat SUDs typically
have limited efficacy, high treatment burden, with suboptimal side-effect profiles, ultimately leading to limited uptake and high
remaining unmet medical need. 40- 60% of patients who receive SUD care experience chronic or relapsing disease course.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incidence of opioid use disorder (OUD) and overdose deaths have reached epidemic proportions. Opioid use disorder is typically
a chronic, relapsing illness, associated with significantly increased rates of morbidity and mortality. Opioid use disorder can
be related to misuse of pharmaceutical opioids, heroin, or other opioids such as fentanyl and its analogues. The prevalence of
heroin use and heroin use disorder nearly doubled between 2002 and 2018. In 2019, 2.1% of those 12 or older in the US were estimated
to have used heroin at some point in their lives, translating 5.7 million people, with 431,000 (0.2%) having reported use in the
last month. This resulted in an increase in heroin-related overdose deaths, with ~15,000 in the US in 2018. Approximately 65%
of people who primarily use heroin have been reported to additionally use prescription opioids and heroin use is increasing for
persons who begin by first having nonmedical use/abuse of prescription opioid analgesics. These prescription opioids can be obtained
from a relative, friend or directly from a clinician. In 2015, 3.8 million people aged 12 and older in the US reported past month
misuse of a prescription pain medication, 2 million of whom qualified for a disorder of opioid use or dependence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unmet
needs are particularly high in OUD. First-line treatment for most patients is medication-assisted treatment, consisting of pharmacotherapy
with an opioid agonist or antagonist in combination with psychotherapy. Pharmacotherapy can include an opioid agonist (methadone
or buprenorphine) and/or an opioid antagonist (e.g. naltrexone). Guidelines for mild opioid use disorder suggest first-line treatment
with long-acting injectable naltrexone (e.g. Vivitrol) administered monthly. Guidelines for moderate to severe opioid use disorder
suggest initial use of buprenorphine (e.g. Suboxone) due to the higher risk of lethal overdose with methadone. Treatment can allow
patients to return to a productive lifestyle but has low success rates and can be extremely burdensome. These therapies require
patients remain on maintenance treatment with an opioid agonist for many years as they are physically dependent upon the medications.
A minority may be tapered off after a few years, with the taper itself taking several months to years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
treatment burden and side effect profile of these therapies is substantial. Buprenorphine is classified as a schedule III controlled
substance in the United States, with use limited to certified and specially trained physicians. Side effects include sedation,
headache, nausea, constipation, insomnia, and sweating. Death is possible if buprenorphine is taken in combination with other
substances, especially benzodiazepines and alcohol. Methadone is highly regulated in the United States, where it is classified
as a schedule II drug. Only licensed opioid treatment programs or inpatient hospital units are permitted to dispense. Typical
side effects of methadone include constipation, drowsiness, sweating, peripheral edema, reduced libido, and erectile dysfunction,
with some patients experiencing severe adverse effects including cardiac arrhythmias, hyperalgesia, and overdose.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alcohol
use disorder (AUD) is extraordinarily prevalent. Approximately 30% of adults in the United States use alcohol in an unhealthy
manner and may need some form of intervention. The 2019 United States National Survey on Drug Use and Health estimated that of
Americans over the age of 12 in the past 30 days, 24% reported binge drinking (five or more drinks on one occasion) and 6% reported
heavy drinking (five or more drinks on each of five or more days). The National Institute on Alcohol Abuse and Alcoholism (NIAAA)
reports 28% of US adults exceed thresholds for risky use alcohol consumption, with 19% exceeding the daily limit and 9% exceeding
both the daily and weekly limits. Rates of diagnosable AUD by DSM-5 criteria from the third National Epidemiologic Survey on Alcohol
and Related Conditions showed that 29% had met criteria for an alcohol use disorder in their lifetime and 14% met criteria for
a current alcohol use disorder. Worldwide, the World Health Organization estimates that 5% of adults (&gt;283 million people)
had alcohol use disorder within the prior 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUD
is responsible for significant mortality and morbidity. Excessive alcohol consumption is the third leading preventable cause of
death in the United States directly causing approximately 85,000 deaths per year, roughly 10% of deaths among working age adults.
Nearly 5% of all deaths worldwide (approximately three million each year) have been attributed to alcohol use with 5% of those
specifically due to AUD. The economic cost of excessive alcohol use in the United States is estimated to be $249 billion in 2010
by the CDC. Therapeutic unmet needs are significant for AUD and the condition is frequently untreated. Psychosocial interventions
can be effective for treatment but up to 70% of individuals return to heavy drinking. For patients who met DSM-IV criteria for
alcohol abuse, 46% were in remission, 24% continued to meet abuse criteria, and 30% met criteria for alcohol dependence in the
future. For patients who met DSM-IV criteria for alcohol dependence, 39% were in remission, 15% met criteria for abuse only, and
46% continued to meet dependence criteria.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
medications can be used to treat AUD, which can lead to reduced heavy drinking and increased days of abstinence. For most patients
treated with moderate to severe alcohol use disorder, guidelines recommend first-line treatment with naltrexone (e.g. Vivitrol),
an opioid antagonist. Vivitrol is an extended-release injectable naltrexone that allows for once monthly dosing that was approved
in 2006. Vivitrol is priced at $~1370/month and worldwide sales have grown to $335M. Consensus analyst forecasts for Vivitrol
project sales increasing to $419M in 2026, with patent expiry in 2028. Acamprosate (e.g. Campral) is recommended for those in
whom naltrexone is contraindicated, such as those taking opioids or with acute hepatitis. Campral (Acamprosate) was approved by
the FDA in 2004 and reached peak worldwide sales of $87M in 2008. Acamprosate is currently only available as generic in the US,
but is still sold as branded Campral ex-US. Given the overall prevalence of AUD, these relatively low sales numbers indicate the
vast majority of patients with AUD are not treated with pharmacotherapy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Teneurin
Carboxy-terminal Associated Peptide (TCAP) as a Therapy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
approach to treating stress-related neuropsychiatric and mood disorders is based on research into brain mechanisms conducted over
the last 15 years in the laboratory of the company&rsquo;s scientific founder, Dr. David Lovejoy, from the University of Toronto.
TCAP was discovered in a genome-wide search for proteins related to corticotropin releasing factor (CRF), an endogenous brain
peptide known to be the central mechanism coupling external stress to psychological, behavioral, and endocrine responses. Dr.
Lovejoy and his colleagues discovered and characterized Teneurin Carboxy-terminal Associated Peptide (TCAP); their further work
revealed that TCAP is of ancient evolutionary origin and plays a central role in maintaining healthy brain structure and function
in the face of the negative effects of stress. Although four TCAP peptides were discovered, only TCAP-1 is expressed independent
of a larger Teneurin protein and is the primary focus of our development (PT00114).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TCAP
reverses the impact of stress on the Hypothalamic-Pituitary-Adrenal (HPA) axis, the endocrine and behavioral control system which
connects environmental stress to behavioral responses via brain levels of Corticotropin Releasing Factor (CRF) and blood levels
of the stress hormone cortisol. Stress elevates CRF, which in turn elevates cortisol levels. Studies have demonstrated that TCAP
counteracts the effects of either endogenous or pharmacologically-administered CRF via a non-CRF receptor pathway in the brain,
that is believed to be evolved over millions of years as a homeostasis-related pathway. There has been strong interest in the
pharmaceutical industry for decades to develop drug candidates that block the negative effects of CRF by attempting to directly
antagonize the CRF receptor, however clinical results to date with prior CRF receptor antagonists have been disappointing. Because
TCAP counteracts the action of CRF by activating separate receptors instead of directly blocking CRF receptors, we believe it
is a superior approach to alleviating stress-related neuropsychiatric disorders; TCAP-1 acts by binding to Latrophilin-1 and Latrophilin-3,
G-protein-coupled receptors (GPCRs) expressed on nerve cells in the extended amygdala, the region of the brain involved in memory,
emotion, and fear. TCAP acts through these receptors to block the effects of CRF and potentially other stress mediators such as
Arginine-Vasopressin (AVP). Due to differences in the mechanism of action, TCAP is expected to be efficacious in clinical settings
in which earlier studies with CRF receptor antagonists were not. We believe this novel mechanism of action can provide an attractive
therapeutic profile for patients who are not fully responsive to currently available therapies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; width: 60%"><IMG SRC="form10-k_001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; width: 40%"><IMG SRC="form10-k_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
key effects of TCAP may contribute to its pharmacological activity in reversing or preventing stress-induced behavioral distortions.
In settings of stress and depression, the activity of specific neural circuits can be diminished compared to the levels of activity
observed in healthy brain tissue. After administration, TCAP crosses the blood brain barrier and concentrates in regions of the
brain associated with the regulation of mood disorders. Administered TCAP can lead to increases in activity in some of the neuronal
circuitry implicated in depression, demonstrated by increases in the utilization of glucose, a surrogate for cell activity. The
fact that the pharmacological effects of TCAP persist after the drug has been cleared aligns with findings that TCAP applied to
neurons in culture stabilizes dendritic spines, structures that sprout from the surface of neurons and can form synapses with
other neurons to create functional circuitry. Stress and the associated rise in CRF have been reported to cause loss of synapses
in animal models. The fact that the pharmacological actions of TCAP persist for weeks are consistent with its producing lasting
changes in neuronal function by changing patterns of gene expression and thus creating relatively stable changes in neuronal function.
In a number of these models, a single subcutaneous dose of TCAP will prevent the behavioral consequences of stress encountered
three weeks later. This is especially notable since the administered dose of TCAP is eliminated from the plasma within hours of
administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead compound is a 41-residue peptide synthetic TCAP-1, which we have designated PT00114. In addition, we have a portfolio of
earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. The initial dosage form is intended
as a subcutaneous injection but is also amenable to other routes of administration including sublingually or intra-nasally. This
affords a range of target product profiles and opportunities for lifecycle management.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
many of the initial studies of TCAP had been generated in the lab of Dr. David Lovejoy, we have designed several preclinical studies
over the last four years to validate the safety and efficacy of PT00114, for which we hired multiple independent contract research
organizations (CROs) to conduct these studies. In preclinical rodent models, administration of PT00114 results in reproducible,
dose-dependent reversal of a range of stress-induced behavioral distortions, including depression, stress-exacerbated anxiety,
excessive startle, drug seeking, and opioid withdrawal. Stress-induced anxiety was measured by an elevated plus maze, an open
field with stressed animals, and acoustic startle in CRF-treated animals. Depression was measured by tail suspension and forced
swim. Stress-induced changes in tube-restrained rodents were used as a well-validated model for sub-acute stress. Notably, PT00114
was found to be pharmacologically active in stressed rodents but relatively inactive in non-stressed rodents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
studies conducted with Charles River Laboratories in Kuopio, Finland, PT00114 showed beneficial effects in Chronic Social Defeat,
a murine model of stress-induced behavioral dysfunction that has features of depression. In this model, male mice are placed in
cages along with older, dominant male mice. This results in progressively more &ldquo;resigned&rdquo; behaviors in the mice experiencing
this domineering exposure. This results in a series of behaviors in the cowed mice, termed Chronic Social Defeat. PT00114 reverses
many of the component behaviors typically measured in this model, suggesting that it reverses the negative effects of stress in
the &ldquo;defeated&rdquo; animals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
demonstrated efficacy in a variable chronic stress model that has features of anxiety and PTSD. In an open field assessment, mice
or rats are stressed by being placed in a tube for several hours, then placed in an open box where their movement is observed
for 20 minutes. Control animals exhibit stress response behavior by not moving around much and staying near the edges of the box.
Animal receiving PT00114 at the end of the stress condition moved around the open field. Animals receiving multiple administrations
of a control small molecule CRH antagonist did not venture into the open field, indicating they were stressed. These results are
also reflected in blood cortisol levels, where control mice had increased cortisol levels, which were reduced by treatment with
PT00114, but not by the small molecule CRF antagonist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="form10-k_003.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="form10-k_004.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stress
plays a central role in a broad range of addictions, including alcohol and opioids. The ability of PT00114 to blunt excessive
stress may be able to provide non-dependence forming treatment of addictions. A series of studies conducted at Porsolt Laboratories
in Lavel France support the potential utility of PT00114 as a treatment to help people defeat opioid addiction. In rats addicted
to opioids, administering CRF models environmental stress, causing them to frantically seek opioids. PT00114 reduces the opioid
seeking behavior in response to CRF administration. Further studies conducted by Porsolt following EMEA guidelines demonstrated
that on its own, PT00114 was not addictive and rats did not develop dependence to the peptide after chronic administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
has also demonstrated pre-clinical efficacy in a murine model of opioid withdrawal called the Saleens test. In this test, mice
are addicted to opioids and the animals are then administered the opioid antagonist naloxone, which immediately blocks opioid
action and triggers profound stress and opioid withdrawal. This manifests as a behavioral stress response with the mice jumping
up to six inches into the air over 70 times in a 20-minute observation period. Administering PT00114 at three different time points
within the experiment &ndash; before the naloxone-driven withdrawal, before the period of opioid addiction, or up to three weeks
before the induced withdrawal &ndash; results in a reproducible, dose-dependent restoration to non-stressed behavior and reduced
jumping. Significantly, this is not accompanied by any evidence of sedation or reduced activity. This effect appears independent
of the opioid used as PT00114 ameliorates this withdrawal-triggered jumping stress behavior in mice experiencing withdrawal from
both fentanyl and morphine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preclinical
Safety and Toxicology </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Preclinical
safety data for PT00114 demonstrates a robust profile in both rats and non-human primates. As the mechanism is unique and TCAP
is a part of healthy brain signaling, we believe PT00114 will have a differentiated side effect profile relative to existing antidepressant
and antipsychotic agents. A key aspect of the TCAP mechanism is that it does not completely block the perception of and responses
to stress; it rather protects against stress overload. Some perception of environmental stress and a proportionate response to
that stress is adaptive behavior and it is not desirable to completely block stress responses. Unlike benzodiazepines that can
cause sedation and are prone to dependence, TCAP prevents the maladaptive response to environmental stress without sedation and
without developing dependence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have completed non-GLP Dose-Range-Finding (DRF) toxicology studies of PT00114 administered subcutaneously daily for five days
in rats and non-human primates. The doses tested were substantially above the anticipated clinical doses and were well tolerated
and safe, with no dose-limiting toxicities observed at doses at least 50-fold higher than anticipated clinical exposures. No major
changes in hematology or clinical chemistries were seen, including prolactin levels or testosterone levels, changes in which may
impact libido. Distinct from SSRI&rsquo;s, there was no impact on ambulation, sedation or weight gain. Importantly, further studies
conducted following EMEA guidelines, demonstrated that on its own PT00114 was not addictive and rats did not develop dependence
to the peptide after chronic administration. The in life 28-day GLP toxicology testing in both the rats and non-human primate
have been completed. There have been no changes in clinical chemistries or pathology that would prompt a stop in the program and
the therapeutic margin if large. The final audited reports are currently being compiled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Process
Development and Manufacturing </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
currently do not own any manufacturing facilities and rely on 3<SUP>rd</SUP> party contract manufacturers for synthesis of PT00114.
We have sufficient PT00114 synthesized under cGMP conditions to complete GLP toxicology studies and Phase 1 human clinical trials.
This material is currently undergoing requisite stability and accelerated stability testing. PT00114 is highly soluble and has
shown excellent preliminary stability in several storage conditions, with the material being stable for at least 12 months.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
initial dosage form developed will be a subcutaneous injection. Because PT00114 is also amenable to other routes of administration
including sublingually or intra-nasally, we will be doing preliminary process work to develop these formulations, and anticipate
using one of these dosage forms in later stage clinical studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Technology
License Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 31, 2005, the Company had entered into a Technology License Agreement (&ldquo;License Agreement&rdquo;) with the University
of Toronto (the &ldquo;University&rdquo; or &ldquo;UT&rdquo;) pursuant to which the University agreed to license to the Company
patent rights and other intellectual property, among other things (the &ldquo;Technologies&rdquo;). The Technology License Agreement
was amended on February 18, 2015. Unless earlier terminated, the term of this License Agreement shall terminate on the expiration
or invalidity of the last issued Patent in the License Agreement</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the License Agreement and its amendment, the Company obtained an exclusive worldwide license to make, have made, use, sell
and import products based upon the Technologies, or to sublicense the Technologies in accordance with the terms of the License
Agreement and amendment. In consideration, the Company agreed to pay to the University a royalty payment of 2.5% of net
sales of any product based on the Technologies. If the Company elects to sublicense any rights under the License Agreement and
amendment, the Company agrees to pay to the University 10% of any up-front sub-license fees for any sub-licenses that occurred
on or after September 9, 2006, and, on behalf of the sub-licensee, 2.5% of net sales by the sub-licensee of all products based
on the Technologies. The Company had no sales revenue for the year ended December 31, 2016 and therefore was not subject
to paying any royalties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company fails to provide the University with semi-annual reports on the progress or fails to continue to make reasonable
commercial efforts towards obtaining regulatory approval for products based on the Technologies, the University may convert our
exclusive license into a non-exclusive arrangement. Interest on any amounts owed under the License Agreement and amendment
will be at 3% per annum. All intellectual property rights resulting from the Technologies or improvements thereon will remain
the property of the other inventors and/or Dr. David Lovejoy at the University, and/or the University, as the case may be. The
Company has agreed to pay all out-of-pocket filing, prosecution and maintenance expenses in connection with any patents relating
to the Technologies. In the case of infringement upon any patents relating to the Technologies, the Company may elect, at its
own expense, to bring a cause of action asserting such infringement. In such a case, after deducting any legal expenses the Company
may incur, any settlement proceeds will be subject to the 2.5% royalty payment owed to the University under the License Agreement
and amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent applications were made in the name of Dr. Lovejoy and other inventors, but the Company&rsquo;s exclusive, worldwide rights
to such patent applications are included in the License Agreement and its amendment with the University. The Company maintains
exclusive licensing agreements and it currently controls the six intellectual patent properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sales
and Marketing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have no sales, marketing or distribution capabilities. In order to commercially market PT00114 and any product candidates
we develop in the future, we would either need to develop an internal sales team and marketing department or collaborate with
third parties who have sales and marketing capabilities. As we enter the clinic in 2021, we anticipate working with a Market
Access expert or consultancy to better understand clinician and payor dynamics in the therapeutic areas we are focused on, so
that, as we begin later stage studies, we are working on a deeper commercial assessment in parallel. We have done some high-level
benchmarking of pricing based on the current landscape of approved and available therapies for psychiatric disorders we are targeting,
both in the generics and on-patent realms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pharmaceutical and biotechnology industries are highly competitive and characterized by rapidly evolving technology and intense
research and development efforts. We expect to compete with companies, including major international pharmaceutical companies
and other institutions that have substantially greater financial, research and development, marketing and sales capabilities
and have substantially greater experience in undertaking preclinical and clinical testing of products, obtaining regulatory approvals
and marketing and selling biopharmaceutical products. We will face competition based on, among other things, product efficacy
and safety, the timing and scope of regulatory approvals, product ease of use and price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Despite
a large patient population and current treatments that leave much room for improvement, the developmental pipelines are sparse
and few novel candidates are in development. The serendipitous discoveries of current drug classes, side effects and lack of efficacy
have led to shrinkage or extinction of many pharma or small biotech neuroscience research programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is a discussion of competitive factors for each of the current drug classes commercially available for TRD, and the
competitive advantages that we believe PT00114 may offer. The basis for our beliefs regarding the competitive advantages that
PT00114 may offer over its competitors is our own pre-clinical animal studies. We acknowledge that these beliefs and conclusions
about competitive advantages must be regarded as theoretical until such time as we have human clinical data that supports and
re-affirms the results seen in the pre-clinical animal studies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Opioid
receptor modulators</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opioid
receptor modulators have the potential to be therapeutic drugs for TRD but have a high likelihood of abuse and thus regulatory
restrictions. We believe that our competitive advantage is that PT00114 targets a different receptor system therefore it is not
likely to have a clinical overlap with opioid receptor modulators.</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Atypical
</U></B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Antipsychotics with antidepressant effects (dopamine
receptor modulators</U>)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brexpiprazole
(Rexulti from Otsuka) is a dopamine (D2 receptor) partial stimulator (agonist) approved as an oral adjunctive TRD therapy.
Its side effects include suicidal risk, weight gain and restlessness. Cariprazine (Vraylar from AbbVie) is an oral dopamine
D2 and D3 receptor antagonist approved for schizophrenia and bipolar disorder in development for TRD. The most common side effects
reported were extrapyramidal symptoms, the urge to move (akathisia), indigestion (dyspepsia), vomiting, drowsiness (somnolence)
and restlessness. We believe that our competitive advantage is that PT00114, due to its low toxicity profile, will be clinically
preferable to these antipsychotic drugs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Ketamine
and Esketamine</U></B></FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ketamine
and Esketamine (Spratavo nasal spray from Johnson &amp; Johnson) the S(+) enantiomer of the drug ketamine act primarily as a non-competitive
NMDA receptor antagonist, but is also a dopamine reuptake inhibitor. Although ketamine is used off-label and Esketamine was recently
approved for TRD, limitations and concerns around use limit uptake in a broader population. We believe that our competitive advantage
is that the toxicity profile is likely to be less favorable when compared with PT00114.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>GABA
receptor modulators</U></B></FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GABA
receptors, when bound by inhibitory neurotransmitters found throughout the brain, act as a brake on nerve activity. Sage Therapeutics
is developing multiple compounds that target this mechanism and more candidates are expected to come from this therapeutic class
that may present a competitive challenge for PT00114.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NMDA
receptor modulators</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
N-methyl-D-aspartate (or &ldquo;NMDA&rdquo;) receptor is a molecule that appears on the surface of neurons. When &ldquo;activated&rdquo;
by a drug that binds with it, the NMDA receptor is a potential natural way to counteract TRD. More candidates are expected to
come from this therapeutic class that may present a competitive challenge for PT00114.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PT00114&rsquo;s
Competitive Advantages</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
preclinical data and the corroborated mechanism of action of PT00114 indicates its advantages as compared to current approved
therapies:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
    has a rapid onset of action in animal anxiety and depression models as compared with other TRD drugs</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114&rsquo;s
    effects are long-lasting and potent (single 1-10 nmole/kg dose lasts up to one week for glucose/insulin blood-based biomarkers)
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
    is rapidly cleared (its &ldquo;half-life&rdquo; is 5-10min if given intravenously (IV), 20-30 minutes if given subcutaneously
    (SC) </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
    naturally crosses the blood brain barrier </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
    is an L-isomer, a naturally modified peptide, therefore liver toxicities typically associated with other psychiatric therapies
    are not anticipated</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
    is stable when lyophilized form, making it delivery in an oral or nasal formulation feasible </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-indent: 0; text-align: justify; vertical-align: top; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PT00114
                                         will be manufactured by standard solid phase chemistry, which is less expensive than
                                         manufacturing processes required by other TRD drugs</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; vertical-align: top; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Studies
    have demonstrated that the compound does not caused dependency following multiple administrations</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that patents, trademarks, copyrights and other proprietary rights are important to our business. We also rely on trade
secrets, know-how, continuing technological innovations and licensing opportunities to develop and maintain our competitive position.
We seek to protect our intellectual property rights by a variety of means, including obtaining patents, maintaining trade secrets
and proprietary know-how, and technological innovation to operate without infringing on the proprietary rights of others and to
prevent others from infringing on our proprietary rights. Our policy is to seek to protect our proprietary position by, among
other methods, actively seeking patent protection in the United States and foreign countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 15, 2020, we have four patents issued by the Governments of the United States, Canada, European Union (validated in
Germany, France and Great Britain) and Australia on our original platform technology. The patent applications were made in the
name of Dr. David A. Lovejoy and inventors, but the Company&rsquo;s exclusive, worldwide rights to such patent applications are
included in the License Agreement with UT. We have three further issued patents and 8 pending patent applications in related technology
that the company has rights in or own.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success will depend in part on our ability to maintain our proprietary position through effective patent claims and their enforcement
against our competitors. Although we believe our patent applications provide a competitive advantage, the patent positions of
companies like ours are generally uncertain and involve complex legal and factual questions. We do not know whether any of our
patent applications will result in the issuance of any patents. Those patents that may be issued in the future or those acquired
by us may be challenged, invalidated or circumvented, and the rights granted under any issued patent may not provide us with proprietary
protection or competitive advantages against competitors with similar technology. In particular, we do not know if competitors
will be able to design variations on our treatment methods to circumvent our current and anticipated patent claims. Furthermore,
competitors may independently develop similar technologies or duplicate any technology developed by us. Because of the extensive
time required for the development, testing and regulatory review of a potential product, it is possible that, before any of our
products can be commercialized or marketed, any related patent claim may expire or remain in force for only a short period following
commercialization, thereby reducing the advantage of the patent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely upon trade secrets, confidentiality agreements, proprietary know-how and continuing technological innovation to remain
competitive, especially where we do not believe patent protection is appropriate or obtainable. We continue to seek ways to protect
our proprietary technology and trade secrets, including entering into confidentiality or license agreements with our employees
and consultants, and controlling access to and distribution of our technologies and other proprietary information. While we use
these and other reasonable security measures to protect our trade secrets, our employees or consultants may unintentionally or
willfully disclose our proprietary information to competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
commercial success will depend in part on our ability to operate without infringing upon the patents and proprietary rights of
third parties. It is uncertain whether the issuance of any third-party patents would require us to alter our products or
technology, obtain licenses or cease certain activities. Our failure to obtain a license to technology that we may require to
discover, develop or commercialize our future products may have a material adverse impact on us. One or more third-party patents
or patent applications may conflict with patent applications to which we have rights. Any such conflict may substantially reduce
the coverage of any rights that may issue from the patent applications to which we have rights. If third parties prepare and file
patent applications in the United States that also claim technology to which we have rights, we may have to participate in interference
proceedings in the USPTO to determine priority of invention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may collaborate in the future with other entities on research, development and commercialization activities. Disputes may arise
about inventorship and corresponding rights in know-how and inventions resulting from the joint creation or use of intellectual
property by us and our subsidiaries, collaborators, partners, licensors and consultants. As a result, we may not be able to maintain
our proprietary position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 15, 2020, we own or have rights in the following intellectual property:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">TENEURIN
    C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">AUSTRALIA</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/02/2003</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2003221575</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/23/2011</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2003221575</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CANADA</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/02/2003</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,482,810</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/10/2014</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,482,810</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EUROPEAN PATENT
    (<I>Validated in France (FR), Germany (DE) and Great Britain (GB)</I></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/02/2003</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">03717086.7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/12/2014</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1499635</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">UNITED STATES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/01/2004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10/510,959</FONT></TD><TD STYLE="text-align: left"></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/03/2012</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,088,889</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
                                         METHOD FOR REGULATING NEURITE GROWTH*</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">UNITED STATES</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/19/2012
                                         (Continuation)</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13/527,414</FONT></TD><TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/01/2017</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,718,857</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
                                         METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL
                                         ASSOCIATED PEPTIDE (TCAP)*</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CANADA</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/21/2015</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,955,410</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">GREAT BRITAIN</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/21/2015</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1702638.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/21/2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2543996</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">UNITED STATES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/17/2017</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15/326,735</FONT></TD><TD STYLE="text-align: left"></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/14/2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,617,736</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISSUED</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPOSITIONS,
                                         METHODS AND USES FOR ENHANCING MUSCLE FUNCTION*</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">US</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/25/2019</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16/336,334</FONT></TD><TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CA</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/26/2017</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,038,169</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPOSITIONS,
                                         METHODS AND USES FOR TREATING POST-TRAUMATIC STRESS DISORDER *</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">UNITED STATES</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/10/2020</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16/755,372</FONT></TD><TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CANADA</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/14/2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,079,724</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPOSITIONS,
                                         METHODS AND USES OF A TENEURIN C-TERMINAL ASSOCIATED PEPTIDE-1 (TCAP-1) FOR TREATING
                                         OPIOID ADDICTION</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">COUNTRY</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">FILED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">SERIAL#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ISSUED</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PATENT#</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">STATUS</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CANADA</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/11/2020</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,093,841</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">UNITED STATES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16/980,176</FONT></TD><TD STYLE="text-align: left"></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">EUROPE</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/12/2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19712494.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PENDING</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future we may file additional patent applications based on proprietary formulations and novel compounds in the TCAP family.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>COVID-19</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the World Health Organization (&ldquo;WHO&rdquo;) declared the Covid-19 outbreak to be a global pandemic. In addition
to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions
and volatility in the global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow
the further spread of the disease. Covid-19 and the U.S. response to the pandemic are significantly affecting the economy. There
are no comparable events that provide guidance as to the effect the Covid-19 pandemic may have, and, as a result, the ultimate
effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent of the effects on the economy,
the markets we serve, our business, or our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Properties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not currently own any real property. The Company leases office space for its principal executive office located at
149 Fifth Avenue, Suite 500, New York, New York 10010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Legal
Proceedings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time we may be named in claims arising in the ordinary course of business. Currently, no legal proceedings, government
actions, administrative actions, investigations or claims are pending against us or involve us that, in the opinion of our management,
could reasonably be expected to have a material adverse effect on our business and financial condition.</FONT></P>

<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PTI
Canada was incorporated in 2006 in the Province on Ontario, Canada. PTI Canada is a wholly-owned subsidiary of Protagenic. It
provides operational support and assistance for the implementation of corporate and operational activities conducted in Canada.
It also oversees and supports research and development activities conducted under auspices of UT. PTI Canada has three directors:
Garo H. Armen (Chairman), Alexander K. Arrow and Vigen Nazarian. PTI Canada also has one part-time consultant, Robert Ziroyan.
PTI Canada also benefits through tax incentive programs provided by the governments of Canada and the Province of Ontario. We
derived credits from Canadian research and development tax credits for the years ended December 31, 2020 and 2019 of $16,830 and
$23,014, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have two part-time employees. We also engage consultants and temporary employees from time to time to provide services
that relate to our research and development activities as well as for general administrative and accounting services. We believe
that our current personnel are capable of meeting our operating requirements in the near term. We expect that as our business
grows we may hire additional personnel to handle the increased demands on our operations, preclinical and clinical activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
and Available Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal offices are located at 149 Fifth Avenue, New York, New York 10010. Our web address is <I>www.protagenic.com</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
make available, free of charge through our website, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports
on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934,
as amended, as soon as reasonably practicable after we electronically file or furnish such materials to the Securities and Exchange
Commission, or SEC. In addition, you may read and copy any materials we file with the SEC at its Public Reference Room at 100
F Street, NE, Washington, DC 20549, on official business days during the hours of 10:00 am to 3:00 pm. You may obtain information
on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site, <I>www.sec.gov
</I>that contains reports, proxy and information statements, and other information that we file electronically with the SEC. <FONT STYLE="background-color: white">All
statements made in any of our securities filings, including all forward-looking statements or information, are made as of the
date of the document in which the statement is included, and we do not assume or undertake any obligation to update any of those
statements or documents unless we are required to do so by law.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_003"></A>Item
1A. Risk Factors.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>An
investment in our common stock is speculative and illiquid and involves a high degree of risk including the risk of a loss of
your entire investment. You should carefully consider the risks and uncertainties described below and the other information contained
in this report before purchasing shares of our common stock. The risks set forth below are not the only ones facing us.
Additional risks and uncertainties may exist that could also adversely affect our business, operations and prospects. If any of
the following risks actually materialize, our business, financial condition, prospects and/or operations could suffer. In such
event, the value of our common stock could decline, and you could lose all or a substantial portion of the money that you pay
for our common stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Financial Condition and Capital Requirements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Company&rsquo;s financial statements have been prepared on a going concern basis, and do not include adjustments that might be
necessary if the Company is unable to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2020, the Company had incurred
significant operating losses since inception, and continues to generate losses from operations, and has an accumulated deficit
of $17,698,936. These matters raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. The consolidated
financial statements included in this report do not include any adjustments relating to the recoverability and classification
of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going
concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have a history of losses and expect that losses may continue in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have generated net losses since we began operations, including $2,548,735 and $1,750,911 for the years ended December 31, 2020
and December 31, 2019, respectively. As of December 31, 2020, we had an accumulated deficit of $17,698,936. We have no approved
products and have generated no product revenue. We expect that product development, preclinical and clinical programs will increase
losses significantly over the next five years. In order to achieve profitability, we will need to generate significant revenue.
We cannot be certain that we will generate sufficient revenue to achieve profitability. We anticipate that we will continue to
generate operating losses and negative cash flow from operations and our current cash position is sufficient to fund our current
business plan at least until the second quarter of 2024. We cannot be certain that we will ever achieve, or if achieved, maintain
profitability. If our revenue grows at a slower rate than we anticipate or if our product development, marketing and operating
expenses exceed our expectations or cannot be adjusted accordingly, our business, results of operation and financial condition
will be materially adversely affected, and we may be unable to continue operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not be able to generate product revenue unless and until one of our product candidates successfully completes clinical trials
and receives regulatory approval. As our most advanced product candidates are at an early proof-of-concept stage, we do not expect
to receive revenue from any product candidate for the foreseeable future. We may seek to obtain revenue from collaboration or
licensing agreements with third parties. We currently have no such agreements which will provide us with material, ongoing future
revenue and we may never enter into any such agreements. Even if we eventually generate revenues, we may never be profitable,
and if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
need to obtain financing in order to continue our operations</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
a prospective basis, we will require both short-term financing for operations and long-term capital to fund our expected growth.
We have no existing bank lines of credit and have not established any definitive sources for additional financing. Additional
financing may not be available to us, or if available, then it may not be available upon terms and conditions acceptable to us.
If adequate funds are not available, then we may be required to delay, reduce or eliminate product development or clinical programs.
Our inability to take advantage of opportunities in the industry because of capital constraints may have a material adverse effect
on our business and our prospects. If we fail to obtain the capital necessary to fund our operations, we will be unable to advance
our development programs and complete our clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our research and development expenses could exceed our current expectations. This could occur for many reasons, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">some
    or all of our product candidates fail in clinical or preclinical studies and we are forced to seek additional product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    product candidates require more extensive clinical or preclinical testing than we currently expect;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    advance more of our product candidates than expected into costly later stage clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    advance more preclinical product candidates than expected into early stage clinical trials;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are required, or consider it advisable, to acquire or license rights from one or more third parties; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    determine to acquire or license rights to additional product candidates or new technologies.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we expect to seek additional funding through public or private financings, we may not be able to obtain financing on acceptable
terms, or at all. In addition, the terms of our financings may be dilutive to, or otherwise adversely affect, holders of our common
stock. We may also seek additional funds through arrangements with collaborators or other third parties. These arrangements would
generally require us to relinquish rights to some of our technologies, product candidates or products, and we may not be able
to enter into such agreements, on acceptable terms, if at all. If we are unable to obtain additional funding on a timely basis,
we may be required to curtail or terminate some or all of our development programs, including some or all of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we continue to incur operating losses and fail to obtain the capital necessary to fund our operations, we will be unable to advance
our development programs, complete our clinical trials, or bring products to market, or may be forced to reduce or cease operations
entirely. In addition, any capital obtained by us may be obtained on terms that are unfavorable to us, our investors, or both.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
a new drug and conducting clinical trials and the regulatory review processes involves substantial costs. We have projected cash
requirements for the near term based on a variety of assumptions, but some or all of such assumptions are likely to be incorrect
and/or incomplete, possibly materially in an adverse direction. Our actual cash needs may deviate materially from those projections,
changes in market conditions or other factors may increase our cash requirements, or we may not be successful even in raising
the amount of cash we currently project will be required for the near term. We will need to raise additional capital in the future;
the amount of additional capital needed will vary as a result of a number of factors, including without limitation the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">receiving
    less funding than we require;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    than expected costs to manufacture our product candidates;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    than expected costs for preclinical testing;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    increase in the number, size, duration, and/or complexity of our clinical trials;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">slower
    than expected progress in developing PT00114, or other product candidates, including without limitation, additional costs
    caused by program delays;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    than expected costs associated with attempting to obtain regulatory approvals, including without limitation additional costs
    caused by additional regulatory requirements or larger clinical trial requirements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    than expected personnel, consulting or other costs, such as adding personnel or industry expert consultants or pursuing the
    licensing/acquisition of additional assets; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    than expected costs to protect our intellectual property portfolio or otherwise pursue our intellectual property strategy.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
we attempt to raise additional financing, there can be no assurance that we will be able to secure such additional financing in
sufficient quantities or at all. We may be unable to raise additional capital for reasons including, without limitation, our operational
and/or financial performance, investor confidence in us and the biopharmaceutical industry, credit availability from banks and
other financial institutions, the status of current projects, and our prospects for obtaining any necessary regulatory approvals.
Potential investors&rsquo; capital investments may have shifted to other opportunities with perceived greater returns and/or lower
risk thereby reducing capital available to us, if available at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any additional financing might not be available, and even if available, may not be available on terms favorable to us
or our then-existing investors. We will seek to raise funds through public or private equity offerings, debt financings, corporate
collaboration or licensing arrangements, mergers, acquisitions, sales of intellectual property, or other financing vehicles or
arrangements. To the extent that we raise additional capital by issuing equity securities or other securities, our then-existing
investors will experience dilution. If we raise funds through debt financings or bank loans, we may become subject to restrictive
covenants, our assets may be pledged as collateral for the debt, and the interests of our then-existing investors would be subordinated
to the debt holders or banks. In addition, our use of and ability to exploit assets pledged as collateral for debt or loans may
be restricted or forfeited. To the extent that we raise additional funds through collaboration or licensing arrangements, we may
be required to relinquish significant rights (including without limitation intellectual property rights) to our technologies or
product candidates, or grant licenses on terms that are not favorable to us. If we are not able to raise needed funding under
acceptable terms or at all, then we will have to reduce expenses, including the possible options of curtailing operations, abandoning
opportunities, licensing or selling off assets, reducing costs to a point where clinical development or other progress is impaired,
or ceasing operations entirely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have a limited operating history, expect to incur significant operating losses, and have a high risk of never being profitable.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
commenced operations in February 2016 through a reverse merger and have a limited operating history of less than five years. Therefore,
there is limited historical financial or operational information upon which to evaluate our performance. Our prospects must be
considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early
stages of operations. Many if not most companies in our industry at our stage of development never become profitable and are acquired
or go out of business before successfully developing any product that generates revenue from commercial sales or enables profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we have incurred an accumulated deficit of $17,698,936. We expect to continue to incur substantial operating
losses over the next several years for the clinical development of our current and future licensed or purchased product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of future losses and when, if ever, we will become profitable are uncertain. We do not have any products that have generated
any revenues from commercial sales, and do not expect to generate revenues from the commercial sale of products in the near future,
if ever. Our ability to generate revenue and achieve profitability will depend on, among other things, successful completion of
the development of our product candidates; obtaining necessary regulatory approvals from the FDA and international regulatory
agencies; establishing manufacturing, sales, and marketing arrangements with third parties; obtaining adequate reimbursement by
third-party payers; and raising sufficient funds to finance our activities. If we are unsuccessful at some or all of these undertakings,
our business, financial condition, and results of operations are expected to be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a recently established public reporting company, we are subject to SEC reporting and other requirements, which will lead to increased
operating costs in order to meet these requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Unstable
market and economic conditions may have serious adverse consequences on our ability to raise funds, which may cause us to cease
or delay our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, global and domestic credit and financial markets have experienced extreme disruptions, including severely diminished
liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates,
and uncertainty about economic stability. Our financing strategy will be adversely affected by any such economic downturn, volatile
business environment and continued unpredictable and unstable market conditions. If the equity and credit markets deteriorate,
it may make a debt or equity financing more difficult to complete, costlier, and more dilutive. Failure to secure any necessary
financing in a timely manner and on favorable terms will have a material adverse effect on our business strategy and financial
performance, and could require us to cease or delay our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
financial and operating performance may be adversely affected by the coronavirus pandemic.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recent outbreak of a strain of coronavirus (Covid-19) in the U.S. has had an unfavorable impact on our business operations. Mandatory
closures of businesses imposed by the federal, state and local governments to control the spread of the virus is disrupting the
operations of our management, business and finance teams. In addition, the Covid-19 outbreak has adversely affected the U.S. economy
and financial markets, which may result in a long-term economic downturn that could negatively affect future performance. The
extent to which Covid-19 will impact our business and our consolidated financial results will depend on future developments which
are highly uncertain and cannot be predicted at the time of the filing of this Form 10-K, but is expected to result in a material
adverse impact on our business, results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Covid-19
could adversely impact our business, including our clinical trials, and financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to risks related to public health crises such as the global pandemic associated with Covid-19. In December 2019, a
novel strain of coronavirus, was reported to have surfaced in Wuhan, China. Since then, Covid-19 has spread to most countries
and all 50 states within the United States, including countries and states in which we have planned or active clinical trial sites.
As Covid-19 continues to spread around the globe, we have and/or will likely experience disruptions that could severely impact
our business and clinical trials, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 87pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or difficulties in enrolling patients in our clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">`</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical
    site staff;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
    of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical
    trial sites and hospital staff supporting the conduct of our clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
    of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel imposed or recommended
    by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures,
    the occurrence of which could affect the integrity of clinical trial data;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk
    that participants enrolled in our clinical trials will acquire Covid-19 while the clinical trial is ongoing, which could impact
    the results of the clinical trial, including by increasing the number of observed adverse events;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitations
    in employee resources that would otherwise be focused on the conduct of our clinical trials, including because of sickness
    of employees or their families or the desire of employees to avoid contact with large groups of people;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in receiving authorizations from local regulatory authorities to initiate our planned clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in clinical sites receiving the supplies and materials needed to conduct our clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
    in global shipping that may affect the transport of clinical trial materials, such as investigational drug product used in
    our clinical trials;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in local regulations as part of a response to the Covid-19 pandemic which may require us to change the ways in which our clinical
    trials are conducted, which may result in unexpected costs, or to discontinue the clinical trials altogether;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruptions
    or delays in preclinical studies due to restricted or limited operations at our research and development laboratory facilities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations
    in employee resources or forced furlough of government employees; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    of the FDA to accept data from clinical trials in affected geographies outside the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerous
state and local jurisdictions have imposed, and others in the future may impose, &ldquo;shelter-in-place&rdquo; orders, quarantines,
executive orders and similar government orders and restrictions for their residents to control the spread of Covid-19. Starting
in mid-March 2020, the governor of New York, where our corporate operations are based, issued &ldquo;shelter-in-place&rdquo; or
&ldquo;stay at home&rdquo; orders restricting non-essential activities, travel and business operations for an indefinite period
of time, subject to certain exceptions for necessary activities. Similar orders and restrictions have been imposed in California
and Massachusetts, and such orders or restrictions have resulted in our office closing, work stoppages, slowdowns and delays,
travel restrictions and cancellation of events, among other effects, thereby negatively impacting our operations. In addition,
even after the &ldquo;shelter-in-place&rdquo; orders, quarantines, executive orders and similar government orders and restrictions
for their residents to control the spread of Covid-19 are lifted, we may continue to experience disruptions to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global pandemic of Covid-19 continues to rapidly evolve. The extent to which Covid-19 may impact our business, including our clinical
trials, and financial condition will depend on future developments, which are highly uncertain and cannot be predicted with confidence,
such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing
in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in
the United States and other countries to contain and treat the disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Clinical Development and Regulatory Approval</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
results to date provide no basis for predicting whether any of our product candidates will be safe or effective, or receive regulatory
approval</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company&rsquo;s proprietary portfolio of five new neuropeptide hormones are in various stages of research and preclinical evaluation
and their risk of failure is high. It is impossible to predict when or if any of our neuropeptide hormones will prove effective
or safe in humans or will receive regulatory approval. These compounds may not demonstrate in patients the chemical and pharmacological
properties ascribed to them in laboratory studies, and they may interact with human biological systems or other drugs in unforeseen,
ineffective or harmful ways. If we are unable to discover or successfully develop drugs that are effective and safe in humans,
we will not have a viable business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to initiate and complete preclinical studies and clinical trials for our product candidates which could adversely
affect our business</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
must successfully initiate and complete extensive preclinical studies and clinical trials for our product candidates before we
can receive regulatory approval. Preclinical studies and clinical trials are expensive and will take several years to complete
and may not yield results that support further clinical development or product approvals. Conducting clinical studies for any
of our drug candidates for approval in the United States requires filing an IND and reaching agreement with the FDA on clinical
protocols, finding appropriate clinical sites and clinical investigators, securing approvals for such studies from the independent
review board at each such site, manufacturing clinical quantities of drug candidates, supplying drug product to clinical sites
and enrolling sufficient numbers of participants. We cannot guarantee that we will be able to successfully accomplish all of the
activities necessary to initiate and complete clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result, our preclinical studies and clinical trials may be extended, delayed or terminated, and we may be unable to obtain regulatory
approvals or successfully commercialize our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
drug development and approval process is uncertain, time-consuming and expensive.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
process of obtaining and maintaining regulatory approvals for new therapeutic products is lengthy, expensive and uncertain. It
also can vary substantially based on the type, complexity, and novelty of the product. We must provide the FDA and foreign regulatory
authorities with preclinical and clinical data demonstrating that our products are safe and effective before they can be approved
for commercial sale. Clinical development, including preclinical testing, is a long, expensive and uncertain process. It may take
us several years to complete our testing, and failure can occur at any stage of testing. Any preclinical or clinical test may
fail to produce results satisfactory to the FDA. Preclinical and clinical data can be interpreted in different ways, which could
delay, limit or prevent regulatory approval. Negative or inconclusive results from a preclinical study or clinical trial, adverse
medical events during a clinical trial or safety issues resulting from products of the same class of drug could cause a preclinical
study or clinical trial to be repeated or a program to be terminated, even if other studies or trials relating to the program
are successful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
regulatory approval process is costly and lengthy and we may not be able to successfully obtain all required regulatory approvals</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
preclinical development, clinical trials, manufacturing, marketing and labeling of pharmaceuticals are all subject to extensive
regulation by numerous governmental authorities and agencies in the United States and other countries. We must obtain regulatory
approval for each of our product candidates before marketing or selling any of them. It is not possible to predict how long the
approval processes of the FDA or any other applicable federal or foreign regulatory authority or agency for any of our products
will take or whether any such approvals ultimately will be granted. The FDA and foreign regulatory agencies have substantial discretion
in the drug approval process, and positive results in preclinical testing or early phases of clinical studies offer no assurance
of success in later phases of the approval process. Generally, preclinical and clinical testing of products can take many years
and require the expenditure of substantial resources, and the data obtained from these tests and trials can be susceptible to
varying interpretations that could delay, limit or prevent regulatory approval. If we encounter significant delays in the regulatory
process that result in excessive costs, this may prevent us from continuing to develop our product candidates. Any delay in obtaining,
or failure to obtain, approvals could adversely affect the marketing of our products and our ability to generate product revenue.
The risks associated with the approval process include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of our product candidates to meet a regulatory agency&rsquo;s requirements for safety, efficacy and quality; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limitation
    on the indicated uses for which a product may be marketed; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unforeseen
    safety issues or side effects; and </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">governmental
    or regulatory delays and changes in regulatory requirements and guidelines.</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
    </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Even
if we receive regulatory approvals for marketing our product candidates, if we fail to comply with continuing regulatory requirements,
we could lose our regulatory approvals, and our business would be adversely affected</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
FDA continues to review products even after they receive initial approval. If we receive approval to commercialize any product
candidates, the manufacturing, marketing and sale of these drugs will be subject to continuing regulation, including compliance
with quality systems regulations, good manufacturing practices, adverse event requirements, and prohibitions on promoting a product
for unapproved uses. Enforcement actions resulting from our failure to comply with government and regulatory requirements could
result in fines, suspension of approvals, withdrawal of approvals, product recalls, product seizures, mandatory operating restrictions,
criminal prosecution, civil penalties and other actions that could impair the manufacturing, marketing and sale of our potential
products and our ability to conduct our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Even
if we are able to obtain regulatory approvals for any of our product candidates, if they exhibit harmful side effects after approval,
our regulatory approvals could be revoked or otherwise negatively impacted, and we could be subject to costly and damaging product
liability claims.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Even
if we receive regulatory approval for our product candidates, we will have tested them in only a small number of patients during
our clinical trials. If our applications for marketing are approved and more patients begin to use our product, new risks and
side effects associated with our products may be discovered. As a result, regulatory authorities may revoke their approvals; we
may be required to conduct additional clinical trials, make changes in labeling of our product, reformulate our product or make
changes and obtain new approvals for our and our suppliers&rsquo; manufacturing facilities. We might have to withdraw or recall
our products from the marketplace. We may also experience a significant drop in the potential sales of our product if and when
regulatory approvals for such product are obtained, experience harm to our reputation in the marketplace or become subject to
lawsuits, including class actions. Any of these results could decrease or prevent any sales of our approved product or substantially
increase the costs and expenses of commercializing and marketing our product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we experience delays or difficulties in the enrollment of subjects to our clinical trials, our receipt of necessary regulatory
approvals could be delayed or prevented, which could materially affect our financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Identifying,
screening and enrolling patients to participate in clinical trials of our product candidates is critical to our success, and we
may not be able to identify, recruit, enroll and dose a sufficient number of patients with the required or desired characteristics
to complete our clinical trials in a timely manner. The timing of our clinical trials depends on our ability to recruit patients
to participate as well as to subsequently dose these patients and complete required follow-up periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, we may experience enrollment delays related to increased or unforeseen regulatory, legal and logistical requirements
at certain clinical trial sites. These delays could be caused by reviews by regulatory authorities and contractual discussions
with individual clinical trial sites. Any delays in enrolling and/or dosing patients in our planned clinical trials could result
in increased costs, delays in advancing our product candidates, delays in testing the effectiveness of our product candidates
or in termination of the clinical trials altogether.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patient
enrollment may be affected if our competitors have ongoing clinical trials with products for the same indications as our product
candidates, and patients who would otherwise be eligible for our clinical trials instead enroll in our competitors&rsquo; clinical
trials. Patient enrollment may also be affected by other factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">coordination
    with clinical research organizations to enroll and administer the clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">coordination
    and recruitment of collaborators and investigators at individual sites;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">size of the patient
    population and process for identifying patients;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">design of the
    clinical trial protocol;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">eligibility and
    exclusion criteria;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perceived risks
    and benefits of the product candidates under study;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability
    of competing commercially available therapies and other competing products&rsquo; clinical trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">time of year
    in which the trials are initiated or conducted;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">severity of the
    diseases under investigation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability to obtain
    and maintain subject consents;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability to enroll
    and treat patients in a timely manner;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">risk that enrolled
    subjects will drop out before completion of the trials;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">proximity and
    availability of clinical trial sites for prospective patients;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ability to monitor
    subjects adequately during and after treatment; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient referral
    practices of physicians.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
inability to enroll a sufficient number of patients for clinical trials would result in significant delays and could require us
to abandon one or more clinical trials altogether. Enrollment delays in these clinical trials may result in increased development
costs for our product candidates, which could materially affect our financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>New
federal laws or regulations on drug importation could make lower cost versions of our future products available, which could adversely
affect our revenues, if any</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
prices of some drugs are lower in other countries than in the United States because of government regulation and market conditions.
Under current law, importation of drugs into the United States is generally not permitted unless the drugs are approved in the
United States and the entity that holds that approval consents to the importation. Various proposals have been advanced to permit
the importation of drugs from other countries to provide lower cost alternatives to the products available in the United States.
In addition, the MMA requires the Secretary of Health and Human Services to promulgate regulations for drug re-importation from
Canada into the United States under some circumstances, including when the drugs are sold at a lower price than in the United
States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the laws or regulations are changed to permit the importation of drugs into the United States in circumstances that are currently
not permitted, such a change could have an adverse effect on our business by making available lower priced alternatives to our
future products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Failure
to obtain regulatory and pricing approvals in foreign jurisdictions could delay or prevent commercialization of our products abroad</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we succeed in developing any products, we intend to market them in the European Union and other foreign jurisdictions. In order
to do so, we must obtain separate regulatory approvals and comply with numerous and varying regulatory requirements. The approval
procedure varies among countries and can involve additional testing. The time required to obtain approval abroad may differ from
that required to obtain FDA approval. The foreign regulatory approval process may include all of the risks associated with obtaining
FDA approval and additional risks associated with requirements particular to those foreign jurisdictions where we will seek regulatory
approval of our products. We may not obtain foreign regulatory approvals on a timely basis, if at all. Approval by the FDA does
not ensure approval by regulatory authorities in other countries, and approval by one foreign regulatory authority does not ensure
approval by regulatory authorities in other foreign countries or by the FDA. We and our collaborators may not be able to file
for regulatory approvals and may not receive necessary approvals to commercialize our products in any market outside the United
States. The failure to obtain these approvals could materially adversely affect our business, financial condition and results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>It
is uncertain whether product liability insurance will be adequate to address product liability claims, or that insurance against
such claims will be affordable or available on acceptable terms in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clinical
research involves the testing of new drugs on human volunteers pursuant to a clinical trial protocol. Such testing involves a
risk of liability for personal injury to or death of patients due to, among other causes, adverse side effects, improper administration
of the new drug, or improper volunteer behavior. Claims may arise from patients, clinical trial volunteers, consumers, physicians,
hospitals, companies, institutions, researchers, or others using, selling, or buying our products, as well as from governmental
bodies. In addition, product liability and related risks are likely to increase over time, in particular upon the commercialization
or marketing of any products by us or parties with which we enter into development, marketing, or distribution collaborations.
Although we are contracting for general liability insurance in connection with our ongoing business, there can be no assurance
that the amount and scope of such insurance coverage will be appropriate and sufficient in the event any claims arise, that we
will be able to secure additional coverage should we attempt to do so, or that our insurers would not contest or refuse any attempt
by us to collect on such insurance policies. Furthermore, there can be no assurance that suitable product liability insurance
(at the clinical stage and/or commercial stage) will continue to be available on terms acceptable to us or at all, or that, if
obtained, the insurance coverage will be appropriate and sufficient to cover any potential claims or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
the market opportunities for our current and potential future drug candidates are smaller than we believe they are, our ability
to generate product revenues will be adversely affected and our business may suffer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
understanding of the number of people who suffer from stress-related indications, including, but not limited to: treatment resistant
depression (&ldquo;TRD&rdquo;), which is a subgroup of major depressive disorder (&ldquo;MDD&rdquo;); addiction, recidivism, or
substance use disorder (&ldquo;SUD&rdquo;); anxiety, including generalized anxiety disorder (&ldquo;GAD&rdquo;), and post-traumatic
stress disorder (&ldquo;PTSD&rdquo;) is based upon estimates. These estimates may prove to be incorrect, and new studies may demonstrate
or suggest a lower estimated incidence or prevalence of this condition. The number of patients in the U.S. or elsewhere may turn
out to be lower than expected, may not be otherwise amenable to PT00114 treatment, or treatment-amenable patients may become increasingly
difficult to identify and access, all of which would adversely affect our business prospects and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Reliance on Third Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to obtain and maintain the third party relationships that are necessary to develop, commercialize and manufacture
some or all of our product candidates</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
expect to depend on collaborators, partners, licensees, clinical research organizations, manufacturers and other third parties
to support our discovery efforts, to formulate product candidates, to conduct clinical trials for some or all of our product candidates,
to manufacture clinical and commercial scale quantities of our product candidates and products and to market, sell, and distribute
any products we successfully develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
cannot guarantee that we will be able to successfully negotiate agreements for or maintain relationships with collaborators, partners,
licensees, clinical investigators, manufacturers and other third parties on favorable terms, if at all. If we are unable to obtain
or maintain these agreements, we may not be able to clinically develop, formulate, manufacture, obtain regulatory approvals for
or commercialize our product candidates, which will in turn adversely affect our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
expect to expend substantial management time and effort to enter into relationships with third parties and, if we successfully
enter into such relationships, to manage these relationships. In addition, substantial amounts of our expenditures will be paid
to third parties in these relationships. However, we cannot control the amount or timing of resources our contract partners will
devote to our research and development programs, product candidates or potential product candidates, and we cannot guarantee that
these parties will fulfill their obligations to us under these arrangements in a timely fashion, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have no experience in sales, marketing and distribution and may have to enter into agreements with third parties to perform these
functions, which could prevent us from successfully commercializing our product candidates</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
currently have no sales, marketing or distribution capabilities. To commercialize our product candidates, we must either develop
our own sales, marketing and distribution capabilities, which will be expensive and time consuming, or make arrangements with
third parties to perform these services for us. If we decide to market any of our products on our own, we will have to commit
significant resources to developing a marketing and sales force and supporting distribution capabilities. If we decide to enter
into arrangements with third parties for performance of these services, we may find that they are not available on terms acceptable
to us, or at all. If we are not able to establish and maintain successful arrangements with third parties or build our own sales
and marketing infrastructure, we may not be able to commercialize our product candidates which would adversely affect our business
and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Data
provided by collaborators and other parties upon which we rely have not been independently verified and could turn out to be inaccurate,
misleading, or incomplete.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
rely on third-party vendors, scientists, and collaborators to provide us with significant data and other information related to
our projects, clinical trials, and business. We do not independently verify or audit all of such data (including possibly material
portions thereof). As a result, such data may be inaccurate, misleading, or incomplete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>In
certain cases, we may need to rely on a single supplier for a particular manufacturing material or service, and any interruption
in or termination of service by such supplier could delay or disrupt the commercialization of our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
rely on third-party suppliers for the materials used to manufacture our compounds. Some of these materials may at times only be
available from one supplier. Any interruption in or termination of service by such single source suppliers could result in a delay
or disruption in manufacturing until we locate an alternative source of supply. There can be no assurance that we would be successful
in locating an alternative source of supply or in negotiating acceptable terms with such prospective supplier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
rely on third parties to conduct our non-clinical studies and our clinical trials. If these third parties do not successfully
carry out their contractual duties or meet expected deadlines, we may be unable to obtain regulatory approval for or commercialize
our current product candidates or any future products, on a timely basis or at all, and our financial condition will be adversely
affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
do not have the ability to independently conduct non-clinical studies and clinical trials. We rely on medical institutions, clinical
investigators, contract laboratories, collaborative partners and other third parties, such as contract research organizations
or clinical research organizations, to conduct non-clinical studies and clinical trials on our product candidates. The third parties
with whom we contract for execution of our non-clinical studies and clinical trials play a significant role in the conduct of
these studies and trials and the subsequent collection and analysis of data. However, these third parties are not our employees,
and except for contractual duties and obligations, we have limited ability to control the amount or timing of resources that they
devote to our programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
we rely on third parties to conduct our non-clinical studies and clinical trials, we remain responsible for ensuring that each
of our non-clinical studies and clinical trials is conducted in accordance with its investigational plan and protocol. Moreover,
the FDA, EMA and other foreign regulatory authorities require us to comply with regulations and standards, including some regulations
commonly referred to as good clinical practices (&ldquo;GCPs&rdquo;), for conducting, monitoring, recording and reporting the
results of clinical trials to ensure that the data and results are scientifically credible and accurate, and that the trial subjects
are adequately informed of the potential risks of participating in clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, the execution of non-clinical studies and clinical trials, and the subsequent compilation and analyses of the data produced,
requires coordination among various parties. In order for these functions to be carried out effectively and efficiently, it is
imperative that these parties communicate and coordinate with one another. Moreover, these third parties may also have relationships
with other commercial entities, some of which may compete with us. Under certain circumstances, these third parties may be able
to terminate their agreements with us upon short notice. If the third parties conducting our clinical trials do not perform their
contractual duties or obligations, experience work stoppages, do not meet expected deadlines, terminate their agreements with
us or need to be replaced, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to
adhere to our clinical trial protocols or GCPs, or for any other reason, we may need to enter into new arrangements with alternative
third parties, which could be difficult, costly or impossible, and our clinical trials may be extended, delayed or terminated
or may need to be repeated. If any of the foregoing were to occur, we may not be able to obtain, on a timely basis or at all,
regulatory approval for or to commercialize the product candidate being tested in such trials, and as a result, our financial
condition will be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Commercialization of Our Product Candidates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have no experience as a company in commercializing any product. If we fail to obtain commercial expertise, upon product approval
by regulatory agencies, our product launch and revenues could be delayed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a company, we have never obtained regulatory approval for, or commercialized, any product. Accordingly, we have not yet begun
to build out any sales or marketing capabilities. If we are unable to establish, or contract for, effective sales and marketing
capabilities, or if we are unable to enter into agreements with third parties to commercialize our product candidates on favorable
terms or on any reasonable terms at all, we may not be able to effectively generate product revenues once our product candidates
are approved for marketing. If we fail to obtain commercial expertise or capabilities, upon drug approval, our product launch
and subsequent revenues could be delayed and /or fail to reach their commercial potential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to gain market acceptance of our product candidates, which would prevent us from becoming profitable</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
cannot be certain that any of our product candidates will gain market acceptance among physicians, patients, healthcare payers,
pharmaceutical companies or others. Demonstrating the safety and efficacy of our product candidates and obtaining regulatory approvals
will not guarantee future revenue. Sales of medical products largely depend on the reimbursement of patients&rsquo; medical expenses
by government healthcare programs and private health insurers. Governments and private insurers closely examine medical products
to determine whether they should be covered by reimbursement and if so, the level of reimbursement that will apply. We cannot
be certain that third party payers will sufficiently reimburse sales of our products, or enable us to sell our products at profitable
prices. Similar concerns could also limit the reimbursement amounts that health insurers or government agencies in other countries
are prepared to pay for our products. In many countries where we plan to market our products, including Europe and Canada, the
pricing of prescription drugs is controlled by the government or regulatory agencies. Regulatory agencies in these countries could
determine that the pricing for our products should be based on prices of other commercially available drugs for the same disease,
rather than allowing us to market our products at a premium as new drugs. Sales of medical products also depend on physicians&rsquo;
willingness to prescribe the treatment, which is likely to be based on a determination by these physicians that the products are
safe, therapeutically effective and cost-effective. We cannot predict whether physicians, other healthcare providers, government
agencies or private insurers will determine that our products are safe, therapeutically effective and cost effective relative
to competing treatments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to manufacture our product candidates in clinical or commercial quantities, which would prevent us from commercializing
our product candidates</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
date, our product candidates have been manufactured in small quantities by us and third party manufacturers for preclinical studies.
If any of our product candidates is approved by the FDA or other regulatory agencies for commercial sale, we will need to manufacture
it in larger quantities and we intend to use third party manufacturers for commercial quantities. Our third party manufacturers
may not be able to successfully increase the manufacturing capacity for any of our product candidates in a timely or efficient
manner, or at all. If we are unable to successfully increase the manufacturing capacity for a product candidate, the regulatory
approval or commercial launch of that product candidate may be delayed or there may be a shortage in the supply of the product
candidate. Our failure or the failure of our third party manufacturers to comply with the FDA&rsquo;s good manufacturing practices
and to pass inspections of the manufacturing facilities by the FDA or other regulatory agencies could seriously harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
products may not be accepted for reimbursement or properly reimbursed by third-party payers.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
successful commercialization of any products we might develop will depend substantially on whether the costs of our products and
related treatments are reimbursed at acceptable levels by government authorities, private healthcare insurers, and other third-party
payers, such as health maintenance organizations. Reimbursement rates may vary, depending upon the third-party payer, the type
of insurance plan, and other similar or dissimilar factors. If our products do not achieve adequate reimbursement, then the number
of physician prescriptions of our products may not be sufficient to make our products profitable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Comparative
effectiveness research demonstrating benefits of a competitor&rsquo;s product could adversely affect the sales of our product
candidates. If third-party payers do not consider our products to be cost-effective compared to other available therapies, they
may not cover our products as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow
us to sell our products on a profitable basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adequate
third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return
on our investment in the product development of that product. In addition, in the U.S. there is a growing emphasis on comparative
effectiveness research, both by private payers and by government agencies. To the extent other drugs or therapies are found to
be more effective than our products, payers may elect to cover such therapies in lieu of our products or reimburse our products
at a lower rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>New
federal legislation may increase the pressure to reduce prices of pharmaceutical products paid for by Medicare, which could adversely
affect our revenues, if any</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Medicare Prescription Drug Improvement and Modernization Act of 2003, or MMA, expanded Medicare coverage for drug purchases by
the elderly and disabled beginning in 2006. The new legislation uses formularies, preferred drug lists and similar mechanisms
that may limit the number of drugs that will be covered in any therapeutic class or reduce the reimbursement for some of the drugs
in a class. More recently, the Patient Protection and Affordable Care Act of 2010 also contained certain provisions with the potential
to affect pricing of pharmaceutical products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result of the expansion of legislation, including recent healthcare insurance legislation, and the expansion of federal coverage
of drug products, we expect that there will be additional pressure to contain and reduce costs. These cost reduction initiatives
could decrease the coverage and price that we receive for our products in the future and could seriously harm our business. While
the MMA applies only to drug benefits for Medicare beneficiaries, private payers often follow Medicare coverage policy and payment
limitations in setting their own reimbursement systems, and any limits on or reductions in reimbursement that occur in the Medicare
program may result in similar limits on or reductions in payments from private payers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Disputes
under key agreements or conflicts of interest with our scientific advisors or clinical investigators could delay or prevent development
or commercialization of our product candidates</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
agreements we have or may enter into with third parties, such as collaboration, license, formulation supplier, manufacturing,
clinical research organization or clinical trial agreements, may give rise to disputes regarding the rights and obligations of
the parties. Disagreements could develop over rights to ownership or use of intellectual property, the scope and direction of
research and development, the approach for regulatory approvals or commercialization strategy. We intend to conduct research programs
in a range of therapeutic areas, but our pursuit of these opportunities could result in conflicts with the other parties to these
agreements who may be developing or selling pharmaceuticals or conducting other activities in these same therapeutic areas. Any
disputes or commercial conflicts could lead to the termination of our agreements, delay progress of our product development programs,
compromise our ability to renew agreements or obtain future agreements, lead to the loss of intellectual property rights or result
in costly litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
collaborate with outside scientific advisors and collaborators at academic and other institutions that assist us in our research
and development efforts. Our scientific advisors are not our employees and may have other commitments that limit their availability
to us. If a conflict of interest between their work for us and their work for another entity arises, we may lose their services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
competitors and potential competitors may develop products and technologies that make ours less attractive or obsolete</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Many
companies, universities, and research organizations developing competing product candidates have greater resources and significantly
greater experience in financial, research and development, manufacturing, marketing, sales, distribution, and technical regulatory
matters than we have. In addition, many competitors have greater name recognition and more extensive collaborative relationships.
Our competitors could commence and complete clinical testing of their product candidates, obtain regulatory approvals, and begin
commercial-scale manufacturing of their products faster than we are able to for our products. They could develop products that
would render our product candidates, and those of our collaborators, obsolete and noncompetitive. If we are unable to compete
effectively against these companies, then we may not be able to commercialize our product candidates or achieve a competitive
position in the market. This would adversely affect our ability to generate revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Competition
in the biotechnology and pharmaceutical industries may result in competing products, superior marketing of other products and
lower revenues or profits for us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are many companies that are seeking to develop products and therapies for the treatment of mood, anxiety and neurodegenerative
disorders. Many of our competitors have substantially greater financial, technical, human and other resources than we do and may
be better equipped to develop, manufacture and market technologically superior products. In addition, many of these competitors
have significantly greater experience than we do in undertaking preclinical testing and human clinical studies of new pharmaceutical
products and in obtaining regulatory approvals of human therapeutic products. Accordingly, our competitors may succeed in obtaining
FDA approval for superior products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
risks and uncertainties include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to successfully complete preclinical and clinical development of our products and services </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to manufacture sufficient amounts of products for development and commercialization activities </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain, maintain and successfully enforce adequate patent and other proprietary rights protection of our products
    and services </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    scope, validity and enforceability of patents and other proprietary rights held by third parties and their impact on our ability
    to commercialize our products and services </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accuracy of our estimates of the size and characteristics of the markets to be addressed by our products and services, including
    growth projections </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
    acceptance of our products and services </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to identify new patients for our products and services </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accuracy of our information regarding the products and resources of our competitors and potential competitors </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    content and timing of submissions to and decisions made by the US Food and Drug Administration (FDA) and other regulatory
    agencies</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain reimbursement for our products and services from third-party payors, and the extent of such coverage </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to establish and maintain strategic license, collaboration and distribution arrangements </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    continued funding of our collaborations and joint ventures, if any are ultimately established </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possible disruption of our operations due to terrorist activities and armed conflict, including as a result of the disruption
    of operation of our subsidiaries and our customers, suppliers, distributors, couriers, collaborative partners, licensees and
    clinical trial sites. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Positive
or timely results from preclinical studies and early clinical trials do not ensure positive or timely results in late-stage clinical
trials or product approval by the FDA or any other regulatory authority. Product candidates that show positive preclinical or
early clinical results often fail in later stage clinical trials. Data obtained from preclinical and clinical activities is susceptible
to varying interpretations, which could delay, limit, or prevent regulatory approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have limited experience in conducting the clinical trials required to obtain regulatory approval. We may not be able to conduct
clinical trials at preferred sites, enlist clinical investigators, enroll sufficient numbers of participants, or begin or successfully
complete clinical trials in a timely fashion, if at all. Any failure to perform may delay or terminate the trials. Our current
clinical trials may be insufficient to demonstrate that our potential products will be active, safe, or effective. Additional
clinical trials may be required if clinical trial results are negative or inconclusive, which will require us to incur additional
costs and significant delays. If we do not receive the necessary regulatory approvals, we will not be able to generate product
revenues and may not become profitable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Intellectual Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to maintain our exclusive worldwide license to use and develop PT00114 which could materially affect our business
plan</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On
July 21, 2005, we entered into the License Agreement with University of Toronto, or UT, pursuant to which UT agreed to license
to us patent rights and other intellectual property related to PT00114, among other things. The Technology License Agreement was
amended on February 18, 2015. Unless earlier terminated, the term of this agreement shall terminate on the expiration or invalidity
of the last issued Patent in the Agreement<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the License Agreement, we obtained an exclusive worldwide license to make, have made, use, sell and import products based upon
the Technologies, or to sublicense the Technologies in accordance with the terms of the License Agreement. In the event we fail
to provide UT with semi-annual reports on our progress or fail to continue to make reasonable commercial efforts towards obtaining
regulatory approval for products based on the Technologies, UT may convert our exclusive license into a non-exclusive one. In
such a case, we would lose our competitive advantage in the development of treatments based on PT00114.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have to sustain and further build our intellectual property rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we fail to sustain and further build our intellectual property rights, competitors will be able to take advantage of our research
and development efforts to develop competing products. If we are not able to protect our proprietary technology, trade secrets,
and know-how, our competitors may use our inventions to develop competing products. Protagenic has obtained worldwide exclusive
rights to PT00114 and related technology that was developed at UT. The Company currently has four patents issued by the Governments
of the United States, Canada, European Union and Australia. As of December 15, 2020, we have four patents issued by the Governments
of the United States, Canada, European Union (validated in Germany, France and Great Britain) and Australia on our original platform
technology The patent applications were made in the name of Dr. David A. Lovejoy and inventors, but the Company&rsquo;s exclusive,
worldwide rights to such patent applications are included in the License Agreement with UT. We have three further issued patents
and eight pending patent applications in related technology that the company has rights in or own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">However,
our patents and patent applications, even if granted, may not protect us against our competitors. Our patent positions, and those
of other pharmaceutical and biotechnology companies, are generally uncertain and involve complex legal, scientific and factual
questions. The standards which the United States Patent and Trademark Office uses to grant patents, and the standards which courts
use to interpret patents, are not always applied predictably or uniformly and can change, particularly as new technologies develop.
Consequently, the level of protection, if any, that will be provided by our patents if we attempt to enforce them, and they are
challenged, is uncertain. In addition, the type and extent of patent claims that will be issued to us in the future is uncertain.
Any patents that are issued may not contain claims that permit us to stop competitors from using similar technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition to our patentable technology, we also rely on unpatented technology, trade secrets, and confidential information. We
may not be able to effectively protect our rights to this technology or information. Other parties may independently develop substantially
equivalent information and techniques or otherwise gain access to or disclose our technology. We generally require each of our
employees, consultants, collaborators, and certain contractors to execute a confidentiality agreement at the commencement of an
employment, consulting, collaborative, or contractual relationship with us. However, these agreements may not provide effective
protection of our technology or information or, in the event of unauthorized use or disclosure, they may not provide adequate
remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
patent position is generally uncertain and involves complex legal and factual questions. In addition, the laws of some foreign
countries do not protect proprietary rights to the same extent as the laws of the United States, and other biotechnology companies
have encountered significant problems in protecting and defending their proprietary rights in foreign jurisdictions. Whether filed
in the United States or abroad, our patent applications may be challenged or may fail to result in issued patents. In addition,
any future patents we obtain may not be sufficiently broad to prevent others from practicing our technologies or from developing
or commercializing competing products. Furthermore, others may independently develop or commercialize similar or alternative technologies
or drugs, or design around our patents. Our patents may be challenged, invalidated or fail to provide us with any competitive
advantages. We may not have the funds available to protect our patents or other technology; such protection is costly and can
result in further litigation expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we do not obtain or we are unable to maintain adequate patent or trade secret protection for our products in the United States,
competitors could duplicate them without repeating the extensive testing that we will be required to undertake to obtain approval
of the products by the FDA. Regardless of any patent protection, under the current statutory framework the FDA is prohibited by
law from approving any generic version of any of our products for three years after it has approved our product. Upon the expiration
of that period, or if that time period is altered, the FDA could approve a generic version of our product unless we have patent
protection sufficient for us to block that generic version. Without sufficient patent protection, the applicant for a generic
version of our product would be required only to conduct a relatively inexpensive study to show that its product is bioequivalent
to our product and may not have to repeat the studies that we will need to conduct to demonstrate that the product is safe and
effective. In the absence of adequate patent protection in other countries, competitors may similarly be able to obtain regulatory
approval in those countries of products that duplicate our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
have to comply with our obligations in our intellectual property licenses with third parties</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
we fail to comply with our obligations in our intellectual property licenses with third parties, we could lose license rights
that are important to our business<B><I>. </I></B>We are a party to the License Agreement with UT under which we receive the right
to practice and use important third party patent rights. We may enter into additional licenses in the future. Our existing licenses
impose, and we expect future licenses will impose, various diligences, milestone payment, royalty, insurance and other obligations
on us. If we fail to comply with these obligations, the licensor may have the right to terminate the license, in which event we
might not be able to market any product that is covered by the licensed patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may need to resort to litigation to enforce or defend our intellectual property rights, including any patents issued to us. If
a competitor or collaborator files a patent application claiming technology also invented by us, in order to protect our rights,
we may have to participate in an expensive and time consuming interference proceeding before the United States Patent and Trademark
Office. We cannot guarantee that our product candidates will be free of claims by third parties alleging that we have infringed
their intellectual property rights. Third parties may assert that we are employing their proprietary technologies without authorization
and they may resort to litigation to attempt to enforce their rights. Third parties may have or obtain patents in the future and
claim that the use of our technology or any of our product candidates infringes their patents. We may not be able to develop or
commercialize combination product candidates because of patent protection others have. Our business will be harmed if we cannot
obtain a necessary or desirable license, can obtain such a license only on terms we consider to be unattractive or unacceptable,
or if we are unable to redesign our product candidates or processes to avoid actual or potential patent or other intellectual
property infringement. Obtaining, protecting and defending patent and other intellectual property rights can be expensive and
may require us to incur substantial costs, including the diversion of management and technical personnel. An unfavorable ruling
in patent or intellectual property litigation could subject us to significant liabilities to third parties, require us to cease
developing, manufacturing or selling the affected products or using the affected processes, require us to license the disputed
rights from third parties, or result in awards of substantial damages against us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
can be no assurance that we would prevail in any intellectual property infringement action, will be able to obtain a license to
any third party intellectual property on commercially reasonable terms, successfully develop non-infringing alternatives on a
timely basis, or license non-infringing alternatives, if any exist, on commercially reasonable terms. Any significant intellectual
property impediment to our ability to develop and commercialize our products could seriously harm our business and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Patent
litigation or other litigation in connection with our intellectual property rights may lead to publicity that may harm our reputation
and the value of our common stock may decline</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the course of any patent litigation, there may be public announcements of the results of hearings, motions, and other interim
proceedings or developments in the litigation. If securities analysts or investors regard these announcements as negative, the
value of our common stock may decline. General proclamations or statements by key public figures may also have a negative impact
on the perceived value of our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Protecting
and defending against intellectual property claims may have a material adverse effect on our business</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
time to time, we may receive notice that others have infringed on our proprietary rights or that we have infringed on the intellectual
property rights of others. There can be no assurance that infringement or invalidity claims will not materially adversely affect
our business, financial condition or results of operations. Regardless of the validity or the success of the assertion of claims,
we could incur significant costs and diversion of resources in protecting or defending against claims, which could have a material
adverse effect on our business, financial condition or results of operations. We may not have the funds or resources available
to protect our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Intellectual
property disputes could require us to spend time and money to address such disputes and could limit our intellectual property
rights.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
biopharmaceutical industry has been characterized by extensive litigation regarding patents and other intellectual property rights,
and companies have employed intellectual property litigation and USPTO post-grant proceedings to gain a competitive advantage.
We may become subject to infringement claims or litigation arising out of patents and pending applications of our competitors,
or additional interference proceedings declared by the USPTO to determine the priority and patentability of inventions. The defense
and prosecution of intellectual property suits, USPTO proceedings, and related legal and administrative proceedings are costly
and time-consuming to pursue, and their outcome is uncertain. Litigation may be necessary to enforce our issued patents, to protect
our trade secrets and know-how, or to determine the enforceability, scope, and validity of the proprietary rights of others. An
adverse determination in litigation or USPTO post-grant and interference proceedings to which we may become a party could subject
us to significant liabilities, require us to obtain licenses from third parties, or restrict or prevent us from selling our products
in certain markets. Even if a given patent or intellectual property dispute were settled through licensing or similar arrangements,
our costs associated with such arrangements may be substantial and could include the payment by us of large fixed payments and
ongoing royalties. Furthermore, the necessary licenses may not be available on satisfactory terms or at all. Even where we have
meritorious claims or defenses, the costs of litigation may prevent us from pursuing these claims or defenses and/or may require
extensive financial and personnel resources to pursue these claims or defenses. In addition, it is possible there may be defects
of form in our current and future patents that could result in our inability to defend the intended claims. Intellectual property
disputes arising from the aforementioned factors, or other factors, may materially harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to enforce our intellectual property rights throughout the world.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the U.S. Companies
have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions.
The legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual
property protection, especially those relating to life sciences. This could make it difficult for us to stop the infringement
of our patents or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory
licensing laws under which a patent owner must grant licenses to third parties. In addition, many countries limit the enforceability
of patents against third parties, including government agencies or government contractors. In these countries, patents may provide
limited or no benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceedings
to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert
our efforts and attention from other aspects of our business. Furthermore, while we intend to protect our intellectual property
rights in our expected significant markets, we cannot ensure that we will be able to initiate or maintain similar efforts in all
jurisdictions in which we may wish to market PT00114 or any future products. Accordingly, our efforts to protect our intellectual
property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts in the U.S.
and foreign countries may affect our ability to obtain and enforce adequate intellectual property protection for our products
and technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Changes
to the patent law in the U.S. and other jurisdictions could diminish the value of patents in general, thereby impairing our ability
to protect our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents.
Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity. Therefore,
obtaining and enforcing biopharmaceutical patents is costly, time consuming and inherently uncertain. In addition, the U.S. has
recently enacted and is currently implementing wide ranging patent reform legislation. The U.S. Supreme Court has ruled on several
patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening
the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain
patents in the future, this combination of events has created uncertainty with respect to the value of patents once obtained.
Depending on future actions by the U.S. Congress, the federal courts and the USPTO, as well as other jurisdictions around the
world, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new
patents or to enforce our existing patents and patents that we might obtain in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Obtaining
and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other
requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance
with these requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment
and other provisions during the patent process. There are situations in which noncompliance can result in abandonment or lapse
of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such
an event, competitors might be able to enter the market earlier than would otherwise have been the case.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we fail to comply with our obligations under any license, collaboration or other intellectual property-related agreements, we
may be required to pay damages and could lose intellectual property rights that may be necessary for developing, commercializing
and protecting our current or future technologies or drug candidates or we could lose certain rights to grant sublicenses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any
license, collaboration or other intellectual property-related agreements impose, and any future license, collaboration or other
intellectual property-related agreements we enter into are likely to impose, various development, commercialization, funding,
milestone, royalty, diligence, sublicensing, insurance, patent prosecution and enforcement or other obligations on us. If we breach
any of these obligations, or use the intellectual property licensed to us in an unauthorized manner, we may be required to pay
damages and the licensor may have the right to terminate the license. In spite of our best efforts, any of our future licensors
might conclude that we have materially breached our license agreements and might therefore terminate the license agreements, thereby
removing our ability to develop and commercialize products and technologies covered by these license agreements. Any license agreements
we enter into may be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution
of any contract interpretation disagreement that may arise could narrow what we believe to be the scope our rights to the relevant
intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement,
either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may seek to obtain licenses from licensors in the future, however, we may be unable to obtain any such licenses at a reasonable
cost or on reasonable terms, if at all. In addition, if any of our future licensors terminate any such license agreements, such
license termination could result in our inability to develop, manufacture and sell products that are covered by the licensed technology
or could enable a competitor to gain access to the licensed technology. Any of these events could have a material adverse effect
on our competitive position, business, financial condition, results of operations, and ability to achieve profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furthermore,
we may not have the right to control the preparation, filing, prosecution, maintenance, enforcement and defense of patents and
patent applications that we license from third parties. Therefore, we cannot be certain that these patents and patent applications
will be prepared, filed, prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business.
If our future licensors fail to prosecute, maintain, enforce and defend patents we may in-license, or lose rights to licensed
patents or patent applications, our license rights may be reduced or eliminated. In such circumstances, our right to develop and
commercialize any of our products or drug candidates that is the subject of such licensed rights could be materially adversely
affected. In certain circumstances, our licensed patent rights are subject to our reimbursing our licensors for their patent prosecution
and maintenance costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Moreover,
our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to
claims, regardless of their merit, that we are infringing, misappropriating or otherwise violating the licensor&rsquo;s intellectual
property rights and the amount of any damages or future royalty obligations that would result, if any such claims were successful,
would depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if
any. Therefore, even if we successfully develop and commercialize products, due to such obligations, we may be unable to achieve
or maintain profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Related to Our Business Operations and Industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we are not able to retain our current senior management team and our scientific advisors or continue to attract and retain qualified
scientific, technical and business personnel, our business will suffer</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are dependent on the members of our management team and our scientific advisors for our business success. An important element
of our strategy is to take advantage of the research and development expertise of our current management and to utilize the unique
expertise of our scientific advisors. We do not have any employment agreements with our executive officers. The loss of any one
of our executive officers or key scientific consultants, including, in particular, Garo Armen, Ph.D., Chairman of the Board, and
Dr. David A. Lovejoy, our Chief Scientific Advisor, could result in a significant loss in the knowledge and experience that we,
as an organization, possess and could cause significant delays, or outright failure, in the development and further commercialization
of our product candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
grow, we will eventually need to hire a significant number of qualified commercial, scientific and administrative personnel. However,
there is intense competition for human resources, including management in the technical fields in which we operate, and we may
not be able to attract and retain qualified personnel necessary for the successful development and commercialization of our product
candidates. Our inability to attract new employees or to retain existing employees could limit our growth and harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may encounter difficulties in managing our growth, which could adversely affect our operations</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems,
and operational, financial, and management controls. We may not be able to implement improvements in an efficient or timely manner
and may discover deficiencies in existing systems and controls. If we do not meet these challenges, we may be unable to take advantage
of market opportunities, execute our business strategies or respond to competitive pressures which in turn may slow our growth
or give rise to inefficiencies that would increase our losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may acquire additional technology and complementary businesses in the future. Acquisitions involve many risks, any one of which
could materially harm our business, including the diversion of management&rsquo;s attention from core business concerns, failure
to exploit acquired technologies, or the loss of key employees from either our business or the acquired business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Healthcare
reform measures could adversely affect our business</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
efforts of governmental and third-party payers to contain or reduce the costs of healthcare may adversely affect the business
and financial condition of pharmaceutical companies. In the United States and in foreign jurisdictions there have been, and we
expect that there will continue to be, a number of legislative and regulatory proposals aimed at changing the healthcare system.
For example, in some countries other than the United States, pricing of prescription drugs is subject to government control, and
we expect proposals to implement similar controls in the United States to continue. The pendency or approval of such proposals
could result in a decrease in our common stock value or limit our ability to raise capital or to enter into collaborations or
license rights to our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
business and operations are vulnerable to computer system failures, cyber-attacks or deficiencies in our cyber-security, which
could increase our expenses, divert the attention of our management and key personnel away from our business operations and adversely
affect our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Despite
the implementation of security measures, our internal computer systems, and those of third parties on which we rely, are to damage
from: computer viruses; malware; natural disasters; terrorism; war; telecommunication and electrical failures; cyber-attacks or
cyber-intrusions over the Internet; attachments to emails; persons inside our organization; or persons with access to systems
inside our organization. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including
by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity and sophistication
of attempted attacks and intrusions from around the world have increased. If such an event were to occur and cause interruptions
in our operations, it could result in a material disruption of our product development programs. For example, the loss of clinical
trial data from completed or ongoing or planned clinical trials could result in delays in our regulatory approval efforts and
significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach was to
result in a loss of or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information,
we could incur material legal claims and liability, and damage to our reputation, and the further development of our product candidates
could be delayed. We could be forced to expend significant resources in response to a cyber security breach, including repairing
system damage, increasing cyber security protection costs by deploying additional personnel and protection technologies, paying
regulatory fines and resolving legal claims and regulatory actions, all of which would increase our expenses, divert the attention
of our management and key personnel away from our business operations and adversely affect our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Failure
to comply with health and data protection laws and regulations could lead to government enforcement actions (which could include
civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
and our current and any of our future collaborators may be subject to federal, state and foreign data protection laws and regulations
(i.e., laws and regulations that address privacy and data security). In the U.S., numerous federal and state laws and regulations,
including federal health information privacy laws (e.g., the Health Insurance Portability and Accountability Act (&ldquo;HIPAA&rdquo;),
as amended by the Health Information Technology for Economic and Clinical Health Act (&ldquo;HITECH&rdquo;)), state data breach
notification laws, state health information privacy laws and federal and state consumer protection laws (e.g., Section 5 of the
Federal Trade Commission Act), that govern the collection, use, disclosure and protection of health-related and other personal
information could apply to our operations or the operations of our collaborators. In addition, we may obtain health information
from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and
security requirements under HIPAA, as amended by HITECH, or other privacy and data security laws. Depending on the facts and circumstances,
we could be subject to criminal penalties if we knowingly obtain, use, or disclose individually identifiable health information
maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">International
data protection laws, including Regulation 2016/679, known as the General Data Protection Regulation (&ldquo;GDPR&rdquo;) may
also apply to health-related and other personal information obtained outside of the U.S. The GDPR went into effect on May 25,
2018. The GDPR introduced new data protection requirements in the EU, as well as potential fines for non-compliant companies of
up to the greater of &euro;20 million or 4% of annual global revenue. The regulation imposes numerous new requirements for the
collection, use, storage and disclosure of personal information, including more stringent requirements relating to consent and
the information that must be shared with data subjects about how their personal information is used, the obligation to notify
regulators and affected individuals of personal data breaches, extensive new internal privacy governance obligations and obligations
to honor expanded rights of individuals in relation to their personal information (e.g., the right to access, correct and delete
their data). In addition, the GDPR includes restrictions on cross-border data transfers. The GDPR increased our responsibility
and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required
to put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Further,
the United Kingdom&rsquo;s vote in favor of exiting the EU, often referred to as Brexit, has created uncertainty with regard to
data protection regulation in the United Kingdom. In particular, it is unclear how data transfers to and from the United Kingdom
will be regulated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, California recently enacted the California Consumer Privacy Act (&ldquo;CCPA&rdquo;), which creates new individual privacy
rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling
personal data of consumers or households. The CCPA will require covered companies to provide new disclosure to consumers about
such companies&rsquo; data collection, use and sharing practices, provide such consumers new ways to opt-out of certain sales
or transfers of personal information, and provide consumers with additional causes of action. The CCPA goes into effect on January
1, 2020, and the California Attorney General may bring enforcement actions for violations beginning July 1, 2020. The CCPA was
amended on September 23, 2018, and it remains unclear what, if any, further modifications will be made to this legislation or
how it will be interpreted. As currently written, the CCPA may impact our business activities and exemplifies the vulnerability
of our business to the evolving regulatory environment related to personal data and protected health information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compliance
with U.S. and international data protection laws and regulations could require us to take on more onerous obligations in our contracts,
restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions.
Failure to comply with U.S. and international data protection laws and regulations could result in government enforcement actions
(which could include civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating
results and business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we, our CROs or our IT vendors experience security or data privacy breaches or other unauthorized or improper access to, use of,
or destruction of personal data, we may face costs, significant liabilities, harm to our brand and business disruption.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with our drug research and development efforts, we or our CROs may collect and use a variety of personal data, such
as names, mailing addresses, email addresses, phone numbers and clinical trial information. Although we have extensive measures
in place to prevent the sharing and loss of patient data in our clinical trial processes associated with our developed technologies
and drug candidates, any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our
clinical data or patients&rsquo; personal data could result in significant liability under state (e.g., state breach notification
laws), federal (e.g., HIPAA, as amended by HITECH), and international laws (e.g., the GDPR). Any failure to prevent or mitigate
security breaches or improper access to, use of, or disclosure of our clinical data or patients&rsquo; personal data may cause
a material adverse impact to our reputation, affect our ability to conduct new studies and potentially disrupt our business. We
may also rely on third-party IT vendors to host or otherwise process some of our data and that of users, and any failure by such
IT vendor to prevent or mitigate security breaches or improper access to or disclosure of such information could have similarly
adverse consequences for us. If we are unable to prevent or mitigate the impact of such security or data privacy breaches, we
could be exposed to litigation and governmental investigations, which could lead to a potential disruption to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we do not comply with laws regulating the protection of the environment and health and human safety, our business could be adversely
affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
research and development and drug candidates and future commercial manufacturing may involve the use of hazardous materials and
various chemicals. We currently do not maintain a research laboratory, but we engage third-party research organizations and manufacturers
to conduct our preclinical studies, clinical trials and manufacturing. These third-party laboratories and manufacturers are subject
to federal, state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous
materials. We must rely on the third parties&rsquo; procedures for storing, handling and disposing of these materials in their
facilities to comply with the relevant guidelines of the states in which they operate and the Occupational Safety and Health Administration
of the U.S. Department of Labor. Although we believe that their safety procedures for handling and disposing of these materials
comply with the standards mandated by applicable regulations, the risk of accidental contamination or injury from these materials
cannot be eliminated. If an accident occurs, this could result in significant delays in our development. We are also subject to
numerous environmental, health and workplace safety laws and regulations. Although we maintain workers&rsquo; compensation insurance
to cover us for costs and expenses we may incur due to injuries to our employees, this insurance may not provide adequate coverage
against potential liabilities. Additional federal, state and local laws and regulations affecting our operations may be adopted
in the future. We may incur substantial costs to comply with, and substantial fines or penalties if we violate, any of these laws
or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Risks
Associated to our Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
common stock is a &ldquo;Penny Stock&rdquo; subject to specific rules governing its sale to investors that could impact its liquidity.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
SEC has adopted Rule 15g-9 which establishes the definition of a &ldquo;penny stock,&rdquo; for the purposes relevant to our common
stock, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00
per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require that a
broker or dealer approve a person&rsquo;s account for transactions in penny stocks; and the broker or dealer receive from the
investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
order to approve a person&rsquo;s account for transactions in penny stocks, the broker or dealer must obtain financial information
and investment experience objectives of the person; and make a reasonable determination that the transactions in penny stocks
are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating
the risks of transactions in penny stocks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form sets forth the basis on which the broker or dealer made the suitability determination,
and states that the broker or dealer received a signed, written agreement from the investor prior to the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Generally,
brokers may be less willing to execute transactions in securities subject to the &ldquo;penny stock&rdquo; rules. This may make
it more difficult for investors sell shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the
rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to
be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny
stocks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There
is no recent trading activity in our common stock and there is no assurance that an active market will develop in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Although
our common stock is currently quoted on the OTCQB (an interdealer electronic quotation system operated by OTC Markets Group, Inc.)
under the symbol &ldquo;PTIX&rdquo;, trading of our common stock may be extremely sporadic. For example, several days may pass
before any shares may be traded. As a result, an investor may find it difficult to dispose of, or to obtain accurate quotations
of the price of our common stock. There can be no assurance that a more active market for our common stock will develop, or if
one should develop, there is no assurance that it will be sustained. This severely limits the liquidity of our common stock, and
would likely have a material adverse effect on the market price of our common stock and on our ability to raise additional capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
ability to list on Nasdaq will require raising significant capital; failure to qualify to trade on Nasdaq will make it more difficult
to raise capital.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have applied to list our common stock on The Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;), a national securities exchange. If
we are listed on Nasdaq, we will need to raise significant additional funding in the coming months to start our clinical trial
programs. We believe that if our stock is trading on Nasdaq&rsquo;s Capital Market it will enable better access to capital. Nasdaq
has listing requirements for inclusion of securities for trading on the Nasdaq Capital Market, including stockholders equity of
$4 million (market value standard) or $5 million (equity standard), market value of publicly held shares of $15 million, an operating
history of 2 years under the equity standard or a market value of listed securities of $50 million under the market value standard,
1 million publicly held shares, 300 shareholders, three market makers and a $4 bid price or a closing price of $3 (equity standard)
or $2 (market value standard). If we are unable to maintain our listing on Nasdaq, it could make it harder for us to raise capital
in both the immediate time frame and in the long-term. If we are unable to raise capital when needed in the future, we may have
to cease or reduce operations. There can be no assurance that we will be successful in including our common stock for trading
on Nasdaq, maintain the listing or that a market will develop for our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a de-listing of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
after qualifying for initial listing on Nasdaq, we fail to satisfy the continued listing requirements of The Nasdaq Capital Market,
such as the corporate governance requirements or the minimum closing bid price requirement, the Nasdaq Stock Market may take steps
to de-list our common stock. Such a de-listing or the announcement of such de-listing will have a negative effect on the price
of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of
a de-listing, we would take actions to restore our compliance with the Nasdaq listing requirements, but we can provide no assurance
that any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the
liquidity of our common stock, prevent our common stock from dropping below the Nasdaq minimum bid price requirement or prevent
future non-compliance with the Nasdaq listing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
market price of our common stock may be volatile, and you could lose all or part of your investment</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
market price of our common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various
factors, some of which are beyond our control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
market price of our common stock may fluctuate substantially and will depend on a number of factors many of which are beyond our
control and may not be related to our operating performance. These fluctuations could cause you to lose all or part of your investment
in our common stock since you might be unable to sell your shares at or above the price you pay for the shares. Factors that could
cause fluctuations in the market price of our common stock include, but are not necessarily limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
    and volume fluctuations in the overall stock market from time to time; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">volatility
    in the market prices and trading volumes of pharmaceutical and biotechnology stocks; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in operating performance and stock market valuations of other pharmaceutical and biotechnology companies generally, or those
    in our industry in particular; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of shares of our common stock by us or our stockholders; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow our company,
    or our failure to meet these estimates or the expectations of investors; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
    </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of new products or services; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    public&rsquo;s reaction to our press releases, other public announcements and filings with the SEC; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rumors
    and market speculation involving us or other companies in our industry; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated changes in our operating results or fluctuations in our operating results; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated developments in our business, our competitors&rsquo; businesses or the competitive landscape generally; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
    involving us, our industry or both, or investigations by regulators into our operations or those of our competitors; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
    or disputes concerning our intellectual property or other proprietary rights; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announced
    or completed acquisitions of businesses or technologies by us or our competitors; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new
    laws or regulations or new interpretations of existing laws or regulations applicable to our business; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting standards, policies, guidelines, interpretations or principles; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    significant change in our management; and </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions and slow or negative growth of our markets. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, in the past, following periods of volatility in the overall market and the market price of a particular company&rsquo;s
securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted
against us, could result in substantial costs and a diversion of our management&rsquo;s attention and resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Compliance
with the reporting requirements of federal securities laws can be expensive.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are a public reporting company in the United States, and accordingly, subject to the information and reporting requirements of
the Exchange Act and other federal securities laws, and certain compliance obligations of the Sarbanes-Oxley Act. The costs of
preparing and filing annual and quarterly reports and other information with the SEC and furnishing audited reports to stockholders
are substantial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Applicable
regulatory requirements, including those contained in and issued under the Sarbanes-Oxley Act of 2002, may make it difficult for
us to retain or attract qualified officers and directors, which could adversely affect the management of its business and its
ability to obtain or retain listing of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
may be unable to attract and retain those qualified officers, directors and members of board committees required to provide for
effective management because of the rules and regulations that govern publicly held companies, including, but not limited to,
certifications by principal executive officers. The enactment of the Sarbanes-Oxley Act has resulted in the issuance of a series
of related rules and regulations and the strengthening of existing rules and regulations by the SEC, as well as the adoption of
new and more stringent rules by the stock exchanges. The perceived increased personal risk associated with these changes may deter
qualified individuals from accepting roles as directors and executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Further,
some of these changes heighten the requirements for board or committee membership, particularly with respect to an individual&rsquo;s
independence from the corporation and level of experience in finance and accounting matters. We may have difficulty attracting
and retaining directors with the requisite qualifications. If we are unable to attract and retain qualified officers and directors,
the management of our business and our ability to obtain or retain listing of our shares of common stock on any stock exchange
(assuming we elect to seek and are successful in obtaining such listing) could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>If
we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or
detect fraud. Consequently, investors could lose confidence in our financial reporting and this may decrease the trading price
of our stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
must maintain effective internal controls to provide reliable financial reports and detect fraud. We have been assessing our internal
controls to identify areas that need improvement and will continue to monitor internal controls to improve them. Failure to implement
these changes to our internal controls or any others that it identifies as necessary to maintain an effective system of internal
controls could harm our operating results and cause investors to lose confidence in our reported financial information. Any such
loss of confidence would have a negative effect on the trading price of our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Management
has concluded that, during the year-ended December 31, 2020, our internal controls and procedures were not effective to detect
the inappropriate application of U.S. GAAP. Management identified the following material weaknesses set forth below in our internal
control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    lack the necessary corporate accounting resources to maintain adequate segregation of duties; and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    did not perform an effective risk assessment or monitor internal controls over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
price of our common stock may become volatile, which could lead to losses by investors and costly securities litigation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
trading price of our common stock is likely to be highly volatile and could fluctuate in response to factors such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated variations in our operating results; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    of developments by us or our competitors; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    timing of IDE and/or NDA approval, the completion and/or results of our clinical trials;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    actions regarding our products;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption
    of new accounting standards affecting our industry; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key personnel; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
    of new products by us or our competitors; </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our common stock or other securities in the open market; and </FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    events or factors, many of which are beyond our control. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
stock market is subject to significant price and volume fluctuations. In the past, following periods of volatility in the market
price of a company&rsquo;s securities, securities class action litigation has often been initiated against such a company. Litigation
initiated against us, whether or not successful, could result in substantial costs and diversion of our management&rsquo;s attention
and resources, which could harm our business and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Investors
may experience dilution of their ownership interests because of the future issuance of additional shares of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
the future, we may issue additional authorized but previously unissued equity securities, resulting in the dilution of the ownership
interests of our present stockholders. We may also issue additional shares of our common stock or other securities that are convertible
into or exercisable for our common stock in connection with hiring or retaining employees, future acquisitions, future sales of
our securities for capital raising purposes, or for other business purposes and some of these issuances may be at a price (or
exercise prices) below the price at which shares of our common stock is currently quoted on the OTCQB. The future issuance of
any such additional shares of common stock may create downward pressure on the trading price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
common stock is controlled by insiders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
officers and directors beneficially own approximately 26% of our outstanding shares of common stock. Such concentrated control
of our common stock may adversely affect the price of our common stock. Investors who acquire our common stock may have no effective
voice in the management of our operations. Sales by our insiders or affiliates, along with any other market transactions, could
affect the market price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
do not intend to pay dividends for the foreseeable future and may never pay dividends.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have paid no dividends on our common stock to date and it is not anticipated that any dividends will be paid to holders of our
common stock in the foreseeable future. While our future dividend policy will be based on the operating results and capital needs
of our business, it is currently anticipated that any earnings will be retained to finance our future expansion and for the implementation
of our business plan. As an investor, you should take note of the fact that a lack of a dividend can further affect the market
value of our stock, and could significantly affect the value of any investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>There
can be no assurance that we will ever provide liquidity to our investors through a sale of our Company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">While
acquisitions of pharmaceutical companies like ours are not uncommon, potential investors are cautioned that no assurances can
be given that any form of merger, combination, or sale of our Company will take place or that any merger, combination, or sale,
even if consummated, would provide liquidity or a profit for our investors. You should not invest in our Company with the expectation
that we will be able to sell the business in order to provide liquidity or a profit for our investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Our
certificate of incorporation allows for our board to create new series of preferred stock without further approval by our stockholders,
which could adversely affect the rights of the holders of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
board of directors has the authority to issue shares of our preferred stock, with such relative rights and preferences as the
board of directors may determine, without further stockholder approval. As a result, our board of directors could authorize the
issuance of a series of preferred stock that would grant to holders special and unique rights, including without limitation, a
preferred right to our assets upon liquidation, a right to receive dividend payments before dividends are distributed to the holders
of common stock and the right to convert into our common stock at a price more favorable then the price at which you acquired
our common stock. The issuance of any preferred stock could decrease the value of your common stock and relative voting power
of our common stock or result in dilution to our existing stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
addition, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, or DGCL, which may, unless
certain criteria are met, prohibit large stockholders, in particular those owning 15% or more of the voting rights on our common
stock, from engaging in certain business combinations with us for a prescribed period of time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_004"></A>Item
1B. Unresolved Staff Comments.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_005"></A>Item
2. Properties.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company does not currently own any real property. The Company leases office space for its principal executive office located at
149 Fifth Avenue, Suite 500, New York, New York 10010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_006"></A>Item
3. Legal Proceedings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
time to time we may be named in claims arising in the ordinary course of business. As of December 31, 2020, no legal proceedings,
government actions, administrative actions, investigations or claims are pending against us or involve us that, in the opinion
of our management, could reasonably be expected to have a material adverse effect on our business, financial condition, and results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_007"></A>Item
4. Mine Safety Disclosures.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_008"></A>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_009"></A>Item
5. Market for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is currently available for trading in the over-the-counter market and is quoted on the OTCQB under the symbol &ldquo;PTIX.&rdquo;
There has been very limited market for our common stock and trading volume has been negligible. There is no guarantee that an
active trading market will develop in our common stock. The following table sets forth, for the periods indicated and as reported
on the OTC Markets, the high and low bid prices for our common stock. Such quotations reflect inter-dealer prices, without retail
mark-up, markdown or commission and may not necessarily represent actual transactions.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">High</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Low</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 60%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019(1)</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.30</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.40</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.80</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.40</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020(1)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.72</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.16</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.17</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Quarter <B>(1)</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.22</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.05</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    high and low bid prices for this quarter were reported by the OTCQB marketplace. There was negligible trading volume during
    this period.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 17, 2021, there are approximately 331 record holders of our common stock and three holders of our Series B Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividend
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid or declared any cash dividends on our common stock, and we do not anticipate paying any cash dividends on our
common stock in the foreseeable future. We intend to retain all available funds and any future earnings to fund the development
and expansion of our business. Any future determination to pay dividends will be at the discretion of our board of directors and
will depend upon a number of factors, including our results of operations, financial condition, future prospects, contractual
restrictions, restrictions imposed by applicable law and other factors our board of directors deems relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Sales of Unregistered Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<I>2019-2020
Convertible Note Offering</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
November 21, 2019 through July 8, 2020, Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;) entered into a Convertible Note
Purchase Agreement (&ldquo;Purchase Agreement&rdquo;) with accredited investors (the &ldquo;Investors&rdquo;), pursuant to which
the Company issued and sold unsecured convertible promissory notes (collectively, the &ldquo;Notes&rdquo;) to the Investors in
the aggregate principal amount of $1,570,000 (the &ldquo;Convertible Note Offering&rdquo;), as reported in Current Reports
on Form 8-K filed on November 21, 2019, December 4, 2019, December 23, 2019, January 29, 2020, March 3, 2020, May 14, 2020, and
July 8, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 11, 2020, the Company notified investors in a conference call that it was re-opening the convertible note financing, with
identical terms to the previous round, except for the closing date, which has now been set at Friday, August 21<SUP>st</SUP>,
at 5:00 pm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2020, the &ldquo;Company&rdquo; entered into a Convertible Note Purchase Agreement with certain accredited investors,
pursuant to which the Company issued and sold unsecured convertible promissory notes to the Investors in the aggregate principal
amount of $427,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both sets of Notes, the Notes will be due on November 6, 2023 (the &ldquo;Maturity Date&rdquo;) and accrue simple interest at
an annual rate of 6% on the aggregate unconverted and outstanding principal amount, payable annually, beginning October 31, 2020.
The Notes have the same Maturity Date and interest rate as the set of convertible notes with an aggregate principal amount of
$1,570,000 that the Company previously issued and reported in the Current Reports on Form 8-K filed respectively on November 21,
2019, December 4, 2019, December 23, 2019, January 29, 2020, March 3, 2020, May 14, 2020, and July 8, 2020. The Company will pay
(a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the Default Rate, as defined below,
if any) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK
Payment will be preceded by written notice from the Company to each holder of the Notes setting forth in reasonable detail the
amount of such PIK Payment and the principal amount of the Notes following such PIK Payment. The Notes will bear interest at the
rate of 12% per year (the &ldquo;Default Rate&rdquo;) following a Default (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
may convert their Notes (including accrued interest) at their option, in whole or in part, at any time prior to the Maturity Date,
at a conversion price (the &ldquo;Conversion Price&rdquo;) of $1.25 per share of the Company&rsquo;s common stock, par value $0.0001
per share. The Conversion Price is subject to adjustment for any stock dividend, stock split, combination or other similar recapitalization
event. On the Maturity Date, the Company is required to repay the Notes (including accrued interest) in their entirety in cash
or, at its option, in shares of common stock at the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may redeem for cash or shares of common stock all or any portion of the Notes, at its option, on or after November 5,
2021 if the last reported sale price of its common stock has been at least 120% of the Conversion Price then in effect for at
least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the
trading day immediately preceding the date on which it provides notice of redemption. The redemption will be effected at a redemption
price equal to 100% of the outstanding principal amount of the Notes to be redeemed, plus accrued and unpaid interest up to, but
excluding, the redemption date. Any such redemption must be applied ratably among all Convertible Notes in proportion to their
respective outstanding principal balances, plus accrued and unpaid interest. Other than pursuant to this redemption right, the
Company may not pre-pay the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_010"></A>Item
6. Selected Financial Data.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_011"></A>Item
7. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>You
should read the following discussion and analysis of our financial condition and results of operations together with our financial
statements and the related notes included at the end of this report. This discussion and other parts of this report contain forward-looking
statements that involve risks and uncertainties such as statements of our plans, objectives, expectations and intentions. As a
result of many factors, including those factors set forth in the &ldquo;Risk factors&rdquo; section of this report, our actual
results could differ materially from the results described in or implied by the forward-looking statements contained in the following
discussion and analysis.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion and analysis of our financial condition and results of operations are based on Protagenic&rsquo;s financial statements,
which Protagenic has prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial
statements requires Protagenic to make estimates and assumptions that affect the reported amounts of assets and liabilities and
the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues
and expenses during the reporting periods. On an ongoing basis, Protagenic evaluates such estimates and judgments, including those
described in greater detail below. Protagenic bases its estimates on historical experience and on various other factors that Protagenic
believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value
of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under
different assumptions or conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to incur significant expenses and minimal positive net cash flows from operations or negative net cash flows
from operations for the foreseeable future, and those expenses and losses may fluctuate significantly from quarter-to-quarter
and year-to-year. We anticipate that our expenses will fluctuate substantially as we:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
continue our ongoing preclinical studies, clinical trials and our product development activities for our pipeline of product candidates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
seek regulatory approvals for any product candidates that successfully complete clinical trials;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
continue research and preclinical development and initiate clinical trials of our other product candidates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
seek to discover and develop additional product candidates either internally or in partnership with other pharmaceutical companies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
adapt our regulatory compliance efforts to incorporate requirements applicable to marketed products;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
maintain, expand and protect our intellectual property portfolio; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
incur additional legal, accounting and other expenses in operating as a public company.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a development stage company currently performing clinical trials to obtain Food and Drug Administration (&ldquo;FDA&rdquo;)
approval and commercialization of our product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, we incurred a loss from operations of $2,551,611 as compared to $2,086,130 for the year ended
December 31, 2019. The increase in the loss is due to a decrease in research and development expense of $108,150 from $807,947
for the year ended December 31, 2019 to $699,797 for the year ended December 31, 2020, and an increase in general and administrative
expenses of $573,631 from $1,278,183 for the year ended December 31, 2019 to $1,851,814 or the year ended December 31, 2020 due
to an increase in stock compensation expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Going Concern</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continually project anticipated cash requirements, predominantly from the ongoing funding requirements of our neuropeptide drug
development program. The majority of these expenses relate to paying external vendors such as Contract Research Organizations
(CROs) and peptide synthesizer companies. They could also include business combinations, capital expenditures, and new drug development
working capital requirements. As of December 31, 2020, we had cash of $671,091 and working capital of $224,060. The Company currently
has a derivative liability on the books in the amount of $83,670 and we don&rsquo;t expect to settle this liability in cash. Removing
the derivative liability from the working capital calculation would increase our working capital to $307,730. We anticipate further
losses in the development of our business. Based on its current forecast and budget, Management believes that its cash resources
will be sufficient to fund its operations at least until the end of the third quarter of 2021. Absent generation of sufficient
revenue from the execution of the Company&rsquo;s business plan, it will need to obtain debt or equity financing by the third
quarter of 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
activities used $1,348,779 and $487,990 in cash for the years ended December 31, 2020 and 2019, respectively. The use of cash
in operating activities during the year ended December 31, 2020, primarily comprised of $2,548,735 net loss, $1,654,754 in stock
compensation expense, ($248,552) of change in the fair value of the derivative liability since December 31, 2019, a decrease in
prepaid expenses of $164,802, amortization of debt discount of $154,899, and a ($196,629) decrease of accounts payable and accrued
expenses, which included payments to tax penalties, legal and accounting professionals, payments to consultants, and other administrative
expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
activities provided $0 and $250,000 in cash for the years ended December 31, 2020 and 2019, respectively. The cash provided by
investing activities during the year ended December 31, 2019 consisted of $250,000 from the sale of marketable securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
activities provided $1,223,410 and $670,000 in cash for the years ended December 31, 2020 and 2019, respectively. The cash provided
by financing consisted of $1,177,500 in proceeds from convertible notes, $150,000 in proceeds from convertible notes from related
parties, and ($104,090) in payment of debt issuance costs of convertible notes for the year ended December 31, 2020. The cash
provided by financing consisted of $420,000 in proceeds from convertible notes and $250,000 in proceeds from convertible notes
from related parties for the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
Obligations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information concerning the future contractual obligations under our convertible notes at December
31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments
    due by period</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contractual
    obligations</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    than<BR> 1 year</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">1-3
    years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">3-5
    years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">More
    than<BR> 5 years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-Term PIK convertible
    notes payable</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,597,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,597,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-Term
    PIK convertible notes payable&ndash; Related Party</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">400,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">400,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,997,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,997,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business
Overview</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is in its developmental stage, with encouraging but not conclusive evidence that its lead drug candidate, PT00014, may
be effective as an anti-anxiety and/or anti-depression drug. It is focused on confirming the efficacy of this drug candidate,
along with performing the other preclinical steps needed to progress along the pathway to bring this drug candidate into human
clinical trials and eventually, to the global market to provide a new pharmaceutical for patients suffering from anxiety or treatment-resistant
depression.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
anticipate $4,225,000 in capital expenditures in FY 2021 to implement our current plan of operations in connection with the development
of PT00114.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are able to successfully develop our drug, PT00114, and obtain FDA approval, we could then begin marketing and selling it in
the United States and generate revenue. FDA approval to begin commercial sales is the singular gating item that will allow us
to begin generating sales revenue in the U.S., so it will have an enormous impact on our business plan and our financial condition.
It is anticipated that the sale of our drug will allow the Company to generate enough sales revenue to support all of our operations
and to generate a profit. However, given the stage of development, even if FDA Approval is obtained, we do not anticipate generating
any revenue from sales prior to 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Development
Milestones (upcoming developmental milestones)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upcoming
development milestones include confirming efficacy of our lead drug candidate in an animal model in a CRO, conducting toxicology
testing in two animal species, and filing an IND application to begin human clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Human
Resources (current state of employees)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two part-time employees: Garo H. Armen, PhD, the Executive Chairman, and Alexander K. Arrow, MD, the Chief Financial
Officer. The Company also has six paid consultants: Andrew Slee, PhD, Chief Operating Officer, Robert S. Stein, MD, PhD, Chief
Medical Officer, Dalia Barsyte, PhD, Scientific Advisor, David Lovejoy, PhD, Scientific Advisor, and Zack Armen, Strategic Advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financing
&ndash; Capital Needs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the working capital being generated via the Convertible Note Offering, the Company anticipates that
it will need to raise additional capital in the next year or so to support its research and development activities as it prepares
to commence and commences human clinical trials. The Company does not have any commitments for such additional capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Over
the next three years, we currently anticipate capital expenditures of $4,225,00 in 2021, $6,278,000 in 2022, and $12,215,000 in
2023. These expenditures are anticipated to be focused on conducting research and development activities in connection with our
lead drug candidate as well as other potential drug candidates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off
Balance Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no material off-balance sheet arrangements that are likely to have a current or future effect on our financial condition,
changes in financial condition, revenues or expenses, results of operations, liquidity, capital resources, or capital expenditures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
accounting policies and estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo;).
The notes to the consolidated financial statements contained in this Annual Report describe our significant accounting policies
used in the preparation of the consolidated financial statements. The preparation of these financial statements requires us to
make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
periods. Actual results could differ from those estimates. We continually evaluate our critical accounting policies and estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the critical accounting policies listed below reflect significant judgments, estimates and assumptions used in the preparation
of our consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
Currency Translation and Transactions. </I>The assets and liabilities of our foreign subsidiary PTI Canada are translated into
U.S. dollars from the functional currency using the exchange rate in effect at the balance sheets date. Additionally, the accounts
on the statements of operations are translated using exchange rates approximating average rates prevailing during the years. Equity
accounts are translated at historical exchange rates. Translation adjustments that arise from translating its financial statements
from the local currency to the U.S. dollar are accumulated and reflected as a separate component of stockholders&rsquo; equity
(deficit). The current year effects of the transaction adjustments are included on the statement of operations as a realized gain
(loss) on foreign transaction exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Use
of Estimates</I>. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets, liabilities, revenue and expenses as well as the disclosure of contingent assets and
liabilities. Management continually evaluates its estimates and judgments including those related to accruals, contingencies,
valuation allowance for deferred tax assets, and valuation of stock options and warrants. Management bases its estimates and judgments
on historical experience and other factors that are believed to be reasonable in the circumstances. Actual results may differ
from those estimates. Macroeconomic conditions may directly, or indirectly through our business partners and vendors, impact our
financial performance and available resources. Such conditions may, in turn, impact the aforementioned estimates and assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Value Measurements. </I>Accounting Standards Codification ASC 820, &ldquo;Fair Value Measurements and Disclosure,&rdquo; defines
fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy
that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority
to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs
(Level 3).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
three levels are described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 Inputs &ndash; Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 Inputs &ndash; Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable,
either directly or indirectly;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 Inputs &ndash; Unobservable inputs for the asset or liability including significant assumptions of the Company and other market
participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Derivative
Liability.</I></B> The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or
embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4
and 815-40-25. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each
balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability,
the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion,
exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise
or cancellation and then the related fair value is reclassified to equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject
to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative
instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement
of the derivative instrument is expected within 12 months of the balance sheet date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Basic
and Diluted Net (Loss) per Common Share. </I>Basic (loss) per common share is computed by dividing the net (loss) by the
weighted-average number of shares of common stock outstanding for each period. Diluted (loss) per share is computed by
dividing the net (loss) by the weighted-average number of shares of common stock outstanding plus the dilutive effect of
shares issuable through the common stock equivalents. Potentially dilutive securities consisting of options, warrants, and
convertible notes aggregating 11,085,039 as of December 31, 2020, including common shares issuable under the conversion
feature of the preferred shares, options, $1,997,500 worth of convertible Notes, which could convert into 1,598,000 shares of
common stock, and warrants issued in the Private Offering and Convertible Note Offering closings and merger
transactions were not included in the calculation of weighted-average shares of common stock outstanding as they were
determined to be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>COVID-19</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the World Health Organization (&ldquo;WHO&rdquo;) declared the Covid-19 outbreak to be a global pandemic. In addition
to the devastating effects on human life, the pandemic is having a negative ripple effect on the global economy, leading to disruptions
and volatility in the global financial markets. Most U.S. states and many countries have issued policies intended to stop or slow
the further spread of the disease. Covid-19 and the U.S. response to the pandemic are significantly affecting the economy. There
are no comparable events that provide guidance as to the effect the Covid-19 pandemic may have, and, as a result, the ultimate
effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent of the effects on the economy,
the markets we serve, our business, or our operations.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recently
Issued Accounting Pronouncements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_012"></A>Item
7A. Quantitative and Qualitative Disclosures About Market Risk.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_013"></A>Item
8. Financial Statements and Supplementary Data.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
pages F-1 through F-20 following the Exhibit Index of this Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_014"></A>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_015"></A>Item
9A. Controls and Procedures.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Assessment
of the Effectiveness of Internal Controls over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer,
we conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth
by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework published
in 2013. Based on its evaluation, our management concluded that our internal control over financial reporting was not effective
as of the end of the period covered by this Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)
Management&rsquo;s Report on Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable
assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles in the United States of America. Internal control over financial reporting
includes those policies and procedures that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions
of our assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance
with the authorization of management and/or our Board of Directors; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
provide reasonable assurance regarding the prevention or timely detection of any unauthorized acquisition, use or disposition
of our assets that could have a material effect on our financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, management has completed a proper evaluation, risk assessment and monitoring of the Company&rsquo;s internal
controls over financial reporting based on the 2013 Committee of Sponsoring Organizations (COSO) framework. Management concluded
that, during the period covered by this report, our internal controls and procedures were not effective to detect the inappropriate
application of GAAP. Management identified the following material weaknesses and concluded that the internal controls over financial
reporting were not effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    lack the necessary corporate accounting resources to maintain adequate segregation of duties. We currently rely heavily on
    our Executive Chairman, for almost every key financial duty and he has access to materially all of our financial information.
    Such a lack of segregation of duties is typical in a company with limited resources. Although the Company&rsquo;s Executive
    Chairman and Board of Directors review the financial statements and would most likely discover any misappropriation of funds,
    this cannot be assured by the existing system.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limited
    level of multiple reviews in connection with the financial reporting process.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report does not include an attestation report by our independent registered public accounting firm regarding internal control
over financial reporting. As we are neither a large accelerated filer nor an accelerated filer, our management&rsquo;s report
was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission
that permit us to provide only management&rsquo;s report in this annual report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)
Evaluation of Disclosure Controls and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 13a&ndash;15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company&rsquo;s
management, including the Company&rsquo;s Board of Directors, the Chief Executive Officer and the Chief Financial Officer, of
the effectiveness of the Company&rsquo;s disclosure controls and procedures (as defined under Rule 13a&ndash;15(e) under the Exchange
Act) as of the end of the period covered by this Report. Based upon that evaluation, the Company&rsquo;s management concluded
that the Company&rsquo;s disclosure controls and procedures were not effective to ensure that information required to be disclosed
by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and
reported, within the time periods specified in the SEC&rsquo;s rules and forms, and that such information is accumulated and communicated
to the Company&rsquo;s management to allow timely decisions regarding required disclosure due to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack
    of Segregation of Duties; Management is aware that there is a lack of segregation of accounting duties as a result of limited
    personnel.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limited
    level of multiple reviews in connection with the financial reporting process.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended December 31, 2020, the Company analyzed and documenting accounting policies and procedures. In addition, management
implemented certain policies and procedures but concluded that material weaknesses still exist and that such controls are not
effective under the COSO framework.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Limitations
on the Effectiveness of Controls</I>. Our management, including our Chief Executive Officer and Chief Financial Officer, does
not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors
and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance
that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are
resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations
in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud,
if any, within our Company have been detected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)
Changes in Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f))
that occurred during the quarter ended December 31, 2020, that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_016"></A>Item
9B. Other Information.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_017"></A>PART
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_018"></A>Item
10. Directors, Executive Officers and Corporate Governance.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Officers and Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth certain information with respect to our executive officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 58%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position(s)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
    H. Armen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman of the Board of Directors</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    K. Arrow</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    B. Stein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    Chief Medical Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Slee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khalil
    Barrage</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Josh
    Silverman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Corvese</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer
    Buell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Garo
H. Armen, PhD, Executive Chairman,</B> is one of our founders and joined us in September 2004. Dr. Armen is Chairman and Chief
Executive Officer of Agenus Inc., a biotechnology company he co-founded in 1994. From mid-2002 through 2004, he also served as
Chairman of the Board of directors of the biopharmaceutical company Elan Corporation, plc, which he successfully restructured.
Prior to Agenus Inc., Dr. Armen established Armen Partners, a money management firm specializing in biotechnology and pharmaceutical
companies, and was the architect of the widely publicized creation of the Immunex Lederle oncology business in 1993. Earlier,
he was a senior vice president of research at Dean Witter Reynolds, having begun his career on Wall Street as an analyst and investment
banker at EF Hutton. In 2002, Dr. Armen founded the Children of Armenia Fund, a nonprofit organization dedicated to significantly
rebuilding and revitalizing impoverished rural Armenian towns to provide immediate and sustainable benefits to children and youth.
He received the Ellis Island Medal of Honor in 2004 for his humanitarian efforts, and received the Sabin Humanitarian Award from
the Sabin Vaccine Institute in 2006 for his achievements in biotechnology and progressing medical research. Dr. Armen was also
the Ernst &amp; Young 2002 New York City Biotechnology Entrepreneur of the Year, and received a Wings of Hope Award in 2005 from
The Melanoma Research Foundation for his ongoing commitment to the melanoma community. Dr. Armen received a PhD in physical chemistry
from the Graduate Center, City University of New York, after which he worked as a research fellow at Brookhaven National Laboratories
in Long Island, NY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alexander
K. Arrow, M.D., CFA &ndash;Chief Financial Officer</B>. Dr. Arrow became our Chief Financial Officer in February 2016. Dr. Arrow
is the Chief Financial Officer of Carlsmed, Inc, a spinal implant manufacturer whose mission is to improve outcomes and decrease
the cost of healthcare for complex spine surgery and beyond. He serves on the Boards of Zelegent, Inc., a medical device company
selling a minimally-invasive snoring alleviation tool, and Paragonix Technologies, the supplier of the leading solid organ transportation
device. Previously, Dr. Arrow served as a director of Neumedicines, Inc., a company developing protein therapeutics in Oncology,
Hematology and Immunology. Dr. Arrow served as a director and as Chairman of the Audit and Compensation Committees of Biolase,
Inc. (NASDAQ: BIOL) from 2010 through 2014, and served as the President and Chief Operating Officer. Biolase, Inc. is the leading
manufacturer of dental lasers. Before Biolase, he was the Chief Medical and Strategic Officer of Circuit Therapeutics, Inc., in
the field of optogenetics. From 2007 through 2012, Dr. Arrow was the Chief Financial Officer of Arstasis, Inc., a cardiology device
manufacturer. From 2002 to 2007, he headed medical technology equity research at the global investment bank Lazard Capital markets,
LLC. Dr. Arrow spent two years 1999-2001 as Chief Financial Officer of the Patent &amp; License Exchange Inc., and three years
as the life sciences research analyst at Wedbush Morgan Securities. Dr. Arrow received his CFA in 1999. He was awarded an M.D.
from Harvard Medical School in 1996 and a B.A. in Biophysics, <I>magna cum laude</I>, from Cornell University in 1992.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
B. Stein, PhD. MD, Director, Chief Medical Officer</B>, joined us effective the closing of the Merger in February, 2016. Dr. Robert
B. Stein retired as President of R&amp;D at Agenus Inc. in April 2017. He continues as Senior Advisor, R&amp;D for both Agenus,
Inc. and its cell therapy subsidiary AgenTus. Dr. Robert B. Stein lead Agenus&rsquo; Research, Preclinical Development and
Translational Medicine functions. He helps shape clinical development strategy for vaccines and adjuvants. Additionally, he
lead integration of the 4-Antibody, PhosImmune, and Xoma Pilot Plant acquisitions, which includes the company&rsquo;s fully human
antibody drug discovery and optimization technology platform, and portfolio of immune checkpoint antibody programs. Over his 35
years of experience in the biopharmaceutical industry he played a pivotal role in bringing to the market Sustiva<SUP>&reg;</SUP>,
Fablyn<SUP>&reg;</SUP>, Viviant<SUP>&reg;</SUP>, PanRetin<SUP>&reg;</SUP>, TargRetin<SUP>&reg;</SUP>, Promacta<SUP>&reg;</SUP>
and Eliquis<SUP>&reg;</SUP>. Prior to joining Agenus, he held executive management positions at Ligand Pharmaceuticals, DuPont
Merck, Incyte Pharmaceuticals, Roche Palo Alto and KineMed. Dr. Stein began his career at Merck, Sharp and Dohme. He holds an
MD and a PhD in Physiology &amp; Pharmacology from Duke University. Dr. Stein filed a personal voluntary bankruptcy petition under
Chapter 7 in August of 2012 and the bankruptcy was discharged in May 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
Slee, PhD, Chief Operating Officer.</B> Dr. Andy Slee joined us in April 2016. During his 37-year pharmaceutical career, Mr. Slee
has taken several drugs from inception through all their pre-clinical and early clinical testing. During the past 37 years, he
has worked for Preclinical CROs, immune-oncology companies and natural product companies focusing on anti-infectives, cancer,
CNS, diabetes and inflammatory diseases. Spreading his influence beyond a single company, he created and ran his own Contract
Research Organization (CRO), VivoSource Laboratories, which for ten years from 2003 to 2013 provided preclinical proof of concept
catering to biopharmaceutical companies. For the 18 years before that, Mr. Slee shepherded multiple pharma targets in several
therapeutic areas from inception onward at DuPont Pharmaceuticals. He is a graduate of Syracuse University and Leeds University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Khalil
Barrage, Director</B>, joined us in July, 2007. Mr. Khalil Barrage has served as a Managing Director of The Invus Group, LLC since
2003, in charge of the Public Equities Group that he set up in September 2003. Invus manages over $3B of capital, with a primary
focus is on private equity investments, biotechnology and health care. In addition, Invus manages a fund-of-funds liquid alternative
investment and, most recently, the newly established public equities portfolio activity. Mr. Barrage is a value investor. He started
his career in 1988 with The Olayan Group, a multibillion private group. He was in charge of the group&rsquo;s US public equities
portfolio, overseeing more than $2 billion of assets. Mr. Barrage holds a BA from American University of Beirut.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brian
J. Corvese, Director</B>, joined us on July 28, 2017, filling the open board seat vacated by Gregory H. Ekizian. Since 1999, Mr.
Corvese has been the President and Founder of Vencor Capital (&ldquo;Vencor&rdquo;), a private equity firm with telecommunications
and technology investments in the Middle East and Mediterranean regions. Prior to working at Vencor, Mr. Corvese worked on investments
in the U.S. and global equity markets as a Managing Director and partner at Soros Fund Management, the largest hedge fund in the
world at the time. From 1988 to 1996, Mr. Corvese was a partner at Chancellor Capital Management (&ldquo;Chancellor&rdquo;), a
$25 billion money management firm. While at Chancellor, Mr. Corvese was a Portfolio Manager with responsibility for investments
made in basic industries, restructurings, and special situations, corporate governance investments, as well as founded and managed
his own hedge fund. From 1981 to 1988, Mr. Corvese was with Drexel Burnham Lambert (&ldquo;Drexel&rdquo;) as an equity analyst
following the chemical and specialty chemical industries and participated in a significant number of merger and acquisition activities.
While at Drexel, Mr. Corvese was a member of the top chemical and specialty chemical research team, as ranked by Institutional
Investor. Mr. Corvese currently serves on the board of directors of Agenus Inc. and the National Telecommunications Corporation,
based in Cairo, Egypt. Mr. Corvese earned degrees in finance and political science from The University of Rhode Island and attended
New York University Graduate School. With over 30 years of experience in the financial industry, Mr. Corvese brings substantial
financial expertise to our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Joshua
Silverman, Director</B>, Mr. Silverman currently serves as the managing member of Parkfield Funding LLC. Mr. Silverman was the
co-founder, and a principal and managing partner of Iroquois Capital Management, LLC (&ldquo;Iroquois&rdquo;), an investment advisory
firm. Since its inception in 2003 until July 2016, Mr. Silverman served as co-chief investment officer of Iroquois. While at Iroquois,
he designed and executed complex transactions, structuring and negotiating investments in both public and private companies and
has often been called upon by the companies solve inefficiencies as they relate to corporate structure, cash flow, and management.
From 2000 to 2003, Mr. Silverman served as co-chief investment officer of Vertical Ventures, LLC, a merchant bank. Prior to forming
Iroquois, Mr. Silverman was a director of Joele Frank, a boutique consulting firm specializing in mergers and acquisitions. Previously,
Mr. Silverman served as assistant press secretary to the president of the United States. Mr. Silverman currently serves as a director
of Akers Biosciences, Inc., AYRO, Inc., Protagenic Therapeutics, Petros Pharmaceuticals, Inc. and Synaptogenix, Inc. all of which
are public companies. He previously served as a director of National Holdings Corporation from July 2014 through August 2016 and
as a director of Marker Therapeutics, Inc. from August 2016 until October 2018. Mr. Silverman received his B.A. from Lehigh University
in 1992.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jennifer
Buell, PhD, Director</B>, joined our board in July 2020. Dr. Buell is the President and Chief Operating Officer of Agenus, Inc.,
where she has previously served as served as the Head of Global R&amp;D operations, Head of Research, and Chief Communications
and External Affairs Officer. With 20 years of biopharmaceutical R&amp;D experience, Dr. Buell has extensive knowledge in advancing
discovery candidates through development and experience communicating with external stakeholders including regulators, investors,
and collaborators. She has a proven record of success in R&amp;D leadership, most recently at Agenus, where she led high performing
teams in advancing candidates into the clinic and delivered on key alliance collaborations. Prior to joining Agenus, Dr. Buell
held leadership positions in R&amp;D operations at Bristol-Myers Squibb and later was responsible for Program and Alliance Management
at Harvard Clinical Research Institute (Baim), where she was involved in the development strategy and operations for a portfolio
of industry and government sponsored clinical programs. Dr. Buell obtained her PhD in Cellular, Biochemical, and Molecular Biochemistry
with an MS in Biostatistics from Tufts University in Boston.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consultants
and Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
A. Lovejoy, PhD, Scientific Advisor</B>, is one of our founders and joined us in September 2004. He holds a PhD in Neuroendocrinology
from the University of Victoria (Victoria, BC) and spent three years at the Clayton Foundation Laboratories for Peptide Biology
at the Salk Institute (San Diego, CA) as a postdoctoral fellow. Dr. Lovejoy took his first academic appointment at the University
of Manchester (Manchester, UK), one of the United Kingdom&rsquo;s top-ranking research universities. He joined the University
of Toronto (Toronto, Ontario) in 2000 and is currently Professor of Neuroendocrinology in the Department of Cell and Systems Biology
at the University of Toronto. He is the author of more than 210 scientific publications including three books in the field and
an Associate Editor for a scientific journal and is inventor or co-inventor on all of our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dalia
Barsyte PhD, Scientific Advisor.</B> Dr. Dalia Barsyte received her PhD in molecular and cellular biology from the University
of Manchester, UK. She did the postdoctoral training at the University of Manchester and Ontario Cancer Institute, and currently
is a scientist at the University of Toronto, Structural Genomics Consortium, where she has been employed since 2009. Dr. Barsyte
is an inventor on one of the key Protagenic patents and author of over 50 scientific publications in oncology and neuroscience.
Dr. Barsyte&rsquo;s scientific interests include exploring chemical biology in therapeutic target validation through peptide or
small molecule chemical probe compounds as well as novel in vitro models of disease based on patient derived cell culture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Zack
Armen, Strategic Advisor </B>Zack became involved with Protagenic in Fall 2018, and brings experience in strategic finance and
life sciences venture investing to the company through roles at Goldman Sachs, Flagship Pioneering, CiBO Technologies, and his
current role as Director of Corporate Development at Valo Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of Messrs. Corvese, Silverman, and Barrage, and Dr. Buell are &ldquo;independent&rdquo; members of our board of directors as &ldquo;independence&rdquo;
is defined in Nasdaq Marketplace Rule 5605(a)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between or among the directors, executive officers or persons nominated or chosen by our stockholders
or us to become directors or executive officers. There is one family relationship between Strategic Advisor Zack Armen and our
Executive Chairman, Garo Armen (Garo Armen is Zack Armen&rsquo;s father).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 12, 2016, the Company and certain of its stockholders (currently representing approximately 43% of the Company&rsquo;s
issued and outstanding common stock), including Messrs. Armen, Arrow and Ekizian and Strategic Bio Partners, LLC, entered into
a voting agreement whereby these stockholders agreed to vote in favor of setting and maintaining the size of the Board at five
directors (unless increased by the Board), the election of one director designated by Strategic Bio Partners, LLC (Mr. Silverman&rdquo;)
and the election of four directors designated by Mr. Garo (so long as Mr. Garo is an officer or director of the Company). The
voting agreement terminated on February 12, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Involvement
in Certain Legal Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, during the past ten years, none of our directors, executive officers, promoters, control persons, or nominees has:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor
offenses);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">except
as set forth above with respect to Dr. Stein, had any bankruptcy petition filed by or against the business or property of the
person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either
at the time of the bankruptcy filing or within two years prior to that time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction
or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement
in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or
to be associated with persons engaged in any such activity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have
violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">been
the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently
reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged
violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions
or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution,
civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation
prohibiting mail or wire fraud or fraud in connection with any business entity; or been the subject of, or a party to, any sanction
or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26)
of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent
exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2017, we adopted a written Code of Business Conduct and Ethics. Guidelines on Significant Governance Issues, and
Process for Security Holder Communications with Directors, each of which is filed as an exhibit to this annual report.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Committees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has established five standing committees: an Audit Committee, a Compensation Committee, a Nominating and Corporate
Governance Committee, a Science Committee and a Clinical and Regulatory Committee. Each of these committees will operate under
a charter that has been approved by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Committee. </B>The Audit Committee will oversee and monitor our financial reporting process and internal control system, review
and evaluate the audit performed by our registered independent public accountants and reports to the Board any substantive issues
found during the audit. The Audit Committee will be directly responsible for the appointment, compensation and oversight of the
work of our registered independent public accountants. The Audit Committee will review and approve all transactions with affiliated
parties. The Audit Committee shall be comprised on two or more independent directors who shall be appointed annually and subject
to removal by the Board at any time. Each member of the Audit Committee shall meet the independence requirements of The NASDAQ
Stock Market, LLC, and SEC regulations, as well as any other applicable requirements. Messrs. Corvese (Committee Chairperson)
and Barrage comprise the Audit Committee, each of whom meets the independence requirements. In addition, the Board also designated
Brian Corvese as an &ldquo;audit committee financial expert,&rdquo; as that term is defined by the NSADAQ Listing Rules and SEC
regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee. </B>The Compensation Committee will provide advice and make recommendations to the board in the areas of employee salaries,
benefit programs and director compensation. The Compensation Committee will also review the compensation of our President, Chief
Executive Officer, and other officers and make recommendations in that regard to the board as a whole. The Compensation Committee
shall be comprised on three or more directors who shall be appointed annually and subject to removal by the Board at any time.
The Compensation Committee must have at least two members, and must consist solely of independent directors. Messrs. Barrage,
Corvese, and Silverman comprise the Compensation Committee and are all independent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
and Corporate Governance Committee. </B>The Nominating and Corporate Governance Committee will nominate individuals to be elected
to the full board by our stockholders. The Nominating and Corporate Governance Committee will determine the slate of director
nominees for election to the Board, to identify and recommend candidates to fill vacancies occurring between annual stockholder
meetings, to review the Company&rsquo;s policies and programs that relate to matters of corporate responsibility, including public
issues of significance to the Company and its stockholders. The Compensation Committee shall be comprised on three or more directors
who shall be appointed annually and subject to removal by the Board at any time. Each member of the Nominating and Corporate Governance
Committee may or may not meet the independence requirements of The NASDAQ Stock Market, LLC and SEC regulations. Messrs. Silverman
(Committee Chairperson), and Drs. Armen and Stein comprise the Nominating and Corporate Governance Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Science
Committee.</B> The Science Committee will meet regularly to review the strategic direction being taken by Management with respect
to developing the Company&rsquo;s scientific assets. A key function of the Science Committee is to ensure that the Company is
targeting disease indications for its drug candidates that take full advantage of the drug candidates&rsquo; potential, within
the constraints of the working capital available to the Company. This process is expected to continually necessitate difficult
choices concerning how many disease targets to pursue. The Science Committee will be directly responsible for the appointment,
compensation and oversight of the Company&rsquo;s top scientific staff. The Science Committee will review and approve all major
contractual agreements with contract research organizations. The Science Committee shall be comprised on two or more directors
who shall be appointed annually and subject to removal by the Board at any time. Drs. Stein (Committee Chairperson), Armen and
Mr. Silverman comprise the Science Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
and Regulatory Committee: </B>The Clinical and Regulatory committee will meet at least once per year to review progress of the
clinical trial programs of the Company. The Clinical and Regulatory committee was created in July 2020 and Dr. Jennifer Buell
was appointed as its chair.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
of Directors Liability and Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Delaware General Corporation Law authorizes corporations to limit or eliminate, subject to certain conditions, the personal liability
of directors to corporations and their stockholders for monetary damages for breach of their fiduciary duties. Our certificate
of incorporation limits the liability of our directors to the fullest extent permitted by Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have director and officer liability insurance to cover liabilities our directors and officers may incur in connection with their
services to us, including matters arising under the Securities Act. Our certificate of incorporation and bylaws also provide that
we will indemnify our directors and officers who, by reason of the fact that he or she is one of our officers or directors of
our company, is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative related to
their board role with the company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnification agreements with each of our directors and executive officers. It is anticipated that future
directors and officers will enter into an Indemnification Agreement with us in substantially similar form. The Indemnification
Agreement provides, among other things, that we will indemnify and hold harmless each person subject to an Indemnification Agreement
(each, an &ldquo;Indemnified Party&rdquo;) to the fullest extent permitted by applicable law from and against all losses, costs,
liabilities, judgments, penalties, fines, expenses and other matters that may result or arise in connection with such Indemnified
Party serving in his or her capacity as a director of ours or serving at our direction as a director, officer, employee, fiduciary
or agent of another entity. The Indemnification Agreement further provides that, upon an Indemnified Party&rsquo;s request, we
will advance expenses to the Indemnified Party to the fullest extent permitted by applicable law. Pursuant to the Indemnification
Agreement, an Indemnified Party is presumed to be entitled to indemnification and we have the burden of proving otherwise. The
Indemnification Agreement also requires us to maintain in full force and effect directors&rsquo; liability insurance on the terms
described in the Indemnification Agreement. If indemnification under the Indemnification Agreement is unavailable to an Indemnified
Party for any reason, we, in lieu of indemnifying the Indemnified Party, will contribute to any amounts incurred by the Indemnified
Party in connection with any claim relating to an indemnifiable event in such proportion as is deemed fair and reasonable in light
of all of the circumstances to reflect the relative benefits received or relative fault of the parties in connection with such
event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling
persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment of expenses incurred or paid by
a director, officer or controlling person in a successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, we will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to the court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no pending litigation or proceeding involving any of our directors, officers, employees or agents in which indemnification
will be required or permitted. We are not aware of any threatened litigation or proceeding that may result in a claim for such
indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_019"></A>Item
11. Executive Compensation.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding each element of compensation that we paid or awarded to our named executive officers
and for fiscal years ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name and Principal&nbsp;Position</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Salary</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bonus<BR>
    ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    Awards<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option
    Awards<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>&nbsp;</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-Equity
    Incentive Plan Compensation<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-<BR>
    Qualified<BR> Deferred<BR> Compensation<BR> Earnings<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    Other Compensation<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Compensation<BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>&nbsp;</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 29%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Garo H. Armen,</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">411,185</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">411,185</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>&nbsp;</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>&nbsp;</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow,</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38,462</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">564,067</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">602,529</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,094</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81,977</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">91,071</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    use the Black-Scholes option pricing model to value the options granted. On February 13, 2020, Dr. Armen was granted 300,000
    options (exercise price of $1.75/option) under the 2016 Equity Compensation Plan.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    use the Black-Scholes option pricing model to value the options granted. On February 1, 2019, Dr. Arrow was granted 41,667
    options (exercise price of $1.75/option) under the 2016 Equity Compensation Plan in lieu of two months cash salary. On February
    13, 2020, Dr. Arrow was granted 120,000 options (exercise price $1.75/option) under the 2016 Equity Compensation Plan. On
    February 13, 2020, he was granted 187,497 options (exercise price of $1.75/option) in lieu of nine months of cash salary.
    On July 18, 2020, he was granted 124,998 options (exercise price $1.75/option) in lieu of six months of cash salary.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employment
Arrangements with Officers and Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Alexander Arrow, our Chief Financial Officer, receives base compensation of $125,000 per year for his part-time work for us, except
for an 18-month period from February 2019 through August 2020 during which he received zero cash salary and three grants totaling
354,162 options in lieu of cash salary. From 2016 through 2020, cumulatively, Dr. Arrow received 100,000 options under the 2006
Plan and three grants totaling 335,000 incentive options in the aggregate under the 2016 plan with exercise prices of $1.25 and
$1.75 per share. The terms of Dr. Arrow&rsquo;s option grants include full vesting acceleration upon a change of control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consulting
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
Slee, PhD, Chief Operating Officer.</B> In December 2020, we entered into a consulting agreement with Dr. Slee to act as our Chief
Operating Officer. We granted Dr. Slee (i) 100,000 options on April 15, 2016, at an exercise price of $1.25 per option, (ii) 75,000
options on October 16, 2017, at an exercise price of $1.75 per option, (iii) 75,000 options on July 18, 2020, at an exercise price
of $1.25 per option, and (iv) 150,000 options on February 13, 2020, at an exercise price of $1.75 per option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dalia
Barsyte PhD, Scientific Advisor.</B> Our subsidiary, Protagenic Therapeutics Canada (2006) Inc., entered into a consulting agreement
with Dr. Dalia Barsyte. Dr. Barsyte is responsible for overseeing i) design and development of ELISA assays for measuring TCAP,
ii) evaluation of TCAP exposure biomarker assay, iii) development of pipeline peptides, iv) development of clinically compatible
formulations for TCAP, as well as all of the bench research and development of formulation and extraction methods. Her consulting
agreement is effective through December 2017. She is compensated at the rate of up to $3,000 (Canadian) per month, if she works
at least 20 hours on behalf of the Company. As well, we have granted Dr. Barsyte 10,000 shares of our common stock and ten-year
options to purchase 150,000 shares of our common stock. Options to purchase 100,000 shares of common stock, at an exercise price
of $1.00 per share, have fully vested; the options to purchase the remaining 50,000 shares of common stock, at an exercise price
of $1.25 per share, vested in March 2016. On October 16, 2017, we granted Dr. Barsyte another ten-year option to purchase 20,000
shares of our common stock at an exercise price of $1.75 per share. On February 13, 2020, we granted Dr. Barsyte ten-year option
to purchase 10,000 shares of our common stock at an exercise price of $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert
B. Stein, PhD, MD, Director, Chief Medical Officer</B>. We entered into a consulting agreement with Dr. Stein effective January
2015, and amended and restated this consulting agreement in December 2020 to appoint Dr. Stein as our Chief Medical Officer. Dr.
Stein is responsible for providing us with technical and advisory services related to our research and development efforts. On
January 23, 2015, we granted Dr. Stein ten-year options to purchase 200,000 shares of our common stock, at an exercise price of
$1.25 per share (the &ldquo;January Options&rdquo;). The January Options are fully vested. We granted Dr. Stein (i) 40,000 options
on April 15, 2016, at an exercise price of $1.25 per option, (ii) 200,000 options on October 16, 2017, at an exercise price of
$1.75 per option, and (iii) 150,000 options on February 13, 2020, at an exercise price of $1.25 per option, bringing Dr. Stein&rsquo;s
total to 590,000 options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2020 we issued 45,000 options with an exercise price of $1.75 to Dr. Buell for her services on the Board.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going
forward, on April 15 of each fiscal year, we plan to grant each non-employee director an option under the 2016 Plan to purchase
40,000 shares of common stock, as well as an option to purchase 5,000 shares for each committee which they chair. No additional
options shall be granted for serving on a committee without being its chair. All options will be granted at fair market value,
as defined in the 2016 Plan, on the date of grant, and will vest over a three-year period in equal monthly installments. Vesting
will accelerate in certain circumstances, such as a change of control of the Company, and unvested options will terminate upon
the cessation of an individual&rsquo;s service to us as a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-employee
directors may be reimbursed for their reasonable expenses in attending Board and committee meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an amended and restated consulting agreement during fiscal year 2020 with Robert B. Stein, PhD, MD, under which we
issued 150,000 options on February 13, 2020, at an exercise price of $1.25 per option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_020"></A>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Plan
    category</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
                                         of securities<BR>
                                         to be issued upon exercise of outstanding options, warrants and rights</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(b)</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted-average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercise
                                         price of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>outstanding
                                         options,</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>warrants
                                         and rights</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(c)</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
                                         of securities</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>remaining
                                         available for future issuance under equity compensation plans (excluding securities reflected
                                         in column (a)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity compensation plans
    approved by security holders</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,477,685</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.27</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,122,918</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity compensation plans not approved
    by security holders</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,477,685</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.27</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,122,918</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2006
Employee, Director and Consultant Stock Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2016, our stockholders adopted our 2016 Equity Compensation Plan and, as a result, we terminated the 2006 Plan. We will
not grant any further awards under the 2006 Plan. All outstanding grants under the 2006 Plan will continue in effect in accordance
with the terms of the particular grant and the 2006 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the pertinent terms of the 2006 Plan is a summary and is qualified in its entirety by the full text of
the 2006 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Administration</I>.
</B>The administrator (the &ldquo;<B>Administrator</B>&rdquo;) of the 2006 Plan is the Board of Directors, except to the extent
the Board of Directors delegates its authority to the Compensation committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board,
in which case the Committee shall be the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Terms
and Conditions of Options</I>.</B> Options granted under the 2006 Plan may be either &ldquo;incentive stock options&rdquo; that
are intended to meet the requirements of Section 422 of the Code or &ldquo;nonqualified stock options&rdquo; that do not meet
the requirements of Section 422 of the Code. The Administrator will determine the exercise price of options granted under the
2006 Plan. The exercise price of stock options may not be less than the fair market value per share of our common stock on the
date of grant (or 110% of fair market value in the case of incentive stock options granted to a ten-percent stockholder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
on the date of grant the common stock is listed on a stock exchange or national market system, the fair market value will generally
be the closing sale price on the date of grant. If the common stock is not traded on a stock exchange or national market system
on the date of grant, the fair market value will generally be the mean between the bid and the asked price for the common stock
at the close of trading in the over-the-counter market for the trading day on which common stock was traded immediately preceding
the applicable date. If no such prices are available, the fair market value shall be determined in good faith by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
option intended to qualify as an ISO may be exercisable for more than ten years from the date of grant (five years in the case
of an incentive stock option granted to a ten-percent stockholder). Options granted under the 2006 Plan will be exercisable at
such time or times as the Administrator prescribes at the time of grant. No employee may receive incentive stock options that
first become exercisable in any calendar year in an amount exceeding $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the exercise price of an option may be paid (a) in cash or by certified bank check, (b) at the discretion of the Administrator,
through delivery of shares of our common stock held for at least six months having a fair market value equal to the purchase price,
(c) at the discretion of the Administrator, by delivery of the grantee&rsquo;s personal note, for full, partial or no recourse,
bearing interest payable not less than annually at market rate on the date of exercise and at no less than 100% of the applicable
Federal rate, as defined in Section 1274(d) of the Code, with or without the pledge of such shares as collateral, or (d) at the
discretion of the Administrator, in accordance with a cashless exercise program established with a securities brokerage firm,
and approved by the Administrator, or (e) at the discretion of the Administrator, by any combination of the above methods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
option may be transferred other than by will or by the laws of descent and distribution, and during a recipient&rsquo;s lifetime
an option may be exercised only by the recipient. The Administrator will determine the extent to which a holder of a stock option
may exercise the option following termination of service with us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Administrator will determine the extent to which a holder of a stock option may exercise the option following termination of service
with us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Effect
of Certain Corporate Transactions</I>.</B> If the Company is to be consolidated with or acquired by another entity in a merger,
sale of all or substantially all of the Company&rsquo;s assets other than a transaction to merely change the state of incorporation
(a &ldquo;<B>Corporate Transaction</B>&rdquo;), the Administrator or the board of directors of any entity assuming the obligations
of the Company hereunder (the &ldquo;<B>Successor Board</B>&rdquo;), shall, as to outstanding options, either (i) make appropriate
provision for the continuation of such options by substituting on an equitable basis for the Shares then subject to such options;
or (ii) upon written notice to the participants, provide that all options must be exercised (either to the extent then exercisable
or, at the discretion of the Administrator, all options being made fully or partially exercisable), within a specified number
of days of the date of such notice, at the end of which period the options shall terminate; or (iii) terminate all options in
exchange for a cash payment equal to the excess of the fair market value of the shares of common stock subject to such options
(either to the extent then exercisable or, at the discretion of the Administrator, all options being made fully or partially exercisable)
over the exercise price thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Tax
Withholding.</I></B> As and when appropriate, we shall have the right to require each optionee purchasing shares of common stock
and each grantee receiving an award of shares of common stock under the 2006 Plan to pay any federal, state or local taxes required
by law to be withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2016
Equity Compensation Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of the principal terms of the 2016 Plan is a summary and is qualified in its entirety by the full text of
the 2016 Plan.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Administration</I>.
</B>The 2016 Plan is administered by the Compensation Committee of our Board of Directors, provided that the entire Board of Directors
may act in lieu of the Compensation Committee on any matter, subject to certain requirements set forth in the 2016 Plan. The Compensation
Committee may grant options to purchase shares of our common stock, stock appreciation rights, stock units, restricted shares
of our common stock, performance shares, performance units, incentive bonus awards, other cash-based awards and other stock-based
awards. The Compensation Committee also has broad authority to determine the terms and conditions of each option or other kind
of award, and adopt, amend and rescind rules and regulations for the administration of the 2016 Plan. Subject to applicable law,
the Compensation Committee may authorize one or more reporting persons (as defined in the 2016 Plan) or other officers to make
awards (other than awards to reporting persons, or other officers whom the Compensation Committee has specifically authorized
to make awards). No awards may be granted under the 2016 Plan on or after the ten-year anniversary of the adoption of the 2016
Plan by our Board of Directors, but awards granted prior to such tenth anniversary may extend beyond that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Eligibility</I>.
</B>Awards may be granted under the 2016 Plan to any person who is an employee, officer, director, consultant, advisor or other
individual service provider of the Company or any subsidiary, or any person who is determined by the Compensation Committee to
be a prospective employee, officer, director, consultant, advisor or other individual service provider of the Company or any subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shares
Subject to the 2016 Plan</I>.</B> The aggregate number of shares of common stock proposed to be available for issuance in connection
with options and awards granted under the 2016 Plan is 3,000,000 shares. Incentive Stock Options may, but need not be, granted
with respect to all of the shares available for issuance under the 2016 Plan; provided, however, that the maximum aggregate number
of shares of common stock which may be issued in respect of Incentive Stock Options (after giving effect to any increases pursuant
to the &ldquo;evergreen&rdquo; provisions of the 2016 Plan discussed below) shall not exceed 6,000,000 shares, subject to adjustment
in the event of stock, splits and similar transactions. If any award granted under the 2016 Plan payable in shares of common stock
is forfeited, cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being made,
or if shares of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of common
stock as to which such option or award was forfeited, or which were withheld, will be available for future grants under the 2016
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the 2016 Plan contains an &ldquo;evergreen&rdquo; provision allowing for an annual increase in the number of shares
of our common stock available for issuance under the 2016 Plan on January 1 of each year during the period beginning January 1,
2017, and ending on (and including) January 1, 2026. The annual increase in the number of shares shall be equal to (i) five point
five percent (5.5%) of the total number of shares of common stock outstanding on December 31st of the preceding calendar year,
or (ii) with respect to shares of common stock which may be issued under the 2016 Plan other than in respect to Incentive Stock
Options, the difference between (x) eighteen percent (18%) of the total number of shares of common stock outstanding on December
31st of the preceding calendar year, and (y) the total number of shares of common stock reserved under the 2016 Plan on December
31st of such preceding calendar year (including shares subject to outstanding awards, issued pursuant to awards or available for
future awards) if such amount is greater than the amount determined in (i) immediately above; provided, however, that our Board
may act prior to the first day of any calendar year to provide that there shall be no increase such calendar year, or that the
increase shall be a lesser number of shares of common stock than would otherwise occur. On January 1, 2017, 2019, and 2020, each
year 564,378 shares of common stock were added to the 2016 Plan pursuant to this evergreen provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Terms
and Conditions of Options</I>.</B> Options granted under the 2016 Plan may be either &ldquo;incentive stock options&rdquo; that
are intended to meet the requirements of Section 422 of the Code or &ldquo;nonqualified stock options&rdquo; that do not meet
the requirements of Section 422 of the Code. The Compensation Committee will determine the exercise price of options granted under
the 2016 Plan. The exercise price of stock options may not be less than the fair market value, on the date of grant, per share
of our common stock issuable upon exercise of the option (or 110% of fair market value in the case of incentive options granted
to a ten-percent stockholder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
on the date of grant the common stock is listed on a stock exchange or national market system, the fair market value shall generally
be the closing sale price as of such date, or if there were no trades recorded on such date, then the most recent date preceding
such date on which trades were recorded. If on the date of grant the common stock is traded in an over-the-counter market, the
fair market will generally be the average of the closing bid and asked prices for the shares of common stock as of such date,
or, if there are no closing bid and asked prices for the shares of common stock on such date, then the average of the bid and
asked prices for the shares of common stock on the most recent date preceding such date on which such closing bid and asked prices
are available. If the common stock is not listed on a national securities exchange or national market system or traded in an over-the-counter
market, the fair market value shall be determined by the Compensation Committee in a manner consistent with Section 409A of the
Code. Notwithstanding the foregoing, if on the date of grant the common stock is listed on a stock exchange or is quoted on a
national market system, or is traded in an over-the-counter market, then solely for purposes of determining the exercise price
of any grant of a stock option or the base price of any grant of a stock appreciation right, the Compensation Committee may, in
its discretion, base fair market value on the last sale before or the first sale after the grant, the closing price on the trading
day before or the trading day of the grant, the arithmetic mean of the high and low prices on the trading day before or the trading
day of the grant, or any other reasonable method using actual transactions of the common stock as reported by the exchange or
market on which the common stock is traded. In addition, the determination of fair market value also may be made using any other
method permitted under Treasury Regulation section 1.409A-1(b)(5)(iv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
option may be exercisable for more than ten years from the date of grant (five years in the case of an incentive stock option
granted to a ten-percent stockholder). Options granted under the 2016 Plan will be exercisable at such time or times as the Compensation
Committee prescribes at the time of grant. No employee may receive incentive stock options that first become exercisable in any
calendar year in an amount exceeding $100,000. The Compensation Committee may, in its discretion, permit a holder of a nonqualified
stock option to exercise the option before it has otherwise become exercisable, in which case the shares of our common stock issued
to the recipient will continue to be subject to the vesting requirements that applied to the option before exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the option price may be paid in cash or by bank check, or such other means as the Compensation Committee may accept. As set forth
in an award agreement or otherwise determined by the Compensation Committee, in its sole discretion, at or after grant, payment
in full or part of the exercise price of an option may be made (a) in the form of shares of common stock that have been held by
the participant for such period as the Compensation Committee may deem appropriate for accounting purposes or otherwise, valued
at the fair market value of such shares on the date of exercise; (ii) by surrendering to the Company shares of common stock otherwise
receivable on exercise of the option; (iii) by a cashless exercise program implemented by the Compensation Committee in connection
with the 2016 Plan; and/or (iv) by such other method as may be approved by the Compensation Committee and set forth in an award
agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
option may be transferred other than by will or by the laws of descent and distribution, and during a recipient&rsquo;s lifetime
an option may be exercised only by the recipient or the recipient&rsquo;s guardian or legal representative. However, the Compensation
Committee may permit the transfer of a nonqualified stock option, share-settled stock appreciation right, restricted stock award,
performance share or share-settled other stock-based award either (a) by instrument to the participant&rsquo;s immediate family
(as defined in the 2016 Plan), (b) by instrument to an inter vivos or testamentary trust (or other entity) in which the award
is to be passed to the participant&rsquo;s designated beneficiaries, or (c) by gift to charitable institutions. The Compensation
Committee will determine the extent to which a holder of a stock option may exercise the option following termination of service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Appreciation Rights</I>.</B> The Compensation Committee may grant stock appreciation rights independent of or in connection with
an option. The Compensation Committee will determine the terms applicable to stock appreciation rights. The base price of a stock
appreciation right will be determined by the Compensation Committee, but will not be less than 100% of the fair market value of
a share of our common stock with respect to the date of grant of such stock appreciation right. The maximum term of any SAR granted
under the 2016 Plan is ten years from the date of grant. Generally, each SAR stock appreciation right will entitle a participant
upon exercise to an amount equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 93%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    excess of the fair market value of a share of common stock on the date of exercise of the stock appreciation right over the
    base price of such stock appreciation right, multiplied by</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 93%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares as to which such stock appreciation right is exercised.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
may be made in shares of our common stock, in cash, or partly in common stock and partly in cash, all as determined by the Compensation
Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Restricted
Stock and Stock Units</I></B><I>.</I> The Compensation Committee may award restricted common stock and/or stock units under the
2016 Plan. Restricted stock awards consist of shares of stock that are transferred to a participant subject to restrictions that
may result in forfeiture if specified conditions are not satisfied. Stock units confer the right to receive shares of our common
stock, cash, or a combination of shares and cash, at a future date upon or following the attainment of certain conditions specified
by the Compensation Committee. The Compensation Committee will determine the restrictions and conditions applicable to each award
of restricted stock or stock units, which may include performance-based conditions. Dividends with respect to restricted stock
may be paid to the holder of the shares as and when dividends are paid to stockholders or at the times of vesting or other payment
of the restricted stock award. Stock unit awards may be granted with dividend equivalent rights, which may be accumulated and
may be deemed reinvested in additional stock units, as determined by the Compensation Committee in its discretion. If any dividend
equivalents are paid while a stock unit award is subject to restrictions, the dividend equivalents shall be subject to the same
restrictions on transferability as the underlying stock units, unless otherwise set forth in an award agreement. Unless the Compensation
Committee determines otherwise, holders of restricted stock will have the right to vote the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Performance
Shares and Performance Units</I></B><I>.</I> The Compensation Committee may award performance shares and/or performance units
under the 2016 Plan. Performance shares and performance units are awards which are earned during a specified performance period
subject to the attainment of performance criteria, as established by the Compensation Committee. The Compensation Committee will
determine the restrictions and conditions applicable to each award of performance shares and performance units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Incentive
Bonus Awards</I></B>. The Compensation Committee may award Incentive Bonus Awards under the 2016 Plan. Incentive Bonus Awards
may be based upon the attainment of specified levels of Company or subsidiary performance as measured by pre-established, objective
performance criteria determined at the discretion of the Compensation Committee. Incentive Bonus Awards will be paid in cash or
common stock, as set forth in an award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Stock-Based and Cash-Based Awards</I></B><I>.</I> The Compensation Committee may award other types of equity-based or cash-based
awards under the 2016 Plan, including the grant or offer for sale of unrestricted shares of our common stock and payment in cash
or otherwise of amounts based on the value of shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
162(m) Compliance</I></B>. If stock or cash-based awards are intended to satisfy the conditions for deductibility under Section
162(m) of the Code as &ldquo;performance-based compensation,&rdquo; the performance criteria will be selected from among the following,
which may be applied to our Company as a whole, any subsidiary or any division or operating unit thereof: (a) pre-tax income;
(b) after-tax income; (c) net income; (d) operating income or profit; (e) cash flow, free cash flow, cash flow return on investment,
net cash provided by operations, or cash flow in excess of cost of capital; (f) earnings per share; (g) return on equity; (h)
return on sales or revenues; (i) return on invested capital or assets; (j) cash, funds or earnings available for distribution;
(k) appreciation in the fair market value of the common stock; (l) operating expenses; (m) implementation or completion of critical
projects or processes; (n) return on investment; (o) total return to stockholders; (p) dividends paid; (q) net earnings growth;
(r) related return ratios; (s) increase in revenues; (t) the Company&rsquo;s published ranking against its peer group of pharmaceutical
companies based on total stockholder return; (u) net earnings; (v) changes (or the absence of changes) in the per share or aggregate
market price of the common stock; (w) number of securities sold; (x) earnings before or after any one or more of the following
items: interest, taxes, depreciation or amortization, as reflected in the Company&rsquo;s financial reports for the applicable
period; (y) total revenue growth; (z) economic value created; (aa) operating margin or profit margin; (bb) share price or total
stockholder return; (cc) cost targets, reductions and savings, productivity and efficiencies; (dd) strategic business criteria,
consisting of one or more objectives based on meeting objectively determinable criteria: specified market penetration, geographic
business expansion, progress with research and development activities, investor satisfaction, employee satisfaction, human resources
management, supervision of litigation, information technology, and goals relating to acquisitions, divestitures, joint ventures
and similar transactions, and budget comparisons; (ee) objectively determinable personal or professional objectives, including
any of the following performance goals: the implementation of policies and plans, the negotiation of transactions, the development
of long term business goals, formation of joint ventures, research or development collaborations, and the completion of other
corporate transactions, and (ff) any combination of, or a specified increase or improvement in, any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of the performance period established in connection with any award, the Compensation Committee will determine the extent
to which the performance goal or goals established for such award have been attained, and shall determine, on that basis, the
number of performance shares or performance units included in such award that have been earned and as to which payment will be
made. The Compensation Committee will certify in writing the extent to which it has determined that the performance goal or goals
established by it for such award have been attained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to awards intended to be performance-based compensation under Section 162(m) of the Code, no participant of the 2016 Plan
may receive in any one fiscal year (a) options or stock appreciation rights relating to more than 1,000,000 shares of our common
stock, and (b) stock units, restricted shares, performance shares, performance units or other stock-based awards that are denominated
in shares of common stock relating to more than 1,000,000 shares of our common stock in the aggregate. The maximum dollar value
payable to any participant for a fiscal year of the Company with respect to stock units, performance units or incentive bonus
awards or other stock-based awards that may be settled in cash or other property (other than common stock) is $1,500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Effect
of Certain Corporate Transactions</I>.</B> The Compensation Committee may, at the time of the grant of an award, provide for the
effect of a change in control (as defined in the 2016 Plan) on any award, including (i) accelerating or extending the time periods
for exercising, vesting in, or realizing gain from any award, (ii) eliminating or modifying the performance or other conditions
of an award, (iii) providing for the cash settlement of an award for an equivalent cash value, as determined by the Compensation
Committee, or (iv) such other modification or adjustment to an award as the Compensation Committee deems appropriate to maintain
and protect the rights and interests of participants upon or following a change in control. The Compensation Committee may, in
its discretion and without the need for the consent of any recipient of an award, also take one or more of the following actions
contingent upon the occurrence of a change in control: (a) cause any or all outstanding options and stock appreciation rights
to become immediately exercisable, in whole or in part; (b) cause any other awards to become non-forfeitable, in whole or in part;
(c) cancel any option or stock appreciation right in exchange for a substitute option; (d) cancel any award of restricted stock,
stock units, performance shares or performance units in exchange for a similar award of the capital stock of any successor corporation;
(e) redeem any restricted stock, stock unit, performance share or performance unit for cash and/or other substitute consideration
with a value equal to the fair market value of an unrestricted share of our common stock on the date of the change in control;
(f) cancel any option or stock appreciation right in exchange for cash and/or other substitute consideration based on the value
of our common stock on the date of the change in control<I>,</I> and cancel any option or stock appreciation right without any
payment if its exercise price exceeds the value of our common stock on the date of the change in control; (g) cancel any stock
unit or performance unit held by a participant affected by the change in control in exchange for cash and/or other substitute
consideration with a value equal to the fair market value per share of common stock on the date of the change in control, or (h)
make such other modifications, adjustments or amendments to outstanding awards as the Compensation Committee deems necessary or
appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment,
Termination</I>.</B> The 2016 Plan will remain in effect until March 2026, or, if earlier, when awards have been granted covering
all available shares under the 2016 Plan or the 2016 Plan is otherwise terminated by the Board. The Board may amend the terms
of awards in any manner not inconsistent with the 2016 Plan, provided that no amendment shall adversely affect the rights of a
participant with respect to an outstanding award without the participant&rsquo;s consent. In addition, our Board of Directors
may at any time amend, suspend, or terminate the 2016 Plan, provided that (i) no such amendment, suspension or termination shall
materially and adversely affect the rights of any participant under any outstanding award without the consent of such participant
and (ii) to the extent necessary and desirable to comply with any applicable law, regulation, or stock exchange rule, the 2016
Plan requires us to obtain stockholder consent. Stockholder approval is required for any plan amendment that increases the number
of shares of common stock available for issuance under the 2016 Plan or changes the persons or classes of persons eligible to
receive awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Tax
Withholding. </I></B>The Company has the power and right to deduct or withhold, or require a participant to remit to the Company,
the minimum statutory amount to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulations to
be withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recoupment
Policy</I>. </B>Awards granted under the 2016 Plan will be subject to any provisions of applicable law providing for the recoupment
or clawback of incentive compensation, such as provisions imposed pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection
Act; the terms of any Company recoupment, clawback or similar policy in effect at the time of grant of the award; and any recoupment,
clawback or similar provisions that may be included in the applicable award agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Federal
Income Tax Consequences. </I></B>The following is a brief summary of the U.S. federal income tax consequences applicable to awards
granted under the 2016 Plan based on the federal income tax laws in effect on the date of this report. This summary is
not intended to be exhaustive and does not address all matters relevant to a particular participant based on his or her specific
circumstances. The summary expressly does not discuss the income tax laws of any state, municipality, or non-U.S. taxing jurisdiction,
or the gift, estate, excise (including the rules applicable to deferred compensation under Code Section 409A), or other tax laws
other than federal income tax law. The following is not intended or written to be used, and cannot be used, for the purposes of
avoiding taxpayer penalties. Because individual circumstances may vary, the Company advises all participants to consult their
own tax advisor concerning the tax implications of awards granted under the 2016 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
recipient of a stock option or stock appreciation right will not have taxable income upon the grant of the stock option or stock
appreciation right. For non-statutory stock options and stock appreciation rights, the participant will recognize ordinary income
upon exercise in an amount equal to the difference between the fair market value of the shares and the exercise price on the date
of exercise. Any gain or loss recognized upon any later disposition of the shares generally will be a capital gain or loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of shares upon exercise of an incentive stock option will not result in any taxable income to the participant, except,
possibly, for purposes of the alternative minimum tax. The gain or loss recognized by the participant on a later sale or other
disposition of such shares will either be long-term capital gain or loss or ordinary income, depending upon whether the participant
holds the shares for the legally-required period (two years from the date of grant and one year from the date of exercise). If
the shares are not held for the legally-required period, the participant will recognize ordinary income equal to the lesser of
(i) the difference between the fair market value of the shares on the date of exercise and the exercise price, or (ii) the difference
between the sales price and the exercise price, and the balance of the gain, if any, will be afforded capital gain treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
awards of stock grants, the participant will not have taxable income upon the receipt of the award (unless the participant elects
to be taxed at the time of the stock is granted rather than when it becomes vested). The stock grants will generally be subject
to tax upon vesting as ordinary income equal to the fair market value of the shares at the time of vesting less the amount paid
for such shares (if any).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
participant is not deemed to receive any taxable income at the time an award of restricted stock units is granted. When vested
restricted stock units (and dividend equivalents, if any) are settled and distributed, the participant will recognize ordinary
income equal to the amount of cash and/or the fair market value of shares received less the amount paid for such restricted stock
units (if any).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the participant is an employee or former employee, the amount a participant recognizes as ordinary income in connection with any
award is subject to withholding taxes (not applicable to incentive stock options) and the Company is allowed a tax deduction equal
to the amount of ordinary income recognized by the participant. In addition, Code Section 162(m) contains special rules regarding
the federal income tax deductibility of compensation paid to the Company&rsquo;s chief executive officer and to certain of the
Company&rsquo;s other executive officers. The general rule is that annual compensation paid to any of these specified executives
will be deductible only to the extent that it does not exceed $1,000,000. However, the Company can preserve the deductibility
of certain compensation in excess of $1,000,000 if such compensation qualifies as &ldquo;performance-based compensation&rdquo;
by complying with certain conditions imposed by the Code Section 162(m) rules (including the establishment of a maximum number
of shares with respect to which awards may be granted to any one employee during one fiscal year).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
Grants and Stock Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had outstanding stock options to purchase 5,597,861 shares at an average exercise price of approximately
$1.34 per share. Included in the total outstanding stock options were 0 stock options granted under the 2006 Plan in 2020 and
1,762,495 nonqualified stock options granted under the 2016 Plan in 2020 to our executive officers and others at an exercise price
of $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
awards to be made under the 2016 Plan are discretionary, subject to the terms of the 2016 Plan. Therefore, the benefits and amounts
that will be received or allocated under the 2016 Plan are generally not determinable at this time. The equity grant program for
our non-employee directors is described under the Compensation of Directors section in this proxy statement. The following table
summarizes these 2016 awards to our named executive officers, all executive officers and the non-executive officer employees and
consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the equity awards made to our named executive officers that were outstanding at December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">No.
    of Securities<BR>
    Underlying Unexercised Options (#) Exercisable</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
                                         of Securities<BR>
                                         Underlying Unexercised Options (#) Unexercisable</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
                                         Price</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expiration
                                         Date</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 22%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Garo H. Armen (1)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 15, 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Garo H. Armen (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 16, 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Garo H. Armen (3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">300,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 13, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (4)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 12, 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (4)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">140,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 15, 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (5)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 16, 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (6)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,667</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 1, 2029</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (7)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">120,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 13, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (8)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">187,497</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 13, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alexander K. Arrow (9)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">124,998</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">July 18, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Andrew Slee (10)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 15, 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Andrew Slee (11)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 16, 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Andrew Slee (12)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 13, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Andrew Slee (13)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">July 18, 2030</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert B. Stein (14)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 22, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert B. Stein (15)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 15, 2026</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert B. Stein (16)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 16, 2027</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert B. Stein (17)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-<FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">February 13, 2030</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Armen was granted a 500,000 share option grant on April 15, 2016</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Armen was granted a 250,000 share option grant on October 16, 2017.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Armen was granted a 300,000 share option grant on February 13, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 100,000 share option grant on February 12, 2016, and a 140,000 share option grant on April 15, 2016</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 75,000 share option grant on October 16, 2017.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 41,667 share option grant on February 1, 2019.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 120,000 share option grant on February 13, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 187,497 share option grant on February 13, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Arrow was granted a 124,998 share option grant on July 18, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Slee was granted a 100,000 shares option grant on April 15, 2016.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Slee was granted a 75,000 shares option grant on October 16, 2017.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Slee was granted a 150,000 shares option grant on February 13, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Slee was granted a 75,000 shares option grant on July 18, 2020.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Stein was granted a 200,000 shares option grant on January 22, 2015.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Stein was granted a 40,000 shares option grant on April 15, 2016.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Stein was granted a 200,000 shares option grant on October 16, 2017.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Stein was granted a 150,000 shares option grant on February 13, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Drs. Armen and Arrow, following a qualified Change of Control, a resignation for Good Reason, or an involuntary termination other
than For Cause, 100% of the executives&rsquo; then-unvested options shall become immediately vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
Ownership of Certain Beneficial Owners and Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding the beneficial ownership of the Common Stock as of March 17, 2021, unless
otherwise indicated, by (1) each person known by the Company to be the beneficial owner of more than 5% of the outstanding shares
of common stock, (2) each director of the Company, (3) the Company&rsquo;s current executive officers, and (4) all current directors
and executive officers of the Company as a group. The persons and entities named in the table have sole voting and investment
power with respect to all such shares owned by them, unless otherwise indicated.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    and address of Beneficial Owner*</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
                                         and Nature of Beneficial Ownership</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent
                                         of Class</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo H.
    Armen<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,832,295</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(2)</SUP></FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert B. Stein<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">590,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khalil Barrage<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">570,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(4)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander K. Arrow<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">830,755</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(5)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Larry N. Feinberg</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">800,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(6)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian J. Corvese<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">215,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(7)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">David A. Lovejoy</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">680,745</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(8)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Josh Silverman<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">210,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(9)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Jennifer Buell<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,833</FONT></P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(10)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Andrew Slee<SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">216,406</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(11)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hudson Bay Master Fund</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">949,530</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(12)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Iroquois Master Fund</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">832,755</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">All directors and
    executive officers as a group (8 persons)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,505,289</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(13)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Address for each party listed in the above table is c/o Protagenic Therapeutics, Inc., 149 Fifth Avenue, Suite 500, New York,
NY 10010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Executive officer and/or director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)
Includes warrants to purchase 1,253,367 shares of common stock at an exercise price of approximately $1.00 per share. Includes
2,296,012 shares held in the name of Dr. Armen and 250,000 shares held in the name of the Garo H. Armen IRA, as to which Dr. Armen
has sole voting and dispositive power. Also includes options to purchase 872,916 shares of common stock at an exercise
price of $1.25 or $1.75 per share. Does not include options to purchase 177,084 shares that are not exercisable within
60 days of the date of this report. Also includes convertible note of $200,000 that converts at $1.25 per share for a total of
160,000 shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)
Represents options to purchase 590,000 shares of common stock at an exercise price of $1.25 or $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)
Includes 50,000 shares of common stock and options to purchase 360,000 shares of common stock at an exercise price of $1.25
or $1.75 per share. Also includes convertible note of $200,000 that converts at $1.25 per share for a total of 160,000 shares
of common stock.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Includes 100,000 shares held in the name of Dr. Arrow and 18,260 shares held in the name of the Alexander K. Arrow IRA, as to
which Dr. Arrow has sole voting and dispositive power. Also includes options to purchase 712,495 shares of common stock
at an exercise price of $1.00, $1.25 or $1.75 per share. Does not include options to purchase 76,667 shares of common
stock in the aggregate that are not exercisable within 60 days of the date of this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Includes 200,000 shares of common stock held in the name of Mr. Feinberg and warrants to purchase 600,000 shares of common stock
at an exercise price of $1.00 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Includes options to purchase 215,000 shares of common stock at an exercise price of $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Includes 148,800 shares of common stock held in the name of Dr. Lovejoy and options to purchase 531,945 shares of common
stock in the aggregate with an exercise price ranging from $1.00 to $1.75 per share. Does not include options to purchase 21,354
shares of common stock that are not exercisable within 60 days of the date of this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)
Includes options to purchase 210,000 shares of common stock at an exercise price of $1.25 or $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10)
Includes options to purchase 40,833 shares of common stock at an exercise price of $1.75 per share. Does not include options to
purchase 104,167 shares of common stock that are not exercisable within 60 days of the date of this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11)
Includes options to purchase 216,406 shares of common stock at an exercise price of $1.25 or $1.75 per share. Does not include
options to purchase 183,594 shares of common stock that are not exercisable within 60 days of the date of this report.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hudson Bay Master Fund Ltd. (the &ldquo;Managing Member&rdquo;).
Sander Gerber is the managing member of Hudson Bay Capital GP LLC, which is the general partner of HBC. Each of HBC, the Managing
Member and Sander Gerber disclaims beneficial ownership over these securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Includes warrants to purchase 1,253,367 shares of common stock
and options to purchase 3,217,650 shares of common stock. Also includes convertible notes of $400,000 that converts
at $1.25 per share for a total of 320,000 shares of common stock.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_021"></A>Item
13. Certain Relationships and Related Transactions, and Director Independence.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Relationships and Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than compensation arrangements for our named executive officers and directors, we describe below each transaction or series of
similar transactions, since January 1, 2016, to which we were a party or will be a party, in which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amounts involved exceeded or will exceed $120,000; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family
    of the foregoing persons, had or will have a direct or indirect material interest.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
arrangements for our named executive officers and directors are described in Item 11, Executive Compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal offices are located at 149 Fifth Avenue, Suite 500, New York, New York 10010, in a conference room of Agenus, Inc. We
utilize our principal office for quarterly board meetings and our annual shareholder meeting at no cost. Our personnel and consultants
all work remotely, the Company&rsquo;s basic science laboratory work is conducted in the Lovejoy Lab at the University of Toronto,
and its preclinical efficacy work is conducted at CROs. Hence the Company does not have the need for a day-to-day physical office
location other than a mailing address and conference room facility for meetings. For that reason, the Agenus conference room suits
its purposes without imposing any inconveniences upon Agenus. Dr. Armen, our Executive Chairman, is also the Chairman and Chief
Executive Officer of Agenus Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2019-2020 Convertible</B><B>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Offering</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
H. Armen and Khalil Barrage invested $200,000 and $200,000, respectively, in the Convertible Note Offering on the same
terms as all other Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Zack
Armen</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the latter part of 2018 and the first quarter of 2019, Zack Armen, the son of our Executive Chairman, Garo H. Armen, Ph.D., assisted
us in the development of slide deck presentations and summaries, video editing, and forecasting and market size projections that
were incorporated into presentations to investors and others. We have included these presentations in various Current Reports
on Form 8-K which we filed with the Securities and Exchange Commission. On June 17, 2019, the Compensation and Audit Committees
of the Board authorized the issuance to Mr. Zack Armen of 25,000 stock options under the 2016 Plan in consideration for his services.
These options vested in their entirety on issuance, have a ten-year term and are exercisable at a price of $1.75 per share. On
February 21, 2020 Mr. Zack Armen was also issued an additional 50,000 stock options that vest over 48 months and are exercisable
at a price of $1.75 per share. On July 18, 2020 Mr. Zack Armen was also issued an additional 30,000 stock options that vest over
48 months and are exercisable at a price of $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Policies
and Procedures for Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than
5% of any class of our common stock, any members of the immediate family of any of the foregoing persons and any firms, corporations
or other entities in which any of the foregoing persons is employed or is a partner or principal or in a similar position or in
which such person has a 5% or greater beneficial ownership interest, which we refer to collectively as related parties, are not
permitted to enter into a transaction with us without the prior consent of our Board of Directors acting through the audit committee
or, in certain circumstances, the chairman of the audit committee. Any request for us to enter into a transaction with a related
party, in which the amount involved exceeds $100,000 and such related party would have a direct or indirect interest must first
be presented to our audit committee, or in certain circumstances the chairman of our audit committee, for review, consideration
and approval. In approving or rejecting any such proposal, our audit committee, or the chairman of our audit committee, is to
consider the material facts of the transaction, including, but not limited to, whether the transaction is on terms no less favorable
than terms generally available to an unaffiliated third party under the same or similar circumstances, the extent of the benefits
to us, the availability of other sources of comparable products or services and the extent of the related party&rsquo;s interest
in the transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently listed on any national securities exchange or in an inter-dealer quotation system that has a requirement that
the Board of Directors be independent. However, in evaluating the independence of our members and the composition of the committees
of our Board of Directors, our Board utilizes the definition of &ldquo;independence&rdquo; as that term is defined by applicable
listing standards of the NASDAQ Stock Market and SEC rules, including the rules relating to the independence standards of an audit
committee and the non-employee director definition of Rule 16b-3 promulgated under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors expects to continue to evaluate its independence standards and whether and to what extent the composition of
the Board and its committees meets those standards. We ultimately intend to appoint such persons to our Board and committees of
our Board as are expected to be required to meet the corporate governance requirements imposed by a national securities exchange.
Therefore, we intend that a majority of our directors will be independent directors of which at least one director will qualify
as an &ldquo;audit committee financial expert,&rdquo; within the meaning of Item 407(d)(5) of Regulation S-K, as promulgated by
the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that Messrs. Barrage, Corvese, Silverman, and Dr. Buell are each an &ldquo;independent&rdquo; director as that term is
defined by the NASDAQ Stock Market, Inc. Marketplace Rules and SEC Regulations. In addition, the Board also designated Brian Corvese
as an &ldquo;audit committee financial expert,&rdquo; as that term is defined by the NASDAQ Listing Rules and SEC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to Mr. Silverman&rsquo;s independent status, the Board considered the fact that he is an ex-CEO of one of the institutional
funds (Iroquois Asset Management) owns just under 5% of the Company&rsquo;s common stock. The Board noted that Mr. Silverman is
no longer the CEO of Iroquois Asset Management, and as such, he does not represent a major single shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to Mr. Corvese&rsquo;s independent status, the Board considered the fact that he has no business relationship with the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to Mr. Barrage&rsquo;s independent status, the Board considered the fact that he has no business relationship with the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to Dr. Buell&rsquo;s independent status, the Board considered the fact that she has no business relationship with the Company
except her consulting role assisting with clinical trial design.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Stein, a member of the Science and Clinical &amp; Regulatory Committees, serves as our Chief Medical Officer, and is therefore
not considered &ldquo;independent.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Armen, a member of the Science and Clinical &amp; Regulatory Committees, serves as our Executive Chairman, and is therefore not
considered &ldquo;independent.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal offices are located at 149 Fifth Avenue, Suite 500, New York, New York 10010, in a conference room of Agenus, Inc. We
utilize our principal office for quarterly board meetings and our annual shareholder meeting on a month to month basis at a nominal
value. Dr. Armen, our Executive Chairman, is also the Chairman and Chief Executive Officer of Agenus Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_022"></A>Item
14. Principal Accounting Fees and Services.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the fees for services provided and reasonably expected to be billed by Malone Bailey LLP. The following
is a summary of the fees billed to the Company for professional services rendered for the fiscal years ended December 31, 2020
and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal
                                         Year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fiscal
                                         Year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit fees</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit-related fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">All other fees</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,800</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Fees: </B>For the fiscal years ended December 31, 2020 and 2019, the aggregate audit fees billed by our independent auditors were
for professional services rendered for audits and quarterly reviews of our consolidated financial statements, and assistance with
reviews of registration statements and documents filed with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit-Related
Fees: </B>Audit-related fees are for assurance and other activities not explicitly related to the audit of our financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Fees: </B>For the fiscal years ended December 31, 2020 and 2019, there were no tax fees, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
Other Fees: </B>For the fiscal years ended December 31, 2020 and 2019, there were $0 and $0, respectively</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Committee Pre-Approval Policies and Procedures. </B>The Audit Committee oversees and monitors our financial reporting process
and internal control system, reviews and evaluates the audit performed by our registered independent public accountants and reports
to the Board any substantive issues found during the audit. The Audit Committee is directly responsible for the appointment, compensation
and oversight of the work of our registered independent public accountants. The Audit Committee convenes on a quarterly basis
to approve each quarterly filing, and an annual basis to review the engagement of the Company&rsquo;s external auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee has considered whether the provision of Audit-Related Fees, Tax Fees, and all other fees as described above is
compatible with maintaining MaloneBailey, LLP&rsquo;s independence and has determined that such services for fiscal years
2020 and 2019, respectively, were compatible. All such services were approved by the Audit Committee pursuant to Rule 2-01 of
Regulation S-X under the Exchange Act to the extent that rule was applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_023"></A>PART
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_024"></A>Item
15. Exhibits, Financial Statement Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a)
List of Documents filed as part of this Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)
Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
F-1 through F-20 following the Exhibit List as required by Part II, Item 8 &ldquo;Financial Statements and Supplementary Data&rdquo;
of this Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2)
Financial Statement Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
are omitted because they are either not required, not applicable, or the information is otherwise included.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>(3) Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has filed
with this report or incorporated by reference herein certain exhibits as specified below pursuant to Rule 12b-32 under the Exchange
Act. See Exhibit Index following the signature page to this report for a complete list of documents filed with this report.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774916034055/ex3-1.htm" STYLE="-sec-extract: exhibit">Third
    Amended and Restated Certificate of Incorporation of Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 3.1
    to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on June 20, 2016).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000142488416000197/exhibit3-1.htm" STYLE="-sec-extract: exhibit">Certificate
    of Designations, Powers, Preferences and Other Rights of Preferred Stock and Qualifications, Limitations and Restrictions
    Thereof of Series B Convertible Preferred Stock of Atrinsic, Inc. (Incorporated by reference to Exhibit 3.1 to Company&rsquo;s
    Current Report on Form 8-K, as filed with the SEC on February 5, 2016.)</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000149315218008098/ex3-1.htm" STYLE="-sec-extract: exhibit">Second
    Amended and Restated Bylaws Protagenic Therapeutics, Inc., (Incorporated by reference to Exhibit 3.1 to Company&rsquo;s Current
    Report on Form 8-K, as filed with the SEC on June 1, 2018).</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex41.htm" STYLE="-sec-extract: exhibit">Form
    of Warrant of Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 4.1 to Company&rsquo;s Current Report on
    Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex43i.htm" STYLE="-sec-extract: exhibit">Warrant
    of Protagenic Therapeutics, Inc. issued to Garo H. Armen on May 17, 2011. (Incorporated by reference to Exhibit 4.3(i) to
    Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex43ii.htm" STYLE="-sec-extract: exhibit">Warrant
    of Protagenic Therapeutics, Inc. issued to Garo H. Armen on February 18, 2013 (Incorporated by reference to Exhibit 4.3(ii)
    to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex44i.htm" STYLE="-sec-extract: exhibit">Warrant
    of Protagenic Therapeutics, Inc. issued to Gregory H. Ekizian on July 7, 2011. (Incorporated by reference to Exhibit 4.4(i)
    to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex44ii.htm" STYLE="-sec-extract: exhibit">Warrant
    of Protagenic Therapeutics, Inc. issued to PENSCO Trust Company, FBO Gregory H. Ekizian on February 18, 2013. (Incorporated
    by reference to Exhibit 4.4(ii) to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000114420416094817/v437233_ex4-5.htm" STYLE="-sec-extract: exhibit">Form
    of Placement Agent Warrant (Incorporated by reference to Exhibit 4.5 to Company&rsquo;s Current Report on Form 8-K, as filed
    with the SEC on April 18, 2016).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1012.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement, effective January 1, 2014 between Protagenic Therapeutics Canada (2006) Inc. and Dr. Robert Ziroyan (Incorporated
    by reference to Exhibit 10.12 to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)**</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-2.htm">Consulting Agreement, effective December 18, 2020, between Protagenic Therapeutics Inc. and Dr. Andrew Slee.* **</A></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1013.htm" STYLE="-sec-extract: exhibit">Consulting
    Agreement, as amended, between Protagenic Therapeutics Canada (2006) Inc. and Dr. Dalia Barsyte (Incorporated by reference
    to Exhibit 10.13 to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)**</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-4.htm">Amended and Restated Consulting Agreement, effective December 18, 2020, between Protagenic Therapeutics Inc. and Dr. Robert B. Stein.* ** &nbsp; &nbsp;</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1016.htm" STYLE="-sec-extract: exhibit">Protagenic
    Therapeutics, Inc. 2006 Employee, Director and Consultant Stock Plan (Incorporated by reference to Exhibit 10.16 to Company&rsquo;s
    Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)**</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1017.htm" STYLE="-sec-extract: exhibit">Form
    of Nonqualified Stock Option Award Agreement under the 2006 Employee, Director and Consultant Stock Plan. (Incorporated by
    reference to Exhibit 10.17 to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.) **</A></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1019i.htm" STYLE="-sec-extract: exhibit">Technology
    License Agreement, effective July 21, 2005, between The University of Toronto Innovations Foundation and Protagenic Therapeutics,
    Inc. (Incorporated by reference to Exhibit 10.19(i) to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on
    February 12, 2016.)</A></FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1019ii.htm" STYLE="-sec-extract: exhibit">First
    Amendment to Technology License Agreement, effective February 18, 2015, between the Governing Council of the University of
    Toronto and Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 10.19(ii) to Company&rsquo;s Current Report
    on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1020i.htm" STYLE="-sec-extract: exhibit">Sponsored
    Research Agreement, effective April 1, 2014, between the Governing Council of the University of Toronto and Protagenic Therapeutics
    Canada (2006), Inc., Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 10.20(i) to Company&rsquo;s Current
    Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000119312516462444/d128148dex1020ii.htm" STYLE="-sec-extract: exhibit">Amendment
    to the Sponsored Research Agreement, effective April 1, 2015, between the Governing Council of the University of Toronto and
    Protagenic Therapeutics Canada (2006), Inc., Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 10.20(ii)
    to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on February 12, 2016.)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774916034055/ex10-1.htm" STYLE="-sec-extract: exhibit">Protagenic
    Therapeutics, Inc. 2016 Equity Compensation Plan. (Incorporated by reference to Exhibit 10.1 to Company&rsquo;s Current Report
    on Form 8-K, as filed with the SEC on June 20, 2016.)**</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774916034055/ex10-2.htm" STYLE="-sec-extract: exhibit">Form
    of Incentive Stock Option Agreement under the Protagenic Therapeutics, Inc. 2016 Equity Compensation Plan. (Incorporated by
    reference to Exhibit 10.2 to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on June 20, 2016.) **</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774916034055/ex10-3.htm" STYLE="-sec-extract: exhibit">Form
    of Nonqualified Stock Option Grant Agreement under the Protagenic Therapeutics, Inc. 2016 Equity Compensation Plan. (Incorporated
    by reference to Exhibit 10.3 to Company&rsquo;s Current Report on Form 8-K, as filed with the SEC on June 20, 2016.) **</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000149315219018180/ex10-1.htm" STYLE="-sec-extract: exhibit">Form
    of Convertible Note Purchase Agreement (Incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on
    Form 8-K, as filed with the SEC on November 21, 2019)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000149315219018180/ex10-2.htm" STYLE="-sec-extract: exhibit">Form
    of Convertible Promissory Note (Incorporated by reference to Exhibit 10.2 to the Company&rsquo;s Current Report on Form 8-K,
    as filed with the SEC on November 21, 2019)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000149315219018180/ex10-2.htm" STYLE="-sec-extract: exhibit">Form
    of Guaranty (Incorporated by reference to Exhibit 10.2 to the Company&rsquo;s Current Report on Form 8-K, as filed with the
    SEC on November 21, 2019)</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774917006686/ex14-1.htm" STYLE="-sec-extract: exhibit">Protagenic
    Therapeutics, Inc. Code of Business Conduct and Ethics (incorporated by reference to Exhibit 14.1 to the Current Report on
    Form 10-K, as filed with the SEC on April 18, 2017).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774917006686/ex14-1.htm" STYLE="-sec-extract: exhibit">Protagenic
    Therapeutics, Inc. Guideline on Significant Corporate Governance Issues (incorporated by reference to Exhibit 14.2 to the
    Current Report on Form 10-K, as filed with the SEC on April 18, 2017).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.3</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000143774917006686/ex14-3.htm" STYLE="-sec-extract: exhibit">Protagenic
        Therapeutics, Inc. Process for Security Holder Communications with Directors (incorporated by reference to Exhibit 14.3
        to the Current Report on Form 10-K, as filed with the SEC on April 18, 2017).</A></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex21-1.htm">Subsidiaries
                                         *</A></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent
    of MaloneBailey, LLP*</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex31-1.htm">Certification
    of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)*.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex31-2.htm">Certification
    of Chief Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b)*.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex32-1.htm">Section
    1350 Certifications &dagger;</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">99.1</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-1.htm">Audit Committee Charter adopted by Board of Directors of Protagenic Therapeutics, Inc. on March 7, 2017*.</A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">99.2</P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-2.htm">Compensation Committee Charter adopted by Board of Directors of Protagenic Therapeutics, Inc. on March 7, 2017*.</A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-3.htm">Governance and Nominating Committee Charter adopted by Board of Directors of Protagenic Therapeutics, Inc. on March 7, 2017*.</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">99.4</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1022899/000149315220007286/ex99-1.htm" STYLE="-sec-extract: exhibit">Science Committee Charter adopted by the Board of Directors of Protagenic Therapeutics, Inc. (Incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Annual Report on Form 10-K, as filed with the SEC on April 29, 2020)</A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[100.1]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[XBRL-related
    documents]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[101.1]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Interactive
    Data Files]</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designates
    management contracts and compensation plans</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_025"></A>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROTAGENIC
    THERAPEUTICS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Garo H. Armen</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
    H. Armen</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    (Principal Executive Officer and<BR>
    Duly Authorized Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons
in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signatures</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Garo H. Armen</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Chairman of the Board</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
    H. Armen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alexander K. Arrow</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    K. Arrow</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert B. Stein</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    B. Stein</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Khalil Barrage</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khalil
    Barrage</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian J. Corvese</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    J. Corvese</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Joshua Silverman</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joshua
    Silverman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jennifer Buell</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer
    Buell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROTAGENIC
THERAPEUTICS, INC. AND SUBSIDIARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DECEMBER
31, 2020 AND 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><A HREF="#m_001">Report
    of Independent Registered Public Accounting Firm</A></I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#m_002">Consolidated
    Balance Sheets</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#m_003">Consolidated
    Statements of Operations and Comprehensive Loss</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#m_004">Consolidated
    Statements of Stockholders&rsquo; Deficit</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#m_005">Consolidated
    Statements of Cash Flows</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#m_006">Notes
    to Consolidated Financial Statements</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="m_001"></A>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and Board of Directors of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protagenic
Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Opinion
on the Financial Statements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Protagenic Therapeutics, Inc. and its subsidiary (collectively the
&ldquo;Company&rdquo;) as of December 31, 2020 and 2019, and the related consolidated statements of operations and comprehensive
loss, changes in stockholders&rsquo; deficit, and cash flows for the years then ended, and the related notes (collectively referred
to as the &ldquo;financial statements&rdquo;). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for
the years then ended, in conformity with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern Matter</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2 to the financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency
that raises substantial doubt about its ability to continue as a going concern. Management&rsquo;s plans in regard to these matters
are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this
uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
for Opinion</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Critical
Audit Matters</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
audit matters are matters arising from the current period audit of the financial statements that were communicated or required
to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements
and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit
matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    MaloneBailey, LLP</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>www.malonebailey.com</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company&rsquo;s auditor since 2017.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Houston,
    Texas</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="m_002"></A><FONT STYLE="font-size: 10pt"><B>PROTAGENIC
THERAPEUTICS, INC. AND SUBSIDIARY</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CURRENT ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">671,091</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">798,623</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">208,156</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,354</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL CURRENT ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">879,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">841,977</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equipment - net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">296</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">879,247</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">842,273</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">LIABILITIES AND STOCKHOLDERS&rsquo;
    DEFICIT</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CURRENT LIABILITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable
    and accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">571,517</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">865,047</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83,670</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">332,222</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    CURRENT LIABILITIES</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">655,187</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,197,269</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">PIK convertible notes payable, net of
    debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,081,384</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">174,821</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">PIK convertible
    notes payable, net of debt discount - related parties</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">292,412</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">104,549</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,028,983</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,476,639</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">STOCKHOLDERS&rsquo;
    DEFICIT</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred stock, $0.000001 par value; 20,000,000 shares authorized;
    872,766 shares issued and outstanding in the following classes:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred stock; par value $0.000001;
    2,000,000 shares authorized; none issued and outstanding</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series B convertible preferred stock,
    $0.000001 par value; 18,000,000 shares authorized;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">872,766 shares issued and outstanding at December 31, 2020, and
    December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $.0001 par value, 100,000,000
    shares authorized, 10,360,480 and 10,261,419 shares issued and outstanding at December 31, 2020, and December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,036</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,026</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid-in-capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,719,749</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,687,172</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17,698,936</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,150,201</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    other comprehensive loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(171,586</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(172,364</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    STOCKHOLDERS&rsquo; DEFICIT</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,149,736</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(634,366</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND STOCKHOLDERS&rsquo; DEFICIT</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">879,247</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">842,273</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>See
accompanying notes to the consolidated financial statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="m_003"></A><FONT STYLE="font-size: 10pt"><B>PROTAGENIC
THERAPEUTICS, INC. AND SUBSIDIARY</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the year ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">OPERATING AND ADMINISTRATIVE
    EXPENSES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research and development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">699,797</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">807,947</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,851,814</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,278,183</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    OPERATING AND ADMINISTRATIVE EXPENSES</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,551,611</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,086,130</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">LOSS FROM OPERATIONS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,551,611</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,086,130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">OTHER (EXPENSE) INCOME</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">502</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,813</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(246,178</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,886</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Realized gain on
    marketable securities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,435</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of derivative liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">248,552</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">343,857</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    OTHER INCOME (EXPENSES)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,876</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">335,219</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">LOSS
    BEFORE INCOME TAX</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,548,735</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,750,911</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">INCOME TAX EXPENSE</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">NET
    LOSS</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,548,735</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,750,911</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">COMPREHENSIVE LOSS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other Comprehensive
    Loss - net of tax</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign
    exchange translation gain (loss)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">778</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,647</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    COMPREHENSIVE LOSS</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,547,957</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,757,558</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss per
    common share - Basic and Diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.25</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.17</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted average common shares
    - Basic and Diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,339,071</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,261,419</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>See
accompanying notes to the consolidated financial statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="m_004"></A>PROTAGENIC
THERAPEUTICS, INC. AND SUBSIDIARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&rsquo; DEFICIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Fiscal Years Ended December 31, 2020 and 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Series
    B Convertible Preferred Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additional
    Paid-in-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Treasury
    Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated
    Other Comprehensive</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stockholders&rsquo;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(Deficit)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Deficit)</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    -December 31, 2018</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">872,766</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,261,419</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,026</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,357,920</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,399,290</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(170,540</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210,883</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Unrealized gain (loss)
    on marketable securities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,823</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,823</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency translation
    gain</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,647</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,647</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock compensation -
    stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">797,761</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">797,761</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt discount from beneficial
    conversion feature</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">402,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">402,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance of options
    for settlement of accounts payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">129,491</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">129,491</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,750,911</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,750,911</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    -December 31, 2019</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">872,766</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,261,419</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,026</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,687,172</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(15,150,201</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(172,364</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(634,366</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency translation
    gain</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">778</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">778</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock compensation -
    stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,427,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,427,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock compensation -
    warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">107,670</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">107,670</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt discount from beneficial
    conversion feature</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">104,204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">104,204</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance of options
    for settlement of accrued payroll</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">93,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">93,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock issued for services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">99,061</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">119,990</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">120,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt discount from warrants
    issued to placement agents</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">179,679</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">179,679</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,548,735</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,548,735</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">BALANCE
    -December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">872,766</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,360,480</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,036</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">16,719,749</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17,698,936</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(171,586</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,149,736</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>See
accompanying notes to the consolidated financial statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="m_005"></A><B>PROTAGENIC
THERAPEUTICS, INC. AND SUBSIDIARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the year ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net Loss</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,548,735</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,750,911</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash used in operating activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">286</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">339</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,654,754</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">797,761</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair value
    of the derivative liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(248,552</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(343,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain on sale of
    marketable securities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,435</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of
    debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,370</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on settlement
    of accounts payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">99,541</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(164,802</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,044</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(196,629</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">662,158</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NET
    CASH USED IN OPERATING ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,348,779</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(487,990</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM INVESTING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sale of marketable
    securities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NET
    CASH PROVIDED BY INVESTING ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM FINANCING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment of debt
    issuance costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(104,090</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from convertible
    notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,177,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from convertible notes - related party</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NET CASH PROVIDED
    BY FINANCING ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,223,410</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">670,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effect of exchange rate on cash and
    cash equivalents</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,163</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,127</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NET INCREASE (DECREASE)
    IN CASH</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(127,532</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">436,137</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH,
    BEGINNING OF YEAR</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">798,623</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">362,486</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH,
    END OF YEAR</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">671,091</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">798,623</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">SUPPLEMENTAL DISCLOSURES
    OF CASH FLOW INFORMATION</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    paid for interest expense</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    paid for income taxes</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NONCASH FINANCING
    AND INVESTING TRANSACTIONS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unrealized
    (gain) loss on marketable securities</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,823</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt
    discount from beneficial conversion feature</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">104,204</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">252,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt
    discount from beneficial conversion feature - related parties</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt
    discount from warrants issued to placement agents</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">179,679</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of options for settlement of accounts payable</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">93,950</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,950</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>See
accompanying notes to the consolidated financial statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="m_006"></A><FONT STYLE="font-size: 10pt"><B>PROTAGENIC
THERAPEUTICS, INC &amp; SUBSIDIARY</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2020 and 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1 &ndash; ORGANIZATION AND NATURE OF BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Company
Background</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protagenic
Therapeutics, Inc. (&ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;Protagenic&rdquo; or &ldquo;the Company&rdquo;), is a Delaware
corporation with one subsidiary named Protagenic Therapeutics Canada (2006) Inc. (&ldquo;PTI Canada&rdquo;), a corporation formed
in 2006 under the laws of the Province of Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was previously known as Atrinsic, Inc., a company that was once a reporting company under the Securities Exchange Act
of 1934, but that, in 2012 and 2013, reorganized under Chapter 11 of the United States Bankruptcy Code and emerged from bankruptcy.
On February 12, 2016, the Company acquired Protagenic Therapeutics, Inc. (&ldquo;Prior Protagenic&rdquo;) through a reverse merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 12, 2016, Protagenic Acquisition Corp., a wholly-owned subsidiary of the Company, merged (the &ldquo;Merger&rdquo;) with
and into Prior Protagenic. Prior Protagenic was the surviving corporation of the Merger. As a result of the Merger, the Company
acquired the business of Prior Protagenic and has continued the existing business operations of Prior Protagenic as a wholly-owned
subsidiary. On June 17, 2016, Prior Protagenic merged with and into the Company with the Company as the surviving corporation
in the merger. Immediately thereafter, the Company changed its name from Atrinsic, Inc. to Protagenic Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2 - GOING CONCERN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
shown in the accompanying consolidated financial statements, the Company has incurred significant reoccurring losses resulting
in an accumulated deficit. The Company anticipates further losses in the development of its business. The Company had negative
cash flows used in operations. These factors raise substantial doubt about the Company&rsquo;s ability to continue as a going
concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its current forecast and budget, management believes that its cash resources will be sufficient to fund its operations at least
until the end of the third quarter of 2021. Absent generation of sufficient revenue from the execution of the Company&rsquo;s
business plan and sales revenue is not anticipated before 2024, the Company will need to obtain debt or equity financing by the
third quarter of 2021. Management believes that actions presently being taken to obtain additional funding provide the opportunity
for the Company to continue as a going concern, however, management cannot be certain that such plans can be achieved. The accompanying
financial statements have been prepared assuming the Company will continue as a going concern; no adjustments to the financial
statements have been made to account for this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 - SUMMARY OF SIGNFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
of presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (&ldquo;U.S. GAAP&rdquo;) and the rules and regulations of the Securities and Exchange Commission
(&ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Principles
of consolidation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of Protagenic Therapeutics, Inc., and its wholly owned Canadian subsidiary,
PTI Canada. All significant intercompany balances and transactions have been eliminated in the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Reclassifications:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassifications
of prior periods have been made to conform with current year presentation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
of estimates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the consolidated financial statements and the reported amounts of revenue and expense during the reporting period. Actual results
could differ from those estimates. Significant estimates underlying the consolidated financial statements include income tax provisions,
valuation of stock options and warrants and assessment of deferred tax asset valuation allowance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentrations
of Credit Risk</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation.
At times, the Company may have deposits in excess of federally insured limits. The Company has not experienced losses on these
accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these
deposits is not significant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
While the Company&rsquo;s marketable securities are cash equivalents it is the Company&rsquo;s policy to present them separately
on the balance sheet. As of December 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Equipment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment
is stated at cost less accumulated depreciation. Cost includes expenditures for computer equipment. Maintenance and repairs are
charged to expense as incurred. When assets are sold, retired, or otherwise disposed of, the cost and accumulated depreciation
are removed from the accounts and any resulting gain or loss is reflected in operations. The cost of equipment is depreciated
using the straight-line method over the estimated useful lives of the related assets which is three years. Depreciation expense
was nominal for the years ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Marketable
Securities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for marketable debt securities, the only type of securities it owns, in accordance with sub-topic 320-10 of the
FASB Accounting Standards Codification (&ldquo;Sub-topic 320-10&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Paragraph 320-10-35-1, investments in debt securities that are classified as available for sale shall be measured subsequently
at fair value in the consolidated balance sheets at each balance sheet date. Unrealized holding gains and losses for available-for-sale
debt securities (including those classified as current assets) shall be excluded from earnings and reported in other comprehensive
income until realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company purchased $0 and sold $250,000 in marketable securities, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and December 31, 2019, the Company owned marketable securities with a total value of $0 and $0, respectively.
The Company recorded a realized gain on marketable securities of $0 and $4,435 for the years ended December 31, 2020 and 2019,
respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and December 31, 2019, the Company held no marketable securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value Measurements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, &ldquo;Fair Value Measurements and Disclosure,&rdquo; defines fair value as the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for
transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets
or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
three levels are described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 Inputs &ndash; Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 Inputs &ndash; Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable,
either directly or indirectly;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 Inputs &ndash; Unobservable inputs for the asset or liability including significant assumptions of the Company and other market
participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amount of the Company&rsquo;s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate
their fair value because of the short term maturity of those instruments. The carrying value of long-term debt approximates
fair value since the related rates of interest approximate current market rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
involving related parties cannot be presumed to be carried out on an arm&rsquo;s-length basis, as the requisite conditions of
competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply
that the related party transactions were consummated on terms equivalent to those that prevail in arm&rsquo;s-length transactions
unless such representations can be substantiated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets or liability&rsquo;s fair value measurement within the fair value hierarchy is based upon the lowest level of any input
that is significant to the fair value measurement. The following table provides a summary of financial instruments that are measured
at fair value on a recurring basis as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Carrying</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value Measurement Using</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative warrants
    liabilities</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83,670</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83,670</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83,670</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides a summary of financial instruments that are measured at fair value on a recurring basis as of December
31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Carrying</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value Measurement Using</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative warrants
    liabilities</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">332,222</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">332,222</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">332,222</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and
liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended
December 31, 2020 and the year ended December 31, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
                                         Value Measurement</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Using
                                         Level 3</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inputs
    Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, December 31, 2018</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">676,079</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair
    value of derivative warrants liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(343,857</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">332,222</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair
    value of derivative warrants liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(248,552</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83,670</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the derivative feature of the 127,346 and 295,945 warrants issued to the placement agent of the Company&rsquo;s
2016 private offering (the &ldquo;2016 Offering&rdquo;) and to a holder of its debt for debt cancellation in connection with the
Merger, respectively on the issuance dates and at the balance sheet dates were calculated using a Black-Scholes option model valued
with the following assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk free interest rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.59</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.09</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">133</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">169</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contractual term</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15
                                         Years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14
                                         Years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of
measurement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring
dividends in the near future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company&rsquo;s
peer group stock price for a period consistent with the warrants&rsquo; expected term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
term: The Company&rsquo;s expected term is based on the remaining contractual maturity of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded
a gain of $248,552 and a gain of $343,857 relating to the change in fair value, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Derivative
Liability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of
those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result
of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and
recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value
is recorded in the consolidated statements of operations as other income or expense. Upon conversion, exercise or cancellation
of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then
the related fair value is reclassified to equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject
to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative
instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement
of the derivative instrument is expected within 12 months of the balance sheet date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock based compensation costs under the provisions of ASC 718, &ldquo;Compensation&mdash;Stock Compensation&rdquo;,
which requires the measurement and recognition of compensation expense related to the fair value of stock based compensation awards
that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock
based payments granted to employees, officers, non-employees, and directors based on the grant date fair value estimated in accordance
with the provisions of ASC 718. ASC. 718 is also applied to awards modified, repurchased, or canceled during the periods reported.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any award granted under the Company&rsquo;s 2016 Equity Compensation Plan (the &ldquo;2016 Plan&rdquo;) payable in shares of common
stock is forfeited, cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being
made, or if shares of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of
common stock as to which such option or award was forfeited, or which were withheld, will be available for future grants under
the 2016 Plan. The Company recognizes the impact of forfeitures when they occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basic
and Diluted Net (Loss) per Common Share</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
(loss) per common share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding
for each period. Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common
stock outstanding plus the dilutive effect of shares issuable through the common stock equivalents. The effect of dilution on
net loss becomes anti-dilutive and therefore is not reflected on the consolidated statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Potentially
    Outstanding<BR> Dilutive Common Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Year<BR> Ended<BR> December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
                                         the Year</FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ended<BR>
                                         December 31, 2019</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion Feature Shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common shares issuable under
    the conversion feature of preferred shares</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">872,766</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">872,766</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock Options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,597,861</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,835,366</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,007,058</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,826,658</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Notes</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,598,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">536,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total potentially outstanding dilutive
    common shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,075,685</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,070,790</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
and Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses are charged to operations as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Foreign
Currency Translation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows Section 830-10-45 of the FASB Accounting Standards Codification (&ldquo;Section 830-10-45&rdquo;) for foreign
currency translation to translate the financial statements of the foreign subsidiary from the functional currency, generally the
local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional
currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record
(if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations
of a foreign entity shall be measured using the functional currency of that entity. An entity&rsquo;s functional currency is the
currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment,
or local currency, in which an entity primarily generates and expends cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of each foreign subsidiary is determined based on management&rsquo;s judgment and involves consideration of
all relevant economic facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts
a majority of its transactions, including billings, financing, payroll and other expenditures, would be considered the functional
currency, but any dependency upon the parent and the nature of the subsidiary&rsquo;s operations must also be considered. If a
subsidiary&rsquo;s functional currency is deemed to be the local currency, then any gain or loss associated with the translation
of that subsidiary&rsquo;s financial statements is included in accumulated other comprehensive income. However, if the functional
currency is deemed to be the U.S. Dollar, then any gain or loss associated with the re-measurement of these financial statements
from the local currency to the functional currency would be included in the consolidated statements of operations and comprehensive
income (loss). If the Company disposes of foreign subsidiaries, then any cumulative translation gains or losses would be recorded
into the consolidated statements of operations and comprehensive income (loss). If the Company determines that there has been
a change in the functional currency of a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date
of change would be included within the consolidated statements of operations and comprehensive income (loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on an assessment of the factors discussed above, the management of the Company determined its subsidiary&rsquo;s local currency
(i.e. the Canadian dollar) to be the functional currency for its foreign subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leases</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, FASB issued Accounting Standards Update (&ldquo;ASU&rdquo;) 2016-02: Leases (Topic 842). The new guidance generally
requires an entity to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use
assets. The standard will be effective for the first interim period within annual reporting periods beginning after December 15,
2018 and early adoption is permitted. The new standard requires a modified retrospective transition for existing leases to each
prior reporting period presented or entered into after, the beginning of the earliest comparative period presented in the financial
statements. This standard was adopted by the Company on January 1, 2018. The Company elected the package of practical expedients
permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward
the historical lease classification. The adoption of this standard did not have a material impact on the Company&rsquo;s consolidated
financial statements and related disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recent
Accounting Pronouncements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material
effect on the Company&rsquo;s financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued expenses consist of the following at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,161</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,161</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research and development</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">393,496</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">650,584</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,273</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">141,860</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">163,029</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">571,517</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">865,047</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2019, the Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment
of approximately $988,000 as an estimate for the study. 50% of the total price was paid upon the signing of the agreement, 35%
of the total price is to be paid upon completion of the in-life study, and the remaining 15% of the total price is to be paid
upon the issuance of the report. If the Company cancels the study the Company will be required to pay a cancelation fee. If the
cancelation happens prior to the arrival of the test animals then the Company will need to pay between 20% and 50% of the animal
fees depending on when the cancellation happens. If the cancellation occurs after the animals arrive but before the study begins
then the Company will be responsible for paying 50% of the protocol price plus a fee of $7,000 per room/week for animal husbandry
until the animals can be relocated or disposed of. If the Company cancels the study after it has begun then the Company will need
to pay any fees for procured items for the study and any nonrecoverable expenses incurred by the consultant. As of December 31,
2020 and December 31, 2019, the Company has paid $174,106 and $0 and there is a balance of $319,799 and $493,905 due, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2020, the Company issued 187,497 options to the Company&rsquo;s CFO to settle $93,950 in accrued compensations. The
difference between the fair value of the options and the liability settled of $163,036 was charged to stock compensation expense
during the year ended December 31, 2020. The options are fully vested on issuance, have an exercise price of $1.75, and expire
in 10 years from issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5 - DERIVATIVE LIABILITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the private placement transactions in 2016, the Company issued 127,346 and 295,945 warrants, respectively, to the placement
agent of the 2016 Offering and to Strategic Bio Partners, a holder of the Company&rsquo;s debt, for debt cancellation, respectively,
to purchase the Company&rsquo;s Series B Preferred Stock with an exercise price of $1.25 and a five-year term. Upon the effectiveness
of our reverse stock split in July 2016, these became warrants to purchase our common stock on the same terms and conditions.
The warrants, if exercised under the cashless provision, do not have an explicit limit on the number of shares that will be issued.
The warrants have a cashless exercise feature that requires the Company to classify the warrants as a derivative liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 &ndash; CONVERTIBLE NOTE PAYABLE (PIK NOTES)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Notes Payable</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fourth quarter of 2019, the Company entered into a series of unsecured convertible notes (the &ldquo;Convertible Notes&rdquo;).
The Convertible Notes have a total principal amount of $420,000. The Convertible Notes accrue 6% interest per year payable on
October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase in the principal amount
of each Convertible Note that increases to 12% per year (the Default Rate&rdquo;) in the case a default. The Company will pay
(a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding
principal amount of the Convertible Notes on each interest payment date and on the maturity date. Each PIK Payment will be preceded
by written notice from the Company to the Convertible Note holder setting forth in reasonable detail the amount of such PIK Payment
and the principal amount of the Convertible Note following such PIK Payment. The Convertible Notes are due on November 6, 2023.
The Convertible Notes are convertible into shares of the Company&rsquo;s common stock with a conversion price of $1.25 per share,
subject to adjustment in certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second quarter of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $850,000.
The notes accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by
a corresponding increase in the principal amount of each note that increases to 12% per year in the case of the notes entering
default. The Company will pay (a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the
Default Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each
PIK Payment will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount
of such PIK Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The
notes are convertible into shares of the Company&rsquo;s common stock with an exercise price of $1.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the third quarter of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $327,500.
The notes accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by
a corresponding increase in the principal amount of each note that increases to 12% per year in the case of the notes entering
default. The Company will pay (a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the
Default Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each
PIK Payment will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount
of such PIK Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The
notes are convertible into shares of the Company&rsquo;s common stock with an exercise price of $1.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated the terms of the Convertible Notes and determined that there are no derivative features in the Convertible
Notes. These Convertible Notes do have a beneficial conversion feature and recorded a total debt discount of $356,204 with $104,204
being recorded in the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Katalyst
Securities LLC acted as the Company&rsquo;s placement agent (the &ldquo;Placement Agent&rdquo;) for the sale of the Convertible
Notes. The Company paid the Placement Agent, including its sub-agents, a commission of 10% of the funds raised from the investors
introduced by the Placement Agent. In addition, the Placement Agent will receive warrants to purchase a number of shares of Common
Stock equal to 10% of the shares of Common Stock issuable upon conversion of the Notes sold to the investors who were introduced
to us by the Placement Agent (See note 7). The Company recognized $104,090 in expenses related to the Placement Agent commission
for this offering which were recorded as a debt discount. This debt discount and the fair value of the warrants issued to the
placement agent of $179,679 are being amortized over the life of the notes from the private placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company amortized $117,036 and $6,821 of the debt discount, respectively. At December
31, 2020 and December 31, 2019, the Company had an unamortized debt discount of $516,116 and $245,179, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and December 31, 2019, the Company owes $1,597,500 and $420,000 on the outstanding Convertible Notes, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maturity
    Date of Notes for Twelve Months Ending December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount
    due</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,597,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2025</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,597,500</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Convertible
Notes Payable &ndash; Related Party</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fourth quarter of 2019, the Company issued unsecured Convertible Notes in the aggregate principal amount of $250,000 to related
parties. The notes accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable
by a corresponding increase in the principal amount of each Convertible Note that increases to 12% per year in the case of the
notes entering default. The Company will pay (a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including
interest at the Default Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity
Date. Each PIK Payment will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail
the amount of such PIK Payment and the principal amount of the Note following such PIK Payment. The notes are due on November
6, 2023. The notes are convertible into shares of the Company&rsquo;s common stock with an exercise price of $1.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the second quarter of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $50,000.
The notes accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by
a corresponding increase in the principal amount of each note that increases to 12% per year in the case of the notes entering
default. The Company will pay (a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the
Default Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each
PIK Payment will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount
of such PIK Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The
notes are convertible into shares of the Company&rsquo;s common stock with an exercise price of $1.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the third quarter of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $100,000.
The notes accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by
a corresponding increase in the principal amount of each note that increases to 12% per year in the case of the notes entering
default. The Company will pay (a &ldquo;PIK Payment&rdquo;) the interest due by adding such interest (including interest at the
Default Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each
PIK Payment will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount
of such PIK Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The
notes are convertible into shares of the Company&rsquo;s common stock with an exercise price of $1.25 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated the terms of the notes and determined that there are no derivative features in the note. The Convertible
Notes issued to related parties have a beneficial conversion feature and, accordingly, the Company recorded a debt discount of
$150,000 during the year ended December 31, 2019. No debt discount was recorded during the year ended December 31, 2020. During
the year ended December 31, 2020 and 2019, the Company amortized $37,863 and $4,549 of the debt discount, respectively, on Convertible
Notes issued to related parties. Additionally, a fee of $9,000 was expensed related to the notes. At December 31, 2020 and December
31, 2019, the Company had an unamortized debt discount of $107,588 and $145,451, respectively, on Convertible Notes issued to
related parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and December 31, 2019, the Company owes $400,000 and $250,000 on the outstanding notes, respectively, held
by related parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maturity
    Date of Notes for Twelve Months Ending December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount
    due</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">400,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2025</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">400,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 - STOCKHOLDERS&rsquo; DEFICIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the consummation of the Merger completed on February 12, 2016, we adopted Prior Protagenic&rsquo;s 2006 Employee,
Director and Consultant Stock Plan (the &ldquo;2006 Plan&rdquo;). On June 17, 2016, our stockholders adopted the 2016 Plan and,
as a result, we terminated the 2006 Plan. We will not grant any further awards under the 2006 Plan. All outstanding grants under
the 2006 Plan will continue in effect in accordance with the terms of the particular grant and the 2006 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the 2016 Plan, the Company&rsquo;s Compensation Committee may grant awards to any employee, officer, director, consultant,
advisor or other individual service provider of the Company or any subsidiary. On each of January 1, 2017, January 1, 2019 and
January 1, 2020, pursuant to an annual &ldquo;evergreen&rdquo; provision contained in the 2016 Plan, the number of shares reserved
for future grants was increased by 564,378 shares, or a total of 1,693,134 shares. As a result of these increases, as of December
31, 2019 and December 31, 2020, the aggregate number of shares of common stock available for awards under the 2016 Plan was 4,304,245
shares and 4,868,623 shares, respectively. Options issued under the 2016 Plan are exercisable for up to ten years from the date
of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were 5,597,861 options outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the
Black-Scholes assumptions and or factors as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected dividend yield</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk free interest rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.64%-1.61</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected life in years</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">140%-146</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were 3,835,366 options outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the
Black-Scholes assumptions and or factors as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00
                                       - $1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected dividend yield</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk free interest rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.09%-2.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected life in years</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">137%-140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is an analysis of the stock option grant activity under the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                         Average</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                         Average </B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    Options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2018</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,846,299</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.36</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.20</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">126,567</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(137,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,835,366</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.34</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.02</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,762,495</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.01</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,597,861</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.47</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.48</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of the Company&rsquo;s nonvested options as of December 31, 2020, and changes during the year ended December
31, 2020, is presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested
    Options</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted-Average<BR>
                                         Exercise Price</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested at December 31, 2018</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">800,210</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.63</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">126,567</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.15</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(584,895</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.46</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(137,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested at December, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">204,382</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.74</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,762,495</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,104,044</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">862,833</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.75</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had 5,597,861 shares issuable under options outstanding at a weighted average exercise price
of $1.47 and an intrinsic value of $38,328.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, the Company had 3,835,366 shares issuable under options outstanding at a weighted average exercise price
of $1.34 and an intrinsic value of $635,536.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of options granted during the years ended December 31, 2020 and 2019 was 1,762,495 and 126,567, respectively. The
exercise price for these options was $1.00 per share or $1.75 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized compensation expense related to options issued of $1,427,084 and $797,761 during the years ended December 31,
2020 and 2019, respectively, in which $1,354,750 and $698,293 is included in general and administrative expenses
and $72,334 and $99,468 in research and development expenses, respectively. For the year ended December 31, 2020, $1,046,795
of the stock compensation was related to employees and $380,289 was related to non-employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the unamortized stock option expense was $898,665 with $305,527 being related to employees and $593,138
being related to non-employees. As of December 31, 2020, the weighted average period for the unamortized stock compensation to
be recognized is 2.99 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2019, the Company granted 101,567 options with an exercise price of $1.00 and a ten year term. 59,900 of these options
vest immediately and 41,667 vest bi-weekly over two months. These options have a Black-Scholes value of $199,807. The Company
issued 59,900 options for settlement of accounts payable totaling $29,850 and recorded a loss of $99,541 on the settlement of
the accounts payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2019, the Company granted 25,000 options with an exercise price of $1.75 and a ten year term. These options vest immediately
and have a Black-Scholes value of $36,374.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2020, the Company issued a total of 1,387,497 options to purchase shares of the Company&rsquo;s common stock to sixteen
individuals with 1,362,497 option going to twelve related parties. These options had a grant date fair value of $1,901,724. From
these options, 187,497 options were used to settle $93,950 in accrued compensations. These options have an exercise price of $1.75.
187,497 of the options vest immediately, 510,000 of the options vest monthly over 12 months, 5,000 of the options vest monthly
over 24 months, 420,000 of the options vest monthly over 36 months, and 265,000 of the options vest monthly over 48 months. These
options were approved by the board of directors on February 13, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2020, the Company issued 124,998 options to a related party. These options have an exercise price of $1.75 and a term
of ten years. These options vest immediately and the grant date fair value of these options was $142,607.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2020, the Company issued 105,000 options to consultants. These options have an exercise price of $1.75 and a term of
ten years. These options vest monthly over four years and the grant date fair value of these options was $119,792.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2020, the Board of Directors increased the size of the Board from five directors to six directors and appointed Jennifer
Buell, Ph.D. as a member of the Board, effective immediately, to fill the vacancy created by such increase and to serve until
the next annual meeting of shareholders. Dr. Buell was issued options to purchase 100,000 shares of the Company&rsquo;s common
stock at an exercise price of $1.75 per share. The options vest as follows: monthly over 48 months. In recognition of her upcoming
service as a Director of the Company, Dr. Buell was issued 45,000 options that vest monthly over 12 months. In each case the vesting
commenced on the date of grant, July 18, 2020. These options had a grant date fair value of $165,426.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Warrants:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Merger, all of the issued and outstanding warrants to purchase shares of Prior Protagenic common stock converted,
on a 1 for 1 basis, into new warrants (the &ldquo;New Warrants&rdquo;) to purchase shares of our Series B Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the Merger and the 2016 Offering, New Warrants to purchase 3,403,367 shares of Series B Preferred Stock at an average exercise
price of approximately $1.05 per share were issued to holders of Prior Protagenic warrants; additionally, the holder of $665,000
of our debt and $35,000 of accrued interest exchanged such debt for five-year warrants to purchase 295,945 shares of Series B
Preferred Stock at $1.25 per share. Warrants to purchase 127,346 shares of Series B Preferred Stock at an exercise price of $1.25
per share were issued to the placement agent in connection with the 2016 Offering. These warrants to purchase 423,291 shares of
Series B Preferred Stock have been recorded as derivative liabilities. All of these warrants automatically converted into warrants
to purchase our common stock upon the effectiveness of our reverse stock split in July 2016. See Note 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of warrant issuances are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                         Average</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted
                                         Average<BR> </B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2018</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,826,658</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.05</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.69</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,826,658</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.05</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.69</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">180,400</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.53</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,007,058</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.06</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.86</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had 4,007,058 shares issuable under warrants outstanding at a weighted average exercise price
of $1.06 and an intrinsic value of $782,668.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, the Company had 3,826,658 shares issuable under warrants outstanding at a weighted average exercise price
of $1.05 and an intrinsic value of $1,375,990.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2020, the Company extended the expiration date for 100,000 warrants to purchase shares of the Company&rsquo;s common
stock. The expiration date was extended by two years from January 2, 2020 to January 2, 2022. These warrants have an exercise
price of $1.25 and are fully vested. The Company recognized $95,187 in stock compensation as part of this modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2020, the Company issued 81,600 warrants to purchase shares of the Company&rsquo;s common stock. These warrants vest
immediately, had an exercise price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $86,968, which
is being amortized over the life of the notes from the private placement. These warrants were issued as compensation to the placement
agents in connection with the Company&rsquo;s private placement offering of debt in which $6,643 was recorded as stock compensation
expense and $80,325 recorded as a debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the third quarter of 2020, the Company issued 98,800 warrants to purchase shares of the Company&rsquo;s common stock. These warrants
vest immediately, had an exercise price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $105,194
which is being amortized over the life of the notes from the private placement. These warrants were issued as compensation to
the placement agents in connection with the Company&rsquo;s private placement offering in which $5,840 was recorded as stock compensation
expense and $99,354 recorded as a debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 - COLLABORATIVE AGREEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and the University of Toronto (the &ldquo;University&rdquo;) entered into an agreement effective April 1, 2014 (the &ldquo;New
Research Agreement&rdquo;) for the performance of a research project titled &ldquo;Teneurin C-terminal Associated Peptide (&ldquo;TCAP&rdquo;)
mediated stress attenuation in vertebrates: Establishing the role of organismal and intracellular energy and glucose regulation
and metabolism&rdquo; (the &ldquo;New Project&rdquo;). The New Project is to perform research related to work done by Dr. David
A. Lovejoy, a professor at the University and stockholder of the Company, in regard to TCAP mediated stress attenuation in vertebrates:
Establishing the role of organismal and intracellular energy and glucose regulation and metabolism. In addition to the New Research
Agreement, Dr. Lovejoy entered into an agreement with the University in order to commercialize certain technologies. The New Research
Agreement expired on March 30, 2016. In February 2017, the New Research Agreement was extended to December 31, 2017. The extension
allowed for further development of the technologies and use of their applications. On April 10, 2018, the agreement was amended
and the research agreement has been further extended to December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to January 1, 2016, the University has been granted 25,000 stock options which are fully vested at the exercise price of $1.00
exercisable over a ten year period which ends on April 1, 2022. As of December 31, 2020, Dr. David Lovejoy of the University has
been granted 553,299 stock options, of which 527,570 are fully vested. These have an exercise price of $1.00, $1.25 or
1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026,
March 1, 2027, October 16, 2027 or on February 13, 2030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sponsorship research and development expenses pertaining to the Research Agreements were $0 and $63,905 for the years ended December
31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 - LICENSING AGREEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 31, 2005, the Company had entered into a Technology License Agreement (&ldquo;License Agreement&rdquo;) with the University
pursuant to which the University agreed to license to the Company patent rights and other intellectual property, among other things
(the &ldquo;Technologies&rdquo;). The Technology License Agreement was amended on February 18, 2015 and currently does not provide
for an expiration date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the License Agreement and its amendment, the Company obtained an exclusive worldwide license to make, have made, use, sell
and import products based upon the Technologies, or to sublicense the Technologies in accordance with the terms of the License
Agreement and amendment. In consideration, the Company agreed to pay to the University a royalty payment of 2.5% of net sales
of any product based on the Technologies. If the Company elects to sublicense any rights under the License Agreement and amendment,
the Company agrees to pay to the University 10% of any up-front sub-license fees for any sub-licenses that occurred on or after
September 9, 2006, and, on behalf of the sub-licensee, 2.5% of net sales by the sub-licensee of all products based on the Technologies.
The Company had no sales revenue for the years ended December 31, 2020 and 2019 and therefore was not subject to paying any royalties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company fails to provide the University with semi-annual reports on the progress or fails to continue to make reasonable
commercial efforts towards obtaining regulatory approval for products based on the Technologies, the University may convert our
exclusive license into a non-exclusive arrangement. Interest on any amounts owed under the License Agreement and amendment will
be at 3% per annum. All intellectual property rights resulting from the Technologies or improvements thereon will remain the property
of the other inventors and/or Dr. Lovejoy, and/or the University, as the case may be. The Company has agreed to pay all out-of-
pocket filing, prosecution and maintenance expenses in connection with any patents relating to the Technologies. In the case of
infringement upon any patents relating to the Technologies, the Company may elect, at its own expense, to bring a cause of action
asserting such infringement. In such a case, after deducting any legal expenses the Company may incur, any settlement proceeds
will be subject to the 2.5% royalty payment owed to the University under the License Agreement and amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
patent applications were made in the name of Dr. Lovejoy and other inventors, but the Company&rsquo;s exclusive, worldwide rights
to such patent applications are included in the License Agreement and its amendment with the University. The Company maintains
exclusive licensing agreements and it currently controls the five intellectual patent properties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Legal
Proceedings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time we may be named in claims arising in the ordinary course of business. Currently, no legal proceedings, government
actions, administrative actions, investigations or claims are pending against us or involve us that, in the opinion of our management,
could reasonably be expected to have a material adverse effect on our business and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; RELATED PARTY TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is provided free office space consisting of a conference room by the Company Executive Chairman, Dr. Armen. The Company
does not pay any rent for the use of this space. This space is used for quarterly board meetings and our annual shareholder meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 13, 2020, the Company issued 50,000 options to purchase common stock to a related party. These options had an exercise
price of $1.75 and a term of 48 months. (See Note 7)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11 &ndash; INCOME TAXES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of loss before income taxes are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Domestic</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,542,428</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,698,689</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,307</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(52,222</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss before income
    taxes</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,548,735</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,750,911</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no income tax expense due to operating losses incurred for the years ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, a reconciliation of the Company&rsquo;s effective tax rate to the statutory U.S. Federal
rate is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income taxes at Federal
    statutory rate</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21.0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21.0</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">State income taxes, net of Federal income
    tax effect</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Perm difference</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign tax rate differential</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in valuation allowance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Other</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income tax provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects of temporary differences that give rise to the Company&rsquo;s deferred tax assets and liabilities are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S. net operating loss
    carryforwards</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,907,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,894,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,217,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">784,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Canadian Provincial income tax losses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Canadian Provincial
    scientific investment tax credits</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,121,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,703,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Valuation allowance</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,121,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,703,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net deferred
    tax assets</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company had federal net operating loss carryforwards (&ldquo;NOL&rdquo;) of approximately $7,550,000
and $7,161,000, respectively. The 2017 Tax Cuts and Jobs Act (&ldquo; TCJA&rdquo;) will generally allow losses incurred after
2017 to be carried over indefinitely, but will generally limit the net operating loss deduction to the lesser of the net operating
loss carryover or 80% of a corporation&rsquo;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as
amended). Also, there will be no carryback for losses incurred after 2017. Losses incurred prior to 2018 will generally be deductible
to the extent of the lesser of a corporation&rsquo;s net operating loss carryover or 100% of a corporation&rsquo;s taxable income
and be available for twenty years from the period the loss was generated. The federal net operating losses generated prior to
2018 of $0.1 million will expire at various dates through 2037. The CARES Act temporarily allows the Company to carryback net
operating losses arising in 2018, 2019 and 2020 to the five prior tax years. In addition, net operating losses generated in these
years could fully offset prior year taxable income without the 80% of the taxable income limitation under the TCJA which was enacted
on December 22, 2017. The Company has been generating losses since its inception, as such the net operating loss carryback provision
under the CARES Act is not applicable to the Company. As of December 31, 2020 and 2019, the Company had state and local net operating
loss carryforwards of approximately $7,540,000 and $7,153,000, respectively, to reduce future state tax liabilities also
through 2035.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company had Canadian NOL of approximately $1,115,000 and $1,111,000, respectively. The Canadian
losses expire in stages beginning in 2026. As of December 31, 2020 and 2019, the Company also has unclaimed Canadian federal scientific
research and development investment tax credits, which are available to reduce future federal taxes payable of approximately $0
and $0 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of losses and uncertainty of future profit, the net deferred tax asset has been fully reserved. The net change in the
valuation allowance during the years ended December 31, 2020 and 2019 was an increase of $418,000 and $661,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
earnings are assumed to be permanently reinvested. U.S. Federal income taxes have not been provided on undistributed earnings
of our foreign subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest and penalties related to uncertain tax positions in selling, general and administrative expenses.
The Company has not identified any uncertain tax positions requiring a reserve as of December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to file U.S. federal and state income tax returns. These returns are subject to audit by tax authorities beginning
with the year ended December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
12 - SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
February 25, 2021, the Company issued 366,000 options to purchase share of the Company&rsquo;s common stock. 350,000 of these
options vest over 48 months and have a term of ten years and the remaining 16,000 options vest immediately and have a term of
five years. All of these options have an exercise price of $5.60.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the first quarter of 2021, a total of 268,233 warrants were exercised for a total of 161,026 shares of the Company&rsquo;s common
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 93; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.2</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_001.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_002.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_003.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_004.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_005.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_006.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_007.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_008.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-2_009.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.4</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-4_001.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_002.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_003.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_004.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_005.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_006.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_007.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_008.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex10-4_009.jpg" ALT="" STYLE="height: 867px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSIDIARIES
OF PROTAGENIC THERAPEUTICS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Organization/Incorporation</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Protagenic
    Therapuetics Canada (2006) Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5in; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.2pt 0pt 0.5in; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.2pt 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
consent to the incorporation by reference in the Registration Statement on Forms S-8 (File Nos. 333-214553, 333-214554, 333-217963,
333-232535, 333-237081, 333-254112) of our report dated March 23, 2021 with respect to the consolidated financial statements of
Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;) appearing in this Annual Report on Form 10-K for the year ended December
31, 2020. Our report contains an explanatory paragraph regarding the Company&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.2pt 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    MaloneBailey, LLP</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">www.malonebailey.com</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Houston,
    Texas</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Garo H. Armen, PhD, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 10-K of Protagenic Therapeutics, Inc..</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
        such internal control over financial reporting, or caused such internal control over financial reporting to be designed
        under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
        of financial statements for external purposes in accordance with</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">generally
        accepted accounting principles;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s <BR>
    internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
    information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Garo H. Armen</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
    H. Armen, Ph.D.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Alexander K. Arrow, MD, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 10-K of Protagenic Therapeutics, Inc.;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
        such internal control over financial reporting, or caused such internal control over financial reporting to be designed
        under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
        of financial statements for external purposes in accordance with</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">generally
        accepted accounting principles;</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s <BR>
    internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
    information; and </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alexander K. Arrow</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    K. Arrow, MD</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 906</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the annual Report of Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;) on Form 10-K for the period ended
December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), we, Garo
H. Armen, Executive Chairman, and Alexander K. Arrow, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><P STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
        Garo H. Armen</I></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garo
    H. Armen, PhD</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alexander K. Arrow</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    K. Arrow, MD, CFA</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Charter
of the Audit Committee of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Board
of Directors of Protagenic Therapeutics, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Purpose</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
principal purpose of the Audit and Finance Committee (the &ldquo;Committee&rdquo;) is to assist the Board of Directors (the &ldquo;Board&rdquo;)
of Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;) in fulfilling its responsibility to oversee the Company&rsquo;s accounting
and financial reporting processes and audits of the Company&rsquo;s financial statements, including by reviewing the financial
reports and other financial information provided by the Company, the Company&rsquo;s disclosure controls and procedures and internal
accounting and financial controls, and the annual independent audit process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
discharging its oversight role, the Committee is granted the authority to investigate any matter brought to its attention with
full access to all books, records, facilities and personnel of the Company and the authority to engage independent counsel and
other advisors, as it determines necessary to carry out its duties. The Committee also is authorized to approve the use of Company
funds to the extent it deems such expenditures necessary or appropriate in carrying out the responsibilities of the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall be responsible for the appointment (and where appropriate, replacement), compensation, retention and oversight
of the work of the Company&rsquo;s outside auditor in preparing or issuing an audit report or related work, including resolving
any disagreements between management and the outside auditor regarding financial reporting. The Committee shall receive direct
reports from the outside auditor. The Committee shall be responsible for overseeing the independence of the outside auditor and
for approving all auditing services and permitted nonaudit services provided by the outside auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
Charter shall be reviewed for adequacy on an annual basis by the Committee and any changes thereto shall be submitted to the Board
for approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Membership</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall be comprised of not less than two members of the Board, and the Committee&rsquo;s composition will meet the
Nasdaq Audit Committee requirements. Accordingly, subject to the paragraph below, all of the members will be
directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Who
    are &ldquo;independent&rdquo; as defined by applicable Nasdaq rules, who meet the criteria for independence set forth in Rule
    10A-3(b)(1) under the Securities Exchange Act of 1934, as amended (subject to the exemptions provided in Rule 10A-3(c)), and
    who have not participated in the preparation of the financial statements of the Company or any current subsidiary of the Company
    at any time during the past three years. In order to ensure the independence of the Committee members, the Committee&rsquo;s
    members must be monitored throughout the year to confirm that they all remain independent as required by Nasdaq rules. In
    addition, it must be considered whether any members of the Committee have relationships with the Company that may create the
    appearance of a lack of independence, even though such relationships do not automatically disqualify the person from being
    &ldquo;independent&rdquo; under applicable laws and listing rules;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Who
    do not receive any consulting, advisory or other compensatory fee from the Company, other than in the member&rsquo;s capacity
    as a member of the Board or any of its committees; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Who
    must be able to read and understand fundamental financial statements, including the Company&rsquo;s balance sheet, income
    statement, and cash flow statement. In addition, at least one member must have past employment experience in finance or accounting,
    requisite professional certification in accounting, or any other comparable experience or background which results in the
    individual&rsquo;s financial sophistication, including being or having been a chief executive officer, chief financial officer
    or other senior officer with financial oversight responsibilities. Unless otherwise determined by the Board (in which case
    disclosure of such determination shall be made in the Company&rsquo;s annual report filed with the SEC), at least one member of
    the Committee shall be an &ldquo;audit committee financial expert&rdquo; (as defined by applicable SEC rules).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Except
under exceptional circumstances approved by the Board, no member of the Committee may serve simultaneously on the audit committee
of more than three other public companies. Subject to applicable law and regulations, the Board may appoint one member who does
not meet the independence requirements set forth above and who is not a current employee of the Company or an immediate family
member of such employee if the Board, under exceptional and limited circumstances, determines that membership on the Committee
by the individual is required in the best interests of the Company and its shareholders. Such member may not serve for more than
two years, and may not serve as the Committee chair. The Board shall disclose in the next proxy statement after such determination
the nature of the relationship and the reasons for the determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
order to fulfill its role, the Committee shall be organized and governed in the following manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Committee
    members and the Committee chair will be recommended by the Corporate Governance and Nominating Committee and appointed and
    removed, with or without cause, by the Board;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
    may be taken by the Committee (or any subcommittee of the Committee) upon the affirmative vote of a majority of the members
    of the Committee (or subcommittee);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    member of the Committee may call a meeting of the Committee upon due notice to each other member at least twenty-four hours
    prior to the meeting (provided that participation in any meeting shall be deemed to constitute waiver of any deficiency in
    such notice);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
    may be taken by the Committee without a meeting if all of the members of the Committee indicate their approval thereof in
    writing or by electronic transmission;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall have the authority to delegate to subcommittees of the Committee any responsibilities of the full Committee;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall periodically perform an evaluation of the performance of the Committee and report to the Board on the results
    of such evaluation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Key
Responsibilities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee&rsquo;s role is one of oversight, and it is recognized that the Company&rsquo;s management is responsible for preparing
the Company&rsquo;s financial statements and that the outside auditor is responsible for auditing those financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following functions shall be the common recurring activities of the Committee in carrying out its oversight function. The functions
are set forth as a guide and may be varied from time to time as appropriate under the circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review with management and the outside auditor the audited financial statements to be included in the Company&rsquo;s
    Annual Report on Form 10-K and the Annual Report to Stockholders, including the Company&rsquo;s disclosures under &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; and shall review and consider with the outside
    auditor the matters required to be discussed under generally accepted auditing standards, including Auditing Standard No.
    16, or other such requirements established by the Public Company Accounting Oversight Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
    a whole, or through the Committee chair, the Committee shall review with the outside auditor, prior to filing with the SEC,
    the Company&rsquo;s interim financial information to be included in the Company&rsquo;s Quarterly Reports on Form 10-Q and
    the matters required to be discussed by SAS No. 61 or other such requirements established by the Public Company Accounting
    Oversight Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall recommend to the Board whether, based on the reviews and discussions referred to above, the financial statements
    should be included in the</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Company&rsquo;s
    Annual Report on Form 10-K.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall periodically discuss with management and the outside auditor the effectiveness and adequacy of the Company&rsquo;s
    internal controls and internal auditing procedures, including any significant deficiencies or material weaknesses in the design
    or operation of those controls which could adversely affect the Company&rsquo;s ability to record, process, summarize and
    report financial data and any fraud, whether or not material, that involves management or other employees who have a significant
    role in the Company&rsquo;s internal controls, and discuss with the outside auditor how the Company&rsquo;s financial systems
    and controls compare with industry practices.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall periodically review with management and the outside auditor the quality, as well as acceptability, of the
    Company&rsquo;s accounting policies, and discuss with the outside auditor how the Company&rsquo;s accounting policies compare
    with those in the industry and all alternative treatments of financial information within generally accepted accounting principles
    that have been discussed with management, the ramifications of use of such alternative disclosures and treatments and the
    treatment preferred by the outside auditor.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall periodically discuss with the outside auditor whether all material correcting adjustments identified by the
    outside auditor in accordance with generally accepted accounting principles and the rules of the SEC are reflected in the
    Company&rsquo;s financial statements.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review with management and the outside auditor any material financial or other arrangements of the Company
    which do not appear on the Company&rsquo;s financial statements and any transactions or courses of dealing with third parties
    that are significant in size or involve terms or other aspects that differ from those that would likely be negotiated with
    independent parties, and which arrangements or transactions are relevant to an understanding of the Company&rsquo;s financial
    statements.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review with management and the outside auditor the Company&rsquo;s critical accounting policies and practices.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review with the outside auditor all material communications between the outside auditor and management, such
    as any management letter or schedule of unadjusted differences.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall (i) request from the outside auditor annually a formal written statement delineating all relationships between
    the auditor and the Company consistent with other requirements as may be consistent with requirements established by the Public
    Company Accounting Oversight Board; (ii) discuss with the outside auditor any such disclosed relationships or services and
    their impact on the outside auditor&rsquo;s independence; and (iii) take appropriate action to oversee the independence of
    the outside auditor.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall approve the engagement of the outside auditor and shall approve, in advance, all audit services and all permitted
    non-audit services to be provided to the Company by the outside auditor. The committee may also delegate this responsibility
    (for services up to $50,000) to the chairman in between meetings, with those actions disclosed to the full committee at the
    next regularly scheduled meeting.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall approve a code of ethics, as required by rules of the SEC, for senior financial officers and such other employees
    and agents of the Company as it determines.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall ensure that this charter is posted to the Company&rsquo;s Web site in accordance with the rules and regulations
    of the SEC or the exchanges.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and approve all transaction required to be disclosed in the Company&rsquo;s filings with the SEC pursuant
    to Item 404 of Regulation S-K (each, a &ldquo;Related Party Transaction&rdquo;). In considering any Related Party Transaction,
    the Committee shall consider the facts and circumstances regarding such transaction, including, among other things, the amounts
    involved (including whether the transaction amount exceeds $120,000), the relationship of the related person (including those
    persons identified in the instructions to Item 404(a) of Regulation S-K) with the Company and the terms that would be available
    in a similar transaction with an unaffiliated third-party. The Committee shall also consider its fiduciary duties, the Company&rsquo;s
    obligations under applicable securities law, including disclosure obligations and director independence rules, and other applicable
    law in evaluating any Related Party Transaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Complaint
Procedures</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
issue of significant financial misconduct shall be brought to the attention of the Committee for its consideration. In this connection,
the Committee shall establish procedures for (i) the receipt, retention and treatment of complaints received by the Company regarding
accounting, internal accounting controls or auditing matters and (ii) the confidential, anonymous submission by employees of the
Company of concerns regarding questionable accounting or auditing matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Adopted
March 25, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
be amended in May 2016 following expected corporate name change to Protagenic Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amended
March 7, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>10
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Charter
of the Compensation Committee of the </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Board
of Directors of Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Purpose</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
principal purpose of the Compensation Committee (the &ldquo;Committee&rdquo;) of the Board of Directors (the &ldquo;Board&rdquo;)
is to approve, administer and interpret the Company&rsquo;s executive and key employee compensation and benefit policies, including
the Company&rsquo;s equity incentive plans. The Committee shall ensure that the Company&rsquo;s executive and key employee compensation
and benefit program is consistent with the Company&rsquo;s compensation philosophy and the Company&rsquo;s Guidelines on Significant
Corporate Governance Issues, and determine the executive compensation packages offered to the Company&rsquo;s executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee&rsquo;s responsibilities and authority include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and approve corporate goals and objectives relevant to, and incentives for risk-taking created by,
    executive officer compensation, and evaluate the performance of executive officers in light of those goals, objectives and
    incentives;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall determine the compensation of the Chief Executive Officer and/or Executive Chairman; provided that the Chief
    Executive Officer or Executive Chairman may not be present during voting or deliberations on his or her compensation; provided,
    further, that in evaluating and determining the compensation of the Chief Executive Officer or Executive Chairman, the Committee
    shall consider the results of the most recent stockholder advisory vote on executive compensation (&quot;Say on Pay Vote&quot;)
    required by Section 14A of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and approve the compensation of other executive officers and key employees; provided that in evaluating
    and determining the compensation of other executive officers and key employees, the Committee shall consider the results of
    the most recent Say on Pay Vote;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and recommend compensation for members of the Board and Board committees; provided that no adoption,
    amendment or termination of any compensation plan under which a member of the Board who is not an employee of the Company
    may be a participant shall be effective unless the same shall be approved by the Board and, to the extent required by law
    or the rules of the Nasdaq Stock Market, by the Company&rsquo;s stockholders;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and discuss with management the compensation discussion and analysis required to be included in the
    Company&rsquo;s filings with the Securities and Exchange Commission and, based on such review and discussion, in the case
    of compensation discussion and analysis proposed to be included in the Company&rsquo;s annual report on Form 10-K or proxy
    statement, recommend to the Board whether the compensation discussion and analysis should be included in such annual report
    or proxy statement;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and consider the outcome of stockholder advisory votes on the compensation of the Company&rsquo;s named
    executive officers when considering future executive compensation arrangements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall make recommendations to the Board regarding the adoption of new incentive compensation plans and equity-based
    plans and administer the Company&rsquo;s existing incentive compensation plans and equity-based plans, including reviewing
    and approving stock option grants. To the extent permitted by applicable law and the provisions of a given equity-based plan,
    and consistent with the requirements of applicable law and such equity-based plan, the Committee may delegate to one or more
    executive officers of the Company the power to grant options or other stock awards pursuant to such equity-based plan to employees
    of the Company or any subsidiary of the Company who are not directors or executive officers of the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall have authority to adopt, amend or terminate compensation plans applicable to any class of employees of the
    Company and/or any subsidiary of the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall consider and take actions with respect to the adoption, amendment, administration and termination of compensation,
    welfare, benefit, pension and other plans related to compensation of employees of the Company, in each case taking into account
    appropriate industry benchmarks and, as appropriate, the compensation policies pursued by companies similarly situated to
    the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall establish and review the Company&rsquo;s policies concerning perquisites provided to the Company&rsquo;s executive
    officers, including benefits provided upon retirement or other termination of employment;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review and recommend to the Board the frequency with which the Company will conduct Say on Pay Votes, taking
    into account, among other things, the results of the most recent stockholder advisory vote on frequency of Say on Pay Votes
    required by Section 14A of the Exchange Act;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee may, in its sole discretion, retain or obtain the advice of any compensation consultants, legal counsel or other
    advisers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall be directly responsible for the appointment, compensation and oversight of the work of any compensation consultant,
    legal counsel and other adviser retained by the Committee;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Company must provide for appropriate funding, as determined by the Committee, for payment of reasonable compensation to a
    compensation consultant, legal counsel or any other adviser retained by the Committee;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Committee,
    other than in-house legal counsel, only after taking into consideration the following factors:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    provision of other services to the Company by the person that employs the compensation consultant, legal counsel or other
    adviser;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    amount of fees received from the Company by the person that employs the compensation consultant, legal counsel or other adviser,
    as a percentage of the total revenue of the person that employs the compensation consultant, legal counsel or other adviser;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    policies and procedures of the person that employs the compensation consultant, legal counsel or other adviser that are designed
    to prevent conflicts of interest;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    business or personal relationship of the compensation consultant, legal counsel or other adviser with a member of the Committee;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    stock of the Company owned by the compensation consultant, legal counsel or other adviser; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9675;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
    business or personal relationship of the compensation consultant, legal counsel, other adviser or the person employing the
    adviser with an executive officer of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall, not less than annually, review and assess the adequacy of this charter and submit any changes to the Board
    for approval;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall, not less than annually, perform an evaluation of the performance of the Committee and report to the Board
    on the results of such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall review such other matters as the Board or the Committee shall deem appropriate.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Membership</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall be composed of at least three directors, at least two of which shall satisfy the independence and eligibility
requirements of the Nasdaq Stock Market and be appointed by the Board on the recommendation of the Corporate Governance and Nominating
Committee. In addition, at least two members of the Committee shall qualify as &ldquo;outside directors&rdquo; within the meaning
of Section 162(m) of the Internal Revenue Code, as amended, and shall be a &ldquo;nonemployee director&rdquo; within the meaning
of Rule 16b-3 under the Exchange Act. Subject to applicable law and regulations, if the Committee consists of three or more members,
the Board may appoint, for a period not to exceed two (2) years, one or more members who do not meet the independence requirements
of the Nasdaq Stock Market and as otherwise set forth above and who is not a current employee of the Company or an immediate family
member of such employee if the Board, under exceptional and limited circumstances, determines that membership on the Committee
by the individual or individuals is required in the best interests of the Company and its shareholders. The Board shall disclose
in the next proxy statement after such determination the nature of the relationship and the reasons for the determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
order to fulfill its role, the Committee shall be organized and governed in the following manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Committee
    members will be appointed and removed by the Board on the recommendation of the Corporate Governance and Nominating Committee;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
    may be taken by the Committee (or any subcommittee of the Committee) upon the affirmative vote of a majority of the members
    of the Committee (or subcommittee) provided, however, at any time the Committee consists of two members, if one member recuses
    himself or herself due to a potential conflict of interest, action may be taken by the other member;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    member of the Committee may call a meeting of the Committee upon due notice to each other member at least twenty-four hours
    prior to the meeting (provided that participation in any meeting shall be deemed to constitute waiver of any deficiency in
    such notice);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
    may be taken by the Committee without a meeting if all of the members of the Committee indicate their approval thereof in
    writing or electronic submission; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Committee shall have the authority to delegate to subcommittees of the Committee any of the responsibilities of the full Committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Adopted
March 25, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
be amended May 2016 following expected corporate name change to Protagenic Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amended
March 7, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>11
<FILENAME>ex99-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Charter
of the Corporate Governance and Nominating Committee of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Board
of Directors of Protagenic Therapeutics, Inc. (the &ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Function</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Corporate Governance and Nominating Committee (the &ldquo;Committee&rdquo;) shall, among other things, review and recommend policies
to the Board of Directors of the Company (the &ldquo;Board&rdquo;) regarding Board procedures, Board leadership, the process for
annual evaluations of the performance of the Board, the Chairman of the Board, the Executive Chairman, and/or the Chief Executive
Officer and issues of corporate public responsibility, including charitable contributions; evaluate the independence of Board
members and serve as the Company&rsquo;s nominating committee to review the requisite skills and criteria for new Board members
as well as the composition of the Board as a whole, recommend a slate of director nominees to be proposed by the Board to the
Company&rsquo;s stockholders, recommend any director nominees to be elected by the Board to fill interim vacancies and recommend
directors for membership on the Board committees. If a director believes that a significant issue exists that implicates corporate
governance at the Company, that director should promptly bring such issue directly to the attention of the Committee; absent unusual
circumstances, discussion with the Committee should occur prior to raising the matter with other directors or members of management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Organization
and Governance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall consist of not less than two members appointed by the Board at the recommendation of the Committee who may or
may not satisfy the independence and eligibility requirements of the Nasdaq Stock Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
order to fulfill its role, the Committee shall be organized and governed in the following manner:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Committee
members will be appointed and removed, with or without cause, by the Board;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
may be taken by the Committee (or any subcommittee of the Committee) upon the affirmative vote of a majority of the members of
the Committee (or subcommittee); provided, however, at any time the Committee consists of two members, if one member recuses himself
or herself due to a potential conflict of interest, action may be taken by the other member;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
member of the Committee may call a meeting of the Committee upon due notice to each other member at least twenty-four hours prior
to the meeting (provided that participation in any meeting shall be deemed to constitute waiver of any deficiency in such notice);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Action
may be taken by the Committee without a meeting if all of the members of the Committee indicate their approval thereof in writing
or by electronic transmission; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall have the authority to delegate to subcommittees of the Committee any responsibilities of the full Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Management
Oversight</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall oversee the development and presentation to the Board of management&rsquo;s plans for succession to senior management
positions in the Company, including the position of Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Other</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Committee shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Periodically
review and assess the adequacy of this charter and submit any changes to the Board for approval;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Periodically
perform an evaluation of the performance of the Committee and report to the Board on the results of such evaluation;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Periodically
evaluate the Company&rsquo;s Code of Business Conduct and Ethics (including the Company&rsquo;s Policy Statement on Insider Trading
and Disclosure by Company Personnel, Directors and Executive Officers) and, if appropriate, recommend changes thereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Review
such other matters as the Board or the Committee shall deem appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Powers
of the Corporate Governance and Nominating Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
order to fulfill its role, the Committee shall have the authority to retain and terminate a search firm to assist in the identification
of director candidates, and have the authority to approve the search firm&rsquo;s fees and other retention terms. The Committee
shall also have the authority to obtain advice and assistance from internal or external legal, accounting or other advisors and
to authorize payment of such advisors with Company funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Adopted
March 25, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
be amended May 2016 following expected corporate name change to Protagenic Therapeutics, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amended
March 7, 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>form10-k_001.jpg
<TEXT>
begin 644 form10-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $4 7L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VC4]5GMKI
M;2SB26<IO8R$A8QG +$>N. .N#TJH=1U="662SF(Y,1C9/R.XX_$4QP1K&HA
MOOF1&'NFP!?PR&_6N:T"6SC\4:W%;%]LIB92P<[RH.\Y;T)_PJ;O4ZH0A:-^
MIU]MK;W,7F+$%()5T;@HPZ@U-_:DH_@CK%M>=1OROW,QJ?\ ?"\_H5K&U[[7
M<Z@9+6UDE_LU%F1@P4>:3N/!^]\@(X_OU*NWN6X04;V.S_M27_GFGZT?VI+_
M ,\T_6N8U?4'ABLKF"=EA?YC$F!)*#C&W(()&>5XSZ\525[N*2ZMX;ZX6:35
M C94,8XF&<KD<9]>G%-7:W$XTT[<IVG]J2_\\T_6C^U)?^>:?K7')?:A_:TT
M+721B*1U\N7G,83Y7"A<DYPV=V.HQ4 U6Y6P@D-U(Y28K+L92UQPO,1V8(R?
MND ]1GBBTNX6I_RG<?VI+_<3]:!JLC $)&0>A!KF[V[EAUVVA$S-%( OD1XW
M!CGYF!'*\#H1C'?-8]MJ5TTNG6[7+6R>3;,Q"JB#<3O!&WJ>  ,8H2D^H.--
M/8[S^U)?^>:?K2'5G4J&6,%CA03U/M7'17U_#$ES/-<2K)'=%XEB7*>6WR;1
MCKCUSFF6-S<7E]:>:[3)%>D1R$[OE,!/W@H!Y)&<>U%GW#EI_P IVHU60D@)
M&<=>>E']J2_\\T_6N4>2[?57MXI7@26_\MWCC7<4\@-U(]1U/TJ*RU&YEFLD
MOKR6 -$"I6(#SY/,92#P>P7@8^]FC7N/EI_RG8?VI+_SS3]:/[4E_P">:?K7
M$&]U*/3;&>:[D N7D\V1ML8BQG8H.TXSCJ1SCMFI'U2]6]L(C,S2DP"8*!Y<
M@?[S*-N2/?(P:+2[BM3_ )3L_P"U)?\ GFGZT?VI+_SS3]:X@:I?"T8?:6EV
MW*K-=*0(U0AC\IV?)R ""#C/7G-6(;^[6[TU9[Q9Q*-I2WQEB6;#G*_,N,9Q
MC!!/>BTNX6I_RG7#5G9F4+$2IPP!Z?6E_M27_GFGZUQEY<7-I>WS1$Q12WJ+
M+-G;M7R%Q\Q4@9( SBGI>ZF);*V>82->I&5FB3Y4VL?,.<=TQU[YQ19]PY:>
MW*=>VK.B%W6)5'4L< 4O]IR_\\T_6N!EN[^]TN_6XE4L87\VVZM&P<8PNT8&
M,]2<\&MNRO)GUN^MWF:<+N9-A&R, X"L,9#?B01DT--=04:;?PG1G595!)2,
M <DD]*;'K#31K)%Y3HPRK(V0?H17"3W=Y>Z3<QFZGD>2QE:ZC\H+]GD&,(..
M_P PP<D@9KK((_)MXX]Q;:H&2 "?R %)W2W'&$)/8T?[3E_YYI^M']IR_P#/
M-/UJE14\S-/8T^QH1:C+),B%$ 8X-:585O\ \?,7^\*W:TB[G+7BHM)!1115
M& 445BZAJ=PUV]G8E4,>/.G9=VTD9"J.YQR2>!D=:!QBY.R-JBN4M]1NI7E-
MGJZ73POMECD",H;^Z2H!4_YQ70:=?+J%H)@AC<,4DC)R48=1_P#7[C%).Y4H
M..Y;HHJO>7D5G#ODR2>%4=6/H*&TE=DI-NR)RP4$DX [FJ4FKVB-M5VE/I&N
M[]>E<GK'B%C*82/M%QVMD;"1_P"^:Q&>^U",O+=,,'!@0[%'MQS^.:QE5MKM
M^?W?YF].@Y[:_@OO_P COGUZ%.L+#_>=5_K3!XCMS_ OX3)_C7GGV*VF3S([
M;&P@G=SGUZU<.G69'_'O'C_=%9^W7=_<C?ZFUO;\3O(]<@?_ )8R?\!*M_(U
M9BU.SE(7S@C?W7&T_K7E[6<,27"B#&S)21>#],BKJ?;88D,%W)]T9CE_>*?S
MY_6J5?S^]?Y$RP<TMON?^?\ F>G @C(I:\[M/$=Q9,%N8W@'_/2'+Q_BAY'X
M5UEAKL-RB&1DVO\ =F0Y1O\ "M5477_@'-*FT[?\/_7I<V** <T5H9A1110!
MA:W:>;>1312&&X1,"0#.1G[K#N/\BLXQZE(-CW,$:]WBC);\-Q('ZULZG_Q\
M)_N_UJE64GJ=]**Y$1P01VT*Q1 A1SR<DD\DD]R3WJH^KVL.IR6,\J0NJQLA
M=\;RQ(P!^'ZU?K&U#2+F\NKLQS0+!=Q1PRAD)=0I)RIZ9.>_UH5GN7*Z7NEU
M]7T^)Y5:]B#1';(-V2I]#[\&E.IVJ%S)/$D*HC"4R#!#YQ^>./6J;Z7=K Z6
M]RJ%[N2X<990ZMGY25YXR.G7&*KV_A^2&&"-IXV\L6H/RGGRF9C^>:=H]R;S
M[&E<ZK!#I$VHPNL\,:%_D; .#R,]J>-5L3;M<"]A,*ML9P_ ;T^M59M)>72M
M1L_-3-W+(X8@X7<<X--N-*G;4'O;>6(2"=)HTD4[>(S&0<>QR".E%HC;GV+A
MU2Q'DC[9#^_&Z(!_OCU%4'N?#]S<^<UU;/([(#B8X<C[F1G!]B:6TT9[>5I6
MF1G>"6-MJX :20N2/1><8J)] =K-X!-&&.GQV8;;T*DG/T]J/=[B;F^AJC4+
M3[4UK]JC^T*"6CW?,,#)_3FF1:K83Q2R1WL+I$H:1@X(4'H?I5'^Q[@R[#/%
M]F6YDNDPI\S>X;@]L L>>I  J*7P^\EK%$)T4Q6D, (! +1N&SP<X..W/-%H
M]PYI]C4_M2Q,<;_:XMLK%4^;[Q'4?A3+K46@N1:P6LMS<%/,9$95"IG&26('
M)X ]C5!M&N-D;0M!;W E:1IDDD9ESMS@D_-D* 0W'3TJW=65V-1^W6,D"N\0
MAD2=6*D DJ1CN,GZYHM$+RML,76U-_\ 9VM9D4SK;>:67_6% V",YQ@]:FT[
M49-10RBUDB@)8)(SJ=^&*G@<CI51-#*:D=15XA=_:A+Y@3&8]BHR'ZX)'IQ5
MG2-*ATNVVA(S,2QDE1<%\L6&?SH?+;0(\]]24:M8,)6%[#B''F$O@+DXY]L\
M9H_M6P^SK<&]A$+/L#[^"WI]:R/^$?O)3(UU>1RN\:Q[FW'=ME#Y()P.!C X
MJW)I5RNH-?6\T/F_:'E595)7:T:H0<<Y^7/Z46CW#FGV+$&JQRZ(FJ,I2,Q&
M7:#DX] >^?ZTEGK$5X]LGER1&XB>0>9CY61L.A_VAFJXT:0Z'9:8UQA(63SG
M0;2X4YPOISM_*H)_#TS031V]Z59K@S12299E#KME!/?.21[T6B#<^Q*WB1%B
M$PL[AH! +EW!7Y(RQ4-C//3/':M*"Y>:ZNH750(64*5;.05SSZ54?1+674DN
M)8XWABMTABB8'Y=K$@^AZCKZ5?2"*.1Y$B19'^^P4 M]3WI.W0<5.^I+D^II
M***DT"BBB@"6V_X^HO\ >%;M85M_Q]1?[PK=K2&QQXGXD%%%%6<P5S"@PZC?
MP/Q)YQE'NC 8/Z$?A73U3OM-M[\(90RR)G9+&VUUSUP?3V/%)JZL73GR2N</
MX=1X=4U<#3;BT@GF62'?$$7 0*1P>N0:ZSP^"\=W<*?W4T^8SV8*JJ2/J0?R
MH'A^-_EN+RZGC[QL54,/0[0"?SK61%C1410J*,*JC  ]!1;6Y4ZB<>5#+B>.
MV@>:0X11DUPVOZU-&X"8^W3C$2GD0)_>/^>370:W<@S+"S8BA4RR?T_J:\YC
MFDO;B>_?[\S_ "@]D' %*$?:3=]E^+)D^2*2W?X+_@D]CBTG*'+"4\N>N[U)
MJR]S&JNT63(S#*KU!%4I,EMH(P1\V>U6+20B,Q6Z!I5.'D/3ZD^M98NGKSH[
ML#45O9OY$H27RG2"+9OZLY_I4JO<(H4P9 &,AJ!!-C,ETW_ 5  J%KA8SM6]
M+GT*@_X5QQC)[([I3BMVA9A=2)\P"QD_,@&21]:D>:;S!'"BG"@DL>*B61Y!
MN))(XWQD@_B#0H;SO-BG+28P4DXR*'&2W0XRC+9HF$CNX1[9@3U;/ J%FETN
M<36@W"0_O(#]V0=^.Q]ZG,Z/;-(5.T?>7N*AM(0TK7&#M/"9))QZ\TXS<7H9
MU*49Q][I^9V&A:S'+#%B0M;2<(S=8V_NM725Y39W1LM1D9E LIY/*EYX#]F]
MO0UZ)I%VTT+02G,L/!)_B7L:[*<EHEL]OU7R_(\JK3<6T]UO^C_KJ:5%%%;&
M!C:U<16[K)-(J(%QD^N>GN?:LHZG;+S)YT2'^.6%D7\R,#\:LW.+G6[B:09^
MS$0Q _P_*&8CW.[&?05BZ?J&I2>(KO3KE[6X@BA$CO!&5\IB>(VR3N)7FLVK
MMG;3DU")N]1FBJ5BH@GN;1?]5$5:,?W58'Y?H"#CV-4=0T^SF\0Z:TMM&[2"
M4N2/O;57&?I2MJ;.6ES:!!Z$'Z4M<K:W=]80;HF$R227I2W\OHR,S+R.3D@_
MG3EU:_.G23_;K8H&C.\2Q;\%264?P@\ @'GJ*?(1[5'44F1DC(R.HKGH]6O9
M]62*.2-(MT6V.8JC21LH);!^;=R< < C%)=2W-MK&I7,,P5$:T5XS&#O#':>
M>W![4<@_:+='1T5S1UB[#NRW"/+FX$EIY8S $#%6/?JJ]>#NXI+B]U6&W!%\
MI=-.:]8F!<,V1A<=EZ^_O1R,/:HZ:BN<DU*]@G>VGO$1/.B#731J/*5XV;'I
M]Y0 3Z\YJ(ZIJ4L#-'=(@BM)YQ((0?.V/A3@] P]/PHY&'M4=117/+JM]+K!
MB#PQ1K(B^5(ZC=&4#%@/O$Y/&..*=:WMS>Z%J*FY+W<4;#S8=K+NV9'EE>H^
MO([TN1A[1&]D9QD9]*6N1-Q<H/MUM?B1XM)64R%%;S2')VGT[@XYJZNJ7TFL
MS0AXDCCE9/)=U!*!,A@/O$YY],9I\@E578Z&BL71KR]GF@2[G67S[%+GB,)L
M8G! QU'UJEIUS?-%8VJZD6DENYTF=HU9XPNXA?8\#KV/TI<H_:+L=/17(2ZO
M=0QPV\$\5JTGG,K;$"[A.5^;=T&,GCG-3G6;YM0OEBF5_LPGQ;E4_>;!\@7^
M(GJ3^E/D8O;(ZBBN9AU+4IX(ECO83YUS%&LR[)&4,K%LA>!T&,\^M7;YY8M=
ML%:]:.)[>52A  E<;>/J1GIZ<=Z7*/VB:NC9!!&001ZBBN1M=0O].T2!5E68
M?V=%,F8P/*^=5/U 4YY]/2M[2)Y[BUD:>6*7$I5'C=6RN!]XKQGKT]J'&PXU
M%+0T****DLEMO^/J+_>%;M85O_Q\Q?[PK=K2&QQXGXD%%%%6<P4444 %%%-<
M,48*VUB.#C.#0!PWBBY*V&JRAN6?R@?;('^-<S /+MXDZ?**VO$4J_V)F5-^
M^X7=@XR<G)_^M641G!';I3PO\._=LJM_$:[)$#,P@D88+9__ %5K6T26UFB1
MX("YS_>/4G\:SEB:1BD8^9L$CL/>K$A-G$SAF52<"+&<D]A7/BW>2BCNP:2A
M*3,F>ZN+ZX,<KF*,<E,X ']:C61V?R[2$$#T7)/O5B_MQ;+$UU(S>9GY8P/E
MXXY/6J21SBW:6)6 /"MTS36D5R(?,I2?M':WS_ NVNJ36XVE492<GC!K7+0W
M=NLB]"1CL0?\:Y*VF2/4(8Y3*\;G#,5+*![X'%:J7[R2M% T,C!=A:-L\=C[
M<5SU82HS_>.]^QU4YT\1"U%6MW-*1V%A(H.Z21S&"/XCTS5T;+> ;F 1%Y)K
M&2YVO$SK(GE\)@!E7\*O;?MUM\TB-M8%2HX)]Q6"9T3C;?8B8QR:9=L_$4KL
M4!Z\]/UKI/#>H.T%C<R'YO\ CWFSZ].?QP:PPT<CJ\B,98>D0YP?4#^M7--9
MFM=1!&TK,' ]#M!_I6]-OD?E9_HS@Q45[2+[W7X71Z-145O)YUM%)_?0-^8J
M6NX\LYS54DLM3:YBB:6&90943EE8<!@.XQ@$=>!UKG].M=/TR:1[&74IWD9G
M:W)<@LQY)W  'W)KKM3_ ./A/]W^M4LUFY:L[J4+P3*UG#)&))9]OGS-N<*<
MA<# 4'O@=^YS4QEB618VD02'HI89/T%/K&OM&:\N-3E!C1[FU2"*4C+(1OS]
M!\PZ5*LWJ:NZ6A?>_MT:VV,LHGE\I&C((#;2W)_X":D\ZU*2'S8-B']X=PPI
M]_0_6L:#1IPT4FSR7^T"23,P?@1,@*X50/O#\J@M=$O;6S95CC^T+%'#O:56
M615;)P-F%/7!;.":JR[D<TNQT)GMSY3&6(^9Q&Q8?-_N^OX4Y98G=XU=&=/O
MJ&!*_4=JY^VT:]MOLC)'$)HYG8R&4,JQM)O*E=O/'0C&#[5/I&CRV%X'G!<Q
MB15F$H(<,V>5V@YZ=2>:&EW&I2OL:SW%O&9=TT0:-=T@W#*J.Y%5X-2AFTG^
MTF0QP>69.2&.WKV)_+\*S(]%N?,5'BM]L;SO]H#9>?S P"L,<?>&<D_=&*M2
MZ7.^C6.GQND(3RO/9 #P@R< C!RP'7MFBR%>78G.K6AL;>Y59)5NL"*)(\NY
MQDC;[8.<],4Q]:C2:&(V%^7F!V#R ,X'(Y/:J<>DZA9SI-"\=R8+B22-9&V;
MTE +C@84ALD<8P:OM;W,]YIUS*D2-#YAD17+8W+@8.!FBT0O-C_[1M?+$Q#;
M?M/V4'9R'W;?RS3H+L;;HR1"%+=B&8-N4\;B<XZCN*RQX?(83[5^T?VC]IW>
M:V-GF;NG3./:M"YTV,:3>VEH@C,\4B@9.-S ^ON:'8$Y;LFM[N":&W8[(GG0
M.D+L V",]*E66&24JLD;2*.0&!8#_"L&>QOM1:SGC2-(0MO)AL(Z%6#,&^4D
M^@Y&.:#X?F^SJD?DPRLMVLDJ=3YI)7D<GMFBR[AS2[&Q+J%E!")GNH1&7$0<
M."-Q. ,BDM[ZWN+B>%&598I"A4D9?"@Y'<C!'-9$FC7,R2S?8[2%\V^RV1\H
MWEL223MXR#@<=!S4_P#8TGVIKD)"LK7ZW&\?>$8C"XSCZ\46CW#FGV+=S9Z?
M?22/)("53R9@DQ4%<YVN >F2>#ZU7,>EV-U:3!CME>1XF\[,4;;2689.!D9Z
M>M9T7AN<:?);2HK2>4D.]I@5D42*Q^4*",X/4GK^-:NIV#S36$EO:V\R6LC.
M8)"$4@J0,<$ Y/I3T6EQ:M7L7S+;Q%09(4W<@%@-W?(]>]-^U0N8BC+*DA.U
MT(91@9/.?Y5B6^@W%M"Y5;5KA;$00LZ[E1][L0 1]W# ?ATI(-$O%<NPC7=-
M+)M+@D!H/+'(4#.?04K+N/FEV-^.6*7/E21OMX.Q@<>QQ3PH484 #T%96EZ4
MVGS1LJ11H+**!A'QEU)R??KUK6J7Y%Q;:U"BBBD42VW_ !]1?[PK=K"MO^/J
M+_>%;M:0V./$_$@HHHJSF"BBB@ HHJ.X)6WD*G#!3@_A0P/.?$>F&1I2N]X4
M+1$H-Q49W!L=\'@UCXNHD59K>:('_EJT9*5V4D+,H'85 T4B]'8?0USTZ\X1
M<;:'=.C&HU*^J_$YR&XMT39]NC4=]O#$^Y-5[R\M$EB9[MI(EW9"C<<D8 &.
M23TK?NY5MHPTP$C.=J1E [2-Z*#_ )'4UDZO:RG3$O)D1+B.4$)" %@&#R".
MK>K?@,#KBE%N^IT)U':*2*-^DM[<PM<0M:D1@):LVZ3'JW]TG^[V%/\ LLLE
MB]S-(RJBGRXAV(X'ZT^VOK.ZGB:YM9I+LE5W(P.\]!UZ5HO%-/>2?:(Q#'')
MO$&<DD\@L1QCGH*4KW2ELBE[B<>7WGN/EQ'"TFT!EPY(&"2.M8US9PW$DCRP
MI*VXDL5Y^N>M;DXW6\H]4/\ *LFTE\J")Y!NEQE<'&%[9]:QD]3JIKW2O)8%
M9MD%S/$ <A2^]1^#9_G58B_LSYD?DS)G+!28R>?3D5LRMEB-JH9.<MSG_"J\
MH?OL)Z&DS2/8L)?P.HFEM9X2>?,\O</^^ES^M7M&N8+F+5'@FCDS)@!6!/"C
MM7.VDUVLRQ6A8NYP%49KJH]&MQI:6]U##/.Q^9V0$EV/8]:Z(V5%M_:T^YZG
MF8F_UB,%]G7[UH=QIP*Z;; ]?*7^56JRDT4VZ*+/4+RWVC 4R>:GY/G]"*T(
M$E2%5FE$D@'S.%V@_AGBNU*R/-;N[F?J?_'PG^[_ %JE5W4_^/A/]W^M4JRE
MN>A1^!!6+=:K<66K78:%IK2**!FPX7R]S,I('4GIQ[5M56FT^VN#.98]QG5%
MD^8\A3E?U)H32W*FFUH4SK6V3)M6^S-+) DV\99T#9^7L#M8 ^W2H#X@G%M%
M-_9C9DMFN]OGK\L:[3SQ]X[NGZU<?3M/CNO-=<23.VU6D.TNP.XJN<!B,\CW
MJ4Z;:%%0Q?*MN;8#<>(SC(_0<U5X]B+3[E)==8MY1L66X=HQ%&91APX9@2?X
M<!6SUZ=Z:^ON 5CT]WF1)FE0R@!/*(##..<Y&/Z5=ETJSESNB(8B,!E<AEV9
MVD$'@C)Y]Z5-+LXU"K#_ ,LWC)+$DJYRV3W)(SGK1>/8+3[E,>(86OX[>.!W
M0M&C-GD%U##Y<= ",G/&?:K6DSR36DBRL7>">2$N>K;6(!_+%.CTVVBG6:(2
M1E0H*I*P5MHP-PS@X''-5=.MH%CANH[X31QF9V=&PCN[99CST'0>E&EM 7,G
MJ1R>([>&?RIH70J9A(<@A#'R,_[P&13+75[K[=,MQ;/Y#W,4*DR#,)>-2%QU
M/).3[U;?2M*U#SI_+CF%PT;R.CY#%/N\@X_+KWJRUA;-(\AC^9IEG)W'[Z@
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MCID=<5IZ)XQMM?UZ6QLHB;9+;SA,YP6;?M(V^@XY/_UZOVEOX>O0PM+?39<
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M6#HO_(?\0?\ 7>/_ -%B@#7%E:@ "VA '81BE^QVW_/O#_WP*FHH A^QVO\
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M***H@R=!^[J/_7_-_.M:LG0?NZC_ -?\W\ZUJ ,K4_\ CX3_ '?ZU2J[J?\
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MV*]%^#=LTFNZE=X^2*W6//NS9_\ 9:TA\2,:S]QGLM%%%=!YYDZ#]S4?^O\
MF_G6M63H/W-1_P"O^;^=:U &5J?_ !\)_N_UJE5W4_\ CX3_ '?ZU2K&6YZ-
M'X$%%%%(T*UC)>2Q2&]MXX'$K!%CDWADS\K'T)]*I:_J$^E6T%W'S$)"DJ;<
MYW*0G_C^W\ZT;>ZM[M&>WFCE5'*,4;(##J#[BH;_ %"*P$/F132M,_EQI"FY
MB<$]/H#5+?8B7P[G+CQ-JEK;%IX8Y9H6%I,6Q&@F&YF;/& 0% YQS4__  DM
MU'J"6RPQ[Y[G;B>3A%Q'D C XW$_A[ULQ:]ITL;RF=(X J$22, &W9XQU!&T
M]1V]JK7-UX=OKAY;N2V>2SD$9>3("DX8#T([]QQ5W7\IE9])&5#X@U6.PA#F
MWW;HW,\VX_NVF9#NZ8(P.1VJ]JFL7%IK/D-,\,2F$1QI&I,^\X9OFZ@<#"\C
MK6N=6T[S98C>P>9$&,B[QE0O+9^G6DNM4M;.:TCF9MUT^R(JN0#QR3V'(&?4
MBE>[V*M9?$<X/%D\[2.L  @E;&QB!(HBD8!@>>J=.*W])OY[Y;A;F*..6%U7
M]TQ*D,BN.O\ O8_"FPZ]ILOV@/<10O;NR2+(P!7:VW<?8G^=3#5]-(@Q?6_^
MD'$7SCY^<<?CQ]:3[6"&FKD7:*SSKNDKC.HVPR2HS(!R#@_S%/&KZ>RQ%+R%
MO.!,0#CY\9R![\$5-F:\T>Y=HK&A\3:?(L6]C$\RAHD8C+?NP^.#QP1UQ5M-
M8L&3+W4,;B(3,C2#**0#SV[BCE8E.+ZEZBF12QSQ)+$X>-QE6'0BGTB@HHHH
M **** "BBB@ HHHH EMO^/J+_>%;M85M_P ?47^\*W:TAL<>)^)!1115G,%8
M.B_\A_7_ /KO'_Z+%;U86B_\A_7_ /KO'_Z+% &[1110!%%;00>9Y4*)YKEY
M-J@;F/4GU-8WA6X\ZPN81G9;W,D<?^YG('X9K>KG/!D7EZ/,S#YVN9-WU!Q_
M2@#H\5'<3QVMM)/*P6.)2[L>P R:DK/URR?4="OK.(XDF@=%^I'% UN>'^)_
M$=QXDU1KF3*6Z96"'LB_XGO6 S4^4/%(T<BE)$)5E(Y!'!!J!FKCU;NSU$DE
M9",U1,U*S5"S9IB;$9N]>\_"[1&TGPDEQ,NV>_;SV!ZA,80?ES^->9^ O!TO
MB?51/<1D:5;N#,QZ2L/^68_KZ#ZU] JH50J@  8 '05M3CU..O/[(M%%%:G.
M9.@_=U'_ *_YOYUK5DZ#]S4?^O\ F_G6M0!E:G_Q\)_N_P!:I5=U/_CX3_=_
MK5*L9;GHT?@04444C0CB@A@5EAB2,,Q9@B@98]3QWJO?Z>;XVS)<R6\MO)YD
M;QJK'.TKT((Z$T^QMY[:*1;B\>Z9I6=69 NU2>%X[#UJGK=M-<+:;8'N;9)M
MUS;QL%:1=I ZD9PV#C/-4M]R)?#L5)?!]A)&$$LR[=N"VUN0&!)!&#G><^].
MO/"MM>02P&[N(X9'#F--N 1'Y?3'H!]".*JVMIK]M]FAB+);R%F97D#?9E#L
MRIGJ=P*J<9QBF6</B4PQ?:9KC>&=G&47)$?"[N?E+^WZ5>O<R]W^4N7OAV":
MTBMEGVK]L^TR%VP2IX=1CJ",#\:MZEH%MJLS37$LX;RA''Y;E1'AMVX =3G'
M7(^45SHTW7;R.)[V&221"P!=EW!?-A8 X/\ LO\ E6CJNG7=QKL\T%M*7<0"
MWNED"K#M8E\\YY!Z8.:-;[A=6^$LOX8MY))&DNKAPSLZJ0N$+.KMCCG)4#FG
M2>';5IFD-S,JRN6F3Y<2 R&0*<C(PQ[<FLR-]?N(Y3'+-(;>[%NJH57SE0G+
ML3TSD#C/W>E1+#K.JI("UR;?[1R7*  I<#!C'480'.?;K3][N*\>D39/ANU:
MW2$S2X2%H<\<AI!(3TZY&/I44OABTEOHYS=3ADE:<1Y7&6<MTQQR2/?BJZ1^
M(1-;JSSD*P ;='M($K;C+W.8]N,=ZKR6GB!+9)4\^2[>U19)-R!T;>20#QP!
MCC/XTE?N-\O\II1>&+>%(UCN9QLXS\O(\H1$=.ZC/UIB>$K*.21UD<F2/8=\
M:/@[0N>1W"CCI6OI_P!I.G6OVP8NO*7SNGW\<]..M6*CFEW-%3B];$%G;"RL
MX;8222B)=H>1LLWU-3T45)HE;0**** "BBB@ HHHH **** );?\ X^8O]X5N
MUA6W_'U%_O"MVM(;''B?B044459S!6#HO_(?\0?]=X__ $6*WJP=%_Y#_B#_
M *[Q_P#HL4 ;U%%% !6?;VDUC?RF *UI<.9&4G!C<CDCU!].QK0HH **** /
M/_'7@$ZPSZII05;_ !^]B/"S^_LW\Z\;NX9K*X>WNHG@F0X:.5=K#\#7U)5:
MYTZRO65KJSMYROW3+$K8^F16<J:>IO3KN*L]3YBM;.[U&816-K/<N>BPH6_E
M7H'AKX2WMVZ7&OO]EM^OV:-LR/[$CA1],GZ5[%%!%;H$AB2-!T5%"C]*DH5-
M+<)5Y/;0KV5E;:=:16EG D-O$NU(T& !5BBBM# **** ,G0?N:C_ -?\W\ZU
MJR=!^YJ/_7_-_.M:@#*U/_CX3_=_K5*MN>TBN'#/NR!C@U6-M8J0#. 2^P9D
M'+>GU]JS<6V==.O&,4F9M%7BNEB-I#>1!%;:S><N ?0GUJP-.MR 06(/((:E
MR,OZS R:*TTL[.5G6.3>4.U@K@[3Z'TIQL+52 S,"3@9;J:.1A]8@95%:QTZ
MW'4O_P!]4?V;!_M_G1R,/K$#)HK5&GVQ8J&;<.2-W(IAM;%;@0&<"8C(C,@W
M$>N.M'(P^L0,VBM7^S[;=MW-NQG&ZE_LV#_;_.CD8?6(&316G+96<$9DFD\M
M!U9W  _&G)86LB*Z.61AD,K9!%'(P^L0,JBM;^SK<]W_ .^J1["UC4L[%5'4
MEL"CD8?6(&516C+;V$*;Y;A8USC<\@ SG'?WJ4:=;D9!<C_>HY&'UF!DT5JB
MPM69E#$LOW@&Y'UH^P6V_9N;=C.-W.*.1A]8@95%:JZ?;-G:S'!P<-T-(UA:
MH<,Y'!/+=AUHY&'UB!ET5K#3K<@$%B#_ +5']FP?[?YT<C#ZQ R:*UO[-@_V
M_P Z0Z?;*0"S DX&6ZT<C#ZQ S[?_CZB_P!X5NU533X4=7&[*G(YJU5Q5CGK
M34VF@HHHJC$*P=%_Y#_B#_KO'_Z+%;U<YI5U;P>(-?$T\49,\> [@9_=CUH
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M;_X4?\*BUS_G_L/S?_"O9:*/8P%_:N*[_@>-?\*BUS_G_L/S?_"C_A46N?\
M00L/S?\ PKV6BCV, _M7%=_P/&?^%0ZY_P _]A^;_P"%6M+^$NI0:S9W-[?6
M;6T,JR2+'N+-M.<#(KURBFJ429YEB)KE;_ SKC0M,NYVGN+**25_O,PY-1_\
M(SHO_0.A_(UJT5H<!!:65M80>3:PI#%DMM4<9/4U/110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
J1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>form10-k_002.jpg
<TEXT>
begin 644 form10-k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $1 ,4# 2(  A$! Q$!_\0
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M.S$FV.-F3);;CE2.F.G0YJ@_AF>Y1K6[O(WL1>M=QK%&\<H+,S%2X?\ VNH
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M-:0L;7.3;HQ]7&[^=+"P_=1;#%U'[:22-%]1LHSAKN$'TWC-1?VM:'[C2/\
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M5.PCGTYXKJ:I2:<QN)9H;VXMS,0SJFT@D#&>0>PI-7*3MH85@C3.5C4LPMY
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MGC XYZYP:@M-/U<Z-J%P7U-M0N(4MW1X70;W<;GY8Y*C/(  % 7/1]I]#^5
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MU#;IVIBS:]MHXH)"[R"%>7<+G/))X]_:M"ZTR^"ZY>645VDMOY<&G1!VX15
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M4$CRT0X7!3')*@GC!!/6@#=N(X9X'AN CQ2J59'/##N*53'%&(U*(D:@!00
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M*4Z]8B(OBX+!F5HA"2Z[0"Q([  CGWIC^'[62%XWEE8NA5G;!)8OO+$8P26
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M)$HR0!ZL<8K9MY&FM89678TD:N5ST)&<4W[);88?9XL,K*1M'(8Y8?B>34U
M!1110,N6'_+3\**+#_EI^%%8RW+6Q!<?\?,G^]7+R0:C+,TYN-01'-S(8HVV
M@(O$:#C@D\YZUULUM,\[LL9()X-1_9)_^>9_,5HFK$M'*?\ $T:\MHIFOPZO
M I:,8B,84-(S'H22"OJ/:HW.I6UC-=RW-VK?9#.X<\*YD!5%'8A05QU.177_
M &2?_GF?S%(UE*X >$, 00&P>1T-.Z[BLSG;Z.:YT407;R)-J%RH\L/@QHS
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)* %HHHI"/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>form10-k_003.jpg
<TEXT>
begin 644 form10-k_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %> > # 2(  A$! Q$!_\0
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M+0M(U"6TG:ZD%N(S=7$%NTD-L)/N>8XX7.10!UE%<Y;^,--N_$4VBVL=[/+
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M1(_,ER#L5E0MQR55V /H><UTM% !1110 4444 %,'WV_"GTP??;\* 'T444
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M&<T 1^;=?\^R_P#?W_ZU'FW7_/LO_?W_ .M3O/\ ]G]://\ ]G]: &^;=?\
M/LO_ ']_^M1YMU_S[+_W]_\ K4[S_P#9_6CS_P#9_6@!OFW7_/LO_?W_ .M1
MYMU_S[+_ -_?_K4[S_\ 9_6CS_\ 9_6@!OFW7_/LO_?W_P"M3)+B>--SVX"@
MC)$F>_TJ7S_]G]:9>?\ 'H_U7^8H F7[[?7^E/IB_?;Z_P!*?0 4U_N-]#3J
M:_W&^AH =VHH[44 <CJWCB'2KR\MFLVD:UF2,XF4;E,9D+?4!2 O4FNH>9(X
MA(V[:<=%)//TJLVDZ=)-)*]C;-)(RN[M$I+,O0DXZBK%W_Q[_P# T_\ 0A0
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MP#OZ]L5UJ6EM&5*6T*E,[2$ QD8./J !4/\ 9&F;57^SK3" A1Y*X&>N..]
M":/J2ZOI-KJ"Q&(3+G86W;2"0>1U&1UK1O/^/1_JO\Q4,:)$BQQHJ(H 55&
M!Z 5->?\>C_5?YB@"9?OM]?Z4^F+]]OK_2GT %-?[C?0TZFO]QOH: '=J*.U
M% !4%W_J/^!I_P"A"IZJWR+);8;.-Z="1_$/2@"U12 !0 .@I: "BBB@ HHH
MH **** "BBB@ HHHH **** (+CJM0U-<=5KG4L-0?5IFGDD-G)O!Q.1E2#@
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ME% $?DI[T>2GO4E% $?DI[U%>?\ 'H_U7^8JS5:]_P"/1_JO\Q0!,OWV^O\
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MZ)6N)^)&>'^%B8;^_P#I1AO[_P"E.HKG-QN&_O\ Z48;^_\ I3J* &X;^_\
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M3Z8?]8OT-/H **** $) !)Z"JUC(DEME#D!V[8_B-6<YZ5#:?\>__ V_]"-
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M'?':I:* ,+POI-SHVA)9W1A\_P QW8P,Q0%F)^4-R!SP.U:-FCK;\RLWSMU
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M5?3U%6ZK7O\ QZ/]5_F* )E^^WU_I3Z8OWV^O]*?0 4U_N-]#3J:_P!QOH:
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MKE/ 6IWNL>&OM-_.TLWGR)NP!P#QTKJ=O^TWYU$XN$G%]"H24HJ2ZCZK7O\
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MQ[2_[A_E3MS?W#^8IDH9XG0*<LI R10 L/\ Q[Q_[@_E3A]]OPHC4I$BGJ%
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HTWYTZB@!NS_:;\Z-G^TWYTZB@!NS_:;\Z%4#/4Y]:=10 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>form10-k_004.jpg
<TEXT>
begin 644 form10-k_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $V ?P# 2(  A$! Q$!_\0
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M4^F#[[?04^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"^: ):*B\__IE+_P!\TY'$B!UZ'GF@ 'WV^@I],'WV^@I] !1110 4444
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M-ORJ,^8.,%3QCIFF67B:VOK>TF6VNXUNI_(C\U-O4$ANO*G';-1Q>+;&6X:
MQW*,D<CR93.S83D'!Z\9_$4AG0>:_P#>-'FO_>-<X/&NC%L;[H=N;9NOI]>O
MY57/CO2XY4$\<\<#HQ6;;D;EY*X['&#^.* .K\U_[QH\U_[QKGY?%=C#JT.G
M-!=>9,459/+&S+@%0>>#@_H:LV?B"RU![06GF2+="0HVW;MV'#9!Y SQG% &
MW$[,3DY^M2_-Z#\Z@@SDX-38;^\/RH 7YO0?G1\WH/SJJK3&^D3>OE+&K!=G
M.23WS[?K5G#>H_*@!?F]!^='S>@_.DPW]X?E1AO4?E0 OS>@_.CYO0?G28;U
M'Y48;^\/RH 7YO0?G1\WH/SI,-ZC\J,-ZC\J %^;T'YU';?\>T?TI^&]1^5,
MMO\ CVC^E #A]]OH*?3!]]OH*?0 4444 %%%% &5JEL+RVN;8D#S5VY.>/RK
M$CT:^,LBR:],QZJD>4V8 '0'].G-='*I,K<'K6/=>'+.[N99Y1)F5MSJ,8)V
MA?3GA16A)370=2=TEFUB575S]S/*[LXR3QD8X'''UST0Z-6;I^AV^F7,T\'F
MEY5"'><@ '.!Z"M,*V&X- #**7:WH:-K>AH$)63=ZM-8SW DM'GBC *>2OS8
MVY.<G'MQ6OM;T-+AQV- '/#Q/OG\M-,NCC@DD#G ( ]>I_*G#Q+EMG]E7F_8
M'(^7'/;.>>/RZ5OX?_:HP_\ M4#*>G7C7]IY[0-"=[+L8Y/!P#^(YJU3MK'J
M#2;6]#0(2G)]X4FUO0TY5;<.#0!FZKJ#Z;!%.MNTR&4+*$!+*F#E@!U(]*S$
M\5%(P+K2[I)0RHP0 C+$].YP!R:Z0*PZ T8?_:H K6%T;VW28PO"2V"C]15?
M5]0DTZ&.5(?-#.58#)/0XP!UYQ].M:(5MPR#UHPP)P#0!S<'B*ZEF@B^PEO-
M,1$@5@H4@%\]<$;@!SSSZ5TG\'XT8?\ VJ7:VSH>M RK>S26UA<3Q1B22.-F
M1#_$0.!46EWKZA9>?) T#"1T,; Y!4X/ZU=VMZ&EVL>QH$ ^ZWTIM/"MAN#3
M=K>AH 2BEVMZ&C:WH: +D/\ JEJ2F0\1+3ZS984444 %%%% #3]]?QIU-/WU
M_&G4 %%9^JZE'I5F+J9&=/-CC.T@8WN%!Y(Z$UF:=XLM[_4H+$6TL;3B79(S
M*4<HQ!"E2<]"?I0!H6RC^W=0;)SY<(^\?]KM6B0,'D_G6/;75G_PD&HCS8O,
M"1*?48W<5H_:K4\"2//:@"K+-#%+$DF-[G$8VY.?:LM/$>BO%]H,FU RQ%V@
M88+' 7D?4_3FM.>6UCFA6>2)96/[H.0"3[5D&X\+RRI$PLB\@78K1\,&.U2,
MC!R6X/O25[A9K5EFUU[2-0BMWMYED62;R8AY1X?!/3''3KTJ.;Q)HMK(R33>
M6ZL4(,+9SG! XYY!)Q]:5;[0/L\6V6V6&UB^TQ@# C0$KO'MG(I@_P"$:EF^
MS_Z TD4A41N1E6)R< ^I]/>F!(?$7A[=L.I6.3Q@D?X54NM?\-2(;6X:"6WN
M)=CEH@8RQQ][ZD@?7BI6E\,?:UMV6P\R52P.T;6 R,9Z9X/'M0T'AHR&$Q6;
M/,D?R*N[<#DH0!WZG/7C/:@"8ZYHMO';!)XS'*N(/+C)#;2%"KQR<D "IY=2
MTV#[0[21[[3;YP2/+P[NF0!D9JFMMX<L;*WM'-L8(2Z1"60R;"!N8 DG! Y]
M15Z.STR]A-Q';PR1W&R0R!?]85^Z2>N1V]* -. <G-3;1ZG\ZK)+'&2965<]
M,T_[5:_\]8Z &H!_:,W)_P!4G?W:K.!ZG\ZH)=6O]H3'S8_]4G\VJQ]JM?\
MGK'0!-M'J?SHVCU/YU#]JM?^>L='VJU_YZQT 3X'J?SI-H]3^=0_:K7_ )ZQ
MT?:K7_GK'0!-M'J?SI<#U/YU!]JM?^>L=5HKV(WLZ-<1&-54J-N",Y[_ (4
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M^]_X]0!E6'V?[;!%:3"6."U\O<&W=QC)]>*UL-_>'Y4F5_O?^/4?)_>_\>H
M=AO7]*3#>H_*DRO][_QZC*_WO_'J %PW]X?E1AO4?E297^]_X]1E?[W_ (]0
M [#>OZ4F&_O#\J3*_P![_P >KROQY\5;WPCXF?2K;3+>YC6%)/,>5@<MGCB@
M#TU W]HS<_\ +).WNU6<-Z_I7@(^.^J"9IO[$M,NH7'G/VR?ZUUOP^^*-YXR
M\02:;<Z=;VR) TN^.5B<@@8Y^M 'J&&_O#\J,-ZC\J3Y/[W_ (]1E?[W_CU
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M3/S'L2>?7D\YK?H Q;6VMQK^H99]Y2)L><W?=VS6E]G@_O/_ -_6_P :J6S
M:[J"X.?+A.<''\7>M'</0_E0!#]G@_O/_P!_6_QH^S0_WG_[^M_C4VX>A_*E
MR/0_E0!!]G@_O/\ ]_6_QH^SP?WG_P"_K?XU-N'H?RHW#T/Y4 1?9H?[S_\
M?UO\:3[-#_>?_OZW^-3Y'H?RHR/0_E0!!]G@_O/_ -_6_P :/LT/]Y_^_K?X
MU-N'H?RI<CT/Y4 0?9H?[S_]_6_QKYP^-"*GQ"D"DX^RQ=6)]?6OI;(]#^5?
M-?QK_P"2BR_]>L7\C0!YX?NCZUZ3\#T5_',X;./L3]&(_B7TKS;/RX[UW_P?
MU:RT?QA-<W]P((C:,@8J3SN7C@4TFW9";25V?0]W;Q 089_]<G_+5O\ &I;B
MWB%M*0SY"-_RU;T^M<_=>.O#;B';JB'$JD_NWZ?E4LGCCPW-$\4>IH7<%5'E
MOR3P.U-T:EG[K^XAUJ?\R^\Q.JX]121QK$@1!A1P!G-. P,&BO%.8YO5/^0E
M-^'\A5+N*NZI_P A*;\/Y"J7<4'Z5@/]UI^B_([+P"BO/>[MPPJ=&(]?2NZM
M?^/=/I7$?#TXN+[_ '4_K7<6W_'NGTKTL/\ PT?*9O\ [W+Y?D/'WV^@I],'
MWV^@I];'FA1110 4444 49?]<WUIE/E_US?6L:^M]5EO)S:S>7"T.V,[P,-C
MT]<X.?3BM"36IRG ;Z53L1?!)/MS1%MWR"-<#;CJ?<U<4$AL>E @W'V_*J*Z
MQ:$R#<Z^4&+[HB-H7J3QT[>]7MC>E49=&M)B^^%L29W@2, ^3G# 'GF@8J:Q
M92-(%G!\N/S&^3^' .1QSP1^=))K-G&0&EY,:R@!,Y5NF/<^E+!HUE:PO%!:
MJBMU(^\.,<-U'%-ET2TF2%)(Y6$"A8OWK93W!SU]^M $IU.R5=S7ELHP&^9U
M'!Y'7UI'U2S3&;F%LC.$(;C!.>.V :C;0[!W#-:C(&T<GIC'\A41\.:=G(MV
M4@YX<^V>/? !H L1:M931JZW,7S;L*Q ;Y<Y^7KQ@TEOK-A=!S#=Q$(<,3\N
M#DC'/N#5;_A&[-=16\C62,@2;HU8[7+_ 'B?KFGGPYII$@^R<2;-XWM\VPDJ
M>O8DG\O2@"[%=QS2S1H?GA(#@IC&>1]14ZL=PZ?E4$%FEL\SQA]TS^8Y9RV6
M_'I]*G56W#B@!-Q]ORJE'K%G-<K;QS!Y&=D&%X)7[W/M5W:WI5&/1;.*42)"
MP82>;C>V-W)!QGL2?SH O*QW#IU]*1GQDG&![4JJVX<=Z1XRP92" 01P<'\Z
M (H+V"Z#&WFCE"XSM[9J?<=G;KZ51L=(M=-,AM82ADQO)<L6QZY[U>VMLZ=Z
M &ER 3Z>@J.WNDNH%FB.4;.,K@\'!!'U%/>(NC(0P# @X.#^![4RVM5M+:.W
MA5A'&NU06)('U- $P8X;I^5)N/M^5*%;#<4FUO0T 4DU>TDO39I,&G#%2H7H
M0 3S^(J[N/M^544T6SBG,T=N48R><0K':7QC<1G&:O;&]* +D/,2T^HX1B)<
MU)6;*"BBB@ HHHH :?OK^-<YXXNVLO"MTP5V$A6(E0Q(+' . K9&<9&,8S71
MG[Z_C6'XLB^U^'KG3XQ$]S>*8H(Y&*AWQNP"",'"D]1TH 7PB)5\*:>L\<L<
MHC^995*D')[%5P/08&!@5NUA>$_-'AFP$S*TJH58K(7&0Q!^8DY/'/)YSCBM
MV@#,MF/]NZ@-A(\N$[LC_:XK2W'^Z:S;8-_;NH<C;Y</&.<_-6E\WJ/RH -Q
M_NFC<?[IH^;U'Y4?-ZC\J #<?[IHW'^Z:/F]1^5'S>H_*@ W'^Z:-Q_NFCYO
M4?E1\WJ/RH -Q_NFC<?[IH^;U'Y4?-ZC\J #<?[IKYK^-?\ R467C_EUB_D:
M^E/F]1^5?-?QK_Y*++G_ )]8OY&@#SNM?PY_R$F_ZYFLBM?PY_R$F_ZYFM\-
M_&CZF&)_@R]#J&_A_P!X58M/^/VW_P"NJ?S%5V_A_P!X58M/^/VW_P"NJ?S%
M>[4^&7I^C/#70]1;[Q^M)2M]X_6DKX1[GJHYO5/^0E-^'\A5+N*NZI_R$IOP
M_D*I=Q2/TO ?[K3]%^1VOP]_X^+[C/RI_6NXMO\ CW3Z5P_P]S]HOL?W4_K7
M<6W_ ![I]*]+#_PT?*9O_O<OE^0\??;Z"GTP??;Z"GUL>:%%%% !1110!S%]
MI^KS:E<20ZEY$!($:<G' Y]N?S[U''I6J)#<[M7<S2J C]E()QP?8C.,=*W9
MO]<WUIE:(DQ%TC5%50-9E&) QP3RN6)'.<=5'T6KFEVE_:^;]MOA=!D4+P?E
M(SD_CQ_GBK].7&&R<<4 -()&%QN[9Z5SY\1R1VIEEMD,NU"L*%BS[AG(&,X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\S7(5U^@_P#('A^K?S-=V7_Q7Z'%C_X2]32KI_!G_'U=_P"XO\ZYBNG\&?\
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M_P#>Y?+\AX^^WT%/I@^^WT%/K8\T**** "BBB@ HHHH **** "BBB@ HHHH
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MZA<W;3+/ H;'!)]/I4'_  @.I9_X^;?]?\*[#1]1O;]KK[=IS67E.HBWG_6
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K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex10-4_001.jpg
<TEXT>
begin 644 ex10-4_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HU_
MUY_W14E1@8F/^Z* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "F#_7'_=%/J,#]^?\ =% $E%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !48
M.9S_ +O]:DJ,?Z__ ("?YT 24444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %1C_7_\!/\ .I*C'^O_ . G^= $
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUJ*** "BBB@ HHHH **** "BBB@ HHHH **** "HQ_K_ /@)_G4E1C_7_P#
M3_.@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+N5KJ2%IG3SI^H)<'(Y].!Z4I;?UY+_-^K&OBO\ UNW_ )+T1Q.KQZGKVM^
M-)O-0NXYVMEO[V,(F4DC0$.05ZELC!R/:DD\?WVF6OC#77N!>6T%ZMAI<;HJ
MC>,[AD $@9S[XKJ_#OA>:'Q)/KM]:PVA%G'8V=G"P98(E +<CCENF.P]ZMM\
M/_#+Z'+HS::#8R3_ &AHS*^=^<Y#9R.IX![GUJG_ )_B_P#)"7GY?@G^K_ \
M[75;BS\7ZGKFJWS7_P#PC>E*N9551]KE RBX X)R/:MHZUXKL-,OO$&J74EO
M:PZ0[F.6-%'VMCE1&F,[5R!EB<D]Z[%/!?AY(M1A_LV,Q:CM^TQEF*OM  P,
M_+T'3'-.D\':%/I1TV>R,]JRJK":5W=E4Y52Y.X@$=,XI/:W]:WO^?X(%H[O
M^MO\OQ.*T3Q)X@.N>&+/4;Z5]^E2W^IHT2# .=C$@  >@&,=ZYNUUW7(? 6K
M^+(M3N/[4UB_CM-/\V.-V\I7("C*XZ%^@QQD<UZ_+X6T2;4Y-2DT^)KN2W^S
M-(2?]7@C:!G X)&1S5/_ (0/PR=-M-/.EJUK:2B:%&E<E7 P#DMD\<8)(IZ-
M_P!=[O\ "R^\2NE_7;_/7[CSS6O&>MV5MK M[YHHM$ABL(71%)N;YL!B1C&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *8?\ 7C_=I]1G_CY'^X?YB@"2
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J,_\?"G_8/\Q4E1G_7K_N'^8H DHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **1F"(SL0%49)/85RF@75_XKLI-
M8_M*XLK.:1ULH;=4XC5BH=BRG)."<= ,<=Z .LHKC/[3UV*\TOPU/=)_:=SY
M\L]\B+E($<[6"XV[F!4<@@<\&I[S4+WP]K^FV-Q?2W=CJCM DDRKYD$P7(P5
M4 J>>HR#WQQ0&QUE%<'8>*K_ $GQ7<Z5K<YGTV6Z^SV5^ZJI678K>7)M 7G=
M\IQVJ/4=;UC3=,UFX-_=3Q0:HMN\P@C9K2WVJSNJJ@W$;CU!QP<<')Y_UT_S
M#K;^NO\ D>@45R%C-?W4=[>6'B)KW2'L]UM.HA9XIAG(R$YXQPP/>KWAR6[U
M7P/I]S>WT[75U:)+)<*%1@6 /&T #\J'HF^W_!_R!=#H:*X.;4M5M/#/A.:'
M5;AI=0N;>*XDD2-BZR*6)Y7@C'']:[#4(+V:P\JPNQ;W!9!Y[(&(7<-W&,9(
MSCC&:;5OOL']?G_D7**X>RN-?O\ 7?$FFP:W('TXPBU,L,6UBZ;CYF$R1GCC
M'%3P2:Q<^(O$MHVNW4<-K'"ULL<,'[LNI8\F,YY'&>WYTGHK^5PZV^1V-%<%
MX:\6W^KZ/<:;JLGV+7H[,7*21*N)HV7*R(&!!]",<&I-/UW4M2DT;0X-0?[;
M-IZ7]_>M$A=$;&%1<;=Q)[J0 .A--IWM_77_ "%=6O\ UT_S.YHK B>\L?$-
MM:-JZ75J\+B2*X:,3+)D%"-H4D$;NU;S,J(68@*HR2>PI=+C\A:*Y/PKXDN]
M5UC5+*_01D[+NQ'=K5QA3]<KD^FZI#JEWKOBF]T?3[M[.UTU$^USQHK2/(XR
M$7<"  !R<9YXQ18.YU%%<7K-_JFFV>NB'7$D%M8&:V?]R9XY4#%@R[<$?=_A
M]:IV7B#5+2Y\+QC4WU=]653=02)$'@!0,77RU7"@]=P/UH6O]>O^0/3^O3_,
M] HKAKW69[?XA7>F7GB1M/T\:>ES&K?9TPY<@@,Z$D8%0Z_K&I:?X!_M>R\0
M/+FZ0Q7GDQ?/"\H7Y@4V\ GD = :%K;^NM@>E_ZZ7._HKE[6[^V:L8-.\5M?
M".W=IH@('VYP$8,B#!SG@YSZ56\!^)K[5M-D@UQXAJ4,:3ED&T20N,J^/S!]
MQ0!V-%<)HGB'5-?\0:]']J-M806T<MB(D0L5<-B1B0>3MR!Z'D53\.Z_/J_A
MC299?&136;QE7R ELV6W'*[!'N V@_2C_@?C_P ,#T_KYGH]%<'8^*=0TGQ7
M<Z5K<YGTV6Z^SV5_(JJ5EV*WER;0%YW?*<=JTM/.MWBZW!'K$AEBU 0PR2PQ
MGRH@$9@ JC)PS 9SVH6NO]?UJ%^G]?UH=517#6=QX@OM=\2:;!K<@?3C"+4R
MPQ;6+IN/F83)&>.,5W(S@9Z]Z.EPZV"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "HS_KU_P!P_P Q4E1G_7K_ +I_F* )**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R(LL3QN,JP
M*D>H-<CX=L]6\(Z?_8O]F3ZE9P,YM;FWEB!\LG(5UD=<$9(R,@CTKL** .4O
MM,U4:QIOB2.VCEO8(Y+>XLXI -T+G("LQ +J0.N >>G%+?:?=^(M>TFZGLY;
M*QTR4W(\XKYDTN,* %8X49).>O''>NJHH6@/4Y.+0_[<M/$%AK.F2PVMY=>9
M$SO&21L10R[6.""N1G':L[1=.\5>'M*:)HUU&X.J%IVWHIGMO+"[AN(PW"\>
MH].:[VBC;^NP'%Z3X=D7Q3J.H6VG2:1875GY4UNS1_O9B<^8%C9E&!D9X))_
M&I-#;7-&T"VT*30IY[BUB\A+M)H1;NHX5B2^\<8R-A/UKL**.EOZZ_YAUN<3
MKFCZE!I'ABPL=/FOSIEU;RS/&\2 K&I!QO<<GL/UKH8;[4KG4H8O[*GM+159
MI9KAXCN/154(['/.23QQ[UJT4[WW]0.7T*RU"#QEXBO;FPEAM;PP&"5GC(;8
MFT\*Q(Y]14=M!J<'B/Q)=MI%RT%U#$+=EEA_>%$((QOXR3QG ^E=914M75O*
MP[ZW^9PNH>$KK5O!NE&*-M/\0:=;*MN[,I*L%VLC%205;'^>E%EX=U/1M5T?
M7+>W-Q(NF1:??VBNH<!0"'4DA20>",].E=U157=V_G_7WDV5DCDCIMU?_$.R
MUG^S7AM+>PDA:6;8&,C,,  $GIGGIS6CXICOKO34TZRM)IDO'$-S+%(BF&$D
M;S\S Y*Y QFMRBETM_7<?6YP^K:!=:1K^BZMH.GWM[+"3;W0:]W?Z.1T'FOU
M!P0!Z<]JMV^E7VA>+]2U:VMGN['5E1IXXV426\J# .&(W*1Z'(/8UUM%%_U_
M$+?UZ'G>HZ'J=YJ'BR_@T>3_ (F&FI:6P+1*[OA@QY;@<C.2.G>K&FZ#?Z';
MZ5JVFZ28[U;:.UU*P#Q*TZJ,;U8-MW@\C)Y!(/:N\HH6FW];_P"8/7^O3_(X
MR.WU6/QY=ZVVAW36<NGI:J!+!O+!BQ.#)C'..O453U[3=:U7PC)IMIH M5^U
MQ&VMA-$#'$C*Y+D.5R2" %SVS7?T4+2WE_G<5M_/_*QSLESJ#ZM'/;^')86,
M96XN9Y(=QC )"(%D))+8ZX R:YD^$-5GM_#\\,365TMH=-U-6="?LY7D@JQ!
M((XQG[W3BO2**$.^ECAM-T[5+#Q5XEN_[&F%G/:PPV826$;_ "U(QC?QG/&<
M?A3-#L]8TCP9I>ER>&I+G4;(?NG>:'R4DR<.3OW8 /.!FN\HH_K[KO\ 4.M_
MZV2_0Y*VT-M<L=>T_7--DA@O+GS$9F0[OW:*'7:S%2"A(S[>]3>"-(U71=.O
MK?5YA<7#7C,L^1^]38BJQ]#A>?>NGHIW%8YC0[*_@\9>(KVYL)8;6\,!@E9X
MR&V)M/"L2.?45T]%%+HD/K<**** "BBB@ HHHH **** "BBB@ HHHH ****
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M@=^W&#S7&0Z1JL>J:C?1KXCM=6FN)&2.'R'M3SA#N<'Y2H7/(/4 =*5]5?\
MK7_(=M[?UI_GJ:,'BC7(K'7-2O);.2VT6YN(I8HH&0SA44I@ECLY//7\*F/B
M+Q)I-K=ZAJFF;]/AT\W!?,2%9A_  LCDJ0>IZ8K6TOPI;V=EJ4%W<3WJZH[2
MW<<VS9O9<-MVJI .!USTJ.Q\$V%I;M;7-[J&I6_DM!'#?3AUBC88*K@#MQDY
M('>C^OPU_$$UN4$U;Q;#!=SW-E&ENNG-<+/*D>(YP,[ J2L60COD'CK5>U\1
M>(9[KPZK3V 37+)I%'V=O]&=45\_?^?.3Q\N..>.=2U\$6UM92VK:MJUPA@>
MWA-Q.KFW1A@A/EQG'&6#$"IH/!]O!-H<JZA?$Z-$T-N"8\.I7:=_R<\ #C'2
MGI?^O/\ X M;>?\ PW_!,6#QAJDFCV<2PI/J=QJ<VG[XT !$18LX5G R57H6
MZGOTIHU[Q?%K&FZ;=V]I:?;;BXBCEFB#LR*F])"$D(!Z@KGG'45J#P%8'29+
M![W4&)O&OHKD2(LT$S')9&50!R3U!ZU)%X*M8]3L-1?4]2GN[-VD$DTB,92R
M[?F^3H%X 7 []>:2\_ZT_P QOR_K5_\  .;OM=UK4/#6FEKN."Z77TL)Y(HB
M!*%F(!QGC. 2,\]*Z[Q9JLNA^#]2U%"&G@MR58# WG@''U-5/^$'M#I<MBVH
M:@P>^^WI,6C#Q3;MV5PF,9[$'K6OJ6DPZGH-QI4Y=XIX#"S,<MR,9SZ]Z3^&
MW];+_@_>-6YEV_X+_P" <I>P7>FZKX)TNQO/*MV,OF!DW>8RPD[F.1G.2?J<
MUGQZIJFA_P#"3:A9"T^S0ZZHFCD1BTBN(E;:00%(W9S@Y]N_21:%)J]EI3:F
M]W::CI3E1-;NH\P[=K$'!^5A]"/8BEN/!-I<V&J6;:AJ"QZE=B[F96CW*X*D
M!?DX'RKUSTZU=]?O_-/\KDKX;>GY/]6BA?\ B#Q'=ZAJL6@Z=YXTZ9(51O+
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MAJC:E?S3V<#P*)&C(D5CEBWR9SD#H0!@8%3:9X;T[2;[4[NVC(DU&3S)@QR
M<<@#L"23]2:'_G^MOS_ E?Y?EK_7F86@Z]XFU:;2[YM-']EWR,\I)C40(1F,
MJ1(6;T.5'7MTK4\2ZK>:?+9Q6TL4*3>9N?RC-*6"_*J1CD\\D]@.W6H]+\%6
M6D7*-!>ZB]I%(9(+&6<&"%CG[HQG R< D@5<U7P[;ZKJ5IJ!NKJVN;9'C5[=
ME&]'QN4[@>#@<C!]Z):K0:\SF#XQU)_#FB:E.5LX+RV9[B]2W,L<,O 0,,Y5
M"<DD],8R.M=-=ZU_97@]]9N_+F:&S$\GD-E';;GY3Z$]#5&S\$V]A:V]O:ZI
MJ4<<$,EN 7C8-&YSM(9".,<=_7.:UX=$L8= CT3RM]@EN+?RW.=R8Q@GZ42U
M3L"W5S#BUC6;+5M&@U%[::#5D9088BOV>4)O Y8[E(!]#Q5?P)%<W*:S/?31
M7)75[C;F  AU(4,#D]ACV]:UK'PO%:36;S7]W>BQ!6S6XV?N01MSD*"QV\98
MGC\ZFT#P]'X?2[2*]N[E;JX>X<7&SY78Y8C:J]?2GI=_UU_R%K9?UT9E6 _X
MNEK7_8.M?_0I*QIM13PEXS\3O:QAK(:6NHRVT?"B<$K] 6 !/YUTDOA1FUZZ
MUB#7-3M;BYC2)UB$!0(N< !XF/<\YSS5JV\,:7;65]:F%IQ?Y^URSN7DGR,?
M,WTX & .V*GHO1E=?FOT.?;Q)XCTBTN]1U73=VG16!N#)^[0K,/X %D<E3GJ
M>F*N7.K:]HFG7NJ:D;.[L8K#[0!"IC=9A_ ,DY0C')YJ:Q\$6%K;/;7-YJ&I
M6YA:".*^F#K%&PP0H ';C)R0.]/L?!EE:VKVUU=WVI0F%K=$O90XCB88*K@#
MM@9.3QUIOK;^OZ_KS2Z7,R/6/%L$-W-<V4:0+I[7"SRI'B.=1G;M25BR$=\@
M\=:AM?$?B&XN_#J-/8!-<LFD4?9V_P!'=8U?/W_GSD\?+CCGCG3M? ]M;64M
MJVK:M<(8&MX3/.KFW1A@A/EQG'&6!.*F@\'V]O-H<JZA?$Z-$T-N"8\,I7:=
M_P G/  XQTIZ7_KS_P" +6WG_P -_P $Y6_UB^U;1M"EN/(:\@\2"U+A"J.4
M:10VW)QQSC-7+CQAKFGZVWAN:""YU-YXQ!<6\816B=78G8[XW#RV&-V#P?8[
M,7@>SBTXV?V^_8B_.H1S,8]\4Q.25PFW&2>"#UJ2]\%:?J,4IN;B\:]DE287
MZR*D\;)D+M*J   2,8[G.<TEY_UHOU3&_P"OO?Z-&3=:_P"*=/LK1KVT@@DE
MU>.S4RA29H'. V$<A&'0]>G:NQTZ.]BL(TU">*>Z&=\D4>Q6Y.,+DXXQWK!G
M\$V]Q:P12ZKJ;2QW27;7+21M)(Z?<W90C ]  *Z>GT_KR#J<?X/BCAU_Q:D:
M*B#4P=JC YB0FN;T>2X2ZTO3[O']A0ZK(UAJ21X,\@+8C89^7+,_S_Q8[9S7
M>Z5H$6DWNI74=Y=3OJ$PFE6;9A6 Q\NU1V '.>E5H_"5K%%!;B[O#907/VF.
MT+)L#!MX&=N[ ;D#=^G%*.C7HOZ_R!ZW^9T'I7(>--%L+G1-2C%JD^IZF!#;
MEQN82 ?)M)^ZJ\L<=/F-:NA65_:7FK275Q<R6\]R9+>.YE$C1C'.,<*I/1>P
MZ\G%0ZEX6?4=5;4%UW5;20Q>4J6[0A47J=NZ,D9/4YYP/04NPT[&=:*[_$1K
M.Y(E^R:-&(RWJ[D.?QV+5/P=;V4_A&"YU79+!IDMU#$9CF-8UD90<'@D*, ^
MA/K70_\ ",0H;.6WO;N*[M8#;BZW*\DB'!(<L""<C.<=?Q%177A&VFTNQTZU
MOKVPMK-@Z+;F,[V'(+[T;<<Y/UY]*I_U][=_Q$OZ^ZQR6@V$VGZUX9TZ>+RK
M=FO[Z"W88\K+#RUQV(1SQVR:Z'P6\B7_ (FL]V8+?57\H#HN]5=@/^!,3^-6
MHO"$4825]4U*XOHIS/%>7$B-)&2NTJ!M"[2,Y&.^>O-:NE:5!I-M)%"69Y96
MFFE<@M)(QR6../RX& */Z_+_ "$_Z_'_ #.4BO9[R?QGJD$OEW%B&LK9F7<(
MQ''O) ]V8_D/2LRV^WM;?#V3SXIKN169995/ :V)YYRQ'U&?:NICT=K37=53
MR&DT[65#2E#_ *J4+M;/?#*!R.X/K3;3P9;6?]C[=1U&0:2S&W$CH<@ILVM\
MG0+P,8_$TH]/E^M_S&^OS_2WY&1%XOU=M.@M6MXIM5DU6;3B\" (1'N8N%=P
M,[1T+=?7I71^';G6KBVN1K5F+>2.=E@?*9EB_A8A68*>Q&>U9[^!-/EL+BUD
MO;\M+>M?QW D598)CU,951C\0>M;&DZ1'I,,BBYNKN:5@TMQ=.&D? P,X
M'8 "A;:_UM_P0?E_6_\ P#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "HS_KU_W#_,5)49_P!>O^X?YB@"2BC%% !1110 4444 %%%% !1110
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MQ@54NS!+X>UV*[,:>+4U!Y+<''V@OO'D^7GDKMP..,9]Z2UM_7;_ #_ 'O\
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M?_&:/[(O?^AAU/\ []VW_P 9K&T[QA<WFNV^ES6EO%+<032B(3[I+=D(PLH
MP"00>.GOUJQX#U34M8\-K?:D8FEDGFVE&)P!(PQ@C@#&![4+7^OD#T-$:/>
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M#VO_ %U_R/2L"CY<XSS2^]>9ZGXG@@\=66KKJEN;2.Z;2)+02KNPW67&<\2
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M#:V\UL1'9&-Y$D4+DMYA&X8!R!CVJW%X6U?^U=)O[K7+>=]-BEBC L"ID5U
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M8(^CPS0&4.!([@[Y%*R(-RX7KG&>W-=VVB:4S7#-IEFQN$$<Y,"GS5'16XY
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MUH+[/]=O\S<'A?5MC!-4O4/]K"[A+W9;RXN-RMQ\P;YL)T&X<\&M'3;MM/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !44O\ K(?]X_R-2U'+_K(O][^AH DHHHH **** "BBB@ HHHH
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M6D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'+_K(O\
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MR0"<;LCVJ[=ZUIEA<+;W=]!#*V/E=P",G SZ9/ SUILFOZ1%=&U?4K47 E6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]>U5=6T;Q3J=G;(4T@&/4(KL0"=PD4<9!"!A%EBQ!)) QG@4ET_KJ_T'U?\
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M7-_-=)]G=F 5SG!RHY%<QX4L-0UWPCIEHZ6::?#?&X^T),6D81SLP79MP"2
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MFNM0RSW#[IG24A(R^=QPN3C/./:G;6W];M?H3?2_I^5SU2BO++NXOH[5;/\
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MW*3H4,1VAN<]L'.>E4X_&6C/<00/+<1-<0&YA:2VD"O$!DONQA5 _O$=1ZT
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MM1::5;2\1Y(I#"V-JJ6);CY1@'K1_7]?<&YH'1M+-ZUZ=-LS=LP<SF!=Y8#
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MRZ)I2:>^GC3;3[&YR\!A4HQ]UQ@].]7Z* (;2TMK"V2VL[>*W@3A8H4"*OT
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M -=!_(U/4%S]Z'_KH/Y&@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!MRQ(.SKD*<GC@CBN1%GK>EZ=X2L[72F;7-/68-%'<1;_(QM9OF.W:25ZG/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J"Y^]#_P!=!_(U/4%S]Z'_ *Z#^1H GHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD5T8D*
MRDKU /2@!:*** "BBFQRQS+NBD5UR1E3D9!P1^= #J*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MISD"H]&72-&UC4M0B_MB3[6Q,43:1=;;<$[G"_)_$Q+'IVK*BTZ"+2(H%O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ1*G]GSH8PFZ-LS=7#'/*' /W:EZ/4:U6AZ717*:WX@DD\-Z7J>GRF.TO+B
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M]F6R2I:89=IG=F ;).')W#J>]8&EZS<WGQ$O;(3W7V-=.CF6WGA\ORW+D9'
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M%/)52<C+8/?C-=Q11<5M+'GVIZ)-9Z!J^L.JVNI?;CJMI$2&,;JJJ$.TX)<
M@X)^_C)KKM T^33M'BCGP;N4F>Y8=#*YW-CVR<#V J#5;;P\VLZ9<ZHEH=1#
ME+$S$;RW4[1W_I6I:W4%[ )K:59(R2-RGN#@@^A!XQ0MAO<XJU\/:E>Z+XOT
MZYM9+)M3NYI+:25T8,KJ "=C$CE>0>QHTW2;^YLYX9?">FZ/<&RDMWN$,3-(
MQ7 "%.0N>3N]N.]=TSJBLSL%51DDG  J"QO[34[1+NQN8KBW?.V6)@RM@X."
M.O(-*UU;RM^%AWUOY_\ !_0X:#3?$/\ 9/AZRGT>06]K;&WN8X;N-)=P50K%
MPP_=D@Y"G)XR#TJ*QT77+72O!T$FC3%]*N'-P$GB.%",H(RXSDMG [#\*]&H
MJF[MO^OZU)MI8\WT[0M:MM$\,02Z-/Y]EJLES.HFA_=QL9,'[^#]\<#/0^V=
M'3-(U:V\107=M83:?#)<S-?Q&='MI5^;;+&NXLKD[<X [Y]^WHHO_7W?Y#>O
M]>O^9S?B/0[NYU?2M=TS8]]IK.# [;1/$XPRY[-W&>,]:MBZU34E\@Z7/IT3
MHPEDN9(V89! ""-VYSW./Q[;-5TOK62_FL4G1KJ%%DDB!Y56S@GZX-*UU8.M
MSA[30M6E\/Z-X=N-/:)]-NX9&O=Z&)DB;<&7#;MS 8P1QDU7NM"UJ31-?A&C
M3M-=:VEY @FART8:,[L[\#A#P>>1[X](HIW=[_UT_P D'2W]=?\ ,X>[TK5Y
M/$3ZA8:=/97+7D7F2K/&;>ZM\+N,B%B=ZC(!"YR!@XJCJVCZ]+8:OIEOH[S"
M754OHIQ/&J/'YB,0,G.X;3P0![UZ-126EOZ[/] >O]>O^9QT^D:E<^*?$$WV
M)TMK[2TMH9VD3:9 'R" VX??'..QKG&T'Q1>:&NEW6BND2Z0+.$17D:XF5<%
MI2&RR_W5&X=R 3QZI11;2W]=?\QIV=_ZZ?Y'#V>G:N/$EE?SZ/.D,>AFU?$T
M1/F[@=OW_0=>F3U[U2T[0M;L],\&R?V2YGTEI8[BW,\8(#(5#!@Q!'(Z'/M7
MHM5K;4+2[EN8K>=)'MI/+F5?X&P#@_@13OK?^MV_U)MI;Y?A;]#%\9Z=>ZAI
MMBUA;FXFM-0@NC"'52ZHV2 6(&?J:S%L-5T^]UX-I4M[%K $L9CE3$3F,(T;
M[B/E&!@@'C-;T?BK09;^*QCU6V:ZF;;%$'R7Z]/4<'GI6Q4VNO7_ (!5]?0Y
MPZ<^D?#I]-ED$DEKI;0LZ]"5C()%8.DZ?>:[IGA4MITUE%86V]IY6C(;= 4
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M44;;?UO_ )L/Z_+_ "1YU>^']7\C[3!I<KO<Z_%J36ZR1!H8D"@[B7 +';G
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M;W>JQ2QP)&<HI1RGS9Y..O'4\=*WH9S8_$RXL8^(;_3Q=,O82H^PM]2I&?\
M=%">!+.);&*/5-36UL+D7-K;;XRD3#/R@E-Q7DC!)]JMZ=I\UWXFNM>NH6@
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MCU6:_5;>Y><6$Z(J*XD+(<[=Q'(8#<1GZ8&NG@JPBU*>YBO=0BMIYO/EL$G
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MS16@O$N[>,Q1F,G:0RLS;2#_ +1R/2J_Q&C:?P[;P):7=TS7L#E+6"21@JR
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M 'XUMV=^);VXL#;W*O:I&6F>(B.3<#]QOXB,<^F:-_Z\OZ^\'I_7G_7W%TD
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MB*UU?3;!9;VU;5);..XFMXY!N7<H).W.0,FKMOK>FWEVUG:W]O)<A68(K9)
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M)P.QZ@6O]>O^0'4_\([9?\]]2_\ !G<__'*IWUEH>F!3>ZE>VX8$CS-5N!D
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MS3V\<$EO>2VI6.0NIV'&02!G\A3NVQ;(VZ***0PHHHH **** "BBB@ HHHH
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MN+^P;2?B.\,\2Q2 ,ASM#;H% (]<GIZYKT;3M)6Q%P\T[W5Q<L&FED51NP,
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M4U&.Z73,_9O+@,;,Q4IND.X@G:3T Y.?:LX^!;Q?#ZZ/%K,8@COENH2]GNV
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M2,<'(R :;_PB<D&JZ#<6-['#:Z/;M;I!) 9&D5@%.7WC!PH[=?6DNE_ZT?\
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M0>#S2T4 )M Z<"EHHH 15"YP ,\FEHHH *:T:N5+*"5Y!(Z4ZB@!,4 8I:*
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M*B*,*JC  ] *=3\@\PHHHI %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUO(V/ED?&W/3=_=SCC.,U=L[NWO[.&[M95EMYD#QR+T93T- $]%%% !1110
M4444 %%%% !1110 456LM1LM165K*ZAN%AD,4AB<,%<=5)'<9I8[^UEU":P2
M=&NH4622('E5;."?K@T 6**** "BBB@ HHJM>:C9:>T"WEU# UQ((H1(X!D<
M]%4=S0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_
MU#<>G\ZEJ*X.(&/T_G0 \$^AHIP&** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KS_ ,?RG5I)=*MVO!-80?;4-M;R29N <Q*=
MBGT)P?5:] /2LW2='72A=D7ES=274YGDDN-FX,0!@;5'   'TI#3L91\27-[
MX%@US3+5YIY4C+Q(F]X_F DPO5BOS<=\5<\,ZFVK:?-<?;X+V+SV6*6)-A"X
M'RNIY5P<@BJ=GX*@L;&XM(=8U7;-=B\5B\6Z*7=N)3$>,$]0016MI6CP:2UX
M\4DLLMY.9YI)-N6; 7HH ' ':JTU_K^NI-MD<Q>>)M7M- O+S?;//::P+(GR
M2%>,R*O3=P<-U]NE6;SQ!?P^*O[-EFCLE-S$MLMQ"=EW$0-^V3IY@).%]N^:
MEO? MG?->J^I:C';7=PMTUO%(@5)00=PRI/)4<$D5;G\)VUS/(T]]>R0/=QW
MAMV9-@D3&"#LW $J"0#_ #-*/2_]:+_@_P!;#ZV_K5F1:^(?$FJ7*W>FZ9YM
M@-0:W9&,2CR58HS[C)NW9!.-O3CGK63XKU2]UWP7?7\<D$=@NHQPQQ>62[*D
MZJ6+9X)8$XQTKIU\$V$>HSW,5[J$5M<3>?+8).!;O)G)8KC/)Y(!P?2H;SP%
M8W5O>6B:CJ-M8W4PN'M87C\M9-P;<NY"PR1G&<>U"Z7\OS7^3&];_/\ 7_-&
MAXOO[G2O"6IW]IY)FMX&D FC+J<=01D?Y]:R;O6==D\11Z593V4*2Z5]M622
MW9V1PP!& X!SGVQ[UT&LZ/%K>B7&E7%Q/'%<1^7))%M#D=^JD<_2J:^%XEU:
M+4O[2OC<1V)L5_U6-G7=C9][(!]/;'%+O_71_K8?;^NJ_2Y)X:U2?7/">GZE
M*$CN+FW#MM'RAL<\>F>U<%!/J-WX!TB[NKA+NYDUZ-D+KMPWVEAR<GCZ#@<5
MZ+H6CQ:#HUOI<%Q//# -J//M+8]/E4#]*R$\#6,=A'91ZAJ*6\5ZM[$@D0B-
M@Y<*,I]W<2?7WJ[KFOTT_.Y/V;>OY-&;?^)-9M=&\6I.;"2[T@*\4@@81R(R
M!\%"YYZC.?3BIM;\2:C8W,$7FQ6,,UK&]O=3PEH)9B3NC=^D?&,9]?;%:-YX
M-M;T:X)-0OU760BW 4Q_(%&W"93CCCG-+=^$+>]AG@FU+4#!<VR6T\68]LJI
MG#'Y.&(."5Q^@J5TOY#?^?Z?\$WY)4AA>:5@L:*69B> !R37F6EZN;?QII^M
MN+U8=>#6\XFMY4CB(.;?#,H7...#U)-=]K&CIJ^D/IK75S:PN KM;E=S+_=^
M96&#WXJ+Q!X>@\1:0NG7%W=6\8D23S+8HKY4Y')4@<@'@#I0M'?^K=?Z\@W5
MOZ\C.UW7KJTUW^S8[B"QC%A)=+<7";A*X.-@R1P.I[\CI6-I7B'Q5JMY8V3S
M:=;3WNE"_!^R./*;S%&T@N<\'KQZXI/$.C75SXEMY+DZ^8;:T6."[T_RF,KD
MY?S%(P#PO10#^0K8T+P]=_VE#KNIWU^;V.)[9(IO)YA+9'F;$^_P"<'M]:(_
MU^/_   ?]?A_P2E:^(O$FJ7"W>FZ9YMB+]K=D/E*/)5BC/N,F[=D$XV]..>M
M%KXB\2:I<+=Z=IGFV U!K=D)B4>2K%&?<9-V[()QMZ<<]:TD\%6$>I3W,5YJ
M$5M/-Y\M@DX%N\F<EBN,\D9(!P?2A?!-A'J4]S%>ZA%;3S>?+8),!;O)G);;
MC/)Y(!P?2A=+_P!;?\$'UM_6_P#P#!O/%GB"WTO6=262P,>DZH;9H?(8&>/<
M@ W;CL.'ZX.?:KUSXIU'1+_78=1,%VEEIZ7\7DQ&+J6&PY8YY4<^YXJW-X%M
M)],U2P?4M0\K4KK[7,P,6X/D'"_N^!\J^O3KUJW)X4M)]6N[^ZN+FX^UV8LY
MH)-GEM&,^B@YR2>O?Z8.G]=E^HW:_P#7?_(YK5O$?C/2-)N=1DL(!;QVJ3&6
M=$PLFX HH25B5(/!/3'?-7IM:UR*\\0:?-<VQD@TP7UM-%;E?+)WC:06.[&T
M<\?2I9?AW93Z4^G7&L:S/ 4\N/S9T8PID':N4QV R<G' (K5/ABW?5KC4);R
M[D:XLQ92PMY80QC/H@.<DGKW^E$M4TO/\O\ ,(Z-7\OS7Z7(O"D4UYX$TQ+V
MX:8W%BFYP"K89!WR<GGK3;#PD+"?29EU:_E?3HG@S(RGSHV.0K\=L#&,=*TM
M$TB/0M+AT^&YN;B*%0J-<,&8*!@#@ 8  [5?D0O$Z+(T;," ZXRON,@C/U%5
M)^\VOZW_ ,R4M+,\U\::D\^I2ZG9B]>7P]-&T*0V\KQRL>9@S*I7[A Y/'S5
MK^/KJ2]\$075A=*D%Q/:G.S=O5Y$QW]P?>N@T[1$T[16TQ+NYD5O,S/+L,F7
M))/"A2<D]1^=9/\ P@EJ/"T/A[^U]4-G#*LD;EXC(NT[E7/EXV@@'IGMG'%2
MM-/-/\KC>NOJO\BE=V=XOQ)TM!=6X1K">20"V'SG=&K9^;J1@9[ 8YK*U*\F
MNO"$D4L5K$+3Q#%:HMK%Y:;4G0#Y<G'YUV<WAY9]?L]8;4;T3VL)@6,>7L=6
MP6W#9G)('0CIQBJ$O@:UET^YLSJ6H[)[\:@6!BW+)NW8'R8VY .,=NM-:6_K
M[2?Y ];_ -=&OS'R:MJ,/B36K4+9NEOI\=S;;E,9R2XP[DGC*]>, UC6WB?5
MKI-8MA=1L\.DK>0W M60!SN!VAC\Z97AOYUT%YX3M-0OM0N;J[O)%O[06<T&
MY @09QC"[@<ECU[_ $J*U\&VMO>-<RZCJ%T[V?V*03R)B2/G&0JCD9/3'7G)
MJ6KQMY?Y_P# &FKW]/T_X)AZ5K>KPZ/X9TRVWW5U=Z<+J2940LL:J@QAW4$Y
M89.>G;TV=-TN\UJ/2M2\0V<=MJ5BTA\I C98Y4-N!. 5.=H.,GGI3&\"6/\
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M(1KJ U$+YB-^]!SW0\9R?ZU8D\(0O=:A<KJFHQRWMQ'<,4:(>6\>-NWY.F
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M)M/RG'*_KS47_"#6']G367V[4 LEZ+])/,4O%*&W94E<<G)Y!ZU;:YFUM?\
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MO[<VBL5:;S!M# X()['/&.M8GC&.\BET74H+6:\MK"\\ZYMX$WR,I1E#*O\
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M$?)A<><1OWJCXP6PPX%3Z5J-YH2:M=7EMJ&HV5O#"8;K["T=U*OS?(RD+OV
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M$>C1013MJ5MY4R"1'#Y!4G ;([$\9J6[UK2["X6WN[^"&5MN%=P",G SZ9/
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M[:^G_#$WT]?^'.A2_M9-0EL$G0W44:R/$#RJL2 ?T-6*Y2_U?4[76=?@B:S
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ML7\+$*S!3V(SVI?U^7^8?U_7W&Q@4444 %%%% !1110 4444 %%%% !1110
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MKF-5MK8V7BV33ECFT91:W$9A :)9@V92F..%"DX_QKU(@$8(!H5%50JJ HZ
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M<>O-7]2CCM/$.N6OAUD2\N?#RRJD#?/+)N;#^[[3UZ\BO3Z*72W];6*OK?\
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M1_[.?,QCL#VKUUE5U*LH93U!&11@ 8P,"B_]?-/] _K\&OU,37//_P"$,O\
M_A'PGG&T<VOD8P21QMQQGTKE+,Z1+JGAFXT)K?"P21ZBL>.(/+.?.'8AP/O<
MY)]Z]'IH15)*J 6.20.M+O\ UW_S#I;^NG^1P_PNM=,?PM;WUM';O=(T]N9H
MR"RIYS,$SV&""![^]4YWT^P\;>+_ +2L44\VGQ20LR %@(W#L#Z= 3]*]&I'
M=8T+NP51R23@"B7O?=;[U8:=G\[_ (W/*M&6RL[OP1+8/#'?7>D3([AANE(C
M0J&/4X8'&>F,"G>#1I%Q=Z,9-0U)O$%FSK<V8BC5DD8'S#*0@8IGG)8]NIKU
M2BJ<O>O_ %O?]2;:6.4\<W5O:VNF?:@BHU\FV:8D00L 2&E (ROH,C)QR*XB
M%K9O#EI'++&8+/Q06N&V^6D49=R&(_A4Y!_&O8J, =JE:?UZ#>O]>O\ F>.Z
M_!IEC)?S6!M8M%_M+3VM]A40K.'/F^7V'RXW8]_0UT=S<V3>.?%$5Q-;E#HT
M.]9&&-H\PG(/;!'YBN_I#@ DX '<TG\-O7\K#OK?T_.YY':#3)=&^'5S?QVT
MUD(I;>9I$#J282 AZY)88QZUIZ;HPAUA?!AM/^)?97G]J1R;!M,!)9$_WA)D
M?[JUZ-N6XMMT$PQ(OR2IAAR.".QK-T31I-+666[OY=0OIMHENI45"RKG:H"@
M  9/XDFKO[S?]=_P9-M+?UU_1V,KXDP"?X?ZLOE"0K$' *YQA@<_@,UD&YT:
M7Q2K:F;/^PYM,"Z<\P"P$[CYN,_+N(V_4=*]"IK(KC#J&&<X(S4_U^%A_P!?
MBF<]X%2YC\(VB71D.UI%A,OWC"';RR?^ ;:Z.BBFW< HHHI %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %,FXA8^U/J.;_4O]* 'J<J#[
M44)]Q?I10 M%%% !1110 4444 %%%% !1110 4444 %%%% &3K>M?V5]CABB
M$UW>SBW@C9MH)P223@X  )Z5S/B#Q=J=KX>\10I!#;:OIJ(2RN61HY.%D0XZ
M]>#T(KI=?T/^V8[26&X^S7ME.+BVF*;PK $$,N1E2"01D5EWO@U]5L=8%_>K
M]MU2%(6EAB*I$J9*@*6)/)).3SGM0O/^MO\ @C6Z_KO_ , P4O[_ $+Q'XJU
M"WTNWGGCLK6YN56?RU;:LFX@[22Q ] ..OKMZAXSE680:7I\MS*+);QQY4K_
M 'P=D?[M&PQP>3@#W[ \(:@_]N-<:U%++JMFEJ6%EM$>T,-V-_/WSQ].32_\
M(AJ-M<6=YIFNBTO([..SN6-H)([A4^Z=A;Y6&3SD]:/+^NO_  !+^OP_X(@\
M6:I=:E'IUEH@2ZETU;]$NYC&4)<*4<;<J1SZYQVJM=>,]1LM#U"]N+.R6?3]
M1%I/&96 V$KAP<>C X]*U;/PU<VGB>'5SJ9G5+$6;I-$3(_S;MY?=C.>VW&.
M*6]\)V]_KEUJ$T\AAN;3[/):C[C-AE\P^IVL5H?]??\ JM/F']?U^?R,[7]<
ME+W<4FDV=]I]K>6D1:24@AW93D#:02I9#U'6K;^)YW\2S:1;06YDMYHD>&60
MK*\3 $RH.A5<X_ U$W@^Y7PA:Z'#JP\Z*:.:6[G@,AE97#\C>,<@#J>!BI-0
M\*7.IWJRW6I1O%%>1W<'^C'S8-N,HDF_A21Z="135KV_KI_7](3V_K^OZ]2L
MOC6ZN+U39Z/<W-B;XV9>."4M@$JTN=FS:&!XW=!GVK>UW6$T/3#=-&99&D2&
M&(-MWR.P51GL,GKZ5D6?A._T^\G2SU^6'29[@W#68@&]69MS!9<Y"D]L9Y.#
M6MXAT./Q!I+V,DSP/N62*9/O12*<JP]<$=*71?UVO^H^O]?+]#-N?$=_I-G?
MRZMIBJT,D4=JT,N4NFDP HR,J0QP<CWK/UOQM?\ AX7D-[I=N]S#;K=QB*X;
M9+%O",,E>&4D<=#GJ*OS^%;S5-)GMM9UE[FY?88IH81$D+(VY7"9.6SU)//3
MBJ>M>"[_ ,16L_\ :&JVZWCVWV5)(;1@B(75F.TR9+$JO? ]#1UU!$LGBC5$
MGURRDL;6&[L[ 7MN5G9U93NP'^48(*]LCWJI8>*-9ATOPO!):6]W=ZM:LRRM
M<%?G6+>-PV\ ]R,X]#6L_AFYGUJ\OI[^(PW6GBQ>%+<JP R=P;>>['C'I]:I
M6G@[4+>3PZ7UJ&5=%#*H-D1YBE-F,B3CY>_///3BFOZ_\F_X =/Z[+];DLGB
MC4F34#::;;S/I<:F]4W!&Z39O9(_EYP#U.,DXJ#PY<6=]XTU/4;) L5]IEG<
M9VX+9,N"??  _"KL_AF\BU+4KC2]0BMX=3 ^U12P&3:^W;O0AA@D8X.1D TN
MB>%Y-$UA[B&\0V7V*&SCMS"=ZK'G:2^[D_,V?E';\2+ZO^OZTL#VM_73_@C/
M$6J:G:>)_#EC9>2(+N:7SM[$%ML9.WH>._U KG=.U>7PP?$<]MI<<EA'KF)R
M)?+*"01C** =Q!;)SCKQGMUVN:#+JM_I=];WOV2XT^5W5C%Y@964JPQD8.#P
M>?H:RKOP7=W.EZU9#5HE.IWRW@<VA/E8*G;C?\WW!SQWXI1T_KS7Z7!Z_P!>
M4O\ @!JGC.ZM[W4(=-TFXOET]TCE6.&5VE8@%E0JA4%58'D\^W6M;Q-KDF@>
M&KC5XK43F!5<Q._EG!(!['GGI5";PIJ$>L7=[IFO/8Q7VUKN 6PDRX 4O&Q/
MR$@#LW2K_B309->\,W&C17@M_.54,TD9E. 0>FX9/'7-'1?UZCZ^1F-XFUD:
MU=:2NEV8N1:"\@9KIMGE[BI#G9D-D#@ CGKQS2NOB!,GA^WU>*Q@BADL/M?^
MDS[1(_>%,#); )SCT_#7?PY>MXC?6!J-N&;3OL(B^RG .=V_/F>O;TXSWK$M
M?AU=VVGBS_MU61M..G2$V?.S)(*9<[#SSUS@=*.G]>?_  !+=7_K;_@FG=>*
M=2_MA-.L-,MI&FTW[?%)-<E!C(!5@$..O&,Y]J:/&$T_A_2=3AM(88[Z$RR2
MW,VV* @<*3U)9N!@?X5):^%K^WU>VU%]5@DD@TPV 4VA )R#O^_Z@<>G?O5:
MS\$WME:Z+''K49ETR*2$$VF4D1^X4O\ *X'&[)ZGBA];?UJ_TM_5P72_]:+]
M;D]IXPDU&S\/_9K1$NM8C>0"5R4B"+EN0/F/0 <>O:JUOXXN9-(AN)=,1+JX
MOY+&"*&1Y@2A8.YVQYP-K' ![<CMS^M:+<Z38^']#FU5XH;,R2I?-IYECX&U
M4(4\-AF.<CO^&S9Z->:[H\,*7:6<VFW(ET[4+>Q,"L=OS'R6/(^9@><'K3T=
MW_6X;?UZEAO&FH064$L^AR)(^J)IY\W?"'5C\LB!T!(/H<8YZU'<^,M8M8==
M$FDV9N-&"RW&V[;8T3)O&P[,EL9'( ]ZN7OA74]1M+1;K7EEN8;Z*\>1K3Y#
MY?W41 XVCU.233+WP==W;^)2-4A0:W$D6/LA/DA5V_\ /3YN"?3G\J73^O+_
M ((]/Z]7^A#>>.;C?=-I>D7-[':>6)%CAE9Y&8*Q5"J%055@>3R?3K2:GXTU
M.TFUY+?2+=UTB&.X=I;IE+QLI;ILX;@\=/>I;?P=J=A<R2:?XB-K'=1HMY&M
MH&#NJA/,C);]V2 /[U/N?!US/+XA9=5C"ZO:QVP#VQ8Q*JE<D[_G)#'TYQ0_
M(4?/R#^W-1N/'MA90"(:=+IANBC,0Q)=1D\=1V'N:U=4UF2VU2RTFRACFOKM
M7D'FN52.-,98X!)Y(  ]?:J<7ABZAUC2]3&IH)K2S^QSA;;B9,@_+ECL.5_V
MNM6M7T.6\U.QU:QN4MM0LPZ*TD>])(VQN1@"#V!!!X(INVEO/\W;]!*_7LO^
M#^IR_B;Q->7_ (&U3RK:.WO+>Z%A>1-(2%)=5.U@!D$,#VX-='-:'0M"U._L
M;*S@OVA::01DB-W5>">/0>E4-0\%37V@WUDNI1Q7=_=K=W-P;<LI92I 5-XP
M/D4<D]#ZUTEQ:/>:7+9W,@+30M%(\:[1R,$@$G'YFIE?E=M_^!_F4K<ROM_P
M?\CS]9[VY?P!J=Q;Q7.IRJ^'#X+AK<GYFQP,\G /MFME/&\ATN)I-.*ZE)?R
M:?\ 9XR\JATR6;*KN*A1GA<]N.M2V7A"]M1X>$FL1RC1BP ^R;?,4Q^6!]_Y
M<#//.3Z=*A;P/<FSF"ZSY5\-2DU&UNHK;'DN_!4J6.\8)'4=:N35W;:[_-?H
M2KV\_P#A_P#@&UX>U>ZU>VN6O-.GLY8)VB'F1NBS*.CH' .#GN.H-4;;Q'J.
MH31W&GZ6EQIC7K6C2+-B0!25:7&,;0P(QG..?:M;2;&]LXI#J&I-?7,C L_E
M^6B@# "IDX'XDDUCV/A2]TV\FBM-;DBT>6X-Q]C6'$B,6W,JRYR$)YQC/)&:
M74?0ANO&4T-A=ZQ#8QRZ/9W+02R>:?-8*VUY%7&, YXSD@$U/'XBU2[\17^E
MV>G6SK9- S2O<$;HI%8Y V_>&.G3W[5#)X,F^RW^E0ZA&FBWTS2RP&$F5-YR
MZH^[ !.>JG&35VPT*?3/$>JZP]]"UO>11KY/D%3$(P0#O+G/!.>!VI+;7^M/
M\[@_+^M?\C&@\>7W]GZ;JUYH\=OI5U<&VFE%SN>%]Y0-C: 4R ,Y!YZ>MN+Q
MC<&WTS4YM/1-(U*=889%E)E3>2(V9<8PW'0\9'6L?PCHEQKOA&RM;^[A;38[
MMY6MA;LLI*RLRJS%NF<'[HR,?4[5KX.N(;.STJ;44ET>RG6:WC\DB;"-N1&?
M=@@''\() %->?E^E_P#@ _+S_6WZ7%L/$VK7\NHM%H\30Z=<SV\RQW!9W*(&
M38"HR6)P<XQ[U6@\97ERFKP)#9&[L]/%XIBG+HK'<#&_'52O;]*N6GA*YAT_
MQ!9S:H"-7FDF$EO 8G@+J%."7;/ 'IW]>(;/P;=Q7;S7.JQ2I+IW]GR1PV@B
M&T9VE?F./O'/7\.E2[\MO+\;?YC5K_/\+K]+E*QUFX>Q\%2:G8VUW<7Q&VZ9
MR7B8PEMP&WJ1D'GCWJY=>,YHK"[UB&PCET>SN6@ED\T^:P5MKR*N,8!SQG)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ.XYMW^E25'/_J'^E #U^Z/I10OW1]** %HHHH **** "BBB@ HHHH ****
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M5)IFKV.L12R6,K.(9#%('C:-D< $J58 @\BN:\ R-+=>)FNN-2_M:03ANH0
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MC_:TD>)"",!4QV]./H*%KK_73_,'I_7K_D=-J>I6VD:;<:A=EQ;P(7D*1LY
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MVY5V@8XZ\Y[,2XUN_P#$MII,NN>5YVD>=,]B$9!,LJJS(2N<'D'/X8II7?\
M7G_D3?2_]=/\SO**\QOM8UR'1?$&I)K5QYFE:N88(S''LD3=&-KX4$C#'H1^
M-=+I%U?0>-M2TF>_FN[<64-TAF" HS,RD#:!\O XYI+7^O*_Y#>G]>=CJ:K7
M]_;Z;;>?<,0I9455&6=F.%4#N236!=7EYJGB^ZT2&]FL8;6R2?="%WR.[$ Y
M8'Y5V].Y/-<Q>7U_KNC^$YKRZEBN#K/V:8P$*KLAD7?C!YRF?3FA:V_KK;]
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M$5(((1<-.(D$S*$,FT;BHY SUQR:+_U\A_U^1S_B/0[NYU?2M=TS8]]IK.#
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MQ;W,"2!4D ! ;IG(#'OCVH?EV_1?\$:M^/Z_Y'/0^(+W4[;7-.NY([B$:/\
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MW-U-=".-C"TJ^R;=I;/!!QGM703^#[&YTUK62YN_.>[6]:\5E$IF4C#?=V]
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M:A)8PK!':K-YLR1@++O *!4E8E2#P3TQWS5O59->C\4^&[>;4X1'<W=PX2*
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MRX#O/IY)B8G[V1CYO7D _4"J]MX2TJVT"^T9(W^R7KRM,-V#^\/(!'3 P![
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M7VHQO%?-?0S"1"\<C9W8RI!!R>H/6C^OR_X(/=V_K?\ X!SVIZQ=:UX(BGO
MOG1:Y%;DB,Q[@EP "5).#CJ*[K7-5CT30[W4Y4+I:PM*5'\6!P*QG\#63:;-
M8#4=16*6]%]GS$++(&W<90\%N?\ ZU=#=6D%]92V=T@E@F0QR*W\2D8-#^%V
MW_X"_P"""^*[V_X+.:36=9LM3T>"_>UFBU9&53%"5^SS!-X'WOF4@'T/'OQ)
MX-U/6=<TZ#4[Z>T\AUEC,,4)4^8LK+NR2>,#I^M6;+PM':R6K3:C>70LE9+,
M3;#Y&1MR"%&X@< MGBK?A_0X?#NE+I]O<W%Q$KLZM<;"PW'<1\JJ,9)/3O3T
MU_KK_D+6R_KI_F:E%%%(84444 %%%% !1110 4444 %%%% !1110 4R7_5/]
M*?3)?]2_^Z?Y4 .'W1]**444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %>ZO[.Q\H7=U# 9G$<8D<+O8]AGJ:I1^)M"ET^2_CU>S:TC?RWF$R[0W]W
M/K[5B_$$PKIVD-/"TT2ZM;%HUC+EAD]%')^@KG?$EA+>6'BV^T_3[QH=0@MH
MHXUM)-\TJL=S!-N[&"HW$=J%K_7I_F.W]?>>@'7](%O)/_:-OY44Q@=MXXD'
M5/<^U2?VQIOV&*]%["UM*0(Y$<,'/H,=3P>!Z5S>J(]IXCT+6A:S/I<<$L<B
MQV[%X9'"[79 -W0%3QD9YK'72Y DTODZI:17.L275A<6L#,]KF/&]HMI.QFW
M@@C^+G&:/Z_'^F+I_7]:';?\)%HH@AG.J6BQS(TD;-*!O5?O$9[#!SZ4J^(-
M';3XK]-1MGM9CMCE60$.>X&.IX/'L:X0W$D5YX.GUG3S'(ES>$I!:/SP<2>6
M 67/WB,<9[5472KC3_$KZZVE:I+HL]U<&.&R$J30EUC_ 'OEH0V&*/QZ$'%
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MY V8! &[\SUJ6[*_E_G_ )#2N_N_3_,[R#Q%HMS=16T6J6C3RC,4?F@-*/5
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M8)K*7RI%N(MF[T9?53S@^U5):OY_H2GHOZ[DB:SILE^+%;R)KHEE$8/)*_>
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M 4444 %%%% &=J^C0:RELMQ+/&+:=;B/RF"_.OW2>#G'I6C6-X@UT:+':)'
M\]S>3B&%%5FQP6+$*"V  3P/RZUC-XSU"&R@EGT.1)'U-+ ^;OA#JQ^61 Z
MD'T.,<]:%V0/^OZ^\[*C\*XBX\9:Q:PZX)-*LS/HP66XVW3;&B*;QL.S);&>
MH ]ZO77B74GUB/3=,TR&>2;3Q>Q237!11\P&UL*2.O&,Y/IUH_K]0_K^OO1J
MW^DVMYJVG7\UQ+'/:,WD*K@ EAALC'.16I7G5[K$&MS^#-:DM1;3"^FCE5\%
MHBL<@==WIE?T%:\/C&X:#3-2FL$32=2G6&*02DR)N)$;,N,8;CH>,CK3MT_K
MI^8/^OQ_(ZZBN0;Q=?16.NF?3X$O]-N%ABMQ,3Y^_'EG.WC=NP.O(IFH>,[V
M"YO8K'2)[PV#1QSI#%*YD<@%E0JA7Y0PZD9]!UI =E^%%<;J/C6ZANKV/3M(
MN;U;%D25$@E9Y&(!95VH5!56'4]?3K6_K6M1Z+HQOY(F=B42*'.UG=R%5>>G
M)'TH TZB%Q ]PT"S1M,@RT88;@/<=:P8-?OAJ\^CWEI;QWWV4W5LZ2LT4B@X
M(/R@@@D?4&LWX?6BW_A_3];O;2V^WN)72X0DN=[DMNR/7ZT+^OZ^0/\ K\SM
M:/PKR&32;6:Y\:0VFBO+J_VT_8;BWM\-"YC4KB7C9R<GD=ZZY=<UZUO[30?L
M=M=:C_9B7+S/.55W#*K@X7CJ2,9S[4+5+^NEP>C9V'X4?A7(7/C.>*PN]8AL
M8Y-'L[DP32>:?-8*VUY%7&, YXSD@$T6NN:J_BWQ##Y27%G8VL+PP1,=[EE=
MAC(QN/3KV%']?J%OZ^=CK^#VJO:V-O9M,T$>UIY#)(Q)8LWN3S[#T' KE]/\
M:F6?4H[N&W/V&Q6\<VDOFX^]NC/'WE*XX_2H9?'-W8M:27NGV_V6XT]]1+Q7
M!+1HH!*[=OS'YE .0.M']?G_ )!_7Y?YG;4?A7&Q>,-5VW1DT*0".Q:[1V2:
M*,,O6)F>,?-CD$#GGI4FD>+KV_U/2[>YTZ""'4[$W=NR3EV! 4D.-H ^]Q@G
MI1;^OO\ \F'G_73_ #.LCECF7=$Z.N2,J01D'!'YTZN)TCQ*L>C6JVNEVUO=
MWNHSVL5M')B,.K,7<MM!Q\I/3G(%=-H]W?W=M-_:5B+2>*9HP%?<LJCHZGK@
MCL>:/Z_+_,/Z_/\ R-#\**RM;UG^RA9PQ1":[O9Q;V\;/M!."22<'  !/2LY
M/$]TL>N6\]E$NI:5$)C&LI\N9"I96#;<C.",8X(I7TN.VMCIJ8DL<C.J.C%#
MM<*0=IZX/H>163X>U2_UBQCO[FTAM[:X@BFM]DI9CN7+!ACC!Z=>*YMO%3:5
M8>*=1@T6V633[\),J3%3/PHWD[?O8(X_6J:L[/\ K6PEJKH[T],55M;6TLY9
ME@"K-,WFRY8LS$\9.3G'8=AC KEYO&ESI]_J%GJ.GQ)/%%#):I!.7\TRN45"
M2HP=PYQD8]<5F-/?Z;X^UN^:SLQ=1Z&DY6.0[9=KMU.W.<#'0]!2VU]?\PWV
M\OZ_$]%HQZ5S(\5.-5TJWEMHTM[^P>\,GF',94*2",<C#=?:DTSQ+J-]]BO7
MTQ5TB\B>43K+EX5 RI<8_B'IG%#5M_ZW_P A)WU1T]%<AI'C&\U6^T\II%S]
M@OPY6402_N0!E&=B@7##T)QD=>M:VJZU):ZI9Z590QS7UTKR#S7*I&B8RQP"
M3R0 !Z^U S9_"C\*XR3QO<)9PM_9J"Z755TR[A\[_5N3PRG;\P((/..M;<VH
M:I9^''O;C3XY-00<V\$N4^]@'<0. .2<>M'2_P#7]:AY&Q^%%<A:>++F_P!*
M\02VR6<D^F ^7+%*6AE_=[P<XS[=^G6LKP_XBUZ?5M%AOI+8VKZ+]ME82$M)
MDIEF^7[PYX'')YH_K\&_T#^OR_S/0R :,"N0TKQC?:I=6!CT6X-E?*[1R^3*
M/) &4,C% N&'H3C(ZU5MO'.I36&DZ@VD0+;7]TUEM6Z)=9=SJ#]T#9E>3UYZ
M>KL!W5%<9/XTO;+2-=N+C38'O-(G2*2**X.QPP4@JQ7.<-TP.G6G77BK5;:Z
MU&QN--@M[A;"2]LG\XNKJO!5_E&&&1D#(YZ]ZENRO_6U_P AI7=OZWL=C16)
MX6NKZ\\(:;=WC(]U+:I)NW'YR5!R>.#ZUS_A[Q9J3^&[&>]CAN-0U&^DM[9%
MD*C[[YR<<*JJ?4D 535FX]O\["3NKG=TP2QM*T0D4R* 60'D ]"1^!K(T;6Y
M;[4=0TN]MT@OK$H7\MRR2(X)5U) /8@@]"*R[G6FL_$7B 0Z5:FZL]/CN/.\
MTJTZ_.0K';\N,''7K^2;MJ%KZ'754U.SL]1T^6QO@#;W*^4RE]I;/8$<Y^E<
MYI7C"ZN]0TV.]L(+:UU&P:]AD2<NRA0I8.-H X;L3TK%UG49]:NO"&J_8H(K
M:;54-O(7S*$*MC/' 8 '&>..O9M:V?\ 6MOT%?2_];7.PM?#EM;30RR75_=F
M$YB%U<M($.,9QT)QW.36Q^%<C<^+[NUT6XOI+"$O;:F+"1%F.""ZIO!V]?F!
MQ^M6+?Q'J.H31W&GZ8EQIAO6M&D$V) %)5I<8QM##&,YQS[4EJ/8Z:BN.3QK
M=7%ZAL](N;FQ-Z;0O'!*6P"5:7.S9M# \;N@S[5O:YJ<VEV<<T,"/OE5'DE<
M)' ISF1SZ#'YD4=+AUL6[NRM[Y8UN8_,6-Q(JDG&X="1T..N#WP>U6*XE?'5
MRVB6>H1Z=!,9M3.G.$N"%SO*AU)7D'&><8]Z=)XOU:/2-=F_LFWDOM'F E@C
MN&*/&4#Y5MH.0#TQVH_K\O\ -!_7Y_Y':45BVVMR7>MVUE!%%+;26(NY)TD/
MR;CA !CD-\Q'^Z:HZYXIN+'4Y].T^Q>ZN+>V%Q)B*5QSG:@V(V"=IY. /?L/
M3<%KL;R6%O'J,E]&K)-*@23:QVOCH2.F1TSUQ5KK7)#Q5JEUJEOI]IHZ1SW&
MFB^07DS1F,[@K(Z["01GMG/M4&F^-[J^&@W,FFQ16>JR&WSYY:1)0&)XVXVY
M0C.<]#@4[=/ZZ_Y,+]3J;#3;;3EF\E6,DTADEE<[GD8]R?8< = !@59#H9"@
M92X&2N>0*XJY\;:I;VFI7W]B1M9:7>M;W;"Y^8H-OSH-O.,Y(./;/:K/JMKH
M/CG7]06 .TMC9A(TPIFE=W503ZGCD]A[4EK;^NBL#T_KSU/0:*YB3Q#JD&H7
M6E2Z=;MJ2VAN[58YB8YU!P5R5RK X[<Y%,L?%TE];:%,EM#_ ,3"*2:Y D/^
MCHBY8].<-A3TY-']?G_DP_K^OO.JHKCM-\:75_<6,ITBY73KQ7<3B"7]PH&5
M9V*!<,/0G''7K3M(\87FJWNGE=&N?L%^'*S""4>2 ,HSL4"X8>A.,CKUIV Z
M^J]M96UF9GACVM,YDE8L26;U)//3@>@X%9^JZS):ZG9Z590QRWUVKR#S7*I'
M&F,L< D\D  >OM7*^)/$EY?^!=4,5O';WEO=+87D32$A<NJG:P'((8>G!I+7
M;^M4OS#U_K=_H=]!<07*%X)HY5!P6C8,,^G%25@RZ):0:!J8^P6L4UW QN$B
M&4=@I ."!VQVK@?#.F2RZ7X/N?#^F26=TA1M0NU@\I)8=OS!FX\S)QCKZ\4+
M5V]/U_R$]KGKGX45Q\'B^]*ZI=W5A!#I^E7$\-W()RS81 RE!M&2<X.<8]ZM
M0^([^/4-.M=0T^& :G$S6K1S%]CA=WEO\HYQW''!H_K]1G357N[*WOEC6YC\
MQ8W$BJ2<;AT)'0XZX/?![5P^B>+-9;PW:WM[%:$W$UP6NI9BD405V"H>,Y)P
MJ@9X'X5K)XQ\[PSHVI1V@%QJLL4,<3/\B._<MCH,'MSP.].P/3\?P.JHKB7\
M<WD%U=V4^F1&YBO191&&223S&V>87**A(4)S@9.>..M.?QIJ4-C!-+H3H[ZF
MM@1*7A#AONR('3)![YQCWI+4#LI)$AC:25U1%&69C@ >YIP.1D=*X>_\37$O
MAOQ,NI:19S2Z4=DUMYY:*5"@;[Q3/0],=1VK2N/$-Z9WL-'T^&XN+:R2ZE1Y
M=@^;.R-< \G:>3P./6C^OPN!TU%0VDSW%G#-) T$DB!FB<@E"1RIQW%<Y=ZO
MJ,7Q#@TX- NG+IKW,@9B"?G4$GCMV'N:-G9@M5<ZFBN2A\87!M],U.:P1-(U
M*=8(9%E)E3>2(V9<8PW'0\9'6NMHL 5EZ7H-KI5S<7$<MU//.Q)DN9VE*J3G
M8N?NKD]!6I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %,F_U+_P"Z?Y4^F3?ZE_\ =/\ *@!PHH%% "T444 %%%% !1110 44
M44 %%%% !1110 4444 8WB+06URWMFM[U[&^M)A/;7*H'V-@@Y4_>!!((K+O
M/"FJ:A;6HNM<$MS#?17C2-:_(?+^ZBH'&T>IR2:ZVN9F\1WK^(-1TFSMK1WA
ML!=V\KSG:Y+%</Q\HR#TS0M'IZA_7]?>07G@^[NY/$I_M2%%UN)(L?9"?)"K
MM_YZ?-P3Z<_E6>T&H6WCW3[6UO[59X=&\EY);5FCD(<< !QM.!G&X\?G7;FY
MCBCB^TRQ12.!P7&"?;/6GM-%&ZH\B*S\*K, 6^E&W]>37ZAO_7I_D<K)X*)A
MT>**^4+8W,ES-YD&[[0TF[?T8;0=[>N./3DM?!]Q!9V>E3:@DND64ZS01^21
M-A&W(C/NP0#C^$$@"NK>6.-E5Y%5G.%!.,GVH>6.,$O(J@#)+'&!ZT7L&YQD
M,%EXE\;P:I9BY$%@CQ71>)XTEE5OW:X8#=MR[9'3(J[<>%;]-9O+W2M=>P@O
MR&NH/LZR$N %WHQ(V' '8]*V[O5K*RN;*WFG42WKE(%S]XA2Q/TP.ON*73Y[
MJ6U+7ZV\<WFNH$,FY<!B%Y/?&,CUH6R_KU!_U^A@2^$[^#5;JZTG7I;*WO0I
MNH6@$K,X4+O1R?E8@#D@\\UK:WH4.M:(VG22R1D;&BF!W.CH05;GJ00.O6M$
M7$)7<)HR-VW(8=?3ZTX.C,RAU++U /(H P8-#OVU ZG?WMO+?I:M:P&*W*1H
M&()8J7)8D@=QP/QJ;PKHL_AW0+?2IKM+H6X*I(L/E_*23R-S<\]:UXYHI2PC
MD1RAPP5@<'WK(?6IH_%ZZ-);QK;M9-=+<>9R2KJI4KCCKUR:/+^NX?U^@S0M
M"N])U35[R?4(;A-1G$_EI;&/RV"A>I=LC ';K^5.?0KAO&46O"]B$26AM3;>
M02Q!;=G?OZY _AZ?G6A=S7:3V8M4@>*27;.9'*D)M)ROJ<XX],U.+B S&$31
MF4<[-PW?E0NGD'?S.6;P=,+74-*AOT31;^5I98#"3*FXY=4?=@ G/53C)J6]
M\(27.I:M<0:I);0:G:+;RQQQ?.I56565\\##=,=NM=,\B1(7D=44=68X H,B
M!58NNUL8.>N>E'2W]=@OU_KN<5-H&I:%#=ZN+[[7+%I?V3[-:600MMR4*#<V
M,9.1SG]*P= T@-:1Z0E]!JMK=P?9;GR]*>WDAB*GGS2V!@XX(Y->DZA>O;Z1
M<WMFD=R\432(ADVJ^ >-P!QT]*9HFH_VKHEA?LJQO<VT<YC!SMW*#BC>]_ZW
M#9*W];&'!X9UK^S)K.]\2-= VSV\)-H$"AAC=( W[P@=.1ZTZR\*7EG<Z!*-
M2A9=)M&M2IM2#*"%&<^9\OW5['OZ\=,)HFE:)94,B\L@89'U%"S1.^Q949L9
MP&!.,XS^=%_Z^_\ S8=+?U_6AQT7@6YBT>*!=75-0MKZ2]M;N.VVB-G)+*R%
MSN!W$=1QBK=_:^(+'383:ZK)<ZG+=QM(1:@Q.G0H%R1$F.2V2?J2!73--$C;
M6E0-D#!89R>@I//C9WB22-I5&2F[D?7THV_KT_R#?^O7_,S->T3^V([22&X^
MS7ME.+BVFV;PK $$,N1E2"01D53_ .$<N98M7GGO83J.I0"W:5(#Y<: $ !-
MV3]YC][O4_AS7SJ^BM?7L<-HR7$L#*)<J"CE>&(&>GH*OW>K65E=6=M/.JS7
MCE(%S]XA2Q/TP.ON*+:6[_J%];]OT&:%ITFD:%8Z=+.L[6L*P^:L>P,%& =N
M3@X [US=WX'NKK3_ !%:?VM"HUFY$^[[(3Y(&./]9\W"CGCO^'4VDMW)<7BW
M*6ZQI+B Q.68IM!RP['.>/2K"2Q2(7CD1U!P2K @4V[OF?\ 77] 6FB_K^KG
M):MX)GUC5)KR;5$CW6\,48BMB&CDB?>L@)<@_,3QCIQGO4R^%K^;6+K4=0U6
M&=KK3S82)!:&(;<D[@3(W/-=.LL3/L61"X&[:#SCUJGJ&I"WT^\FM/)N;BWB
M9_),NW) S@D X_*I;23OY_\ !&MU;R_2QSUEX.OEO=+N=0U>*Y6PMI+3RDM-
M@DB8 <G><-A1D]/85/H_A6^TR*.QEUJ2XTFWR+>V$(1PN" KN#\Z@'I@=!FM
MC2-2?5= L]05(TGN;5)_*+<*67.,^F>]3V,\TFG6\M[Y"7#Q@R"%]R!L<[2>
MHJI)W:?];_\ !)5K*Q@Z'X7U'1C!:_V_+-I5LV;>U\@(ZK_"C2 Y91GI@=!V
MXJ[K&A2WFIV6JV%REMJ%H'16DCWI)&V-R, 0>P((/!%;*.LB!T8,I&0P.0:9
M]I@V[O/CVYQG<,9I#.5N_!=Q<6Z;-2BCNVU)-2N)6MBRO(N JJN\;5P .I-;
M7B+1VUW19;!;IK9V9'$@3<,JP;#+D;E.,$9Y%6M0N)X[&Y-C]GDO(XRR),^U
M<]MQ'(%1-J]NFH0Z:9(SJ$L#3K$&XP,#KV&3QQZ^E'3^OZZ!_7]?>95CX8N8
M9]9>[U%9TU6,"5([<1[&V;"5^8\8 P/U-4]-\%7=A=:;.^LK+]DLS82+]D"B
M2'*D ?,=I^7D\YR>E;/AG6I-=T.&^G@2WFD>5#"K[P-CLO!P,]/2HO%.O3^'
MM/M[J"RCNS-<QV^QYS%@N< Y"MWH>G]?UW#^OZ^[\"GH_A;4]($5HOB"673+
M8DVUL;<*RCG:KR!LNHSTP,X'-4X/!%[!HFDZ<-6@/]G:A]N\S[&?WAW,VW'F
M<<L><GM^.KIWB4S:[<Z)J=K'9ZA# +G$<_FQ/$3C(<JIR#P00/QK<,\(1W,T
M85#AFW#"GT/I3UW#R_K^M3@/%>B7.F^'O%=X]ZDIU22*2.)+<AHV!50/O'=P
M >@Z&MY?#\VIS&^U*_AN'>R>UB-M"8U5'P6;EFR3@>PQ6QJ&K66EV\4]W.J)
M+*D,9_O,Y  'Y_E5DW$*R*C2H'?[JE@"WT'>E;2W];6"^M_ZW_X!G^']+GT;
M0[;3KB\%V;=%B201>6-B@ #&3V'7/^%8-OX&EMM-@MH]5_>V-XUWI\IMQ^Y)
M9B5<;OG!WD'D<8Z5U[S11NB/(BN_W5+ %OI1+-%" 994C!. 68#)IMMNX=+&
M7I>CRVFH7FIWD\<U]=JB.8HRB*B9V@ DG^(DDGO5&[\,7=QK&LWR:C"BZC8K
M9K&;4L8L9PV=XW?>;C [>G/1O+'&"7D50!DECC ]:JW,]TMQ9"V6W:"20B9I
M)""%VD@IZG./PI-7T^0)VU,"W\'W$,NA^9J,,D.F63V;I]E(,RLH4G._Y>%'
M8]_PK)X)U".VTFS&MQ-9:5=)/;*UGF3:N0$9O,P>#C(4=.]=B9HA*(C(@D(R
M$W#)'TI].[O?^M[BMI8XS4/!5]>)J%K%K*0V5U>+>JAM=[I(&5B"VX97*^@/
M/7ULV'A.]TVZEBMM;>/29)S<&T6'#JQ.YE63=D(3DXQGDC-=5126@WJ<M:>$
M[[3[V=+/7I8=)FN#<-9B ;U9CN8++G(4GMC/)P:T/$&BS:PMBUO>BVFL[E;A
M=\7FQN0",,F1GKD<\$ ULT4=@.+_ .$(O?LJ6_\ ;491-6&I@O9Y.=VXKPXZ
MDGGT[5=:&+PM=:UK.J7HEL]0FC)BBLG9HSM" ':6+# '\(_I73T4=+?UT_R#
M^OZ^\YGP1H@T?1Y&995:YE:1$F)W10Y/E1\],+CCL2:?JGAN]FUT:QI&K_V=
M<O"(+A7MQ,DJ DKP2,,,GGWKHZ*'N!S</AF[@\00:J-5$IBL&L]L\!=W);<7
M9@X[@< #CBJ%GX(N[33- LQJ\##2+MKG>;,_O<[OEQYGR\.W//;TY[.BB_\
M7X_J#U_KY'GFCZ;=:X/$]A]OACTZYU.42Q_9R93&0N=K[@,-@C.T]_PU-5\#
M_P!J:K?W;WXCBN8(8XD2'YX'B;<CABV#R3QCI77T4;6_KI8.YSGV.33+B3Q%
MKMXD\MI:-"OV6V955"0S';EB6)4=.F*I^%-'MVN=7U:-)A9ZA*?LL4RLNV(@
M%R%."H=RS8P.U=?10!RVD>%+_2TBL7UZ6?1X"1!:>0$<)R CR Y91GI@=!VX
MIVB>%]1T<P6O]OS3:3:MFWM?(".J_P *-(#EE&>F!T';BNGHHN!BZOH<MYJ=
MCJUC<I;:A9AT5I(RZ21MC<C $'L""#P169J'@R:^T&^L5U*.*[O[M;NYN#;E
ME+*5("IO&!\BCDGOZUUM%"T_KY_F@_K^OO*ES;W5QI<MNMQ$MS)$4\TPDH"1
M@G9NSCVW?C57PUI$V@^'[/2IKM+HVJ"-95B\O*CID;CS^-:M% ',V7A+99:]
M9:C=QW5MJ\[S.L<!B,>\ $9+-GH,=.:?9^';W[1IKZIJ,=VNF9^S>7 8V9BN
MS=(=Q!.TGH!R<^U='10#U.(L? =]I]Q:/!KP\JT:;R89+,,JI*Q9OXOOC. W
M3'\/7-#7=$FT?P7I>@2:A(8A=*#?+9&1(44EUWH,YY &<CGTZ5Z-10'6YYU8
M:)=:Q +:WU&-#92K=6FJ6^G- !,<JRLC,1)E>I!'7%;=[X5U+4+2T6ZUT2W$
M-]%>/(UK\A\OHB('&T>IR2:ZJBG<#DKWP?>7D'B2'^U8$36MO_+H280%"?\
M/3YOE'MSS[5)/X6U!-1AU+3=82SO#;);79-KYD<ZKT8*6^5ADXY/7O74T4@>
MIS\4.K6OB2RMH;N:?3$M"+@3Q9._/ROYO=C_ '1P!SQQ3[_P\]WXDMM8BO!$
M%MFM9X6B#B6-F#8!S\IR.N#P>W6MVB@#E+3PA/#96>E3:BDND64ZS01^21-A
M&W(C/NP0#C^$$@"NKHHHN 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !3)?]2_^Z?Y4^F3?ZE_]T_RH <**0#WHH =1110
M4444 %%%% !1110 4444 %%%% !1110!S7CR2XC\+R-"LC0^=%]K\L$M]GWC
MS,8Y^[G/MFN"\0W/AN?5?$3VDVG/:2^'04,14HT@=MN,<;@=OOTKV*CBE_7X
M6'?;^NMSRWQ!>619[N*YL[T#3(/.T^X(!GBR2KV[@Y#Y[8.3CVJ>YGT>77-=
MLO$\4@N[B6*2P0*WFR0JJE%A(YW!PV0.YYKTH#%& 2"1R.E5?6Y*6ECS>]_L
M^?4O%$'B3RX;B2-#8>>0&\GR_E\H_P!X/G.WG=CVJG;6UI=^*-/BU]+5KMO#
M0:\2Y"Y\P,O+@]P,GGIBO4V16(+*"5Y!(Z4I -3;2W];-?K^!5_Z^[_(\AL)
MM.;2?A[>WS6\UM$)H)97 < ^60J'KSD<#UJO$^E2>#M(42VFQ/$Q1-K*-J&9
ML@8Z#:1^&*]FVBC:*J^M_P"MTR>EOZV:_7\#RBZBTV#3_'-C:+;>3:W<$Z6\
M*KB+"Q[F"CI@ALD>AJS?Z@FH^)/$LOA^=9KBXT%#;R6_61@SY*GN<8&?\*].
M(!H5550H  '0"IZ?UVL/K?\ K>YY_P"#/^$>N-7MKO1]0OKBX6R\B6'RHTCA
M4$'$H5%^?.0,Y/7MS5G6X=-OOB/;6NHB&6+^QYB\4I&TCS%ZCH> 3SZ9[5W'
M%(1FG+7\?QO_ )@M/Z]/\CRK2+O33H'P^FEN+<SI>-%&[N-P4+(I7/IG8/KB
MKNC7%M'XLLQ"]OJ,4U]=&-L;+NRD(;>L@!.Y.P)QCY>O%>D@8%%.^MQ/:W]=
M?\SC_$\L47BS0VU7RQHNR8%IL>4+@@;-^>.F[&>YKD+[[':Z=;AYH4TU?$\;
M:>[. HA."_EG^X"6Z<8]J]>95=2KJ&4]01D4!5'08Q26G]>=QO7^O)K]3)O;
M6RTCPK>PVT45M:16TI"( J*""3].M>?Z*EC97G@F:Q>%+V[TB5'?<-TI$:E0
MQZG# XSTQ@5ZO2$ T=_Z[_Y_@'3^O+_(\J\*KH<[Z2;G4+\ZY9^8MW9M%&I1
MF!\TS'8"4SSEF/;J:W/A?::;)X7M[ZW2W>Y1IX#*A!94\UF"9[#!! ]_>NZH
MIW \^L;73;WXA^*8E6TENHDMIX$)4E9E1AOQ_>!*@GW]ZS?" T>:XT8OJ&HM
MX@LV=;FS$4:LDC ^:92$#%,\Y+'MU->I\48'I26EOZ[_ .8/6_\ 78\;TO4-
M/DM[&"26W#-?:CLGN/WD"DN?EV @-(RGY03T)//0SZ;+I_\ 9WP^N[L1-#;F
M:WF>2/.U_+(5#QUR, >M>NX'I1@=A36EOE^ /6_S_$\GFF'V/QK'II1XQJT3
MW4=N?F\C">;@+SSA\_\  JN:D-*DO]5GTI[-]'ET.7[9Y)4P>8,>43C@-C=[
MX ]J]+"@4*B(,(@49S@#%2U[MO+]+?\ !&GK?^M[GE6A-I=CJG@^>%X(IKK1
M)1.8BHDF(2/&3U8Y#8SZ'TIVB75K;1S1)-:7UN-%E:#48?D=8ACY+A02-^?X
MN^&XZUZI@>E&!Z4Y^]?SO^-_\Q1TM\OP/(+9-&LX?"4NZUC:[T2=+IW8?O5$
M2D!R>H!!QGIC%/LFTB72OAY)J$ML+8V\T,CR. A_=8*,>F,\$'CM7KF!Z5CZ
MEH;:AK6F:B+KRQ8ER(C'N$F]=IR<^G^33;O*_G_G_F*VGR_R,OP+;1VMOJ\=
MESI1U!VL=IRFPJN[9_L[]V,<5S6OZ#)%-JWA_3K&/-U*-8M)#$"D90#>OU+*
MH^DA]*]1    & *,#.<<TGW7]?TTF-?U_7WGFVN&SU/X;Z]XCN+6.!]2M%,8
MF4!@J@",?7=DCZBK"R:='\0]%NYO(*7&B[8)=H;S) ZD;3W('/L*]! P,#@4
M@4 FGUT_K1K]1=+?UNO\CR'33I<.D^%]322!;MM?EC\_>-VQI)<KG^Z05XZ<
MY[UU7Q.N+6'PU;"XNDMRVH6Q5BX5AB0$D9]!DUVN!Z4<4NWE_P #_+\1O=O^
MNO\ F>=>/=#TJR\':QJTLQN;V>&*-+JYD#-@."H3& .YX&:L:E#IECXAT.66
M*UCT"X$TSR<>2]RP7:[GH25W8)ZD^M=[2,BNI5E# ]01FA:?UY?TP>O]>G^1
MY+?V]O%H?F,L;:+;^)8I+61@#&EN2NXJ?[FXL/3\*;XIOM/>[U5X&BMW@N+*
M0B:,F5T5D(>/IY<:@G)P<G/3OZX%"\ <4N >HIIVM_7;_('K_7K_ )GDOBO4
M-,DU_P 0:5>WMF#JEG;^1/>L46W&#]W(Y'\7&.35C5X]'MM>2TU:_:ST:;2T
M@T^:&*-H&Z^8%)1@K$;2,8R/PKL6\.7D6I7MU9ZW/!'>2"22,PQR%3M"_*Q&
M0, <'(%;&GV,.FV$-G!N\J%=J[CDGW-);?UY_P"8-Z_UY?Y'FL=EHDOC"TM;
ME5D@'AX[AJ(7S&"N-K2@]PHSR./:H=,O+%M*^&\K7-N\R3M%O+KN $;*5SUZ
M[1CUQ7K.!Z48'I3OK_7=O]1-:?UV2_0\ST>?2)KR2UUJ.5O$MOJKSB.,$3-\
MYV,#WCV$=\8%>@Z;J=GJ]DMY83B:W9F4. 0"5)4]?<&K>!G..?6D "C   ]!
M26UAO>XM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %,F_U+_[I_E3Z9-_J7_W3_*@!PHH%
M% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4R;_4O_NG^5/IDW^I?_=/\J '"B@=** %HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *YOQKJ.H:7IEG<Z?<B F_MXI08P
MV]'D"D<].O6NDKF?'-C?ZAHUM!I]E)=RK>P3,J.BX5) QY=AV%'5>J_-!T?H
M_P F='+YHA<PA#+M.P.2%)[9([5R>BW>M0^,KC2[K5XM4M1:">4B)(S;2EL!
M!M_A(W8#9/R]:WKJ^OH+MHXM+DF@6U:;S5E4$R \1!3W([YQ6%9:>VH>+K+7
M8M&ETTQVTJ7+S*B/*S[2JX4G=@@G)XYXSV%O_7F#V_KR.NHHHH *KWR7,EA<
M)92I%=-&PAD<957QP2.XS5B@D#J<4 <2L^MGQQ)H']O7/DKI@NQ)Y$.[S"Y7
M^Y]WVZ^]0VGB:XT+7-9B\1ZD\R6UK:RD0VY=8BRMYC (N0F1G+=..:TUM;[_
M (64VI&RD%A_9GV47'F1X+^9N^[NW8Q[5GZGI>I3ZCXPDCTYY([_ $Z.WM&$
ML8\UPK@CELCEQUQT-%[*_DQI)NWI^ES<DU2S;Q/9PC4+KS'LI)DMDB)BE3*_
M/G;RP[ '//2F6GC31;VV:ZBFF%JL+3-.\#J@"OL(R1][(^[U]JQ[.PU2'Q#X
M=NWTN<0VFD/;SMYL1V2D)A<;\G[A&1QR.>N*-EX?UEOAQ#IQM#;ZC:WWVI;>
M:5")@LYE"[E8@9!QSW'IS3:2T_K>WY:DIMI/^MK_ )Z&OI>M7-Y\1;ZR\^Z^
MQKIL<ZV\\/E^6Y<C(X!(( ZY[_2H];O-2/CVPTJ+7;C3[*>QDG811P'YU8 8
M,B-Z\BG:9'J=QX^EUBYTF>RM)=,6WS--"Q619"V"$=N,'K1J^FS7_P 0=*NI
M-'^U:9!:2Q23R&(HKN5(.UFW'&TYX[\9I6^'Y_\ MW_ #^;^NW_!&^&O&+7&
M@R7&KD-(FHR:?!+"G_'X5.%95'<\YQQP>E:O_"8Z,+*VNVFE2*XNOL:[H'!6
M8$J5;CY3D$<_A4'BBVOFL["'2K7S;>.Y4W$5NZ12B+!_U3$@*<XY!!QG!KDQ
MH>MP:/!9IHTK&#Q +X!;J)LP[R^<LXR<''/)/YTUJ_N_3_AQO3\?U_X".CT[
MQ[9ZCJ6IPK8ZA';V,*2,[V<@<D[LC9MSC"C'KSZ5L1>)-,F@TN9)G,>J,%M#
MY3_.2I;GCY> 3SBLNSM;VQ\=ZM?26RMI]_!!BY\Y0(S&&!4KG.22.V/>LSPQ
MI<<'BO4 ;B%['39GCTY ^2IF"R2#K_#G:/8D4+6WI_G_ , 'UM_6W_!-K7-7
MNO\ A(-.\/:?)Y%Q>1R3S7. Q@B3 RH((+$D 9! YX-07.HWGASQ#I=G<WDM
M[8:I(T"/,JB2"8#(Y4 %6P>HR#WQQ4FMZ9=Q^(M/\1:=";B:VB>VN+8.%:6%
ML'Y2Q W!@#R0#SS45[87?B/7](N9[.6RL-,E-R/.*^9-+MPH 5CA1DDYZ\<8
MYI1Z?C_7I^(2ZV[%#0/%T%D-2BUK4;B5DU>:V2>2 [(E! 17=5V+UXSCK2:G
MK,UGK_B>"]U:\ATZ'3H9D>"(.UL6+@L@52>P.3G'KCI!+H&J2:/XDT-M/8KJ
MM_++'=^9'Y21R8.XC=ORN#QMZX^H76]'U>34_$[6NF2W$5[H\=G;2":)0\@W
M _><$??ZD=C[9.B]/T7ZCZ_/]?\ (ZJ[U^RTV*%':>YE-N9]L4>]_+4#+D#I
MU_'L*@3QAI,UC97<#7$JWRL]O&MNXDD51EF"D X []#D8SD5R>KW%S!X@MFL
M[.;[4-)$%[''<VZN@8_*K>8^W(PQ!4GKZ5/&)[^PT6#2=.G;2[2.2TN8$N42
M>&10 H:0-RG&3L//'!'%#ZV_K?\ X!*Z7_K1?\$W;GQI9K<^'ULX9KJ'6"S1
MRI$V%0(6SC&<YQQZ9J6RUO3X6UVZEU.X:&TN-LZW,906Y"+\J J"0>".N2>,
MYKEM.T;7++3_  >S:7NFTB26*>$7$>=K(5#@YQC)SZX[=JLZCH6KZHOB01V;
M6[R:A;WEH998]EP(@@VG:Q*Y*=P.H]Z;M^?YK]+_ '#_ *_/_@?>=,GBO2VC
MO6=KB)[*+SIHI+=Q((ST<+C+#@\C/2DT_P 7:1J=[%:VTLV^:W^TPO) Z)+'
MQDJS !L9&<5@W^GZAK%_=:NFESVS)I,UDEO*\?F322$$ 8<J%&.I(ZU!8Z3J
MUO=>$W;2I,V&E26URS2Q%8Y"J  C?DC*'IGJ/?"_K\_\E]X?U^7^;.KT[Q%8
MZI=I;VXFS)!]HB=XBJRQY W*3UZC\Q6M7!^'-.U?2;L2VVFW%K8FR=I-.FN(
MY$2XR"%A(9BJGYN"0.G'IVME+-/8P37-N;>=XU:2$L&\MB.5R.N#QFFT(P-5
MU6[N_%5MX;TZX-LWV<W=Y<HH9XX\[55=P(RQSR0< 5:BMM3TW5_.FU1Y]&%L
M[2BY"!HI 5((8*"5V[NO3^5+5-'O[/Q=%XGTN'[6S6OV2[L]X1I$!W*R%L+N
M![$@$=Z?J\&I^)M%U+3?L;Z9%<6KQ*UPZ-(7(XXC9@%]><GT]9O:-UOK_7W%
M;NSVT+MIXHTN]N%@C>=9)(3/")+=U\^,=63(^;J.!SR.*K6/C?1-1GLHK::X
M87K,D$C6TBHSKG*;B  WRGCKQ6;'9ZIJE]X?GNM)ELGTC>\Q=XV$C&,IMCPQ
MR"3G)QP!61INA:W;:'X8@ET:?S['59+F=1-#^[C8R8/W\'_6#@9/!]LU97_K
MN3K:_P#6QV2^)]/>\6WC6X<N\L:2+"2CO&#O4'N1@_7!Q21>*=*FBTN5)9?+
MU-S';,86 9AGY3Q\I^4]?2N?TS2=7MO$<-W;:?-I\,MS,=0B,Z/;2J=VV6-=
MQ97)VYP!WS[T+;2=?6'P[9MHSA=)U-I)9OM$>V2,^9AT&[)&''7!]C26MK@]
M+V)U\7W>BWNLQW;7-^/[;BLK8% ?+5U0D?*!TRV.Y.*Z:[\6Z59W+03239C>
M))F6%BL+2?<#G'!.1],C.*Y*^\/ZY+=:M<1Z5(W_ !/;;4(5\Z(&>) JMM^;
M@_*3\V*3Q%I'B+59M0+:2\A\VVGM/)NT2/:A1G5AN!:3((!88QC!'<CLK_UM
M_P $;W=O/]?^ =1?^-]%TZ>^AG>Z,ECM^TJEI*WEJ1D,<+]W'\72GOXGB'BV
MUT..WE<36C71G5"5 W*%P1VY.3VXKF]1T;6+RX\9R#2)L:G810VH\Z+YW",I
M'W^ "W4XZ&K]KIVK0>*=%U/^S7,(TK[%<!IHP;=]RMEL,<C /W<\TX]+_P!:
M/]4@?6W];?YLW]5\1:?HUS;VUVTPFN$D:%(X7??L7<0,#EL=!U-5;CQCI%K%
MYLSSK$B1O,_D-BW#XV^8<?*>1QU'4XJMX@L;^Y\7>&KNVL)9[6SEF:XE5XP$
M#IL'#,">3G@'C\JQKSP_>VWB+5R?"VGZW;:E(L\5S.8AY#;0I20/\Q7*Y^7/
M4\4E_F#_ ,C?U#QOH>FS7D,\\[26>PW"QVTC^6K#(<X7[N/XNGO4EUXPTBUN
M!;F2>:5K9;I%@@>3?$S!0RX'S=1G'0=:YR*2ZB\6>*+2/29+UI;2UC)@,:H&
M\MA@AF!"_3/'ZSZ'H&I:1XHT</9R26=GH@L)+M739Y@96^Z6W8^7'3N*:Z?U
MW_R7WB?]?A_F_N-^3Q7I45XMN\L@#7 M?.\IO*\X_P &_&,]OKQUXH_X2K3!
M="%GD6,M*@N&0B(M&"7&[IQ@_D?2N7TWP[?Z;?3V,GA73;U3?/<P:O-Y1"JS
ME\LI^?>N2!CT'(JMJ/A36M1%U;V-I+I:WS7*7R/.DEK("&V2HNXLK,=N< =6
MS[KH5U.N7QCI&)O,>YB,5M]KVR6SAGA_OJN,D?AD=Q2V'B_2=3O([6U>=GEM
M_M,):W=5E08R4) #8R.GK7/6NFZE)I5TI\%V&FW8L98&D@: O.Q7 $94C:I/
M)W$=N.]+I6D:K:ZCX0>72IE6PTQ[:ZD\V(B)RJ #&_)Y0\@'J/?#M_7W_P"2
M)Z7_ *Z?\$U=%\:6NJZ/#?O;7$37%S)!!#Y1W2;6;&/?:A)],&MW3M1M]4T^
M.]MRXA?</WBE6!!(((/0@@UP%AX?U./P[9Z1?Z%-+';WTK^?;W:)*FYG99HC
MO&,;@,$YY/'KU_AV'5X?#:0ZHP>_4R -)MR5W'87V\;L8SCOFD]FQO>W]=1+
M/Q;I-_<QP6\DS&6*26!_);;,J'#%#CYL'MW[9J&Q\;:)J,]C%;37!%ZS)!(U
MM(J,ZYRFX@ -\IXZ\5S.CZ/K]MKFBZC>Z/-YL$5Q#=M]JC*9;!4QH&PJ?+@
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M3AL.!AT?U'H>G2G;6W];V!:G??\ "*^'?^@%IG_@)'_A1_PBOAW_ * .F?\
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M-=>6!-);',;..&*^V<U=H8(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M.)F2$/\ =WL.!G.?IR>*AO/&>C6,M[%))<O)8A6N%BM9'V*P)#\+]W /S=*
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MS%TM_73_ ".+;3]3TO4?$,::;+J%MJ_[R*2-T&QC&$*/N8$#@$$9XSWJ'2=
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M=S_:)(G$@(V J8R0 -N,'!^M8OB?0M<FO?% L=+:[BU:T@2*19XT"LF000S
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MHH **** .5^(VH7.F>![^:U=HW?9"TJ]8U=@K-^ )K6?0=-N?#O]C&!?[/:
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MMB\:V[!IHV9!G)<[2 _OGVK6N==U>]N-<_LAK9$T@A-DT18W$@3>P)!&T8(
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M:?YC5M+_ -:_Y$GA>[U34M*M]2U":W:.[MH9HHHHRIC)0%LDGG).>V*YR_\
M%&KV.E>++N+[$9M*O%2/,# .A5#@_-G=\W7VZ5V6D::FCZ1:Z='-+-';1B)'
MFV[BHX .T <#CI6)=>![6[M-9MI-1U#R]7F6:XVF(%2,<+\G P%'.>GUJI6Y
MFUM_P5^ER8[*_P#6_P#P"C/XKU+1;W74U0V]S%9Z>E]#Y$1CQN++L.2<\@<\
M?2KDUUXGM+&]NI;BPDA6P-Q'(L1!CF R4VY^9".^0:N2^$[2YU.YO+JYN;@7
M-F+*:WD\ORVC&?10<Y)/7O\ 2F:=X0M;&W>">^U"_3R6MXQ=S!O*C88*K@#M
M@9.3QUJ7L[;_ /#_ / &MU?^MO\ @F3J/BC5H)=.$#6H%WH\UX0\)8+*B*W9
MAP=W3]:V_"]UJFHZ5;ZEJ$UNT=W;0S1111E3&2@+9)/.2<]L5FGX?V[);"36
MM59[:WDM8G+Q9$3@ K@ICH!SC/Z5T.D::FCZ3:Z='-+-';1B)'FV[BHX .T
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M\ ]ZRM1@2^U*[U/3M/NT@CT2:TD_T.1&=V(\M%0J"Q&&Z#C(I-V3\O\ *_\
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MVDN)[%KJRNE@*@,I"LCKN.1DJ00>AJMI?BF^U&UT*0&+S'@EFU-?+/R>6-K
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M^7[WZ4@6NQWN**Y.37=5U:_GL-'>VMY[>PCNF:="X>23.Q.HPOR\GKR*AO\
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M^T_9$=S<?.I.?F()7@8SN%=1IC7K:3:MJ/E_;C$IF$8PH?'('7C-#5OZ]?\
M(F]_Z]/\RYBC SFN(T?Q1J=QXCL;*Y:"5+J"=Y%AA;9&\;#"I(>).#@D=_RJ
MM;>*]<OVT=K2>Q2;4+J:&>TEMVD:T5-W4!U.1M .>,M0-Z'H%%>>VOBW7CX4
MBUR;[',T[FTBMHXBN9S.8U<DMC;C^'(_WN:MW/B+Q'I-E?R7NF;@98(=/DD\
MM3(\C!2&59", G/49Z<=:+?U]W^:#^OZ^X[>C K@KWQ!XMTN>%;BR@2VFO[:
MWBFN$0-(LF0PQ'(VT@\@]P?QIEYXC\26D/B:,W5@TNB*L_F_96 F5H]^S;O^
M7H1NR>O2CS_KI_F%CT# HP*XR^\1ZS>:@]CHMF6EBL([IF"QMF23.Q3O=<+\
MIR1D_3O&^M^)IM<ATL+8V,TND_;'5XC,890P5ER' 89/'I[T/3?^M_\ )@M=
MOZV_S1V^!17G:ZWJNM3>!+E;E+;[?YLD\2QDJSK$?<<=>/?VKJ?$.LS:=+IM
ME:"/[7J-R((WD!*QC!9F(&,X X&>I%-JWWV"_P#F;>*,5P6K^+-:TC3_ !#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4R4XA?_=/\J?3)O]1)_NG^5 "QC$2#_9%%
M"?<7Z"B@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %,E_P!4_P#NFGTV7_4O_NF@ C_U:_0?RHI(O]4G^Z/Y44 /
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ IDO^J?\ W33Z9+_JG_W30 L?^K7Z#^5%$?\ JU^@_E10 ZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2_P"J
M?_=-/IDO^J?Z&@ B_P!4G^Z/Y44L?^K7Z#^5% #J*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **S+SQ!IEA=M:W5PT<JJK-F)RJACM4E@, $\9)K3!!H **/QJM>7]MI\<
M<EU)Y:R2I"AVDY=CA1QZDT 6:**I7>JVMG=PVLC.T\N"J1H6(7(7<<=%R0,^
M] %VBLVXU[3K6_6RFG*SLR+@1NRJ7.%#,!M4GMDC-:5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %,E_U+_[II],E.(F^A_E0 1?ZI/\ ='\J*5!A /844 .HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "FR?ZM_]TTZFR?ZM_\ =- !'_JU^@HH
MC_U:_044 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ ILAQ$_^Z:=39!F)_\ =-  @PBCV%%"'**?844 .HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK_
M .K;Z&G4U_\ 5L?0&@ C_P!6OT%%$?$:_044 .HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&&5(]1BBB@!$!" 'J
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex10-4_002.jpg
<TEXT>
begin 644 ex10-4_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HIQ
ME5_WU_F*EJ.;[@_WU_F* )**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "HI_]7_P)?YBI:BG.(_\ @0_G0!+1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5%<?ZK_@0_G4M17'^I_$?S% $HZ44"B@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X_P!2?J/YU-4-
MS_J3]1_,4 3#I10.E% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%9]_K>G:;/#;W5R%N)O]5 BF21_4A%!8@>N* -"BJ6GZ
MM9:IYXLYBY@?RY5:-D*/@':0P!!P0<>XJ[0 445@WGC3PYI]P8+K5H(W$AA/
M4KY@QE-P&-PW#(SD9YH WJ*JZAJ-II6GRWU].L-K"-TDC X4>IQ3[*\@U&Q@
MO;5]]O/&LD;[2NY2,@X/(XH GHHI"0!DG% "T51MM8T^\U*\TZWNXY+RSVFX
MA4\Q[AE<_45;FEC@A>:5@D<:EF8] !U- #Z*IZ7JMCK5BM[IMRES:L2JRIG:
MQ!P<'OR#5R@ HHHH **** "BBB@ HHHH **** "BBB@ J*X_U)^H_G4M17'^
MI/U'\Z ):*!THH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !4-SQ ?J/YU-4-U_Q[M]1_.@":BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&[_X]GX]/YU-4-W_Q[/\
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M_.GO,\.$CF#;0&.>A;C(SCOC-:NOZA-I>@7U]! TTL$#R*%V\$*3DY(XX^M
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M"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&Z_X]GJ:H+O/V9\#_.:
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MQZ5]J2XTR"TN;87"!X)(BVT@DX*G><XZ'UK1BL]7MO%$&HS627 ETU+:=H)
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MA(Y_H,>JRV%G/.L\UK!),HPLCQ@L![$_4U$-&TP1^6-.M-@;=M\A<9]<8ZT
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MPI8Q'5UU"WC\16S H"L5J'SF-&W'@<'&?EW>]6);M-2N]=:?6X].NK"Z0VV
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:"*26:XM988T1<DLR$#Z<GK0!B1>+9;_ ,(ZO<1A;36])@<W=LZ[A%*J%O\
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MJK(APS*QX8 ]2"<5Q.E"X:>S.HB^L]0?3#IEI(]D8HP[ -EF#,-WR#'0<'U
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MR^"7WLP8L#M&[MBH(+BQ\^*VU%I8;.QUVYN_M$]E,P?+RKAI-AC W.?FW?=
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MKO*IO"*JKZDYR>P'J01S6AZA?:=X<MBC6Y>?Q+-;SDQ'!#73AMHS\OMG/]:
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M[WS $X8@'MD]<TRTM6M(O&):VTV>UL)U:.T:UQ&/+MHG0 ;B% .3C'4D\9H
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MEU ST*LZ;0<?Q#UXFE\4W2NL4<43/<WTUM:L$=_W<0.^0JN2V""N!C/'(!H
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MNG7;:Y=[1[:6VN'@=22RN1C#HQ W*01@X'>MF@ HHHH **** "BBB@ HHHH
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MLFMGA.HZAAM1&IEMT>?/!# _<Z9 ./:MC^W=(\AY_P"U;'R4D\II/M";5?\
MNDYX/M4]UJ-C8[/M=Y;V^_[OFRJF[Z9//44 2R1&2W:+S74LNWS%QN'OR,9_
M"N>3P1IB^$X_#;S7<EE"087:0"6(JVY2K*!@@]#6U<:KI]H9!<W]K"8D\R02
M3*NQ<XR<G@>]5[GQ!IEIJ%E8RW<(GO 6B7S!RH'WNO0G 'J30!GP>#K6".-E
MU+4GO$F6;[;+,KS-M5E"DLI&T!VXQW)ZFL75O#SV>O>'4L%OBD5_<7=W=)&&
M*M+&XW'Y=O+$# ' ].M=S-/%;Q-+/*D4:_>=V"@?4FH!J6GO;"Y6]MF@+;1*
M)5*DYQC.<9S0!C7?@G2[[39+6>2[,TEU]M^V+*%G6?@!U8# ( "@ 8P,8HE\
M%V$^F"UFO-0DN%N%NEOVF_TA95& P;&!A>,8QC/'-;D%]:7,,DUO=0RQ1LR.
M\<@8*R]02.A'>J&F^)M)U33'U"&]MUM5E>(R-*H&5<H#G/0D9'J"* *\WA*S
MFLX(3=WJSPW8O!=B0&9I=I7<21C[I*XQ@# &,5/IGAZ#2]5OM0BNKJ22]$8D
M25E91L7:N.,Y XR2<]\U!J^N26\VAOI\MM/:ZA?+;/(#O^4H[94@X_@QWZUJ
MIJ5C(LY2]MF$!(F*RJ?+(Z[N>.AZT 4=.\,:;IMEJ-G%$7@U":6:='.<^9]Y
M1Z+@X JMHGA"TT26)UO]1O%MU*6T=Y/YBVZG@A.!VXR<D#C-;=M=VUY")K6X
MBGB)(#Q.&7(Z\BF2:A917:6LEY;I<O\ =A:50[?09R: ,_4_#=MJ.L6FK)<7
M-GJ%JC1I/;LH+1MU1@P(9<\\C@]*I1>";2&P6T74=0V+J!U$,6C+>:7+]TQC
M<<XK=DU&QB<I)>VZ,'$9#2J"'/1>O4^E*-0LFNVM%N[<W*C+0B0;P.O*YS0!
M0M/#\%K?ZI=&YN)UU)@T\,NPID($& %!^ZH'4U0TOP39:9&+=K_4+VR2-HH+
M2ZE#QP(PVD+@ GY25&2< G%=#;W-O=Q"6VGBFC)(WQN&'YBF17UI<3R00W4$
MDT?WXTD!9>W('2@##T[P9:V-I]EFU#4+Z!('MH%NI%;R(V&"%(4$G'&6R0.!
MWI(/!MO;+ILB:A>M>:<"EO=.4+",J%,9 4*5PH[9R,YSFMS^T+(O,@NX"\(W
M2J)!E!ZL.WXUFPZX-6TW3[_1Y[1H+B:/S#</@^6>H7'\?3 - $#>$8"+4I?W
M2207K7S280F:8@J2WRXQAB,#'0>E+J?A2/56NX[B^N#9W<L<LMMM0@,FW&TD
M97.P9_'&*VVN[9+A;=[B)9W&5C+@,1[#K1)=VT1827$2%<9#.!C/3\^U &1H
M=GJ-MJFKS75Q=26D\X:WCN75C'C(;;MZ(?EP#SP2>M)=>&8Y+_4+NUO9[5M2
MB6.[5%4AL#:'7(^5MIQGD<#CBMB6[MH'1)KB*-W^ZKN 6^F>M1:GJ5MI&FW&
MH7DFRW@0NY[X'8>I/0#UH R7\*0?VMH]];W,L"Z3 UO;0(JE-C!5(.>3PHQZ
M4?\ ",/LUM?[1DQJY)F'E+\A,:QY7_@*CKGGGVJ/_A)9!XX71V%LNGG3&O1<
M^9DEA*J8] .3Z_A70R7$,*!Y9HT4G +, #0!S(\%)"VEW%IJEU:W^GV@LA=1
MHA,T QA74@@XP"#CKFI+GPAF[M;W3M6O;&\AA-O),H20SH6W?.'4@G<20<<;
MC6U-JEI!J5M8/,OVFX5G1,C.U<9)]LD#ZFK32(A 9U4MT!.,T 8=GX:%CK4&
MH17LK"*U^R>6ZAMZ[MQ9FZEBW.??I5:+PJ8)+":;4)9_[,:1[5S$#*-R,FTM
M_$H#<# Z+DG%=$+F J6$T>!U.X<4YI8E=4:1 S?=4L,GZ4 9/A>'4H-!ACU6
M>::YW,=\X42%"QV[]OR[L8Z51T_P@VF2^5!J]T=,CF:>"Q9$V1N6+ ;@-Q0,
M<A<]A72>=%@GS$PIP?F'%8[:U<+XS@T4V\7V:6QDNUG$A+$JZ+MVXP!\_7)_
M"@#,/@E_[*T_3QJ;;+'4/[0C?R!DOO9]IY^[N9O?&.>*S?%&@RV&FZ[=1W$T
M\VK75M+Y45N6*%'C&5QGHBY.1VS[5TNJZW-8:WHUC#%#)'?W#P2R&3YHB(GD
M&%QSG8>I'XTSQ'KT^B76BQQVL<L>HWZ63.TA!CW G(&.>%/<=NM $<OAQK\7
MUU<7BO=7ME]B65(-JQQ').%))R=W.3V''',-IX0.GRZ9=6E^R7MC8C3_ #'B
MW)-",;0ZY'((!!!')/8XKIE967(8$>H-*KJZ[E8,/4'- '#^(-*CM?"\GA:T
MM[VYN]1,DL=R(B52=I0YE=U&$PS;P..%P.U:VH^$HKO2]+M[2^GLKK3&5K6[
MC 9E(7:=P;A@P)R#UKH2R \LN>G6E#*20&&1U&>E '*W?@QKM+:Y?6+O^U[>
MX^TQWVU?E8IL*^7]W85&-OXYSFK(\/Z@NQVUAKB5O,%P+FW#Q3!P@QY8*A0
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MW6[)]8?;JTZ3R,;=28V58U.,$=?+7KT]^M6KCPH]SK5QJ9U&6)[NQ%E=)$@
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M$'$,7EQ1@#HH))]222<^W2M&BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *@NP#:2@C/RFIZANO\ CUE_W30 _P M#_ /RHIV>** N+1110 4444
M%%%% !1110 4444 %%%% !1110!S/C*,3PZ5&;66X"ZE;RNL<#2A45LL3@'
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MS?BQ)_&O.-(NS+>^'9+$R12G3[RWBA$$A%M(?+*QR.<EF# EB3C@G S7K-%
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MY-=*J0QQ")518\8"@8&/3%+$D4*!8D5$[!1@4 >3>(;32FB^(DC-&TUJ(KB
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M'#&-L9PP'0^QJQ63I>A0Z;J.HWZ^5Y]\X:3RHA&N%+;<@=6^8Y8G)]@ *UJ
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ML-1M[DVM]8LWER;-ZLCC#HRY&0< ]000*RY/!:E(6BOMEP-2&ISS-#N,TPX
MQD84#C YP!SG)(!L?:=2MO#\ES=PVIOXH6=HXW;RB1D\$C./PKF[7Q=JDFBZ
M1=S6EL)M8BB:TCB#R,I,1DD9E'4  8 /.1DCK777UL]W83VR2"-I8V3>5W8R
M,9QD5STG@L/X7TS25U*:*YTO9]BOXD DC*+M&1R#E<@CH0: (D\2ZV/[,AET
MB-+B[OIK3,KM$&"Q/(LBC!(4A.0<D<CGK5&3QQJ5FUS:WEC;?;;/5+:QG\MF
MV/'/C9(F>0<'D'/3K2ZKIUUI]YX=B.I7-S>KJ+W-Q>O;[@!]GE0%E4!54_*F
M!CKUSS6A>>"(K^RU#S;^1=0O;J*\:[1 -DD6/+"H<C:H4<$G.3S0!G^(/$VI
MKI_C*UMQ%!-I44?DSJ3DB5-V<=F&>/<9]JO>(_$NH>'[6YFDBM,6MH;D;F)-
MR06W(B@[EPH!+$$?,/>D/@4S?V^;O6+F<ZU D<W[M%V,J[0RX'Z?GGK1?^"K
MG43>&;79\W^G_8;LB!,R %R".,*/WC# '(QSGF@"1K_4Y/B(MDDD?V-=+\]8
MB6&2T@!)QP3\N!QP"?6H-*U^3^R=-AM=.M+6[O[^ZMEBB_U,7E22[W. "WW"
M>V2W;FKR^%[E-9L]476IS<PVGV68M"F)U#[QG &WGCCJ..O-00>#9(=.LXO[
M3/VRROI;VWN1 !AI&=G5ESRI\QQC(X([C- %+4/'%WI]IJL364,FH:9>V]M,
MH<JCI,5V2+P3T;E2>"#R>^WHVKWMUKFJZ7?P01R68BD1X7)#)(&P#GN"A'O[
M50O_  4+^SOD>^"W=_=PW5S<"#KY17RT5=W"C8.Y/)]:U+'19K3Q%J&K/>+(
M;V**-HA#M"B/=M(.3_?;/X>E $-UJU_/JU]I^E1V[26,"2RM.3AW?<5C&/N\
M+DMSC<.#S7,R^(;CQ+-X(O;)8X;6_N)9&@G!8B1()>&QU 8''N :ZBXT"8:Y
M<:MIU]]DGNK=8+A6B\Q7VD[' R,,-Q&>01U'%48?!262:!%87ODPZ*6:%7BW
MM(S*RL7.1U#$\ <G\* *?Q TRRL?A7K-K:VL,,$5NSQQH@"H2V20.W)/YU!I
M^D7B>)]-U32M+.G6<.GNEX&9$2[8JOEC:A;[I!.XCH>,UTOB71&\1>'[O2/M
M0MX[I/+D?R]Y"^W(Y]^:N06MQ#I*6OVB-ITB""7RB%X& =N[^M '+VOC#4&T
M32M1N;*U3^V%MH[*-9FR9I02V_CA0.>,G ]34'B+Q/J=CIGB33\01:E8Z=]L
MAN$R%>)MPW!>2K*5(ZD=#[5I?\(8DGA33M%FO29=,,3V5VD>UHFB ",1D@G&
M0>Q!/2I;SPFNJ1:N=0N]]SJ5E]A,L,6P11#=@*I)YRY)R>>/2@"OK_B+4M"M
MY'>WM-L%F]P9))3B=USB)%^]NVC);! ]#V>GBF;47T2#3X8XIM5T\Z@K7.2J
M( AV\8RW[P?0 FH+WP7>W]U+<3:_)YESI[6%RPMDRZDL0R=D/S$$8.<#N,U@
M:GHUS9SZ+HKW]Q#;:98%(KZ73%N8I6.%"[<$*RHO4G)#'KS0!LVOCFXO-(TN
M?^SQ'=:@)72./S;@1QQD*S$(FX_,5& ,<YSVJ>V\5ZK<_P!CPG1?L]S?F='C
MN7:/8T8)!P4SM8<@XSCC'I6B\/ZIK&GV-Q'J;:=J&FRNEI>16(C$L#!<JT#'
M@$@#'^P",9K43PS>+?Z7>/JYFFLWDDE::'<9FD7:<88! !P  <8[\Y ,:7Q2
M;_1].N+[1K6:4:ZFG2*TFY8I5FV"5,KS@C(Z$>M;*^(KV]GNWTG3TN[6RO!9
MS?O=LCL"HD*CIA-W<\[3TX)SAX%NAIZ6O]KQ976?[7#?9#]_S/,V8\SIGOUQ
M5N/PE=6NIZ@]EK#6VFZC/]HN;18,N)#C>4DW?+OQSP>IQ@T :^MZO_9%C',D
M'GSSSQV\$6_;O=V"C)P<#N3@\ \'I6'?^,KG2WUJTN=/B:^TW3_[155G(2>$
M9S@[<JP*D8QZ<\\;7B#1!KNF"U%P]M-%-'<07"+DQ2(P96P>O3!'<$UCZAX.
MN-4?5KFYU&'[=J&G?V9YBVQV10G<6PN_)8ER<Y[#CU -O2+S4+R&2:]LXK=&
M*M!LEWED*@_-P,'.>!D>YK$C\93?V[8:?<:<L'VZXF@1'G_?)L5B'9,<*VPX
MYZ8/.>.ELK>2VL(+>659)(XU0NJ;0V!C.,G'YUQUIX"OK2;3V&N(ZV&HRWL9
M>TR\@D#!A(V_YF <@-QP.A[ $EKXWO9X(KJ32(H[8ZM_9<O^E;F5_-\H,HVX
M(W'G)'XU<G\72VL'B$S:>HN=)*[(%G)-R'4&,@[>-Q.T=>0156/P3>1Z5]C&
MK0%O[7&J[_LA^]YHEV8\SID8SGI4<]M:^(?'MA=69F9-/26/4'V,L;NC Q1G
M(^8J^YQC.,=>10!T>K:TFB>'IM5OH2##&K-#$VXER0 JDXSEB #Q5./7[Q=8
MCTF\L(8;NXM6N;;;<%D<J0'0G:""-R\@'(/M5SQ%H<'B/0+K2;B1XXYU $B?
M>1@0RL/<$ _A5.+0[Z34[74KZ\MYKNRM9+> I"54L^S<[#<>NQ>!TR>3G@ R
M? M@FHZ18:Y>VL7V_P#?,MTDK%Y-[MN#\#(X& <C@8QBF:MKDMA!XSN+#3H8
M=0T^U21IVESYW[MF4D;>J@<#OTR*Z#POHUQH&APZ9-<Q7 AW;9$B*9RQ;D%C
MZUFW?A2ZOI/$HFO85BUNV%OA(CNAPA0')/S<'...E "ZCXJO-/O?[,6PMIM2
M6S-TL!O"AN.6 2(E/F;Y<D8&,CKG(ZD'*@UR&L^$]2UVQGM=0O[&=9[=8P3:
MD?9I07_?1?,2&PR\9ZKUYQ6YJ5A?S>'I-/L+_P BZ:'R5NY%+LO&-^ 1EN_U
MH Y*V\12CQQ;W\MW%_9FHO)I<$*N,J\9)20_[["4#VV>M7O$S7-UXS\/:7);
M036$Z7,CPR2D+*511\R[2#C>2!SSSQ@5:UWPB-4\(IHMH\%G-&(O*N!&3Y+1
MD%67G.05'4U-=:+J=UX@T757N;4-I\4R2($;]Z9 H)'/RXV@]^M '+Q6,#3^
M)8+_ $R.YL]$$2VZ?:W:2)4@60*C$ \[CDY[XY%3VSV]QK'P\N[2U%K!/83.
MD"N6$:&!2JY[X!(S6W_PCNH&3Q(S7%MC65PH"M^Z(B$0S_>X&>U0V?A2_M)/
M"I-W;,NA6S6[?(P\[,8CR/[O"@]^30 [3M;6#3[E[+1FCD?59K=X_-)4."2\
MLC ':O!/0\D#O5#5?&-[<:+IESIT4,3W&MQZ=,WG[EXFVG8VTY5@I&< @-TS
M5G_A$]3^R%/MEH6.K/J)C>)FBD5]V4=<\X+!@?51Q3)_!FHS:<L/]IVWG1:R
M-5A;[,P7.\N48;^G/;]: )K_ ,=QV4EX$LUG2PD6*Z"S_O"Q"EA$FW,FT,,Y
MVYYQTJ_%XG:YUFXL;2T69;6Y2WN#YV)4W*&\SR\<I\P&[///89K.B\+:YI^I
M:@^F:U;Q6>IOYUPDEL2\,I4!WB(; +8SAL@'UIUSX2N[O6;2]FGMS):WWVB&
M[52)Q#U\@GNIZ9)Z=J .PKF-0\7BQM=1U 6+2Z9ITQAN9Q)\^1@.53'S!2><
MD'@X!P,WO#]UJ-U'?'4#&X2[=;>6.,H'BP".#UP25SWVYK'N/"%X;'7=)M[R
M)=-UB625BRGS+?S?]:%[,#R1G&"3UH MQ>*KF\UZ[TRQTAK@6IMF>87"J#%-
MN_> 'T"YQU//3O+XFU/4;&\T2WL$B(O;X0R,[[>!&\FW[IX.PC/;^3=%\/3Z
M3XBU&^62'[)<V]O;QQ#.Z-80P7GH<AOPQWJSX@TBZU1M,FL[B*&>PO!=+YJ%
ME<;'0J<$'HY.?:@#E8]:E\-ZMXSO%L7N+2TNH)9_WV/+0V\9;;G.XY)..![U
MNZUXQATJXNXHX([AK*-9)T\\)(<@G;&N#O?:,XXZCG-4K[PGJ5[9>*+=KFU#
M:V%4/AOW6(EC)([\+G'OCWJS+H.NV^MW&HZ5J-G +^*-;R">%I LBKM$D9!'
M.,#!X.!0!&NN6#>++N6WTR:2[31TNA/YF/-A+$J@4G .0W)P:U/#VN7.NVL5
MXVER6MG/;0W$$SRJWF;UR5VCD8XY/7-9@\,:A#X@GU&.ZCG1])33AY['S&*D
MGS&8#J2QR,5L^'-.N-(\-Z=IER\;R6=O';[X\X<(H4'!Z9QTH S4\8&35=4M
M?[+F6#2Y@EY<O*@6-#$9-^,\CIP.><^U5X?'UIO_ -)MMD;V<EY&8)1,VU!N
M9' ^X^.0,D'GGBI+;PQ.]WXG%\\)M-<X*Q,2R#RA$1R,'(&?:H[/0_%2:7]B
MNM=MMUO \5M/! 5:1BA5&E!)!VY!P.I /:@">;Q@UKH=YJTVG^9;001SH]K.
M)5E5B00&('*X&1SU&,TZ;QA'8:O<V6K6$UA%':27L-P[JRRQ1XW\#HPR#CG@
M_A7,>)_#_P#8OAOQ)J(%I80W-DJ-:6I/E-*&R9<$ !B#C ';J:Z#5/#,GBI_
M,U26!(!8SVL?V5R^3,%#29(&,!1@<]>M #8?']BKS_;H?L\45B;_ ,V.43 1
M@\JVW[L@R/EYZ\$U->>*+^VLKZ1M%ECDAL&OH2[Y1E&<H[8PKC@[1G@]:JR>
M%=;UGP]/HFOZK;26[6K6ZR6T+!Y6XVR/DXR,9P."3UJY'HVNWVE7%EJ^HVWS
MV4EH#;1MB1F4#S7W'J,'Y1QR>3Q@ IC5$.H^#X]2LI)=2NXY3#<+-M1&$)9R
MP&,E@.F,#/M5VS\7B[TV\N1I\J3VM^-/>V=QN,A95X/3'S@CVYJI_P (WJ\F
MI^%[R>:R)T?S!(J;UWAXO+P,@].N>_3 ZU>_X1@?\)G)K7FC[-)$C&W];A0R
MB7_OVVW\O04 0WOCBQLKMXV16@BNEM)9%F7>KL0,A.I4$@$^QX.*VM7U:'1M
M,>]G2210R(L<0R\CLP554'')) K MM!U_3K^_M["_M%TJ]N7N=[JWGVYD.YP
M@^Z06R03TW=#6IXFTBXUC28XK.X2"\M[B*Z@>124WQL& 8#G!Q@_6@#DVU"2
M#Q3XMFU*VO/LT.CPR2VR7&[Y?WNXQG< ORCMCD'V)VH_$\=A:Z59V>DW]T]S
MIGVJVC1U8E4"?*69OO8<<GKZDG%4[OPUKU_?:[=R_P!GQ-J>DBP$:3NP1QO&
M[)0<?/Z?XU=T_0=4M=3T"XD%H8]/TU[*;;,Q+%C'\R_)_P!,N^/O>W( 3^/=
M.M[X0-$WD_;%L7E\Q,K*3M^YG=M#?*6QU]AFK'_"7V[W<20V-W/:RWC6*W42
M@IYRYSQG.W*E=W3(].:J:?HOB/2KN[L[:\L7TF>[>XCED5O/@#N7= N-K<EL
M$GC/0XQ2:%X?UO0E?2X+JT_LD7;7$4WS><J-(7:+;C;U)&[=T/3- #],\7O+
MIU[=WME-&4U)[&")2A:1Q)Y808/7(R2< 9ZX%.OO'5IIMKK+75E<K=:3&DMQ
M;(5)9&^ZZDD KV/<$'CUHMX2U7R9D2XM0T&LMJMF<M\Y:1F*2<?*-KLN1GU]
MJA\0^#=3UT:Y=YLXKW4+!-/BC,K%(T#%B[-MR22>@'0=>: -QO%1$BPC2KO[
M3()9(H'**TL484EURW?>N <'KG&#6Y:7 N[.&Y5&02HKA6&",C.#[US/B+P_
M>:[#;QS6EG,B6[  SM&]O/QMDCD";ACD'IVXJUI-SJMKJUIHUV]O=QQ::C37
M2,WF^>NT$N,8 ;)(YS\K4 7[_6!:7\5A!:RW=W)$TWEQE1M12!DEB ,D@#U/
ML"1S.M^*_P"T-'T6?28[EH-1U&*WE9&6-T 8[XCE@5;Y"I[=>>E;%]I-]%XJ
MBURP$,VZT^QSP2R%/E#EU=2 >02P((Z'KQ6(?".JV^G:9!;&SEEBUEM5N2\K
M(H)=F*)A3G[^,G'3ISB@"O\ 8KB7Q-<>']VM)9K8?:8PMXN^%Y)#\P;?DA-F
M%!SC)[5LZ'K]C%X8L)K2+4)OM=Q+#;PW$@>>20.Y;+%L #:YY. !]!4XTW5$
M\;S:R(K4VDFGI:!3.P?<KL^<;,8^;'7MGVK%L_"VO:?HVD- ;$ZEI=W<3+$9
M6,4\<K.2I;9E2 XP<$97WH W?^$NM!9),]O/'.]V]F+>7:C>:F2W).W: I.[
M.,>YQ52/X@:7*EF8X+IWN;V2P,:*K&*= 24;#8YQP1D<@Y IFI:3XANTL=3C
M:Q.I6MPT@LY&8P&)DV-'OVY)XW;MO7C&*BNM$\07=YH]](EAYEI?-=R6Z2E4
MC0Q&/8K;/G.6+9('ITH T8/%T=Q(8H],O3-%Y NHL)OMFE(VAQNSP""<9P/6
MNCKB]=\-:AJ>LR7L$5M#<I+$;/4(96CEB0;=Z2 #]XI(; )/WL<=:V]'U6[O
MM5U6UN(8!%:RJ(98)"X93GY6X&'&,D#H&6@#9HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *AN_\ CTE_W#4U0W?_ !ZR_P"Z: )110** %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 1F"@DG '4FFB1"@<,"IZ$'@URWCJ?[/::
M;)<LZZ5]M4:@ZH&V1[&VE@01L$GEYR#7+W4&A6UKI0TR^::R.OQ2K)O585W
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M A%I;+MQ;Q#;TP@XH%I;!-HMX@NX-C8,9'0_45-10! MG;),TT=O"DS#!D5
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M J !C/!.2.G< ZRBL"":]T6XU"?6=2673$CB-O-(BHP)+!E;:/F;.S& ,Y
MSG,Q\4Z0MK?7$ET8EL%#W22Q.CQ*1D$J1NP1WQV- &S16)_PEFC_ &B2W^TO
MYZ1B41B"0M(IXS&-O[SG^[G%(OB_0VMK.=;Y2EZKO;@(VZ3;G< N,Y&",8SG
MC&: -RBLB'Q+I5QI<6HPW1D@E<Q($C8R,XSE-@&[<,'(QD8/I49\7:&(;>5K
M]%6XF:W0,K B502R,",JPP>#@T ;=%9$/B;29[ WD5T6C$YMBOE.)/-'_+/8
M1NW>V,XYZ4@\4:0UM#,MR[B9I$C18)#(QC)$GR!=WRD8/'% &Q17.7'C+3DN
MM#BMO,NH]6+&*6&)V4(L;-NX!R<@#'49R<8J:TU6RMVUJZFUCSH+>YVR"1=J
MVIV)^[!Q\W4'ORV* -VBL?\ X2?2!!>2O=B(62![A)8V1XU(R&*, V#V.*DT
M_P 0Z9JEX;6TN?,F\H3 >6RATZ;E) ##) ."<9YH U**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "HKK_ (]9?]P_RJ6H;K_CUE_W#_*@"5>@HH7H** %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH R/$=WJUKIA_L;3I+R[=@@VNBB,=
MV^<@' Z#UQVK'TJYUS3=#NQ%X7E1K95-O;R7T;2W3LQ+LSC(!YSD]3FNOHH
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M5 SV\A!:,^A(JW110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)EDG 7:OF9) P.>.I .>QM:SI-W?ZQHM[;M %TZ=YF60D%]T;1X& <<.3^%
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MU9BSGO\ 2[-K"YMVG98YXFVG*OM^4AD4\K[4 =&GBRSFL;.X@MKJ6:[$A2U
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MEW<R&2>>P@ED<]69HU)/YFN5T:PU*^TKQ1%I]_Y#MK-T NW&?G!/S#D9'&:
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M:RU(2Z=AKF$6^62,KN#]<8P">N>#QFI[GQ;I\%V+6.*\NIVM!>)';P%B\9.
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MXV19(@<%U8@!EY'(]0>E.M?$VEWDZ0PS2%Y(#<Q!H77SHAC+)D?,.1T]1ZT
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M)10!P<>A:KI^K:I#'H5CJ5M?W374-Y<NF;=G RLBGE@I&1M[<<=:ZO61J/\
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M#>BQFF:'"1R,5"Y)/0EU&1GKS@<UE^/_ !$T/A;Q!#IC7BW5C /-N;;"B!R
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M':;JFKZC!=7T-R+\),N[<(LC! X()XZ@?D:D+ZI=G5EM]<^SS:-/'$LMU=,
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MV*TS$<HY(QG&,Y(';F@#L:CG@ANH'@N(DEAD&UXW4,K#T(/6N5U2*]O?&O\
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ML=J\#@8' ]!2S>'].GU<ZJ\<PO3"8/-6XD4B,]5 #8 [\=^>O-8VDZY<W_Q
MU"Q6><V,>G0SI#-;F(H[.P/#*&/"CKZU?N_$447BJWT )/YLMH]P9%A=@N&1
M5Y (QECD]!@9QF@ 7P;HBV]G +><164OG6R_:YL1/ZCYOK^9]3F(>!/#:S+*
M-,0,EU]L3YWPDO.2HS@ Y.5'![BJ7A3Q7#-I.F0:K?\ F:G>/,BL8R%=ED?Y
M<@;0V!]W.<#I6K#XNT.XN#!%?JSK)+&QV,%5HU#.&8C P#GD^OI0!%=>"M!O
M+FXGFLW+7$JS2HMQ(L;2 @A]@8+NRHYQG\Z6\\%^'K_4HM0N=-C>YC14W;F
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MFLI'DMKF&81S1;CE@&4#@YY!_P *T;KQ'I]KK=EI3SQ_:+M&D0;QPHP ?Q+
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M.F68BNY+&WL[:"9HRTFV5G=NI4':V%SW'/%==J6DV>K1)%>QO)&CAU42L@W
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MM AGB'6/>"5S]0#0!Y]=:=??V%XST:ZTRXEN]1N9Y;*6.(LDPD4>42XX4H0
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MY+1_,70^6HQCN23CB@#2_P"$NU&S768[VTMI9=/N(;6-[=G_ '\DH0I^[PQ
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M-=^(+N42S696./,ULD;1SVDN?]7(K,2<#/S  '!]J .MP*,"BB@ Q28%+10
MF!Z4N*** $P/2C I:* *\%C!;7$\\:GS9R#([,23CH.>@'8#CD^IJ? ]*6B@
M P**** $P/2C ]*6B@!,#TI<"BB@ Q1@444 &!28'I2T4 )@>E+BBB@!,"C
MI:* $P*,#TI:* # I,#TI:* #%)@4M% "8'I1@>E+10 8!I,#TI:* $P*,#T
MI:* ,BZT62Y\1V6KB["?9(9(5A\O(99"A;)SU^1<>G/6M; I:* ,C6M$DUCR
MH_[3N;6TVNEQ;PJFVX1A@JQ()'U4@\GZC65%50JJ H&  .!2T4 )@>E&!Z4M
M% "8'I2XHHH 3 ]*7%%% #6C1UVNBL/0C-+@8QBEHH 0*HZ*/RH*J>H%+10
MWRT"; B[/[N.* BCHH_*G44 -V+D':,CH<=*011CHBC QT[4^B@!OEI_<7\J
M%14SL4+DY.!U-.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC!R!CW.;T'A2]M;.:S@NM&BM9@1+"FCJJ/\ 51)@U!/X(DNH[6.9]#DCM"3
MAT88C).3M'F<<T 4[2YFN?'.DVYU:YN;:XT&21G5FB25P\8$H3/RD@GIZ\5E
M^'GN[KP[X)OYM6U%KG49VM[IS<L1(GDS-C!X!RB_-C=[UU,WA?4+F\^V3W>C
M2W.PQ^<^CY?:005W>;G&"1CWJ%?!]TD=M&DVA+';.9(%&BX$3'J5'F_*?<4
M<UK+2#0Y;1KR=TM/%5M##)-)YCQIOC8?,^<X+'[V:L:V+G2#XEMK75=0DMK>
MRAO49[IV:VF+L"N_.=I50VTD@?2MW_A$+P174?GZ%LNSFY7^Q>)CURW[WD^Y
MJ2V\,ZG:V,UG!?:,EM-N\V,:2V),C!W?ON<CCGM0!G:S?2)X@\1PVVH3JJ:
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MP6S-Y83<"21P..!@?A69)X4T^6W$3O<EC=K>O,)2'>9<;7)'IM7 Z<#BML#
M SGW- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-(8RDR1^66P%.58!3ZC'?-5],\)ZCHWB'3;JW-O/9V&AC2UWRE7=@RL&QM(
M^7'7O0!HP>-+&]M=.EL;2\NGU"U:[BBC10PC7&=Q9@H.2!C)Y]N:R;K7Q+XF
M\.:G8KJ%Q;:CI=Q.EG$Q_>?ZDH2I8(I 9N21Z9SBJNC^$O$.G66@V-S_ &?=
MV5E:/;SVK7#B,R;@5E^Y\^!D;6'&<CUJYI7AS6M,B\+RM%9RRZ38RV,T:SL
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MNQ)I-NU3SG^- 2 1\WUQ5OO'6EZ>=2\V"^*Z;*L=VR09$0(4ASS]W##IR>2
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M_&&K3Z/K,QFCMM3T^PDN9K"ZM"CPR*,X'/SQ'! 8'^>  >A,RHI=B%4#)).
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M;N)/8?>]3[5<L_%VH:MI^CFQM$6[OK WDN5\Q8N57 &Y<@LQYSP%Z<T =EC
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MCG\S8V<&-QM&UQW&3WKHJ $VCT%($4=% _"G44 %%%% !1110 4444 %%%%
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M@*2IV]6R<#CIUJUN&<9YH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!DCUKV8Q1E"A12IZKC@T"&,1^6$79C&W'&/I0!Y%XIO=(>367L)[=);".S:
MS,I:-058&U48V)M.2_.3VP*N^+KO3;K6=9M;F]T]KBXTZ#^RYY[J.(6K-O\
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M=),EE8GDMSC=^F>:Y;0I+]+I9K&XE.JR7#RR6%SH95TWN2ZO<848 .-^><#
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M0)=2 7F(VB9688;9G?\ *1C&./O5-=^'-9U&P$=]K$$ES]IMY@4M66)1#()
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M0JEKYMK+?&QWQRAI%<,4WF,#B/<"-V??&*AM?"VHVVE:59BXMF:QU&2]+;6
M<,TC;<=O]8>?8<<\26/AS7-,EN+.UUB%=)EN6N$4VY\^$,^]HE;=C:23R1D
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M>N!GD@"M"/Q?&=-FGEL98[J._&G?92ZDM,2N &!QC# Y[#/I69IOA35K'2M
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M=U$D+_*B _*')Z-C&?>N+T>X6+6O"U[-#<^0V@M:[S;.?WV^#Y3\O'"L<GC
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M((-</"]B_A_P992IL:#556Z1XR@&(YE(;(&1DJ#]0#U% 'J27EL]J;E;B(P
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MG9KC3FU",JRY*KMRN"1\WS#OCWH T-'TDZ8DTDURUU>7#AY[AD"[R %  '
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M %%%% !1110 4444 %%%% !2-]QOI2TU_N-]* &P_P"HC_W111!_J(_]T44
M24444 %%%% !1110 4444 %%%% !1110 4444 87C1;=O!>L_:EB,:V4Q'F
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MUCE94R3]X[0.>IQ6L=!THSVLWV" 26B[+<JF/)7IA<=!CCBHD\,:+''&B:=
M%BN1=H-N=LPSB3_>Y/- &M1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %(_W&^E+2-]QOI0 R#_CWC_W1_*BB#_CWC_W1_*B@"2BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;:2.[LA%/<R&!HQ'%Y!60%B.=S,N!_%UZ#- 'H2ZMISWC6:W]J;E02T(F7>
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M0!W\VMZ5;LRSZG9Q%9!&P>=5PYZ+R>I]*B_X2'3?[?.B_:HOMBQ"0H9 #R<
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M=T[Q#X4L(-6U^Q#QV,IA-S=QQ/Y<DA^10JXZ@;<D#'(SSG !VE%%% !1110
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MI.Q&&3G/<#(P<]7=WL\'AN:]B>T:X2U,JO))MA+;<Y+=ESW]* #_ (1S1/\
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M.A_@W<GH/O>_M19>*]2U+0=#O ]I;/>Q3&;$;2R-(GR@11@Y()R23G &.^:
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M0CE]HRQ&U"=H[\9[UV6@:CJ-\+U-1M#$T$VR*81-&MPA4$,$;E<$D$$GD>]
M&I/<0VT9DGE2)!U9V"C\S2QSQ3?ZN1'X!^4@\'I7'>&V37_%OB+4KU-[Z?=_
MV?:Q2#/DHB@LX'8N6)SUP .U7;^*W\+7,]YI\*&ZUBY@MTA/RQ^;R-YQ_LY)
MQUV^] '445PNL>.+[1(_$%O/902WVEVL=Y&P8I'/$QQG')!!!&,G/J*T)?$V
MHV>I:A:W&GQ3/#IAU"".V<EGP2/+.1U) Q@=Z .JIKNL:%W8*JC)). !7%2^
M,[D:#=ZO9OIU]:P>25DA9AN+MM=",DHRD@\CD'MVO:SJ$EVWB/1KB"%H8=+%
MPC\Y82"5<$'T,?7WH Z:*6.>))H762.10R.AR&!Z$'N*?7F^AZCJ:/\ #_3H
M)(EM9M&$\BG(+E(HQSCMAS@>OX5MV?BRZFUO3[&XM88FO)9XF@#[I(/+!92Y
M!(RRKG;QC(ZT =;17&V_B_4I(+.ZETVV2VEU5]-DVSEF!$KQAA\HXRHZ^IX%
M6/"FHZEJ&K^)!=R1M!;:DUO$JY^15CC( ^N23[F@#J<4,P12S$  9)/:N9U#
MQ'?V&IZK9M:VO^C6!OK1FE($ZJ2'5N/E(^7GG[XID/B274K."6"VM;FWFTHW
MLP,A !/"H>#PWSCD<;#Q0!T\4L<\2RQ.LD;C<KH<AAZ@]Z$DCE!*.K;3@X.<
M'TKSS2]?O+J;P/:Z?:6MEI^HV<T[6RDX4(@ 3I]T!\].2!3] U2XT*&:.&P@
M%A+XBN+0D/M9=\Q"E5 Q@$@<D=_Q /0L"EK.UG4)]-L%G@MUF9I40EWV)&I.
M"['LH'/^<US!\>W']F2W,6G0W#PZTFE-Y<^%?<4Q(F1W#C@D?7% '8WEJE[9
M3VLA=4FC:-BC;6 (P<'L?>N?T_PI=0-;1ZAKUYJ-I:LCP6\D448!0Y0L44%M
MI (Z#(YS56;Q=JL,7B-!I$$EWHOER-%'<,1+&R;^#LSN !XQS6Q9ZV]]JT%M
M;QPRVSV27;SI(3C><( ,<AL,0<_PT ;&*,"EHH 3%&T8QCBEHH .E%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4UQE&!]#3J1_N-]* (X$7[/'P
M/NCM[440$_9X^/X1_*B@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@!D
MT,=Q"\,T:R12*5=&&0P/!!%8T'A33[>T6R22Z.GJNT6;7#-$%_NX)R5_V2<8
MXQBCQ??7VF>&+R]T^:.*XA 8-)'O&-P!XSUP??Z5;L->TG5+FZMK'4+>XGM6
MVSI&X)C/O_GM0!7G\,V$U[=72&>"2[C$5UY$A03*!@;AV('&1@X[TY?#MG%J
M O89)H95MOLB"-L*D0Z*%Q@8/-(GBK0G%P1J=NJV\8EE9VV!8ST?)QE3V(X-
M2V/B+2-2O6L[+4()[E8A,8D;+!#CG'XCZ9&: *-OX.T^SLH;2UGO(88K<VH5
M9NL1.=ISGU.#U&>#3[GPAIES.LJ_:(,6@LF2"9D5X1G:C 'G&XX^M6H?$>D7
M%T]M%?1/*B/(5!ZJAPQ!_BP>#C.#7&P^+K[6+*?5;/7M.TVTCO'@:.[@W8C#
M%48'(R[%3QZ-ZCD Z>T\(:;93:3+ UR#I4)@M 9BP5" &!SUR ![8&,4T^#-
M+"QB-[R+RKIKN$QW+CRG;=NV\\ ^8^1WS[#$T?BC37\17.B^>HN;:))')X&6
MW''U 3)^HJYIVM:=JSRI8W:3/$JLZKU56SM.#V.#@]#B@#)7P/ID:!(IKU +
MXZ@H\\MMF))W?-GN2??/.>*F?PCI\JZJLLERXU.19;C,F/G7;M9<#@C:OY5O
MUR^MZUJ>D^*]#M-]H-*U*1H&D>%C(DH4LJYW ?-@@<<8[T :]UHMG>Z'-H]R
M))K6:)HI-\A9V!ZG<3G-9H\%Z:[SM=37EY]IM!9W N9RXFC!.-WN-S8(QUSU
MYJ'0]<U*XU?Q#IFJ3V"S:88S&\$3*#&Z%E=@7/H01QTZ\BHM'U[4+ZU\/RWN
MHZ;;W%^7F:U\LH\T.QBFQ2Q(( #'\1VY )Y/ VFS:5-I\]S?SQ30_9V>:<NX
MAR#Y:DC@<#)')P,GBIT\(V<-W<74-U=137-LEM<%"F)E4$*6&W!;!QGKBLB]
M\<QWEO#)H=W:N5U>"RN PWL8VF$99<'C))P3GI74V6LZ;J*7#V5_;W"VSE)S
M'(&$;#J&QTH SH?"=I VCE+J[QI,1AM@63&PJ%(;Y>?E 'X>O--LO!NF6(LH
MHWN'M+&8SVEK))F.%R" 1QDXW-@$D#/':KT?B/1I;:YN4U.U:&V ,[^:,1@]
M"WH#V-/?7=*B<H^H6RL+<W6#*,^4.K_[OO0!!/X;TVYUB;5)HB]Q-:?9'!/R
MF/)[>OS$9].*J/X,TUO"$7AA9+A-/C14.QEWN =W)QW;DXQ5S0/$6F^)+#[9
MIMS'-'N((5@2HR<9'49 S@\X-0PZW!!=:M)?ZMIHM+:5%3;(%: %1E9"3C);
M)'L: (;KP=9W.IMJ27VHVMY+&D5S+:S^7]I5>%W@#&1SR,&FW/@O3I9;M[:>
MZLEO;86MU';,H69 I5<AE."%. 1@X]:V;35+"_GN(;2\@GEMGV3I'(&,;>C
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M^ 8WANM^L7OVF;4!J4=Q&J*8)P@3*C;@@@8(.1C\ZZ#2M.N+%)&N]1GO[B3
M:6150 #. JJ !U/N?7IBZ946/S"ZA,9W$\8IP(8 @Y!H PY?#IBUJXU;2[U[
M*YNE47,9C$D4Q485BO!# <9!''7--O\ PN-3MO\ 2M0N#>+-%/#<)@"%XR2N
MQ.5QRV<Y)!()Z8U=2U&UTG3;C4+V416UO&9)'/8"L.\\1ZK::#/K7]A-]FB@
M:<0-< 7&T#/S)M*CW&XD#L3Q0!!JG@A=8M]4-W?9O-1MDM)9TAP$A4D[47=P
M22222:M7/AFXN=3EO_[4:&:33S8[H8MI0$YW@[C@AN?T]ZZ%7!53D?,.*4D#
MK0!RD_@B&[BUDSW2I/JL<*RO;0"-0T9+*^TDY;+<DGD "IO^$6O'NK^ZGUII
M)[VP6SD_T954;3(0P .?^6AXS^)Z#I20.II: .6MO!IM?^$?>/4I!-HUL;1&
M$0Q+"0HP02<-A%Y'OQZ0:?X'FTXZ7LUN=UTVYEFBWP(6=9 P8.>K,=Q^;],\
MUJW6N26WBVPT7[,#'=V\LXGW]/+*@KMQ_MCG-:-AJ-MJ=J;FU??#YCQA^Q*.
M4;'J,J: .?'A"X738;-=3C_=:F=15C;'[YE,NW&_IN8^^/SJ_I/A]M)U;4[N
M.^=X+^<W+VYC&%D*JI.[KC"# ]SUK;SQ56_U"VTRRDN[N01PIC+=>2< #U))
M _&@#.UKPY#K.H:9>/.\364K,P0?ZZ-@,QGV+*A/^[CO5?2_"<6CV&J6MI<G
M_39)&C,B;A C$MY8&1E0SN1R/O&NCHH Y&S\#M8P>'A#JC+<:)%)!'+Y Q)&
MX (*D\-A1S]>*7_A#[K[";<:I%N_M7^TP_V0XW^9YFW&_IG\<?G6SXAU9M#T
M.ZU);<W'V=-QC#[<\^M:@Z4 8_B#19-:T^W@2[%O+!<1W"NT7F(S(<@,F1D>
MV>H![5A2>!;IUO%&LKBXU6+5?FM,[9$"?+PXR"4'T'KUKM:* .8-DGAS5=9U
M^^O/,M]0,*O%%:.S(5&Q?NEB>#SQ^5,\":(VCZ/.SQS1_:)W>"*8_/#;@D0Q
MGTPN#CMDBNJP#61KVM_V'#92?9FG%S>0VG#A=AD<*&/KC- &O1163XEUL>'?
M#M[JYMGN%M8S(8D8*2/J: -:BH[>7S[:*4KM+H&QG.,C-24 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4U_N-]*=2-]QOI0!'!_Q[Q\?PC^5%
M+!_J(_\ ='\J* )**** "BBB@ HHHH **** "BBB@ HHHH **** ,+QE9SW_
M (0U.UMH#/-)#\L2XR^"#@9^E<GKND77BO49[K0X9;-!HMQ8F6X@>W+2.5V)
MA@#@8.3C SQS7I-&* /-[62+4M-NIE\,ZK:ZC!ILMK,]RLAV$KCRHLD^8"W3
M P ,\<5/:6TRR>$X8;.[MWBTF>WDD%HZB"1DC #';Q\R-^6>XKT&JKZA91ZA
M%8-<Q"\E4ND&X;RHZG'I[T <)X65'?28+OPSJ4.IZ/%Y,D]PS^3"-FUFB;)#
MAL#A1WYZ5G06]X/A7J=BVG:@+MM0>18#9R;V5KGS 0-O(V\^W0\UZMBB@#@=
M1D:#Q!XE,VCZA?6VHZ1$8TAA<"4(LV^,MCY6.X #KEAQ4.@WUSH4NKW3V^H:
MCIEM:6_V>=[%ENR 6_<$$*9-F<YQQN.237HF*,#TH 0'(S7/^-=-?4?"]T8$
MS>6H%W:D=1-$=ZX]SC'XFNAHH \OO=!U2WN]%N8T=YM<$UIJ[#.467]YG..-
MBAT!X[=*Z;7T6/Q1X4$=M,P@NI2SQ6[,L2&WD098#"C<RCD_RKJN*@CO;2:[
MFM([B)[F$*TL2N"R YP2.V<&@#S.Y64:+=Z=/IM\QC\4?:''V1W1HC=^;D8!
MW#R\DD<=CR<4W7M/U"\U#QC'I5I.1+#I\B1^2R+<I$6,L:DC!)7:,=\XKU7
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MFF:;=-!)!M/FRHC!)&#[L @[L#!R%ZC/'2:3IC:=!()KR:]N)6WRW$P4,QP
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M\EL7(W1,((1E0?NMN4@XP<K@]* /5Y+B&)D625$9SA S %CZ#UI[.J*69@%
MR2>U>6ZQ/HE[X@UFT\0WMQ%%?+"VFS0*KB> (I"PMM8[Q)N.%Y)(/-=/XVMH
MKOX9:O\ :86<IILDBBX +JXC)!..-P/IWH ZA)HI'=$D1F0X8 Y*_7TIBWEL
MZNR7$3+&<.0X(4^_I7G=Q'IEIXCCU'0$,T#:1=2ZJ;%\O*,*8BQ'60G?@GYC
MS53PU<:7?^)X+-I;&:RO]#%NL%LI9"%?_5LW\;*I.3@8ST% 'J/VJW.S]_'\
MYPOS#YCZ#UI?M$.Y5\U-S$A1NY)'7'TKSSP[IKI<P:!?PQ?8/#3R,9I5&)0R
MGR#Z<1L^[W KF-*31(_ NBW336L=S'KPC,XE"O'&;IL@-G*KL8DXP,'- 'M:
M2QR E'5L$@X.<'TIJ7,$D1E2:-HQP7# @?C7DEZT5G=^-=.T+:+='L99+6Q*
MAC#P+@HH_BVC!_QJ#Q*?"\WA+7+[1]0-TMP]HSL-B0I(LJ@;0JKB39NSCG Y
M[4 >O7.H6EI:7%U/<1I#;J6E8MP@ R<^G%/MKF*[MH[B%@T;J&!^M>7ZU;Z7
M#=^,M.TI;7R[CPXL_DP[3YLP\_Y\=VP4.>O(/I7=:)?:=<^%TN-,VR6RPG_C
MU7&Y@O.W&,G/&1WH V$N(9'=$E1F0X8*<E3[^E"SPNP594+$9 #<XZ9KQWPY
M?Z1)XFT"7S;6/3[K2KF%XW.X@ HQ2=SPTG+,V0,9_$R^&VT2Q7P%=136<=S)
M)/#/+Y@WE/)D"HQ)SMW;0!TSC% '?^)_$DFA2:7';PP3M>:A!9R!I<-$LC8W
M8 Y[^E:^I:E:Z3I\M[>2".&,9)[D]@/4D\ 5X[<:EI+Z)H#W<ELGB&#Q'!+J
M:.!YZ.)3O)'7:!@#M@ 5Z'\0XX)?!5U)-&CI$\,I+*#M42H6;V^7.?;- %ZW
MUYY/%%]IDT<$=M;VD-S'.)<EP[.O/&!@H?7^E;,DT4*[I9%1<XRQP,UYGJC>
M'M2\2:Q%)):/9_\ ".Q-%"Y"Q\23D':<#(#*0<<;@1US698:AIDUEH!\37I3
M3)]!@AM[F0(\/G@,)T<LK .1L]#P1F@#V!G55+,P"CN33?/B) $B9/3GK61H
M]A8W'A*WT\K-=Z>8/)47R@M+%T!88YR,'IG&,\UYSEM'&GW1L%D'@^X:SNW\
MH%W@D("%/4K&4<^Y]S0!ZA>WEXEQ9"Q@@GADGV7+M+M,:;3RH[G..*S=;\5Q
M:?HFH7]@L-X]C,L,J>9M 8E0>0#G&\<?45RNJ6%GHL_@B*=;6WO7U5IYP"J_
M/(DC/CVWD#_OD5B3/I%EX7\:V9%K;ZBNK3-L "2+"9XRO(Y"G((_3I0!ZGX@
MUAM&\/:CJD,*7+V4#S-$9-F=HR1G!QQ[5;T^[^VV%O.VT221)(R*<[2P!KS/
M7GTG36\;VEE/;1QW'AY)RBR@^;*1."W7)8C9D]3D4L)AT[5()?#S0MJ=WX7F
MD"I(&:>=3%Y1;GYFY?&>P(Z"@#U(2*Q8(RLR]0#TK+\.ZS)K>CF^GMUMG$\\
M+1A]X'ERM'UP/[N:XO37L6G\&WFA&+[7+N2_VD>8T7E$RF;N6$@7[W.X^]9P
MU.%/#^E13SQMHDGB"\34Y P*JIGE,:R>B,Q7.>",=C0!W$/B+4+MM?AM=,C>
MZTR58XHS< "?=&K@[L87AA71;U'4@&O(;^31CH_Q"AL)K3[.D\$L:P2 )S#'
MDC!QC=N'IG-:OB&UTB]U[Q6+AXI1_84,X0S':7!N,-C."1\F/3(/>@#TDNJ_
M>8#MS3LYKR?^UK![7PC/K]S:WEI<:%EH+J5$!F*QAI-SD*S'++UR,DCO7;^"
M[467@W3HENHKMQ""\\,WF)(W<A^_UH Z#<N<9&?2L&_UZ\CU.>RTS35OFM$B
M>Y!G$; .3@(",,0%)()';GGCA8WBN?"6FZI"43Q<FI1QS$']^\YF"RQ-W*[-
MQQT"@'H!70:#IFBK\1O$,D-I9"X@%N\;(B[D9D?>1W!.>: .X) ZFLJZUB6W
M\1V&E?9,QW<,LHGWCC9M^7;U_B'-<7\1+C3I-2NK2=H_ML>BS2Q?:Y (D!)
M:-.K394 $$8&/H=#3M1AO]3\$SB[CN'ETVX+.) Q9MD6[GN<@Y]P: .E\/ZP
M^MZ=)=26WV<I<SVYCW[O]7(R$Y]RN:U-P]:YGP*Z/HEYL<-C5+[.#G'^DR&N
M"US4M.76%U"UNXX;B'Q-%#//=3#[0%#*CHN,;( N>#D')/&<T >Q[AZT9'K7
ME.HZ;8W*^/+B2YE$]A,EQ8RBX<M#+]F1D9>>I;@?D*N/IUIJ>O\ B.'6KB6,
M+I5G<.K7#*(WQ*6<<\;2 ?0'F@#M+O6I+7Q)IVDBT9DO(Y9/M!< +L XQU)^
M8>E7-/N+JXAE:[M/LKK-(B+Y@?>@8A7XZ;A@X[9KA="N;R[G\!2ZF[F]DTZY
M:4R<.Q*1\GODCFLU=0CL/#]FM[<2QZ._B*\AU";S2<)YLWEJ[9SL+",,2>G!
MX- 'JVX>M8^LZ^-(OM)M3:O+_:-T+99 P"QG:6R>YX4]OQ%<E<2Z!#%:Z=I]
MX][:SZHYC@:=5M-WE,QB+[<>6OWMHS\V!ZXYVPNTO=)\,P2:@)5A\3S0*\<Q
M.V/$P0*V<@$<#G.,8- 'JGB#65T'0[K4S;O<"!03&A )R<=3VY]_H:U"0*\L
MU6W&G:#XWTRUFE?2K9(&@$DK2"*1AF1 S$GCY&QGC?[U;\1RG4O%^IZ1J&M1
MZ5$MC'+9-,& 'WM\L;"10'4XZYP!Z$T >C.ZHA=F 4#))["F6]S#=6T5Q X>
M&5 Z,/XE(R#^5<UKR"[^%VH>9.UWNTAW\]D,9E/E$ARO;)YQ7/QMI\FE:-81
M3!RND/.\3W)2%/EBS(S#)WKG@= &)XXH ])R*,BO++E[R]\)^%=7TR[N;C7_
M +%'*T*.TBW*B(>:9%W 9&[()_B('>KE]J&GBW\*6EEJZIH=[%*%N;EGD6>4
M!=B2-O4Y.9#@G[RXQ0!Z/P*6O,I(;R.WL+&SUA-=CM7NG>S,CP-.@*C$<F6W
M&(M@9;OU!7(ZOPCK&F77A[1K>VOFDEDL$ECCN9!]H>, +O89YYZGIF@"_J.L
M+IVI:79M;R/_ &A.T*R*1M0B-GYYST0]!6ED5S?B4X\0>$_^PF__ *2SURUC
M=/J%U]OF\2I:7UMJSPSVOEN\I4RLBV^WS,;2NW!"=MW7)H ]-R*K6]S++>74
M3VDD20LH25B,3 J"2,<\$D<^E<%;0WEMK6I^$Y);R0W%Y%>VTYN'+)9DY<;B
M<@*4*=<_.M2:OJ-SI<?BMXKN=(X[VS1I7E9OL\+B+S67G( #,>",=1C% 'H>
M: <UY[+!>6]K?VUAXBM;F6ZDM98+7=(L2@L<H)-[D"4*1UZY]:W_  ==?:=.
MO5,-W;S0WCQRV]S+YK0O@$JKY.Y<$$'T- '1YHS7G5MJ$DGB#1[J&\G>WNM6
MN[=YI;AE,JK'/\GE?="(R* >"=N<#/.8+N^MK6TO5U.^:9?%K6 #W#%?(-PR
M%"IX8;>YR1V(H ]%U[68] TB;49H)9HXL;EBQGD@#J1QDBGW>J"VU33[!86E
MDO#(25/$:(N2Q]LE5^K"O.M6NCK?A'Q7?7-Y.UU:ZBUL+<2LJVZ)*JJNT'!R
M!N)(.=WL*W]?U"ZMX?%.LV*[YM,L#;6Q SMDV^9(P]1AHO\ O@T =MFBN$G=
M[3Q%X=CT[4[JXL-5M;A9R]PSEPL8=)E.?E.>,C ^8>U6?AU!-<^%M*UF[U&]
MN;JYLE6033ED/).[:> W;/>@#LJ*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *1ONGZ4M(WW3]* &0?\>\?^Z/Y440?ZB/_ '110!)1110
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MY)=LD_0=^E4XO%=Y?7.DP6&FQN=3TLZA$TL^T1X\OY6^4\?O!R,G/;O0!U1
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MS$LD*L(_]T$<?A6:?$PDU*XM+:T:=;:Y2UG97&]&8*0VSKL^8?-]>,#-1?\
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MEEBB>.3<CG (8-C@\$=1[U>E\8+ ZPS:=/!<2/)Y,=Q)''YD:!<R9+8 .]0
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M\4RHBJP<GD QJP&.HZXXK0MM%NVU>TU+4[V*XFM('AB6& Q+ERNYSEFR3L
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M%LB-&"7@D@9G1QGAOF;...E==FJEWJ"V]O>/%$]U-:Q&1K>'!=N"0H'J<<4
M<KK/A?Q#XB\-7VFZGJUEYMS"(5-O R1J-P8N06)9CM '( Y]:M77A>\O_$-_
MJ4]Q D=YI/\ 9K1Q@DKRS%P3UY8C'M7402F:WCE:-HBZAMC\,N1T/O4F1ZT
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MI1D^7Y.OS9YQTK<\(Z1?Z.NKK?) OVS4IKV/RI2^%D.<'*CD?C71T4 %%%%
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MFOP)'$EP%B(:&$A9&P<195@0!SC:/2HX[J%M(>T34D5;?Q/#&JVTY14B9T.
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MZVS*N/*#_>Q]<<T :%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(WW#]*6FO]QOI0 V'_ %$?^Z**;"@\B/D_
M='?VHH FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/UH ]&HHZ44 %1W$;RP/'',\+,I D0 LON,@C\P:DJ.>40022L"0BEB!UX%
M'$^%O%-]/>S:'KLP2ZD:;^SKT!5^U1K(R'C&T2+MR1CH0<5>\-:X\7AR"\UK
M4I)YKB[F@CS$NYBLCHJJL:@DX3)X/<].E&+1(M>\)&QO$DT^]@NI;BTG9D+P
MR&5G212I/8C(SZBJ%AIVK65CX8U&6"*6XT^XNC>VD;+D^<S9>/)Q\N<@9R58
M]Z .^L-2M-3B>2TEWB-S'("I5D<=593@J>G!'>LGQIJFH:7X=F;2(_-U67*6
ML> =S %FZ^BJQ_#'>H/#ULT6M:_JTV((]1N(VBA=ANVI$J;B >"2#QZ 5$\4
MVM>*YI+D75G9V,/EVDB2!/.=S^\;(/3"J "/[Q[T ;NF:O:ZEH-KJ\<BK:SP
M+/N8X"J1DY/;'?Z5@VNOO?>/[>VM[N9M.DTJ6X\IX#&-PDB"N"R@L"&/?%<X
MNCZK+X8\2^$;:":VMFDD?3+N5U*2(S!VB;DD MN7)'(;VJU=C5?$&KK*FD7>
MGB?0[JP:25XL6\LAC(/#Y*C:>0.>..N "_?^)VN?''A:VTW4)#I]ZUSYR>00
MDP2)F5E<K\PSC[IQTJ]_PDEOIM@UR+Z74UN-5%JFR$_NMT@!3Y1SL&?KC%<[
M"VK76L^"YI?#]U;?V3YT=V-\6Q-T/E@J=_S+GG@=/4\5,MIJ)T:>5=,N6DB\
M1?;Q!\H>2$S;LKEL9P>A(Z&@#J+?48&\1W['6@T4-I&\EB\806P.X^8S'D9'
M8],5:MO$6E7<OEQ7:[_)^T .I3=%_?7<!N7W&17#:MH>K:_J?BF,6LMB=3TF
M"&*20@H)5W%D)'^\!GIUQ6TBW>IZSH&I3:=/9'3+><W*,O1G0)Y:8^]R"<C(
MPH]: -RU\4:+>W%I!;:A%(]XA>WVYQ( ,G!Z$XYQUQS3K?Q'I-W=QVD%ZCRS
M-(L6 =LC)]\*V,,5YR 3C!]*X72].U*WT_P!%)IMT'TQG%X-G^JS$R9/J,L.
MF>*AL+;6CK'AJ]N=!OHGL[ZX6XCB\M+>%72108T#?=RP)<C)R>3TH [/PE>W
MM['JXOKG[0]MJ<UNC; N$7;@8%5AK=YK?BW4="TZ9K2WTQ(S=7:HK.TCC*HF
MX%1@<DD'TP.M2>#XYX/[;^T6TT'GZI-<1>:FW=&V,$?D>.HJI9Z9<^&O&>KZ
MDD<ESIFLE)'\I=SVTR*1RHY*L.XS@CICF@"M?>)=2M)/$.A27 74=/TXW]K>
M"(?O8\'[R= P88)'!SG Z5N:-XBL=2@@L(]1C?4OLJ2NI')R!EAV89/..*P+
MOP_>:UK.OZ]Y+0-<:.^E64$A"O(#EB[#^'+$  \X&3BI[*TN+[4O#=ZUG<6J
M:19RB?SH\$NR*GEJ/XNA.1D<#UH K^'-<N]1\*>';K4=>%O>W.H2*W[E2;L+
M+(HB  ^7@#D=-M=7=>(M)LI9([F\2(Q.L<K,#MC9AE59NBDY& 3DY'J*\]T[
M3-4@\)^$K273+L7%AK;75P@0?NX]TQW'GGB1>G/7TI+R1FOM?LAI&JW&C7&J
M+<RS644<P+Q^66VMO!'S1X(VG&" <\  ]#D\1Z5%,L378W%XTR%8JK28V*6
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MDDLKNW@>998W<OM8("58%B#D 'M0!NV6I75K!>-KTEK!Y=UY4,J HDJ%5*D
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M6^1GM+F&=5;:S1.& /H<=^:\WFBTC4[.ZOH(]>CFDMH+>>=K9HS;;9D**$*
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M\.V6G6]E;7%YI:WLH\L^5;Q[4 54!!.6; &1@ ^PH ZZ2>&)D661$:1MJ!F
MW'&<#U. :DQ7-?V1/XETO2+C7;&&SU"UG6X:-2)#&Z-GY'!X#8![\''7D5_^
M$JGD\6RZ*C6T<L4ZI]FG5EEEA*!C*C$A6 )(P 3@$GTH ZMV2-&=V"JHR23@
M 5%:WEI?(9+2YAN$5MI:)PX!],CO7,_$7[4?",B0/$L<MQ;PS!U)+(\\:$#!
M'!#$'V)HLVN+#Q1J=A%!I\=S/8I>O<10LN^3<4 8;N>%'((H ZA[B".:.&26
M-99<^6C, 7P,G [\40SP7 <PRQR!&V-L8':WH<=#7"K??VQKOP_U>6&-)[VT
MGE<*.FZ!6*@]<9-7/ARB1V?B%(U5$77[T*JC  \SH!0!V>*,5R.K>*KS2]86
MW>*V$1OK>V2$G,LD4I5?.R#A0'<@ CG:>>:HZIXPUVR/B1X=.L6CT,K(Y>9O
MWL9C$F!@?>()[8&.^> #NV944LQ 4<DGH*;%)'/$DL3K)&X#*ZG(8'H0:X_5
M==EUM=4TK3[>"1+?31/=&Y&03(I*1 =B0"2W...#GB_X0N(K/X;Z'<S-LBBT
MF"1V]%$2DF@#I,48KE[7Q!J8M;?5+ZRB329K*2\DD1OGM0 &4/D_-E2?NC@C
M'(YJ%/%&I6]YHT>H6=NB:S&WV<1N<PRA=ZQN><@K_$!P1T(YH WM7TB#6;'[
M+-+-#B1)4E@?:Z.IW*P/3@@<$$5%9:(;>[2ZNM1O-0GC5EC:XV (#C.%15&>
M!R03^9KF;/QAKESIVE:@=,LQ%?73V9B$[;UD!D"G.,;<H >,\D@=JFD\7ZK:
M6%X;G3K>2\L]5@L)4@F.UEE\HJR;@,MB4#!(&>] '9NZ11L\C*B*,EF. !2J
MRNH92"I&01W%>;>)==O+[0/%^@:WIUO#=6^EO>0&&0RQR1$, >0"&5E].O2M
MF3Q!>6MO!I^EVJW%S;Z;%<NK([!BP(2,; =I;8_)Z8'!SP =AQ2X'I7&KK^I
MOXIW3+':Z;%I2WLL,VX21AF.[</[R[",?6K6C>(]3O\ 4;..XTJ1+2\MS,LJ
M1R#R&X(20L #E3U7N"/0T =11110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4C?<;Z4M-?_ %;?0T )#_J(_P#=%%)!_J(_]T44 244
M44 %%%% !1110 4444 %%%% !1110 4444 4]4TRUUC39]/O8R]O,,. Q4]<
M@@CD$$ Y]JYK7/"$8TC5&TV*XNKV]MDM9EGO7_>Q@X8Y8XW[2V">^.V:ZZ66
M.")Y975(T4LSL<!0.I)]*R?[=M-4L[J/2KY%NTA\Q/-B8$*>C[6P64XX(X/K
M0!A:3H-RUVF(M<L[-D>.YBU'4O/$BE2 J 2/M(.#NR#@$<YXVKKPCH]WX>@T
M.2"3[%;;/LX$S[X2GW"KYW CMS5+PIXLL=6TO2;6?48I=8N-/BN)8\8W,44M
MC QD$\@=*H6VMWDWAF[GO==AL+E=7EM4N6@4@A+@H$5.Y95QW/.>U &M-X*T
M>YTDV%PMS.?-$PNI;AVN!(/NN)"=P([8Z4]?"-A&EL8IKU+FW9W6Z^T,\K,R
MA269L[N !@Y P,#@5=O]?TO2YO*O;M8F"AW)4D1J3@,Y P@)R,M@<&H[KQ/H
MMFJ--J$6UT$@9,N A. Y*@A5SQN.![T 6]-TVVTFP2SM$*0H6;!8L2S,68DG
MJ2Q)_&LN'P?I4"(B"Z"QW1NHQ]I?$;Y8_*,X R[<=.:D;Q+9KXGDT(Y$L=L+
MAY""%&2<#ICHK'.<<4:;K%K!H%O=W>KQ7JR.RI=1QX$QWM@*JYR0!CC.=I-
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M8@@BMH(X((UCBC4*B(,!0.@ H Y&VN+Q/&?]J-H^H+:WFEP1 M&,Q,DLK,'
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M$=P[\$<'E17HUI>6U]!YUI/%/%N*[XG#+D'!&1Z$$50O?#UGJ&L6^I7+W+O
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M",[ >"3Z5Z+@8HP* /.M/BMO[3FTW5-,U2758M7>ZA91,(9%,I9)@P_=@*A
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MIM/F&>78AP.N!P#VQZBNZII13C*@X.:=0 4444 %%%% !1110 4444 %%%%
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MIV^O:K+JLEFTEF0=%2_1HTW 2DD'!W89>,C^=6;#P9;:986]G9:E?Q0PI+&
M3&VY9&W,&!0@X.<'MD]J<?!MBDMD]I=7EH+6R%AMAD&)(!T5MP)XQU&#UYH
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M7?2FQN&GUV>#<]LWF)ON959E;><''3CIQS7H5M:M;V@@-S-,P!S-*07)/?@
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M(]NYMK\%3_$,H,=1D"K5I;:3+JW@_P R*V<R:7*)MP!WD"$KO]2"K8SW!]*
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MN8#P"><5?TS6=6AT>^O9Y;:7_B;36S2291+=%F:,N=S\J HPHP<GK0!V]%<
M?'M\=)FN(;&"6:#7%TE\LR*X8IAU!!(X<<$\>]&M>)-9&@^*[5X[>VOM.5 D
MT+,RF.5<@CH0PR1GU&<=J ._J$7=NUR;83QF=1N,6X;@/7'6FH+H6A#-$UQM
M."%(3/;C)/ZUY]H=R8M-LM0O+2TN=5N-9NH+.7)#*[2RJY)Z[1&AP/10/0T
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M8#;SD*V!Z$<G-4O&>L/K?A'6VM;.*6PM+A;?SWE(9W610[(-N,*25Z\X;VR
M>B>](S*BEF( '))[5RVK>+YK&6^%EI<E^FGR)'.L18R.Q"LPC4*02JNIY(SR
M.U8GC[5YM7\&^*+>VT])+.S@\N2>60HQDVAB%7;SM#+G)'.1V- 'HFX;<YX]
M:%(=0000>A%8/B:*.7P%JJ.BLHTZ4@$<9$9(/YUEZ9XFO;632M*N-)2'[=8[
MM.D:XSYKH@8I( OR''/&[@&@#LZ*Y&P\:2ZAIVBSQ:=&+G4;MK62V^T$M;;
MQ<L=G)79R,#DCGFCQKJ,XN-#T&!WA.L7GE32HQ5EA1=T@4CHQ&!GW- '6Y&:
M6L*7POI\=S87-C#'9R6<WF9A7;YJ[2I5\?>X.><X(S5$^-!':6.I260&D7EW
M]ECN!+EURQ5'9<8"L1ZY&X<=< '58% 4#I7%-X\NU@U&Z.AXM-.U+[#<R_:A
MTW*N]!M^8@OD@XXZ$G@:C>)Y'UNXTVULXI6MIXX9E:XVRA74'S FWE!NQG/9
MO2@#HL4T!=YQC<.37+_\)A,MA'=/IR _VL-+D47!.UC*(MX.SD9.<'%8%YJ,
M^@:G\1=4L8HVN+>"UD4.<#/E$^A[DG'?VZT >D;1DG')H  Z5RUYXGO-*L(V
MN+!)'CL3=33O.8XB1T17*89S@G;@8I6\73RZI96%EI$D[WNGF^A=IE1<908;
MJ1]\<\_0]@#IV16SE0<C!R.U!C0]5!_"N&/C.]U4>$Y]+MDBAU:XE65)I<,#
M$C[DR%/&Y/O>W3GC?\5ZE>Z5HBW%BD9F>Y@@S(V-HDE6/(X.?O?YZ$ V3$A4
M*44@'.,=Z54"KM48'H*Y^?Q'=+>7=C9Z9]LN[&W2>Z1)]H4MDK&A*_,Y )Y
M'3D9K4TS5K75=&MM5MG_ -%N(A,K-QA2,\^A'>@"R;:$J5,2%6Z@J,&GHB1(
M$10J@8  P!7.0>+DD.DS369AL=7;99SF3)+$%D#KCY=Z@D<GT.#7)ZKK=]KG
M@N]U"\A,'V76HHH5@F8\+=)&RD #=QGKG.>@P* /3?(B,WG>6GFXQOVC=CTS
M33:VYN!<&&,S 8$A4;@/3/6L"+Q>D<>KG4M/FL9-,5)&C:1',B/G9@@XR2I&
M,]>]4+KXAP6,.JM<:;,\FGVRW1%O,DBR1DX.&R!E3U'7TS0!U;:?9,6+6D!+
M'+$QCGOSQ1_9UD)4E%I!YD8PC^6,J/8XXK#;Q7)YD4 TN5+FX>3[-%/*L?GQ
MHJL74^^\ *<'@YQ@UNV%T;W3[:[,3PF>)9/*D&&3(!P?<9H 3[!9D2#[+#B3
M[X\L?-WY]:<EE:Q6_P!GCMXEA_YYJ@"^O3I4S*'4J<X(P<'%>1Z?>P1>'/$U
MW>ZIKBW-EJ5Y';31W-RXC"'Y!U*$#_:X]: /5WM;>65)9(8WDC^X[*"5^A[5
M&=,L69F-G;EF.6)B7DYSSQZU@:;XDN1H^@PW<27.MZC;"4Q0N-GRJ"[EAD!<
MD#C/+ "JU]XTF?3]-EL+%Q<3ZJNG7,$S*&@<$EE."020."#C# T =8EK;Q^7
MLAC7RP0F$ V@]<>E/EBCFC,<J*Z'JK#(/X5YVOB)_#FO>+KV:RO[N&%[669$
ME#_9D,(+$%FQ@$GY5_+%=]=*EUI\F'?8\9(:-RIZ=00010!,(HQ(T@1=[*%+
M8Y(&<#/IR?S-0)IMC'')&EG;JDGWU6)0&^HQS7EVAW]__9G@FZTS4M0O=0O9
M(UU.&2YDN$,!4EY&#$A"#C!&,YQS7:VGC."YU2ULS8W,0O6N$M'< &4PGYOE
M)RN<$@GJ!VXH VVTRP=G9[*W9G&')B4EOKQST'Y5(+2V6U^RB",6Y&WRM@VX
M],=*XJ]^(,\GANYU+3]$O5412;)I@@1)%F\G:W)YS\V!D$<9ZXUFU" ^,+*.
MZMKVVNQI\\H+2KY C#H&R W+#Y><=#0!N+IEBEN]NMG;K#)]^,1*%;ZC&#3F
ML+-[,6;VL+6P&/),8*8_W>E<U;_$#3);G;+')%;/:R7<-QN5Q)'&,ME5)93M
M^8 CD>^16MHFN-K&XFQFMT\F.>.1G5TD1]V,%2>1MY';(ZT 7)M+L+B&.&:R
MMY(HQA$>)2J_0$<4M[;-/ID]I!L0R0M&F1PN1@=*M44 8/A;PW%X?T6RM'BM
M7NK:!8&NHH@K2!0 ">_;IFM*/2=.A8-%8VR,LAE!6%00Y!!;IU.3S[U<HH I
M#2--6VEMEL+403<R1"%=K_48P?QIUIIEA8$FSLK>W+  ^3$J9 Z#@5;HH @>
MSMI+I+I[>)KB,%4E* LH/4 ]13+;3+"SF>:VLK>&5\[WCB56;/)R0.:M44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !39/]6WT-.ILG^K;Z&@!L'^H
MC_W1_*BD@(\B/G^$?RHH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH @
MO+2"_LIK.ZC66WG0QR(W1E(P16+8>'+S3=.32X-;G_L^-/+CW1*9XT' 42=,
M <9*D^]= S!5+,0 .235>TU"SOXC+9W4%Q&IVEX9 X!],B@#(7PNMIJMSJ&F
M7LMG)=0QPW"[1(K!!A&&>0X!QGD'N#267A2+3+W3YK&Y:**PL6L8(63<-C%"
M23G).8U_7UIWB'Q ;+PKJFK:3+:74EC%(Y!?<H*#)4[3U]N*UX;N)U1'EC\\
MH'9 V#TZXZXH YS3?!C:5I=OIUOJ;/;11SQ/'/"KK(LK[SN&1R#G'L>0:>O@
MQ+::PDL=2N;<6NG+IK#:KF2%<8R2.&X//OTKH8KVUGE$4-Q%)(8Q*%1P3L/1
ML>A[&D6^M'NI+5+F%KB,!GB$@+J/4CJ* .<T_P $KIT?AY(]2F<:(KK%OC7Y
MPZ[2#C'&#QW]2:5_!C;'6'5IXP-2.I0*8D98Y&9F8'C+ EVZGCCTKH?[0L]H
M;[5!M/ /F#!K'\5^()=$T66]L1;330S0QR1R,?E$DBIG [_-GM0!FGP!^YNX
M_P"V)V%QJB:J2T2?+,NT]L<$J/P'XU;N_!_VYM?\[4&VZQ&B.$B \HH,*5YY
M]\]?:NBFO+:WEBBFN(HY)CMC5W +GT /6L_Q%JYT;1;J[A-NUS'"\D,,TFSS
M2JEB!U).!VH N6\%S#9"*2[,]Q@_OI(P!D_[*XX'IZ#KWKG8_!;)H\%D=1/G
M6M\U_:W"PX:.5G9V!&<,IWL,<<'KWK?MM1B.G6=S=2Q0M<(A 9@H+,,X&:LR
MS10IOED6- <;G( H Y;4O! U.+4FEO@MYJ,ENT\RP_*%@8,BJN[@9&223G)]
ML=2$=K?9(X+E<,RC:,XZ@9./SI^X!2Q/ YS7-7GBK#Z#+IT<5Q9:I>FV,S.0
M0 KMN48Y!\L\Y].#F@!L7A*7[0MW<7\4MZNG/8&=;;890VWYY/F.XC9QTZGU
MI;3PI/:W6@S_ -HHQTBS>T0?9R/,5@@R?FX.(U_7\.D$T;1^8'4IUW \?G5>
MZU.SLHH99YU59Y4ABP<[W<@*!Z]?RR: .=7P;<+H\FG_ -IQ8?4O[1+_ &4\
M/YPFVXW]-P_+\Z=<^#YKFY\22_VDBC7;5;:1?L^?*"HR CYN3M8_CCZ'I+R\
M@L+*>\N9!';P1M)(YZ*H&2?RK(?7YAXFT[3A;1BTO;.6Y69G(<;"F5*8X^^.
M_P"5 &:?!5SYZRKK&-VEC3)5-OGY1GYTRWR$\9Z@X%7=,\-W>GZAI]TVI1RB
MTL!8E?LQ4NN0=V=_!^4=C70EU5-Y8!>N<\4H((R#D4 9FOZ0^M:6+6.Y^S2I
M/#<1RF/>%>.19%RN1D97'45F7/A:\NM1OKR35(R]WIG]GL/LW098[N']7;CT
MQ]3TN]2VW(SZ4NX9QGF@#E[/PE<6A\-XU*-ET2W-NH^S$&4% F3\_!P!Z\U7
M_P"$)NDM5-OK/D7T.HS:A;W"6W"M*6+HR%CN4AR.H/2NOWKG&><XI0P.<'I0
M!1TNQN;.&4WEZUW<S/OD?;L13@#")D[5XZ9/.3GFN5'@"Z1H NLH4M]7.J1E
M[7+LQW95VW_-@-@' Q@<&NX# YP>G6@,#G!Z4 <I+X0NI=,U*S_M.$?;=06^
M+_93\A#(VW&_GE%Y^OX,NO!UZTVN?8]7CAMM:B(NH)+4R!9#'L+H=XQD8X.>
ME=<&!. :-PSC- &5!I,\/A==(%\1,EI]F2Z1-I4A=H<#/4<'K6'>> (=3.H2
M7EU'%/>0PJTEE!Y)$L;EUE.6.6R?RXKL"Z@$D@ =3Z5F+JDU[;:9>:5"EQ9W
M;AI)'?84B*DAP._.WCWH R-0\+:OJ^CW-EJ.O1R2S!$$D=F4155@V=F_EB0,
MG.,#@"M;7=%?7-#>Q:Z,%QE)([F-.8I48,K@$]B!QFM7(SBC<* ,&]\-F2ST
MBST^XCM+?39HY8U:$R;M@( SN'8G)YJK#X3O+2[OELM;DM]-OIVN);98071W
MY?RY,_*&//0D9."*Z:0N(7:)0SA255C@$]@3VJOI\]S+IMK)?Q1P7;QJ98T?
M<JN1R >_- &!;>$KRPN;R*RUR6'2KNX:XDM?*!>-G.76.3/R*QSQ@D9.""<T
M0^$)SJ>F7UYJ27$VG32R13"W*S.CAAY;.6.5 ;T_A'2NISQFD#JQP"#QGB@#
MC_%TA'BKPDD5Q%%*MY*Q:1=P4&"102,CJ2%'/4BK$WA&>1VFCU")+F748]0G
MD:V+!F0*J*!O&%"J!U)/)XKJ,J6(SR.U0VM];WOG?9Y!((96B<CH''4?AT^M
M &-+X<FB\2S:[I]['!<W-LMO<QRPF2.3:258 ,I##)'4C'YU!=>"X)?"-OH<
M%W+#);2+/!=@ NDROOW@=.23QZ&M+Q-J\V@^'+_5(+9;E[6%IO*:39N"C)YP
M>U7[.X-S8V\[@*TL:N0.Q(SB@#$UCPN=130X;6YCM(-)NH[F.,PE]VQ2JKG<
M,##'U[5F3>!;L:9JNDV6L1Q:;?W#7 BEM3(\+,X=@K!P-N1T(XSUKK%O[=M1
MDL%DS<QQ+,Z ?=5B0"?J5;\C5C<#0!S#>&M5@U2\NM.UM+6+4-K7<1M-^) H
M0R1$M\A*J.H8<9YJEJ'@>]GL=;TZSUE(K#5@6DCGMC*\;E K,K!UZ[03D'G-
M=IN![T;A0!GW&F->>'IM*N;C+36S6[S(FWJI4L!DXZ^M9*Z"UM)IVI:O>1S+
MHD$AA$$#(.4VL[#+$G:#@#U/7C&X9KS^UA!]F7[%Y!<W'F#(DW !=OIC)S5K
M(- '(>&+*SO/$6J>(;$N;&Y*_9MR%%+LJ^:Z@@'#;(AGU1O4UL>(-!37+>V*
MSFVO+.X6YM;@+N\N1<CD=U()!'&0>U:XP#@5D:OK4NF:GI%JMJ)(]0N3;F7S
M,>6=COTQSPAH 6VMM:F>(:A=VJQQL&86B,IE(Z9+$[5]1SGUQG.+%X(D71[;
M0GOT.D6MTL\2K$1+M63S%C+9Q@' SCD#''6NFOY[N".%K.U6X9IXTD4R!-D9
M8!GYZX&3COBK6X=^M '%R>";]]&UO3O[3M\:IJ'VXO\ 9F_=Y96*XW\_<'/'
M4U9U+PG<ZMJD%S=SVI^S7D5U;SK$1/"%VEHPV>58ANO9NAP#764F<T <;<^$
M-2E\^WAU*UCM#JJ:G$&MV9PXE60JQW@$9!]^1Z<OOO!MU?R>*1+?Q+#KEND(
M"Q'="50H#U^;KDCBNO) I<T <9/X2UBYNDN)=4M'=M-:QD!MVVQ$Y^>(;N"0
M0#GK@?2I]-\,ZE8ZII-])>6LAL=+.GE%B90^2AW#DXQL ]\GITKK,TF10!P=
MAX&U/3M+T""#4;0W.D7<TR2-"Q5TEW[@1NSD>8<<\XKI?$NE3ZSH3V=M-'%<
M"6&:-Y%)7='*D@! YP2F/QK7S2T <I#X>U;3M>O=8LKFSEGU**)+R.5'1!)&
M"JNF"3]TX*GK@?,*UM*T.'3/#4&BES-#'!Y+,1C?D?,>.F<FM7-5KR^MK!(F
MN91&)94A3()W.QPH'XF@#E[/PI?BST72[^>VDL=&FCEMYH]WF3>6I6,,I&%P
M",D$YQVJ@_@W6X]#U#2(;BPDMYM4%] [EU8#SQ,0V 1G(V\=CGVKJ=(UP:KJ
M>KV7V62!]-G6%B[ []R!P1CH,,*UZ .,U#PMJ6JW^MO/);6\.HV]ND4D4C.\
M,D+,Z-M*@$;F'&?X??AFJZ+XLU[PQJ&FZA/I*S7,#6Z"W\Q4YQ^\8D$Y&.%
MQR<GI78"Z@-VUH)%\]8Q(4[A22 ?S!_*EEN88)H(I) LD[%(@?XF"EB/R4G\
M* .6UO0+_6=,L;&[T_3;NV%LR7,,D[*4E^78\4@0D8PW8=16EHMIK.FP:;8W
M4]O<VUO8+'/.2WFO.NT9YX*D;N3SG%;;$A20"2!T'>L[0M8CUS3?ML<$L*^=
M+#LEQN!CD9#G!(ZJ>] %^0N(F,:AG .T$X!/N><5Q.C^'_$FE:9K%D(M)?\
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MHQ].:Y>P\(^(K;6='U"Y.G33V%W<R37'FN9+E)58!B2ORD @!.0/48Q7H]%
M'"P^%M7/P\OM G^QI>/++-"T<S,C%IC, Q* CD[>A]?:K5SH>L:MK5I<ZE;V
M26S:=<V5TL-PQ9?.93\N4YP$ R<9)S@8Q7844 <58Z9XRL]%?2A<:8%M+5X;
M.Z&XO<$(5B\Q"N$QP6P6R1Z9JWX7\.SZ-JU]=K;06%M=11E[*WF+Q^>"V]U!
M "@@@8'7'05U5% !145Q<0VL)FGD6.,8!9CQR<#]2*?)(D432R,%1%+,Q/
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MA:3J4$,%[IEG<10$&))8%8)_N@CBI+K2K"\6$7%I#)Y'^J+(,IQ@[3VXXXH
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MC(A=MQ!PK'. ,G!XZ53?P1=/HUQ9G5(O/?5?[5BE%L0J2>;YFTKO^9<\=0:
M)M1\87.GQ^("=.CD;2##PMP1YJR#(/W>",]/UJ2;Q'JL>KWFE+I-N;J.T%Y
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MTC=M(P3WX!JGI_A/6M-TC1[:.:PEFTK4);B,DNBR1NLJ\\'#?OLX&1\N,]Z
M-"]\<Z=8W6R2.1H5NULWE5T)60D#.S.XJ&."<=0>,<UC>/=?:\\):P-.CO%2
MSN8[=[N*7RQYGF(&488%E&XJ>V>QP<:UCHOB+2I[JUL[K3SI]Q<O<"617\Z
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MN/NGCE3R,CUH V**** "BBB@ HHHH **** "BBB@ HHHH **** "FR_ZI_\
M=-.IDO\ JG_W30 D'^HC_P!T?RHHA_U,?^Z** )**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@! JK]U0.<\"EHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *0@$$$9!I:* &1Q1PKMBC5%SG"C I]%% !1110 4UT61"CJ
M&4C!!&0:=10 R*&*!-D,:1I_=10!3Z** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *CBAB@4K%&B L6(50,D\D_4U)10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %-E_P!4_P#NFG4R7_5/_NF@ B&(D_W111%_JD_W110 ^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2_
MZE_]TT^F2_ZE_P#=- !%_JD^@HHB_P!4G^Z** 'T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRH 6/_5I]!121@;%/L** 0^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***,CUH ***,T %%&:,T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-:KH;ZKX
MF#7$$K:;)ITMK,R2A<EG4[3@[L$*>GK7-ZSI6HV-[J.K&%[*WCANXS<PS+D1
MM$HC8$G=PR]" %[#&6KTFD90RE6 (/!!H \PM-/NM3BFCCMI9K4W(DO;*VDA
M"X: (OEGS&3AE9R"0<ONZ@$]EJ*ZI%X?M;6RM9VN'1(I725&>%<?,P+D!F[
M^IR1Q@[4,$5NFR&-(TZ[47 J2@#E[_3+QO#6E6=A8M%#;2PB:P,JY:W3@QYS
MM/&TXS@X(SS532?#]Y;ZQI%Q=V6]+6.^19&96,"23*T*=<G;&"O&0*[.B@#D
M]1\.37?B&&2V\V&U:]BO[MF92DCQJ H4?>W':@)X&$[DUUE%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)?]2_
M^Z:?3)O]1)_NG^5 "Q_ZM?H**(_]6OTHH =1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !3)O\ 42?[I_E3Z9-_J)/]
MT_RH 5/N+]**$^Z/I10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "F3?ZB3_ '3_ "I]1S_ZB3_=/\J '+]T?2BE
M7H** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
8*** "BBB@ IKKOC9?4$444 ***** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex10-4_003.jpg
<TEXT>
begin 644 ex10-4_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HY_
MN#/]Y?YBI*CF^X/]Y?YB@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J.?_ %?XC^8J2HY_]6/]Y?YB@"2B
M@44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %17'^J_$?S%2U%<?ZK_@0_F* )1THH'2B@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*X_U1^H_G4M1
M7'^I/U'\Z )1THH%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%8]]XEL+/41ID7F7FI%=_V.U4-(J_WFR0J#W8B@#8HK.T
MC68-86Y,,4\36TQ@E2:/:RN%#$>_##D<'L36C0 445R]SX^T2VFV[KF:+S_L
MXN(8&>,R!E5EW#N-PR>G4 D@B@#J**S]9UBTT'1[C5+]V2UMU#2,J%B!G'0>
MYJ?3[U-1TZVO8TD2.XB655D7:P##(!'8\T 6:**9+-% F^618UR!N8X&2< ?
MF0* 'T5F66O6.H:UJ.DV[R&ZT\1^>&C( WC(P3UZ5>N)X[6VEN)21'$A=R%)
MP ,G@<F@"6BL[0]:LO$.DPZGI[N]I,6\MV0H6 8KG!YQD&M&@ HHHH ****
M"BBB@ HHHH **** "BBB@ J*X_U)^H_F*EJ*X_U)^H_G0!*.E%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1SLZ6\CQIO=5
M)5<XW'L*\T^#2_:=(UK7+]LZO>7[B\,@PR;0,*1V W-Q[^U>GUBW'A+0+K4)
M;Z?2K=[B;'FL5XE_WQT;\0: .>U3Q"+OQG9Z%82K;6#VAU74;Z)MF^(?*H#]
M@2JY;KMQ@BN8&M^)=0\,^%K2WO+F*]U;5)#&Q;;(]BA8DLQY^[M.>I&.I->H
M7WA_2=2G6:\L899%C,.6'WHR02C?WER =IR*G?3+&6]MKQ[6)KFU5D@D*\QA
MA@@>F0!0!YA:^(=0F\*>/]6N=5N6MHIY8[!@X5E"@J"G'"LV /H><Y-,L;6^
M\.W7@7PM8ZA=0@HU_J:@C"H K%2<9"F3</\ @1'.:W[_ ,$SWHFT*WL=-T[P
M[)>17$IMB?-N%7YF5EQC)<+SG@#OTKK9M"TRXUB+5IK.)[^*+RDG89*KDG'I
MU)_.@#R35-=F\<:;81M<S)!KVKBW@M5.%2RA;,C,/[Q*Y)/88'&:WKO5O$7B
M>\UF#1[LZ;9V=X+""Y#HJ)(C#S'?/+'G:J 8.[GMCKK;P/X:LS:FWT:UC^R3
M-/!M4_([8RW_ (ZOTP/2K$'A71+?5)M2BT^-;J:7SI&RV&D_O[<XW>^,T >:
M:_XIUZ+4/&MW;:G.FG:7;QV=J5"X^U/L!VC')SGUQGWXU+E+[6/$_@[2;W49
MP+/3EU+4 K+M:50H1CD==^X\^G&#S7;3>$]"GL+BQETR!K:XN3=31D'#RDY+
MGWXIW_"+Z*=2.H?V=#]I, M]^#_JP" ,=.A(SC.#B@#S;3?%VMCP\;S[:\UY
MX@U?[)I7G!<6UN6($A4 9P WUP.M+>>);Z?P[XVD@OY;JR1TTC3%?!9Y6&QV
M!QEB6?CV%=\? WAHZ=9V!TF!K:SE$T,;%CM<<9))R?H<TT^!?#9MFMSI<9B:
M[%ZPWOS,,X;.<]SQTY/% &AX=TN+1?#FG:9 XDCM;=(@XZ.0!EOQ//XUITBJ
MJ*%4 *!@ =J6@ HHHH **** "BBB@ HHHH **** "BBB@ J&Y.("?<=O>IJB
MN/\ 4GZC^= #MX]#^5%.'2B@!:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *BN?]0?J/YU+45S_J#]1_.@"6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^(UVD[Q@8.UT.!NZGGCFWXFN[:W;2$NK![E9=1A2)A)M$4F3M8\Y..>,8]:
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M:U_M%X[6XN8-,XO980,1':&( )!8JI!('0'N>*CN_&$$%W<VUOI]Y>/!9I?
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M#D8.5Z\]:S(O!VI1:986@U2TW6FIOJ._[*V&+.[[,;^.9&YSZ<5V=)D9QWH
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MF=E>"5XPCD@*0X. 1R/3WJ6+PU?6FIW;VPMFM6T>+38/,F8/F,OAF^3&#O\
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M3_$?F* '_GF#VKU$6-HMT;H6L(N#UE$8W],=>M.-M TDDAAC+R*$=BHRRC.
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M*** "BBB@ HHHH **** "BBB@ J&Z_X]G^E35%<_\>[_ $H DHH%% "T444
M%%%% !1110 4444 %%%% !1110 4444 8&N>(+K2]9TO3K?3Q=/J)E6-C-LV
MLB%N?E/''7]#T.;!XTNI(+<2Z1LN3JATRYB6XW>5)MW!@=HW*5P>QP>E1^+)
M]OC?PC'#<P17"RW)Q+R #"P&1D'D\ ^OK5E_"5V2DL>H0+<-J?\ :<[-;DJ[
MA @51O\ E&T =3R,T 2V_B74+F[N-/CTJ(ZE9VR3W<1NODC9RVQ P4Y)"$]
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M+P,DUYJ-_: H@;+-M4%W9F/ &1D^I'K5_1;7Q7:0QVVH/ILL5G$4B>!V#W9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$=23&.F ,]*DDU+5M%\0:3IES?\ VX:M!/B1X5 @FC3?D!0,H02,')X'/)H
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M\S(N"KP["XS\^ SXSG]*WAX9<*5&NZIM/4?N,?\ HND_X1EQ@C7M3R!@'$'
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M;^!=*D:.4G]XF6B=MP&2<N"?]KFO09;:"XV^=#')MZ;U!Q^=$MK;SX\Z".3
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M]:[NTLK:PLTM+6".&!!A8T& !69!X3T*U>W:#3+>,VSM)!M'^K)Z[?0>PXH
MX[3[[5XK#1-1FUF[G>37);!XG"!'C\Z9,L O+?*N.@&!@=<Y_B:]GU[P1XBU
M.:\E @U1+6*T5L+$D=PB8=>[$_/D],C&._HO_",Z3]FBM_LF(8IS<QH)&PLI
M))<<\'))SZDGO5>\\&>']0FNI;G38G:[*FX 9E$I4@@L <$\#GK0!;\0->+H
M=S_9\D<=X5"PF1]@+$@ ;NQ.< ^I%>?:AJ)U#38HO]/AGM_$E@C6M_\ ,]L=
MT?&[)WJ3E@<\[J]*N].M;ZP-E<0J]L0H\O) ^4@C&.F"!^54G\,:3(A62V:3
M,R3EI)G9BZ_=8L3DE<#&3QVH YAK^]TUO$MA)K5RP@EM/L\\RJ\H,V R*% &
M2<A>P+>@K'U_4+RX\'_$#3[HS>79B,0).X=XU>%'*EAG."2>IZXR<5Z!<^&]
M)O&O&N+02&\V>?EV^?805/7@@@8(Y':H6\(:$RWBMIZ$7JJESEV/F@8QNYYZ
M#/KCG- &4"/^%JV!['0)O_1\56/$+:A)XFTFPM=3FM(+VWNED$:J2K*J[77(
M^\"W?(]JV$T2PCU&'4%A;[7##Y"2F1B1'_=Y/(X!^H![5)<Z5:7=];7LT9:X
MM<^2X=ALSUX!QS[T <5#=:[JXU62TU:*"72;S[.#--L3;&%+-*H0Y#@L<Y&!
MC&,'-;6=2UF"#Q?=0ZU<J=&N(Y+9 D>U@88Y-C?+RN6(['GDGBNQN_">B7VJ
M'4KBP1KLA0[AV42 =-Z@X?'^T#3YO#.DW$=_'+;,Z:@0UV#,_P"](&!GGT '
MT ':@#F;S5-3T?Q1JME-K6Z!M$?4%EN8U\NVD5]N5"C.S!'!)/'4TS0M0U:?
MQ5<Z--?7Z0R:/#=H]RD?FI(79"X&" #@':PX]!TKJ;CPQI%W.T]S:^?(]L;1
MVED=MT)ZH<GD=^>_/6F6WA31[2[6[AMG6Y6 VXF\^0OY9[;BV3CMZ=L4 <GI
MNIZWJ&F^"G&L2Q2:G#(+IO*0[B(6;<,C@Y'';U!KI?!]Y=W.EW<-[<O<S6=]
M/:B=P TBHY"EL #.,#@=JMP>&M*M5T]8;9D73R3:@3/B+(P<<^A(Y[<59T_2
MK/2UG6SC9!/*TTF9&;<[=6^8GDT <)?ZUK4,'Q!$>JR!])1)+-_*3]V##YA7
M&W!Y.,G)X%=!I=SJ,'C.XTZ[U![N&6P2[56C51$V]E(7 SM(Q]XD\=:T)/"^
MD3?VGYEJS?VF +S]\_[X 8 //IQQVXJQ%HME#J2:@D<GVI(!;B0S.?W8YP03
M@\\Y/- &A1110 4444 %%%% !1110 4444 %%%% !1110 5#=?\ 'M)_NFIJ
MANO^/:7_ '30!,.E% Z44 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M/K>OPZ1-:6O[EKN[+>4DTOE(%499F;!P!D#@'EA7-:EXAN];TG17@LA%'=:H
MMK<PRRD9*[R4R%(9"4!W#J.W)K:\1Z!?7]_I^KZ1=Q6^J6&]$%PA:*6-\;D<
M#D?=!!'3%07VBZ]>)IC27%E-/:W@O9"=R(6"LHC10"0N&ZDDYSQS0!SXTJ.7
MQ9>^'+BUC&CQ:=]H$7VDX@,TKEW0[>"-H"@8VCIU-;>E>-;6>6TA>():SVSS
MPW'GB1E1 #^^&/D8J=PY/0YP>*F_L#49O%U[JEPMH;.\L5L9(EE;>J@N=P^7
M!R7QCCUSVJ'2_#^OKIK:+J^HVDVE1P-;1O!&5GFC*%!YA/R@@'/R]2!TY! +
M,7BB\EB$QT:>.*:T>[MG9^&"X^63C]VQ!! YXST(Q5WPMJ%YJOAG3[^^C1)K
MBVCE)1LAMR!LXQQU/%9VD:+X@BL8].U74K62UMXC!&]O&1)<+MV@R;N!@'.%
MZG!R.AT/"VGZCI/AZST[4'MI)+2%+>-H V&1%"@G/<XS0!C6_B*UTJRU6_BT
MF[3.LK;7"&4.WF/Y2>9C)P/F7Y5S].3BROC>"!=;_M*QN+.32EBD>+*R-(LN
M?+V[>-Q(*XSU[U1G\-:]-IFIVX73A)=ZM%J"$SN0JH\;[3\G7]T!_P "/IS%
MJO@O5-7U'79WGM;5=1BM?)DC=G>&6W8NA(*@$$GGGH/?@ ?#?2VOCVXO=2@>
MSB31&N)%-R944"09..@( YP,>YK2T[Q=_:5XUDEFHN6M1=0HMPKAEW8*N1PC
MC()7GKP3@XIS>&M:UJ]FEUIK"**YTJ73IUM&=CESG<I8#'T/3WZU>TFV\71Q
M'^UKC39G@C*0K;ET%RW0-*2#MZ=%!Y/MB@#D-,6"30O#6O:K97T]U?7%NK30
MWA5'>64.KRKD$JK'"CG XZ5T^J^.#IG]KM_8]W+%I,B"Z<.@Q&RAMZ\\\'IU
MX.<<9H1^%_$$?@_0=&QIK3:7=6\K2?:'"R)"P8?P<$XQ[=>>E2ZOX8UO4;;Q
M7;1BP1=9"+$[3OF,!%CRPV>@SP>O'O0!;?4+?_A/+N*WTZ9]3BTE)%F>XVQR
MQ&0X &2!\V[)(SQW&*KZ1XTFE\,Z1>WT$*WFIKNA1IU1",;BS,?NJHP.A/(X
MYJU9Z'JZ>-!K5RMD+=],CL9$CF9F#*Q<L,H 1EB,>@S[5E6GA#Q'IVC:*+2]
MTX:GHRO!!O5S#/ V PD[@G:IX'!'?- $6K:W%KK^$[^ 30.-=%K/%YAVY5),
MC@[7&54@]QBM]/%Q-EK<LNGR13Z5+Y3V[R+NE) *E?9MPV^IXXJEJGA_Q#J/
M]C3RSV,US::BM_,I=HXU 0IY4>%)(^8G<W.>V#@0M!I_B+QQ!=:7?)-;PIG4
MUA(9'DA?,"L>S!F=L=PHSQC(!T/B+6'T/PO?:F8E,\,.Y(RW!D/"KGTW$"L:
MYNM3\.OH.GQ)]MN-0N7%W<22!3(XB=V !Z#Y !Z  5J^+])FUKPGJ-C;8^TO
M%NA!/!D4AT!]MRBJ=]'<>(X-$U327ABN+&Z\YX;L,-A,;QNC <AEWYQZCKSF
M@##L_$!\,0^(IVLKNZM8-7/GR&7=Y,;1PC.7.6P3T'0>G&=K6?'-EI-W=PA%
MG6Q"&[Q,JNF[!PB'ER%(8@8X(QD\5EZAX6\07N@>)=-"Z:&U:[\^*3[0X"*5
M13N&SK^[!X/\7MS;&A>)=.UJ\NM'GT];75&6:[CN2[-;3;0K-$0!O!"CAL<C
MM0!O:]!?7_A^XCTF6);J5!Y;2.RJPR"1N7D97(R.1G-9KZ%J=_J5XM]=>7I\
MHMVC^RW$D<@V<M'P1A2V3N&"0<'I72QJ4C52Q8@ %CU/O4-[>16-N99=Y&<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45S_QZ
MR_[IJ6HKK_CUE_W3_*@"4=**0=** %HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *S#XAT@:R-(.H0?V@1Q;[_F/&<?7'..N.:TZX
M[Q:);6^T&<V$#Z;%JL32NDFV19)-T:MMVXQOD!/.3^= '7331P0O--(L<:*6
M=W. H'4D]A5'2=>TK7H'FTJ_@NXT;:YB;)4^A'4?C5F\M+:_MC!=1K+#N5RC
M="58,,_B!7/Z';B\\5ZIKT$0CM)H8K6)P,?:2A<F7W'SA0>X4D<8H ZBBBB@
M HZ45QOQ1U"\T[P%?2V;R1L[)%+-']Z*)F =A^!QGMG- &U)XJT.+S"^HQ+'
M'D/,<^6".HWXVYXZ9S6QUKFO$D]IH?@2[DBT^"ZTVWM"K6WF;%:';C"D ]JS
M]0U37KR_N]/TA&AN+*UBDPAC=&E<,0KE\$IA0,J 3D\\8H [6BN"O-9\13:W
M>V"7=M9&+1([_"1"7RY2SAE!)PPRG7T[9YI+?Q5JNN1:1:62O!=W.D1ZE.\"
MQL07("@"0@;<AL]3TZ9S0!WU%<0;_P 4W%_IFFRSV5A=W>FW$DNR+S1%-&\2
M[@<_,/G/R\8SR3BH+SQ'JUGKEHGVR"XCEU=+"6"&',4<;*<$OU$N1DJ"0 <$
M=Z .TM-3LK^6YBM+F.9[:3RY@ASL;&=I]\$57NO$&C64\D%UJME!+&0'26=5
M*D@$ @GC((_,5D>&/^1H\8>G]H0_^DT50^/K>&'PQ*\:*C3:E9/(0/O-Y\2Y
M/OA0/PH Z6RU.PU$R?8KRWN?*($GDR!]I/(!P>*M5S?B&^;2KNSCL(!]OU6<
M6YD0+NVI&[Y&XA2< @9/?/.,')N=:\36$&FQ7*01S3:PEF6E"EI8&!(8A&(1
MN"".^.,9X .ZHKC&N?$9U>?1/[4M!-%IB7'VH6?5S(ZYV;B.0OX>GI!IGB76
M;BY\)W%RUK]FUZ!BUO'&<PL(3*&#9YZ$$8'7VR0#LK._M;]9FM9EE$,K0R;?
MX74X93[BK%<(WB'64TEYT>S,ZZ\-//[DJK(9ECX^8X.#DDYIY\1:U:W/B73Y
MI].DN-.BMYH;F5#!$!+NR&&X_=VDCGG.* .XJNU];+?)8M.@NI(VE6+/S%%(
M!;'H"P'XUYSK?B75+GPKXN@BN=DFGO%%'<FW,;O'*B$Y4XVGYB ?3!QWKII]
M7NM.\4P65XUN]LFDSWDDJ0E7!1XP<?,>,-T]AS0!U%%<0?%&K6EKX=U6Y6UD
ML=9GA@,,2$-;^<,QG=GYL' / SG(Q5>S\5Z[)!%>S_8?(77#I<D<<+;G7S?*
M# EOE(.#C!S[4 =Q=7MK9",W5S% )'$:&1PNYB<!1GJ2>U3UR_CPN- M6C17
MD&J6)56;:"?M,> 3@X^N#5"?7O$L6J:QHD::?+J=O9KJ%DXB?9-&693&R[\A
MLK@-GG.<"@#MZJW&I6-I(([F\MX7(R%DE521]":QM(UV;6+W3?LLD+VDNGB[
MN6\HA@SD",#YOESB3(.?NXK(\:.T?CGP3(EN]PZSW>(DVAF_<'IN('YGM0!V
MT,\5Q$LL,B21MR'1@0?Q%25YU:)JWA.UO+]+*&U75M<A$=@[[A"DK)&QRIP&
M8Y;C(&>];4&J:[/JTNBB735OK:U%Q/.(G9/G=Q$H3<"/E3+'<>V.O !U=%<#
M;:[JFN:IX7FCEAM$F%W]H@,;./-A/EMSN&1DMCCCKSVOVOB:^?Q!96,XM,7,
M]Q"\,2EF@V!F7,@8J6(7)7 (W>U '7T5PDGC'4W2QN+=+'9>:LVFBVD5O-AP
M6&YB&Z_)N*XX##GC)LCQ5JEZUS<:7IXN;>WOFM?)$3%Y51]DC"3(52#D@$'(
M7KSP =E4*W=N]W):+/$UQ&H=X@XWJIS@D=0#@_E7%:AXPU>QL]=U#[-9-::1
MJ"V\BY??*A$1..P(\S.><XQCO4]]XH31M?\ $DMW96PBT[3HKKS8E_>R@E\(
MS?5>![T =I16-IMQKC7Z)J%M:BUDMA)YD)(,4N>8R"3N&#]X =#QR*V: (I+
MF&)@LDJ*QY 9@":>KJXRK!AZ@YKA_B0$\_PDS0>>1KL(V  EAL?CGBJJ2:GX
M8'B;7H--\FQN+BV%K8RD)SQ')(%4D L6''&=N30!Z)17./K&IKK4&B,MDE].
MLURK*6=8[="H4E>"6)<#&<<$^U8EUXAU;4CHL,/DV=Q_;,EC>+\S*SQ1R.,$
M$'8VQ3CKR!ZY .^HKC;OQ9?V6JQV\]M;(KZE'9"#<6E,;X G)!(4$DX4CD#K
M2ZAXOO(5U.YM+:W>'3[^&P>*9F5Y&<H"P(Z &08&#D ^HH [&BN3O/$^I)+>
M_8M.^T_8)HX988XY':9BJ,^QP-HVAQUZD'IP31U7QKJMB?$TD6FVKPZ$T;.6
MG8&5&C60@<<-AN_ ]Z .V^T0_:#;^:GG!=_E[ANVYQG'IGO4E<FVN00^*IWG
ML;:.*/1OMOVT<S&,-RAXX Y.,FKVF:EK-S>6ANM.B6RNK7SS+&_-N_&(VR?F
MR#]X <@\4 ;U%<[K&O:A8^)=*TBTLH)?[0BG<2R3%=AC"GD =/F'_P!;K638
M^-M2N=.M+^;3+:.$ZF--N=LY9MYE\K<@Q]W<0>>>OID@'<45R=YXLN++6(;6
M:V@59=02S6$R?O2C#B; Z+NR,$?CVIK^+;JV_P"$@@NH+9+W32GV>%6;_2%<
M#RSS_>8[,#.&% '745A>*;^_TSP9J=_;B$7=O9R2DDD*"J$DCOVXK/'B#4;6
M*UT]+:.>^%E]H=@)'7'1 =JDY8AN3P,'K0!UM%<=_P )=J]SJ5C86FAA+B\T
MU[U8[N4QM&ZLJE'&WC[QP1G)QT'-0:EXYO\ 3['7-0;2H6L]&O1;SD7'SNFV
M,DH,?>'F9P<#C'/4 ';L0JEB< <DFD1UD171@R,,JRG((]17)R^)+[[;K.E7
MVDVS2V^GB]CC%P626)MRE&)3@Y4]B.:99>(KI8O#-CI^DVJ)J6F&XB43%$@V
M)&=F OW0) !CTZ#K0!V-%<I!XKN[G2=+O%L881=-*EQ---B&V*$J<G )W,,+
MTZ_@<O\ X2O4]7G\&W%E##!#J4TYFB:4\E(I/ER!]W(STY('2@#OZ*Y5?%ES
M/=QM::9)<V+7QLVDB21F #E&ER%V[0X(//09]J=XZU'4-/T6V.GE$>XOK:W:
M0N5*J\JJ<$ ]<XSV!/6@#I@ZE]H(W8SB@NH=4+ ,V2!GDXZUYT]Y?:3XW\3W
MMIIUO-=)I5K<3(9MB$KYI(W;<DD#CCMR16]%K4&HZOX:N?[-B/\ :%C+<P7#
MMF2$%$9E QW#+SGMTH ZFBN;\-^)W\0%)(XK;R6C9G$<VZ6V<$#RI4(&UL$_
MBI'N;GB;51I&AS3B:.*>0K! TC  2.=JDY[ G)]@: -<$$9%+7'?#VZCCTJ[
MT,7HO'TFY:%9]X8RQ-\\;$CCHVWZJ:='XTGN%TRXMM/B>TU*]DL[=WG*L"F_
MYF 4X!\M\#MQGJ< '7T5R#>-9XK/4+^?2]MCIUQ<6]S(L^6S'C9L4@;MY.WM
M@D=:<_C*6R2]DU+3'BC@MEGC>$NRR,S;1#EE4!]Q4 <YW9H ZVBN0NO&5Y96
M6LS3Z,<Z?:"[1UD?RIDP=RAV089<=,'((/>II/$NKKK,VDQZ$C71MOM4!:[
M0IDJ1(=ORMG'"AA\W7@F@#J:*XZT\>QZGI^E36%GNN-0M7NO*E<JL2*0IW,J
ML>6.!QV)[4Z#QE>W7]B)'H$\<VJ12L(KB7RFA>/[P<%<X]QU'04 =?17$W7B
M?4[W3=&FL[2&&6YU5K*XC:X/RM&SAE#!#E28CS@<'ISQVB;BB[@ V.0#D T
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M8:A,9KNQ2>T,<CG[Q#%]R;N^#S[5V.GWMPUQJC7EU8/;P38B,#_-&@0$B7/
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M<>8V#D=!76Q!UB19&#N  S 8R?7':G44 %%%% !1110 4444 %%%% !1110
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MRK)N>2'S%8LN"=Q R3CZ=>*?+:3WVI>))KC3-5BM;R]LIH9XHRDL82-!YB
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M=!\)8TZ\CF@UF26Y LI R*5G&YAMS@[TY]_:O2I[F"V56GFCB5F" NP4%B<
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M;R-8\*ZSXEU"UBLI#I9L53:(_+:-3Y@!Z_ZW*@?],QCK7I91"X<JI8 @-CD
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M!UY<:+<66H>(+J\N9O+!NI(D78J-N 5!@9R.2<D_ECJ4#B,"1@SXY(& 3]*
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M)_NFI:BN?^/:7_=- $B_='THI$^XOTHH =1110 4444 %%%% !1110 4444
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MMC&QVDY^8!LJ#U&W@B@#UR25(HFED8*B LS'@ #O3+:ZAO+6&Y@??#,BR1L
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MFZNY9+BY-N0SN<LY5B!DGO@"N4&JWY\ VOBZ&2X?7C?*);42-ABT_E-;;"<
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M7W)-7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.X_X]Y/\ </\
M*I*CN/\ CWD_W#_*@!R?<7Z44)]Q?I10 ZBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHKB=;DN+'Q7I!3Q'(+JZOA'_ &>TB+$;
M?8Q(V=2WRY#9R6.!QP #MJ*@O8YY;.6.UG$$S+A92F[9[X[FN2\&7DLNN^(;
M./7)-5L+66)8GFD5Y(Y"I,BY'5?NX..NX#H: .THHHH ***S]<5VT.]:.:6&
M1('=)(FVLK!20?S['B@#0HKB]&\5Q:?X>\+KJ1O;F^U>S259 F_?)Y7F,,]
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M"$M/*@4$R,JCCJ,^YP.>*63QEHD:6+_:F9+^)I;9EB<B0 9(!Q][MM^]GC%
M&_15'2=5M=;TY+VS9_*9F0B1"CHRL5964\@@@@@UQ^D>,X=+N]9M]?U&:4IK
M+VT,IA^6&/9'M#E!A!N8C+8SSZ&@#OJ*QX?$MA/>ZE:(MP)M.3?<*T#+@$$C
M!(^;(!(Q5JUO(M:T:*\L9Y8H;J(20S!-K!6&0P5Q^/(H O45YKI?B778-$\,
M:K<Z@;TZI?+93VSPHH4,S .A4 @KMR0<Y&>E=9:^,=$N[HV\5TV\231DO&RJ
MK1 %P21Q@'OUP?2@#>HK#MO%FEW7GB-KD/% +GRVMI%>2(]'12N7';@']:J:
M3XTLK_0++4YXKF%KLJ(X?LTNYV9=P"#;\_RC)*Y'!YH Z>BLF/Q)I<VDVVIQ
M3M);7+B.';&V]W)(VA,;LY!R,<8.>AJ.'Q7I%Q9S745P[)"XC=?)?>'+%=FW
M&2V01M SF@#:HK /C/0EM8KB2]$:R70L]LB,KI-G&QE(RI[\XXYZ57O_ !5I
M5YX6U*^M-9-BD&^%[HP$O!(!G_5L,DX((&.010!T]%96J>(M-T4 7T[AA&97
M$<3R%(QP7;:#M7W.!U]*THI4FB26-U>-P&5E.00>A!H ?12."R$!BI(X([5Q
M^B>)VATV_O\ 7]1A2*+4IK"+$6T'9*8UZ9)8X^E '8T5FZ7KVFZS-=16%TLS
MVK!9E"D;<]#R.0<'!&0<<&FZGXATO1Y1%?7)C;8)&Q&S!$SC<Y4$(N>,M@=?
M2@#4HK%\0Z];:18SJ;M(KPV[RQ QM)M"C[S!>B@XR3@<]:I:'XAW>#-$O]2N
M<WE_:1OE82[/(4#$A$&<#DG'0>E '3T5QFA:_/J>CZ#/<:U;Q75W>3#8L(/V
MN-6E 51GY1A5.[G[OO3QXTLM3T_Q (=033/[/D>W2]F0LH(13OVD '#,1MR<
MX]Z .PHK,N];L-+MX7OKM5+IOR$))4 ;GVC)"C(R3P,C)I+KQ'H]D\27&HVR
M/+$9D7S 2T8&=PQV]^] &I15;3]0M-4L8;VQG2>VF&Y)$/!'3^?%9'C;5[WP
M_P"$K_5[#R#-:()-DZ%E89 (X8$=: .@HKE?^$CN]-\51:3JLEHUO/9/=I<Q
MJ8A%L(#!PS,,88'.1].]:T7B/1YHI9(]0@*111SN=V-J2?</_ L<4 :E%8&H
M^+])LO#MUK,=S'/# 3&54X/F] A&,J<XZCCK5F?Q-HUJD;SZC;QK(N\%FQA=
MVW<?1<\9.!F@#6HJA?ZUIVE[/MMW'"&4MECP%&,L?11D<GCD4RX\0:1;6D=W
M)J%O]GDR4D1PX8#[Q&,\#N>@[T :5%9ESXBT>TW^?J5JFR'[0W[T'$? #?0Y
M&/7/%0W>IH^HZ,EKK%E$ETQ<0MAVNX]A(\LYXQ][//2@#9HJ@=;TT:DNG&]A
M^ULQ41;N2P&=O^]CG'7'-3W5_:630K<W,433.(XE=P"['H .YH L45D'Q5H*
MVCW3:Q8B!)?):0SJ%#_W<Y]P?ISTJQ?:UINF[/ME]!!O4N#(X'RC&6]AR.>G
M(H OT5136-.DU%M/2]@:\1=S0!P7"XSG'7'O3[75+&^LVO+6[AFME+ RHX*C
M;UR?;O0!;HK#TCQ9I.L:3)J4-W"MLDKQEFD'0.R*3Z;MN0/<5=36]+DAMYDU
M"U:.Y8K"PF7$A'4+ZD8.?2@"_162WBC05MS<-K.GB%460O\ :4P%;A3UZ'!J
MU%JVG37?V2*_M7N!'YOE+*I;9Q\V,YQR.?>@"Y16/8:Q +1'O-5TZ5IKB2.&
M2"0*K_.0J#).6 P#CN*LP:UI=S927L&I6DEK$Q5YTG4HI'4%LX!Y'YT 7Z*Q
M]0\3Z3I^E#46O;>2 S+;JR2J09&8+MSG'!//H :M3:UI=ND+S:E9QI, T3/.
MH#@]"#GD4 7J*K7^H6FF6$U]>SI#;0H7DD<X %<_%XL2YU#1Y(9K4:9?6DUQ
M)(SC=$R!#@L#M'W^?3% '4T5E7NJ(UG97-AJ&G".>>,"2:3*2H6P0A!Y8YP/
M>KAU&Q6\%F;RW%T>D)E7>>,_=SGIS0!9HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *BN/^/>3_=/\JEJ.?\ X]Y/]T_RH <GW1]**$^XOTHH =1110 4
M444 %%%% !1110 4444 %%%% !1110 4454L-2M=26X-I,)!;SO;RX_AD7AA
M0!;HHHH ****  ]*Y/6[+4O$<1TV?3!:1Q7L<T5\9U?"QR*P90/F#$#&" !D
M\GH>LHH Q[N_UB*;4!;:.MPD,<;6I^TJGVAB3O7D?)MXZ]<U4TO3+B7Q/<:]
M/9"Q,MHML82ZL\A#%MS%<CC.!R>O;I71TUY$B1GD8*BC+,QP * '44C,%0MR
M0!G@9-5M.OH]2T^"\BCFC29=P2:,HX^JGD&@"U63XDO([30KH.4WS1M#&'E2
M,%F4@<N0/Z^U:U(RJV-P!QSR* /,+6588? L;SV6=&7R[O%]#QB Q97Y^1DY
M]<#UXJ!Y2WA[6[3?9>?>ZT+Z$'4(,>7YJ2<G?P<1D8]2/?'JOEI_='Y4GE1_
MW%_(4 >:ZE<QW+>-!%+9D:O9K#:L;Z#!81&/YOGXY;/T![X!2[:WU2XT6W>Z
MM[>"+2+JQN)Q>P$Q/*D:@@!\G'ED\>H]\=W=:KI]IJMCIDP87-Z7$ \EBIVJ
M6;YL8' Z9S4UE/;7R3-' ZB*5XB)82F2IP2,CD>AZ&@#SO194DLAI-W8Z%IL
ML%J]L=6BNH6,N4*!H@OS*3P3G&!D<YXCM+^\EN/",<]M9Q?V+,8KB7^T(?+=
M?(:/>F&)QR#@@'G'N/3WCMXEW.D:C(&2 .2<#]:=]GA_YY)_WR* /*[26_LM
M(OHXFM5^TZ[+>2QK?P+*UM(Q;$;[\*XXSR.,X.>:?"CVNFW"(; O#KR:A#"N
MHQL98LJ3AF(P1S][&2#[9]#MK_3KO5+S385S<V:QO,K0E0 ^[;@D8.=K=,]*
MO?9X?^>2?]\B@#S.28PZS?Q2:;X?U*#49/M"74]Y"PMG**&20,-S*"O!4<C
MX[=\FN:4L2AM4L20 #MG0#\!FKWV>'_GDG_?(H^SP_\ /)/^^10!Q'A&[BL=
M6\23WLMM;Q7]\;F!C=PME=BK@[7.#\N?QK'T%?[*FCTBXTS1;J.WN3-%K#W,
M)W)YA<$K]_S1G [9YS7IWV:#O#'_ -\BD-I;GK!$?^ "@#S@F2;P#XHT[RXT
MO+^XO'MXFNX,LLSL5.0^!@-SD]N,UJS7_P!I\8:%J A5;>WL;B*=C=091W\L
MA<!\G_5GIQR/?'8&PLSUM8/^_8I/[/LO^?2#_OV/\* /.(8KM=#\-P&T ELM
M;>[G7[3"=L1:4AA\^#_K1P.>#^-34K"_G\,^++&*S#3ZAK:7=L/M,(#Q!XB3
MDOQ_JFX//(_#U$Z;8GK96Y_[9+_A5>]MM)L+*:\N+& 0PH9'*6X8@ 9.  2?
MPH X+Q+_ &EJ,NIHMDTJBXMI[0P7<4<;HC1LV\;P7E^5A\WR@ 8([WKZ2Z6]
M\5Q16?G)JEJIAE6XB"AO(\O8<MG=N ]L'.>U=DNG:5*J$6%J0XW*# H)'T(]
MZ4:3I;C(L+,C.,B%?\* .'TE;S1]3T;4YK=IH#HL6GW,,<B-);RQG.[ ;YE;
M)'&>@IVFV=S87?A\O;DQI>WMU*%D3%LDQ<HI^;DC>,[<]Z[;^QM+_P"@;9_]
M^%_PH_L72_\ H&V?_?A?\* ,'P2LEG;ZNMW%]G,^JW-S&'=3NCD<LIX)[=JP
MKK3KLZ?XPT4V;22:U>R26TX*F())'&FYCGC:5)(QDX&,YKN_[%TK_H&V?_?A
M?\*3^P])/_,,LO\ OPG^% '(^)=)?^V=*ELKU0VH0MI%Z"^"\.UG\P?[2A7P
M?]O\^T,UM:6N$*^7&N%CCP>!T  K*@\'^&K34[F^CTBS%U=8\QF0'(  X!X'
M;. />I+'3_#NIVQN+73+)X@[QDFT"G<K%6&"H/!!H Q_ >DVUAX:L?MNG0V^
MI0>8&9T3S!N=CPPSU!'0UEP:+?WWA3QCIR0M9W6H7MS-;O+@"5'QMZ'H0-IS
MR :[7_A']%/_ #"+#_P&3_"D_P"$>T7_ *!%A_X#)_A0!S0BN_$'B30M3%G/
M8"PM;@723KMRTBJHB']X C=N&1\H]:S=-.KV_ACPQ9MH5Y']A5;:Z<)&9XRL
M17=%EL!2>"_!P?Q';#0-$).-(T_C_IV3_"E_X1[1/^@/I_\ X#)_A0!YQ9Q7
MVD:'H$,FDWRZE8ZM=21Q I,[1L9BS!=X+KMD4%B003G)Z-8GBEN-*2:RT[4I
M[NQU5M0O].E4VTTBRK(I,>UNVXD88YV$$YKI_$/A3P=<6<8U6PL[=!(/+>+]
MRY8]E*8)SZ=Z-&T3P8B#3K"QT^66)2[131AY@,]6WY?J>] ',7VEO=VMC=:?
MX;O;*-];L[J9;C+SR)&Q+R.-S8 & .<G'3I4VKZ;J%Q8?$"*'3[IFU!HS: 1
M']]B%$./^!*>OUKM_P#A&=!_Z FF_P#@*G^%'_"-:%_T!=._\!4_PH YJ]N+
MW2_%5]=OH5[JNGZO:0QH((06B9-X,<BL1A3OSD\<G-=%IEY/'<P:5-I;V^RS
M64R0K_HZ'.WRE;U 'H.*D_X1S0_^@-IW_@*G^%78(+>QMA%!%'! F2$10JKW
M/ X'>@"5F"*6() &>!DUY=>6%]/X"UVQ&F7C7$VN-<1Q&W;,D1NUE##CIL!/
MZ&O2+#4K+5+8W-C<)/"':/>AR-RG!'X&K5 ',:='*/B!JUS]FG6VEL+:..5H
MF5&9&E+#)'HZ_P"0:Q?'$&HWAUZRM]-NB+C2?+@EM(%8W+_O,I(Y^Z%R"%XS
MN.,]*]!HSSB@#@)KFZ@U35YKC2-1DAU338UM72U9RA57!A<#.PY;<,\?,<G(
MJAX:34]'N/#-U?:;?&S&AI8%5MW9[6=2"Q9 "0KA5&<?PC.*])N+F&TA::XE
M6.-<99C@<\#]>*E'(S0!YMID-W'HWA17TV^C:VUF>69&MFS'&RS@,<#@?O4_
MR*A>UOX= ^(.EMI=\TU[<7<UNR0,R2"2)%0*1U).>F<;3G'%>GU4NM3L;*XM
MK>YNHHIKE]D$;L TC>@'>@#EH))].\5&]O+6ZDL;W2X(8G2V=S"\;.61E )&
M[>#R/X<=A6'H&B7^FW?@B.]L;@FSCOS(WE,XMUD(,2LP& =N!CMBO2+V^MM.
MM7NKR=(8$QND<X R<#]2*L4 <3X=U3^PM)2.]L;]!=:S<Q(?LS 1B6=VC9L@
M84[E&?5A[U<^(\%Q>> =7L[2WFN+F>'9'%#&79CD=@*U-:O-$LF@GUBZ@@$.
MZ>,SR;5&W +8S@D%EQGH2,<UK=: .>;2=-M-,O+^ULYC=36K)O<223%<<( V
M6 S_  C\JY8:;=P>#?!5Q%ITY_LR2U;4+40,LN%C*D[<9;8[%L#KR17I5% '
MFNNZ?=7UOXPOK&UN'M[N*S$4?D,KRO$2795(!/RE1TYVX[57\:&[U9->2ST>
M^0W.DJL$T=DY>[(+_NV)&$"]=I 8[OH#Z3:ZA9WS3+:74,Y@?RY?+<-L; .T
MXZ'!'%6: /*]0G']MW"+#?@7V@16]QG39;CR\EPHV(-RGER0V,\>]696M[&_
MTJX":M>:')I:V"7%I%*9(Y(V(82(HW#=P#QP4QQ76W?A6UN-7FU.&]U&SN+@
M*)_LMP467:, D'(SCC(P:T!_9^@:6/,FCM;.$',DTF .Y+,QY).223DDT <C
MI%A%9^)-*QI5U;VMMHSQ1+)&\OD_O%*H7P?FV \9]N:RM'MKN*T^'RR:??*;
M.6=;@-:R#R08G1=W' R5'->GQR)+&LD;!D8 J1W!IU 'GOAZ62".+0M4T6ZN
M-6M=2DG$[6[>2^Z1F^T"3&T?*YXSG/&*W/&48EM=+#6LMPJ:G;R.L<#2[5#<
ML0 > *Z:B@#S6^L'?7/B!)_9UPRW>EQ16SBU<B5O*=653CYCDH#CV]*ANUNW
MT,V?]G7T4S^&TB\V.T=WG<(X,)RI";3R00"=_!&.?4** //]7%]86.@^)-+@
M9KJ.!+">"9#&TB2[53(;!!67:>G0MZUV6D:;'I.DVMA&2RP1A2YZN>['W)R3
M]:IR^&K6?Q"NL3W-[*Z;6CM7N";>-P" XCZ;L$_SZUM4 >36B7]AX7T7S;34
M5CTK5;A[^.*W;S%5WG"R)D'>%WJQVYX.>HK0DM;3_B67%G9ZB]K+KZWCRSPR
M%G_<MNEV;047=M'(&3ST.3Z310!PL5G;P_$?5I'L&6R&CQ1(PMB8_ON61<#!
M.&&0/6J?A^V^RV?@$&SFB>&U=+C-NRF-C" 0_'&7'?J17H%Q=6]FBO<SQPHS
MK&K2,%!9CA1SW)( %34 >6"W$OA;3;>:RF?R_$KRO&ULYQ$;F1MV,?=VL#GI
M@U9U-_(U'7V&G2S1/JUBZ/Y4A2+:D>9L+@NJ,G('<#/%>E5'%<0S/(D4J.T3
M;) K E&QG!]#@C\Z /,<3#2O$!:*]D*^(K2]WO:NI>$-;$N!M&0-C' Y '-2
M:C);3>)=<@UI-4CT[5[:%;9X;-F$T80JT1^0LK!BS <?>KTF>Y@MO+\^:.+S
M'$:;V W,>BC/4GTJ6@#G[ZTD?X?W-I%;S+*=+>)(';?(#Y1 4D=6[?6N>TV2
MWO;[P:SV\I6WL)48S0,H1]D0'WAQR& ]P?2O0:B:Z@2Y2W::,3N"5C+#<P'4
M@=30!Y7;Q?\ %%:5$UN_F6_B5953RCF.+[87W8QPNPYSTQ6BDCP>*XC;*;F&
M?67,UE.A\ZVD",GVB-@>8RHZ$$#=@'M7I%%  .E%%% !1110 4444 %%%% !
M1110 4444 %%%% !4<W^HD_W3_*I*9-_J)/]T_RH 6/[B_0441_ZM?H** '4
M444 %%%% !1110 4444 %%%% !1110 4444 97B._ET_1+B2V&;R3$-LHQS*
MYVIUXZD$^P-<EX< \+>-/[$^QW%K8ZM;>?;_ &AT+-<1*%D/RL02R;6)/)(/
MK7:WFEVM]<6\]PKM);OOBQ*RA6]< @9P2/H2.]1ZCH6GZK<V]S>0L\UL287$
MKJ8R>I&TC![9ZT <=J=]XAEDU9+*6^74H=4BAMD@B#PBV.S))*E,[69B6Y!Q
MT&,VXIM2G\7:];/J][]FTQ+2XBBC6,&3*R%D/R\JV!GOZ$5 WA.[>^OI)M)@
MENKB>25;Z'4I8!@GY-R( 00H4'&<D9SS74Z9H-MIT[7F7DU":)([FY:1B9MH
MP"5)QZX],F@#D-.U7Q -)T[Q%+J-E-9S6CRSP^>6\]S&658UV+L92",9/&<Y
M(S5C2Y?$=R-+U-]7M18W=LQE"S"0RNR;D:(&(!2"#QDY'7)&:Z+3_">A:5>O
M=V6FPPS.6/RY*J3U*J3A<YYP!4=EX-T#399)++3T@9PP^1W 3=][8,X3.3]W
M% '(Z-J6MWFG>"[J76[DRZP'BN1LCV_ZEW#*-O#90<\CGICBK2ZWJT-I_9\=
MYYL[Z])IT<]PXC/EA&D +!" QV[0=IZ^O-=1#X5T>VCL(X;9T33R6M%%Q)B(
MX(X&[T)'T)'2DE\):+<6MW;369EANY?.E5YG;,G]\9;Y6X'(P>* .6OKOQ/I
MGV&UNM7@66?68(E6 B5EMY WRN61<\H<$ 9[YJKJ=YJ$VE^*M.N-2N)DL=3M
M(XI2$#F.0Q$H<* 1\Q[5V7_"(:']F@@%FP2"87"%9I WF@8#EMV6(' ))P*>
M_A;2)!J(>V9AJ)#76Z9SYA&,'[W!&!@C!&!Z4 7;E9(=*F5+B7S$A;$N%+9
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M";FMF;<F!P!T STQG)YJQ;:SJ#:7MDU&1ISKL]FNV)#+-&CN!&F %#84$L<
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MQ)9D<8(R6;CIR>U %*XU+6;*XL-)FG6>ZN;B?$UN$$GD(-R\-A!)ADSQC )
M]-?P_+JLEA*FL+$+J*9T#1L"6CSE&8#A6*D9 _D:KW'@_3+FQBMG:Z62*;ST
MNUN7$XDQ@MYF<Y(X],<8P!6GINF6^EVQ@M]YW,7>25R[R,?XF8\D\#\ !T%
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MS0-LE1A$P.W=PP$OJ1\M7M0\2W%IXI72I)H;/S)H%M1<0MLNT)'F;9,X#C)
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MX3,L+$$HW'^R.1@]?7@TWP.-+.EK#K%XT6FRR/#&R1_<<$%2=N3U^\3G\>:
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MVX/:NDTJPGL+4I=7\U]<.V^2>4!<G '"J,*..@_4DF@"]1110 4444 %%%%
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M87@N2[QG:?($8;AN06STYP,T =?'XDTN;28M3BN&>VF;RX]L3EW<$@J$QN+
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MTLIU2+3&RH6YE0. =PXVGJ2,C'O3+_Q3H>F33PWFIV\4L$8DE0MED4]"0/\
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MUP+0Q3VXCC18$ZA9@J*=P;@9)/7MDU>U:UTRY^)EI'?I \;Z//O24C:Y$L>
MPZ,,;B <]">U ':-(JIO9@%ZY)XI001D=*\ET"Y1+/P>M\Z-H:?:X6+L#&DX
M<B$/GH-@8+GN1[5V'@:/RK75HX"#IJZG*+#9]P187(7MM#[P,<4 =71110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)?]2_^Z:?3)>(7_W3
M0 1_ZM?H**1& C7D=!10*Y)1110,**** "BBB@ HHHH **** "BBB@ HHHH
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M_P!GK>VYO.?W D&_C!/'L"#^-9+ZE>'QT^D*MJ(SIC7,4IB)=6\P+@G=RO?
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MD^Z-K;OEYR%Z@G 63Q7=P:]:6<L4 CGU%[(Q+EI$41NRR,P)4;MF=I .&!H
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MOHY0F.(JI;S%903C&<%C@\]:EU68V'CZPO;^-CIKV$D$,VPLD,Y<%MQ_AW*
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M4 %,E_U+_P"Z:?39/]4_^Z: &QN!&O7H.U%$/^IC_P!T44"U)****!A1110
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MB">2ZM&I /5@=^>>XXP.*=XLM;N?Q#X86&_>!'OI %$:L%86TYW<CD]L=.]
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MGEFU./3YXG"J]O)N&]&!8?-C(&#C)!SBM*7Q=:0W?D26EXH6>&VFD*IMAEE
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M$V,R[9#GYA@]1DX],D#K1+X2T.>&ZAEL0\=W*)[A3(^)7'1FYY/3\AZ"H/\
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M(4,UK#);W=F\@&Z.3:3L;IN#(IYP".XKJ*CDGBB=$>15>0D(I/+$#)P._ H
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M=6LOV@_9G#OO7?AP%*$X/&?ER,UW]E?VFHPM-9SQSQK(T;,AR RG##\"*LT
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M'.-I[HV<?0C*GV8U%9^';6QUC4]3@9TN-0"!\8Q'M7;E1CC/!/K@4 <B=?\
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M50@4J<\X$:_KZ\/MO#NLPP1O<>))KJ]61&,LENJQLBJPV&-2.N[).<Y Z8%
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MVQT-97@S[+;^*?%]I:"*. 7D3QQ18"C,*!B /]H$'W%+*=-_X6JWG?9=W]E
M'?MSYGFY'7^+;SZXH U9]<O-,\-3:CJEM;I=JY5+>"8L,LX5%+$#GYER<8ZT
M[3-8N_[7DTK5?L8N60SV[VSDB2(;025/*D,P'4YY(Z&N$$FDK\/-2!-IY::[
M*80=I 3[8#\OMLYX[>U;5ZME:_$2TN+>*V5;C1VBLI!%NC:;S5V@%1V!SQT&
M3T!H [M9XGE:-94:1/O*&!(^HH6>)Y'C25&=/O*&!*_4=J\J\,_8KK[ UG?Z
MD_B6TM9HIK22&-!#*8SO\YA&I93( 02QR2#ZT_PP^AW@LY?[0U"34;6SEAO;
M2>&.-8<K^\$Y$:EOG P2223GGF@#U0.A( 922,@ ]O6J6KZFNE67G>6999)$
MAAB!P9)&(51GMR>3V )[5YGHAT^U_P"%:W%O)"ES)"T-Q('&]A]F(*,<YP'"
M@ ]#@"NP\3B8>*?![DC[&+^42Y_YZ&WD$?Z[OQQ0!H:AK5QIDVD0368D:^N%
MMGE23"HY1F. >2/D/IU%.UO6YM.N+2SLK-+R^NBQ2%[@0C8N-S;B#T+*,8[U
MF>,KNV@U#PRLT\4;+JR.0[@87R91GGMD@9]Z7Q))X0U&YDTS7#9F\6#S$\Y,
M2A3G!B8C);(Z*<YQZT 7Y-;GL7TTZI:I;)>LL!*R[_*G.=JDX&0<8!]<#OFI
M/$VKSZ'H<VHP6\<YC*AD>0IPS!<\ YQGIQ]:Y'Q7%?I\'88[\R/JJK9@,WWS
M-YL>W/\ M9Z_C70^/E+>"-2 #<(I.T\@!U)/M@9.: .C##'WAQUI<C/;->7:
MSIEG+K&KMH$$,FGS:!<?;%ML-$\W6(D#@R?>.>N/J*KVVJZ7/KN@SV]XN#X;
MGBDFMB"X=5C.T'^^HR=O4?C0!ZE>23I93O9QQS7*QL8HW?:K/C@$X.!GOBGV
M[R/;1-.JQS% 716W!6QR >_/>O(?/M[;PSXCLGCT^=AX?\R+5+)MJSH XC$B
M?PRY.>IS^%;6GKI-[XA\.QW)MIHG\./YB2,"KX:#&X=#QO//H?2@#T@LH7<2
M,>N:,CVKQVSU*T&B^$AJMZL.C&"X@\YD62%)PX$:RALJ/D#!2>G-6&@M8;?2
M+33M36^2W@NG@@UD 0WD.Y0VQ_X2O1&P?E)_AH ]:R/6CBO(=0O+632(]1AA
MCGLH])M1+I5T=MW"G)1X'YRW.",?,4'-=KX^NIK;P;-/%YZ0^9"+IX<B1+<R
M+YI&.<[,_3DT :D>KR-XH?1VME5!:?:5G$F=WS[<;<<?G6MD>M>8:A>>'[/6
M=4GTV2(6S^')&/\ 9CHKD*Q.4QP&"GK[#TJ;1K?2M2US5]),^GF"^TFV98[)
MAMW;I@64Y^9U&SY@!T7@4 >DYHK@/":7&I:G:VVHVJQ7'AI'M965,++,V KK
M[&,!OK(/2K7BQ()?''A"*9R%EFN5D3S"H=?(; (SSSQ^..] ':Y'K5:_O[;3
M+":]NY1'!"NYV/\ GD^U>;6]S#;V=G9EE&BKXEN+>X ?*)'F0Q(>P0R;.O'0
M=ZS_ !7 5TWQC;*BMHUM>:=); @&.&1G3S@GH,$$CH-Q]30!ZOY]U_:8A^R_
MZ)Y6_P"T>8/OYQLV]>G.?PJWD5P5W=+'XMN)-%D1W_X1Z9[:*-\H75QMVKG'
M8=.M4;>^TQ] 74O#M]-/K#:/,/)BD#,\@3=OG'7>'& 3SEB/H >ET9%>?>#W
MTFYU>QOM*UQ;@SV1$MK GWL8/F3_ #,1("<9/)R1SVNZU9VUY\1-/M+N24VU
MQI=R7A\Y@DA62' QGT)/'I0!VF1ZT9'K7DUG>R06VB6.JWT*Z.UQ?P0W-^#)
M%+Y<H$ <EE!R@?;DX.!QG!JW#;Q-JGA/3AJMS>63F_A,@D9%G0+P!ACE5R5#
M9S@=: /1([BX;49H'M2ELD:-'<>8")&);<NWJ,8'/?=[5:KS?4[B[TBZ\:II
M;SF2TT>S^SIYC.T>!,"RY)Y  /N0,T:O.^DZSH]SX7<S)<Z9=R26\;EEG"1!
MHI".[;\+NZG=UH [34-9^PZQI=@;61QJ$KQ"8, J%8WDP1U.0AK4KS'27TR0
M> -3CNQ+=7$SFXGDD&^5VM9MV_GE@_'MG KTBVNK>\C:2VGCF179"T;!@&4X
M(X[@@B@":BBB@ HHHH **** "BBB@!HC0,6"J&/4XY-.HHH **** #&:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ IK_P"K;Z&G4U_]6WT- #8?]3'_ +HHHA_U$?\ NBB@"2BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #%&*** #%5-2T^'
M4[-K:8LO*NCH<,CJ0RL/<$ U;HH CA1UA197$D@4!F"XW'N<=J?M&<]Z6B@"
MA>Z7'?WMI-<,6BM7\U(L#:9,$!CZXR<#UYZ@8OXXQ110 U45!A5 'H*!&BG(
M4 ^PIU% #!$@! 10"<G [TOEI_='Y4ZB@!ABC*E2BE3U&.#220Q2@"2-7 Z!
M@#4E% $;01/(KM&C.OW6*@D?2I,<8HHH B2WAC&$B11C&%4#BJ][9RO921V$
MT=G<E-D4_DA_+_X#QD>U7:* ,_2-+_LR"827#W-Q<2F:>=P 7<@#H.   H ]
M .O6K<EK!*X>2&-V'1F4$BI:* (%LK5$=%MXE5QA@$ ##W]:<EM!'!Y"0QK#
MC'EA0%Q]*EHH @%G;"42BWB$@Z/L&1QCK]*=%;00.[10QQM(<N44 L?4^M2T
M4 0PVMO;L[0PQQF0[G**!N/J<=36-?>'3?\ BJUU6X-M+;06LEM]FEAW[M[(
MV[).,@H.W<UOT4 02V=M/;BWFMXI(!C$;H"O'3@\4R33K*5HVDM(':, (6C!
M*@=,<<5:HH KI8VD=RUREM"L[<-*$ 8_4]>U%O86=H7-M:PP%SES%&%W'WP.
M:L44 4TTK3XYS,EC;+*7\PNL2ABW/S9QUY//N:L0V\-NK+#$D:LQ<A% !8G)
M/'<FI** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:_\
MJV^AIU-D_P!6WT- "0_ZB/\ W1120?ZB/_=%% $E%%% !1110 4444 %%%%
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M->DT8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR?ZMOH:=39/\
M5M]#0 R$GR(^#]T440D>1'P?NCM[44 2T444 %%%% !1110 4444 %%%% !1
M110 4444 <IXZMDN;31TD>95.K6JGRIGCX+^JD?AZ'D<US&M0LJ>.+JSU"[@
M-A:P7-O)!<$%F2W)4LW5QQT)(/?->E7UA::G:-:WUM%<V[$%HY4#*<'(X/O5
M5O#VC.)PVEV9%PH28&!?WBCH&XY P.M '-IJ%T?&D9DOY(X'\/-=%&;]TDF]
M07V^P_K3/!EQ=QZU-8:HE[%?QV2,V^[:XM[H!L&:,D_*22,K@=174#0=)69)
METVU$J1>2KB%05CQC:#C[OMTI]CH^G::Y:RLH8&*A,QH!A1R%'H.>G2@#(\4
MRW5U+8Z/9VRW!N)/.N49]H\B,@D$\_>;:N#U!;TK(\"2W&D)J_A6X"17&GR&
M>S1Y-P-O)EDY[A6W*2.G%=BNEV*ZBVH+:Q"\9=C3A?G*^F?2JE[X?L9YYK^W
MM;:/5C$R17K1!G0XP.>I /..E '%>&Y=;U*[\.W:W6I$2K.^KN7S S _)L)R
MNTMT\OJO6FR7NH:?X5EUR36KWS$OY[!I)'!CAB:^*&5EQ@LJC@] #TQQ4^B^
M!;BWN++S]#T;3I;1XW:_L9W:6;:02-NQ0-V"&R3P3P:[>VT33+2TFM8+&".W
MG),L00;7)ZY'0YR<^M '#:Q=:GX5T^[E36UDANWME3S)7F-FC2!'FWN2=I!X
M!X!&1QD4_6(]5T+0-:>/7G8YMYK>)96DDA#.%;YWRQ5NW/&#@UV-CX;T73+*
M:SLM+M(+:?(EB2(;9!Z,.X^M11>$] @T]K"+2;1+1W#O"L8"NPZ%O7'O0!S=
MQ:79\3ZSI/\ ;.IBU_LR*]XN,.)"\JG:V,JOR*<#'3TR*R]&US5/$::!IEQ?
MM"]SHJWC.LK0O<2;BIPR\Y4 -@<'=SD#%=^WA_2GN9+AK*,SR1>2\G.YD_ND
M^GM[FH)O">@7&GP6$NDVK6ENVZ&(IQ&>^WT_"@#F+0ZI=>)],TFZ\0331MI$
MYGDM,1B22.:--P.,AN3DYZYQBLZT-SJT7@<7E_=LXO[Z!I1,59Q&DZJS$=6P
M@Y]SZFN]/AW2?M,=R+*-)HH?(C:,E2D>,;5QT'L/05"?"6@M8)8MIL+6J3>>
ML39(63NPYXSDY]<G/4T 6;"S^SZAJ%Q_:,]R+AT(AD<%;?"@84=L]3]:QO%<
MES>WECHUK9_;(V875[$&49B0_*IW$##/CZA6%;UII5C875W<VMLD4UVRM.R_
MQE1M!/T I(=)LH-3FU&.';=S*$DDW'Y@.@(SCCG'ID^M ''>%+BYL/"VL:!(
M9;6\T;>D.YE>00,I>%L\J< [?3Y#65]EO;_P=X7U*]UF_GDO[C3#)&9 J*VX
M'<,#.3G)R3R ?2N\F\,:-/?S7TEDINIUV2S!V#,O]TD'I[=*<WAK1VT8:.;%
M#IZD%8,G"$'(V\Y&#TQTH Y>_P!:U#1O$?B 0W$UW!8Z MY!;N01Y@,@)X&3
MG8.22>M7X89(K)KK^W9+N*]TQW\B4AO-?:#YJ<_*,'!4#'(_';M_#VE6M]]M
M@LTCN/*$&Y2<>6!@)C.-H]*AL?">A:;%<Q66FPVZ7(*R^7D$J>J@YX'L,"@#
MDM+N[N;2?!^B6]S]G2;1(YS^_,+3%4C 56"D\ EB!C/'8$&/5;S7M.TZ#[7J
M4M_!:VTJ7MSI;@30/N(6=DXWJH4@@=PQP>W73^#] NM+@TV?38Y+2W;=!&S,
M?*/^P<Y4>P.*?-X4T2=8E:Q5%BA,"+$[1CRR<E"%(RI/4'@T .U/5)X/#4FI
M:5;/J$QB5[>.(9,F[&" 2.,'/7H*XCPE>NGQ&GMVTK587ETN(2RW<2*=_FS.
MTC[6. Q) QWXX KTQ$2*-8XU"HHPJJ, #T%4Y-+M#>7%\MNC7DT MW=F(W("
M2%/MECV[T 75970,K!E(R"#D&N(N]/NO"NNVFH:=J5Q<6NK:D([RSN6#KF3/
MSQG *E<=.1@>U=)X=T9- T.WTR,@QQ;MH7.%#,6VC))P,X&3T IFF>%]&T>7
MS+&Q6)MQ9<LSA">NP,3LSZ+B@"/Q1>R6>F1F*Z>!Y;B*)1$@:27+<QIG@,PR
M,G@<GC&1R?\ :^MKH&K8OY(9[+7[>SB+[9#Y3O;Y1S@;O]:W(P??O7=:KI%C
MK5G]DU" 30[U<#<5*LIR""""#[@UFR>"O#\@N5_L\(MS(DLPCE= SIC:?E(Y
M& ?J >HS0!RFJ>*=4\-S>+8C=O=K9)9M;/<*O[IIR4).T ;00#CZ^M;5C:O:
M?$=$>]GNLZ,3NF*DY\X9Y '7TZ#MBME?"^D"[O+IK4R2WL8BN?-E=Q*@& &5
MB0<<XXXR?6F:;X3T72;F*YL[0K/%$88Y))GD94/\(+$\?RH XCXO _VIX*P0
M#_;$>"1D [EK;L//M--OO[7D\K6YYKU+>6,$,8\EP8\YPNU5//&<>M;FL>%-
M&U^XAGU.U>X> YBS/(HC/JH#  ^_6F1^#M$CNGNA;3-</"UN99+J5W\MOO %
MF)'X4 <-X4N?$.L_#R+Q/=^(;DR)878,"HH#.K-M<G^\-OIC&..N7:7K?B"W
M^&R>-KK5);N9-,D'V+RE"-)YF%E)'.0!S[9QCOWEIX6T>PT*71+2U:'3I0P:
M!)G'#?> .[(!]B.I]34^G:#INE:3_95G;!;##+Y#NTBA3U'S$\=>.G- '#Z/
MKFIIXCTG2+B^GN8M5T(7LDCXW13=V4@< YZ= <8]V_#2XU_Q3X>TW6]4UQY(
MD:XBGM?)3%P"< L1C!!]!_7/8V/A31].+M;6\BN]N+4.UQ(S)",X1"6)11GH
MN.WH*ET7PYI7A[3WT_2[8P6C$L83*[J">N-Q.,^U &/\-M(BT3P5:V44R2[9
M)BSI('!)D;'()'3%<1J-[?:;\;?$%[IEB+Z[AT0.ML7*EP#%G& <GV[UZEH>
M@Z;X;TQ=.TFV^SVJLS!-Q;DG)Y))JI%X0T6#Q ^NQP3C4WR&G-U*2R\?*06Q
MMX'&,<"@#S/2-?'A;X+:AX@T>Y%S?WEV9I0R?+;3R,JLNW)X4#C/7(/0XK4\
M2KXA;P1XH&H7;G339K-9,9(FE<;<2*^U<%"2",8/;-=FG@3PW&^I,NFKMU//
MVR,RN8Y23NR4SM!SR" ".U-B\!^'H='ETI;2;['* KH;J4ED'1-V[.T9^[G'
MM0!QT6M:A9IX+\.V4\ZF]TL7$DR"(2R;8QL168!1CJ>"<*!W-2ZEKWBZRO\
MP7:W-U#;WNH3RVU_%$$DB;:1AQQD'!S@$<\5UU]X&\/ZCI^GV5S:2-'IW_'H
MXN)!)"/0.&W8X'?L/2G7'@K0;F;3Y6M9%;3B6M?+N)$$;$Y+<,,L3U)R3WH
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M:_\ JV^AH ;#_J8_]T4409\B/@?='>B@"2BBB@ HHHH **** "BBB@ HHHH
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M\$8=2""Q'RAE*Y;)*GVS-KEO?ZKI27UIX?EM@FIV=XT)15N9O+D4N[*#C[H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37^XWT-
M.IK_ '&^E #8?]3'_NBBEA_U,?\ NBB@!]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %9%QX8T>YOY+U[5EN)<>:\4SQ^;@8&\*P#<<<YK
M7HH CM[>&U@2"WB2*%!M1$4!5'H *DHHH **** "F30QW$+PS('C<%65AP0>
MU/HH ;'%'#$L42*D: *JJ,!0.@ IU%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ110!BRZV&M-L<=X+@K]YM-G*Y[\;<_K7(VVBO;Z/X<T[[9<LNB7"SH_]BW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+'!$\LKJD:#<S,< #U)H ?167;^(]'NI$CAU"!GD8+&I;!D/^R#]X>XR*U*
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MKZT 7**16#J&4@J1D$=Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4%BM?M4-M]DCD-Y.<1<<8Z'D YZY -5V\&2/IEAIYM;40V$ADMBM].'C)!!
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M"L"6P1F1<DGU/3FFZKH.LZA<>-_LEE(K7\EG-:&7"K/Y*IO3.>,E2.<=<]*
M.Y3Q'I3_ &@?:UC:WC$TJ2JT;+&>CX8 [??I18>)-(U.Z2VL[Z.:62'SD"@X
M=.,D$C!QN&0.1GFN>U&UN=4UD:K#IUS"L.DW-K('0!Y'D*%4 SR%VL2>G(P3
MS3=-LKN"[\&[]/G066G207)V#$3E(U //JAZ>QH V/%>NMHMI:)")1/>7<-N
MKK"SA [@,W (W!<X'<XX/-,T[6X;"QU$ZEJSW?V%O,EEDM&BDBB897>H49P
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M>(];M=8U"TMK6U>W2V,A$?WTW'))YY/7@4_PRDT>O^)Y)+>>.*XO8Y86DB9
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M2.!Y%C9D0*"R@@_=QU[5J?$N*>[\ ZI96EM<7%U<(JQ100M(6(93_"#C@=Z
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MMUX.T]P#Y"6D:2&6,JIP@W?> R.O/3K0!=TV^E>P2349K)9WF>,&"7*'#D*
M3_%@#(]<U=M[F"ZC\RWGCFCR1NC<,,CJ,BO'-FFR^%O",3)!B#Q%+YBXQY<!
MDG)SZ(0T9/8@KZUW'@UK.+7?%-M9>4EL+])(HX@ N#!&&*@=MZL..X- '844
M44 %%%% !BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:_W&^AI
MU-?[C?2@!L/^HCX_A'\J*6'_ %,?^Z** 'T444 %%%% !1110 4444 %%%%
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M]U-.UPSW5K]CE/G,-T7/RXSQU//7DT^/Q/HLAGQJ, \F(3N7.T>6>C@GJO\
MM#(J(>+M!:18UU*(L[1HH&3EI!E ..I .![&@!Z^&[!;JUN#YS/;6S6D8>4E
M3$V-RD=#G:O7^Z*J:;X(T?2V81"ZF@VLD5M<W+RPPJP*D(C$A<@D?0D=#5G6
M=:M(+.^B&JPZ?<6ZIOFF3*Q;ON\' ;.#@ U:O]<TS2VVWMY'"0GF,&/W4SC<
MW]U<\9.!0!G:3X+TC1U9(%N98MK1Q17-P\J0(PP4C5CA0?S[9IUKX0TRSATV
M*%KK;ILGF6VZX9MAV;,<GH$)7'3!]>:O7NNZ7IQQ=WL4/RJQ+'A58X4L>B@G
M@$X!ISZSI\=X+1KE?.+*FT D!F&0I/0$CG'6@#-?P9I33W##SUM;J;[1<62R
M8@EER#N*]>H!(! /<&EG\'Z;<+JZRM<,NKX^V#S3^\ &T ?W?E '&.*Z"LIO
M$NBI>BS.IVOVDS"W\L2 GS",A/K@=* -*&/RH$CWL^U0NYSDGW-84W@W2)[2
M[MI(<QW=\M_*..9 RMCI]T[<$>C-ZUH6FMZ9?7)M[6]AEF"EPJM]Y0<%E_O#
M/&14<7B/1IKB.!-2M3+(Q6-3(!YA!VD)G[V#QQGGB@!]WH\-YJEEJ#RS++9%
MC$J, N6&#D8YR.*R+GP'I5U;W]NTUZL%]=?:Y8EG.T2;@Y*CME@&^H].*UXM
M>TJ:X:"._@,JJ[$;QR%.&(/< \''3O38?$6C7#!8=3M')A><;9E(\M6VL^<_
M=!XS0 EKH<-IK5UJJW$[W-U$D4H=AM*IG;P!QC<WYFFWF@6]WK*:H+BZ@N%@
M\@^3+M5USN7([X))';GG-8S>*)I_$U]9V%U:36T.DM=H A)63=@;OFY&!D8Q
MUK2TKQ! ?"VD:CJMW!#->6<4S$D*&8QAFP/09)]A0!!:^"["SM-(M(;F\%OI
M,OFVL9=2%;!')VY/#,.O\1]L/'A*!!*8M2U"*62\^V^8KIE92I4D93&"#@@@
MCBK\VOZ1!;17$FHVRP2QF6.3S059!C+ _P!T9&3TYI\NMZ9!-'%+?0)))L*J
MSCG><)_WT>!ZGI0 FD:3#H]K)##))(TLSSRR28W.[G))P !] !4>E:)'I(N_
M+NKB9KJ8SR/-M+;R "<A1V &#TP .*T99HX(FEE=4C0%F=C@*!U)/:J4>MZ9
M-#/+%?6[K;X\TK(/DSTSZ9[>M ')ZGX4;1/#5S8Z2-2O8+R\2:YC69?,B4ON
MD>(87).!\N<<]#R#%8>&KK4X;W39K_7#H=W;M',NHB-9=Y9<"/"Y P&#9]1C
MOC9\*ZQJ.O6MKJKW=DUG<V_F/;1H?,@9B"@W9.?E/S9 Y''I6K_PD>B^3YW]
MJV7E>;Y&_P ]<>9_<Z_>Y''6@"IK'A:'6;2S274+Z&\LVW07\$@2921AN0-N
M&'48Q5>^\$V=Y:621W^H6UY9LS1ZA#-_I!+??W,000W&1C' QC%)XM\2MI6D
MW+Z9<6KWUO-;++"_SLJRRJF2H((X;()]*VK75M.OEG:UOK:<6[;9C'*K",]<
M-@\4 9R>%+6.\TRZ2[O!)IXD\O+JWF&3[[.2"6)^H]L567P3;)IQL5U/4!&;
M_P#M MF/<9=XD_N=-XW8_IQ5R]\5Z/::-J&II?6]Q%8QEI1%*K$'&57@]3QC
MUS5*3Q5%#XE$,U[91Z1_9QN?/+@8?S0F"^<8_K0 Z3P5:/K<VH)J&HQ07+;[
MFPCFQ;SOC&YEQGG S@@''--N_ ]G>V&LV4U_?F#5Y1+<@-&/F 4?+\G'"J/P
M]:VY=7TZ&SCO);ZW2VE&8YFE4*XQG@YP>.>*CDU_2(8(YY-4LUBDC,J.9UPZ
M 9+ YY  SF@"K!X:@@\0'61>WAN'@CAF3> DVS(5F  Y&YNF!STJ35-!34+^
MWU""\GL;^!&C6X@"$M&V"48,I!&0#TX(X[U?:^M5LA>M<1"U*"03%QLVGD'=
MTQ[U637](D*!-3LV,DWD(!.OS28!V#G[V"..O- &6/!5BCZ:\-W>1/8W#W2L
MK(3+,^=[OE3DG<W3 YX XQLZKI=KK.EW&G7J%[>X0HX!P1[@]B#R#ZBECU2P
MF2X>.]MW6V)$Y652(B!G#<_+QSS6-KWB06^AF_T>YM;DI>6]O)@^8!YDJ(1P
M>&P^>?RH @@\"VW]HB^U#4[_ %.3[$]@ZW13;)"QR58*HSVYZ\5:T'PE#H,@
M8:EJ-ZD2E+:.\F#K;KZ+@#M@9.3CCUK6L=3L=261K&\@N1$_ER&&0.%;T..A
MK*N]=N)O$X\/Z6(?M,=O]INIYE+)"A.%7:"-S-R>HP!F@"?3?#5CIESJTT09
M_P"TYC+*C\A<CE1[$EF^KFJ6C>"[;19!Y6IZE/!#G['!<3!TM,@CY!CG ) W
M9P*O6MYJ<&K7%MJ0MC:+;B:.ZB1D4G)#*P)(&!M/7N:M1:SID\4TL6H6KQP
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M_9-/ME6V#Q-'-)O:+R\C" XVC/&*Z:QL&MM.%K<W#WCD-YLLH^^6))XZ <X
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M^@U+3K:_MF+6]S$LT3%2I*L,@X/3@U9H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *:_W&^E.IK_ .K;Z&@!L/\ J8_]T?RHH@_U$?\
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MBP#.%QD@=3C(S]:E.!R: /-M;MKO5_A[=7L^EW(U#5[FUF>S$#2/'&DL>$(
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M;5+8(W[,\9)&2*SM!^U6>A> ;BZM+[_0A+#<+]G<O$QA95!7&1S@ XQTKU+
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MIK_ZMOH: &P_ZB/_ '111#_J(_\ =%% $E%%% !1110 4444 %%%% !1110
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M"P:>*#:L4&22%4L>26)R2>W'%7K[0I;\Z,TEXH?3;@7&1%Q(P1D]>!AS^.*
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MHPO]1L/,6?5FL8Q#,"4S<-$ 05'3 ]<Y[5T?ANYU&\T"VGU:)8[QMP?:A0,
MQ"MM/*[E ;:>1G%8!\(:FNG+8I>VAAAU8:C%F)@Q'GF;:QSZG;P/?VH FU;Q
MG<Z+I\]U>Z+-"MK 9[@O,H7&\JJHP!#N0-VW(P".<FKNH:U]K\VPL;5[B3[&
M+F8^<8O+1\[ ",G>VUL#C[IR1QG,\2>#M2UVZU-EO[<0WMA]E1)HV<VK<Y:/
M! ^;(R>O Z]*FMO#>K:?J;WUI=6;->645M>1R*P4/&"%D3J>C$%3C.!S0!1T
M/Q3'IGA#PY:$1RWDFD0W#>=.(QMV*/O$'+,<XX[')'?J-.UVVU/PZFM11SI
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M6FZ;!;/:.XMWB8MYHC  #( ,84<L6P. .I%=%0 4444 %%%% !1110 4444
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M4M% !BDP*6B@ P*3 ]*6B@!,"EP#110 F!Z4;12T4 )M'I2T44 )M'I2T44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !39/\ 5M]#3J;)_JV^AH ;#_J8
M_P#=%%+#_J4_W110 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FR?ZM_H:=39/\ 5M]#0 D/^I3_ '111#_J8_\
M=%% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *;)_JV^AIU,E_U+]?NGI0 D/^HC_P!T44D'^HCZ_='\J* ):***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*;)_JG_W33J;)_JG^AH ;#_J8_\ =%%+#_J8_P#=%% #Z*** "BBB@ HHHH
M**** "BBB@ HI,<YI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR?ZI_H:
M=3)?]2_^Z: "'_4I_NBBDB&(4'^R** )**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+_ *E_]TT^F2_ZE_\ =- !
M%_JD_P!T44L?^J3Z"B@!U%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %,E_U+_[II],F_U+_P"Z?Y4 +'_JD^@HI(R/
M+7GL** 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4R;F&3/]T_RI],F_U,G^Z: ",#RUX["BB/\ U:_044 /HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MIDW^HD_W3_*GU',,P2?[I_E0 L?W%^@HI(U!C7CL** )**** "BBB@ HHHH
M**** "BBB@ HHHH **** *MY<7$ 0V]F]R2<$(ZKM'K\Q%5O[1O_ /H"W/\
MW^B_^*K0DECA0O*ZH@ZLQP*?0!F?VC?_ /0$N?\ O]%_\51_:5_G_D!W?X2P
M_P#Q=:=% &7_ &E?Y_Y =W_W^A_^+H_M*_\ ^@'=?]_H?_BZU** ,O\ M*__
M .@'=?\ ?Z'_ .+H_M._SSH5W^$T/_Q=:E% &7_:E[_T K[_ +^0?_'*7^T[
MS_H!WW_?R#_XY6G10!E_VK>?] #4/^_EO_\ ':/[4O/^@#J'_?RW_P#CM:E%
M &7_ &K>?] #4?\ OY;_ /QVE_M2\Q_R =1_[[M__CM:=% &9_:EW_T =1_[
M[M__ ([1_:EW_P! '4?^^[?_ ..UIT4 9G]J7?\ T =1_P"^[?\ ^.TG]JWG
M_0 U'_ONW_\ CM:E% &5_:UY_P! #4O^^[?_ ..TO]JW?_0!U'_ONW_^.UJ4
M4 9?]K7?_0!U'_ON#_X[2_VK=_\ 0"U'_ON#_P".UIT4 9G]JW7_ $ M1_[Z
M@_\ CE(=6NA_S ]1_ P?_'*U** ,O^UKK_H!:C_WU!_\<H_M:Z_Z >H_]]0?
M_'*U** ,LZM= 9_L+4O^^H/_ (Y6F#D X(SV/:EHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9-_J)
M/]T_RI],F_U$G^Z?Y4 $?^K7Z"BB,_NT^@HH ?1110 4444 %%%% !1110 4
M444 %%%% !1110!E>([6>\T&X@MH3-,Q3:@(&<.#U) XQG\*I^-X7D\)WSQ7
M5S:S1(&CFMY61D;.,\$9Z]#P:Z&J&LZ6-9TN:P>XE@28 ,\07=C.>-P(_2@#
MD4U*XU"\TW1]3FG@UBQO0MRL$KQ+<P[7*RC:0&1BJY'.#D'W/[!*>++;2&U;
M6'B?29)7?^TIP6E$B*'^_@?>/'3VKJKK0K.]U#3-0N 6O-.=GAF  )W(58'V
M.<X]0*1M%5_$B:T;N;S$MVMA#A=FQBK'MG.5'>@#FM-TM[WQ5X@M;C4]3_T8
M6WE-'>RJ$9HR68+NV\GG!!'M5OPCK^JZE9-#<VXNI;34[C3KFZ4K&-L6[$I7
MN20H('<D]!6@GAMXM4U*_AU>\BEO]GF!$CPH087;E3C@]\U8L= @TN"SM].G
MFMK>WD:22-2&^T%@<^8S DG)W9!'(H N:E>QZ;I=W?RJS1VT+S.$&20JDG ]
M>*Y73M*O=>\(V^J/JEW#JU_;K<++%<.(HBXW! @.W: 0.F3USGFNS90Z,K %
M6&"#WK"M/#/V"S73[75+R+35R$MUV@QIG[BOC<%[#G('0]* *\OC"*&<R-:/
M_9BWOV!KS>.)MVS[G]S?\I;/7MCFH[3QHMS<Z>CZ9<0PWUQ<VJ2EU;$L)<$$
M YP1&W/K@<]:E?P9:.T\1NKC[#/?+J#VG&WS@P?@XR%+ ,1Z^@XIB>#(T2P7
M^T[K_0KN>\1@J@EYM^X9QT_>/C'(X]* *4WBN'6/"]Y>BWG%LHB(>SNEWC<^
M-I(P49<#<O;/>G>*-;N)8C!IZS)':ZI96\]U'-LPS31;D '+#:^#_O8YP<69
M/!4<L=_NOF6>^BBBGFCA52XC)(9@."YS@MZ8&!3[OP=]I>ZV:K<00W5S#>2Q
M)&A FC9&W+D$@'RUR.: )(O%BW&I_9K?3KF> O+"D\0R&DCW;@1P%!*LH8G!
M([9!-KP]KK>(=/CODL)K>TF@CFADE9?W@8$D8!R,<=>N>,U!:>&IK"XF^RZQ
M=)9M*\\=H40HDCDEN<;BNYBVW.,^W%7M!T@:%H5II4<[31VL0BCD=0"5' SB
M@#FO#7B4V]II=C?+=S27LMXL5RYWEVCDD.WKN^XIQQCC%7%\<0_8]2G?3KC=
M801W,L4;(SB)]W)&1AEV-N7J,=Z1/!(5-+4ZG*#I\US*CI&%8F8.&YSQC>V#
M].N.;>D^%8M,E9WNWN$>QCL7B:)%0I&7*G '7]XV?7- $6MZ[;FRND"7AAA-
MJ6N+215YDD&T!L_[I;_988SFI)?%D4-[-;M87/EP:A%I\LWR[5>18RAZY()E
M0=.,\XJ*#P9#:^%AH5O>RA!*C^=(N]R$92B]>RHB?1?6G7/A26X:]/\ :.W[
M5J$&H$"#[KQ"/:!\W0^4F?Q]> !TWB^"*]2%;*>6&2^.GI,A3F< DC!(PHVL
M,^HZ=";>O:^FA0B5[6:9?+>5V0JJHJ#)RS$#)SP.IY]#CDX]/U5=9N+RW@N!
M?->O,L-Q9AH0,[ XD! !,?<9;!(Y[]1KOAM-<NK>9[MXA%#-"4"!@1( "PS]
MUP 0&]&8=Z %UW7&T_PC=:U:1><5MO.B5N,Y'RD^W()J&Z\5V]G?+:/:W#NK
M1I/LVL86<@#*@Y. 03C. 0:LW&@)=>%&T*>YD9&MA;F<* W P#CIVJJOAJ[C
MU.2\BUJ>,703[;&D*XF91M#*>J': IQG@#H>: (I/&D4<$MR=,OOL\5U]D>3
M"'$OG+#MQNR>6SQQCWXHD\:6\#3"XT^]B%M>I9W)(0B%I-OEDD-R&\Q/NY(S
MSBE?PF[Z1<6!U ?OM1&H;Q!T83";;C=TW*/P_.F7_@^2^CU1#J(07]]!>L1!
MG8T7E[5'S<@^4F?^!>HP 0P^*+6PN-1_=ZG<%M96P*R%&"2LB8"#/$>"#ZY)
MJP?&MN+![C^S;W?%--!-%A!Y31#+;GW;!GC'/.1[XC;P8QN)Y1J('FZLFJ$>
M1T=5"A/O=,*/UIA\#[KDS-J1.;N>Z*>0"NZ50IP"3\R@':W;<>N: %3Q6=0O
M0MO;SG3I='74%F3:),/G&,MP0!^9'84[3/$]NNB:6EG#?ZA-)IJ7GELRM/Y.
M  SDD N?0=2#18>"VT^"UCBU65A#I@TUMT*_.BYVGV(SSZ^U.T_P<=*&GR6.
MH>7=6E@NG-*\.X2PKRF5W<,IYSG')X] ".7Q_8A+B6ULKN[@@L(]1:6(( 8'
MW?,-S#D!3D=>. :W-2UFUTS3H[R3?(LKI'"D0RTKN<*JCU.?H.IXKGT\ Q06
MUW:VU^4M[C24TH*T6YEB7=\V=W+'>W;'3CCG7U7P\-4TBSLVNY(;BSEBG@N(
MU&5DCZ':>H/((]#0!B:=XANK74=>^UP7LI348X(8&VD0 V\;G+ [53)8Y)[@
M=>*DB\<17>IZ48(2FFW6G3W\LTF 45"H(QGMDYQGMC-3-X-EEU%[Z75G::2_
MCOG00 1LR1"( KDYP%##)X(!J&V^']O!%91/J$TL=O:7%DZNB_O896!*G'0\
M=?<T :^B^)(-:N)88[6XA*Q),K2*"KHV<<@D!N.5/(R*K7?C*QL3.+FWN8S!
M?Q6,F=GRM(%*/][[AW#GKUXX-7-%T>[TQ56ZU>XOUC3RHA(BKM7U;;]YN!\W
MZ<FJ6J^#;+5M4O+V:5P+NS^S21 ?+N&X)+_O*'<#Z^PH 5];AN]8T^-8[^,_
M;+B"/:RB.9HXVW;N<E<Y Z?,O/2N:LO%&J:I>>%;YTG07<M_NM(6 68('\L'
MGJ !R2!D9]*ZQ?#ICDT9H[L_\2TLQ+Q[C,S*59B<\$[F/U-9^G^"?[-ETEH=
M3=DTN6X>%'A!R)<Y!P1TR>: -BPUVVU'PZFM01SF!HFE\OR\R?+G*[1G+9!&
M!G)K.C\96C6\TDEG=1M#<V]M)'A696F*JA.&/=@".H.>*GT_PVUCX2?01?RX
M,4L2W,:['0/GD<GD;N#["J(\%NELT46HI&"]I(%6U 1#;N&7:H(P#M4$9]<=
M> #;TK5X]5CNBL,L$EK.UO+'*!N5@ ?X20<AE/7O6:?&-HLUQ$]I=H\-M-=A
M650SQQ,%8A=V1U4C=C(-7M)TB33+C4Y6N5E%]=&YVB/;L.Q5QG)R,(/UK'M?
M!"PR*9=1:1/L]U;28A"M*L[*S,S9Y?*#YN_I0!-K'BZ.RTJ_FM;:5[B#3UOH
M@X4*ROD+GYNQ'(X]LU:O?%%O8"Z,EI=.ME$LMXR!2+=2"?F^;D@ L0N3CZC.
M>_@N6YM9X+O5?,\[35T\M';A,!22K_>///(_E5BX\+7$QU';J84:I (;T&#.
MX[2FZ/YOD.TXYW#@>^0!]WXQL;7[2Y@N9(+:6&.:>-59%$H4HXYRR_,.@)]J
ME7Q/ QNH_L5W]IMKA;=[?:N[+*&5L[MH4J<Y)&.AYXJA<>"S)8:E90WZPP79
MM]@\@L8A"%"C[WS9"#T[T^Z\(S7.H7EV=1C'VFZ@N'A:VW1MY2;0K#=\PZ-V
MY4&@"6#Q2M]>:.EG:R/#?B<L[%<Q^40I'WO[Q[9''%,L/$EO'I=IY":CJ$TX
MFD2,JAFV(Y#%N0H )"CG)R.IS2VGA6>SEL9(]4R]I-<N";<?,DS[V7[W!![_
M *5#:^$+S3Q8S6>KI'>6JS1%VM=T<L4C[RK)OSD,,@AOJ#0!M7VMVUAH+:S-
M'/\ 9EB$S*(CY@4XZJ>0>>1VK/O?&-CI[2)<P7*/$IDD0JH98PQ428+9(.TD
M 98@=*M:MHLNI^&YM)%\P>6,1M<2Q[V/J2 5&?TJM=Z#J3ZLNI66L+:S2VZ6
M]VOV;>L@4L59 6^1AO;&2PY&0<4 /D\66,=W+ 8KDB&\BLI91'\B/($*$G/(
M/F(.,]>1CFD'B[3VU/[#&LLDA>2)&3:0\D8)9 -V0?E89( )&,U3N?"-U,FH
M*NJ(/M>H6U\"]L6*F$18!^<9SY*Y/'4_A:TS0+[3;IXTU7.F&=[A+808=6=B
MS+YF[E-S$XQGH,XH ?!XMTZX6%T$H2:P.H(S  &(8W=^"-P!';-*_BJRBN[:
MWEAN8_M$D<*R/'A5D==ZH><YQZ @'@FL9_A["\JN;U_DNV>,!!A;5RV^V_W3
MYC\]?N_W15S4?",]_K7]H-J$?R7<%S$)+;<T8C',8;</E)R>F<GG/2@"]X:O
M+F\L[\W4S2M#J%S K%0"$20JHX ["JMCXGM([2T_>7]Y)>W-U'!NM\.6C=\H
M0  ,;2HSCH,]ZT-%TJ?2K>\CDN$F,]W+<J5C*[?,8M@\G.">M95CX5O;233'
M-] YLKN[NCB!AO\ /9V*_>XQYAYYS@4 ;5MK-I=:&-7C,GV4QF0Y0[E SN!4
M<Y!!&/:LBZ\5V]UIFH"Q:>&ZCTY[ZV>6':)$"Y#KNZ@$@'ZCUI\=B^@^"KNT
MN[B.0I'.?,1"H.\LP&"3SEL5EZ9H%YJF@6EQ+<0I)_8K:?"%C8!1(L>]G!/4
M&,# ]^>> #8M_$UO;V=D+OSGE>&V,TRQ_(C3':F?JV1QG'? JR/$M@;W[.IE
M9//:W-PJ9B$JJ69"W8@ \],@C.>*P[OP;?WD4:OJ%J3#!;)!YELS^2\3ABR_
M,,;L#/?CKBK%GX5O;-+W34OX_P"Q;J669H_*/G+YI)= V<;<DG.,X./>@#0T
MGQ9I6LWPL[29C*T'VF+<N!+%G&]?;)'!P>0<<T^^\3Z;I\TZ3M)Y=LZ1W,ZQ
MDQP,^-H8]LY'T!!. :K^'M(U?3(XK:_U*WN+:UB\FW\JW,;NHP 9"202 ,?*
M ._TI7WA.[N/[<LHKN$:;K3;YUDC)DA8HJ/LYP<JHQG[IYYZ4 2PZEJ.J>*M
M0LK>X:U@TZ2$%3 &6967<X8GD'D;2#VSSTJ#Q!XGN+>TUJ.R5H)M-:!?->/*
MMO9<]>/NL,?C6GI6E7UGXAU:_GDMV@OFC*H@;<FQ=HSG@Y'/;'O6?K/AB_OG
MUD6US;B+4?(?;(C91XRO<'IA>F.I]J +EWXCLVLYREU/:/;7L-M+NMF+!F=-
MJ[2.CA@-W;=ZBK\&N6EQJ)LH_,9Q(T6\(=F]1EEW>HK!U#PSJ=Z^JE9+11>W
MUI=(&+?*("AP>.I\L?3)].;%EX=N[?Q6^K V\*R-(9V@=P;E3P@>/&W<O'S@
MY.,=Z +>I^+M(TBYN;>[FF62UC2:<);R.(XV) <D#&W@Y/;'-/\ ^$JTG[7<
M6XN&S;*'GD\IO+C4H9 Q?& I4$@YP>E<IJ"SZE\1M=TVRELRUSHT-O*9G.8P
M7DW$*!\Q <':2.HY&:NQ^!YWM-=TZ>X2.SU"UAMH9(V)D01)L5F! !SP2/PH
M W9/%>EP074UQ)-"+6-9IEDMW#+&V</MQDKP>>V#G%&L:Y:VD<L1O'MI8GM]
M[BV:0 22;5'3'S;2N>V0?2JUKH5W?7LUYKB6GF2V)L7BMV9E="278D@$9XPO
M;GDYJ@_A75/^$2_LXW,%SJ$EQ#)-<2LRJ5B="N, \[8U!]RQH W)?$-B)I[9
M99 \?F*9%@=D#(NYAD#&0.<=^<=#52R\2V46B:?/->R7LD]H+D216S;Y(\#,
MIC7)4<CC\!6<_AK5E\0W6HV[6L*S";S?+G<+=!E*QB2/;M#*<?O!DD+C'-1:
M+X6UG0?[,N;=[.:Y@TQ--N(I)66,K&24D1MA.>3E<<YZ\<@&Q<^-="M5=FNV
M=$M4O&:*!Y (&SB3*@C;P<GMCFMY'62-9$8,K $$="#7GK^ ]2BM-0L[::T:
M&XT-=*C=V96#AG)<J%( _>' R>@]>.OTF'5+?;!>?9?LT=M"D?DEBWF $/DG
M *_=QP#US0!JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !3)O\ 42?[I_E3ZCG_ ./>3_=/\J '1_ZM
M?I10GW%^E% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** #K1110 4444 %%%% !1110 4444 )@9S2T44 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4R;_42?[I_E3Z9-_J)/]T_RH 5/N+]**(_]6OT%
M% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *9-_J)/\ =/\ *GTR;_42?[I_E0 J?<7Z44(,*![44 .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKF2\\H29$URZE"^WHHPS$]RQS@<YZBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HY_]1)_
MNG^525'/_J)/]T_RH >.@HH'2B@!:*** "BBB@ HHHH **** "BBB@ HHHH
M**** ,/Q/;SW%K8^1;O.8K^WE=4QD(K@L>?85S&I:#JEU<O-8VS6K/J7VVU5
ML8B=+=EW.%. '? ('4$D]37H=% ' Z=::C%JNO:AJ6FW(_M""T*B-%F,;CS,
M@#H=@:,'C!()YYJYI>ESZ7IUHESIBW 72T$D"J& E@ "#N-S!L=_N#FNRHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ J.?_ %$G^Z?Y5)4<_P#J)/\ =/\ *@!XZ"B@44 +1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<YQ;R?[I_E4
ME17'_'O)_NF@"044HZ44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %1W'_'O)_NG^525%<?\>\G^Z: )1THI!10
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
4444 %,D7?&R^H(HHH ?1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex10-4_004.jpg
<TEXT>
begin 644 ex10-4_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HI_
M]7_P(?SJ6HYC^['^\/YT 24444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %13_ZH_4?SJ6HY_\ 5'ZC^= $@HH%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !44_\ JC]1_.I:BG_U1^H_G0!+1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<?ZD_4?SJ6HKC_4GZ
MC^= $HZ44#I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH *BN/]2?J/YU+45Q_J3^'\Z )1THH'2B@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM=@2K$J22!C!%6=.UO7-3_LZ\ATV'^S=0CDD63?\]NN,Q,XS\V\=5497/4T
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M(([B1((E8F-]V&'S#.-AXZ^@- '145SG_"9V$DL4=G;7EZ\]D+V 6\6?-C)
M&,D8//?'Y\5CW7B"+6=9\&7VEWD_V*\NKA)8\LFXK#)\KKZJPZ'N* .[HKFK
M37M.M(=5N3)>8CU'[.Z7# DRE4PL>3@+R.N /F/ YIJ^.](,<[-YXDM[N*TF
MB55=HVE(",=I(*G(Y!/<=>* .GHJK87GVZV\[[/<6_SLFR=-C<$C./0XR/8U
M:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&Z_X]GJ:H;O\
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MXD;["UB\2P[0R,0Q.<G!R!^'YU<\/:/+H>A6VF27SW:VR+%'(Z*F$4!5&!Z
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M0<*K;@ A/)&.I/UJW/X<U.6_UFY-U:$ZEI\=F?W;#8R!_GZ]#YC<>PYKJJ*
M.)TWP?JVBR:7<Z?J=L)[;3H].NHY86:.=(\[' # JPR>Y!SBMOPQH]WH'AZ+
M3I[F&YDB9RKI&8QAF+8.2>YZ_I6W5&[U!H[2]DLK=KVXM?E-O&P5F?:&"Y/
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M=7F2SANU$B7<]LS WBG[F]=H&1P<\]/>NOHH X*U\':S;6OAYQ/9?;-!D98
M"^R:)E*.&./E)&W& <$=\\6[[PSJETM].OV,75[?VMRZF5MJ1V[1LJ@[,L3L
M/.!C=WQSV5% '+7>AZG/=>(Y$6T":G9);Q9F;*LJNN6^3I\_;T]^*-GX;U_1
M[VRU#3WT^28Z?#8WUM-*ZQL8L[)$<*3GYCP5[_C7;T4 <K9Z)J\?C&WUB[>T
MFC73C9RLK,KEBX?<%VX !& -V<<U;\4:9J.IP6*6)B>*.Y$EU:S2M&MQ'M(V
M%E!/4@XQ@XP>*WZ* //8/"&MP6:6RIIX6+7_ .U4VS.H\LN7* ;.",X';CM5
MG5/"NL7UUJUU ]K!.]]:WUD3(S M"H7;(-O (!Z9QGVKN:* .;TO3]77Q9>:
MM>6]I#!=6<,!2.X9V5HVD/= "#Y@_*L_Q3X9U+6[^XEMDMXITA0:?J"2M'-:
MR9._.!\R$8."?48[UVE% ' :[X6UV[M/%-A:"S>'651TFEE93&XB2-@5"G@[
M 1SW]JLVCW\7CK5EBM8)9_[)LPZF8A0^Z?'.WE>N3C/3@UVU58],L(;Z2]BL
MK=+N08>=8@'8>A;J: .'T?3;CP]XJTK2X$6[-KX?$3G?L+$2CD<=,]JDL?!V
MIZ=-X>=#;2_8[^YO;OYRHS,'&U!CG;O[XSCWKL_[*T_[>+_[%;_; ,?:/+'F
M8]-W7%6Z .'F\-:R]OJ<L!M8KTZPNIV0=RR-A%0I)@9&0&Z9QD>E2ZMIGB35
M[%#+;V43K=VDZ6L<Y(012B1B9-H)+8P!C P.>379T4 -0DJ"5VDCD>E.HHH
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M<9J>\W+\7M,,X_<-HUPL&?\ GIYL9;'OMQ78X%4-3TN/44A82&&YMY/,MYU
M+1MC!Z]002".X)]B #AH[O29-0U:SU>VEEUZ+5?/MX(P5FF0,/(*-Q\@7 /.
M!\V<9-4-0^SW&A>,K74EV:^MY+)99SYS\9M3$>I'0#;T.[U->K >N,T8'H*
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M,,OV&UP1G//[KUI?^$1??N_M5L[=F?L-MG;C&/\ 5],<8H Y717@@\*>#X6
M2QO;UHKMU;A\+*41O8N%'OC'>J7B"6YM(?%=C;7EQ%86NHZ<;5HY2/(:5D\V
M,<XVC(.T\#=TKN!X4E6V>V35W6"3[\7V&VV-]1Y>#0WA25[5;9M4!@5MPC-A
M;E0?7&S&: ,VZTJV@\;Z1IZ2W*VD]E?2RPFY=A(Q>$G.2?[S'C'Y9K!TT.OA
M+1M2:\NI+N'7$M(Y'N&.V'[88=F,X(V<'.3^0KLCX7G::.5M35I(U"HYL(,J
M/0';P*C'A'$(A%W;>4&W[/[.@QN]<;<9]Z .;O+^)-96\CO I37U@>:>?$F/
MNO$%' C ]3SUQT)@U06]MX0\=M:W3P7:7%PZ>5<,K@!(VSP?<?G[UV#^&KAW
M=VU*-F<@N6L(26(Z$\<X[4V;PQ-.TS37UM(TV/-,FG1-OQTW<<X[9H SH775
MO%S:9?F06L6DQ36J"0@2%F822 @_>7" 'J,Y&,UBZ7->:K=>"DOKV[87%K>K
M/MG9/M"Q[51FP>I!SD<\]<5U<GAB>6**&6]M)8H1B*.33HBJ#&.!V_"GOX=N
M))H9I+JP>6!=L3MIJ%HQZ*=W ^E &=X!1;_PW$UX3<R6-]=1023G>R!975>3
MSD+QGKBI?'MO%9?#O6C;*(6CA:="@P?,#!PWUW &MK1=(&D12QJUOM=@VV"U
M6  ^X7K1J^F/JWDVLKJ+$2+).F"6EVD,J>@7(!/7(&.] %JWO()I#;B:,W*(
MKR0AAN0-T)'4 X/Y59J!+*UCO);M+>);F50LDRH [@= 3U(&34] !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5#=?\ 'L_TJ:H;K_CV?Z4 2BB@44 +1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%V<6K_2IZANO^/:3Z4
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M?&/AQ;*_\W2]0L[F8K&%*N4"%6!QGHYXSCI5O3M=L(=)N;Z75);J#[9)$'>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *BN?^/:3Z5+45S_Q[2?2@"044"B@!:*** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRMO8G)=GPN%&.!R>37>T4 <+KOAS4-?UJ_?R&MK:\T4V(E9T)CEWEP2 >5Y
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M?S=Q!.X/C((QC/.:])'*@XQQ2T4 %%%% !1110 4444 %%%% !1110 4444
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MZNC<AE.0?QH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUAM[:.YB2&W-JNVZDR8B<E3\W(S^7;% &&NL:SK^I7NG:-JMM'):6-O-#,,
M3O(FX2$%&S'T&!CJ>>F.EO+^>#PC-?27UC;W"VN\W7+P(^W[P[E<].YJO=>"
M-!NI;27[+)!):P"VC>UG>$^2.D9*$$K[&M2ZTBPO='?29[9&L'B\DPCA=F,
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M]MI-C&UYK4^GO%&Y14822@L/EYR8R2?4]#6C9>$+JVN]'FFUJ:X&DJ\< :%
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M:FJ&Z_X]9?\ =- $HHH%% "T444 %%%% !1110 4444 %%%% !1110 4444
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M1110 48HHH **** "BBB@ HHHH *,"BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *AN^;67_=-35#=?\ 'K+_ +IH E%% Z44
M +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 52U32K/6M/EL+^-I+64;9(UD9-P]"5(.*NT4 ,BC6&)(U+%4
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M17A/VA(I%SNZG+ $'N#Q4VE+I6E^,YXA!J-K=2:>UVR3W(-O!%O4%54,5'S
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M5Y)P!@G.!FM?3=8MM2FNH$66&YM&"SP3* Z9&5/!(((Z$$@\^AH T**Y6_\
M$-Q-J^MZ1!;W,0L[%)?M*!1M=Q(0>3TP@QQUS57P/XD2?P_X>L[PWDEY=V2R
M"YF0E97"AF&X\EL<^G7F@#M**Q+;Q5IMUJ-K9H90;S?]EE91LG*?>VG.>@)&
M0,@9&15W4-6M].>")UDEN)R1%#&!N? R3R0 !QR2!R!U(H O45SO_"::28=-
MG4SM!J$WV>*81_*LN2I1\GY6!!'/IQFJVH^-HK?3])N[:QNG74KU+:'='C()
MR6Z]U#;?7@]* .KHK%O/%.G6!<W'G+%$\<<\VSY('?&T.?\ @2YQG&1G%5;W
MQSHMA)J"SO= :?(D=VXMG*P[@""3C[N".>^>,T =)17.P^)O/\;3:"EM+Y<-
MHDS2[."S$XY_NX4\^IJ[J'B&PTR_@L;@W!N;A'>)([=WWA<9Q@')Y'']* -6
MBL>+Q-IDVGVEY%)(ZW;-'!$L9\QW7(9=O4$%6SG@8.:9#XKTBYM8)X)WE:>9
MX(X5C;S3(F=Z%,9!7!SG&* -NBL6#Q5I5U8V]U;2RS"X9TBA2)C*60D.-F,C
M:1SGV]12)XLTF:TM[FWEEN$N$DD1(869]J$!R4QD;20"",Y.,9H VZ*Q9/%.
MEQR*@DEDXB9FCA9A&)2!'N('&<_AU.!2GQ3I"ZA]C-PV\7(LR_EMY8G*[A'N
MQC=CM^'7B@#9HKG_ /A-=$\R>,2W+-;RR0R[;24['1-[ X7CY>GK@XSBK<?B
M+3I1I9C>5AJ@W6A$+_.-N[)X^48YYQ0!JT5SGBS6Y-+33[:'[0DEY=QPM+%
MTA5#DMC"D;B%( Z\Y[4V#7['1+:>#4=5GNC;XEEFDMFS;QOR@E*KA2!W.#CD
M^M '2T5AW?B[1;*]:SFNF\]8DG*)"[_NV8*'& <KDCD=*W.M !1110 4444
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M,7VL>)+J[NOL\=A=Z.^F2B.9C(N\[BP^3!].OO[5UV:,B@#B+'0/$IN- CU
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MA!9VZ[88(UBC7T4# J/^RM/_ +4.I_8K?[>4\LW/ECS-OINZXJY0!Y_!X?\
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M0Z8NG7ELLRAEVD%70G /((()'!'IBDM_#NIP3Z9<&W0O_;4VIW*"48B62.1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFSTP,Y- %JBF22QPQ-+*ZI&HRS,< #U)J&#4+*YGD@@NX)98P"\<<@9E!Z9
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M(F[:"[,%7+'A1DC)/04 59M%_P"$ABTZ\OA<:=JVGR-LFMF *L1AMNX$-&V
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M=:5%!IWG1JQ9!N$B,75BLG^K/8GY>XKU%HT;&Y%.#D9'0T-&CXW(IP<C(Z4
M>7:S+';3)+#/'=M'!917>G:I@73J#NC>)E_Y:98Y&,%AV[]WIL^BOX@UB*Q,
M?]J(8C?A00WW/W><\'Y?2M5HHV969%++T)'(JO#I\,.H7%]EFN)U5"S'[J+D
MA1[98GUYZ], 'FOQ%NK-[SQ#:.HBNO[$)5IPSF<99ML*]%P5!9O8<<9J-H]"
MU/Q5J,]RMG/%+X;AF8S8*O)E_F(/5@I7D\@$>M>L%5)Y -&T>@H \NTC5]/6
M[\-2:]<6_P!A?08ELYKD@QM<\"8$GC?C:.>?O#UK?^%4\,OP\TY(7#"%IHR
M,;?WKD#\B*[!HHWQN16P<C(S@^M*B+&H5%"J.@ P* '4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%17'_'O)_NFI:CG&;>3_ '3_ "H <GW%^E%)'_JU^@HH ?1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)O]3)_NG^
M5/J.<X@D_P!T_P J %C_ -6OT%%)&P\M>1T%% $E%%% !1110 4444 %%%%
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M^QW,J@17.!GY#G/0$C(&1R,T^R\36=]/M2*>. Q231W4B@12)&0&((/'WAU
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MC875G>?:X TR3IY-S; )O$J;CEE&\ @9X7!K,OO#^N3>&?$5DFDRM/>ZXM[
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MC-9-=Q);-YBA%*N=@&XX)[#WZ5-XATVY_MR&>P$T"^)(5L+V/(#1%06\SO\
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M 4AE>"11\R@<$$Y^89% 'H$42PQ+&F[:HP-S%C^)/)I]<')>>)+?39[U[]#
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M=8VD9=:B(5<9/[J7U(% '2VMW;7T GM+B*>$\"2)PRG\14U><W,>O>&)M?\
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M0B(D$'^+GAB.<\$TMKX8TRU:$K')(D$+00QS2M(L:-C<H#$\$ #GMP.*V:*
M.>L_!6BV-M-;0Q7!@DB:$1R74CB*-OO)'EOD!_V<5;C\-Z=%=:?<(DHET^$P
M6Q,SD)&<97&><[5ZYZ"M:B@#.T;1++0;,6E@)5@'W4DF>0(.RKN)P!Z#BJDG
MA/2I'N-T<GD7,PN)[82'R9),@[BG3D@$CH3U!K<HH S8="LH-<GUA!*+V>-8
MI',K$,BYP-N<<9/;O1J>B6>K3V<UUYI>SE\Z I*R;'P1G@\\$CGUK2HH HZI
MI5MK%B;.[,IA+*Q$<A0DJ01R.>H!_"H;[0K2_NK6[=I8[RU!6&YB?;(H/WAG
MH0<="".]:E% &)+X5TR:TAMRLR^3<F[65)F63S2&#,7!SDAF'T/TJ"3P7I,C
MLQ-XJF[^V*B74BJLV<E@ >"223]37144 >>+H.I"\U*;[)KEO>W%U)*DMG?H
M+<C[J$AGS]U5S\O7.!C K>/@RQN;O[?<RW*7<\:+?+;3M%%=E5QET'!]/IP:
MZ6B@#$G\+V%S'JL<KSE-401W2A\!E"[<#^[\O'%*?#&GOJ2W\IEEF%F;$B1L
MJ\).2I'?) .>M;5% '-6G@ZQTFT=+2749ECB:.VB>\8^0",8BR?E.. >H]:T
M]!LKJPT2VM+R=IIXUVEW<N<9. 6/+$# R>N,UI44 <^GA#3X[.UM5FNO*M;P
MWT0\SI*6+$].1N9CCIS]*T-/T>#3;R_NHI)6DOI1+-O;(+!0H(]/E51^ K0H
MH YZ[\':==ZM-J/G7L#W( NH8+ADBN<# \Q1UXX[<<4R[\%:;=R7+&XO8EGN
MDO#'%.559D*D.!Z_*..G?&:Z2B@#G'\%::VH7%TL]]''='=<VL=RRPSM@ LZ
M]R0!GGYN^:=-X.L)[;6+=Y[KRM7;==@./F^4+@<<#: ./2NAHH JSZ?!=Z7)
MIUTOGV\L1AD63^-2,'./:L*/P-IO]G2V-U=ZC>QM"8$-S<ES"AQPG3!X')R>
M.M=/10!S)\$V37L]ZU_J)NIX8X9)O/ )\M]Z-P, @^@Q[9YIUQX(TN\AO!=2
M7,L]W-'.]R'$<JR1C",I0 *0.X'US7244 9VE:/'I22?Z5=W<TF-\]U+O=@.
M@Z  #)X '4U5N?#%K=7&K3/<7(.J6ZVUP%9<;%# ;?EX.';GW^F-NB@#%3PU
M;)J]AJ9N;EKBRMC;1Y*X*'&<@+UX'Y5/JVB1:O)9/-<7$1LYQ<1"(J/G (!.
M0<\,>/>M.B@#-UG1H=<L%L[B>:.,2QRYB(!+(P9>H/\ $H/X5%>Z!%=W]MJ"
M75Q;7]O$T(N(=FYXV()5@RE2,@'IP>F*UZ* .<E\&:=):6,*374,MG=/=QW$
M3@2-*^[>S$@@[M[9X^F,5!)X#T]I RWM_&J:@=1B1)%VQ3$DL1\N2#N/!)QG
MC%=510!YK)I]^^LZA<QKKMIJ\EQ(T CMHI8, ;4/FNAPI55)&X8R1BNB'@Y)
M;V2_;4;ZTFO$4ZA;V<VV&=PH!;!&Y2< 94J< 5U%% '-S^"[">+6HC=7:1ZP
MBI<(A0!55 @"?+Q\H [_ )U9/AFUDNQ//<7$Z_838/%)LV/$>N<*#DX]:VZ*
M .?T;PK'I#0!]3O[V*UR+2*Z=2MN,;>, %CM) +$D#IWJ_J6F/?R6TL5]/:R
M6[,P\O!63*D%74CYASGMR!S6C10!FZ+HMOH>E?8+=F,?F22$D ?,[%FP!P!D
MG ' K'A\#VA$$>H7<VH1063V2"=5WM&X 8.X +<*,=,=>3S7544 <_8^&!:R
MV+3ZC<72:<I6R615'E979DD#+$*2,GU.<GFJK^!X?[+M;6#5;Z"YL[B2XMKQ
M=GF1M(6+C&W:RG<>"/3TKJJ* *.EZ<=-MF1[J>[GD;?+/.1N=L 9P,!1@#@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAD"D,0,#(9<X[4U/#^HZ?XD;6[2>&[FN+-+:ZCN&,0=D)*R*55L=2-N/3GU
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M6!Q(9"3C@#KZD]AS7G/GO<^$;W4F)3Q7;ZN5 W8D$GG@)$!U*&+ V]",GWH
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M,$10H8UV'DK@8/>@P1%@QC0D# )4<5)10!#]DMRK*8(]K8R-HP<=*E*AE*L
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MB6YMXQ%#(HP8T_NC'0>U03^%M"N9+YYM*M7>^ %TQC&9<$$;OQ /X#TK7HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "F2_P"I?_=-/IDO^I?_ '30 1_ZI/H**(O]6GT%
M% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBJVH7T&F:;<WURVV"VB::0^BJ,G^5 %FBN?M-9-CI4%_K4
M[+-?,&BM8XB[1DKD1(J@LY !).#W/ X$6I^(!!IEKXCL+I+C2"56=<?\LV8+
MYBGJ"I/(/8'@$4 =+1110 4444 %%4)]:T^VU%=/EN-MVT33+%M)8H.K# Y
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M +12;A56YU*UM+NSMII,37DABA4#.XA&<_@ IY^GK0!;HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *9-Q#(?]D_RI],E_P!2_P#NF@!L;CRUX/0=C13X
M_P#5I]!10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***C,\2
MSK"9$$K*6";AN('4@>G(_.@"2BBB@ HIDLL<,;22NJ1J,LS'  ]2:<KJZ!U(
M*D9!'>@!:*9%+'/$LL3J\;#*LIR"/4&GT %%)N .._I2T %<Q\1+>[N_A]KD
M-D3YYM6.%ZLHY8?BH(_&NGI",@@]#0!Q?B:]MUG\,SQV[B%Y6>.\6-Y%M@8C
MC"+D%F#;5+ @=<'I7-Z>6_X4+J5E+%<+<PI=0[)8V1@YF?8!D#/WEZ?2O2],
MTR/2X&MX99#;!LPQ-C$*_P!Q<#.T=@<XZ#@ !+S2HK^[MI;AW>&W;>MOG",X
M.59AW(QP#P#SC(! !;@$BV\8E(,@0!B.YQS4E%% !1110!R'C2VFLKS2O$=G
M;>?/92_9YXE W30S83;^#E#^=9?AG1KRRU :#=0QM::5.=0#I&%1VE0E50>B
MR&<^P6/\/0\9HQ0!Y-H5];R:SX7GCAN+=1<7<9M#!(3;[PQVR2,"2Y;DY./;
M S6KX*E\O7H+>-X+VTDL9);6?;BYM$+H3!/C@G+<$\DHWN:]#P*7 SF@#B=?
M>S3XF>&FD, 86EZLI;&<$1[0WL?GQGW]ZXS1X].M?#/A&YC$$-XGB%P[C =8
MC)-D$]0NUE]L$>M>T8%&!0!R?Q!AA;1K"YGB1XK;5+.65F7<$C$R;B?;'7VK
MF-0&CZAXM\0,T=L]L/#\8A25 %4@R]%;H0".V0#[UZIBDP* /(;74;2-?#LV
MOWDT6FW&@0007'EK+&)\?OD?<C8<C;SQ]TBO1-(M;4>$+:UBCN&LUMMD:W@R
M[1@87<#ZC'!Y]1FMK:/2H[B.26VDCB=4=E(#,NX#\,C- 'DVB6]G<:?\/IM'
M\I]358TO6C.7^S^2?,$G?;D* #QDC%1:+=6-OX6\+V$K1K?6&OND\97YH,RS
M'#<?+D$8SUKU'0-).B:'9Z9YWGK:1+#')LVDJHP,\]<"M'8I.<4 >2ZG96=Q
MHWB.*!4'B4:Q*=/VG%Q&YD4H4[JIZDCC&2>]:(GLV\5?$*.ZF@*G3[0,'88)
M$<@/7T)'TR*])VC.<<T;1Z4 >96M_I4/_"/QZ_) -)N- 2*W><CRO.P!*N3P
M&*[0._# =Z[#-PG@:3^R(+A+A+!Q9QW!)DR$(CW9R<G"GGGGGFMPHIQE0<<T
MZ@#R6UOM"?5? 4^E26@N<7$<A8@2B0V[ K(>NXOUSU)]Z=8$S^%=$E7"^+(]
M4C6YW8\\R>:1,'QSL\O<?3:%QT%>K"- <A1G.<X[T>6@<OM&XC&<<T >0ZLN
MF+X:\1W<<D N[;Q$A@E60!X<RPABASE<C=G&,@'TJ_K,^D:/KGB=+>,_99-$
M@EGAL)-CR.995+DKSG!7<W)QR<UZ=Y4?]Q?RH$4:G(10?4"@#R:UFLU;QU U
MSIYAFTB&:-;,;(21'*"4YYP0@+#N!TZ5H2II>H>-/"L<[6TT$NC3>8C."L@Q
M'@,.A'7@^GM7I)BC(P44CT(I/(A_YY)_WS0!RWPWDB?P3;I%(LD<5Q<Q)AL[
M46>0(/\ OD+CVQ7'26EF_A:XN;!A_;]IK\R66V3,B-]L8; ,_=*$Y'3')Z5Z
MV(U1"(E5,^@XS61H&@G1H)DGFAN9'N)IUE6#85\R1G*_>/&6- ',>&K'3;SQ
MCXKGGV2/:7Z/$3*<19@4,0,\9RP/_P!:LG0[J%],\ P:@1)I4]M*LA+9C:Y
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MY]L-E;&ZSGSO*7?TQ][&>E '$)+)!XL2:[3[797>HR16][#*5>)]CH8)4/5
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MO)&I1'BMU4JIZ@$#@4 <?I>D27TCK#XL+PZCII$4=K)*'#@C%P&,C$,,@'&
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MMH9H5CD+/EERP88P,<8P36=:^$+R"Q2SFUZYNH+>)HK59HER@*E,N5P9"%)
MSCKDY.,;NC:>^E:/::>\XG%M$L*R;-I*J,#(R><#_P#50!Y_XIN;^^\-_$!+
MMX7MK7,428)V8AC<8SQ_&2?>NATK7=1.IG19K&VR-,2\MB)3RN=A5_E.#T/&
M1S2ZIX,DU%->@757AM=8YEB\D-M;RTC)!SG[J# ]<]>E6H/#=S!KD>JB_B,J
M:>+$(;<[2 =P;[_7/Z<>] &/8^+X;?P]X=>.WL=+@U&U:6,S,5MXF&W;#D8
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M/Y_EC"OR1A\$C/(/''%/'A>X6[U&5=14K>6$=B!) 6953?ABV_YB?,;/ [4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_JG_
M -TTZFR_ZI_]TT )%_JD_P!T440_ZE/]T44 /HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HQ110 =**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK(;IVCA(1MK.N<KNQ@-\I."<D#BFZ!XB37;G5(TADC2SO&MD9HW7>%5<DDC
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M?@G3]3^U'5)[B^:XL_L3/+L4B/=OS\BCYMP!SVQQWK8AUC3+B*66'4;22.(
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M<737,HR6E90N>?0< 58HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"FR?ZMOH:=39/]4_^Z: $A_U,?\ NBBDASY$? ^Z** )**** "BBB@ HHHH
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MX\*W%WI%P/$,'FM+!;O$S*GEA9& +A2A8ISN!'%>BUEZIX=TO69X9[VU#SP
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M !DC@X)_&N5U'PCJMZ?$;*]DC:C>6MW;YD<@&'R_E?Y>,^7U&<9]JWM?,_\
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M?$TEB\SRLS1P@;DBWD[@"VU<YSCCO0!ZE37=8XVD=@J*"68G  '>O-=8GNK
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M>@H ]4%YG4FL_(GXB$OG;/W9R2-N[^]QG'H:DN;A+2UEN) Q2)"[;5+' &>
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M4 %%%% !1110 4V3_5/]#3J9+_JG_P!TT $7^J3_ '112Q_ZI/H** '4444
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MW)]:Z^B@#,TO0;#2K2UAB@C=[=-B3.B[P.>A X')X' ' JR=,L#?B_-C;&\
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MA,<C($C./E"@XQP.W8>@K)N/!UG&NEP:=#]FBLKS[6K_ &B0LAW!F"C.#O\
MF!R<#<3@DUU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R7_ %3_
M .Z:?3)?]2_^Z: %C_U2?044D?$2?044 /HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Q?$6C2ZLNGS6LB)=Z?=I=P^9G:Y *E6QR 58C.#C@X/2L36_"
M>I:M9ZXZM9Q7NJ+;Q &1BD:0L6!+;<L26;C [?CVM% $<)E,*&9420@;E1MP
M!]B0,_D*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *9,,PR#_9-/IDO^I?\ W30 D:KY2<#[
MHHI8_P#5IQV%% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HJO;7UM=RSQV\HD:W?RY=O16QG;GIG
MU':J:>(=*DFEB2[4M%.MM(0IPDI (4G& 3D8]R!U- &I1110 4444 %%5+O5
M+*QNK.VN9UCFO)#%;J0?G8 L1^0-6Z "BBB@ HHHH **** "BBJLFI6<6H0Z
M>]S&MY,A>.$M\S*.I ]/>@"U1573]2L]5MC<6,Z3Q"1HRR]F4X8?@15J@ HJ
MH^J6,>IQZ:UU$+V2,RI!N^<H.K8]/>K= !1110 453GU6PMM1MM/FNX4O+G/
MDP%QO< $D@=<  \^U7* "BBB@ HK,F\1Z);WCV<VK64=RF=T33J&7 SR,^G-
M:0((R.E "T444 %%%5IM1L[>\M[.:ZACN;DD0PLX#R8!)VCJ< $T 6:*** "
MBBB@ HHHH **** "BBB@ HJ%[NWBNHK9YXUGF#-'&S ,X7&X@=3C(S]:FH *
M*** "BBB@ HJ.*XAF:18I4=HFV2!6!*-@'!]#@@_C4E !1110 444PRQB81%
MU\PJ6"9Y(Z9QZ<B@!]%%% !136=4QN(&3@9/4TD<T<I<1R*QC;:X4YVG&<'T
M."/SH ?1136=4QN(&3@9/4T .HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *9+_JG_P!TT^FR?ZI_]TT )$?W
M*<?PBBB+_5)_NBB@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2_ZE_\
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M-:75R(H+J<.3 KY("N5.,\GIUK6%Q 4+B:/:O5MPP*\IM=.TZXT/1!:11_\
M"16VKJQ\L?OT47!\SS,<A/++9SQT]16M<:4UCXBNO"]K9#^SM9E742X4;854
MK]H4_4B/'H93Z4 >AEU5"Y8!0,DD\8ID,\-S$)()8Y8ST9&# _B*Y_QQ/!:^
M%IC<1,\!F@5L,55!YJ_,Y'.P=6'<9'>LKP3=HWBCQ5;_ &F.7?<03H8HRB.#
M @9U7)X)&,Y.<=30!T-WK]O'<ZA8VNR:^LK87#Q%]JX;=@$@'!^0GITQ4N@Z
MJ-7T+3;Y_+CGN[.*Y:%6SLWJ#]<9)&?:N.F-C8>/?%37*1PR3Z; T#O'C<0L
MV\@X^@)]P.]9V@?V?:7GP]EA:&.:?3)([I@XW.?)CPKGJ?G7 !Z$8% 'HVG7
M-W)'<G4$MXF2Y>./RI=P,>?D)ST8@C(JQ-<JELTL3Q,3PFZ3:K-V&>>_'0UY
M!;?V9_PC=P'DMXUC\8[HB'"[8S<KDJ1T&S)R.PKHY;?0M*\9'3K^VMK32CIW
M_$M5@%MR[NYG SQO.4P!VSCK0!U7A/7&\2>%[#6'@$!NT+^4&W;?F(QG STK
M7\Q-X3>NXY(&>3BN.^%WES?#+1HFVN%A9'4C./F;((KCK>TL7\,:+-IHB.OP
M:V5B\H@S!/M4@9#W$?EDDCICF@#V'S(_,\L.N\#.W/./7%-EN8((Y))941(U
M+.6;& !DD_A7DW]HZ>NN:9>PW%O 5\1S+.LKYN%W+*I,K<;5)"A4QTV\GI4^
MGZ/H^H:)XTG2""YN[6\O_LVP[C&'A PH'8_J1[4 >H6EU%>6<%U$3Y<T:R)N
M&#@C(XJ;/I7F\\6DPZ%H?B[2UMY!HP7[2;= 0T+(!+TZL@.[VVL.YKK/"UDT
M&EO?7%J+>\U"5KN>/ #(6^ZA]U7 /N#0!+H6M-JXU#S8%@:UO9+0*)-V_9CY
MN@ZYZ5KEE#!2PR>V:\FFDTU+34M0^T0?:H/%<9CE,HS&K31*VWG@%2V?49ST
MJ#7=1TXZM=W<=S%%/;>(;3S7N90TX4-&"5Z>7#M)QUSENF: /8<CUJFL]V=6
M>!K919B%76X\T9+Y(*[?0  Y]ZX74;-=+\3ZAIMK'NA\50#RB$R(Y5^64^@'
MEMYG/=3ZU-J*:?:^*M;ME>*-!X=1?+\S&W#2#IGC@+^E '?AE/0@]^M&X9QD
M9]*\G\.1Z?:7GPYN;:1%N;O39(KAA)\TH$"D*W/(## ';H*;H?\ 9NKWVDVT
M][I\FH6FHW+W-RUU&)+Q29 JA V_)8H<, !LXSQ0!ZWD#K29![BN1^(7DC3-
M*\Z7R@=7LQO#[" 95!P>W&?IUKD]4D.CS^-+71=R0!["29+=SNCC?B=QCD$J
M.3U[]: /6\@]ZR-8UL:;=:?8Q0K->ZA*\=O&S[%^5&=BS8.  OH>2*Q=-BMK
M3Q[Y6C^2NGSZ89;A+?'EB02*(VP. 64OSW"^U5/%UO82?$3P8+F&W=I);I7\
MQ5)8"!MH.>HST]Z .ET'4M2U*WEDU/1Y-+=7"I').LA88&3\O0;L@>H&>,XJ
M*/7V?QG-X>:T*^79+>"X\S(8%]F-N..0>_:N*U*\^Q#QN(9G$']IVB7$B2$M
M# Z0B9@>HP"_TY]*H:Y%I2^)/$D.CFV*2^$W:%+9U(,H9R"@'< *>/8T >P4
MC' ..37ED6KA=3TRXTJYAN-0/A68QQK(&,LZ^444@=6^]QUZUK^&?^$?O(=/
MO+.^>2^N-/:.[CBE&YR0&9Y\<APP(!.""Q'T .STVXN+K3K>>\M3:7$B!I("
MX?RV[C<.#5K(KRC3;FRN/#W@NUNYXF=]+DE(O)0+<X5 SL#]]QGA<CJQ)&*A
MTD0Z^O@*WO+V69;K2;F&Z5+@C?M2,8.#PWS')&#ZT >NYHKSK58#HFLWN@6\
M4IB\0VZQVDNYF,,BXCD&>V$/FCW5_6O08(4MX$AB4+&BA5 [ 4 24444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4V3_ %3_ .Z:=3)?]4_^
MZ: %C_U2?044D7^J3Z"B@!]%%% !1110 4444 %%%% !1110 4444 %%%% !
M17/^*]3O]*MM/EL3!F;4+>VD652=RR2!>"#\O7K@UDMJ/BA[FXT>&>VEU"SM
MQ--<0VX".\COY2[&D&%"IS@DY/!&#D ZPZC9+J*:>;J+[8Z&18-PWE 0"V/3
MD<U:KC(YKN?QMX=FOK86]XVD79FA5PP1]\&0".HSFHM'\1:I>ZO964MU YOK
M*XFW1P'RX98W0 (W'F+B3D]RO49Q0!U]YJ-GIZPM=W$<(FE6",N<;Y&.%4>Y
M-6:\QT+6-9MO!/A>\DNK:X.I:E%'-YL!W!9)"6P=V-V<\X[].*U[OQ/J5QIV
MO:QI;P?9=%GDA-O)&2T_DC,N6S\O&0N!VR<YP #I+_0[?4-5T_4999EFL'9X
M A 4%E*MGCG*DC_Z]:=<#=>)M=NY-;;2YK&.VM=-M]0MWF@9FVNLC;6 89)V
M#G(QZ'M%K7C/5+>TL;A#!IT5YIT<]O<W,1>"2X<9\EG!'EX&,$]<]>,$ [J#
M4+.ZNKBVM[J&6>V($T:."T9.<!@.AX-.-[;"^6R,\8NFC,JPY^8H" 6QZ9('
MXUY]>W6JV7B'QO?:3):QR6L%K<,+B,N) L+G8,$8SC[W./2N@_M6]D\210I'
M:B*727NH24.]7#(,%L_=^;L!0!U%%>?6'BSQ#]F\+ZK?06+:;K)B@DCA#>9%
M)(N5?)."I/&W''')KH/%6JW^B06>HPRVZ:>ES''?>;$6*QNX7>I##&"><@\'
M/;D Z&J\5]:S7=Q:17$;W%N%,T2L"T8;)7([9P<?2N*3Q5K$L^MZ;%/8MJ5M
M?1067^C.$DC=MI8_/\VTB4'&,&,_2C5]7U:*+QHMN;&WN--L8YHYU@)9QY<C
M'=\PYXX[#/>@#M'U"S2^CL7NH5NY%+I 7&]E'4A>N*LDX'-></'J:>(O" 66
MUEOVTR\"S&-D11B#!9=Q+8]-PR>XKJ_"&M2^(?#%IJ5Q&D<[F2.14^[N1V0D
M9[$J3^- %Z/6M+EF$,>I6;REMH19U+$^F,]:O5Y;<:;=ZSI_CG2;'3VFGN-6
MQ%,714A?RH2'))W J><@$^E;UOK'B$^*)O#T LI!96MK-)<3;LR!F(DZ=&(4
MD<8SUH [2C-<+<>,K^VT:T\3,EM)HEQ<K%Y*JPF2)WV)+OW8)S@E=HX.,\<P
MZ1JVO*_B^\EN+.X^R7QAB1P8TCVQQ_,69\! &+$=20>><4 >@45Q:^+[JVTC
M7[FXCBN'TUD$<B0O"KJZ*0S*Q)4#=R<G@9HE\5:CI=UJ\-^MI<QZ;;0SF6 -
M&9&EW*B8)8#YEZYZ,.* .TK*U#1([W4(M0COKNSNHHFB$D#*04)!(*NK+U Y
MQGCK7.WOB/Q+I6G:Q=7.FV\T=I8-=PW 5HH]ZYW1,I)8G'(88!]JM:9X@UBX
MUR*PO;6S"WFF&^MO+=LJ5**RN3ZF13D#CD<]: -K1;2QAMY+NRN/M?VQA-)=
MF0.9C@*#D<8P  !@<5IUQ6CZ]<W>C:!9Z;:65I>7]FURR!#Y-M&FT'" @M\S
MJ  1U)[8/3://J%QI<+ZK:):WN")8DD#KD'&0?0]<=1F@"_17$V7B_4I?$]E
MID]M:@7@N0(D8EK9XL$*\@)5B5.2!RN>]1:9XRUB\TS1]4FL;..SO-0:RE59
M&+@F5XU*\8P"HSGKSP* .UNKRVL8&GN[B*WA7K)*X51^)I9[F"U@:>XFCAA0
M9:21@J@>Y-><^/-2O-7\&:_-#%:G2[:;[/\ O 3)(R2*KNIZ* P(Q@YP>175
M^.(TE\ >(5D56 TVX8!AGD1L0?SH WU974,I!4\@CO4%[90W]OY%QN,).70,
M0''H?4>H[]^*YVTUS5(M1FL9K&&3_B6?;+5(I<.Q7Y2CDX ))7!Z#)Z]:IZ=
MXKU74+J^T^V6QN;R.Q2]MY8U=87)9E,>23G!7 =3@YZ<4 =MTJ.WN(;J$36\
MT<L1) >-@P)!P>1Z$$5R>C^*K[6O["-M';,;RTDN;Q"K+Y.TA=H.>#O.WD'[
MK'MBJEEXGN[?0_#TEGI-E&-3OI;8PQ.46,YE;(^7N4R3[DX- '=T5PZ^.;J/
M1[EI[.+^T(=8&CDHQ\D2,5Q(2>0H#C/N,=ZVM"UB^O\ 4=5L+R"W#:=,L1FA
M<XE+(K@["/EX8 C<>10!O45Q^J^*-6MM0UZVM+"T<:59Q7>^6=AO5A(2,!>#
MB/ [#J3VJQ%XDN]7N4M=%MX?-%C%>S/=,=J"4'RX\+R2=K9/0 =\XH ZBBLK
MP]K:Z]H,&I"$P,V])(BV=CHQ1QGN RGGO6#_ ,)I<)8Z9K4UI$-%U&X2",JY
M,L:N<1R-V()QE1R,CD\T =?#<0W 8PRI($8JVQ@<$=0<=Z;]KM@\J>?%OB4-
M(N\90'."?0<'\C7FVD:Q?>&]*UZ]MM.MWTJTUN[:ZS+L=8_,Y,:@8.T<X)&<
M8%:T(CM/%OC:6.TAE'V&TD>)OE67Y9LAC@]1[&@#MHIH[B%)H9%DB<!E=#D,
M#T(/<4^N+TKQ)G2O"]AI]E!:SZI8_:(X\$0P(J*2HQR3\R@#TR>V#/;^*[VZ
MT*SU V5M:B>>2%Y)+@M'%L++SP"2SKM &>H.>U '6U''<0RR21QRH[Q';(JL
M"4.,X/IQ7#MXHU35?^$2GL;>* :A<SB:*29ADQQ2_*2%^[E<],\#@5/!XCM=
M.NO$\W]E0PSVU]#;DPO\UW+(J!"3@8)WJ.^.>M ':T5RMWXIN],NK^QO+&$W
M<-@^H6_ES'RYD0X=22N58''8@Y'3FC2O%=W=ZQIEE=Z:ENFI6!O+=UGWL-NW
M<K#&!]\8P3TH ZB12\;*'9"00&7&5]QD$?G4%E9P:=:""'(C4LQ+')9F)9F)
M]222?K5+4M7>WU.TTJTB26^NDDE D?:J1I@%C@$]64 8YS[5Q_BOQ'>:EX&O
M_(MTMYX=0CTZ^C:8_*?-C5@IV_,K*XY./E;IGB@#T*&>&YB\R"5)4/1D8$'\
M169I6BR6%U-=W>H7&H73KY:RSJB^7'N+;0% '4\GJ<#TJ$)IWA72-3UB2TBM
M-RM=WBV[%E9E7DC(&20!V&34,WB&]TNTO+S6-+\BU@M/M(DAF$F6[Q'('S],
M'H<]: .CHQ7+S>)[VPU.#3]1TR.*:[MI9[4Q7!=6:-0S1L=HP<'.0"#S5;1O
M&=UJ?]@2S:4MO;:U&_DM]HW,KJADP5VXVE5;!SGV% '6/<P1R;))HU?:6VLP
M!P.I^E2!@0"#D'H:\TEM1?Z?XHU+6M#L;[['=RS%?M3;LQ1( @.P?+MW>QR<
MCDFNK&K&6>WT>QL(I7-BMQ*DDNR.*-OE5<A223AAC'13]" ;Z.DJ[D8,,D9!
MSR.M*0#U'2O-_ VM?V5X)T;3[>R,EU<2WKK$"VV)$N'#%BJL< LJ\#G-;:^,
M[MI-&@.@7,5SJ4LT/E3OY9C>-&;/(Y4A<@^G;/% '6,&$9$956QP2,@?AQ61
MX=TH:)I_]GFZ2Y>.21]X38P#NSX(R>[''M6!?^*=4N-,TY[2TA@N7UD:?<HU
MP2%*.<A6"<JVW&2!@'IZ6;758+?Q+XF:+0V.HVEK;2SM;R;WN\J^Q5! Z8('
MKF@#K#''G)5>N[IW]: T8( 9<L./<5QE_K\6NZ1XJTJ6"#S;&Q+NT%QYT9W(
M^!G (92AR,>E,LKJUAN/!-O)IHFNI;!_LMT9-HAQ I88[Y 44 =!JNBW&J7*
M(VHR1:84VSV21+B;G/+GD C@@=1FMFO/](\8ZK#X4GUS4+.*:'^T98F*W!'D
M1^<8\GY/NK@9/4C)]JZR#5I+CQ#=:8EL/*MH(Y'N/,_B<MA-N.N%SUZ$>M %
M\VT!&#$A'^Z*0VL#;MT,9W8W94<XZ9^E<]J'BR;3]4U2P;30TEE8_;XSY^/M
M$0)#8^7@C!Z^H]<B:R\2_P!IQZ<UO9K*E]8->_)-G8ORX7D#DE\=NC>E &]M
MCD9),*Q7[K8SC/I3#;6\C,QBC9CPQ*C)^M<%!K\\">!+/0K%;?3]2C:00O,<
MB-;=F$9)!/&0<^JXJ+P_K3>'8]<<V,TUE_PD4D,LYE'[OS&C1< Y+8++GT'3
M- '?RV,$D3*(U1L$*ZJ-R'U''4'FN<L_!KPVMK9W-Y;7-M;.CI)]C"W#%&#
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MMO);HF\$,LA!<L2-Q)*@DYSD>YS!IW@VRTV?398KR^<Z=$T%LLDH(6)MOR<
M9 V+SUXY)'%;IN[=;A+=IXUG<96,N-Q'L.M))>6T)(EN(D((!W.!R>GYT <]
M!X&L+?3;/3X[R_%M97*W-NID4^6RDE0,KT!)]SW)J>;PA9RS:CY=S=06VI9-
M[:Q,HCF)&UB<J2I8<':1GZ\T_6==EL]5L-*LU@:\O(YI%:=B$C6,#KCGDLH_
M$GM@W-(N]0GLY9-5BL[>='YCMYS((UV@X9B!\W)]L8H J2>%;1I]1DCN+B$7
M]JEI+''L"K&H8*%!7C =OS^F*<_@>TGTY].;4+_[%+:1VDL):,J\:9"GE.&P
M<;A@\#N,U>TK77U+7]5L0D'V>SC@DBFBEW^8)-^<\8&-G09^M:JW=N\+3)/&
MT2YW.&!48ZY- &(WA&T+:L5N[M1JD"V\ZADPJ*I4!<KQ\I(YSU]:>^AQV=S#
MJ7VN\DDM;)K14"JP=#@G(5,DY5>GI6N]Y;QQS.T\86$9E)8808SSZ<<U134Y
M[V/2KJP2!K.[ >4SN4=49-R[0 <MG&02.] '-^#O#;2>%_#R:I)?[]-2-UL[
MA @CG5<9^Z"P7)QR1]<#'6:QID&M:/>:9<C,-U"T3XZ@$8R/<=:L^?$96A61
M#*HR4W#(^HK+\/ZQ-K":@9[9('M+V2UVI(7#; .<D#KGTH @L_"6GV>J:=J"
M;VN+&T:U5F.3)D@[V/=OO\_]-&]:=+X6M9KG6II;BY==8@%O<Q$J%"!2HVX7
M(.&/4GK4=KXBN;CQE>: ;"-5M8$N&N!<$Y5B0H"[>O'//YUO"5"0 ZDD9 ![
M4 8,'A2.&^TR\?4[Z:?3HI(8FD,?S*^W.X!!V5<8QT]SFYH&A0^'=)73;6XG
MEA62216F*E@78L>@ ZL3T[U17Q%>7NKWMGI=C%<16%S%;W+/-L;YE#,4&"#M
M##J1GD>F>@61'!*L&P<'!S@T 96D: NCW=]<1WUS.;Z;SYEE"8\S:JY&U01P
MH&*(?#\4'B>[UU;JX,]S"D#Q';Y>U<D8^7.<D]^]:HEC/1U/3H?6CS$QG<,9
MQG/>@#F1X)MOLZZ>UY.VCI<BY2P(7:K!]X7=C.P-SM_#..*6?P5;S#64&H7<
M<.J3)</$NS$<R[/G4E<G_5KP21UXYKIC(JXR0,\#/>JYU"W&I+IX?-R8C-M'
M900,GZD\?0^E '*:YX?N;/3=7G@N=2O9=2$4=PL2QEE PK2!=HW?*/N\@],<
MU3T[1+C4/-TUWO;C0KN!TNUO-/CLV1L#9LVHC$^^".!R.E=KIUQ=RV"RZA!%
M;W&6WQQR^8JX) ^; [8/3BK6]=H;(P>AH Y4>"YI]'N].U+Q#J-\D]N]JCRA
M T<;#!Z+\S$#&YLGTQDYO0^&C!JEE?KJ$YEM+%K) 43!5MI+'CKE%/IQTYK=
M# ]#FEH Y)_ RII^DQ66KW=K>Z4&2VO%5"VQL;D=2-K X';J :Z#3].%A:&$
MW$]P[DM)-,^7=CU/& /H  .P%7:* ./T[P&FFS:3)%J]VW]E/-]G#I&?DD'S
M*QV\DG'S=>/?-2V_@E;;0[/2H]3G\JTO?ML;M&A;?YADP>,8W$^^.*ZNB@#C
M=0\!&\M=6L8=:N;;3M3D,\ELL2,$E+!G96(R Q&2/4DCTKH-7TIM6\/W6DR7
M<B+<P-!+-M4N58;6/3&2">WX5I44 <W>>$A?RN\^HSXDTY].<1JJDHW5@<<-
MD ^GM1IGA66PUR'5I-6FGF6R6S=/)C1'16)7@#C&X]/_ *U=)10!C:3X>AT>
MYU2>VD.Z^G,H!&1$",[0/3>TC]N7-9L/@OR+#2+1=3DVZ7=M=Q,8ERS'=PWM
MB1^GJ/3GJZ* ///$'AJ73],NX8Y[Z>#5-66]NGM[43&#@$_NP"70^6@VX/7)
MXXK7\(QWL,]RGFO-IS*'2273?L3B7)W#;A2P(P<E?Q/;K** .<N_"SW5]K5S
M_:!4:K:+:2)Y0.Q5# $'/7]XWZ>E5X/"%SI\]G>:=JWDWL%FEE*\MOOCN(D^
MX60,/G'9@>YXQQ75T4 9^C:1#HNDQ6$+,ZH69G;J[LQ9F./5F)Q[U@P>!_+M
M[73)=0\[1+2Y%S;VAAPZE6+*ADSRBD\#:#P 21UZZB@#E&\&.PU"R_M'.D:C
M<O<W-LT ,A9SEE$F>$..FTG&>:LOX:N6U36KU-113JEND#(;?(C"!@I!W<GY
MVSZ\=,5T5% 'F6M:3<:4OAO2&O;F.STVV=5O!IAN8W; 1%9%!VL%SSD Y/KQ
MKZ;H>IZE;:;.]^+<Z9<O]F<:?Y2S0L@&?))^1AE@#[9QAJ[:B@#C8O!%U;66
MG16^N2+/IUY+<6\S6R-A) X9".A.'/S>O;M4LG@D7!UW[3J!<:I/'<(4AVM;
MR1A0C Y.<;%/0<@^N*ZVB@#EI?"U]?\ VNXU+4;>2_EL7L(I8;4HD4;XWG:7
M)+$@=P!@<=<EIX3NK?5="O7U.*3^RK-K3:+4J958 $YWG!^1>Q[^O'4T4 8F
MLZ%+?:G8:M8W*6VHV6]%>2/>DD;XW(P!!QP"#G@CZUE7W@F:]T"XL%U***XO
M+Y;^ZN/LQ8/(K*P"KN&T?(@ZG@>IS7844 4=1TR+5]&N--O\217,)BFV#;G(
MP2.3CVZU@0>$=0N]&NM,\1:X^I0RVYMD\N$0X4X^=N3N<8&#V].376T4 <JO
MAG5+J:VN-5U6"YN+*WEAMGCMB@+.NTR2#<<G'88'7VQ#IW@V\T^V\,0#5(77
M0V8@_92#,"C1X^_\ORL>>><?2NPHH Y8>&-1_LK7[$ZG;'^U9)7#_93^Y\Q0
MI&-_S8 XZ<TDOAK5H-3L]3TS5+6&[6T2SNQ-:EXYD4DJP4."K ENYZUU5% '
M VG@+5]/TS3_ +%KT46IV$UP\,WV7,;QS/O>-UW<C=@Y!&,"M1_#&IS:IHFH
M3ZNDTVGS23R[[? E9XS&50!OD4 G YYZD\UU5% '%R>#M3;3WB75+47*ZN=4
M@D-JQ16+$E&7?EAR>012W?@S4+JZ\03'61&VK6D-N'BA*O$T0.&SNY#;FR,#
M@XKLZ* .,3PAJ@GU64ZE9*-1TU+)HH[0HD;*' *C=PH$AXZD]P.*G3PM?K?>
M&+@WUMC187B=1$W[X,@3(^;Y> #WYKK** .%BL+7PAH=]I_B"_CGTB_N98[>
M)+5RY\YG<HQ7.2<D# '3U-;'@C2KC2?"UI%>M*U[(H>=IB"_0*H8CC*HJ+_P
M'\:Z$J#U&:6@# U[PXFLZII5WO"+;.ZW"X_UT+#)C/L76,GV!'>H_#WAR70D
MU(B=97FF<VP/ AA+,R1].@9W/X^PKHZ* .(C\%ZG!9>%%@U"U6[T$-$)&B9D
MD1HC&3MR"&QSUQFEF\'ZE)HVJV(NK4/?:LNHA\-A )$?9COS&!GW/'%=M10!
MC^)M)N-<\-WFF02Q12W*;-\@)5>1DX'7I5'7-%UFZN]-U;2;NTM]4M$>*1)U
M9H9HWVEE.,,,%%(/M7344 <EJ?AO4=5L8;?4CI^IHT<GVB.=3&HE8@HT1 )4
M*-P]3GKFLS3HK[3?&<>FVUS;7MU;>'[>&5KB4HTC+(XWY 8^Y&.XY]?0*B%M
M LQF6&,2GJX49_.@#BT\'ZQHB:1+X=U"T%Q:VIM;E+R-C'<*6W[OE.5(8L1[
M-BK%SX=\16NJVVJZ7JEG+>/;?9K[[;$VR0!V=64(1C:78 >F!GO78T4 <F?#
M6JQ>*M-UF+4H)I([)K.[:>(Y<-(LA9 #@=" #T!'7%:'B/2;[47TJXTZ:WCN
M;"[^T#[0K,C QO&1@<Y^?/X5N44 <1<>$=2DTK5]!6>U.F:G.\IF)82PB0[I
M5"X(;)W$'<,;N<XYZ+5K"ZDT+[%IGV<.IC4)=+NC>,,-R-P>J CIWK5HH X.
M/P3?VVFS1V<UO"4U.'4+*R,CM! $VYC#$9 ;#'A<#/0TMUX0UJ]?6+I[RRAO
M)[JWOK)XU8B*:)%4!P>J_*1[YS@=*[NB@#D+W1_$>K:.8[^;3Q=-=6THBA9Q
M#&L,BR'#%2Q9BN.@ &/3F]I>C7EGXQUK5Y6@-OJ$5NB*KDNIB##GC'._U[>_
M'0T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-D_P!4
M_P!#3J;)_JG^AH 2+_5)_NBBB+_4I_NBB@!]%%% !1110 4444 %%%% !111
M0 4444 %%%% '*>/;"ZN=+TZ]M87G.F:E!?R01@EI40G< .Y ;<!ZK6HGB33
M+E4%E<)=S.P @A8&09/)9>J@=3G'3UK7HQ0!Y;?K'-X2\3V-ZN/$)O9Y;= /
MWTDF_-L\?\1 &P CH 1V-,U*UTN6Z\?-<16;7!T^,H6"G,ODN&V_[6[:..<X
M[UZI@>@HP/04 >?R3V%QXU\(RRRVTC-IL^]V*G+'R=F3ZDAL?0XK%BE@BT?7
M1"L;Z=_PE(DO$A&0+8F/+$#JF5Y[$!O>O6\#THP* /*-8N+>XG\9-HV+E9K>
MPE860#&>(.WG;."&.S([^F*SO$L>A3>#/$EYI.H7=^]U:1*[21)'$KHXV*%5
M$'F8)XP2 O..*]GP/048'I0!YU>VVEGQ#K-I8Q6K+<^'PPBA53YKAI"#@?>;
M!!SUYJE#<:6T_P .6MC;J49E=E4+R;8@\]_F('^]QUKU/ ]*3 ]!0!X_I][9
MOXA\,W4 6U U>\26"3+7$;.L@_?.>[$#"XZ8 )Q7:^![B&9O$(BFCD/]L3M\
MC \$+@\?2NKP/04N!Z4 >?6]UIS?%;Q!'=7%L87TN!'61UVG:S[@<^@ZUC:%
M_95E%\/[J&2VCEEDFBFF#C<P\B0;6;J1NVC!Z''M7K.T>@HVCT% 'D<7DQ6?
MQ!?1XH7NTN_W0M@/,$7EQB39MYZ!NG<>M:VH_P!G_P!L^;HK6ATJ30[@7HA*
MB( ;?))QQNY<#/.,^E>C;0.PI!&B@A44 G)P.M 'D]G;:-!X!\'W(-NEQ<SZ
M<)Y3( S[, @G.?ER1[#CI46KV6C11_$>V1+5(K6U2:V@7:$BE,!RZ+T5]P7D
M#.:]=V(>JK^5!C0]44_A0!X]KU_8ZC8:H))8VO1X<C=9+M]_F,4=A]G3CYLC
M+."<$+QQ716<NC-XXMKJY:R+7FC0M%*X4F9_,8$J?XC@C)';VKO]B 8VKZ=*
M"B'JJGMTH \>\+W48\/^"HKEE?1WO;Y;MBV8Q+YDAA$G;!).,]]OM6CJ45G'
M#J4 F5-+3Q#8?9-LFQ$W/#YRQD$8 )<G'0YZ8KT_RH]A3RTVGJ-HP:3R(M@3
MRDVKT&T8% '!Z%?:9H/C+QG$9[>STRUCLY]BD*D99&#M@=SA<^^*[Y'61%=&
M#*PR".A%-:WA8,&AC(88;*CD>]2=* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_JG_
M -TTZFR?ZI_]TT )%_JD_P!T441<Q(?]D44 /HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ILG$;?0TZF2C,+_ .Z:
M "/B-1["BDC3]TG+=!WHH DHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%.E36]U,L\B_99$BECD@=) SXV#80&.[<,8'.>*!XHTS?"C23(TMU]C57MY
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MXVBVG( .<.1CITK'CUO4XM$\+:\E_).VK7=O%=6S!3&%F[( ,J4)'?G:<YH
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MNE(T4,LJ,8+=%P"J]< < "K]>=VL-U]H\#QQW9,KZ=/B61 Q0&*+H!C./?\
M6NH\*:E=:GHC2WCJ]Q#=7%L\BKM#^5*R!L=LA0?K0!N45P%QXIU2'7=.C6XM
MYX+G5WL9!!'NA1-K%1O."91M^;&0.0<=VW/B#Q%!I&H:Q]ILWBTW4G@DMUMR
M/.B60*>2Q*M@Y'7D<YS@ 'H-4DU:QDU233$N4:]BC$LD(.65"< GTKC]1UOQ
M(+/Q5<V=Q8J=%G)C1K<GSD6%)2A^;CACSW/ICDTJ[.I?$IKV)1&;GPU;RJ&&
M=NZ5R,],]: .UL;ZVU*RBO+.42V\J[D<=&%6*X?1O$NH:M:>&K7S((+K4K.2
M[GF"?=5"HVQJ>,DN.N<!3P:GNM4UVTM[6VO+NR6],$[2"QB:5Y)%(\O"$?*F
M#EB> <#(SF@#I7U6QCU2+3&NHQ>RH9$@S\Q4=3CTI]WJ-G8R6\=U<1Q/<R"*
M%6.#(Y[ =Z\YMM0U#Q!KW@K48Y(+:\O-'N9'?RRZH3Y62%R._J?SJW+J=]J5
MKHZ:D(C>V7B46DDD*E4DV!\, 2<9!'&>N: /1*J:CJ=EI-F]WJ%U%;6Z?>DE
M8*!7(2>(/$E]/<76D6 EMK:^>W,;M$L;QQN4D)8OO#9!(XQC'!ZU=^)Q_P"+
M::]_U[?U% '6@Y&:@O;*#4;*>SND+P3H8Y%#%<J1@\CD?A7*>+_$FH:+%J4U
MK)!_H=B+F*$1M([MN;=YF.$3"@ \9)/IBEUC7]4TWQ#<6+36T=O/ILEU8RO"
M3^]C(W(V&^;@J1C!Y/I0!T^GZ?:Z79I:V<(BA3.!DDDGJ23R2?4\U:KA]+\4
MZMJFFV,UM%!)>C3IKF]M3&4(F4[%BR3\F9%D'.?]6:O>$?$%QKD]SYUQ"3%#
M%YEJT#0W%O,=V]71B?E^[M/?GKUH ZJBN:?6+[4O$6JZ3I<MM"VF0Q&1IHB^
MZ60%E& PPH4#/<[O;G(T_P 7:OX@;1UTV*SMO[1TZXG;[0C.8)8G1#T(W+EB
M,<>N>U '>45A>*-4OM%\-O?6JV\ES')"I64'8VZ14/0Y'WNO/XUG7^M:S::M
M'HR+%<7DR2W6^V@!\J ,JH"KR#)RQR0?X>G/ !UU%<?'X@UISI%C>V]MI=]=
M6L\L[SCS(U>,J JX<<D-OQN.%!'N$T?Q)JU\GAR6Y2T1-661GC2-LIMC+ AB
MW(X].AH ZB[U"SL%0WEU# )'")YKA=S'@ 9ZGVJS7G6J:M=ZSX4N6O5@\VU\
M1P6@,*E0RQW<:@X)."?K6IK7BC4=,U*1%6T,,=]:VXB"-([1RLBEV93B,Y<X
M##G9WSP ==--';P23S.L<4:EW=C@*H&22>PIMM<0WEM%<VTJ2P2J'CD0Y5E/
M((/<5QW]IZG#J'C2X\ZWEBT]%\N"6)B,"W$@&=W3+'/'/M4NE>([K46T72[-
M+.WNI](CU&<F(E(E8*JJB!AU8MWX"]\T =C17$P>+]4N5TR)+:T6YEU2?2[L
M-NVJ\:2-O3GH=@.#ZXSWJ%?&U_#IMY+=01?Z#K,FG75U#;.Z1QJF\2F,,6 Y
M53R<9S[4 =Y16=H=[)J.DPW<LUK,9"Q66U.8W7<0K#D]5P<9X.1537=<DTZ_
MTG3;98C>:G<-%&TN2J*B%W8@$$\+@#(Y(H W**XK4/%VI:?;ZG$UM;2WNGWM
MK Q 94ECG9 K 9)4C<1C)^[[UT]N-3^Q3"Y>T6ZW-Y31HQ0+GY<@G)..O(H
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M?:J2+',Z1S*OW1(@(5P/0@^G2I4\3Z4XN<32A[:$7$D;6\BN(SG#A2N2.#R
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MN'L['2Y%MWGC16DEFQE@-P("KP.A))[=[]M>7>EB_;6[E'@6=%M9ECVEU95
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M[V:2*WN8HBJ3L'8;5 R,@#'7G:36A)KFFPO=++=+&;1D6;>"-K-C:,D<DY&
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MNUF%+-.LJF-0/O98''&#GZ5''K^CS/;)%JMD[76?LX6X0F;!P=G/S<@CCTH
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M;3_/C@^W6WG2.T:1^:NYF R5 SR1W%3W%Q#:PM-<2QQ1+]YY&"@?B: .;OO
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M444 %%%% !3)O]1)_NG^5/J.?_42?[I_E0 Z/_5K]**(_P#5K]!10 ZBBB@
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MVW0 ))N4[7R>!P>?:L/2+/4D\0^&+^?2[]%M[.X@N5\I4CMV98\(B*<!%VL
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M?<C !, ]L8QCMR:<_A"RE2X:2>X:ZFNX[W[4"H=)44*K* NT?*N,8Y!.<YH
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M=7BV_EC/FI&TOEI+NS@Y."5P, ]>*OQ^#O+NM$G;5;F5](+&'S$3YPR>60<
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M#4'BN+V)$NVDB5_,9!M60 8"OCKQ@\<<4 6M)\06FJ^%[?7ES%:RV_GL&ZH
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M(^,2!8E0D<YZCOBL'5+35K:]\80'3+F\CU>US9SP!2 1 4,;9(Q@Y(]=Q[T
M;.EZN;B]T:.XU<"YGTT3R67DC,A(4F3<!\N,D8Z<UIV_B'2KGS/+NP%2'[0S
MR(R+Y7]\,P *^XXKCXM-U9=;T"[_ +)FVVFA2VTBR;<"4A=J-@GKL/3U%9\W
MAO6[S1+W2-,6Y2RETS$5MJ"#-I,'1A;I(>6C90RGD@8'- ';7?B&WNM+U'^R
MKM1>P6AN$$L3#Y2"5?:V-RG!Y'%/L]>MXM$TN?4)_P#2;NU279'&79SL!8A5
M!.!GGC S64MY>:MIEW._ANXLISI[P.947S&D(XC3!)* ECDX'3WQ5TVVU#2=
M7TC4+BRN9+0Z+'92K''O>VE0@\J.2&Z9 /W!ZYH Z<^(-*^RV]REXLT-RI>%
MH%,N]1U("@G [GMWIMOXCTF[D$=O=B5VM1>*JHQ+PG&'48Y'(Z?2N#L/#=Y9
M6-J)X]2L+CS[VYM;FS7S&M%DD4K"Z ,&5A@D8(!7J*NZ)::O8>(M!U"_T=X@
M^ABQDCM$79!,)%;:0#A5P.O0=* .KE\6:#!:Q7,FJ6ZQ2PM<1DM]Z,=6 ZXJ
M23Q+HT)B\S4(5$FS:Q/RC?\ <RW1=W;.,]JY+0+&\C_X0T76EW,9L[>XCF\R
M+_5,P 4GTS@C\><57DTVXBU'Q#I6J^'KW4K?4+LW5I)#(WD2@JN$EPP";2H&
M2.@XZ<@'HEU=065L]S<RK%"@RSL< 50;Q)HZ6LMS)J$,4<,HAD\TE"DAQA2I
MP03D<8[U6\4I=GPQ(MM9+=S!HB8MN_ $BEF53]XJ,L!W*BN0O]/OYM-\40+I
MVHS?:[FSEA:>,%I@!%NX'3&QN,#&,8'2@#O;76],O?M7V:^@E%I_KRKC$?&<
MD^F >>G!]*QK?Q*;[QQ;:;:7,$MA+ITMU\L9#;E>-5(8GE2&."!CCJ:P_$NG
M:G?WGBE;"RF<W>FVB0[D*I-Y;R-)'D]"5<#GU]C5Z*]FO?&VFZI'I&IQ6Z:7
M<Q.9;8H4<O$P4@]_E/L>V: .W)Q7)7OBJ/2_"VK:H-1M-0>&69;?RD(0,/NQ
ML03DCH3Q6_H^J1:UI4-_#%-"LA8&*=-KQLK%65AV(((_"N$DLKUO OBRT&GW
MGVB[U&YD@C\AMTBO)E6 QTQ^7>@#L-*N;E8;NZO-2MKC3QAH9MGEE  0^_M@
M$<'TZ^M26?B;1-0NX[6TU6TFN)8_-CC24%G3U [^OTJQ?.)=&NG 8 P.1N4J
M?NGJ#R*\V\-68U3PCX$BLK29+BRE2X><V[*D<>Q]YWD8.XD# )SG/8T >C_V
MUIOVT6?VV'[0SF-4W=7 R5'JP'..M*NL:>U\+);N,W)8J(\\D@9('J0.H[5Y
M[;:9JDO@:P\.2VMS'KEIJ,;FX\EO+RMQO:<28VG*%CUSDXQFKT5O>V_B%7L[
M>]FLVN[N2XL;JW;; Q67]]%+@<.?X<M_K3C&#0!UDFO:;-:71MM3M$>*$R>9
M(PV(.@<\C*Y[YP?6LC_A)9++6].@OK^R_L^32'O);K;L#2*\2Y!)P%.\D#]3
M6/I-M>VUM>6B)?76G#2&2#[79LMQ;MT$&[:#(,>Q(QUYJ6R@>TU;POJ-WIUT
M8+;17M2XM7=H9R8N"H!9>$<9QCWYH WM4U]P-"N=*N;6XLM0ODMWD4;PR%6.
M58' ^[CH:U)=9TR"\6SEOK=+AF""-G&=Q&0OL3V'?M7#V^F75G9:7ML;A(6\
M127L<"0,3! WF8W #Y>6!QVW>QQ$]HS7&MZ/JOA[4[V:>^>ZM9(WE6WN 6#1
MEG4[4*8523SA1C)XH ]+K)A\0Z?/X@N-&2=3=01I(ZY_O;N!ZD!"33].UJWO
M]2O].6*>*YLBOF+-&5#JV<.A/WE)5AGU4USFLVFHRZ_XDM[.&=9=2T>*&TN1
M&?+61?M&<MT4@NGOS]: .HL]9TW4)C#9WT$\@7?MC<$E<XW#U&>,CBG7>K:=
M831PW=];P2R!F1)) K,%!+$ ]@ 237'6T5QJNO\ A&YL["YLETV&9;Q9H'B$
M:F,*(^1AOF /!(^7/I6KXCMVG\4>%7%I+-';W<LDKK SK&#!(JDL!@?,5_GV
MH TXO$NAS?9?+U:S8W3;( )ES(V2, >N01]>*A3688=6U7[5K&G?8[2.(M$&
M"O;$[LF1LXYQQP.AKD;FRE'A_6VATR[\Z3Q#%<HJVC[W19XG+@8R1M5CG_&I
M+NUNFUGQ_(+"[:._TV".V86SD3,L4BE5XY.77_(- ':0Z[I5U+/#;ZC:R2P)
MOE590=B^IYX%4]-U^S33+ ZAK6G37-Q&SK+"P1)@N2S("3P #DYQQ6180-;^
M*M(F2RN8[2+0GA)%LX5&WQD(>.#A6X_QK T'3+N*P^'D-UIMVK6$D_VD/:O^
MY)B=5+<<?,5P?Q[4 =['XGT*9;8QZO9,+IMD&)U_>-G&!SUR,?7BFC5X(-0U
M-KK5+ 6EJD6Y P#VY.[/F'..>,=.AKB/[-F3PSXE6/3+I9[C7A<PA;1PSIYT
M;!P,9(PK'/\ C6Z9/LWB#Q+>SZ9>7,!AM)(42U=C,T>XX7C!(8K]/P. #H8-
M?T>YF>&#5+.25(S*R).I*H#@L1G@>]2V.K:?J9E%C>07!B($@B<,5R,C/ID<
MCUKSR_L+Z^\.ZA.-,N;K7[^..XND>&2*/RHY4;[(K,!QM+#CJ=Q[UTGAQK._
MU5]3M-*U&WD>V6&>>^$J-PV5C"O][&7RPX' R<\ %ZZ\362:O<:/!=6XU".W
M,H5V! 8YVJ1D$G@G'H*C\->)K75])TG[3>6@U6\LH[E[9' ;YD#'"Y)QS5&]
M\ZT\?WEP]K=/!<Z/'#')% SKO225F!('! =3@]<\9-8>EV$UI9_#M$TZZA:R
M1A= 6CCR6:V9#N^7C+D=?K[T =^FK:<]_P#84OK9KOG]P)1OXZ\=>.,^E37-
MW;V<7FW,\<,>0-TC!1D]!SWKSOPM H73=-U73-2?7=-NGD>1O-6#<S-NG$GW
M"&5F.WN3C'<;?C)I[34=$U%[>[FTVVEE%U]E#-)$73:L@5>2!\P..S&@#?.N
MZ0J6SMJ=F$NCMMV,Z@2G.,+S\QSZ54U'Q9HNG6B7+ZC:NCW*VHV3*?WA<*1U
M_ASD^@!KE+G2+74=".FZ9IE]:_;]2^U6EU.),PN ':Y(;F/G=A#C<>P#$U'=
M/<W/@O1@^F7<-QIFJVDE[&+:0D[)@9)5R,NIY;(R>>>: .]DUC387A274+5&
MG"F(-,H+AONXYYSV]:2;6M+MV99M1M(V618F#S*"'/13D]3Z5PE_):R:SKEC
MK=CJLD.JB*2S2"*3$\?E*/*)4?(RN&/S$8W9S46L:>9K7QU(=,F-Y/81QP$0
M,[.WDX*HV/F.[ R.X% '<GQ%IG_"0C0Q=Q&^\KS3%O&5&>!C/4C)QZ GTJ]=
M7MK8Q"2[N(H(R<!I7"@GTR:Y*UF>/XDK=/;W)AO=&ACBE\A]I=99"P)Q\I 8
M'G'6K.NS26'C+2-2O%8Z3';3Q>8J%A!.Q3:[8Z J&4'H,GUH O:_XGLM(T,7
M\=W:.T^U;7=*-LA9E4$<\J"P)QVJSI5U>O:W$^I36+PARUO<6I(22':"&.2<
M'KW(XS7"&WN+3PAJ2^3/]FN/$$=SI\*0LS+;BYB<D*!E5^61_H?>NW\3"WF\
M+WR7"W#6\L)1_LPS)M;@E1@Y(!SC% %E=;TEXQ(NIV;(7$883K@L>B]>I]*G
MCO[.6XFMX[J!YH1F6-9 6C_WAU'XUYK>27USX>UT2NFI);7-C,-1MX"IN(TF
M5W#*O!=%4YV]B. >*J^(#=:QJ_BQ](MKFX-SI5GY86%U\Y%D8R("1P63<!W.
M>* .Y\1>)TL/"NJ:KI$]E>RV,1D9/-W*,#.#M/7%;5M?VMU+)!%<PR7$./.C
M1P6C)Z;AU'XUYUKUUI&L>$O$%]HNFW7G76FFV>4P21Y9>$A"$<L-S?='&,9K
M<L5M(?B#;-:QA(I-'*EUC(#-YBLH)Q][&XX//6@#K+FZ@M(3+<31PH.-\CA5
MS]37+Z'XGU#6=%6]VZ=#*-4:T</*=AC678=A[N1T[$XJ/Q)>PZ;XUT2\U6-_
M[*2"989PA9(;IBH!;'3*;@"?4^M<CIJVJ^%K4?9V7R/%?F1;H&4H@N<DC(X
M4<^G>@#U<ZA9B\^QF[@^U=?)\P;^F?N]:47UJ]TUJES"URHR81(-X'N.O<5P
M272Q>,8EM+J.[BFU20SZ?<)BXMI C)Y\9')CP.X( ;KVIOA6]TZ9-/TZ^M)Y
M/$NG7<KW"*CJ8Y'+!YF;[I1E;(R3G( Y H ZOP[K<NJZ//>WR0VS175Q P1R
M4412,F=QQ_=SGBM2.^M)K8W,5S"\ R3*K@J,=>>E>7172'0[&64&?28/$=U+
MJ*("=L;2RM$[ =8PQ1SVP >E7+TV$]WXDO+:_$&BW;6)%[;A7C%T),%O[K*
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MA[)/B'XQBMGA#,;5F1",EO+;<<#W//O4GPWW?V%J! _<'5KPP>A3SFZ>V<T
M:_B#77T:*U:&&*=IKN"W=&EVLBRR*FX#!S@MTXJW;W5X^J7T$\$,=K$L;02K
M+EGR#NW+_" 1QZUY5+JFFMH,,FMRVD7B:'Q!!+>)(0)8\72X*YYV"+;@CC%7
M[LZ4_B'X@6\VH1V,,\=@))T"MM)R"6!ZKE@&SQACGK0!ZBD\,D?F)*C)_>#
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MIMJ1':06X>*$-D(SVN6(^K=?>MG7PN@:KI'BJWLUN(Y8?L5WL7).\#RG'N7
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M&4D'!(VX!QCKZUSW@W5KK1/AUH%Q%'";%[^6WN68',2O=2*'&.,;B ?3.>U
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M9<N6CC3<&7& "&R"">G(%6_&\:'4O"4A4;QKD:AL<X\J4X_,#\J .NP/2C:
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MA*_OKZ2XU;4X+A)]-?3IXH;4QAD8Y+ ES@_F/84MOX8UH:2UA?>(1=(EN]O
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M/AV3[#?KH44-V+=I8G8PS.ZE7< 90%-X7(&-V.*]'HH XWX;IY6AZA%]GF@
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MN1FVD_W30!(.!12!00.** '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5#=?\>TO^Z:FJ*Y_X]I/]TT 2#I10O044
M +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !CFBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "HKG_ (]I/]TU+45U_P >TO\ NF@"0=**!10 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %177_'M+_NFI
M:ANO^/67_=- $HHH%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIS]<'&<&MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HKG_CVD_W34M17/\ Q[2?[IH D'2B
MD"T4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **BGNH+50UQ-'$I.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *BN?^/>3_=-2U'<?ZA_I0 \44HHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN/\ 4/\ 2I:BN/\ 4/\
M2@"044HZ44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %17'^H?Z5+45S_J'^E $HZ44#I10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R5-\97UHHH
'?1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex10-4_005.jpg
<TEXT>
begin 644 ex10-4_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HIQ
ME5_WU_G4M1S?=7_?7^= $E%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !4<WW5_P!]?YBI*BF^ZO\ OK_,4 2T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %13GY%_WU_F*EJ*?A!_OK_,4 2T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0W'^K_X$O\Q4U17'
M^J_X$/YB@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBJ-YK.G6%Q';W%TBW$@RD"Y:1AW(098CWQ0!>HJK8ZE9ZG"T
MUE<QSQHYC9D.0&'4'W'<=JM4 %%%8TGBSP_%=I:OJ]H)GE\E%\S[TF0NT'H2
M"0".V1F@#9HJGJ6J6&CV#WVHW<5K:IC=+*V%&>E6HW66-9$.58 @XQQ0 ZBB
M@D#K0 454M=4L+ZZNK:UNX9I[1@EQ&C@F)B,@,.U3SSPVMO)<7$J10QJ6>1V
M 50.I)/04 2456L-0M-4LTO+&XCN+:3.R6-LJV"0<'OR#5F@ HHHH **** "
MBBB@ HHHH **** "BBB@ J&Y_P!5_P "7^8J:HKG_4GZC^= $HZ44#I10 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN?
M]2?J/YBIJANO]2?]X?S% $PZ44#I10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQFJ__"<Z8+87+P7D<277V2X9H>+:7>$VOS_>('R[NH/2@#IZ*P;GQ;86UY+
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MA]C$K(<8 P"<<=!CI0!VM%<_=>,M'LVG\V64Q07*V<LT<+.BSG&(_E!)/('
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M>RA,UM'Y4+;<;$X^7CMP..V*K1>%='LV@EM-/@CFMMWV=L$^5D8P.>%Z<=*
M.,TV[U_5KG2VBOM2BNSJ%PFJ*B#R$A5F"A&92F 50 K\QRV>0<6M'U#5]<M8
MM>348K=5U%TFBDN&V)"LAC\DQ[<!\8(;.=Q]#BI-,\&7-O;V\+:=:VEU$RL]
M_;W\F6;=N9A&%4<G/RG@9[CBNF'A30UU9M5738%O7;>TB@C<_P#>(Z;O?&:
M./2YU>*TEU"36[N4VOB);,1L$"O$UPD1#X S\K<8P!Z9YI=4\3:CH=]XZN#<
M2W":?%9?98Y "L'FA@6P ,@$[CGDA>M=>WA;2&M9+5K9S#).+AU,\GS2@YWG
MYNN><^H!Z@5*GA[3$N[RZ^S;I;V,1W)=V83*!@!@20<#(_$^M %;3+2;3M4=
M9-9DN[>>V5TAG.YPZG#R!O[IW)P!@'IC-3^)Y+N/PIJTFGAC>+9S& +UW[#C
M'OFJDOA'2H=&N]/L].A,=R@C=)9'P5SPN[)8*.3M&!VXS6OIUH;'2[2S:5IC
M!"D1D?[S[0!D^YQF@#*\%BS'@C119%#;?8HMNW'7:,Y]\YS[YK(BN8[WQ.WA
MK3;E['3[/3EGB:T8 NSN5!4\C:FWITR>>!6^OAG28VD,5NT*2,6DBAF>.)R>
MI:-6"G/?(Y[U-<:'IUS+!*UOY<MNACBD@=HF1#U4%"#MX''3@>E '%Z;J>M:
MX_A])-5FM?M,=Y!=>1&@WO!($\Q<J=I;!/<#/ [TL&K:T_A73Y\W=_\ 9[RZ
MBO!:NJW4L44KQJRCC=C"E@,$\?0]@OA[3$GM)HX&C:T0QVXCE=5C4]< ''/<
M]^*B@\*Z3;)&L$,T?ER/(A6YE#*SG+\[L_,>2.A/- &'HFI7%YJFB1QZO-=V
MEYHT\K.452\B20J'QC(;#MD=,]JY^QU*]U?P_P"!+W4+AKBZ?794>5E52P7[
M0HX  Z*.U=Y)X6T>1+%?LI3[#N%N8I70H&QN&5()!P,@YSWJ*+P9H4%M96T5
MF\<-E.;BW1)Y%$<A))88;W/YGUH Y6T>\L8/%]VNM7*2)JWD*951_O1VX&T!
M<E\':HZ9(R*IZUXCUNQ\->,/)NKBWGTNZMQ TP1Y%258B48C(/WVYSGGK7>3
M^%M'N9+QY;3+7C*\^)'&YUVX8 'Y6^5?F&#\HYXJO/X)T"YAO(IK-W2]*&Y!
MN9<RE,;2QW9)X'/? S0!RNOW>L6+>+M-?6;B01Z$=1AD5$1H7_>@JF!POR#K
MDCUSS77^&(C:^$=.#7#RXM(V#3;1M&P8'R@# _.I'\,Z5)>S7<MN\L\]M]DE
M,LSN)(>?D8%B".3V[D]ZLV&D66FZ=]@M8BMMC;M:1G.,8QEB3T '7H* //#J
MM[=^'_$5EJD]['?QZ)<-<6EPB^6[%3^]@=1AH^<=>..^<[5A>ZAINN6=O-J(
MDM;K1GN0DR*L=N\7EC((&=I$ASDGI6VOA+1Q;O;F&9XVMC:8>XD8K"<9126R
M <#.#S@5(WA?2GFMY9(99&@MVM8_,N)&'E-C<A!;# X&<YZ#TH Y7PQK>J3>
M([*RNKV:[MKW2'NR\L2HK2K(HWQ@ ,$(?@,!P ?KF^&>?A_\/3Z:BG_H$]=M
M:^#M%LI[>:W@F26W@:WB?[3*2D;8^09;[O P.W;%+#X0T:WT^QL(8)H[:PE\
MZV1;F7]V_/(.[)ZG@\<F@"/QC?WVG:992Z?,L4KZC:PMN0,&1Y54CVR#VYK)
MNGUYM6_X1Z'5I&N(K5KQKE5CB=M\C*BX*L"$QSP"?E]\]1JNCV>LVT=O>K(T
M<<JS*$E:,AU.5.5(/! /X56U3PQIFL/;2W:SB>V!6*XAN'BE /4;T()!QR,T
M <U9Q:I=>,]/^W:J\=RNCN9ELS&\(D$J*X7<A."1SW&,9XJKIWB/6;C2/!-Y
M)?LSZE=M!=@Q(!*-LA!^[P1L'3'>NR/AS2_M-E<+;E)+)/+A\N1E 3(.T@'#
M#*@_-GD9JE%X(T.%[=HX)E%M=-=0*+F3;%(<YV#=\H.XG XH YB\U#Q&OAOQ
M)K UO8VF/>Q1Q+;)M8)C8W/0C!]>O.:W;2YU2T^( TRYU W5M=:=)=",Q*BP
MNDB+A,<X(?G<3R.M:1\*Z4VF7VG-'.UK?NTERAN9/WA;[W.[(SW Q4R:!8IJ
MD&I_Z0;N"$P)(UQ(W[LX)!!;!R0#D\\"@#&\0074OC3P\D>I7-O$RW#>7&L9
M7<J#YOF4\X8CZ'C%95SXCU9?#5QXO@N\V\%XZ?V<8U"&!9C$<MC=YG&[.<#@
M8/4]EJ.BV.JRVTMW&[26Q8Q,DC(1N&&!VD9!'4'@U4?PII3S3,8I/*GF%Q-;
MB5O)DD!SN*9QG(!(Z$C)!- &T.12T44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !4-W_Q[/4U0W7_'L_TH E%%*.E% !1110 4444 %%%% !1110 4
M444 %%%% !1110!QGC.1[;6_#S#4KJSANKLV]SLN"B%!$[CV!R!R.>U4]-\8
M/I,7B"?49Y[_ $:PNX8;2]1 QD$@4%=PP&"NV-W\ZV/$NGZE?:SH4]E:K)%I
M]W]HE9I0I93&Z$*.Y^;/.![T_P ;Z5?:SX7FT[3HDDGEEA<>9)L4!)5<Y//]
MW'3O0!,?%$>Y84TV_>]=I=EGL59&1&VF3YF "'(P21G(XJA<^-%EDT!M*LY[
MN+4IY4?:%5D\N-RR89EPX9><\<'VS+>:5?P^+K7Q':PF8261LKJU,@#(-V]6
M4G@D'((SR,>E9$7A35=+.E7UG#!<W4>K75_<0-/L1?/21<*VTY"[U[<X/TH
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MW#R KELYVMT..A]LIJNCZO<>&O&5E%I<[7&HW_G6J[HP)$V1+G.[CE&ZX[4
M=G;^(=,N9KJ)+G8UK'YLIE1HP(^?G!8 ,ORGYAD<=:A;Q7HZ0W<LMR\2VD(N
M)A+!(A6(YPX!7)7@\C/2N?U_1]2UK5=56WM98([O11:Q3R%=HEWLVU@#G'S
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MB"!9+@$XV@CEO3&0>1P,4^/6;/489TT^\C:=8?-7<I^ZP.U\'&Y20>1P<=:
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M9Q?60L;B)C&$>,!O[J @Y=SD'^+TP*L6'AX6!T\KJ>H3"S1TQ+,")MP4#>
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MI'YC0W$Q5O.V@$E<[UX' ;\^PU/1H+V_AOKN_NDMH K-:^:%@<JV]688SD$
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M[]?,F'R+]GC9=T;*=Y+'H&&._&,5L:WJ\MIJNDZ3:O&EWJ,DF&D7<$CC7<[
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M@:TO7M0!)NW[54[N@Z[NE:N1ZUY1?G31I^M:CYEL;R#Q+ 89]X+1@RP!MI[
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M:9;D*.I_=+Q63IWC.^N=8M].FLK3S[JQDNDCCG),$B%<PR'!&[##)'0]CUH
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M:3DL"!QS@G@5FZSXCN-:\/Z7+8VFV.ZU..SO()IMC(RR;7B; .02I!/IZ@T
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M=W>]N6NIV8 9D8 $@#  P!6>W@NQ\G4;2*XN(M/U&4S75HNW8S-]_!(RH;N
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M0U'[,\1@B(>WE@.48$DAN>HP*[.B@#DK[P]X@U70;JRO]7LWN)U2,-':,D:
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M_P!H:A;W$EK?&."WV:G;1[!<)\^%=02H=<'..S+P*ZZ66.&-I)75(U&69C@
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M>HK>V@M(1#;PQPQ#.$C4*!^ J6@ HHHH **** "BBB@ HHHH **** "BBB@
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M;1>=Y64E1@-RLF<XRH(^;@BJ,O@B%K:+R;UX;Q=4_M5[@1@[YB"I^4\!=K8
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M5YY(2R/*X96&P,"%VL0/FSP.30!D^,-4_MGP7K0GM(XI-.U:WM@0^_)$L)W
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M*08&598P#C^\1SW27P=J<UOKT;7UDO\ :4D%Q$$A8".2,1@ _-]W]T/?G\*
M+>K>,_[+FN+46<4UY:6PN;B+[4%X.=J(2N7<A6(&!VYY%+<^(DUF.;3].LWG
M8Z>MU.9)3#Y2R E%) )WD G'& .34,OA[Q%:Z[)K.EW^G"YO8HXKZ&XA<Q'9
MG:Z8;.0&Q@GGVI4\,:KI^O76HV-];SC4;:*&_%TA!+QKM65-OJ#RO'UH O\
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M'(D PQ.23QD$TNGS>&;NW2\TW6KF2\.GS)<6J,B$#823< *&R&P Q.=Q[Y-
M'JN11D8S7D>BIIQ/P[(G DOK*2.Z(G(:8" 85CG) 8=.F>*L#4+:TTGR9;L0
MZ+;^(;B&Y:/#)!'\_E*P(($>\IU&.G:@#U3<*@N[V"Q@\ZXDV1[U0''5F8*H
M_$D"O,;E=)A_L&+3]6NKJPEU_:LOG!8\-#)N2(I@; V.G )(!JO,+)=*URWD
M:$V.G>*;5D60ADMXB\!;K]U<E\]N6]Z /7AR*3(%9VGZSI-W<'3[&ZA>6&".
M7R8^-L;#Y"!Z8_I7"?$:]LS<ZO:&2&.^CT5I(3=/U^^1Y"<$R97EL\87@\T
M>F9%!.!7F>F?V=K7BW3Q>W"74,_AN.21'G)1WWC)(S@]/TS4&C:I;26GA!-:
MNHSI#V,RA[B0&)[I64(KD\9";\9[^XH [SPYK$VMV%Q<3VRV[PW<]L8U??\
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M8$GCISQ0!V-%("& (.0:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*CN/^/>3/]TU)4=Q_P >\G^Z?Y4 .CY1?I121_ZM?H** 'T444 %%%% !111
M0 4444 %%%% !1110 4444 -:-&8,R*6'0D<TCPQR9+1JQ(QDC-9&L^($TK4
M=/T]8TDNK_S/)$LOEH=@!(W8/S'(P,<\^E9\_C(1+;QBR$=[)8K>R6]U<+#Y
M8;.(\GJY(88QCY3DCB@!/^$2OMMY;-JT$EE=22.WG6*O.H<DD"3=CC.!E#@
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MV09"*P/RC''(SD#H,UUE% '*:#X9N--\0RZM)'9VK3VHBNX[-FV7,V01*5(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CG_ -1)_NG^
M525'/_J)/]T_RH ='_JT^@HHC_U:?044 .HHHH **** "BBB@ HHHH ****
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M '30 1_ZM/H**(_]4GT%% #Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M,7Q/H]YK>F);6=\EI(DR3;I(!,C[3D*RDC(S@_A4?A2]FNM-N(KJTMK:\M+E
M[>X6U&(F< '<O?!!4\\CI5S5-).IO;NFI7]D\#$@VDH4/D8(8$$,/J..U1OX
M?@.FI9075Y;*)UG::&8B21@P8[F.20V,'VXXH UJ*.U% !1110 5Q/AY%;XH
M>-U*@@QZ?D$=?W3UVQZ5PZ>'-6@US4=4MY;^*XOR@G9;N##JF0@ ,)Q@$].>
M>M &)8ZO+X5\2^*M+T^,36PO+)+*V+82&6X!W*.0 ,_-MR/3C.:W[W5O%UEH
M^KWDEE:I]BVS0,\88SPXS("BRG:ZX..<'CBED\-))HMSI3>'U\JYD\Z647^9
M6ER")"^,[@0"#GMZ<59T?3M3TJ*426US?S2@*\][?*[%1G"\( !R>W.3F@!-
M0\2W%JFH7MJ(+FRM[> 1 *5,D\I&T;LX"@-&3Q_%UK-\0W&N2^$/%4&JV:+;
M#2II(9P%0EMC;E*!WZ<$'/?';)N6N@-:^&'\/?V&);!T9&#W@W,"?7;VX ]
M!Z527PI?MH]Y87']I7374#6K7-QJ$<DJ0M]Y%)CP >YQD\<\# !?L-9O;S48
MM"T]H8&M=,@N)9YHS)EGR%4*&7C"DDY[@53M/%^K:G-H]M;06<4]U)=VUSY@
M8B*6#@LN#RI/./PR.M3?V!J,=Q:7=M#<P7UO;"T-TEU$6FB'(5P8]IP>00 ?
MS-9&HZ?J5EK/ARVL=-U"!;0W#/<P$2G=*.6=O+*Y9LYX[YXZT 6D\9ZVL?V2
M6&Q.H6^MQZ7<,%<1R*X!61>25.#T.:?J'B7Q!I]CXBF:33W.A.K.PMW'VE#&
MDFT#?\A&XC=EL\<#',D_A:ZFAA7[+<QRI?#4);A+N+?/..C/F,C P   !BB[
M\+WU[%K<,R7QCU@K]I NH1@!0H"_N^/E '.>GKS0!?U/6]<EU/4;/0[*.9[!
M(\B0*1+(PW;23(NT;<#(#<GVP:5[XD\0?VIK5G;1V-O]ATR.^3SD9V5F#DHV
MU@#RF-P/'H<TEWX8U"ZOTOD.I6UTT2PW,MOJ$<9NE'3S $QD9(!4 C-+_P (
MQ=K<WTT%M=0+>6:V)BBN8=D42Y"A 8^, L.<]?I@ ;8:QJ6K^,]$=)XX;:XT
M'[<8#&6&7DBW#.X<XX![9/!S5KPYXEOM<N)[9I;6&]A@?S[&:!TEMI<@+U/[
MR/K\PQG ]<"O!X9NK:;298K:]$FFVWV-7%Y&#-!E2$?"<@%5Z8/'.<FG6GA_
M4;..,M'?3RV]B]C;S-=Q"2.-MN2&"#+?(N"?3W.0#K;>&>33(X=0,4D[0A;@
MQ A&;&&V@\@9S7'W=M#:?%3P[;6\:1P1Z5<HD:C 50R8 'I6OHG]O:=H]O9W
MEH]Y-$"IGDNU+N,G;N.!DXQD]S5*[T74;OQ1:Z^8;M+BV1HXXDN8?+V-C<I!
M0DYQZY';% %&XLI;/XE06FC?9[5_[#F9&EC+HF;E&/R@C/)Z9 'X8J[IOB2[
MU)/"5Q)!:C^U(Y&E&PDQNL3,2ASP"1CZ4ZXTG4YO$O\ ;BQ7D=R+5K1$2XA*
M*C$,>"A.=P!Y/;TJK:^&;ZRAT>.%;_&DEOL^;B DA@5(;]WSP2.U #8O%VK1
MZ+JFLW<5B;;3[JZM6AC#!I7239'@DX4$\'(/K[5:MEO5^)5L+Z6WDD.C2G,,
M10#]]'D<L<U!:^&IX-&U32KFPN[VTU&62:99KF$$.Y+,5*JN/F.1Z$<4:?H.
MKV>KVVISR:I>7%O UNOGW, W1D@X;:@SRH.>OO0!8\:X36O"4@@,KKJA 5<9
M.8)>!D@=O6J5E8ZIX<O?$>L[;6RL[^YMS!:S2#9;J $DE8*<;FSG:IR2 ,\U
M>UG3=3UC4-/NVMKZW-A+Y\*0S0%=^"N3N!)X8C&14VNVE_KME';MIMW;/#,D
M\,\-Q%N1T.0<'(/XCO0!E3^-]1C\-:AJ,5M!)-9ZHECB2-X1(KF/#;&^93B4
M<'TJ[/+KO_"8Z1:3W=G&7M;R8K'$[(=KQ!<Y89.U_P \_AF7'A"[N+&_M'_M
MGR[V[BO)#YUL3YJ!>1QW**3VXP !6OJ%A?W^IZ=J!M-3@GLD>,M#- /.1]I9
M3DG&2B\C!ZT 06?BK4Y8#:7$=K'K":M]@:$1L5*8WEQ\V<>5EP?P]ZL?$I5;
MX?:H&4$$1Y!_ZZI5+2)KG4?$4_B9?#&IV_F6R6J1W!CCDRK,6<J7XX*@'J0#
MVQ5[Q):WWB/1Y=,DTW4+:&7'F-%);EB 01C+D#D"@#,\4QHGQ)\'%;+[1^XO
ME\I F2-B?WB!QGUJ[X=TC7M'TR]2"*UB^T:J]Q#:SN2MO;,1E!LR W#$ <9;
MK45WI>IWNO:5J\MKJ7VC34D2( 6VU_, #EAYG< =,8JYXB?7M1TWR=,L]3L+
MI)!(DJ2V^&(!PK?.?E)QG% '4DX4D\8KS"R\2J/&=CKK7!-KJ\K:=]G)/[E
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M2/\ U:?044 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0FU$90V\?-R,'.!S["I)_$DUKXHU&UG@9=/L-/2ZEE&T\,9,MUS@",C SUH
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MID]\=O2J]YX;T34;J6YO-*M)YY8_*D>2(,77T/K4-_XGL+#SB1-.EO MS</
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M-I-C<06L,]NLL=K(DL D);8Z_=8$\Y%9=GXTTB_A,MNUPZF.%XR+=OWOF@E
MG'S' .0/NX.<8.,?Q+XG%UHEI=:/?30/'K%O:7<>P*ZYD"NC!AE>#GC';L:
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MTEW5WM2Y6V:T&^5V_<L,%,$\@\?D/05-J6JVVG>3%*TIFN"5ACAC,CL0,D@
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M)Y/*3^^^T':O7DX'!]#0!K45BW?BS0[*=8)KY3*\'VE$B1I"\>0,J%!W9W#
M')&3T!K1T^_M=4L(+ZRE$MM.@>-P",@_7I]* +-%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4V3_5/]#3J;)Q&Q]C0 V'_41_[HHI(6 @CY'W1_
M*B@5T2T444#"BBB@ HHHH **** "BBB@ HHHH **** .?\0:)=WVIZ3JVG2Q
M+>:;)(5CGR(Y4D7:ZD@$J> 0<'ITK'?PGK,RZC<"ZL[>]DU./4[0KND1'6)(
MRCY )4A6&1@\Y]J[BC- &'#INH:EIU];Z^]LR7</D&VM02B*00QW, 23GZ#
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M[7#>Z;K7]BV>HND4L%SIOF*-BNZLK(S_ "EAM ;H#VKM\TTNJL%+ %N@)ZT
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M=.BL+"-HK6(8CC,C/M'H"Q)Q[51N/"6C77]I>=;S.-3Q]L'VF7$N!@9&[C@
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M=@.@W.2<#)P.@R?6@#FGUK5=6?Q4]C>_9#H[F&VB\M3O=8PY:3<"=I)P,$<
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M\]K:WF,\%L\I,<<A).X#O@DD D@'D8IDO@_2KBUU.VN5FN(=2E$UPLDG60
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M;1[:ZMH1%)&^#\P[Y!((JA:Z9?3>(/&&;:>T34DC2UO"%Q\L.PD8.1AN1G%
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M6[DD<D#U([CJ*X_PU%?6%K;^']3T*XNKRUO'F&H/&I@?<[-YX<GA\,>,9SZ
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MH\0Q7EJGV-QYHW1X(0@%Q\KDJ.>,\=: .PU77[*;1+Y[#7M/M+B*,_OY75A
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MT  Y)/H.:9I^I6>JV:7=A<)/;OD!T/&0<$>Q!X(KD?&Z7#^)O!ZQW)C1M0;
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?_5M]#3J:_\
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MA0O\.1PBC@CI0!C1^)?$&IW4]SI-@TEG;:@UJZN8E1HXWVR,6,@8-P2/EQC
MP<YK3\<O<IHMK]FN!#OU&SC?Y-VY6N(QCKTY_&G/X(TUM:GU)+B^A6XD66XL
MXIRMO.XQ\SICD\#/.#CG-:NL:1!K>G&RN'EC3>DBO"VUT=&#*P//(*@T 89U
M+6;Z[UFTTZZMUFTI$C&^'(N)C&)#NYX3#*..<YY[5L>'=6&O^&].U;R_+^UV
MZ2E,YVDCD?GFJ9\)VZW$T]O?ZA;2W$"P7#QR@F<+D!F+*3N )&X8/Y#&M;V$
M-EIL5A9@V\,,0BB"8^10,#&<CCWH \STO0M1\1^"M&L;5(K:*VU22Y^VM)EE
M"7$APJ@9W<XZ@?RK>/B'68F\0WTUQ:#3]#N91)$MNV^>-8%D"@[OE8%NO.?0
M8YZ/0-"B\/:<+&VN;B: ,SJ)RI*EF+-@JHZEB><U'9^&[:T?52\\]S'JCE[F
M*?84)*A#@!1QM4#\* ,F35]:L-2T.WNI[::/5U>)GCBP+>81EP5^;YD.TC!Y
MZ'/:LKPOK6JGP1HEW/?0[[^YD,TK1EI1EI&(1!G>Q8#@#@9..*Z:Q\+6UE/I
M\CW=W=#3D9+19W4B($;>H4%CM^7+$\54@\"Z?:V]G#;7=]#]AG>:T=9%S '#
M!D7*D;3N/4$].>!0!2M_%5_-HFD2S-%;R7FH3V4]V\>U(A$TJ@E2>&8Q@8)P
M"WT%58?%VM&TV[+>XGN-5DTZS:&#:'2,.S2_-(%?*KP 5&<]:=K'AEM,M=.M
M++^V9K);Z:[EEM9E>>%G#\ -]Y29')ZG\\B:V\+RZ_IES8ZS/JK6*O%)8R7;
MQI=PR+NRZM&  .5QGG[V>"* (;KQ'XJL;6!;JRM[>275H+2*2<*3-#(V-Q5'
M;8PY!Z@]L4Z^\1ZS9Z3XPBD>SGN]&B$T4I@*I(C1>9M9-W48(Z^E:;^![62"
M!)=3U*6>*ZCNS<R2H\DCQ_<W$J1M'H !R?4U+=>#;:[.M^9J%\!K,:QW04QC
M"A=H"_)Q\N1W_/F@!+W4=6O-5U#3='EM(I;&U23=.A822ONV*<$;4^3D\GYN
M,8.=&\O;VV\-2WHCM?MT=L9"CS;8?,"Y(+GHN>_I5"\\(0W>I0ZDNJ:E;7RP
M"WEGMY$0W$8)(#C;C()." ",]:O7_A^PU#PW)H,L;+8/ (-J.0P4#C!ZYXH
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ME*KB.9T'!)[*.]<_I$DC:QX3D-G>HD.C30RM):R*$<^1@,2O!/EOU]/<5J>
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M[70X9W@\Q5O(&\Q@S) 0X(E=5.652 <=SCIUKC+A[)]-U.VNS*[KXCM;C?+
MT3;&> LX^4;?E#DXYQDT >IPW=M<AS!<12B-BCE'#;6'4''0UBVGB(WGB]M*
M@>TFLQ9&X$L,F]MV\+@XX'7WKS_58YDO_'%GH4/[J6*P*P6J[?-B7(N!&!P6
MVD XYZ#KBNFTO4M,OOB';W.F@M;OHYA5XX&501*"%)V\8'8].E &GXE\0:EH
MVJZ-:6=M:S+J<YMP9G9?+8*6SP#D8%.3Q-<V.NVND:Y8I;/>DK:75O(9(96
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MJD!AG PP++D<\'@]: -A$2- B*%4= HP!3J** "BBB@ HHHH **** "BBB@
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MA(JQH58AN8V6+!&,G<>?7!UW0=1T?3O$FI7%WIXAU.R@M/*BLCY<# E%)!)
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M]G*OF,-Y81\K\O\ TS'7U]N:=GX*OXOA^OA^6Z@CO;>Y-U:W,99E#B8S(6!
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M9<=-R<\]#6Q#87NH^)M.U>[M/L8L;2:(IY@8R/(4SC;_  @(>N"2W08KHZ*
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M LYN)$6<K(%$F >,@ \<'KS7;Z?H-C9:3!ISPQ7$43,P$D2X#,Q8X7& ,DX
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M-'OM7GT!K-(V%AJD=Y-O?;\BJP('')^;]*RKOPYJ\^D>*K1((-^JWHGMR9N
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M4#(W7@JP.0>0>M0:UX3OIM'TF:W@MKR_M+PWUU:W!'EW3.K"1<G(&-YVD]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMHMZ8YEW,'EA"(QV]@P#YR>.V.]6+KQAJ=Y)J!\/V*W8L3$/*>)B9V95=E#
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M7^X/Y44EOG[-%P/N#O[44 2T444 %%%% !1110 4444 %%%% !1110 4444
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MRO,8(EC,C_>?: ,GW.*HZ[K;:,M@PM3.MU>PVA8.%\LR,%#>_7I6O0 4444
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M8Z@\S220LL>2[9N!+C:<HQXSDGC'<>AD@#)Z"HHKNWG)\F>.3!VG8P.#Z<4
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MXKF;P;/I4HV^*DU8R(P!#F0W&]9E/79Y9QNZ!05[8KU%65U#*05(R"#P12T
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M@C$8GD7?^Y$)9=S1E,# .,;LXR37JOV:#&/)3'IM%*8H_,$A0;P,!L<X],T
M<;X2L-+NM;UN[VQRW=IJ\WDMYF3$&B0' SP#S_D5;UIK6/Q[X>WR*LCPW2D%
M\$C:N./S_6NG2**,DHBJ3_= %#00N^]XT9NF2H)H \JT9-/@TGPS?H\0NCX@
MN83.9,MY9DN!LR3]TC;QT/!ZU1>>WTW3O%"0IY/E^(V-\+9!YR61\LL< 9V9
MZ]B-WO7L'V2V(QY$6/38*D$489B%&6&&..M 'F-V-#M?"GB5])U<W=K,D,C;
M6C%M$Y.,1[  &( +#Z'O6MKEU.GBG6SISAK\>&]ULJG+%P\I7 [\XKM#9VQB
M$1@C,:G(38,#\*46MNL@D6&,.. P09';K0!Y1;W&F+H<VI^%]9O+G4&TJ4-:
MPA-XVC)>8 9\T'(!;DD]QFM66/PEJ&D7L^A,ES)<Z-*K0P-O4J!N#3+_ ,]-
MQP"WS$D]<''HD<$43.T<:(SG+%5 W'U/K216\, 811)&&.YMB@9/K0!YOI%U
MIEL? UQ!+;16S6<D-Q(C*J&3R$;:QZ$\'K[U3TW4M/DLH;62>&0'7[Y85GF
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MB 000*=OF2210!5]N223V )K5M/"NI:?-=6]EKGEZ3<W#W!MS;YEBWMN=8Y
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ME&"EJ'8QJ/;+.1GG#+Z5JZMI-U=ZUI>I6EQ#$]GYJ.LL9<,D@7.,$8(VC\Z
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M!\\SG<YX[;B<>@P.U9>CP+H7BC6;23Y(=3G6^MF;H\A0+(@/]X; V/1N.AP
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M9ZO UB8EDOQ"P9))H6'D D?Q#<Q/?Y$KT.-UDC5T.589!'<4 .HHHH ****
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M'.$)R5#*&Q^M<CJ,B277CED<,#I,1!!R#^ZFK=\(A9O FA*2=K:9;@E20?\
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M  0S+@X!_O'D=:Q=*\(ZU8_\(NLSV#+HLLY<I(X\Q9$9!@;>OS9_#'O7>44
M<-=6-MIGAS6[#Q#=V=LNJW-Q/ (YBSDL-P" A274@$ 9R<5N^$;*\L_#MNVI
MG=J=R/M%XQ !\UN2./[HPOT45KRVT,[QM+%&[1MN0LH)4^H]#4M '-^--#O_
M !#I$5C9&W4K<Q3L\TC*/D<-@84YSC'M[T[Q)I.I:O%HYMA:K)9W\5Y*))6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&^Z?I2TA^Z?I0!%;HOV>+
MY1]T=J*6 _Z/'Q_"** ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBLS6?$.E^'H8I=4NA;I*VQ/D9BQQGHH)Z=Z -.BH;6ZBO
M;2&Z@8M#,@D1BI4E2,@X/(_&LJ/Q=H4VO'0X[\/J(<QF%8V.&"[B-V,<#WH
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M;&V<1PR!6MY%R&97!&1NV@9!&,"NIK)N?#FFW>H37L\<SR3J$E3[1)Y4@ P
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M3+T*D1\$=/IQTJE=^&+J_P!-N["ZT^TDBO'#W+_VE*))B,8W,(\X&!@# XH
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MG))[8KB];LKF3Q+%:6\!%KXCMPE\C$ PB+!9B!UW1L8SZ'970>+?._X1:_\
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M#J:234;*)]DEW C;Q'AI #O/1>O4^E>=:@D,E]XATS6(=4^U37BW-FMK"/\
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M >EK<P/*T231M(OWD# D?45+7FGAR3R-?T.&)K;4[26.X-O=1J4N;0%=S+.
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MB.<5)/?VEMO\^ZABV+O;S) NU<XR<]![T )I]DNG:?!91R2/' @C0R$%MHX
M) ]*P;KP+I5W]L5IKU(KNZ6\>&.<J@F#*V\#L25&?TP>:Z975T5T8,K#((.0
M14"WUM)<26T5S"]P@RT0D!9?J.HH RW\+64ERDLDMP\:70O5@9P4$PZ-TW=>
M<9QGG%0V/@S3-.O3-;27:V_FF<67VAC;K(3G<$Z#GG'0'G%'AGQ(=5\-KJFI
MM;6A-Q-$</A!LE9!RW?Y:U+J[E,5K)936A269 S2OPT9Z[".K>G:@"'5M"MM
M7N+&XEDGAN+*0R0RP2;6&X;6'N"#BJ,?@ZP@2T2&XO$6UO9+Z(>;OQ*^[=]X
M'CYWX_VCWQ6T]]:QL%DN858N(P&< ER,A?KCM3H[NWEDECCFC=XCB158$I]1
MVH P)+ ^'!>36-A?ZJ^IW1EGA5XL*Y7!8[MH"X50>OTZU?\ #&C)X?\ #ECI
MBA T,0$A3H7/+$9[9S5^VO;6\W&VN89@OWO+<-C\J6:[MK=T2:>*-I#A%=P"
MQ]!GK0!1FT..;7%U8W5RLPA-OY8*[#&2"1C;GD@<YS69I_@73-.DTUX9[UAI
MID%JCSY6-''*8QROUY]ZGUKQ";+5]/T>T>V%Y>K*X>X;Y(E0#D@$$DEE &1W
M/;!U;&>Z.FQ3:E%#;W.W,R1R;T4^S$#([]* ,G3?"%EI;J+:YO/L\3L]M:O*
M&BMV.>4&.V3@-D#L!4,G@BSETI=.>_OC"M[]O#;HPPEWF3.=G3>2<?TXKH/M
MMJ85F%S$8FX63>-I^AH%Y;,S*L\191D@.,@>M &4_ABVEU#4KN:ZN9#J-L+6
MXC)0*4 8#&%!!^=N<]_I4<7A2&.[TNY.HW\DNG*RQ&1T(8, IW?+Z #C'3/4
MDUM_:H-F_P Z/9MW;MPQCU^E$EQ##'YDLJ(G]YF 'YT 8%AX+L-,N";:ZOUL
M_,,J6'G_ .CQOG.57&0,\XSC/:FKX3ALX(G%YJ5U-:6<EK;-YD8E16 !VMM&
M6^48+$UT3W$,0S)(BC!.68#@=333<Q>:85EC,X&1&7 /^- %31;6[M-#M;:[
MGDDN(X]K22/O?VW-CYF QDXY/-9D7@VSBTG4M-:]O9(-0G>YD+,@9)6;>64A
M1@[@#W%7/#VM'6-(ANKA(H+B229/)5]WW)&3@G!/W?3O5JUN+MKF\%VMLD,<
M@\@QR$L4VCEP0,'.?PH R)O!MO<G4FN-2U"5]2LELKEV9/F0;N0 F%.'8< #
MGIGFG'P=9O=6L\]U=3BWLGL/+D*;9(6QN5@%&<X'((Z5T"2QR%@CJQ4X;!S@
M^AJE-K-E#K4&D-*/MDT+SJGHBLJY/IDN,>O/I0!DV?@NWLFTL+JFHO%I;DVD
M4CH512I383LW,NTXY)/3FK6G>&+?3[ZTNS=W5S+9VS6L!F*?+&Q4D$JH+?<7
MJ3^M; GA,QB$J&0#)0,,@?2G/(D2%W8*H&22< 4 9=_H,-YJMOJD5Q/:7T,;
M0B: K\\9.2C!@01D9'&0>G>J"^"K"*6PEM[FZA>RN9+M61D)EFD!#N^5.20Q
M'&!SQC QT0FC**X=2C8VL#P<]*;]HAQGS4QG;G<.OI0!!JNEVNLZ7<:=>Q[[
M>==K@'!^H/8@X(/J*Q%\$VDNGSV6I:CJ6IQRPF &\G!9%R#\I4#G*J=QR>!S
M72"6,N%#J6(R!GG%86JZ[J%AXATW2X-/MIUU 2^7*]TT>SRU#'("'KGCF@#&
MM-(GL?B%:M+)J-];+I,MJ]W<J6R[21LJDJH7[JMSCZG-:ECX,M["32VCU+4'
M73-RVB.Z$)&5V[,!>0!QDY;CK4MGXF)\1'0=3LFL[]H3/ R/YD,Z X;8^ =P
MSR" ?K6Y]HAWNGFIN098;AE?KZ4 >?Z_X7DT^+1+73Y-1N ->&HSRA%9H01)
MO883'WG!P0>O3%=%<^$;:]M;N.:]O#+>2Q2SW *!V\L@HOW=H4$#@#U]36[]
MHAPI\U,,<#YAR?2E\^,R-$LB&4#)3=R/PH QY/#4<E_?WAU"\$E];):S >7C
M:N[!'R<'YV_/V%41X$LHXM-^RZCJ-K<Z?;BTBNH)561H!TC?Y=K 8XR,UI:!
MK$NJV5U/=0QV[6]W/;%5?</W;E<Y('7&>E:BSQ/%YJR*T9YW Y'YT 9$'AJ"
MVU.&_AO+M9(K5K55+*P*L0Q8EE)+%@#DGK5"W\!V%I9Z7;PWVH*=,DEDMI1(
M@=1("'4D+@@Y/;([$5TRS1MNVNIV'#8/0^]'GQ'=^\3Y1N;D<#U- &3H-E?6
MD^IM=7%U)#/<F2!+J17:,'J 5X"9^ZO) Z\G KWWA&WU#^V1-J%Z$U:)8;A5
M,>%0 C"_)D<$CG/6M\S1K%YI=1'C.\GC'KFCS4(!###=.>M &-:>&8;36;;5
M!?7<DT%G]B"N4VM'D'D!0<Y .014^HZ%#J.IV.H-<7$%Q9K(B-"P&Y'V[E.0
M>#M7D8/'6K-WJEI9I;O+*H%Q*L,6"/F8^GX9/T!JP)XC((Q(N_&=N><4 <T?
M ]L;"*S_ +3O]D6H?VDK9BSYWF&3^YTW$G']*D7P7:1:A<W%O?W\%K=2F:YL
M(Y1Y$KG[Q(*EAN[@$ _G5GQ%KLVB3:.D=LDRZAJ$=DS,Y!CW!CNQCGA3W':M
M@31% ^]=IXSGB@"CK>BVVO:=]CN6EC =98Y87VR1.IRK*>Q!%4)/"5O<6:I=
M7UY/>++'.E\SJ)4= 0I4!=H !88VX.XYSDUOB1"P4,,D9 SVI'FCC(#NJD],
MG&: ,*X\(V=[!J:WT]Q<S:C"L$L[%5947)4+M  P6+=#R><U#)X.2>6\FN-7
MU"6:\L18S2,8_F3+'( 3 /SGH/UKH_-CP3O7C@\TK2(F-S 9X&3UH QF\//Y
M%@D>J7:O91M$KXC(E1@!AUVX/W1T K,7X?V5M'IYT[4+ZPN[%'B2YMV3<Z.Y
M=E92I4KN)(&..U:UMK3S>)M2TJ2!(X[2""99?,R7\PR#!&!C'E^IZUKLP52Q
M( '))[4 5;73H;73A9?--&0V\S'>9"Q)8MZY)/YUCVG@^VM8]/MFNYY['39?
M-L[:3:1&P!"Y;&6"@G;GVSG%+)XI25M"EL(EGL]5N6@69GVE0(W<,!CD'RSW
M'45K:A/=QV?F:?!%<3;T&R238NTL QS@]!D_A0!0T3P]_8EUJ,Z7\\_V^<W,
MJ2*@ D( )7 ! PHXYK*FMKRY^(-[+;RWMG&^FP0"=;4F-F628L-S+C(#*0<X
MY[]NNW =2,UBZUK[Z3JNC6:VRRKJ-T;<R>9@Q'8S9Q@Y^Z>XH J67@JTTW5-
M+O+*ZGB33K9K:*$@,&5B&<L2,EB1G.:+KP;!<IJ5JM[-'INIR&6[M% PS'&_
M:V,KNQSU[XP373$@=: P(R.E &-JWAFRU>;2WEW(-/EWJB' =,8\L_[.0AQ_
ML"G76AM=>(+?53=D"&"2W^S^6"K(Y4OD]<DHOTP?6M?<,9JM+J%O#?6UF[_O
MK@.8U'<*!N/X9'YT <O'X!\BUL;&'6KQ+"PO%N[2#9&QBVYPFXJ25&3C/0>M
M3W/@V6YM-9@;56 U6Y2XD(@'R,H4 +SZ(G7/0^M=5D4M '&ZUH>H6<VJ>(+6
MXGNKZ73/L:VUO&$8XR0RDDX8,Q/?CC!-9OA;3[_3-1LELKI[J @172SZ)]C*
M1A#SYA5<G=MXYZGZUZ)10!E:II5U>7MK>6>H&TGMXY$&8A(CARA(89!(^3L0
M??URY?!D5[::A]OO7DOKV2*8W<*"(PO%CRRB\XVD9Y)SDYXKJ:* .3NO"6IW
M^C2V=]XADN;B62)VG>V50JQN'4*BD '<!D\DCCTQJ:]H;:]H9L9+LP7(9)([
MJ%<-%(I!#*,\=#WZ&MBB@# U3PX]Y_8J65U':1:5.LT<9A+AMJ,@7[PP-K-^
MGIS5M/!\UAJ%U]EUFZBTFYG-RU@B@;9"=S!9.JH3R5'J>>374T4 <M:>$KNP
MU"3[)KUU%I$DYG.GB-3M9FW,%D^\J%CG ]3R,U'%X2N(M4M=3NM4\^:PCE6"
M5+;$S!P0!(VX^8%'08'(!YKK:* ,?PQ'JL>A0QZU.UQ>*S@RO&L;.FX[2RJ2
M =N.!6=J/@BSU/4=8N)YF,&I6@@:#'"28VF4<_>*B,>VSKS74T4 <M<^$KB7
MP]I>EPZFJ26=Q%=27$L!D,\R.)-Q&X8W/DGD]<<57O?!5Y>_\)'NU>)?[=C2
M*7%H?W:JFSY?GY.WU[_E78T4 <M-X6OQJJ:E8:U]BNIH(X+\I:JRW 3.UE#$
M[&&6 //7H<4X^%[M-6O+R'4XPD^GI8*DMNSLJIN*L6W_ #-EVSZ\?6NGHH Q
M]$T(:7X6MM"N)ENXH8/LQ?R]F],8P1D]N*S-)\'SV%H-,N]8EOM'AC:&WM'B
M"D1E2NV1P?G 4D 8'8\D#'5T4 <O8>$IK9-,M+G41<Z?I4@DLHS#MD!"E4#O
MN(;:K$# &< GIS0?P)?&.&UCUP)96NJ#4;6/[*"T9WLY1FW?,-SG!P,#UKMZ
M* .+E\!R7/\ ;@N-34_VC=)>PO%;E7M9DV[&!+$-C:O89Y]:T=+\/ZE;>(I-
M9U#5H;F:2TCM7CAM?*4A&=@>68_QFNCHH P7T*[;QJFOK?0B%;,V9MC 2Q4L
M&SOW=<@=NGYU0T_PAJ&EW[PV>NO%H+3&<6 A&]&+;BJRYR$+9.,="1GO76T4
M <K9^$[B/7;+5+R]MYY[,R[9X[<QS2HP("2/N.Y5!].J@\<YJ67@K4K0Z.@U
MJ$P:1=/):I]DY,3(Z;7.[EL/C<,#CH:[6B@#BH? ]XNE:]92:I"6U34/[1CD
M2V(\F7<C $%SN7,:^G>NOM(YXK6-+F<3SA1OD";0Q[D#L/;]34U% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4AZ&EI#T- #(/]1'_ +HHHM_]1'_N
MBB@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO'Z))X(U16C\QS%^[
M3;N);/&!Z_2LB6+2[CXH37<\=M);-HJ?O74%"_F,>IXSL(/KBN\HP* .9\$A
MSX TR*,E9H[01@..48# !!]..*QO"5WI\UEH5O<:;<IK6G1O'<&2)U-NY7$K
MLQ&&#L,]3DL#V)'?T8H \CT:Z2VT3P[$]LRR#5;UA=M&[BTR\I!V#JSJV%W<
M<YYIND+%'X0\,QRHZSVGB%]WG0E'C3SI23R!@8*YQP,CI7KV!Z48'I0!Y-K]
MG9MH/Q!\JWA-TUT#;[8QO)\F'E.,_?5NG<'TJSK,&F_V_?QA'6RG\-M',UDO
MS',F3C'5@I+8ZD9KT_ ]*7 ]* ..\&R70U34+>Y:SO3';V^S5+5"@N%^<!9!
MD@.HY..SCIP*S+@1KJOC6VUQ!F\B7[&9!D30^40$C]2'W9 YRV>]>B8HP/2@
M#SF+?!XD\#)JKQF[ATN:.\:0@[92D. Q]20V,]<'%;OC4R1PZ1,Z%].BU*)[
MX 9 CPV&8?W0Y0GZ9[5U.!Z44 >;OX?3Q)JWB^UMG4:3>VT'DS)S&+L _O$Q
MP2,)DCO[UGV]_J\U[8:\NFF*?4K8Z,R",9\\+N\UO]@2"1>?X5SW%>L8'I1@
M>E 'GC:3H=MXY33YHK0VEMH2Q;)=I7*OQN!X)"\\\@<U@Z=<V[Z=X7.M7MQ;
MZ>^C+;K.L:2)'.,!TDWHP4E=H'3H17L.!1@>E 'DUEI6BGQ=X<T_R7GL%TRZ
M@"WX#-(GF#RPX(&01DJ",XQQD5I64T=IXKBD1[:[M)=4G'E2+MNK"0)(I;(/
MS1$*<9 P&7T%>CXI,#T% 'DB_88M \,W\)A%V/$3!Y@07$1GEW<]0NU@?3#
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M*F*-Q (ECCW;L!03R>,GOM''%:ZQHC,RHH9SEB!RWUH =1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2'H:6D/0T ,M_\ CWC_ -T4
M40?\>\?^Z** )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *0_=-+2-RI^E #(/^/>/_=%%-@0?9XQD_='>B@":BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/&MS>6[6
MTCPZHNCPJ\MY<Z;,$DC/ 7(SN90"Y; ]#SBNOK(OCKK7DL5K!IS63Q@+++*X
M='YR2@7##IQN7O0!9TQ[==&M9+>Z>XMO)5X[B5R[2)@$,6/7(YS7(^'_ !)'
MJEU9:EJMQ>6XU25AI<!5XX0@SM#$<,[*-WS9'.%Z5T5AI<^EV6F:-;K#+I=O
M9_9YGE8B4[555P ,<C=G\,5BV_A34/L&@Z3<-;FTT:ZCFCN0Y,DB1@B,;=H"
MG! )R>A]> #M**** "F21B6-D8L P()5BI_ CD4^H+RZCLK26XE>-$1<EI7"
M*/JQZ4 >=:!?)>^';>.XU?55U:ZO;BU@F\V5E5EED"9R=A 5!GUQZUN:'>R^
M*]9UN:2XN(]-T^[-A!%#*T6YT \QV*D$\D #.,#UJMX/N].TG0UT_4]3T4R1
MW,TZ-'>HX^>5Y!U P1NQ4>FW-EX<U75)-,U32+K3]1N3>-$]^L;PS, 'QU#*
M< ]L<]: %\61:AHGAG4+HZK=*JZA;FVE^T,&BA=X8W1CQD?ZS!.3\V<YYJ30
M]7N)?']UIVG:@VI:"M@)6E+^:(+C?C8)>^5YP2<>U5_$NH?VWX=ELTU;0_M$
MMQ#,J&_4)$L<J/@MC+$[3S@8R/3)Z&?Q/IXTUGM=0TEKPI\L3WR!-WNPSQ^%
M &3=>([R#QM:N[JN@R2MI8/K=D!PQ]LJ8Q_M9]:[6O-=2T[0;OP.=/74-(&L
MM&'%S]M0$7.=WF[NOW_F/'<UUVE:G?Z@E@ZC3IH2CK>RV]UY@20 8"8'S DG
MKC Q0!N'I7'^';N7Q;<:KJ,MU<)80WCVEG#!*T0*QX#2$J026;=P3@ #C-=@
M>17*Z3H^I>&;G4(+"W@N]-NKE[J)3,8Y('?EDQ@@KGD'((SC!H MPW,^@QF"
M]FGOY;J\,=DH(,CJ4W;3G &T*_)/09SDU#<>-M.M;(W$T%VKI?)830",-)%*
MQ &X D8(8'()R#Q3=1TG5[N[TG5@UNUY87$DGV4.0C1O&4*AR,EA]X$@<\<#
MFLC5/"FJ7DEU>PQ6XN;O5K2]>)I2 D< 0 ;L<L=A[8&<9XS0!MQ^,K%HM2,]
MM=6TVGS10RP3*H<M*0(]N&*X8L ,D8[XJ:;Q1!:M;K=6-Y \]\MB RH<2,H9
M22&/RD'J,]#61-X?U*34_$EQ)8V-Q;:F;4)!/)D.D>%<,-O!*YP><'%4F\(Z
MO#ID<5L_F)9ZM#?V-I=W)<QQ( &C\S!QR6*]<#'/H :'BO6_/\->(H[.2ZM;
MO3"B.ZML(9@K J5/0JP_.M*3Q!,GC%=%^PRB%;)KEY]R8/S!00-V<#YL\9SC
MBL._\.ZW>V?BE/L]HCZN86A N&.TK&B-N^3I\IY_2M.[TO5Y?$\>K6HMXA)I
MK6C^8Y+0/OW!@ N''MD4 6-/\6VFI7,,$5K=H;BS-];,Z+B>$$#*X8D'YEX;
M!^8>]1Z;XSLM3?3/)M+U8M2C9[:62-55RJ[BOWLYP"<XQ[UD:-H&N66LZ7J=
MU9V9FAT^:VNW%TS232,T;;R2G.2AX_A!]L4:3X<UC3[+PC#);V[-H^];@K/P
MP:)DRO'/WL\XZ4 ;/A#Q!<^(K"[NI[1X%2\FACR5/RHY7'!/(QSVYXS3I_%M
MI;V.K7<EK=A-*G\FY7"%@=JMN'S8(PZGKGVJ+P?H^H:%:WME=BW:%KR:>&2)
MR2XD=F^8$#;C('4]ZR=8\-ZW/#XIL[.*S>#5W6:*66=E9&\M$*E0I_YYYSGO
M0!M:AXM@L)]3@&GWUQ)IT233"%%_U;!CN!9@#@(>,Y] :ED\16ES]FMK..XN
MIKNT^UK' 0KK"<8<EF&,DX'.<Y]#C,N='UBXNO$4IMK8?VEI\=M%BX)VNJN#
MGY>G[SK[=*IZ1X=US1-4LM1BCM;@MI<.GW5NTY7RVB^ZZ-M.5.3D8!^M $WA
MKQ(+7P?H9NVN+N^O('D"M(N]@I^9F9V XW*.O<5:C\?Z7<PZ<]E!>79U"*9X
M$AB!8M%]]#DC# \>GOBL>R\,:_IEAH<R6FFW5U8V\MI/:2SMY<B.RL&5RAVL
M"O3;R">:T?[#UEO$FA:E+%9;+-;D31PML$8EV *GR_-M"<DXSGH.E &M#XGA
MNKEHK>RNY42<6TDJA-L<NW<58;LC&0,XQDU2TWQ<T^F-=W>GW$;/?R64$2["
MSLLKQA>&QD;"23@>A-4O^$:U)_$<>J+%#:7:WQ:2[MIBJW-KDX26/&&?! R>
MF <]J0Z%K\&F264"VK0C5I+HJMRR&X@DEDD*$A?DP77.,YVD=Z -4^,;%;2"
M=[>[4RWYT\Q^6"R3!BI!P3QP>1FD3QGIWV+4+BYCN;1["=;>:"5 9-[8V!0I
M(;=N7&#W[5AQ^&-8AMHH$L[)$AUW^T56*<X\K).T#8,'G ^G:H]3\(:U?7FL
MW4)MH9)=3M=1L]\A*L8%5=DF!P#MSD9[4 7K;7VL_$_B"YOUOK>UMK"UE-O<
M.&"LSS E &*\X4=>HYKJ+#4#?&=6M+BV>!PC+,%YRH;(*D@CGUZ@US,^E:[>
M:KJ=])IVG>5=V$%M]GFG,@?9)(S*WR8PRR$9YQQ]*T?"NC7.BK>P$R1V#RAK
M2VDF,I@7: RACT7=D@9./TH R_$7B"^DL/&%M!#<6W]F6#/%<HZ@B3RG<-D-
MG'W<<=CFK>@^*8&L[&TO([N.4:6MY]IG7Y9D55#L#DMD%AG(&<Y&:KZUH&KW
M$GBF*TBMG@UFS\E'>8JT;^4T>"-I&,D'.>F>*C.A:\LFDR6JV\$]EHTUCYS2
M;@LS"/:V,<J#%^HXH UK?Q;;W2D)8WBNUE]OA1@@,T6<97YN#R.&P>15GPQJ
MD^N>&K#4;FW:"2YMXY2"1AMR!LK@GCGO@^U<[I/AW6(=5M+NYM+6(MI<EG=2
MBZ:21I"5.\DJ-V2IXSP/RK>\*66H:7X9L-.U".!9;.WCMU\F0N'"(%W9(&,D
M=/UH X.XU^[L;'Q6R>(9EU+3]1>'3K:217,H"H5CV$9?)8C/7WXKMK?Q6C78
MT^6PO/[0CCMWN(HHMPC\W(SG^ZI!R?Y\X@\+:5?Z=J&N37]I&BW]^UW"RR!R
MJE47:?0_+GC(J6VTR]3Q?K5[)"%L[ZU@@CD60;U,?F9..V?,X^E $\7BRPED
MMB$G%K=3FVM[LJ/*ED!(P"#D9*D D ''!Y&:-KXSB$&JW5_;36]O:WYLXCM!
M+M\BA>&/S%V..V".>M9MCX6U1/#FC>';E(_+TR\AE^V(X"R11/O7"]0QP 1T
M')R>E%SH?B2WM-6MM/2#;<:K]M#K<;'EA9E+Q@[?D; (W9^GJ #H(O%FGOI^
MH7<BS0_8)_LUQ"Z@N)?EPHP2"3N7&#WH3Q79>9?Q7$-U:R6"JUPLL>=N[[H!
M4D,3G@ D]NM<;=Z1>:3I.OVMS:6L7]K:G ^GA+DY\TB/ !V\,IC+!B,9'((Z
MVI=*U'4[?5-,NK5K?6+U(KM+B>=)HY/(D0JC!%7:N<?P\[F/.* .BN/&FFV=
MO?R7L5U;2V*))- \8+A'X5AM)!!.1UX(YQ4R^)[":]O[!DNX9[6W^T,K0D,\
M1)&] ,DC((Z9]JYW4=$UC4_#U_ F@:=IT\\2Q+#;R*Q=MX8LS[5PH X').>V
M*T;C3]1E\87&JKI[_9GTC[(H,B;O,WE\8STYQGU_.@"[IVNV<.AZ.+=[Z_>\
MM1+;*^&GEC"@EW)('\2Y)(Y('4UJZ9J=KJ^F0:A9N7MYEW(2I!]""#R"""*X
MK3=!U_15\/7]O9QW$]EI0TR[LVG"\#:1)&W(/*]#C@UVVGBZ2R7[8L0G)9BD
M7W5!)(4'C.!@9P,]: ,#2_$FF16MU)%=W]VTFJ26B1W Q(9^IB0$#"K@XSC&
M#S6[IFIPZM9?:H%D5!))&5D3:P9'*,"/JIKA[?PWJ)T^^MK_ $1;B"[UN>]9
M!.JRQQN"5>-@PVR*V.XX)P:ZGPI::I8Z$+;5IVGG263RY)"#(8MQV;R."^W&
M2._<]: %MO%6FW=Y;P0M(RW4LL-O-L_=RO'NWJIZ\;6YQ@[3@FJZ>-]&D> !
M[@)-=FR$K6[A%F#%-C$CY26!'/MG&17/V&B>(?[5T2^O[!3<6>H7$ERRW(\O
M9)'*JF).RC<N1@,3UR<FFW.@ZU+X7CL5TR3[0NNF_*^;'_JOM+3==W7:<8]?
M;F@#K/%-[;V'AV[GNKVZLH0H!N+5-TD>3@$<''IDC'-/N_$%G8W,EO()G:$1
MF9HXRPBWG"[L>N#]!R<"J?C>QO-5\'7]A86S375S&$1-ZK@Y!R22..*R-=T;
M4[[5SJ.GV=U9WZ>3Y5Q%.@CF3@M'<(6^8#+<@'KQ[@'1+XCL9+W[-$)I/W[6
MWFI&2GFJI9DSZ@*?;/'7BF0^*M*N+&RO(YI#!>W)M86,+#,H8J5(QQRK#)XX
MKGXM#U2'Q2FHV-K-8![Z0W<:S*;6YA.[$NS)992-O( R<YXJE;Z%KEII.GZ4
MNE,XT_6VO//\^,++"99'!49R#AQD''3C- '7R>)=.CODM6>0;[C[*)O+/E^=
MC.S=TSQCTSQG/%,L/%>F:G?&TM&G>19I8'/D.%22/&Y6)'RGG@'&<&L#3]%O
M[349K6X\-V-RGV^2[AU24QMA6E,G*_?\Q=Q (XX'-:WA*RO;(:NM[9/;_:-2
MFN8BSHVY'.1]TG!X[T :E]K%M87"6S"66X>-I1##&7;8N,L0.@Y'UZ#)KG_$
M7BN-+'0I-,EDD@U:\BB%Q#&S?NB&9MO'WB%QCJ,GTJY<V=_9>,WUB&UDO;2X
ML4MGCC= T3H[," Q *D.0<'.0/PYI/"NKV&C^&K2.T-PUGK+:C<+%(@6*-C(
M=@W,,D>8.G'!H ["VE.AZ,TVHZA/=1^9F.2:/$F'8!(R ,LV6"CC).*=_P )
M%9>1)(RSH\=P+8PM$WF&4J&"A>_!!R.,9.<"E\16GV_0IK8Z>+]9&C#VQ<(6
M7>NXJ21A@,L.1R!R*Y ^']>AL89#;OJD=CJ1GM[34)4,TT!A,9#ORI=68E23
MT&": .MC\3Z9)9/<B5P8[C[*T)C;S!-_<VXSGD'TP<].:B@\7:1<-;HL[AYK
MMK$(86RDZ@DQMQ\IP">>#VK N])U3;8:MIWA^VM);.^^TMIL;QJ\ZF)HV+,/
MDW@/D<]!UYP)]9L=8O4TO4(]'1&M-62\-G'(@F:/RW1BS$A"^6Z9Q@=30!KR
M>,-&BM[B=[AUCM[T6,S-"XV3$J IXX'S+\W3GK5>/Q!9:AK6G>3>:A"[1W)%
MFUJR"4(0K%MRY!4C@ Y.ZN;?0]=:RUM#H\A:Z\00:A$JSQ'=$K0LV<L.<1GC
MU(^M='J5I?3^-M!OXK"5K2UM[E)Y-Z#89/+P,%LG&PYP#VZT 5U\4V^IZ U\
M\UYIL8U 6ZR+ Q8E9]@4Y4CYBNT^F[L:UM1\3Z7I+RK=S.B0;!/*(F:.#=]W
M>P&%SD?0$$X'-<J^C:TGA.?21I3R2)JXN8V6:/$L?VSSR1DC'RX'.#GMCFIK
MC1]0AUO5TE\,VFL6FI2B>&>>2,>43&JE)0V3M&P8*AN.U '4'Q!8C4/L8:5F
M\X0>8L3&,2%=VS<!C./PYQUXJ'Q1?P:?I]N\^HSV >[AC62&+>7)8?(>#@-T
MSQ6 FB:G#XE@OK.UGM&^U 7:I*IL[F$+CS/++$JX  ! !XYXK1\>:=?:IHEM
M;Z?9O<RK?6\S!71<*D@9C\Q'84 6+OQKH=E->PS7$N^P95N@MO(WD[AD,V%X
M7'.[I[UJZIJ,>DZ5=:A,LC1V\32LL:EF( SP!7#W^AZO./B $TN4_P!L0I'9
M?O(_WA$ CY^;CGGG'%=AJEO/JGA>^M8XC'<7-G)$J2$95F0@ D$CJ>V: .3/
MBZ[;6O",\DLT%KJ5E/+<VBPDYD6.-@$RN]N7.,=<5U,/B72[G2;;4H)VD@NF
M,<(6)B[N,Y4)C=D;6R,<;3GI7*6>FZR=8\&W,^BW$4>E64\%SF6)B&:.-1T?
MG)1NG;'T%>WT76+;3;"XDT22X:RU*\FEL6DC#2Q3/(RLAW%=RAAP2.K"@#OM
M-U.TU:T^TV<F^,.T;94JRNI(96!Y!!!&#5RLGP_;^18RM_94>F":4RBW7;NY
M R7VY&XG.<$]N:UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*0]#2TAZ&@!D'_'O'_NBBB#F"/\ W110!)1110 4444 %%%% !1110 4444
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MCZT >HV\RW-M%.@(61 X!ZX(S4E>?C5-1T.Z?_2I;R+_ (1Z2_$$BKM62+8
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M^/>/_=%%+;_\>\?^Z/Y44 24444 %%%% !1110 4444 %%%% !1110 4444
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MWLOF*!@ @$=L ^H&#Q6=X/\ $5YK%QJMMJ,)@N(IDGMXF&&%K*NZ+/\ M##
M^A!IDT7BD1W7V>]D+C55:VWPQX:V.-R-Z(,M@_>.T>M &S%X=TR&_@ODAD^T
M00?9XW:>1L1\?+@M@C@=>X!ZTS2/"^C:%/+-IMC';R29!*DD $Y(4$X49[#
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M&2-9&C8E2I#*<,"" 001BLY?%^@M(B+J43%KC[*"H)42\?*2!@<D $\$\=:
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M'>.=1CQ9D"? 8E<@D' &2, \C(X/H:=)J]K-JFDI;ZO"HND>6.W50YNDV9#
M]@.N>_2@"M>^#--O[N"[EFOH[N.'R'G@NFB>:/\ NR%2-W\ZEN/#-A]MCU"!
M;F*:"T^RI%;S&-6C&=JXSC(W'&>!FK"^(M*DEDB%XJLD<DA9U*KL0@.P8C!
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M[>"9PK!1*@8[3C.,]NF?PJU0!CVME._B;4-1N$ C$,=M:\@Y49=V]LLP'/\
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M$R00-Q&<'%:M '/>!YQ)X,TJ!E*3V=NEG<1MP8Y8@$93^(_(@]ZH?$R&:_\
M!5[I5JBO=W841!IHXQ\KJQY=AV';-=5':017,MQ'&JRS "1AQNQP"?4XXS5/
M6I],L[+[7JJ1&!'5 TD6_:78*.,'J2* ,?5;3P]KVCZC!/-;6LNHVHMYF\Z/
M>H&XKG#$$J6)_&J^B:_<Z=HMMI][;QSW=K$L/GPWD'E3;1@."7##.,D%<CGK
M72C2--'33[3_ +\K_A0='TPG)T^T_P"_*_X4 <;=E;WQEI-YJ$%G=6T-A+;W
M$PEA,7F.T9RJL^[:-K=LUJ^(+RUN;"'2++RFM;B1([AH;B)%C@W#>N"X/*C;
MP.C9K=_L?3/^@=:?]^%_PH.CZ8>NGVG_ 'Y7_"@#B]2@33/&FD:UH[-<Q"&2
MVU$&_1B8CRF#))U5N<#L37H",'0,.A&:Y^_G\+Z==I:WD%G'([(O-KE5+DA=
MS!<+N((&XC-2#Q9H2ZA'I@O56Y=_*BC,; 2')7Y#C# $$$C(!ZXH H3^9+\1
M);RU3S_[/TAXI(U(!:22165,GC.(R?;<#WKI[:22:UBEEA:&1T#-$Q!*$CE2
M1P<=.*9:V5O9(R6\2H'8NYZEV/4D]2?<U'9ZI9WUU>6MO,'FLI!%.NTC8Q4,
M!SUX(Z4 ,UM99-$O8H8'FEE@>-$0@$D@@=2!WKEK73-37X//HDFGRIJ8TE[(
M0%T.9#&4&&#;<9/7-=;J>IV6CZ?-?ZA<)!;0KN>1^@']3[5:'(S0!QUK:W\6
MM>&YVTRX6.STN>WN&S'\DC>3A>&Y_P!4W3(Y%9=AH-TWAC1[+4--U"WGMFN&
M%S9S*LULY?*D;6Y5E8@CD<#(KT:B@#*T$7]OX:L5U1!]NCMU$RQJHRP'8#C/
MTX]*XC1M-UNRT?PQ:7&D72QV[W*W8A:(3(6;,>U]V50@G<5(/ '3->F53N=5
ML;._M+&>YC2ZO&9;>(_>DVJ6; ]  >: .'T_0]5M?A]I\0TZ1=7T>\-Q!$TB
M_O<2L6 8$\-&[+D^O2K.B^'=7L?$YAO7%QI[[-2DG4X5KS:R2*%/122''IM%
M=E:ZA:WK7*V\RR-:S&"8#^!P Q4_@P_.F_VE9?VK_9?VA/MWD_:/(_B\O=MW
M?3/% ',?$@[=$TPB,R8UBR.P8RW[T<<\<U0\0Z7=ZFWB2^M-.N%^V:,=/A0H
M%>>4^802.P&X#+8Z^@KL=5T2QUN*&._CDD2&59D"2O'AU.5;Y2.0>15UF2"(
ML[A409+.> !W)- '':A97ZZKX5UB"RDEMK&.6*ZM@ )(MZ*H<+WVE2"!S@G&
M:R[W1K[=J%U'I\_E7^O6=ZENJ998HC%YDC ="VQCCJ>.,\#O["_M-4LH[RQG
M2>VDSLE0Y5L'''KR*LT >;ZUIM_<_P#"?1PZ?=/_ &E:11V9$9Q*PB*$#T^8
MCKCUZ5?MX+JS\7V&JS6%T;,Z&MIN2$NR2B3<591\PX[XQ[UW-% 'GNG:1>Z7
M)X3CDLY@MO=WEQ*L:%UMTF$NQ"1D<>8J\>GIS5>WTJZBT[4M.U#2;XQOKTUT
MMQ;-AXXW9G2:(KDEE.W(QZ\'I7H<][:VLD$=Q/'$\\GE1*[ %WP3M'J< G\*
MGH YWP>NIQ:3.NJ@M*+J41S-"(GGCS\LCJ ,,1UX!.,XKE-1TZ\NO"?B2VCT
MV[:>[UE+B%#;L#)'YD3;N1Z(W7T]Q7IM% 'F>NVNIMKOB6\L=(ENH[C3[1(5
MEM\JY60E\*W!95;< >I&/6J]]INHM'XW":=J<@U32X([629-S2N$D4@X/RG+
M#C  '85ZI10!QF@R7NG7>K6=[8SO#.S75M>I;-ND5P3Y<F!G>GW1GMM'48K*
MT:SNHO\ A 5GTV[5M.M)(KK=;MB%_*5!DX]0>1]:](HH \RN$N+;2"ZV=ZMV
M/$<EU:I]G)+!F=MVPE2XV;N 01UXQ5_3?$5EX>TW6+RYM]3DNFG_ +0O(39F
M)DC?"[U4D_(JQ\G)Z'UKKM4T6SU8P/<B59;=BT,T,K1O&2,'#*0>1U'0U3_L
MK0[2>.UN7$MS=D "ZG,DD^P%@OS$EE'S';T')Q0!2^(K!OAOKS+T-DY'Y5EW
M%L]]J&FZC:VERD-IH]Q!.3;NK.9!'LC48RV"K'C('KS74:C9Z=XGTJ[TV2X\
MVV9C!<+!)@Y'WD)'3W[U/I\UDF[3K:[2>6T55D3S SH#D+NQTZ'KZ4 <.NDZ
M@GA;P/-%8RDZ0UN;^T\O:_RQ%&8*?O%6).!UY(S47B#2[N\@\57EK973Q:D+
M.."'R&#R/$V7<KC(&W R0,[?IGTO@44 <+=PN_C?4[Y;&Z:WET)+>*7[*_,F
M^1BHXZX9?Y=1BJ7A^RO+:T\!P3V-VDMC!(ESN@?$1,10!CCCGC]>E>CT4 <!
MX=AO-/U:W>*&^72FM9'EL[JU9FL9"5.V*0KEU8Y^49^Z#570K"X@MO :7.GW
M2FQAF2X#6S?N6*;5SQQSW_'I7I-% 'DTR7%II,1:UODNU\4S75E%]G)W(S2.
M#Y9P6786.%Y!(/&#77>#'@SJH_TE;ZXN?MEQ%<6C6^W>-J[5;MB/KDY()[XK
M9U70[/5VMY)S/'/;$M#-!,T;QDC!P0>A'4'(J6PTN#3R[1O-++( 'FGD,CL!
MG R>@Y/ P.3ZT <A?6EW$OC&QNK&XNFU0%[-XX2ZR*T"QB,D#"E64_>(ZY]:
M9HFEW%MXWM1J%M//Y?AZWLI;IX&:-YT<LPWXP<C!ST_&N_J%;NV>Z>U6XB:X
M10[1!P753T)'4"@":BHGN8(YXH'FC6:7/EH6 9\<G [XJ6@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "D;[I^E+2-]T_2@".W_P"/>+_=%%);
M8^S1=?N#J** )J*** "BBB@ HHHH **** "BBB@ HHHH **** ,3Q7JLVCZ"
M]Q;L$FDFAMTD*Y$9DD5-Y'MNS^%9+3ZC:^,/^$=;4KJ2UOK!KF*X(0S6[HZJ
MP!V[2K!AU!P<^O'4W]C;:G8S65Y"LUM,I22-NA%4;7P[8V@E*&Y>:2(0FXEN
M7>54'10Y.0._!Z\T ><W.G3#X0Z<QU2\(>ZM24(BP,W*#'W,]?FY[]<CBM^X
MFUS4]6U?1-*U1X+C2H81'/,Z*TLCJ7#N!&0R=%P,=&]L;K>"]&;18]':.Y-A
M'()%B^V2\,#N'.[/!&<9QGFG:EX/T?5IK>>\AF:>"/REF2YD1W3^Z[*P+CV.
M>_K0!DVLVKZKXGN;5=<,-O%:6-X!;(CH2S2[U5B,E&V#GKTQCI61%KFNOX=B
MG&J'[2/$@L&D:)"&B^TB, @ <8],'WKMK?P]I]IJLNI0)*ES)$L+8G?9L7.U
M0F=H R<8'&35)/!&BQV@M42Z$(N_MN/M<O\ KMV[?G=G.[GTS0!S][K.O:1H
M_B](;N34;O36C:WEDC4.JO&C-\J@ [<L0,<XQ6EX=NM4N?%%_!_:,]YHT-O"
M\,TD2X>1@=R[PHSC .!TW8/:G>(?"*3Z;JAT^&2>YU%H_M4<MXZB55*YVDY"
MMM7 ..*B\+:'?66HBZ\G4;"W\MDDM[W4S=F0\;2 2P7'/(.><8H =J4<P^)%
MK)]ONXXXM)FF\J,(5.)8]RX*D_-QGOQP15&#7M6CT[POK[7QGAU>XABN;,JH
M2)9Q\NP@;LH< Y)SS[5UE]H%AJ&K6FISI)]IM5*QLDK(""0V& (##*@X.>15
M>T\*:79S0M''*8H)6F@@>5FBA=LY*J>!U./3)QB@"GXTU'4=-MM(?3KI8&N-
M5MK:7=&'#)(X4CV_#GW'6N?U/4O$5E9>+(HM<8R:*BW<4S6T9:0&+>8V&,;<
MJ1P,X/7CGM-8T*TUQ+=+PS;;>99XA'*4Q(IRK<=<$9%5+CPEI]TVJF5[D_VK
M&(KL"8@.H& /;C(X[&@#D_$_BS5K;3;K4+&^57MM.ANUM;>(/M9LEC.6'RH1
M@*%8,>3SBI/$6MMIOBPW4;B"6[TF"W2X?[ELTDSXD<X(P#ZC!.!QG(W+CX?:
M'=),D@NPL]JEI,JW+J)40$)N /)4'@G]:LGP;ICF3S7NIA)9&Q<33E]T)['/
M4Y).>N30!GW]SK*ZC;Z#:ZE</<BS:YEN@D*R.=P5< KMV@Y)P,_=YK6@U.]L
MO"$FHZJD#WMK;227"6K[D+H#N"G_ (#T[=*JW/@C2[NUL8I)KX26&1:W,=TR
M31J0 5WCDC@=<UMV>G6EAIT=A;PJMLB[0AYR.^<]2>22>I)S0!REGJ>M0Z1:
M^)+G4K>YL)=/>[N+0*!M;9YBB$@9( !!W$YZ^U-LM8U>.V\-:I/?"YAUHHDU
MN(U"0&2-I$,9 #$ C:=Q.0<\5J:5X(T;1YMUJEP8E#"*VEN7DAA#9W!$)VKD
M$CIT)'>IM/\ "EAIJVL<#W!@LRS6D$DFY+<D$97(R<!B!DG /% ')RZWXF7P
M'J7B,:M"'M8KQ%A^R @LD[*KYSQA5QCD=SDUJ7-YKNF>,-!L[C5Q<6VJW-SN
MB%NB")%@+JH/).&'4GG/2M4>#]/_ .$>N=":6Z:PN6=I$,G)WL6< XR 6)/X
MU-J?AFTU6*P%Q/=+/8OO@N8I=DJDJ5/S#U!(- ''?\)/KZ65@%OXGED\32Z2
M[R0#+1*S@'C !PG.!SGM2:W?ZVFD:[H]YJ;2S6=U8[+R.)4:2*>5059<$<?,
M..HQ[U/XA\(BP728-&M=0E7^W4U.Y9)=WE##[BNXXSEAQR3WS753^%["\TZ^
MM;AIY#?.LD\Y?;(67&P@@ #;M& !C\SD -?N+W1_!NIW=O=>9>6=G+,LTT8.
MYD4MR%P.U<]I^L:];7^@2W]_!<VFL6A/E&$1_9Y5A\S=O'4$!LY'!Z8Z5N>(
M=.D7P)JFF6:7%U-+8S01!G,CN[J0,LQ]3U)JMX=\/1G1M,;4$NGGM[(6H@NF
M!\G*A7 QUSC&22<=#R: ,[1-7U:_U=+!]3DD2[TMKI;@0($24,BDPY4%H_GX
M+ YP""<FHM&US6]1@TO3I;N5-8COIH]3_=IA8XAEL#;]UM\6WO\ O.IQ6JG@
MZRTD6]_9G4;J[TZV>*VB:]8>8HP5B.3C&47K^.:G\/V-Q/?WVNWVG?V=>7T<
M47D%U=T1 <%B.-Q+'IV5: .=77?$1M8KXZE!\NO/IC0"V 1T,YB#'G<"." #
MZY)SP2>+-8T>\\2Z?=7,5Y+92V2VUP\0C"FY;;A@"!M4\]02.">]=&/!UB+)
M;07-YY8OO[0SYBY\_?OW9V_WN<=/PI9O!NE75WJUQ=++<?VM$L5W'(WR.J_=
MP ."N3@CGOUH YO7-7\6:!X=UVZEN(\0PK-9S7"QF;J%=2J?+@;@0W;."#5S
M4KW6[6XU^QFU7?C2#>P/%"J&W<;U*KUR. ><GWK0_P"$!TEM)N=.FFOYXKE%
MBDDGNFDD\M>0@9L[5SS@8K1D\.6LVH27D\UQ-)+:&SD5V&UHCU!  YR2<^_I
M0!QMSJ>I:)X=T9/[1U".R;3A(]_%;QR_9WV+L$J["1%][Y@,\<FNN\133#P3
MJ=S;71CF6PDE2>+!Y"$@C(Q5>'P996]JMO'>Z@$^S&U<M/N+Q'C:=P/0=,8Q
MSCJ:VI-/M9-+;33&/LC0F Q@X^3;MQ^5 '$Z->7RMX?\,6^H30J^CB]>Z\N/
MS HV(L: KMZMDD@G _&NA\)ZK=:G87<=Z5>ZL;V:SDE4;1+L;A\=B5(R/7.*
M9!X,TVVBL!%+>+<6&X6]TUP6E12 I7+9!7  VD8X'>M?3M.M]+M?L]LI"EVD
M=F.6=V)9F)[DDF@#SA+Z?0-9^(.K374MV+$P/Y#QIME/D*4S@9 !/;MR<FN@
MFU+5=&\1Z/IUQJ/VV/6(IE5WB51!-&F_*A0,H1D8))X'/6M>#PM80WNJ7+--
M,=4 6\CE8,DH"[1QCC"\<?CFDM/"UG9^05GNI'MH&@M7FEWM;HV,[21UP ,G
M)P,4 <KIOB#7Y?".C:Q-?K)-JP@MDA6%%\J1F8M(&/&2HP 1C('7G,^K:IXF
MT7PQJ$]Q=1^=%>VXMY)5C:4P22(A#A0%# EL$#D#IFN@3P?I2^%QX=9)I-.0
M 1J\AWQX.5*L.00>0:B?P3IDNCR:;+/?2QRR)++++<M)+(4(*9=LG"D @#CC
MW.0#$\2^(]8M-2UN&SN1;RZ?:Q36-JT0?[>S$[O<C(V@(0<\D]*N377B&YUP
MZ7'J<5KG2EN6=;4%DD+D' )([=^/;N,O5=%U)_%.H71L-?;SQ&D-QI>I)#&Z
M*HQYBEE(;<6Z C&,=\]/I_AV1&BOKV^N'U,V8M)9%=2"O7^[@G/.<=?0<4 3
M>'M9?4?!NG:S=*!)-9)<2A!QDKDX'YUS\&N:PNB:%XCDO%E@U*6V6:R6-0D2
M3L%7:WWMREUSDD'G '&.LTC2H-%TJWTVV:1K:W01Q"0Y*J.@SWQ6?9^$=.L4
M@@A:<V5O/]H@M'DW11OG((&,X!.0"2 >0!@4 8VC:?>R^*?%*G5I.)H,$P1G
MGR5*GIVK+\/W>H:;X)\'RI>"7[;=002>9"I98W!)52/=>IR:[2#0(K:]U"[B
MO;M9K\@S'>IY "@CY>, 8XJJG@^QCTK3=-2XNUM]-E6:V&]<JR_=R=O(&3U]
M><T 4+?4=;UF2[OM.O[2WALM1>U:UE7*M%&VV0NV-RN<$KC  QG.:KQ^(-3S
MXL62\M(CI]W%#;RR1E51&1">!DLWS' [G XS6K)X)TB35Y]0Q<H;EUEN;>.X
M98)W'1G0'!/ SV/?-%QX+TVY74Q++=$ZC/'<RNLFUDEC(V,A ^4C:OY4 <OK
MFJ7EYX+\;6=W))*MB@6&6:(1R,C1J_S 8&<D]AQC(K6\0Z]?V'B(6INI;"T9
M8A;W)@#V\DC,0T<KX)0XV[>@YSD]*OR>!]-EAU2)[B_9=415NMUR6WX &><X
M)  XZ <8JS=>%[:\^TBXN[N2.Z6-;B,LNV79T)^7@\<XQF@#=S7%7.H^([WQ
M7KFD:=?VELMG;6\\#/;%SEM^5/S<YVCGL.W>MC2=)O+/Q#JU])=3&TNRGEVT
MDID"LH(+K_<!&!M&>F>^!BQ:7=W?Q#URX)O[2TN+*"!)XD"B0J7W %E."-PP
M>.^#0 _2/$UYXI^Q064R6#RZ5%?ROL\PAI"0JC/&T%&SW/'2LRWUJ7Q#J7@7
M4+B%8;@WM[%,BG*AXX9D;'L2I(KK&\+V23V<]E)-82VEM]DC:V*\P\80A@00
M,9'&14:^$K"*326MWG@72G>2W1&&"S@ARV022P9L\]R>O- ',ZYJFIW/A?6L
MW,44EOK<-H&BAVAHS)"N""3_ 'SDY_*M._\ $-WHGB*ZAO&AGL[/1)-09HXM
MLK,C@$9R1C /8=:T9O"%G/I^HV4MU=M'?W NI&W*&24%6#*0O&"B]<CCZU(O
MA:T&J?;Y;BYG<VC6;I,RNLD3')#9&3D\]?;IQ0!5LKOQ 8(M1FFT^:SN+$S^
M7DQ^5-@,JAN04QG)//&?:H?#^O7UYK:V%U/'<QRZ>MV)5@:,!MVU@A/WDY!!
M_4U+9^!=-M;.2R:ZO[FT,$EM%!<7&Y8(W&TA./3@$Y(' XJ:T\(PVE_;WPU3
M4I+F"V-JKO*O*=L@* 2/ISWS0!4^&P(^'.DA2 1&X!(_VVK)3Q9XB30Y]<E&
MGM;6.HR6MQ D3AI8UF\O>K;OE('.,-GU%=?H>C0>'-%CTZWFGFMX,E/-PS $
MYQ\JC/)/;-<MX5T%K[2M1M]1^W0P2:O/=&UEB\M70S%TY*YVG ) /L>XH MZ
MCXGO['6%AWVS1G4X+/R$C9V6.3:-[N#A&RQ(4CH/?-36>JZ[J.HZO#')810:
M=>F L8G9G3R5<<;L AG'/0CL.[[GP1;SR7#1ZG?P)-?+J CC,96.<$'<,H3R
M5Z$D<]*TM-T&/3;S4KA;RYF_M"42RI+LVAMH3*X4'[JJ.2>E '*:5J^HVOAK
MP/).UK='4I(8W>2$[TW0,^X'<?F^4C/OTJ[;^*-;U2=;G2M.$U@-0:U=64 ^
M4KE'D#EQ@@@G;M/'>KD'@>W@L])M1JFH-'I4RRVVYHSC:A15/R= I(]3G))I
MZ>#+6'4;FXMM0O[>UNIQ<SV$;J(9),Y)^[N )&2 P![T 4M(\4WVH>(!I]P;
M>UG6>9);":)DF$2[MDB,6Q(IPN2H_B]N=K5M5FM]7TS2;4Q+<7PE?S)06")&
M 6.T$9.64=1U)[8J"U\*0P7.GS2WUS<_V=+));"4)E"ZLI&X*"5 8@#Z9S@5
M=U318M3NK&[\Z6WN[)V>":+&1N&UE(((*D=1[#TH YT>*M4)@M_*M3<IK)TN
MX.&"M\AD#KSQE=IP<]2,]ZW[G49]%\,7&I:L89)K2W>:;[.I56V@GY022,@=
MZJ2^$H)%@*WMU'-'?'4&E79F2;&W+94C 4XP,< 5M75I#?64UI<H)(9HVCD4
M_P 2D8(_(T 8(U#Q%!;2W4UM8SP_V>UP@C?RBLXY$99F(*D'[_'3D<UG?\)7
MJ*VVN[&M+B2PTN._AE$$D:.6$N5P6.Y?W7# X.?:KB>![=M(FTN]U34;VV:U
M>TB$[IF&-@ <%5&6P ,MD_F<R2>#_/>\>?6+Z1[RP%C.Q6(;D&_!&$X(\Q_S
MH SD\87]CJEK'JT=HMG<Z3)J), ;=#Y84L"2<,"&]!C'?K587FH:IKG@?4[Q
M;>);MYYD@1#NB#6SE07W8;CKP.:VG\&6LUY97$][<R_9;)[$1L$VR1. &#87
M.2 .F*CL/!*6#:0J:QJ$D.DNQM(Y/+.U2A383LR1M8CKF@"K;>)KE+.[06]F
MM])K3Z;!L4JC,!DNW.20H9CR,XQQUK-M[W4=)\0>-+K%E-=1BQ^=CY$04J07
M;<QQM!)QGG';-;LG@>UELKJW?4+W=-?_ -HI,I0/#/G.Y,+C';!!XS45WX"@
MOVOY+K5;^2>\:W=I,1KL>$Y1@ F/P.0: ,75?$^IW_AKQ-"DD44UA<PVPG6!
MT\R.383\K-E3AR,Y]Q6WJ.NZS'=WMAIL,-S=V-NDC?Z.Q6:1MQ"#Y_D&%'))
M^][<O?P/;RQ:S'+J5Z_]K&-YB?+!61 H#KA?]E>.G'2I)_!Y>_2_@US4[:],
M'V>XFB,>;A 21N!0@$;C@J 0#0!0N?%]]'J5O:30PZ9-.ENT,%ZA/G%S^\19
M0P0.O("\DD#L:[0'BN<G\'6TUI-8_:YQI\WE%K=L-@Q[<$,<L"=HR<D]Q@\U
M9T>VU2+6M7FNKB=["61/LT4Y4E",ARNWHA^7 /.02>M &?=^(-4GN=>728;5
MDT<!2)MS&XDV"1D&"-F 5&>>3TXYK6_B?5M9O+.+2(K)([S2TU")KG>=N74%
M6Q[$\^M:EQX5B?5-2OK6^N;1M3B6.[2/:0^U2H<9!VMM.,^PXJ2Q\,P:=JMK
M>6MQ(D=M9"QBM@%V"(8(YQG.0.<T ,\4ZU=Z+%IKVL4,OVK4(+1Q(2,"1@N1
MCO\ YYK$O?$_B"RM_$>4TYY-$C%PS[) )HS'YFP+N^5N"-V2.GRUTFNZ$FNQ
MV:/=2P"TNH[M#&%.70Y7.0>,U1NO",=V->$E_.!K40AG 5/D4(4^7CKM/?-
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MP):R:==+-IL\1NU\O/E!('C)XZ_,PZ?T- '>7M[;:?;&XNI1'$"%R03DD@
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M2P!&X(&[^M4])FDTO2_"]U?6^HQZ?;VMQ:R&WMW+VLI=2I9-I;:5!&0.,^]
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M ,48%%% !BC%%% !1BBB@ Q1@444 %&*** #%&*** "BBB@ Q1@444 %%%%
M!BC%%% !@48HHH ,"C%%% "8XK.TK0[+1GNVM!*#=S&XFWRL^Z0XRW)X)P.G
MI6E10 F!6=;Z%86VJS:FL<CW<I/SRRNX3.,A Q(0':,[0,XK2HH ,4F!Z4M%
M "8%+@444 &!1110 8HHHH *3 ]*6B@#+U/0;75YX7NY+AHHP0;99F6*4$@_
M.@X;IW_K6H!BBB@ P*,"BB@ Q28'I2T4 &*,444 )@>E+@444 &!28'I2T4
M)@>E&!2T4 )@>E&!2T4 )@>E&!Z4M% "8'I2XHHH 3 ]*"N5(!*DCJ.U+10!
MFZ1HT>D)<(ES/.)YWN&,VWAV.6QM4<9K1P/2EHH 3 HP*6B@!,#THP/2EHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "D/W3]*6D/W30!';_\ 'M%_
MN"BEM_\ CVB_W!_*B@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "D;[I^E+2-]T_2@".W_X]HO\ <'\J*+<C[-%S
M_ /Y44 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4C?=/TI:0]#0!%; ?9HN!]P?RHI;?_CVB_W!_*B@"6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;
M[I^E+2-]T_2@".W_ ./:+_<'\J*2W4&VB_W!_*B@":BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;[I^E+2-]T_2@
M".W_ ./:+_<'\J*+?_CVB_W!_*B@"6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "D;[I^E+2-]T_2@!EO_ ,>\7^X/
MY44EO_Q[1?[@_E10!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2-]T_2EI&^Z?I0 R#_ (]XO]T?RHH@_P"/>+_<
M'\J* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *1ONGZ4M(?NGZ4 ,M_^/>+_<'\J*(/^/>/_='\J* )**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I&^Z?I2TC?=/TH 9#_ *F/_=%%+#_J8_\ =%% #Z*** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2'[I^E+2-]T_2@!L/^IC_
M -T440_ZF/\ W110 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "D;[I^E+2-]T_2@!L/^IC_W1120_P"I3_=%% $E
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
544 %(1D$444 (B[$5?08HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex10-4_006.jpg
<TEXT>
begin 644 ex10-4_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYN
MB?[XJ2HY>B_[X_G0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5%-T7_?7^=2U%-]U<_P!]?YT 2T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %13_=3_?7^=2U%/]U?]]?YB@&2T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07?^
MI'&?F7^8J>H+O_4?\"7^8H F'2BE'2B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH BDN(89(HY)41Y6VQJS %S@G ]3@$_A4M<]KET\'B/P]$UC:31W
M%S)&L\A)DA<0R-E!CC(4@G/?I60GB[6=DUU+864=K:ZNNG3@2LS,&D6,,G Z
M%P>>O(QQD@'<45E>(=;CT#1I+YX_-?<L4,0./,D=@J+GMDD9/89-8U]XFU/2
MKS4+&XM+6>YATYM0MG1VC214.'5N&(()7'KGM0!UU1Q7$,SR)%*CM$VUPK E
M3C.#Z'!%<F/%&JC^S(WL[03:P8OL(61B57RO,E>0?[.. #SD#(ZUE:'J$F@2
M>)%-K;I=3Z\D$44"L4+-!$2^ ,_=#.1USD9[T >BT5Q\WBG5[.W5KC2U).J0
MV2R$/$)8Y"H$BJPSG+$$$\$9R:WHI=4&AO)=QVL.HJLAVQLTD0P3MY.">,9Z
M=Z -*BN*\/:_J<VB^&[:1X)M0U6T%UYKAL)&(U+,PSECN=0!D=?;G:\.Z]_;
M45]%-$(;W3[EK6YC4Y7<.0RG^ZRD$?7':@#;J-9XGF>%9$:5 "Z!AE0<XR.V
M<'\JY.Z\87)TW5M8L+:*?3M*G>*523YDPCQYK(>@V\X!SNVGID5G17E_'X@\
M1WWARQM;J2:VLKG$SF)9%*2'C )+$ =<#U- 'H-%<5I/B2^UWQ+IDEJ\4>FW
M.CB]\ED);+.H()SC(Q@<=S5C3/%=W=ZS96%Q!;AKR">0I$V3;/&RCRW8$@DA
MN<8P1TH ZF&XAN4+P2I(H8J61@0"#@CCN""*DK@K'Q+<V?AW3KJST6RB^UZQ
M)9S00R[51C.Z%A\HW$E<DG'7..U=!X>U>^O[G5++4K>WBN["=8V-L[,C*R*Z
MD;@#G#8/TH V5GB>5XED1I$ +H&!*@],CMG!_*I*\^>XU+3/%/B^?1-.MKB9
M$M9Y$ED\L/B-R0, Y<X[X'O6CI'C"?7-62ULX8EM[G2(]2MY9 =REG*[& /.
M,'D$4 =A3/.B\\0>8GFE=^S<-VW.,X],UQ$?CR272-$NY5M+%M3LVN%DNF(A
M\P;=L6_@ G).3Z=#6B-0N3XGVMI5F+O^R#-'-YQW-\RYC)"G:NX]MWK0!U-%
M<5I/C6^O;CPT;K3(8+778&:)EFW.DBQ^8<C&-I ..<],@9P)]/\ %M]J=S8W
M%KIK3:5>3/&)4CDW1H,[)22-I5BO0'(W#KS@ ZZBN(L?'-U>6%U?I90SI;V<
MT\ME"Q%U!*A&V)T/.6!8YQV[\$[/AO7)M<2>;=9S6H"&&XM9-RN2"64@\J5/
M&#^G0 &]16?KE_/I6AWVH6]NEQ);0/,(GDV!@HR1G!QP/2L)_%6HQ2VD,NG1
M))J.UK(*[2'8(PTC2*HR-I(  SDD<CK0!UM%<)=^)->G30U%@EE/<:HUI.DQ
MD4/M1W4H2H)1@@.2,]O>M&[\5W-GK26LMK L+WT=FJM-^^<.H_>A?[NX[??!
M/M0!U"R([NJNI9#A@#RIZ\_A3JX2\\2?V%!XPU2+1;<7.GW$8GVSD&X'E(5<
MG;P0K*,>W6M[3=:OKCQ!=Z7?Z?':E8$N;=DF\PM&6*D., *P(Z D<]: -O>N
M\)N&XC(&><4ZN*U-[JT^(K3:98)=WKZ,<(\HC4XF'WFP2/P!_#K4FF^.)-5N
MM#2#3U2+4Q<1N))2'MYH0=Z$!<$9&,Y]\4 =C32ZJP4L QZ#/6N/'CAUT^"6
MYMK:VEDU&>P9YIRL"&)G7)DV\;BF ".IJ:34VGU[PV+W1HUO+B.=HY?/W?9V
M"991@?-D8YXXH ZRBN+M/'%U,FF7%QH_D6=Y?R:>TOV@,5E$CHN !RI*8).,
M$\ CFICXTFEOHC9:5+=Z:UX;-[B(.SJ0Q5I H0@QA@03NSQG&* .NHKDM/\
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M **** "BBB@ HHHH *@NO]3_ ,"7^8J>H+OB#C^\O\Q0!..E%(/I10 M%%%
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MKFVBMI8S;B0HL88*8SD!2 Q^\&'3BMI;^!]2DL%8FXCB69P/X58D#\RI_*K
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M-U-X?)UB>696A9B8]Z*N#D#)&T'/?T]=:^U'3] T[4;F*V!^Q0?:9X;95#;
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MSV9AOM.-G$UP&+6I(8.4 XP^X9.0?E'7&*1?#6MVNHSWEK<V+"_LDMKV%U<
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MB@ HHHH **** "BBB@ HHHH *@NO]3_P)?YBIZ@NO]0?]Y?YB@"<=**!THH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .(\83V)\2Z3:7856>WN&1[K
MFW/"@C9_')CA1D8!;KTKDO#S66H'X<)=RQRL;*ZBF1WSDA% 5AWP<C!]Q7LF
M >U)M7^Z/RH \KM;W3X=/T>UN)(AH46O7T,PW?ND DF\A'[!,E2,\<+VK>\
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M^Z=@X[\4X01+*TJQ()&&"X49(^M '(?$"WLV7P[/=I"4CUB -)*!A5(8'D]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8B9&D[D!2H0$$;>ASQT6D6H_X3CQ'>W.G3+#<):M#));,0Q1#NP<=02/Z9H
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M^>W.H"+9-+;?,GF#@D9 [CI^% "_\(]HO_0(T_\ \!D_PH/A[13_ ,PBP_\
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MP[1X]'U2.25I776;U6D8 %R)FR2!QSUXH TK?3?#EW>7EK'HUEYMHRI+NLE
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MO-4,D]U*R@[R7.%Y[*,*!T&*M0.NB7UGX4T4PQN89[PF92RPQ>9PH4$9^:3
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ME37LPFEDM(7,G.6RBG+$GDYSDT ;-%%% !1110 4444 %%%% !1110 4444
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MRI)+9.>G7C%:DNIZ=!:QW<U]:QV\@RDSS*$88SP2<'CFLO5=8N;;6_#UO:M
M]IJ,\D<KX+':(7D4J0<=5'K0 7'A&PGNM1FCGNK==34+>Q0N D_&W)R"5)7@
ME2,_7FK>J:!8ZO:VEM<H1%:SQSQ*F!@H>!]",@CN"16)'XHNM7U^_L-$N=-=
M;&6%'25]S3A@&D*%6XVJPQP><@XKI[J^M+% ]Y=06Z'HTT@0'\Z *-[X?@OM
M?T[6)+BX2?3UD6%$*[")  V<J2<@#OQBLV+P/:6Z6\,&I:A%:VMX;RWMU:,I
M"_S<+E"=OS-P3WJUX@\1V^DI91I=6B3WDZ1(9G&U4.27(R,@!3W'.*2YUY]
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MSCWQ5EKB&,'S)HT(QG<P&,\#\Z ,72;34+?Q%J3M+<?V68XT@AFV[4900?+
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M:%E4DX_O$?3K6&NGZ@OF7D5C=&*#Q&U^\!B*M+ R;=R@XS@G=CKQTSBO1Z*
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M/Y<A$2HT<A5@%^92V6X^<\\5TOARSTN&?5;G3+Z2Z:>[;[668$"=0%8< 8(
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M[;75]\.-3OGT^Y_M'5Y(IQ;+"SR( R;%( )!"*,^A+58F C\2^(HM:TJ]O\
M3]6A@%H8K5Y%>-4(,38'[LABS#=C[Q.17?T4 >=7UNG]IZS8ZWI>I30ZBD+6
MR6BR.CA8U'E%T&%*NK'+8'S9S3IA>IXB\VT2X=)M5A%YI]S 652 H^T0R@#
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M 2ID\?>%*\T<>-[JN3@;CC)H P+;QGH]U %@E=[[;DV C(N%;^Z4(R,'@DX
M[G'-<K<E%C\;V&L*5U"_=FL,@[IXO* A6+^\5<'@<ACGO7I.]-WWAFG@YZ4
M>826>FS:]KAU6*UDN1H5N)2ZJ09P)A(?0OAEYZ@,.QK),X/A+3Y([R)K]?#T
M4-QIUZF5O(QN#1HP^99=P(XZG;D'''L@8%BN>1R10Q"C+' ]30!Y=J%U%9Z]
MXQ6^BDADU71H&MHF0L9"L<H91CJ02,_GTJWI=Y:C6/ :-*J%=&FC9'^4AF6
M*"#R,E&QZX.*]$BDCGB66)UDC<!E=3D,#T(/<4^@#RB'4[*U\.Z%"\6V2UU:
M1)YY$<16D@:4@N!C<>< $X!*D]LX\8L&T_1K:X W6_BV97$T?ELL#&0G((&%
M.Y,CIR,]17MQ*C@]Z!C- 'E5^;&WTKQ5#;+"D%KKUG<>7&HQ'&#;;W '0 J^
M?HWO7HEW96&OZ#-92Q%K*[A,94H4.TC&0",CU'X5I=:* /([>XU+3!I6O-9!
MIM+SH-QL3#7))**W^[YBPX_WW]JVKNTL=#\6>"+9I(%E@BN8Y)3A6;='@$^F
MYRWU)->@[1Z4N* /)WO[/_A%/'H^TQ$RZO(T8WC+@I$!CUR5;I_=/I7?>)6N
M[KP=J;:.QDN9+.0VYB;EB5.-I]3V/KBMJB@#RF5O"E_I&H7=B\\CII,EG+#+
M L4<"@92.0; -X? 4<G.<5)H+:19ZUX+>T>TBGGTB6.Y=&7>[E8=JN>I.Y6
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MB@'(HH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;L?Z,_TJ:H;O\
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M/3[(/.TD9<R/(K$* ", *N2>OS#TYM:%>QZ?\.M-OI03%;Z5%,VWJ56($X_
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ML WH[8W^7)GY0V#G@XR<$'F@#JJY_P <:M<:'X,U/4+4A;F.+;$QZ*[$*&_
ML#^%:=E;7L%S>O=7WVB*64-;Q^4$\A-H&W(^]R"<GUIVIZ;;:OIESIU[&)+:
MYC,<B^H/]: ,:;P;I<WA^73C"OGR0&-KTKF<N5QYA?[Q;//6F7GB.^ADU2.R
MT]+P:3$K7+-+Y9E<IO*(,'D*0>3_ ! >XL6NCZW;Z>NGR:ZDT*KL^T&UQ<;?
M]X/MW8_BV^^*KR^%;F+4=5N=-U,6Z:I"L<\<T)EVNJ;!(IW#G;@'.<X!^H!6
MC\9W6I:E'9Z/IL4_GZ4FIP23W!C#*[8"L I*G@^OX4#QN+BWT9K:V@2;5+'[
M7"EW<>4K'"XB5MIR_P WY"IK#P?)I6M0WUE>Q+#;Z4FF10/ 6(5#D,6##)SV
MP*K)X)N1X=M=%N+ZSO+6&R6T,=Q9DJ2N0L@&_P"5@#^/'(Q0!H_\))<#4-1L
MFT]5FM-/COAF?[^[>-A^7Y2"AYYK$EO%U3Q=X'U:.W6-[W3KJ;:3D@-'$P4G
M'.-Q[=S6G+X4O$N_.L]45/,TQ-.N&FA,CN$W;7!W !OG;.0:99>$KVUN/#4C
M:E;N-$M6ML"V(\X,JKG[YVD!!Z\YH AT3Q+JLWAP:A<V<4LDU_- I68[(D6:
M12SG;\J*$'/.>,XS4R>,Y7TVVNDTY)FDU,Z<ZPW(*[@Q =20-P..^.M1CP9>
MQ:?%9PZK%Y=OJ;7\"R6Q*X9W<I( _P _,F0>,%5.*<?".H"'8NJ6[$:K_:0+
M6IZYR4X?U[]AZT 4]9\6ZH-#UV.&SAMM2TZY@MY"+@N@678596V#G#XP0,$=
M3777=Y<6>D3W;6R/-#$TAA27@X&<!B!_*N;O?!=W>MXC)U*%!J\D$J8MR3"T
M00+GYOF!V#/3K707%G>W&B36CW4374L;(TOE$("V>BYS@9X&>W6@#"/C2>&R
ML;FZTQ81J0B-B/M&[?NC+OO 7*A0.P.<BH8_'LK&RB;191<7-^]AM\S"EE0N
M'4LHW(1WP,<^E3WW@^ZN]#T2"+4Q;:IHQ0VUW'%E20FPAD)Y5EX(S6'XFAO[
M/6/"S7NJ6\U_)JIDW>68X8U$++M5"Q(!/<D\M]!0!LGQM/!:7?VO2"E]97\%
MG/;QS[AB9D".C%1N!WCC Z&I;SQ?<V<WV*73H$U(1/.T#W6%$88JAW!#\SXX
M&.,')XYCO?"5Y>+>3?;($O+R]MKJ1C&Q1%@9"B 9!.=G)/\ >/'059U/P[J+
M^((-=TC4(+6]^S?9;F.XA:6*6/=N!P&4A@2<'/>@"F?'OG>5%9Z6[7CZ>M^+
M2XE,,K@DY1%VG<XVG(XZCUX?JWCR'3KJ]C@LC=QV,R0W(CD/F[FVD^6@4[]H
M<$Y([]<5'K'@Z_UBQGLKK4H+A)8D$<\T!\VVF!):6,@\9R,+QC'6I1X5U:QU
M34)=*UM(+34BKW*36Y>2.0($+Q,& !( /S @$9]J ([[QS/9KKTJZ1NAT255
MN7:Y +(4#[E 4Y.&'!Q]14MWXAO['Q)K(FMT?3M.TV.[*QR$R,"922%V\G]W
MC&??/.!6O?!E_>6GBFW^VVRC72OS>6Q,($8C]?FX4'MS6C<Z#JLFK7FHVNHP
M6TMWIR6KCR2Y21/,*NIR.,R9((_A]Z +VB:Q+JWF.8+?R/+22*XMKCSHI0VX
M$!MHY&WD>XK.UKQ@VBS732Z:WV2U>%'FED\LRF0C_5 C#[01GD=ZL:#X?.DZ
MGJ%Z$MH!>+&&M[52L>]=V9,?WFW '_=')K)UOP;J.J76MF/4+58M1$)C::!G
MDAV;?D#;A\A*[OJQ^M %G4/&-W:7VNVL&BM,=(MX[EW:Y""1&5V..#@X0X'<
M]<5<?Q -1>WM-/L_M+W-B+UUEE\H)$W"@D _,W.!_LGD52F\,:E-?>(+EKJT
M)U:QCM,!&7855UW=3G/F,<>PY[T6'A?4M+OK&^M+RV\U-.CT^ZCD1BD@C/R2
M+@Y!Y;CWZ\4 2?#8EOAWHK%F8M 22QR22QSFNJK$\):+<>'O#5GI5S<13M;)
MM#QQE!C.>Y/K6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %07G_'J
M_P"'\ZGJ&[_X]G^E $PZ44#I10 4444 %%%% !1110 4444 %%%% !1110 4
M444 5IM1LK:YCMI[N"*>09CB>0*S_0$Y-0KKFDO;/<KJ=F8$8(THG4JK'H"<
MX!K*\96KC3K;5[>%Y;O2;A;M%C7+LGW95'J3&S\>N*P-)L-5376TN^M'2VO)
MTUJ4J 8XG!R8=P_B$BQ-[_,: .X74[!KS[&MY;FZY_<B5=_ R?ESGH:8=9TP
M-M.H6H/S#'G+_" 6[]@1GTS7G%Q+(VI:;(+2\MOL_B5Y9K=+:5MB,)5\QGP=
MV\D$;3MPP&.,U/9Z?:?\(WXS9]//VHW=\;4O;-N*R+M7R\CHW3Y>M 'H+:QI
MJ+(SW]JJQE0Y:90%+#(SSQD<CUI_]I67EQ2?:X-DPS$WF##C&?E.>> 3Q7"7
M4=I9Q^%)K?3#&TC@S7PMY&:!UA*?.@&6<Y*@OD YX-8NAV$$FB^$;6\L96:T
MUJZ699[9@4C/G[=V5'RY:/VR0* /1[[Q-I=EI]O?&]MY+>XG2")TF4J[,X7@
MYP<9)/L#5P:MIQGC@^W6QFD *1^:NY@>00,Y.:\_D"06%X\4$JV]OXGBN2$A
M8@1;D)< #E<[N1[U:GDE7Q*MQ92/<V]SJ4)N=/NK<J\3;% GB;@@!0I(;('S
M#@\4 =;KWB"Q\/6UO->R*OGW$5O&I8 LSN%SR>@!W'V!K.T_Q2)?$&LV5]-9
MP6UH]NMM+YF/-\U"PY)P3TP!^M5?B$C_ &#1+A8I'CMM:M)YC&A8I&K_ #,0
M.<"N:UJVM[^3X@SFT:62:PB%IYD#;F80$80$9W!BHXY!Q0!Z7<:E8V<B1W-Y
M!"[_ '%EE52W.. 3SS54Z_8#Q"-%\^/[7Y/G%=XR.< 8SG)Y/T%<'XJD^W6W
MB**&WG66?18PCI;R2M=D+(0HX*H%)YP,Y;J,"MVUOXV^("W8CN3!>Z3%'"YM
MI &999"<Y7C 8'G'!H V->UYM+N=.L+2!;C4=1E,=O$[[% 5=SNQP?E4>@R2
M0.]*UYJ]IJ6GP7,5M/;W3LCS0JR&(A&8 J2<@[<9R/IS61XEMYK'QEH7B/R9
MY[*VBGMKD11F0PAP"L@4<XR,$CL16TNN07^(=+8W,CJV9%0[(OE."Q..^!CK
MSTP#@ O)J-E)=-:I=P-<KG,*R*7&.O&<TW^U=/,J1"^MO,D<QHGFKEF')4#/
M)'I7GMK ;OPIX7LA;SIKVGWUNTRF-@\;!Q]H=CC[K*9"3T;(QDD5EVNGVD.A
M:G.MCLNT\5":W80'>L(NE8,G&0FS>>.,9H ]6?4[".Y^S/>VZ3XSY32J&Z9Z
M9STYH74[!TA9+VW99V*Q$2J1(W3"\\GZ5Q3&:#Q,KV;+>6\^J@W%E<0D2P/M
MV^?$XZIM Z@C&1D=*S4F^SZ9I^G/;W)NK3Q*\TL:6TC%8S<2N'X'(*L"#[T
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MDD*F/S0Y\U6S_P M =I&>,=!D<@'KF12UY9I#:5?7]C=7NJM;^)K>^(GMXD
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M="UANQ)DEBVQ6*8X1FX!SGD$@9XAE\;-!'<W$VD7$=I::@ME/,TJ?+N9%#
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M>63WEO(65RZH%+#:#D'# CU]!4,?CD2>'I-=337ET\637J2Q3*V57&Y&[+(
M?NY/0C/!H Z9K"R,*1-:0&)!A4,8VJ/88XJP  H"@ #@ =JPUUR&]UN/1'MY
ME-SIYO5E63 V;E4KD$$'+#I7->'-:U&V\.^"[:&)KC[:C^<[R#<VV-VQD]R<
M'/MCO0!W"Z98*BHME;!%#*JB)< -RP''?OZU&VD:>%_=V-HCKRC"!?E/4$<>
MO-8\WC&.VU*UMY]/N(H+J_;3XI9,*S2 'Y@AY*$@@-^F#FH1XW!%S+_9%X+6
MUU$6%Q*SI^[8LB[L!B2,N.G;GVH TM$TB[LY9;W5;V.^U&1%B,T</E*L:DD
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MX7EEU.TNKF^69;2\>ZA)@_?+N##R_,W?<^<\8'  KHV=5&68 >](74=6 ^M
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MW-9O UQ<C4]YM+ ZCIDEG<)9%C'-,^/WQ0@ $8/J3N.3Q7<LRHI9F"J!DD]
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M62&"*-Y6W2,B %SZG'4T 3=**** "BBB@ HHHH **** "BBB@ HHHH ****
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MP7MG,LUM.@DCD7HRGH:Y3XDSV\>AV$<]RL&[5+-L^8%8*)EW,/H.<]J[( *
M   .@%!4$Y(YH X3Q9H 3P!XG-O/-J#7<!GC\P^:PVHH^4]^%R,>M5[*_P!'
MNO&&CW"7%G);RZ!/'+*&4JQ#P':QZ9 SQU'->AX&,4@C0# 4"@#R2RT[2?\
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M!;1-=VTUA]CFMU90\9#[U==Q (.2",CL>:Q9?"VJVVEZ;'#:F:4:^=7GC21
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M?A-RE0,%CG.<D&OWJ17.H7%M<N'LM6L;?S9YR'C^:$-'&.NPJQ)+'G+<'&:
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M)'R OC/&,]*D\3K/I/A_7;BR\13/YME'<0102R'R2KA3('+L0&#?=Z'!/8T
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M;2.$4LQ &3@#J?:L/_A,;2&/5/MMK/:2Z;#'/-&[(V4?.T@AL=5(.2,8].:
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M-I0D%MWR[<YR1Z@UGZ==W$_Q3E$MO?6H;1Q(8)YMR9\T#*@,5!P,'&.1WZT
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MC1YK*TLY+)'@M&#VZEF/E$# VG.0,<8'&*9%X3T2!56&P2)5N#=*L;,@$O\
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M44 %%%% !4-W_P >DO\ NFIJAN_^/27_ '30!***!10 M%%% !1110 4444
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M;(8'H1Z]:,CU'% '(:MX$AU2YUR5KIU&HPXB0#B"8JJF7W/[N+Z8/]XU8O\
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M)QTRY&/;WXS[+POJ-G-X6D$MJ_\ 8EB]FXRP\[<J+N'''$8..>OMSV-&1ZT
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M +IJ6H;K_CUE_P!TT 2CI10.E% "T444 %%%% !1110 4444 %%%% !1110
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MQ1]IO[RWGL$3[(BRM"8HO)#K-@8R6<OG.?NX]<]A<Z+I=[?07UUI]M/=V_\
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MEM;^ZDM+:1)5#,Z;^2IP #Y;XY)X&0,TZ3QBD&HVUO/830PW.H-I\4CMM=I
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MK&.ZAN7-]-Y$)ACW#?@D _7!Q5:T\8V%S8W5P]O=VTUK<+:RVDT8$PE8@(H
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M=HH5GROW\$8!/7&.*X7PQ?7,6A>"='2^FC35+5YI9?EW#9&&,:G'!8L22<G
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M+4-U_P >TO\ NF@!X8 =_P J*<OW110+46BBB@84444 %%%% !1110 4444
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M2K.GZK#J6G"^BCF6(E@ Z_,=I(. ,YY!QZT -DT'29=735I--M7U"-=JW+1
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M!ST''M5J+Q-I4UW';)-(7E61H3Y+[90GW]C8PV/;.>V:@M/&6A7UNUQ;W;O
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M^Z:EJ*Y_X]I/]TT 2+]T44+T%% "T444 %%%% !1110 4444 %%%% !1110
M4444 8OB32I=7M;>V%K:75OYX:XAN25W)M;!5@"58,5(/'0\BN?A\*:U93:%
M>Q30W=QI<MV%BNKE_P#43<*OF[225 3DCG%=?J>I6ND:=-?7LHBMX1EFP3[
M #DDG  '))J@_B'R%MGN=+O[>.XE2%'=4(#.0%W!7)7D]Q[=>* .;3PEX@M8
MX;NUFL!J-KJMU>Q!W?RI8IV8LC?+E3AA@C.,5HW6D>(;ZYTJ[N6L6DMM1^V/
M"LK!(D\IXPB'9ES\Y8L<>F!76 BES0!A:!I=]I^I:Y<7:VX2_O!<1>5(6('E
M(F&RHP?DSQGK6/JOAO6=0L_%ENB62?VQ&(X"T[?+B,1Y;Y..F>,^E=KFC(H
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M<20,WR$1%I"4+8;H=P''\N:L>/+*ZOK715M;26Y\C5[:YE6-<XB1LL?R[=Z
M-5O%.BK9)>?;=UN\;2[UC=L(IP68 95001DX%5QJLQ\9QVJW,;:;)I;72X ^
M\)%&[=Z8-9&JVEU;>*;R]N-*U#4M.U"TBA5;.3:T10OE'7<N5829SS@YS2FS
MO+;6;=H='(CCT)[5(.6B67*E8BWIA<9Z4 ;T/BC1KA)&@O1)LM_M6%1LO%_?
M08^=?=<BL_3_ !-%K.EZ%J NQIQOI05@EB),X*D[%SCL0VX9Z5RFBZ7JYU72
MY9]+ODW:'-8R%XTCCAE)0A%4'"H,$ ]\=^M7-,LM27PQX*M)M*O(IM,O(A<*
MZ [52%T9N">-S >_7IS0!UK^+O#\;E6U6VR)O(;#9VOD#!/;D@9/&>*LWNO:
M9ITDB7=VL9B022\$B)"<!G(&%'!Y..A]#7#ZOI][<>%/%5I!I=VUQ>:D)H$$
M)!D3,?S#_OANOMZBF:PLTOB'Q'!8VU\;?4[2&&\>.T^T88H5(4;U*,(V'RL#
MR0<<_, >B)?6TEB;V*42V^TN'C!;('ICK^%9FE^)['4="MM5<M!%<!?+5D;<
MQ;E0HQEB01TS5G2+JTO]#@EL':2W,?EH74AOE^4A@>0000?<5P^EV>L0Z=X*
MGDTV\CBT13;WULR LQ,/EB1 "2P4YZ<D.<9H ]!L=0M-2@,UI,LJ!BC8!!5A
MU5@>01Z'FJL_B#2K:\-K->HDHD6%L@[5D;!5"V,!CD8!.3D>M9_ARPFAUOQ!
MJ1B>&UO[B)X(Y 58[8E5G*G[N2._/&:Y'Q-9:M=MJ\2:3>_+JEM<11VL*^7+
M&C19E+9R[D C;V"CCO0!Z-J&IV6E6PN+^ZBMXBP0-(V,L3@ >I/I4%EX@TC4
M9+J.TU"WE:TYG"O_ *L>I]N#STXKG/BE^\^'%Z6B)W2VN8VP3_Q\1\>E5?$.
MBWVN7>KW.E6KPM+HCV0,R&+SI"^Y4P<' &X$]/GZ]< '60^(=*N&D6*\5GCB
M\\IM8,8_[ZC&67W&1571_%>GZKH5OJI8PQ7#$1(RMN;J5 &,DE1G SW]*QKB
MTN=<\5:!J5M87%K'96MRMSY\9C(\Q%58AG[W(SD9 V]>16)I-GJEEX:\+?:=
M%U(KI2O;WD$1VR@LI42)M8%@IXXZAB1F@#O#XET00V\K:K:*ER&,):4#>%SG
M'TP<^_%4]1\8Z79Z=97L$RW4=W=QVL?EY/S%]K9XXVC<2#Z8ZUBQV*+JWA^2
MWT2ZMK9+ZXN6$B-(R[XW'F.>=I9VSC.1G)QSC*-CJ"V4TRZ9>OY7BH7Y00,&
M:W+??4$9/T'/M0!W$&JV[:MJ);5[5[>V@C>2W"@-;??)9VSW Z'&-M1WVO02
MZ)JL^EW,3W5G;-+M=#\IV%E)4X.#C@]\&N>U2.\FO_%,\.C33FZT>"**">$[
M977SMR$C@D!UX!YZ U#&EZUWK\K66JS)?:/%%%-/;A2SKY^1M'W?OKA<9YST
MYH ZOPYJ4EYX.TG5+Z0&6>PAN)G"]69 S' ^IXJ:#7])N;&*]@OH9+6:411S
M*<J[DXP#WYX^M5?!T4L'@K1;:XADAG@L8898Y$*LKJ@5A@^X-9&EZ1=VWB>X
MTUK=UTBUN6U*VE_@+2@CRQ_NN97]LI0!MV6J6ZQ:E=7&K6<UK!<E=ZD*MN J
M_(S9P6!).?\ : J+4]?B/A_5[O2;NWDNK&W>1E=2VQ@I8!ER",@=ZY6[L[^6
MWU1X-/NI$B\017[6[0E3<P*(\[-P 8[ER!WV^XS9U:TGO[_7]3M+.Z%O<:&;
M,*ULZO-,2Y4!"-QP&QG&/F]C@ Z>/7K&UTRSEU&]AAEEMEG?<<<8&YB.R@GD
M]!2R^(M/BUV'26F7SY+<W .> NX <^^3_P!\UQFJQ7T\2V\6F7R&;03;K+%:
MDM+(01Y+EA^[ Z\XSNX/'-_2C<6WB+1[V73[T0RZ*MKG[.Q,<BN"0_'R\9/.
M,XXYXH Z+3-5@_L<WMUJUE=1-.ZK<P86,C>0J#DY(X7KR14_]O:3]D%T=1MA
M 9?)WM( /,SC9S_%GMUKA+&SU&"RT.Z:QNFM;#6KR>ZMC;L)-DCS>5*%(RP7
MS V!D\^HJOX@T>]N5\47<5C<RV>IW>G&"W^SN6<Q.AE<IC(&T8Y SM^F0#TB
MQU73]3,PL;V"Y,#;)?*D#;#Z'%%[JVGZ;C[;>0P94O\ O' ^4=6^@XR>E<YH
M<4D?Q!\0W'V2XCMKFULUAD:!T1B@<, 2,<;EX_P-#QSZ?XXU:ZU"VGN;&^L8
M8[:2*!I1&$+[XV"@D9+[AG@_A0!9\1^*(M-O-)T^"YMXY-2E*^>YR(HPC.7
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M="W>:YCB+*NZ5@3RL8P07/N, 9)QC-<O%KNN-HJ*MV4N8O$ TYI+B)&9XC(
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M9&?<^M3444 %%%% !1110 5AOX5L/M]Q>0RWMM)<OYEPMO=R1I*V -Q4' .
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M)'_:=\0^HKJ628\B48/]SH2,X_D*Z>B@#F[WP;:7Z:VEQ>7;+J^SS@"@\LH
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M0NX;EZ<<]#V[NB@#GX_"=M:7>FS6%U/9I86OV18XMI$D0*D*VX$]5'(P3DU
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !45Q_P >\G^Z:EJ*X_X]Y/\ =- #T^Z/I10OW1]** '4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8^K^(
MH-(N([<VE[>3NA?RK.$RLJCC<P[ G@>N#Z4 ;%%0FY2.S-U-^YC5/,?S.-@Q
MDY],5FV/B.TO;V"T:*>WEN8#<6PG4+Y\8QDK@GD94D'!&1Q0!L4444 %%%%
M!15"75[.'6H-(>8"\GA>>./U52H/_H7Z'TJ_0 44F:Q8_$D4\&I26]C>S-87
M8M)8HXP79B$.5&>0!("3Z T ;=%0BZ@-T;7S4^T*@D,>>0I) ./3(/Y5-F@
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M#4I93*F""@7 &#QR>1V&<$=,/"VC#1AI'V,?8 XD6+S'^1@=P*G.5(//!'-
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MD^&]1LXUAUJW,=AY4A!+K*H1E.TG.TA9.O1#7:Z=91:;IMM90Y\J"-8U)ZD
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MOM"EI?+$BB' R1@/P23@ ^M$NKZKIB^'=0FO1>6VI2I!<Q")0$,D996C*C.
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MJ3((VN[6*<H#D+O4-C]:OT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1CS<1K]W>"A&1DX8 &IX_"T$-]+=0WUVA>R6Q5/D(2-<D8)4DMECR2>M;U%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN/^/>
M3_=-25'<?\>\G^Z: ')]T?2BA/N#Z44 .HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBC(]: "BDW+DC(R.V:6@ HHHH *
M*** "BBB@ HHIH=68J&!9>H!Z4 .HI"0H))  ZDT!@RAE((/(([T +11FB@
MHHHH **0,K9P0<'!P>E!8+U(&>.30 M%%% !1110 4444 %%("&&000>XI:
M"BBB@ HHHH ***,CUH **,C.,\T4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !11FB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MH[C_ (]Y/]TU)4<_^HD_W30 Y/NCZ44)]T?2B@!U%%% !1110 4444 %%%%
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M"^7=2 %'&?XD7!X_YZ4T>);[4_AE+J-MF'4X +>[4$!TD1PLP7_:P&*CN2M
M'=9HS7FVH_VI#I'B[5+6_P!7M["'3]U@)V=6601DN<2#?C(7!/JV*OW8O;.^
MTBR;4KF8ZL[2R>;<M"H9(A^[1E&Y0Q^; .?E//)R =UFC-<!YNI07FD>'KG4
MUN'D>[9I%NGC9]A4I"TBC<6"R9.,$[.>XI(QJPU+P]IL^O2RL7NX+E[9^'V+
ME=Q(Y< A2?7)X/0 ] S17ER3:I%X?OKXZU?-)I&M?9( 9.)(A<*I$O\ ST)5
M\9/H.^<Z,EWJFL7NN7%OJ"V)TN^$2F6Z=4BC0(S%X@NU@X+<D]",8Q0!W5S:
MVU[ T%U!%/"WWHY4#*?J#Q4%E::;IK&SL;>TM21O,,"*F1TS@?SKS[6+G58Q
MXRNTUJ^4Z5<PO;1JZA1F*)R#@<K\Q&.F#SD\UK:?;Y^+FL.T\WR:=;,JF5MO
M+2 C&<8[X]>: .XHI%974,I!4C((/!I: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN/^/>3_=-2
M5%<?\>\G^Z: 'I]Q?I10OW1]** '4444 %%%% !1110 4444 %%%% !1110
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M@#,?P[H\MNMO)IMJ\*R>:$:,$;_[W/\ %[]:EN-%TRZN//N+&WDEVA2[("6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYEMTD5I8@#(@/*YZ9_*@#@=+AO(?%]G]CAO4LGN[I[NRN[9C';.1)^^AF*@
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M%9K>==KA'*GKG@CD<BJ&G>&TLIXYKC4]1U%X3F'[9*&$9P1D!5&3@D9.3R:
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MR5^1<?="D$\GG&*W;KP997FFZM87%W>/#JLHFNOG4$MA5X.W@811^'UJ#4O
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ML,ISF-7W@<\<X&>*QM3L'UKQ#IRR0LMGI<OVLNZX$DVQE15]0H8L3Z[1SS@
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MR[DM+N2WN!*R,A 9@I"Y49SGKCM6YX3CL[;PU;16%U/<V,098)YR/F0,<8(
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MP3]*EHH ;L79LVC;C&.V*;';PPG,4,:'&,JH'%244 0S6MO<,C3012%#E2Z
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M 4444 %17/\ Q[2?[IJ6HKG_ (]I/]TT 2#H**%Z"B@!:*** "BBB@ HHHH
M**** "BBB@ HHHH **** ,CQ/H[:YH,UE$ZI-OCFA9ONB2-PZY]B5 /L364-
M,U6?7I/$36D$%[!IKVEO;--N$CLP<[F X7*@#OR3@=*ZRB@""R:Y>PMWO8TC
MNFB4S)&VY5?'S 'N,YJ>BB@ HHHH *X765T^^\67T.J362Z?-IQL)@]VBR E
MM^=O4<'KUSBNZHQ0!Y#<:<4\.Z7 -7TR]U6+4+>[N9Y+Y$4K!@(@_P" @=NI
M8]ZW+R_BF\1:O?Q7&DM%<Z2EI$EQ>QE6D4R-AQG[I\S'?H>*]"Q28H \I6QM
M(]-O;;3-8L=/MXY+:[TZRN=165(KB)R[#(8XC;Y1C/!!.!TK1U+5I]>T"1KG
M4= L;Z*6*:VM6OTFC9XVW'S&XX;I@#CKD]O1L4F* /+M4O7U7PGJ,!;P[975
MR(DCM;>_B(&UPQ=Y..N,!0#CWSQJW.LP3>*UU*WU#38H_P"RY+99)+V$[)F9
M6&5#<@;<'_)KO<4F* /*=)NIK;7-.U6Z?2&F&GS6EY*=8C>1W)1M_/&"4("@
MX&[^$4ZQ,<5MX)@GO-.7^QT>.[*ZA%T,)B!7YN>N>W KU7%&* /*_#171UM]
M$FD\-O96C$1ZN+R/S7B!)4>7C(?&!G=@=>>\E@EO%H6B^'KG4]-\K2[Z.87J
MWL6V2*)RZ87=N#'Y5(QCJ<FO3\4N* /(M7:>33=7TNTN-'EBN-72_BN&U2-0
MR^:CE=O)!&T]?PSTJ_YEM_PDPU2WO-/L;YKU3/<6^HQ"&ZML])4W9+A<J#MZ
MX.>P].Q28XH HZ5/J,\=P=2LX[5TN'2$)*'WQ _*Y]"1V[5?HHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 3T&>M "T44 @]#F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ53;3+X65M%!H6N0W5O>M?BZ$UF7>9]X<L#)MP0[#&.!CTJ)-(U!(Y$_L?Q
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MR%E+>4S,65HB<G."I&X''MQBKNI^#4U;49;RYOYE:73'TV00J$S&Y#%@>S9
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M=P09!W?+_JQQSU- '34444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@6VGV4UVVG->J[SLB$B54VGY21P??G'2@#K**Y8^*+B'7;*PN(+=/M=Y):B
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M9!&,Y&>F* .O$L7R?.OS_=Y^]QGCUJ05Y[H5Y%#IWP\M7TR">2?3@8+IY,-
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MSL /E1MIPV>XX&:PO"?B%],T/38+FUN9(+K5+JT6[>0-^\,\NP8)W$?+C/\
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M>5<)("K#=MRK8/'!K?\ #FF:E9:MKEW?Q6T:7]TD\8AF9R,1(A!RH_NUT5%
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M_P"8L3T&#S7;XI#CH: /*[^+1[^^\>/(MO)&NFP&V5\80^0X!53T8$J,CD9
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M+>!=VV&,;AAL*.1[T ><W\,4&J>(K73;^*TTJ:SMG9\;K>"Y:4KMP. &4+N
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MW+:0/<Q#$<S1@N@]CU% 'F?B&--GC[4%EE2XLIK>: QS%0CBWB(; (R>W/\
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MJ^GVIU!5VK=&)?, QC[V,].*@NO"V@7UY)>7>C6$]S( 'EEMU9FQC&21ST%
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M;[0BL^\Q9SMVY)&>N"1[@ W=4U"6PC@\BSDN9)IA$-IPL8P27=L':H ZX/)
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MAMX_UN._W>G-94GA'7WTNPTZ5]/GM8-&%@87G<)'.%VB8#9\^1C@X*XX/)H
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MT^UK';QJ=Z;MO!+ 9SZXZ>I ,<'C*PO;"QN]/M[J\6]ADGCCB0!@L9 ?.X@
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M% !1110 4444 %%%% !1110!#>7<%A9S7=S((X($:21ST50,DUEGQ !XOCT
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MS-S]I-K 9^OFF,;O3KUJ6&&*WB$4$211C)"HH &3D\#W-/HH **** "BBB@
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M*Q:%:W6I:E8R,R@-<Q.%AD8G'RY/]:F76=+9$==1M"LCJB$3KAF;H!SR3V%
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MM9"1^Z<-E "X([':1R?6J]W%87/A[3X[1)[YQXECO+R+[#(K0(\K2."A7<$
M)&2,'GZ5Z%>:99:_<PZA::G<07%KYMN)[*53C+ .C!@RGYD&<C((J[INDPZ:
M9I!+//<3D&6>=]SOCH.,  <X  ')XY- '!:O;7+W?C!+.QN70O8S>5'$R_:(
MXRIE1#C!)4%>/I4=Z;;4]&U35=$T_5;A9/LWV\W"R*]S%'(&>)4;&X[-P) P
M0<#.>/4** //]'U"WU'XJR7]E;W7V2?1(XQ,UG)&I<3.<$LHQQCKZ8J]K4=M
M#\0K"^U. '3_ .RYH1-+'NC67S(V )Q@$J&QGKTKLJ* /-&TJ[TWP-9ZO;1&
M*?1[R?4+>%EVM]C,CDQ8/3,+?=[$ <8KL_#EC-:::\UV<WE[*UU/_LLW1/\
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MZ_+JFCWNI7;RV@CN#+ D,28(V*RK&@,@^8<9P <]17>T@&*6@ HHHH ****
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MI,5=58%67<.<$$^_O2R>#-(FBU.&59W@U&4S31&9MJR$@ET&?E;*@Y[$<8H
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MW%Z(+F7SYK,3D0/)P2Q7KR1DC.#W!J[H^APZ*UX8;BXE%W.UQ()2I D;[Q&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17/_'N_P!*EJ&Z
M_P"/=_I0!,.E% Z44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8VH>);/3+R>WN8YP
M((DGEE5051&8J&/.>H.>*U1<0LSJ)4+)]\!N5^OI0!)147VJ#RUD\Z/8QPK;
MA@GT!J"_U*#3TB\P.\DSB.&*,9>1L$X ^@)).  "30!<HJ/S56'S)2(QC)WD
M#;]>U4[K5X;:^ALUBEGFD <K$H.Q"P7<<D<9/;)ZG'% &A160GB/3WU1; 2-
MO>9K9)-OR-,J[FC!_O 9_(CJ"*UZ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YVZT'^T/%-Q=7D
MDL'LHH ID(W,LC/\RC@CYAU].E<E?>'-5TXZCJ-TMO';26US XAE;[TER'C<
MC83M )+;B<9;M7I]'6@#S&WT"76T:ZAM(+RTDEN1<VYN6BBFDE"$2HR#D#!4
MYYY;'-=+XB\/2:L]@\MK%>Q0V\\,EN[;1ND50)%)Z%=I&>H#DCFNIQBB@#F;
MG2-1_LW0(Y2M^]BR&]C=N+C$3(6&>"0Q# ''3UQ4/A_P[<Z9J%A)<01,MOI_
MV;S 02AWY"C/. O&?:NLHH Y5_"RR^)K>[C1[:RM[M[YDW@B:X9"FX#^$89B
M?4XXZD]5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN?^/=ZFJ&Y_X]W^E
M$HHI1THH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *AN?^/=O\]ZFJ*Y_P!0WX?SH E'2BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDJ>9&5]:*
)* 'T444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex10-4_007.jpg
<TEXT>
begin 644 ex10-4_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKC
M_5'ZC^=2U'/_ *H_4?SH D%% HH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *CG_ -4?J/YU)4<_^J/U'\Z )!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5'/\ ZH_4?SJ2HY_]4?J/YT 24444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %17'^I/U'\ZEJ*X_P!2
M?P_G0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUH4 %%%% !1110 4444 %%%% !1110 4444 %17'^I:I:BN/]0U $M% Z44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKG_CW?CM4M17/_
M ![O]* ) ?:BE'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7NH
M6VGQ+)<R%0QVHJJ79S@G"JH)8X!. .@-<QXMUK4=.O)8K.ZBC6/39KI8T3S)
M6D7&TL",+%C.22"3@ UF7ES=:IXN\"7/VJ2$7EG<W!2-5*HWDH>,@_WB.: .
MI?Q;H,<,,S:I;B*5599,_*H8D*6/1 2"!NQR".M6H]<TV4Z>$NXRVHIOM%YS
M*NW?D#TV\\UR&F0SQ>)O'!6976!H"D<L*LA_T<.,@8X!/8U+;WTVJ3?#W4+D
MJ9[J%IY-HP-S6A8X';DT =C:ZA:WLEREM,LC6TIAF _@? .T_@P_.K)XKB8_
M$&J"QUMI;BR26TUE;)9"A4"(K$3M7DO)AS@=SCZ52U#5]2O/#FK1R7+HUIK5
MM9AS"%=X7>W.&'0'$Q'&.@X'- 'H8Y%%<;>ZKKT]UJMEHP$MUIBQJN]$VS2L
M@?Y\L"%(('R]\\\8K3U_7Y=#\%SZV]NAN(H%?RC)E1(V  6'8$]?2@#?HKD[
MG5=6TO6K?39[B"?[98SSQ2^3CRYHMI8$ C*$/QSD8ZG-7/"=WJNJ:-8ZK?SV
M[1WMC;S+#%$5*.R9<ELG(.1@8&.G/6@#8BOK6>]N+..96N+<(TT8ZH&SMS]<
M'\JL5QFH:_JEH?&)C>UWZ39I<6Q,)_YYN^'^;G[N.WTIVBZ[J\OB33K"_>VD
MBOM)^W 11E3&ZL@(SGY@=_H.E '8T5@:EJL[>*;/0;2587EM9+N:4J"P1650
M%!XR2W).< >]4X-6U9]0TO0[J6VBU&6WGGNI81N4+&RJ @/&3O4G.<8(QR#0
M!U=%>?/XMUMX8(8ELUNH=>_LBY9XVVR C<LBX/'RE21]>1UJ2Z\1Z[9V.MQ^
M=9S76FZE;6XD:%E65)O).,!CM(\TC//0<4 =[17$W/BC4M)E\0P7AM[F2QCM
M'MV2(QJ6G9D"L"QX#*#G/0GTHU#7_$6A1W\]Y:0RV@@B^RS2E(OW[R"/8P5V
M^3+J=W&!D'UH [8G%5WOK6.^BLGG1;F9&DCB)^9E7 8@>VX?G7&>++OQ)I_A
M;Q(TMS:^5%8^9;7,28D+8Q(I4DX]CVSW-:DVIW.G>)M,LIY('MGT^YG>3RB'
M!C:/H<GC#],?PB@#IZ*X>+Q3JJ:;X=UBX2U:SUB>*)H40AH!-_JB&S\Q&5#<
M=^,8ID?B37E1;N=K$V\>N#3'2.)MTB&81!@2WRD$@XYSCKVH [NBL+Q?J&HZ
M1X<N=2TU8GDM0)9$DC+[H@?GP 1R%R1]*PI/&-W'J^M0>;;26T5DMQIKI"W[
MYR%RA.[#$&2$8&/]8.E '9B]MC>M9">,W2QB4Q;AN"$D!L>F01^%,FU&RM[V
MWLYKJ%+JXSY,+. \F 2<#J< &N=N-3U*WUG4+1_L?G0Z.+I9D@.[?E@0<MRN
M5) ]ZYMCJ#WWPX;[1'+>2V\YCED0X&;4<N-Q+'J>HS[4 >H5!=WMKI]J]S>7
M$5O!&,O)*X55'N36;X9U*[U+3IS?"'[3;W<UL[0J51]CE0P!)(R,<9-</XDE
MO[C0?B*;FYCDA@7R8XQ&1M7R$<8^; ^^<\<GTZ4 >GHZR1JZ,&5@"".A%.KA
MX/%5YI%Q=VVII;M:VVBKJ<1A5@RJ"5*,22&/ Y 'TK8TC4-;EU7R+^SC^R/;
M"3SXXS'Y<N0#&0S$L,'(8 =#0!T%%<YJ&JZN/%*Z/8QV862Q:Y6:;<2C!U7D
M C(^;ID?7CG+TSQ=JM]9>'M3EM+6*RU.<6KP@L9$?:YWALXQN0C;C.#G/:@#
MMZ*Y&S\2ZGJ4UI=V%FL^FSW3P,!$P=(P642[R=I&Y>5QG#>U5T\5:TFA:CK<
MUA:-:6*WB/%"SF1Y(961<<8VD*<D\]\4 =M17'/XKO=.OKY+\64]I9Z8NHO/
M;;E)!W#: 21U3@YY!]J?+X@UVTMK^6;3XG6'3VNDE\N2)%E49:)MV2W'(8 9
MP>!0!UU%9>C7.IW:-<7T5M';RQQ26XB9BXRN6#YXZ],4FO:L^DVD'DQ++=75
MQ';6Z.VU2['J3Z !C^&* -6BN9N=<U73HFAO;.#[3-?1V=C(K8CG#J&WD9)7
M: ^1WV<=>,W6_&.J:#:ZXD]E:S76G6Z7<3AF1)H6)7..2&5E(VYYX.10!W%%
M<FWB75;/4]3M+S38G>'3CJ%K#;.6=P"08VXY8D#IQSWZU'#XS']C7FI+-8ZC
M#'Y*0&T<J7FD;:(G4DE"&*<GLW3C% '7LP4$L0 .2342WELZPE+B)A/_ *HA
MP?,XS\OKP">*YR36)7UR?PUK%O;R&YL6N89(T/ER*#M=&5L\C(/H0>U8WAV\
M%OHWPZMVL+>87%L%2X=OG@86K-E1CN 03GOTH [V>Y@M8_,N)HXDR!N=@HR3
M@#)J6O+O&6HW6N^'8-0%K:C3DUJ".V<DF1E68(90>@!(( _NG.>U;]_XQN]/
MUB.WEM;<0OJ<5@L?F;I2D@ $QQD*-QP <9 )SVH Z^66.")I975(T!9G8X"@
M=23VIRL&4,I!!&01WK@[C5M1.G>.)[Z"TOK2P:2,6CEE5HU@C<J3SU#-GCD^
M@K5M=<N[@6NG:396WGIIL=W('8K'%N&(XP!SR5;GL%[YH ZBBN+MO&M_J8T?
M^S])B)U*&<@3W!4PRQ':ZL OW0<\C)..@ZUN^&M7FUK1ENKF!(+E)I8)HT;<
MH>.1HVP>X)7(^M &O165KVM)HMM;'8)+F[N$M;:(MM#R.>,GL  2?85AZGXO
MO](@UJ.XL();S3;=+M0LI5)H&R-PX)# JP*^PYYX .QHJE8S7\@N3?6T4 68
MB 1R;R\>!@MQPV=W'/3J:YW1_&-QJRS316D,BQ03226<<F+J&1& 6)XVQRPS
MSP 1CD<T =>2 .:;'(DT:R1NKHPRK*<@CV-<CI?B-]?N[_1=0M+7/]GI<MY,
MGF)A]RM&V1R5*D9[^@JIX=UN6Q\'>%=.LX5ENY]*CF^9794140$D(">691^9
M[8(!W=%9>AZK-J>AQ7][8RZ=,0WG03@@QE20>H&1QD'T-8D?C*Y:RT[6)-/2
M/1K^X2&.0R'S460[8Y&7&-K$CC.0&!]0 #JWGBBD2.21%>0X168 L?0>M25P
M%I82:]XX\10:M:VT\%LUJJ'SGW0@)YB^7P,$MR<$?CBMWQ'XBNM&D98+2%E2
MUDN#-<S>6CLO2)< DN>3[ =Z .@,B*ZH6 9N@)Y-"2))G8P;!P<'.#7&RRP7
M_CGPIJ,<>TW>EW;\]=I\@@'Z;C^='PQ18O"DZ(H55U&[  [ 3-0!VE%<E=^,
MI(K34M3M;)+C2M,G,-S-YI#G81YK(N""$SW(SM;VS+'XJO+OQ)<Z38Z6LZ0+
M;3&?[0 &AE+9<#'8+D#O[=P#J**Q/$'B!=$:PC(MU>\E,:O=3&*)2%)P6P>3
MT [_ (5!:>(;Z;5;+3Y],C@EN].>\'^D%MCJ45HS\O3,@^89Z'B@#H"ZJ0"0
M"3@>].KSB^U635]8\$:RE@PN7GO%%LLN<LL,BXW' Z@G..E:G_">A;1%N-/%
MGJ(O_L$T%S.%BADV;\F4 C:5QM..20,4 =G17&WOB/6_[:\-VL6G00?;GN#/
M')<\GRU;@,$(VGAP>^ ..:M#Q<R:[:6%Q8B&*\N);:!FE_?;D#$,T17A&V-A
MLG/''- '44'@5R<?C21]DAT:X2U&IG39IFE3Y',GEJ0 3NRY /H#U/2JB^(+
MZXO?&$-_8B33=-3R_+@F =E\K>3R!RP;UXQQSR0#M^M)D9Q7*3>)QI6A6DUM
MIC&V33ENV,LVQ$C"C$8<@[I,= <=.2,TWSTO?B!HUS&TGDW&BW$BJ6( !D@(
M.,X!PW44 =<#FBN T'6Y="\.12/:R7%O+K-U;23M-S#NNG1"Y;)(Z#.?2NML
M]4DO-8U"Q%J5BLBBF??D,S*&VXQP0""?]X4 :5)D9KG=3\6#3+YHI;"86L=S
M#:O<.P7<\I4 QJ?OJ"ZY/&.>N#6-?QM'K7CC;/<#_B46\JD3,"C8N/NG/RCY
M0<"@#O <]**RO#KA?"NENQP!90DDG_8%9T7C*W<Z9-+9SPV&J2"*RNGQB1F!
M*97JH8#*D]>^* .ER*7/.*XG2X9==\3ZM-?6TZ/I]^B6\J7&/)588GV8!Y#%
MVW>H.#T&->ZO+9/&=K;FSNFOOL$SQ2B4")D#1[EV[OO9*<D?C0!OT5Q^C^,)
MI]#TNYO+3;=:G,ZP1^8BJ1\S 9SV48]2>W4CJ;*Y-Y8P7+02P-*@<Q2C#H2.
MAQW% $]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_P#'N_TJ
M6HKG(MWQZ4 2"B@?2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** ,35
M/"VGZMJ+7L[7"2R6K6<ODS%!+"23M;'H23D8/)J*+PC90S:3,EU>>9I4316K
M-(&*JP ;.1SD #GICC%5-6\12:-XU@M[Z^B@TAM-FN7#( 0Z/&H.[J>&/ _6
MMJ'7M*N'LTAU"WD:]0O;!9 ?.4#)*^N #G'2@"M'X;@AO-4NH[NZ$NI@?:.5
M(.%V*0-O&%P/YYID/A6TMX]'2.YN@ND+LM?F7A=NS!^7GY>/_K\U=;7=,6S-
MW]MA: 2&+<K;OG!P5 ');KQUXJK-JL-Q>Z0;35[5(KEW(AP&:Z4(QPASQ@C)
M/MB@"M)X,T^6*Z5KB[W7%ZM_Y@<!HYUP Z\<<*!@Y''3K2R>#-.E@U&%I[W%
M_*D\I-P25E39AUST.8T/IQ@8'%6QXIT)IXH%U:T:268P(JR@[I/[H]^WUXZU
M8N-;TRTO8[*XO88[F0@+&S8.3PN?3)X&>O:@#-G\'V4M]]MCO-1M[EH1#-)!
M=,IG49QO]2,G!&",\&M*ZT:PO-$?1I[9&L&A\@P\@; , >HQ2G6=.%^+$W<0
MNBVT1%N2VTMM^NT9QUQS1!K.G75ZUG!>0R7"AB8U;)PI 8CUP2 ?0\4 4H_#
M4"[&DO;N::*V:UAEE9"T4;;=P'RX).U<DY/'UJ]I.F1:-I-MIMO)(\%M&L41
MD(+!%& ,@#H,"GWNHV>G*C7ES'"'.%WM@L>O [\5#-KNE6\<$DNHVJ)<*7A8
MRKB10I8E>>0 "<^E %*Y\*VMT^L-)=77_$VA$%R R@; I4!?EXX)'X^N*6V\
M,6UKJ=EJ"W5TTUG:FTBW%<&(X)!PO/W5Y]JU([VUEL5ODGC-JT?FB;<-FS&=
MV>F,<YJO;ZYI=W;SW$%_;O#;C,S[P @QG)ST&.<],4 0:OX=M=8NK2[>6XMK
MRTW>3<VTFQU#<,O0@@X'!!Z5"?"MD/L<D,US!=6C2.ERC@R,9.9-VX$-N(!.
M1V&,8%7$U_2I+26Z6_@,,3!)&WCY6(!"GW.1@=>13CK>F"Q%Z;^W^RE_+$OF
M#!;.-OUR",=<T 9TGA"P=( LUS&T5[]O9U9=TL_]]\KSZ8&!C QP*;<>#[6Y
M.H;[V\_T^XBN9\,G+Q[=F/EX V)_WS[G,FH>+](L/[+)NX9%U&;RH661=N,$
MLQ/H,8^O%7_[:TS^T%L/MT'VMFVK#O&XMMW$ >NWG'I0!0N?"5A>W.IRWCS7
M":E EO<PN5V,B9VXP 01N8Y![^PJ >"=/FL)[+4+F^U**6 V_P#ID^XI&2"0
MI '.54YZ_*.>*W+K4;*Q:-;JZA@,A(02.%+8&3C/7BJA\2:*+:WN3JMF(+@;
MH9#,H5QG&0<],\9H H_\(?92Z;=65[=WU\+FV:U::YFW.L1ZA<  =CG&3@9)
MQ5A/#D0U&ROY+Z\EGM(9(5\QD(=7(+[OE[E5Z8 QQBJ<&MWQ^(=UHLKP&P33
M$O(ML9#@M(4.XY.?NGH!U]JTQXATAK:YN$U&V>*V3S)F24'8O."?8X.#WQ0!
M0L_!UC906=JEQ=O964WGVUK(ZE(F&=N#C<0N3@$D#\!0?!]L;,VIO[TH;\:@
M3F//FAQ(/X.FX X_I1#KHU-=#NK'4K&"&Z.Z6WE8-)(#'NV)@_>&03["M(:[
MI)N(K<:E:&:5S'''YR[G8=0!GDB@"\\:R1LC@,K#!!'!%<]:^"M)M(-'A59'
M729&E@+MDL2#][U .TCT*+Z5K7&KZ;:7'V>YO[6&; /ER3*K8.<<$^Q_*DU'
M5[+3-)FU.YN$2TBC,IDR,$8SQZY[>M %63P_#-K-QJ4EU<,T]K]D>'Y-GEY)
MQ]W.<L3G-4+;P7!;RZ+*VJ:A*^C[A:ES']UD\O:<(,C;QZ]^M:Z:WIW]G07T
MMY;Q03#*O)*H7..1G.,C!_*KRR(\0D5U9"-P8'@CUS0!GZ/HZZ/'<HEU/.+B
MX>X8S;>&<Y;&U1QFLK4/!5OJ$FMAM1O8K?6% N8(RFW<$";@2I()50.N.]0W
M_C!)=-%WHLUK.$U*&RF+'=PTRQ%EP?4G!/I6[-J$<]C>_P!GWMH;F!67<[AD
MBDQQOP<@9QD<&@#,;P?:S7[7-S=7$ZOI_P#9LD+A-KPGKG"@YR>H-3Z/X=?2
MWC:?5KZ_$"&.W6Y*8B4X_NJ"QP -S9/TR<VHM4M[;3K.34M0LDEEB4F02A8Y
M&P,E,GD=Q[$5I Y&: ,B?1'D\0#6$OI8YEMFMECV*4"DAL],YR >M9EKX+6T
MTS2M/34[@PZ9<_:(243<S<X#<=/F;ICJ/2KL'B2&;QG<>']A!BM5F60C 9\_
M.@/<A6B/']ZM:YO+:S56NKB*!6.U3(X4$^@S0!@VWA!;*Y<6VJ7<>G-.;D:?
MA/+60MNX.-P7=\VW.,^Q(JIJ.CWNB>"M5L[*2\OIKEY7!@55DC,SEG9?4 NQ
M Y/:NHEOK6% \MQ$B$$[F< <#)_(4&^M!/' ;F$32C='&7&YQZ@=Z .(T/2&
MF:73D>>XT>[@>*\BGT@6. 5P,$(A8]N 1CN,#.M'X1NSIL]E=^(+R[5K=[6$
MRQH/*C88.=H&]MHP&;/TY-=$;NV6Y6V:>)9W&Y8BX#,/4#K0U[;)($:XB5R_
MEA2X!+8SM^N"#B@#$OK'6+;3=*M=/OI#-;W,0D=85"RP@X97ST^7NO)(XZU=
M\0:%#X@TX6LL\MO)'*D\%Q"</#(IRK#/'X'L36A%<P3O(D4J.T9VN%8$J?0^
MAI([NVE5VCGB=8R0Y5P0I'7/I0!STWA&2\L0+[6+F?44FCGBO-BKY3QYV;8P
M-N/F;/KN//3$6J^#9=:L-1BOM3!NK^!+62:.WVJD*L6VHNXX)+$Y)/TKI5O+
M9BX6>(E%#OAP=H/()]!4>FZE;:M80WMH^Z"9=R$]QV/X]: ,6Z\-7UUJDVH_
MVN(;B33VL0T5O@IGG>/FZAN?IQ[U7G\#QZ@^HS:A=H;F^ABB>2T@\D!HVWI(
M06;+AL<GL ,5UM<K>>)M6L8XI9M%@2.?418P![PJ[9D*+(1Y9 !QNZG@B@"P
MGARZ>^.IWE_#/J:6K6L$RVQ1(U8@L2F\Y8D#/('' '.:UIX0N;2'PW$NJ1LF
MAY"9MCF4>6T?/S\?(Q_'GVJ:YU_5+.\L8+G38(OM&H+:%UN&<;3&7W+E%SRK
M*1QC'>M?4+FY&G/-IGV628,NWSY"L>-P#98 ]L_C0!RUQX N)-.DTJ'7'BTO
M[6MW! ;96>%A*)"H<GE<YP",C(Y(&"ZX\!SRO<^7K3)')JD>J1 VRLR2JRDA
MF)^9?EX&!CCJ!BNP:XBC=4>1%=NBE@"?I4M '+77A&>9?$,4.JF.WUI"'B:
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MM2:S%;KK/C*.WAS!<>'T2,1Q9220"0 +@8+#<G YY%>FR21Q(SR,J(HRS,<
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M.JXB!0EL?-N&*S-4M]+U#QQK,=T8IH3H,4FQWRA.^7YL9QG 4Y[<&N_:-)
MZ*P'(!&:;]G@_P">,?3'W1TH \STG4+4:QX+OKVZB$5YX?>.6:5QMEDQ$=K$
M]6^]P?>J6@-:7WA_P2DTX96U6\B=?-(^4K<X0C/^Z,'L1ZUZR((0% BCPIW
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MOME[?7U_IGV3RA"K;RH<KM5%SGYR/YYK;C\/PZJ(+K4IWO%%F]M$CQ^7A)
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M=]T%<8YSZ5VE]XHO;+5S;NEJ(QJ$%H( 2\K1R;0)20<(-S'"L.=O7FM7PWH
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M*4"B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** (I[JWMAF>>.(8)R[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(**0SMM)4,Q/0$_=!ZFM6#5[>X>P6,3,+Z SQ-Y1VA0%/S'HI^88!Z\^E:%
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M.&_NI;S['-;N;-PTN%0$J @Y&"/7 _&O8J* /,=9L1+JOBBWTNQD$=UX9$,
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M,91T<L&R6&!@DG&!Z58M-$L;#4;N_MXG6YN\>>YE=M^!@9!)' X'H* .4O\
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M#VK7T;R&UE$T.V9TV2#HWRD9(YZ^M5;GPGH]Y!J$%Q;221:A()+I#<28E8
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M^8'!SNY/.>G'3B@#D[CQ#K-D=9LFO2\VD7]FBSF-/](AN'0;7&,!@&897&<
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M<$8(7C)XX!8D@<#K0!QGA?4]4@\"Z9,=2C#WU_<))(Z;IN9I<^4N"'=B!U&
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MJL+??  [L<9/L,8JK8^#)K.[TJZ;7+N>;3;>2VB,D<>UD8( " .VP<]3Z]J
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MT0!561Y2P/.>CKC .<UDZ7I]Y;6'@**33KA)-,&V[_=?ZK-L\9R>^78=,^M
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MMG;RR'"=6!V%25SUK-GTJ]CD%P+&Y>.?Q(NI+$L1)CA5 I8CL2PW8Z\],YH
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M[AJ6HKG_ (]I?]TT 2+T%% Z"B@!:*** "BBB@ HHHH **** "BBB@ HHHH
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MK=U.<?@:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\
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MP-];9A4/*/-7]VIY!;G@>YH JZ'H%GX>M'M;$S"W+$I')*66,$D[5!Z#)/\
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M>>,[=C YZ8-37=M)-X4\6:/=V4QUF>^FEMRL9W7#,P,$B'T4;!U^78<XKU/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17'_ ![R?[I_
ME4M1SC-O)_NG^5 "J3L7CM12)NV+@]O2B@5R2BBB@84444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4449H **** "BBB@ HHHSB@ HHHH *
M**,B@ HHHSSB@ HHHH **** "BC-% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)FL(H1/N#/*02Q.!A1M&.YR>!CD NZ=XUT[4;FTA^SW=L+RR^VV\MQ&%22,
M%L$$\KN&>,'J"1S0GC.R?33J(LK[[&;)[Z.78N)(4VY(&[(.&!P0#CWXK%MO
M#NMVY\+D06V_2=*ELI6,N5:1DC52!CE<QY/3@TVU\'W@-Y%:VZ:3:7VFSV]U
M9QSF2W\]P KQ)_"!\^>%SD<=Z .H@UZUO[NTLHTN(VOK(WD,F  8QM!YSPP\
MQ>,=ZYCP_P");ZV\/^&(98KF_N-1N)XI)F92Q">:W4L.?D'M@'V%6](TO7;:
M_P!!N+JRME2PTR6SF"7.XECY."ORC.?*/'OR>U5;'P]K=EI'AW9:P-=:5>S2
MO"T^U761)5!5@#T\P<$=C0!O#QAIAU..R43,)+QK$7 4&/[0J[C'G.<X!YQC
M((SFJ\?CS29BQCAOC%'>_89I3;E4AD+!!O)QC+,!Z^H YK#NO#OB*ZU>VO)X
M+:>2TUK[7'*;G&;;:RJBKMPN P+=R5[U+-H&L2>']:M!8@37FLK>Q#SEQY8E
MC?DYX.(R,>I'O@ Z73]=>^U_4].^PSQI9.B>:VW#$J&SP>.",<4_5O$5II$C
MQ/'/<31P-<RQVZAFCB'5VR1QUP.IP< X-5M.M-1M/$VJ7!MH_L=\T4OF&7YD
M*Q!"NW')ROKC!JE<Z=K.E^,KW5].M(;^UU&WBBEB>?RFA>/=@\@Y4AN<<Y[&
M@#3N?$]C"J&%)[O=:_;"+9-Q6'LYR1UYP!DG!P#@U'+XNTM9K6*'[1<O=6AO
M+<6\+/YL8*CY3T)^8<=NIP*H6NE:MI/B.]U3REODU&T@29(G">5+$&'RAB/D
M;<>^0>QS6?X=\+W_ (=N] B\EKB"PL+F&65'4#?+(D@"@D':-I'0=O? !OP>
M+M,N]/T^\M/.N/MX=H(8T_>$)]_(.,;>A]^.212-XOTXV%K=PQ7=P+FT%ZL<
M$)9UA(SN8=NO ZG!P#@UR&G>%-3B\,Z7I-_I<A-LUVYN;2X5+BWD>7?&\3;@
M,89@P/<#J.MJWT'Q#9W5G?W^EZ?KDLVGPVUY'(ZJT4L9<AT++@J0YR!CD9H
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MH;(8COSQ3Y=+NM1L]4M(M.NH-:N+R'5Y+>_,:Q7*QN@\L&-W 7" ?,<Y.?H
M=D?&.C)9W%S-/+ MM(L4T<\#QR(S8VY4C(!SP>GY4A\3:9?V&K"WOWMFLHCY
MLSPLIB!!VR ,/F7@D$9!Q7/7^GWM]H%^;3PF;&XN# ICWP^=)LD#$L0VW: #
MC)SDG@=[6HV.HS:[X@N(],N&AO-'CM86#1_-(IERN-V1_K%Y/'!H U[;Q#96
M?AS2[N>]GO?M-LCQRI;,TMP-@8OY: D<<GCC-:]E>VVHV,-[:2K+;3H)(Y%Z
M,I&0:X/2=-UO0G\/:@=*N+L0:+'IEU:121^9!(NT[UW,%()&#@]E/:NSMK>9
M]#-N8H[&1T952#&(0<[<8XR!C..,YQ0!%;>)-+N[];.&=C*Y<1L8G5)2OW@C
MD;7QWVD]_2L*UUJ]\0^(KR'3M0N+*/3[J./R7LB4N$V(\F\LH*D[\  @\9P0
M:S[?1-4N]%\*:-+8RVD^BW=O+/<94QLD*E<H0<G?P,8R QSCON^&H[J+6_$,
MEQ8W$$=Y>K/ \@&'40QH>AR#E#UH ?J&M7<WBN+PYIVR.7[(;NYNG&[RDW;5
M55[L3GKP .AJS"=6L=55;R[BN-+%M([3O&$=) 5QO(.,;2QX Z'/:LV^T[4=
M+\;OX@L[8WEG=V:VUW!$P$J,C$I(H) 888@C.>XSTI/$\.I^*/"VJZ98VDEI
M]HM61)+HA"[Y'RA1DA2,@DXZC@T :UGXGTB^:58;P Q1><PE1HLQ_P#/0;@-
MR?[0R/>DL?%.C:E=06UG?1RRW$/GQ  _.GJ#C&>0<=<$'&*PY%N]2UO2-4.E
MW=HNF6MP+A&099G50(DP?FY7.1QP.?3.T.RO;'3O \$VF7:2:>CI=XB_U1,)
M3)/<;B.F?6@#KD\3Z3))-&MR<Q(\K$Q. 40@,RG&& ) )7-3IK-A-/;6\5W&
M9KN'S[8<_O$P#N'J.1^=<1H>F:E'<R6UK;WL5A/8S++:7R';82L!A(9#RR,<
M\#(&T'CI3])_M)K_ ,&O)HFH0II]G-:W1D11L;RXUS][E<J<'OV!H O:=XS-
MII?FZS,LMQ)K$VGQ^5$5!"S% <#. %!/)YKH9/$FDQ7L=F]Z@FD9% P<!G&4
M5FQA6;L"03VKBH+'4#H:2#3+PO;^)7U!H3'M=X6F=@5!P"<.#C/'-1Z[%JEQ
M/J;#1-041:C9W<<5M$@25%>)F=B#F23"E2.0 H^M ':77BW0;*2:.XU2WC:"
M012Y;A'/.">W;/ID9Q3AXCL7\1MHBR?Z4L(E/IR3@#U. 3[?C7$ZY:7=U;>/
M$ATJ]\[488DM?]')\PB((0"..&_#N..:WM/^UP>)K*Y_LZ[:"XTJ&WW[ HB=
M78L'W$$8##Z\XH O:1K5W#HLUWXA,,#)</%')&C*)EW84JARV2> .IQD=16S
M9:A::C:"[LYTF@)91(IXRI((_ @C\*Y_QQ;)=:?81O;W[8NPRW5@&:6S8(^)
M0J@EAGY2,=&JQX2EU$>'R=6MU29)I<.D!C:=-Q(E,?56;DE>N3TH M1^*-#F
MN(((M4M'EGD:.)5E!WL.H!_ CZ@BISKFFC4AI_VR+[46V"//\6-VW/3=CG;U
MQS7GRK,-& 72]15SXG^W;?L,H/D_:?,WXV_W.?7MUXJ6Z&H2:VLO]DZA&MKK
MJRF"WMP(FC(91-N_Y:,VY23G"]P,$D [@^)-&69(CJ=KO>?[,H\T?-+Q\H]^
M0/J0.M2V>MZ9J$MU':7L$SVK;9PC@^6??\CS['TKSO6X);KPCXNMH=)OVN;K
M4@\2?89,S+F,@CY>1\C<]N/49M^)+*\U?4M6ATBTND-QHL,4;/;R0I(5E9S%
MN*@ E&V^VXCC!H [JPUC3M4,@L;R&X,1&\1ODKGH3['L>]+>ZQI^G2I'>7D,
M#N,J)' XSC/L,D#)[FN?\,RV>H:K)J%MHFK6<H@\B6?4C(K<-D1J'8Y RQR.
M!VSDXPO'\5[>2Z[8VVGWF^;21Y4EK;[OM1!D.QWQA0N<A1@DMWZ4 =S>:_I.
MGF<7>HVL!@"F422@&,-G;GTS@X^E27NIV=E;++/>00+)Q&\C##'&>.>>.>.P
MKB[Z6.[U_7KK^S;[;<Z#%'"S6$F2^9BR [?O8>/C\.QQ0T%[[1KKPSJ&HV-^
MVGQZ#'8;4M9'DMKD%=^Z,+N 8*!NQCY1VYH [7PGJMQK7AR"_N6A:6224;H1
MA"%E901R>P'>MNN8\ +)%X3B@FM9[9X[BX_=S1&,X,SLN >V"*Z>@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "H[CBWD_W#_*I*BN/^/>3_=/
M\J 'I]Q?I10GW%^E% #L<YHHHH **** "BBB@ HHHH **** "BBB@ HHHH S
M+_6H[#6-,TY[>=WU"1XXY54;$*QLYW'/HIQ5/4?%":7I]U>7.G7BI!>):*"@
M'F%BJJXY^X6<#/L>*C\0X_X2/PG_ -A"7_TDGKE=6DED\)Z_'<7<THB\16\:
MO*^2J">WX'H!D\"@#TVBO.;K5I[/PIK/B&*\NEU03"&Y@DE=H]/RZHV(R2OR
MJ=^['/48!Q57Q(FH:%X7U^YM/$4K*]DMQ;PQW#RO&0P!=9&)(5@1QZC(/6@#
MU"BO/]3OM1\.:UK1MKR[O2-#>^6.X;>!,C$ JHP%&#R!C.!4834+.W>^L_%,
M'DWUA(L(GG>=9)MI*S M]P#N%&WIP.* /1**\X@N]3;2-2LH%O;76(GMO,TZ
M]OV;<&8Y$5P22!(JL >""#T[=+X/NX[K3KD(U\'BNGCD@OF+RV[ *3&6).X#
M((.3D$4 :MEJ!O+N]@-I<P"UE$8DFCVK-E0=R'N.<9]0:NUY;J.IZJNF>-GC
MU:[22QU*%(&##Y$(CRHXX'S'I@^]=/I#75GXZU/3'O[JZMVL8+P"X<,4D:25
M6VX VJ0B\#B@#JZ*XKQ/=-HOBFQN[N\O4TG4();201SLJPSA=R,H!^\P#J,=
M\=S6?X5GU:_FL-*O;F]6^TJ2=M2E-P26)_U*L,X.Y6#CC'[L]CR =UJE]_9F
MEW-Z+6XNC"A<06T>^23V4=S4L=S&XB!.R21-XC;AL<9X]LC/UKS*>;58OA=?
M^(QKVI?V@EK/&!YB[!B=L-MV\-@8R.W3'&-V.S2X\=V4LMS= G1@WRW+J,^8
MHZ XY[^O% '9Q31S(6B=74,5RIR,@X(_ @C\*?7E&E7MSIWA;PI9VMS(G]KW
M#QSRSW3C! D8('Y*%V&,@9//0\U>O'UW3&T73Y?$#N\FNBW?R7$C)"\3.L;L
MRY9AC@GJ",@T >DT5S7A&6X\S7K&XNY[I++4FAA>X;<X0Q1O@GOR[8]L#M7-
M:U=ZH^K>.D36;V"+3-.@NK58F50C^7*_ITRHSZ]"<4 >E45P=CJ%];ZYH5Q/
MJDTD6JZ3-<W,<Q'E1/&L1#(H V_ZQL\\C'UJOHE_?SZS!:/>WLMK>Z))=--*
M^TRR*T8$L:Y)B!$A(7CMP,4 =TT%CJ0@N&CM[D1MOAD*J^T^JGL?I5JO+]%N
M;RW\/>#-)M+ME_M*P,\AEN3&7*QQ_NT<*Q7.\MP,_*>:O$ZZE_HFD7.ODO//
M=V]Q):E68*(F=,L5'[Q05YQC@'% ';0ZBLVJW.GBWN%:WC1S*\1$;[L\*W<C
M'/ID5)?WL.FV$][<%A# AD<JA8A1R>!R:X2ZU:_TO6?$UK-KK16]AI5L\-Q=
M1AQ$[;P7*J 6)*@X]3^%,CU&_=O&&EW+W1M8-)2:%;ME:12Z2!LD=CM!P3Q[
M=* ._LKI+ZPM[N(,(YXEE4,,$!@",^_-3UYO?ZCJ%CH.GNLUY#I\>C1,UQ8[
M7>UE*\22QGEH\#L#]UN.XZKQ1K,FC^$+O5+5D,BQKY;D952S!0Y'<#=GZ"@#
M>HKAM2U#5-$\26^F)J,]S;WVG7$RR2*A>&:( [AA<;6#8P1C/3%7/ 4FIZGX
M>T[6M1U2:YDN[-"\!1%16R3N&!G)!P><<=J .MHKAKO5=5O;'Q1J%IJ+6LFD
M321V]N(U*GRXU<^9D$G<2>A&!C'/-.LK_5-;\2-!'JDUG:'3K+4%C$2$J7>3
M<F2/ND+@]_0B@#MB0JDGH/:J.D:Q9ZY8_;+"1I(/,>,,R%?F5BK<$ ]0:Y+0
M]=U.;7-&BEOGO+;4(;IGE\I5A<H5*F'@-M 8C)X/!!/6K?PTY\)./^HA>?\
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M7-W?2W<<ZW$=\TP$Z.HP"I "@8)&,8Y/&36I#K>F7&HMI\5["]VN[,2MS\I
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MKOK.F1Z8FIO?6ZV+@%+@R#8P/3![YJQ:W5O>VL=S:S1SP2KN22-@RL/4$=:
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MZ<>G3T4 >;6GA;7[;0?"NF26D#'1=12=Y([@'S(U$@R 0,$[Q@>QSCC-V_\
M#>K7K:Q+':0AY-5AU&VBG=3',(XXT,;XSC.QN<'J*[RB@#AK_2-6O-$,<.@6
M=C(]Y:S"W@E3.(I5D8N^ ,D#  !QW//"^*]"U35KV2YL+,V]ZEJGV'4()UCD
MBERVY)>?FB^[QAOXN.]=;::G9WT]W#;3+(]G+Y4^,X1]H;&?7!'YU;H Q-/U
M6]DU^YTF[LXU6&W25+B.4-YF>&W+CY.<XSG.T^E9T]Q/!\0[CR+.2ZSI,0(1
MU4@^;)C[Q Q74I%'&SLD:*SG+D* 6.,9/KQ55=*L4U$Z@+>,7C#:9L?,1Z9]
M.3Q0!Q>A>$]3T&^\+IY(N(=/M[M+F1'4!6G=7 4$@D+@CMQCZ5<N="U:*T\4
M:;%;+=1:R\DD$[2*%B,D:H5D!YPNW(*@Y''&*ZFPU6QU3[1]ANHKC[/*T$WE
MMG9(.JGW%7* .-U3PI?>3H/]F7'EW-G ;"XN =K&W>/:S#_:#*K#WJ_?:=<Q
M^(M!DL[$M8V,4L3LKJ @9550 3DXV\^W3/2NCI&940LQ 51DDG@"@#SU=#\0
MQ>'-.T0Z;'*VG:C!.MT+A0L\4<X?=@\AB.H(ZYY-3:=X<U/3-0O;5]$TV^AN
M+Y[R'49G7=$';<592I8LIS@@X/'(KM-/U"UU2RCO+*99K:3.R1>C8)!Q^(-6
M<@=30!YY<:!K\&@ZQHL5B+H3ZB;RWNOM"*'1IUE*ODY##D="#@?2NI\3Z;=:
MUX/U/3H%1;JZM)(D5F^4,5P 3]>]:-MJ%K=W-U;P3*\UJXCF4=48J& _)@:L
MT <C96>KKX@TB^N-+:..VTR:UDV31MAV:(KW'_/(_B1[XR]-T77K2QT*TETZ
M0V]N;D7*1W*(^YGW1DL#DQX)W ')('!'7T*H+R\MM/LY;N[GC@MXE+222-A5
M'J30!Y_H?A[7]+L/![/IJ/-I,=Q;SQ"X0<. %?/3&1SC)P>AZ5U'BO36U6QM
M;;[#)<Q^?N=H)A%-;X1MLD;%AA@VT=>A/7I6XDJ20+,C QLH8-Z@\YJ#3]1M
M-5L8KVQG2>VE!*2)T;!QQ^(- '(6VD^(+7_A&[RZA>_N+"2Z2<"2-93')D1L
MW(4L%"[L'J3C-5[+2/$.G6^G7J::LL]EJ-[))9BX0>;%/([!D8\9&Y>#C(ST
MKT&B@#B-3TS6K_5_#UY_9B)%:ZB]S+'$Z#RHVC*_,2PW/N8D[>.>^,G2\(6%
M]IYUL7MF]O\ :=3FNH2SHVY'QC[K'!X[UO7MY;Z=937EW,D-O"A>21S@*HZF
MGO-%'"TTDB)&J[F=F  'J3Z4 <%JVC:Q=Z/XUM8M+E,FIS![3][$!(/*CC_O
M<<H3SC@CZ5H:Q;:O=>(;:_LM)+!-*NH +EX_+$KF-D5P&)*_(0<9ZBNJLKRV
MU"TCN[29)K>4;HY$.58>H-3T >;:5H.L_P!L&XN-.N(EN=!-E))--&2DP8G!
M"L0J'/RA>.#P*ECT_6;>#0+V?P]+=)8V!L)[+SHO,4D1'S4^;:1F,C&X'&#[
M5Z)BB@#A(=)O8/$_ANXBT!+.RM([Q7CMRA6#SBFW/(RQVDMM! )ZGK4=_::P
M;GQ=/:Z0\ANQ;FV\U8V$@0!7*J3C<.2H88) KOZ* /,K_1M6FTKQE;0Z5?L=
M2M(A;&>9'=W\O80QWG!SSZ ?E4FLZ5JDY%WINGW]GJHM(HD==CP7@ .89T)P
M "3\WHW!/2O2<4<4 <YXVTJ_UCPS);:>%:Y26&<0LVU9@DBN4)[9QBL;6+*^
MU>]U+5+?3[J-6T.:P6&10KRRR,"H ST7!Y/'S<$\UVTMU;PSPP2S1I+.2(D9
M@"Y R<#O@ FDMKNVO$9[6>*=%8H6C<, PZC([B@"IH =-!L8Y+9[>2*!(VB=
M0"I4 8XX[=JX:[MY=4T;QGHEOI\TMQ?7\L<4@3]WN,<>&9NB[3SSSQQFO2B,
MC%4-.T>RTE[A[42J;B3S9?,G>3<^ -WS$X. .GI0!RFC:5?1>*O$OFP3Q+=V
MEM!;WQ3@M'&RL1SD?,01GK5?P_93PVUC8W7A:Y%_I=LT374TV8&Q&4S"=Q)W
M\<;1@$YZ#/?6\\%U D]O+'+"XRDD;!E8>H(ZU+B@#R^VT'5Y])U73+$7ILY;
M "WBU)-KV\@8'[.LAY>,@8SR!@<\U8U"&35=#UB:W\*ZE:WTNEW%GYEVY>4L
MZX6.,;FRNXY+< 8^N/2,4G&: .#TZVNE\8:#<G3[I((M$:TD<PD".0LA"G_O
M@\]/SJEI5IJMEH'A.QGT:\C:T#V]Q+$B--&0N %.?E1^07R.@Z9S7I6*AEN;
M>!@LT\49/(#N!G\Z /.M'M-3TW2?"DLFCWS-IUS<QSQ(JL_S+(JL/FY7)')]
M<].:BDTO5[AO%)MK.Y!.LV]_'%)&46[BC\O<BL>.2A^N!V->G(Z2*&1E93T*
MG(-.Q0!Y[K-O/JEWK&KVEG>B"30I+#RWM762>9V)4!"-V%R1DC'S]>#526VF
M?5M&D_L6^FMHO#\]K+%]G=!O(7$9.."=C#\O45Z;Q1B@#A_!<5_;:O=6Y^V7
M.EI;(+>[U"V:*YC.YOW!+ &15'(;'?&363XUM=0O+GQ-9V^CW1\[3T:*2UA&
M+Q@#_K)/5#P$')SWR /3J,4 >?(]S8^(M:.HZ%?:A9:ZD+6^R#>%41[3!*#Q
M'SD\\?,><YI[+=:?KVKVNI:!/J%OJT,/DBWB$D VQA&A=C@(N[)!;CYC7?8%
M,,D8E$1=/,*E@F1D@8R<>G(_.@#SGQ%'?Q1^++,Z5=S3:GI*B VL)DBW+$ZL
MN[L0<8!Y/& 3Q5O3HI)_B1#=SZ9=I"VA1VV^:U;8LHD+E"V-H.".^,\=>*[[
M%&* /,K!KY=;T6YETG485@U*ZCDMX[;$,&]9 "IZL&)W%^1D]NE-F@U,>'H[
M=-'OYFTK6IKNYA4&,W$333,OE-D%B Z.,=UQG->GX'I1@>E 'FNI^1<>&=1N
MM/T+5H6O+JT8^?%-)/.8Y5+,4.XJ B\$XSCZ9T?%%C>QZS::CI,IC.KQ?V9<
MK]TC<"R3 '^)!OXZX/M7<X'I67%H%E%K,FJDW$MR[;E$L[ND1V[3L0G:N0.2
M!GKZT )J.G3KX6N=,T9EM)Q:-!:$' B.PA/ICBN)TZ\8S>"H!I&IPR:=YEO=
M(UE(!"WD%,[L;2I;^($CN:]+HQ0!YMX:@3?IVGWNA:JVL:87$EQ,\JVX)#*\
MJ-G:V_).T#.6[8)%&SL-5N=%O=,TLW-Q!)I,JVGVZW:&>R)*#[*7(&X, 0#U
M&SK@@UZO@>E&!Z4 >>:A?VNM>']3NK7PY>P3C29K1WN+1XW0E?EA1<9?YCVX
M&.O-27ZVT?AGPQ)#8S*XO+)I EH^]1&1N+ +D8YZUW^*,4 >::W9P75MXVTV
M33)9M1U&0&R'V9CYN;>)8R'QC"R*Q//RX).*@GMCIVJZA8>)[35+^'4;2WA@
MDLEE=) L81XFV?=.\LPS_?SD5ZE@>E&* ,'7K6:X\ ZG:0V[^?)IDL20AM[;
MC$0%SW.>,]ZYZTO;._\ $WAV>:VG$,6E7"!KFU=0LFZ C.X?+PDF,XSM..V>
M_HP* /'=.$^GZ/X>OKBWO_[)L+J_2XCMHW$D#22L8I-@&2NTD<= ]>B>$X+2
MWT8FPM+FVLY)I)8EN=P=MQR6VMRH+%B >W/&<5O8'I10!Y.B6L7AV:6.WVS+
MXJ\]2L)#"+[7O#CC.WR\G/3&:KZ]>+)JDACL[JU^S>);:XECBM9)/-0% 9VD
MP>"N %7'XU[!BDP/2@#RN\CF_L[X@Z<MC=&YFG>[B MVP\?E18PV,$DJ< <\
M&K>KZC9:IJVLS11326]QX>,<;O:N%=@TA R5]QC/4\#FO2L#THP/2@#RSR([
M#P;X0U(6TJ6D*0'5'M(<S*RPE%=A@EMCGD8)'7M78^$([)=,NI=.2[%I<7+S
M(]T"IE+ %F"D JI;/&!SD]ZZ+%% 'ENH)<3^#];TID*^)SJ3RVX7B1Y#-NAD
M0]=H3:-W10I!Q@UTUI):'XE7ZCRC)_9MN 0!_K%DF+#/]X!E)'7!KK,"C ]*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;!C&=V5*'=\G/RL1QBM36=%@UJV@CEDEAEMYTN()HB T<B]",@@]2"",$$T
M<GJWC35=+76[7R;22]TN>TPY1ECGBN'"@@9)5@20>2./?%=?;RWEI8SSZI)
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M,1^8?7:.!0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "HY_\ 42?[I_E4E1S_ .HD_P!T_P J '1_ZM?H**(_]6OT
MHH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !3)O]1)_NG^5/J.?B"3_=- #H_P#5I]!11'_JU^E% #J*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L9]=,^M3:5IUO]IF
MME5KJ1WV1P[N54M@Y<CG '3J1D9V3TKRBZBEL]"US['/)'XH36I)K>(3$-(S
MR@QX3."C1;0>,8!STX /4;JXCL[26YG<)%$A=V/15 R3^59>AZMJ6J#S;O1_
ML-NR*\4AN5D+Y]E''%-U#Q#X>\K4[;4+NW,-F8XKY)DRB>;C:&R,$'(]O6LK
MPM8V=EXBU/\ L*0'0Y(8W$<+9@CN,MN$>.!E=I('&<4 =C1110 5FZ[J-QI.
MD7&H06J7(MHVEDC:782J@DX^4Y/'0X^M:58'C>5(O NO%W5-VGW"KEL9)C;
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MH]U]NL8'\@QJJQOMR6!'][(R/4<8'%=70 4444 %%%% !1110 4444 %%%%
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M K9N[VWN/#DE\8)IK:6V,IB7Y9&0KDCDC!P?44 :'EQG<=BG=][CK]:<
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M!3;G3;&\E26YL[>:1.%>6)6*]^"1Q7,VE_->?$>VW17]O$VCRR""X8!3^]C
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M:B+VVN)KET<*;@3%&4(<D'<,YZ=JU(='\4:7JE^FFOIKZ?J$YN6DG9O,M)&
M\S: N)!D9&=O)YXKL\U@7WBF+3=/^VW>G7T49O!9@%%SDOL5_O?<)((/H>E
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M$G^Z?Y4^F3?ZB3_=/\J %C_U:_0441_ZM?H** '4444 %%%% !1110 4444
M%%%% !1110 4444 8FL^)8M&U*PL'L;RXFOO,$/D*I!95+;>2,$XZG@9R2!5
M6'QE:2Z/%>26\L%S)<O:?9)65769"=REL[< *6SG&!ZX%2ZSI%]>^)="U&W^
MS^1ISRO('D(9M\93  4CC.>O^-8H\)ZS&POK>2RBU&WU2>^@5G9XG2;(>-_E
M!'!X(!Y% %J3X@V<>C#4_L%V\,=V;.[\LQG[*^X#+G=C9R#N!(P13-=\9W5I
MX;DU*RTJ?F]2TA>5H\2!I-GFK\W*GMG&<@].:OW6F:YJ>G&SO9+-(KN3;=QP
MNW[N#;@HA*Y8MSECMP"<<X-9%UX6UZZ\'MH<LMD[6ES%)8RM*Y+Q1R!E20[>
M&VJ!N&<^E &_XCEFD\$ZK/B>SG6QED 63;)&P0D?,IZY'8UEZ;XOAA-AI4EA
M?^?+9"2UED0*MV40%E0L0=P'/S8SR:W;ZRNM3\-W=C<&&*ZNK:2%C'ED1F4C
MC."0,^U9,.A:C=S:&=06UABTD%P()&D:63RC&.2J[5PS'N2<=,<@$ECXTM+^
MVT*YCLKM;?66*02,$^1@K-AQNR.$;ID5-9^*8KZXV0V%V8&$WE7"[&20QMM8
M !B0<] 0.E<_I/A/7=/T_P -Z>_V!X=$NR_FB9]TT925 <;/E(WCC)SZBK>F
M>&-0L/$*ZO'#;6TKQR"^2"=A%>,<;'*;<*W&2P'J.<YH ETKQ-IUAH^A0Q1Z
MI.FH*XMFE7S)?E5GPY'?"X_GZU<B\9:?)HZ7S13Q2O<M9BTE"K+YX)RG7;D8
M)SG&!G-9>G^&]:M8_"RO'9$Z1)*TVVX;YP\;H-OR=?GSSCI5<^$=;!-Y$UBE
M];ZO-J-NCR,\<J2J5:-SM!4X/4 \T :MOX\TV[M(WAAN&O)+QK$61V"03*I8
MKDMLQM&<[L'C')Q4K>,H=ELL6F7\MY-'-*;-5C$L:1/L<G+@'YL  $DYXJMJ
M6CZIK-E'!JFE:5/;22$S6BRM^Z 7Y723:"7SWPN!^9RI/!FJ3Z+:Z;J$<=^+
M>.0V]T;MDNK:0NQCVR[<G"%5)XSMZ$4 =U!>PS:;'?D^7 \0FS)\NU2,\^F!
M7'RZ[+J7C3PRUO%J$%C<+<NAD(6*Y41Y5MH8GOD;@.#G%;=WH=SJ?@>30[^\
M)NY[$6T]R@^\Y3#-CN"<G%9%KH_B22^\.RWMMIR_V4LD<LD=RQ\T-&$W*NSC
MUP3[9[T :=KXPM;N[@MTL[P&ZCEDLW94"W(C/S!?FR#R"-VW(-,MO&EI>:+!
MJD-C?>7->?8EA98UE$F_9RI?C# YYS@9QCFL+3_#>O6NKZ)JE[!8O<6;3B]N
M6NF+3"10-XRG &.$S@=,@5;TK2[.]\<7=]97,5QID>R]58B&07<B-&S @X/[
ML X]9,]Z .WKG8+^?5/%5]"KF/3](V*Y5L>=.R;B#_LJC+QZM["K6B:I=ZA<
M:G%<P0(MK=-%%)!(761.HR2!AAW S@UC6%CY.N^*=$NBZ0:L?M=O+W</$(Y
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M>@(;F<6<UO=M+;1)O,C(J;<*HW,?F/'Z5?M?&.C7D=A)!/(Z7TYMHF\EAB4
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M%@, X(_EUXI+/Q'IE_?):6\LC22J[1,87"2!" Q5R-IP2.A_2N671-4'BO\
MM&TL;FQF>_\ ]*9)D-K=VXZ2,A8D28  ( .1Z'A/"NCZQ8:Y:SK83Z?:31RM
MJ%I)*CP),2,- -S,NXY)'3'O0!V=_J5MI_E).[^9.Q6*.-"[L0,G"@$\#J>@
MKG/"_B5)-!2YU&\FN)KB_NH+?]P?,D5)'V@(JY&$7)X&,<U+K=MJEGXMT_7;
M*QDU*V6UDM)K:)T62/<RL)$WL <E0",CC'I6%:V/B*VTVWA?1;I86U6[FG2W
MN(A/Y<CNZ%6W84?-AL$-CIWH ZW_ (2O1MFG.+IRNHR&*U802$.X)!4G;\IX
M/!QT/H:OVVIVMW?75G"[M/:E1,#&P"EAD#)&#QSP37$6^DW4'PVN]/U&W&GW
M.GRSW-M*\BN R2M*D@(.=O0<X)&?6NH\,6,]II1N+S_C_OI#=W(_N.P&$'LJ
MA4_X#0!-/XBTNVO&M9;DB19D@<B-BB2/C:C.!M!.Y>"?XAZBN;U#Q!>7WBZ_
MT2RN[JQ%G9I,LL=@TQ>0LV=P*G*83 QC<2<'I5'Q+IVNWUUJ:KI%U.([ZVN+
M4V\T<<4D2/$S94L"TOR,/F&  ,$=]73K;4D^(VHZC-I=Q'9W5C! LQ9"H="Q
M;.&SCY@,XH OZ+XMLM2T"RU.7SH_M6/+C^SR%G)!(VJ!EN!D[<@<\U.?%VAK
M%:2F^&V[,@@'EOEB@)=<8R&&T\'!R,=:XK3](UZR\/\ AR63P\US)HT;VD]C
M)+'NG5@H,D?)7@H,9()!/3O??3=1;6O#=Y%X<%I;PWTUS-!;B,&%7B* R8;#
M.6.X[<\>I'(!U>J:_:Z?X7N-=4/-;1VIN4"H<LNW<.,9';KT[XJBFMQ3W^C"
M746M);B"21K%K<CS\*"3E@"H4\^^?I5SQ78W&I^$-8L+5-]Q<64T42YQN8H0
M!GZUS1CU:^\3>$M4DT2[MX;*WNDN [1EHRZHJY 8]2AZ9P",XZ4 =!%XR\/S
MB%DU./RYG=$D*L$W+G*EB, _*V 3D@9&:LP>(])N;*XNX[U/)MY/*F+J4*/Q
MA2I .3D8&.<C&<UQ5KINJ1^&M%MWTBZ$UMKKWDJ87*Q&:1PWWN?E=>!SUJ/5
M-"UF_P!4\17-MIKG_B8V=];1SD*EVL,:JR9S\I)!P3Z T =#XC\3*WA35[O1
M;W9>6&%D#PD/$QQPR. 1D'(R*W8]8L9-3FTU97-Y!&)9(S$XPIZ'.,$'!QCK
M@^E<7J%I=:AX3UW[%X4ET^>\CCC6-A'Y\[CNVUB H& "3GKTXJ[XN@N_MVC:
MKIDAM[VX8Z:Z.,,T4PSG']Z,J'QZ!J .LL-0MM3LDO+20R6\F=KE2N<''0@'
MM7/7WB59?$7AZVTZ\#VUW=3138A)615AD;Y7(P<,HSM-;$^DK%X8ETC3C]G
MM#;6Y'_+/Y-JG\.*XC28=82T\&6<WAR^AET>7RKHJ8MF!;R1;U;?R"6#?GWQ
MD [A->TR2^2R6Z'GR,Z1Y5MKLOWE5L;6(P<@'(P?2N=M=;N7\+3S7^MQ6-RN
MJ36J730*P(2X9%0)ZE5QZ\YK.T'3+VT>STB\\-&2YL+C>NJ2E6@9 Q/F+\V[
MS"IQC'!).<5!>V&I3^!KZS32[S[2^N-=)$8^6B-YYP;KC[GXYXH [R/6K"6\
MN[1)F:XM$#SQB)LHIS@].<X.,=<'%0R^)M'AM(KJ2]40RP^>K;6/[K_GH1C(
M3_:.![UA^)=+OY]7LKW2XGQJ$#:;?$?*8H6RRR_5#O'U>JFMV-QIWB:6=O#]
MUJNE7EE';!;-P&A:,O\ (REE!0A_P.?6@#IKKQ3H=G*T<^IVX=8TE*JVX[&(
M"GC/4D8IP\1Z2=.N-0^UC[+;R&*:0HP",#@@\=0>#Z5R^BZ9=6?Q @N)-*^R
MVR:%'9KY*$Q12"5G\L-Z!2.>AQ^%%QHTQ\=3:9'(#I&H[-4N8P>4EB95V_[L
MA$9/KL?U- '4>(->MO#VA3ZI<AC&@&Q0IRS,<*O3C)(&?>GSZ]IMM&CSW.S<
MADP4;<$!P6(QD*/4\5D_$+3KO5?!-]:V,#3W&Z&18UZL$E1R![X4U5MKN\@\
M476J7>D7WV/4;&)(OW.^2$Q-)\CJI.-P<,/J0<$4 =?%-'/"DT3J\3J&1U.0
MP/0@]Q5"'Q!I-Q-Y45_"6V,X). RJ<,5)X8 ]2,XK,\':3?:%X$L-/N0)+R&
M%CY;-PI+,RQY_P!D$+Z<5R^B)J*:CX9O+G1]0MUMX;B*XACMPL-JQ5<(B#G;
M\I^;G/&"3P #N+7Q+HE]<P6UKJEK--.&,2)("7QUQZ^OTYZ5?NKNWL8#/=3Q
MPQ @%W; R> /J3Q7GFDVMW;:3X0233[Q)+34II;E?LSYC5DG 8\="9$_/V-=
M!XRM;UVT34+:V:[BT_4%GN+9%W,R%63<H[E2VX#V]J -1_$FC1V4EX^HVZV\
M4GE2NS8\M_[K?W3['%66U2Q2Y%L]RBS&$S[&.#Y8ZM]*Y:#0!K.M>*9IK>:'
M3=5M(;7]XA1I757#2!3R,!E ) R5]@:I1:7KFL^#=6DOK8IJ[V@L$B<E1,(B
M<G/&!*Q;\"O- '7#Q)HIM[B?^U+00VZAY7:4 (IZ,<]CV/0]J/\ A(]%$[PG
M5;,2HYC93,H*L$WD'GLO/TKA+V!=5T36+JU\,ZS;ZA-I$]H\E\TLDFYA\L2*
M6;<-Q)W# 'KR<;VI11S2>$C%I]QY$%WYDB"T?]RHMY4&X;?EPS(.?KTYH T]
M1UZSFT![W3M<TZ!/-$:W<Q#Q!@PW*1N&21D8SWK0O-8T[3F5;V]@MR5W_O'"
MX7.,GT&2!DUY_JUK=S>&/%UNFGWS2W.L)- @M9"9$S#\R_+R/D?\O<5-K\Z#
MQ-K<,4=^T>I:5##.T>GRW03)E PJ<H=K$E6QG(/KD Z"3Q/'#XH,4M]9+H_]
MFF[$^0!N\P)]_=@CKT Z]ZO77BC3+;4=+L_M$3G45:2&19!M*!<[L]P<J!CU
MK!L#;MXNT^]@ANI[&/1?)CN6M7.&#@X)V\-@'(ZY!'7BL/P_#?:;;>!I[G3-
M0_T.WN[:=!:N6B=]FP$8X!V]3Q[T >GW%S!:0M-<2I%$OWG=@ .W6JZ:OITE
MFUXE];M;*Q1I1(-H;.,$^N>,5C>,ENXH])OX+2:]@L;])[FV@3>[IL==RJ.6
M*LRM@>GM63>;YKG3-7L]%N8M/AU8W%S&;=EEFW0M'YYBQN^5F'49^7..!0!U
MHUS2C;QW']I6GDR2>4CF9<,^<;0<_>SQCK1)K>E0FY$NI6D9M<?:-TRCRLYQ
MNYXS@]?2O/\ 5M-OS)XGU>VM;F2QGOM-N(;=8F#R&%XS,ZH1GD =N=A]LKXA
M,VH?\)G);Z=J#K?Z+!':G[')^]<>>, 8R#\R\'![].: .SNM:@FNK2/3]8TL
M8O/(N(Y) S,0.8TPW#\KQS]*OOJNGQ7JV4E];)=M]V!I5#GC/"YSTYKD_$MN
MGVGPG)96,Q1-4CGE,5J^43RG7<^!QU4<_P!*Q[*P\J[N=.UG3=4N-1CU=KRV
MDC\WR)LR;DEWJ-J[5."">BXP>!0!Z'#K&F7%PEO#J%K),^[9&DREFV_>P >V
M1GTS5VN2\&6L6[6)7LWCD.JW$L3S6[(=CD89=P'! [5UM !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !3)O\ 4O\ [II],F_U$G^Z?Y4
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M?3[D73W-Y>W*H42:\F\QD4]0O0#/&3C)P,]*NR:A9Q7L5D]U"MW,"8X2XWN
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M]G+YT&R5D"/@C=@'DX)'/K5:\\)Z9?G4_M G<:FBQW2^>P#JO0#!XXR.,=:
M,G6KS5]%:!Y[VZN+66226X:QMXVEMD"J%VH02T8;<2<%AD=J@TV:XOO&FER_
MVQ+<0MH8G#1*@CD)D0,P&W(#8!]1VQ72S:'!-):S?:+I;BUC>..99CNVOM+
MY^]]Q>OI4"^%-)CEL98X)(WLHA##LF=?D#!@K8/S#<H/.>: *'B;4-4M?$'A
MVQL+M((M0FFBF+1!SA86<$9]"/\ /2L>'7=;@\_2;S4H7NK75A:-<+"!-<0M
M")5$: %3)\P!XV@ GCK6KXITN_U'Q%X;EMK6X:WLKB66>>&1%*!HF48RP)Y(
MXP>,U=E\&Z5.D)87"SQ71NQ<).RRF5AM9BP/=>,=,  8P* .=C\0Z[)I6GD7
M*QW#:])ILK30J6:,2. 2%^4-A1G'!--\0ZQKVAVE_$NL1W-QI^FM= Q6Z>9(
MX9CF92-J)M4 8().XCI@=&O@S3$C2..2[1$O3?*/M#-B8DG=SGN2<=#DYS2Z
MGX.TK5KV[N[D7 DO+7[)<+%.R++'SC< >2-Q_.@#%U3Q%J OYK<W0TY%TH7E
ML_EJWVF8YROS Y"_*-HPQW=:?]M\1W5]H^G?;XK.>^TF6YF8V@+13*T7\)/;
MS",>QJO=>&[J'Q!+*MMK;0):PVMO<:?J"HS(FXGS=[J2=S''48K>TK0)E>PU
M#4KJX?4+6.6)"7!Q$[Y"M@?,V%C!/JN1[@&#)XEU:+Q#81?:H9H)]7>P=(4#
M0K'L8K\Y 8R@K\P!*CD'FJQ\0^)!H.HZW]MM2FEZG- ]NMO@3Q)+L.222IQD
MC'<<YS@=!_P@ND1.LD;7JB*]-_%&EPP6.4YW;1G@')S]3C%9WAGPS-);:K%J
MT-Y!#<:M/=BV=T,<JM*70G&3_=RN0..0: ,S5=1U/1Y/'>JZ=<11-8W4$Y1X
MM_FXMH<J>>!CTY]Z[3Q'KBZ#X5OM::/?]F@,JI_>;'RC\R*K7?@^PO8-7AFG
MNC'JS!KM0X&["A1CCCY54<>GK6O+I\%SI;Z==+]HMY(C#()<'>I&#G&.HH P
M?M>J6.OZ?IMQ>BYCU&VE(E$:@PRH%.5P.4(8\')&!R<U0^&UN9/#TD\[B9EU
M&[92Z#*MYT@+ ]<D&N@M?#T%K+#+]JNII+>%H+=YF#&%#C...3\J\MD\=>N7
MZ%H5OX?M)+6TFG>%Y6EVRD'#,2S$$ =22?Y8H XO6S=R6GQ%\Z]>2."Q:-(R
MBX"FU+@9'H7/YUIZ/J6K1>(+#29IK=[:ZT?[5$!%_J70HN,YRP(?O@\=JU[_
M ,)V&H3ZE))-=QC4HO*NHXI<*XV;,X]=O'Z]0#2Q>&((M2M+];Z\^T6MJUI&
MQ*?ZLX)R-O)RJG/L/?(!SD/BO4?^$4T;5+QI$AN&E-[<VEMYAA"L0IV<G9ZG
M!Q@>N:['1+E[S0K&YEN(;B26W1WF@/[MR0,E?8UG67A.WTZULX+/4+Z'[&)%
MB<,A.V0@LIRI!&0#TR*TK+2H--T>+3+)Y(88H_+C8$%E]^01G\* //?%=Y/<
MZE)XDMUN_P#BGKH?9EC@D9)HE^6Z.X#;T)7D\&(^M=AX@UMK.STV2UF1+>^N
M8XGO" 4AC920W/')"J">,N/H;EOH<%OH)TA9YF@,;1[VVE\'.<\8)Y/)'/>N
M:U3PY<:=IFC:58G5KG3K2;>TT$\?GVZK&515R!N7+=\X Z=, $,OB37H= OK
MR*:RN6AU>*QMG,)431M*B%BP8C)WXW 8!4\'M:N=5U\:O+H5O*DUY!:F[>XA
M@0??D81)L>0< *=Q!)/'3-/M/#MYJ=K<6>H7VK"P$D$UN;IH3/YB,6)RJD;<
MB,@'G(;/%:FI^%+34]0M]1^UWMIJ$,7D?:K60(\D><[&X((SSTX/3% &0VN>
M(+V5-.@M/L^IPZ?'<W21>7(%E<NH7+.!LS&V<9/(Y%/AU?Q#>ZNFFM]DL9FT
ME;J1?+\TPS;]K+D-A@"#CI^-7[GP982SVMQ:W=_87-M#Y FM)MKR1YW;7+ [
MN<G)YR2<\U-;^%K:TU$7MM=W43K:?9%0%&4)G.?F4DMDDY).3UH YS3?%NLW
M*^#[ZX%HMOK>8Y;=$.4/EEPP<GU7IC@'&3C-6].U_7]6EM-0L[17TVXNI(F#
M! $A#,JR!O,W%LJ"5V]#@<C)O0>![&VM=%MH[Z_$>C.7M<M'GH1AODY&"1^-
M/MO!=C9WCRV]Y?1VS3&X%B)1Y"2D[MX4C/WOFQG&><4 8>E^*-=GL-$U*Y>R
M-O>:G)820QPL&(#RH'#%CC!1>,'C//IL>$)[^ZGUR2[NEE5-4FA51&05"[0,
M')XP!QCKS3H?!5I!IEE8)J%\(K.\-[$28]WF%F8Y^3!&78X]_I4>I>&)8+#5
M?[*OM4BFOI?."6\Z((Y25)8,1D [1GD\$X'.* -O6KNXL-%O;NU2%YX86=!/
M((X\@<;F/0>IKDYO%.IV]CXF:.2&=],TZ.^MY9;5X@^Y9205)!(_=<$?WN^*
MZK4M)CUG09M+OW<K/%Y<KQ':<_WAZ<\UE3^#(;I=1^T:MJ,C:C9+97+$Q@N@
MW<@;, X=AP,<YQGF@#)'C&_TS49/[5%O):'0VU8"%"&C*%04R3\V=W7 HWZI
M/XK\'76IO;;YXKF0Q0QD")C$#M#;CN&#UQU&>^!KMX*L9;N*>XN[NX":>VFM
M%)Y>R2!L9#84'/ Y!'2DLO!L=G<:5+_;&HS+I>];9)3&0$9=NTG9DC'')SQU
MH E\3ZC<Z?-H@A2W>.YU.*WD\V/<5!#'*G/!^7&<'K7.7WBSQ#:Z=XDU!?[/
M\G1=0\G88F)FCQ&2,[OE.'//.3V&.>OUK0H]:-B9+NX@-G<K=1^3MY=<@9W*
M>.3^=9=SX'M;K3]:LGU*^$6KS_:+C'EY#8 POR<#"KUST^M &AXMN;JR\(:Q
M=V4PAN(+*65)"N[!5">!D<\?_KKE+M=1_P"$W\++'-;M=MI=T/.>-MJC]U@E
M=V6/_ AGK[5W%YI\>H:1<:==.\D=Q T$K# 9@R[2?0'DUCQ>$1'JNGZBVKWT
MMQ8P/!&9!&0ROC.<*/[J],=/<T 9EEXNU&]TC24\F(:G=RW,<ICB9T40.R.R
MKN!.2%P">-W?&#T6@7>HW>F;M5M!;722O&0!@2*&.UP,G 9<'!.1TK(7P)!'
MIMM;0ZK?17-I<RW-M>)L$D;2DEQC;M*DL>"/3TK>TS31IMJ8S<37,SMOEGF(
MWR-@#)P !P ,    4 8VGZQK.IFTU&U@M)-+N+AXRF2LD<0+!9=Q."25'R <
M;ASP:S=/\9:C-XBTK3[J&T OY+N)XH<N;<Q LH,H8HQ*CD#!!(]*U++P;!8W
M#*FH7CZ;]H^U1Z<Y4Q1R[]^0<;L!OF"YQFJ=CX CL)-(*:S>NNE32/;(Z1X$
M<@(9"=N3G/WCS].M %/3_'-S)#=W=X;15LK&:XO+ Q-#<VTB[2J$,WS*1N&\
M#!('KBM?1M5U^;5HK?4;!/LLMN9&FBA>/R)01^[.XG>"#PP ^Z>.:A3P+;3R
M0-JE[+?B"RDL4+H$9XI %;S&7[YP..F,D]3FKFA^&9M(>(7&MWVH0VRE+6*X
M" 1+C')507..,L3WH 6_UFYD\2)H.FO;I="T:[FDGC+A%W;4 4,N23GOP%]Z
MY+Q#KE[K?AW0I%,5M(?$%O97D&PNOFI/@C.1E-RYQWXY%=EJ'AX7.M0ZS97/
MV34HX3;-+Y>]9(B=VQER.AY!!!'/8XK/O?!4=SIMA9PW\D(M;\:BTAC#-+/O
M,FX]  68G ^@QB@"[>RVOA3P_?:@EK%YF3/*D*[!-.V!GJ<;FP,G-5+W6M:T
M.TU&XU.VM)H8H8VM98"8UDF=M@B(+,1\Q3YNF&Z<5L:KI,&MZ)<:7?$M%<1[
M'9/E(/\ >'H0>164?"<E]I-S8ZWK%UJ+31^4LNQ8C& 0P("C&[*J<G/(' H
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M*3'-Y& Z^AW<$]<]:Q-/D\.SV4-]%>ZPNH6FFW,5W;Q0)%) GE$R>9B-22&
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M*2TT35_%D,,]S!:-HL5R_P!GES()"TRLZEB<,1MR?;)JCJ4T,5AXTMHKBVA
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MI,X*MY&%8#G8S':3_M5U7@VX\Q-6MY+)K*Y@O=L]N)?,C1C%&1Y;8'R$$-C
MP2>!0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !3)CB"0_[)I],E_U
M+_[IH :C@1I][H.QHI\?^K3Z44"U'4444#"BBB@ HHHH **** "BBB@ HHHH
M **** "F@JV0"#@X..QK*U?5S9WUAIMO&DM[?,_EJ[85$09=V[X&0,=RPZ=:
MY#0=9_L"QU.,VB"YN=>G@C@@#.H.P,2 JEBH52>%]!QUH ]&P*:6165690S?
M=!/)^E<;)XYDM]/CFOK(V#-?_8S<7:2108VEEERR@A3@+R!AC@G')MW&I.^L
M>&1>Z5:FXNI)U682[S;D1.24.WD,!C/'!Z4 =1@>E8$?A8V]U<R6FM:G;PW4
MK336Z-&RLS=<,R%U_!ACMBLFY\=7"Q&ZM-/BFM?[6_LD>9.8W\S=LWG"G"[N
M,=<<^U/U#QG?V1UYQI4+0Z+(@G<W1&]&17)4;/O -T.![F@#J[*RM]/L8+*U
MC$=O!&L4:9)VJ!@#)YZ5/@5RGB?QA+X;CO+F6SC-I:(CDR3['GR?F$2XYVC!
M//MQUJI/XGNM.\6>(Y;[8-*TK3X9BJ2$MAO,8L%Q@L=H&,C'')H [; ]*:X5
M@4W;68'!!Y_"N2B\;/$UT^I:=+;VT-D]X9T60JH3[T;%D4;\$8QD'GTYJ[KR
M;XD>'KB]L8+:273;LCRY"[=8?E;*CD9]^I_$ ["PT^WTVU%O:IM3<SDDDEF8
MY9B3R222235G K)UG5KG3YK>*WM8V617>2XN)O*AB"XP&;!Y8L ![$]N<?3?
M&RZW9:+]BLLWFJP23^3+)A840X<LP!S\Q ''.>U '7#;VQ1\IXXXK@/"^JMI
M>D26J6J->7FNWMO#;K)A%(DD9OFQG:JJ>=O8#'-4;?6Y?"]YXYU233D=X+RU
M\RWAEX^:)!D,5&<E@<8[F@#TW H(!ZBN7N?%%[9W"6EQID,5W*97C5[DE/)7
M: [%4)!8MC;CL>?6K'X\-U!8"WTTQ7MY;RS):WTI@9FC;:8U^4[F)Z=.,'Z
M'9  =!00HY./K7,S>*W_ +:;2[>UB:YC2%Y()9_+E*R$99$VG<%&2>1T(J/X
MB(C>"[B1HR[1S6[*!USYR#C\\4 =5@=<"L+1O#TNEZOJE_+>K<'495F=/(V;
M'"A1M.X\;0/Q[U3_ .$JOTU._P!+DT4K?P6OVVWB%R"+B(-M.&"_*X/&WD<C
MG'-6[+Q)_:+:)]EMUD34[9KHL)?]2@"GTYY<#M0!,=!:;7_[2N]0GN(8F#VM
MFRJ(X'VE2PP,L2">I.,G\-FL'5]?N=.US3M+M].:YDODE9)/-5%4H 2&R,X^
M8<C/T-5K3Q?]KL[-5LPNI7-W-9_93-\JR0EA(2^/NC83G&3E>.: .E*(5VE1
MM/;'%* !P,#VKC-1\6W<EH8+6WCAU&#5;>QNXGEX3>Z$%3MY5E88) QD\9&*
MG.LV%AXHUB:\L/LUQ9Z7'<7%V)=X>++G:![$/S@$^E '6TT(H& H ^E<\WB>
M>S2ZEU72Y;2"&S^V"57WJ1T,9. !)T^7)!SUI^C^)AJ>JS:=)!&DJ0+.KP3B
M:,J3@J6 &'!ZCGJ"": -XQHR[612OH1Q6)K>@7.HWEK>66IFSGMU9%5X%FB8
M-C)*''S<#!!'&1WJG/K=_'X^.FE(DT^#33=2,9,$[I,;C\O\.QN,_P 1I;;Q
MBL]OI=^]C)%IFISB"VG9_GRV?++)CA6QP<D\KD#/ !J:7HL6G0RB5Q<33RB:
M:1HU4,^T+D*.!PH'X=2>:T/(A/'E)U)^Z.IZUSGC76+_ $BQTXV$:%[K4K:V
M9F?&U7D4'L<Y&1[9S6 -9N- \3>,;Y;">Z2WM[6XG03\1((W9]I;J>I   ..
MV: /0WBCDQO16QR-PSBE6.-/N(J_08KFM8\9VVF/*(HDG\BV6ZE5IUC8HV[
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M[   8')[@"M*#QEI=_8V$UD+BXDOV>.&"- ) R9WALD!=N.23CD8SD4 :/\
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MDWL=N\,ZX"2LJ*J1 XX8LIYXRV<XH V;S1M,U&XAN+W3[:XFA!$;RQ!BH/4
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M,GV!'7'EV^]F&!C.&=G8?[)7TKKNM% &'J6DWEWXDTK5(9(!%8I,IC<'<_F
M \]L;16-:^#+RWGMK\7-N=0M-1NKR$A6V,EP29(V[CJ,-ZJ#CM7:T4 <A<>#
M[B<7]ZMS$FIWE_;7K$J6B7R-FU,9!(PIR>.3T[47?A&ZU/4]6FU"YA:WU'2U
MT^00J59<%SO&21U<\>PY-=?10!RDGAS6-7T6XTW7=3A97MC CVD10EN")6W$
M_,"H( XY/7C&CHUIK\;A];O[28I'L1;2%D#G(^=]Q//' & ,GKQC:HH YK5/
M#5Q?^)7U!)X1:7.G'3[F)T)8H7+94@C!(8CGIP>>E4K3PE?IH^E:'=W,$MAI
MES%+%.,B61(CNC0KT!!"@L"<@=!GCLJ* ,+Q3H=QKFG6D5K/'%/:WL%XAE4E
M6,;AMIQS@UDW/A?5[A_$[-+9EM:LDM0P+*(RJ,A;&#UWDXSQC&3UKLZ* .1&
MA>(;'45O-+N]/3[1;10W<5RCNJO&"!)&01G@\@^@YK8UG0UUKPQ=:-<W$G^D
M6_DM/@;MV/O8Z9SSBM:B@#FH]$U.\U?2M0U66U#Z;%*J_9]Q\YW4*6.0-HP#
M\O/)Z\<YNG>%-8L+;PQ TUE,NB2-@Y9#(GE-$.QYP^[TXQ[UV]% '!KX.UJ-
MKJ[M[NT@OQJ\FIVC'=)'AX_+:-Q@'!7/(YY]N;NI:)XBU2'3GN9M.,]MJ$5X
MT:%U15CS\H."23D\G&..*Z^B@".4S"%C"B-+CY5=BJD^Y ./RK!\$:'>>&O"
MEGHUXT$CVH91+"Q(<%BV<$#'7'>NBHH X=O"6L-J-O=/-82RP:HU[]J=6,LL
M9#A4/IM5P  <';VYJYIWAJ_BT?Q'87;VRC59[B:)XG9]@E7&""!T_7VKK**
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MR0./3?TJ\O+VVDDO=/:QD69XUC:0/N4,0KY'J.<5>HH **** "BBB@ HHHH
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MYKI!I-B+R[NC;JTMW&L4Y8DB1%S@%3Q_$>W>FV6C6.GR+);Q,'6,1*7D9RB
MYVKN)P.G ]!Z"@"_1110 52UC_D"7_\ U[2?^@FKM4-8M)K[3VMX51M_#J\K
MQ@KW&4YH X[PTFN#PEX3EFN-._L>.T@DN1Y11UB%N2I9F8@X;83@#IFJ^H:C
MKEK:^);X:U.RZ5J,26\7E1@,C)"Q5SMY7]X<8P>I)/&-E?"]REG%9K;VWV2(
M*J6YO[DQA5Z+MS@C@<$8HE\+W$T%[#)9V;17LHEN5-]<?O&  !/X!1^ ]!0
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M22#G>T8386SSDCKSUH_X167[%/9C2[?[//<_:Y5_M>X^:;<&W9V9^\ ?3(%
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M0HQ\S13LQ^I))_&NOK'UGP]%K=Q9S37MW";.43P"!E 60 @-RIR<,1@\<]*
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MF)R#R"!P,C!H [&BL?PS%J<.CJFK7$MQ.)'VRS(J2,FX[=P7@'';TQGG-;%
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M15MKJXEOEACM4$DWG(T91#]UL, 2#@X(X/:G)XETF6[FM(KL/<0PF=D1&8E
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MENF: /36N(4E6)I461_NH6 +?05C:OK=S!J::3ID,$VH/;27(6=RJ!5*J 2
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M.] '8T444 %%%% !1110 4444 %%%% !1110 4444 %,F_U,G^Z?Y4^HYO\
M42?[I_E0 L?^K7Z"BB//EKP.@HH ?1110 4444 %%%% !1110 4444 %%%%
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M*1,2!M((R#R/H.>E '/WGAO[#K'AZWTRQO1I]E)/))+'<?ZLR*0,;GR1G)(
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M2;LMABS\]1( XZX(XKIY)XHCB21$X+?,<<#J::+JW+QJ)H]THS&-PRX]1ZT
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MX9\!V\VFWL4]G>2-<J;20&(&*9<M\O RZ<^_M7J>*CFEBMX7EFD2.-!EG=@
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MF^9]['.0OI7JA53C('%!53C(!QTS0!R_A#7=,?0?#VF+>PF]ETN&5(<_,55
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M[-Y 3Y>2YW=?DY'SMZ=?84 8VG^(]2LK/6+B[GBN9Y-<.GVL8B*_.61%_BZ
M<XXS@\Y-:%QXAUO3H+E+RSA\Z6Z@MM-D9?+65I.#N4,Q&S#$\C( QS5J7P58
M3Q:G!+<WAM[^?[3Y8D \B;*GS(R!N#94$9)Q^)HF\'17FG26]]JNHW5PSQR1
MW;NBR0M&2R%-JA002><$G/.>* ,W04N8_BAKXNI(7D.GVAW0QE PW2=02>?Q
M]*V;K5KR;Q(^BV#6\3Q68NI9IHRX&YBJ*%#+_=<DYXP/7@TSPU]@UZ?6)=3N
M[JZGMDMY!*(PK!22#A5'/S&I[W0EN-8CU:VNIK6]6$V[L@5EDCSN 8,.QR01
M@\GUH YB+QMJUZ_AF*TMK-9=4EN;>X63<1%)"&W%2#R,J3[CCC.11U'5[K6]
M TN34(H!>6?BJ"SD: $(QCN0NY022 ?K73)X+LX;G1IX+JYB.E/++$!L/F/+
MGS&?*]3N;ICK4'_""P_8S;C4[O!U3^U=VV//G;]_]W[N[G'ZT %SXFO=.U37
M+*]:U5K:U%W8!8FS.AX_O<D/A2!CJI[UH:LMU)X'U#^T!";HZ?*91$I"!O+.
M0 2>/QK-O[5/$7BC3E?2[R/^R;EGDNYD\M)%"Y"H<_."_EMTP/+YP<9ZB[M8
M[VQGM)L^5/&T3X.#AA@_SH XG0-8UFPM?#%G<0V8T[4;&.&UD3<TD4RP;QYG
M(# A6Z8QC&>]6=/\5:E>6%K"PM%UEM2:RN;=8F*Q;"2Y^]G[@W!NARH[UIV7
MAM;!+!KF[GO4TN,K9QE%!7"; 3C[S[<J#P.3Q53P_917_B6]\2IIUU9+<6\<
M*I=(8W=AG>Y3/' C7)Y.P]L$@%SQ3K5_HL>F-8V]O,;N^BM'$SE<;SC(P/\
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M8O+&,YYQ\V?P]Z32/#FOZ2ZZ='JUO_8D=P98<1'[2D>XMY.[.W;GC.,XR/<
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M]RNVH **** "BBB@ HHHH **** "BBB@ HHHH **** "F3?ZE_\ =-/IDO\
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MK2_B,MG<PW$:MM+1.& /IQWYKSMHFCL?%&G7EMJ<!?61=I<VT#'RU9XC'*A
M(?:PW$#/"MG%=/X,EOI+"_\ MZQR3+=E1>1PF(7@"(!+M/0_PG'&5XH VY-3
ML(;Q;26]MDN6("PM*H<D],#.>:1]5T^.Y^S/?6RS[UC\LRJ&W,"57&<Y.TX'
M?!KS[68+F3P[XKT2:UF?5KR\>6S*QL?.#LODLK8Q\@"J>?EV9X&*O^&[2/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR!]%!-<7?ZAK^N:OJUCHEVEI)IL</EJ74;Y)$WAGRC93!"X&#PWMCK+B1Y-
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M/811^>(8YI4!C1@0<;4SU.,]3S59IY]5U_P9-;:JLTEQ8ZAMOA$,D?NOF"8
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MWB/6;FZC:VO(8;J357L&TZ6 2>3&"V)" 0Q.U0^=VW#=.] '6_\ ".Z)_P!
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MG/90 6 Y^<<CO%8ZWK.JS:;IK3P6=[/IHU&XD6V.4#$!8U5F/(.=Q)/3H,\
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M[DJO(Z=/2@#LJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.?\
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MH-;TJY$IAU*SD$*AY"DZG8IZ$\\#WIUMK&FWMQ]GMK^UFF\L2^7',K-L/1L
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M@@BV+<*CGSD7C!8QG;CW KJ?#9TZ[UJXU'3X]09Y[9$N)KB$P*"I^1-A5<L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\>TG^Z:EJ
M*X_X]I/]TT 2 ' HH'044 +1110 4444 %%%% !1110 4444 %%%% !1110
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MWI4CW*,% #+%&X92 "#ECDY.<U<TK4;^:ZC\.SW\[ZG9ZG(;F0L [VH!='(
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M.M:A>7=Q9W5PUQ#)I"W0D>()ER65MG .PX&-PS[\UD:>/]"^%7_7(?\ I&U
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M#3HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_X]I/\
M=-2U%<_\>TG^Z: )!THH7H** %HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **R]9UR'1/L?GP3RB[N%MH_*4'#MTSDCTK(N_'=I8V<DUSI]W%+!;_:+F
MV<QK)"F6'(+_ #,=K$!<\?49 .KHKE;KQ[ID%O/<PP7=S:V]O!<S31(-J1R_
M</S$$\<D#.![\5<N_%5K;7]S:);7-R]K-!#<&$*?*,I 4D%@<?,"2 < ^QP
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M];MTUM](\N8W8MC=*H7AT!"G!SC.2!@XJBGC/29(K!U-RWV^)Y;=5MW)<+U
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M.[GN[GS[7[$7DE&Y8,Y* @#KW)R?>K$WA;3KF423B:3%B^GE6DX:%\;E./7
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MUP.O3BM&H;R[@L+*>\NI%BMX(VDD=NBJ!DG\J . C\,:['H%Y9_8X#-/KO\
M::XN.%C\]9=I./O87'IFKAT/6;?5=0C@TO3;FVU"8W$=[<L"]H64;E9-I\P
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MY,7D#S65"-TD@7(!P  "<X4?0=Q5:#4+2ZN[FU@N(Y)[;:)D5LF,MG /H>*
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MWX&[ZN:O:UX?LM?6!+XW'EPN7V13M&'R,%6VD;@0>AK31%C0*BA548  P *
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M#1.NT88>HZ@@Y[U)/KNL:AIWBK4[&]%N^BW4L4-L8E*2+"@9O,R-WS$M@@C
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M"[0P /.3GL.=Z;P?$^JSWUOJVI6GVM5%Y%!(@2X*J%W'Y<JV  2A4\=JAN_
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M9836]R%F1MK.L:C'(SCRR3]1C-4;7PYKEOI:2I:J+JVU^75%MVF7$\3E_EW
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MX?AP[':.)9&.<]#M8''H:F\%:[I]EX2\)Z9//MNKNT6*)=IQOC0%E)Z CT-
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M 9NN:0+ZQB\'V^B2II+)#FZ1E$42(X)4#.[=A1C@\MGL:ZX(JQA$4*H&  ,
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M[1(Q<*-@P"^">%R1^=+!XBT:ZN+6W@U2TEFNX_-MXTF4M*F"=RC/(X/Y'TH
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M QCI7J$EI;2RK));Q/(N-K,@)&.1@TJVT"SM.L,8E88:0*-Q'N: )1THHHH
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M-%;VTT8\52Q-'.N0 ]TB @>H+ CZ5U+:SJM_<:F-%BM)%TZX6V:.?(,SX1G
M8$!,*X )!R0>W6)/!,2:7=V U*Y"76H_VE(^U-WF^8LN!QC;N4<?K4USX167
M5;R]M]4O;2._51?6\)39.0NW.2I*$K@$J1T]>: *>K^*KS3-8CMF6V,;ZA;V
M@B"L[F.4JOF,RG$?S,<*PYV\=>,Y;W5M(7Q??:3!9216NI/<31SLP:0"VA9E
M7'"G X)SSV[UKW?@F.Y>Z\O5+R".>]BOU1%C(CF39@C*G(^1>#Q5B;PJLO\
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M5CWO@=;[2-<TR349?(UB<3S,(UW*V$7Y3TY$:]O7UX &:AXJU)[W5+?1-/\
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M0KJ%/S]<.>?8<4:GX+OM2T?7=/\ [1MXQJE\EX'\@GRMOE_+C=\W^J7GCJ:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !4-U_P >S_2IJANAFW>@"8=**;MHH =1110 4444 %%%
M% !1110 4444 %%%% !1110 455N]1L[ QB[N8H/-8K'YCA=QQG SWP"?PIL
M>JZ?--;Q17MN\EPK/"JRJ3(J_>*\\@=\4 7**H7.M:99I</<7]O$MNP68M(!
MY9(R WH<'/TYI9-9TV&#SYKVWBB\TP[Y) HWC.5R>_!_*@"]15&+6--GFCBB
MOK9Y)(?M"*LJDM'Q\X]5Y'/O2Q:OI\UN9TO(3$)%BW[P!O8@*OU.Y<>N1ZT
M7:*I'5].6ZFM6O;=;B%/,EB:4!D7&=Q'88(Y]Q3?[;TS;"QO[8">0QQ9E WL
M#C:/4YXQ0!?HJM<ZA9V<T$-S<Q127#[(5=PID;T&>IJS0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !45S_J&_#^=2U%<_ZAOP_G0!+1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%
M<_ZAOP_G4M17'^I/U'\Z )1THH'2B@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ IDJ>8FW/<?SHHH >.E%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex10-4_008.jpg
<TEXT>
begin 644 ex10-4_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F3?
MZB3_ '3_ "I],E_U3_[IH <**!10 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %,E_P!2_P#NFGTR7_4O_NF@!PHH
M%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX2MF5-%AAM(IO+#!YBHP"Q&U4102V>2< >_1)\/?#R; MM,JI>M>J!<. LC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9-_J)/]T_R
MI],F_P!1)_NG^5 "I]Q?I10GW%^E% #J*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\UU4LL<$3RRNJ1HI9G8X"@=237-GQ6;C4O#BV44;Z?K D<3.Q#J%B,@^7'?
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M0F%KR>W:(G)6/<RD9[D#FM*LO2-975I=1C%M-;M8W1MG67;ECL1\C:2,8<4
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MR\''KWJ_?JNG:_X@@ATB6XBGT6%;:WAB98Y1']HW1AU&%/SJ,<'YABNZI.*
M/,M/N$EUF]EE%W+!<:$(E9]/>&(%6?* %<@ ,/O$DD\&H]-2RFE^'(N+=6>W
MTYHYO,A_U3"%0%?(^7YP<9[BO4L5$UQ GF;I8QY0W298?(/4^G2@#F/ 3)_9
M>II&"J+JMXR+MP-C3,RD#^Z001CBL[1=7L[#QKXPN+AI1%//;&%D@=_-VP*K
M;=H.[!!'%=XK*Z!T(96&00<@BEP* /([_2M3"ZSXGFT^\6TO]4M)WLHUS/\
M9H5*[RG/.XJ^WJ O-;%OHFG:]H&MOHBWQEN9$NH;N]1D#72#*LBL 1@JH)
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M1D$="*:LL+(&61"I. 01@G.,?G0!YQ!/;P^+A=S132+=>'(1#)%&2TDBM(7
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MXQ4S0PO 8&B1HBNTH5!7'ICTH \YU:RU'7-%U3Q#:BW=S*EWISM(=T:6Q)C
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MLNV<$3OP3+/VSC'MT'I6!HNKW]QX=\,VMQ?2E[^]O%EGEN&1I"DDNR,N.1G
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M%]YT:RO'N\F%\A4 R,A58@<]: *^B^([Q;_2]%N-/2);K2_M-L_G98[ H*N
M,+G<#D$UEV]Q:ZAX>\'W=OIL-A'_ &T0EO&=PBP9P<' ZD9Z=ZWX_"US'K>D
MZG_:$1?3K%[-4^S'#AL?-]_C[HX^M5[3P;=6>BZ3IZ:G$QTZ]:\61K4_.27.
MTC?Q_K&YSZ4 .N_&-S'-(]GI$]Y:PWOV20P*[2$ [7=0$*D*V01NSP>G2M7Q
M-K,N@:+)J,5G]J\MXU:/S-A.YPO&1@G+#CCZUGQ>&-2M+V[6QUPP:;=SM</;
M_9P9(V<[G\N3/RACD\J<9.,5H^)-(GUW2&L(;J.W#R1NSO$9/N.'  W#NHH
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M -(C))*NWRG"D9W'(K0\41R0>+O"FJ,N;6"XFMYFQD(9H]J-[?, N?\ :]Z
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M>G.T-BJ_B&TO8_!/B66ZEN_(>ZC%DMS(S,L.^+J&)(^??C/.,4 >DLZHA=B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLM3T+4()(9=0MK=W0!P5>949?8_,?<5LW.M:=97*VUS=QQRLRKACP"QPH)Z
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MF <XX)Y],'TK32:.6%9DD1HF7<KJP((]<^E #Z*KVU_9WJ,]I=P3JAPQBD#
M'WP:RM?U\6?A?5M3TJ:TNIK&V>;;YFY<JI;!VGT% &[156._MBT<,EU +AD#
M^5O ;IG.,YQ3XKVTFE$45U#)(4$@5) 25/1L>GO0!/14 O+5KEK9;F$SJ-S1
M!QN ]2.M,&I6)0.+VV*$X#>:N,]?7W% %JBL#Q5KTNBZ%=7MC]GGGMV0/'(Y
M^4,P7) Y[YQQ6U)<P0O&DL\:/(<(K, 6/H!WH EHK)\2:NVBZ#>WT(AEN8('
MFC@EDV>;M4L0."2<#_\ 54NFZHEQHFGWUW)#"]U!'(06VKN90<#)]Z -&BF2
M2QQ(7DD5$'5F.!2//#&%,DJ*&.%+,!D^U $E%1R31PP/-)(JQ(I9G)P !SG-
M<^/%(NKWP\;*.)].U97?SW<AU B,@^7'&>.I_"@#I**C,\0B\TRH(\9W[AC'
MUJIJ6LV6EP6\MQ*,7,\=O$%()=W8*,>W.3Z $T 7Z*JW^H6VF:=/?W4@2W@C
M,CMGL!GCU-9#>(IE\<QZ$T$2VS:<U[]H\PY)$BIMQC ZGG)_"@#H:*:SJJEF
M8!1U)-*"",@@B@!:*3<N<9&?K0&4]"#^- "T56O+^VL(XWGD"B65(4]69V"@
M#\3^6:G9AC@C- #J*IZ;/=SV*2W]LMM<$MNB60.%Y('S=\C!_&GW%];VL]K!
M*X$EU(8HE_O,%9S^BF@"S15&QN;V:YO4N[,6\44NVW<2A_.3:#NP/N\DC!]*
MO9'K0 449'K1D4 %%%&1ZT %%&1ZU6N+^VM9[6":4++=2&*%>[L%9B/^^5)_
M"@"S129'K5:TN+B=[H7%HUNL4Q2(LX;S4P#O&.@))&#SQ0!:HHR/6C(H **R
MX]9$GB631OLTBM':BY\YF&U@6V@  Y['KCI5F:ZGCU&VMDLI)()5<R7 90L1
M&, @G)W9/3TH MT49'K4-U=P6</G7$@2/<J9/JS!5'XD@?C0!-16/9Z^EYXE
MU'11:RQO8PQ2M*Y7:_F;L8 /^SWQ]*O2W4B7\%NMK*\4BN6G4C;&1C /.><G
M&/2@"U11FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9,,P2 \_*?
MY4^F2_ZE_P#=- #8XT\M?E'0=J*=&?W:_044!<?1110 4444 %%%% !1110
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MA[[7J=AJT=SY&IVB-%YRQY65&QN1ESR,C(YR#WH YV;Q%JVHW&BV\30VD_\
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M"CL00FTG[O#'=G)X%:%I;HGBJZO]1TJ[EL[K1+>! ;)W+$%]\97;E3@C@XH
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M=-2@4VC);.XEC\@+Y>0/E(?<<'!^;- '6W6O:18R21W6IV<#QA2ZR3JI4$@
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MJ=_\2GG/([56M?%FMOIFFW<UI9YU>&!K%8_,9E9HC)*TB@$X ' 4Y.0"1R0
M=SBC%<7_ ,)?J4%M#:WFFO%J=Q=M:VS>2_ES*$+F8)]\*%!^7KGC.#FHY?%^
MM6=KIJWFD1QW-UJZZ=N=FC612"PE12,@$ C!.0?6@#N*,"N&N?%VN6=EKTDN
MGV+2Z(^^Y*S,%DB\M9 $XSNVL02<#('KQ=U;Q9=17UU9:/9?:Y[.!)Y59)"'
M+@E8U**=K$+G+<#(ZY. #K,#TI./:N+E\7ZO/J=]8V6D1));:=%?8NYBA&\$
ME& 4X8;2,<^N>U2PZ]J.H^*]%2UCB6QN](>],;RD$Y>$9.%/*AC@=\GD4 =?
M@>E+@>E8>O:[-HM]I$?V19+:^NEM7G,I7R68';QM.<D8ZCDCUK-LO&<UY;:C
MML(?MEGJ2Z?Y NB0Y+!=^[9P,$GH?NGTH ZL/'E@&7*<,,_=[\^E*"AQ@CGI
M7G?BNXM[SPIX^C&GPP2VPV22J=QF;R497/ P0K*/PK2MX8U\=^'I%C4.^B3[
MF Y.&M\?ED_G0!V>!Z"EP/2LO4]4EMKZTT^S@2>]N5>15DDV*D:8W,2 3U9
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M.,U%:>++F\L'OXM#O&MU$J_*RLQE27RM@4'//)W=  >: .F"HB!%554#  &
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MP4:$9(QNYSSR,]/P%C_A*I3J$%D-&NS)=6QN+0ATQ*%V[@<GY,;U//4'UXH
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MPO+&2R$EM>R^=.DDCOODZ[\DY#<#D8/%-_X0_1#;0V_V639%.+E3]HEW>:,
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M6!(4L,X['VXKKC?6@B60W,(C;(5MXP<=<&GK/"TOE+*ADQNVAAG'KB@#EIO
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MQ_WOF^5 >W)J[%H%\FO:7J3WEN5LK)[1HQ"07WE"6!W<?ZL<8/4UT.1ZT9%
M&'KNB7E_J&G:GIE]':7]EYB S1&2.6-\;D8 @]54@@\$51E\,:H^I65\=7CG
MFB682_:;?<H,F,-$H8;"H7:.O!.223GJLB@G@D<X[4 <=:>#M0LD\.21:I;F
MYT:W>T#-:G9+"RJO*[\[AL4YSCKQ26O@Z^MM.2QGO+._M/-NGFMKBV^2832^
M8I/)PRG/('<\=ZV?#>O_ /"0V-Q<FT>U,-U+;&-W#-F-MI)QQUST)^M;.10!
MQ5KX,U31KFRNM&UB%9X[)+*Z6[@:2.94)*, &!#+N(')XKK+>">VTZ.'SS<7
M"1X,LW&]O4XZ<^E6J3(H XJR\&ZA9)X4 N[9SH7F!OE8><'0IQ_=X.>]:=IH
M%W'X@UR]N7MWM=52-#$I;<@12HYQSD'VQ[UT615;4;J:STVXN;>TDNYHD+);
MQD!I"/X03Q0!S>A:#K.@6EMI]SK5M)H]A_JG\DI.T8!VH[;MN!QR!R%'3FLO
MP?I]SK7A'PX));;['93"Y#1L2[E2VU",87!().3G'09XZB37D'BFWT![*3?/
M:/=><Q79M5E4KC.2<L.P'UK3N)?LEI+-';O*44MY40&Y\=AD@9^I% '(Z?X2
MU>RN]/G:\L9'M+N:9Y3$WF7"NKC+MG[P# =QQ^%3)X9U5?!USHRW5M'.UR\R
M.A8HZO.96C?@'!!*$CJ#GVK>T/5DUW0K+58HFB2[A698V.2 1D U%H.N)KMO
M=S);2V_V:[EM624C=N0X)X)'7/>@#"D\(:A+;ZY$;JRC&H>1)$D4+*L3Q!0%
MZ_=^0=/4].E6+_PW?:E=7VI3&V2^ETQ].AB61C&@<Y9BVT$\A<#'&/?CJ\U$
MEQ#+++$DBM)$0)%'521D9_ B@#CX?"^N:?-I&H:?<V(O[73TTZZBFWF*:->5
M8$#*L#D]#]XCMFNJM(KRWT_;/,ES=_,Q;&Q2Q)( ZD*,X'4X'<U;K"U;Q.FD
M:M9Z=)IM_/+>;A;M J,LA5=S#EP00!GD#VS0!S\/@_6(M&\.6)>Q+:1J'VMW
M\Y\2+\_ ^3@_O#^7OQ'#X)UL7^FW=S=V,]Q9:G)=/<OO,EQ&P8 -Q\I4, %&
M1QU%=?I&NV.MQ3-9R-OMY#%/%(A22)QU5E/(/Z>E:6: ./'AS56\+^(]+8V8
MEU62Y:)A*Q5!-D'=\G\.>W7VJW'H^JC6=$O66SV6%C-;2*)FRS/Y?(^3H/*'
M_?7MST,L\4+1K)(J&1MB G[S8)P/P!_*I,T 8WA?3+O2-$6RO?(,JS3/F%RR
MD/(SCJ!S\V/PKFIO ^IS65_:"\M8Q_:[:O93 ,6$ID\P*XX  Y'!.<@\8P>^
MHH PK/2+M_$S:Y?""*468M$AAD,@QOWLQ8JO?  QV/KQ4U?0]3O?&VAZS +3
M[+IJ3HRO,P=_-51D (0,;?7GVKJ*I'4"-933_LER5: S?:0G[H88#86_O<YQ
MZ"@#.\3:5?:HNE_81;DVE_'=N)I"F0F>!A3R<U7_ +#U"Q\77>NV)AF6_MHX
M;BWEE*;'CSM96"G(P2",#U]JZ:D=MJ%L%L#.!U- ''VGA;4=,F\/S6K6LSV"
M7*7 D=D'[]E=BF%.<%> <9'<5GVGA3Q!%JFCZA>&PGN-/O9Y9KI[AS)<12(Z
M@_<^7:&'R XX[5MQ>/-"=+B266XMXK:Y-K/+/;.L<4O'RLV,#J.2<<CFNFX(
MXZ4 >3Z0;B#38M8:RLKK2%O)+^WBBU$KM+.VPI#Y?W\-D(7^\>@/ Z:VT'7K
M"_O[6W&FOI]U=R7,=XY/GV_F/O==A4AN2V#N&,C@XQ73)I&FQW9NTL+5;DG)
MF6%0_P">,U926.5G6.16,;;7 .=IP#@^AP0?Q% '#7'AG6Y="U.R6*T$MSK*
MW\9-P<",3))@_+U^3'?K3]6\):GK-SXE#M!;1ZE#:BVE$A9DDA)8;EP."Q'0
MGC-=S10!S\,OB9K6:YGL[&.YC@*Q6B7!9)I>/F9R@*CC &#U.>U;ZYVC( ..
M<4M17$RVUM+.RNRQH7(12S$ 9X Y)]J ,OQ98W6J>%=3TVSC5[B\MI($W-M5
M2RD9)]!FLK7M&U/4_AK+H<-O&+Z6T6VVM*-BD  G=Z<>F:Z>RNDOK&WNXTD1
M)XUD59$*L 1G!!Y!]JGH X+7?"NH^(=6O2\8M;:[T0Z?YN\,R2%]^=HZKVZ_
MXTY-+UV?1;RWN-"TNTN6LY;8R6CJ3<.R[0P^5=B=R"2?:N[HH X;5/#NJ7&E
M>&KB"TM9KO2%VS6%RP\N=3'L8!L$ ]P2/KBG:GH^JW6E64<.CV=NZ:K;WK6]
MM(H5(XV1B"Q"[G.T]!CH,\9/;T4 <@VF:K;:GKT\-H+B#6(T9%:55:"01>65
M?/&W 4Y7)Z\&J?AWPMJ&@Z[HP*>=:V.C-I[W&Y1ND+H^X+G.WY2/7D?6N[HH
M X?2-#U/3KUK*71M,FACO'N(M5=E9RC2&3!3;N\P;MN<X[^QW]!UF?5GU&*Y
MLOLTEE=-;_+()%D& P8,!UPPR.QR*V:H2:A8V%_9Z82(Y[K>8(EC."%&YN0,
M#_Z] '&:EX>UB\_X3H1V)QK,,<5H3*G)6+RR6YX&>?I[\5O16M\?&<&H-92)
M:_V=]G9RZ95]X;! ;I@8R,\_G724R66."%Y975(T4LS,<!0.I- #Z*SM,URP
MU>2:.SF9WA",ZM&R$*PRK88#(.#@C@X/I6C0 4444 %%%4[O5;*RO;.SN+A4
MN;QBD$?)+D L<?0 \T 7**** "BBB@ HHHH **** "BBB@ HHHH **** "F2
M_P"J?_=-/ILG^K;Z&@!(?]3'_NBBD@_U$?\ NBB@"2BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#F?&$_D'1R;9V3[>I-R$=UMCL?#E5ZYSM&> 6!/0 \
M;9-=6KZ?+-!=OI5IX@O9+P/;L&7>7,,A7:/E!;<<#@D'M7K%0SW-O:('N)HX
M4+!0TC!02> .>] 'EVI.9H-<^S65U-8'Q#:W=TD=O(/-MO*AWL./F&Y<D#J
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M  D.EZ5<RVKVT]MKUO Z;B4)#CYD8@;U(((./Y5IWWAC4I])T5[2\M[;6M(
M$$Q0O$XV[&5EX.&4#W! P:==:'KU[I]F+N^LY[R*_BO'VHT<2JA!"(.3SCJ3
MU)^E %=-?TO2=<\67DUBUJUH+;[3.9=QN6*D( N<+P5 Y&<\XQ2#QI<W>GZR
ML-G"+VRM3<(T-R)8F4AN=^T?,I'*X].2#1?^#+G5+GQ&;B>.&/5/(>!XF)>"
M2$#8Q!&#R <?ASUJU'IGBFZT>_M]6O-.FGFMFMXTMD>./YA@R.3N)/L !U]>
M !W@W3(X=,MM5-NT-W=6D7G$3%Q.=H;S&']\ECSU]ZSM-\36.G:1=7=EH]VJ
M2ZV]G)&90[><TH1G.6. 6)P 2.G0'(ZC1+6YL=#L[.Z6+S;>%(<QN65MJ@9Y
M QG'2N6@\)ZQ#I,MKFQ+OK@U4'S7P%\X2[/N=>,9]\^U '1Z+K;:I<ZA:SV4
MEG<V,BI)&[J^0RAE;*\<@].Q%9VN^,5T26\9]/G>TL1$;JX)" >8<#RP?OD=
M3TQ[GBKFEZ9>V?B/6;^80?9[XQ-&$<EEV)MY!4#GKUKGO$O@W6-<FUM1<V3P
MWL48M7N Y>UV@910. &(R6'//0X% &KJ?C%K&\U:UATB[N9--MTN92KHJM&V
M\D@D]@AXZD]N]78/$D$^M6NFK!*/M=G]L@G8J$D0;<@<YW#<,C'0UE3>']8F
MO_$-R18_\333HK5,3.-KH) 21LZ?O#Z_='KQDZY:PS6?A[04OHHO$UBT*1BU
M?>Z1,NR5N0"%,88Y(ZA?;(!VNCZLNKZ/#J7D/;Q2@LJRD9VYX;@XP0,CV-9N
MG^+$U"ZLO+T^Z&GWRR-;7VW*,$&<L.J!ADJ3UQVK:^PP?V;]@6,);^5Y(1>,
M)C&!^%<OH'A[7M/TFVT&_NK.32[5&A$T6[S;B':5564C"$ C)!.<=J +]MXM
MAN)+!C9SQVNI9%C.Q7$Q"E@",Y7<H)7/4#G!XIB>-+-].TV^^R7:Q7]^=/0$
M)F.42-'\PW=,HW(S5/3_  QJ:6?A[3KZ2V:WT682+/&[;Y@D;I&"I7"\,">3
M]WWXSW\*>(4M+"PA733;V&MMJ*2/,^Z6,RR2;2-GRD;\=3TH TY?&Y*ZI]ET
M:^F_LZ6:&9_D"HR1"3).[H<X&,^^,BMOP]?7&H>'[&[NHFCFE@C=]VWYB5!)
M&"< D_6L33?#FHQ6GBFVNC;(NKW$LT+QR,Y0/$L>&!4=-N>,]:V/#UI?VF@6
MUEJ2VZS01)"!;NSJ550N<D Y)!/3C(Z]: *3>,;)5CN3#/\ V;)=?9%OOE\O
MS-VSUSMW#;NQC/MS60L]YX@\;ZYID[ZC:V]@MK]G>VG6/RF;>S.V&^;=@  A
MN.H&33(/!5^GA)?"4CPOIL=TK)=>8?,\A9A*%*[<;^-N<XQSUXK7TG2=2L_&
M>NZI-%!]DU!;=8RLI+KY2L,D;1UW>IH TM0UE+&[CLHK:>[NWC:;R8-N0BD
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M<VUT)0P93C"NO!5B"#@9&,\YK=KD_!-SING^"O#,32V\$][8P;$+!6F<1+G
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M[]:CM]06:X,L=ON@W(J.""(W8(<Y7&XCC- 'J=11W$,TLL<<BL\+!9%!Y4D
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MBXN5U*V$2,MJJ%L <9 W*J D_,&S] #T.JFH:C;:98RWERS"&+&\HI8C) '
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M<_,/W8].IJM;:]KFH:CI%G;O8Q?;M&^W/(\3-Y<F8QP-WS#Y^F1]3C% '8G
M&3TJO97]IJ4+36=Q%<1*YC+Q,&7<.",CTKC]'\6ZEK46@V<8MH;^^MIKFYEV
M%D18G"':N1DLQ'4\#/6H-$U2^TZS^PQ)%+?WNMWL99$P@"L[LP5F'.%P 6[Y
MYQR >@8%%<?-K?B.R@TQ+RVM([BYU3[$=P^_$59ED 5CM.%Y4D\^E=/8+>)9
M1+J$D,ET!^\>!"J$^P))'YT 6<4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !39/]6WT-.ILG^J?_=- #8?]1'_NBBB'_41_[HHH DHHHH ****
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MQ@[B""",&NIHH YQ_",4B6Q?4[]IX;L7C3DQEY90NP%ODP %XPH KHQP***
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MXJ]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V3_5M]#3
MJ;)_JG_W30 V#_41_P"Z/Y440_ZB/_=%% $E%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !115>\OK6PB$MU<1PH3M!=L;CZ#U/L*
M+%%-1Q(@=?ND9&>*BM;VUO1*;6XBF$3F.0QN&VN,$J<=^1Q0!/152VU2PO+B
M6WMKVWFFB)#I'(&*X.#D#WX^M6Z "BBHKFZM[.!I[J>*")>LDKA5'XF@"6BF
M1317$*30R))$ZAD=&!# ]"".HJ."^M+F::&WNH)986VRI'(&*'T8#H?K0!/1
M110 4444 %%5OM]K_:'V 7$9N_+,IA#?,$R!N([#)%6: "BBB@ HHHH ***@
MBO+6>3RXKF&1\$[4<$\=>* )Z**K+J-DU\UDMY;F[5=Q@$@W@>NWKB@"S111
M0 4444 %%,EEC@B>6614C12S.QP% ZDGL*<K*Z!U8,K#((.010 M%%% !133
M(@;:74'&<$]J=0 4444 %%%-61'+!75BAVL <X.,X/X$?G0 ZBBB@ HHR/6B
M@ HHHH **1F5!EF 'J3BEH **"0.II%974,I!!&00>M "T444 %%%&: "BBB
M@ HHHH **,BC- !1110 4444 %%%% !1110 4444 %%%&10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V3_ %;?
M0TZFR?ZMOH: &P?ZB/\ W1_*BB#_ %$?^Z/Y44 24444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %>;W5]J2:OXH\4JD-Q%HA^RP6DN
M01&D:R3%2.%9MWWL'A0*](K"OO"EC?7&H2-)<1)J,:Q7L43@).H&WG()!V_*
M2I!Q]!0!JV-U'?Z?;W<8(CGB650?1@"/YUQ.C7$NG>$_&MS9H/.M]0U"2%5'
M\2C('YBNOATM(-0>ZBGG56MT@6WW#RD"DD%5QPW.,^@'I5?2- AT<7JQW%Q.
MEY.]Q*L^PC>WWB,*.#Z4 <5.HTN#X:FQ&"9$@)'\<<D.7SZY(#'W&:],K"T_
MPI8Z?-8NLMQ,FGJR644S K;AACY> 3A?E&2<#BMV@ K)\4''A+63W%C.1_W[
M:M:LOQ!;37ND36<4<\BW"F*40.BL$8$'!<$>WKS0!QNA:E<>%K36?#?E[I+
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M4DLK?/R,G/KD=>U1'PZ\,>GM8Z;KME=V(D6.ZADM"SK(VYU8,Y4KN.0,<=J
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MB@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDO^I?\
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M[4->F2,1#C]RFXX;." R\#&<C/(!W$?B31)8;F9-6LC%;8\]_.7;'DX!)S@
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M\U>&QL;FXE1VEM;<7,UNA4R*G/OC^%N_.TU8L+Q-0TZVO$5E2XB255;J P!
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M %3_ .Z: &P?ZB/_ '111#_J8_\ =%% $E%%% !1110 4444 %%%% !1110
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MQSQTH [+ I 49F4$$KP>>E<U'XDU%_L,;:7"L^HL#:H;G(\ORP[NY"_+C.W
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M3;?9;B]CTFVFCN[B,#:I>,*,9()&1C@=,5Z)10 4444 %%%% !1110 4444
M%%%% !1110 4444 %-D_U3_[IIU,E_U3_P"Z: "(?N4_W111$<Q(?]D44 /H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH PO%4Z1Z?;(P<L;VU?"(S':LZ
M%CP#P "3[5S6DZ5<Z9J\^CR1>5X;TVX_M"VE.<,).4B ]$D\QOPCKT$LH(!(
M!/04 @]* /+M'G^S>%/",4UK-'+#<RAYWMY'^ROMDQF,=68-@%@0,YYXRNG1
MRKX?TJ..\N--U*SN+WRYKNT)@.92=D@( ^92,%<8YQZ5ZC10!Y1=O<RZ!;7,
M5M_9]VNCK%+I-Q$S074.7'DH?OJ^!Q@YPRY![3>*)VN6UV)+6Y@F$EE*8A;R
M2O/M,;!]V"%5>1@#.Y6.><5ZC10!YU/-ITVI>)-/U_3[R<ZC)%):*EO*#<0"
M--B*P'RE7#D@D8+$FLGQ)!!>V7CYY+96O'A@\A2-YWB)00A[D,,9'<5ZW10!
MYU?SHFJ:VTRR.-1\/0B!EB9Q,R^=N' ZC>I_&J.J2LND07%JZ23'18(Y],O(
MF47<?S?+"W#"4'=TSG*<=#7J190P4L-QZ#UI: /,M26SGUG7M.\0/J,<]W/'
M)9I:VX;SXE13&(WV$AE<-D9&"2>]/UR!9(/'=FMG(UY=6@>WC6 L7'V8="!C
M[RD?7WQ7I0.:* /*=:GAFM(;C3I(2\>C!)+.^B*V]Y$Q8.B'AEERG;KE>O4=
MGJHMKCX?3B[MA%#)IW^HGY*$Q\*<_P 0.!ZYKHZ* /*[RVM-.T?PMJ<,$D>G
M2&)M5N+2,2/O6$B-Y 5;<%<G)(.#@]0*5[+3;:UM7T74WA*W%U=6CZK$OV2<
MLJ>8H&%VJ=YVD#^_C(KU.CI0!Y58R6\FO> +J#3TL)OL%U&;=R28AL41J6/.
MTG=MSUSQWJ+3[VS&B^'/[0VIKD&LB34$D7]\DK>8'9AUVG(P>F-N.E>L@@]#
MFEH \LMAIEW?26^K76HPZ_;ZJ]R(+>!=[D2$1LK;,F,QE0?FP%R#@"LQX-%B
MT#6KV,6HN[?Q*CVLFX%HD^T1',?]T%0Q..H!]*]FHH \UN;32/[6\8PR&.R>
MX6!EN8H%++&\:!GZ8*%OO=CS6EX4U6&PCU9]26QB9;R*-[RP!-O<LZJJ%1SM
M;[H(R0#WYKN*3:/2@##\9RQQ^"M;\R14WV,Z+N8#+&-@ /<UYSJ[6Y\ :!+I
M=\=2U>V%I)#I1E\Y9' 52K1CD!<DY.,$5['10!Y7JO\ 9MYXD\06/B>^N+*:
M1X_[/*1*6:$(I'D,4)WB3<3M.<D58EGTJ?6==M?% 9-0:6)M.XQ.\"HC1B'U
M?S Y(7^(^E>ED D$CD4%02"1R.AH \I\37MD=2U6=9+>"\M-5L6?[1@S@!X<
MLG(V1!6//()+],U%XGETRVA^(%HWV>-[FSANK:(J 93Y1RZ#N0PR2.G4UZUL
M7).!D]?>D>*.3[Z*W&.1GCTH \EUF6S^UKJ!:SU2W5+*.XMG8+<VWW&22W;G
M<"6!*XY((SVJ5WTR_P!:U,:QJ<UEK]MJ;/;HL8^T-&&_<B D9*,F,J."2V>N
M:]4:")W5VC5G3E6(!(^E*8T:02%07 P&QR* .2^(UE=7.A65Q;))+'8ZC;WE
MS#&NYI(4?+ #OCAL?[-;@\0://;QR0W]O<+-@1K"X=I">P Y/].]:E0QVEM%
M.TT<$22O]YU0!F^I[T >9:W*DNB^*;]SY?B2QO6%FX/[Y "OD+'WVNN.!PQ9
MNO-075M;:CJWCO\ M-RTL&G6LJH9SB*7R9#D<\;6Z>A/'6O5'M+:2Y2Y>")I
MT&%D* LH]CU%1OIUBS,SVEN68Y8F)26YSSQZX- 'F.LW_G06FL7"PZI##IML
M]Y 7\NXM=WS>? >C%CPR]]@'M3_$]Q;V6F_$"V-P(90(Y[6/S-K F!#N09R/
MF#=.^:]*.F6#-$[65N6A.8F,2Y3_ '>./PI\MA:3R-)-;0R.Z>6S/&"2F<[2
M?3/.* .&UEK>]\8ZLB,DR2^&#M"-G>#(^,8ZUBZ7<:/+X>\':=]HB?S[#=+%
M/,!:[Q%&':3NTBY&$!'7)Q@&O4S8V?VH71M8?M Z2^6-_3'7&>G%-&FV($0%
MI !"YDB C'R,>I''!Y/- 'G>B>3K$?@R.YOIIUFTZX2<+=,/,*B,?-ANO7/?
ML214%@;.;2/!TVH7'[J#5KVU,LEP5V1JMTJ*6SZ(@]>!7I#:/IKR+(VGVK.H
MVJQA4D#G@''N?S--CT32HH6ACTVS2)G#E%@4*6'0XQU'K0!C^-RO_"(22Q7$
MD6)8-DD<I7@RH.H/(()X.0:P)]-B/CC6=&^TWBZ?+I"7KPBZ?F;>Z[]V=PX
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M)%:1+88CM$>.%?.DPJ-C<A^;E3C[IR/:@#F-+U&YU>[^'&H7CA[FXMKEY'
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MME/<A+FY$MW! D=P4)_=DCCR]XY8C!X&<9- '82:[IL>G07_ -J1[>X ,+1
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M\0V>I:A<:>J3V]] @D>WN(BC;#P&'9ER",@GFLGQ\&.F:0$95?\ MJQVEAD
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M+,W1DN1&J/(Z_9)=\:(Q5F9=N5&0>H&<''2@"TOA[3%NC<>0Y<S"X(:9RGF
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M;-+%=WJ1M#L\XX)6+=]TNP&$![;B*BO?%N@Z=<7%O=:E$D]N@DEC&695/(X
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MV%X)0UM,)X7BD:-D< C(*D'H2/QJM-X3TV9[S'G1PWQ#7ENDF([@@ 98=<D
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MT\:CK'C^Q%Q]D-TL$(G'&PM; 9_6NMTC25TFWD3[3/=33/YLUQ.P+R/@#)P
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M-4M#;S*7CD\T890<%A[ ]3VKFO$FAV>GVFA6FG:7(T,6L0W<JPP/+@#):1B
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M*MIS[PJ" J/,V'LF_?TX_"@#UR.1)4#QNKJ>A4Y%.JKIUC9Z;816FGPQPVJ
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MX'N68^4ZNJ%2!]X D],9]14%AX\O=2M;"VCL5CU::2XCN$53*D/D,$=@N5+
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M *9,<0N?]DT^FR_ZI_\ =- #(W B3K]T=C13HO\ 5)_NBB@6H^BBB@84444
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MWA!MW=>@Z8SSD5JB5"@<,"IQ@YX.:!-&02'4@''7O0!E:+H"Z+/?21WUS/\
M;9VN95F"8\P@ D;5&.%'%$6@+%XFFUS[;<--- MNT)">7L4DC^'.06/.>]:P
M=20 1R,CFAG5,;F SZF@#G(_!EFEO!8M<3/I=O<BYALCMVHP;<!NQN*AN0,^
M@Y'%,G\"Z?<QZG#+=WI@O[G[7Y8=5\B?Y3YD; 9#94$9) Y]373;U]1074$
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M)?\ 4O\ [IH (_\ 5)_NBBEC_P!6GTHH =1110 4444 %%%% !1110 4444
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M'<H%N0MS>+?2_P"DR?-,I!#=?89'3@4 =#1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %,E_U+_[II],F_U+_P"Z: "/_5)]!12Q_P"J3Z"B@!U%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %,E_U+_P"Z:?3)O]2_^Z: %C_U2?0441_ZM?I10 ZBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_6?$Y?Q+J<-S'?KH.BI&;N
M2T!^>1U#$LP(.Q%()5><GD8%>@5R=WX;U!+C7TT^2U:TUI,R+.6!@E,8C9@
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M2 54MG P.Y P172T %%%% !1110 4444 %%%% !1110 4444 %%%% !4<_\
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MUAJ=Y$EU*FFRM#,D<#%RZJK$*N,G[P__ %<U'X6ENKK1_MUU),WVN62>%)0
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M"2"XF6XDW.Q)E7H^<Y# <9'..*3_ (1#01!/ NFQ)%<2)+*D>4#NN-I.".A
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MEE?]_,]O%-Y9\N25<[D#="1M;V^4CJ*/^$HTO[1%&TKJDUPUK'.T9$3S D%
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M $[/@')(R>Q/ JKKN@Z_/X=\3:%!IOVC^T+IKFVNEF15P[JQ5PQ# K@@<$$
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M'$'8#>Y!(4>IX/'M4U 'E]D]P-6U.Y>WU22*X\/K"LLNGO$"Z-+E0@7Y<;@
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MR6EQXDUZ4(-D_AU0=\17<VZ0X((SNP5X//(KT&B@#S*YB@L?"GA?5;>V;['
M8#J9M8=TQ"PLJLW!+;'8$@@D=>U.DNM/M(=.UFRM[^701JKW%X\L+DLS1868
M1D;M@?'\/7YL=Z]+IK2(K*K, SG"@GJ<9X_ &@#S^^ETQ$T/4K;3IHM+&M2R
MLQA=C()()@9-F-RJTCX QSP>A%.LK"P\1>(/&^G72;K>]%L-KK@C$(4D9[JP
M_ BO0*S==LFU#2V@74[C33O4_:;=U5UP1QD@CGI0!S_@QKW5)6OM4AVW.GQG
M3 V!AY$;]](O^RQ5,?[IIVIS0VGQ AEU8*-/ETTQ6TLP_=)+O)D4D\*679C/
M4*173Z?8PZ;8Q6D ;RTSRQRS$G)8GN2223ZFI]Z[PFX;B,@9Y(H \BT^SL_[
M0\)6][#&;1K[45MXYQR+1Q((58'G:>  ?4"NV\;6UI;?#76;2*&*.!-/DB@B
M  52$(15'KG  ^E=336=5QN(&3@9[F@#S2Q31[GQ!X5:Z6S<#P^ZR^;M(R/)
M*AL^F'(!]">U5-!U"UM[+PB^HR1?V1$+N%F=@8X;G?\ N@_9?DWA<^OTKUBC
M% 'CT$^FCPG=A3;A(/%H:+@ (GVQ3E?;8#T[9K>^P6=[KGC$V$-M+JD.R6R(
MP3'/Y& Z^AW<$C\:]"QBEH \ATN33;S25GT&741XDM],N(#;^4$:&3RR2)L(
M"3Y@&"226.?6M6QD\*ZSHZ'1[$R7QTR:"6%02T0VY*S@]7W@ ;LDDDCN:]'R
MH;&1N/./6@;0<#J>: /,-$N]-&E_#B."2"-E<+,!A<R?8G5L^IW$*3Z\=>*G
MN=":VU^\\*0P(-,UBX34@508CC1E\^/\6$8'IYIZ8KTG:/2L;1M"N-/NIKN_
MU2?4KIP8XY)HT3RH\YVJ% [XR3R<#TH LV&M:;J%]?6%E<K)<6#K'<1@$>62
M,@?_ *O2N7U#^SI_$OB*WU\1+']BB-FTQ&!%M;>4ST8/G)'/W/:NKM-,CM;^
MZO3))+/<[06<CY47.U%  X&XGUYY-7'C20J716VG(R,X- 'DF@VRZIXJT.S\
M1#S;F;PP#<13OAGD\Y"NX==V!GUR,]JZ_P"(<5N=!L9KE(C!#JMD\KR@%43S
MT#$D]!@G/L:ZORD+[RHW>N.:<RAU*L 0>H- 'G,+Z'?>(O$-OJ[6XLQ:PMIS
M.P6);7R_F:$] 0^<E?\ 9]!71>%[B]'P[TZYU3[0]V-/5YL?ZUODS]=V,>^:
MZ%XHI2N]%;:<KD9P?:G\'B@#R[PO>::?$6CLEU81VUYHTZ^5%+ER0T! FDR-
M\N"Y)P",MUZUE>'A:VMA\.[R&4+<SW4T,TQDRSH5D^0DG[N<<=,^]>Q^1$5Q
MY:XP1C []:9]BM3C-O%QT^04 3CI1110 4444 %%%% !1110 4444 %%%% !
M1110 5'-_J'_ -T_RJ2HY^8)/]TT .C_ -6OTHHC_P!6OT%% #J*** "BBB@
M HHHH **** "BBB@ HHHH **** ,/Q1>26EA;B&YDADFNHXE2% 99\Y)C3)
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M9'FA%NTLMP[R",9^4,3D=>W7O5*7P+H4FE66G>1.D5@2;21+F198,\$+(#N
MQQC- &6XOSK_ (.74YX)+Y3>)-+;'*,PC(R,@<\<C'!S4']L:[#/J.A27DK:
MM_:$*6<QCC&ZV?YM^-N#M5)<\=5[9Q72KX6TR*73I(EF1M.W?9]L[8!;[Q;G
MYBV3DG).:J:39ZAJ.N_VWJVF1:?-;PO:V\0F$K,K."SE@, '8F!U&6SUH F\
M:(Y\#:WLF>-DL)VW+C)Q&W'(/6LZRN;LZII^@1:A+&/[,^V27'EQF0C*HJ+\
MNT 9)/!/2NDU738-8TRXT^Y,@M[A#'*(W*EE(P1D<X(JA+X6L9?L+F2Z6XL
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MG*L <CZ<YS7:Z;IEMHFGF"U65U!+LTCF225CU+,QRS'W]AVKFO#>A/<PW_\
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M70X(=32_B\B\DN?L<Y C+>:SHW')'(;&< ]N*UY/"6G/->E6FCM[Z4375JC
M13.,98C&1G S@C/?/- &7<>([J+Q.;&YG>QBDN(4LVD@W07*,%+*9 /EESO
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MWRR6&HWIA<JH(D3RI&[C((9!Z'J*TQXDTDZ@MB+K]^TQM@?+;890-Q0/C;N
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MB2;/N^7M4DL,!2#@5H^ +/1[G5-?G6&V>ZMM:N)+5@ 6BC=5&Y/16^89'!H
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M* /2-5O_ .S]/FN$$32HA:..238'(&<9P?Y&LS0]<OM8TO0=0%M;I#J$'FW
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MTV]LO$UO>1W=NXEMH8I&:; !\R0M(VQE/!.!][;Z8 /0J*** "BBB@ HHHH
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M?7K0!V/2LR?7])MDOGFO[=4L,?:F+C$.>F[T/M7.VOB'69-+T26:2R^TZZL
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M5=""3_?4@YYR>!BJ]Y/?OX_L;..YC6S_ +.FE>)HRV\^;$#GYAS@\<<9/7/
M!OVUS;WD FMIHIHB2 \;!ER#@C(]""/PI8KB"9Y5BEC=HFV2!6!*-@'!]#@@
M_B*\T\#:K>Z1X1\.A8[<Z==:A/:$'=Y@9IIB&!Z8R,8QTYSVK<?Q++IMAX@O
M'L((6L]42WE>WC:0;2D),S@89B%?G'91]: .TQ369$QN95R<#)QD^E9^A7[Z
MGI:W;3VLZ2,WES6K9CD3)VL.3@XZC/!R*XOXBW;WLOV.RU&.VN])1-2C1GQY
MTX;,<?OE5DR/5D- 'HV**YR\\50Q^%;#6K2/S4OVMTAW'"H9F50SGL%W<_3%
M9M]XOU/3X?$VZQM)FT.$2F02L@FW)O'R[3C SGYCV]> #M<#THP*Y2]\2ZA8
MWEM8SVD2W-Z7D@$(DG\N%%7<755R6W,!@<<YSQS&GBZ\:*QMI=.DMM3N$FD>
M-H9) B1L%W[5&[#%EQD# )SR,$ Z^C ]*Y&#Q1JT\NCV[:.+>YOTGWI<2,GE
MM%CMMR5.00>OMZ01>,=2-A:7LNFVZPG4AIMQB<EM_G&'>@V\KNP><'KZ9(!V
MN!Z48'I7'2^-+F2\F&GZ5/=VUO??9)3'%*6;:P5W4A"F%)/!8$[3TZ4DWC#4
M8DU"X.EP?9K#44LIF^TDLRL8QN4;>2/,R0<=,<T =EQTII9 X0LNX@D#/)%<
MUH]_J-UXV\06TS1FSM/L\<:!S\N4+YQCJ=W//85GZF+B'XJ6DMC;02W+Z),/
MWC[%XFBY9@">/8'KVZT =OC%&!7*VWBRXO-%TJ_BL(XA>*_G27$^R*W*\8+8
MR<MP.!Z^U5;?QU+<V'AS4!IJK9ZQ/]FDD:<YMY,L ,;?F!*D \<D>M '9X'I
M2X'I7,W'BI[8R@VBL6OS8VI61F\TA-SL0%) 7#@X!Y7WJ_X?UB?6+6Y>XL9;
M26WG:$AU;;(  0Z%E4E2".W4$=J -8[1DG QU)I>*\R\6WE[J7@?QF+Z*'R+
M:Y:*(K(6*!1%C *CKDG.>I(KIV\5-8WVHV^K6:VJ6EB=05XYO,+0@D'(P-K#
M'0$CGK0!>GT22;Q)!K'VPCR8&MQ 8@5*,RLV3USE%Y[>E:^T>@K TKQ'-?:Q
M_9\]AY6;?SUFBD,B @@%&)50K<@X&<C/I46K^)KJP\10:+::4;NXN+62XA)G
M$88H0"IR#CKUH Z,A&/(4D'/TI656QN4'!R,BN,?Q-IVC3^+=0FTXPR:>T/V
MF1'W-<,8U*>PP&45/<Z]/>76IZ#=Z>(9TTXW3/'<;UV,& P< Y#*1^1H ZLJ
MC@956 .1D9Q0T:/C<BM@Y&1G!KB_".MSPZ1X:TI[':ESHZ26TYF^^8XX]P9<
M?+G<"#D^X%:G@K4[_6?#4&H7ZQB2=I'78^[ WMA?NC&!@#KG% '0-&C$%D4D
M=,CI2>3%Q^[3@8'RC@5Q]AXKO$3Q!>7]NAMK/4#9P1Q2[G+8C14 *@?,S9R3
MQNQVS6Q9Z^S^(WT*]M/L]Y]F^U1,DGF1RQ[MIP< A@2,C'<4 :QMX2NTQ1X]
M-HKFU\(R#[1;/JIDT^X>1VBDM8VERY)8>8>W)'(SCOQ5^_UG&KC1;6V^TW36
MQN)09?+5(\[1EL$[F.<#V/(KE?"5[;KH?@R"YLYI9[B6X,,S2_ZEPLI.[GYB
M5W#G/7- ':V6DV]C=SW4;.TLRJA+8^5%SM48'0;CR<GGD]*M-:V[N7:")G(P
M6* D\8_EQ6!8^+([UVE6W7[ K3K)<++N,)B)!\Q<?)G!(Y-26>O2ZC/;6\VE
M7<%O?6S3PS@DA5X^60C_ %;$,"!D]^<B@#<B@A@!$,4<8/78H&?RIHM+87'V
M@6\0FQCS-@W8^O6N$\!:Z8/ OAFT.^ZU*_BE:-7?&0K,7=V.< 9 S@G)%;:>
M,K:2&-?(,5XU^VG-#-(%"3*I?!;G@J,@@<[AQZ '0?9+;S&D^SQ;V8,6V#)(
MX!SZBE^SP>>)S#'YP&WS-HW8],^E8<WBE8([6.:U\F]N#-M@GF6,*L3;68L>
MQ)7&!SN';)%_1-9@U[1(-2MHY$24']W( &4@D$'MU!H F_LK3B"/L%J03DCR
M5Z_E[FIY+:WF@\B6"-X>!Y;("O'3BN0L_%%CI>C0W$.F:@(KK5I;/RRXD=9C
M,RL3ECP6#8 R/I6]HVM_VK-?V\EG-:7-E*(Y8I2K'YE#J05)'(8?B#0!;&E:
M</+Q86H\LY3]RORGKD<<4ATG3F\S.GVI\PY?,*_,>O/'-9FH>*([*6]$5C<W
M:6+1K=-  2A?!P%ZL0K!C['OTIFI^+8-..ILMC=7$&EJK7LL07" KN( )^8A
M2&([ CKTH UCI&FDDG3[3++L)\E>5QC'3I@#CVK"U?PM+/J$-SIYTQ84A,/V
M.]L1+"F6W%D"LNUCQGKG Z8I+GQQ;I>W-K::;?7CPV*7X:$)MDA;.""6'H>#
M@GL#5;5];;4[SPS%:6]S+I^IJUR?+D$9E3R2RH?F!Q\RD_3'- &_H.C0Z)8-
M;1&/,DC2N(HQ'&&;KL09VKQTY]R22:E_L32?+>/^S++8[!V7[.F&89P2,<GD
M_G7,Z)J6E:%!X@^?5&&F2JER]Y-YK.=@*"/YCU!4#H3QGFE367M?&6IW>H)=
M6EI;Z.EP\<LH=5P[Y8!6(SA0#CT[T =?#;6]O ((8(XX1D"-$"J,]>!53^P=
M&\@P?V38>26WF/[,FTMZXQUYZUAR_$#38/MZ36MTL]G8F_:$&-F>$'#$$.1E
M3U!(/3K5ZU\5VMQJ(M);6ZM5DM6NX9[A51)(U*AR.<KC<OW@.#F@#0.C:69)
M9#IMF7F79*WD+EU]"<<C@<'TI\>EZ?#GRK&U3,?DG;"H^3^[T^[R>.G-9=IX
MML[J:W#VUU;P75J]W!<S*HC>)<$DD'*\,#A@./Q%)IWB^PU'4[:Q6*:)[NW:
MXMFD*8E0;<\!B5.&!PP!Q]#0!H6V@Z192I+:Z58P2(,*T5NBE1[$#BI+/2=-
MT^:66RT^UMI)CF5X850N?<@<_C5RB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *CN/^/>3_=-25%<?\>\G^Z: 'I]Q?I12K]T?2B@!:*** "BBB@ H
MHHH **** "BBB@ HHHH **** *.KZ3;:U8&SNMX3>DBO&Q5T=6#*RD="" :Q
MY_ NDW5K?P7$E]*NH*BW1>Z8F0(!C/OQUZ]N!Q6EKNN6V@V<-Q<Y/G7$5NB@
M'EG<+^F<_A0_B/1TN!;MJ, F+QQ^66^;=)]Q2.Q/I0!6;PGI\NJ2ZA<-/<33
M6?V&59G#))#S\I&/4DY]345CX-T^QN[2X\^^G:SB>&W6>Y9E2-MN4QW'R#KG
MWSQC2MM<TV\N_LL%W&\Q5F51D;PIPQ4]& /!QG%8VH^)A_PD>AV&GW<$D5U=
MRP7 \LDD)%(QVMTX9 #C.,]J %LO FE:>'2VEO5B <6\33ETM=P(8Q*V0IP2
M.^ 3CJ:V=&TJ'1-*@TZWDF>WMT$<7FL&*H!@+G'0"D&NZ4VH"P%_!]J+%!'N
MZL!DJ#T+ <D=:L7=];6$2R74RQJS;5SU8^@'4G@]/2@#*/A>W:_-P]W=O";L
M7@MF9?+$HZ,/EW=<'&[&14=IX.TZRU62]AFO!$\QN!9&<_9UE/)<)ZYR>N,\
MXSBM"37M*CLX;MM0@\B<$Q.'SY@'7;CKCOCI3I]<TNVLXKN6_@6WF7?'('R'
M7&2PQU&.<^E &+8>!;#3IK&2"^U+_0&?[,C7&5C1@/W8&/NC ]^.21Q4]IX2
MBLK*TM(=4U(16MY]L4"51O8EF9&PHRA9B2*OW/B/1+1 ]QJUE&IB68%IE^X2
M &Z]"6&#[U(=<TM;[[$=0MA=%BGE>8-VX#)7ZXYQUQ0!?[5F66CBSU>]U'[9
M<S/=A0T<NS:@7.T+A0<#)X)/4U7TSQ7I.J6MW=17<2V]M.8"[..2#MSCW;('
MKCBM2UO;6]MA<6MQ%-"20)(V#+D'!&1Z$$?A0!SX\$6#W&L-<W5Y=6^K\W5I
M*R>43@ %0J@J0 !D')P"<D9HM/!%A'I]Q97]W>ZI%+ ;9?MTH<Q1'&57 &.B
M\]?E'/%7M.\3Z7J45]-'>6ZPV<SQN[2@#"X!8^@SD9]JOV>HV6H!S9W<,_EG
M:_EN&VGK@XZ4 8=MX*M$TVYL;^_O]32>#[-OO)06CC]%*@8.0#GDY4<\"I&\
M)K-!<+=ZG>7-Q-:&R%RXC#I$?O 87&3QDD'H*9J>KZG;^+]/T>W>T$5[!-,'
MDA9FC\O9QPX!SO\ ;&*NV6JO':W-QJMU8K;I/LAN8GVQR+@>K'#;MRXS_#0!
M4?P?:R>'=/TEKR[W:<8VL[O*":%D&%(.W:>.#D<@\U2N/ $5W9ZQ!<ZSJ4C:
MNL:W<A\H%MBA> $P,@8Z5T@U;3VT];];ZV:S;&V<2KL/./O9QUXK(T#Q&-0@
MUBYO+JR%K97S6\=Q$VV,H$0@DEB,Y8CK0 ]?#!77)]7_ +5NS<S6:V;96/;M
M7)#8V]<L3Z<],5R^K:'+IL^BZ6MUKJ6&GV)BAO;2V6Y+$E0$D0(W14&&V]^O
M7/=KK&F-;Q3KJ%J89I!%%()EVNY.-H.>3GC'7-1MKVCK!%.VJ60AE!,<AG7:
MX!P2#GG!XH YRR\/W^KVUC-JFI7X;3KXW%F\L422R+MV@R*%P/O/@  X(S@T
M^&V_X2'QK;ZLVEW=FFDK- 9+I-AN') 78,_,@ 9@Q_O#'?&O_:ET/&2Z21#]
ME:P:Y!"G?N$BKC.<8P3VK:H P-/LM3C\8:I>27-T=-EBC6.&=U*B0#DQ <A<
M=<\DGT%/O_#BW?B*#6HKZYMKB*W-NZQ[=LJ;MX#9&>&YX(ST/%8__"4ZG>Z3
MJ>J:8EE*EG-+#]B9',PV.5+,0>#P6";>1CGFMV/Q)ITOB670DN(VNXH!*X#C
M@DD!<>N%)QZ4 92>"0EEHEJ-5N"FD3^? 3&F7." &XZ89NF.M+9>!X=/U!GM
M=3OHM,:Y^U?V8K+Y(DSNX.-P7=\VT'&?;BMU=:TN2">:/4K1X[==TSK,I$8]
M6P>.A_*H++Q%I=YHMOJIO((;:9%;=+*J["RAMK'. V#TH C\2Z$?$>F?V>UY
M);1&1)&:- 6)1U=<9X'*CM4VK:.FM^'KK2+Z9REU"8I)8QM;GN.N*OPS17,*
M302I+$XRKHP96'J".M)<7,%I"9KF:.&(8R\C!5&>.IH Y)/ ;^9?2S:Y=S2W
MVG_8+AGBC 91D!@ HP0K$>G<YK1O_#,E[IFE6ZZG/!=:;*LL5U'&A8D(R<J0
M1RK'MUY]JV!J-BT,,RWEN8ICB)Q(-LA]%/?\*6&_L[FU-U!=02VXSF5) R#'
M7D<<4 8,_@Z&[_MI+N[EEBU9$610 K1E!A&5AW& <^H_"F1>$[P6Y-QX@O+J
M^!B\JZD1!Y:HX?:%4 '<1AB>2/H*M:/K[:KXBU:RC>UDM;..!XI8'W[M_F9R
M>G&P=*:VN70^($>@&&$6K::]Z).=^X2*F/0#DT 7M(T==+>_EWJ\U]<?:)BB
M;%W;%3Y5R<<(.YR2363=>"H;YM9AN;ZX>PU1O,:U"J!%+A!YBMC.044CL#GK
M70Q7]G//)!#=0231_?C20%E^HZBA;^S>[:T6ZA:Y49:$2 N!QR1U[C\Z *%C
MHTL.HQZA?7GVNZBMS;1N(Q& I(+$C)RS%5R>GRC %,U'0I;O7K+5K?4)+66W
MB>%T6-6$J,RM@YZ<H.1V)Z=:T8[^UGEE@M[J"6>/[T2R LOU Y%97A#7+GQ!
MHCWUU#%%*+F:$I$25 20J.3]* ,ZR\$-8Z-I>F)J6Z'3KXWJ,T'S.Q=GP?FZ
M9=OT].;D?AN[AEO9H=4$<MS?K?9$' (14*$;N5*J/?K^&V]_9Q7(MI+J!)R-
MPB:0!B/7'6EDO;6&:.&2YA263_5HS@,_T'>@"EHVCKHUK<Q1NK-<7$EPVU-J
MAG.<!<\#\?4]Z;HNCR:4MZTMQ'/<7=PUQ)*(BA+'@ _,>  JCV ^M:(NH#(T
M8FC+J,LNX9 ]Q3'O[.*%)9+J%(W.U':0 ,?0'O0!P6I:%=^'/"!TA;Z>>TN+
MY6$D-EO%HA<R.&0%MT7&W;C^+!.*=;:=?ZS8:AH4=Y;S:9?VL@EO8M+-MY3D
MJN -V)"5+<CIM&<Y KOI+B"(XDEC0GGYF [@?S('XT&ZMPX0SQARVP+N&2V,
MX^N* ,'6?#-QJITR[BU+['JVG,3%=Q0Y4JPPZM&6Y4@#C/4 YJO=>$KR;^S[
MR'6Y8M8M))'-XT(=95DQNC,>0-G"X&>-HYSS73O<0QG#S(IR!\S <GH/QI5F
MB>1XUD0NF-R@\KGID4 <[%X7NH]2TN^?5/.FLS,TK2PY,S2X#=& 4     XQ
MWJK_ ,(==_V0+#^U(>-4_M(/]E/WO.\[;C?TW<?2NK2>&1W1)49D.'"L"5/O
MZ4":)CA9%)P&P#G@]Z .63PC>VNH7YL-::VTS4)_M%Q:"#+!S_K#')N^0/WX
M.,G&*)_"-Y-IVKVG]IPC^T;]+W=]E)\O:4.W&_G_ %:\\=371:;J5MJUDMW:
M/YD#,RJ^.&VL5)'MD'!JR9$$@C+J'(R%SR10!AV6@W=GXHO]66_C,%\L1FM_
M(YWHFP$-NX!ZXQGCK2SZ'=2>+H==2\B58K)[00&$DD,RMNW;O51QCI3=6U^Z
MM]3DTS2K%+Z_CM#>-$\WE@KNVJH;!&YB&QGCY>:J-XEU>Z@DGTK1(KJ-)I+9
MQ)=B-DD0$,6X(VAP5."3WQ0!5M?!>HV0T9H=6MFDTPS@>9:%D<2D$MMW\.O(
M!ST)XYJ6T\&3P> I?#4]_'*P#_9KE(=IB;=O1R-QRRM@]NG2NMWJ "Q"D\<G
MO5?S[K^U/(^S)]C\G?\ :/,^;S-V-NWTQSF@##O_  H\VB:;:V-\;>_TZ9;B
M"[9-^Z3!#EQD9#[GSS_%6KI5G>VR3R:A>+<W,SACY2%(XP  %1220.,DDDDD
M^P%V61EAD:)0\B@X4MC)],]JRO"VOCQ+X:LM9\C[,MTI81%]VT;B.N!Z4 8N
MK>#M0U#3?$.FQZC;1VFK2F5=T#%XV(0')W8(^3C@=?:K=_X7GU;5[JYOI8#:
MW6F-ITL48.[#$DL"?<\"NHHR!0!@:)IFO6LD U;5X;N.WB,:>3 8VF/&'DRQ
MY '0<9)/IAMWH5W<>-K#74FA$-K;26YB(.Y@Y!)SVQM'%=!D>M!8 $D\4 >?
M^)-+N=*T_P 6ZC-<VRQ:P8D7?&66$[5A&_/&W');^$>N*;H\CRW,MI9-H5\U
MY;- ]SI\SR-"JJ=F]B6^3G &1R>.^.ZL;^VU.QAO;242V\R[HW X8>M3JJJ,
M*H ] ,4 <MI_AO4+*7PR6EMF31[)K23!;,F51=PXX_U8./?VR;OA/1[[0=&7
M3;N>WFC@+"%HD()4LS9;)Z\@8'I[\;N11D4 <5<>"]0FM]<M$U"".&^OAJ-M
M)Y1,D4X,;+GG&T&/ZD-VQSL6ND7DOB6/6]1:W66&S:UCB@9F'S,&9B2!UVJ
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MRECC1U)Q&,KD8!ZL3UZ]J;'?&"#PE>W$&I1Z=:V#6\TL5FQ:VN-D0#,K(3C
M=-P'!)&>37J&!1@4 <IH6H:/H-GI^EP)?0PWL\OV3[1"XW$G<2?E&P$L< XS
MV%3^+Y?*&D,;=W OE;SQ&\BVQ"/AV5.6_NC/ + GI6S=6-O<3P7%P6*VQWHA
M?"!O[Q'<CG&>E6E99$#*0RD9!!X(H \H%M;S:3HMM>6LS-!XEN'<3VS(?*:2
M8Y/R@;2&3/;D ^E5[J*>+_A(([:SFDTP>([>XNX(8S\]KM7S&4 ?,NY1G'4
MU[!@48% '(>'KB"?QWX@GMXW\FXMK-EE\EE60@2 G<1@G!7_ "*S];-TWQ)F
M-@<71\.7$,#G[HG,BLBYZ9XSCTKO4=&+!2"5.& /0XSS^!%.P* /-]-ABFM_
M ZZ=;20:E8R;+V-E(D@C\E_-$F?60+U^\2"*L>&);.:UTFVO+"Z?Q#83R&X
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M] K)L/#&AZ7J-QJ%CI=K;WEQDR31H S9.3],GKCK6M0 4444 %%%% !1110
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MY(GA\Q'2/B,_>!W*"1G/0]* ,Z'QCJ&JMI::1IT!;4M/FNHC<S%1')&R*5?
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M&HZ7<B57F#2SY:(JTQ&!YAW-QC(^89/-5TN)M/:S9S)_Q2EX\6H2.S?O;=W
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MP<@<9 .HVCT%  !SBN>;Q=$^KMIMIIM[=RBWAN@\6S8\4C;0X)8<#!)!P>.
M:23QC9PPQ7DMM<+ITMU]E6\^4IOW; 2,[@I88SC].: .B(!ZBEKD;+Q>ZR^)
M;C4H#!8Z7=>2C97H$0X//)8OQV QS4\'CK2IOMX.X/9K$S+&Z2^9YC;4"%&(
M+%OEQQR1V.: .D6)$.510?84"*-9&D"*';JP')KE]<\67%AH>L3)IEU#>64<
M>U90NTF3A6# X8 YR,YX]P:L:OXSL-$80W<;K=>0UPUNTL2L$!(SEG ))!P
M2>* .A$:!V<* S=2!R:;Y$6XL(UW%MV=HSG&,_7%<Z?%5EJUNL&FQ7=V\]BM
MX1;L(VBB<':2Q9<,<' !SP>E3>"II9O 6A3RL\TKV$+LS-EF)0$DD]3]: -P
MPQ=#&O\ WR*40QAMP10WKCFO-K/6_/75?$FJQ:K'_9>KRVZ?9YEVB-6$8C9
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M#"KV\I,B#S(PB@D\+D@$>A-=%J?BNRTHW@:"ZN%L$5[QK= WD!N1N&03Q\V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %17/_'M)_NFI:BN3BVD_W30!(.E%
M Z44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !4-U_Q[2?[IJ:H;K_CVD_W30!***!THH 6BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BC-%
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MZK@ ;>G''6@#UVBO&?!-U=:[):ZM-K,%IJD.K2B_MY78R2!SM$ 7^Z%V[1R
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MC'_%\I.IQX<49/\ U\&NZH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ANL_9I,>E35%<_\
M'N_TH D%%*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"T;0)M(U?5[L7BRPZE<?:
M3$8<-&VU5P&W<C"^E:::9I\<HD2QMED!W!A$H(/KG%6J* *TFG6,TK2RV=N\
MC#!=HE)/&.N/2D;3;%K4VIL[<VY.3$8EVD^N,8JU10 V.-(HUCC1411@*HP
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MTQ[73AJ=I;:C>V<"1"[N(%:1BH W9.2,D9_&MNB@"O>6-IJ-JUK>6\5Q;O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-
MU_Q[/]*FJ"\.+5R<].U $PHI!^-% #J*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *@N_\ CV?Z5/4-U_Q[/]* )0**
M4=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "H;O_CV?Z5-4%V ;5P: )QTHI,44 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-W_Q[/\ Y[U-4%V?
M]&>@"<=**044 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !4%W_Q[/4]079Q;/^'\Z )A10"/6B@!:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN\?9VS
MTX_G4U0W7_'NWX?SH EP/2BEHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *ANO^/=OJ/YU-4%T,P'ZC^= $]%-V
MCTHH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !4%W_Q[GZC^=3U!=?ZD_P"\/YT 3CI12"B@!:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ANA^Y/U'\Q
M4U077^I_X$/YT 3"BE'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J"Z_U/_ E_F*GJ"Z_U/\ P)?YT 3CI10.
ME% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !4%U_J?\ @2_S%3U!=?ZG_@2_S% $XZ44#I10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 45A1>*].EU#[$PFB<W;V2NZ?*TRKO* @G^'D9P#CUXK9%Q"T9D6
M5"@ZL&XH DHIID0,%+ ,W09ZUF7GB&PLM1%C*[></*+[5R(Q*_EQY_WFXXS[
MX'- &K12%E4\D#-9ZZU;/JKZ=&LLDD9VS.B$I$Q7> Q[97D=N@SD@$ T:*S-
M-UZQU67R[9W):(31ED*B6,D@.N>HR/U!Z$9TZ "BBB@ HHHH **** "BBB@
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M^IX/2@"S14<EQ#%+'%)*BR2DB-68 O@9.!WJ2@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M0W/^K7_?7^8J:H;CE%'^VO\ ,4 34444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %0W'W$_ZZ+_ #%35#<C*)_U
MT7^8H!DU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !4-Q]U/^NB_S%35#<<JG_71?YT 34444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1R(7V^
,S T44 24444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex10-4_009.jpg
<TEXT>
begin 644 ex10-4_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HW_
M -:/]T_TJ2HW_P!:O^ZW]* )**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "F'_7+]#_2GTP_ZY?H?Z4 /HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *8?]<OT/]*?3&_UR?[I_I0 ^B@=** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HV_U\8]5;^E25&W^N3_=
M;^E $E%':B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J-O]>G^ZW]*DJ-O]=']#_2@"2BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)SBXCXS\K
M?TJ6HV_U\9]C_2@!X;/:BEHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *B<_P"D1#V/]*EJ*3BXB/;#?TH EHH%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%10F7;B;;OST7L* ):*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%5K+4+/4H6FL;J&YB5RA>)PP# X(R.XH LT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1O\ ZV+_ 'C_
M "-25&_^LB_WC_(T /'3\:*!THH 6BBB@ HHHH **** "BBB@ HHHH ****
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M[L2KVU"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "HY/O1_[Q_D:DJ.3[T?^\?Y&@"044"B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]E$T#!)5:9<HQ&0",\''- &K16"WBG3GU34M-%U%!)96ZRR3RGY%W!CSG P
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M:K9[K-29W\P%8>N"W/3@_D:;::M;0:%97=]J=M-YL:XN8QM69B,Y4<]>3@4
M:U%5/M@N]+:[TQXKG?$7@97RCG''/IFN4_M7Q:OBJWT)[W11)+8M=M*-/E(4
MA@NS'G\]>O'THZV#I<[:BN/3Q-?Z?XBM[/7YK"TM_P"RC=7##Y5242*I^8L?
MEYX'\ZZ.?5]/MK.*[EO(1;S &*0-D/D9^7'7CGCM1YAUL7:*R7\4:!''O?6;
M$+Y2S9\]?N$@!NO0D@9]ZG36]+>_^PK?P&YW%!&'Y+ 9*_4#G'6@"_167_PD
MFA^=#%_:]B9)Y&BB43J=[KU4<]1Z5-=ZUIEA<I;W5]!#*Y4!7?'WC@9],G@9
MZT 7J*SWUW28EO&DU"W469 N<N!Y.>F[TJCJ'BO3;/4TTU[R&&22S>Z^T2']
MW&H("D]L')/7M0!O45E6>K6T&@V5W?:G;3>;&H%S&-JS,1G*CGKR<"GS>(-(
MM[*&\DU&W%M,I:.0/D.H&21CL.Y[4/0%J:5%5Y)3/I[36<\?SQ[XI<;UY&0<
M9&1^-<WX2\4->^%-/U/7K^RAGOG98E \H$AB HRQR>,T=P\SK**H6FMZ7?VD
MUW:ZA;36\!*RRI("J$#)R>W'-26.J6.IK(;*ZCG\LA7"'E21D9';CF@"W145
MU<PV=I-=7$@CAA0R.YZ*H&2:Y>U\1ZH]YI9GLW^SZC')<*(K=F\M0H*1LV<*
MQ!R2>,\#UH_K^ON ZVBN$D\4Z]-9>'Y;=+6TFU*[:UGCO+*3="V&/ \Q2<;<
M>_7CI6AIOC!(]0UG3M>EM+272WB5KK=Y<4HD7*D!B=I]LFG;^ON_S0?U^?\
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M1);=[1YO)E78J^6Y1@J$,O5NQZUVNBZ/:Z,;U+:YFF-Q<M<S"5U8J[<G& ,
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M^#6Y_P#CE'2W]=/\A];_ -=?\S'O8GL_%.BZPEE.^G?9987$-L[/#(^PAVC
MW<A=I...^*P[G2;Z'2)+N*QNC;'Q)'J$=NL+&5(-PW-Y?WADY;;C//2NT_X1
MFR_Y^=6QZ?VK<_\ Q=!\-6 &3<:H /\ J*W/_P <IWL[_P!;W%;2W];-?J<-
MXD_M&^DU;9I&IP'[5:SI%;VA87*J8R7=P#EE (V*>,=#V@)M_MNJ6MW'J5KI
MD6LC43.VG33Y*[68>8@*@;@>O*CK7?CPYIS)O6YU(KUR-6N<?^C*R!\.= )+
MQW&IK:."S6RZE+Y+9Y)/S9.<DGFDM/Z_KL#U,6]LXFUO7;75M&UC4K;4I$GM
M7LWF\F5-B@(Y1@JD%>K=C4EU:3#4/&Y;3+L^?I<,4&VUD<2,(V!5&V_/@LO3
M^AKJ;;PQI(MXS;7&H&#:/+\O5;C;M[8Q)TJ5_#VGQ(SO=:FJ*,EFU:Y  _[^
M4-:6&F[W_KN<[&ES-XGT)HK2\C']ARPF9[615B=MA4,2N%/RG@\_F*7PD76S
MTC3+WP[=+J6F QO<30[8X^"&D20C#[O0<\\XK>B\.Z9/&LL5WJ,D;#*LFJW!
M!'L?,IW_  C%C_S\:I_X-+G_ ..4V]?Z[M_J2EI;^MK?H;5<EX&C;S?$=R/]
M1<:Q,T3=F "J2/Q4_E6E+X6L98FC-UJR[A@E=4N<_J]6M(T2RT.W^SV*S)#@
M 1R7$DJJ!G&T.QV]>V,TD/I8T:*CDN(80QEFC0(NYMS 8'J?:I.O2@ HHI"Z
MAPI8;CT&>30 M%%% !1110 4444 %%%% !1110 4444 %%%% !4<O6+_ 'Q_
M(U)4<O6/_?\ Z&@"2B@=!10 4444 %%%% !1110 4444 %%%% !1110 4444
M <NWB746\0ZEIL.FV_E:>T#S3-<D?N7#$MC;]X;>GZU!I/C&[U.^T_;I%P;"
M_5F298)1Y(QE2Y9 N&'H3@XZ]:T;3P]-!XDU?5);N*6#48HXS;B J4" @?-N
M.<@G/ [55T/PMJ.C>1:MK\D^EVK9M[;[.$<+_"CR _,HSTP,X';BA=+_ -;_
M / !^7];?\$R?#FH2:/X5E-K;P^7_:UU&SRN(XK>/S7R['T&,?4BB]\7WU_X
M<TZ\L%BAEEUF.QE(<E2!+@E3C.&QW[$U;3P3>1V5O$FL1^=;ZE)?HQM"8V+E
MB59-_."QP<C'%./@>?\ LJ2S_M?,HU,:E!,;8?(^[<0R[OF&<]Q372_E^G_!
M!^7G^O\ P U'QE>6]S>1V.E37WV"1(ITAAE=I'(!8(50KP&'WB,^W6JGC+6)
M-4\.>);.VLXI+6RM"+AYV(/F%-^U1CJH*G)[\>]:1\*ZG!JEU=:=XA>UBO@I
MO(C:JY:0*%,B-D;&( [$>U,OO!US(VL1V&K+;VNKP[+F*>W,Q#[-F]6WK@D
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M$\/W6E:[K.HS:A'<)J4B2>2MN4\HJNT<[SG@#/ Z4FE?Y?Y?\$=[+Y_Y_P#
M,J/7?$&GF#2)K*VN+Z'2H[J6XDN"%9@P60-A>/XB,9S[4[3/&EU?W-E(VDW
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M<-YJ>XZC=)=Q/!!Y9MI$"[2,LV[&Q?3OZ\)>?];7_4;\OZWM^A=DUC6[6WU
MW&CH\EOY?D213?NI@W4DGE0G)/'0<5@:QKT?B+P+XN@D2WD^PPNGFP/OCE_=
MAU9<_7].M:U[X6U/5-(EMM0\0-+=,T921+8)"-C!OFBW'=DCG+<CIBHY?!UY
M-:>(89-8C+:S&JNWV3 B8($) W\C X&>/4T/K_78$[-,WT@BN="2&:-9(WM@
M&5@""-OH:X7P=X/T74_AOITAT^VAOW@8K?11A)T?<V&WC#9''>N]%M=)I"VL
M5Q$+E81&)FA)3<!C.S<#CVW?C7/Z5X5U73?#46@G78OLL:&/S8+(QS%"22 Q
MD8 \GG;1+5RMU_S9,=%&_3_)&)HGCO4KGP_;(MJ;[4X;3S;EEBE97;<RJH\M
M&P6V$Y.!]>W0VOB6]FU[3+2XT[[+9ZC9M/$\Y*RI(H!:)E(X(!S^!J!O!3:=
M>V]SX:U%=)$=LMK+"UOYZ2HI)4X+ A@2><G.:O:QX8&KZ):V#7]PEQ;R)(EY
MG,N1PQS_ +2EAQTS[4V[Z_U_6S!+I_7]=#,3QK/-#:1I8C[5=^=+$%6251 C
M;5<A%+?-E<<8YZ]JJ7>H2:S/X-U&ZTZ:QNO[2=&AG0JR?NI <9 .TX!' XQ6
MYJ_AF2ZNM.O=(U#^S+RQ1H8W\@2HT1QE&3(X^48YXQ3+CPU>7,FCRR:OYDUC
M=FZE>6#/FDJR[5 8!% 8X'/;KSD5KKU&]OD5;CQE/#ID^MI8QOHUO<F"1_,/
MFE%?8T@&,8#9XSR!GVIEUXPU/[7KMO8:+%.=(,;NSW6WSHV3?\OR_>QV/'OV
MJ4^"W&GWFD)J*KHUW.TSVYMR9%#-N=%DW8"DY_A) )^M9MK;W&H^,_%=K8W=
MM;QNEO%)O@,A(\L@E2& R,XYSV^E3K;3>WZ+]?P'IOT_X/\ D2CQW?7D.JSZ
M;IEL\%C:0WH>:Y92\3QE\8"'#<8QT]ZTK+Q3<3ZE9I<V4<%C?63WEO()=SJJ
MA20ZXP#AQT)Z55@\"O9Q:S!:ZC$EOJ%C'91HUJ2851"@).\;C@GL.<5;M_"M
MS#=:+))J,,D.G63V;Q_92#,&"@G.\[?N+Q@]_7BG;I_6_P#P!+S_ *V_X)6T
MSQA>ZG>6!BT>X:ROT=HYA#,!#QE#(Q3;AAW!.">_6HM+\9ZC?PZ->2Z5!#9Z
MA=/:,5N2SI("X! V@%?D]<\]*N:)X7U+1UAM/^$@DFTRU)^S6_V<*ZKSM5Y
MWS*,],#.!SCBJ]EX,O;+2=(L5U:!O[/OVO-_V,CS,ECMQYG'WVYY[<>II?\
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MJZ:X+FS/[T'=\N/,^7AVYY[?CEZ%IC^(K;Q)8B[@33;C5IO/C$!,C+E?NON
MPP'7:>_6GI?^NZ_X(/\ K_R;_@&OK?C&;1[XK);0"W$T,:!YL2SJY4%T4#[J
ME@.>I!Z4W4?%NJ6UYK]M:Z5;2?V1"EPSR717S(V5F. $X;Y3QT]Z;J7@BYO9
MM4\G6!#!?2PSA6M0[1M'MV@-N&4^7[N!]:GG\)WD]WX@G_M.$?VQ:I;8-J3Y
M6U2N[[_S9#-QQV].5T&K7U\OSU_ M+XBN/\ A(K*REM(X[&]LS<07!D.XL,$
MH1C&0#GKTJO!IS^)IM"U^[ABMI;5I)HO+=F8HW"C/ PPP3D'T%9^N00ZA#IW
MA43SOJ]N87-Q!;R1JD8^5W#<@93<N-Q/S8KN$18T5$4*B@  =@*>FZ[Z?U^!
M*O:S[:_U^)S&D^*9]6UN6TA@MO*AN)8)XS-BX@V9VNR$?=8CC'J*T];U@Z4E
MI%%")[N]G%O;QEMH+$$DDX.  "3]*S8_"D[:W8ZG=W\4TUE-*Z2I;;)71MP$
M;ON.5 ;TYP.E7O$.@G6HK22"Z-K>V4XN+>;9O ;!!#+D9!!(ZCZTNB_K^OZ\
MA]7_ %_7]>9Q]EJUUX?D\::BEA!+-#?P&2&.0JK;HT!8<=3G../K71VVN:S_
M &[?Z;>Z?9Q".V:ZMGCG9BR!MJAQMX/KBJ5SX+U&[M-<CDUN!9=6>)V9+$A8
MB@4<#S,G(4=^*T[[P_?7.KV^I6^J)!,+0VEPIMMZRJ2#E?F^4YSUW=:6MOE^
MC_6P=?Z[K]+E*S\83:A8>'&@M(X[O6E9U61R4B"KN;D#D] !QU]JTO#&LW>N
MZ;+=7=E%:E+B2!1',9-^QBI;E1CD' YKC-:T:31=)\.:)-JS006.^0W\FG&2
M$D#:JL W#?,<?,!P:ZWPB]U_9TL$QADMX7"V\\-FUJLJD D^62>A)Y'!JM-;
M"U5K_P!;F-)X[U!=.OM3_L1!9:;?26MX?M.7"JP&]!MYZY(./;-:5UXGO&&K
M3:98Q7-MI7$V^4J\K!0[*F 1PI')ZGCCK6'H>FR>(K7Q)8B[@33;C5IO/C$!
M,C+E?NON PP'7:>_6MZ3PM<17.JMIVHI:V^I@&>)[?S"K;=I9#O&"5 Z@\C/
MM4Z\OG;]%^I6E_G^O^17?Q?>W>J06>CZ=!<BZTY=0MY);@IN4LH(8;3CACW/
MX5F-KFNRZ#XTN@]N&L9YXX<LWR!(UZ?J?J:W+/PJ=/\ $5CJ%K=QI:6>G_8$
MMC"2Q3(.=^[KD#^'UJ"?P?<M:^(;6WU810:PSOM:V#&)G4*QSN&[@<#C&>].
M2332\_ST_ (NS5_+_@E/29/[/FTRSL-+L$UFZT]9)I5D81B%,!2V%RS$MCIZ
M\\5!=ZJFN:EX9N)+98+RUUF6TG3=NV.L4FX X&0<*?RK8/AF]BGTJ^MM0A74
MK&V-J\KVY,=Q&<<% ^1R 1ANN:B7P;(D]A.FH1B:'47U&Y8VY(GD=2I &_Y
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M-<']XT<:Y5QM(4$'@@M].U=)-I.I7MI>1WFIQF2>W>!!#;E(H]PP6*ER6/\
MP(?0<UG)X0O(ET(1:K!G2;.2U!:T)\W<@3=_K!C&T<<]^:EWLU_6TOUL5II_
M7;_@E>S\41V^B:#;Z=IR137MD+E+>..1XX(P!VC4GJP X'?Z&EK&M:KJVF>&
MW_LU;0W>I)%<6EZ'0[EW$=1G:2N1D<\<5HIX+O;>PT3['K2V^I:5";9;H6FY
M)HCCY6C+_P"RO.[J*GU'POJ5^FDDZVIFL;S[8\DUJ7\U^0  '4(H!(QSVYZY
MMV<OG^O^1/3Y&G)I-C9^'KRSALX8[>2.1WA493<P);@]LUQG@C54\+Z5>Z)?
M22/%96J7]FS_ 'I()!G:/4A\K^(KT&^@EN;">"&5(I9(R@D="X7(QG;D9_.N
M=?P3;W4N@3WUQYT^DQ^6S)'L6X4 ;0R[CP&56QD\BI6[_K^K _Z_KS.:T*]_
MX1R^\6:GJ,8NM3:]@A!5,L7D1"(P0"=H+8X!X'0FN@3QE<V]KJ+W^DW"-;-$
MMNXBDC2Z:0A553(H(.XX/7UIDO@:>[_MS[7JRDZE<1W,3P6WEM;21XV$$N=V
M-J^G?UJQ<>%+_5-)GM=7UV2XN&V&&:&W$*PNC;E?9DY;(&<GH,#%"V7R'U^\
MY?6+N:Q\0^)[R]TJPNG3187GM_,/ERKO;.25Y(''3G Z=NPN-<N_M4FG:390
MS75M9K<RI))M4;L[(UP.IVGGH,#UK+U/P7JVK/J$ESKMMYM[8"QD,>GE5"AB
MV[!E)SR>^*OS^&+]=4AU33M86TO?LR6UT6MO-CG5>00I8%6!)P<GKWHZ6_KJ
M'6_]=/\ @_U8@UWQ=>:/9"[DT^*W1;,7+)=3A6=^284VYRP ))Z=*25HKCXA
MZ!>(@5I]+N#DCG&8B ?ID_G2ZAX*N+R>Y:/6I1'=:?\ 89O/A$LF.?F5LC:3
MNY&,'VXJ[;^'+J+5]'OY-1CD_L^S>U=!;$&7=MRP._Y?N#C![\TUO?\ K9_\
M 3VM_73_ ()T-%%%(84444 %%%% !1110 4444 %%%% !1110 5'+UB_WQ_(
MU)4<W6+_ 'Q_(T 244#I10 4444 %%%% !1110 4444 %%%% !1110 4444
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M>0\#CN>:;5G;Y?U\M24[I/Y_U\S;HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^NJ?Z(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:Q'N?4_[0$LEIG'[P2;<!Q_$.OIVJ]<:>NAZWJ/B:74'2TE@C^U0+;ER3&"
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MLR/,R6.W'F<??;GGMQZR-X,D_L^]TA-05=&NYVF>W,&9%#-N=%DW8 )S_"2
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MREN#MV[L\9V[@,^IJYI<VGG^I,=M3K@RE0P8$'H0>M5-0U6STS2Y]2N9E%M
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M0]!Z<]>E6_!]_!+J/@R-KE6F32;F)E9OF#!HQC!YS\I_(^E7;WK?UU%?2_\
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MN3>VYZP+B%I%C$T9=EW!0PR1ZX]*DKR728-(%X-/U"^OK?6K+4R\5E;Q1J[
M.1'L.S<8_+V@_-@ 'H*]+TW6M.UAKI;"Z6=K28P3@ @HXZCD?KTHW5T/9V'6
M6JV>HW%Y#;2AWM)?)EP1PVT,<?\ ?0'US5J.>*4L(Y4<J<,%8'!]Z\TMS+#I
M_CRSTU"FL&ZGEB2-")-A1,$''?G'J>E7K%M-N/$GAF?PVT&U;>1+U+<CY8=G
MRB0#H0^,9YSGWI+6WR_%7_X /2_S_3_,Z6]UY[/Q;IFBFW0Q7L$TOG^9RIC
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M+?3WTVWEO)+Z&2>&$,J-M3 8?,?O G&/KZ4/0"[KNB2:RVFE+S[/]BNTNO\
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MF8*?]8S%6&<@@CIWH7Z@_P!#ME4(,*  .PI:Y76/'NE:-<W,<I#K:,BW)65
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M1110 5#<G"K_ +P_F*FJ"Z_U:_[P_F* )Z*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#B[Z6YC^*(-C!!-<?V/ADFG,>5\[@@A6Z?3O18^%=2TRZ
M\/FV>UDBLI+B6[+R,K$S$DA!M.0">Y&<59USQ%I^A7=]J$OA^\G-DBBXOX(8
M?E# 84,SJS=1T!ZT^]\:II^G7MW=Z)J<'V6&.8I)Y/SH[%005D8<$<C.?:B/
M2W]:O_,&KO\ KLB.30-6M+G7%T\V<MKJQ\P_:)65H)"@1B %(<8 .,CT]ZRK
M:SET7QS9:=ID4-S):Z"D)$\QBW*), \*WIZ=Z] 4Y4'U&:A^Q6GVPWGV6'[4
M5V^=Y8WX]-W7%"T_KR:_4-U_7E_D<;H7A#4O"U[)=Z<]K=-=PD7<4\K1@2;V
M<,A"MD?.1@@= ?:FOX(G_L:STN2"PO8(TFD=Y)'ADBN'?>'B958@ DCMVKH+
MWQ38Z;XAM-'ODFMI+P'[-/(%\J5AC*@AL@\CJ!GM5B;6TA\00:0;.Y,DT+SK
M.-GE!5(!S\V[JRCIWHW7]=/\@V9SD7A[Q+I=];7UC>6-Y<2645M?B]9UWO'G
M$BLH)S\QR#UJT="UNSUK^U+::SO9+FR6VO$G9H1N4DATVJW'S$;2/3FK(\8P
M/!'>1Z=>2:;+<+;Q7B;"KEGV!MN[<%W'&<?TJU+X@#7]Q9:=8SZA+:X^T&%D
M58V/(3<S#+8YP.G<BAZ[^?\ 7X@M/Z_KL1>%](O]'\)6FE7<D N;>(QB2 EE
M'7!Y K"T7PGK5CJ^DW]U_9C2VJ317<Z.[27._'[PDJ/F^4?*>!V/:NMTG5[3
M6;0W%JS#8[12QN-KQ.IPRL.Q%7J;WN+I8Y_PCHU_H&E/IUW);211RR- \);<
MRL[-EL@8/S8P,].M86I>$-:GTOQ-IUM+8-#JMR;B%I'=64MLR&PIP!M/3.<]
MJ[QB54D*6(&<#J:S?#^M1>(-&BU*&&2%)&=1'+C<"K%3G!(ZCUI?U^7^15_S
M_P _\V86J^%KW6=6OGN&MXK.[T@6&Y)&:1)-Q;=MV@$9/KVK1T*'Q,C1+K<V
MG".&/;_H>]C.W0,VX#;]!G)/7C%;^:YN]\8PVEAKMW_9]TXT>7RYD!0%AM#;
MAENF&!]?:B]OZ_KN*W]?UZ#KC2-1;QPFLPK:M:IISVNUYF5RY<,#@(1C@#KW
MZ<5B6?A;Q#IMIH=S9R:;_:6GP26LT4DKF&:)F!X8)N# @'[M=O9W*7ME!=1@
MA)HUD4'J 1G^M9QUQYFF^P:?/=QPW"P-(C*JD[L.1D\A._OD#H:=FG;^MW_F
M%[J_];&9J6@ZQKMI;Z=JT]HVGREWOUA+*S?W(TX^Z#@EB03CH.E5)O#WB.]\
M+Z?9WT]A)J6G7D,\<HD?9.L;9&_Y<JQ'7 //UKIX-4BEU2?371HKF)1(JMTD
MC/&]3Z9X(Z@_4$WLT@.?\6:1J&N^#[K2[<VOVRX159I'9(P<@DC 8]N!5?\
ML;5O^$O?6!'9>2=+^R!/M#[O,W;O[GW<\9Z]\=JZBBC^OPL']?C?]#A;3POX
MATRST&YLI=-_M/3K9[.:*61_)FB)!X8+N# J#]VKE]HGB-K[3]:M;K3Y-4A6
M2*>"7<D#1.0=JL 6RI4<D<\].E=3<W,-G:RW-Q((X8D+N[=%4<DU*"" >QIW
M>X')Q:%KJ^)[+6Y;FQDD^S/;7,>&41J7#@1\?-@#&6QZ^U9R>$]='AZQLF_L
MXW%OK/\ :#8N'V>7YADV@^7G=EL=/?/:NT>ZF74XK86<C0/$SM<AAM1@0 I'
M7)R3^%6:$[?UYW_,'_7W6_(\_P#$]G=6&F^*KB\.GQP:H\,=JTDC,%;"QCS/
ME 7D [LG'X58\*7%U;ZVUO>)IES<74.6NK*_>X=5CX4.&48'S'&.^:[9T21"
MCJ&5A@@C((J.UL[6QB\JTMH;>,G.V) @S]!26@/4Q)])U*T\47&LZ9]FF6[M
MDAG@N)6CPR$[64A6SPQ!&!61)X1U2UTWP_:6#64IL+\WUP\TSQ[F)8E4 1N/
MG/7T'K7<44+3^OF#U_KRL8_BG1Y=?\+W^EPR)%-<1[49\[0001G';BLZ'1]:
M/BNWUFX6PPFF/:ND<S_ZPN&&,I]W@#/7OCM6OK>LQZ'917,L$LJ27$<'[O'R
MEV"@G)Z9(Z5I4?U^%OR8>7];_P# .!T_PGXATBRT.XLI=-.I:?%+;312R.89
MHG;=PP7<""!_#796":A'8YOI(9;QB6(B!6-?10<9P/4\GKCM5SBBBX>9PNC:
M)XJTG2]3L?LFBR?;KJ>X$C7LI$?F'."OD_-CZC/M4NG>#;[0%T*73[J*ZGT^
MV>TF6X=HUE1R&R" Q4A@,#!XKHH=:CF\27.BBWE66"W2X,K8VNK$@8YSU!ZX
MK3H7=?U;0/+^M=3@_P#A#M674?MA?3[B.ZN)KB[LIG?RE=@H1E^7YRH7^(#)
M)/%2Z3X9US31X7C8Z>\>DB:.<K,X+JPV@J-G7')!(]/>NWHH6@/4XO4_#&L,
MWB.#3S8S6>MQDG[3*\;02&/82 $8,, 'M6Q=:')JG@Q]$O9$CFEM! \D.2JM
MC&1G!(R*UC=0+>):&4">1&D5.Y52 3_X\/SJ:CI;^M!WUN<Q'HVK7NH:/=:J
M+)#I:NRFWF9S-(R;,G*#:,9..>3[<R>$=)U32+?4(]26T!N+V6ZC-O,TF YS
MM.Y%Z?K[5T=%._\ 7XDVZ'*RZ9K\7CB?6[:VTV6U>S6T"27DB/@.6W<1$=\8
MS^-.A\.7K:AJ6MWLEM/JMQ:FUMHURL4$?)V[L$G).2V/H*ZBBIMI;^M2KZW.
M(\.>%]:TK5M'N+O[ T-GI/\ 9\IBG<L6# A@"@!'R@<D=?;FSIFB>(](GGL+
M2ZT_^R'NGGCF?<;B)7;>R;<;3R2 2>,]#TKKJ*IMMW_K>_YDVTM_78Y/2M#U
M_1I[BPM+JQ_LF2Z>X29MQGB#MN9 N-IY) ;/&>AJE/X,U.0:Q%'=6J1SZBNI
MVDGS%A*"A"N,8"_*1D9//;'/<T4EI_7I_DA_U^?^;.3O= U34[N\U&X2RANV
MTV2QMX8YW=,N<LS.4!'(  "GOZT^?0;^[\,Z3I5]9Z9>+"BQWL,TC;'"H5#1
MOLR&S@]!WYKJ:JQW,[ZG-;-9R) D:NER6&UR2<J!UR,#\Z/+^NO^8>9RWAY]
M;T75K/P]=26UY:"WED9UE>2:W^<E%=FQE=I"@GDD'L*T->T?59=:L-9T22T^
MUV\;P2PW998Y8G(/WE!((*@]*V;^ZGM+=9+>SDNW,B(8XV"D*2 6Y[ <U:HW
MU Y74M!UC7;2WT[5I[1M/E+O?K"65F_N1IQ]T'!+$@G'0=*J-X?\3S:+I9FN
M]/.M:3/O@F+.8KA-I0B3Y05)4\XSR*[6BC^OZ_K8#D]1TOQ-J-M822OIGVF#
M4(KEH5E=8TC0<JK;"68YZD #^<M]HVLVWB=]:T5[%_M5NL%S!=LZCY22KJ5!
MY^8C!_.NGHH YA]%U@^*-/U(W%K+';V$MO+*Q*NTCD'(0*1M!4?Q=_;G*M_!
M^LVYNI[*:RTBYNK%XIQ92NT4ER<8E"%5"8P>1S\WMSWE% 'F]SX"U>Y2YVQZ
M3:^?9PQ%(7D(\V.7S-Q8J"V[G)(R/>NE&CZA=:S)K%XEK'<)9-:6\$4S.OS'
M<S,Y0'J .%XY/.<#0TS6H]3U'5+-;>6%]/F6%S)CYR5# C!/&"*EEU.--6BT
MZ*-Y9V3S)"N,0IR 6/N00 .3@^E#U5N_ZW_0%I\O^!_P#D[3PMK^EV/A^XL)
M=..I:;:M9SQ2R/Y,T1P>&"[@05!^[77Z<E\EH/[1EBDN68LWDKA$ST5<\D#U
M/)]NE58=3OI/LN_1[B/S9Y(Y,R(?)5<X<X/(; Z>M3Z?JD5_+<P;&BNK5]DT
M+]5SRK#'52.0?Y$$4[MBM8Y'4_"FOW-MJEC;R::;:YU%+^&221PXPZ,490I
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M]6&:8=1:P0ZJELEYEMPMF8IC)VXW<],9]ZN444 %%%% !1110 4444 %%%%
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M_>48X/N*4=+?+\QO6_\ 70X(:FS>(=,O;6\<PS:U+;R337!#R#:X,?E]!&I
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MK="K..C$8Y/OUJU<VEM>VKVUU;Q3V[C#12H&1AZ$'@T=/N_)?Y#Z_?\ F_\
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M_P"T0,G\:BN-#TF[GEGN=+LIIIE"2226Z,SJ.@)(R1[4+=/L#Z^9F^.(X9_
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M6"XM;HHC/LD/*-D8."#SC.#UK3DN-:M-7UBRM]3:YE;2UNK;[4$58IBSK@$
M +P.#GZT=+_UM<=M;?UT_P SM*J:GJ5MH^F7&H7C,MM;IOD94+$#Z#FO/[76
M[_[?:QG4]3M[@:A;0W-A>HFY P8-\V,,C%1@@]CZU8U:^N[C0_B%:7%P\T-H
MK) & ^16@#$<#U)ZT/;^O+_,4=79_P!;_P"1W$R6&I01Q7,4$\<J^8D4R!LC
MCG:?3(_.K2HJ*%4!5 P !@"N%0$_$/32UU*D4>A&3;NP@/F)G/L<#/TJ+1-9
MU.77]*@>]N9[6_M+B1KAU14E92I#Q+U51NP-W7T/4MK73S_7_(2VN_+\4O\
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M2]-;4M3A\R"U(<,(?,*'ID#''UKESJ=]8V'B&TEUF7=:7L4-O<S1J\N'6,E
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M6/(;RW8@DJ<@E1GO[T/17?\ 6B?ZC2N[+^M;'H50P6=M;23206\,3S-OE:-
MI=O5B.I]S7GU[XBU?2+:UU8WCW7VS19KQ[9T411R*(R-N!D#YSG)-7"WB.TM
M;NZEU:W^RRZ:\D1%P)9?.5=P>,&)1M(ZCGMBB7NW;Z?\'_(4?>MY_P!?J=W3
M4=)%+(ZL 2"5.>0<$?G7#:'>ZL][X;EN=5GG35=,>6:)D0*KJL9#+@ @_,>I
M-9>ASZM;^ ]/N;-[RZ+WT[7<<,B^>T8DDSY>[J<X)'4\XIM6;3Z?YV!:J_\
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M=7BRPKY;7'R[1DIP,ECA".%'X[MQJ.HZ!JFC'[=-J-MJ$$HF60*3YB1F0.F
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M8X' Z>@IFH>%]&U6\DN[RS\R:2'R)")7421\_*R@@-U.,@XJ=]<TN._%B]_
MMR7">67&=Q&0OUQSCK4-WXFT.PDFCNM6LXG@95E5Y@"A(R 1V.!FC<-CF=:\
M(F75;=ET07UA;VJVUL(M1D@EBY);><@N.F.2>#QS6QIGA2!(K";4O.DN[&5Y
M+7%[,X@5C]W<2-_'&6!XXZ5J1:YI4]Y-9QZA;-<P)OEC$@RB]R?:FP>(=&N;
MN"U@U6SEGGC\R*-)E8R+ZK@\C@_E0OZ_K[P*]_X1T+4]3_M&[L0]T5".ZRN@
MD4= ZJ0''^\#2#P?H U9]4&G@73N)&Q(X1G'1C'G82/7&<U;M]<TN[G>&WO[
M>21%9R X^Z#@D>H!X)'2H[?Q)HEW<6]O;ZM9S2W(+0I',K&0#.<8Z]#^1H7D
M#\RK>>#-!OGN6GLY,73B2>..YECCD<8(8HK!<\#G&:U+W3K34=.ET^[A$UK*
MGEO&Q/(^O7\:KQ^(-(EL[F\34K9K:U8I/*)!MC8=0Q[&M%6#J&4Y4C(/J*.E
M@ZW,N3PYI<EO:0FW=1:$F"1)Y%D0GK\X8-SWR>>]7+&PM=-MOL]I%Y<>XN<L
M6+,3DLS'))/J3FK-% &1_P (QI'VF2?[,^99OM$D?GR>4TF<[C'NV9R >G49
MZU'_ ,(AH/\ :[ZJ+ "[>02N1*X1G'1C'G86[YQG/-;=%&P&?:Z)IUEJ-U?V
M]L$N;HYF8,Q#'C)VDX!.!D@<X&:9;>'=(M+2SM8+*-(+.8SVZ G$;G=DCG_:
M;\ZTZ* ,C5O"^C:W=0W5_:%[B%2J2QS/$P4]02A!(]CQ4=_X0T+46M6N+ !K
M2/RH&AE>$HG]W*$97V/%;=% &4/#>E+?QWL=N\4\5M]DC,4TB*L7]T*&"CZX
MSP/2K.EZ79Z-IT5A8QO';19"(\K28R<XRQ)_6KE% &19^&-(L)(7M[9P(79X
M8VGD>.)CG)5&8JIY/0#&30_AC2'N99S;-F64321B:01.X_B:/=L)X!Y'4 UK
MT4 9-UX9TF\O9[R>U)N)X?(E=973<F"/X2!G!(SU /6B'PSI-O+ILL4$JOIL
M9BM/](D(C4C!&"V&XP.<]!6M10!F:IH&FZU/9S7\,DCV<@E@VSR($<=&PK $
M_6I-4T6PUF.%+Z%I/(D$L3)(T;(PXR&4@CKZU?HH P&\%Z"UOY LY$B^U"\"
MQW,J8F'\0PP^OIGFK]WHFG7NHVVH7%ONN[8%8I [*0"0<'!PPR ><X/-:%%
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M3@=!DG@5H44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "H+O_CW./4?SJ>H+KB GT(_G0!/12"B@!:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHI RL2 P)!P<'I0 M%(S*JEF( '4D]*6@
MHHHH ***165QE6!'3(- "T4UY$C7,CJ@)QECCFE) !)( '4T +134D210R.K
M*1D%3D&EW*6*AAN')&>10 M%'09-1M/"H4M*@#?=)8<_2@"2BD) &2<4*RN,
MJP(Z9!H 6BBCH,F@ HI%8,H92"IZ$=Z1Y$B0O(ZHHZEC@"@!U% ((!!R#T-%
M !112.ZQH7=@JCDDG % "T444 %%%% !112$@ DG '4F@!:*;'(DL:R1NKHP
MRK*<@CU!IU !1110 444CNL:%W8*HY))P!0 M%%-WKO";AO(R%SSB@!U%%%
M!1110 4444 %%%% !1136=$V[F5=QP,G&3Z4 .HHIN]=X3<-Y&0N><4 .HIC
MRQQNB/(JLYP@)P6.,X'KQ3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBD
M5U?.U@V#@X.<&@!:*** "BBB@ HHHH **** "BBFHZ2('1E93T*G(- #J*16
M5\[6!P<'!Z&EH ***;O7>$W#>1D+GG% #J**8\L<;HCR*K.<("<%CC.!Z\4
M/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H+O_ (]V^H_G4]0W
M7^H;/^>: )-_)&#Q12CI10 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M+U+C^T;LW6U83'Y9(QC.XYX ]*W:71#>["BBB@ HHHH **** "BBB@ HHHH
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MEA<R8^<E0P(P3Q@BN+FEETM+/2SK_P!KL[K5Q%/+"&06Z,A<0AR['!8 ?>R
MV/2M?PA#%:>)_%=M&W"W<)52Y8@&%?7G%-?U^'^8/3^O7_([&BN$CM9;SQOX
MDC-U>LMF+6YMX1<N%$FUSC&?ND]5Z>U9WAK?J46CZJ_B>,7-PKQW-M&C^9-(
MRG<C?O#M*$$@A1@#L*72_P#77_(;T_KT_P STRBO)]-CU!?"GAK5_P"TM1FU
M)[Y;2;=<N1+$TK*RD9QD#G=][CKQ26DEU:_#N'7/[2O?M#3&TGN)9WD6* W1
M#,1N'('&[.<=Z=OZ^[_,7]?G_D>LT5YW+:3P6FI6UAXGM)GNFMWAMEWK$A+
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M9)KG3;.:6-0J/) K,H!R "1P,T\Z7I[:BNH-8VQOE7:MR8E\P#T#8SCFK=%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBLO4/$&FZ=,+>28RW1^[;6ZF24_\!7D?4X% &I16,-1UN8;H
M-"1%/075X$;\0BOC\ZECO=71=USI$9]K6[$A_P#'U2@#4HK/M-:LKNZ-H'>&
M[ S]GG0QN1Z@'[P]QD5H4 %%%% !1110 4444 %%%% !1110 4444 %%!( R
M2 />B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "H;G_4M_GO4U0W/^H;_ #WH
M E'2BA>E% "T444 %%%% !1110 4444 %%%% !1110 4444 +1110 4444 %
M%%% !53^TK4WWV%)0]R!N9$!;8/]HCA<]LXS6-+JLFM>(+K1-/N1"EAL^WRC
M_6?.,JD?ID<ENV<#GD:8.E:!9A#);64 RWSN%R>Y)/4^I/- #YK>\N'^6\-M
M'Z11J7S]6R/T_&LS2DU"/Q!=Q#4'N]-CB53YT:!EGR20K*J@C&,]>3]:NZ=J
M]KKJ3/83)+;(QC,R.#EAU  Z?CCV]:OV]O%:P+#"@2-1@ 4 2T=**Y#XC>+/
M^$4\+2S6_P VHW)\BT0<G>?XL>@'/UP.] %WP_XE/B#5]:A@M<6.GSBVCNMV
M1-(!^\ '^R<#\:U+S5]/T^ZM+6[NXH9[M_+@C=L-(WH!7-:4MM\// =A9SJ9
M;L*$6&/E[FY?DJOJ2Q//8#VKF/"UA<^(/BE?:GJ4PNFTB,1NR_ZM+AL_NT_V
M4!8>YYH ]:HHHH **** "BBB@ H-%!H 2BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *"0!D]**Y_P 9W$L/AN:&!]DUW)':
MHP_A\Q@I/Y$T/R!>9GIJU[XOOI[329'M='@8I/J"'#S$=4B]!ZM^5=)INE6.
MD6WD6-LD*$Y;:.6/JQZD^YI]A8V^FV$%E:QB."% B*/04Z\O;;3K5[J\G2"!
M,;I)#@#)P*-%L&K)@0<X(..#2URWA29;C6?$LL4JR0M>J496R#^[7D?I72SS
MPVT#SSRI%$@RSNP 4>I)HZ7#J8WBB"-K2RNL 7%O?0-$W<%I%4C\02*W:Y2T
M:Y\5:U#J!#PZ'9/OME88-W)T\P@_P#MZGFNKHZ!U.<EU?7)]1NQIFF6L]C:O
MY3-+.4DE8 %@G!'&<<]Q6SIU_#J=C'=P;@CY!5AAD8'!4CL000?I63IVH6^E
M^%)-3NG(B5IIW/<DR,<#WYP*E\*6L]OHOFW*&.6[GDNFB;K'YC%@I]P",^]"
M_P @9MT444 %%%(S*BEF("@9))X% "U4U+4;;2K&2\NF(B3 PJEF8DX  '4D
M\8JC<>+?#MKN$NMV *]56=6(_ '-<+JOQ1TV?7(1;(S6=JCNDDBD>9,5VKQU
M"C)Y-+R0ST+1-9M]>TU;ZUCGCB9F0"9-K9!P>,^M:-<C'XV\,Z3I\,,5\UP$
M3CR('?>>YR!C).3UJAI/BX>-]>?3(+2>VTV",RSF0X>7D (0.B\Y(SSC'3-5
MN[(GI=G5-K GD>'2X?MLJ':SAML*'T+X//LH)'<52N-+UF]#-?Z\;*W R8]/
MC$9 ]Y'R?Q %:.I7MOH6B7%X8L06L181Q@#@= !VK.*^([ZRS_Q)ECG3)BDB
MDE&".A^89_(5(R#3O#/A>\C:>-8=6PQ5II[@W7S=QDD@&M6'0K"UQ]D22UQT
M6"5D4?\  ,[3^(KA? VH:A87&LK_ &$)++[<ZO+I^U4B90 0L1.[' /&>M==
M<^+-+&G2SV5W!<W/W(K8/B1I3PJ%3R#GU'%/IH'6S)/#6I7.I65T;HJTEM>3
M6P<+C>$; )'K]*VJSM#TXZ7I45O(P><EI)W'\4C$LQ_,FM&FP1Q4*W^OZE>6
M.H:QJ&E7<$C%+6T*1J\6?E=6()<'OSP>PK1CT#7;3_CT\4W$@'\%[;)*#^(V
MG]:VKW3[>_5/.0^9&=T4J':\9]5/;^O>LK4==?PW"LNL R660OVR)>5)Z;T_
MJN?H*6P;C7U#Q)IR[KO2K?4(AU?3Y2K_ /?M^OX,:U-+U2VU>S%S;>:%R59)
M8RC*PZ@@US.NZOKNK6%O<>"KB">*4E7<Q8*_[09\+QTQC-><R2>,Y[B"[U2Z
MNGT\SF)I&NC% V"0<LA& 2,!L4+>P/:Y[S17)?VIKNC:9OET33X;2!/OOJIP
M![DH<UDZ7\0M?UDYL/!\L\><>8+K:A^C,@%'6P=+GH=%06<MQ-:1R75N+>=A
MEHA)OV^V[ S4] !116;-;ZF_B&WGCN433$MW66''S/(2,'Z 9H TJ*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y_U#?Y[
MU+45S_J&_P ]Z )%Z44+THH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@!:*** "BBB@ I"<5E:U-KD8@71;2SF9R1*]U*46,8X. "3S5./P]=7S*^OZ
MDUZ =PM8$\FW!]UR6?\ X$2/:@"CJVC:#X@U1IH=.^UWR#9)<PS-"@]GD4_-
MCT&XCVK*N].\->%9UGN]-BO[AIH4ED=-ZVJNX13E\GJ<XR3]!79W]R;2.&RL
M407,WR0H -L:C&7(_NJ"..Y('>L7Q3H>E1> ]1M[TS"UAC:[DD5P)&=#OW;B
M/O$CT]J ..LO%5KX=\=^(;:RM/M$NH:M;6L5M&P0*0@5WZ8^\?Q([5ZK'?6D
MMY+9I<PM=1*&DA5P70'H2.H!KQ"T\(ZY;^%?#'B+3K$WNJ-=-?W2L<NQ<#R\
MY.2HP">>I)]:TK*#4?A_XZL]<\1S>=#K-N\5[=JOR03E@P!QV 4 <#OV% 'L
M4LL<$+RRN$C12S,QP !R2:\1N]4A\2>/K?7-;E6'0M.MCJ$",>/*#%8R1_>D
M8!@.I 45UEW>W?Q(G;3-/BN+;PRC_P"F7S HUX ?]7#_ +)QRWI69H7@"YU+
MQMJ^IZ[:&#38;M?LEINRDPC&V)B ?NJH&!ZD^G(!HI<W0TF_\?Z_ J-#:M)I
M=DQS]F0CY2>WF/D9/8<5C>#_ !)I'P_\-V-KJTDLNJ:D_P!NO3$FXP^9C:9.
M<],<<GKQ7:>/_#.H>*]!CTNPNX;93<(\_F@D.B\XX]\''MVJ7PYX&TGP_IT]
MN8_MDUT!]KGN0':;V(/;V_G0!L:?K6F:K LUA?6]RC#(,<@/Z=15T.I&0<BN
M,NOA3X2N9VF6PD@=O^>$[*!]!G JO_PJ+PR$*@WX!]+CI^E '>9%+7#?\*LT
M=.;?4=8MV[&.[P1^E2P> ;BTDW6WB[Q"BX^Z]PLG_H2D?I0!VE%<M%H?BFW)
MV>+5F'87.G(WYE66KD7_  E$!8S#2;P # C\RW)/?KOH W:#56QN9[F$M<64
MMI(#@I(RMGCJ"I(Q^1]JM&@!**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K$\6VKW7AVX:)2TUL5NHP.[1L&Q^.,?C6W1U&
M#1Z B&UN8KVTANH&#Q3('1AW!&:;?6-MJ5C+9WD*RV\J[71NXKGTL=1\,7,C
MZ;"U]H\K%VLU8"2V)ZF//#+_ +/&.U:</B31YQM-]%!*!EH;D^3(OU5L&AV8
M*Z/,[1;[P1KU\;:>>W\-M=^1)((Q*8VV@ACD<#YL9]N]>AV.BVURT>H7.J7&
MK(R[XO/9#"/1E15"Y]SG%6=)6SO],N)$$<]K=S2,<C<L@SM_$$"L6U\+:CH5
M^R:'=0-H]P?WUA=LV(\]3&P!Q]#Q1K:W4/,QM9^)TJZHUCX;TPZEY7^LE"LP
M..NT+V]ZV=*\=-K.EBZLO#^JS2="$1-F[N Y89'X?A6=X9UC3?#'ANZT>_NH
MXKZQEF3R&.'ER25*CJV01C%=-X2TV72/"NGV4XVS)%F1?1F)8C\,T6T![G.>
M$-)O=7TZWGUYOW=G<R&&PV8".&/,G]X@]!T[\UTWB/75\.Z7_:,EK+<0)(JR
M^61E%/&[!Z\XX]ZH+JUKH&OZC;ZI<):P7;I<6TLQVHQVA74-TR"H./>H->UO
M2M=TJ?1=-O(;Z[O5\I4MVW[ 3R[$<  <\^E#U2L"T>IT]I=0WUI%=6T@DAE4
M.CKT(-<MXA\7SZ5XNT?1+2W2=KI@;@<[E5C@8_(GGL*LV7@R'2(/*T?5=2L!
MC[JR+(A/KM=2/RQ7(:'>2:1XRUI]2@O=:UQ76&)[>W&!'C.>RID8S3TYA:\I
MZK2$ @@@$'J#7. ^+[]/,4:;I*XRL3AKB3_@1!51^&:E\-:]/JGVNQU&%+?5
M;%]EQ&A^5@?NNN?X32&:9TG3223I]H2>_DK_ (5R5_::1+\3-'LH[.W$EO:R
MS2!8U R<!<\<XP3^-=;J.H1Z=;"1@7D=A'#$.LCGHH_SP,FN=DTMM-\4:'?2
M!7FN&GCNI@.LCH"/P&S:/8"A?$OZZ,'L_P"NQUW08%<SX551JOB5MHWG4B"<
M<XV+C^9KIJY779T\*7LOB+=_H4^R.]@4?,S9PLB\]0.".X^E&S_KR#H=+<6\
M5W;2V\\8DAE4HZ'HP/!%<Q!I?B3P\GDZ7<6VIZ<A)2WO79)D'95DY! ]QTKH
M--U6PUBT6YT^ZBN(CW1LX]B.H/L:P_'^O?V#X4N9(WVW-Q^XA]06ZG\!DTI7
M0UKH8/@3_A(9M,U.:WL[6T2[O)+B*>X<R EC@@*N,@8ZY&:NZIX6T0A[_6-6
M@BUPX9;]I?*$;C[I5-P&!QP<D^M6-%\&6DND6;7^J:AJ*&%"J&Y=(@N!@!5(
MX^N:UFL/#?AZU+-:V%G$2!DQKECV'JQJI*S]"4[Z]S)TCXAZ+-#-!J.HVT5U
M;,4>0']W-C^.,]P?3J*U].\1PZV@ETBWENK;<5-RV(XP1UZ_,?P6N6NO#%WX
M@\46^O6UG;6EI9X6&"ZC(-R 22Q7'R YXR">,XKM=/MK*R$D=M8QV32-O=4C
M"AF]<C@_SHZ78WV0+;ZC)<EIKV%;?'^JAA(;/NY8_H!3%T+3!<_:7M5FG ($
MEPQE8#V+DX_"M&BD!PWB:VG\*V=Q>:3*L%C>,(;B \) S_*)D],$\CH>M=;:
MZ;:6^D1::L226J1"+8X!#*!CGUS6!\1_LI\#:@EU,(LJIBYY9P00!ZYQ6KX;
MN3/X4TNX=BQ:TC9B>YVC-"^%WZ?Y ]T<5K>CWMO<W.A6EY$EBH34;2VNCE'"
M-\\18\[0<''O4^A_$J[U@K#:>%;N4CY2;>0%%_$@ ?B:H:"UM\1_$EQJ6L"+
M[+8D1VEEN'S9.<MW/0>WY5ZA%#%;Q+%#&D<:C"HB@ #V IJZ6O\ 7]('OI_7
M],(F=X4:2,QN0"4)!VGTR*?5:XO[2UC,D]S#$@."S. ,^E4SXET3.TZM9@_]
M=U_QI :M%9:^(]%<X75K-CZ"93_6I(==TR>1HX[Z NK%2OF+G(_&@#0HI 0P
M!!R#2XH **,48H **,44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5%<_ZAO\]ZEJ&ZXMG/M_6@"5>E%"_=%% "T444 %%%% !1110 4444 %
M%%% !1110 4444 9U_<:M%,@T^QMKB,KEFFNC$0?0 (V:J_;?$G_ $!]/_\
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M7)_$UC%;03PI/=":V-VJP("?) !W')'J,#J>< X- $7VWQ1_T ],_P#!H_\
M\8J=;KQ 5!;2M.#8Y']H.<?^0:S_ /A/-&>2TCMA=W4EY:&[MU@MV;S4R!@?
M[7/([8.<5LZ1JUKKFDV^I63,;>==R;UVL.<$$=B""* *WVG7_P#H%Z?_ .![
M_P#QJC[3K_\ T"]/_P# ]_\ XU6M10!D_:M?_P"@7I__ ('O_P#&J/M6O_\
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M,HRGZ'FM"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;O\
MX]GQ[?SJ:H+O_CV?Z?UH F4G%%"_='THH 6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#"\2P7MRFGI9V3W'E7D5PY5T4*J,"1\Q')[8]*S-;\)3S^*--
MUO37$7[^(ZC!QB=4.4?_ 'E/YCCM78T4 <!=:-X@GU4SRV,<[6^L)=0S-<@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3*MC82073^;$1$Y5%'1\G[AZ9ZC\'97_ *\_\E]Y/3^O+_-G:T444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!1U2VOKN".*QO
MVL6\T&29$5WV<Y"A@1D\<D5R&A-XAU*XUG_BI+MCINI_9T22W@*R1+M)#;8@
MV2"1E2.U=[7)^$+'4K#4?$;WMC);QW>H-<VY9T;>I '\+'!^7OCK0MWZ?Y ]
MOZ\R%/%=O8>'K.\M9KW45NM2^RJ]Q$5<%I2&!& 1M&0..PJ[;ZI/'XTU6*YN
MV73X=/@N520!1%DN&/3/11UKGH]!UMO"=K&=,=;NUUO[=]F::/<\?G%^&#%<
MX;N1TJ]J>@ZIK6IZ\KVAMHK_ $B.VCG,B,@E!<E< [L?,!G'8T?U^"_X(_Z_
M\F?Z'0VGB33KRZ>V4S13K!]H6.:%D+Q?WU!'(_49%7=.OX-4TZWOK4N8)T#H
M74J<'U!Y%<WX=M+R.9)Y_"%AI4\4!22:,Q%Y6XPJ%.0I(R=V.W'<=)IMQ<W>
MFP3WEFUE<2)F2W:0.8SZ;AP:;)N<]I5_?>*;W4IXKZ6RTVTN6M8%MU3=,R?>
M=F93QG@ 8Z<YK.NM0US1/$NCP:GJDDUK/=W"@)"F9HA"&3*HN2P;(P.I[=*N
MZ/8ZEX3NM0M(M.FU#3+FY>YMWMY(P\1?ED979>,]"">O.*6^M-:O_$WAW4)-
M-V06L\[R!94)A1H]J[_FY;.3\N0/4]TNG]=/\QOK\_\ @%B_\1Z7>:-9WD6H
M7EM#+>QPJ\,#!_,#X,;@K\H)&#G%7]1\3:;I<LBW,D@2$J)Y4B9D@W?=WL.!
MU_ <G%<C-H^M_P!AW<*:/,9I/$ OD3SH>81*'W9WXZ#&.N:GN=!O;?Q#JS-X
M7L=9M=1D6>*YG,7[EMH4JX?YBH*@_*#]*%_7W+_@_<']?B_^ 7M3U.?5/%K^
M'[>YU"Q$=F)EN+>+(+LV%8G!!48/!X.3Z4WQQJ>MZ)!IEWIESO$3L]Y 8TQ/
M$B[GQD$AL G@BI[2UU.+X@RWCZ=(M@VG1VOVA'C"%U8MD+OW!><#C_&K^L07
M-QK>D>7827%K&\GVB4.@5%:,KR"P)Y/8'BCHK?UO_P  .]_ZV_X)G^+_ !--
M8^#9-0T5TDN;BW,UL_!"H%W-)@\<#]2!WK2M]56PTC3A>SW%Y>7$(8!(@TDA
MVY8[4   SZ#MW-<<O@[6=/\ #&NV2QO?/Y,MAI4*.B[('.[<S,P'4@?1!Q6A
MJ6CZB\N@ZH-!BU(VUF;6YT^=XMR;MIW*6.PD%<=>AHTUMY?D_P#@7#7\_P!#
MHT\3Z5-86EW!.\RWC%;=(HRTCL,[AMZ@C!SG&,<US.EZ^9?#8GU+5K]&;6FM
MXIXX/F8"7"HP"X4$<'(%3+I6IV&IZ/JUKH=ND,"3PR:;9M&AA60J0PR50M\O
MS8(Z\9K/_L;7!X;EMET:43'71>I'Y\1/E><),D[\=!C&<YIK?^NZ_03V_KLS
MKY?%&EP7JVSRN-UP+7S?+/EB8CA-W3/]>.M+'XGTR34$LUDDW/.ULDOEGRVE
M4$L@;ID8/Y&L31K37M':XTG^RXI[<WDEQ#J#S*4".Y<[DSOWC) P,'CD5F/H
M_B"?6+.[N=*>2:UU8S&1+I%B,!W %$W<'# L2 Q([]DM;#?4Z7P[>7=SK/B.
M"YN7FCMKU4A# #8AB1MHP!W)]ZCOM3O-0\6#P_8W#6L<%N+J[N$"E\$X6-<@
M@9P23CITZYJ3P_9WMKKGB*:YM'AANKM98'9T(D41JI. 21RIZXZU'>:7>6/B
M]=?L+;[5'<6PM;N!&57^5LHZ[B <9(()''3-"Z>GZ?Y@^I6DUVX\.^)X]'OK
MB:]MKNV>>UD,>Z963EHR% W#'(XSUSFN8;Q)JW_"')XOBU34%E*S&2R:Q+PL
M3N"8;;\BKP=V<'&"<FNKN-*N]4\30:Y<V,D,>FV\L=K 70RS2.,%N&*@8&!D
M]SG%8?\ 9.N)\(O^$?\ [$N6U%H6@,8F@PN6)W%O,QCZ<^U'37?_ (/^0U\7
ME_P/\S5TB7[-KUC'/XDU*4WENTL.GW=L5+8 W$N5&,$9 XZ\<5L6_BC2KF_@
MM(YG#7!<6\C1D1S%/O;&Z''ZXXS6-?Z?J6H>)M!N!IMQ%;6]I<13RM)%^[:1
M0!P'R?N]L]1^#= LM=M](M= N]+BA2TC,!U#SE99(PI4&-0=P8C'W@ .>O2F
M_+S_ #?_  "5Y^7Y&K+XST:!AYLLZ1NCO%+Y#E9@GWMA ^; YXZ@9'%7-)UZ
MQUO>;%I718XY-[1,JLKKN4J2,'CKCI7#6/A_5+70?[,?P?8"\M;>2%=14PDS
M#85#)R&#-QG=@=>3TKM?"UO<V?A;2[6\MVM[B"VCBDC9E8AE4 \J2.WK1IJ-
MFO1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "H;G_4/]/ZBIJAN?]0_T_J* )5^Z/I10OW1]** %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ&Z_X]I/]TU-4-U_Q[2?[IH D3[HHH3[@HH =1110 4444 %%%% !1110 44
M44 %%%% !1110 45R_CZ^U'3/"[WNF7KVEQ'/"NY41LJTBJ>'4CH:J:]=:SX
M0@AU8ZK<ZKIZRI'=V]S%"KJC';O1HT7D$C@@Y]J%K^0/0[.BL:/Q1I<NH)9K
M))F2=K9)?*/EM*H)9 W3(P?R-5=.\6VUVVM/<126]OIUV;?>R'YL!?S8LQ
MY/'K1_7]?>!T=%8B^*M,^S:C,[3Q-IR[[F&2%A(BD9!V]2".A%;$4BS1)*F=
MKJ&&1@X/M0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
MR?$][=Z;X9U&_LGC2XM;=YE\Q-ZG:"<$9'7%8L^L^(-*\,0Z].;+4;=8%N+F
M"*!H9%0@%BC;V!P,\$#/J* .PHK)_P"$FT9;2UNI-0ACBN81/&7;'R''S'T'
M(Y-)-XCL8?$<&BM(/M$MNUQG/"@,H'YY/Y4[:V#I<UZ*S[;7=*O/.^S7\$OD
M)YDFU_NIS\WTX//2K5G=V]_9PW=I*LMO,H>.1>C*>A%(":H[AY([>1XD5Y%4
ME59MH/XX./RJ2HKF1(K6621U1%0EF8X &/6E)V38UN<QI?BC6=5\.6NM0:%;
M-%/AO(6_8R[=V#@>4 3QG&1]:Z1K^S2[6T:Z@6Z896$R .1[+UK@?AYHEK?>
M$_#FHP7]P9+.1Y)(S</)&2=Z[=A;:I&X$$#(_&LVT?3)[B]TO7+_ %%=9AU5
M[E+*)$#S-O)B=&V;B-NT9W8 '.!5M>];^NG_  Y/2_\ 77_([;PSXADU>VNV
MU#[-;SQ:A-:1HC8WA#@8R>3]*V9]0LK7=]HN[>':0&\R0+@GIG)[UY3=6.D/
MX>\56<D=L?$#:I<-9H<"YWLP,93^+GJ"..OO6WH-GI=Y\0O$%K>QV=Q=I!92
MF-@K?O54[G _O D<]1GWJ5JOE^B8WI?^NMCO!?V;"(K=P$3'$6)!\_\ N^OX
M4G]H61O?L8O+?[5C/D>:-^/]W.:\GM]4L%\-^&+#S5%U9:^HN(<?-#^\D^]_
M=SD=>M27&JV3:G:2I*EHEOXDW3VK*6E0G<IDD8] QQ@# P1R>S2NU_7;_,'I
M?^N_^1ZE/JFGVH)N+ZUB 8J3),J\CDCD]:>M_9M%#*MW 8YSMB<2#$A]%/?\
M*X/PAI>@:Q=^*(9;:RNC'JTVU=JL8U=%4E?[H.&''7'M5GPQ:22:C!HMW 67
MPR61)F48D+KB(CW$9.?<BDM;?)@]+V.KU>[O[:")--LUN;J:38ID8K'&,$EG
M(!(''8<D@5DZ/XBU*[DUFQN]-B_M33'5?+MY<QS!UW(06 Q[YZ5H>(O$>G>&
M-+>^U&=(U^[&A8!I6[*N?\CJ:P/#/B/P^(M1O1J<$]Q)F[U"ZC#>5%T54W$=
MA@ =\$]Z%U!]#2TC6]5E\27>BZM9VL<L5LETDMK(S(59BNT[@#G(/UKHF.U2
MV"<#.!UKB-+6W;X@M?Z'?&\T^ZLF:_D%R9T5PP,0!).TX9_E!QCM74:7KFFZ
MUI[7^GW:36JLR-)@J%*G#9W $8H>W]=V'7^NQS\GB;7+&]TJ34M)MX=/U*Y%
MM&JS,9X"P)3S%(QVY /'O1/XQN([2[UA+:$Z):7?V:20L?,90P1Y!VP&/3N
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU3_P:7/_ ,<H UJ*R?\ A';+ 'GZG_X-+G_XY1_PCEC_ ,]]4_\ !I<__'*
M-:BLD>';(?\ +?4__!I<_P#QRC_A'+'_ )[ZI_X-+G_XY0!K45D_\(Y8_P#/
M?5/_  :7/_QRE/AVR)SY^I_AJES_ /'* -6BLG_A'+'_ )[ZI_X-+G_XY2_\
M([98QY^I_P#@TN?_ (Y0!JT5D_\ ".67_/?5/_!I<_\ QR@>';('/GZG^.J7
M/_QR@#6HK)_X1RQ_Y[ZI_P"#2Y_^.4?\(Y8_\]]4_P#!I<__ !R@#6HK)/AV
MR./W^I\?]12Y_P#CE)_PCEG_ ,_&I_\ @TN?_CE &O162OAZT4$"?4N1CG4[
MD_\ M2HW\+:;+@R2:BY'3=J=R?\ VI0!M45A-X0T=AAEOB/?4;C_ .+I&\&Z
M*QR8[S/_ &$+C_XN@#>HKG_^$+T7/^KO/_!A<?\ Q=3IX7TZ%=L4FHH/1=3N
M1_[4H V:*Q6\*Z;(<R/J+'U;4[D_^U*:?".DD$$7Q_[B-Q_\70!N45#:6L5E
M:QV\ 81QC"AW9SCZL23^-34 %%%% !1110 4444 %%%% !1110 4444 87C/
M>W@W5XHX9YI9K22*.."%I&9F4@#"@GJ>M8D^H75_X$31]-TO4)-0GLEM"MQ:
M26Z1$H%9F:10,#)Z9SCBNXHI6T:?4=[--=#RS6-%O-/TZ?0+6ROF6/0Q;Q75
MK;%S=N W[MWP0B@G.."<]>Q=KNGZK>2V[V>GWVZ\\.O9(PB*E)BRG:^<;. >
M3C\Z]1HIMW_KU_S$M-OZV_R.'\/?8IKR/4D\.ZW;WEO9M%,]\TWR+P?+178A
M\D<;>..O:NMTRY%YI=M<+:36@DC#"WFCV/'G^%E[$>E6Z#R.N/>FV)*P4C*K
MJ58 J>H(ZUE'2+W/_(Q:G_W[MO\ XS1_9%]_T,>I_P#?NV_^,TAFHD:1+MC1
M4'7"C%.K*.DWIQ_Q46IC_MG;?_&:3^R+[_H8]3_[]VW_ ,9H UJ*RAI-[@_\
M5%J9_P"V=MQ_Y!I/[(OO^ACU/_OW;?\ QF@#6HK)_LB]_P"ABU/_ +]VW_QF
ME.DWI)/_  D6ICV$=M_\9H N:A!<W.GSPV=V;.Y="([@1B3RV[':>#]#5?1M
M*;2K1UFNGO+N9_-N+ET53*^ ,X7@    #L*B_LB^_P"ACU/_ +]VW_QFC^R+
M[_H8]3_[]VW_ ,9H UJ" 1@C(-9/]D7W_0QZG_W[MO\ XS2C2;T?\S#J9^L=
MM_\ &: --45$VH H'0*,8JMIVGQZ=;M&DDLKR.9))96!>1CU)P .PX  &.E5
M/[(OO^ACU/\ []VW_P 9H_LB^_Z&/4_^_=M_\9H UJ*RCI-Z3_R,6ICZ1VW_
M ,9I/[(OO^ACU/\ []VW_P 9H UJ8T4;LK.BL5Z$C.*S?[)O<8_X2+4\^OEV
MW_QFD_LB^_Z&/4_^_=M_\9H UJ*R?[(O?^ACU/\ []VW_P 9H_LB^_Z&/4_^
M_=M_\9H UJ*R?[(OO^ACU/\ []VW_P 9H_LB]_Z&+4_^_=M_\9H UJ*R?[(O
MO^ACU/\ []VW_P 9I&T:]92#XCU3!]$MA_[1H UZ*Q/[ NO^ADUC\X/_ (U4
MO]D7W_0QZG_W[MO_ (S0!K456LK6:U1EFO[B\).0TZQ@K[#8JC\ZLT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<_^H?_ '3_
M "J2HY^('_W3_*@!Z?<'THI$/R#CM10 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "H[C_4/_ +I_E4E1S_ZEQ[4
M.3[@^E%*GW%^E% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5'/_ *A_]T_RJ2H[C_4/_NG^5 #D^X/I10GW!]**
M '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5'<?ZA_P#=/\JDIDW^I?Z4 *GW!]**5/N+]!10 M%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,FXA?Z4^F3
M?ZE_I0 Y/N+]!10GW%^@HH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "F3?ZEOI3Z9-_J6^E #D^XOT%%"?<7Z"B
M@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *9-_J6^E/IDW$+_2@!R?<7Z"BA/N+]!10 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1S_ .H?Z5)4<_\
MJ'^AH <G^K7Z"BA/N+]** '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4R;B!SZ#-/J.<9@D_W3_*@!RD;%^@HH51
MM'THH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !4<_\ J'_W3_*I*CG_ ./>3_=/\J ')]P?2BA/N+]** '4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M'<?\>\G^Z?Y5)4<__'O)_NG^5 #D^XOTHH3_ %:_044 .HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.?F"3_ '3_
M "J2HY_^/>3_ '3_ "H >GW%^E%(GW%^@HH =1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<__'O)_NG^525'<?\
M'O)_NG^5 #D^XOT%%"?ZM?H** '4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5'/\ \>\G^Z?Y5)4<_P#Q[R?[I_E0
M Y/N+]!10GW%^E% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *CG_P"/>3_=/\JDJ.?_ (]Y/]T_RH <G^K7Z"BA
M/]6OT%% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *CG_P"/>3_=/\JDJ.?_ %,G^Z?Y4 .3_5K]!11'_JE^@HH
M=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !4<W^I?_ '3_ "J2HYO]3)_NG^5 #HO]4GT%%)%_JD^E% #Z*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9-_J
M)/\ =/\ *GU'/_J)/]T_RH 6+_4I]**6(8B4>U% #J*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CG_P"/>3_=/\JD
MJ.?_ %+_ .Z: ')CRU^@HHC_ -6G^Z** '4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5'/_J'_P!TU)4<_P#J7_W3
M0 Z/_5)_NBBB/_5)_NBB@!U%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %,E($3$],4^HY_]0_TH <GW%^E%"?<7Z44
M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***BN+B.UB,LI(0$#A2QR2 .![F@"6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ J.?_4/]*DJ.;[A^AH <G^K7Z"BB/\
MU:_044 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *0Y/3BEHH 0#G-+110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5'-_JV/HIJ2HYO\ 5L/]DT .C_U2?0441_ZI/]T4
M4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J.;[C?[IJ2HYON-_NF@!T?^J3_=%%$?\ JD_W110 ZBBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BC%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1S?<;_
M '34E1S?ZMC_ +)H ='_ *I/]T441_ZI/]T44 .HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9*,Q,#
MZ4^FR?ZMOI0 )_JU^@HI4^XOTHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "FR?ZMOI3J;)_JV^E "I]Q?I10GW
M%^E% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4V3_5M]*=37^Z1ZB@!4^XOTHI$^XOTHH =1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37&5..N*** %
*484#VHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex10-2_001.jpg
<TEXT>
begin 644 ex10-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M*,4 )FC-+BC% "9HS2XHQ0 F:,TN*,4 )FC-+BC% "9HS2XHQ0 F:,TN*,4
M%)2TE !1110 4444 %%%% !1110 4M)2T )1110 HHH%%  **04M  :2E-)0
M HHI*6@ HHHH 2BBB@!:*** "BBB@ I*6DH **** %%!H%!H **** "BBB@
MHHHH 9WI&^_']3_*E[TC??C^I_E0 \]**#THH 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "DI:2@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 6DHHQ0 4HHQ1TH **,T9H **,T9H **,T9
MH **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **
M,T9H **,T9H **,T9H *2EI* "BBB@ HHHH **** "BBB@ HHQ2XH **,T9H
M *#110 E+1BC%  :2BB@ HHHH 6@TE% !1110 M%%% !1110 E%%% !12TE
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M* "EI*6@ HHHH #24M% !24M% "49HI* %HH%+0 444E !F@4=:* %I*,T4
M%%+BC%  *#124 +124M !1110 4444 )BF-]^/ZG^525$_\ K(O]X_RH EHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0T4M% ""E
MHI* %HI** %I**6@!*4T4E !12T4 %%)10 M%)10 44M% !1244 +1244 +1
M244 *:2EHH 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BE
MQ28H **7%&* $HHQ2XH 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**,44 %%%
M% !1110 4444 %%%% !112T %%)FEH 2BBB@ H%%+0 4TMS3J:5H 4')I:0#
M!I: "BC-&>: $H-&:0'- "BEHHS0 44A.*3=F@!U(:6@T -%+28I: %HHHH
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MO]+TJW#2);W.M2Q,^ (UZJN!QN; 'IS5F[\>,NN:#:6EH)(]3LS>.S2$&)
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MHH 2BEHH **** "BBB@ HHHH #2"EH[4 %%-7/>CG?0 ZDHR:* %I*3)I>U
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M2R $GYUW XSR"#Q5=_$5UI5EJ]_?E9X[6Z%I!%!'MDE9@FT#<Q&2S@?K0!V
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M<-YK<-W(DTNF21+:/,/+C82!@0%RGF$E>OI]: .A#$KDXYZ<T98R<8V8KAM
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MR: '4M%% !10:* "DI:* $I:*!0 4444 %)2TAH 3-**2E% "T444 )1110
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M/&$FHZ[X1C73K34K35GDCVJBO&\8##=\P^4\9[D5UEU(^EZ,7M[6>Z:WBS'
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M*6DH 4]*@FZQU/4$_6/_ 'A0!,.@HI:* "BBB@ HHHH **** "BBB@ HHHH
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MB&2-M^YF*@GD*,8Z ]<UI:?I]W)KT^L7<4<,C0"WAC5BQ50S,Q)('WB1CZ4
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MF\XGHS[@-N,=!GG/- '1^GO0WRTNWYA0ZY% "J<BEIJC IU "4M%% !1244
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MR#TR.M+96%K?V,4\L+R&XMU2269=LCKZ,!T]\5F>(+4Q>(O"@M@(\7<L.U>
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M'/>@#K=#U:+6M#LM416BCO($G5'/*A@",TFNZG'H>B7.I2122Q6J&1UC&3M
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M=-:F!+>TDF#NJ$QX(C!/WCSTKBTN<:MX=TV+7KBZ@E%U#+<)( T@56QEAZ8
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M@!B2 .:EL[C6;^;7[ 74MK/9",V9PDC1EH@0&^7!Y[<]>IH ["1D"Y#$8!(
M[XJ#3=0CU&RCNECDC$F0%E0HW'L>:YKPSKMQX@BM9X[EXT@LU^VH(UXG.0RY
MQP5*M^E<QIWB_5[[3_ 32:HWF:M-/%=.(DR^T$C'& > .!0!ZNY*C([4WS!D
M;3D$9!KAH-:U8:+X@$5WY\VG:JL$<C*OF>3F,L,  %L,X'')Q6UI$VI3:UJ!
MF:3^R46);3S8Q&=V#Y@QM#'!QU]Z .B!S2TP<4_M0 4444 )112T  H-!I*
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MP1\V.M=)IVI0:K9K=VW*$LHR,'@D?TJOH^MVVMF]$"./L=PUO('4@[E//!H
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M?A/P[<V;3/>>:7G$@7R2Q>4+M/+<'!QTKK+NZTG4(;0RS(ZRRD6ZG=B1@,\
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MW]N7'_0#U3_OB/\ ^+H_MRX_Z >J?]^X_P#XN@#9HK&_MRX_Z FI_P#?M/\
MXNC^W+C_ * FI_\ ?M/_ (N@#9I"V.QK'_MRX_Z FI_]^T_^+H_MZ4==%U,>
MYC7^C4 :Y?'8TGF?[)K(.ORC_F#:D/K$O]&-)_PD$G_0(U#_ +]?_7H V/,_
MV31YG^R:Q_[?D_Z!&H?]^O\ Z]'_  D#CEM'U+;_ +,&3_.@#9W^QH#>QK&_
MX2,?] C6/_ 0T[_A(HO^@;JW_@"_^% &QGV/Y4%NU8__  D46/\ D&ZM_P"
M3_X5/8:HMY(RBWNXCGI<PF,_AGK0!R$UY+>?#WQ9J,<K17$CW^)0/F"PEXU_
M2,5E36$[>(_ ]I:W\L<ITN\V7+H'9%98^QXX'3.?QKL(M),3:KHTMNIT_4&D
M='4\A9!^\4CZ[CZ?-^%,M/!]M:7&G7'VZ]FNK")X8GE?.4< ,#QCLOL,# %
M'-Z3XFUC5].T>R1B+F[EN5FF7:KM'!E<KD8#,0/IFNQ\-KJRZ.T.MB$W<<CQ
M[TDWEHP?D+<?>((S6;%X TE;!+-WNF:"=KBVN//(D@=CD[6'3]1[=JZ#3M+@
MTR)HX3(Y=M[RS2-(\C8 R2Q)Z ?E0!SL7@31K5;:)!=!;:]%W:E;AP8GQM('
M<*1P5Z&J/PKF>]T'5+FYG>6ZFU2X\[>.5P0JK] H&/K7<S,50E!ND ^4$X!/
MIFN.;0;^*]GNK.RFTQIVW3+9WZ[96]2IC(S[CF@!^M7;V'B+3-"TT):G6))7
MGG7J@CC7)4'@,<J.A]<&L[4=6U^PAOK*/4%:6QU*SMUN)(06FAF:, -CH1N8
M9 !.!ZU<NM N+Q;:-](<2VDOGPW0U#,R.>"VYE],<'C'&,"G7?A^[O+:2"2P
MN0TMU'<R3+?H)':,J4)^3 P5' ':@!GVWQ#92>)-/BN6U*XMDMYX&\M%=5D+
MJRJ ,$@1Y7/<X)-9+^()&M].OM-UVYG5M;MK*:.2!4DC5V :.92@(;W&.O>M
MF;1KU[G4;AM.NVFNUB7<+Z,;1&Q967Y>""2?QJ.71M0EAN8KK2;B::\G2XEN
MEOXED62,@QE<( -NU<<=N<T 5M5NKR:?4+&XN7FCM=;TX0;PN55WC<\@#/)/
M7VJR\MY:Z]XHNDU<#['%%Y:79VPQ[DRN2.P.3]344GA6?SYKCR-5+2303-NU
M&,Y:+!4X*G&"!]<>E+?Z#>ZA/>SSZ-</]NB6*>/^T4"':,*^-OWA0 RY\0:G
M9P>*((+N>1[32$U&TENX%#9(E!^4 <'RP0" 1D]A4\=]JD>MMI]Q?F3[9H\E
MXA2%4$$BE%&".3D/SG^[QBEE\.WMTM\+BROY'O+-;.:9M1CW,@W$<!< _.W;
MO2II-['?VUT^GW;RQ6ALRK7T6TH<9!^3DG YXZ4 2>#=-?4?"F@WNH3RSSQ1
M":,%L+N(&&(QR1U&>E'BG3HM*\"ZI- SFXMB=0$TC$MYJ$-G/KQCT] *U/"F
MF3Z39O:R0SPPK@1)-="8@ =!@ *!TQWZG)--\4VMSJVG/H\$8,-QM%U,QQLB
MS\VWU8@8 _/% &S#.+K3HK@ @2QJ^#VR,U-%]RA(ECC$:#"C@#TI>G% "THI
M*44 %%%% "4O:DI>U "4444 %%%% !2TE+0 4444 %)2TE "]Z@F^\O^^O\
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MFQSA?H,\#Z^M6L>E(20N<<THSCGK0 $TM-8'-')% "M2CI28XP:6@ I,4M%
M!BDI:* &YI<TT@YS2X- "TM HH *0<4M-<$]* '"D[T'.WCK0.G- "T444 %
M%%% !24TAMWM2X.: %H%% !H 6BDI.: '48HI#G'% "#[].IO\Z=VH 3.:,4
M@!SS3J $S1FD/6B@ 8\4@%*12X-  !2TE)@T *1FEQ0** "BBDS0 N:*2E%
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M2SQR;9LRP,C%1O0J" V,CGN/K4^L7VH1:[I-M:K"8YTE,N]V4G:N<< C\>M
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MENUD:)ED7!$8!;.2,'D8Z@^U3Z)K]IK=K-<1!X9;>9X)X)<!T=3@J0"?3L:
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M:Z+;@ 9X^E 4CH: .3NO#>HB;78;2>V^PZL"\F\L)(I&0(V."""!GL<FJ/\
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M1SFEHH 6FD'/6E%+0 F#ZTAR.].I&H !G%'- '%&* &8)[]Z>*444 (1D4T
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MO;/'+L8)(HA7+!L8(JE>)HP\;^(DU-(F\[2K5@)5!! ,P. >">F* .S?5+.
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MZM=2;[/?-9G[&CM\S0?9UV@=B?,#D@=S0!Z/I5Q)>:59W$@ :6!)&'N5!/\
M.K:C&:R_#<PG\.:;(H;!MHP=PP<A0*TT.<_6@!]%%% ""EI!2T )2BDI10 E
M%%% !2TE+0 4444 !I!UI32#K0 M07!Q'G_:'\ZGJ"Z_U#^V#0!*OW1]**1/
M]6OTHH ?1110 4444 %%%% !1110 4444 %%%% !29I>]-;[RT 4M5U>TTBT
M%S=LPC,J195"WS.P49P..6')JY\I8$8YY_"N5\?[_P#A$+@Q@&0WEH%R,C)N
MHJHW>N:EHK>(TFNOM'V2.UFMGD51@S%TQ\H'R@J#Z^] ';A5W$$@D<_2E0C
MY!STK@M5O?%.F:)XAN!-MB@L3<6LESL+K(N=XP@ *D8P>WXU-?WFM6>K6VG1
MW[2S7WFW8:*-%:*)/*7RER""<R$Y(]: .LFOHEU6*Q+'S'B,H7:<8! //3N.
M.M7#C(!(Y[5QUEJ&MIXATZQNY(2[Z;--,@P2)4=5!R/][IVZ5B:!XDUZYT[P
M?J-_=Q^3J5X]M- (P"PV2%6#=1@H/PH ]*!5>20,G S2_)\P^7:>37/^*M1O
M+.WLVLKJWA$ETD<OF#,CISE8EP=SD[1T.!DUR-EXJ\07.C_:-P$]MXA337\V
M(!O*9HQ\P'&?WG:@#TW8  <CCI5*/4H)M:GT],?:8(DDD^7^%B0.?P-<A=Z[
MJ>A66K6<]['<W?VZ*"SFE4*JF8+A3M SC)-:&CVTUIX]U-);E[EO[/MOWL@4
M'&Y^/E 'Z4 =>0,YXS4$CQPA#\NPG"_7VK$N[J[OO%5QI5I>O:^18K.S*JL2
MSLP4@,",#8<COD5PEGK>HZ]J?@FYEE:&X%_>074:<)))%$X)P<\>V?Z4 >BZ
M;>Z7X@D:]@C#RV5P]OODB*E' &<;@#WZUK.@/.0#7F.GRZO:6>O7L%XMM%!X
MA(>(1*1,C-$K#)Y'!."*U;Z_\0WFHZB/#\H7[%.D/DRF/9(1S)O).Y>",;??
MK0!W/ R%(R!G %-X90"!DG./6N,M+KQ!J/BG5+(7B6]I936T@00AS+&ZL67)
M(QTZBM37=6EL]5T;3S/]B@O9)0]TVWY2BY5 6! 9LDC(Z*>] '0_NV4#Y2.U
M,'EH<DKP<9QWKAM.\2:O=Z?I,<M[ EWJ=Y+%'*8,*D<1?)'/S%E4$'@?,.#5
M74/&VJ:9<7^B2Q127L6H6]G;W3*=K)/N*LP!'S (W3CCI0!Z,Y4#!VYZU1?5
M[,:VFD^8INS"TWE[3G8&"DYZ=6%<CJ?BN]\+W6KQ:E,MXEO8F]M7*!&?#;-A
MQQ]XK@X[\U9L;6YL_'VG?;;K[5))I%PWFF-5PWFV^X J!D9(QD9'O0!V>Q!G
M(7!'I2,R)@L1G^E<WXCU&_M+B-+:XCA5K:9@ -\KNJY4*F"-O<GCIC(SFLN'
M7-8O8/#,%O<0Q/J=C),\CQ[OG4)G _X'TH [=VC6)GRH4#D]@.YJK8:A;:I9
MQ75I(DT+DA)%Z'!(./Q!'X5Q^AZWJ>O-::7->)'+"EPUY-$@_>;+AX$ 4@C!
M,9)]A^-:/@!)#X(T]92%E62<2;1@;A+(#@=N10!U)"AAMV@=SZT[:!N/!SVQ
M7G\/B+7TBUC2FEC?6HM3CM[4&,;6A?YU<#_KFLG4_P !J/5O%&J:?K$4/VJW
M\G^UX;-X(5+[(I&P"[D<.?0$X].] '7:7>Z-=:CJ/V"2*2ZB=8[N15.=V#A2
MQZXYX'2M)E#)&LF#SDYKRQM8NM"_X6)J6G+&LUMJ%N3N7((*(#Q]"/QKKM0U
M+58=>O[&&:U*IICW5NLGR@/NVC>WI[T =!?WUMI=I+>7<RQ0(I+.W10!G-2Q
MW,4EI'<K(IB9 ^_L5/>N"O=:O+_2?$4$SB:V;0OM46^';AF656 R,E<H,$^M
M6=,U74].U;P_9WTL=Q9ZK:;88TAV&W=$#<G<=P*[NPY% '86-_::G:QW=G,D
MUNV=CKT)SCBK.,$$<GH37G>C:I<Z?X;T33]/C87-]-<',:*Q1$<EB 2!W%=;
MX>FU22R<:Q 8[D2NJ$D?O(P?D<@$A21U&3B@#5/48(VCH/>E8#<AR.N*Y32]
M3UC4_LVK6TUH;"XNGB>W93E8E9D#AL_>)4<8QSCWK/G\67UIX<_X2MI8GTD7
M.TVJQ_,82^P,'SG=G#'C&,CWH [I@F0/EW=1F@'+#D9'WJX35/$^MV5MK=[L
M@\K3-4AM]HC),D3^2< YX/[P\\\]A5BY\17O_"6'2Q,+;+Q20)- 0EW'@;]D
MF<%_]GVZ&@#I[34;*_N+RSMW!FLV"3+C[A89'YCFDBU6P;67TJ*>-KV*+S9(
M5'**3@$FN4F\4WUHOB-GCM0]IJ,%A9*0RAFE6,+YA!)ZR@G'9365=ZK/X5\=
M:SJ>J2K>-;>'XYSY<>PE?.;Y>I[YY^F<T >F!$5<_*$'3 XQ3R,XVG&#7#3:
MUXNT^QU.[GM(7MXM->[CEEC"".90#Y6%<EE(S@\'CFI8M9UV'1["^O[FS6.]
M:%@88V9XD,>2 O61F?   XSG% '7812@4+LS@ 5!9ZG::FUP+:9)4MY6MY<=
MG!P17%:/JVJZSK7AV6:Z14DM[[S8EBVDO%*B>O'!_#WJQ8^)-0N-(NE8V\=X
MVMOID4@7"J%<@LP[G"-^8Z4 =P50E0VTA>1[>E*J!6).-QK@/$'BW5]$M?$-
MNS6LMWI]DE];S!" RLVTAES_  _KW%;-AK.I'Q<FD7CV[Q3Z?]M3RD(,>'5,
M;L_-G.>@H Z8H<84XSUJA>ZE8V+PQWDR1"Y<11ENA<\ "KSL05YR.<X^E>7.
M][=^&=%:[G2:<^)RB-L^X1<2@\YY'Y=* /4D&T<$;<<8INU6D9E(+8P:XI_%
M>HV8UNPN1#=WUI=P6]N40QB3SU0H",]06(X/:M?P[>Z[/=W5OJMO^XB5&AN?
M*$?F$Y#*5#-RI'7/0B@#<0* 1D<'I[U)D'E2,YQ7&3:_K<GCZ[T&T-JMO;6T
M%RSNA)V,^''7[V 0/KSFBR\0:Q<.NJ1P,^DR22 IY0'EQ -B4/OR>5&1M[\4
M =DXVD$8].E 5 0.,8X%<AHNNZQJ-CIFM&.W_LB[C>>92Q\RWBV$HV<_,3@
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MBB@ -(.M*:0=: %J"Y_U#U/4%S_J'H D3_5K]!10G^K7Z"B@!]%%% !1110
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MM2TY;:XF@V+LE;*@LRK@X/\ M>HH BO_  :][;:I!_:LJ)J-S'=/B)3L=-F
M..G[M.#GIUIUUX0DO90EQJ]S)9&>.X:WVJ,2(005;&5!*Y(^N,5J+KEF==.B
M^8#>) L[ = "<#\>":MQW,4JR*D\;E3@[&SM^N.] '.7O@F#4(=:@N[^=H=5
MG2<B-51H9$"!&1@,Y C7KFHXO 4,FIW%YJVI3:E]IL1I\L4L2*KQ!BP!VC.>
M3SGFNGCNX7)5)XG95WA0P)(]?I[U'IVJ6^IVSSV\B21K(\>Y&W E3@X]1D4
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MHI** "BBB@!:0TM(: "BBB@ I:2EH ****  T@ZTII!UH 6H+G_4/4]07/\
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MU+2$4 )O]J4-D4F*<!@4 )FDW<]*6@"@!"W'2E!R,T$4#@4 )NYQBE"XI:*
M"CK12'B@ /2FJ3C'-.S0!B@ +8%';-&.32T -7@;:5FV]J#US2'F@!<\9HZB
M@4M "9QQBC/%+10 F<T9I<4WO0 [-&:** $S1FC%*>E #2_(&.M.I@%/H 3%
M%+10 E%+1B@!**6B@!,T4=Z6@ I#2T4 (*4T44 -I<T8H% "T444 %--.I,4
M  I:** #%)2T4 )0:6B@"(GFGK2%>:<HQ0 &BBB@!:2EI* %I#2TE !1110
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M4M !1110 &D'6E-(.M "U!<_ZAZGJ"Y_U#T 2)_JU^@HH3_5K]!10 ^BBB@
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MK*%\H/,$4X/+<D<<<>M;DVMV6D7OBC4$L#%/9I"T[EA^]&T[2<$@ >O!]>E
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MAYHSC<03VI'NK:-#-(XC4<,Q/0^E '%Z;H]SITMFRZ/<NMBC164,MW WV96
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MLX#*"LN8BK*Q5E?: 6!'*XXJCIUG96.I>'9WT<0WEVCQ1R+)E5(C+;R !EB
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M#W_"K\\$-S \4\:21M]Y77<#WZ&LG6+VQ\.Z7=ZBXACG>,D%B%,K*IVC/?\
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MA"& QG&-P(VGBNTLVTU/B'>2-*%N+RRM7@7SS^\8>?N*KGD!=N>W(]: .Q)
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MGBFD@WK&SQ(7V%C@%@.@YY/85QPO8_LC7ECXSC8ZA:,L:,-ZHW:0C<Q0 GD
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M#ECZDGDGWJ26VLI;E9I8H&E485V4%A]#3-2ODT[3Y;QXY9(X5+E8EW,0!V%
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MT;0S:A/<1W,K_<1I!*LC$<'KM.!CT%4-3T&]U37AJ,=HD-];7,+0WL$VP^0
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M[3?#^I:G',]]J4D7VJ-P)8(!%YBHS8P'/"@X!(.>M;/A*%H?%'BE#=2W"^?
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M&NET*6*/P_:106CVJ01"%;9V#-'L^7;D<$C&.*YN/P?;ZCX>U*74K&0:E?\
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M^ 0,_J*K:3J1U:S>X^S3VP$C($G4!N.,\$\&N2M4EE\?:;+/=R%CH 9E:5E
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M8U-((7^7/D, ZOMV\C9G.>^>: .NAU&&6^N[)$E\RU5&9BA"G<,C:>]6CTW
M\-UKC;_7;_26\1M]H5UM'M(K=9%&V+S2 2>A(^;/)[4FJW.J^'+*\>?5(+J&
M=K:&W,P"R(TDJQLYV[0$&_(]/6@#LQP[,<Y. >/Y5DS:!9SZ[%KC-<?;$C,*
M?/A0A()&/J,\US%U?>(]'AG>[^U2::DT3^9&T<UVD6'$AVJ,, 0IZ$X)QR*Z
M7PW>K?\ A^&Z74DU%7,A%WL"!AN.,@ 8(& 1@8(- &RV I//3-,&URI(8$?-
MTQ7GFE>(M9E\1:)937B2I?PWAF9(E,(EC(*^2>&*C=C)X./?-5M)\1^))O".
MD^(KF^CD^VF.S%LL"J%DDN%19<Y[+GCI0!Z?D$'D_P"%(,.#C(;IG%8?A]=<
M6:\35HU,.]&@DD=#*05PP;8 O!'!]#[5B:K>^(WO?$4.GWUM$NFQ1W%N'M]V
M3L+;&R>AP>>OH!0!W!)!R2,8YXI", EB23CI7GMMXEUKQ-I,9TZ)(;I]+@NR
MJA#F216."'ZQY"CY>>3SQ5^&Z\2ZCJYM%N;.T;[#;7$B1Q"01L78,@.?F!V,
M,]J -V[\1Z?:7T=E<-*K/(L)D6)BD;L 55V PI.1C/J*U@,DJQ)(KSZ[O;C0
M%\7:B]R;D0WL*QQR1+CS'BA"L2 #@%A^56]3UG5M#\01Z-)=K<)?Z?//!</"
M%:*2)<L,+@%<$'GG/>@#MQT(!/'J.M(4#$G+?-U_"N&FU37T\-Z5JRWT %\^
MG(L7D#]V)F1'Y]]^>G':H+W5/$%C;>*(!JB^9HUL+M)_LRDR;HBX0C.,;E;G
MK@]>] 'H. _)SZ5#+,EK;R2.K;(A_"I)Q7)3^(-5U6Z2TTE'CN%TR*].TQ\M
M)G:"'_A^7G'//:I+34M;U;59-+=X;*XL]/AGNO+7S TLI<;0<CY0$SQUS[4
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M HH% "'I4-Q_QZR?[IJ8]*AN/^/63_=- $J_<7Z44+]Q?I10 ZBBB@ HHHH
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M*DBO=1)TPN( UP2$5@!LQCE>![\=:MVG@O2K?PL?#Q>YFT_C;YKYD7#;E(8
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M49=0NKJZFC2.1Y%1%;:21\JJ/[QK;Z\>AIQ&>]'6@!:*04M !1110 E%%+0
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M>TO4<PL0<)*T9R""""I!!! /X4 < \=U<Z/JDUM:W\NL&[@OY[2YM3;"=$*
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MH(R:4BEQ0 AX% I#0.M  1DTZD)Q1UH 6BD'4TM #&^]3ATI,<TX4 %)F@T
M4 &:,9HQ2T -"XI:"<"CWH 6B@&D)H 9)S0@Q2D4N* !AFE48%**3K0 "EI,
M8I: $Q\V:7O1UI#0 IIBC&:=2&@!@'S9J7M3<4X<4 ,=<]*5!BG44 %-9232
MT9H 0<&E/-!%+0 P*0<THIU(!0 #@4AY%*:* #M3<<YI32XH 3^(4ZFXIU
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M*!R8Y.><<$8QTK3\*:1J6BP2VMW<VTEL)97A2-"&4/(SX/./XNU="X/\.,4
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M6%*D*?E(+ \D]\5M:%87MKXGUZ]N+79#>R1&(J^2 D84YX'!(R/Y"@#-\/\
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MMI/]TU*>E13_ /'O)_NF@!XYC7Z44B_ZI/I10!)1110 4444 %%%% !1110
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M3:62;*Q^UHXC>.-R,[H\NH.1P>G.3TJQ'XCU+^TI+&XM;2-Y=+:]M?+9F/&
M5;@=V7H?6@#JEC1L.T:ACSG%1,T"A"ZHOS83/'/M63X-FU"Y\'Z3/J$JS7$M
MK$[29.6R@.3QUR32^(-%N=7.G_9;S[/]DNUG=6C#K(HX*D'ZY![$ ]J -A)8
MYU(C(8 X;V_^O3@B*FT(H4GH.!7'[KOPE'Y,NH+?SZKJ16S5XA$<MEB'89+;
M5'7&< "K,_B+4X56VGT98KZXO/LMDC3#9, C2&3(!( 5&XQG\Z .B^S1(6$4
M,:E_O$*!GV/K3Q$ QPBX(Z>E<5JGC2_T:/6%NM+0W6FK#,0DF$DBD) <'!.<
MJP(P*LZIKNN06FO0-;V=O<VUDMS Z2,<JV\'/'# H?;GK0!UCP1.%1HT9<$
M$9Q3'M(9 %EBC=5.1O4-C'3K7*)XAUF-=(T^.P@FO[W3Y;A)))<+N0+A3QWW
M YJ&X\7ZE_9NI:E'IMN]KIDPAN0)2&W( 9=O!!"Y_'!H Z^2:Q+&)W@S$GF,
MK$?(H[GT%11I9O(Z+]G\^52V$P'V'OZUS2V=I>^+;U5@CE2_T=7D#<B12YX/
MMBKVD>$X-,O]-N(R ]E9_9O-VG=(O92<X 'IC/ Y]0#9L+&"PC\FWPL:DX3/
M3)))_$DG\:F-O"%;$40)Z_*.?\Y-86JZQ?6?B*STNRLH))+N&21)))-JC9CK
M@9[UBQ^-[YM.L+]M+@6WEOH["X#RY9)6<(VW P5![G!]J .Z2/RXEC11M QB
MFB&.)G>.-%>3&X@8+?4]ZYR'Q3+/XACM(K4R6+330-<(CYB>/.=WR[=I964$
M'J!4=IXKN9]4MK2>P2&2Z@EECB$F9(BI "2#'RL=P/MCI0!TT=G#'.\PAB#O
MU8*,^_-/$$((Q%&"N2,*.,URFD^*[Z_;0I9[!+>UU,%4/F[G#B)Y,<#!7"-S
MP<XXJ70?%$VNW9-M'9O"CR),$D/FP$$8612/E;&?RXH Z$00J&8Q)DG!)'WO
MJ>_6HI7T^YME:1[=HMWE@L1MW9Q@>^>*IZEJ4\>KVFEVD,4\URDDS+*^U4B3
M 9CQDY9T 'O[5Q6G7JVGA'3DETB&=9O$,T(CEDXMF-VX!!QSCG'3H* /1_(0
MJ%\B+:/N#:./>GK;0*S$1H&;DG')KE(?%>H7?B#4K&+3(EMM,G5;F=KC!2(J
MQ+CY>3Q]W]:9IGC7[7,C7-D8+66TDNDN%1QY:K@[7W* "5)/!(XH ZJ"SAMP
M8XH(4B)+%40*"3["B'3[2!@\5M"C#HR1J#^@K"L]9U>789M.18I;-KJ&5)-R
MYX*QOP.<'.1QQ4_@J]O-1\':3>W[*T\]G#(2A)SE <GCJ230!LW-K!=ILGAB
ME&<@2(&'Y&LW5]$_MHPPS74\-DF[SK>)E"7 ('ROD$X&,\$=:Q9/&,ME9Q:S
M>6B+HTMS]G\P.3(F9"BR8Q@J3Z'.".M6=+\1ZAJVKW=I#I:1P6=\UM<RO-T7
M86# 8Y.=HQQC/>@#HVEA@,<19%).$0'!.!G@?2HY;"VFN%N'MX7E3.UF0$C/
M7!(R*R-1NDA\4:3"]@DKR>>8[@M\R;4.0!CN,#.>E4+/QE=7*Z?-)I)BM[F_
M:RWBX#;6#,N0,<C*^Q]J .FE%K9AKN18HRJ_/*0 0OU]*4R6<\P@WQ22A-^P
MD%@IZ''I7G/Q#U>;5?!7B+R+.)[+3YUMVG=SO>570-M4#H"=N2?6MB'5X[?Q
M7>PPZ1!)?0Z3#*9]^UI8RY"H3C@ [C0!UZ6-NEPTX@A$AS\X0!N>O/O275I%
M>0O!<0Q2PL,%)4#*?P/!KD[7QG>OIMI?W&FQ1P:E' =/*R%C,[QM(X90,J%"
MGGG-6[7Q-/<0!?LP&H27AM(X&)$;$*'\P$J#MV'/3(.10!T$=A;18Q;0#YLC
M$8&#C&>G7M3TM+8*\?D18;.\;!\^?7UKE1KNLW'B'2+":P6TW_:?/!?.[RB@
MROJI$@8?2M_6-1?3X(A;PB:[GE$4,9( 9N2<GV4,?PH GM].L[8X@MX8N ,Q
M($.!T'%)'I=C#$\<=G;A';+*(E ;ZC'-<EJ?CJXTN+5XI-)$E]I"Q3W44<N$
M>*3HR-C)Z'((X_6M ^+?+UR[TR>W@B\C3QJ N!-N1H\D8P%SVSWX(..: .GB
MC6.((%4*.@ P*A6QMEG-P+>+S\8\S8-W_?76N4B\7:E=ZJNDP:(IO&TY+X*U
MRJJ S[=N2,]CSC\.]2#QFDNG:8\(A%S>VINE2638B(-H.Y@IQ\SJ!Q_*@#H_
M[-M3>K>&WB^T!2N\H-Q'3KUI_P!DM0K[X8=K<R948;Z^M<K_ ,)?<S?V;):Z
M5+*]_:RR1++((PKQCE2"">>QZ5/:>)FU2\:Q%G""D_V:\B,P\V+*]2F,[2<8
M/?.?:@#H5L[.3#110DQY0,%!V]B/;W%-6WT^5F@B2W\R$@E%49C)Z'';O7$^
M'-6FT"T2U:S9K&37+NU\[>/D+W3H@"XR1D@9R,>]6;SQ%!I>J^)[Q-("W%A!
M;/<3+(-\ZMO"?0*,^IYZ=J .R%G T,R&&+9-]\!!\_&,GUJ.VTFQMK,6D5I;
MK #DQK$JJ?P Q6+:^+-_BM-!NK%[5Y[<W%G)N#+,BD!L]-K<@XYX[U8U+79;
M;6H-(LK47=[+&UP8VD"!8P0,DG..3QQS@]* -6*QM+3]Y';PHZJ 76,*< 8
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MX52(+Y3'@E<#@G%:%M:6]E;K;6L,<,2<JD:A0.<]!4Q."!ZTN.<T '6@4M%
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MNV:>S)TFX,K$,WSKL= /N\\.?3G%2Z?X6O5\0V6J7ILQ<VL4D4MQ;Y$MP&
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M$./O,H!#<\MFN]70-&2- NG6P19/-11$ %?.=P & <]Z=_8FF/J?V^2Q@>_
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MKIKJ0+!MC<-&4*(,Y7J3DD\GFKVL>'9-5US3KZ*X:".)6AOHL#_2H#R(S]&
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M\C\A8X_]<W(\MN.!D\YQTK,L=!UVVUCPY=ZE)'>26%M<PW$XD),K2L"O\/.
MH!)QGTJMIOA75K;P[HNG-#"9+#5#=38D.-OF%_E^7D\^WUH Z&3QOH]K)LDE
MN=@NOLKS>0Q2)_EP';'RCYUY/'O6[>7L5C8S7=P=D42EF/?_ /77!#3+K7;7
MQEH\-M$UM>:BT?GN^!'F"') QR0.F.^.G6NL\0Z3/K?AN:PAG$4[[")&Z;E8
M$9]LB@!D/BK37:='DEAEA@%P\<T94^5W=1CY@#P<=#4VCZ_9:]N>Q\XQJD;[
MY(RH8.I(P>_ YK U+1]5UK4)+JXBCMI+?3;BS2-9-_FM-M ;.!E1MSS@\]!6
MOX0L[K3/"VFZ=>(%N+:$1/@Y&5&,@X''X4 37?B?3K">9+J1XXX71)I_+;RH
MBP! 9\8'WAD]!GG%9NI>(GGOM<TF!9XC:6:.MU$OW7<.>N" ,*N#ZD^E5=0\
M/Z@]IXAT>*U2>SU@R&.Z>4'R#)&%(92,D \C&>,#BEETF_L];U5+6'S[2\T^
M*!6:4[T,2R#ICYBV\<Y'>@"[X<\1V]Q;Z?I\[S&_?3HK@O(F$ER@+,&[G/6K
M$?B[2VO4LQ,YEE61H7,3!)BA^948C!(__5FN;?0-5GE\)A+5H$L+66VNRK_>
MWPB(8XY *AN<=!3=#\/Z[9+9V]_I&D2MIIQ%?QMF66-1@!4V#:QXR2?SH ZG
M1?%.FZ[-Y5D\TF59MS1%5^5BIY(]0>.OM3M5\1V6D2E+@RD*H,KPQ,ZP*20&
M<@':.#^59_@'3-0T;PZUCJ42),MS*Z[&W JSE@?8\UG:OH&ICQ)J$MOI6FZG
M8ZHL9;[7-L-M(J["<;6W*0 <#OGUH W;OQ;IEA)>Q7$DN;*-99FBA>0)&V<,
M=H/H>>E*WB6+_A(8=+BA>42VHN?,C4L "VU<X[<-D]N*PY-"U(W7B18X1+'?
M:=!:H1A09$1U.,]!\]2Z;INIVM]IU]'8QK$FG):7$<DNTQLC9W#@[L]NGOB@
M"O#XOL]'T:UG@O;S5X[_ %5K99I8B#&S.04Z#A2"!ZXKI+7Q'I]U]O,4D[?8
M5W3AHF!7C/''/'IFN&M_"FM#P[IJBTC6ZT_Q =46%[@?/$7=MN_'!^?Z<=>]
M:?B&SDO/$NEQ6,D4;:DKVNK(O.^%5W$?4<KG_:H [FVFBNK:*XA<O%*@=&(Q
MD$9!P:EP*J127"ZBULMJJV*0*4F#CE\D%=O8  '/O[5<H **** "DI:* $HS
M2TS/- #NM%*** $HI:* "BDHH **6DH **** "EI*6@ HHHH **** &]Z;/_
M *AOI3N]-G_U#?2@!4^XOTHH3[B_2B@!U%%% !1110 4444 +244M "44M)0
M M%)0* %Q1110 $9IK*&Q['-.I@.": ';12XYI <TM "8%(1\VZC'-.Z"@!N
MT8(]:7 XXZ4AZTO04 (%Y8^M(@QD4K4%1Z\T *<4B@8(]Z3&>*<HP* # X]J
M38,$'GG-*10!0 $#DF@@'J*0\\"C((X/2@ 4Y&*7@<XIH6AA@=: '<<@CBA1
M@'WI#@@ GK2C&,9H 3"Y''2EP.F*3'<FC /(/% "X'H*;( %SC)IP&!2#DF@
M"&YMX;N'RIX(YHVZI*H93]0:?!;06T2Q00QQ(HPJ1J%4#V Z5+GG%(,'O0 F
M!NZ=*7 (Z=:,48H   #^&*0*N,8%!]*-O-  $ ;(I!@EL]*=D9QGFDVC/!H
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M#Q^M.-*3B@"A9Z5:V)<VL8B\QB\FT8WN?XFQU/09]JN(2V[(Q3@,4'@4 -)
M(P,G.*4D GBD7@&DQDT / "CBFE0RCL?:G @]#FC S0 9YZ&D8XQP:=1UH 3
M@'%-<@+C!Y]*4CO1C.#0 PY.T_,.<$ TYCM!.#Q^M/H- #2-QQSCK6?9:'IF
MG7]S>VME#%=79#33*@#.1ZFM$'/%)C'?K0 B?>;K3Z:%P:4G S0 M%(#F@G%
M !GFEI@Y.:?0 4S%/IIP3CO0 HZ4M(!@4M !1110 E%%% "TAI:0T %%%% !
M2TE+0 4444 %%%% #>]-G_U#?2G=Z;/_ *AOI0 J?<7Z44)]Q?I10 ZBBB@
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M+IS*L,,$6-TKLP55&>Y)J@UYKMC';3W,-K*DDL8FBM]^^%6(R26)R #SP.E
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M*?>A<Y)..E  >,9I'YIW!I<4 (.E+129H 6BDHH *4444 !I*4TE !2TE+0
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M3Z?=O:W"%MP#K@Y4X&0001P*Y/QYJ,^L^#-3D2V2"WMM0CA265OGDV7*(S*
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M/N+/3;RSWV9B*,]K=VX;@@<$#C*^F:[/3[&>+2OLNH737DS;C)(1MSN)X [
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M^1%<PAI'!AQSO4E^!D'(S@X-=U9Z]I]]J]SI=M,7NK109UV, N>V2,'\,XH
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MF/"\%CIVGZI%::FU[;B9I6\L#9 2BDHF,\9R<=B37(^'+JV_M70'B($5[;7
MEDDE#33@JK*\I &UB2?EQP2>30!ZMN4\^G-('0+D$8;D<]:\4T.X%MIW@V^C
M<I<W&L3V\SLY),7FOE>3T(P??.:Z&72GTS4]0\,Q!C::O-'=0%BS-'&6Q,!U
MP$PF,D??H ]*54*%1@J?QIPYX(Z4D:*@PH 4= .U/H **C+-FI.U #-NQMPR
M1Z49XQC%.ZBFKSUH <#D4M%% !1110 E%%% "B@T"@T %%%% !1110 4444
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M3Z=?PH ?=Z;'-8R6"8BCE^\RJO?KP1@'WQ4]C8Q:=86]K;(%B@C6.-!T50,
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M0#*JV.#[U%I_Q!L=1O=,:&U+VFIR&.WN%E#$'MNCQN4'L3Z\XH Z[[';D;#
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M: %S2444 %%+10 44E%  :*** "EI*6@ HHHH **** $[TR?_4M]*=WIL_\
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M48H7&,4 &X$\4XTU4"FESSB@ %!/-!]A28R3GM0 M+2<49&,T +12' (I>*
M"FOP*=33ACC- #0:?BF[1G%/H ,T=:08-"D= : #.#2TQQTQ2J?EH =2&C-'
M6@ HHQ2T %%&:* $HHHH **** "EI*6@ HHHH **** &]Z;/_J6^E.[TV?\
MU#?2@!4^XOTHH3[B_2B@!U%%% !1110 4O:DHH *6DQ1F@!:#29HH **,4M
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M!T^F>*]+OM"L]3DO;=(+F/<I>15.0,D'GC QGTS6B=4LUT<ZIYRBR$9E:3/
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MM/ LB88&\M22"K,=O(4;5W8';I0!W5[XDTJQT.\U?[;;RV5M&SM)#*'!VC)
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MJ?B[2+/1[O5DOH)H;0.)/+D5OG5=VS@]3CIUH O:/HT>EO>7!=WN+V833DX
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M/%-BUBQD,K+>VICC1)&*S*=H;[I// ../6@# B\#QP3:<R:KJ12PG,MO$'C
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M!]S0!SE]X2EO_P"W!%J;P0ZO$$G3R0X!\L1G&3_='MSZ]*E_X1BX;7[+5WU
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M-3+"LUH=-N,/(N%!!B]?8$_05VT-K#;VT5O#$JPQ($C0#A5 P /PI^Q "RH
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MA]JLFGA&N%NM0,"QMD%S-(R#CU)%=TRK(I1TW*PY!Z5&D"1?+&@1!_"HP,T
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M+:3WL>F2R/IU^G[F==_+*_\ #(.W7@FO2_#>IVM[X2L-2@BDM+1K<,L<OWD
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M<0>(5.K1$:VBHQ-M_J@%*_WN?O>U "KJ.J7/C#;#/ 8AI8N$BVG=AF''7&>
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MQH+Z=;70M&+1M&[)O5=CJX!7(W [<$=QQ7/7GP_OKZWU^%];B$>LP11R!;,
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M:^*IHH?#&F:5I4:_VIIOVF$>9M2%41#M/R\#YUY _"K5OXS>[TK2G2WCBO\
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MW%>?V\%[J>I:?IUUXAFD1]-E62:U<QF1E<*KKZ-R3N'7Z5WL2E8R#][)Y]:
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M\E(OG#IDL""1C&TCKU(QFFR^*O.U'0196EQ/;ZG \Z.B@# 4-SD@_P 0[<4
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MU?<5.3U.>.3FM+PQH5SX>T>'39=0:\CMXDAA+1A-B*, <=3ZGVK<"L <OFG
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M:&H :F>YI](*6@!.](X)'%.HH CC##J:?CFEHH 3M0 >]+10 4444 )1110
MM(:6D- !1110 4M)2T %%%% !1110 WO3+C_ (]W^E/[TRX_X]W^E #H_P#5
MI]**(_\ 5I]** 'T444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 ,(
MI,5)10 #H**** "BBB@ HHHH ****  TT"G44 %%%% "$4 4M% !1110 444
M4 )CYJ6BB@ HHHH **** "@T44 )BC%+10 4444 -Q2BEHH *2EHH 04M%%
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MRX_X]W^E #H_]6GTHHC_ -6GTHH ?1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@ HHHH *6DI: "BBB@ HHHH ;WIEQ_P >[_2G]Z9<?\>[_2@!T?\
MJT^E%$?^K3Z44 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ H
MHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F
M@ HHS1F@!#G-#' XI:0\\4 -1BW6GTF,4M  !BD)I33": '9HIHI: %I124H
MH ***#0 "BDI<T %%&:,T %%&:,T %%&:,T !I*7K1B@!*448I* %HHS1F@
MHHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ I*,TN* $I12
M8HH **** "BBB@ HHHH **** "BBB@ I:2EH **** "BBB@!O>F7'_'N_P!*
M?WIEQ_Q[O]* '1_ZM/I12)_JT^E% $E%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %)110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "TG>DI
M: "EHHH #28I:* $Q2T44 %)2TE !1110 M)2TE !1110 4444 %%%% !1FB
MB@ S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1FBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ I:2EH **** "BBB@!O>F7'_'N_TI_>
MF7'_ ![O]* %3_5I]**5/]6GTHH ?1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2T"B@
MHHHH **** "BBB@ I*6DH **** %I*6DH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ I:2EH **** "BBB@!O>F7'_ ![O]*?WIEQ_Q[O]
M* '1_P"K7Z44)_JU^E% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *2EI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 4444E "T4E% "T
M4E% "YHS244 +FDHI: #%)2T&@ I**#0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !2TE+0 4444 %%%% "&F2C="P]13Z3O0 +PBCT%%"
&]Z* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex10-2_002.jpg
<TEXT>
begin 644 ex10-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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MB@ HHHH **** "BBB@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ I*** %HHS1F@
MHHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1
MF@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ H
MHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F
M@ I*,T4  I:2ES0 &DHHQ0 9I<T8HQ0 E%%% !FBBB@ HHHH **** %HI*6@
M - HHH *2EI,T %%%% "B@T"@T )2TE+0 4444 %%%% "4Q_]9'3Z8_^LC^M
M #S1110 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )111
M0 4444 %%%% !1110 4M)2T )1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2TE+0 E%!HH
M *6DI: "BBB@!#10>E)0 M%%% !110: $S2TE H =1110 4444 )1110 =J*
M6DQ0 HH-%)0 M%)2T %%%% !0**04 +43_ZR/ZU+43_ZR+ZT 244M% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "44M&* $HI<48H 2B
MEQ1B@!**7%&* $HI<44 )11BEQ0 E%+BC% "44N*,4 )12XHQ0 E%+BDQ0 4
M4N*,4 )12XHQ0 E%+BC% "444N* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2
MBEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&*
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M@"R .HI:@M+F&\LX;FWD66"5 \;KT92,@BINU "T&D!S2T )112T  H-%)0
MM%'>B@ HHHH #2"EI* %J&7_ %T7UJ:H9?\ 71?6@"844@HH 6BBB@ HHHH
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M M%%% !1110 4444 %%%% !1110 4444 %%%% $;9IRYI0*6@!.:0TZD(S0
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MZM8ZE)/%97,4S0'$H1PQ1O0XZ?\ UJ236["VNQ:3W42S[@FW</O'H/J>P[T
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M4M% !BDI:* $S2YI** %ZTE**#0 E+24M !1110 4E+24 +WJ&7_ %D7^_\
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M>UGM()V/F7LS0VX520S*"2,]!PK'GTH XF]\'ZU<Z/XALT:#?J&KQWUN7D8
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MY/I7H@#>82<;:-F =OKF@#RZ*/4K.Z\*QIIUW)?66E/;W5NC(Y4!53."1C+
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MTF*.U2"SV+:3>;"OG/A#@J2.?1F&.F"10!6\):I>ZC%JEM?7*7,UC>RVWFA
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M%&[G% "'=NXI>U+10 G.<&@@,,&E[TG>@ -)D[:=28H C!;<<]*D%-*XIPH
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M/Z5-WJ"?[R?6@"844#H** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)0 O>H+C[R?6I^]03_>3ZT 3#H**!T%% "T444 %%%% !1110 4444 %%%%
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M,Y('(YH ZL6T+?-Y:_-]X>M2!%CB" ?*.,&N4;Q5+;07MX=,NFM;4"288_>
M&+> J=2<X!'N*T-"U_\ MV3S(80]FT*RQW4+[HF))&SD AQC)'O0!9U73!=Z
M5<6EO<R63S*5%Q#]^+.,D?E63IWAB]B@M(M1N[*YCLV#0B&P$).!@9.XXX]
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M&8+(!EUZ#C_&LS0DM)X_ =YJ,<4C2Z;,))9F^Z5\DJ"3WX/7WKTC^S;$RR7
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MO!=LBLP^6,$AO+3DY500!R:XS2;J)M=T"_M'*17FH7BO<7$N9YU(DQN'\*9
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M/,NA%Y'FB1E/EY)VG!&>23ST[4 >?Z?/>:4O@*Y34+@KJ-F(YK;S,Q,%M-R
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M$%[F$132&5V=E'(&XG=P<]ZM7'AZPN;6XMYHY)HKE52;?/(6=5Z MG/<]^]
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M"<=C0 V/I3FZ4BMQT-*U "CI12"EH 2BBB@!:0TM(: "BBB@ I:2EH ****
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MJ%TMU=:=:33KQYDD*LW'8DC-<LEUK%S>VNA7-S,MVNEB]FDC<0,SE@N P!
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MCB;[3)G:VT%2=W*_(GRGCY1Q73=!2 >OUH PH/"FF6\FG^2DR)IR,D">?(0
MV,C[W(X'!XXJ(>"]*2SBM5$PBBN3=1XG<,DA!#$,#GD,P(SC!-='U'%-Y/6@
M#&M?#5G9W(FB:4A)Y+F.%I&*(\F[<0">Y=CCIS3/"^B2:%8W%NTTKK-<--'%
M)*9/(4XP@8\D<$_C6[CN.M ! )XR: ,=/#5@NH_:RC'$QN$B9V*)(00752<
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M #J?O4%Q]T?[Z_SH D'044J]!10 ZBBB@ HHHH **** "BBB@ HHHH ****
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M[,"3ELC&0>E7K:RO]$U;5+6/2]-U&WU&Y-S!<R728A8HJD.IY(^0'CKTXZT
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M0FTF6SEDN8W$S2D86-022RY+<C(]ZZ77[234O!K7%A%+#/;A+NVA="C!X_F
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M[>99K..?3_)\VVO$'E9D#$81H\D;@?\ EF,T >@W=W;V-I)<W,B1PQ+N=V.
M!7*P>)8XM<U9[F_0Z7;6D,^94*^0S.X.?EW8PJGGUH\?VNJ3Z+I\]A"\RV=_
M#<7=M'RTT*$Y4#N<X./:LK6(VUZ#Q0=/LKUQ?Z"(8/,MGC5Y!YWRC<!S\RT
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M1RYVR(O4XSV[,<5Z!X3@M$L[I[/3+C3[:6X,JI< J\Q8 F0J>5RQ/!YXSWH
MZ+/-'0T#J:&H 6BD!!Z4%L4 !H%!Z4"@!:2EHQ0 E%%&* %%!HI* %HI*6@
MHHHH #2"E-(* %J"?[H_WU_G4]03_='^^O\ .@"4=!12CI10 M%%% !1110
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M<K=:Y?77C)]**PG3Y- >^4%/FWEPN,^F#TK#\%7VM:3X6\&RI+;RZ3>A+:6
MQ8>)FSM(8'GD<@B@#T;3M6L]6BN7M)"XMIWMY=R%<.APPY'ZU;"!B=R@XZ<5
MYS-K^K:AX7U&66:"":WU]-/+1J0"GVB-/7KR:]$CWQVRAV$DBJ,D<9- #3/
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MRPW)OQPP[@'-=A-,EC;2S32*J*-V6/ ]J *E[H-C>7=O>2)*MW AC2>*5HY
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MD;RK&5)+*OWB,#G%5H_$^DW6G6MY'=[H+J;R(I(XW.Y^>!\OL>3@<&@"M?\
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M5++X3BDTZ>T-S<$37ZW[ME,F175Q_!C&Y!VS[U'J?BNWC_MBUM)87N]/M/M
M21OO-M=MNW() VC/IFM+2-7M+J""V^V0M>BW262#S 74$ Y*]<<CGWH 9KFG
MSZIH\NG#F.XC,,YW8)1AAL':W4$]JRD\/:C':6]B;J5["%DQ TZ_,%((#$09
M(XZ9_&MZVU>RN[F:VM[RUEEB(RD<RLP'J0#D5E^)-<DT^]TS3H9HK:349#$M
MQ,A9$(&<<$?,>@&1DT 4;WPG<W++/E?MB7GVQ;OS_P!XK=-H'E8V[0!C'(IE
MQX3N[V+64FEQ_:RJDY$OW54;0%S%QQQSFMO2K[4 MX-82*)K>4(DD(8)(FQ6
MW8.<<E@>3C'6K4.M:?<VYG@O;=HP<,PD!VG/0^AH YY/"UPNNQZHX$DB6!T_
MRS.0IB)!/(BSG(SQ3--\)7&GV5C9AA):6#;K:W>?"QGG&2(@6QG@GI[UT:ZS
M9MJ M!>6IE8LJQB52Y(.",>W3ZU7OM0$OD"UO=/5OM20R">0$GGYHQSPY'04
M 8%IX1FM-*O=/?,L5Y>"^:0S?.DV\29'[K'WE!Y!K?-KJ9TG[#&ZI((]@N#.
M3)TQDYCQG\,>U3R:E:VES%9S7=LLS]$DE4,3QP!U/6GOJ^GPWL=I+?6Z7$IV
MI$TJAF/8 9SSVH Q;C0)Y_"QT!8HE@-M]EW^9EMF,<?NPH/OBM'1[*YL-&6P
MN)WDD1=B22,K-CMR%4<?2K+:C:B]2S^UVZSM@^6T@#\^B]:KZW<M;1VWEW5I
M!(T\:DW0)5T+ ,HP1\Q&<>] '.6WPWMK?1[+3UU.\,5EJ1U.)BL>3+DG!^7I
MEF_.M$>#K>/5;FYM[^\M[6[?S9[&,KY4LF.3TW ''(!YK9EU>QMY DU]:1MO
M$;*\RJ0QZ#GO[5:,P*AL[5SWH PM.\)V]G8:K9W%S+=0:G*\UPLBA?F< -@@
M=, =<]*@T_PAY,'E7VIWE["D+6\"3%1Y,17:1E0-Q( Y;/2MZVOK:\\SR;F&
M4Q_>$;AL#U.*BAO[2Z>>*"]BD>$XE1'!,?U Z=.] &9!X5:T:SGBU.X:\M8V
M@2>1$)\E@G[O 4#'[M"#ZYZY(J?3]"73&TV.PN9HK2RMS!]E&-LG3#,>N1C]
M35ZVU2TN!,R7EM(D)P[1RJP7ZX/%":E87-O)/;W]O)%$<R.DJD+]2.E %W!V
M]><5@:)X;.BWM_,E]),+Z8W$ZNJ@;SQP0!Q@#KFM-]0L_+E=KR%$C(5F\P8!
M(S@_G6+X:\2&]TW4+C49+:!;6]EMD<2C:ZIT.3QR.: )+_PL]QK#ZC9ZO>6!
MN%"W<4&PB4 84@LI*MCC(JO=>$&_MAKS3]8O+ SJB7<<*JZSJJA0?G!VMM &
MX8X K;.J6C,CK>0>5(=B-Y@PYZ$ ]Z?!?VTUJ9XKN"6(9S+'(&0$=LB@#%/A
M!7,D+WLC63S1S"!D#&,H5QL<\@?(OJ>N",U=\1:.=5TP1QR!)K=UN(689 E0
M[D)_$5H1WMO+;FYCNH7A0'<\;AD&.N2/2DL[B*^M%E@N(I4<YWPN'4_B* ,2
M\T%]8OK?43<76GW"0-;SP1E'$D;'.-Q!QWY&#S5.U\'W5II\%E'K4TB):?8V
M6:W1E:$$[1M  # '&><]\UUX"Q+M ZT_(H K:?91:?I]M90;O)MXUB3<<G"@
M 9/X59/2EHH 04M%% !WHI*6@ -)2TE "]Z*.]% !1110 &D'6E-(.M "U#/
M]T?[Z_SJ:H9_NC_?7^= $@Z"B@=!10 ZBBB@ HHHH **** "BBB@ HHHH **
M** "D(Y%%+0!R/C>SU*231M0L+,WR6-\LUQ:KC+( >5!ZL#@@>U8&HVVK:M?
M>(KZPTN\0R)93PQ7*"+[3Y3,63GD'GCCKBO2R 1M)QD^M!*@$D\4 >>2Q2ZS
MH>LS6OAFYL9;O3WM0UPF+B63:V!C)^4$\$D=?K4FJQ7][J7@NZMK"Z=;.X)N
MMT>#$#'LRP[<GWKL(M1B&J7%@3+YD<2S'<C;=I)'#=">.G:F7&J6EGK%M8/*
M5GN0S(FT\JHY.<8[C\Z .-N["_DO?"SVUI,T5KJ]U<3MMQM1S+M8Y['S!TJM
MX6L+BR2TT34_"T[WEE>&>*[)_P!'VF0L9MV[&_#,<8SG'&*],W*%&2=I/7-9
ME]K=CIZ1O-.5CDN$@W[6<!V8*%X!QR>IXH \UCM=4@\,Z5H=]H%Z=0L-6AGE
MN((M\<P$A8R[\XRV22.Q/85W'B[3+Z_T")[3+R6]Y!>O 3@RI'(KF/\ )<_4
M"NB.V9@PW;1T(/%/R' VG(H X#4H+W5[S7-2@T^[2%]#:PC2:(I)+*Q<@!3Z
M;@,]/F/-7X8-0;QCH5TUG,MO'I3Q3N5^5)"4.#[_ "&NN+J6922,\?C3AMR4
M!Y Y&: .$^(:37[Z#'!9/=K;:E'=S*J@A8U5P20?=AQR?:KAU."SU":72M&8
M1M;F:[8Q>5YFT'9&@Q@L2?P%=+-86UV4::"%I%[N@)Q0NEV2 _Z);DGUB% '
M$>&8H_"NJS6)MWGM;R-;E;B&/*VTG.Z$<Y" 8([ EO6LW1O-MM(\&02V5VKV
M5](;A/)_U:&*9<\=06D3GG]*[Z.#26U.:T2R@%Q#$LC?Z-A=K9Q@XP>AX[58
M.CZ:W/V"TQG</W"\'UZ4 >5ZMIVHZAIOBJ**TG9I=>@O(0P"^9"OEY*9/)^1
MN.O3BNHOI!J,FHZI;0S(ITB2U"O$4EEE;YAA2 ?EVXR<?>XKJFT7369A_9MC
MM89.;=>?TI!H>E;@1IU@1C'_ ![IS^E ''P7#V>H>%KQ[2[F1-->TE1(QNC<
M^7C<"1@?*>?:MGQA>33Z6-,LA*3>D0R31(7\F-CAR<=]N0.>IK8_L32P3NTR
MPS_#_HZ?X4)H>FJ^XZ=9?06ZC^E '%W]E_PB_B31]1TS[9J"&-K.X0$/LAP"
MIX Z,!QZ5N7 %W\0M*>$[EM]/N6E9>V]X=JMZ9P2/]VM=M*T@#RVL+ ,QP!Y
M"=?RJ>TL[6P!BMHE0L=S$#!8^Y[T <[XU2\M(+'6-,LFNKVRN%41*I)99/W9
M.!V!96/^[6=X:T/4])UR^T^X=Y]-M3]NMW<=9)5*E!_NE7/_  ,>M=YN5\ \
M'/ZT*H#ENY_6@#S^.*\":$QL;MA'KU_.^R%B8XI3<[&/H/WR?G6CX2@N8/%'
MB^66VECCN;Y)(7="%D41*A*G&#\RFNN5E>1L'D<$9[_YQ6?J6LV.DH6N)O+;
M:9"H1G(0?>8A0< #J>E &#*$TOQ?JMW<Z?<SV]W8P11NENTH8H92Z?*#C.]/
MO8'Y5S]M97GAX:,-5T_4-1MWTF&RF6R5I/)F0Y92%(RK9QD\<"O2TGCGM8YX
M6$D<BAU*'@J>].8J&#'( &>M &;9P"V\,K EFMH(K78MLC;O+POW0>^*XCP]
M;+J/A?P/;VEE-#-:K%</(8RJJ!"0S;NA#9Q[YKN+FYL+J^.BW$^)YHVE6%6*
MLR# 8Y';YA^=6=-TVWTBQBLK176WC 6-&<ML Z $DG H X#3!=)KVAW!TO4D
M$37%O+ +8BWM@W380!E3@G<<@GO586^JV5@;PZ5<W-K;>);F[EM1&=\ENY?8
MRJ?O89P^!W%>HR<[0,YSG /:DD8;6#*<#I[F@#E?#MS+=^*-9N?[/O+:&Y6V
M=))[=XPP5"#]X#GVK'\51W4.J>*T6RN6_M+0A;VLD$+."ZB;() P/]8O7&:]
M">2.WB\R1]J@<EC6/'XM\/2K'Y>K6\@D<)&4?(8DX !'7)(% '"Z)=+:?$'3
M)KRUF29?"<*,C1.71A,1\R@$CIZ59T73;W0[GP[<R6MU_9J)>Q>4(RS6ADD#
MQ,5&3]T%>^,BNTAT"R;7#K@$AO6C\KS=Y_U?]W&<8SS]:MP:K83ZC<:=!<K)
M=VP#2PJ>4!Z9_(T <59Z=-#*MPUE<2177B*2[A0H<QQE"-Q Z OEN?6KWA>V
MN(O%7BTR6DT4=Q<QO#*Z$*ZB(*=I/!Y':NINM3M;2ZCMIIE26169%/5@HRQ_
M"C3;^VU2W%[9S>=;N2%<'@D'!Q^((H \]U=;RTU3QI;W6DW4C:G9%K.[@A:0
M2*MN$,1(R%P^YN<9R>M+X=%]IWB*TU"_LKN.SN-!M[:,^2S&"2/[R.H!9<Y!
MSCKQ7?0ZC:7M]=6L5P&FM&431J2-A90P!^H(/XU=3:3N4Y![YH \JTBVO?"=
MQIE[=V%[/I1M;JWBMX86EDLS)<&2,,BY8 QA5/!P5 K6F!L/$7AO4X](N+;3
M8X+F,PPV[%XV<J4W(H^4D*?H3BNY:XMX[E("X\]@S*N>6 QG\MR_G4@DSL^4
M_-^E 'G?A99XM6T>6ZTVYC,%OJ22.\+ *SW$;*<D8Y56Q4-O9W \(Z?&--NO
M,'B1YW01,3Y?VIW#X_N["O/2O2^">00!ZU%;75O=6[36\@>+>R;E/<'!_(@T
M >>QQ0'4M1TC5=)U.>8W;W-LZ*ZPSY;=&?,!V@J,#+8QBJ^J6\K:'XG-O879
MG?6X)4S$V616@8D>HS&W-=Q+XGT2UAO99=0B$-BVRY<GB-NN#[UKQNDRAUZ'
MH?44 >::S9:A>ZGXGM["VN5O-3TR(6LWED1[E7HS]!45S!%KWAV^_LW1-3M]
M8329+7-SYT:P K@Q+N.&R>!M^M>GM\HX!)STSTIR@ 9^;@8Y- 'GUC>)<:MX
M0:UTZ\3R+62WG#V<B"'Y H!)7 Y![XK5\674NG:UHFIR6L]S8VS3K*((FE>-
MW0".0*H)./F7V#&NMS['BC.>"IY]* .$E*0ZMH.HP64UKH<<UU\ODLK))(.)
M&3&5!)D'(XWY.*QH],N4U"[O/L<CZ?=>(H);:+R6PJ*")),8X4MSGICFO4G3
MD':2!V]:51C@@^O)H \TUFTGGC^(8_LZ>26>T6*U?8W[W, 7"^OS>E3Q267_
M  FEU]NLC\WA^W"[X22/WDV5Z'!.%]SCBO1 H+EN>/>LM-"MH_$,^L@S&ZFB
M6(_O/D*J20,>V3^= 'GV@Z=>:=%X(MY+"Y5(;B\)4QM^YBD#B(-_=.PKP:L>
M&X8EMK#2]8M=1N-;L+TEE9)!$6WD^>'QL(VD'KSTY->FKPO.?Q-5GU*RCU*+
M37N%%Y,C21PD_,RKC<1],C\Z /-+*VD'PZET^>RNC=6^K1NRF!@Q_P!+5R5X
MYXR>,UM3?N=5\56VKVTCQ7T*-:,$9M\7E!#$,#[P<,=O7YJ[O  Z$XI&QM[G
MOUH \ATK3;^'6]).J6$US+%X7:.63:3B<R ]?[V,UU_P[BNH/AGI,$J31W4=
MMY>R="K(PR ,'TKL <@':>:4CC'I0!Y;X:M=05?"=M-;3IJFG3W"WTCH0K*5
M<,2?1F\L@]ZZKP9),\.J^=&Z%M2N77>,94N<$>V.E=*Q(7*J<FJ]O<6L]S-#
M%.KSP$><@;)3/(R.V<&@#C-6_=:EXNM'2XS>V(,3+$Q4[8=N 0,=<]?6LK4+
M.X;5_#LMA;7*7#:/<VS2E" &,? <] =RC%>HG[V<$_CQ2CI]V@#S;PFUC<Q>
M'%:UU :M8VYB,4T+JENPCVOD_=(/;DYS72^)TL+Z2VT?5]/^TZ=>*^^4@XB=
M0"OS#[O&<'CD#FNB'WL!3A??BE9=ZY.0?3- 'EKVVIV/A[4+))KV^T:PU"UD
MMY'7?*T *-)&"!EP#GGKQBG:U::=>:#J]YIPOKV6YDMS+,Z.I<JZ\*A )(0<
MD#VKU':,8 //I0W"XP2/:@#B_$FGVVGQZ9XBL+#][IUT)I#;IEWB<%)0%'4X
M;=[E1534]/N(]%\.M>VH%X^KPW5T8_F\MF<LW/H,@9]!7?J,Y/K36)60'!(-
M 'G>F-:Q2:QIWB.QN9M0EU-[J)1$Y\]-P:$JZ\?( HY(QMYJC8&.,:SI7B)=
M3746OGGBCMT8BY7(\IHW"\%5"K][C;7J2_-D,I'?K4=Q<6]G;27=U(D442EW
MDD; 11R23V % 'G-K'.GB42V(-UILFKN9;.^B*SVTV[!FB;J8^AP> ._8=#X
M[C632K I;"6:/4[)T'=0+A"3] ,Y]JZE2)0'7E2 58'K3F48R1DB@#S?5M*M
M&D\<S)8HT\EFAA?9G+F(YVGLV[TKJ=2=9? EVSV\U[_H#;H8V*R2_N^5!'(8
M]..:V;2YMKI'>VFCE56*L8W# ,.H..]3;06W<],8S0!Y6XU!]6UDV<WG75YH
M"1V;16S11[E>4^6#SR P&2<\]N@NW$]KJ7AV9_#^GW2ZQ_8[VJDHZ"W"H=B-
MN RVX\<$UZ(V3_"<YXIX &,#% 'G&JW.DZC9QW&D6,\I$4$=[MBD&VU25&:'
M! !;:7X'/!IGB.T2YE\22VD1EM)]$1)67D27 )V8]6V\<>@KTB3Y0H ZMCBG
M;51<!<9["@#SW4K>VT[6?"]PEBZ:=)YKW;I$?]?Y<8B=S[<C)]*P;:YA1VA@
MTZX4CQ-,T-PZ.([<G)$A (W9&X#/'/;->P8XZ'Z4W;\X.T@#]30!XO963S:7
MHB2Z?.SQ>*)&;[1&4:.-I2Q;'H<Y]*U=56\M;?65M+#.G1:_;RWD$,?^LM/L
M\7F%54<_,,''OZ5ZEM2-]S-C)P,GO3M@+$\X/7F@#SGQ$UI<:;+>Z!;SFSDU
M&"XU1X(VS,@P&V*>&^4 G (/N<UT7AJ+3$U'4+O39+N;[7Y<DTSKMB9\8^5=
MJ@-@#.!Z9YKI&>.,88A1Z4@_=K@+U- #R,D4M1R2QQ1&25U11U+' %"2"2,/
M'AE8 JRG((/0T /!S2U&S,'4;>#U-24 %)2T4 )1110 HH- H- !1110 444
M4 !I!UI32#K0 M0S_<_X$/YU-4,_W/\ @0_G0!(/NBB@?=%% #J*** "BBB@
M HHHH **** "BBB@ HHHH .]-)PP'K1GFE(!H YWQA?ZCINCG4K":..*TD22
M[WINS ''F$>F%W'\*QWU_4%O?$=HE\CBW2)+$QQJ?WC/L8'/WBKE0?K79W=O
M'=6TMI(BO%,C(ZL,A@1@@UD6OA33+5K"1;,;]/#"#YV/+$$L3GYC\HZYYYH
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M%M.N'O9)D:5KPHTV9&&63[K#!^4CL1@U;L-&M],CQ!YDDN,>;-*TC8],L2:
M,*\NM8;Q1J%M;ZA%;6MK%:W8!@$A=&,WF)R1@D1#![5FZ-KGB6_6QUA+82:=
M=DM<QN$18HCG:8VSN9L@ @\<\"NP32H(M7GU%0?.N8DA?+$C:FXKP>.-[?\
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M4BVW,D&1L+,,;B,9)QTYXJI=>&[>[URRU@336]Q9HT:+"0%96Z@C'.?\X/-
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MC@$'OZ5Y#I-P;/5/#,\;RQ27/AV1KS;EG,JQH5X/=<, /:I+)6FL=0TV&/\
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M&_&-PZXI8[=4.<+Z9 Y([9I^[FG DT &.,4HZ444 %%%% "4444 **#0*#0
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M5(! SR,$9-=3D%V&\^F/2@.KM@/T&30!RY\&P)+?M'=W""\LULS& NV&-1A
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M66\#I&!.^]L $^N*S];UB;2(;(Q6[3O<WD5L=S!0F\XR>.<>@K7+#;R<9]*
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MO(,P&)2"A!9!M&WGH>N1GG%,L%N=4TC5+S6(%$VGVLVF!BG612V^10.S?N\
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M7"&1<].V,UUGE1E@VWYAQGO^=8WBK1)_$&C+96UPD&)HYMY3=]QPP&,CKC%
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MU[KVH:.;)XI++899?,#(=ZAAM[]#W KF-=TV^TW2-9-W<6<)U35('@D9CLC
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MAI8K6\@TZ:ULUB8MM>3JY;C'' &._6@"_:^+?-:[MOL#O>6UG'=O#%*&.'+
M+SC#?(W!]J?:^*(-1TK2KRUMV9-14N(]XWHH0L2?IC'UP*Q](TV]\/:L^IWD
M6EV&G2V202K S@0>6SD,"R@8._DG'3OUJ3PYH<,=[JU[I\B2VRN\6FXQL5'"
MNX!'52_?T% $]EXX:[L-)O%TNX$.HRM;Q$LFXR@-\I&[CE&YYZ>G-6H_&%NE
MI?R75K+!<V=VMF\3,I#2-C;ALXQ@@Y.,#.:R;#PSK-GIWAJT<VAETZ_DNY"K
M/M*L)!M'R]<2GKCI4DWAC69YM7N(Y+6.:6^CU"Q9BQ"R(H7;(, @$ @XSP:
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MRPL2@;'.":TJ $V\$9ZT8XQ2T8H !P*2EHH 04M%% "4M)2T )1110 4444
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MTBJN\GY?7TH,J! ^Y<$9'/45XKH>IPKX=\(#6;MH+1S>1M/.N^-9EE41"3/
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M5#[0S+_$ <XR/P/Y&G;5Y;"[NQ-<%J&R+Q9XEE%Q<Q2?9;!!Y<ARQ9Y1L09
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MKQS6AQUH!!H SI]%TVZE0S6-K)L4!28E+ #C&<=,=JO%1A=N-HXQVQ3\@4'
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M * ,6/PGHJ6MK;I81)'9J4M]FY3&IZ@$$'!]":M-H>G216D/V=!%:N)($10
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MW!B)DGB\B5BQ)>/GY3D].3Q[FKFEZ39:-:_9=/@$,.=VT$GGUR235W@"E[4
M)T%(M'6B@!U%)FEH **2EH *#110 E%%% "TAI:0T %%%% !2TE+0 4444 !
MI!2FD% "GI4$_P#Q[O4YZ5!/_P >[T 2+_JU^E%"_P"K7Z44 /HHHH ****
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M0H]L"LK0-(\2:7:V^C7'V4:;:296\CE/F2P@_+&4QUQP3G'I7:XI"N2?<=:
M.%TC2/$.FZ$='6"S,-G T-G*S[FNP,^7O!7Y %P".<D#M3]%T'5- 75IM+L_
M+CDA4VNF2W6^!9N=Q3^XI/;]!7:JFU2O4GO2J J[<=* $0MG#  ^U244A.*
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M ,>[U.>E03_\>[T 2+_JU^E%"_ZM?I10 ^BBB@ HHHH **** "BBB@ HHHH
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MP.QH 4YII!XXI68C&!GGFEW<X(H 09 IU-!/IQ1DY/'% #A13%9B>5IP/)H
M#P*!TS4-U=VUJ$^T31Q;SM7>P&3^-$%Q!.I-O*DH!P2C@X- $O/>C&>M#-P,
M<DT@;C+<'I0 $=,4Y>E-)8 X7..GO2ACQD=N30 Z@4F>,X_"C- "=S3JADN(
M8I8DDD57E.V-2>6/7 _"I V3C'- #J:<YXI<U$UU EQ';O+&L\@)2,L-S =<
M"@"4YQ0*,U')<10E!*ZHTC;4#,!N/H* ):#TJ**YBFDECCD5FB.UP&!VG&<&
MI": &MG'2D&2:7<Q(&W@]ZCAN(YE<Q.KE&*/M8':PZ@^] $HIU0K(WF[2M.2
M>*1Y$CD5WC(#JK E21GGTXH >3020*0M[4$G;TY]* $R?2G#I30Q*'CD=J<I
M.!D4 +28%,=MN2W"#J2<8ID5U;2 ^5/&XW;3M<'GTH E)- S2;CN/R\=J"Q"
MD[>E #@32TU2<@8I<\F@ ([BFY)/2F)/&TS0JREU&YAD9 ^GX&GAP3D=/6@!
M2#2\T,2!P,TFXY&1P: '4T$DFE/(([U%'<P2NR131NZC)57!(% $K=*1#D4!
MCGD8H3/.10 ZFXI3UH% "BBBDS0 M%)FD!YH =24M(: "B@4"@!:*** $HHI
M10 E%%% !2TE+0 4444 !I!2FD% "GI4$_\ Q[O4YZ5!/_Q[O0!(O^K7Z44+
M_JU^E% #Z*** "BBB@ HHHH **** "BBB@ HHH- "9I:9WIPH :!D\TX8[4U
M@<X'6A-V* 'T4QMQ'%,P^<4 2F@=*0#@9ZXH! H =7(>,[:SN-#OM'@@WWVL
M@QJBCE6*A3*?0*J@Y]5 [UUQSVKF+[PC]MU.74?[;U:VFF41X@G5551G "[3
MQR>N: -UH8;JV,$R[UDCV.".HQ@C\<_K7-"QBU/QS8W]NY6#2+:2"25?NN[E
M<1@]#@ D]P<>M:L>@&*3]QJ-Y! EF+.*%7!5,'(D&03OQQDG''2LS2_ T.E2
MVY_MO5[F*W;<+>:X7RW//W@%&>3GZ@4 =8B[5Q3J3ISVH) &30 9XI&['W'\
MZ:<YR.@ZU5U-YUT^1[>-Y) 1M6,J&/(Z;B!^= 'D?ESZ_P"#='\/7(2QMKS4
M)0NHYR5\N8N%QQ\Q/ )...YXKT'6+S4Y=6?2],;RY(;19RPC5B69F5?O$?+\
MC9QSR*QX?#DB:!+HLVB:K<VCR>8GFW%MOA<L6W(RL,$$Y&<X(IU_HNHW<MI-
M##X@MKNTC\D74=W:[Y8R02K9;!Y&<X_G0!;M]7UQ?$.BV-\;>![O3Y9KB&)=
MP26-D4X;/(^<\<'CK5$ZYK\5GHNH-<0L=0O39& QX49$F'SG.04''_ZQ<33;
MM+ZQO(]%U%'LXWBB7SX"-KD%LYDR3D ]15>?P_</965E]AUGRK*[%["WGVVX
M29)_O\CYCQQUZT <]XFU/4;OP]KVF:@\-S<:7K%E%',(_*\T,T;@E02 ?FQ6
MMJNM^(M$36K2:_CDFM=.?5+:580N53AHF!)XR0 W6IKOPW]L?66NM'UB3^U)
M8IY@MS;KL>/ 5D(?CA5X.?NU;_LBXG@ODU#2=3O9KZU-G),\ELI6(]E428'7
M)/<@4 6M0U'4;?Q%<65O<(ROI<EW$)8\[65U7J""1@GK_P#6K*_MCQ!;>%[+
M6KNZ9[:XCMY'^R61FDMT*,9#C)WY.P9Q\H)X-*-'OA=&[F379IOL;6;2%[4?
M*Q'8/^7I[U82VOK/1;*TMK#5XQI^%AE#VQ8KM*[6_><\'/;D"@"O!KVLZO!+
M;:/?Q7$L%DEQ'<0HK+<.[2;-VX\)A #CD$D=JM#4_$-]K+Z8&AT^0:=%=,PB
M$OE,6(90"<-T(']:RX_#ERKPS:;%KFFW0C:*:>%K7$Z-(TARI?&<NV".1N[U
MI06%Q979U"RTO5E(M%L0K26^U(U)P5'F9R"2>OX4 0Z+X@U>[/@^ZNI8A#K<
M+EH8XL>41"TH.XDY^[C&!U]J?I^M>(K_ /LW5K.W\_3KZ0&2-511%$Q(1@Q.
MYF'&Y?<XQBF6NF26T.BV<6FZRJ:$,V[[K<F0%"A#?O.?E8CC'6JL6A7&G709
M;776TP3"X@TXS6YCADW;@5(D# *>0N<9H DLO$^N&W\/ZE>FV^RZCJ1L3 D9
MR<^8 ^=QQRG3FKG@AKRX\0>+9+B[:3R]2:  I@-B-,$<\8'&*J'26:RL+$V.
MN&/3;T7T#![8'>"QP?GY'S'TK1TZ!]+UK4M1AT_6L7\@F>W:2V,:-M"[E&_.
M2 .I- %FXU&]U+6M5TW2KE89+&VB?+Q;BTK[R%/(PN$'/J3Z5BG4KGQ%+X%U
M:*X%N;U9)1%Y9=8Y/L[Y8<CL6'XUH7-O=SZS-JMA8:M9SW$:0SA&ML2HN=IR
M9#AEW'!'J>#44>F^5_8ZVNF:M:PZ/D011FWPV5*')\S/0G@8H T_&=JL/PZ\
M0QI\I&F7&2O<^6U%D^HW<^GPW6FQ6\*VSRP7 E$ICD"JBX^48RLC^M5]?%UK
MVDW&DR6.KV\5VC12/$;?.UA@C_6^AJL(;\-9PW$6LS6UM(LBP>7:HLC)]TDA
MP3@@''J!0!%INMZS<^*)O#MQ<Q+=VT[33NL8VO;$?N]@W9#9(W>E4]0\5^([
M3P]J^LA+"2#2=0EADA9&!GB1L8SGY#@]><^W2G2Z9,39-#IVOQWMI*\XO8TM
MRTGF??#?/@@YZ>U4+*WN-6AU[3;BTU=K.ZU":2>VC@B4NA.1AV88!QSC/L10
M!N7?B'7;F;4/[#L5NFM;B*-(V51YP*QN^YBPVX5SC@]!FJ&L>+-?LY?%A6.R
M:'1;>&X4&,EG5T+%3SU^4_-^E27&C7$^JW-_96WB33H+S N[6$V^V<A0F[ER
M4.% RN"<=J9=>'S<KK^_3_$"IK,$5O*J+;[HUC4H-I\P]B>N: +6I^+;Y+VP
MC62+3[6[M8I+>XN$/E32,<M'YG16"] >IJ6]\0:]-+=RZ)9F]6TO!;M:LBJL
MH&T-^\+#!R6(X(X%4+S0I]1T[^RIK37O[/GMX[>:$QV_*H  RGS/D;CT/TJ.
MXT:>2_N9X;7Q1;V5V?\ 2M/00;)2%"[@Q?*9 &=IY]J -NV\1W4_C :4]U!;
M2K/)FQFBVO+ $;;)&^<-EMA('0$^E=:6(S[5PT-E<#4;.:XL=8:WM+YKNWCD
MABS$75E(+B0G8 YXQG@=:Z[3;:6TL?*GO)+MS([^9(,'#,2%^@!P/I0!@^,2
MROH4JHTC#580(U.-V0_'-<YJZZWX>U#Q5XRM[2&UABL D=M*=_GNF#YCA6P,
M*"!SGU%=KKNBMK'V+;>-;&UG6Y4JF[++TSR..3Q4FN:,-<T&YTN>X>);F(Q2
M2H!D@C!H PTU76UOK&RG^QQS:JQDMVC1CY$2H"^X%N6RPQ@^O%9.J:[K%W'/
MIB7,-I?Z=K5K:SRK&6$L;LCHV-PQD$9&?;WKI+OPW]IM]+DCOI8KW36)AN<9
MR"-I5E!&Y2,<9'05!-X.CN+2X)OF2^N;V&\FO$B&YVBQL&TY& % P<\4 9?B
MCQ=J/AI;N::6U<6BP%8D0EYPQ4.S -\G)P,Y^M&O>+]1MK[Q''9Q6X71;.*Z
M\NX0@76]68KNW#&  ,X/)JUJ/@3^U4U*&;6+E8=1:)YU"C):/ #;CV^4?+P/
M3%8&H!QXLO3<ZU<V;B.&*,S:,+E9@J@LZL%(&6'('?M0!M)XJU2^:.TM(HDO
MUTZ.[FC:%F"M(?D4 ," <')R<4?\)!XCN]4BTN"RM[6:32OMA\]2[PR;PI7
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M Z'Q#JO]C)-<QVL4ZWTUK<SKQ'$$+@.%+9)8JHVY/WCUQ5*YU.77-#\.ZA.
MLPUI8SY:LH;;*\><'D9VYYJ[)X/G_<746JO'<0:A-?J!!E2TN<J06[;FP<\9
MJ2/PI*EI#9_VG*5MM2-^LCQ9+'>7V<$<98T 2Z'&J>+/%94DDR6YZ=,PBFW.
MMZR/%[:%9VMJT8M4N?/FW?*/,*L#CV!QC//6M+3](>QUK5M1-R9/M[1DP[,"
M/8NT8.>>!3'T65O%9UI;XJC6HM&M_*R"H8MG=G@Y- &-IWBO4]6FLKRQL1+I
M5U.RD^4P9(LE1+OSM/J5QP.YJN/$>I0:->7":;9QRQZXMBZ*<!E:98_,)'5L
MM5W2O"=QI%ZUK9ZS*NC+,;F.P%N/D).[8)<YV9[8]LT3>#9Y-.GLSJ0VW.J+
MJ3N+;G<LJRA/O],J!]* *5_XCU[3KC4%EATYQ8-;F5EWAF28X&./O*0W)X/H
M*BGN=5TW5?&%]I$%M));FWEF2=B/,1;=20N!PV,X)XZ5K:KX4EU.;5)6O?*.
MI?9D91#GRUA9FZ[N<YZ\=*DN?#E]/)J,D&HI"FK(BW7[C+QD($S&=W' Z'.#
MSSTH J6/BZ741?RP01&)-'M]4MW9#DB7S#M89Y_U8Z8ZUE6/C?6=5G\.P6EA
M:_:=6TUKS=*S!(W ^[QSCI6TW@Q[2<?V5J1M('TV/37@:+S (DW;2I)X8;SU
MS5;1O!4VG3Z!(=4\S^R8'MMOV<CSE;U^;C]: )K7Q5)=>)9-,CDM%EM[EXY[
M27*7'E@$K*N3AU/!X!P.],TCQ7J.KMI=]96@N-(OI&&XQ,LD2<XD)SM(/<8R
M/>KLGAB2ZU."ZN[J&9;.Y>>WD-OB=%((\K?G[@SZ<@8]ZJZ/X0O=%GCL8M;D
M_L2&03062P!2@!W!/,S]S/;'(XS0 SQC=M<>(_#6@,SK:ZA=.]QU"ND49?8?
M4,2H(]!6U>^'["7[%<NBPS6,JS))&,8QU&.@!&1^-/U_0(M<@ML2M;W-K*)K
M:YCQNB<>QX(/0CN*ACTO5;CREU#45\N/JEM$4\W_ 'B68@>PZ]S0!B)XSNKG
M3K378K6(Z-<WJVRMG$B(TGEB7/0Y;M@<=Z2\\7ZQ%#K<ZZ=:FVTJ_%O(TDK9
M=-J'Y0 ></W(%2VW@R2WTS^P4O%_L6.Y$\:>2?,7$GFB/=NQM#=]O3CWJ>^\
M+37-EK]I]N"1ZI<+<A_(),3 (,?>^;B,>E $=YXIF@\2RZ1'-9K-'-;J(9SM
M>:-]N]U.>=H+# !Y7M5-?&.H-H6M:@+2)Y=*U-K-EP<2*-G/7C[YQUZ=ZOW7
MA274YHWO)H9HTNHKN"1X/WELRLK,J'=P"0?^^N]4[GP1J31ZS;6VJI;V>I78
MNV40%G1OD! .X CY,XQWZT 2:D7T_P 7>(;ZS ^UIH4<BAAD%@\N,_D*;;:Q
MK5IHNER3I88N;9IGN)G.U<(A48X)9V8\#/3O6O+H,]QK5YJ#W2>7>:>MDT8B
M((P6.[.[U<\8K-M_"NIPII,G]KQ/)80O;9>RSA6"*"F7RK#8><G.X\"@" ^-
M-0E_X1?[)IT+_P!MV#W*AGP(V5$;GO@;QTR?:LJX\8:[J,&BI;K;07$FN-97
M*(Q*DQDG:#UPP!)X)^E:]AX+N--N?#<DFIK,=&BEMXU%N1OC<*H!._@@(/J2
M>!TJI;?#ZYBL#Y6IB.\36GU>)S =H9L H1OZ8R,Y[T =7XADO(O#-[-:[5N5
MMW)).-N%.<5S>E7-S:P>'K=+&S_MB^T\*LX;(CA158YZ,?F;H.*ZW4[.6_T2
MXL=X62X@,1<C(4D8SCC-8,OA.\0:)=VU_"NIZ3;F!7>$^7.A4#:P#9'W1SD]
M>E %:#Q9JUU;QP1:;:KJB7TFGSQ22DQK((6E5@=H.U@%[<9/I77VCRR6T3S*
M%D* R*#PK8Y ^AKF;'PO=07,5\]\LEP^I&_N"T1&<PF'RU^;@ 'KS76*NT<=
MSF@!U%(<T"@!:0\4C9SQ2,">E "DT'A:: 0.:4G=P* '+TI:08QQ2T &****
M $S1FBB@!:2EI* "BBB@ I:2EH ****  T@I32"@!3TJ"?\ X]WJ<]*@G_X]
MWH D7_5K]**%_P!6OTHH ?1110 4444 %%%% !1110 4444 %%%% #<<TN<'
M%+3&!WJ: *]_?6^GP?:+F>.",$ O(<#DXJD_B;1HH&N&U*'R4F:%B 3AP,D?
M@.367\15\SP3?1"-Y7D:-51%+,W[Q2<  G.T$_A63XBN+73_ !+8:HUIJ+:9
M):R1M-IL;XBD+H=[A.>0",X- '52>)-*MX([B?4+:.&56>-]X8.JC)88/(J2
MX\0:9:0)/<7L,43Q&59'. 5'4_0?UKADBM]/NM-M[/3+ZPL_LLXC>6UDEF8$
M\Q*?F\O=C=DY..F*SI$GNO#&C75O>75C>PZ+% (;F!FM[XD8>%E(SO!4<@@G
M<,9YH ])?Q#I<=RMN;^W\]@I5-XS\W*_GV]:6^U[2=,\\WM_;0^0%:4.P!0-
MG!;T!P?R->?-YI\,>)=&O+.>'4[Z4R6JF,G?N1?+"GI\A7!';&:O7,<<6I>)
M3-MDN/[ @A60Q%M\H$X8 XY.63@<\B@#M;[7=-TQ(WOKZ"V5UW R,!QZ_3D<
M].:Q;OQ,FF^+)8-2O;:#2S8I/&9.#N+$'YNF.E<KJ%U+<6(0P2QO+H!'GI;,
MTEP0I!AY4[0#C.1G)&,<UIVUW9P:WIU_J<$L=O/HL<2/-;O@R!LLA!7AL>O6
M@#1UWQ+<VVO>$X=-EMI[#5+EXI'7#AE$;,"K X[?I6])KFE1:HFFM>P+>.<"
M(N S'&<#U/TKRZVTR[T:7P/%/!<"-=7N;G8R$FVAD5@BN>@QN ZU<T*SMUV:
M/K=EJ<^LVFJ27<842^6^92RRA@-J@*V""1TQWQ0!Z!XB\16?ARPBN+P\2RI$
MH]V(&?PSFI7U_1U:.*34;57D9$5'D 8ESA1@GN>GK6'X^MIYO#UK+# \IM[V
MWF<*A=E19%+$ <\#GCTJK8K97GB[6;G[*T@>PMVAB:$@[U\PD D8##(]QD4
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M2KMY?6VGP_:;V>*"'<%W2,%&3TY-<#I:0Z;\0--::"6*T.@1VUJ)D+N668D
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M1110 44E+0 G>EHIC'YUH KWUQ;VT9ENC&L<2M(7D( 4 $DY/MFILQ>6> $
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M&6+;EQUR,<?6IX9[UM9GAF%O]C$0:':Q\TMG#9'ITP15H7=NRNRS(PC)5RK
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MD$@>-A!+$YR8N.0!Q@]>*=>>']7U/3HK751IFHQLDAN;>5&2,2,1M,9 ) 0
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M<)#O)(<,/,#'EF^;)R!]37;^(-5;0]#NM02!IVB .Q3R<G%:3N$^8GC'3UH
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M:+'YUW;20 R/A5++C)P#Q]!5O3[B6XLH9IK22VF=07B=AE20,BK8.X'(Q^-
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M6,5G+:JT$3AXUW$;& (!4CD<$CBFW7AS2;RUM[:>P@>*WE$L*[0!&X_B&.]
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M2TE+0 4444 %%%% "'I44W_'N]2GI44__'N] #U_U:_2BA?]6OTHH ?1110
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M>(1/)Y:,4 R-W8G(P.<\^E5%T"]_M'0[DW$.W3K5X' !RQ8)DC_OC]:D\0:
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MQ(_*@"QIWB8W5Z\%Y:FSQ9+=J'D!^3/.X?P,,C(/YU7M_%QN+K2HUT^01ZO
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M6SOIC;)=NJ8$V2 A ;(Y&,XQGO2:-X;U#0_$,FHQW-O)'>Q;]20Y'F3YX>,
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M (>E13_\>[U*>E13?\>[T /7_5K]**%_U:?2B@!]%%% !1110 4444 %%%%
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M+G[2^2IO.<\\Y QGTXZ5T3:182^-[C3O/N6LYM),\Z?:G&7#* P(.1PQZ$4
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MRRXQM7>6 &?7Y2?ICUK-NO%^GVVISZ?Y-Y-/!)#'*(8"X3S"0K''\.5.3VH
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M:.&24-]E-VA>)@LD(.-ZD Y&2/?VH O_ -CZ9);16[V%N\$1RD;P*54^H!&
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M'N.>E1Z;X=NK"#1(4O%E339I)BQMR#,7#J?XOEP'/K762,K$1G'S=,T_.U0
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M^$]&N]$35$NA 3>:A->#R6)QO;.TY JI?:7XKNM7:]4Z*R1MBUCF,K>4.[8
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M%]EP!DC!P K*,]>H/05D:O>7T'B#^P-1UL64::;$]K<S7<D/FS'(=Q(,!BI
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MNZ$C'I0 ^D([4 Y&:83M;/)_I0 +UP.E. (R3C/M0O/-.H 08H89&*,4$XH
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M%_U:_2B@!]%%% !1110 4444 %%%% !1110 4444 %%)F@&@ Q2T4@().#0
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M+'#.=KW(5PS(R]E(&.>N>PJOJ4=YK.N)J-O874!M]-N+>2.>/8T[OMVJ.?F
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M$6\W]H3;<PE"8]V4QD#*X/&.* -.ZUW5?^$HGT6TL+:1HK-;L/)*0"K.Z@8
MSU0^O7I5CPWXGLM>T2'4%E$)D9T:.5@"KJ2& ]0"#SZ#-8<RQ7'Q0G:078B;
M2HX#-%O1"WFRG:7&!G# \'O5/Q!HMI8^(O!UI9Z<8[2&YF,^R-F54:)@=Y&>
M"QZL>2: .^%S$IC7S5)D^[@_>XSQZ\5!:ZQ9W-]<6*3H;B  NH;IG/\ @:\^
MUFRG2YUZQ>V(OG\C^PIUB/[L+&H"QMCY=C!F//0FK6H);V&L>+S'H_GS36T4
MD*Q6[CS 4PYWJ.,GJ 03B@#OH;N"[C=H9XW5#AFC8$#\:='/%*6>.57"_*=C
M9Q_]>O,6$$"^*A8M?"WN=$BD6>&S\C+*)MVS"J <;!@\]!GBK-O);ZA)J*6#
MPP:TVEB"&&*TD@.5W99"ZKV(&!T % 'H@GAF5C%.CB-MKE&S@]P<=Z4W$;EH
MXW1I NX#/;_"O+8Y]*U#PKK4NBZ+?07#Z9-'<1RPR1K%($.V,*1B1]Q/(R>G
M-;%I8I:>(_#LR6BHMQI,\=XXA(W,3%LWG'7'F8!YZT =AI=W=2:<TVHQV\$R
M.X80R%D"@G&2>^.OH:N0SQW";XV#+ZCH:\DM9[S3M#T":ZM;J72K74[K^T8(
MH6.$9G\MG3&2BY4XQVKL](U+1M'TX&STZ[LK*YO1% ABD^=WP2X4\HF2>N!Q
MGH10!U@.10:C3<  W6I.M  !2T44 %%)2T )2BDI10 E%%% !2TE+0 4444
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MM3N+6XV*7$K+;[U(YX4K)T.3GOQ6A_PD]['K%M;R)"\,U^]H3"C,$ #D'?\
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MC!Z9S^% '5B-0?N\CN>M*0JXX[UQFF^,-2U'0M/U8Z?;P0WY2.%6N2Q$C2[
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MR6L*Z7^_;59-+N(S/PDBQF3<&QR"HST[XJ2Y\9-:6NI2W&G2?Z!?):R^4S2
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MW:(#RI+(H!&.@!/U_"N=\%ZW-HGABPA^R))#<ZS-9APVPH6F8 A0N"/Q'XT
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MV9U>YVWDZW+.4&58;>G_ 'R*Z<WUJLBQ-<1+*XW+&S@,1ZXZTQ;VWDA21;B
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M,5E);W3>2P,3-&@!?CCYD[XZ5Z=M1V/"$-][CDD=*AFN+:.>.*:1$ED.(PS
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M45GZ=+#)IGA5KR2.2SL_$=VCO)]R%#OVJV>,9('ITKVN&TLX%0100H(_N!$
M I_V*T,)22"%TSN(9 1D=#S0!@>--0M;7PO))<I(\4CQHI5]B\MP7/9./FSV
MKB+VZ^S1>(DBE@DL5U&REO\ [*F%,.V/S"JJ2=O')YR%->LO;Q31-$R*T;##
M*>01Z4U8X&+NJH&(V'C@@=J .#U6\\/IX<UNYTBXA\NX\AVDB(^SEPP&% .-
MV!D@<X(S568Z=_PC?BVWOH4_M_[-*;AG97:;*$Q,A'\)R,#MT/.37H8TVS2
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M* "EI*6@ HHHH *!10* $/2HI_\ CW>I3TJ*?_CW>@!Z_P"K7Z44+_JU^E%
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MQ0!5U[Q7>6&FK>QO!$K:<;N*-P7>>4+N,8 (*J .6/J/3F2SU:^U/Q1HSQ7
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MMJ%OXBB.H!#K+QREEAYC=%15QEB",(/SKIXK24Z8;2ZN//E*%7EV!-V?8=*
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MX!ZGK0!U1MXC="9H8_-QCS-HW!>>,]<4Q;6Q"M''!;KM?<0J#ACSGZ\USO\
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MD;R]Y7'52!G&>N*ET[QE!J6K6FF'3I81J-K)=6K2L SHAP5=, H<$'!SQWH
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M'&Q^?$("C;G;U;J>GK5N#QYI\^B0:E+$T%Q/<O91VLKJ&$ZL05+9QVZ],<T
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M2U&+3M M9)+3_B6WK3DC?^\!##'3@_,?4<=:F@\*:D^L1:E-/;0WL,$D#7D
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MQD#/&#CK6!XE6>UU34]/2YND;5;('3P+AP1=!MOR$'Y1\R,<=A79Z7HNG:-
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MX120')SGZ Y.0..: .!MI;^75-1TB.ZF9-3O([RPF:9SLM Q#[3G(P5R.?\
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M>#R[N6W,4:@Y&$&&^8DY/3@4 5].;48-?\/V6H7-P9KG2Y'NHI' S(I09P,
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M\THH8$CBFX(H ?FDSS3"&I54]Z '&@"EHH **** "@T4&@!**** %I.]+24
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M+U- !@=,4=Z 01D'--=PI )P#WH ?C--VC\^M!.!R<>]#$8QG&>] "XI:0$
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M5(FIZ?+=?9X[N!YD)&Q91N!'48SGCOZ5S_P_N$E\ :3&@W&WLXHY L90B14
M(Y YR.:XW1;J&;4/#<]G'):(MY=Q&U>,AH'=6 \USG>S,?7'(P.] 'J1U&W:
M:2T2Y@6]QQ"T@+ XSRN<^AK'\,^)EU+PY9WVJ2V\$]Q+-$N&VJY21E 4$Y/"
MCU-<SX9OM-AM-.L-7@8^);&[FDF_<L&60E]\I;&-A1R>3@C '(K&\'WR:?-H
MUUJT<=Q82RW$%O,JY%G<>?*S%AC^-73!SQ@YH ]3?5]+B">=?6\9,GE@-,OS
M/_='/)]AS5B:^L[6413W$,3/]T/*JD_0$UY*B:7'X:\72.T:'^VY);=L?,!O
M# @^G)-=1-)8C5O%-KK?EK#>QI):F3 \VW\I5*H3WWASCK\P.* .ODU2PCG:
M"2ZA64(69#( 54=2>>![FD34]/,<8@O+9VFR(0)E/F,.H'/)^E>?7&GZEI>E
M^%M86S+WJV2:=J,;J"\@DC"KGZ28S^-6/!>ERV=\NF7@&SPVTRQSA<),LH#*
M0/\ 9!8'W% &WX/\2S:SX:N-3U=[: Q7D\)*91%5'*C)8GT[FM]-2L&L#J$=
MW"UH1GSUE4IUQG(..M>+Z9=,/#^C7LXD?1[;6[V:^>*/=Y.YV\J1A@_* S-T
M[BMB==+M=2T/4K=KJ;0/[5ENKR[E5O*,C0X1\$<(&_#/- '>Z%KCZA_:[W<M
MN4L;OREEA/R[/+1P3R>?FYK5AU*RNR1;W,4V.3Y;AACOR.*\ZO6T\Z)XJ^SW
M$$</]H0W*B&/*."D)&0."I88)YJN]Q:ZI:>*M1T>>RFU2ZMHU6WL_FD2./(?
M#%5.6&X#CTH ](@U?3KM9)H+R"2&'B61)5(0]MV#Q^-68+VWNK9I[>:.6,9&
MZ-PPR/<<5YE<S^'M7G_M#1=;NENI&BC%\T>;>%T8M&KKA1U8@]P .G%=1X$N
M?M?AF=WTR*R<7=P)4MF+1S2>8=TD9/.UCR* -^+4+2>Z$4<\33 <QK(I8?4
MY[BDCU*P=UACNX6=W(15E!+$'!QSV/7TKR/1]3LG\1>$KF$P6=L+^^B:SP3)
M!YB/_K'/)9FP<< <5'H\>F6^F^';A?(61?%4^)/E#*FZ4 9[+DKQ[B@#TGQ%
MKITE(S93V;3M=6\<L,DF7"22JA95!ST;//%=*.@SUKR 7\47A.Z_MQH8M=AU
MJ"2X6< R!?M:%6'?;Y>W'TKUV)M\8;L>0?44 .HSS128YH =1110 4444 )2
M]J2E[4 )1110 4444 %+24M !1110 4"B@4 (>E0W'_'K)_NFICTJ&X_X]9/
M]TT 2K]Q?I10OW%^E% #J*** "BBB@ HHHH **** "BBB@!*!10* %HHI"<$
M4 ,< L :$38>>IJMJ,TT.FW4UND+S11.R+,VU"0I(R>PSU-<S9>(;U&U4RNM
MZEG8+<H4B*[VPY8#).1\H /UH [(TWD%B>G:N-TC7]5N=9L[/S+:XAO-/%X9
M$4L(WS@H,-T&1^1'?C,M?&.K?\(QI.M7:V^S5O*MH;?8Q9)V=LMG/*[02!P<
M@<T >C#H,]Q2Y^E</+KFO+-8Z9):QQ7UW/<!'&"?(C *N%W?>(905+=B:JS^
M+-6T^QL)=>M?[(CFEFCDNTC\V-=N/+9@&RBN"2<Y^[U&0: /0CP"0*S;C5[&
MVEMK>6>)9[R0I A<?O& R<#O@ ]*2VGNY?#Z3R2PFX:V#B2$[T+%<DCU7/3U
M%>86LEY=Z-\.KI;H2SSW[.C.A7EHI2V>>><^E 'KXSN"XQWZTKF- 6<\#UKA
MX/$&L'3=3:ZDL8Y[/5Q8O.V8T6+:C;PI8EGPV H/)/X',OO$&KWGA^8)*(Y8
M-=AL&F\A@94,L0R5W97[_3/;MG@ ]+5@R9-57U6Q74H=.-Q']JF0R)%N&XJ.
MIQUQ5#7)+NW\*7\L4JPW45K(RRK&?E(4G(7/'3UX]ZY6=;T:]X/"M')?26EU
MME>,J /*3!(W<XSZC/M0!Z&  2M(Z[LQG[I4UY]I/C+4]7TG2(1%;Q:I>3W<
M<A53M5('V,RC.2<E.,]SZ5TOAV_UBZL9SK%FD%S'*T<;H1ME48PX&25SGH3V
MH MC0-/R&^R+GOB1J!H-CM(\DCZ2-T]*Q+74]?U.2"]L4LVL#?F!T)(8P D&
M0G. _'W<5EZAXPU6UT4^*XXK9M(CO3;O;A&WM#YOE&0MNQN#=MO2@#L?["T[
M8%%L-HZ#S&P/UIO_  C^G%\M; +CIO;FN,G\2^(0/%LMK]D6/0BLD8>-F\Y/
M)\TJ?F&#SC=S]*V(]6UJ+7_LUU]F:"YTN:^@"1D&%T:,;#\QW?ZP<C;TH W&
MT&P9@1:J,=#O/'TH?1++;D1\@_+\YXKDH/%.K6-SX;N]4$!L=>6*+;&AW03.
MF5PV[!!/;''J:N:5K&MWUWIUQY4#V-Y$7;$>%@!7,9#;SOR< \#KVH Z(Z#I
M[,6-L-YZG>V3]:C/AW3R/]1SZ[SP/2N9T3Q+KMW;^'+N]BM1;ZD[1R")3N5M
MC,&'S'CY3QC\:FT'Q%=ZEJT]O+=1074/G&;3IXS')&H.$8$DAEQC)'J* .A&
M@Z:%"FU&!G'[QN/UJ&:QT2&_M[9PJ75P"8T$AW.!UXST&17%:EXEU<^$O$8-
MQ;+=6EG!-Y\2'8/,5@R*2W(#*<-G!R.O?HH]2N;+7-&LK@B87%A+,\NSYE*F
M,<<G ^<G\.M &TV@:<5*FU&TG@>8U#:!IVS'V8'W+GFN1O/%FI66BZ/XD803
M:7?3HK1;"&BCE.(W!W')Y (QW]JIW/C77(K6]OO(M'MK/6AI[+L8,ZF0)G[W
M!&<]\^U '=_V%I^Y0;;*@<9D;C]:1_#^G,#FV#?[)8D50\;:Y<^&_"MUJEI"
MLLD05=I. "S!<_K6=_:WB'3M>?3K\64ZWEI+-9&)60HT>,H[,<'.0<\=.E '
M1_V+9!A^Z;.,?ZUNGI]*:- TW;M%L$]0LC5S5IKVKZA=W-A9R6<US_9L=Y#)
MY3&,2%V1H_O_ #+E1\P..2>:GT;Q)>:Y!H+6WE)/<P237RO$<(8P%=!\W'[Q
M@!G/ /I0!MMHFEQ0/(T"HB L6\PXP.YYJC8>'="NK".XM3//8S1AHE%],T3Q
MGG[N[:5/IC%4-%\0W=_K4.EW8MB+BSEDE6 ';"Z,JE V2'&&ZCTK*\):KJFG
MZ#X,CGBM3I.H6T5HH ;S4?R69#G.""$/8$>] '7V.GZ+>VH>SVS0QLT:LDS,
M%920P'.!@@@_2I1X?TYL,UMDGL9&.*Y73-3N-(\/+%:+YMQ<ZY?Q)O0M@"YF
M9C@$9PJGC(KH?#M_JEXMS'J-EY(AF9(IA\HG7LP4DE?H2>: );6ST>ZDN%M'
M#O;2E)O+N&RCX!Y(.0<$?G4_]A:>%($! /5?-;![<\UP][K%[X=C\7ZC:00&
MWMM5B,J29^9&AMP<<C'4G//7I6A?>*]5-QJ5MHEFES/IZ1;XV4L96=0V =RA
M>#U.>: .G_L.Q*X:)F&20#,V!^M']B694*8Y&0=$,[[1^&:Y.R\4:S>>,KO1
MX[.*".WM[:\E,^=RH[?O$P.^,X[9J?3?$6L:C-ITEO:(^G7RNPD2(EH%P=C$
M[P&'3( !YH Z8:'8>6R&%O+8Y*>:VWZXS4@TNWC \OSA@YXN'&?UKF+#Q+?W
M%KX8E>&'.IW4UM,@0C;L25@P.3C_ %0X.>IIC>(M;CMHKZ>.SAM$U,V<R+N9
MV7SO+R#G Q]#F@#HKJUTRV>#[7.\9F<0QJ]TPWL>BCGGOQ4SZ5;[?E\\GT-S
M)_C7):EJEQK5[;R0I;FQMM;BM<E3ORI&YPV<?>RN,=!G/:K3>)=5N9'N=/T[
M[3;17K6KQ)$Q>0(^QVW9"J5(;@@Y ZB@#HO[,@2(LWGN^.<W,G/MUH&EV[0K
MAK@8Z 74@'/;@U@Z;K.N:KJM_;K:VJ65C?&"65V;>Z; ^%'J-R]>*EU[5-5M
M=8L-*TJ"U)O8+ADGG8_(\:@C('.,L* -M=+MPN?](4^UU)_/=2-I$&W"R78.
M?^?V7C_QZN5?Q+KA2=K73UNVM;D6\L,<#L9F 42%7SM4!B<!N2!VIVJ>(O$D
M=OK<UGI]C)%ILN65Y64O&(PY ." V#W&* .I&F19Y:ZP.G^FR_\ Q5']EP,=
MQDNP?:\E_P#BJY6U\6:QJFOR:9IMG:R1I8VUZDLLA!=)#SG ZX!Q4^G>)-4U
M*;3+NVMHY-,N9F218XFWQ(02DFXG!' R,<9[T =$=+A9C\]T0.WVR7_XJE_L
MJ ,#YEWQZWLO_P 57)67CQ)+2XOY&MS:6L,TM[%$"L]J8P3AD8Y.<$9P!G&,
M]:5O%.L1P2W#6<4UL=-DNTEBB=1$RKN",6Z@C/('7B@#K1I=NHQYEU@G_G\E
M_P#BJ1]+@8GY[OD?\_DO_P 57+:5XFU74;K1$FL[2"'5M->YM]KLS)(%1N>
M "']36+H'B^_M/!&BWVK7,*M>73J][-N**"[?>Y^49^49.!@4 >@_P!EQ;O,
M,MV,#&W[9*0?_'J@CBTU;P0B\F><G@?;9#@CM][]*GT>XN+W3%FO(8X96>1=
ML3AD*AR%8'N"H!_&O-I+$7NCZS8Z98/-J\>LR&"X\L8A(EP&WG[N /Q]#TH
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MA;BTU2/3YXHI=P!=T4,K%1GAP<8% '62Q6\<+-(D85N&R!CDXY_$U.@#1;<
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M7[^;<6J0*6W%0&,<F<H3@<X-4[?2KW4[KQ+8PWDUI::A*JYEMF/R")8W,;9
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M9^*,6VKW.I*ENEEJ'V10K;@W"8P<#DEO2@";_A'W:_UMIYHYK35E"/&(RIC
MCV=<G.1["LZP\(WUGI&EZ3<ZI'=:?ILT,D),)$KB(YC#'=@8(';MVKK1.G[O
M<=ID^Z#U--$JY*,0"#^?- ',3>$KMH;V"#4H4BGU#[='&]N7&XN'97^8;@3Z
M8_&L37=#O]%T;5E0R7T6IZG%<RM':&5K< )N8H&RR_NPOR_,-V<]Z[>?5K6'
M6[;2S<I]JFC:58/XMB\%OIG JW)-'O,3CH-Q]* .!TW2+S7+:6>WN(;6XAND
MO+6[339(,R8*N&21LNI4@$Y'!QVK=G\/ZI>?8Y[S4HGN(;Q+IT2)A&0H "("
MQ*@XYR3SDXK?$D<:A@ NX\^@_P XJ8L"-P88'4T <M<>%;JXM?$%NU[$HU:[
M2XW>43Y858UVXW<G$8YXZ]*)_#6I+KESJ&EZJ+..^VB\A:(LQ*C:&C8,-K8
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MC)K5\_\ >H@!._.".V.M!(X4.HW''UQ0!RLGAK5=7TF[L==U>WF2:V-NOV2
MQKN./WK L<L"!TP.M6#X?O[O4=/OKZYMWFTZ"5("BD!W==I9LGT[#U/-=(9
M"JA<YX..U*7'3ISCF@#BX_!=['9>%+9;R!3H#!MXC)\X+&8P.ORD@Y[UG^)M
M.FT6PU&4W4;OJ&LV=Y"@4_N@DL60W/( 3/&.]>A),9 X P5;;SWIV1]X@9Z
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M*M_#A=G?CGI75>-(+F?X5ZE;LRO<BP"N3T+;1D_SKK)%&Y"#R.,5+G)Z'Y:
M/++VVL[JXTRY\,%5U#^RKE7D5?+\S,.$+9 R?,V]:M^#I?#^H7.DFUN9_P"T
M[>WDAD@V!?+! $@9@@W@,HQR>?:O1SD$+R<G.:';: <4 <EXCATR;Q5HEM>1
M1S&X\^.2-X]P>,Q$;3QRN><5REZFA276L:#K5_<6UP)U-K;VR#/D*J"$J^P[
M",8QD="2.:]45?+=I&X&,FGI-'* 8G5UR1E3D9'44 >2^*4T\^&O&TZQXOH+
MZ&6-V&3$^R AE../FW9QU_&K\MWHDVO>*[;509;Z:!&MF9"P:U,*D8X^7]YY
MF0<9XKTS=E_I4%W(L>'DE$<2\LS' _$T >6>;H-U86UMJM]>6K2Z59FV^S(N
M\QJ/X6*DJP<'G(ZBM+38;>]\<>*WCBCDO8DMY;6-T&%E$8(?TW;L<UZ- <PA
MO7GB@2@DGG'I0!Y9X7GTRZ739[74;H^(+6&59+8QH%\PJ=X=]@WC=S]XTS2;
M_219> [@N%U!;YQ>.T1WM,UO-YN6 Y_>'KG%>K1$X&XX ]:A9@MV7,@)QA4S
MUH YWQZ8%T[29+AF6%=5MF8IUZGI7-+X:AUC6?%^D6B)'HMY:1;-H 6&Z(/S
M*G;H&) Y)KTXDR1C&5)Y^E5M1LI=0L&MTO;FS<D'SK<@.,'W!'/TH Y'PCY^
MM7L5_>Q*&TRU_LTM@9:=3B9QZ#Y0!^-,U='TCXG:;K]XQ;3[FTEL% .?)EW*
MP;'^T%(X_&NRTVQCTRQ2UB+&.,'!8DDDG+$D]222?QJTKAE!YZXH YOQ#K4C
MZ5>VVC.)-6^RS26JE,#>$)'+8 YX_'TKE[2*SDL_!EWI:8N9G*7C@;7DA\E_
M,WMP6PP'KSS7I9;;N8@X%-=6=@03@?,.* /*-*6PM-$\,:A!EW'B.XMTG8?,
M(C)<J%SUVXQQZU<MIHE\56R3VT-]::A<72VMTH*2PL58/%(&^^HP0"/;BO35
M#%3DG)]NE+]Q.><4 >/>'[NSAT[P5;23XO8-7NK=R4)8(!<@+NQR,[:O:A%$
M_A[Q(\X1@GB.-BQ7. 6@SC\,UZGMW GH3QFFN-J9 Z'- 'E/B6?3I?[4.GI%
M D/V0+)(F2@ 5E$*A?W8PW)SUZ =:O:O!:ZAJ?C:29Y)-FDPRQ1,<JA\J4[@
M#P#D Y]17H[;I(<J2I/2FKM2(;C@].>* /+?#M[%=^,_"][?[6NY_#K2'*9+
M2&2/G/M75>*KJV@UWPO<2A44W[QO)LR<&WF 7U()QQ74QJ(D8[< =,>E/P"^
M<=!D&@#R6VDMKWQ1:6R3.;8Z]<(T<647:;;.,>F1_.KDS6UK#9Z>Y\K2#XEF
MBGCVY&T*S(@4?P^9L&,8P?2O3?+4;GVY8C!/K3%4EMS [CP3[4 >97UY:Z;'
MXGCMY$AM3KEJUQ^[)"PO#!N. .><\>E2:C:Z?#H%^+.]DD$VJV+2K;H84C9I
MXT95&!@%>3UY)KTOA&ST4#\*>6!3*G(]J ,^TTBRT[3I+&T@5;9BS-&W()8D
MMP?4D^U>8^%3:77@+PG;C[_]IH)]HP2Q,PY/?H?RKU@;<Y5L_C3LXDSU8C\A
M0!Y=JD*67AKQG:6H:*"UUB Q(AVA2T=L6  XVY9N/>M'7VFM/$%UJ'EPZAIL
M<]O'=J2T<]H_RE&C8\,IW D<=Z]"9,8VC@= .U-(Q@[?F'>@"CJNH+HF@SWG
MEM(\$7R1@\NW0+GMDX&3QS7"7>G:CX3FT+7=0N89EM9'MK^6)2&E6=\DXSR%
M<@@8R!FO1U5BY.#QTJ8=1G[WK0!YWXIG!\37MI-"TXFTC%N%8!K>3<^&R>[$
MCD=-O-13Z/!+XB\)Z7>RS2++I5TEPB3.$E(6(<\Y_B8YXZ=JZV]T;4'U:6\L
M-6EM?/"K+$T2R*0!C(W#Y3[=.^*NZ7ID.D6)MH^$WM(SXQN9CECCIR>: /-)
M4MM1U#5XM2U V5W8WH6V*0%Y8X8\&,I)SC(QD$YR3FFEDUO5M5FU+4!8:C8Z
MD/+:. O(D2X*;6&1M/)*\<YS7K"@ GC.[DGUI[#>,$?2@#RK5-/@>V\=73O.
MTEC,LELQD.8F\I&^7TYK1U59=%U+7VTG<DK>'Y+GYG)S*&;:QR>N#^@]*]"9
M$ #;,L. ?2F^4J0D*FWG./?UH \YM(K +<WUAJV]9M+E3R(+<Q>:H3(D9B!\
MXZYZG-&F6\=MKG@F>(R%KW3IOM#LY)EQ$A&[)P<9.*]*C55& N*7:NX''(&
M: .*^&]Q:V_@?35^6.1R^Y53JQDD[C_=/Y5VBIWI2HVX ^E,AE\P-P1@XH >
M5!-*% HW# Z_E3&?#;<'CF@"2BF&11COGTI^>* "DJ/>C R ].,'O3U<,H/3
M/K0 M I X(!YI(^A^M #Z*** $HI:* $HI:* $HI:* $I:** "BBB@ I!2T4
M !Z5!<?\>LG^Z:E-,G_X]I/]TT .'^K7Z44T?ZI/I10!+1110 4444 %%%%
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MJ;^TDAAG6&U0E H"&14 .0%!.T4 :D_CF73]9U+3]1T\1BQL!?M-%-N#(<C
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M,C9&,9&4'''&: -O7-0N--\-7]^+>&2Y@MVD\AGRA(&<;L#C\!7%V]U=K?\
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M'L+A[Z^@:=+=6C&Y0 Q8$M[\#K]*Z*QU!K_0;?45MY%,]NLZPL KX90P4Y.
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M10 4444 %%%% !1110 4444 %%%% !1110 TU'<#-K(/]DU(:CN!FUD'^R:
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M>6:U*EOI7CS2L3"Y>Z%S;110,08S#%AEP,'Y@W3D&IO$D\4OB._M]52[B-Q
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MEX]TK3+<>7+'%+;*4^5G )<@?WLXYZY(KTO2([&>PM9K6V58T3$;-;^41GN
M0" : -$RQAB PW9QCWJM+>PVMQ:VTL@66Y9EB4]6(4L1^0-<!X7D6/7K0F*V
MNV>:Y87,$3130!B21.O(()X#$CG'%:_C5($\0^%KRZ13;P7$_F$P^9C,#A1T
M[MM_'% '0V5W>_;=034(H8H(6'V>19MQ=#U++@;<<>N:O^=%N9=P^3[W/2O(
M-6EC>T^()C-RK3^4+7YB&9PK<*?3.!CMD"NBFTC1;GQA<*T41M[NR,MV H"S
MNL@P7['Y2WOC)[4 =ZKH55D(9&YW \4Y<.0X/:O)4U*WMM$\/?VG*8=)AMI(
M)6FMS.J2A@ KK@Y^4'!]<5W?AO%AX0MEA-S/##%B)Y% D=!]TX)./QQ]* -U
MI%8[,X?N >12!XQ((R?FZJN?UKR;P[>6I\5Z5<H[1VT^F30RRLK@E\[B)9.
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M;:9ITEG\S&Q599 3G!))! XY]J .VI#36)VGBG#[M  *6D%+0 4444 %%%%
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MK'UGQ -,O;6T6TN9YKD2>4(@NUBJ%MN20 ?TK/L_&UM<6UG*=/NHI)KTZ?+
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M_#^[D55&M1;4US^V $MN0W)V9W>I)S^E:6J>$;K4[?Q#;2WZ;-61-O[O!1E
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M:2PRPK"]O>6GFJFTDY4[EQG/(YZ"KFF>'K33].-C.D,^^9IV40!4#$]DY H
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M/$NV-Q"!M7T4XX'L.* .,T&XDN-/TO44UPS7LMNPDL0Q+32^6<K)\QVD,#T
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M,Q+SPIZCDYH XC0=3OK[1=,UR?Q0D2&%_/MQ&Q=W*'<K*7(4HQ)^51T]*O\
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MK9I"[@(6&68J.@R><#TZ"@#GO%%Y=K<W4-C/<-/#I[S[?-\J*(9;YV(P2>,
M=..:BM-1GU2_M[*YU&6WWZ+!<AD;;ND<L&88ZXV@XZ<UT=_X>TK4[K[3>V$,
M\P38'D7.%],=*JW'@_P_<Q6<$ND6\D=I_J%(.(_I0!BVU\^H:\^CR:M,PCTB
M&6&<-Y9G+-(KR_+C)&Q3CIS19WKWWB9M(N-2F:UM])B=)2_EM<L[,K2'&.FS
MZ<UT6I^'=)U?R/MUA#<_9_\ 5!QP@[XQ4EYHFG7OD/):J6@79$48IL4]0-I'
M&.U '%^%=7U+4HM*>\FD*OI^H!W<[?,,4T*HYQTX+G/O4NB7L^I)X0^U:A,7
MO-&>>X$<OWI (3D^A^9JZR;0-+N8K:.2RB:.U)\A2,"/(YQ^55X_#VE0^0MO
M8)&ULHC@*DC8O<?3CIWH \[TG4K[5(?!9NKN6=WU:^BEE:4C<D8F";L<'&!R
M?2NZ\<1,?#8:(L"+JV4X<@%6G16!QU&#WJ8>#_#XA:W_ +(@\A7\Q8SG:&.<
MD#MU/YUK75C;7U@UI>0K-;M@-&PX.#D?J!0!PU["\FN>+I(KR:*6'38&0PR$
M$MLEVY[G!Q]>^:6WU>^UB^M+".Y6+S-%M[L,\IC)>7>'88(R5VJ<>]=0_AG2
M]DZK9(!<HL4H4E=R+T4D'H,G\ZAO/!F@7UG;6]UI<-Q!:?\ 'O'*21&.X&3T
MXZ4 7=&:7^QK59[L7<R((Y+@+M$C+P6Q[D$^E:2'(J."&&&!888UCC4?*BC
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M&#4;:.WQ$YW HI5B1M& =W')H M6/BQ+Z\TV%+.4)?QN\4FX,!M&</C[I(Y
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M8X)'E;%N%"[E VXRV#\W!YZ4 =1I_B*:_P#&>J:,+4K#I\<.Z8'[S2*S?EP
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M1[?WG+'^(#W%7/'RO=>$6LXUCDNKJ6*.!6<INDWJ>&'W2 "03P".] $I\:V
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MI2:QY(N[18E1K8.BEI!MQ\JDG.<UTL'CK2KF_L;=1=*M]--!:S&+]W,\1(8
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MI<4 -/+8%*Z!EVDT*N#01\U #?+&U1DDCWJO?Z;:ZI9-:WEO%-$W\,B!@/<
M]ZLKP:<0.] &9I.A:5I",+#3X;8MP2L8!(],]2*T511GKUZFG%0:4# Q0 W8
M,YR<_6@@<<4N*3;S0 N,#%-**7_4^]./3%(%H -J]?TI=HQCI]*3;DYH(R:
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M%)2T %%%% !1110 4444 %%%% !1110 4444 --1SC-LX]1BI#3)O^/=OI0
MO\"_2B@?ZM?I10!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4=Z** "BC-% !1110 449HS0 449HS0 449HH ***,T %)2T4 %
M%%% "4M%% "4M%% "4"EHH **** "DI:* $I1110 4444 )28IU% "#I1BEI
M,\T &*6B@G% !1130V3B@!U(*"<4M !1110 4444 )BEQ110 4444 %%%% !
M111F@ HHS1F@ HHS1F@ %%%&: "BC-% !111F@ HHS10 449HS0 E+24N: "
MBBB@ HHHH **3-&: %HHHH *#110 E+110 4444 %%%% !1110 4444 %%%%
M !1110 AJ.;_ %#_ $J0U'-_J&^E #OX%^E% ^XOTHH ?1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "48I:* $I:** $H%&*6@ I*6B@!*
M*7%)0 4444 %+24M "&BEI* "EI!2T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 '>D/6JTU_;17:6K7$*S, ?+:0!N<[>.O)4X]<'TJP
M) ?4?44 +FEIA<;@,'ZXJI>:C9V9'VN[AMQGY?,D"EOIGK0!=S14<<H=-_\
M">0:BDU"VB9%EE6-I#A%8X+=.@^I ^I'K0!9;ITHSQ51;ZW6Z^SM<PF3.W;O
M&X-Z8]<<U9/<T +FG5$#S4@Z4 +1110 4444 %%%% !1110 4E+10 E%&**
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M$%"N$V@*_P#%G"\#..>:Z_L?K2GD]^:7KQZ4 ,QS3QTHQ2T %%%(: %HI**
M%H%)10 M%)10 M%)2YH *2BEQ0 E+1BDH 6BC-)0 4M&** "@T9I.M "BBCI
M24 %+1BDH 6BC-&: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** $-1S?ZAOI4AJ.;_ %#?2@!P^XOTHH'W%^E% #Z*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEQ1B@!**7%&*
M $HI<48H 2BEQ1B@!*!2XI.E "T4F:7- "444N* $I:,4E "FDHZTN* $HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I3P*!24  .12T44
M (:6D- - "TG>EHH *2EI* %S2444 %%%% !1110 4444 %%%+B@!*6DHS0
MM)1FB@ HI<4E "TE+FB@!*!2XI.E "FDHZT4 +249HH **7%&* $%+110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&HY
MO]0WTJ0U'-_J&^E #A]Q?I10/N+]** 'T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 49HI* %S29HHH ,T9HHH 7-&:2B@!<TE%% !1110
M 4N:2B@!<TE%% !2YI** "BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BE
MHH 2BEHH 2BEHH !2=Z*,4 +FBDI: "DQS2T4 )1110 444HH 3%%+10 E%+
MBB@!**6B@!**6B@!*7-%)0 4444 %%%% "YI*** "BBB@!<TE%% !1110 44
M44 &:,T44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% "&HYO]0WTJ0U'-_J&^E #A]Q?I10/N+]** 'T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 M%)10 M%)10 M%)10 M%)10 M%)10 M%)
M10 M%)10 M%)10 M%)10 M%%% !1110 4444 )12TE !2BDHH 6BDHH 6BBD
MH 6BDHH 6BDHH 6DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH 0U'-_J&^E2&F3#,+#VH 4?<7Z44H^XOTHH =1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% "T4E% "T4E% "T4E% "T444 &*2EI* "BBB@!:2EI* "BBB@ HHHH
M 6DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #36&4(
-IU)WH .P%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex10-2_003.jpg
<TEXT>
begin 644 ex10-2_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M %%&:,T %%&:,T %%&:,T %)2TE !1110 4444 +2444 % I<4=* "BC-&:
M"@T9I* "BEQ1B@ I.]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 "EI!2T )1110 M%)FEH #24II* %S
M29I<48H 2BBB@ HHHH 4TE%% !1110 M%%% "4"C%+0 444F: "BBB@!10:!
M0: $I:2EH **** "BBB@!H^]3#_KEIX^]33_ *Y: 'T444 +1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% "4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 +BC%)10 N*,4E% !BEI*,T +0:*0T %
M%%% !1110 M%%&: $Q112T %&*2B@!<48I** %Q1BDHH 7%)110 N*,4E% "
MXHQ244 +BC%)10 N*,4E% "XHQ244 +BC%)10 N*,4E% "XHI** %Q1BDHH
M6BDHH *6DI: $HHHH *6D%+0 4444 %)2TE !12TAH **** #-%&*3I0 ZBD
M%+0 444&@!**** %[4E+1B@ %!HI* %HI*6@ HHHH **** &C[U-/^N6G#[U
M-/\ KA0 ^BBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH 2BEHQ0 E%+BC% "44N*2@ HHI<4 )12XHQ0 E%%&* "BEQ1B@!**7%&* $
MHI<48H 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEQ1B@!**7%% "44M% "4M
M%)0 &BEHH 2BEHH 2BEHH 2BEI* "BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2B
MEHH 2BEHH 2BEHH 2BEHH 2BEHQ0 E+110 E%+24  I:04M "9I:3'-!;! H
M 6D-+1B@ HI,XHSQ0 =Z4T@-+0 @H(I:0GB@!*-U-)YIP% #J0TBG/%.- #1
M2T8I: "BBB@ -)2TE "]Z*.]% !1110 4444 -'WJ:?]<*</O4T_ZY: 'T44
M4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%&:3- "T444 %%
M%% !0:** "BBB@ HHHH **** "BBB@ HHHH **** "CO12=Z %HHHH ****
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M ):*!10 M%%% !1110 4444 %%%% !1110 4444 %%%% !24M&* $HHQ2XH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH *2EHH
M**** $HI:* $H%+10 4444 %%%% "44M% "44M% "44M% "44M% "4M%%  :
M2EHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2EHHH **** $HI:* $I:** $H
MI:* "@T44 %(>E+2&@!!22/L7-*M#H'&#0!R?Q(UVY\/^"[Z[M%/G/'Y2/CB
M-FX#'VZU/X1\/V.E>#K+3_*5O-MU:X+ $R2.H+D^I))K9U?3K/5M,FTZ^B$M
MM<KY<B<C(^HY%9NG^&/[/2W@.IWUQ:6ZA8H9'0!0.F2J@MC_ &B: .1F\;W
MNDCT1572;#4+72@2FXW#NVU@#V"J/3KW[5%K/CG6(KOQ<=.-L;/2 D,4CH3F
MX/WEZ]1Z=*Z[2_!NF:*<0^8\)O&O5A?!59F&"W3/3IDG&<^F,B[^&VCKI%S
MJWL[M?-JC(LZJTT^#@$D8V^QH QO&BZGK.N>#=&>Z$'VN7[5=0;,G=%M)SSR
MI.1M]NM):>-AI]QXNU1[:T*6MVNGV/EP"-[BX^;(R"<@G'Y'I73Z5HUY=>+#
MXAO;06HBL(K:UA>02,G):0D@]<G'N!6=_P *IT7^Q(]'%W?^7%J(U-)"R[_,
M&>"=O(Y/7GWH RFOA8^--4U[7Y4NAX<TU%WQQJI$\H+,BCUQ@#G.&&36MIFO
M^([J5]1O4ACTV+3'NFVQ%568G<B9)^;:G#8XR?:M"X^'VDW%CKEM+)=2+J[*
M\^9.5*[<;3C_ &1USWJ6X\(+>:3>Z=>:GJ%TMU!Y4CLZ(0OHH50 ?4D'- '(
M:+XW\0W=QX0MKI8B^MO-/,JQ;"L2X8$<G  SSG)Q4$/B76;FS\8^(WN-.EM;
M,M8V<;1L5=A@D?>[[@#^F*[0^";&76]-U8/,DMA:K;0*K (JC..,9SSSS@^E
M48/AAID.@C1A?WWD+>B\5_DW%QG@C;@CYCU'IZ4 07&N:AI(L=&LH+&V>PTW
M[;J3JNV.#:OW%4<<D$>PKF-4U75/%WAGP=::M%#%=ZQJ9N?*B4X-M'E\<D\X
M*G\*[?5OA]8:K=ZG+)=7L1U&S6TF,<H^ZN<'D$YY^GM4\/@RVCUK2M6-U<R2
MZ; UO%'(P*X)Z],@]N,#&!CB@#I N(B!C9@;0/2I.B4I&5QVII^[B@!4.13J
M:@Q3J "BBB@ -)2FDH 7O11WHH **** "D%*:0=: %/2H9/];%]:FJ"3_71?
M6@"84444 +1110 4444 %%%% !1110 4444 %%%% !1124 +11030 44F:,T
M +1110 4449H **** "BBB@ HH-(* %HHHH **** "BBB@ HHHS0 44F>:6@
M HHHH **** "BBB@ HHHH *2BEQ0 44E&: %HHHH **** "BBB@ HHHH ***
M* "BC.:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HI,TM !332FDH !3J04M "$9_"CJ*6F,VU@/6@!])@$YH)XH4\4 -W9&X
M=!3A@\BC QBCH*  G% (/-'4TO2@!,XHR,YHQF@CB@ R*3< <4E&,G- #Z,4
M44 %&:*2@ HS110 M)2T4 %%)2T %%%%  :04M(* %[5 _\ KHJGJ"3_ %\7
MUH F/2BANE% "T444 %%%% !1110 4444 %%%% !1110 4E%% !2&G=J: <T
M )S1S3\44 (.E+12 T +3>].I#TH 6BD7D4M !0**#0 AH% I: "BBB@ HI,
MTM !137) H0DB@!U)2T4 ,_BI_:FC[YIU "=Z6D-'.* $8T"FC)-/QQ0 M%(
M.E!XH #29H!S2T ***0].*!G'-  :;3C01Q0 "EI#TI!GO0 HI:2@G% !WI<
MT@.11VH 6BFG/%!)% #J8QIPSBF_Q8H %-/IN,$4Z@ HIK'%*O2@!:*0DBF@
MDGVH =2]J**  44@ZFEH 2ES2&@4 +29H-)0 N:,T@YI.] #A2T#I10 'I3<
MT<F@]* %SQ24U22V*>: &T\4W'%"GF@!31BD&=U*: %%%%(3Q0 9Q32,G-*.
M:#UH .O%*!B@#FE- !113<G=0 ZBBB@ I,TM)CF@ Q333Z3%  *#0*#0 @I:
M** %HHHH #24II* %[T4=Z* "BBB@ I!2T@H 6H)?]?%]:G[U!+_ ,?$7T/\
MJ )CTHH/2B@!:*** "BBB@ HHHH **** "BBB@ HHHH 2BBF.2N6/04 .SQQ
MT[T!U)P&&?2N4UJ>;4O&5EX>CFFBM1;&\N_*8J9%+;%4L,$#(/0]AZU<ET^'
M1-1&JQ2F#3X+219X QV#E6#@=CA6''7//:@#?W8.#BF[RI!; !KFD\5Q?;-.
MMKVRF@;5%;[$QVDL0I;:PS\K8'')!]JJ6?CVQNK33KDV5[]FO;UK".1T3"2A
MV4 _-G^ \@$>] '9MG;E<4S?@J#WKGKCQ3]GL;V<64S1V\$LZ,I4ATB(# Y/
M#=3@_P ^*LQZW#<ZI967E.!?V;7,+@XVJNP,#W!_>)C'OS0!L&3)4*5.?0T\
MDX]Z\FT;Q!?Z7X*\/+"KW,U_JIMM[N2ZCYFX)/.0A')[UV=[XNMK+4(X9K><
M1_;8K!I"H!$L@4K@$Y*?.H)'?/H: .D0,.#C%.YSVQ7*7?CBVLIKM'LKV5;2
MX$5RZ*NV)2 0_)Y'(Z<^U7+?6+FZ\5W>FBW=8+>&%R^Y<9??R><\[1V[4 ;^
M:1B0,BL'4/$*Z=<?9/LL\]PD+W,FS:H2-2 3EB 3SP.],NO%MO#-:00V-[>2
M7EH;J!8(P0Z<<9)&#\R]<#GK0!T/S8&>O>A75AE6!'J#7,IXQLKBSTV:RCN+
ME]3#FVB10&.WAMW.% /&?6J/PYEN);'7/M!GRNLW,:I/(7:-05PN23TSCK0!
MV*2I(Y"]OUIY.T\XP:\SEN4'BOQA!<ZO<VR6MK;R6>+QT,;NLA.Q=P!.57C'
M/3O6MIWBN[BTO2[6_P!.O+G59=+6\>*% S-AD1C@D?-EP<?6@#MLD8SBD!8^
MGM7,7OC:QL[::^DMKI["&86TMPJ*4CDW;3WS@'@D# Q4-MXI<^)O$<5Q;R)8
M:1;PR%T*MN#+(Y;&<\@*!QV[4 =<W*Y!XH!W+\I%<[:>+]/F.H1RI-;O96ZW
M<RR*,"%@2&!!(/ -$/BRS^W"REM+FVF-J;P&4*%\H#.XD,?;\30!T0.>.XZT
MI(& 3UKE_P#A-=/1@DD%U$[V[741*J?-C4C. K$Y&0<$ XR<<58LO%-CJ=Y:
M)#%=J+NT-S;R21@(ZC:3CG.?F'44 =![T9&,URFE>)M/;2K<6 NKIYFN)$BE
M.92J3,LC'<>%!! R?05NZ=J-OJ6E6U] LH@F4,HD3:P!]1VH O')Z4BN&^Z<
MUAZ=XHL=0N+>*%;@+>6[W5J[H LD:%0Q'.1@NO# 'FH;?Q-87TUK;0Q7<,>H
M!C:W00;)P!DE2#N QR"0,CI0!T"R"0Y6GE@HYKAO">O%?#>C02O<W>H7-NTS
MLI#;$5N2Y)Z<@#J35P^/=(9IG>.\\F&Z-I)+Y/R1R;@@W'MEB /K0!UBY&<]
M*1]Q5MOIQ6#>^+-.L[FX1_M$D=D/],:*(NL.1D;L<GC). <=\43^*+*WENHE
M6XE,%J+W,2 AH3W3)&[\/Y\4 ;D>Y1ANN,TN_<?EZXK'MO$=EJ(L!;><?[1M
MC- ZKP%XY/IU%9?AS7&C\&:')=M<7>HWELI58U!DE(&2>2!P.I)'ZT =?DXY
MZT@<?C6&/$^FW6FVMQ!+(WVQVBAC1?WFY<[@1VVX.23@8ZUB^'->$>DWEU>S
MWDQDU.>WMTD7,I_>81 #W'IP !Z4 =L"0?FI37/Q^+-.(N4D%RDEDXBN%>!L
MASC" C(9CD$ $Y!JYINO6>J7EU8Q%TNK7'G02KM=,C()'H1W&: -,$[L'&.U
M 8$X[UP^I>)KJ;6->TFW62%;+3_-2=0-XE(<CO\ =PH[=3Z5-X.\1I>Z7I%G
M<-=/J,VG1W'FSH=LI &[:Q^\030!V1S@TAR4&>M8&G^+K'4+DPP1W3M+;O=V
M^8MHFB4A25SCN1UQU%2^&-9;7=%M;\QM&9 692, #)Q0!M1L"I]CBG<_A7-V
MGC/2;O4TL8$N]TEQ);"0P$1F5 2R[O7"D_05/_PE.GQ$M*\BP"?[*;C8?*\W
M=MV;O7=\OIGC- &V&.\Y^Z.E(V25QTSFO/O$'B>\GTKQI!:M):-IT.(+B/E@
MX3<3]..*W-(\3VUS&FGG[9]K2R%P)I8L"9  &=#WY(_.@#IE);YAT/K2<E\B
MN5L/%.E:=H6DL;R^NHM0=TM99EW2R$%CAO<8(]\5?B\5::=)%^S31HUT;14D
MB(<S!MNW;USD&@#=/7WHW8&#UK+TG7[36'N8[=9UEM7,<ZRQ%=C#L3TS@@\$
M\$5ES:U86_B^[B>]U$W,%B)7LPA,(CW ;@,<MG ^F: .G.>_2G=ABL#3O%^E
MZI+8QV_GXOE+6\CPL$DP-Q ;ID $D9[&I-:US^R&T]?*DD-U>"W.T9"C:S$_
MDM &TS=1WQFFH3MVG[W6N)MO%,.CZIXB.I7-Y<6]O?11J1&9!!&T$3EFVCY4
MW.W-;']IVD?BRYC>^NA-%IZS-:D#REBW$[^GWN".O04 =#3&#-]VJ&F:S;ZI
MY@BCN(R%60">/9N5L[2/4<5%XFU&33-#FDMSBYEQ!!_UU<[4_4C\!0!K8.T>
MO>C))Q6!X/UV36O"T%]> 172;H[M&X\N13\PIL'C/199[9%N)#]M+"T<1,4G
M*CY@AQST- '1,0..YH!!'%<Z/&V@M,8S=/O02$DPN NP?,"2, ^QQGM5F/Q-
MI)6YS<>2UL@EF2=&C948X#8(S@^OX4 ;&X$X!YHSA<FN>'BS2%DD#R2Q/YL<
M.R6!U??)G9P5Z'L>G6B3QIHRPW$IEEV6^/-4P2!T&,[RNW(3'.[IB@#H%..O
M<T%@*RK_ ,1:;ITJQW3MN\L3-Y:%_+0Y&]L9(7(//3@U6O/%VAVDIAEO%,JP
MBXQ&C/NC/1E(!W#Z9QWQ0!T'.>.E-9Q@@'FL*;Q/;#5=(M($EE34HVD21(RR
MA0N<Y''<9] :N7VI6^E+ONRV99!'&L:%V9L9P !G./Y4 :*GCGI2L<#/:N'U
M3Q2L/BKP\\-XYTNY6\\Z,1'[\2@8QC<3DD8QU'2M]/%.D7.F07D5R9(KDE84
M5&\R0CJ%3&XD=QCCOB@#64G=N7[M/S\Q!_"N3U/61?)X>O-(U!A97FHK ^Q/
MOKM<D'(RIRF#T[YJUHEY=W.M>)(IYF=+6]2&%"H 13!')QCK\SF@#H^>E,7Y
M6.ZN2F\2IH_BW5DU74-MA#;V[1(4SL+%MQPHSC@<GI6U=:_IUG#'+<7"LDL9
MF3RQO8H.2V!SM'<B@#7HJM#>07=G#=6TJ202J'21&!5@>^15*R\1Z5?W0M[>
M[C>1@S1C_GH%^\4/1L=\$X[XH U0<D^@II.2,=*R+;Q'I=Y.+6WNXC+)GR\M
MQ)CKL/1OPJ*'QAH,\UK;PW\3274C11+R-S*<,.G_ .OMF@#<4_,1WI0PS@]:
MR?\ A(-._M%K(3@W'*@*"<E>J@XP6'<=JS=,\::;>6"7D[K;^=<-!$'4C>=Q
MVXXY)&#[9YQ0!U6<BD) '-8$7C/09K6:YBOXC!#%YKN=RA4R1N.1P,@C/L:M
M7_B#3-+8QWURD3*H=\@G:O\ >..@]S@4 :O-'7IU%8/B/6H[*RFBCO%@N&MF
MFBE">8%P."PQ@ ^Y .#4^CZB\_A2PU*Y.9);**:4J.2Q0$\#ZT :Q..6Z"G5
MR6@^,[#5?#L.J7,H@2XE>.-'!!8AV"A1C+$@9PN3726=];W\1>VD5U4X(Z%3
M[CJ/QH LT4@/.*6@ HHHH *2C-% !12TF* %I,T44 +24HH- "4M%% !1110
M 4@I:2@!>]02_P#'Q%]#_*I^]02_Z^/Z'^5 $QZ44#D44 +1110 4444 %%%
M% !1110 4444 %%%% !2, RD'H:6FG.<4 <]J6A7$GB.TUO3[LQ7,<+V\B21
M[XY8R=P#<@C##((SUZ&IK[1[O6M+N]/U&2&.&YMWB86X/5AC))]*V6D5'"EA
MD]O\_2G(21R03[4 <I+X8OKVXT.2^O(I3I$@EB9$(,SA"@+#)P,-GBJR>#;S
M^P=(T]KVW#66IG4&94.'S([[1^+D?E79ABRY!&">#Z4X>G&: .,E\&2RS:@T
M=Z+.#4+6:&YBA'RSR-D"8@G ;!).!SGGI5FUT35(=7TJ_FN+0_8K*6T\J-"=
MX8Q$-DGC'E#L>M;:7L\FJRVC64B0(JLER2-LA.<J!ZC'ZU;WXGVDCYAQ0!PE
MCX'U&WT/1K07UN]QI>IM?H[H=KY$@V\<X&_]*LZEX3U74I+II+^VF9M1ANH7
ME1BT*1NCB,<@ 94\X)^:NT!(^7(W8STK(F\0 W\UEI]H]]/  9_+=56'(R Q
M8CYB.<#MUQQD R[_ ,.ZA?Z3XALQ)"AU*13&S*> (T3+?]\ \>]7;/2+Z'Q3
M<ZHTD'DW-O#'*@!W;H]^"OL=Y_+\KVDZQ'JL<Q$$]M)!.;>2*X3:P8*&XY((
MP1R#6B20<DC'>@#FM=T*^U;4XIEN('LA \9MYBP$;M_RTP.'(Z '&,]:KZ7X
M=U2RO]$GEN[=EL=.-DZHIS)]S#<^FS]:ZU<8)!&T\BHW#EUY &,T <1HO@S5
M-"M],:UOK:2[T]+F%EDC.R>*:42D9SE2"H&<'Z5M>%]#N=#_ +6^T31R"\U"
M6\58QPF\@E?TK4U?5(M%T:]U2=&>.TA::18P"VU1DXR?2GI>*Z1*Q"32Q^8(
MB?FV\9_+- &%H^@W=EXIU?59)H9(-0BB38,EH_+# <]^&/:K,^DWDOB^#6ED
MB^SPV<EJ(N=QW.C[NF.J#\ZVU!95*,-IY^M/&<]MM '&OX4OT\,ZCX;CN+=M
M/O3,@EE!$D22LS/P,@GYS@Y';B@^%M3@U/7Y].O(;0:C:P11RD$M$\88 @>G
MS$_AT-==%<1W*OY3!MC%#[,#@C\Q49N5DD:%)%$T:K(Z'J%8L 3]=K?E0!PM
MYH\F@6^N:O?):7%M<Z6+>>%=[Y95(PQZE3DY)Q^%0VEM_:3QZ==7]KJ)OM.D
MTY[FRNQ(UM$4)+D!0,,54$G)R5QQFO1R%*G.-IYX/6JUOIUG:L_V>)(O,.Y@
M@QF@#FTT?6ULI()5TC>8WCCFB5MSAEVY.1\AQS@%LD8R.M.L]"O[8>'%\Z-C
MIEFUM)G(W$J@W=_[G3WKJ-V03E2 <#'KTI!(IN"-PX^5A[T <9I?A?6=$:"Z
ML[JTGN@EQ%+#<LRQLKSM,K @$@C=CI770).;-4N'B,C Y:)=J@^P)-6!G>.5
M/'/TH<!F"A@".<4 <9I_AG5[>XTZZO9X))TMKBWNG$CN[^84.Y<CC[@^7H,\
M$U>T2Q\0Z=IUI83S6#VUE"L4,J;O,N B[5# \+G R06^E=,&#+NR,=C44=W!
M)+-&LR%H7$;@?PL0#@_@10!QGAOPQJ_AU;5H?LLI>W$%W&[$*=F?+=#C(/S$
M$$'J*J7/@W5KCP[JUIFT,MWJPOU^9L@>:LA0\>J@9]_PKT,,?,VY!!%*0W."
M* .)_P"$:U&V7Q';V[6UQ:ZU(\["9R&AD= C*0%.Y< $<@\5/)X6N;:'1(]/
MO #8VATZ:209+VY5<D8_B!C7KZFNNX5@,CGCZT)@J5!!(X- '->'- N-&::/
MS89+:V5K>P1<C9"6W!6/KGCCLJ^]9,'A?5+/1]#"KI]S>:7!+:M!<D^7/&Y3
M+!MI*L-@QP>X[UW00A=N1G.>E9^OZY:>'=&N=5O!*T%NNYQ#'O;'TH Y^XT#
M5;>;3=3LX+ W=K'+"VG*QB@99#DE6"D[A@<D#/.0*S+[3;[2K%8KJ2Q-[>ZX
MUW9;YRJH6)<@N4P#LW+]T@Y->@Q3+-"EP#A60-@]1D9J*>UM=1M6ANX8+B$G
ME)4#KQZ@\4 <"FG7^H75[8%+8:@]S'JC2+<_:+=W0JJQN-JE,J%' / SR:ZG
M0["YLEEFNK+3;:X8<BS!8GV9BJG'MC\:U[2QM;"+RK.WAMX^NR) J_D.*F7#
M+R0<]<4 <?<^&=2;Q5K6IV[VOD:I81VYW.PD1T#@9 4@J=P.<YX/!J+2_#NK
M6*^&;64VS?V9:26\DJ2-D%D"AE^7G&T=<=:[12P<YQMZ"G# ).1\W2@#B]$\
M/ZS:ZIIE_?O;-/!9S6]S(DC$,SM&0R @ #]W]W P#U..=?PQ8WNE:%'I]]Y&
M( RK)&Q.Y<G!.0,'GIS]:VW5F.W(P:7 QAR#G@T <38>'M46XM7,=JB6^N3Z
M@R^:Q8QNCJ /EZY?Z?+3&\+ZI)H<GAF>2*:U>[\];TN=X7SO..Y=N-V[CKC^
M5=P!L<LS  \4N#N!R.?Y4 <!?^#]7>/QA;6\EG]GUJ)5B>21@T;",(<@*>.^
M<GZ5JPZ/JD.M:3J)B@D%KI<MG.#(0SR,T1!!V_=_=]3SSTJ[>>)H;(N]Q#-#
M']J6S3?&?F<D -Q_#DX!/6MQ'!4 L,@<T <5::!K%I;^&T5+8G2[B668I(WS
MHZNNU,KR</WQTK.U?3[ZQTMHI(K.*ZGUX7ECON"JJ0V\_,5X;:''0]37H[[@
M5((VC[PJO>Z=9ZG$(KRVAN(_[DT8=?R/&: .3\+W$\>LZG97MNHOK@?;II(K
MM9U!PL87A%V\ 8'/ ZUHMI>I)XZ;6XTMY+1K VRKYA#[MP;)&W&.,=<UM6&F
MV>EPBWL[>&WB))\N) @)]<#BK*[MYY&T< 4 </IOAW5;:W\&0R6]NK:.K)<N
M)2>/(:$;?EY^\#SBMOQ#97UU'IS6"QM-:WZW!61BJLH# C(!Q][T[5NY8#)(
M [TR25(/G<G!'8$G\AR: .'O]!U:YTSQA:QP6[-J^WR#YC! ?(2(D_+D?<+<
M9ZU8N=*U6[\27VJ&QMQ#=:.MGY4LK'YPTC%6PH^4[\9!S73:3JMOK-A]MM6/
MDF1XAN4@[D8J<@\]0:O 'N0: .4\)Z!>:/<2J[[+#R5$%I)*9F@;JP1R ?+]
M ?TZ5-JFEWNM^(+4W*/%I=G^\C\J4J[S=F.,8"CI@]S72')W#<*5B!U(QZ4
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M6,.%D#*#D@'GKTKU.6SMYY5GDB5I%X5BH)'T].IH:QMWECFDBC>:/[DK("R
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M;V[>+P?J-YJ4DTU]+-!<@S';L\F1EW#/WLHHS[X[UZ&-'TQ)%9+&%70E@50
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MY=RP,$,OV@Q>8_EF7.=^W.,YYZ=>:C;PS8&"^B%NX%^0US_I,A\PCC).[(X
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M;JV-S#L#U[T >BQ:C;S67VN!_,B SOP>GKTS4,6K6,KV:QW<;I?1F2W8'B4
M;B5.,$8YJQ)*1:DK&09%X0CD$]C7!:39Z]!;>#K<:),C:.C6]S*TT>TXA,>Y
M!N^8$X/8^U '71^*M$D>%%U2V+32>2I5LKYF<;<XQG/&#UK)\:^((]-\/:B+
M2^1;ZWCW-\OF>4V,@-V4D'@,>?0US1T37)/!T%@FDG[5'K(O=FY!^[$WF;LY
MQGVZU+>:1K4>G>*M'CTF2\_M.:2ZM)TD0 B3^!RQ&"O;KGMB@#MI-:L;.WAD
MOKY86\I9)L]$!_B? ^4=>3@<&GS^(M-AN&A%U&TRM&K*IW8WYV9QG&<5Q_\
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M9&X'YN/8XIA@ ?>A()Z\]: ..@AN9_$.K7L4UU'+>6:VT32:=+&L93>RL6;
M."[<<=J["V#K;Q1S2+),J .ZC 8]SCM3@BA-J9Z]Z>%4-GC)H <.E)124 .H
MIN:3F@!^:*:#FEH 6BD) ZG%% "T4F:,T +1124 +11FB@!**6B@ HI,T9H
M6BC-)N&<9&: %HHI,XH 6BDW#U'YT9H #2BDR#WHR!QF@!:*,T4 %%%% !12
M9HS0 M%)G-+F@ H%%)TH 6BBDW =30 M%&:3- "T4F:,T +129HS0 M%%)F@
M!:*3-+0 444F: %HI-PSU%&: %HI,XHS0 M)1FC(]: "@444 +2444 %%%%
M!1110 4444 %+24M !1110 4@I:2@!:@F^_!_O\ ]#4U03?ZR#_?_I0!.>E%
M(W2B@!U%%% !1110 4444 %%%% !1110 4444 %%%% !3#UIQIM !2&EI* '
MCH*:_:G#H*",T +VII8=.>E!;:.:P[#Q7HM_K$FF6VH"2Z4;E1@0)!T)0D8<
M#OM)H VXON4XU!<2I;QO<22*D:#+,3@ >IJ'3-1@U738;VV??!,NZ-\$;AZX
M(H O#I2&E[4V@ H!P*.M4=0U>QTN6);N8HTN0JJC.6QZ!030!H9HK$L?%>C:
MG-;0V=Z97G+"/$3@.5&2 2N.,&MK([T 1D')IH%2%P.<$Y]J7>H]?RH 1NE'
M1*7(9<BD=A%&SG. ,G%  ) 3T/Y4X')Z&N>7QAHBF&(WIS+&94)!RZ#JRCJ0
M/I5RS\1:;J.HI8VMW').]L+I5C);]V2!DG&.I]: -4'YB*9_RT-53?PC5UT[
M>WV@PF<+M."H(4G/3O5J5L+[T /Z"A3E0:9)(L4)=B  ,DGI1#-'<6\<\3!H
MY%#JPY!!&0: '+U--_C%.$@/J/J*02 [OE8 #J10 X=30* P(!]>U(SA<$]*
M !1Q^-*WW31D9QGGKBDW#.* $3K3C2;P#@\#U[4;UP"3@'N: &2]J>6VJ.*0
M$%S5:[U"VL6A%Q,L9GF6"(.<;V;H!ZGK0!9YR.*&;:0<&G@@]*HZGJUII-A-
M>WDRPP0XWN_ &?UH NYR>AZ4O45G1ZWI\NKG24N%-\(A-Y6#G8<<^W4>]:&>
M<4 !ZBEJ/S  _!.WTI1("<8(XSR* 'T4TN,$^E+N&,CGZ4 )_%TI5I XVYI2
MP'4@4 'K40'[S-2,X5=U(C IN(Q]: 'TQZ=N&W(I&8#C!_ 4 0_QCBIC]VFJ
MRE!G@^].W!B0* &)PQ-#'+YIEQ<06UM)-<2K%%&,N[' 4>I)[4RRO8+^QAN[
M>19(95$B.ARK*>A!H M#I2T@8$ ^M5[N^MK)%:XN(80QP#+(%!/XT 6 <FC/
M.*J0:E9W,_DPW=M))C(2.56;'K@?6F?VUIWVEK8WD F4$LAD&0 ,G\N] %T]
M10U5;+4K+4!*UI<QS&-MCJC@E3[@=,U.9 0>#Q0 ].AI5YY]:8\\<4+RR,%5
M%+-GL/6FVL\-U;)<V\JRPR@.CJ<@@^AH FI&Z4N1ZTTMA2<=* %4Y%1O]ZJ_
M]J6)E$1O+42'C9YR[L^F*M@J5X.=O% "C[M-[BFF49]N@IY("C)H .QI%ZTZ
MDW#D^E  U*O>C-0/>V\=Q';O-&LTBEDC+ ,P'7 [XH L4W/44H.1FH&GB-R(
MA(F_&XKGG&<9QZ9H F7K3J;NS[8ICW,$4T<4DT:22?<1F +?0=Z )>U,YR3B
MHK>ZAN&E6&:.4QMM?8P;:<9P<=#R*F5MRYP10!&OWS4BT9  -.S0 Q^E-#88
MY':I:KW%W#;B/S98X]\@C7S&"[F/8>I]J )3]T<4@ZBE5@S<9&/6E;&&R<#'
M6@ ;[IH4U!9RK-$&21)$;E70Y4CV-2H^]CQC% $E%%% !1110 E%%% "B@T"
M@T %%%% !1110 4@I:04 +4$WWX/]_\ H:GJ";[\'^__ $- $QZ44'I10 M%
M%% !1110 4444 %%%% !1110 4444 %%%% !2'H:1F(Z#-#.1MP,YH 0 XIV
M!3?,&\#/!X'UI4;(YZT .H%)G@^U )ZXH :^T@JPW ]17 Z\MQ;?$OPO=R10
M7=M.T]K"@C^>V/EE]ZMGKA2#D=":[IU28<X>-P5(ZY'2LW3O#FEZ/(LEI9A7
M52JDLS;,]=NXG;^&* +EV5&FW?DOEDC<'!Y#;3_]:L;X>LS^ =&9_OF#G_OH
MUJ0:-800WT4<#*E[,TTXWGYW8 $@YXZ#IBI=/TVTTFT6VL+<00)PL0)PH]J
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M).V0;>>IQC&,GUJ*Z\$V-SJ37$%Q>V5O*J+<6=K*(X;@* J[E SPH"\$<#%
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MVR3JHNXXY1_I14 !G)&=V  2"#Q0!K:K=75MH+W,!@2=(M^Z>0*B<=21G/\
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M1110 4444 %(*6D% "U!-]^#_?\ Z&IZ@F^_!_O_ -#0!,>E%!Z44 +1110
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M 3G%+0 O:F;\G&*=2;><T +[T ]L4M!H 0M@TG4CVH(S0* %4YYH;@?6EHH
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M(* %J";[\'^__0U/4$WWX/\ ?_H: )CTHH/2B@!:*** "BBB@ HHHH ****
M"BBB@ HHHH #TI@SNI]% #&+!QA<C'6D5<$80=<FG\T'.* $QAC@=>]*/N]
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M&<4=: # %+24M !13:=0 444E "YHS244 %%+10 "@T&DH *6D[TM !1110
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MD<]* .HSSCO2%UY]JXZV\>Q2 3W-I);Z>VG_ -HK<[E.(2<#(SPW3@ XSUJ
M_$'R1.T^FR>4EA)?K)%(KJ0G+(QX"MCMD@^M ';*X )/2GY%<GI?BZXU&]T^
M Z9Y,6I6K7-M,TH^; !VE1R.#G.?RI^G:_$VDVKV]K(DUU?SVJ1/+YG[Q'DW
MDDGA?D<X!.!@"@#J2>W>@G:N36;I.H3Z@LGVJSDM)X97C9&Y# ' 93W!Z@UI
M'KD]* &C+<@\=J4'*YSGT(KSV\OHT^)=];WD]PFGC2(I_+CD?_6&5E+87D<
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MBY:]@DFMUBCR6"8W ]@>0,&H[3Q]I=ZEHZ07ZPW,YMO/:(!8ILX\M^<AL\<
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MXW9X4=^ %IH,4.TM("LG"YQS0!YN^G1-:>*8!?W(77VRK?V9<$P_NQ'SQ\W
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M2ZMY5LKF>=H);2?RY1(Y8,?DY=,G';TP>:]/W(/EW8 X[4A W*KC<>2&P.*
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MU?/W<?PXZ]ZZG2=6AU:;483:O#)87/V5_,*DL0JMGCMAA6H3'&O*X&<=1UH
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MP?J6G:O8S:;=Q^1;Z+_9S/)N#H<J1(@ (SQT)'6N\VL%/S'GIGM1NX Z^IH
M\ZL="U309;+5M2CL88+/2YX-3F1VD:4Y5VFSC+$["2#SSU-9WAF"ZL+316OK
M729(F4VR&+4FD>,2\-Y4>"N.1D;B<# XKU8J&5E=<@]0>XK,MM'T?3KE[NTT
MRSMW(+>9%"BDGN<@9Z4 <WX>T+Q%H:Q:1&MD=+MW)2\#GSFBSD1E"N >Q8'I
MTYJ*W\-ZTOAVPTR6&U,MIJPO=WF'!3SC)Z?>PV/3WKK?[45HK>>RADO8KB41
M^9"1A%Z;SGL/:KZ%2"=P)SR: .-OO#>L7:>(&0VT,US=P7=@^XG#Q>60']BT
M?..QK:T,:W*1/K$-M9/MV_9;9O,4G^^6P/R] .:V=^X$+USCZ5%<W4-I$TL\
M@CB3EF/04 <MJ&FZM)XDU6_BB@-O-IWV*$%R&+Y)!/&,9;%4M-\.Z[;V7A))
MA:>9HA87!5S\P,#1 KQS][/.*[LA&!]CD_6E"A<^_6@#@_#^D:SH]]:W&L06
MTC1P3K?:BUWN,K,8R'P5&!^[QCL/RJWX8TJV3Q!JUY;RQSV:7+I:;#E8R^V6
M;!SS^\)]/3M5S4]>T^XLM1233KC4=.@5DNS&BNC8'S+M)R^.^ <5?T0Z>FA6
M4^EVR0VLD"31PQJJA489' X[_G0!G>*M(OK^]T.\L(8YI-/O3.R22;,@HR]?
M^!51M-.\16&K:C!;6EC-I]U=O<1WLTAWVX;!8>7CYCNR1R!SS7:-M8 ,<9YQ
MFD.TC/;'#>U ')6VE:HEIXH2:*(/JDKR6^&SUA2,9]/N_K5+1- UNPL?!EM-
M%"#I4#QWK!\XS&4&WUKN4\MU&WD>H/2J&HZQ!IVH6%K)%,S7DPA1T VJ=K-\
MW/HIZ4 <PNA:N-+:%;>!)SKW]H !^!#YV\G/KCM2ZIX?U2\L_%D$4,)&I/$U
MF&? ;:B*=WIRIKL8KJVGDGBAE5WMW"2A3]PE0P!_ @_C4I4$[CE3T[4 >?\
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M\$AGCL+2-]V\&.%58M@C)(ZGFL/PUX<DTJ&Z&IVUE//)=RSQ31Q@E0[;L$D
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ME;B6*:4"5_F>/[ISNSGCUYP,YH Y+Q*UY%HOCC3FU&YFC@L(IHV>3YE#(V\
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M*EM],GC^T2#4&DC@2.(L^] 2RD#H1@U)#XGMKG1DO((+MG,S6_D,BK*)%!+
MAB ,!23SVK*%CJ-SJ/A^X73([:.)[AYHHR@6!70JH/3+9(S@$<G%4KS1)9]-
MGAO=*N&5]7FNHVMYE26+*L4D1@W!!P#SW/!H W)_&5E';6T@ANW>>&2X6)(P
M)!'&0'+ D8Z\>N#C-4W\:P3ZYHUGI\4DUMJ-O)=^<@!!C"C'?U89]JQ5T_Q1
M-::?;WMK+>P/8W,4CO)&KO(7/DF;&,CR^3MS\Q.0:@\/:%K^E2>"[@Z65%EI
M\UG<Q^8F8R=N&/S<CY3T)/M0!UNGZUIT-A?7:W=W-#'>O RS+EEE+ ;$]LG
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MQI5MJ*&8Q7#F*&,1,96<<8"#G/'X=ZX/PSX?UK3I/ L=Q Z+H\-[%=-E2,N
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MDB*K Y^9%#$'Y>.&')P#ZUGP>(+;68O#=ZVIW%A+=R*RVR1-MN<IGRR2.@W
MY]N,T_3K>>X'B^.*RE@DN9V:!W3:),P(O!/;<#^=81M=1N8? 6_3-25M+N$%
MR'@^YM@\LL<'IN/7N.: .R77]/O+^2P@N2)07CWJIP)%&2H.,%@.<>GT-8W@
M_P 1R3>$+:\UBX>:ZEGDC^Y\SL'("JJCD\=!53PI'J6D(-"N]$D=[>]FG%ZP
MS$T;L[>8&_YZ?,5VCU/:L+3=,U2QT#1+NXT6^NDLKZZ:ZMB-DRH[$B5 ""Q!
M'3.?F- 'I^FZG9:M:M<6<JR1;BK$ @AAP000"#[$5QVOWGB;2;^PU W\8@N-
M12T;3_+7'ELV P?J3U8CT^E;GA1+9+&Z-MI$FFPS7#2JDP*R2Y5<NP/()Z?0
M5BZGJ,E[XA@EN_#6MW$%E)NLDCMU$9E(V^8Q+=1D@<<#)[T =9K.I1:3H]Q>
MS;L1(?NJ6.<<<"N<T?6)(+6SU"\U>:6&X@C5K66U(>29E#9BPH8CG&!D<=:W
M=?CD_P"$9U%(DDEF-K(B+&I9B2O  '6N/2+4;"3P=JGV"YN+>SL'M+N,1YE@
M9EC ?8.I&Q@>O!H ZM?$^B/9K>"]B\J6<6V>?];G;L(QPV2!@XJ_I6JV>LV*
MWEC+YL#$J'VE>0<'@@'J#7GDNFW#:?K%X-/O/LNH:Y:W<-N(27:..2-I'*CD
M!MK$?A7I46<@J24(R,^YH >6YI5.:3;G!IP&* %HHHH 2BBB@!:*2B@ -%%%
M !2TE+0 4444 %)2TE "]ZAE_P!9%_O_ -*F[U#-Q)'[-F@"4=Z*!THH 6BB
MB@ HHHH **** "BBB@ HHHH 0T"EI!0 M,[X[T^DXW"@#(U765TV>ULQ&]S>
MW9?R88UY(4 L23P  1]<@=Z71M;759+V%[*>SFLW$<T<V.I&>"#@C'>LWQ3H
ML.M:A81PWLUCK%LDMQ8W,?.W!17#+_$IW*"/>N:D\1ZQ!I6J6.K11V^JV]U:
MV\VH6QPACE;"RD#E3@$8[$B@#TT$8SQ43QYX^7'7!'6O/-;M=2TCP]K3)K'&
MR":UBCE=C"-^&&YCDAL]/K5OQ#;7?AS4M+UN#4K]K".])U""2X)012# .. $
M1L=>F: .A^S6^CZI:6^FZ(@CO'8W$]LBH(\*6#/C[V2,?4ULJ48EQM(QUKS^
M]N+FW\4^$&BN[K;?W%Y<26[29#YB=U4_[N<#MQ2^'F;6M,TGQ/+K<\=R9]T\
M6<Q2[F*)#MZ+@D8(&<D^M '?X2-<OMX/7%*V-P# $&O-_#RWVJ6FD>)(M>A&
M^3-V9'=L[N#!L/"[6(Y&#D&K7@R::VU=+'5S<1:BUNTB,)C);WR[P1,A/W6
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MF@#TY-VV,$CD9/%..,8X+*<?2N$_MC4[6/4=-FO7EGCU2&VMKA47=MD56QC
M4D D<UN>&SJT;7D.HAC")0]L\[+YQ0@9#A0!PV<$=1C/- &\O!*DKP,_Y_*G
M84*!E<C@>QKSVZU2^TWQ!KWE73M-<7%C:P(0"$,F3P./4]_KFKFHZMXDTW1[
MJ7Y5D%_;16S7.S?+%)(D;!@@P,%C@XZ8[T =J2I)Y7>!0J!5 R..#QUKA;R[
M\2VGBK2]);6+<B[@O)=_V<;E*LNS Z$ -CGKWJ#3]6\2-I6GZA?:B@$>H1V-
MQ#' NV;,XA+;OO#KGCTH [FVU"VN;NZM8FS+;,JR@J1@LH8<GKP1TJRR@_,2
M"I&#D=JX?5=>UBWT_P 9/#/;B;29$^S-Y6?E:%'(//7YCS2W&LZQ9>*-3L&O
M(&W:6U_;).!&D!$FS#,,Y'(.3[\4 =LVW[@P&'3V%4[G5K2VO[&RE;]_>%Q$
M-I.=HRW/0<>M<%=Z]JW_  CGBFW-ZTTEMH\=W;SF((,LL@8K@ E<IP3SUY-:
MLVJZIHOB?PQI,LD,EI>0W3W#[>28TW+@]NH_*@#LP@$F1M"@<#'>G849P5 '
MWJ\_C\5ZG-X8A\7)<1_8'OA$;0+D>09O)W X#;_XN21[4_4=;U^WBUV[6[AC
MATO4HX_+\C<9(BD1(SD8^^>>: .]50#E0-I%# G!!&X=ZS?$&J_V/H%Y?#'F
M1Q@1YZ;V(5?_ !XBL&75M1T_Q/8Z)?W2SG5+67[-,J!=DL>"ZG'!&&!' /!Z
MT ;?_"1:/)JHT_[9%]I\PP@8R"XQE PXW#(R,Y'>KE]>1:?:SW=W*D5O"AD>
M1^B@=:XSX8V[W/AM+NZ$3LE[<L-T>7W^:P9MWOC]!5768[J5?B";J=)((]+\
MN.,+R%\AV'/^\S?I0!Z%#/'<V:7$; I*@92/0C-5=(U&RUG3X[ZR8/$[,%8J
M1RI*GK[@US>B:CJ=OJVG:;-<VTEM=:5]H@18RIC,>P'G)W9\P>F-IK%M/&VK
MR^%M(U*^9+2UN9[F.\OH("ZVVR1EC!7G"D#!8YQCM0!Z8Q"C..*B>X@CN88'
MFB660,8XS]YL 9Q]*KZ/<RW&BVEQ/+%-(T",TL7W';:,LOL3DCVKSSQ)?6][
MJ3^(XYKA1X?NEV[%<I(@.RY!P,<#(]BAH ]2(!Z@5"=B2!0$'H,5E:U>SXLH
M;.[6T:Y+D7+('4;4+;<'UZ_16KDK3Q1XBGL_"DGFV"2ZR9%/[E\*!'N0C+$D
M9Y[9'I0!Z'Y2!P0 %7L*<ZYP1M]\BN)N-5\22?;8M-B%Q>:=Y<4R)&/+N9O+
M5V7<S@H,,N"/7G/2G7VO:[>7^H1Z+;F=;"586AV+MG;:K.I<L#&0& !P?QH
M[5E1QM8 CT--*AU(&TL..G2N,UK7==AC\3S6;VL*Z1$L\:21%C(@C+LI^88)
MQC(_*IX]7U:T\0JNHRPFQNM-FNXH(E(:,QF/(+$Y;(DZX'0\4 =:2#$3D' Y
MS[4&2.-1R #TKC;/7?$,]Y82PVCRZ?>P;V+PJHM,H60[@Q+ _=.1U].E8NB^
M,-=GL_"6HWSP/'K,LD#01Q8\M_G(;.>F$QC]: /30P#;2>O2GFN*\!76IW7_
M  D!OKQ+CRM7N($(3&T)M [^F./UKLU8-0 ZBBB@!**6B@!**** %%!H%!H
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MV[C#H&90P]]I!JI%X8TN&[ENMDS33V_V:1GG<[H@,;<9QW/(YY/-;?6F%@:
M*5EI=OI^EIIT"8M8X_*C1B6VKC&.>3QZUEZ?X-TC3;M+BV@<2Q1-#$7E9P$;
MJ#DG(]CQZ 5T0.3[4N0* ,/2?">CZ(&6RMV",I58Y97D1 >JHK$A5/H,4W2_
M!VCZ.LJV<#A'4H$EE>140]516)"CV&*WN.M 8&@# C\)Z5%9W%LB3"&>(0-^
M_?<L0S\BL3E5Y/ ]:==^&=(O=+M+"XAD,=H0UNZR,LD3#H5<<@_Y-;IQTI"!
MS[T <O\ \()H-Q92PR1W3F2X2YDE:X?S&E7[K[L]1Z_GFEE\!:).MS&R7.VX
MG2ZD'VAQ^]0Y5@<YR#SUZUTX('&*=0!@OX6TR2:\GNH6FDOH!;70D<LKH.@Q
MGC'/(QU-1VOA#1["QGLUBEGCN(S"XNIGF_=_W!N)(7V%="&!I,@G- &-HGAC
M3O#^39_:)'90F^XF:5E0=%!8\#V%6-2T.RUB2Q>]B\S['<"YB!Z!PK*,^V&/
M'TK2R#2]* ,FQ\/V6FSZC-:!UDU"3S;@ELY;:%X].F?J2>]4!X.TO^R]/TTB
MX\BR9FMR)V5ERK*<LI!(*LP_&NDW>E Y- ',3>!M+N=+N]/F-P\%Y-YUP#*3
MN; ''M\H_*M6^T:#4-"FTFZS);31^5("QRR^F0<UIT YH YVV\(6%M>6UQON
M9'M8GBA,DQ8@.,-DGK2?\(=IJ6<%M$;F-()FN(BLG*R-DEN01_$:Z+-&: ,&
M+PU:PWBS&6Z>-+EKJ.)Y<JLS;@6'&1]YN,X]JNWVDQWUU:7,DTZFU;?'&CX0
MGU8=ZT>#Q2%MO!H Q=5\-V^L7UG<SSW43V66MV@DV;&(P3TY...>,=JP'\(7
MKZA>7$<VH0RW,K2"2UU5HH\=%^7:<':!G@\Y[5W*MN%1M$=P<'D4 9,/ANWD
MLKZ'4C]M.H*HNTEY1R%"G XP,*/R%4[3P+HL$%Q!.ES>6TL1@$5[<O,J1G^%
M0Q^4=/?WKIU.1F@'DT <J? >F'2KG3S/?R07,1@;SKII"D1ZJF[(4?09]ZLI
MX1LTU2UU!9KA9[2T-I 0XPD9QG@CD\#DYZ5T5)F@#EG\#:5]C@M ]VGE2M-#
M+'-MEAD;EBKCD9R<YSUJPOA.R7[%Y<][NLG>2-FG+%G?(9G)R22"1UZ&NAR*
M0,* .;;P99-:SVQN+P+/<?:]ZRA6CFSNWH0.#GGTJ7Q1I=SJ'@O4-'L(_-FN
M+1[9#(_0LI 9B>H]:WRP%-*[UP#CG- '/P>'H&M[<W$E[YZP&"+S)$9H@>"0
M0",D<9.3BG#PAIZ>'K71 ]R;.VE22,;QN&P[E!..@(%;ZH$11UV]*4'+4 8E
MWX:MKRXFN/.N8Y;B%8+GRV4><HZ;OEZ^XP:98^$M.T_6+?4K;S4EM[46D:Y&
MP1Y)QC'J2>M;_3 I: ,[6-)BUG37L;B25$=D??"^QU9&#*5/8@J*RY/"=G+?
MM?075[!*\'D3E9 WG+S][<#D\]>M=)FF@@<8ZF@"I:6,%MI45G!&$@1"BH!@
M =*QK?P38V=E:VD$]WY-I<)/ K2AMA7.T<C[HSP/YUTPZX[4M '-7?A.PNO[
M3BG>Y/\ :4J3R%'"E)$ "E"!E2 HJWI&APZ.[R?:[R]N9!A[B\D#R$#H,@ 8
M]A6S@'!/44%0: .7O_!6GZI>:C-<272M?A-YCEV[&3[CKZ,.,'_$T3>#8IK!
M[:74+ZXFDDB>2ZF=#(WE,'C&=F  P'0<UTYPN">PI5.1F@#"N?#<=QXBL]<>
MZN#=6ENT$2_+M(?&XM\O7Y1TQ56'PA&FCKI[7ET5%XMZ6W)DR!Q)_<QC>,_U
MKJ** .7O/!T-VNN(US<JFKE3-M9.,*J?+\O]U0.<TS4?!-MJM])>7=S=--+I
MYT]RKJH,9(8]%SG<,]?PKJZ* .5D\(1S7%U+=WEW.MY8?8+@NR9:/Y\'Y4'(
M\QNF.V<TQ/!,8U'1K\ZE>2R:7YGE>;L/F>8 K!OEZ;0!QBNLZT$9!&: .:_X
M0ZTPUJ)91IANOM?V,!0OF;]_7&=N[G&?TXJ.Y\'">WUF%]0N/+U69;B7 0E'
M4(OR_+TPB]<]ZZGOBCIB@#.U+3+?5-$FTV_W/#<1&*1EX;GJ1Z'/(]#5"V\,
M^7<QWES>R7-W!;R6]M-(B@QJY!9L  ;OE49XZ5T& .M!Y! - &#X7\/)X:TY
MK"WN9IX3,TNZ8+D%CD] .,U!JO@^#4I]4F%Y<P'48/(N$4J58;&3(R,YVN>^
M.G%=)_%GVI2#D'/% '.1^&S'JMGJ U&0-:VCV:J(EP58J<GC(/RKTQTJGI?@
MJ;1M-M;*QUF=3;-*09(E9761BS!EP >2<?7O76E#@<]\T[.>E &38Z&FDZ!#
MI6G3/$((PD4LAWE<#J1T/TZ5#;^'UM?#[Z6TXDWQO&\S1#Y]WWBRC@GD_G6X
M3B@'- ' ZKH&J6^B:7I<=WJ%]%;,0MTD-N\H 4*JM')A6X+?-U&!UR:NV_AK
M5KMM+N]3U'_2-.G=[<I;QJ2C+MPX7@'&?NFNO*9?=GMBE4;5P3F@#FM2\)37
M6LS:C8ZS>:<+I%2]B@"E9@HP"-P)1L<;EYX'I3;KPFS:U->V&JW5A;W:JM];
MQ*I$^T;0<D$JVW +#G@5U -&1G% '*MX1>6+7$>^<+JT8@D5(P/*C"E %SU.
MT]\U--X:>;5M/OY[QB;6VDM#'L&)(Y"N[/H?D7ICO72TC'% '):;X1N-)DC1
MO$.H7-K;C%G;S!"(>P#,J@N!Q@'I5>S\!K8V&@6<.HN%T68S0;H@2Y(8 ,?3
M#-T'Y5V@8,?I3J .7MO"LNGG5UTS4YK9=0G>YY16\F5R"S+D<Y(Z$D5T4*E%
MP>2.,^M2G@CTH H 6BDI: "BBB@!*6DHH **44&@!*6BB@ HHHH *2EI* %[
MU!<?>C_WQ_.I^]07'WH_]\?SH GHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** &DTTM3\4$9% #5-.H P*6@ HI*!0 M)GG%+WKC/[:\00>*=(M;B
M&W>QU R_+"KE[<(,AG/0@],\<D4 =F3BDSS5+4C?_8733DC^U.,(TQ(1>>IQ
MST]/TZUD^%M1U.[;4[35Q;FYL[@1&:VW".7Y5;@,201G!'M0!T9-)WS2J,"E
MH 0\TF[C)%**YOQWK=[X=\(WFK6(A,UML.)@2I!8+V(/?UH Z7-%9,6IVT=D
MKW]];)((A)*Q<(JCCGD],FIXM5T^>:*."\AEDDCWQHD@)=?[R\\CIR,]: +N
M0#UH(!Z5GMJFF)+ LE];*\CF.)6F4&1QP5 SR<]JFM=0L;AYTM;J&9X7*S+'
M(&,;=PP'0^QH M\4@.1C%5+?4+*Y5V@N890OWC'(K8^N"<5C)XC%YXL&GV=S
M:RV?V&2??&=S"1711G!QCYCVYH Z13G/:G=*R+744AT>SFU:_LC+)&-\T3!8
MG8#+%<D\<$]> *+OQ#IMI=6,+WD(-V?W>7 &W!.[)Z\X'U(H UCUH) !/I56
M&]M)[F6**XC>9<%D#<J",C(K*U.ZU2VDDEM([<6L=JT[O-NRSCD*N#QP"23G
MMQ0!O9R>E.ZUS7A_6-5U2'2[Z:&W^PWUE]JS'G,9(4JI)Z\-UXZ=*V(=1LY8
MI98KB%XHP6D=95*H!ZD'CC/7TH N<4W(&/>J0U'3RQQ=1ELX(5LX/7''?VI3
MJNF>1'-]MMS&[;4<2C:S>F<XS[4 75Z4ZL\270U@1^=;K:^3O\H@^:&SC/IM
MY_.I8M1M+APD%Q'(Y7?A6&=O][Z4 6\"D!R3Q56.^M9I&6.>-V4<A7!((ZYQ
MTK/?6UO--2YTRZM6!N A>0DC8)-K8QWX.,\9Q0!M$\T#BJDM[;V_E1W$R+,_
M**6 +GVJ2>]M(,BXN(XL)O;>P "^I/84 3G@9H4[AG&/K433$V_F1J'RN4!;
M ;\1FLCP[KC:MH<%W<JD-U-YG[D/DX5RF1T)''7% &WGFE8@#=C./2JR7ELZ
MNPFC*)P[;Q@?7GBJ&O:M-I'AV^U"%(W:VB:0!V(4@#)Y /;VH U0_P"\V[3R
M,YQ4E<=I'C&>ZN]"AO[!(H]:M?/LY89B^&\O>4<$#!VYY&>G:NJ-S$,#>,9Q
MU]\?SXH F^Z*;_&/0U0O=;T^RL?M<MPAMS(D0=6R"68*.1[FK O;98XR)%_>
M#* GEL]A0!:IO\-02W<,1B\UU3><)EA\Q]!4DD\4>PR.J;CA=QQD^GUH D'2
MD; ICSHC;20#C<<G&!ZU4O);L7-F+80M#(Y$I=\,%V$C9ZG<!GVS0!=497FA
M>#4;7$:OL=U60]%+#)'KCTJ8?,H-  6P"<&F9[]*SO$FK'0O#M_JBP"?[)"\
MQC+E=P49(R <' ]*-)U1=4TJSNY$6)KF)9%C5]V 1GK@9X]J --3FG5'&ZR1
MY3D=O>D-Q&)O)SF3&2O?'K0 X'!.:/X\XK&\4:Q/HVCS7=K DTL97Y&<K\I8
M#/ /K5C7M3?2=%O+V*)96MX6D"LV 2!G&<'M[4 :E(3@9K$MM0OY[BRE6&+[
M!-:B>63>=P?&<!<8QCW_  I4U9M2TZ.^TDQSHUQY6=V 5$A1B..2 "?ZB@#:
M!Z4C' XI@G4-M[G[O/6G>:G]X=,]: #J"#2K\H P:,ADW @@\@BN<U;Q/)IW
MB+2M%2Q$TNI>9Y3^:5"E$+G=\IQT]Z .ES29K$T'7DURTND>![:[M9S;W%N[
M E'ZCGN"""#QQV%:RR1HA0L,)UYZ4 34@^[5:2]A2:UB=@LEPQ$:D\G"EC_*
MIBR>8%_B/;- #DZ<TA)W4,^'QM)H5MQ/'0XS0 X>M!/' S3&E"\XSS@<]:K0
MSW+:G/"\"I;"-&CE\S)=CG<-N.,8'.><T 7%.:0G;0K*20OUZTUV ^4CK[T
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M1110 &DI324 +WHH[T4 %%%% !24M)0 O>H+C[T?^^/YU/WJ"XZQ_P"^/YT
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M[E+@7]_)>Y"[=I?&5/)SC:.?>FZEX8@U+7K&_:7$$4317%OCB8 [D)_W6YH
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M%%% !24M)0 O>H)^L?\ OC^=3]Z@GZQ_[X_G0!/1110 4444 %%%% !1110
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MQ001-([-T4*"2?R%>7?9K=8+2%X$%I:^)9QB9052(L^!S_#G&!]*ZOQ\S_\
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M83M(66)E'R8 X.[ISG%0V]YJT5FU\FKVTD-WI\LBJTP=S*%+*T0V@ =<@YX
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M 2EI** %I*!2T )2TE+0 4444 %)2TE "]Z@N.L?^^/YU/WJ&XZQ_P"^/YT
M344G:B@!:*** "BBB@ HHHH **** "BBB@ H-%% #.]&#NIV.:7'- $<DD:$
M;V 'O3BH<'(X(P?I7%^-8X_^$G\'2&-2YU386/\ =\J0X_/%3S^,REOJ=_;V
M9GT[3IS!<S&0*RLI&[:N.0N1G)'7CI0!UBJ%))Z],^U-\E=A4\KV&.WI7+WW
MB^>%]72UTXS'3+>.Y=GE51)&RLV1Z'"G@]?:I[GQ2ZWT-I9V9N)GLC>L&D"*
M(^.A.<L2<8Z=\T =$%5!G'Z4VX@AN[:6"X0202QF.1&Z,I&"#^%<C)X[7[#%
M/!9[IGLDOS;RS*C['!*JO7<Y )QP/<=*M3>*KB34186&FR37'V.*]V2,$)C=
M]OJ<$<D@X/% &MI]N^F6:6TL\TX!Q&TGS,$[*3CG'J>:+#3TT]KFYN)S-=7#
M#S)GXR!]U0/X0,G ]2?6FZSJSZ7%:&.T>XFNIA B@':I())8X.  IYKSG7O$
M$'B&V\,:Q]G$<\/B-;-DB??DHS?*&X!!P.?>@#U8O&1O<[ HZGCBG81@F1NQ
MRIQFO/\ Q/J\NM>"O$UC=V+V.HV$0W1&17'S#<CJP['!ZX.16SJ_C"'0TF@$
M*R2VMJ)W4S*A9<$X0'EVP"=H'ISS0!T[Q@[6_N^U+@-RIZ]>.M9=_J<B^')=
M3LTS*MLT\<<@VY(4G!].E9=IKM_#8:5:M:"XU*X@WB-90%9%"Y=F/3)/8'K0
M!U 7C.3CZ=J9M"%410%/4 5EZ%X@AU_2S>PQR1&.1XI8Y -R2(<,O'^>:YNY
M^)'V:ROKYM'NS:65^UC<3 Q_NB&"[B-V2"3VZ=Z .X,,0/*@D]\?E2/'&A\P
MC)'W>.E<EJ_Q!M-+>Z"VTMREBZ)=M&5RNX Y09RV 1D<8]ZMVOBPZCK^HZ1:
M6<KR64ZQ22L0%7=&9%;KR#P..>>10!T2^21G@_WN._O3_)CW%@H!)R>.]>=:
M?>6EG86WB/5+;&H/=S10-$Q+3R2RM&B$9 ('RCG@8SVK:N?&Z6-MK1O;*:&[
MTF..66#<K;D?.UE.>1P<]"/2@#K/E4;B.?I43PQR%5E7<,[E4CH?6N?C\5RR
MWUM9OI=S"]S)(ELSLA68(F[=][(R.@(^M5E\<H;6.[-C*L'VO[%=,77_ $:7
M>$VGGYOF(&10!UQ5003R?7%,E6&4;'P<_P )K"\;ZU>>'O"-YJ-E$DMQ%L4!
MVP!N8+G\,YK$NI[JV\=6=W';7%S=OI$K"V5UY/F1Y^\P4<9[_G0!W @C0Y Y
MQM''0=ZY<>&-5^W7+Q:\/LUQ.\K)-8)(Z9.<*^1P.@R#4)^(6FII4=]$LD\3
M64=ZZ^9&CK&^XC 9AN("MP,]/<9Z"]N9KWPY<7.D.))Y[<FU9NF\K\I^F<4
M366GVNGV%O91X\B&)88U/95& ,_A5ED1>0O)&,@5YYX?U'3=7U+2H([F[LM8
MT^4MJ6GW4K[Y"8W0D@_*_P [*00.W:MJY\=Z9#<P0$R;)KXV*RAD/[T.4&5S
MNVEAC.._IS0!U+JA52ZY(Z4QX(D7.SCO@9KFK;QFMW;7%S#IFH2);FX6?:B?
MNVAZKRW+'MBKMKXFAO+?1Y[>&5UU2!IHP=N40)N!/.,Y*CJ>30!KR6UM/()&
M17D0%0>I4=Q2JD3.0$&3R<COVKFM(URQMM$M'T^TNY#=SRQQ0,=\A8,V>=Q
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M\4 =%'I-C'>":.V1)XHO*CE Y5/[H]N*@M?"^A637;6VD6L'VK_7F.,#S?\
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M,.H/<7UNMY?V\=GO$1*0Q(Q8[><EB6SDGVKLMXW@8^;&>M(TB;P#C?\ W<T
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M.TP:VAGE\V2)0O0OR2,]!DX%9.I^%]3O;KQ#:)Y"6.LQ9>?=\RD0^6%*X_O
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MT33-/NIKJST^UAN9^)IHXE5Y._S$#F@#E]*NOMEK871U^6X34+"0RVX.=SD
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M2".&]@694D$B@G!5AT((Y!^E5I/#VF26BVKV@:)91./WC EP<ABP.2<\Y)H
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MVGU!R"#U!!'!'-5;CP_IUS97=I)"Q2[(,S&5F=B,8^8G/&!CF@#3W$'!IU,
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M!57I3?,0D4[S%]: %.,8]:,CI1QS0"".* (V55&WH#4@QQ32RL0*7<N2,]*
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M[<G. 5((. 0.I% 'IC7T!\S;+&6C&YEWKT]>O ]S6-?ZQ=6^N:)#;B"2QO\
MS5=@Q+$K&SC;CC'R]:Y:RBFL?%=G>:AI,Z1WGA^&T\J"W9_WRL2R$X./E(^\
M>W)J31!,ECX$A-A=QM;M()E:!AY7[EXQNXX!)% '7V'B&QO(KMHGREI*T3L3
MQ\IP3^=7Q?1.B21,LL;OL#(X()^M>>-Y5CI>H6\EA>!HM<>XE<64D@6-K@LK
M */G^4@X&0.X[51G2YDL[^*32]0?RM?BNHC]F9,Q%URRX P<9)Q0!Z-?ZW9V
M&GWE_)<1FWLT+2$,.H'W?KVQZU:LKZ*^MH9X^DJ[A^5>5Z[I%W)-XVM=,TJ;
M[-<Z3"T"I"0LDRC# $#EL;??K7>:)K5NZ:?8Q6=T@EM_,CE:!E3 P#DD#!)Z
M ]1S0!T))9&VD!N0,^M<]H6NW-^VJ?;EBACL[A[<2!LAMIZG@8^G-="6"(6/
M0=<5Y1JYN+CP3XUM;:TNI+B2\DFM]L3;GRXP5&,YXH ]3AGCF#>5(KA3M.WL
M?\FL;4/$<$5_>Z9:;)M0MK7[249MJJ"#@$C)YV]AWJEH/^C^(=0M[:T:WLVL
MK9T CVKYF'W_ %;&S/T%8=W&MA\1==N)[9V%WI*):R+$S9=1)N&0,#C [4 =
M9X5UA];T"QO;@1)=7-NLSQ(?N!AQP3FM5;J)Y'B5U\Y<DIN&['KBO._#4"VB
M^"W:TFBG-M(MPZ1$=4 'F'TR!C-.\,^1/<V-G?V>I#Q!ILDGV@^5L1MVX-(9
M,?.C!B0,DY(X&,@ ]":6.&$SS.$C49+$\"HWOK9>#,JX&[![BN:\7-+93Z/=
M2I</IT+R"Y:!/,*$H0C%,'<H.>@.,Y[5DWFG10^#5U?2+61Y=*N6U"T%S%\\
MB8)D 4C(5@S[1@8^4X! H [Z.Z@<R,LJ_)]X>E.6>)XEE1@T;\AATK@=5@O(
M='L]9-I/)#-?"^U"&VBWRNA4J@V?Q!1Y>1WVGU-9UW9VLMA87.FV%]]DGUBV
MN%\U#&3\V9&6/ *# '8=30!Z'JNMV>CZ/<ZG<N!;VZDL<@9QQCGO5AKZ)=--
MZWRQA-YSV'>O*/$UL6TCQUIUC:/AIK>>*W2(JFT>5YA0 8YVL>.<_6O06\C5
M_"%U':0GR);5TCC>(KG*G VD?TH J?\ "6BZU#P\ME'%+INK-*#<ECD;8FD7
M:,8YV]S73"9/+WC[H[^@]:\IT!;:Y\/^ K1M-E1(7,%XK6Y12XM7C8G(Y&\@
M9Z=:E$T=M9R6_P!A(LY?$#,FV(ND*<8(1?O G( P1W- 'HFH:Q:Z?;Q322J1
M+*D,8'\3.0!C\Z75;^6RT6XU"")'>&(RF-V*Y &2,@'^5>:316YT2/S+2X:#
M3O$GFNDEJQ*1&;( 7;TP>@' X]J[S69(T\&W[%'A22T=(X_+VL"5("[>QYZ4
M 9EEXVN'N-$34-+6&+6,_9IH[C?M;&0K*5!''?D<UUB7,;LH5A\P)Y[8KC/#
M&AZ=?^'M U2Y6>6XL+?]RLAV^4=FTY4=\>M8.D:-!)X)O=3@LI'U:TFNHBQ#
M"06YG9F1%'K&2  ._% 'ITUS%%:2SO,HCC!9F] .M1:=JMMJ>DV^I0-_H\Z+
M)&Q_B4C(_,&O/]5M(;W7)KG0T3[#+HERMVD4>$D; V#;C[W)/(SC%4=-N-.E
ML/"-D+-U@%B\;.\+$/,L<:M&8QP7_P!I@0,<<T >M.ZQKDL%'0$^M-D<+'EB
M%Y R>U>/Z=J=L/!WA:/4I%_>Z?=0R&^CE9DEW1C<,*3D$]3C@G!]9D%EIK^'
M_.N[B^\/)I[VLEY%&TB+<A^6D4ANH+=1P<=* /7"X .!D8[=ZI7]Q>PM +2W
MCD1Y$64O+L\M2<,1P<D#MQ7G*6]NGBGPS8H+R6P^PW:E[N0[G0%1'NZ<$$X!
M&3WJOI++#X,T#S&D'V775BCS,6V0B;C.3R-N.3T'- 'J[2X>- "=PSO[<4\2
M?O&7TKSA=0TQM?O+#6EF/B!-1WV@BW*\D0;=%L;& N,;AD#J371>,KBXMM%A
MN%\QK);J$WGE9WM#N^8#'/IG';- '2,Y**!\C-TS0DH*_?#$C(QW%>=WEUIS
M::]QH?G-I U&V?4"H*H8L;7"K@%5&(V; P1N]ZJZR;%M*\62Z:6_L^2V@:(6
MS_+YY+%MFTX_N9 [Y]: /4/,ZC;SG &>M(9%YV_,5["O.;F'3&^(9LR6;2KW
M1VN)D\T^4\J2##L<X)V$G]:Y_0+D:B_@**^FGE6:QO3,#(0),$! ^#SW'O0!
M[-YH+;<>Q.>A]*H2:C);?;Y+Z.."SMU#QS^9G> N6RO;!X]Z\KL!!_PBIO3-
M)]KM_$:PVLC2DE8/M:C:O/">6?RK=U9$ND^(4$$C2[K+*H)-V"8"3M].3GZT
M >A%V?:\7W>..G!J8-G/L<5Y?KTMA-9(VC7MHR16C&2VG+".<$_.8F!!$N5Q
MN&>U=;KU]L\"7]XL%WN-FTAC1MDJ[ESU[$9Z@=J .B617&1[TU&948L,^@KB
M?!]]!)XKU**&\MITFLK:1?LR[8BX\P.5!)SQM!/MS3]3M=.N_'#V5_.3;R:7
MO: W)0,PD/) ((P#0!VN\?-GMQGW]*C3<)3DC;C->1Z=>1+IW@75GU"1KR6\
M2TNIFN/O1^6QV,,XQD+U_K4>E:R9_$NB7+73Q;M8NH+B%I&>0 I)M65B<$9Q
MM7''09ZT >MP:C;7D$DEK*LBH[1G']Y3@C]*LY&T@G)'6O']"NM.T[1/L5[-
M+;1#6[B*\56(\J(M,8B^>%3(7/MC/%7KEK'[3X8LK?5=3N-/NKR:)WN+DJTB
M>6V ,;3M#9 /7@8.,4 >C+<3IJ3PO:E+?RU*3&0'<VXY7;VP,'/O[4^_G>VT
MZZG"EFBB9]HZM@9KAKR_BTS6/$2K/=&"T\/Q%8$F)D4HT^=F<X;:JG./0TW2
M;N&&ZUF)=1M+A)=(CD0V[GRB090Y!9CN/3+=^^* .XT>_75-(LKY8VC%Q DV
MQNH#*#_6KX.:Y_P=('\'Z$596_T&%6*G(R(U&,^U;P. ?K0 N!1WIH?+8Q3J
M "BEI#0 44"B@!:*** $HHI10 E%%% !2TE+0 4444 !I!2FD% "U#-]Q/\
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M.KA1N(P#CM2MM"]<%3UQTKF[[Q-/IVJVVFO9!KJ<2-$BR%OW: '>^U"5Y(&
M#R>M-M?%,E]-961TR>*\N_/S;W!,95(SM+DE<[22,''.1TH TK_2[B>]CN;#
M5);$[-CK'$DBN 21PP..IY'7/M4]A8KID&SS#(SR/+(^T N[')) Z?A6-X,6
M46>J_.&*:G<JJF0N!\PP-QY-5W\9O;6EK>7=LJJ^J'39PK_ZMO,*!AGD@X#?
M0B@#KAM*[CZY'%-_=&(N<!/O'(XKE/$.KQSZ1>R7&GO-:VNI06RE)"N]M\8W
M@CLKMM(]4-0ZSJMW='Q7IR>5$ME8_(Z2,& ,;MD8Z'.W\J .R&QU\Q'&#R&&
M,8IV4*@\%>O'-</X>\13Q0>%]%N;20_;]*\Z.7=][8B[@P[9W#&*?HWB".UT
M&S>QTR8K=ZC+:F-[@NRR;G))9NWRGC/&: .T6-0QD_B/?%,/E9<%@&QR?05G
MZ+JTNI2:C#/;B&:QNOL\@#94G8C@J< XPXZ]\US^I6G]N>,;VRN4_<P6,90P
MSNDB;W<%U('WL(,>GK0!V"^4$+9!7IN]O\*5T5MI!^8=.*\\N+\Q> ;)--CD
MAMIM62S?S;AVD.;SRY,MUPV&],!N!5[2M0CT/6=9MEBCATZRM(;MHS.S&/?O
M!" K@#Y <9'+&@#M46,@!5PJGY>.AJ0@8)_/BN57QH@FECFLI4$5F;PN Q4
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M%QX/CN;.[AEO[EYKNXCGEN/D#MLP47[N  1G 'KZUT-S/%;Q;I9$C4\;G8*
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M'-'C.X=UYX(- !!HD\6HP7SWS2SQ6K6^6B4 Y(8L<=\@<#MFL[3_  8-/M]
MA6_F>/1=WD[D7+@J5PV/]DD<>U=+'>6TSF.*XB=P,E5<$X[&FI>0O(T:R(77
M.5#@GCKQ0!B6?AFXAU2POKO4!=/8K*L3&$+(0_9FR<@?05>NM+DO]2TZ[>X
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MU!B!4J-[ CS, X[>O6GV/A*;3X/#Z)J)<:-O"AH0/,#*4^;!XPI/3O72O/
M"TJ#C<,N!QZTT7-ONVB:,EQE?G!R/:@#EIO!MQ-9DPZK);WB:E)J%M<) I,3
M/G<I!.&4AB.<=JL+X7U"5;"2\U19[F&]%[-(81AW";,*N?D7:/?GUK8UG6+3
M0])FO;N8HD8& J[V8D@ *HY))(&*S5US40EM<3:++%#<2(A;SPQA#, &9<8Q
MSG@F@"O)X1D,OG17NRY_M5]223R@0A:/RRN"3GY2>??.*MZ,^L?VWJIN[AYK
M#S/]'WVXC*]B%(Y8#^\>O:MH3Q;S&9%\U1N(W<_E^%(L]N),"5,MP!O'7V%
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MLRJ48GN>0=Q'/Z5J>'_$=GKVG+?*DEO'+-) J3@*S,I(/ )[*>];:R+TQCG
M]Z //W\#7"Z9X@MM-6QT^/6%13#&[M&C@L6DY48+;AP !QUKH'TF^FU'5;H/
M ([ZQ2W"%SE77?\ ,?EZ?.?R]\5T!*%" 1CI^-1K=6[7#0I(IF3 = >5SZT
M<6OAKQ%I\^G7ND7.F-<PV$5C=QW>\QS"/.&4@94\D]*?JOA>_P!8A>RU1K/4
M4DM_W4DI:-K>X#.2Z%5^[RF!D8V]\UVCXSY>.&[@T&6-%4!@<\#WH XK6?"M
M]J\D4$LEJ\T)BDM+PEA- 5 WY(&6R<D#('/-=M$I4$DY))/TII9 IP1N(IPD
M0D,2 #TYZT /Z]:6D!!Z'-% "T444 )1B@4M !244HH 2BBB@ I:2EH ****
M "DI:2@!:AN/NQ_[Z_SJ7O4-R?E7V=?YT 2+WHH7I10 ^BBB@ HHHH ****
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M?MDEQ=6DK.<!&90RKMQN4C<3T!R*O:A:V<VMZM8^(K34[I[RX6YL!:>:8[E
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MR6IMI-&%T4+@*\FYAN*]"=H')&>^:Y[3M2L[WP]H=O<S1_:F\-L6ENW#PXR
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MA?VZWK7VFW#VNI6[';=)PY69.T@^4^F6.*GM;U7UKX:JL\32&TD2ZVN"PQ;
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M"?[H_P!]?YU/4$_W1_OK_.@"8=**!THH 6BBB@ HHHH **** "BBB@ HHHH
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M_(:Z0LQ$IP!R,^@ X]!4</AG1K73)-,33D%G/_K8BS.&^I)S6X2!UIHQ@C-
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MG,\>_P"3:W3D8.[;Z]ZYS2=1U[6(]2,%U"&L=5>T*-!P\2. Q^]][;GGU[4
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MYGTVS:\N?,C7R57.4+J'_P#'=U;.]<9W"J-[86>HJD5Y#',H<E5?IG!Y_+-
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MTYYX[&Y2WF\607]O"L9+K!E2S%>J\AB0>G?%:?B#2M5U*^\;P:8LJ37-I9+
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M*C^RVX)58D!)+$]P35C&T"@!:*** $I:2EH 2E%)10 4444 %+24M !1110
M&D'6E-(.M "U#/\ <_X$/YU-4,_W/^!#^= $@^Z/I10/NCZ44 .HHHH ****
M "BBB@ HHHH **** "BBB@ IC'#K3L\T$ D'TH X3XB3WD5_X6AM9'1+C6(8
MY2AP=O7^8%5M5?4K?4/&%UIEW]EDLK>&Y7Y%;S66-C@Y!X..V#S76:[X?M]>
M-J+EYH_LLJW$+P,%=9%/!!(-0S>%;.5-4C,UP5U.(0W)+#)4#;P<<'!/YGVP
M 4X]6U.7Q.MOA/LC:4+P1XY\S<!C/ITJMX,UJ[U.[>*^GNH[V&V07.GW=N(I
M(I"3F08 #(W&"">E:$_A>V>]AF,]X62R-AD.HS$<]<#K[CT%3V.@+8ZE]N^T
MW,TXB%LAF*_+$,'^%1DY Y.30!D^-2^I7%IH!64VEPCS7ACC9SL'"#Y02/GV
MGZ*14'ACQ!?S_#Z[D6!I]8TF.6VF@[O/&O _X$-A_&NDL])CMM7O+\S3R/=@
M*ZRE2H"_="X ('7OWYSQ6#J?AIM/MO$%_IOVNYO=3@*2VHD1!(=NP,N ,,%S
MWY_(@ KZ=J-_<ZO;VMEKBW<+:<UW+*859=P8!1D 8!W9YS]TU0M_$VKP^'=%
MO;F]$EWK BM88XXE BDW-E\DX)(& #QD"I-,L-2EO+:/3+WQ"( P2]758E5!
M%L(Q'\H^;.W!Y& :Z"/P1ID?A:'P\7N6M(3NB=G EB(.04=0"""<@_S'% &5
M=ZYK6DK%:78+2WFHQVMBY9/,VLA8AP %W?(V#P/F]N8[W5O%.E6>Z["HTFK6
MUO;M+L9GADD5#O"' (R>1UK7?P-IUQILEK>W5[=SNR.+R:4><C)G858 !2N3
MC [GKFB7P?'+8K;2W^H3L)XKAKB61&E9XV#)R5P%!'0 =30!@W&H>((E\3Q)
MK6YM(C-Q%*;9-TF8W;RB.F!LZ]>:T[S6]7U"\N+31MRW-OIZ7&%$9!ED!*!M
MYSL^4YV\\CFM&?PO;/<ZK+YMSNU>$0W6"N H!7Y?EX.&;KGK45SX/MYIH+E;
MZ^M;I(OLSSVTH0RQ?W7P,'V. 1VQ0!0>^\1WVL:AIMO=P69BTN&X1_*$FV1S
M(#@YPPRG4^O2DTC4;S5]2\,7/V@Q"ZT:2YFB4#[^8?4'NY_#-;"^'(K:>[GL
MI+B%Y;9+1579M6-"Q7;E<YR[=<]:@M_"4-M%I<,5[>1#3HC;1.K(&:'"_(Q"
M^J+R,'WH TM-M]3BENO[3NH)T:=VMO*3;LC.-JGU(^;GWK \9Q6^K36VBW-O
M<O;%))YO)CD?!'RQY$8)'S$L,\?NS71:=8&P$I,UQ+OGDD_?/NV@GA5]%'85
M#I^@QV.JW]_]KN9Y;TH660KM0(,*%PH(&,]2<Y- '/VNO7[_  LDU>%O+U&P
MLY?-WIN_>0A@P()'4K^M5+E?$$^K^&I+S5X56ZOI&6.&$?NA]DE.#G[V"&Y.
M.HXXK7;P5"$UE$U&]6'6-QNH\Q[4+##%1LXR"<_X\U;OO#9O;+3+=;V>"33W
M$D-S%M\S.QHSU&.4=NWN* .:N_'%]I$WB<7,5O,;*^MK*S"(5WR3(N"_//WA
MG'84_P 5Q:TG@CQ,NHS075K]A9[60+B0'8=X8 8X.,'KUS6E=^ =/N!JRRS7
M,T.JM')<(S+E610H9"!D' ZDGFIY_!D=YHMSI]UJFH3_ &N#[/+/.ZM(L6#\
MJC;M'49.,G% %?4];U:XU*]TW1(R]S8P1R84(=S/RJMO8?(0#DCD?H:>H>)=
M2L=;BL[Z=-'6=8'@EN$WP3R$CS8C)R%;LO(SGO6O?^$EN-2CU2WU*\M=0\C[
M//-:[%-Q'G@,", CL1@CM4>I^#X-0MY;(75P+*:.*.6U.T@!.A4D94^I!S]*
M $\6Z[!81V=@UZEF;XD/,RL=L0QO*D#[QS@=,9SVJ#X>ZCIESX>:TT^YC?[+
M<3$H@("*TKE>OL0?QKK<;2OW0W05RNM>';J#PI)I^D7E_%=BX>>"2!T$FYI"
M^&8\;,GGOM&.: .HN$:XMY(XY"ADC*JX&2I(X.#7'>&(]2T;5_\ A'-7-K<0
M16_FV-Y!%Y3.BLJ%)%'&X;AT]ZZN]M)+S3V@6YGMI6&?.MV =3[9!%5;'0Q;
MW8O+J[FO;T1F(32JJA5)#$*J@  E0><GCK0!7UZ\OH;^TM;:Z2VBF1\%$\R9
MY!C"A/[N,DMVQU&:Q+/Q%K>H0>%I8&M8VUBS,LK-&S!7\L/\HW=.O!/XUOZK
MX>34-4M]12]GM9HH7MW\L*0\;LK$'<#CE!R,'W%9^F^$3I]MI$4=Y.ZZ3E;?
M?L^92-N#A1T'3]<T 9NG^*=5U"SMM.BD@;4I-0N+(W+1':4AR7?:&ZD8 YZD
M4O@I)U\4^-1<,C7 OX@SHNU2OD+MX]<=:N)X#BCMV\K4;N&Y2]>^AN(BH='?
M[RD8P5/0C'-7_#WAL:-JFKW[7TUS/J+QR2APH *H$X 4>E ')^(;B>U^,UC)
M;6WG2C19654X)(9VQ^.,4NHZI-X<^&5SXDTZ6/\ M>6RMKZY9URLSNJ(6VC'
M7^E='>^$);KQ3%XA74Y8KR& V\854V!"2>ZDYY/>J5]X"35=-U6TOM1N)/[2
MCB@=D2-1%'&255 %  R>>#VH Q=5\2^,=*\$7?B:273VB:SM[BVACB;<K/MW
MAL]>M2:WXL\2^'_#$^O79L)$NUM4TVWV,#'(_+ESD9XYX].U=+J/A*/4_"$/
MAJ:ZE2V2-(3* N]D4#';&>!VJ35_"5MKGA.+0M2F=EB"%)HP P9/NG'3- '+
M7?C74M/N/%>BM+')J6D6:WL=SY> ZE0Q#+G /..*GTP>(O'/A-6U,VD>EZGI
M&&2(,)5G)'S'MM(R<#U'7K6E-X MKF?6KV>^=]0UB);>XN1&H"Q@ ;57H.%'
M7//Y5HZ?X:.G^#X_#EO?W4:1PFWCNU(655 P"".,@=Z $\#61T[P'HEK*N)!
M:1AP1C#%1D8KRI=>@\/^.OB'<W^GRW5HH0.(E4Y&0/FR?N]B>:]GTG3WTS1+
M:Q:YFN)(4"^=<'+L1W-<[:?#VTAU?6;ZXO'NEU@!;N&2-0I Z;<<C\<T <_H
M>H77@;X5^'+59HKR[U&[2VM7CRZ+YS,_&,$A5S@#'8<5F?$;4=9O_AEJJ7J2
MVWV>_CCWO"T3749*E2 3\O7!'/(/2NE?X8VP\,/X?&I7WV6"Y^V6,B!1):R9
M.-K=P-QX/YU<U;P'+KGAMM(U#7KR8RR(\UPR)SLY4*OW5&0,]<_K0!FR^(+[
M2I[B"QL/M/V:*WN;NVL[5S)/),Q,A)4D+A1N]SD5#<>+?%5UXU\1^'-%BL)9
M+*WBF@DN%<!=P4D-@\\' QCI6ZWA&Y;7/[3AUJ\MG>TCM[J*!5 GV[L,#U5N
M>H[5/IOA%--\;:CXD2^DDGU!$BF@9!@*B@*0>N>!D]Z .>O/'>KC4]433;+[
M:FES1PS6D$$DDDK''F'<.$*\X'?%4-?\>^(M-G\7K VGE-'6*13)&^XAPIVX
M# =&QG]*Z8>!VL]=U'5-/UJ]M(=1?S;RVA5,NV.JN1E3[C]*I:I\/O[3E\0L
MVIRHNN)&LX$"':$"J-I)S]U>_P!: $F\;ZEJ4VG:7HL<":K=:8=1;SD+JH(P
MB8!'4\_0'O45]XVUF*6'1[:R2'6DTMK^YC,+SJK\!8@$)(W,1SDX'O5V;X>
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M#^(QU&]TI4M8X;'5[BYMK,LQ+QO$%P7[$-STZ<=>31)\0-172([PK:!GU_\
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M1<8 4]L'!H X_6_#=M9:OH?]F0.VLS:@)Y+K=\ZPKS)N/=/NK@YQN&*[]2
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MM^OI69KM[K%O$_\ 8]I:3R)&TCF[E,:#'88!))_ >_:L+2HK'3OB%<6MA'%
MEQI$$ABCP-[+*XW$>NTCGN*V->FTNY@;2[_4$M7N(F/,QB8J" 2#D9 STS]>
M* +VB:D=6T:PU$QM']JMTEV$=-P!K%?Q1>W7B*[TO1K&WO/L+JETTMSY11F
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M :1S2CF@TN* #%%%% !333J0B@!.M*!1BEH **** $/2E'2@]** "DQ2T"@
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MD'6E-(.M "U#/]S_ ($/YU-4,_W/^!#^= $@^Z/I10/NCZ44 .HHHH ****
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M;'(C9=IP#CD#/7M5BWU:RNM0NK""X22ZME#2Q#JH)(!/XJWY4 7"A)I0..M
M?.,=#1@<\]>O-  %QWIU4Y]0@MY+=&?!GE\E."<M@G''3@'K5H,">#DGF@ (
MPV<T,,X.:J66I6NI-<K:SK+]FE\J7;_"^ 2I]^1^=5QK6G_VN-+-Y&+[[P@_
MB*^M &K2 YHW#.,\]:S+O7=-L;D17%VD1+K&25)568X4%APN>V2* -,]:,>]
M,CPRGG/-/X(Q0 F.>M*1D4@P<<_3GK0&!_I[T (%QWI<<TUBH.YCCG YJ*RO
M;?4+"&\MIUE@E4.DB]&![T 3$4JT$9 I(SN7=0 ^DH//%5;Z^MM-A^T7<R00
M=#([8 /8?4T 6Z:35"TU>QOI5CM;N*:7!8HCC( X.1U'4?G5X#J0<T . Q2$
M9/6E _.LF]\0Z3I3,+[48;?:0',AP%)Z9/09[9ZT :V.* ,5 EW"]F+I9%,)
M7<'[;?6H].U&TU6U^U6%S'<V[,0LL;;E;'!P>_.: +AHIN3DC'2FD[P >.>.
M>M #F[4H.15=+RWFN)[6*96G@53(@ZJ&SM)^N#^5,N[ZUTW3Y+R[G2&VC&YY
M7; 4>M %RHRAW=:9-=PV]JUQ/*L<*IN:1C@ >M1V&I66I0^98W45Q&."T4@<
M?F,B@"WVI ,#%(YVH2>W-4+'6=-U&::"SOX)YH@&>-) Q4'H>.WOTH O@$&G
M5&7.2,=!S2(SL.G3B@"3%)C'-*"3G(Q2?>R".* '9!I",U1N-0LM/"-<W4<2
MR2B%3(V-TC'"J/<GH*OT -W8IW:H6#%_Y5+GF@!%&#3JKW%S#;6[3W4J0QKG
M<[M@ >YIUM,LT"R(V]&Y5AW% $I%)M^;.:)&"1LS'"@9)/:JRZE8D6^+J+_2
M/]3\X_>?[OKU[4 6Z0G%!..W:F.&.W [\T /HQ1TQ2T -[TZF$G>H X-/H 3
MO1CG--.?F..G2@L=K''04 .I:9&S-&"1@^E/H *3%+10 E%%+0 4AHHH ***
M* "EI*6@ HHHH #2#K2FD'6@!:AG^Y_P(?SJ:H9_N?\  A_.@"0?='THH'W1
M]** '4444 %%%% !1110 4444 %%%% !1110 4VG44 (3BCK2, >II<C% "]
M*3<*,@C.>*CV8&2>* ),TN:9E0N<\ 9I1P1Z&@ ;(X'4]*\C\1^(;'4I[:XD
M6=9[76+00A[27 B692[9*XW'G@$G P.M>N$@KU_&J&J:1;ZM% DQ=1#<1W*;
M&(^>-@RY]L@9H LQR+/'%(I)5U# D$<$<<'D5S_A!D*ZX4<-_P 36<Y'_ :V
M(=-6WU6ZOA/.3<11Q>2SYC39NY4=B=W/T%0Z3HD.C2W7DRRR?:IFGD,A!)<X
MST ]* -7O2T=Z0_I0 N:R_$+ >&=5)Q_QZRCG_<-:0*\8/7I6=K%I)?Z=-90
M@,LRE) 9-GRD8(SM;^7XT <^UK:WOPFC@G$;QG1UR7P0I$/49Z$=<]JR-/U/
M7=7\.Z7!;O<K>)HUM<J\(B_>3R*VTL7/W?D)..>>M;,WA62;3[33)09]/@4)
M]G>[94=1QAMD8W<=B<>U/UCPY=ZK<6UW:3R:9<6T9@#65T4#1'^$@Q$<=CCB
M@#(OXM1G\9^&S=7<EK>S6-P\B1&-TB8>5N525.<\C)S[8JC>^)]:M?#?B2>/
M48OM&GZ\EC'(T"@"(M$NT@#G_6'GK73'PY+_ &CI]U BQ26$)@@3[02NTXW
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MJN@5CSU/K3$\&W:21!+V7R(;YKZ*$S#".Q8GDQ9;[QZYQF@"]X6*_P!O^+0
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M"SLK%",,C#Y?^!=C5JS@OKB#0!J>G$7$%]<-,UO;NL;CRY5$F"/D#%E.#ZT
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MM&<75[:P"-0[&615"J> 23T'(YKF38I)J/B:WUG39[F"\91#LMV</!Y:C:&
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M9CCT )H =I?B4GQ!J&A:H(HKZRB6X\Y#B-X6X!.?NG/&,GZUN_;;7RY)'N(
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M!UI32#K0 M0S_<_X$/YU-4,_W/\ @0_G0!(/NCZ44#[H^E% #J*** "BBB@
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M[4(EN+J9URSEOF')Y&,@#TQ3[2_FTZ:'PII$,5Q<:;9QF5YY"JHAX120"=Q
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MWVORXYA()8^<D' (P00<C\ZJGQG+;WFFQ3:'=*NIR)';2F1<,63=^&,'KZ4
M=?M7D8'Y5%^ZN&9'16('7%<J?&-Y#97-Q-X=GC^PS;+L&ZC(B7"MN!!^;Y6!
MP/TJW-JT%GKNJ&/2;A[NVL8Y3(&_UL>]\*![$,?QH Z(10QC<J*H'7 IQ".N
M"JD8QR*Y:#Q@JN)KS3Y+6TDTM]169Y0<K'MWKM'(QO'/>I++Q)//J]O82:3)
M#)<VWVM/WP/R9 .<@8()7(&>M '1!(BQ!5=^,''I[4J)L;:@58P. HP*Y;Q3
MX@O=,U_PY86,'F_VA<R"7! RJ1%MH)Z$\'\*Q=*UB?07UP+:W-U:1ZV4:0R@
M^2K; .IR0">U 'HVY0I/848KE-8\;V6C7-UYT:O#:.J7!$JATR <A.K8!!X]
M>,UU:,'0,.,]O2@ 4<TZD'6EH 3&!0*#0* "BBB@!:2EI* %I#2TAH ****
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M^F)=RW20($B>50IV@<#  J=[B^?4[>."*%K-E8SR,^'1QC "^AYK0.#SN/%
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M+%+.9#&L:E0SG( Z'+FB'PE='2[W3[[7KJ_BN;=[)6DB5#%$PP>GWCVR?TH
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MO$?BWQ'8ZS8V]U;V-O;%51VRN1(XVG:IR3UP1T YK5_X0>-;&"P&I3>5%?\
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M;FC*E1DYQNP?8?6@#H?"NL7VM6$\]]:?9VCNIX5^93D)*R8X/;;60K?9-?\
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MRQ(0AS'M7 SV/X55U#PIKNI%9)]1L6>737L&5H'*Q,2W[V/+<,58*<XZ=>U
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M@@CO69HFM+/:6$"17-VRVD3RS)A@C%03N;.2WM@FM*Y@N;[PY/"A$5S<VS*
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MCRYF#I&95&W/IC(Q3=0U>XM+CQY;VFIW$ MM.M[J"261G\HE'+,N>A.!T[T
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M -7_ ,"'\Z?_ !4R?_5_\"'\Z )112BB@ HHHH **** "BBB@ HHHH ****
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M,4HH &SVJ-!ALU+BC% !2T@%+0 444@ZT +112&@!:*0=*6@!IXI1010HXH
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MDQ2@4 +1110 4444 %)BEHH ,4444 %%)2T %%%% !1124 +1128H 6C%%%
M!1110 4444 %%%% !1110 4E+10 E+110 44@I: $Q2T44 %%%% !BDQ2T4
M(*6BB@ HHI* %HI*6@ HHHH **** $Q0*6B@ I*6DH **** %I*6DH ****
M"BBB@ I:2EH ****  T@I32#K0 M07'^K/\ O#^=3U!<?ZL_[P_G0!,M% HH
M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %S1FDHH 6BBB@ HH
MHH *,TAHH 6BDI: "BBB@ HHHH **** "BD-** "BBB@ HHI* %HHI* %HHI
M* %HI*!0 M%%% !1110 444AH 6BDHH 6BDI: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "D-+24 %%% H ,44M% !2444 %%%%
M!1110 4M)2T %%%%  :04II!UH 6H+C_ %9_WA_.IZ@N/]6?]X?SH F%% HH
M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,48HHH **** "BBB
M@ I*6D- "BBBB@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!*6D%+0 4444 %%%% !1110 4444 %%%% !1
M110 44&@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4E+2&@ H% I: "BBB@!**** "BBB@ HHHH
M*6DI: "BBB@ -(.M*:0=: %J"X_U9_WA_.IZ@N/]6?\ >'\Z )A10** %HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**** "BBB@!<T4E
M% "TF:** "BBB@ HHHH *,T44 +2444 %%%% !2YI** %S1FDHH 7-&:04M
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M !1110 4444 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )2T4E "T4E% "TE%+0 44E% "T4E% !12T4 )12T4
M%%(:* %HI** %HI** "EHI* "BEHH **2B@!:2BE% "4M%)0 M%)10 M)2BB
M@ HI** %I**6@!**6B@!*6BDH 6DHI: $HI:* "BDHH **44E "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :0=:4T@ZT
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MQH S/[?3_H&ZI_X"/_A1_;R_] [5/_ 1O\*UL<]_SI<4 8YUY?\ H':I_P"
MC?X4C:^J]--U1O\ MT;_  K8%% &.-?4\G3=4'M]D;_"G?\ "0P@X-AJ8/\
MUYO_ (5K [@#287KC.* ,V/7(I&"BRU!2>[6C@?GBM)3N4,>,]J"<+G%& 0#
M0 ;AFE/(IOEC-.7I0 @^7J:-P)Q2D!AS3%4<'UH =N%*"#4;C# #O3PH% "D
M4W%/SSBDR=V,<4 )C S1O&*4C(Q3 @R1GF@!X.:*  *,"@ S1GG%(W ) YH&
M" 30 N11D4;12%1^5 #J0TSS/D#8I_:@!-U+FF  GFGX% !U-&:#A031C/-
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M!INGRK!,DERDFX8)6-XVVNI;IG=T'?GTJ&'PYJD%WK!MM7$,6I3F8NL'SPY
M7"$L1G"CDCJ>E7]/T/\ L=K"TTUU@TN"*026P4?O'9@V\GUSNX[[O:@"[JFH
M0Z5I5Y?7)(@MXFD8CT )K$B;Q)<:-;ZC]HA2[8)*]FL>55>"4!/);'&2>IZ5
MO7UI%J.F7-G<('BGC:-U/0@C!%9%AHNK6D,-E)JJO:6X CD$)$K*/X6.\CVS
MM'2@!Z>*M.:[6$3$H\S6ZR[3M>5<[D4XP2,?CVJM;>-](O5MVAFDQ<+(T;O$
MRJPB)$N"1R5P<BJ$/@B2WEAM%O/^)=;:DVJ6\93.U^2L9.?N MGIGCK56P\
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MFN8;=9)-T\CQ0N(F*2E&VMM(&#@\9_'I3]5\1Z?HC[+YW0!#*S*C,$0$ LQ
MX SWKB]!CO[76(I;>.*X$EW*SVLEK/%):+*Y:0AF;RP><G &>@ZUT7B3PQ=:
M_P">JWD44$EC+:A)(?,*,^/G7YAAN* -/Q)KT?A[2X[YXFF#7$,(5>O[QPF>
M^>M*_B724OULS=@2M((3E2%$A (0GH&((XZ]NO%5O$N@W&N:!%8+=I#<I-#,
M)C&67=&X?E=P."5]:J0^'-7L-3FEM=92*QNIA<SQ"V!?S>-P5L\*W?()'8T
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MK/S(]LZ%DD23&X'!!ZJI'N* (-/\6VZ^'X+_ %&4EG,[,8XF(6..1E+G ^4
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M.(:C'?;8T<#(C",.^<XZ^] '36&J0:C;23VS^9&KL@)4J=RG##!Y!!!%4?\
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M>XK,U.QGT[X:O97(A>>WMU0A6.PL,8Y..,^M1:MX<U#6+C6+M!;6]W<Z8MA
M Q*[=Y<,6QQR3P ?K0!U$NJV45R;5[A!,"$V9R0QY /H2,'!JNFM:9YWV87L
M/F[6D";QD[/OX/?'<=N]8=]H>L7FO?:G@@,9FMY4D-PW[M5QO79C&<Y(;OD
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MBB@!"!CI4; /M/I3R,BD";<T .%+3:6@!:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH #2#K2FD'6@!:@G^Z/\ ?7^=
M3U!/]T?[Z_SH E'044#H** '4444 %%%% !1110 4444 %%%% !1110 4444
M %)2T4 -QS2T8I: $'6EHHH **** $I:,4E "TC=*,T=: $48IU)TI<T %%)
M0#0 M%%% " 8.:6BB@ IF*?28H !P*6DI,T .HIN:,T .I#29HH 44M-I<YH
M !UI:** "D:C-'6@!M.%)BEH 6BDHH 6C-)10 M%%% !10:0&@!:*0'F@G%
M"T4@.:6@ HHHH **0FDS0 ZBF[J-U !BC'-*#2T %%%% !1FBFGK0 ZD- H-
M "T4@I: &[<&G444 %%(329H =12 TM !0:** &TM&*,4 ***2ES0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :0=:4T@
MZT +4,_W1_OK_.IJ@G^Z/]]?YT 2CH**!T%% #J*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **3O2T %%%% !24II* $I110* %-)2FDH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2FD9_,&G&FT /HHHH
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ex10-2_004.jpg
<TEXT>
begin 644 ex10-2_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M** "BBB@ HHHH **** "BBB@ HHHH *6DI: "BBB@ -)2TE "T444 %)2TE
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M49HS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4=Z**
M"BDS2T %%%% !1110 44E&: "EI*6@ HI,TM !1110 4444 %%'>B@ HHHH
M***0T %% I: "BBB@ HHHH 2EI*6@ HHI* #-)FBB@!:6D%+0 4444 %%%%
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ML-B77EW[A()FA(BW'HA;LW7BF_\ ">:0D$EQLO?L\5RUI+)Y!VI(&"8;TRQ
M% '5$TG/4]*P(?%5A+-J2/YL#:<B23BY780K?=('N ??I4,GC73K;[<MS#>Q
M264"W4T31!G\D_Q@*3D#OZ=\4 =*ISDT9.ZN4U/QK:66A:I>6UM=22V03=%(
M@0_O!\C<_P )/?V-= ;L)IRW4H>(*N^3S!@J ,G./I0!;)W# ZT _+QU%8EA
MXEL+QI JS0E;9;W_ $A-FZ%L[6!].#P>1W%5)?%]JEM?-#;W?VJ&S:]6&6/:
M6C'<<]LC@X/M0!T^>!ZFFJ3MP>M<U!J\=W<:+Y\U_:75S&TT5OMPDF(SN#8R
M".<@9SD9I+?QKI4VG7]\?M CTV46]R6A(/FD@8 [\D?F* .HSV/6FYPV&'7T
MKEKSQ#I]I=^(+D75ZS:;;1RW,#*?+C&V0@H".^TY_P!T4Z'6+>XO?#HO+J\M
M[NZ63RX$R(YB(\L7XP0.HYZXH ZK--?[O%8</BG39-1CM7>2,S.T,$LB8BED
M7[RJW<_S[9J:S\0VE]>);Q)<9EB>6.1H_P!VZJRJ2&]RXQ[9]* -89"T YZ]
MZ;/*L$#R/G"C)P,FN?M/&VC7CV2Q-<8O'\N"0P-L9N3MW= V >">U '29YIC
M;@<]A7/#QGI(1Y7:>.*)YDEF>,K&ABSOW-T'W3CUJS:^([.]N/L:^?'<21&>
M(31%1)&,?,K=#C(XSD9Z4 ;*X S2D_KTKB[CQ!]M\0^&#8W-TEG>7%PKKM&R
M9%@D((]LJ"#WX(XK2@\6:;<FPDC:8QW<S6\),?'F*2"&].5- '0$_P (^]3E
M)Z'&:PKCQ1IEMJ*6[,Q:2?[(LJC,9GQD1Y'?@CZ\=:9H6OG6;S4(_L[Q_9KI
MXD)7&54 '/ONW?E0!T)II.%S63)XBL8]5CL#YID:86^X)E%D9-X4GM\O/IR.
MYJG-XTTB%;D/]I*VMT+69Q"VU)#MQD]A\Z\].: .@7*C<>E.=L#WKE_%7B&R
M@TS4;)+RXANX[0SE[>,LT8['I@9].M:&A7,D_A/2;V>0RR/8122R=W)123^>
M: -=2>IZ4X,",@\5S5OXYT2:*!C)/''<;A%)) VURH)*@@'YL*>.O%3CQ-IG
M]FO='[0D27'V9E>)@_F$[0NW&<DX_.@#<9@,>]+N !)X KG[CQ=H]KI[W\\L
MJV\<_P!E;]TVY9<XVD8X.>/2LTZVT_C/3Y5N[B/3I+"[>:UGC*!7BDC7<01G
M/S&@#KPZ[BV>*D![]JP_[<LGMK>5%G9+L9@01,)'XW9"D9QCVJ*/Q7873::;
M3S9H;V5HT=(SM&U6)!XX.1C!]Z .BS32<X(/>N;MO$.GVR:I>3:A/);Q7RPL
MKQD"!V2/$8XZ?,ISTRYYJ_:^(-,GM[MTE=!:*'G6:-HRBD9!^8#(QW&1QUH
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ML[AX2\UW-/F$$;!(Q;G/<$G]*Z-6R<9!-4]2U.UTJ%9KEL>8ZQ1J 27<G 4
M4 <C9^%-9TSPW<:'%/93VRW1N()I"WF',PEVLN,=<\@^G%7(?#5_8ZG=-;&P
MNK:[N3=O]J0EXG8 -MQP1\H(!QC'4UURY"_,0:8 X<#<N/I0!S>L^&FU+58I
M8KA;>*6 6M]M'S2PAMP4=N3N4^SFH+SPU?6^OZCJ=A#I]VNHM&\L=ZS*8BJ"
M/*D Y&!R./K6U+K,!U6?35#>?#"L[_*>4+%1CCGD'IFK6F:C!J^F6M_;$F"Y
MA6:,L,$JPR#B@#G+OPU=ZGJMV99XHK2YTHV&Z!CN3G)8 C Z],GZT^#1-1FN
M/#\^HFVC.D,Q!@<DR$Q-$."HP"&)ZGD"NI1=B 9%,F>,XC<*PD!7:>=W!R/R
MS0!P%IH]SXD\(:1:R744=M!>1W?GJQ9_W<FY4"D  \8)SQ[]*ENO"&JS:)J=
MH#8B6[U=;^-GD8!%\Y9"#A>ORX_&NJT:2SDAN;:SLOLD5O.\.SR/*4D'JH[@
M^O>M A_+!8KD'T[4 <3K7@V^U?5=9>66UAM+VVMTC?>Q97B<.-PP!@D '!Z9
MJ:_T'5]0T#4[-[+2+:>\LWM0]LS'EAC>6*@@=]H!SQSQ74ZIJ5OI&G3WUV3Y
M$"%WVH6( ]@":L1S+*D<B,-CKN'TH XO5O"NJ:K'XB5'MX?[0M[=(CO8_/%D
MG=\HX)[CTZ5TQ%]/HDH)@M[YX653S)&CX.#R!N'3L*T5)^8>AJK/?VUO,8)9
M-K+$9F)4X51W)Z#O^5 '##P3J=Q<SFZN$ NM'-C<2).TDN\.6#991G.X\<8[
M5OQVNOZCI5U;:J-.MO,MGC#VSM(79EQGYE7:N><<_6M"YUZQL[*WO)Y2D5R1
MY8,;%V)&0H0#<3C/&.U):>(+6\O#9".>*X">88YHF0A<@9Y [D=/6@#&BTG6
MGD\,R7"6RR:8&\X1S,0V8C'QE.3SGM3[CPBK^*Y+Q"/L-ZL<U[&W/FSQ<1MZ
M>A/^XM=3G]X#N&".E/R.#D8- '%WV@:AJ-YXI5C$(=5TQ+.(B0DQE1*,L,<9
M\W/4]*?#I&LW=]X<N[F&R0Z:LJ7$0F9LAH]@*G9S^E:FI^*=*T6Y:.ZN#G<B
MN(XF;RR^=NX@'&[!Q]*T[._AO;&"]B#K%.GF*)$*MC&>0>1]* .1TGPWJ&FR
M06<]AH]Q;VTVZ&\=6>54W$GY"  ^#]X-QZ=JCTO1]4T.1[V/RX(!:2>9827;
M-:B<D;6C+#*+]_(/3(XKJ]*U:VUVS^UV3,8-[QY="IRIVG@@'J#5TE9$8Y5D
MZ$$9% %#2KN:\T>&YOH5@DD3:ZJVY>N,@X&0>HXZ&N2\/V5UJ/A/08O*5(K:
MZ$_FL>R2,1CCJW0^Q-=PWE16\BRD>4!@XX '3%4=-DTJQNI-%L8_),$8E,:Q
ME4"D]0<;>I[4 <[-X5O[WPGK>DRF&WDO;J:YBE5BRX:3>%?@'GH<=B:EN-#U
M37)K%M0,6G&WM)X ]M*7;=(JKE<J,  $G/<+757UVFGVD][.Q\B&,N^U23@=
M>!R:9:ZA!>:=#?PY:"5!)&6!!VD9Z'D4 <O:Z)KD \-131Z<$TB0J9$F<^8G
MD-$&V[>#\V<9/UJI;Z!K5I;6MC%#9M!::N]ZLKRMF5'D=L8V?+C?[]*ZVQUJ
MQU=9ULYRYAD,4N8V4(X/*DD8R/2M$$;,DC&* .4TS3=<TZYFT\0V$NGM>RW:
M7;RN9 ))#(PV;<;@6(!W=,<=JN:);:C8ZCJ:3P0?8I+J2XBF20EV+8X*XXQR
M.ISQ5FR\1Z=>ZC]@@E=I=C.A,;!9%5@C%21@X8@<5IMEF*9 7O0!QVIZ+K%]
MK(N8?LI@M[^.Y@)E91L";2" I&[))W<Y&!P!5?5?"VK:AH?B6U1H1)JEZDT.
MZ0X5%$2_-\O'^K)XSUKMX>"0&&T=JFR.Q'I0!PO]@:S9WVNRPQ6UTFLP(&\R
M1E:%UBV[>%(*]<=^:W]%MKG2?"5AI\J1-=VMFD&Q7.UF50, XSV]*UC, K,&
M! YJM>7]M80F[NG81AQ'\D;.=Q.!PH)ZF@#D[/P]JHTKP[;/##'+I]X\TK!R
M0$99!\OR\GYQP0.G6IKC2=>_XFK6RPH;C48YT"2;6:((%;:2IV.2.O/&<$'F
MNR#Y498!B,TH!SU'Y4 >;R^%=<?3=5L5AM<3:M'J,1,SG=@H65B5)_@Z]SZ5
MH>)M"U+6]8M)(46V@M[*6)I&.<N7B=1MQADS%A@2,@UU,^LV5IJUOI=Q<(EY
M= M!&>L@'7%5].\1Z?JIM_L=P)H[A6>-MI4, <,!GN#U'7CI0!@3V&MW_P#9
M6JSZ99M?V+.DMI)*1$Z/CYHWVY4KM[CH2*NKIM[96VDRV>F6$!AO'EFMXI"J
MQJ\;ACNV_,VYLG@9KJ3N^7&.O-( 22"!M- ' ZCH.JS:5XAMX[>-C?ZO;WD6
MYB!L00[MV ?^>)''J.E2Z_;S>=X@N;FS_P!"O]+2U\QGV_,OF<'@X#>: #Z]
MJ[I@2&]^E07-K%>6CVMQ%'+;R+L=)%W CZ&@#@O#T&H:5KNBR:MIVV=K,:7#
M<QW:2*R@;R2H&<DIU'I5GQ6ID^)/A';;-.R6]^VU2!CY8\'GO73:5X>TC2-X
ML+&&$AL@JO(X['L/88%27>A:=>ZM;ZE/"&O+=2(9=[!D!ZXP<<]^.: .9N-!
MU-]/:2.U7[1<:S%?M LHQ&BNI()Z%CM/3C)ZU7U/0]<N+R=EM(F1=6@O(1%(
ML<<B1LA^8 9,GRGYFR.!CTKOQNYSCVIK!]HQC(/Z4 <+J>@ZE<:=XQLX[7)U
M&026S[PH?Y%&">W*GK3KW3-8/B-M3L;>6W:26W+H9D>WE1=N[>F<B10" RXZ
M+BN[.[!QC/:FE6RN#TZT 9&D7\UQJ>J6<L&PVLBA',H?S$894X ^7OP:YJ;3
M-7GUNUNO[/6-;+5Y+I4B9%62)D=-P ZO\^6W'.0<=A7<QV\4!D,,4<9D8NVQ
M0-S'J3ZFI-IR#WQ@T >=W6C:I=>'M7M8]-=+FZUA;N%6E3[@F5R2<\'"G@\\
MU)K.F:L]MXHL1I[70U)B]O>1R(-N4"A'#$$;<=1D>N*[]58*,XR#2[3AL8Y.
M10!S_B#3I]4\'WFFQRI%-<VK1#<<KR,8)'8]#[5D266L:]IMV+W0+33]0;3Y
M+0W'G"1R6&=JE1]S< >3GV[UVQC#( 0,CI0=_EC'WJ /-%T;6?-LY9]":06W
MAZ;3)(YIE/F2'9Q\IP5;;C(.>N0*F&@ZVOAC5])A%S) ]B%MA>.AE23)_=B0
M'#(!T)Z9KT?G/.,4C!MIVGGMF@#A0^MV_BTZ_/I%R\$]B+:2VBDC=[=@Y(S\
MV"#D=.F>:JV7A^]L;_PT8K%C:6DUY*^R12(%EW[$'/S$9'(S7H11BYSC:1S]
M:2-&4[>-HH \SM/#NL1^%-5LTTEQ<7>MM=QQ^<@VQ^>L@;.<=%Z5I7FD:G#>
MZQ;3:,^J66I7(N%F:\V*OR(NR5,C(&P8P#D8KO@& [4U=^6W8QGB@#FM%T^Z
MC\6:W>W%FRP7*P>1*SJ<[%P0 #D#)[TWQ%#J/]M:5-:V!F14F$MS$B&6$D*
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MJ7G/M1WH 6D-+0: $I:2EH **** "BBB@ HHHH **** "BBB@ -(.M*:0=:
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M3(ZL5W*&)*@XP. 0N>^*2\T&QNM3;4)A*7>V>VE02$))&W]Y>Y'.#VR:C&B
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M-9UY;[3-.DOK5)#J%Q:W$B .758C(I/& ^,;@. :D?P47TR33I-&T5[9IOM
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MQRIYK+TOQ%K?B/6-*AM[];*&]T/[<0L(:19-ZJ2 W&/F[\5J76A7D\QDDLK
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M"@ /&2.M"Y(YI3TI!0 $G/M37W<;:<:6@ '2BB@T )2T8HH 2E%%% !1110
M4444 %%%% !1110 4444 !I!UI32#K0 M0S_ '1_OK_.IJAG^Y_P(?SH D'0
M44#[HHH =1110 4444 %%%% !1110 4444 %%%% !0>E%% $1Y-2*.*;MYIP
M% !CG-+110 W:,TN/SHQS2T -VT$<8!I0,4'.:   [<'K30F/K3NM+0 PJW'
M/UI]%':@!I&3G/%(!ELB@#BE7K[4 .-,<';@'!IWI2#YLY]: %ZKC/-(N1U-
M*!CCM2 X;% #J8N0Q!-/II4%LT #GC /)IC+N=>>@ZT.O.<]*?L&* %[YSQ2
MTW8,8H8<4 .IK DCFE7I2-GG'4=* ##=C2].] Z#/6F/AFVYYH 4ALY#4[MU
MIJ\#KQ2E!ZT  !QR:: VXC=TZ4\#'%-"C.[- #N?6FD'(^;ZT[:#490;NM $
M@!]:.] &!35'S$T *V>@.* "!R>:10&;=G-.X!'/6@!.0.3WI3R.#BFNN]MO
MXTH&T 4 *0>,'ZTF#ZTZB@!,''7F@ #I2$4HXH 1EW#WI$# ?,<T[-!&10
M<<\U&$8CK\V>OM4@&!2T (:!TI,YIPZ4 %)2T4 %%%% "4M)10 4444 **:>
MM+2T -%+11F@!:*;WIU !24M% "44M)0 M)110 M%)FES0 E+24N: "BBB@
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M1L:-71LA@?2G*R]*<2!0!$+:-8DC5!M3&T>E.,,154*#:#D#W%.# FA@#UH
MC^SQ9)\M2"<_2E2-5=B(U4DYR.]/&U1BD#!FXZT /I.]!.*.HH 4&BDQ03B@
M!:*:6P,TJG(S0 M%&:3(H 6BD!S0S;1F@ Q2TBG<,TA;!H =2=Z0/2YXS0 M
M&*16R*6@ HII;%(9* '$9I:8C;LTI;% #J*16W"ESS0 4AHW<XI3TH 0<TM(
M!BAFVC- "T4Q9,TX'- "T4A.*,T +1129YH 6@TF:6@!NVG4FX9Q2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &D'6E-
M(.M "U!<_P"J/^\/YU/4%S_JC_O#^= $J_<7Z44+]Q?I10 ZBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6D(S12T (!@8H"XI:*
M"BBFDT .I"0.2:%Z5D>)->MM T.>_FPQ4B.*//\ K)6.%3\20,]NM &MD,,
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M +_ -"MN4&N.UGQ<;6_T*/3IK:=-0U'['(<E_EPQ)0@X)!7!]*Z\,& ([C-
M#Z*** "BBB@ HHS29![T +111F@ HHHH **** "BBB@ HHHH **** "BBB@
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MNBG[0O08H ?12 YI: "BBB@!CTB=:5Z1.M $E,/6GTT]: %%**04HH ****
M$I>U)2]J $HHHH **** "EI*6@ HHHH #2"E-(* %/2H)_\ CW>ISTJ"?_CW
M>@"1?]6OTHH7_5K]** 'T444 %%%% !1110 4444 %%%% !1110 444E "T4
MTT"@!U% HH ***0T !-%)10 X44"DH 6DI:#TH 04M(*1F*C.,T  ;)/'2@G
MG;C-1^=&CA2P#.2%![XZT]F /3+8Z9[4 .!]:0BDRQ )&#Z4X4  H)P*6D-
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M1$?EV%F#9W<\OZ#I6-!X3O\ 3[#1)++4D^WZ2DD"%H"8YHWQE&7>#U53G=U
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M'9W,<\+>7,$ VOP<@C'OQQ[U-8^$7L;O1+E;B,FP\YG'EG,KR[MQSGCECV-
M&QHNIG6M,%R\/D2+/- T>[=M:.1D;GN,J:S[/Q5;7%Q<Q(856SEF2YC:7$T2
M(#ARAY"G'!]Q5SPYI,^CV$\%S-%,7NY[D/&I7_6R-(1@D]"V/PK'N?"<^IZO
M!<ZB;)_)GG(N(XB)Y8)$=?(8XQM <<Y.=HX% $UKXP6XL=(U V+IINK7"Q6\
MK2?.-^?+9EQP&(XP2>1D51TC61HL/B&6ZDEG;^W3;QJ<L2S1Q84>V2:EL?!]
MY;V&D://>1SZ9I5S'-"Y4B5A$28U;M\ORC(Z[1TI9O"-W/::M$M^D=S+J0U&
MTG6-OW4BA0 WKPN#C'4T 5O%&L37GA76A%!<6<UN\/[U2X61&9<E&(4GC*D8
MZYZUM/K_ -C\1RZ--;;"MH;J&=I<B502& &.H(YSV(JAJ.A^(=6\/7UGJ5[9
MB[NMBJ;>-Q#$%8$X4G<2<=<]\=JJ^)DL-:UC3;"*[B&NV\H22&%MS)!(H\T-
MQPI4=_:@#IM(U"75]"M[J2S>VEEC#_9Y'^9<C@$^M<;I\P:!M:U#[1#>#5Y;
M6%8+H_O6%PT21.,8*\ 'D]">*]"VGR=R_,^.">,GUKCX_"UXN@/9RRQK=PZD
MVIP3E207,S3!6 YP"Q7CM0!9U'QK'HYU6WO[1A=:?:"]*12;A+">"RD@'(.0
M00*W-.U"6^MVE-F\*E5:+=(#YBLH;/MUQSZ5S&K>#[[6WU2]N6M(;^ZTW^SH
MA#N9(T9MS$D@9)/IV KJM+MY+32[:"4AI(T",5Z''?F@#B+S6]2O[RRE='A6
MW\0?9!#%-_K5"-PW;J >?7VK=F\3Q0V$S74+Q7$-XED80P/[QL$'.?N[6#'T
M&?2J+>$M02_9H7M?LQUC^T!DL&VE2".!C//'\ZDU'PSJEXFIW%O<6\-Z=3CU
M"PD.XA62)8]KC'0A6!QG[QH U]"UH:L]Y"MN\1M)O+9CED?(!!1N-PP15"Z\
M7_9UUIUTNXDBTF3%TPD7.P1ARRC//RGID5J:/'JY@-QJSVZ7#@#[/;DF-,9Y
MR0"2?H*X^W2_U#5/&^GVD<$B7,Z0M(9<>6&MT4G;CYASZCZT = /%B'^T#%%
MYJ6MA'?JX./,C?=MP.Q^1JKKXT5KJPMK?2[B9[^Q:\A5'3G!&1DD=F!JM+X6
MOK.]E_LY;5[2XTF+37$S,&7RO,"D8!'(?N>U5_#GA;6-.NO#EU>26K#3=/DM
M) C,2VXKR,K_ + ZX/)H T+KQQ%:P:G<?V;<M:Z9=K!=2AE^4$(=P&<X^<$^
MP_"K>H>*8;7^U)8K>2YBTL*;G8<,I*[B%'0D*0>2*YZ/3KK71XQTJU\C[+>Z
MEY<TYDP44V\0? P<\<#IS6I>:!J=O>ZW_9\5O)::TH:4R2E6@EV;&8#:=P*@
M>^10!</BVUN9S%9Q?:"L,5P!Y@1FCD&0RJ>6 '7'TJ.]\9VUK+=H+2>1+>X6
MVE>,J6+$*253.64;AD^H/I67<^")3IMGI\:6\@TR&"&PU $I=0[% )Z8(R,X
MS@YQCO5LZ1XEL-9O(-,GLO[*O9_M)EE+>;;,0 P10,-D@MR1]XT ;^HZO#I-
MA]JG#%<J@08#.[,%"C..235"+Q$LFM7&E2V,L6H00"X6(R B2,D@$$>ZD'/3
MCUIWBK0VUO24@20)/!+%=0RL"0LL3!U) YP<$''K5:WTG4IM9EU^[M;6"^6R
M-G##'*9 %+[BQ; ZD#C'^% %'P:MYJVFZ3K]W<W@GFMQ(\9FS%*9!G.P]-N>
M,8J:\\<+;1ZK(VDWC0:7.([V163$:;%?>/F^888<#GVK0\*:??:/X7T_3M1,
M+2VD20J\))#JJ@9.0#G\*Y:WBU/67\;Z7:0PR6U_=_9FE>3:T.ZUB1FVX^8
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M#%<!IB:'9?$?31I4D96;1'11$<JP$D9#9[G //>N_0$(H/6@ 5=O 'O33NW
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M0:>I)'-"YSSTH #]\<=NM)C+$E>1TI1G=[4Z@!@7 (" #%(@.6RN :DI"<4
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MDD:)MF(GR[^9C:=R@C@Y.ZO2"H!#;<GW[576_M&61HI8Y!$_ER%6!V-Z'T-
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MV>E/9SM+;N/(G9(^2",X."F<8X/.*ZCP= 8;;5)(4$=A=:A)/:*$*80A>W&
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MH)3.E_YV9PQ&#R01@C@KC&.,5;T;PW'HCWTL5W=7$EY,;B0W#*?G( )&%&.
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M#NSDNV.<_G72D9% !VI10>E% !1110 E%%% "B@T"@T %%%% !1110 4444
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ML!(6 XP3AAQU]JYO1&?1M*\$7>H6DXL;.*Y6X/D.QMIF'[MG4#(^7>O3JXH
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M5OO*C']JR16;>4<)(W/!Q\N=S#/&<^]=B"NXJ.HH "%R/:D"X)]*4CFE'2@
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M% ";5V[<<4W<J#;T IW>F,FXT . 4*<#@]:$"JH"]!2X^7%)C%  =K8S@TK
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MK,36(6U&WL@CF6>'SEP,C:,9R>@ZBJ^I^(M-TC4DM;J5S=2PO+%$B,Q<*0,
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M.N7(#,$C502SNQPJ@#J22!5 ^*]-33[VXEED@^PMLN$EA;?&<9&5 )Y'.>E
M&]N&,]*0N,5SL?BW1[R,JL\QE^T&VC0V[JTK@;B(P1\XP"<CCBL_PWXAB-GK
M<UU>7$PCU5[>'SDQ(3LC*H%P.<DX % '9!L\X-*#QG%<_!XPT9K5YY+MX]EP
M+:1)+=U:.4X 1ACC.X8/0YK3TS5;;5[4W-H9#$LC1'S(VC8,K8/# 'J* +U%
M%% "444N* "BBB@ -)2FDH .]+24M !1110 4@I:04 *>E077_'I+_NFICTJ
M&Y_X])?]TT 2#[B_2B@?<6B@!]%%% !1110 4444 %%%% !1110 4444 %%%
M% #6SCBF9.1237$<!!D8*I(7)Z9)  _,@4OFH GJ3A?K0!+VIJD\YI0>.<<U
M&SG<=@Z#DF@"0]*1 1G-(7P.>W!JKJNH6^EZ=/?7)(A@0LV.I] /4DX 'J10
M!<.2.*C!.[&.*I6&J&]GEB^R7-JT& ZSH!G/0J02#^!J^"0S CCJ,4 .:D4D
MYS30Y,A!'TH#$R8 ^7O]: )**KRW,<;K$\BJ\AVH"<;CC/'X"J.BZ[9:W#=-
M9,[?9;A[67>N/WB?>% &KD^E<WXWT+^W_"M[8(V)9-KQ>\B,'4?B5 KHPQ!P
MW4BJ>J:I9Z3ITE]?2B*VC WN1G&3CMR>O:@#F-0CO-7&A:_I3V\DEH)$GMY6
M9-PDVAUR 2K J.".V#4%I97GAS3?$=WJ(MT?4+N2:%(G+E]P.$Y4<G.!]:V]
M+UJUN+N2RCM9[6XEW7"I/!Y?F#(W,"."<D=\\\UM26T<ZJ)8T=EY&\9P?49Z
M4 9GA;3'TGPOI6GR_?MK9$/UQS6PI))SZTW<RH!CYJ;/,L%NTCJ[84MMC4LQ
MP,X '4T 2 Y-+SFH+2X%Q:QW 5U60!E#KM8 ] 1V/M4V[YB.* .;U>PU2W\4
M6FKZ;%!/&UN;2XBEEV$ ON#*<$=>H[U@Q>']=70O#]M);VPGT_5OMA596.8@
MTA(Y7[V)/I]*]!1F*_,.<XXIJLQ4G'4\4 <)-X3U+5-3U1Y$6QBOK:X@G:*0
M[9I-X\B78. 0@(8\$Y YZUHZ<GB:;2YH=4M;6%HH&@C%O<>:)W8;0V2H**/3
MD_E76$G&!UH.<@8YZT <3IN@ZMHTF@W\,4<\UMI*Z9<P++M^Y@JRY SR"#TZ
M^V*KKX/?^RS9WNE)?I=7ES>7($P5[>25RZM$QQC P#C'//M7<W<Z6]JT\P?:
MGS'RP20/7BH].U"'5-/M[ZVW&"X021EA@E2,@_E0!QO]B^(=*N=/O(DMM5NI
M-/CL[U9Y=A9HV)60,0?[[9'?/?I776T-V+*&*\N$DN0=SNBX7Z >E7SUZ4A7
M)SWH \ZM-!\06UKX=MKNS@:+2+D8,=P"778Z;AD#^\#CKP:9=^$]>O+[5[^V
M2V@NO[4AU"S65LK(!"8G5_EX)4MZXR/2O1@-^2PZ'CFD+ON(V\=J ,O1FU$J
M9+^QM[%6 $=O"XDV^I+  '/%8EKHNJ>%]=U6_P!/MEU"TU2<3R0"81R1RXP6
M&[Y2#]<\"NSVC%,;)8''3WH Y36;/6;ZSAO&2&*ZM;J.[MH&D& %X=&;IE@3
M@\@9K$\2>$=7UT>(M1B@CM[N_L([&WMW<,>'W,S$ CL .O0UZ.?F&&7\*""%
M+ ')[9H XU+74QXQAUAM.>6)-)-L5\U5(?<'(^; /3&<_A52'1M7'A?2;%M/
MV36>H13[!*,;%EWGGUQQSC\*[W;\P;';UI><9QSZ9H \ZUC0M>&G>)].LK2.
M:UUSS9XY7N%1[>1HU0JP/WA\O!SQP/>K5I8>)=(U!9[?3[.\MKFV@66)YPC0
M3H@0N6(^9"%'3GJ<5W>6STXH(.00.>_- 'GK:!KAOO$DDMHCM?:1#:*\4J*C
M2JC!L G(4E^,XX%3:-I&L:=+X9D%G\]EIC:=<(95PARGS\'!'R'@>HKO2#G_
M .O3%!95R,'O@T <'::7KD<ML)--5K-M1O)Y+<W*X/F.&B=L9#*N7!7DYP1G
M%2Z7IFM0:+X>M+FQ07&G7@#A)U(9!&Z;QG''S#CK[#I7<@$'IQGUI2-PY_0T
M <UXZTVZUOPAJ.E6=J;B:YC"*OFB,#D=2?\ Z]4DLM1F\0Z%?IIQ$=IIT]O+
MF9" [-%QUY_U9Y'K79$<?_7I .>F!]: //;31]:L_#<,*:=NN?[;-V8OM$8Q
M']H,IYSC..,5I066K:1XLU;4TLOM-CJRPR,JR*'@D2/80VXC*GY>0>,'BNPQ
M[?K05RW/3'K0!P^E^&]1T_Q#H$YB$EO9::UK+,C #<Q!R!G..U4M2T+5;KP[
MXJTZ*PS-J=R7A#2IPA4#))/'3H?6O1O3 XI.>3CG- ' :MIOB>?7;[4=)A6T
MFET7[+;S.Z,4FWE\[<D]P.G7FJ/_  C>J7<^H%=+DMC?:')9M,\ZN_G]MY!Y
M)QG.3[XZ5Z6X8*< Y/O2@L6VE<#'7- ' 6EAK-U/X-EN=+DM/[,$B3 RHX56
M@,0R0>3GG SQZ=*AM/#^H67A/_A$9;1IPMY\EYO&SR?-\P$GKO XQCD]Z]&V
MC &./K3<'.W;QG.<T <+JUAJ=QIWC&"*P9WU"1%M_F4>8!"B$]>/NGK6WK6E
M3^)/!ES9-_H]W<6Y !XV.>F?;-= 0</\OTYI23MSCGTH X35+'4]>O[+4)=.
MDLFL+6Y!AE*%I'>-D"J0QR!D'/2LK2-#UFWTOP';-IP+:<Q-TPD0@?NRN0<\
M_A7IJ[F&QEX]<T$%,(B_+GL>E '(V6E76HZ'XBL-3MC;+=W,SQR%@>& PW!X
MP1GUXJWX'CNGT7[=?3)-<W!56E7HZQCRPP]FVEQ_OUL:GH]CJT2QWMLDZHX=
M _8BK<$20PK%'$L4:C"H@P%'H!0!Q'B&TU>7Q']I73WN;>WN+26W:,  *&)E
MSZMTY]/QRR33KX>*$O+2WO[5GU!EO4R/LUS#M8++C)P^ @R ,GK7>[<'C//O
M37!!! SCWH Y'QC8W=S=Z/J]II@U,:=+(9K$E<R(ZA25W<;A@$9]QWJ.]MYM
M4T>324T,V=MJ<AC?RXT!ME(R[O@X$AP=I&<$KS79\XR%YS2G(Z+UZT >;.]_
M9^#=-L=0LIH[FQU2S@1W0+]H59E =<$\E1S[YJ+Q1H5_JC>(=9M+"4-<6,5A
M!;M&5:7#ABQ![8XY]*]#O--MM0BC2ZC+B.595!<C#*<@\=P:L[2JL ,^F30!
MQ'B"VO\ ^T]*UE=).I0K;2VMS8+MWJ6*L&56X)!3!Y'%4=4T^:^B'E:/<Z;?
M0PR264VF-@6[%FRD@!VMNX)X*\GGO7HVW   X^M!0#)51D]: /-[O2M7D,6H
M-:7-MK\*6J22VIS;76 NY63)7 .[D8/IFMS3[&1]?\1V5U9,;*],;Q2/RK@0
MJA_]!KKL8'3]:JWMA!J=G+:W<9>&3JH<J3^(Y'X4 <E\/HKE[:>YO6\Q['_B
M50R8^^D+$%_^!'^53ZQ.;7XC:1-]EEG0Z7=AS$FXJN^')QU(Z#C/4<5U<%M%
M;P+;Q(J1J,  8JM)I%E<:A%?RQ%KJ!&CCDW$%5."1C.".!U]!0!YQ#X;U6P/
M]N'3&N+=M8N+V32P5$AAEC\O@9QNS\VW/MUJWJVGW5U/HDEKX<>V@CU:.ZDC
M6,!U10H+N%[G';/ %>D8(3IDY]:.<CC]: .8*2IXEU6;[',T<FF1QQR*A*LR
MM*=HXZX=:Y>UT_4H$\ @Z7,AT^=_M0 P(@T3)S^)%>G[<,6 [>M&6.W*]>OM
M0!Y4-,U>;PSK4?\ 9<ZS1^)#?+#@%I(?-#94?3-:VK:?J.IZGK,$.GW42ZSI
M44"3D +;MMER'.>OSCIGFN^52!G;SGGGK3Z /-3;3ZCIQN+#PO-I][;"*643
M(@\WRY8W,2,&.5;:W7'1?PV]&N9;_P ;76H+IU];V\NGQ1&2XBV NKN2,$Y'
MWJZW;M7"KTY'--.5DX4!<9_&@#G[]+A?&MI<1V<DL"6$L;2J?EC8LA&?P4UP
M>C:9K%KX=\'6EQI,_FV.KM<7(1#\L?[WYB!U'SCI7KS Y# ?7FFH&9067!SZ
M]J .5\9:;?3'1M2M$:X;3+Z.YDMDQNE3&U]H)P2 <@>HK"\2Z9>:I8^*KZVL
M+AX[ZR@M(H!$RR22(TC%L8X_UBKD_P!TUZ1)G(P,XYIVWT'UYH X77[6_A\1
M^&?$%I83SV=JLD<]K%&6DB$JCYPO&,=QUQQBL.[TW5;\7-])I%P_V7Q"-0:U
M==K3VY@5/D&>6'4 XZ5ZJ^[*X&1WYH&[;RO/UH X*_C6[T&4V7AN:T6:]M)/
M+> )+-Y<R,S,HZ8 XR<G'%=Y%M*#;G'7GK^.:&7C(7)'3)IP0)R!R: '4444
M  HI*6@!*6DHH .M%**0T %+24M !1110 4444 (>E0W/-K*/]DU,>E0W'_'
MK)_NF@"0?<7Z44#[B_2B@!]%%% !1110 4444 %%%% !1110 4"BB@ IK9W+
M3J* .*^(5N\\.BJMY+!$=6MA*$<J&!D7K@CH<$>X%5KB[NM1NO$\*7ES9MI*
M 6JJ=I)\K=O(/#!F..01A>.M=;JNCVFL1QP7B%XDD68 ,5(=2"I!!!!! Z54
MN?#.GS3K*!+$QB6!_+F=1+&N<(P! ('O[^M !97LVI>"X-0W&">>P$N5&-C%
M,_H:X]+K6-/'@_5!JEQ=)JJQ0WEJ[ IS#OWJ/7(.?7(KO[FS_P")5+:6J*N8
MBBKG '&,5CZ!X<CM+'2A>)FYTZW2*-!(S)&P0*S*#ZXXXX_$T 84,VM3:)+J
M37PM[>^TII522Y+2"<Q[U>,,N$P-V5''0]JJ>(;>:?X<+J5UJE[.UP;&389-
MJJWF(#@ =#G."3R!76VW@[2+1+Q8(9 +O<),S.>&.2JY/R@]PN*EN/#UA=:1
M'I$T3_8HBA2,3..%(*C.<D @=^U &.\LM_XENO#Z7MY##8V<4B2K*?,D>0L-
MY/5@N%XZ9;GI7*Z;K>N:W>^$H;K6)K5M034(+@6P"[S%N5'&<\\9KT:\\/65
MY<PW3F>&YBC,0F@G9'9#_"Q!R1G!^HJ)?"NDQ7.FW4=J$FTT,MKL=E6,,,,
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M66>FZGX=DL]4E\FVG9$$B]8Y"PV$>^[;BEU#PEIE]J1U"1)$N)<+/LE=5N%
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M;I&DV^C:>EA:!A!%]P.Y8CG.,DDXJ&V\/:?8Z'-I%O$([6;S-ZKQG>23_/%
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M_CUD_P!TU,>E0W'_ !ZR?[IH D'W%^E% ^XOTHH ?2444 %%%% !2]Z2CO0
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MOE/LI#9F)QV90I'7)'8YI=1\5ZQ;7FLI9:*EPFEE#*3<8,B%=Q*C'WO;]>E
M'46NG06,"VT ;[./NQLQ94'H,]O;MVI+_2[74RD=[&9H$PWDL?W;,"""1WP0
M",\=\9 KGCXGU*;55M].TZ*X1["&^C$EQY>5=RIR=IP0!G'.:9:^,WN;RS,=
MA(]C=7#PQS1AW,?+!7;Y=NQL#&#QN&: .M&5;I@=*D[5QVC^*9M8WR110R6T
M*3&:."0O/"Z' 1U]6Y(^E:'AC7YM>5IQ]DDLVAC>*6VEW@.=VZ-L@$,N%//]
M[VH Z 9*>]*>G'6N0N_%&J'6[_2-,TM)[JVMXYU,L^Q7#,P/\)QRI Z^^*2'
MQ;J-\M@ECI*R2WMA)=Q;IMH5D9%*-\I Y?K[=J .I2YAFNI(8Y59HN)%!Y5C
M@@'TXYJ5 23N'0\5PMIXFLM/U#Q7-_9,,%S:W5O%,T;_ #7,KJ FXXX/S #K
M6L_B6XL[R\M+JTC,J64E[;F.;<)$0@,I^4$$%EYP>M '1F)&."@(!W#([^M+
MMW*%8 CN*R=#U6[U31X;Z:S$!GB22%#)G>&16R>/EY)&.>F>]8$7C.[%KI5S
M<V<$"W]ZUC*K7!S;2AV0 C9\V2I';J.W- '8K$GFL#&N,#' J*(Q-.RMY9F7
MMQD#I^7-<S=^+[VRE@,FEM/'-JKZ=&89/F; 8AL$#NK#&>QYJ5=5+:MLO-+2
M'4XM*>Y,@FSC#+NCR!TW '//3I0!T4C)Y@8X*D84X_E4YB7<&" 'N1P:\]LM
M>UF[T3PE)'';F;4Y,C,AQL^S22<_+P<K[]._6M'4?''V6XE"V$DD,%VELY5S
MN?+!6=  <A6R",@\=Z .N,2"==L28.22%'7UJ18D1F*K@MUQWK@;WQ]<Q1ZK
M<IHUQ]CTJ\%O=,SX(3"L7 QT ;)'' /TKL-6U2WT?3)M1NMWDP)N<+U)[ >Y
M. /<T 7-FQ<HH!SV%-2%9-CRH"Z'Y21TKGF\275C:7EQJUB]O%#9B\,BG*;3
MN_=;L#]X,#CW]JCF\37EK>W%K>:8RR)9/=PK#,&\Y5QN3H"K*67M@YZT =.D
M:EMQ0;AD ^U9GB#1%\0Z9+ITL\D,$C*SF/&X[6##&0>X%9&C^++G4+G2(Y=*
M>UM]4M3<6\C2[FR%#,K+CC@Y')_"HH/&Z/IK:N\$8TY+9YWFBG\S:590(W&!
MM<[CQS]T\T =;%"L,")A21U( &3W/'O0\$:(NR-?ER!QG&>M<3>>/)K:WOS)
MH[LUK8F]S!<;QQ@E"2H 8<GC.<<&M&Q\47ES=PVSZ4T0N[%KNSWR\MMV95N.
M#\XZ9X_*@#H;:WB21I(X8T<G#,J $_4U/Y$1!!C4ANH(ZU@>$-3O]4\,P:C?
M11I+<IYRA&SP?7@8_6J=[XS6PMSJ,MMMTF*\^S3W1?D?-M,FW&-@;C.<^W:@
M#I)5M(+A9WAB68_*DFT;C[9ZTLD%J%!D@0ACW -<%-!_PD_CG7-,U2V26QBM
M(5A03'='OWMYB_*,,=B\@@CG!-7O&T$*WGA99&9;?[>(9!@LSIY;?*>I8<#C
MUH [+8DKF.2,&, $*P!YYYI#:6\@/F01MD\Y4'-<9I^ICP_+-##87LMG<ZI]
MGM5D!0H#$&. P'R[U?'^%7QXGOI)X[!=+#:NMH;JYLS<A5A4DA09 ""6(X&/
M<D4 ;>HZ6+NQ>"UNI;"9_NW%N%WKW_B!!SCG-2Z9IT6F62V\>YCDO)(YRTCD
MY9B?4FN5'BN\OM1\/C3+=?L]]%/+(L\@0J8P%*'@XP3R1Z8JTGBV5M1L[:33
M'A@O;F>VM9))2)':(.23&5X4A&P<GJ.!F@#J!&CIAE!!Z@TD-M! ,0Q(@Z_*
M,<URD_BZ>!6FM[$7EL=0_L]'28*QDZ9P>-N[Y>OOBFWGCF#3+N[$EJIMK:9(
MYF%P&E!8#<5C )(4G!^G - '4BRMTE:=+>,3/]]PHRWU-5_)MGE\EX(BY;+
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MC<5_NYZX]NE<3H7BRXL]/8WJ7=Y;7.K2V>ERD9:6,#*9)P3G:P!YSC\:V?\
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M (TA\.:(R2HVDV1295613 I#A>@88Y ]ZGTS4;75M.AU"SD$EO.NY&'<5<H
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M ",TJK@4 TM #0N#FAES3J04 )C:!2!<TYJ!Q0 $9&*!P,4M)WH 3'RXI%7
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MU%1PL2G(IZD'IP?0C% "XI:** #J*;C%.%(: $)Q1CC-*2,?_6I$;<.A'UH
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MLC.,<9H 4]* >*8S\+@=:=GY: %/2F@TY3\HI%/4T *>*7M2$\=*3< N3Q0
MH.:"<"@8[4F<T (.33A3=X"[L'KBGT (U Z49RV,4F[CH: '4W=S2YH&" <4
M %!H!ZTUVP 10 C'%+GBA"'Y(HX+8QQ0 X=*6C(II8#^E "TWO3ZC)^;I0 X
M4N>:. ,TU#OYQB@!QH)Q2TG4XH  <T \TBGYB*=0 AI-O%.I,\XH 8O6I*0
M9I: "DI:0T %%%% "T444 )1110 44"B@ I:2EH **** "BBB@!O>F7'_'M)
M_NFG]Z9<?\>TG^Z: %B_U2?[M%$7^J3_ ':* 'T444 %%%% !1110 4N:*2@
M!<TF:** "BE%% !FC%-[TZ@!H-+FD;IQ3 6.!B@"6BFY('2E!SU%  3@4BG(
MI3R#2(",Y% #9.AYQ7+>+/$%WIK6D&G;1)]IM1=2,,A(Y)EC '!&YBQP#V#'
M/%=2X)/3([CUKSO6? FM"QN?L'B"X9[J^@N)(W@A ^65&R&(S\NW(&<9&.]
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M"_;Y+(K;-,BM^ZD9I)&);:"0P&,YX'% '?#Q)I/V26Z6]C>))A =F6.\@$*
M 22001@'(.>E6]-O8=0M%N8)1+$Y(5@".AP>H!KB=4TJ6]GORL-U&9M1BFM[
MNTN8TDA*VPCW@$\_,"I4XR&-;>AS:TEC9)?VXF>2>0230!(P%Y(D=0QP6/4
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M7)-=M+RYDMS!Y5Y+;JA.6PAQDXR,TGB#3]3OYK%[&>U2"WF\V:.X1F$A7[G
M(Z-\W7J!6)X9EU#1M/UBYU*W:4/J,S(MG V\[I,;@I)RO?/IZT 6M=U[6M)@
MNM0MM/M9-,LAOF>:1A*4 #.R@#' /<\D5U>\+EF/R]<GM7&^*M8GFN)-)ETC
M5)=.&TW4EO9O(+A>#Y:$<8/W6)[$@5NWUR^H>%+F8VMW"\UJW[E #,N5/0=,
MC- %+5_$(A\/W>H:?):W'V8GS0LH.T;L=N_!X]JVH+VVE$L<=S#(\9Q($<$I
MG^]Z5YVL%Y+X9URVFM#=S/91(EY#9R1&X"EL(T9&=Z]R..>W2M"YMA:Z[K:V
M>F3/#/H@<K:Q-$9Y@\C;0P7&\A@/7F@#KY;M)--NWLIX)Y8D8@)(",@9 ..E
M<E!XTOWM?"$LEE HUJ7RYL/_ *HA2WR^O0U!I!F_MQYH[-UADTCR2R6<D*H5
M8[4(;)R 3R<9[5DII>H_V9\.P;"X5K&\_P!(4PN/*'ED9;CY1DCDXH ]2N)8
MX=IEF2)"V,NP ^E$=Y;S*_ESQ/M;:WEN&P<=ZY;XBVDMYH%K!#;37#F^@;;$
MA8A0^6) YQCK6?J>FW$$WB>#0K$P%[*W>,0HR!I S^9M( !<IL''<#- ':QW
MEN;>5_M,3H@)9D<$*!UR:73]0@U+3XKNV?=%)&KJ?8@$?SKCS!;ZMK7GZ9;/
M';OH\\%S&8&C#ME/*0[@,L!YGTK4\'.C^%[."*SFM'@MHXI5DB:,%P@# 9P3
M@Y&1QZ4 ;BW<)NY(?M,1=5#% XW >I'7'^-2)>6TSF.*YA9]@?:K@G:>^/3W
MKS#3'C&F)&=*N[:'R+Z.9)H9'9&8[OWDI'.<<=A@#)J32]--VWA&\TJ#RKA+
M1%U-RC*)H/)'RL2.<M@CZ>F* /21>VCS1HMW 7;(5!(,L?I^!K$T/Q!-J%SJ
MMOJ:V]I)978A4"3AAL5AR>_-><>&M+AOO!OA*338)CJMO?AOM$,1^6(3MYBN
MV,!2A/?K^-=5#X=77?\ A++6>+RWFNRUM-(C+M;RU <9'.&'TXH [P2J;C9O
M 8?PYY(]:I?VG;Q:VFFO*!<2Q-+M)Z*&5?S)8?D?2L/P?='Q AUV>+RVV?8U
M5N,/&Q$A7V+@X]@*KZI&T?Q"-X^F33*VFK'!,D#2!91*V,D#"XW Y.. : .M
M^TP).T)N(_,4 A-XW'/M5H=*\L6V6?0-*LK:PEM?$MO>P239C="9!*GG2$XY
M1AN//53^%>H*I5CDYSS0 ^BD;M2B@ I*6@T )1110 M%%% "&BE-)0 4M)2T
M %%%% !1110 WO3+C_CVD_W33^],N/\ CVD_W30 L7^J3_=HHB_U2?[M% #Z
M*** "BBB@ H[T4=Z %I*6DH ***!0 M%%% #>].H[TUB=RT #,%Y-5(-3M+C
M4KBPAG1[FW56EC'5 V=I/UP?RK \>3W4/AY);6<0M]MMHW?_ &6G1?ZUF7/]
MKVWB#7_[.O+2.ZCTNWE:9XMVXKYVWCTSWS^!H [TMB0#'!'6ESQTKBAXDO[[
M[+:V$4R7$FG1W1=8UDRSYP,,PX^4Y^HZ5N6&IWH\-I?:I;+!<I 9)XT<.%(!
M. 1P>@_.@#9#9'I2!\[L\8-<7I^J>);ZPG9TAMGFL5GLIY]F/-QEE*JY)3IA
MN#@U!H?B+5=;T2^O(IHX7M+4Q20RQ .MRJDLW!^YTQZ\^E '=JX=0R\@]Z;*
M2!D9..HS7 :+JNJ6?AWPU8Q2FXNKS3TE#"(,T<:QQJ<98!VW,O)/KQ2IXG\1
M6VH:#9:A;65K<ZC=SVTX+;Q\D1977:QVYX^4\\=1F@#O7PNQCT'5LT[>H&<^
MV:\KN?%&MWNB(C7UN)XO$ATF698=HD5&!#!<G'(]:[3Q7-=V'@C6+BVN$6Z@
MLII0Y7[Q5">!GCI0!IIJNGMJ[Z>MY&;P1F4PYY"@@9_,BK^17#317B^-M,A2
MYA^W2:-<KY[1\)^\@YV9Y/3N/KVJGIGB_5K[1-*G66RBEN99HKF5@6;Y,X\J
M+.YR3CUP,F@#T%9/G.[@'@9[TRY@M[B,BZBCE@ W%9%#+Q[&O+T\27_B%/ 5
MV)5LA=WLXDB4$Y=%D0=3R."<$]Q6U\4[EX-"TNT,IC@O]4M[6YD' \LMN(]@
M=H'XT :T=SX2NYC&'T=D8[(SLC 9LXPI/4YQTK7.BZ:%V_V=9%CC/[A>?TJ*
M[TC3KW2S87,$!MU"D?* %(^Z5]".WI7*W7B?5FTW6]:TW[/-::9<O;BU<-OD
M6(XE;=G@XR1QVYH ZXZ+IY8YTZR^7[I\A?RZ4/HFE.RA],L21R";=#S[<5R$
MGBO6KK5?$%O926B0Z?I\=Y"S0EBQ92V#\PXX_+WI]]XIO]ED1<6^GFZL(;FW
MFNHB87D<'<A?("L !@,>=PZX- &['X3T&WU&:_32XI+FX&UFD&Y=O]T*> /H
M*<UCX>;5%L/(TS^T-AE$0@3>$! )Z<#)%<[/XFU6W7QEY<]J7T*%9( 5)W@P
M&7#<_0<8JZYDN?'-K+&T45W+X?F._;P',D6#] 30!OC0M+(V?V7I_D]=OV9,
M?7I39/#VE8.-)TT*3DC[*GY]*Y/2M4UB'P?X;9+V!FO+2.1[EDW,N4SA4!S(
M2Q'3MGI5V#Q)J]]IGAUHXK9;G4GDBF1PRA616)(ZD#Y.GOU'6@#H$\.Z+%NW
M:7IP!.<"U0#/KTJU::7:6,92T@BMT)R5@C$8)]P.M<6NKZS>:SX>M9+VUCDD
MNKY)BD)*LT)=!@%LXVD]3U&>:Z'7]5N-*6P@LHTENKZX6"(RMA4&"68^N "<
M=^E &Z/E4D]JC.3*C;3@_I7*RZQXBMHEAO8["W=]0-M'<F3(>#86$HCSDL6
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M9RTD)6-ACT8ASST'I5^3Q/=OXCFTW?;V^V6%(EN(V47*/C>4DR%+ $X7D\4
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M%%% #>],N/\ CVD_W33^],N/^/:3_=- "Q?ZI/\ =HHC_P!4G^[10 ^BBB@
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MG- "TF1G'>D)R.&&<=:Q;7Q/8W>I)8()_,D>5(YC"?*D:-BKJ&]05/7'3C-
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MY')A+].F[<N,]>:[QM.L'N'N7L[<W!!0RF)2Y4]LXSC':HET;2(UMPFG6:B
MDPXMT_=D]2O''/I0!SWCJ*%[SPX9;B6%#J061UG,:J/*D()/KD+@UR>JV[OJ
M_P 0KVVU&>U:VBM+F)XKC:&9+?(W?WA\N,'@Y->J7EE9WB*MY;Q3JIW 2H&
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MK=V6E3):R6MA%<9?:5=Y-V,Y!.T;><8//6MFY\-:;-_: =9S_:.!=#SY/W@
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M!2T$XHH .]%(>.:.M "T4=!30X(- "_>HZ"FH1G&>:?UH ,TF>:,>E(!DYH
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MOD*':^P'@88' /7'45H:1K.H:IJ-_ +**"&QO/(D=G/SKL#97CKDC(.,>IH
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M^WC/KBN#3P3JT6F:7IR:O;K9:9J"W5L7A)D"*Y8*WS8;&<=J]#!S2$J<@XH
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MAM-.O(6TZZ,5[$UJ^;=FA8$$[<8W'J#C%>N!4! "CU'%1[%3;L^5<YP%')H
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M/YFN<^'5W;Z'X6B\/ZC<11:GILDL5S'*VUVS(S"0 \E6# @\CWKO4PJ*NXG
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M WFE'2D.0<]J7O0 @S3J** $I>U%-9L#@\T (N[<<]*<N>] -&1UH 6BBB@
MHHHH **** $-**** "DI:2@ HHHH 6D-+24 %%%% !2TE+0 4444 %%%% "=
MZ9.<0.?:G=Z;<<P/]* '1_ZM?I11'_JU^E% "T444 %%%% !111WH **6DH
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M9^;)OCMK;GRUV@88X&6R"<X[CDXH PW\6+J>D>*)HX]0M8-,:2W>:-%$BNB
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MNCZ441_='THH ?1110 4444 %'>BCO0 M)2TE !110* %HHHH 3O2T4A."*
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M](!'- 'O0!AZ/X;M-.CMWEBADNH-ZQRB/'EHSEMB=2JC. ,] *M_V%I+:O\
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M%%% !249HH **7%&*  4&CI24 +124M !1110 4444 -[TDO^J-+WI)?]4:
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MW&*=0 W:,YI<]AVJ-[F)'12PW2':H]3UJ."ZAN59[>5)%5BC%6S@CJ#[T 6
M*6D7('S=:B:>-9%#.HR< $\D^U $N><4C<4N0>1UIIR<>]  &YI0V:-HYQZ4
MW*AR,CI0 H;-.IK  C'>G]J $R*6CBF[@<X[4 +2T@-+0 4F*6B@ I#2TE !
M1110 M%%%  :2EI* %[T4G>EH **** "BBB@!O>FS'$+&G=Z9/\ ZAOI0 Y/
MNCZ441_<7Z44 .HHHH **** "E[4E+VH 2EI*6@ HHHH #24M)0 M-I:0]*
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M3M$U-A8:J<7L;H"7++M<H01M+<YR#R<UTBV%K'8+8F)6M8XA"$<9&T#'(^E
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M2TE !12TE "TE%% "B@T"@T )2TE+0 4444 %%%% #>]-F&86%.[TDO^J-
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MTS7/^/$7^RK"\QM^R:A:SF7IY:"9-Q/MMSFN*\4W6FW4'BZ6U\N3?9V,T)+
M*QWN"RG//6@#U6&]M)[F2.*X@DN$ $BQR!F4=LCM6.=?67Q=:Z9!-:36TUO-
M*7CE#LCQE!@@=/O_ *5S.H8@U'4ET.*WAOY] D:(P;=[R\;3QR?KS3-.U#1;
MO7?"C:0\4CC2KJ%45P2C?NL*XS\IR&H [_\ M&V:6:*.YAEDA(#QHX9DS_>
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MCJ<5H:]XDTR'5]!UH7EI);3VLP"22!5&0N6#9QN RN.OS'TH [DWUK@?Z3"
M<X.\<X&34;:C:#R UW;IYO*YD W\<;?7/6O.K*PTJTM/ ]FT]A/"&G662&16
M20-"W'^T"2O7KQ5.Y72;77=?TO7[V2Q0^6+"U5%^:!%"Q^2Q7(92,X!ZD>E
M'J,U];1300S7,,+RD[4D<*SX_N@]?PITU]:QR$->0(4(WJT@!7/K7D]S'IUQ
MJ>O6/B?5;RUNI[M)+-(PHEFA54\KRW*D[@P;(7G)JW+#I<VL_$1[]+9G6TMR
M@F*G8?(/3/0[S]<T >G+>VKRM#]HA:11N,8<%@/4BB*]@FE>-)XY'&,HC L
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MUN36='2\NHTMIS/-;M"K[@&CE:,X) SROH*V&<*,$GT)QTKRJ/3;)-)M-4C
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M.P07N#>.&DG8$D;V)8@9SP,X'L* )/#>M'Q!HWVZ2V-L1/+"8V<-@QR,AY
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MAD4@'(R-HQTQBK%]XJO?)UZ\T^WMI[+1F:.=69A),ZHKR!".%PK8YSDCMUH
MT-=T"76[_1[J.Z-L=.NOM&/+W>8=I7!.1@8)_'%;S@;3D$@GI7&WGBV^EO)(
M].M[4VXTQ-1BEEE<;U;.,X7C@57N?'4QM=+:U^QP2:A8?:[9+UF F?\ AB##
M #'CDGN.#0!V:W$3W+P),KS1@-+&",@'."1VS@_E399K6&2.U9X_.?+11%@&
M..N!U./:N-GNK[3_ !9XBN;&WMFG.E6<S1R.5&5,Y/*@DD@$#Z5<;6EN]?\
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MS*&VE(]_#<#!ZYXJ]#JMO:3:]);Z?</>P7<4-Q@DFX<QIM(ZX&TK0!K?V!I
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MS[&[-[*YB^65RI0A1GY1@^]4T\!W4=U;A+^W$$&IG4U9H,S&1BQ8,V?F'S$
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MC:6=D6VD$A-BY/ +DG@\"J>B:;>*8[*2"QNK:XMC93M!9SPRQIL.?GD)&,@
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MH$\=<<X_6NS5<<=NM&Y@V,4 >=:S;WEE_85EYMLKV%FT3SS).B,Y"J K1]\
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MI2T >=VWA'5+*W?0!"D^G/JHOX[QI<&)=ZR%<=2VX-CM@CGM71>*=*.IVMM
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M!#TI :7K10 M)WH%+0 4AZ4M% #1Z4ZD[TM !0>E%-SVH 7/%(#S3<\XIXH
M1J/X:=28H !TH[TM% !0:** $S2TPTX=* %I!2T@H 6CO12=Z %[TUNE.I.M
M  #Q2TE)0 O6@G%'2EH C#'=4E)@44 !Z4 DT"EH "<4F:#FFT .SSB@C(H%
M+0 @Z4M%% #=QSTIU%(3@4 &:0$T*<T4 .II )^E*,T$4  YIN2":.:7% "C
MI2TAX%(O2@!0: 30*6@!!G-+110 4TGFG4F* %I*6DH ****  4IHHH 2EI*
M6@ HHHH #24&B@ [TM)2T %%%% !1110 WO22_ZLT[O39?\ 5F@ 3[H^E%*G
MW1]** %HHHH **** "E[4E+VH 2EI*6@ I#2TAH **** %I"*6B@!"<=*A3+
M/DU(0<TX*!0 C9IC!S4M% $>,K@]^M& 2!V J2DQ0 G&T$]J0%FI2I(Q32VU
M> >/2@!-H!P*?R0<T<$[L\4F[Y\=L?G0 J #(%.I *6@!O)X[4O.?:EI"P7K
M0 8/'-,R=QIP; YS]<4 C/UH 4X'-,  R!WYIY%&,T -1B3S2E0.0.II NTY
MS2A@1G!H 7KUZT8R*7O2%L''/Y4 (JA1@=J7!H.3T./PII;!8G. /2@!]%,1
M]X)P>/44H.X_2@!U-!^;%*<]CBFD[7R>] #J6FYSVHW>QH =12=:6@!*6DZ4
M'UH 44T'YJ-P+;1G./2D'#8].] "[?FS2]Z6F;OF''6@!]%-)(<>A]J4G!%
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M!F@!]-)I:0B@!1TI:0=*6@ HHHH ****  TE*:2@!:2EI* "BBB@!10:!0:
M$I:2EH **** "BBB@!O>DE_U9I>])+_JS0 )]T?2BA/NCZ44 .HHHH ****
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MA:WD\!?_ %:81RH)R3CIZUA^$[<1Z3I-OK.BS_V]82.'D,#[-[DB259"-A#
M[CSWZ9JO%:W\=G$_V.Z: >)I;JX00L6,)9\,!C+#<4;C/2@#MH]6M&TXW[7,
M @&29/-&Q2#C!;IFF_VUIYLQ?M?6PME.#*)E*9)QC=G&?:N.N](GN-6U]K?[
M7:V%U)92P316Y?9=1L27V'DKQ%DXQP?2J21:^;S2KG4;>9+:"\N1>3Z?;-F=
MF1!%.L1!8#@@\''.* /2K6\M[V$36L\4\+?=DB<,K?0CBN=@U74M=OKZ/3S:
MV]K8W!MS<31-(TD@ )"@,H"C(&2>N>.]6_#6GVECILL-FMV(I)F?==1^6S%C
MEB%PI R3P0*R/"4<WANRO=)U);MI$NI9$N%@9UE1V+*VY01GG&#SQTH U]%U
MBZDL;R;7(K:PDANY(1A\(Z*?E8%O4<UIIJ%G]G$ZW<+0,?EE,@VD], UQVOM
MJ%_XI\,WATVZ?1K>XF%RC0[F#&,"-]@R<!N^.*R;[1VN8?$$<>FW)TZYU>SF
MLHE@88P8_/<+CA3AB3WR30!WQUVP^QWMRM[:R1VI82F.=6"$#."<\'V-<WIV
MNZE?IIVI?VAHPLKSRW:*4L)8]P!6-,'#2$'OT/8BHELV3Q#XM>'3I1!+IL*P
MA8?DD<"0$#'!;[GYUEZAI]S+H'@$C293/:75H;@^4=T(55!+<<=* .K\5Z^^
MBZ--<VOV9YX4\PQ3O@D;L9VY!(ZUKR:A9V;".XO(8F?[HFD"D\XXSUKSB_M[
M^3PQXOBU73;J35)[MY(BL#,&A# 1!"!@X4?F:T]5M!J.M:S::J=2CM;P0^4D
M%CYN^$(!C=L;8P?>>V,YH [.;5+2)<R7=M&R[2RO* 1GI^/%1R:Y8KJJZ:US
M&+AX]ZC>.>0 /J<C [UQ\NBQW5[XME?2IG\W38(XB\6YI'"RYP1P7Y7.*GTR
MU":_IUU-8SN#H\41D,+$+*'^8,0#M;DGG'>@#I-/U":WTE;C6+S3_,,K+YD$
MF(\;B ,GN!U]P:674I(?$EI8F-?(N+>659,_,2ACX^GS_I7!:%9W%OX%M-/.
MEW,<JS7TC));.YCW%\#;TRPDP">!S]#MZ-]H>;PA));W7[O3)4G>2%@8WVPC
M#<<9V-UH [D'Y 32]1367<IYI5^Z* "EII/-*3Q0 N:*8.:=TH 6BCJ*3% !
M2BF]*4&@!:2EI,4 %%%% "B@TE+0 44E+0 4444 %%%% #>])+_JC2]Z27_5
M-0 B?='THHC^Z/I10 ^BBB@ HHHH **** %I*6DH **** "EHHH *,T4UOO"
M@"*[NHK*W:>9MD2#+-@G ]>*KV&HVNJV:75E,)K5^4E (##VSU'O3M7V_P!C
M7V[&/L[]>GW37 Z=J>I6?AGP!::7-!"E]#%#.S1;N!!NR!ZY% 'HMQ-%;6DD
MT[A(8E+R.3@*HY)/X53T_6;+4)IK>&?=/;X\V-HVC9,C*Y# 'D<UQ6NW&KW/
M@CQ3!?7T0N+)Y(7E6':LL9C5E&,\'#X[]*W1>7T_B*71;>ZMX+F&S6XFN5@#
M%P[NL:@$]%V-GZC&* .G;!/S'%! R *XRWU;7-2U2.RCNK6#?IZW*2F$G]XL
MNQ\C/0C./3/>LR;Q'XDBT/5=2%W;'^SM6-H8O(_UL1>-1\V?E(WGG!H ]'4Y
M!]J9&RD$H2P)[5R9U37;+5-6L9[NSN'CTU;VWDDC\F-"68$.03P-N<_RK,O=
M9O&\.>)A;W;M]DTC[;;3F$Q8+)+D $ D9CR"?6@#M+K4[*TO+.VDN$2:[+"%
M.\FT9./IQ^=7"H8%<\GFN)6ZOM+UGPGIH-G);W:2%\P_/&%C!PI[9+#/TJ*/
MQE?3>'8O$\#0C3GO/(%M(A,AC$_E%@P/4$;N0>,T =VS;65>YZ#UI68;<MP*
MX34?$&NQV7B.^CFMHTT2Y,>P1%C.GEQR8Y/RG#XR,\]A72>*)IX/">IRV[B.
M1+*9@2.A$9- &OQ%'["F21I/\DJ*RD<JPR#7)0:AJPN=/T&&\M1,;'[5+<R(
M6*1Y5$PN0"2<\D]OQJYX1\0W'B#3[Z6[@CAO;"[FL;CRR2C/&V,KGG!X/XT
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MMS^- &RJ@#///-!''0G)]:X^Z\47UIK=O;7!M$274?LAMU;=*J'.R1B#@;@
M<$=#Z\U0U#Q?KMKI&JZM'I\!MM.O)(;B+S&+M$C8W)QUV\G./ZT >@#@8QTZ
M55DU&SBO#:-<1BZ\HS>27^;8.K8].G-<9J7BS78V\12:=86\_P#8Y0J&=AY\
M9B61L'!^8!AVQ]:='JD>H>--#U")4/VG0+J4+WYD@."?SH [*TO;;4;07%I*
MD]NY($D;AE)!((!![$$?A5@ *,=JX+0_%\U[I6B0Q6<%O?:I)=%4&?*A6)R&
M8X )ZJ.V2W:K\^N>(;>TM/M=C9VI>259KJ6;]RH4CRR%!W'S,\+G(P<YH Z.
M:^M+>^@MI9U2XFR((F?!DP,G [X )IUU>VMBB->3+"C.%5I&QEB< 9]2>U>=
M7.LWFLW?@K542W2_:[OK<("=A=8Y(\@XSMRI;IG%6-:U:ZU+PQ?6VIPQ6][I
MVK6MO((V+(_[R-@ZD\X*N.OI0!Z&5RP9127$\%M TMQ*D40&2SMM _&N3U#Q
M5?K=W@TFT^U164JQ/&L$CM,< L%9?E3;G^+J1VZU?\<%7\ :_G ']G3D;AT^
M0X- &[& 2'P1Z<TR\M4OK*XM':1(YD,;-&VU@",'!['WKEM<\1:EHEL'CM83
M:1V#7'VB:7&^0' B4#DD]<]@*(?%MS-J5C;0V\44>H:4;ZS:9V^9P 6C; [!
M@<CM0!N:%H-MX?LTM+1I6B7)W32%W8^K,3DFM(J!ESGGMGBN&L/&E[>^$X-8
M%BJLMK-+>Q"0EH61@H7D<\[\]/NFM_0-5FUBWEN&EMI[3Y?)N+9ODD^7YN,D
MC#9&#S0!N=4Z$>E)M# <8P<\5R][X@U,'57T^TBF33AAR9"#*_EK)M VG&$9
M>>Y[=ZK0>+[O4M;M]/TFTBEBGTM-025Y2.#*%(/RGG&['7..U '8LH;##.1[
MTI'(Z\>E8NOZQ/HMM9M#;BX>YO(;7E]NWS&V[NAS^E8UQXJU>WN9;(Z= ]_%
M ;AUA:25-FXA%&%SN8#/(&,]Z .R";7R <'K054>N <]:XQ_&MS)$%M=+:&=
M-)_M.:"[8HZ+DCR^GWLKWIVE^-)-4ETR..V2,:II\E[;DRDE-A48;Y>^X&@#
MK99XXF D94+G:FY@,GT%28!1=R[OK7G<^KMXBM?"6JM#'!*=<:W8 [N4$Z'!
MP.#LSBMVY\4W-MK-I:/:Q*DU]]EYF/F;=ORR;,="W'7IS[4 =++/#!&7E<(@
MZLQP!]3VI5".JLO*]L5PECK]S>^%_%=YJD-M?065Y<0>3]T.D>%((P?2N@N-
M9G.HW.G:9!'/):VJSRAI"N"Q8(OW3UV-SVQWH V5CPF,$<\T_:  F"0/6N#M
M_B"]^OAS^S=/^T1ZN9HSF7:8I8T+%&X/0C!/Z&FVGQ%WZ;87%Y;P6K75_<6+
M/+<$10O&2,EMO0D8' ZT =X N=C L>O/-/ ![<^IJEIL]S=6,$]Y;_9[AUS)
M$&W!3Z ]Q[U1UW6GT^[T^PMHO-O;^8QPJ6P  -S,?8#)/TH VM@(Z8^E*$53
MP*Y.[\7W5C:77GZ<IO+>ZCMVACFW#:Y^60''H>G%;5A=ZG/IDLMW8)!=*[A(
MO.W!E!.T[@.,C!QCC/>@"^5#38*D #J.],EFBC<1@IYI'RID D=\#O7-:1XR
M;5+31YVM(K?[>TR,CW!+1-'G*XV\G SVZ?2H[76UU.\T)KO35BO[JTFN89/,
M)\E?DRO09)##/TH ZMIXHPF]PH=M@)/5O2I",# KR&;5;W6?"'A[5[R.&:5?
M$<1B$1^8XN&7:,CC[H&>_M7H>@ZO<7]WJ-G>VHM[FRD5"%D+JRLH92"0/7TZ
MB@#;*\CCCO2@<XKD_$'B^309+J6:QVV=KLWO-+Y9FW#)\K@ABHQQD<G%;NJZ
MI#I.DW%_.<1PH6*]SCM]>U %X<$_I2]<YKFO[?N[47<NK:8;6""Q-YYJ3%P%
M!.5.5&& Y(Y'O2'Q'<P:E86-Y8+;RWL$CVV)]P+H 3&WR@JV#V!'!YXH Z8<
M<4$X!-<79>.#=Z?X;ODT^1(=:G\A0\GS0MAB,C'/"GO43^-=3N++5IK/0Y%6
MP:YBEEDG4A&CBWH<#.0Q./;O0!VH?<!ZTX52TUI9-.@GN,"9XU+A3QG:*NKR
M,T /%%(*6@ [T4=Z*  TE*:2@!>]%'>B@ HHHH **** &]Z27_5-2]Z27_5-
M0 D?W1]**(_NCZ44 /HHHH **** "CO11WH 6DI:2@ H%%** "BBB@!,\T8!
M(-)WIV: *U[:K?6LENSLBR*4;;W!&"*R%\(::D6E1KY@72F#68\QOW>%VXZ\
MC;QSFMZ1TBC>21@J*"S,QP /4UF1:[IEP9&CNX2L$?FOEL%5.<-@_P /!YZ<
M4 03^%K"ZM-1MIS*\>H-ON/WC?,=H7UXX ''I5BXT*TGNX[S+I>I%Y0N%<AB
MN<X/.#SD\TEKJ]IJ4H6RGCD^196"L"=K9VG'OM/Y4LFN:;!??9YKJ))RZQA2
MPR&(R%([$CG'I0 RVT*SM=12ZC0^8EN+<9<\)G.,9QUJH?!VF/97EEF7[-=W
M N9T\UOGDR#G.<CE5Z>E,\0>($LI+6.SGA-PUY!!(F<DJ[@$#G@XR>_2K4WB
M;0K?>K:G9 B40G]^O^L(!P>?<?G0 R^\+V%_<7%Q=&25KBW%K)ERH,8.0.#Q
M@Y.1S[T^7PSI\[70N$>4W=I]CF+RN?-CPPP<G_;;GKS4B:YIES+=645Y \]M
M&))E20'8#GKZ=#UJAI7B?3AIM@U[K-K=S3JX2ZC 1)=A.YE&>%&,9]J )QX4
MT];C3KG]Z9]-W?9W,K$C< &SD\Y  YSTXI(_"^FQQ?9T@V6C2B?[*&)3S X?
M<.>/F ..GM4>I:]9SZ5'>V.KVD$;R*J7)971OF *CGECRO'0FK\NMZ9!<Q6T
MMU&EP^U4C9P&);[HQZGTH K3>%K&:VU2W<N(M3?S+M0Y_>':$]>/E51QCI6C
M<Z?#=Z9)I\[%XI86B<D\LK+M/Z&LS3_%FDZ@FH2"[C$-K/Y#N[ *#A1U_P!X
MD?A5IO$6CI;M,=1M"B2&+(F7[XQD=>V1GTH K)X5LHY+>99+E;NW0I'<^<3)
MM.#M.>",J.""!5[2]'LM(MIH;2W$*33/-)\Y8R.QRS$GG)-5+_Q#96NK:;I[
M3IYUXK2(0PV%0..?<D8]:KVVN6MFEY/J6NZ;+:&[\F!@ZIY9P/W;$G#/^5 #
M+CP/H]U:ZE:20L(-1G-Q<1B1L,YQENO!.U>GI5RX\-V-W/=O>;KE+RW6WDBD
M/RE%)(_(LQSUYK0-_:"YDMS/$)EB\YE+CA/[Q]O>H['4K'4Y)/LEQ#,8<!@C
MABN?7'2@"+3="M=-*;'GF,:[8S/.TGEC_9W'C^?O46H^';*_U%=1S/!=A!&T
MUO.T;.@.=IP>1DD^OTJS>:I9Z8W^FW,,.\%AO<+P.YSVJ.YUW2K:)))[ZV16
MB,X+2  QC&6&>HY'/N* *USX7TZ]C>.96>)K8VJ1LVY8TQ@E<_Q8[]:>WAJR
M:73Y/,N#+8QM'#(9FW;&V[E)SD@[5Z^E9GC'Q1!HWAZ^FL[^S6]@A,L:.VXG
MC(&,CDY&,]<]ZW;C5M.LY52ZNX(92  LCA2<].OJ>!0!1LO">G6#D0?:/LX;
M=':-.YAB.=WRH3@8/([#L*K-X(TPZ?;V*FX$%M=B\A7SC\DH8L&SCU)..E:@
MUO2UN?(-_:+*7$?EF9=^\@D*1G.< \=:T@H P* *%GIT%AY[1;E:XD,C N2
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M\50227EO;7<L0*F/$<\0@2,X)&0<A@2I' %;2>$[>'4[2]M;F6W6TLVL[>%
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M93V#<CG/O77BXB"GYTP,YP:J_;98[BZ>?[/'8Q0*ZR&3G=E]^X=@ %P?<^E
M'-6^B:EX?N= TW1KZ[ELHI)#=QS!-GE')Z\$8. JJ,8^E;.N>'X]8NK"]%Q)
M:WVFNTMO/& <%EVL"#U4C((]^HJ4^(-/9+ JYW:A&)H%*X.T -EAV&"*U/-3
MS-N1NQDCOB@#FKOPFVH13,^I2K/=3Q3RRK$HSY>-JX[#CZUTT:L(P';<V,%@
M,9_#M2"96;"LIS[T-*HX) )Z9XH Y>Y\!:=<75S,9)!'+<I<)$I(6(\"0+@\
M"0#!^O%7;S1I9]?L]3CN?+CM(VB6 19!#[=W.>/NK],5M%UPP0@LG) ]*BN[
MZWL;">\G;;!#&9&8=-H&: .2?P&T&G064&KR)965ZE];P^0#L=7,F,Y&068G
M\JWM/TJ2TUF\U!KKS?MB1[T\O: 4& <Y/:IDNKU[RTC2U1K.2-C-(\FUXS_#
MA<<@\^G2KJR+D1L1DDA0.^* .0USP9/K3:N9-5F2+481'Y9B5_)"=-I/0'DX
M]23WKH+[2H=8T*?3;OYUFA,;/T.3W_/!K261&8J&!(Z@'I0=JKDXZ\?6@#FH
M?#%U=:==6&MZU<:I!- ]L0T0A 5A@DA3\QQW-+'X:-S>:;>ZK>&^FTG<;8B,
MQ99AM+M\QR<9'&!R>/3:U/4K?3-)N[^X;$%M \\A'7:@)./RJKIEUJEP\RWU
ME' FU&BDBEWJP(Y'0$$?3'H>P .:L/ $MA;:59G7IYK;2;@7%HC0*"#\W#-G
MYAAB.W]:T]/\-R1Z=K=G+>&6/5WDED*Q;/)9T"$+R<\*#]:Z< 87V%+P* ,_
M3K*:QTZ"VFNWNVC4)YC(%X P.!5Y>!BG'GBD Q0 ZBBB@!.]+24M  :2E-)0
M O>BCO10 4444 %%%% #>])+_JC2]Z;,<0L: !/NCZ44J?='THH =1110 44
M44 %'>BCO0 M)2TE !2BDI10 4444 -[TI'(I.].H Y_QA8:AJ?A34K+3RGV
MF6(A$=L"3D93/;(R/QK)N(+C5]=MM3BTNZMX+?3;BWN(KA-CLS%"B*.C8VMR
M"1R.:[1C\P_.F;>H5L@\G)S0!SO@;36T[POI\=U9"VNXH%256 SD9[]37*>*
M+'5;N[U"2#2;A5BU&"Y7[.JXN0IC!<LS9+83;M  P!G/;U!B I)Z55N;B"TB
M>:XN$BBC7+,YP * .#G^VFRFM(]!U$72:T+WS$C&R6,W(?=N)_N<8_V?2H;_
M $:\DT/QU'!I,[2ZG./LOK(!#&H/7IN5J]*0*S>8IR"HQSQBA@ORA6 VT <J
MUJT7BI)XM-D6Q&EO;':H5=V]2%P/49KC_#WA[4;/2O L=_I,V_2YKMKP,NXQ
MAQ)LR/<LI]N:];*I@YQCKBHY0I7KCS, T >9MI-^/#.O6DFE7)GN==DNK554
ML?),J/NX[84_C6GJ$&IP^*+B>PBGDMYKRV:>QN+5GBFV[/WL<F?D*C!P>,Q]
M*[M8_G#9Z+@8]*B$]M)?-;AU^TQH&*9Y"G(SCWY_*@#S>[TN_P#[#\6Z:-*N
MIY;C4);B!POR%&\L_*<\DX:M;Q+;R1:E:1Z9HCK'/;RF2[M[<NREL?(0" "V
M.7(.,?B.X"JJG)YQS3@H5 ,\"@#S?3;;4(9_ ]Q-IM_MM+"XM)U,>&C<K$%+
M>@.QN33['PHVL:+XJT^Y@NK5KS4VN;5YD*D8"F-Q[!ES7H;1[\C)]1SWIRKC
M'/(XH \[O;#Q%K/A"[O/LP@U"6*.$6F3\\498R*?>3<X^FVM+PE]GNM4N]3C
MT74[">2)(9Y;U=GF,O0*O\0'(W?EFNR&T';GI2,NX#!X!H XIH+G3O'.KW.I
M6EQ>6&I01):R0P-,(%50'B8 '&YOF]/6L[0M%NK:^\+6M_IDKK!H\]K<.8LI
M'N:(HAR,?=4C\*]&EP(V+?= YIC3Q)*L;2 2.I(4GL.O\Z /++^WOXO#_BW3
M9/#^HR:A=S3M!/% &2=2V8?F[;5VI@\\<9J;4+"^?6-8@UG1=8U"PUCRS UL
M5VH@4 12\C9M8LV>1R:]&CO;5DMG-U&YN!^Y*N,2<9^7GGCTJ=7CE$<JRAEQ
MD;&R#GZ=: .'T+29H?'OBN_N[&80S"T>VD:+*MY<6UPI(P3N[]ZZC0=>@U[3
M3=103V[)*898)U DC=3@JP'>M*:/S(74%AD=02#5>"TMK&R\BWC6*( DA..3
MU))[^YH \YT[2?MS:2+&S=;BPUZ_EN;EH2!Y'G3@@/CG)*# /8^E2/X?U&\^
M'D]G:V1M]22XE?RG789H3<,YC#?[2C'!QR,UW.B:=9Z=IQCLIWGA=Y)/,9E;
M<7=G8Y4 ?>9C^-:4:[5 )RP% ''65BNK^+%U)=/GMK*32GM+F.ZB:)I'+H5&
MT]=JAP3[\$U%X7TZ_22.TU.TEC@T2.2U@<C/VE6.%D [XC &/4FNW .[G! Z
M4T(V]BQX;B@#R^WM;ZTT3PRT^DWES:Z?>3&ZMQ;,948AQ'($QR%W9X]JSXM,
MU)#XGF30]1N('UJ*_2W,?E/<1#^YN')!P<8[=:]:DDMP\D+. Y&]EW $CU^E
M21/#+$)8G#(R@AE;((]B* /*]4TV>]TJ34=.T+6%CGU&TN;ZWN\+/=QQDE\1
M$\=NN-WH:Z;0!YGC?6M0BTV]M[>YL;5$DFMS$K%#+GKCH&0?A77K&H0!6)4=
M"3FEP#EMW;!QTH Y2;S;'XAR79L+N:"XL$C\^&/<J%7)()Z#CG'4]LFL#0]'
MET_1_ S/IUU'<6BNEV5A8% 864[\C^\17I>Q2"I.<C]*3RT(VDYQUYZT >=6
M*WHUK0[@:7?10P3W,3VXMVQ%O!Y+GEMQ^;=PO-=!X,B:UTNXM)+":WFCN)]S
MR(560&5V&TGJ,-VKIO*4$D=2=W6F;<,P5CEN?I0!Q>D1S>$M>UJ*\M;FXL]1
MO6OH[V&%I C,J@QL%!(Y'&!C%6?$5S>7^FVEW#I5S+:6U_%)-;^23+-$-V6$
M9&3ABC 'G@\5U4\B6]JTD[*%09)(XI<JP()SN&,#TH \I\1Z5=W_ /PEUYIN
MGW<UA?:? $MO)<--<JWWE3&>%VC..WI4E_I++K6L^1I>I)87/AV*%UM86WO+
MYC$A ?XPK?TZUZ?:R1SP*R?*N2% [8XJ00JI++][&!F@#S#[/?2:5J_F:=)>
M-%<:?<"^M[8QRWJ13*S*8R?OHBD<<'-3*)[GQGXEU :3?1V=YI$444C0L#(P
M#$C'4'D#'7VKTH(NS;A0?0#%-\I2N),9/I0!YSIEO=6.I6[R:7>7+GP_!#'L
M5DVRQ>9N0MCY&(8#G'456TC3YF\0Z'>3Z=<Q6']C26LL9LV"Q8QB%E8%B0 1
MEA@D<=<5Z@&B1E 903D<]Z;<&".$O,P2-.22<"@#SW0-)2PM?!K)IDEM/%YJ
M7C"V8,JF)QASC(&[:>?:M_P9#]DMKNQ>TGADAOKL[GC95*-<.R$$_>RK Y&1
MS72>7$4#=B,]>M*L:*[2+]Y^3S0!RGA^1!XC\56ET?\ 2'NXY03_ ,\&B54_
M(HX_"L9K8V?PBURUEBEMR1J.!(A5E#/(R'!YZ$$5W,^E6]Q?1WN-DZKL9X\
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MGW%^E% #J*6B@!**6B@!*.]+10 4E+10 E**** "BBB@!,<TC-@@>M+WH[T
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M%UJEQ?:Q>7']HV*VDX"JI8+T/ P".>W>M>U\/W DAFN]1-Q-;PO%;/Y054W
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M$\\)GMAE")@,9"G=P1D?>VCG@FDLO&]AJ.DVMY:Q2F2ZEDBCM]H#,Z'#*3G
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M58RS.%4=6/:J\>HV9C5A=V[ G:"L@()]![U0\2012:!?17"W3PR1E'^RY\P
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MA=YEEVF621BQPN<#GH!D\>YJT5$NQP,'.<BN4N/$3:AX)U+5[G1F-@MI<F:
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M6/+2V_M*W^SV^IOJ$+>0Q;+2&7:WS8(RQ QC^E-U#PGJ-_:^(;,W,4<6L.)
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M;+3KK7M,\2:5!+:+9W>IW$<LH+&2,/PV ."<=,XQWKT(* OW0,]:CBM8+?\
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M3&)S3Z0C-  >!0.E+10 444E !1110 HH-%% !1110 4444 %%%% #33)O\
MCW?Z4\TR;_CW?Z4 *G^K3Z44)_JT^E% $E%%% !1110 4444 %%%% !1110
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MD?-D=:DI,4 (/FZT*,'BA1R:4T +12 T9H :P.3BC#>M/HH ;@XI0,"ES10
MBTM%% "4M%% "44M% !1110 AI#FG44 ,YI>:=BB@!HS2TM% !1110 4444
M-.:3FGT4 ,YIPS2XHH **** $IIS3Z3%  *6BB@!IZT<TN*6@!.:2G44 )S2
M<TZB@!**6B@ %(W2EHH 8!3Z** $Q12T4 )2XHHH 2EHHH 0]*;SFGTF* %'
M2BBB@ HHHH **** "BBB@ HHHH **** "@T4E !1110 M%%)0 44HH- "4M)
M2T %%%% !1110 TTR;_CW?Z4\TR;_CW?Z4 *G^K3Z44)_JT^E% $E%%% !11
M10 4444 %%%% !1110 4444 %%%% !2&EH- #,FC)I:* %[4M Z44 %%%% !
M1110 AH%*:* "D/2EI#0 T=:?3:6@ I:2EH *0TM% #:*7%&* $YI.:?10 P
M9S3Q28I: "BBB@ HHS10 4449H **3-&: %HHHH **** "BBB@!#1110 4M)
M10 M%%% !1110 E%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4449H *2EHH 2BEQ1B@!**7%% "44M)B@ HI
M:* $H%% H 6BBB@!**** %%!H%!H 2EI*6@ HHHH **** &FF3?\>[_2GFF3
M?\>[_2@!4_U:?2BA/]6GTHH DHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** $Q28IU% !1110 F*,4M% "4M%% !1110 4444 )BC%+10 4444 %%
M%% !1110 4444 %%%% !24II* "BBB@!32444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 +129HH **** "BBB@ I:2B@!329HHH ***
M* "@444 +2444 +2444 %%%% !1110 4M)10 4444  I:2EH **** "BBB@
MHHHH **** $- HHH 6DI:2@ HHHH 44&DHH *6DI: "BBB@ HHHH ::9-_Q[
MO]*>:9/_ ,>[_2@!4_U:?2BEC_U:_2B@!]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 AHHHH **** "BBB@ HHHH **** "BBB@ HHHH *6
M@44 %)2T4 )1B@TM "8HI:2@ I:2EH 2B@T4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 HH-%% "4HI** %HHHH 0T444 %+24M !1110 4444 --,G_X]G_W
M33S3)_\ CVD_W30 L?\ JD^E%$?^J3_=HH DHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS24 +1
M1FC- !11FC- !11FC- !11FC- !11FC- !11FDH ***,4 %%&*,4 %%&*,4
M%%&*,4 %%&*,4 %%&*,4 %%&** %%%-)Q2@YH 6BD[T$XH 4T4G:D#9.* '4
ME*3BB@ HHI* "BBB@ HHQ1B@ HHQ1B@ HHQ1B@ HHQ1B@ HHQ1B@ HHQ1B@
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MIH 4'-+48/-/'2@!:**#0 44E+0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !2TE+0 4444 %%%% #33)_P#CVD_W33S3)_\ CVD_W30
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M*2B@!:#244 %%+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4M)2T %%%% !1110 TTR?_CVD_W33S3)_P#CUD_W30 L?^J3_=HHC_U2
M?[M% $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ***!10 4444 %%%% !24M)0 4M)2B
M@!**#10 M)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!2TE+0 4444 %%%% #33)_\ CVD_W34AJ.?_ (]I/]TT .B_U2?[M%$7^J3Z
M"B@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %+244 +1244 +1244 +244M "4M%(:
M"BE%)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
CM)2T %%%% !1110 AILJ[H77U&*?2=Z $4811Z"BEHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ex10-2_005.jpg
<TEXT>
begin 644 ex10-2_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M 4AI:* $I:,48H *2BB@ I<TE% !1110 4444 %+28I<4 )0*7%% !1129H
M**** %%!H%!H 2EI*6@ HHHH **** &=Z1OOQT[O36^_'0 \T444 +1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "49I:* $I<44E "XI**
M6@!*6C%% !0:*0T %%%% !1110 4444 +1110 44E+0 4E+24 %%%% !1110
M 4444 %+24M "4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 +2&EI#0 4444 %%%% !2TE+0 E%%% !1110 "E
MI*6@ HHHH #24M&* $HHHH **** "BC%+0 4444 %%%% "4444 +VI*6DQ0
MHH-%)0 M%)2T %%%% !1110 E1M_K(ZEJ)_]9']: ):*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BDHH 6DHI: $I1110 44E&:
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MTM(* %J&7_7Q?6IJ@E_UT)]Z )S12&B@!:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 2BBB@ HH%+0 E%+10 E%+BDH *!1BEH **** "B
MBB@ HHHH 2BEHH 3M12T4 )2T44 %%%% !1110 4444 %)2T4  HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU1@4Z@ HHHH #24II* %[T4=Z* "BBB@ I*6DH 6H)?]9!]:G[U#+_KH1[T
M2BB@<44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12XHH 2B
MEI*  4M)2T %%%% !1110 4444 %(32TA% !FC-)10 ZBD%+0 4444 %%%%
M!1110 444AH ,T444 &:6DI: "BBB@ HHHH 3-&:** "BDI: #-+FD[T4 )F
MG"FTHH 6BBB@ -)F@]*04 .HI*6@ I,TIIM "BEI!2T %%%% !1249H 6BBB
M@!**6C% !1110 4444 %%%% !1110 4TFG4A% ""G4BTM #<Y.!3J0CG-+0
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M-,W'- $E!HHH 04M)SFEH ***0T )GFG4G:EH **3FEH *3%'.:6@!**6DH
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M\7UJ>H)?];#]: )CTHHHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBD)
MH 1@2.*5>E0S7$<(5I)%1681@GNQ. /S-$;E\[7 "\$4 3$48--1MR@YY(S3
M5)POS@X.#[T 2#CK0!BJ5]?R6<]I&EC<7*SR>6TD0&V'C.Y\GIQCC/)%6C(
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M,K?WN?N]1ZBNK70='W;ETZS/_;!?\*@M;+0+V&XCBL+-EAE:"4?9U&&'4=*
M//-#Q9Z7X>FO=,O8M.T^>26VN0T++Y<I.QF8/N*D,,D("?2KEG'K"3Z'/-IL
M4,EA?R3S6MM/$L*QO%(FZ/G+<R9)8]C@5U%G\//"MC.)X-'MPZG*!LLJ'IPI
M) _+BM0Z!H<2^8ND:>H0=K9!C].* .(N;'4AX5UO2X[;>]QJ,MS:.+B,"9&N
M/,P,MQA3@YQ6C+'<)XAU6[?3A=VNIVB1*5D020N%(,+@G[IZY!XJ^UWX,",[
MQ:/A."_E1E01_#NZ9]LUKC0-&8<Z38+CD VZ<?ITH X/0M!U#1K_ ,,FYC%P
MNF:9<02S)*A(D=E957)R<!2N<#K56RT35+/2]$3[)>P7=HET5N(9(I!&9'SL
MD0G#HPQGN-IKT9O#^C%\'2]/R1_SZIG'Y=*&\.Z-M_Y!6G =_P#14_PH SO#
MM_JD=OIFGWND16^;/=--;.ODPR X$07.<XYXXKHF8 J&.":CM[2VM(?)MH8H
M8P2=D2!5!/).!5>?4[--0ATV2X1;N92\49ZN ,G'Y4 <QX>@O_"9U6PN+&YO
M(I[V:[MI[9 RE9#NV-SE6!X].^16!X@TZ[L/#WAZ.^B5YIO$D4K1(^X$/*[[
M,\<XPI[9S7J.!*!EN1@\&LS6M L==:T%\'86TJS1;9"N)%.5;@]10!R6L>']
M4OKGQ#J%C;&V%S:V\2V[L/\ 2C&VY@<=,K\GYU?N+&[N]4CU:/3IH0-.FAG2
M1AOF9CE8^O&TECG_ &O:NS1-B*N<X]: JLIP>"<_C0!YGI^A:C!J'@><:/+$
MNFV<UO? .N49HXU!//.2A/&:WO&UA?7%YX=O;*"6X_L_4%N)HH0"[)M*G&3C
MN#^%=/>WEOIUG->7,Z10QKO=W(  'N:EB99XDECD#JPR&7N#0!Y[K>GWU_8>
M*@NBW!GU!(_LW(W$B)5(_ @TNHV=Z=8U/[9H.H:C9:K!&JBWE550A K1R L,
M#/(;GDFO097C@B,TC!4C!)8GH.Y-9Y\0:8L5C+]MA*7SA+7#C]Z3TV\\CGM0
M!>M5,<$,;=0@&,D_J>M3'I2$9P>E!." 6'/2@!%.:?3 -H8;O?Z4[G)Y[4 +
M13%SMP6!- <!_++9;&:  AN<4H![TBMEC\W0X(I003D-D=,4 .HHHS0 48HH
MH 2BEHH *2BB@!10:!0: $I:2EH **** "DI:2@!>]0R_P"NB^M35!+_ *R'
MZT 3"B@44 +1110 4444 %%%% !1110 4444 %%%% !4;@F1<=*=WI>,T </
MX^B!U?PP6:58WU#9)MDVJ!Y;X)_''-8]YJU[J&K:Q&=3@TN;3KM5@2>X9<Q
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MT!\/:0QN<Z?!_I"A9OD'[P#H#ZCD\&A- TF.:&5;&$/%%Y,9V_<C_NCVX'%
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MOC-#;-:HTDQ<B,X.WGL,#'ZYJ1_!=DUKI,#7-WLTJ026WSJ>5&%+?+S@>F*
M)_$NI7]@NG1:>81/>77V?=,"54&*1\X!!X*5BMK6NW<5W;Z;'$TVF,D%UO
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M6Z1SZ-+?JUTFR*!U>-1DCG;\Y)R2>.M '<Y&>E5;J^M+5H%FF5&GE\F)2?\
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M>^#QGO5E<'- #J*** "@TF:* "EI** %HHHH 2BBB@ HHHH *6DI: "BBB@
MI*6DH 7O4,O^NB^M3=ZAE_UT7UH E%% HH 6BBB@ HHHH **** "BBB@ HHH
MH **** &]Z4C/-+10!G:GHECK#V[7T)E-O()8L2,NQQT88(YJ"?PSI,RZ@)+
M3S/[04+<AYG/F@#@'G^56M1U2WTU8WN&($LBQ( ,L[DX"@=2:Y_6_$Q;19[O
M2IDCFM+B*.XCN(B&C#2*IR#C'!)!Y'% %RZ\(Z/<O(TVGI(\MN+5BTC?-& 0
M,\\XSQG..U6/^$=TV)I9UB?S9+<6LA$SC,8SA>O !)_,U7C\36M]:ZDEG+B_
MLX&D\N:!T8#!VMM8 E21U%9JZW),?"PFU$6LM_ LT\ M2PN?W08@/T3!.: -
MJU\-:7:3)<0120R?9DM04GD'[M?NC[W;/7K49\(:"=$.C-IZ/8%BWD/(Y ))
M)().0<DGBA?%.DOJ5O8,TJSSEA;J8'_>[3AMIQC [D\4EAXITG5I8X[21Y#/
M')+ XB8+*$(#;3CG!(Z>M #+7P5HEG;V\4=J5:WD:6*597#JQ&TG=G.<<<FG
M+X,T);>RMUL L=G*\T++,X8,^=Y)!RV[)SG.<UB#QK'JF@)J,<DVEF6^%K$U
MQ;-)N_?;, #CY@",D\;JZ"_\2Z?I+/'<RNWDH&E:.)W$0.>7(&%& 3SV!/04
M 5QX&\/"Z2Y73U$BW1O%Q*^$E.<LHS@9).0.#4UUX2TJZ^W;H707Y)N0DS@2
M @ C@\9P,XQG IUWXHT:PN7MIKG]^MM]J\N.)G8QDXRH4'=WX&:C'BS2VMK>
MZ0RR1W,33Q^5"SG8O5B%!P.W/>@"S<Z!8W5S%<,DRW$41A$T=PZN4/56(/S#
MOSZ5%_PC&GM/ITY1U?3XS%;".5D5%*[<  @=.*T%OK9K(W@<" IO+G@!<9R?
MPJFGB*PD2X?=)&MM"LTOFQ,A"-G& 0,_=/2@"K;>#])M5AC@BEA$!D9 EQ)E
M2Y!;G=GDJ#CVK4T_2[+2]/6QM+=(;9<_NP<CGKG/6L;4/&.FVNDZC>K'<M-8
M(#+;^2R2 D?+P1P#_>Z5N+<K+9^<$<<;BC*0WTQC/Z4 4;+PWIFG2QR6\3!8
MF9HHVE=DC+9!V@D@9R>E.TOP_8:1>WEU:1,DEV_F3,9G?>_]XAB1G_"N?T[Q
M'+<1P:U=WL<6GRR-$EL;=AEBS*FU\?,WRG(&>W2M:7Q?H=O9WEQ+>1QQ6<JQ
M3F0%2CMT!4C(SD8XYH NZEHEEJ<L,\Z'S[<-Y,T;E'C+=2&4@_AG!J"#P_8Q
M1W$-PK7;741CE:YD:0R*?X?F)P/8<5"?%NG2:E:V5MYDYG:9"Z1MA3%@-V]6
M'-9>B^+;<R3PZS=P+=_VG/9V[+&P0['VJ">0"?<\T ;-MX:L[4 (\K.D)@B=
MY69HHSU523GG YZ\46GARPMI=,:-64Z9$8K9=[$(A !'7G@#DY/%6-?O(].T
M2\NWNXK/9$Q%Q*"4C.."P')%5+SQ-I6D2""^NA]I6(.RHC,Q4]\ $XR#0 DG
MA33&T>^TW;*;:^D>693._P S.=S'.[(R2>E23^&+.>XL[I7FCN[6'R%GCD9&
M:/\ NG:1D9YY[UH17%O/IJ7<+;X)8Q(C*"<J1D8'6N1O?&/FP:->V.Z&UNM2
MCM)&N(V7*'<25/0YV8[]: +B_#S0HXK%(HIHWLH!;I(ES(I>($G8V&^8<G@Y
MZU?7PGIT-]?74/F1/?0+;S*KG!0#  &<# /4<U%/XCLKI-/EL-2M(A/<^2/M
M$;@R8SN11P0V1W]#Q5[^WM.:^^Q^=BX9VC4%&"EE!+*&Q@D <@&@"NWABQB7
M3S''(?[/@%O"HE89C^7 8Y^8#:#@YZ5!'X*TR.TBM]UQM@N'N8&6=U>*1LER
M&#;N=S9&>]="S!$\Q^ HR3Z"N8\*>+3XBN+ZWFM1;20E)X5W F6VD7=')[9'
M4>M "+X&TV.P^R*TPB-VM[L\UL+*&W*1SQ@X.!P<<UO75B+NP-G)*Y#+M9P<
M-BL\^*]#>^:SCOX7N%E,3(H).X*6(P!R<*WY517Q9;WFB:;J=O<):+>2QA5N
MHV!D#GA5Z DCN#B@"Q!X2M;=-,CAGG1=,S]ERY8Q@KM(![C''.:;<>#-/N+2
M]M-\T<-[/]HG5)7&^0'=NZ_+S@X&!Q5^\\1Z38WHL[F\BBF+JGSY"AFY52W0
M$X. 3S69H_B&>XUSQ-:7XBBMM+EC6.7GE&CWDD_B* +]SX?@N;J*_6:XAOHX
MQ%]HAEVLZ>C @@^O(J*'PI9PWVF7432Q?V;"\-O"CX0*V-P([YP*O:9KFFZO
M)<16-RLKVS!9DVE2A/(R"!Z5D>-/%)\.:3++;0"YO0GF)$3A0H95+-[98# Y
M)(H ?<^#+&\L]6MI+F\\G5GWW*";@G '''R\*J\=A3;OP987\HENWN;G_0VL
M&BEF^1HCC(( &22H.>N1701R%;9'90&*@L < 'O7,:UXTM(O#NJ7NCSV]S=6
M=N)RCDJ I. 3QG!P<$>E %FW\&Z=;7:78-U/+%;-:?O[EG$D3=4;/4#M20>#
M;*WM+"VAN+V..PF$\ ^T%MI"E0O(^Z Q ''%6M.\3Z7>QM''>6[7,, FGB1O
MN# R>>PSUJ6U\0:?J4C0:?=0W%P$$@0'^$]&]U]QQ0!3F\(V,[7>X2?9KR3S
M[BS$F(I9./F8>^T9P0/4&F7G@VSOUU>.>>Y$6J1K'.%D ^51@!?EXP/<U4T_
MQ)?7&E>&;IH8]^JW)BE3/$8\J208_P"^ /QKI;_4K+38D>^N(X4D8(I<]23@
M"@".UTU;72DT^*YG58XQ&DFX;U ''.,9_"LNR\'V=C'I:Q7%YC2RYMU:4$'=
MG.[Y?FSFK<GB718+$7LE]"+?+KO&2"4.&_(\&GR^(M&MPIEU"W3,(G7+8RAQ
MAA[<T /TC2(-'@GACEED\ZX>=C,^X[GZ]A@>U9DG@RS:U:W^VWR1F\^V+MGQ
MY<GF>;E>,#Y^<$'TZ5HV^OZ3?7<=O:WD$\SP^?&L3!BZ<'<,=N1^=$6O:5=S
M?9HKR"2;#/Y:L"6"]2/7'3B@#-N_!6F7]YJMW=F2=M3MTMYU=@4V+]W QU')
MZ]ZMZ)X9MM%D:5;R]O)B@B62[F\PH@_A7@8' I;36[$V8EGO[-Q+</!&T+Y5
MB&(VCU(QSCT-6].U/3]5C=]/N(YUC;RW9#P#Z4 <J=/OI/B3J,ZR7EM:2Z?%
M%'-''\K.'8LH8@@'!7GZ^E;$?A&PMTL7M&EL[FRC:**XB8,Q1NH;<"&!//(Z
MC-3G5X;?6KJVEU"P6""V$KQ&3$L?/+/V"XQC/O4MIXBT;4+Q;2VU"VFNC$LX
MA20%MC $-CTP10!53PQ'!!;):7EU:O;O*XE1E8R-(Q9V<,I#$DD].M4AX#L(
M[&6RAO+M+>>T%E/&&4B2, CG(//S-R,=:Z2]O[?3[;[1<N$BR 6],UC:OXIL
M;&PLKFWE@E%],D4,HD'EX8X+DC/ _P XH K7'@/3Y=7EU&&[OH#.B1W5O#<%
M(KD(H5=X'.0 .A%2KX4ADD5S=3?9UN5NQ;-AD61>A4XR.W>L^/Q7=/K']@P'
M3GU(V[7(E+L(9!N 51QD$@Y[X]ZZ&SUFQFN$L!<VQO\ !,D$<H8J1U]\9]J
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MM6]8ZOINHNT5C?6L[JNXK%*K$*>AX/0^M-FUFPM+L6EQ=PPSG&U)) "V?04
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M2>YMY%B2ZM6VS".42*#C/WA[8.,<9H T[&SCL;.*UC+,L:A0SG+'W)[GWJ<
M <572]MIH&FAGB9!U<,"!]:DBGCE>1$.2APV/6@"6D)I,Y.*3O0 M** *6@
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MU(/)&%_>B;[3O+^NP@YSTQWJ:^N]+MK#Q99ZB8DU1[V2:,3)EF3Y?+*$]@H
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M!!PQQDD=LGUKE-"M[^UDA_LZ_P!0-_O5KFPNM/6),%LONE*!B,%B#N.2!ZT
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M#/0GDG+'KZT 9MAK-]K6O>%[I;@00W^D2W;0",E5<&#/?GAR!Z9[UVT;!\,
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MRW3)K<Z)/=Q7@1H58K+&01\QZKD<*<@5HV7AU]/UB^U%;^0QW;"26V\L8WA
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M0MMRI*R%AY;##*0".O7KUQUZ4 <U>ZQ<:G#I9EMH'U.PUO[*T:,0A<(_(SR
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M?G2+6TC&@W,<B2ZY;RXWEX$D<CA,<!> 2%Z'-9\AT^3P3JC$F'7/MD<6I!6
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MBN$) 9N0">M*6&00>,X.#WKRNWB2^TO15%[('@U^YMG:"5@/+\^4!0<D@8
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M*6DH 6DI:2@ HHHH *6DI: "BBB@ I*6DH 7O4%Q]Z/_ 'Q_.I^]07'WH_\
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MQW-ND>Y\O<QNV&=0#QLR,Y!'/:DM];U&7Q-XP@N+:.>"PMHC%"QRI^21N?\
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M\&\IHV9WCP"1Y@V[5R!QACZ<]: .J2VMVE6401;U& VP9'XTUK&UY/V:)V+
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M=B]N+&VEN!&8A(\2L=IZ@G'3GI6==^)X[&*$7%DT%[<221Q6\\BQAMF<MO/
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M2.0IP41<KSURI/I7H !Y!QCM2?.3VQ0 V%2&<MWJ6D/6DH =0:044 %+110
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MILTX>>U621(3;HS$G$1&"OT-1_\ "/:5!)%/#:GSXX_(1Q*Y98_[H.>GMVH
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M8P;S38;3<@*8>,RDG;@@*?,7N?NT 7H/&&G7-U:P1I=%+J)I;:<QCRY@J[F
M.?O  G&*J6_C[3;F'3KA+;4#;WTI@6X$'[F.3>4VNV>,L./PJEIGAF^T^P\(
M02M:R#0E;SRK-\^8'BPGR\\L#SCI5+PI8S:KX%MM/2"-(C?R2F5R1L"W;/\
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MMO\ (#SMX/'IVQ3M-U:[GMO#^DS7T["ZN;Y&N#)\\J02,J*6_O%<-GC.P^M
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MO\ZG[U!<_P#++_?7^= $W:BCM10 M%%% !1110 4444 %%%% !1110 444E
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MGATZWBDC;<I1 -I]O3\*?;:)IMGJ,VH6]A;0W<P(DFCC =\G/) R>E:(&*3
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M+-C'U]* +'44$XJ**:(G8LJ.P'*ALGK_ /KI1*FY 74.X)52>3CK@4 /Z&G
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M),H)Y'7I79DX88[]:XA;755UFXU&.WU59KB-(VQ]DP47=@@%L@C<>M %2UU
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ME-5B6P: 'TS:-NT@D>]*9 O/84!LKN'2@!IPCX"GYN:>#D9P::"3SBE&[TH
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M=P'E4@AFYY/ _*M*VUK3;Z98;:]@G=D9U$;ALA6V$\=MW%+=ZMI]B[1W5[!
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ML[R"W=A&MTL*(KID].5[CL*@\2Z9<ZQX4U-;'PR+*6\\IN-GGRLDBLV[#;<
M*<9;/M7J'5.>:JVFH6E^9EM;B.1H7\N780<-@'&?Q% '&ZXFI7-KJYM[6YDD
M-S9W,,849D$;1LX49Z_*>N*HZEIM[)KCZII^F7ECJKO;+&48>1=1XC+),,D
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M$&X8;(VD\CCJ*UP@&?3TH X'3VOK'Q9=WD%E>K:RM.U[;M$Q0,H&R6$G S(
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ML=N%(]2#70>&KG[;XTUZ^BM;I+.ZM[4132PL@<H'!QD>XKL BAF./O=>.M
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M +0&A)<ZI=M-<S,T[;@!Y2LV50#_ &5P/6J.I:+>3P#0+*QACT@B-C/-.78
M."RA3D]!P2>]=-&R[65%&U>,4 >;VFOZO?\ @-/%'VYEO!>[OLP0;2GF!/)*
M^N">1SG'-3:H VG?$E9&8NMLR#<Q.W-H&Q^9S77GPMI7VT7"VRKF83M&"1&S
MCHVP':6]R/Z4E]X6T>]FO)IK+=+>H(YF#L-P (!X(P<$@D<D<9Q0!S>HZGJ6
MCZS<Q07<LX&B27WE2;67?&5 VC QG)S4;2>(+:TAO!K=K);RZ?+G,_F/<R["
MRR1@H #Q]WICMFNF'AG3X[^WO&6XDGAC\E7>=V^7T;+<CIUST%5=/\#Z'IL5
MREK8B%YT9&8.Y50W4("WR@^V* #PE]LGT>RU&[U*6[DO+:,RH<;$?!)*\9'7
MD$GIQ6+XAU+5;.\UC3K2[N&NYXHIM,V[25.2)$&1R %R<YX-=EI^EVNE64=C
M9JR6\?W$+EMH] 22<5)+9VTE_#=O#NGC1XT?'0,5)_\ 01^M 'G^I^-[E-'O
M==TR5VLDBM;5<J&2*:0YDDZ9^163CI[5IZK>:EIVL2Z?:WLQCN-(FNXG8(QB
MEB9!N!(Z,).0<].,5T<?A[2X=%DT@6D;6,I<O"RY#;B20?SQ^55CX8T\PO R
MW,F^+R=[RDL$[KNSG!XS]* .-UMKF/0?#.HWMY+>2WFI:<XBR J.1DA0 , D
MC@DUJ?VAK<_@^+5--NI+^\OI5F6W<I&R)RSPIE>&"@CYLGCK707/A32[JRT^
MUDBD\JP=9+=0_P!U@>"?7%51X*TA9KIT6['VFY-VZK<N%$ISN91GY<Y.<<&@
M"QX3U.+5=&\^*YEF FE0K.A22(AC^[8'NH(4GOBN.U+Q'J\?@J^\26]XP>WU
M+:+8*NWRO.">41C[V#U]<5Z!IVEVFE6\L=K$RB21I9"S%F=V^\Q)/4UEGP;H
M[W,\JV\B+//]HFA$C"*63.=Q4'GG!],@<4 5+:%I?']TC7$CB/38Q(I;*DEV
MXQV'T_'-6]:N)K76] ABFV6EQ</%)!L4AP(G8=LC!4'@CI5R+P[91:W)JZ^<
M+N5=KGS#M(SGI3M2T6UU.\M;B=9#);/OB*M@*<$']"1^- ',6VHZG_;>F/+J
MLC0WFHWUH(62,(8XA*4Z*#D>6.<]!4*:[JDMUJ'AX3RG4X]26*&?8F?LKC>)
M,8P0JAESCJ*Z(^$-+=K<NDQ-O<27$)$A&QWSN/XY;\ZOOHMB^M+JQAQ>B#R!
M*/[FX-C\P* ./>Z\3ZHUW<Z9J%JJ6>IRP,)3M00QMAE9=A.['.[/X=JSY]:U
MQ[7Q)=QZU,K:1J8A@B6./#1_*=K?)R,,.>#QUKK)_!6BW&LR:FUM*))FWRHD
MK+'*W7<Z@X)!Y%1S^"-*GM=1M=DZ)?SB>X/F<L0<\'M0!4LC>2^-?$42WLX:
M.SM'C60@I&6-QGC'3@>_'.:JZ/KEYJ5AX,M9+MHVU+3C<W,RJH9V6-#A>,*2
MTF>!T!'%= _A:RDU%[X&=+EK<6Q=96 :,;MN5S@L-S#..YI(_".FP:;IUG;^
M;%_9HQ:3*Y$D8Q@X/H1P0>,4 <,WBCQ!$[Z>=2 DL_$L.FO<-"A,T#@, >,;
ML=2 .O:NH\+ZC?R^)?$FEWM\;R.PN(?(9D1657A#E3M !P3Z=ZNS>"](G@AB
M=)2([S[>S^82\DPZ,Q/6K>FZ!::?JVHZE"KBXU!E:9BV0=HVC [<8H R3J=_
MJ^J:_;V5\]D--C2.)2B$-*5+[VW DJ?E7 QT/UK,T_6-:U[5]*6+4FM+:_T.
M+4-@B0XD++D9()Z-73ZAX;LKZ[FNRUQ%+- ()?(8+YB D\Y'7GKUI+?PY9P:
MY%JB[UFBM_LR*IP@CR/EQVZ#IZ4 -\07L]E:6GEW;0;YU5_+0/+*.?DC4@Y8
M_H 37/Z3KNL265EYL\I<Z[+92F6- [0@M@, , \#)&*ZC6]"MM<CMEN'FC-O
M,)HY()"DBM@CAAR."1]#6?'X.L4LI[6.>]B$EU]KWK.2R2;MV4)SCGKZT <K
MKVKZC<0>-+1+R40VMW8Q6Q3:I19!&7&X#)!+'D\C/!%:%U92OXZ@M[747M;A
MM"</< *7_P!:AS@@KGCKMK5D\":4Z:G&[WCC4E07&Z<G<4  ;_>X'-6K7PM:
M6NHI?0SWGVE+9K99)7#D(2#SD')R,\Y_+B@#!\/>(=0UE/#^GSWC17<^GO?7
M4J(F756"!0""!DL#TZ TL6O:S*;.T%[&+A-:ETZXD\M<2H(W=3CL<!1QCG\J
MU[7P=8V-CIMM#)./[/9FAE##S #G*DXP5P2,$'MW&:>WA*S:.R8SW7F6ERUT
MCE@6:1LY9N.3R?;VH Y[4-4U?2=:73]2U6YM[9Y+9;74C;Q&&5OE,J28!*,W
M(7H.1BJ6J7U]I.D>,=7TN_6UFL]5\QMR*XE'E0C:<@G&#VQS78WWA2RU&:XD
MFGNREQ+#-)$)!L9HMNSC&0,J"0",U!<^"M-O=.U?3[@W+6^IS&:Y =078A1P
M<<<*!Q0!D>,M;U71=)\1:A8W4:RVT=LT!>)6V!SM(]^3GFK46H:UI_CJRT^\
MO5N[/4K>26-%A">0RX. PY*X]>?<U6\?>'W?PIJWV*&[O+J\B@@\A<'>(W!!
MX'!QNY]3]*Z&PT*W6^BU5Y;B6X6$Q1F; V(2#@  8Z=Z *6I2B\\:Z3I[LPA
MAM9;S83\LD@950_5?F/X@]A6#J^N^(K"/Q%80WHDU&W,$FGQQ0(6='(!7!&#
MSE<]JZC6;&5-4L-5MXC+)9QRQM&N SQN!NQGJ054@>Q'>K$NB65_K%CKDD;I
M=V\+QH"<</@_,.Y!''IS0!P/BW5+W5O .OWIF7^RSI,8$94;OM#'<W/^ZRC%
M6KCQ'JGARZO_ #KM+FQ303J-O$D04Q.A4%%/<'WS733>#M/E\)7/A]O-^QSL
MY<(1N(9MQ&2#]/I0OA*P>_COYFN79;+[ 8I"I0Q<=0!UXZT 8]G-XLE+/-.1
MIL^G[Q._DAXKC@@HH!RN.S9JK9QW+_\ "&LU_NOKB"4_:C&I;!@8].AQVS^-
M=!I7@VUTA\&^U&]MPK+#!<W!=8 000@&,<$CG)IUAX.M+$::8[R^9].#"%IG
M5^"I7!RO0 X&,4 8]KXBU>?2M+LC*UQJ$]_=V<MS"D:LZV[R*6"M\H)"*?0<
M\=JE;4/$J6NEV5RZV]S<:A):F7$;,\7E2.CL!D*WRKD#BK\O@BTETS[+]NO8
MYTO)+Z"[C9$EAE=BSE2% P2S9!!X.*F7PG&GV(B_O&EM;G[29Y&1I)7V%,L2
MO]UB !@"@ U:^O?#/@BXNYKE;V]MH0/.= @DD)"@E1TR2.!67/K6MZ-X@TS2
M+F>&\&HV=Q(DZQ8"2Q*&.<8^0[A@=>.M=7J>FVVKZ7<:?>(7M[B,QR*"0<'T
M(Z'WK'C\)1^?!=76HWES=V]O);032LA**^-Q^[RQP.3F@"CX#O-<UC2+76=5
MOH)([JV#?9XXMICD#$$@]P1C@]#W-4-7UW7A)XH>TO[:%=(B22*,P;B_[H2$
M$D]\D=/RKJO#NA6WAO1;;2+2262"V!"-,07P>>2 !5*X\)17#:N7NIP-501S
MA0G "A/E^7T&.<T 5;C4M5U'Q!?Z=IUVMJEC9H[;D#%YI<E!R#P O/'>N?LO
M$FLZOKG@O?/]E%Y#>&\MD^XTD.$)Y&<9SBNKD\*1F^2]COKF*[-NMO/(I3]\
MHZ9!4\C/48J(^"-,3^QVMC<02:4)%MWW@G:^-X;.<YQUZ]>10!9\2ZA>V,>G
M&R>)&N;I(':12V W&0,BL./Q!J]M_:^G7=]:RSV4UK(+WR_+5K>8GHHW9<;'
M '<XK1\9QRSC1X81+Q?Q2,8HBY55.2> <?C3[KP?:W=O.WVB>.ZN+B"X,\3
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MDUO+<W3 EU2-'5%*CU?=GD\8(YJUKOA@ZU>V>HVE[-I^H6NY4GB"M\K8R"K
M@BF-X/CBDLKVUO;B/4;3S,7,I$A=7.YE8$8()Z 8QVQ0!BKXQU8'[%=16T=[
M;:O'IT[A&VR(_*RJ,\97!(.:1M>\76<6O6$OV"[U;38DO8C' PCN('W?*%W
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M18#+</B>(SQ;8G?<@QR-H.?O#\ZJMXNL/M&D):F26+52[0N(VP%5"Q.,9SG
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M^2&>%'++Y5Q'LD4JQ4AE['(- &+XI\9)I M8+%HIKN6_@M)%8,54.X4\C +
M'IGCN*NPZ]#'J.L)/J%M+#8F-3'$/GB+9^5CGDDX Z5P=Q#J%MX;329=)OQJ
M4&NI=.\-NT@ND\_<9=P!'0C//'%69+;?JOC3^T+;46LKN:T:)X8V#*JORZ$#
MJA(;VQ0!WH\1::]M<W/VE5@M7\N=WRNQL9QR,Y]J?%KVF36$EY%<AH(G,;D
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M_P#6KD-'6WOM)LH[:/4?^$BL+*:-+8Q,([>4Q,#N;[N"3QR>O%5[.\M;C2_
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MEDBM;N&:2/F18Y VSZXZ=*\ZTVZT.^T>S_L>)FU^+2YH&5=X,+&+Y@^?60
MGKR15GPS=>'M1UC2+BSN+J74H+9HFB2-4\I&^\LPPI.#G&>^2,T =]=R6D:A
M[H1A%ZO+@*OXFB6ZM%2+S)8!'(=J;G #'T&>M<GXDF6#QSX>_M&/.F[)\.2?
M+68XV[^W3IGWKB;RSL[5;0(T8T\>+(I+1RP"I$ ADQVV^8']N: /8UN[9K1[
MB.:.2! 3O1]P&.O-4].URRU'1XM3$RQP29*L[@<9XZ''2D_LRQTSP[<VMG:Q
MQ0>4[&.*,*"2"3P.YKS72+C1X;#P7:0BW2=8Y29YI,QP.$42*5Z-(>@!/&.E
M 'JGVNQ=T_?0,T@RGS@E\<\>N,U)'=V[VWV@3QM$!DNK[E ^M>,:+';:C;^
MHY@CA)[J&8.0"0",(P[=>E7HY;2V\(:AYDT<%O8^)W(MP?W;QK./D)'W5P2>
MPX% 'JDM\CQQ-9RVTH:55+&? VDX)! .3V [GN*R]"\31:O/J$<\0LY+.]:S
M5'F#&0J!R![YZ<UQ,::,\$]]:W.G'[1XELY@MM.KB+F,$%AZ[7?&>Y]ZJW=A
M97-AXT>Z0?VG'J,S6(<#S%D*@QE!UY.,>OO0!Z1'JSOXHN]*>$QK;6D5UYF_
M=O#O(N,=L&,UJ07,5P#Y;J2." >A]*X#5;BX34?$AMI ^J_\(S J*"-QE#7!
M/'KEE_,5;\)'0+G78[O1;J69C9&-XXT18XT#*5$H !\P9(&>V[TH [=T5P%(
MR,YH<=*=P,4C4 +VHQ2]J* "BBB@ HI*6@!,4M%% "4444 %%**#0 E+24M
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MV*Z3=UX+(QS@$#YNF<&L99-9N?B%920_8[?5;CPVS/YJLR1'SHST!R?3J.M
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M=V+9$]JR G:^3SGKD#'-:.G:]KS:Y:VEWI!:TGA+/-%&RBV<9(5BQ^?/ RH
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MT3_A'O#]GI2R^:EK$(A(1@L!P,^]9T>O:K<2_:+"P2YTZ.^-F^T_O&"MY;R
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M36\*RZEJ'V65"21&!OSC_O@_X5T>MO<IHT[64EK'<@#8]VQ6)>>2Q'.,9Z4
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M:G>Q7316DMI)/#&8I)D="F'Y(. >/>K>B>&M0TU8;>_UV:^M;<@P1^6J..,
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M1?,"X/&5S7;>%O#8T#0K73Y1;R2P+M-Q'$$9QGOR3[=:V4MH82S10JC,,$J
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M8M>6WB=88IVF8LB->!77KSE2V<\D&NZ\;7%NGAMA<;RLDT**BN%#EG "LQ!
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MFPC;C&. <Y_"@#H4]/2G$XIA)4#C/K3QR* $==ZD9Q0@P,$TW+!^G%.)([4
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M  EL@98-QQP<T =\][,/$(TXP#RGMGN!*6Y+*RC;CT^:H_#.LOKF@VVI2PB
MR[\QAMP7#,.N!V _.L[3[^.XUC19?/$H.DR%V#9RQ>#G]"<_6CX?#'@BP4\D
M&7(_[:/0!;.NSZAJ5U8Z/!;S?8VV74T[D(KXR$&T$DXY/I^(J;1-9DO[6[>Z
M@-M);7,D#HQ^5=N#G=@9'/6N7\ ;=(NO$VE:@Z1W?]KRW69FV^:DFTJZYZ],
M''3 JWK6KVE_XCT&T3;)I,UW/%=.01%)*(<QJ<\,ISUY!*@<T =D&&S>NW##
M(/;ZU'/=QV=L\]TZ1Q1\LQ/ QUKRW4;0Q6.M::DKP:3%K]JMF\,Q7RPXC,BJ
M1T"EF '8Y':K\>GVR:GXXTQ&WV"VMLZV[N2 Y1]S<G@DA2?SH Z+3=9UJ_GL
M'&DVQTR[19UN?M(#QH5W .F.6QZ''O5GQAKLGASPW>:G#;+<30[/W3MM#;F
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M'^Z3V!-<A=W$RZ'KUN]TUI);:U#'&MO,W[I76'<HYY7+.<'CK0!Z:'5P=I!
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M6G9Z5966G6MC%"K06BA8A(-Q7'3D^E9 \3/Y6NB2RV7&EL%,+2G,H(RK [>
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ML]*>]E9W%HEK);1-;8 $+1J4P.@VXQ6+I_B62[U$:=/I4UO+)9&\BS*K%D!
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MUF.2&TSL,,;(THQ@!\D\#VQ61IO@2^TW1?#]O;ZA USI%S-.LDL3%9!('W#
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MU-=Z='T\@K]@LRKMND'D+ACZGCFG2:1I\LEO++96[O;<PLT8/E'_ &?[OX4
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M^$M7M+JX$=WIFIVUNSPH,3*TD#JQZX.'Y P/;M7:W\9_X1N_6XD$KM:NKR8
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M!*6DHH *6DHH 4TE*** $[TM)2T %%%% !0:*#TH 9_%39ON,:=_%39_]2U
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MQOI(VN[&VN&C^XTL88I],CBK##)IZC H 1%"C;UQQDTT@"3 4'=UI6.TYI>
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M) (0G<QX/ ':NC#'8">#T- #Z*** $HHHH 6D-+2&@ HHHH *6DI: "BBB@
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MQ!_9QE,PTOSK<P*^[<&'S[@-QSMW8SVKOVF5'1)) KN"0O<X]*D=E4<M@>M
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M6UK "!<)<!Q*P..% R!CGGGVH R;'P)_9VAZ)86NIR>;I-PTUO.8>65E92K
MG'1SS[#BI9/!]U))(G]KE86U'^T%46X)5BV2I)/S#DXR./>M"3Q#)%XKL=%$
M*LEU;RW FW]%0J#QC_;'.:W 1G[S'/?'% '+77A"XNK35;;^TEC2_NTNN(26
MBV;, '=S_JQSBK5GX>GM?$ESK)OLFXCC6:V6+"EE &X$DD< <?K6^LD;8VR!
MNPP<UGW>H3FQDGL(H[B5'*B)Y F[#8;D]"!G\: ,?7/",FKZQ<7T>HM!'=:>
MUC,C1;R%))!0Y&T_-[U37P7JMJ-/FL?$$EO?PV:65Q*+96CFB0DH=A/#+N8
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M<+KBMJ!1=3G2YA9(OFMI4"[",DYP44]!S75&:,KNWC;V.>#2[T5B"^,] >*
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MB28L CC!&&*\_E6ON&1R>N,8H Y1?"4\&HQSV]U'#$FEQZ<28RT@"%]A4@@
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MIR-'$Z@;595+'=SD< ]JURV!D>N* '4444 )1110 M(:6D- !1110 4M)2T
M%%%% !110>E #.],N/\ 4M3_ .*FS?<84 /3[B_2BE7[@^E% !1110 4444
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MX'B260E;-MXA-PQ!SMR$VD'TQ7J[X56?C(YYID%Q#=Q^;#(DD><*Z'<I^AH
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MDBC,R$$...#\HXZ>U175G_PE.O:?:W.DW\%OHMQYS7=R-HG(4A0AR=X)P3G
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MT20D.I*[3^\C(Q@C@\8J]+X+W2ZC</?W+W>HVZ6MS,WEX*+GL%P#\QZ #VH
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M #24II* #O4=Q_J6J3O4=Q_J6H >G^K7Z44)_JU^E% #J*** "BBB@ HHHH
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M++S_ +1/.: .YV@-GVP..E!C&,?AT'2N0MO%%Y=>)GTU?LL3QW)26RG8K<+
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MQ 9P0%C4 YR<DYYX!XJF?$]_>W>C1:=9P;=2L#>AII2-N-G!XZ?/VY^E '6
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MDU;3S<RH%1YI4B .=T:N55C_ +P ;\:Y[0H6F3Q<LD[MY6H211YD;]VOE1G
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M[4 --O"<@QJ<^U-%O;I;-$(P(NI4#CUJ:FD9X[4 0F"%^"H.>3_2I&C3<I
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M -)2FDH .]1W'^I:I.]1W'^I:@!Z?ZM?I10G^K7Z44 .HHHH **** "BBB@
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M+:6-;BZ:429A@BW2*8\A]PXQM((.>_ S1%XRTN<V1MS/<"]MY+BW,$1<2*A
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M3Y8KMB;B&2U:-98982LBL_W !CD'!P037,3>&M=O?!@DF43:R+JVF\EFPKI
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MJT;S4[73M-:_N)O+@^7YF!SEB  !C)))   SFN.UC06O/&D%K;>6+#4U6[U
M*P^9X&'4?[8*J?\ <%=#XM^VKX><Z=:&YE66([5C5W50X+.BMP74#<N>X'%
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MH6E$W-UY>V&U@ 9SYBL=V/8'DU)<6UW:>)-&UIH)GTU;%[6:)8F:2"1B&WE
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M&@#J]=T.WU^V@AN'F003I-&87VLKJ<J<^Q /^/2M;[JA<D\<FN:\5:K<^']
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M/E#AP99 ^[KTCQCIS5[2-9\07Z6.IQ([6-Q,?W.V/RUMR2%;?G=O'!(^HP*
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M@N%8#/)Y I4;=R!B@ Z?*.E*1QQ01R#2%@IYS^ H 44M,5MR_*<^XI<D#)H
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M4P:SKGA:_P!.V S7Z!!']GE"6ZYS]X)ES^ KHTU)UTU2MI(MX$P8E@E*;_\
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M;/*@\V60J$WVR*3@*<XZT[2H-<TW4K7PI:ZI$L=II,+^>8P[A@Y1N#P<X[]
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M[)+.^IP".%PCY)RI]QC/XCCWJ9[V/^W["'^U%B:2!Y39+&&\X<8?=U 'Y'-
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M S*/4@$'% &U3"W-.!!)%-*\T *#2BD XI10 4M)2YH **** $HHHH ****
M"EI*6@ HHHH 0T"@T"@!:AN?]2U35#<_ZEJ )$_U:_2BA/\ 5K]** '4444
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M4M% "4444 +2&EI* "BBB@ I:2EH **** $- H- H 6H;G_4M4U0W/\ J6H
MD3_5K]**$_U:_2B@!U%%% !1110 4444 %%%% !1110 444"@!.](6PP'K3J
M* ,/Q9JLFC>%-2U"$@311XC9AD*Q(521W )!K,ENK^P\3V&F_;))[;4[>7+8
M4-#)&8_F''<.>.1P..N>M=%D4JZAE((((R"*S+?1=/L7D%K9Q0F1=F5'\/\
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MF_\ ",::!<G[$AEN(S%,^\Y>/^[G/ ]AQ0!S6LZ]J!TY;R'4&AG71_MD<,"
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M8!U(X_"MF/P=8+IYMI)[ZXEWQNMU<7323*8VW)AF' ! /3ZTQO!=BXO5:]U
M_;IHYYR9\Y= H##C /R+T';M0!5'BJ^L)]?34HK=S811S0_9]P#>9D*AW=]P
MZ\#G/%5H$OH?B(K7DMN]T='&##&54-O;U))&1_\ 6K1NO!]E=:CJ-Q<O<3#4
M8%M[A)) 59%SM(  VD$DY%26W@^WM[]+]M1U*:ZC@,"2RW )VDD\C: 3D]\T
M 8.A>,;JYT7PW!%;6WVW6Y)?+*ILBA5%+LQ4$9P .!C)/6J^B7NIZ4GB.06U
MO+.VO*LCHQ6.)###F3:3DX&"5!Y[5NVO@'2K;2K*PCEO%-A(9;2?SLRPL3R
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M'$(X=SDCJ<L.!R<ULR^ K9GMO+O;V$6UZUY%$DO",YR_)7D$DG!SC.!BI)/
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MH U8[J%Y75;B-R K;58$@'H3[>]-@O()Y)ECN89&CZJC@E?J.U>:VMH;^_\
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M 4444 %%%% !1110 4444 %)2T4 %%%% !1110 4444 %%%% !1110 4444
M(>U+110 4444 %%%% !1110 4E+10 E%+10 E+110 4444 )2T44 !I*6B@
MIIIU&* &BG4"B@!**6B@ Q1110 4444 %%%% !1110 4444 %%%% !1110 &
MD'6E-(.M "U!<_ZH_P"\/YU/4%S_ *H_[P_G0!*OW%^E%"_<7Z44 .HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  T@ZTII!
MUH 6H+G_ %1_WA_.IZ@N?]4?]X?SH E7[B_2BA?N+]** '4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 E%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%+0 E%%% !1110 4444 %%%% !1110 4
M4"B@ HHHH **** "BBB@ HHI<4 )12XHQ0 E%&*,4 %%&*,4 %%+BDQ0 4M%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &D'6
ME-(.M "U!<<QD?[0_G4]0S_=_P"!#^= $B_<7Z44#[HHH =1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% "4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% "TE+24 %+24M !24M)0 4444 %%%% !1110 444
M4 **2EI* %%!HHH 2BBB@ HHHH 6BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -(.M*:0
M=: %J&?[G_ A_.IJAG^Z/]]?YT 2#[H^E% Z"B@!U%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_?7^= $HZ"B@=!10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *.M%% !03@4M(3SB@ 4Y'-+
M110 &DSQ0>E-S0 X=**:":6@!:6DI: "@T4&@!*#10: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #2"E-(* %J"?[H_P!]
M?YU/4$_W1_OK_.@"4=!10.@HH =1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BF]Z6EH
M2EI*6@ --Q3J* &XI:6C% "4HI** %H-)10 4&EI* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #2#K2FD'6@!:AG^[_P "
M4?K4U07'W1_OK_.@"5?NBB@=!10 ZBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EH%% !
M1110 4444 %%%(: "BBB@ HHHH 6DI:2@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** %HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "DI:04 +4,_*@?[2_SJ;O4,O;_?7^
M= $J]!10.]% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 HHI** %HI** %HI** %HI*
M6@!**6B@!**6@T %)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%
H% !1110 4444 %%%% !1110 5$XW8_W@?RJ0]*9WH >**!THH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex10-2_006.jpg
<TEXT>
begin 644 ex10-2_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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MQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* #-&:,48H
M3-%+BC% "9HS2XHQ0 F:,TN*,4 )FES1BC% "9HS2XHQ0 F:,TN*,4 )FC-+
MBC% "9HS2XHQ0 48I*7- "8HHS1B@ S1FEQ1B@!**,44  I:2EH 2BBB@ I:
M2EH #24II* %HHHH #0*#0* $I124HH *2EI* "@444 +1110 &@4&@4 %)2
MTE !1110 HH- H- !1110 4444 %%%%  >E1GK4AZ5&?O8]LT /'2B@=** %
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*2ES0 449HS0 449HS0 44
M9HS0 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0
M 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 4E+1B@!*6C%&: "BC
M-&: "DI<T4 )2T8HH 2BBB@!:*3-+0 &DH-% "TF:7%&* $HHHH **** %-)
M110 4444 +124M  :!1BB@ HHI,T %%%% "B@T"@T )2TE+0 4444 %%%%
M>E1'_6?\!_K4IZ5$?]8/]W^M $B]**%Z44 +1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1BDHH 7%)110 N*2BB@!<48I** %Q1BDHH 7
M%&*2B@!<48I** %Q1BDHH 7%&*2B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I:2ES0 4E+FDH **** "EI*6@ HHI* "EHHH 2BBB@ I:04M !1110
M 4E+24 %%+2&@ HHH(H 3-+28I: %HHHH **** $-%%% !VHI:3% "B@T4E
M"T4E+0 4444 % HH%  >E1'_ %H_W?ZU*>E1?\M1_N_UH DZ"BANE% "T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%+10 E%+10 E%+1
M0 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+BC% "44N*,4 )12XHQ0
M E%+BDQ0 444N* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1B@!**7%&*
M $HI<48H 2BEQ28H **7%&* $HI<48H 2BEQ1B@!**7%&* $HI<48H 2BEQ1
M0 E%+1B@!**7%&* $I:,44 (:*6C%  **** $HI:2@ %+2"EH 0'FEI ,&@G
M! H 6D-+1B@ HI,XHSQ0 =Z6F@]:7- !2T4A.* %I"<4W>*,9H >*0TBGDTX
MT )112T %%%%  :2@T4 +WHH[T4 %%%% !0***  ]*B_Y:C_ '?ZU*>E1?\
M+4?[O]: )#THH/2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBDS
M0 M%)10 M%%% !1124 +1124 +1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2=Z6DH 6BD
MI: "BBB@ HHHH **** "FDJ2>>12L<*2>PK%N?$>DV-_+8SW0:Y10\JQ1-(8
MP>A?:#M_'% &T"",CI1N%4]/O[;4+.&[M9EDMYON,O1O?]*MY0-CC/6@!&("
MDGH*=QC J&YN+>WM9)[B6..!!N9W8!0![FLZP\2Z/J=^UE97T4UTJ%VB (94
M! R0>@RP^N: -88P/>@#%9U_KNFZ=?V=E<W<27=V<6\)^])]*T$;=SN!'I0
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MM #MPI-XSBEP*,#- ",.,TJCB@\T#I0 M%%)0 4444 +10*#0 4444 %%%%
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M>NXGZU(A;:-V,US>LW=K%XOT*UEL9)+J0S-;7 DVB,B,[AC/S$CCD=ZHVGQ
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MXSZ]* -I3EL5(>E8]OX@T^6[CM!)^^E9HT?'[MW7.Y5;H2,'(]JUE;<@;L:
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M>IV5C/!'=74<,D\BQPJY^^Q. ![DT </;^']3M?#>J>'+B$W/VF[ED@O@PV
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M1110 4444 %%%% !1110 4UCR*=2$9(H XOQ?>K#>BT:\EB46<TWEI/]G /
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MR6YC%KA'3RV7S&)*<_+G.<<GCIS22>%]&G1$FT^)T2W-JJL20L1&"@&< $4
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MM;J_@O958S0',1#$!3C!. <<C(^E 'G;+=MX,N7>_-Q.?%")&TH7$;+J(4=
M.P!QZ=,5V7A^]O7U75M-O;M;E[1XG#A N%=,XX]"#^'<U*_A7193=;K0@RW
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MKI?^$.TP6\<1,X:*Z>Z@F29Q)%(Y)<ALY^8DY!XYI8O"6G0S2R0R74=PT[7
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M9VRQP,9)[FI10 8%'.[VI:*  TS+9I])B@!I+#%*,T[%% "$FA<XYI,\T[-
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MDGTH =VZT '.2:0@''-.Z4 - Z\\TX=*,<TTCGK0 N#N//&*!P.31M%! /%
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MZ3+G;'M&"J;\N!^)ZUI:SI4:W7BF#3]-FCCO?#^R+R[<[)9AYI'.,%_G7WH
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M:RM^+F)D^\(R2,JP7<!P<'CG%.U%;%[6&6VBO!IO]K6LZ2N#""Q?][L3"E5
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M@!XBIWB2X1Y,'/=MA!]P!3;&?0Y?%GA*^T2*<P);74<C;264E(\"7T?GG/-
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MR3AWY!B:-"V1ZUG6/C;4K[^R/(LK1?MUY+:R6DA)FMMA;+,PX.0HXP,;AR:
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MM;-G>:DOB%-,E6VELQ9"222%R6CF#<AL_P +!OE[_(<UT!; ''Z4U45&9E
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M&V23@F(HP9%SU;?CY>O2N\*HPPR@X]102,\9R?:@#S?1K..37](BUJ*&:<:
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MFC!W*DJ!E!]>:1]/M)DB5[>-UB_U>1]SZ4 <]X,AM[5=9T^V$:06FIND4*
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M7IUC?WKR:=<B6Q)NW9PQC21E+9R0QR#GIN.*V_#5Q#X@UNXUNUDD-A%;0PQ
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MK;B;RKUI5MIRAV2F,X<>HYX''/:D\'6VK6WASR]5N))KI9)?+,N-XCW'9N(
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MLM*\+WU_J-D;VRMUS/;@*V\9YX; /XUI:8]O)IEK-:0K#:R0HT<:J%"*0,#
MX'%>1Z_>WAT+Q]87$LT<$>FQ316LL_FM%N7D[LG))!)YXR*W+'5W@TC6=36Z
ME:_TZT*)IAD(58PGR2;/XMR@-GD<T >EXZ8[>]!'?G/3@UQFBI?0ZGI-\==6
M:SO+=T>&61I#<.!O$B$G"D '('&">*ZV>YV6,MQ'M<HA=0#D-@4 2[E#;>K
M9I,JS+UR><?XUYQ::OJESX2T/Q&]_,+ZXOX/M-LK'9Y<D_EF+9T^4-UQGY>:
MU_#UM=W^M:I=2:U>.ECJ4L44 8>6R&*,A6'?!)(]": .Q+C.".^W-9ESX<T:
MZNA=7&F6DDZX)E:%2S?4XR:YGQ=J=S!J=W'::A<![?3'N/LMN=GER G$COGI
MP %.?I5,ZG?ZCKGABR_M>YA35M%DED\@CB150[P>><L?RH ]$VK$%"K@#@!>
M@IP88R!U->?QSWT[^(KJX\0W-O#IERRQ$ %-IMU/S*!DX+;@!CD5G)K>HVT>
MIJNHWF(?#GVZ'[21YC2KN_>8ZKN"C*].>@H ]07UYSZ$TF0V HX!P:X"VOM:
MC\,M-#?R7FHSZ.]RBN5"+(I'0@=]W)/IFJ<&J:O:(^K6USJ%SIEOH+W;FZ3#
M/=*/N'*YYY) P <>N* /3%954@=%.#FLJ]\0VMEX@T[1Y4G^T7X<PLJ?)\H)
M.3GC@>]<;<WFNZ1I,VO#5(+VQ_LUI'B>7S//EV;EDBP!M&2,C.,#I4UQI\UA
MXY\(32ZE+?%TN4DDD(P7\HY9<# '^R.* .VU._@TRU^TS[B@94VCJS,< #W)
MJ/2M634HIB+2ZMI(I#&\5PFTAL9ZC(((Y!!(K$\<P^;8:<WGS1_\32T4;",
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MH]#UJS\1Z:-0LMY@\QHP77:<J<']0:FM-1BOKR\MDCF5[20(Y="JME0V5/\
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MD=R.U=.I)'(QS0!'LW,7.[V7/%/"A>G\Z,G=BESQF@!%78,<GW)H(S2@YI:
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M9]JLZ7X?N;;Q+#J@M([623S/MQ@)5;HG[K;> &S@D^QZYKMV8*,FC SG)XH
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M<Y KNR%ZGGZ4B,I&!P1VH \JETO5)!X@*Z;J4D=_H1M8Y;A0&>7#X#(OW/O
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MNS>Q&*9D>.5BQ<A@<@$N^0"/O&GCPQ:"YC<M,\<<YN4B9R564@_-R?<G'3-
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MO[*]\7W]E.D<5KJ4#20R1AO-'E1 KD_=ZYR*[36='CU>.U5KBX@:WF$T;VY
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M\5R[!E\T8(W+G)'R^G>@"Q<^-XSX?U*^L[:7S[2W2X$4@'SHZ[D92"<@]>Q
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M+QR&(PW4< \5&_B[1HOM+OJ&U((?M#%H7 \H$ N"1AER>HR*P;"WFB?P4O\
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MHH *04M(* %[U!+_ *^+ZU/WJ"7_ %\7UH F/2B@]** "BBB@ HHHH ****
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ML_$6O:KJ%KI,'V.VN"MY'<.\)=4>"2-=P&[G(D!P?7KVKH/!^K76M>%[>\O
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M$EY+:VR(U[(99_1V(Y)^O/YFJ4/@_1+:!;>"TVP ,%B\URJ!@5.Q2V$X8_=
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M*T#^TEURTU:UN5M+R^DF\MY"(Y8R1C@?KZUHZKKLXG\/OI<]O-9W]_\ 9Y9
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M[I6A#97 \;R:FUB?LW]FI;AU9,&1'9L ;LXP< D5U:,"F0,8XI"D8.[:,]*
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M-;"&(JS 0R>8!( =C']3CK5>&6.YG\0VL<3/!J&BQI"BV$D<;NOG*?O#D@%
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M,5K>R7D"%8R4,F_<N2N2")&')/&,8QF@";2?$\NI:R(!%"JLTJ21>9^^AV,
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MHQ3BP'6D#!NAH -N<_A2!0K,^2<TX9I: (HK>.(EDC12>3M&*D-(=WI2G)%
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M>X&*J^,HP? .M!MX!LI<YZCY36#H_A^[U6P\':J9X+==-TT;2@+/)YD 3!Z
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MJ%Q'<"V6":*5(O+P)-XV8R>!LZT = I.*>#38^8U)[BE'6@!U)2TE "T444
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MZ6+@0F\02,[HJ%2"[*NY@/7 YH SM'\)65DD$D\,0FMY'D@2*1V%OG@*A)'
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M3FJ7BJ^N--T4W5J5#BX@C.[IM>54/Z-5JVUW3;E9_+O(F:W&Z4 X*#W';^M
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ME:ZI-J,?F?:IXUCD+.2"JYQQ^)K5"KC&!2! 'W4 +C  %(!@TZDZT +1110
M4&DI30 E%%+0 4E HH **** "BBB@ I:2EH **** "D%+2"@!:@E_P!=!_O'
M^1J>H)O]9!_O'^1H F-%!Z44 %%%% !1110 4444 +24M)0 4444 +12"EH
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MEM;?F*,K]P]25.<@^^:+GPGHM]I5OI]UI\3V]LVZ%5+*T;8QD,#G/OF@#!D
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MKZ:\9  ))553@#  "@#  % &A24M)0 M%%% "444HH 2BBB@ I:2EH ****
M"D%+2"@!:@F_UL'^]_2IZ@E_UL'UH F/2B@]** %HHHH **** "BBB@ HHHH
M **** $- H- H 6D)Y ]:6FL.0: ,_5-7L]+DMDF9S<W3F*VB1"S2,!D@8Z8
M'))P *QM2\90KX<U2^L(9FN+'='(CIM,,F,C<">1TY&<YI/$^D:A=:_H.L6,
M27']FSN7MF<(761"A*DC&1UYQWYJEJVE:K<Z7XAG@L-UUJ0CB6 .@SM&-S$M
MCN.A/2@#?T&"\2&=KF[GDCDVE(YT0-&<9;!3@J<C'<8/6G:MKL.ESP6WES37
M4Z/)%#"FYF1,;SR0!C<.IYSQ55_$$EIXBTO2;C3Y%2]A.R<,I\N0*6*, 3@8
M4_-TS@=ZJ>)K?5GUS3!:6T\]@Z2),(9ECPYQMWY()3&[(!ZXX- $K>.M+Q$$
MCO9));..]CCCMF9FB<9'3N!USZ5NVU[%=V$5[;DM%-&)4..JD9Z5Q>E:3K%H
M]EYUB\8308]/VK)&0)4/^][?J*Z#PE;7ECX8TVSO87CN+:U2)E8J22O'4$CM
MZT 8NF>,]-M]'@O[O4+J[AN=3DM(9FM@A#ER A5>PY&>IQTK0G\<6%K87U[<
M6NH11V$@CN5>V*L@*A@^"?NX[UQ</A;Q$GAJQMCI\D<T?B;^TI%62,_N?,+?
MW_?I78VFF2WNJ^(TO[1Q::DJ1CS-F"OE[&Z$GH: -BXUJULKMXKEV14MFNF?
M&5"#KTYS[8YYQTJA#XLL'EN5F\^VDMX?M#I<1E"T/0,O7/) ]>16):>'=;NO
M!^JVNHM&-9E@6SCE)W*\<(/ELW^]N8D?[1J6(7]]I5RMUX0M;7?;^7-;EXW:
MYR0&12I&%VYY8CG''% &AJ_C*+3M,O+EM/OA):21I+$T8! <X4Y!(*GID9J=
M-3B&O^4UX\:_8?M#6C0\* W+E_TQTXKFY=%UA?#NMVD4=]/:,8)-.M[V16F7
M:P9HPV3\OR@*&/&3VJ[>27"Z_/?WVFR&RFT5H9"SJ I!9F5B#GIW /6@#3MO
M&.G75U96J)>!KU3);$V[8= 0"W&< $C.['459L?%&GZC=QPVQF9)HWDMYC&5
MCE"$!MI/7&:Y'06GMI]&DU?0]8$]O$+:TN9Q"8X?,*\,4?)!PH!(^H%.T&'7
M%O\ 1[F_T2Z6[C6>&[)EC$:;BI!0!L!/E[#.>U &A?>+A=:!%J,=S/I*27<<
M4<DEKYWF#S=NT=OF"D$]MPYK=OO%&G:=)<)/*\C6BJ;LPH7%N&&07Q]T'K].
M>E</?:/KTW@>#1UTFX%Q;ZDLQ<21XE1;DR%A\W3;C&<$DXQ6S;Z+J6F:AXK'
MV.2[AUDB6"0%?O>5L*/DC !QC'8&@#:N?%^E6]W-9![B:YAA6<I;V[R%D;.T
MK@?-T/2M>POK?4--@O[63?;W$:RQO_>5AD&N4TC3;[3_ !(AFM)/LUOH\%KY
MJ[3YDJ'/ SG\2*T/!]G>VO@K3=,O4>&ZM[*.!]V"58+C(P2#0!97Q3I8NK:W
M\UQ]HE,,,C1L$DD&?E#$8)P"1ZXXIFE^*M,U6_:VM&N'<3RP$F%@H>,*6R3T
MX88SUYKEI-&U2^\*^'M!>SFCN=,O+9Y97VA/+@<?.&SSN4=.N3R!6UX)AN;9
M]<^V6DEL]UJDUU&'VG?&V-IX)YX/% %V^O[^#QEIE@D\?V2ZMYY&0ISE-F/F
M_P"!&G6_B?3)YD6!II3+"T\&V)L31K@$IQ\W+*,=>:JZK!=3^,=*FMX'>.WM
MKA)&; 0,VPJ#SGG:>@-<]HMIJCZOX=O9=.OHYH;:XCNO,,82,L8\*BA@ GR-
MT'.!UH ZK2?%NF:O-#%:O*TEQ UQ#F)@#&&VDDD<$-P0><D5IZ=J%OJEC'>6
M;%[>4;D9E*Y'T/->?R^&=8TB=;O3?G-K>2V\,98A1:SEY'./422)CVA7U-=]
M#IR0:5'81.458!$&7J,#&?KWH JP>)M,N+Q;57E#O$TL1:)@LR+U*-T;'M4%
MEXNT;4VM(+.X:3[6I,+&-U5L#)7<1@-@$X//%<[X7MIK"/3K*Z\+-!=Z;'Y3
M7C;'C(5"I:)@2<L<<$#@FJ-MI^HPZ+X*CEL)1)8W1:Z5E_U8V,,CU&2.F: -
M.V\3ZCK.J:K'!<1Z=::3<".8W5JQ$D84-(6;(V'#<#_9R<BNA@\2Z;<SB 22
MQR>2;A!+$R&2(=74$98?K7#7&BZQJ-AXYTV*.>"74;Q9[5V $<J!8P5R#QNV
M,,'!P:Z"4W6LZOI-^VGWUK]@BG>=)8<$.\>T(O\ ?Y).1D<#F@#47QAH<\*S
M+>'R6B257:-E5E<X7!(Y)/\ ".?:I8O%>D31SR+<,&MY1!+$\;+(LAZ+LQNR
M<<<<UQJ6&KQ>!?#!M-.E>[T>:)Y[*4;3*%!!*\X)'4<X)%6=8&I:E%;:O9>&
MG46M\EP\%R%CGN4,4D;$@'[R^9E03U]* -]O&>AI$MPURZ@W0LRC(RLLY.-K
M _=^IXI9/'/AY()KA[TK';MME+1.I0^I!&0/]HX'O7):G8-=VMK=:?X7N[-3
MK-E<RB1/W[K&V9'<;C@!1P2<FI=3L;V27XA>7I=ZXU&S2*U*PG]^XC=/E^A9
M>>.,F@#L[_Q+I.G*)[BY.T1"5_+4N4C/\; 9(7D<U!<>,=!LIIHY+MC)%$LS
MJD3N2C<J0 #NR.>,UQPLKBQOY7U7P[?ZG8WME;J!;+F2.1(U5HW7</E)!//&
M>M6M-@N[3QI?7DNE74$)T>&W0Q0ED61&8E%/\1 (Z>E '32^*[%=7TZQC,LG
MV^$W$;K&2 O&#QZY_"K>JW;6USIX6Z6W::X2/#1;_,4]4]B?7VKC= M[[3SX
M/>:TO$%GIGV*X1HL-'(%7EO1?E//?C&:Z+Q9&\G]C2113R"'489G\I"VU!G)
M..@YH LW7B[0[6:9);Y?,MYE@E158E'/3/' ]^@]:DO_ !+I.FSR175UL=8O
M.? +;8_[QQT'O7#^(M+N[JQ\>106-V]WJ<D?V1DB.9%6"-.,\8W*_/O6A;7]
MU8:EJ,$^B7LGVZWC:"Y6+A<1*IB<D@+@AB,]<F@#J+7Q+I-],B6ERTKO:"[4
M"-QNA(!##(P>H]^:@_MN&X_L=[#4(DAO)FVI)$S-.JJQ(4\;3QG)'0>M<CX=
MCGLI_"&K-;W4UL_AM+0K;Q[]CDQ.I;L!@-R3C@5'IMM=16_@J2XTR\22SDG>
MY7RB3"K(P!/IR1_]:@#JI/B!X<BGN(9+TJUNQ20^6VP$-MQNQ@G<0.O4CUK:
M&J6@U1-,$I^V/%YPC*M]SN<XP*Y2PT"/5O#OB+3-2@FM8]1U"X92\95B&(99
M #[X_*K'@BUO)H?[6U09O_+^Q!MVX,L3;&<''1V4M^- &Y?7QM]7M85O$3='
M([V^S<\@ &".> IZ^N15>W\5:'=7,$,-\KO<LR0[02'89R,XP#P>#S@&J>L.
MR>-]$G$-RT,,5RLTB1,R*7$>W)QC^ USUK!/%I&@(+*]C>'Q!-<SH8&W"-GF
M(=AC@$.G/2@#K;/Q1IUQ_:A:5HH].<K*\RE H &3N/'7/?M5K3=?TS59YH+.
MZ$D\.#)&5964'H<, <'UKA-7L-6NM-\26%G9W$EPVJB]CW)MBFB C.S>< D[
M6& :W[(#4O'%KJEM9SQ1PZ?);W$D\31EF9XRB@$<[</G'0T :^I^)-(TB<6]
MY?1QS+&93'NRP0'&2HYQ^%2#7-,?2K?4([D/:7 S&\?SEN_ &2>_2N8U:XMK
M+XK:9/<"0D:9/M94+;/G&3@50L]/NM'DT349+:X2Q2YOB8A&6>V$S$QL5&3\
MH^4]<!S0!VXU[3!I\=XDYDB=S&@1&+LPSD;<9SP<Y'&.:CG\3Z5;V4-Y)<@0
M3!BC!3R%^\Q&,@#N3ZUQXLS)!=3K]LL(KW6)+JSO+:+<\"F%5+%64X#L),AA
M_'V-077]H7.CZ<TS2P:Q!%>+'>1VI:&?E?DECQC;*,,1P05&.E '6S:PTNJB
MWLK^V;.G-=+!C<Y.Y=KDYX7G&,<YZ\5G^#?'5GXATC2_M=U;Q:M>P>=]G7Y0
M.O"Y// Z9S63IPNAXHT=Y=/EMA_PCIAFCCBQ#'-NC81@].,,/H!5+PUID\W@
MWPIHXL)X=2TZYBDN/,A($(1BSG>>,,. 5)SF@#N=.UEBFJRZA+%'%9W;0!A\
MHVA5.3GN2U7[#5+/54DDLIUE$4ACD R"K#J"#R#]:X>^-Q-IVM2VMI=SI;:W
M#<RVRH5>:)?++;.A)^7(P>JBN@\,O:W$UW>V>G7MJEQY;227@=))G V$E6.<
M *@!^OI0!.VOV46I:E%<:A:>391+)+AB&ASG.\GCGC'?@U(WBK0UE:%]2MUD
M$/GE2Q!,>,[@,<\$=/6N5U<JU]XSB2"<F72UA0B,XD?9(" >_P!Y?SK-CC \
M1_#US9S&WLK"59W,+$1.8TVYXP.5/7O0!WT7B31I;2UNH]0@:&Y)6!]^-Q&<
M]>>Q^F*(/$VB7.GK?0:G:R6K2B)9$F!!<D +]<GI7 ;HEL[226.YBB_X2N1U
M5H6R8V$K*=I&2#G/3I4NJV[QMXBO$M&:RN]1TTP"-&S(T;Q^:V,=,#KWP: .
M[;Q)I B6<7\#0EVC+K("H((#9.>,$@'TR*+KQ'HVGO(+G4K6,K$)R&G7[AX!
MZ]">GK6'JR0VNH7\<L<OV6\TXI;A(S@R9DWJ3CJP=",GG;[5R'AFS;1?$6@V
MVO0'S[?PN(I%)W>6?.QC(.,!<C/O0!Z==:[IEM9P74U["MO/\R2"0'</;U'T
MIKZ]I"!&_M"V&^(S+F8 %!U;KTX/->:65BFA/HT][I]ZNC!+R*$VR.S68DN&
M:,$+\P#1E0>O*@5H6NG64?BOPLMOH]Q9Z<MM=Q11RJV8PWW-P/W<C=P>F<4
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M\)N=@HW9P!S[U87:22 ,^OM7F?\ :FL:)\-KS4K>]1[E-1N5+W*!@%^ULA&
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M\0VBZO?::\KHUK$LC2&)MHW;N^,<!: "^\-V-[?7-RSS1&ZB6*[$,I19U&0
MWX$C(P<<9J2#0K&+68M30,+I+<6P"MA!&#D#%<]JWC'^SM+\/^5?+<2:K)#&
MMZL!PT;*6,@3'!(7IVST.,5LZ5>^7>ZA%<ZTEX;8*\BB'R_(3!(WG/4X.3QT
MZ"@"GXZT^XU6VTNU@MIYE2_BGE: X9$4\GZX/%:":!I\UI>K<)+*]\JI/),^
M9"%SMP1TP3D8Q@\T^U\3Z/>I.\%]&1;Q":8OE-D9S\WS ?+\IYZ<5!=>*=-A
MTK4KR&;S38Q^8\91E8$@E<@@'!QU^M #SX6L)/M)N);J::XB$+2R2_.$4Y4
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M-N,G)!]?:MH:WI1BBE&I6GES,5B?SEVN1U"G/)X[57^W31ZXZ27VGBR%OO\
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MWIV8\ZC9#?R,SJ.W&.: ,-/!$%O9Z>MG>R6UU8W<ETDT<:8+2!A( IX52&.
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MQZUZ+XA<2>$;[RX6D:>U=(XPC$DLI 7 &><XZ5L[$9&. 0>3P.:2/H5;GUH
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MZ\>W45U]I8KI^E0Z?:2,!;VZ01/)\Y 5< GID_SKG]+\)W%@NBQB\1DT=62
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MI-0M+#28=%N/.ALK"_F\R\N7V['E\@JA?=\H&><^H% '?-/ $,[R((DR"Q/
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MR;C\DD@&2>?N@=: /3F*JRY90W3YCC-5KR]:*TN7MH1<7$,;,L!<*7(' !/
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M_0+72M*CM9]4B=K>UW[4MT7DL2%/'/IU- '<(JKP !@=J"$8E<\X(/XUQ?\
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MR\CG  ]S5;3?$&D:M,(K#4(+B79O*(_S!>S8ZX]Z -6D(I:C=U5"6("=VS0
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MYI H"Y8XQ4;W,:S+"K*TS#=L##./7'I0!+FE%,88)-.Z8H =1110 AI:*.E
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M+-)N]1729+.))38ZA%=.C-M+*IY /3/UXK)U+P[J>I7%]J5N5M)9)[21;=Y
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MV:&YB)DC8Q2+T8EN0PZ[&Z\&M^._M;KQ;J-]:Q7/V=]$ ,SP.JEE=L@Y'4#
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M$H."><T =3?^&=(U"\DOIXG%P0 \D<SQE@/[VQAG'OTIVE:AHS*VFZ9=02-
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M0!TQ 0$TBH%)*GACDC-<RGB];;[>M[I\L9MA$8S"_FK<>80JJC$+\VX[2O\
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M3)&,="".1@XK1PP(YXH/;VH Y>/P3:+8K'<WE[=7*S13+=RRYEB,>=@4@
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M4M(* %J&3[\?UJ8]*AE^_']: )J*!THH **** "BBB@ HHHH **** "BBB@
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M'\%QQ6M/IFI76K:Y+)IT$UOJ,%NB03L"LH0G>K=1@AC0!U5I?I>-*BQRHT9
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MA0#\[?PYR /6KQ;+ ?-R<'BN!M=;:\U7PA+IE[>S:?=V5VS1S-\\K(J[2_\
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MH^@%3[?EQF@# Q0!3M],L[>X,\=G;1S'/[Q(@&Y]Q2SZ?;74RO-;0R,G :1
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M[B?J: *$>CV%II[V,5I";1O^7=HP8_4_+TZTZTTFRT[+6UM%&[D;W1 "P P
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MDP,;$C^$]QQ4-YJ\[C2KG2(H;^PNIP)I(Y,A8S_&N =PSSU% &VY4,,GFGD
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MJ6+,B"]M?-=BH7S1DD=0/>L[Q3XBM?#VCW=])Y,LUO"TR6[3*C2!1SMSU/%
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M0:2@ I:.]% !1110 4@I:04 *>E03=8_K4YZ5!+UC^M $PZ"BE'044 %%%%
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M0P4*$W$G"CL!G 'H!7-6G@.^LI]&<ZK'(=-MYK54%H%#1.,#)W?>R%R?;H*
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MCU/UH [*.1S$#(H63'S*#D _7O4G:JMG%<+;HUT8_/(_>"($)GV!YQ5K/%
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M6OQ7^DVQ=-?@^R3!5VX<#<DI![!!)D=:ZZ2TCLM">W@1?+AM#%&F.,!< 8H
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M1_$NF6LSI#;?V9+%(,RRPD8A.3SN,BQC)_OUT6D7ECHEMI>BW5U''J5T&E6
M\-(22SD#V)- &[-=6\+^7+*JMC.">W/^!I?M$;1!U;*MPI]:YG6KFWM/'>AW
M%W-%!";.\B+RX 9LPLHR?97('L:Y'0QI\_ASPWYTT4D2:S=K)M7&%9IL C'
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M#36M[#HYM/*0[<3QH=_ [B3*_A5B--WBWX?3([2HFGW8\PY)),:$9/OM/Y4
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ML3Q*%B7>P8$'+]<<Y XYYJU<:1:72PF:W@FDA;=&\L88I_ND]*O!1NW=Z,T
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M'3]*M-*MS;V4 AC:1Y64$G+,Q9C^))-:(Z4=12T %%%% "&@4&@4 +24M)0
M4444 **#0*#0 44E+0 4444 %(*4T@H 4]*@EZQ_6IZ@FZQ_6@"<=!10.E%
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M*4,"2 >E<Y9^,+"XU%;.2&6UEFM6NX?/V?O8EQDC:QQC(.#@T^P\56=Y=6<
MMKB%K^%I[-I54"Y50"=N&)4X(.& .,^E &^3D<4HQ^-8$'B>UDBTJ813!-4<
MI!D 8;!.&YXX!]>E26/B"+4YHEM[:989G=8KEMNQRF=V #GL<9 S0!N44W.,
M'/6G4 %%%% "9YI:;WIU "$4M%% !1110 49I"::.M #Z**3/-  >*7K110
M4A%+24 *.:*04N: "DHH% "XQ1110 8HHHH ***2@!:0C-+10 @4"CJ.:6B@
M!A6GTAH!H #3>AIQHH 6BBDH 6BDR:2@!U%%(: %H(R,4@I: &_=I>M!I: "
MD[T4=Z %I#ZTM(>E !UI::*=0 444E "#[YH89(H[TZ@!!2T44 (: !UIK4Y
M:  ]*0#-.HH ***;0 ZBDHH #0*6DH 6DHI: $HI:*  4&BDH *6DI: "BBB
M@ -(*4T@H 6H9NL?UJ:H9>L?UH F'2B@=** "BBB@ HHHH **** "BBB@ HH
MHH **** "D(Y!]*6B@#GO$VC3ZQI]N+=D%Q:W<5W&'Z.48-MSVSC&:A$>IQW
MFJZO%IT8G:TC@M;=Y@#(5+DEF ( RPQUZ'I71KN.<'FG(#CF@".!W:*,R !R
MH+ =,XJ4=*:1@C':G&@ - I:* &\!N>]>;:I]DUJS\10&ZLK6XE=9["9[Z$A
M9T4;#PQ(^91GV)KTE^F?2JHTVS"JHM;? .>8P: /-)].%GXB\,7-O-9W*VD]
MQ=W\OVZ)=TLX&\J"V2-V2!Z8':K\Z1R7?B82V]A/;:K=0.L<U[$5FB5$23^+
MY3A6(]\5WITRR(3-K%A#D?(*:=*L61D:T@*L<D>6.: /,QI=Y9V=K+I^HP3?
MV3J?VC3[*_OU=FMO*V&/>"<'<6*YS@<9K1UU-3U>/3-6']D&\L;AI$TR2[1D
MDC9"C OT#_-D'&!MZ\UW/]BZ<-H6TA"@8V[!@TAT732^5LK<$?\ 3(4 <3J@
MGOM.TN06FG6TD&K0WAMK>ZB&Q(\9#-D!G//3CI1JLVI+>>)+S1;BQM[B]BMH
M[:66\B^;9D.!R=I(8X)[UV_]BZ;NS]BM_P#OV*%T7350(+"U* YP85/]* /-
MKNVN)+/Q*EG%91KJFD)9QAM1C9A*!+DN2>2?-Z@G[IK5U)(]>U%A)+!:V<FC
M26AE^UQ'RIF92,A7R0-N*[%M"TEMZMIMD0_K O\ A3_['TPE2=/M#M&!^X7_
M  H X6V2?4-)OK'4K+1=)9[.6V:Z@NXW:0LA4;, %1WY/X5:A$FH7GAU[YX+
M1]+!DN)Q<(R3/Y31XC 8D+\Q.2!C XKKI-$TS9M73K-2?2!?\*<NCZ<N#'86
MB-C&Y(5!&>N"!0!YI&NJ>3X=M#;6L<>DWQDDF>_A EBVL-R@$D=>AY_G6KH%
MDMGXAAO;55T^2Y:1]2BCND>"Y8YVLB!SM<M@D@ 8SGG%=K_86DY0C3+/*]#Y
M"Y'Z4Y-&TV.<3QV%M'*#D.D2JP_$"@!-(N+N[TZ&:]M#:3E</ 7#;3]1UJ_3
M2/F%.H *#1FDH 3O3J;CFG4 (:44A&:0&@!U%(3BCK0 "D YI0*6@ I.]+10
M 444&@ HI*6@!*#2FF]: %%+2 4M !110: "BDHH 4T@HZT 4 +1110 4444
M (>E(*4]*3% #J2BCI0 M&*** $Q0*7.:2@!:0TM!H 2EI*44 (:444E "T4
M44 %(:0THH !0>E+2-TH 133J8O6GT -/6G#I3<9-+TH *6D!S2T -(IPHHH
M **** "DI:2@ HI:0T **#24IH 2EI*6@ HHHH #24II* #O2TE+0 4444 !
MI!2FD% "U#+U3ZU-44O5/K0!*.E%)VHH 6BBB@ HHHH **** "BBB@ HHHH
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M &YH!YI.]*!SF@!U&:0@'@TAQC!/2@!W6DR*0<<>M!0&@!2?UH Q1@<>U+0
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M?-M%!OW[24C Y[*.3FKM[XLNFTJ*>QLF:Y;5%TV2(NORL'PQ!S@@@$ ^^>*
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MKLU98U4$\'O[T1A5D;:V<G)]J .5BT2]3QEJ.M@1M%<Z=':1KYQ!+*6)S\O
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ML$]I)(VX*T:H &7'3*>_6NRG;$#E5+'!PHP"?SK*\.ZW%X@T6WU:**2)+@,
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M I*6DH 7O4$_#QGT-3]Z@N.J?6@"8=**%^Z** %HHHH **** "BBB@ HHHH
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MH9N98A[U-WJ"?AXSWS0!,**!THH 6BBB@ HHHH **** "BBB@ HHHH ****
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MU'2;[S+4S6$\LIB *KB2-D W <[<YS@9]JO>)+*_U#2XX+&41N94,J^8T>]
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M* "BBB@ I:2EH **** "DI:2@!>]0S<RQ#WJ;O4,O^NB^M $HHH%% "T444
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M''Z5GP:!I5O>M>1Z79)=%MQG6! Y/KG&<UI@Y%&3GI0 W+;6.WGM[TC+C!"
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M !1110 4444 %+24M !1110 4E+24 +WJ&7_ %T7UJ;O4,O^NB^M $HHH%%
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M "BBD- "YHIII1TH 6D^M&:&H 6BFYXI0<T +1110 4WJ:=3%/S4 . I:**
M$)Q3:<PR.*3'% "BEH%% !2&EIK4 '6G4U13J "BBB@ HHHH ** <T4 %-/6
ME[T&@ %+2"@G% "&@4$4H% "$4 TZF'D\4 /I.]+29P: %I#2T4 )24M&.:
M%HI,X.*6@ HHS10 4UNM.IC=: '"@4 TM !24M-S\V* %"BC%*:* $I12'TH
M' H 6BFIWIU !111GM0 4G>EIH.30 ZBBB@ HIN<G%.H 2@8H-( =U #J2EH
MH 2EI,YI: "DHHH *6DHH ,44M)0 4444 %%%% !2TE+0 4444 %)2TE "]Z
MAE_UT7UJ;O4,O^NB^M $HHH%% "T444 %%%% !1110 4444 %%%% !28I:*
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M5KZ1EMY'MF22X16\J)FPKN.@)[<\52MM8!2PM[DPIJ-S$THMXWW+P,GGT]Z
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M1:E_PCK&R>14U!'"A"=BF-P<XZ#H.>*X_5?#T)3X@VB:/)(CJ'TR$6SF,RM
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MBSM@#$+6+RC\Q78,9]<5(\:-$T<BAD/56Y##WH X"VM["Z\96EO#=RBS.CG
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MW!9 H,AW<XP>!CDDUSNKZ2- \/>'] ?5Q"MK(THOY;4M'P&(#J&R,EL9SV%
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M;IMA8S20S1VNHS73$J?WD<BR KUX.93S[=*L:1X>\1:1:VM@^N136-EM$&V
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M$ATF3S5E@5@;AU&%9@?NGN0"<D]J -_4]6BTR2U0Q2RRW,GEQK&OH,DDD@*
M 3DFL=?'6D2:?IUXOVEXKZ\-C&%A)/G D%3SQT/<YQQFI?$NB:CJEQIT^GW,
M %G*SR6URK&*8%< ';W4_,/<5S=AX&UNPTW2K1[RRG%EK;:FQPZF127.#P?F
M_>'VX'6@#KM"UT:N;R)X)K>ZM)C'/#,@5ER,J>"005(/!K9R*PM(TV]M-8UJ
M\N'A:.]E22/R]VX!4"8;( _A!X]:W .AH =1110 E+VI*7M0 E%%% !1110
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M'!P?44NT4F0O% !M!4 \XYI0<_6@ #I0% .: # SG'-'0'VI<4A - #%55;
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M **** "BBB@!",T 4M% !1110 4444 )CFEHHH **** "BBB@ HHHH ****
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MI+<Y/7- '*^'=$N+;77OW+K9P6*6%JDIS(55B2S>HZ =3USUKK ,"F!/F(Y
MSFI* "BBB@ HHHH **** "BBB@ HHHH **** "BC-&: "BC-% !111F@ HHS
M1F@ HHS10 449HS0 449I,T +11FC- !11FC- !11FC- !129I<T %%&:* "
M@T4&@!**** %I*6DH **** "BBB@ I:2EH **** "DI:04 +4$W^LA_WC_(U
M/4$W^L@_WC_(T 3=!10>E% "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 E%*:2@!:2EI* "BEHH 2BEHH 2B@4M "44M% "4M%% !1110
M 4444 %!HHH 2E%)2T %%%% !24M% "4444 +1110 4444 %%%% !1110 G\
M7X4M%% !1110 @ZTM%)F@!:*2EH **,T4 %%%% !1110 4444 %%%% !1110
M E%+10 E+110 4E+2=Z "C%+10 F*6BB@ HHHH 2BEI* "BEHH 2C%+10 4E
M+0: $HI110 E+110 4&B@T )1110 M)2TE !1110 4444 %+24M !1110 4E
M+24 +WJ&7_6Q?[Q_E4W>H9?];%_O'^5 $O444#I10 M%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 !I*6B@ I**6@ HI** %HI** %%%%)0
M M%)10 M%)10 M%)10 M%)10 M%)10 44M)0 M%)10 M%)2T !I*6B@ HI**
M %HI** %HI** %HI** %I,TM-[T .HH%% !28I:* $HI:2@ I:2B@!:*2B@!
M:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:3O110 M%)10 M%)10 M%)10
M M)12T %%)10 M%)10 M!I** %%%)10 M%)10 M!I** "BEHH *2BB@ HHHH
M **** "EI*6@ HHHH *2EI* %[U!-_K(O]X_RJ?O4,O^LB_WC_*@"4=**!TH
MH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #O1124 %+V
MHI* "BEHH 2BEHH #244M "44M% "44M% "44M% "44M% "4444 +24M)0 4
M444 %+24M !0:*#0 E%%% !112B@!**#10 4444 **3%*** "BBB@ HHHH *
M2EI* "BBB@ HHHH **** "BBB@ HHHH ***6@!**6B@!**6B@!*7M124 %%+
M10 E%+10 E%+10 E+124 %%+10 E%+10 E I:* $-%%+0 E%+10 E***2@!:
M*2B@ HHHH **** "BBB@ I:2EH **** "D%+2"@!:BD_UD7^\?Y5+4;#]Y%]
M3_*@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*
M*6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI:* "DHI: $
MHI:* $I:*2@!:2B@4 %%+10 E+10: "DI110 E%+10 44AI: "BDHH 6BDHH
M 6DHI: $HI:* $HI:* $HI:* $HI:* $HI:* $HI:2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
LBB@ HHHH **** "EI*6@ HHHH *!10*  ]*81\R'TI],]: 'BB@=** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex10-2_007.jpg
<TEXT>
begin 644 ex10-2_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M- !11FC- !11FC- !11FC- !11FC- !11FC- !24M)0 4444 %%%% !1110
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M )12XHQ0 E%+BC% "44N*,4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N
M*,4 )11BEQ0 E%+BC% "44N*,4 )12XHH 2BEHH 2BEHH 0T44M "44M%  *
M*** $H-+24  I:04M "9HS1CFD;@B@!<T&EQ10 "BDSBC(QF@!:0T!@:*  4
MM'2D) H 6BFE^*:'W4 24AI%.2:<: $HHI: "BBB@ -)2TE "]Z*.]% !111
M0 4444 ,/6FM]^.G'K36_P!9'0!+1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !0:** "BBB@ HHHH **** "BBB@ H
MHHH **** "BCO10 4444 %%%% !1110 4444 %%%% !1110 444E "T449H
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M **** %HHHH **2EH **** "D%+2"@!:@E_U\7UJ>H)?]="?>@"8]**&Z44
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M51@D'.1WQZXJO>>,-)TG3M5FN/M"R:8%:[A$>9%5AD-QD$8[@_7% '1H7/\
M.GEO3K6##XILI5N6CBN=T+1*(W0*TGFD",H&(X)SUQT-.;Q!;Q64AEBNDN!,
M(/),?[QI"> H!P?7.<8YSB@#;#C'/7IBFLQ*9'<YQWKA?%?B4-X)\1_8Y;FV
MU338091DI+&QP0P(ZJ1R"#S6O!J-FOB6RM3=7CZE_91D%OR8I(]R_.?]H$@9
M]S0!TA?:,-U/2D\S(P.O:N)U+7CJ>H^';BQEO8[:74'ARHQ%<*$?)]2,KQG
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MEP)"H+ = >X'M3+N:"Q@DNIYEA@C!DD=N@'O31J%O]@2_9P+9D$@D/0*1G-
M%K!QUI0#4%G=0WMM#=V\RRV]Q&LD3KT92,@C\#3I-RD-O&,]* )J**1C0 M)
M2 YIU "44M% !10:2@!:*.]% !1110 4@I:04 +4$WWX/]_^AJ>H)OOP?[_]
M#0!,>E%!Z44 +1110 4444 %%%% !1110 4444 %%%% !3&/S #K3ZC88;-
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M3X[7S(4FN[=G\F5HQF%6<ML0]0HS@#/0#.:OG0=(.J?V@VFVQO3S]I,0W_\
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M&G3&<^]=G<Z393W*W<MLDER@PLAZ@=#59/#^D.B(;"+RXY?.1"#\LG4M]<T
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M#H=I?PV\3:0+X/Y(=E82JI&">01D>V:W;WPEH]_+<33VK///;?9Y09GVNF,
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M2"*1$F"A96D7?\Y)!5<$#CG.>>U0ZMJ^O;]:-G>6<,=KID=]$1$9<[A(<9R
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M#/C^$8/Z4)X.T@6;PR).\;W'VMMUP^X2]-P(.1QQQVK5OK"RU*Q-I?0+/ P
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M[O?% '0]B/2AONT*""<\TZ@!B"GT@&*6@ HHS10 &DI:2@!>]%'>B@ HHHH
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MC:!-2MFB^R"06:[3)]__ %N<YVD$#ICWKAIM,UE;)MTFK275J\W]FWR#$CJ
MGR3KC#!CQ\V/]6.15RUL]1A\9P:CK%MY:+X;-M?7* )&LI<.54], !N1Q^5
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MHS29H ",T#I2!J >: '4444 %%%% !12,VT9-"G<,T +3>].I,4 +129Q1G
MS0 M(1F@,&Z4M #-O-/'2D!R:"><4 +28I:* $Q2T$XHH *0C(H!I0<T (%Q
M13&D"G%.#9YH =BBD!S2T -4;32D9%!%-#=J %48IU)FEH 0#%+110 W'-.Q
MQ110 PKFG$<4M% !2$9%+10 BC H  .:6D)P,T +CFBDSQ2;J %-&* V32T
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M<H/-CV[L=QZCWINLZE'I&ES:E.6\BV0R2%5SP.M &@I!SBG5&KJ^W!P?2I*
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M.!7477AK1[ZX^U7.G12RM%Y+,XYV=-OTI\6@Z=#=1W8LXA/"ABC=5QMC/\(
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M !1110 4444 %(*6D% !WJ*7_61?[_\ 2I>]12_ZR+_?_I0!***!10 4444
M%%%% !1110 4HI*44 )2TE+0 4"B@4 %(:6D- '+>(/$5YIGB/1=,M+>.5M2
M:9,NQ&SRT+YX^G^>HRK7QS>-:);3102:M)J\NE1^6"L99!EI,<G:!VSGWK=U
MKP_<:CK^CZG;W<</]FO(_EO%N\S>I0C.1C@^AK)3P'+LGDFOU-VNIMJMI-'%
M@12-]Y2"?F!Z?C0 FJ>+]2TNRUL/;0276G"%P4<A98I.CJ"#TPW'MUK3M?$4
M\&MZC8ZLUK##;6<5XLJ,?DC<NI#D\9!3.1C@U!J'A6]U.PU,/?PI<ZBD4;,L
M/RQHA)"@9R<Y/)/?IQS>31)I/$5SJTMQ#)'-9I9M;F'*D*S-G.>>7/&* ,VX
M\7/=:I8V.AR6ETM]#+)#<&7,99-O!P#Q\W4'\JIZ5XXN]0.E)-:I;W$NIS:9
M>1LY.V2.-I R\<@@#CC[U1:TBVOQ)\-0:?):6TD=G=8B*80YV8&!CD_TJZ/
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MA'-K:&PD9=+MHKG>'XF1P2-O'7CI^M0KX\:ZN$M=.T\W-Z;"*^:W,NQF209
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MU[K=M>P9FC&$0P$Y^?@_N6X_VA0!TD/BFPG_ +2-PEQ9G3XQ-*+A I$9S\V
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M^8N3P1CCCCUK&T"[QI'A/4WO9I;V6]^RL[S-M>(I(,%<[>RG..H% 'I4DBD
M*PW9[=N]4[?4V>YNA/9O!%$ZK'*75O-!'4 $D<Y&#@\9KSN*ZN$U[2KNRDE:
M&?5KF'[1++EY$VOE"O9%., ^@X%4M6OKB'3/'834+I&M=2M4MY1*VY ?*#<Y
MY'S-QTH ]>EGCABDEE9$C09=F. !ZU"6M=1LED*QR12#<HD&0??%>=ZY;I;-
MXMTNVFF>&7P]]M >9WW39F#,-Q."=J\#C@5-XADA&FK91W4HEM]#DG**^Q(L
MX D!')<$8 'KSVR =UYIM;V"TALE6U=&9I4VA5(Z#&<\]<@=JO C;@;>G !K
MSO2KF6ZU/PJ9+^9A>Z&SSKY[!=P2/YNO#98\C!ZU5T>9H].\&W7]IW;SW.I/
M#(7G<AT\N;Y2I.#\RJ<XSG% 'I0D"@# W'HO?\JHZQK46D+;&2(R&>XCMU"L
M!M9V"@G/;)[5QVBRSZHT6L3:N+>:/4Y(9$^8NF96C$)&[&#D8^7CAO>JLFW5
M?#NG:O/.[7<VNQNPEE8",+<;?+"YP  .F/?K0!Z%J%Y+::7+=16<MW*B%EMX
M2-[GT&2!FI4G66&-I8S&SH'*-R5]CCBL#QPTB_#_ %B6WNGMY8K&26.2*0H=
MRH2.17.6S?VQXQMM,NK^[^Q/X>AN)(X[EXPS>;@_=(QP!TQ[YH ]'1]Q88Q@
MXICLHD!.!C)R3@5@^!K^34O!NF7$KL\AA7<[')8C@Y)KE]/FE1[FRU+[2;F>
MRN)+>]CN3);WZYW!]N?E=1CC XSVH ]!AOK>>&.XC<&.4 HYXR#@@_J*9;7K
MSW-XCVSPI;R>6&<@^:-H;<,'@<D<XZ5YWI=FE[J>C:7]ONXK:?PZLC)'.ZXE
M$D6&X/!QQ]..E37VISP6'B/%_,MN-?@MVG\PEH(66#?C/W0,L,C&,DT =_>Z
MG::?9R7EQ*%@C^\_:K:.LB!EY!Z5YCXUL(K3P]K$$6J33QSM:R):O(62V595
MW-N/.6SG!/;TKL?$E]/I/@[5+K34\Z>WM))(EW$G(4D>Y- &V2C#@YP<?C[T
M>8H+>J#D#H*\_EO'T?05\36.J7%].^F,RV$CEEN9@N\R8SD$8(P!BI[8W"?\
M(A<6NI74\>HJR7CR.3YH:W,@D()PI!3M_>H [D2HSA,')&>17.WWBN&SN[JW
MM=+OM0>V9!<"T1692XRH )!/7G'2N9L[N[M;+PUJ$NK7<\]QJLULX:4['C#2
MC[HX. J\G)IUDB6VI>/9X)IHI+5@T3&9F /DYY!)!Y]>G:@#O[6Z%QIT5W+
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M25C9EW L1T7'\6,9/IS2VOBRUNIK2-;>XC-ZCO:-(F!<;020.>#@9 .,@9H
ML?\ "+Z.T%G#]C"QV:[+;9*ZF)<8VJ0<XQQC.,5&_A'0)--;3Y+"(VKS>>8]
MQ&9#GYL@YSR:+?Q/9WFBIJ,44_ER71LU39A_,\PQD$=L,"#Z8JC8ZMI=I>^(
M;HSW?^C3I]H27<RHY4 "-??(Z#D^O6@#1'AC2HY;%X[? LI&D@7S&^1V!!;K
MR3N.<]<TV?PKHMUIMW82V*O;W<WG3*TK$L_ WYSD-P.0:P(M1:7Q5X@-S)J4
M-G'I4$K6\A(,)9Y0S(!D9(0<C/(/TJQI7B[2;+3=$LXI;^Y:]L_.MC*ADFE1
M0,DXX+=._>@#7;PIH[:*VDR68EM'D\Q@\K%BV<[MV=V[WSFJ.I>#[.;3K.QL
MX?)6&Z6X%QYS%T8$$N><NQQCYB?QZ5:C\6V$^CVU^D=P#=3-;0V[1XE,JE@R
M%<\,-C9R<#:>:L:1K]OK32K#'-&8G,<D<L14JP[$]"?H30!-J>D6>M62V]\A
M=$D252&*E64Y!!!!!X[55A\)Z-$MQLMWQ<3)<2#SY#F12"&^]P?E&<=<<YI9
M/$=J+TVZQS.%N%M7D"?(LC $ G\1[>^>*1?$UD;&"\Q((9KP67*GY)?,,>#_
M ,"XSTH 6X\+:3<W%]-/;&3[;&([@-,^UU'08S@8[8'%,T[PGI6F:C#?P)*U
MU!"8(GDN9)"L9.=OS,<CI^5.F\3V,5X\#K/Y:3)!+,(B8T=R @+>Y91QG&><
M5AV?B*'0[K7DO[J<PQZJD$+LI<0J\,)&<<*NYSS[]Z .DU+1;/4IX[BX1S(L
M;0Y61E^5L9!P1GIWZ9XJI#X2TRW;3#")8X],XM(Q.Y6,;2N.3S\I*\YXIWB6
M[MK?0WN+VXNK15=-K6XW2!R<  8/4_Y%17WC#2M.N+VVFE8SV40EGCCB=MB$
M$YX!X ')H AMO ^B6=SI\]M:&-M.+FV"SOA _5!S]W@?+TXZ5I:+H.GZ%#Y.
MG1M'$23L\QG"Y.<+DG:.>@P*Y[6]::ZUOP_8VLEREKJ22S/<6RMEXUC#+L(!
MP26!]<"M"TUVWTNUCLKR_ENGAF6TEU&2':K3'& V!MR<@<<9..O% %J\\*Z7
M>27S212?Z><SA9G4,=H7( . 2% )&,XJ5O#FGRZF=0E1Y9_LQM#YDKL&B/)4
M@G!Z YZU&_BK2UOKFR:9Q<6TJ0RIY+G:S $9.,8Y'/3WJG:^.M%NOLTD4TC6
M]WN\J<PNJ$@$[=Q &XA3\N<^U %K0_"VFZ$X:QA:-0,)&9G=8AZ(&)"CZ 5;
MU71K;68XA<HRR0/OAFC<H\38QE2.AQQ5-?%VG/IL]Z#,HAG%LT4D+I)YQQB/
M80&R0RD<=Q4-YXLMTT8W<$,SN+I;5X]C!D8D=<CC@C'KD4 7;'0K:VN7NGEF
MNKMHS%]IN)-SJA()48  &0#P!S4,_A:PG:UP]S$UK+)-$Z7#[@SYW?,23W/'
M2H(M1L3XQFC.IW G^PBX-B\96-4S@R9(^]R!CMZ5+9^+M)U"[@MXIV5IXC-
M7B<+.@')1B,''L: 'Q^%;".TOHI3/<27R[)YY9CYK+V&X8P!SC&.M:%[817N
MF2V$JLT,\30R#<0=K#!YZY]ZR[;QEHE]/96]O?!WOF9+=A$X5F4$E<D8#8!.
M"<\=*LZ_JZZ/9P,R2.TTT<"A$)Y=PO) P.O?KVH A_X1>QN8+Q;]9+YKJ$6\
MGVA\YC!R$X XSSGKGO44/@W25TRZL)5N+F*YB\B0W-T\K!,Y"AF.0,\\=ZLW
M?B6PL-QN'DPL7GRXA<F&,]&< 97H>N.AK0-W";,W4;B2$IO#1@OD8SD 9S^%
M &1#X/TV+2[K3Y#=745S%Y3R75T\DFP=%#$Y '48IJ>$;"(2B2:\G>>U-G)+
M/<NSM&2QY.1SECT%<O=^*;F]M/">I0336MO=ZHB2HR9$B.K.!DCD8'\)ZFNB
MU+7]-U#P[>W*:I+8002".2X,!#Q-@'!1USR".W>@"Q>^%;6_TJTTR>21[>TD
M26(%CP5^Z,]\8[]>].E\+V5SJ%]>LTZRWT0BF03-L("[<[,XSCC/M4EYXGTK
M3[M[.2Y'GQF)3&JEB/,)"$X!P,@\GCCFN>\1>)D.IZ)#I^HL"^JQ6TI2([)O
MG(=-Q4C([X(H V)?"6G7$<'F&X:2UB\A9(YV1I(O^>3X/S)P.OI2R^$K*>9O
M,EN?)>9+EH!+B/S$Q@XQGL.,X..E:6HZO9:.D37D@C$K%$_VFP3@>^ 3^%9\
M7C+1+FQM+VWOEDANIO(CVQL6:3G*;<;MW!XQGB@"YKFAV^O6AM+MY/()!9$<
MKN(]P<UGWW@ZQU+[:UU+<XNU19MD[)NV?=;C W>_Z59/B[0_L4%W_:$?DSW'
MV:,A2<R9VE<8R"#US56Q\7V.JZFEO:>:T3Q%O-\IMN=Y49XXZ'K_ $H N7OA
MVRU*\TF[N!YLNF.TD#L<G++C.?R/X"HX/"FGP:9J5B@/DZA+)+-VR9/O54TS
M7K"TT2.Z?6&O89;N6..0P$,S>8P\M549."-HP"3CO5J+Q;I<EO#/%<":*>=H
M(_+4ES(,Y39][(P<\<8H M6.BP6=XUX\TMS<B%8!+,V2$4D@?F<D]36K5"TU
M"'4K&.[MF+12#*L01D>N#R/H:NH<J* '4AH.:2@!1124M !12T4 %%)10 M)
M2B@T )2TE+0 4444 %(*6D% !WJ*?K'_ +P%2]ZBGZQ_[X_G0!+VHI>U% "4
M444 %%%% !1110 4HI*44 )2TE+0 4444 %!Z44AX% ')Z_HEY?^)_#VJ6SQ
M;=-GED>-V(+!XRG& ?4G\*CO=%UZSUZ^N]&GL?LVHE7F^T(V^W<*%WIC@Y '
M!XR/<UU>5$H/J,#BEW;F/S$*>,$4 <5JWA.]O]9M[P+9B:TN8)+74 YCG2-0
M@DB(4?,& ?@G'S4RY\+:N^E>)+&)K1H]2O6N(BSLK*&*$[L*1QL_'/;%=3I.
MKIJDM_$()(FLK@P-OQ\WRALC!/&&%:6X;F'.0/2@#D;_ ,/WVK^(FN;F.);2
M?2VLIE$[!E+DDD#;SCIU'7/M3] T_P 26RVUEJMU:_9K1?+C:VW;K@;2!O#<
M  8Z=3CIWZKE022>*3CJ7)STXZ4 87A2QU32-"M=,U/[*S6D*PQM;%B&"C )
MSC!QCC]37.2^#-8BTS7]/MY[*2/4K_[;'([LI3YT8@C:1QLQ[Y[8Y]!##=M.
M23T.*:["->222>!B@#DM:T74[WQ#97<36L]D+1H&@G9ML,A/^M4 $,<<?,!C
ML>35'2O#?B'13H]["UG-<6UI]@N8&D8*\08%&5MA((QR-O.>M=\ N,#I42W,
M;321!PS)C<%Y*Y&>?2@#SN/PEKH\/1:=)]DDE;6FOY&65@H3SC+P=F<Y..E;
M$^AZO.GBMO+MP^J((X 9#T$>SYOEX_6NN!PPRQQ].*?N!7=SCZ4 ><ZQ]OU#
MQ3??8TTY]EA#:W<4]ZUN26WL02%RR[67!P,<X[BNIT28ZUX=>.6T^Q!HWM_+
MCE\Q0!E 4; RI !' J#2+O0O&27%V=,AF^R7+VNZZMT8[DQG&<X'/MTKHDB6
M*,1Q@(BC"J!@ 4 <1!X6U*2PT'2]0$!M]'N$G$ZR$F8Q@^7\I'R\XR,D>F:I
MR^'M??2K"V^S6OF6^N2:@6\\E3&SRMC[G7$@'X5Z$3@*6)/.#Q2@GS!][&/3
M@4 <[XWT&Z\0^'5M+22-+F.XAG7S#A6*2*V">V<=<&JO]F:LNLZG>O;PE;S2
MHK;8DI)65#(3V^Z?,Z]>.E=>>G!I,[0<DGZ4 >?6NA:]I2Z/>65E9W4D6GQ6
M%Y!/(R@[,8>-@IP.O5>E=E';W1T=H[F1)+J2(AV1<+N(YP/2KSMM7COZ50UC
M6+?1-(N=2NO,\BW0NY5<G ZXH YO2=%U.2U\.V5[;QV_]BQ@&0/O69Q"8E9>
M!@?,20<'M5+2- UU;S2;N_LX!<V;2&XF-RQ:XW?QYVDCI]S./<5WZON1>S,,
MU5N+MXKRWMO*E<3LREU0E4PI;)/;.,?4T >>2^$M:N/"NMV 6&V.IQP9MQ)M
MBCG#$S2KQ\JOA>,=03CFK^N>&M2U21IX[>&"^ACC%C?V]SY<D#@?,'(&7CS_
M  \@],"N_4<;3DG'4BL"\\5V=KJ(L%@O)6%Q';23Q0[XHI'P55B.1G(YQ@=R
M* &>,_#TWB7PX+.&X2&XCFBGC:0$J61@VTX]<8JN-.U&YUU=8N;3RW@L9+6*
M%9@S.78,22.V5 'UKJ7;/R@G((S@=*,$,,LW/M0!A^#+"]TOPII^GWL"Q3VU
MNL1Q('!([@UBKX=NSXKCU=["&TNX[F427-O,!]KMSN\M9$'5AE.3GD9S7<'@
M8W'ZTFX#&23^% 'FC>&O$<6F6>F):VK0V6N"]AF-QM\R'S3)C&#AN3US6E9:
M9XFTB^U6SM(K)["^O9+J&YDE*M"7)9U*#ESGIR!ZUV[2*&5-X#/D@=\#K_,?
MG573M134HI)DCEC2.:2$"5"K%D8H3CTR#@]Q0!P%[X8UR70?%EM'8(\^JZC]
MIMP]PJ@+A0,^A^3./>NQ\3VMUJ?@S4[&"WS=75F\*Q,W&YE*\D9X&??I6V3R
M#DX],4$=2#R?TH X>PTC5;;7]-O9+#]U;Z-]BE99%W>;N4\#N..HJK9:-J]E
MH/A6U_LYFETR[,LL8N$(V[)%!#$@'[X/K7H7S;^O&.GO1@\<]* .#N]#UF"#
MQ)IEO;)/::P99(IWD7-N\L85MZGEP#DC';BFZ+X:O]/\;"YEA4V4>DQV*W"R
MJ"74KSMZX.TUWRA@#N;//%*%XP>: .#ETC6'\.SVW]G!IFUX7P03QX:(70FZ
MYQNPNWZU4U71O$G]O>)+_24$$U[:6T5N[S*#NC8E@#SM)#$!B, C->B[7VXW
M\YSGVI2I.>?I[4 >67O@O6;VW\9016D5I%K-C;I!YDV]EDB4C#D ELYR6Y_&
MNA@LM4?7?#US+IKQI;VDEO<-YRL4+!<=\G[O.,]:[+:QQ\W2D*M@8;F@#AM-
MT'4;2+0+:YM 5T$RM'*LR_Z1\CQQ@#ME6R<XZ#KVIZ%H.LV/A7P_8W6FM]HL
MK]YY565,*C&0@\'!QO' R>*]&VGN<\TN#ZT <[XITR]OHM.O-.59;NQNTN%A
M=MHD X9<]N"<'L:YCQ'X<U?7+;Q!?PV"Q3ZAIT5A!:R.@<;69F=SG;W  R3Q
M7I&.F#C%# G&#B@"GIGF?V?;+/"89?+ :(L#M(&.HX_*O.X["7Q%X6U?0HK=
MXTEURYWW>0J1HMX69AWW8!'3KSD5Z>8PPPW-5;/3K2Q22&TA6..1VDD4=&9C
MDG\30!RNG:%=^;XJL);=[:'49O,@O ZDE?)2/L<@@H3SZU'9:9JE]#X8M+[3
MVMY=)G$MS<AUV-MB= $QSABP)R!@<=:[G:>>?I[4A4E< \]_>@#C;70;^#QI
M>)L"Z(TO]IQ2 @!;AD,;IC\/,],MGK6/-H.M3W7B::UL'5IM3MKZV$KJ$N5B
M*Y3.>,X/48KTL#WX]*:,B3:.@'% '!7$&JWVK:U?G0[N%+_1X[,(TJ%A*K2Y
M'#'C]X,'OBL[0="UG3+KP4\^E/MTK2YK:Z8,K>7(X4#OR,KVSUKU +UY/-(4
M.X\\'J* /,IUU&QM;./[!<1Z@^NW5Y!%$RM,(V,LFX G:00Q4@_WO6NG\'RP
MA+V.2TO;6^>47%RMZB*[,^<, A(P=I_*MF^T>PU&2&6\MTEFASY4AR&3/7!'
M2IK73[6S5_L\*H7(+MU9B.!DGD\4 <7/I.HR>*?[2LX[RUN#=Q"X!<&UNH 5
MRQ0GB0+D!A@Y JK+8ZK%I[Z:FD7,C#Q -0$H*>6T1N_.X.[@@''(&#7HH&,>
MW%*%QWS0!Q%M'JVG7VIZ;%I#7"7=\US:7A93"@;!/F9Y&T@XX)X&*J:OIVHW
MND>+X(]-D9[Z_BDM1@9D58X5)'T,;&O0MOI^%&P<8XQTH YSQE#<WWA:2&VL
MI)YY9(B(EQD8D5B?P -9%W;W+:EXHF;2787UA'#"^!\[;7#)]1OY^E=T0"1[
M4GE*<@C(SD>QH \XL;#4X[[P"TFF71_LVQD@NV7&(G:*-!GGIE3^=.L](OK7
MPOJ/AJXM9IKB:\DDANC&2FUY-X<MT&W/KGCBO1M@^; P3UI/+RO)RV,9H X[
M1S<VGBCQ-<MI5PL%P\<L4S(3YNR%5*@=3\P/UK#\/66H67A/PA:3:/-%/9W8
MEN!MR47;*">.<_,.E>G!%"@8XQB@HI.2.@Q0!Y_/'J@EUY[;3)_+N]6MYSM0
M%S#Y4,;M'D;=X*,>3QUJHVG7Z:#K132;\O\ VK!=Q12R!I9T7R\G.3S\ISDU
MZ4(P!A>*4J"V?48H \XU>PU+5_$VIO:Z9<VL=WX>>RCGE3&R1F8@$C(!QM[T
M]K/4+YO"QFTB6SN-)+/<DJ J@1%=BD<,&/\ =)]\5Z+CG.3]*;L4L??@^] '
MET&EWL>B^$]ND3B:QU(23JD)#(N3ESQTPQX_"NS\7VDMUHL+PV\US+;WEK<"
M.'!8A)D9L D9X![UO[ .G'KBE(R?:@#B%^VPZWK4LVFW+PZM:PM#A<F-E3:8
M6QG:<\Y/')YK6\+:7<Z3X*T[3;Y\W$-OLD.<\^F?;I^%;XC&.>2#Q[4FPE0K
M'- 'E$%C?OX=\"6K:)>P-I5_";I'3=M"0LN_C/&2*L^)+"YN-*\96T&F73?:
MKV&6V58F'G 0QJQ7CLR-S7I[1*W7ZGWH\M#_  CVH Y73X''CG5KH6LT:7>G
MVRQW+1D+O5IB5SC@@.O\JYB&'4!H.A:6^@7@O=*U*&6:3R<+(J-\T@?H=PYX
MR?6O4#&@' QQ@4"(=6Y8C!/K0!S/BXQBY\,22QE@-5!*[2Q ^SS=AR:Y>>#4
M=-NI;N#1KG[+=:UO!BM1)-#'Y8!D4'[I9AU([\UZ/>Z;:Z@ULUS$':UE\Z$D
MD;'VE<\>S$?C4YC#':>5QTS0!Y%%HVI16-M9MHE[MB\3K?,6C+8AW*Q8$9SP
M.?4D]:[>[5XO&BSI97,J-8K"DJKN1&#LV6/;@_C74E01@^F*0JI!(% 'CMMI
M&M6>C:#>R:-=3K8:C>275@B[9&BE=RLB \$@,#CCZ@UMW6D6UW;P/#H.I:2C
MW$D\-Y #]IMY-B_O&0%OO'(P<Y &1S7HP0#'TP?>@H&RK<KCIF@#"\-_VFWA
M^V.J6J6URK,"J +N7/RN5'W2PP2.Q.*W8^E(P(7!.:<O H =1110 E I:* "
MBBDH **** %%!H%!H 2EI*6@ HHHH *04M(* #O44_6/_?'\ZE[U%/UC_P!\
M?SH F[44=J* $HHHH **** "BBB@ HHHH 7%)2TE !2BDH% "TC#/%+0: .0
M\6I=6=QI>M1W<T5I:7:QWD2RE4:*0A-Q /\ "6#9] :YK2+_ %.ZDDT2=[YI
MKG44N;:=YWWI8,6=2<8[)M(/]_Z5Z3?:?;ZG936=W&LMO,C))&W1E(P1^1H2
MPMEOA>")?M"P^0KXY$>0=OTR* /.]9DN[2/Q)J]G?3QRV>K0E%CFV(RF.!2&
M ^\#D\&M26YO-7OO%+)J,]K+IA%O;I#)M5"(EE$C?WLL2,-D84CN:Z!_"NE2
MVUQ;36Q>"XD$LJ&>3#L,8)^;MA?R%/G\,Z=/<M<-'(LDD8CFV3.HF49PKX/S
M#D]?7T)H Q=4U>^N/A8=7A=K>]EL(KD-C!1F"L?YU5^Q7+>+?[&.L7_D7.F-
M<RXFPPD#JH*$ ;/O'.WT%=??:7;7]@UC/'FU9=C1AB@*XQC*D&JQT"T^W0WJ
MJXN8H#;K)YTF0A[=: .&T/6;[6/"VB?:=0N9+R:TN-T=JVR1RC!1(S@C:J].
MAR6%$5_J;:5X1\57%],UJI$.I1&3;&5D)C64CU#,N?;)/2NK3P1H<45K'%8*
MJVS-LQ+)PK<LO7E20#M/''2H+SPR\>C7'A_3K:VCTFY@:.1Y)W:1-V=P52#G
MCI\PP>U $WA"2^NK"\U"[\U8[FZE>UB=RVV#.(^#TR!G'O7-ZH;O3M'\>7-G
MJ4BSVNYHF:0DIBVC?N?7N:]%6-4B2- %50% '85C7/A72KO[;YUJ'%Z@CN!Y
MK@2# 4\ X&5 &1R0* ,'589[+5+"TDUJ^F2\>68VX.TD;47'F# 2-3SSSEAR
M>E9.BZ_>ZC%X.TVXOY%>]AEEN)T8!I#&3A-W49R"<8.%-=M?^%]-U1K"2\B=
MYK+/E.L\BG:<94D,"P.U>#D<54E\#Z&]M%;_ &+9'!-YUOY4CJ87(QE6!!7Z
M B@#SWPWJUUIUJFF1RC=?^(KR.1PY7<%&0/,'W2<=<'V]:]&\,IJ%E!>VVHW
M\5VR2"2$*YDECB;HKM@;CP>>]"^"M!2QELOL"FWFD,K*SLY$F,;U8G*M[J16
MCI&B6>BV[16D94.VZ1G=I&=O4LQ)/YT <-<:MJ^H^'?$>O6U])!-I-U<>1 O
M"-%!DE70YR6 Z]>XQ574K[6IKGQLR:O=0QZ4MO<0JH4#_4F0KR#E23CMTKM[
MGPCI%S-=2&W*"[8-=1I(P2<YZNH.#_7OFDG\*V-PVI;_ #G34D"7(,[C<HX
M&#P,$C QUH MSSW$GAV6>U:-+@VK-&TIPH?9D$^@SC->;:CK]];^%]7EM;O4
M;/5+26R26WO!EX=TH1F#GAU8%L$<<5Z3)I%O<Z+)I4QD>UDC,3AV)9D(P5)Z
M\CC/6J;^$M-FM[N&Y66Z%S#'!(T\K,VV,ED .>,,2?7- '.:]X@U'0M9\0SI
M.9XK724N;>$C(1MQSD#MQ^52>)+"[M/#'B-7U5KNW.AS>7%(<L'"-F3KP#N
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MVXDEF+,D9QE5...@YZ\#FH[CPG93Z9ING&6Z%KI[H\ 68A@4QLR>IVX'7\:
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M9S(60+Y*EE&1&5&,9!)QW)KC+VRL-03QT9VVW\=QYMGN WI+Y0,;(.N<XZ4
M>M;XQDC!P<';S44\Q6T>6 *S@9"G."?0X&?TKSJ\CU'P[J5AKUO:AK_6+!+&
M:/G:MX5S&Q/8,V%)[ 5W>C:?'HVA6UJY \F)1(V>"0.30!SL/CF9--AU*^T?
MR-/DO6LGFBN0YB<3&'+*57C<.H)XKKQ*JD)N0OG:1GGIFO//"F@PZ]X>CCNM
M1E>UAU2ZEDLT*^6[+=R,NXXR1T.,XI\]G;3IXPO;:))[_3[M[BQV,=T4K6L9
MW#'<DF@#OTN8Y0Q1TP!DY."/K45KJ%K=VGVF"6-HBS+N!X)5BK'Z9!YKSO3U
MLTC\$7NG$-<7Y%O>AC^\GB,$C/YG<D.,G/0\5%IXTVW\&:=:,D"SMJ<T9B\S
M$9VRR\2\'Y0!G'? '>@#T]IX1"79T"#@DG '..:2*1#%NC*,I&593D'/O7EM
MM>QV_A(HLH:TM_$/D>1&P598O-'R<MC;@YY.,=>*LM;1Z;H&J7 ,,-K/J\49
M,;+(L=H6C!!"G 4G<2 1@,>E 'I1GA:/=N5E)VY'(JM>2RIIUT]BD4EU'&QB
M21MJ.^/E!/H3@9KS_4(+*UTG5XK75Q/YEW9RE( $B@)F0,5P>"5))'OTQ3M3
M6WL!XXM+-S%;+I$5Q&JR'/G,L^6SG.?D3G/I0!Z':RR2VD<EPL:NR@D(VY0W
M?![\U.S;4WX/'.*\]SI^IVZ0ZC/':P1:3;3V,J2A7B<F3S'C)_B&V/I[>M;7
MC'4KJT\ WNH6S3HXC!+%-KQQL1N8CL54D_44 =,TN8RPY&. !SGOQ7.:-XDN
M=7EM[BST_P S1[EI%BNQ*H9"I(^9.N"0<$'Z@5C20Q6OQ TJSTN0?V=J.F3-
M=PQOE"%V^7(1ZG=C=W"U+\*8H8OAYI<B\O,C!B>I^9J -N375DU6XTO2[1[N
MYMPIG!<)&FX9&6.><=@#U'0<U:TK59KN:[MKFT>WEM2H(+!@^1G((ZC\!]*Y
M[PI=0V/B7Q)H]X5749=1-S"KG!F@,2*C+Z@!2O'3%6/%6H6T8MK=9%$,M_;V
MMZZG 2-CPC'MD\'V- '6,=JDX''4"D64*A+%20<';SS7F/B1Y=,G\6V-H)%T
MU=.@N52,E1#<,[@JN.F54,1TS]:U-0BCTS7=5BAU&2TAFT@SRS2,S%)?,($A
M'J!@<8Z4 =T\BJ QPJ@_Q<9-5;^_:UTR[NXH_,:&-G" @;B!G'/%>9W4L]KX
M8UVWFM_L6L6PMIV-O,Q@=-ZCSHV^\NY0=P/.1WSFNEO9(U\1^*+6&50?[)AE
M:(2'[Y,P8[<\':J=O2@#=L=8M7MM.GN7$<]_ LT:$YQ\H8@'C.,UK[ANYQGM
M7F=A:POXB\%3W$:$'1&#,W086,J?Y_G6=9WZ#7?"=_9W-P8K^\N(9+FYF(FN
MU4-]]>@ 884=@!TH ]:!C)'')/&15*74XA#>-;1M-<0+_J$X=FQD  ^N1BO-
M-%@9/#5SJ$EY<F\MO$9AAEDN')$9NU0C&>05.#G/%=;H5EI\/B'Q5$$B5I;]
M L>[!<?986.!]68_C0!MZ'J\6K:1%?HDL2NO*SC#(1P0>W4'D<5H^8!@D@J>
MF.:XWQ7:7,-QIJ:9;P7<-I!*\FDES%YJ Q@/'@;=Z= #Q\YK6T*\LM5\*VEQ
M:S3"S,)57E8K*"ORMN/4-D')H V_,VDGY<'GCTIV5#'&!@9)KR#2;B>V@^'E
M^-2F>YU!GAOG:9CYB^4S!6&<<,/3.3[U:L9[B/Q?X8N()KG[+J+WOG3SSDO<
MQK&S+O . H.-N>1[=* /4C-'@X93P3P>PI^]5CW*/P KRKPU#]HT+P[<3W]Q
M++>ZC=6D[&=B7B)G.SKZHASUX'-4]+U.1M-L-,GU-DLVUV_M!),YV.J;O+B<
MY&5.>F><"@#V&,DKEL;N^*;YJ;P&(&<X!Z\=:P/"EHUC!>VG]J_;42<LJ@D_
M9P5!\L$D\ Y('8'%<-)?'_A)M*O[74;F2.3Q#+:S7-Q)M+1A9-T 3./+4J ,
M]2,]Z /5DD20ATQMS@YXYJEK.H2Z=I-Q?K"\JPQM*R1D!BH&3R>*X/68Y++0
M]9U%+V62]T[5X1;-]H;$:,\&Y>N""&8<]JLW<T6O)XW6]DV2:>K0V\>\CRH_
M(5O,'/&XL1GV% '=Z9>+?Z9;WJ(46>)9-IZC(!Q5L'-9GAYUD\,Z:R'*FTB_
M] %:,?W: 'T444 %)2BB@!***7% !2&BB@ HHHH *6DI: "BBB@ I!2T@H .
M]13]8_\ ?'\ZE[U%/UC_ -\?SH F[44=J* $HHHH **** "BBB@ HHI10 E+
M24M "4"EH% !2$]J6FM]Y: *MUJ%K8S6\=U<1QM<2"*)78 LQZ 9Z_A4<VL:
M=";P2WD"FT -P&8#R@02-WUP<>N*YOQR-UQX;8@;O[:MUSZ#<*H>*KV6?1O&
M5H;>)6M;=0'0?-)NC8C)QU% '?[U,:,K J1D$=Q2D*<'C%<I;>(W&FW6IIY#
M:-8VY+2!COD>-3O '0 %2/7(IB>)-:3[0L^D@HED]PLP#HL;J,^6Y9>21@@@
M>O% '7\X&#QFEXKA;+QO=A;PZG911[=-AU"$12'+*_R[6R.&SCIQS4LOB?5;
M-=1:\T::9+:Q^U1R012JN02#$VX9+=#D=1GTH [,@LRX/ ZT&-=N !M QM[5
MQ)\87%KHLNI2-875FT\*1WMG(SPQ*V<O+R2H4@ \_P 0SCG'0Z'?WMYILL][
M';!ED8126TF^.5.,.IST.3^5 %ZVN8+B29(I$9HF*.JL"4; )!QT/(_.K"A0
MN%Q@<<5P[^(9XM(\2WT>F6\,VGZB8'$,FTS86,[\[>6._'/IUK:TW5=0G\07
M6FZA!#&R0QW,7DR%L(Q9<-D#G*]N* -_ [=:;NW [6''6N9U37;ZQ\56>ENL
M$5O?0RFTG9CS,N/W;#&.020?]D\5DZ-XTO\ 7[#2)[6WA^TW-U+'-&9"!$L:
MDMD[>>=HZ#[PH [F>XB@@DGEE2.)!EI&. H]3[5%<6\6H1(&DD"'#YBE9"1V
MY4CBN!/BS4-7\!7VNWNB026$=M<L\#RD[VCE9=I!7!7:O7&<]JZ#[3?GQI:V
M2%4M1IC3LF.CEU7'T&!^M &PVFVXA8"XN^F<_:Y?_BJ(])@V?Z^\.?\ I[EX
M^GS5RFC>*-2&@:;)<QQ37>H^8800P (+,S':"2  . .<@9'6K*>*+[.G0MHT
MJW%U=S6HW.T89DC=PZ;ARC!"1Z#U- '2G2[8_P =R2!C)NI/_BJC_L:VPA:2
MY.SINNI?_BJK^'M7?5K69IXXX;FTF>VGCC<LH=#R02 <'KR*YV^\9:A$^OO;
M:2KKH;J9V>YQO3:6.T!3\V,'!X]Z .K_ +'M53:&N ,[L?:I>O\ WU0=*M%^
M9I+G&.OVN7_XJLBQ\07$^K&QN;((+BS-]:*DVYG12H(8;1@G<. 3]:I#Q?=B
M;4[26"!+JWT]KY-DOF",*.4<;1A@2/7\* -J]\.6UXR!KK4$BPRND=Y( X(Z
M-\V:OVFF6]F%$/F;57:JO*[@#V#$@=*Y33O$-W;>%_#UN_EM?WEA'*)9)"$
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MQ2S2H[_,-H^X,#J,YS[4 =9;PV\;R- D:DG#E1R2/6I&CC9\E5+>]<E8:_;
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M$\KYR^2,$9^7&ULD],4Z+QGI-Q>VUM&\VRYE:&*X,)$3R*<&,'J&SZC![9H
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M'OWJDVB7]OK.MW-N\4UKJ<<8,3L5:)U3R\@X.00%XXQSUS71F15.#^='F+N
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MU.ST>7QO<VVI);F"72E9HYR C'S6&>>]=6ME$EX]R S2R *69L[5'8>@_G5
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M.!C/O7J/ C567)[+34A@\H(L:;<D8 & <\_K0!S_ (+L+>WT.SOED:2YN[2
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MZ6]ME8K?,\:N%;<W# L2A/<G&*]/6&.,MMC4!SDA1@'W-)Y$9"AHUV@\+V%
M'D7B.)TF\?Z7#)+/;MH\-RD!E9QYI#[BN23DX7I[5?UI[&>WM+**Y+^7I#S>
M6;G;#&Q!S*&SEI 05"C@9'2O33;6ZLS?9XMS<,=@RP]*1;>UPH\B-0N=N% "
MYZX]* /--+F>X\0^%+Z\F1C)HC,\QDP&D!7C/<X'3VJZNJS1Z5%%)=DVT_B2
M:VGN%G),</F.5!;.0"55>O :N^6VMWVD0QE4X3Y1@#VI$MH5#1B! A/*A>#]
M?:@#R;Q1>7NEP^-+/3;^>.QM[""ZM3&Y*6\A8!E5L]\$D>]:EY+/%K^K:99Z
MR88Y]%\Z*:6=F6*9F5?,Y)VCG/ QCM7HPLK86XM_L\7D@;?*V#9C_=Z4IL+0
MDDVL!8KL),8Y7T^GM0!R/@C43->ZCI]Q:7-E>P",R6[3>= %VX#1/GE3UZ#&
M:P_%&HR'6M5:+5)B+.:Q.UY/*2VRR[@HW?.7#9.5P *])ALX+92+>WBA]HT"
M@_E3&L+2:9KA[.W,KJ8W=H@68>A/I[4 <5<O#J=]KZ76O3Z;)93Q+9M%-M"P
M^6D@=5X#[F9U).>F*F>Y@U:ZU@W>IS:?<65U&MNJSLI6-41PP3(#;B6&2/:N
MP?3[1YX9WM;=I822DC1@LG^Z>U#V%G)=1W36T#S1\+*R NG^Z>H_"@#A==U*
M>WTKQH$O6B:%HY+0&8J5S"C':<YZD\5:CC?4O&^IV\FKW,44=A9W"1P2[?G\
MR4D]^/E (Q@YYKKWTVRFE,LMG;N[*59FB!)'IGTI/[-M5G\U+6!)-N#*L8#8
MQC&>M 'F6C:M+=>(?#LD&J3W-MJ$ESYES-,4^TYC+*1!G]V >!T/'05+8W36
M/A**"*[6-KG5[B"X=KMP(H_M,VTELY3=M"[N.O6O2(=)T^W*M#8VT15S(/+B
M"_,1C=QWQWI?L%JL4Z+:0!9CF11& ']V'?\ &@#@KN*>W\-WL4U[#=0#5;&2
M%%E,GV=#<195G)))R"W)X#"K>O:C?Z%K^H6\;3R0ZM8[=.9F)1+L$KY8[#=O
M5_7"MV%=;_8]DMC';?8[7R8U(6+R5V#Z+C K,AT;4)M;M9[V6T;3K-FELX(8
MRKQL4*#=S@@*S 8 ZT 5?$-S<>&/!L,:WTSMOAM7O7.7178(TA)ST!SDUR][
M/)HOB[Q#<V4SR&/P^DD&Z9IR&WG."<D\\UZE-''+&8Y8UDC889&&01]*S[/0
M],M!_HVFVEN -H\N!5.,Y(R!TYH XQUU.-;VYLO$]FR7%CB"-[II<2#)\S<>
M$!! P!CN*B&N2PPS1#^T].>?4+:TNDNWWM8JP&=LFXY##HX/!-=Y%H>EP1S1
MPZ;9I'.2956!0),]=W'/XTD>F6-M UG#8VZ6\V=\2Q*$.>Q X(]J .1U22ZT
M[39XK/7;AV.IV)1-Y=H(Y)8XV0N22P.6;!.<$=JN2QWNF^+-$M$U2[GLYENC
M)'</DL<;E],@9P/I6^-$L4MH;5;&T\B,Y6$0*(U.<Y"XP#FI7TNT:[AN6M;9
MI(!B-S$I9/\ =..* /-].CO['P]::O;ZG=1M'KLD!M P,4D;WS1L-N/O ,6!
MZC%:ZW^H:G>75Y#JD5H;/4FCD2:Y8 0H^W88=N/G49#$Y^;BNQ73+"WG>[CL
M;=;ACDND8!)/4_7WI!I&FO?KJ3Z=:&]4?+<&%?-'_ L9H P/B#;)-X9@+SRQ
M[+^TPZ.1UN(P3@=>#FLC4(96UCQ6MKJ=S!]GTRTE22.3YR5$YY8Y/4<^O2N[
MO[*&^M6@N((IXG&UHY4#H?J#P:K_ -B:<9)6.G6F98_)<B!?F7&-IXY')X]Z
M ./N[^^U>_%M'>K;&+38+A2+HP?,X.7X4[U&T<=.N1750R3W/AV-I;V-KD0?
MO+BU(VLX7DKD8P3STIT_AS1[R.""ZTNTFAM\&))8594_W01@?A6@;2)[9H)(
MT>)\AD(^4CTQZ4 >:6%[JUK+X!O9-7N)_P"U856YCD8;&'V7>#C'4-R3GFET
M?7KR3Q!X=CAU*:ZM-3:^CFG8[(Y=@+(T:'D!<8W#&<YYZUW0T'25-H/[+MO]
M#)^SXA7]S_N\?+^%-B\+Z-;W"3P:38QS)*9E=;=!M<]6''#>_6@#R[PU=76F
M>#=/NK;4)5FG\2>3<EFSN4SLK%B?4 9-=7XBU'4(+/QA]EU.1&M(8I82H!\D
M[3D#(]A[UU)\.Z3]FNH!I=F8KM]TT;0+M<^K#O3)/#6BE)%.D6;1N%5D$*X8
M#H#ZCD_G0!S=XU_;:]!HXUFXD2]2>\W33^2[8:-5BC<+PJ[F..O3FM_P]+>C
M10^HW5K=SQ!D>:U;<&*\<_[7'/OFKM]H>F:G9K:7VGV]S @&R.:,.J8Z8!Z5
M;MXXX+98HHPD4:A50#  '8"@#A-+U"\N=.\.ZC)>RW,FKRM#<HK#9 &C=^%
MP"A3;^)S4OPQMV31[YY)WD*:I=QJN05P)FY^I^OI760:-IUM<M<6]C!#*_4Q
MQA<^I..Y]:33=*LM(25;&TCMHY&W-'&@4%N[8'>@#0R,XI:8O)S3Z  T444
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MBMW>50NV=-\; D9##N",C_&J'AG1KG13>QR2XAD9#!;+*TB0#'(4MR,^@X%
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MW-LECV[0P(&1\G./4UI7VA:MJ,EY?7!LX[R736L(XXV8HH<Y=F)7)Y P,>M
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M$DT4<!GEUH:E,CN2(E&!A3CDX&>F,D_6@#J-*UBWU>&X> .K6\S02I(C(R.
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M+RT-I<O&&D@+AS&V.1D<&@"ZW(H)I:2@!H.>*<#FF]#3Z "F%MIQBG T$ T
M .1FD!R>G2G8Q10 4AZ4$XI!0 ;LG&*7..* .]+B@!I/!H7[M.HH 0MB@G S
M2XS2'F@!-W?%!?"DXI0*,"@! W-+FC% H 3=3J3'-+0 A/6D^\:=36XH 4#%
M+2 Y%!- "T4W-+0 9H!H%+0 4AI:0T %%%% "T444 )0*** "BBB@ I:2EH
M**** "DI:2@ [U%<?\LS_MK_ #J6H;G_ %:?[Z_SH F7I10O044 %%%% !11
M10 4444 %%%% "TE+24 % HH% "T444 (12*H0848%*#2;B6Q0 SDDDJ,] :
M;MV9*J,@<5,<T<T 1JF4#,H##FGY;'W?UIU% #<8#84?XTTY)"[1C'-.8D#-
M)N(//>@ V 9PHH(QR%&:=S1D$T '48(XI%4+P  *=3&)S0 H)SC&!2D ]10"
M2*1L]J !5"J  ,"@C((VBESTHYS0 @4*#M44@&T\*.>33CG'%,3=N.Z@!VP9
M!VB@C X4&G44 1*I7< @P>:K7&E6%S=QWMQ9027$?W)'0%E^A/3\*N\TQOFX
M- ",WRAE^E*0?F.T9Q@>].50% ]*=F@"-E)C7Y02,<4,"V1M!%/.:!G H 3D
M, %&,=::<AU.,^M24AS@D4 -<;DQM!]J7=\V.U*"2.U1E&R.>M $AZ9IJY8*
MQ7!I6R  *4$GK0 W8,'Y1R<FD9=JL50$_P Z=N._&.*=S0!&B\@[1TZTOS%L
M;>*7E1ZT[M0 W8O]T9II)!W!!2LS*/QQ2J3C!ZB@ .=N=HSZ4A)!'R\'K[4[
MFD;.WB@ 7ITQS0!D9*C/2D7)7GK3AG% " 9ZC%!)SPH(%+S0H('- #"S%@ H
M-+CYONCIUIP&#1S0 #) R*;@@Y"C/3KVI_-% &"?"&A"^>\_LV$W$C%F?D9)
M.<X'&??&:V\'(^48QBF[2)*D^;VH :4 )8*-Q_6@$YQMXIW/Y4W# =NM #@.
M^T GK1BC)]!1S0 M)2T"@!,4F:=2$<T  I:3'.:6@ HHI!D'F@!"* *<>E(!
M@4 +12"@T &>:6DQ2T %%%-4'.>U #J*** $)I!P:&!)XH89P!0 M%(O2G4
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MC%I(]T:#N-I'F%L\YQT K:N?$>J6&L:S97JV\,<=FUQISA3^](ZJ26.6!*C
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M#/PD?^^O\ZEJ&YXC3_?7^= $PHH'044 %%%% !1110 4444 %%%% "TE+24
M%**2E% !32 6!IU% '(^,;)[N_TDQ1WT4J-)LOK(;FMF*X!9>0RG.,8-8FDP
MZE_:/AE]7TLN]I:74,DD%ME5!:+9E0,*<(>!TX]:]%=<C=U(Z4H;Y-^T@XZ4
M >2Z;9:IIUGX?CFT:ZC2'4[MWDCC\R6W61F*;<_=!#8)[=.,YHL[+4;?PGX6
ML7T:^CN+#6C-*OE;MJ!I2'X)ROS+S[^QKUL88 E3ZX-0RR^6-Q0X/\J .?\
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MH;<&X94A#(A^=LY$9;.1G!R1WKT86T*840IM[ +POTI?L=N-^((R''S J.:
M/,+K4+:7PSXEMTOH9%BUFU,*+TCC+6[?*N3A<B0CMUK?/V6[^)$T4DN8IM&5
M%"DJ2?.8\$<],&NQ>TMY%(>"-@2"0R@@D# JK=V4AM)C9F&"]92L4[1!]A/3
MCC('IF@#CM"AOWUI=*GDF-KHDLTBW$CL3().8 6ZOA'Y)SDJ<YQ78Z;J5EJU
MBM]87*7%N00LJ'@D<&HM)TN6PAG-S=+<WL[AY9Q&$!(4*N%R<   =?6IM+TQ
M=,@EC$C2M+(9'=@!DD 8 &    ,4 <!H'F7'PK\5M(YDNY)=3$[-U,F6 'X
M ?A6BS3Q^+?#G]E7-R\$]O*=142.Z%0BA"020O.[!&#72VFCK9:I>3P +;7;
M;YK<K\I?&"P^HQD'TSW-6FM([2*3[!;P02OR62, 9]3CK0!SV@+Y/C;Q5'
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M1W$4L8;&R028!!.<CRCSQG(XXJ23P=#=VEQ%<7UVTES/'<37 *!Y&0@J/NX
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M74\>ARC2QY.L<19G(,3["^&^7IA3R/RJS'XG?[#//-91Q/;WS6L^;D!(P/\
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M*6DH 7O4%US&H_VU_G4]5Y^@_P!]?YT 2CH**!T%% #J*** "BBB@ HHH[4
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M<8'K0!VFLZV;'PK>:S:1^>L-KY\:9QN&,]>>U7(-3M9+=6,T"R>6KR('!V9
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MHH ]%6XB+;%EC+9QC=SG_&ED=-RKN4.>0">3]*\E9=)BTJ\OH]@EA\5(J%
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M0MQ@@%MQR/[PH ]#SGG':ER .F!7G&I::VGZ1<H-7>;9J=C,D,)=5@$D\:E
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M"B@=!10 M%%% !1110 4=J*.U !2TE+0 4E+10 E HH% "TA/(%+2-P,T !
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M,$7 _O;&YSQCH<UD0^,;W4ET;^S;!&_M2":0&=]OEM'@,I SW/4>E '7?9T
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M2WD^"$CF?[\GS8VC"]^<"K\7Q"24Z=!'IL_VR_-Q''#D8WPJ"0&XR.1\V *
M.T<$G'!7'S UGPZ!I5O<17,.GVD5Q&Q=7CA5>3U/ K+M?%_FZ:6FL)(M3%Y]
MA-D74XF]-XXVX.[/ISBAO&,4,&HK=6WD7EC<QVTD+2@H#)CRV+XX0Y&21QSZ
M4 ; T;2Q>27GV&U%U*-KS")0[#T+=32#1=,$!MAIUG]G+^:8_)7;O_O8QC/O
M6)J.LXLK1[ZPN89#J<%IB.<  M(H5MW&Y#D< <]*FT+5;V^\0:Q93VR0Q6,Z
M0C$FXMF)7S^.X4 ;C6MO+Y(DCC/D.&CRH^5AT(]#4=[I6G:EY7VVSMK@Q/OC
M\Z(/M;U&>AK#U/5X;?QQ9:?)%>M*;.6Y3RYPL3!< @IGELD8)QBJ^D>.AJHT
MFX_LR>"SU.5X(YGE0E9%#L%VCD\(>>F?SH Z&XT\1"[NM/@MUU&5.)73[S <
M!B.2OMFJ7AO3KZSCNKO5C;MJMXZO<-; ^7\JA0%SS@ =Z76-3O+/6-(L;>W2
M:.^>59G,FTH%0D8'?G^70U@V'B6ZTTWHFM[B[M5UEK,W#.H$ :14C7DY898=
M.GO0!U]_IUGJ:)%>6\,Z(P<),@=<CH<&HI-#TV>Y6ZFLK=YP,>8T2EB!TR<9
M.*P]3\;6^F7US&462*UE2&Y82J&1F"GY5)RX&\9].>N,5<\9W%Q:^$-2O+60
MQ74$#21L#]U@,]^#0!LSVD%U:RV]U$DD,BD.CC*D'K5#_A'-"2(J-*L0IB$!
M'D+CR_[O3I[51UYKBR\$7MU!,Z74%H]PDF1Q(%)!P>.O;%5[WQ8VF:A+I2:9
M=7EQ#9?;,AT ==Q!Y)[8/7\,T ;$/A_2K:X@N(+.!9X5V0OL7*+Z*<<#Z58O
MM+L-0C"WMK#. VY?,0$J?4'L:YE/%=IJ6H>%YK1;YEU5)9;<[E2,@1%B)!G)
M.!QC@&I+/Q?(MCJ-Y>V3HD-\UK$@="68/L"_>ZYSR<#WH Z:.SM;:W,,4,<<
M)!!1% !SUXJ*+3=/AT]-.6"(VBKM6$J"N/ITK'A\963V-Y/(C"6VN8[8PJRO
MO>3;Y>Q@<$,'4^W.<8J'P_J%W>^*O$=K<R2*MO\ 9_+@9E81;D).TCKG(/K0
M!I#PIHB6T-LFG6JP0-OCC$*[5/KC&,\"K<^D6-Q=)=S0J;E(S"DV!O"'JH/7
M%<OXC\2)H?B-(]:DN;72WC3['=1*#&)<G<)#@XQ\N-WRFJ]SXCU;1(/#5@QC
MU*YU&Z=)KF,J0Z99@%Y #$;!Z#)H Z6/PKHD=O###80)%!(98E5 !&Y.2R\<
M'W%<@?!-W<ZA?R:GI&B:A<7<S/\ VG(SAU7[JC:%ZJJJ.&'3-="?&5LU^(8+
M>9[87PT^2X("J)O0 G<>>,@8X].:;:^*V,FOR7L#06VF7/DJX93YA\N-@.">
M27XZ=1WS0!I6V@:<D,HD@226YA2.Y=ADS!1C#>HZ\'UI3X>TOS[.<V5N[6:X
MMW>,%HO]T]JSH_&5JT>H+/;S036<<<CH=C?+(2$.0Q'4$'GC%:FE:E)J(NDE
MM);9[:41,KX(8[%;(*D@CYO7ZT .U71]-UNS%MJMI!<P!LA)4!P?;TI)]!TN
MZM8K>>RMS'"P:$*@4QD="I'W3[C%9%]XXL;(7Q-I>216$OEW4JQJ!$-H8L<D
M$C#?P@GVJQ'XNL6GOHY(IXA:VQN]TB##P@D%Q@D]0>" ?:@"XWAS2'M8[8V4
M/E1R&55"CA^[_P"]R>?<U#!X4T*%8!#80#[/,9HR$&5D)R6''WO?K63J'BV'
M^Q]3^U07UH]M:QW1\G:)#'(6",AR<'*-G.,8J^EU(GCO[&)F-O\ V<)%AP,!
MO,(SGK0!J?V5:-J9U!H@;KR_++^J]<'U'/2J%MX4T2R%P+?3K6 W"XF:&((6
M'X?4UN@_*"?2F,0><4 16-G;6%G%:VD4<4$8PB1J% 'L!5@#%"XQP,"@'- "
MT44F: %I*** "BC%+0 48HHH 2BBB@ HHHH *6DI: "BBB@ -(.M*:04 +4$
M_P!T?[Z_SJ>H)_NC_?7^= $HZ"BE'2B@ HHHH **** "BBB@!:2EI* "E%)1
M0 M%%% !2&EII'S"@#FO%>D2ZB-.U6V#O=:1="Y2$#_6#&' ]]I)'J0*H?:6
MU'QK.]C=6Z"73HE5I(]WS[W.,;@<CC(]^E=+K&IVVEV+37 +!F6)(QUD=V"J
MH]RS ?C4JW$<:1_:3%;R,<;?,&"WH"<9[=J .;L/!RZ0VG36%V;:ZMDDBD)B
MWK<*[[VW=,?-D\$<U);>%;^QVBWU.-A--/+?+-;AH[DR[3RF0!C: ,'IGUKI
M9;J&%]KR*K'L6 S2O.H<(3@D9S0!Q\G@C]S(MKJ3PP3:<FG3@0C<416564Y^
M4_-R*BDT34-%,VO2WTMW/9Z2]L;>TM0AD ^8;!DX;\\_H>F74)9H8I;1(I4>
M=HG+2A< ,02.#N/'3BJEQK[R:E?6%A;+=S6L$4CJ9@BGS"^ .#D@(2<X'(H
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M(VJ>+--E0B5-*AG$\ZC"F5]BA1R>V\D9X( /6NE,@ )+8&,T%D0 D[1TQ[T
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M-@!B/ZT2V=O<S++/;PR,GW&= Q'T/:@#S>]M-!AUC5="UJ[M]-L8[6)=/$I
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M1N()[O3[2Y>'[CS1*[#Z$]![54USPU8WMO-=QZ79SZH(&ABFD0!E!&/O8)P
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M**0=!10 ZBBB@ HHHH *.]%'>@!:2EI* "BBE% !1110 G>F.Q#+3OXJ&&:
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M$@9]<$$]1G.">M>>6>E:['HWA"=M,G\WP[*$N+5&0^8I7870!OF*J,@=]QH
M](TG6+'5/M$=G(2T#;)(W0JZ-W#*0"/Z]JU!7*>'[::X\5:SK9@N+:"XCA@2
M.>/8S[ <L5/(ZXYQTKJ#DN,=* 'T4=J:F><T .HHHH 2BBB@!:0TM(: "BBB
M@ I:2EH **** "DI324 +4%Q]T?[Z_SJ>H)_N_\  A_.@"0=!12K]T44 +11
M10 4444 %'>BCO0 M)2TE !1110 M% HH 3'-+12,#D8H Q_$.N#0=.^V/:R
M3PB1(V\LKD%F"C@D9Y84VP\00WFJR:3/:S6=]'")_+FVD.A.,JRD@X/7TR*R
M_B1SX'N=K!#]JM"&/8BYBIFI:'-$NK:]<ZH\MVVF26]NT">4(5P7)!!)R2HY
MXZ4 =8$6-BQVY;^=17=Q!IUG+=3D+#$NYR?X1W->=SSS:>GA&W;4;PPZ[)&M
MU-+.QQMA+*B?W-[<'&,U'K8S;^*M*EFFET^Q:REMLRLQC9V^9,YR0"F<'.-U
M 'IT>PQA00589^M*1A-HVC^0KS>[D\G4Y+FTO+EDLM2@M%E>Y95&-B-"(QD.
M "22V.3QTJ36X]7U&;78+-[Q=12]A6R>"8[(X?DW<KPC9$A.[G!7K0!Z, ,L
M1C<>M(K>I7 X/UK@-0@O=5UG6;&+5S9R:=#"T$SROF-2FXRX# /\P93N[*1W
MJ/7HKD:=XJGBU74,6FE1W=MY%PR#S1'(V5QR 2J_+T]0: .W>ZN8]3BMA9.\
M+1,[7"D;5(90%(ZY(8G_ (":N,V%;.*XLWMY#XJTZ42W++)H,TYMS(=CRAHL
M';TW?,1GWJGX8E_M+3?#>O3Z]-Y\K.+B(ON6X<@C9MZ+M.#\H['U- 'H(^4'
M.-O:D5448&,#]*8CK<1AU97C8<%3FO+M7>]TB34M*6ZU6YO8KY-1MF6Z?FU
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M;_X2.\TZTO8;:%+$7$3/#YA+;F&.H]*Q-(\:ZS>-X4O+D0"UUJ62U>)%.4=
MQW[CZ[#P!QGJ: /2,AAU!!%(I1QE2".A/TKSRV\6ZV/$FGZ=<2V+B]N;F%FM
MT9XXMF-F')PS8/S#L?2K-GK^M+;7.G7MQ"=<74TM85\G:'B+AM^ 3P8MS?@:
M .Z( ;<,<D9S5.ZU*SLKVULY[B-)KHE8(R.7(ZX^E0:Q/>QBSM[*2..>ZG\H
MR.,A $=R0.Y^7 SQSWZ5Q&K+K,VM>$%U5;5=5%Y<JLL).S:% 5\'U&#CU[T
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MVN?L2$NYE,9R8R^<[MGW<YYSCKSUK#TCP9Y=[KT^K1Q21:C?_:TB61F51M4
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MM[Q]0B:"Y7?"T1\SS%QG*A<DCW%)-XIT.&V2=]5M1%) ;A'64,#&.K#'4>]
M&98^ =+TZ.UB@FO/L]I.L]O;M.6CB8;N@/./F;@DT^3P/IC32!9[R.W>X%U]
MD23$2R!]^1D9'S<X! ]JWKJ^AM+<3S.D4995W2L% ). .>^35*'Q)I5S!>RV
M]];N+(XG_> >7CKN]* ([;P[:VLVHS[II?[0QY\<S!D.%"CC']T 5EVGP\TB
MSMIK:.6^^RM%)## UR2ELL@(;R@>4.#CJ<5M)X@TQXIY4O(G\AE214<'#$ A
M>.Y!Z=:0^(=+%M'<-?PI"\GE;G<+A^@4YQ@Y(&.O- %-O"\9O/M_VZ\6]/EC
MS R8P@<*" N"/WC$Y!Y/M4EIX6MK"6TF@N[P&WGGN&7S %F>4L6WJ  0"Q(
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M4JBC:=@( /R\88X/>H-$T35;HW=MJ$ERVD7D3I-;WL$$;[B."GD\?4M[8KN
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M(RX"H5Z*>I)] ,4D?]LZAXD\)7DVA75C%9)-'<[Y(B 3'M&"&Y&0.?TKT((
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MTF* %HS2%@" >]!P.M !D4M-.!R>E(9%3(].M #N :7-,+J4#=CTI=RD=10
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MK:Q#"%2$:%I&#??Y!\PC'MUKL=-EUB86,]P(HHMC"XA:(J^[^$CYR /SS[4
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M!U;ZI=W46F7.E);36MRP:9YI"A$9'!3&<GIP:T1=(Y 5@"25 R":\Z5K*(^
M#"L3I$Y1_+VC8?((R?\ @6/Q]ZH6EI(F@>+[_3+(MJ=KJEX+)E4EEB?;NV >
MHW_4@>E 'J<4WF)^[D23#%&VG."/ZTDUY' R"1PH=@@)_O'M7)^%K70X]074
M-)NDE=[81210(JJH!&-X 'SC)Z\XS61\0A!=7&N0'BYCT1G1I6!Q_K"H@7KY
MFY?F?M\H^@!Z'/=Q0B/<P#,VU5/<T/,D>9)05P#U/ ]37 ^)[NU.KJEU-9W%
MG<Z.PMQ-.B".3=PV6X).0,CD8/&*KP:78IJ?A73)Y%NX)=-N8KAX&_=3']T#
MR.""2WUH ](%PA9DWCS$7>R9Y I_G*SF-6#,H!8 \C/2O/K6.-]::ZFNE35[
M2\G1;*"$>:T1=DB#D DQF/RVST'6J/AZ*S?^Q]0DU25]4CR+JUAMU\XM)Q()
MN^P9)R>F : /31*&D520I.3C//!P:579FWJP*<XQWKRBXL],B\.^&9K:0QS_
M -J>4T\<AWB(^:&0L#G:1C(S45U++I-SXEL]'\V&Q76+02K;KN$,#(AF.T=%
MY.>PYH ];2Y1H5E# J_((-,DNXXX9)V<*D2EGS_" ,DFO)_$=CI]GX8U::RU
ME[A+N[LI<V8"0Q-YJAMFSC+ G(YZ<UL7NG:7;ZWKEI96\8%QH8D9"-XEE4MA
MN<Y?&#GKWH [Q;@WVG1W=H25EB$D8.1NR,C_ #BL[PUK4VN^'[:^N(%MY9VE
M!19-P79(R=>,]/2D\'FV;POIR6A@VI;QB180,*VU2<XXSSS7FL>GHO@W3+JQ
M:4Z_;:PWEQQ2'S0INVW+MS]TH2Q&.@SVH ]C#HCA#(,E=V"><=,_K56RU:WO
MVN4MF,AMIF@D.,?,H&?YBO.[2&/5+B>>]UB6QUBUU-Y&A6+%PX1L(B<Y,3(
M.!@Y)S4=MHB:AX6\7:?8M$-4BU>[N;>)  Y*R;D4CJ5.-OI@XH ]367U!ZD?
ME3RZY"DX9N ,UY(!J-Y?W4]HBQV_B.R6&U+(3Y<RA=^0>Q&X\8SM/6I]0L[6
M^U/6=(U'4X]+%N8H[%Y$57$2J,&)CGYLCG ]>#0!ZD7"LG!PV><]*42J6*]P
MV.OMFO*KV&RO;_5H+[6I;"[B>%[*9H&\XQK%&P:#/4EM^0!G/%4?$$$$I\?#
M[5/+)#I]K/;L7;Y)3&P+ ?WLA?H?0T >Q,X$1D+?+C.?:L1_$B/?Z&MM%Y]M
MJC.J3+)C;M0OTQSPOJ*72Y6OO!]J) )6DL5+;AD,2OH:X72A9OI?@.*,$$W#
MQSQH2I0M!(#G&"* /5]PP#Z]!WI!^\0-R,CI7ESO#9:6FG+<11Z1#X@GAN3-
MS''"5=U5CQA/,V+Z8.*[#PG:6]JEXMEJJWMLTH9%C0"*$%>50C@C/.!TZ4 4
MK[QBVD1WUY?:7,MG8SB&>:.;=LW*K!B"!\N''3)'/'>NKCE61(V0[A)A@1Z8
MR*XZ;1H/$EWKVGW%YBREND^T6Z,I:11!".O.!D=O2N6\97MO:G6X;>]E6?3C
M:"-YYL+!@I_JD'S$$'YF/'4<]* /7<XDZ=>E9DNJO=:>+G2H/MF+DP.%<+MV
MR;)#SUVD-QWQ7%Z?;6NK_$W5HY[FXE1;.TN8O+G955^3P 1_=&1R.:HPM86W
M@NT6&[\F:'Q GGK$VPD&^92#CMMS^ H ]5+8(!Q@]_2D1R5!;!!&017F^K>7
MJ^H:W9WVN0:5>17 2TE)8311!$*R1C< <DL,XYY&>U2_:I(?$]K/>"*YLKBX
M@2.\AE*SV\FQ?W<L9Q\K'GCID9% 'H>3&QW8VX)SZ4JG<@(Z'GFN;\>6UY+X
M8EN=/69[VS9;F)(SS)M.2I]<C(KC#+<76I:E%:RW LO$L*&P?S&. K!9]O\
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MF%=I$BY.,$X^4\4 >@-D G/O43J-X?<,''%<>B7=]XQOK=]3GCCBLK*Z'D.
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M-5"%1C)!Y.X8''?GBJ*>+WGFL(K#39[M[[3O[0@_>(@9<J "2>#\XY_G0!U
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MMH4,A66+=CAMV-P(Y4]/>IF\8R_VH=/72+TW4MJ;FT4&/;.@(!ZL-N"1][%
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MXUTM8&E<7:>7>)9R1F+YXY7("J1V!W#![YH WK2RMK*,QVL$4$9).R.,(/R
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M /*,D*L4 Z $@UCW&NP7^NZ/'IMW(\;W<L4KQJ3%*JPR$C?C!(8#@'UKJ&<
M9]\4 5!IUE'=-=M;1F[=0K3;?F('0$^GM4-GHFEV=W+J-O86T=Y,,2SI"JN^
M/4@9K38 BEH RX]%TZUNOMD-I#',3N+I& 23]X].,]_6I+32=.L+N6[M;**&
M>XYFD1<%S[^M7F(Z4O!% &=J&A:9J-W!>75A;S7, VQRO&I=!Z D9'X5$OAG
M1HVCDATRU1X4VP%8P/+!Z[?3/?U[UK]*0G H QD\+Z''I\FF_P!E6OV.9O,:
M#RAM+_WOK[]:GTW1;'3)7DM+2&!G 5C&@7..!T]@*T0P(I>O2@!!UI:7%)0
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M<'Y>2"B\^W>NA5  3W-9NHSZE'?6MMI]I;R1O'(\LL[E0FTH !@'.0S?]\T
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M6<$'*L"6(QCI74":%<+N /8'J?H.]9WB#4VT31+K58HEE%NAE:-F*[E49."
M<' H S;;PS-;ZG;ZHNJROJ$49@FN)(U87"'G:4& H!Y&,8Z<T?\ "')'86,=
MI?O!>6EW)>BZ,8<O+('#DJ>.=[58TK6=1N_L,T^DI;6]XA?>L_F,,KN&0%&!
MQC/J0.];C2!$+8P3G&>.?>@#F%\'R)'<1OJ/G)<7C7,L4UNK1OD8*LO&1T//
M0UKZ#HT>@Z4MA"P:)79E0+M6,,<[5&3A1V%1Z#K4VKK>F:T%LUM>26VP/N)V
MX^;H.N?PJEKVMZAHUEK=]]BAGMK*V$\06X >3 )<$;3M QQUSSTH JR>"H9;
M"?0VNI#H\TIF>V9-V,MN*!\_=SZ@GWJ^F@SK+JY&I2QG5!G=$NUH2$$8*MGJ
M !^(SQ6G978O].@F "&:)9, Y"Y .":JQ:P8K6(Z@D4-Q-.\,*1/Y@?YCM(/
MJ5 )';D=J ,;2O!LNFZE9:B-5::X@LVLW+6P E7.<G!SG(!)SD_C6SH.E-HF
MBQ6'V@W'V=2JN4V]3GI^-:H?>@*]_6L:S\16EYXJU#0TS]HLXXY&..'W YQZ
M[<+GT+"@#(MO!T]M<6EU_:SRSV=Y).LC6X\R4.K+M=B26(#8!XQCI4R^%9OL
M$-N=2),.I'41)Y'\1<N4QNZ9/Y?G764UGVGDJ,]!GDT <7<^#+B2'5-/BUET
MLK^Z%X8C;[FBDWK(Q5\]"R]"#U_"KWC9_+\ ZJDDI$C6CJ'XR6(]/Z5TAD^;
M:@.<9S@XI&VN58<'/!QT/O0!R</AHZF]AK%U>1RSP636ULT<6U4\P89L;CDX
MXZ]JE7PC)!X)M/#D-]^[M/+43/#N+B-@P!&X8Y Y_2NH5XPH;>A ZL#Q6=XB
MU@Z'H%SJ:0^?Y*[M@8#(SC.30!F3^&KA+_4[BUOU2WU.,+=P20[_ )MNPNIW
M#!V@#&#TIFE>%!H>M6=S:7C-;VNG)IR6SQY.Q22&+Y'//]VNGCV;>&W'H3W-
M/4CMC\* *6IV$6KZ3=6-RO[N9"AQ_">Q'N#@_A7.VW@T0W^DWMW>23W<2$7S
MD ?;&!#H7Q_<<9&/ITXKKBR[BH(W=2/:F&2,A%VG+#@;3D?7TH P?[!FENO$
M$WVP9U.)(54P\1;59=Q.[YLY]NGO6=;>#+NP@\-K%JBK)H]N;7<(,B1"NP$
MMP0.YS]*['<5&T8W#M6;KFK_ -D6T4YA\W=/#"0K@%?,D5 3GMEATH PY?!]
MZUC?6R:H(RU^^HV3>3DP2M(TAS\V&&6(Z#@U/-X?UB\TZ.&[U.W:87D%TWEV
MNU$$4@D"*-^>2O))-;"WTRZG>Q7%H8K6!$D2Z:12'!!R HY&,#KUR:P=,\97
M6K_8)K/0KF2QO=KQ79= HC)QN;)R&'7;@DC'0\4 :=AH]U:>)M3U-IHVAO\
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M3Z "@T4&@!!1110 M%%%  :2BB@!>]%)WI: "BBB@ -(.M*:0=: %J&?[G_
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MS.PM7\P6X8Y)XSM.1[<UMZK%+<^'/%%AJ]A/+K-S*\D7DVKN)8P0(MC8/"C
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M>R:3ILT[S2V-H]PZE3(\*ERIZ@GKBB33-.O)4GGL;6:6'_5O)"K%,>A/3\*
M.%UR]74_^$I@O[JYMC:V :UB61H_E\HEG('7)R/F[#H*ZWP_J=G-I>EVT=S$
MT[64<HB!^8IC ;'7&0?RJ]=:9I]U.)KJTMYG VJ\L88K[ GH/I4#Z1;'6+.[
M$81K:%XH?+7: &Z@^HXX';F@#&U>],OBVPTVZN9K6PDM9I0JR>7]IE5E 0,#
MN. 2=H(SD=>E<?;ZWK5P=+A_M.[6/_A(9].$[8#36ZY*Y(')P,9ZYZ^M>H7=
MC9ZA;A+R".:-7RJNH(!]>:C;1=-DB@22PLW6$_N]T"G9_N\<&@">SMWMK*&'
MSY)@BA?,F;<S #&2<<FK7)'%)P% '3H*5>XH 0MM'-.'(ICG)V]Z=D* #WXH
M 6BF%@KX+#GGFG=,DF@ + 4 Y&136Y(]Z$.%_&@!](>*,X(H;I0 44M% !FB
MDI>U "44M(: "BBB@ I:2EH ****  T@ZTII!UH 6H9_N?\  A_.IJAG^Y_P
M(?SH D'W1]**!]T?2B@!U%%% !1110 4444 %%%% !1110 4444 (.M+WI!U
MI: ,;Q%K@T2P6Y^SM*AE5'?)"0KGEW(!PH'?%8-OXW:YO=&C>RC U.ZFMX9(
M+E9DP@)#@@#(8#/8CTKH-5TZXOVM7M;K[-)!-YF[9O##!!4CCC!/>N;7X=K!
M%:O:WJVUS9ZC-J$#) #&K2+@KL)^Z!C'- %R3QK)%;.[:5(SIJ@TUE24'YRR
M!6Y X._I4$WCB\L8-7&HZ(\-UIIBD:**X$@>&0D*X.!W4C&.U8OBK2WT;3@3
M>37,E[K5M=[C&,Q$2QY; _A&W/7CVJ[XKLFM_#&M7]U<B6\OX8HE*1!"%1]R
M*!DYQN<YS0 NO>(7U;PUXDTV\TU[.[LH4D\IG#[HV.4<$=^.1V([ULZMX@FM
MKB>SL-.EO9;.-975692^0Q"+A6RV%)YP.G/I%=>%6U'3-0=[]C<ZC%'&UPL8
M&V)0=H"\Y^\3R>:??^%KR?4X=3TS7);"Z,*17.RW5UN%7.#AL[6&YL'W[T %
MSXHNVU*ZTZVT66:6.S2\R\XBW*V[Y3P2#E<=.I_&H[/QFMUJFC*=,DBM=8B)
MM;AIE))$?F$%.PQWS^ J>#PFUGJ4EW:WY4/8K9HKQE]@!)#9+<DECFJ\'@@V
MY\,DWP?^PE98_P!SCS 8]F6^;T)_''I0 MGXLN[ZXTVXM]!N9=/O\^7<(3NC
M7!*NZ[<!6XQ\W&>0*JVOCJ6]AL;Y=%E2UGOO[/,S7 RLGF&/.T Y&X>HZ]ZG
MTCP?=:2HM+;7[HZ9'*SP6CQ#Y!U";QAM@../UJO9>!9H-$MM.34F'V75/[05
MVCSN/F>8%QD<;OT_.@"S9>)+N%O$EWJ4<36]A>"WB6)CNW%(B$Y SDR#!]ZM
M/XJ>VM[Z6_T]H!:^6(&5RZ7+N=JHK%5PV[:,'^\.U)_PB4DLNMB34'^RZH_G
M>2(P##*$C4.&ZG'E@@>]0OX2O[[29K/5]<:[N1M-M<);",1,K!E<H"0S!@#G
MO[4 1Z29U\?ZG/=6PMYIM*MG8),70G?+TR!S^':MB]UB:/55TJQMA-=_9_M+
M!WV*J;MHYP>2<@#'8U6T_P /WUOXB;5+W4!=,]FML56/RU&UBP(&3S\Q[U8O
M=(FEUN+5["X6*[6%K:021[T>,D,,@$<J>1SW([T 9D'CF&_2P^QZ;<7$MU+/
M T895,4L0.Y&)./Q'%<YXKU7^W- \.2R6SVS1>(X;6>)G#$/&[HV&'497K72
M6O@\Z=<Z?/;W8Q:SSW$JM'GSGE'SMU&/853N? DUY81VTFIC$6KMJT9\@_>+
MLX3[W3+F@"\OBUK:\UJWO[#[(=-02AGGR)XST=>.G;N<\8YJQK;/<>";R2XA
M,,S6+R/"'W%&V9*Y[XZ9K%ODTWQCXMLH81+))I4C+J!V,B#:0PC)(PP+J&&"
M?NYKL+ZS%_97=L>!-$\1/IN&,T <QHOB"X@BTO3+C2I8OM=H&LYVN%87#*@8
MKQG;QD\^E6;'Q9_:>G6#169-U<SM;R6JS O;LH);=QV !/U')R*L6VAFS_LV
MYO[A732("(ECA('W-I8\DDXST]363X3MK#4?$FI^(M+20:?-&B)YD93?/UDD
M //*B$9_V3Z4 ;^N:Z-$>P)LY;@7<XMQY9 V,02,Y^E8$WCJ[M8=9 \/3O-I
M!$EW&+I $B(+;]V>>%) Q^5;7B'1KC5_[-DMYTB%K<K<,'0L#@'W'K69<^#I
MI?\ A*)/M,8_MZ$02?NSF--C+D<]<,?QQ]* +MYXD9+HBWTNZO(%D2%I(%+,
MI95;(3'*@,"3GC/?!Q6O_%RZ=K-O:3VCA);E+)7,@W;W( ?9UV$G@]Z;%X5U
M1;B5H-<DMK6Y$;74"1<M(J+&2C9R@947(YYY!!JE>^ K^X!6#61$JZNNI(3!
MEN'W;6.X;AV'3'O0 Z7Q\8[?4K@:%<M;:;J L+B;SE&TY4;P.I'SCBK]SXUC
MB\2MHT%GY\\<L43+YX20JX4F1$(^=5!Y(/&*H3>!KV32O$%BFI1_\3B^%XSO
M <QD;/E'S<_<'/'7I5G4O"-QJ[HM]J :"&^CNH"(,R0%6#%%;=]TD =.F: -
MS6M:M]&BMVFC>1[FX6V@C3&99&SA020!T)R3V-9\GB&XADO+!M+E2^@@\]8Q
M*K+)&3C>K<=.X(!],U9\1^'X]<LK6)IV@EM;I+J"4+NVR*>XXR,$CJ.M55T/
M4);BZOKBY@-]+;_9D01$1I&6R?XLDGZC\: *7@:PCGTG3M<FMGANYK)"S[P1
M<!@&+G'4YZ9Y .*M-XOCC\06VGM82H+F9K97=P&W*K-N*=0A"L0W?'05I>'=
M(DT7PY8Z6\PD^R0) DBH5RJC ."3S^-<RG@C4(+R)UU"$Q0:I+J*DVQWR&02
M!@YW\X63 /'0<'I0!T/B/Q"/#UK#>O:R3V[3I#*Z$ 0AFQO;_9%94WC.!GUR
M#[!,;G2GCC\K(S<%VPNP^YX]CUKIM0T^#4]*NK"= \-S"T3J?X@PP?YUSUOX
M16/4-$NYKIY&L(9%N"1_Q\R,0P9OH^YOJ: +-IXDDU#4KK3HM)N";2Y2WN&$
MBCR@T0<-UY^\!@<\UC6>L_9M)\,IHUE)%:7M[)$8)'W/&%65R,D],H?PK<T[
M1;RPU36+Q+F+_B82++Y9B.(W6-47G=R"$!/3FJ"^$;N/2-'MH]0C2\TZ[>Y6
M4P$J=ZR*05W@])#CYNHH CMO%4T-WK\]]9S>1:ZC'9PJF&8DI$%0#/+,TO'U
M]J?=>-X=-TS4KR]TF]B6P57*[ 5D5B "'Z=^1U'O4=[X+N+DZQ%_:SP1WT\=
MY%)%#^\BG18P'!W8X,8.,=^M1:CX2US6-!N],O\ 7%D>>$1*5MRJJ ZL7(WG
M<V5QG(P": -S3/$ N=:;2)["XM+C[.;F,R[2)(]P7<,$XY/0\TS5+FT'B+2;
M>6SN9+ETF-O*C[8QA,L#SR2!QD8YZU'%H>H-XPM]:GN;<11V)M&BCC8%B7#E
M@2>.1TQT[U9U'2[VX\0:7J$+PK!8^861@2TFY=IYS@8'L>: ,^'QJDJ6LITJ
M[2VN+][#SVV8217:,9 ;/++C@$5;M?$]I<Z]+IL*;GCD,,C+(NZ,@9RZ9W*#
MC@XP<CUK,'A34QHL5DEW;*\.JMJ,<AC;G,[3;",\<MC/H.E6)/#%Q=ZQI^HW
M#VHEL[N247*(?.DA8,!$3W W <G^'IGF@"K9>.;@V.GO<:3/+=:A+="WA@9"
M66/<P )(&< #G'-63XV@CM=7GN+"ZA?1HTEO8#L+*KQB3@[L':IY^G&:I:7X
M,O+&[T=FNHGM]-N+F10(RI9)01M.2>1G.?PQWI-7\&WFH7GB46EY$MIK=JL4
M\;QMO5UC"*4;.,$#G(H U%\6E[E+2WTN\FN9;47D42[ '0D ?,6XY(SG'XTR
MT\8Q7DVDLEA=+!J@*P3L% WA2YC(W9SA6YQCC\:BTW0=2M-6L;QS%(L.F"P<
MXP7P0=W7CIT_6J^G^%]4L[3PU:%X631KDR>;T,B&-X\8SQQ)GOTH U8_%D,E
MY$@LKDVLTYMTNT 9"X.#D=0,@C.,5!'XQBF D-E>0PM??8#+)&N(Y?,\L X;
M/S-@ C/49Q5:T\/:[ITLMK;:C"-'\]Y8U",)U5FW%%;.,9.,XSC\Z9-X9U6?
M2OL?G6\<HU<:D)!N(($PEV'CU &?3G':@#4TC7+O4-9UBSDM'CCLKH6ZL2I!
M_=(^3SGG?GI3K[Q5:V6M?V2L4L]VJ+(\4> P0G&Y02"X]=N<=_2H]/TN_P!/
M\1:G=YM6L[Z=)\!&\T,(DC.3G;CY,].]9_B+PQJFOW5VC36?V5MCV,[*PGL9
M !N="!U) .,CIS0 JZOHNG>)O$=V\MY#/96\;WDDV6A5 H(V*"3TZ\5<3QA
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MLN1SSBI](U8W-GX.BN-6GDDEFNHIRL[#S-B28W$'/! ]Q0!Z0>!C)X]NIH+
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MK+Y=N\"&0' +'IT.!TKI-X901T- #A2T44 &:2BB@!:2EI#0 4444 %+24M
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M14-U:Q7=J8)H4DC;AD;H10!YZEKJ=S;:QI*0:3)?ZG8LANK>]DF. -H$F\9
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M<*(7 :$KOE"G 8L>@R<=>:ZOQ=87.I>%-1M+-C]HEMV2,= S=@?8XQ^-;04
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M 4M)2T %%%%  :04M)0 M0S_ '/^!#^=35#/]S_@0_G0!(OW1]**5?NCZ44
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M0WW30 F,TH%"]*6@ HI V1GF@&@!:0]10&W#O03@9H :PYI0*4'<,XII.&H
M?13032@Y- "TF*6D)H ,<TM(.E)NYQ0 IHH/2F DF@!^<4M13$@"G!L("0:
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MEF:\ALXY9I3&?+)/R\-T)R#Q4&GV[7'BK5K^3.R,1V< /HH#N?\ OIP/^ T
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M=;3[1&DBHJ0@%0;*,'''J&Z>E 'HUE>PW.GQW2R*8W7<&R!P>]23W*Q0&1L
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M 4444 %%%(* #O44WW?^!#^=35#/]S_@0_G0!*OW110OW110 M%%% !1110
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M&:[$, QW%=W]*2,*5/3@^G2@#@[SPUXABO-56R>UGL[Z:WN]UQ(5:.:/RPW
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M>:4'(H 6BBB@ HIO?%+F@!:*** &]:7H*7%(>E "@YHI ,4M !FDSUI,8-'
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M$6OZE=> /&"1W[YT]HTBNTM_+>1&CC<@J?\ ?(! !P ?>@#U9#E1T/'6G9Z
M]ZY[5);_ $SPBTMK=VBW*1K^_O/W42#(!)QTP,D#/6N.O/'6I6NE>+Y(9(YG
MTE(I;6=K8KN5T5B&7([G /'':@#U#:><8]J?7&V5]X@EUO[%<75L#=Z9]IMM
ML!Q$ZLH8-\WS_?'=:;HOB#4M4L]#C_=)J$S3_;XRI(B$64<#G@^9L SG@DT
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MO;S0:Q;6=W"D992WVF, K\P(X921D]<<=:Z365GTKPIK%[:"&.]%K),SQQ;
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MW>O2:OHGC&PFDMYEL['>L]N"%8.CGC)/0J1UI&A1OB!X,?G*Z5, /^ K0!Z
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MCO[&=(GBO(2MQQ$RN").,_+SST/2D76M->T2Y74+40LYC63S5*EAU4'/)X/
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MZ&ZL[R;2Q:P7_E7:[2;GRQC((/W0>AQTS5WST6Y$#R*'895>YH>=$8$L%).
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MXC_T1;.>W:7/W&8J1P.>BGIZ5U"6\'VAI_)03$;3)CYB/3/]*F9E& QQZ9H
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M\8%2V\\-C<ZUI6HZ3%>7KWCW%K%\N)TX,>">%*@ #=C%>D/P ?>F[@CXY(-
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M53;;\X+9!RV,^W2NTU?1;76K%;2Z,H".DBF)RI#*00??D \^E49?"5A+;ZI
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M7'BBX_MR33A;VPVW@@*S3>7,4XS*J$?.,D 8]#Z537QG/+8PZY%IT7]AM=B
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MV]I-IWVRW:1B"Q4XD5ACC8W7D]>G6MW2[^ZN=!MKVYM##<21AF@!R1^/']*
M-('!R<#/ (I2J[<$#UQ7*Z+XEN-1UBWLKJTMX1<V9NXQ'+N>'#*#&XQC<"XZ
M'UK0U?5YX-3M]+L+>*>]GB>;]Z^U(T4@9. 3RS #_P"M0!LE%89*@\8P>E"
MY(8"N<@U^ZF?3+..TV:E=V[W#VTT@'V9%*@[L<GYG4#'J?2JMCXP>_DMX1:Q
MI/'?O87J&3F&158@KQ\P.W@\>M '7$98<#UIA0@8XP3FN)U#QY<Z;#KUQ+IR
MLNDWD5NZB?.Y'QAQ\O'WEXY[C-6;C6]>_P"$@TNSDLK>WBEDN&;]Z6+QH%"G
M '!)<'';'6@#L,=N*"!GC&ZN6\;ZKJ>FVFDKIBQB:ZU*W@9Y#@!2XR#[$ C\
M:@O/%]PL>KW%G9+<1:*-M\X8*6=5WNL?][:IYSCTS0!U9<*K;@O Z'H:5<2#
MS!MPR]0<USGB.>TUCP%=WP#&UN+$S*".=I7(X^AJEHOB"XL#I6G:G8_9+.>T
M3[+>&=664K&&(<8^4[03U(P.M '9!2&' Z8)]: .64 ?XUS>E>)[C4-0L%_L
M]Q97\1EAN$);:-NY1(-N%RO3GVZU?UC5WT^XMK2V6)[NX#R*)B0BHFT,20"1
MRZC\: -<CTP,]Z8<X!55ZY-<K_PF,T5AIVH7>EM:6<]Q]GN))VV_96R1N;('
MR$C ;CJ#5N'Q)+)IVGLVG>5>:A(RV]L\G! RV6;;P-HST/XT =$,!0..*3:
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M,E=C8P1U.>,<YQS6CH>LVFM6<DMKYJ^3*894F7:RN.H/^<4 32:18N)1]EA
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M#RSMVKU^;I^%:#9.%#C=G/X4 .;D4+TIU)0 M%(#FEH **** "BBB@ HHHH
M****  T@ZTII!UH 6H9NW^^O\ZFJ&;M_OK_.@"1>IHH7J:* '4444 %%%% !
M1110 4444 %%%% "4"BB@!::P)9:=10!RWCJX6W\/L'MGG5Y8T.Q68Q@NH+[
M5Y;&<X[XQWKC6^WV_P#;0T]+VXMTU"VNKE!&8S/;8_>!0,=<'('8>]>M$#.>
M]-;8?O ''/2@#S74XM&U#POJ-QI.DD6OFVTS[K9ERPE&_$9&1A <D+STYK2@
MN+"X\?QA+,QV]QHWE@-'M5_W@PF.V!GCT-=P=J'><Y(QG%(%4$$'D]<#K]:
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M=O%$3Y:[3C&0.U 'F2ZAI:V4-WI>IW%SHMQ?0?;Y1A(E0H^1E<;3O\O?G'#
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MPO0_G6A)XCGBN)X+BQV2QV)OXPLF=R X(8;>&'MD5G7/@Z_N%\4(NHPI'KD
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MB@+TH &4,,4$#=[GO1M^;-&.10 !1BEX 'M13<<T .P".128 7UQ2]12;>:
M%' IA&&)J2D(S0 @QGITYI3P.*3'&*4<"@!,#<2:"JXQ@<T$9H9<T )@ #GF
MG?+Z"F[*0I0 ['S>U+@>@I%&!2[:   #I2-CO2@8I"N3F@ PN?NCGVI<#-,(
MQ2D9H << 9-( #S05RN*-N%Q0 O&>M+3 ,4[-  /QYI  ./QYIPI,<YH  ,4
M@QG/.33J3&3F@ Z]J,#&,<4M!&: $. /6FE?D)[GUI0N#2D<B@!@X;&WJ.33
ML +G!-.-(* $ZGD'&.]+CK2]J0# H :&R2<'TI3SZTH&*,T (R[AU(^E!VY
M/Y4H.:8Z[F!H ?CBL6Z\+Z)=:H;Z73+=KE@-TNP?,1_>'0_4C-;0( I"JF@!
MD:A!@*0,X '0"G?=4@ T[M2=Z #ACC!II08/S-U]:=WHVT (44*0,@>QI0J@
M<"D*Y%*!Q0 N!494&3...E/Q2GD4 ,P!N]J<0%!..U)MH'I0!EZQH6GZY';M
M?6:3M;MOBWY^4GKT(].]:.T +MX4# %2X!(]J3% "]J!2 4Z@ HHHH ****
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M**** "BBB@ HHI,T +1110 4444 %%%% !2&EHH 93NU)0* &D9-/ Q1BEH
M2BEI*  4M(.M+0 4444 %%%% !2 <TM% !0:** "BDI: "BBB@ HHHH ****
M "BBB@ HHHH #2"E-(.M "U#-V_WU_G4U0S?P_[Z_P Z )%ZFBA>IHH =111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&:
M "BC-&: "BC-% !111F@ HHS1F@ HHHH ***,T %%&:* "BBB@ HHHS0 449
MHS0 4449H **,T9H **** "BBC- !11FDH 6BD)P:44 %%-)YI6;% "T4=J,
MT %)2TE !2T44 %%%% !111F@!#0*7K10 4444 %%%% !24M% !1110 4444
M %%%% !1110 A% %+10 48HHH *2EHH 04M%% !1110 4444 %%%% !1110
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M?SI1]ZD?M_O#^= #Q12BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** %HS244 +FC-)10 N:2BB@ HHHH 7-&:2B@!<T9I** %S1FDHH 7-)110
M4444 +VIFWFGBB@! ,4M%% !28I:* $HI:2@ HHI: $HI:* $I1124 *:2BE
MH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEH
MH 04M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 &D%!H% "U%)U'^\/YU+44G4?[P_G0!(M%"T4 +1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% "BB@44 %%%% !1110 4E+24 %**2E% !110: "D-%%  *6DHH 6BDHH
M6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #2"EHH
M*CDZC_>'\Z?WIDG;_>'\Z 'BBE%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2TE%
M"T4E% "T4E% "TE%+0 E+124 +1244 %%*:2@ HHHH **** %I*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $II&?S!I32#K0 ^BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex10-2_008.jpg
<TEXT>
begin 644 ex10-2_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** #-)FEQ1B@!,T9I<48H 3
M-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7
M%&* "DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C-%+B@
M!***.M !1FC%+B@!,T9I<48H 3-&:7%&* $S1FEQ1B@!,T9I<48H 3-&:7%&
M* $S1FEQ1B@ S29I<48H 3-&:7%&* #-)FEQ1B@!,T9I<48H 04M%% "4444
M %+24M  :04II!0 M%%%  :!0:!0 &BD-+0 4E+24 %%%% "T444 !H%!H%
M!24M)0 4444 **#0*#0 4444 %%%% !1110 E,;[\?U/\J?3&^_']3_*@!YH
MH-% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 449HS0
M449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 449HS0 4E%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ***2ES0 E**2EZ4
M%%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:
M,T %%&:,T %%&:,T %%&:,T )2XI,TN: $I:2B@!:*** "BBB@ -)2FDH *!
M110 M)110 4444 +1110 E**,44 %%%)F@ HHHH 44&@4&@!*6DI: "BBB@
MHHHH 2F-]^/ZG^5/IC?ZR/ZG^5 #S10:* %HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!**** "BBB@ HHHH **** "BBB@ HHHH ****
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M*  TE+24 +WHH[T4 %%%%  :04II!UH 6HG_ -9%_O'^52U$_P#K(O\ >/\
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M4E "T444 %%&:3- !2TE+0 44F:6@ HHI* %HH%% !0:** $I:;2T +124M
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MFE% "8I:** $Q1BEHH 3-+3>]+VH 6DIJGFG4 &:*7%% !11FC- !24O6DH
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MM$(G+."2 4 'SC((^7- &T""#BA22,G&*YZ36["\DT.6VU*1$O9FD@6)?DN
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MM;VD\Z0M,T2%_+CQN?'.!GO7+Z=XZM;O04U[^R]1&G2AF,R1JY158JS,BN6
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M:?9M2GDN4F=6$B.[!BN!D$<8SD?2NYCN(99GC$B&2+&]1U7/0&I0"/3.>.*
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M/XU'+H.G-KHUAPYO @09E;9P<CY,[<^^,U/J&K6.EQF2\N8H1M9QO8 D*,G
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M%% !24M)0 O>H9?]=%]:F[U#+_KHOK0!***!10 M%%% !1110 4444 %%%%
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MC<?4\<T +*ZC2)) ZX$!)?=Q]WKFO/OASK>E:3\*-.:_O(4B"3!D+!F;,TG
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MPY_ICW<-QH,MR5VB,R2*8,,%(W D.W!/\JZ >&]*6.%$L8D6 ,(PHQL5L9
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MMU-XXTIWGA\G^S[F5(FBW$+NA!S[\KSZ9]:N2>$;.Y@U6&>ZNF75,+<@O]X
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M +?O%91DC[AQD?=]ZCU/1-9EU+6WL;NVB6_L(H5D<MYD;H) ",#IE^N<CL*
M+DGBZV^SZFPM[A)K"T%V8I$^9D(8@\9Z[3[TEMXL1-&T^XO+2?[9<VZR_9H4
MRQ.T%B!GA<G )(YXK$_X1?5C<WIBCTVVM]0TH6#&&1F,;@.-WW1OR7[XZ=^T
M\.B^*+5M(OH7TL7=M:?8[BWEED:.9/D.0P7ALJQ^[C! H Z2XO5OO#S7UI+)
M&LMOYD<FW#J&7(.#W&:YC1=2@E\/^#6U"_OS<W81HG1F(FD*,=LAYR,9X)["
MNIFCO#H4RLJRWC1$,N[ +$8(!QTY..*Y:T\-:S;Z7X2LRMMNT:=6G(E;#@1E
M,K\G7YR>W2@#5E\<Z5"]VK1WQ2TN!;W$JVY*Q'CYF/IR/_U5;MO$%I=SWMJ1
M=1/# )L20LK.AW#>@QDCY3VS[5S<OA;6#IWB2V5+<OJ][YL9,[?(IV]?DZ_*
M?SK9.GZK_P )8VJ"WA$$FGK:,OFG=N5F8'[O3YO_ *U &7#XLBLHO"%CIPO+
M^WU./BZN,EVB1 =[=RY)7MT)]*W9/%NEQZK#92/,AEN#:Q2&,^7)*%W% <=0
M._3T.>*YNR\):U9VG@W M3/H<3V\ZB5MK@HJ[E.W_9SC ^M12^%?$C7T%S))
M9W-U;ZD;SSY7.9(B"HC&$^3:#GC(SZ9S0!K2^*+?4-,\2+=?;=/M["1X&N(T
M.]0$0D@C.&RS 8] :V-0\06>FRFW?SY9E@,[)#&79$'\38''?W.#@&N>N/#6
MMG3/%FG(;5H]6EEFMG\UOE9U488;> -IZ9ZBKIL-5L]=N=8M((I%OK2.&XB=
MB"DB!MI'!^7GF@#1D\5:4DEH(YI;@W<#3PBWC,@D12H.,#D@LO'7FK6D:U::
MWIBZE:&0P_,"K+AE*\$8]>V*Y71?"=[X>O?#\-NJSVNGVMQ',Y8@[II4<E1C
MD#8PZCJ*TO!6CW^B:-<6=\J!VO)KA-CEALDD+@9('(SS0!(/'6B_8I+J:>6*
M%+O[(Y,+;DEXPC#&03D8[<]:R/'/B)ETBZCTB]E@N].O;,7#8P-LLBC;GZ$<
M>XJUJ/@VVU#7-1DG _LV^M@EU"0#OF&Y5DY'!".>1SE5/:J>K^&=3N? =O80
MI&^JW-Q!=7DK< R)(LC'H?[N /I0!N2>)M,O['5X5GNK:2QC*SGR666(,"!(
MH(.1U((STJC;W\TWB3PXL%Y++IMQI4\_SC!E*F JY'KB0_G4#:-J9USQ/J:0
M(5U"SCM;<%CDD CD8Z<]<GZ4_3]&U.&Y\.?N8]FGZ2UE<-O/WG$0^7CG B/I
MU'% &K;>+=*DU%+)KAUDF;;"TB%5E/\ =4D $_3TJ]JFN6.DRVT5U(Z-<R>7
M&$C+%CM+8& >RD_A7-:#8>(K.WLM*DM=/6ULL0B^60R-- AP 4(!5R!RV2,\
MC/2M+Q):7D^H:%-;6AGBL;TS2$-S@Q21C [\N#^% !+XUT9+4737$J(LWD3!
MH) 8&W ?O/E^3J/O8%:-WXATVQR)KC[BAY2B,_E*>A?:#L'N<=^P->?3>#]5
MGTKQC;FT99-7U%+F!3*!N <-R3@?P]/YUNQZ'JNG7NNRP6JSVNM1*["250;>
M3R]A!SU7H>,XYXYH Z7^VK">_6R29G9\;9(U+1DE-X&\#&=OS=>A'K4>@:VN
MMV+7*Q21JLTJ R*5R$=DSSW^6N3MO"E_I^J:<^F1BWEMA!;RW(E!CNK>.$*R
MNF<EPV=IQD#'..*Z#PK9WVFP7-C=6RI!%=3O%-YX<R[Y6?.T#Y>&Z&@":7Q5
MI-M/)'/>)&(W6.1@K,D;MCY78#"MR.">]9^D:S/_ ,)?XM@OKM196!MO*W8"
MHKQER?U_2JFG:9XBT#5-8AM+2TN;34[QKV.Z:?9Y#N "&7!+8PI&.N,<56U'
MPM?ZIJ'BTB$0?V@('LYFG&&EA3 W <A<@?AZ4 =9;Z]875S)"L[QRQQ&9DGC
M:+Y <%AO RO/4<=*8OB+37,CFY:*..,2NT\;Q *3@$%E&03Z5C7UCJFI7=OJ
MOV1+:ZLM.NHXX9Y58332A-H.TD>7E3U/<<5@W?@C49]-OK+2T?3K62*":&QN
MYQ+"DL<H?"X8E4*@@\CD@@4 =)K?B:*3P[K-QIEV8KNPL)+H))&R2#",5;:X
M&5RO7D'%:5CK5K)]DLIKEC?36RS[60C<,#+ XP0"PS@\9'J*Y^[M]9U30-6M
M3X?M-/EN=.EMDCCEC=G9U(#9& J#)Z\G.<56\21W5EX:T>_MG2WUG3YHX84<
MA]WFXC9..HVDMQ_<![4 =OI^I6VIVQGM7+(K%#E2N"#@CD#O5-/$&G?:#;+<
M!K@E@BE6"NR]55B,%N.@)-6M/LAIVE06RD?N8PN?7'7^M<AX<T[6--2TTJXT
M:U:.Q8H-6\Q"9(E/&%Y;>1P>F,YR: $BU^2X>\U5=1GAM=/O'C-H+3<K(GRL
M"<9W,V2"#QWJWI&K2V_DZG?:JT]M>0C$#6G[U9."VS8"S)@],'&1S45I;ZK!
MH&M0_P!E/_I5U/- F],LLA) /S<=>]0SZ9JJ_P!@WXTH7ALK-[.ZT]G0,V[R
MR&4D[>#&#G(R/RH Z6+Q%ICVUO>"Z22.Y4M%Y.9&<#K@*"3@CG X[U#/XIL1
MJNG6<$AG6\C>598@60HO4@CJ<D ^F:P9M-U;3=;L?$=EI4<\HM)+&;3+>=%\
MM3(9%92<*6&2&QU]ZLW,6MR:MHFIKID;311W,<L"S*JPB8H5RW?&SG .<]*
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M4_U)<@ L/3CKTYS6KH-E-IJ6NDZEHMY<7=E=$I?%%-NZ^8664'=][!Z8W9H
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MSC@\9H [^"]M[QF6"YAD*<L(Y Q /3..F:S[W49QKMOIEM&KED\^=V/$,0.
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M%% !24M)0 O>H9?]=%]:F[U#+_KHOK0!***!10 M%%% !1110 4444 %%%%
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M- "T4F:,T +1110 4E% H **6DQ0 M)110 M% H- "4M)2T %%%% !24M(*
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MCYJ4'<,T=Z '4444 %(12T4 (!@4;>31FEH 0#%+03@9I <C- "T@&*"<4M
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MR?6@"8=!10.@HH 6BBB@ HHHH **** "BBB@ HHHH 2@4&B@!:8Y.Y?2GTA
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MFN]5EL+Q/O8:+>?E.!P=GIT-=%!X9U&WUG3]2.J&:2VAGCE,R<R&9U=L8.%
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ME78R+"9O-9&&,;^H!!]Z75/"^KWVE^*]/C6U"ZLJBV=I6&,1I'EOEX^X3WH
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M1I]W:+)))J$AC@MN!(Q7.\<G Q@Y.>U1>";^ZOK35WN))G,.I30Q)/C?&@.
MIQZ5RVB^%M=TE_#NJ?9%:73C<V\UF9DRR3.3N5LXW#COSTKK?!]A?V2ZL;^
M0M=:C+=1J'#':QR,XZ&@ U/Q?!ITMVWV6YG@L2B7<D2C$<C8PN"<L?F7H#C/
MX5+>>*(K,3!K2YE:U@2>\"@!K=&S@D9Y.%/R@D\5R5_;WMUK>NRVNG7=[I<M
MPGVE+>XB1&:-5)/S@-D$ '!QQCWK2LWO9;G4=5L+%KW3_$-O#+"K,J/"PBV8
M?/\ "<*>"<<\4 ;L_BFPBLTNX6>[MS"+F2>WY6.(D[7(SD@X;H#]T^E%WXFL
M9%6"T\^[>6W%SNM> D1^Z^XD#GL!R?2N9TCPS>^'=$>S@B.H/=Z5'8;U(5$D
MC\W!;)X4^;U .-OO2:+X=USPA<QP6T"ZG:3:=;VKR(P5HY8E*YPQ'R'/8G'I
M0!?\(^+%?0_#5GJ,L\^I:E8?:!*1D3%5!<#WY'&.XK6LO%EG?6,=VL%T%ENO
MLHB9,2(^_80P[8;@^E<U8Z'K%I\.="06<<6KZ0\)B61U/RC"L-PR "I.?I6C
MH7A:?2==EAWEM*A=;V L<L]PT9C;)[CJV/5@: *FO:S(OA/Q!>:;=74<UM>B
M*1G/(8;,A<CA<,/UK3:_O!\5+73A/(+)M'EG,&?EWB5%!QZX)K%O],UB[\->
M++5;#%U=Z@)8$#KRI6-=QYP/N$\XK96SU*7XD6NKM9,ED-+>V9BPRKLZOR.N
M/EQ^- &YJ>LV^FSVUL5EFNK@L8H(4W.ZK@L1T QD=3],USVO>+R?"HOM/BNH
MY);I+8Y0*\3^8$96!Z-U'?FI=;L-1M?&^E>(+.(74"6\MG<6X8;PK$,'0'N"
M.>G%9M[I6H-HMYY.GRRR7^J1WJ0Y5?*"NA.XD@ G83@9Y- '36EG*]E>$W5R
M8YR7C68@O%Q@@''3()YSUKSS1O%NJGPQX6U!=:>]U._NDBN+1T4^;$SD,0 !
M@J.<C\:]2NIV@TYY/(DDDV_ZJ/&XGT&37,?#O1KC2/"5A:ZA8+!>VRL&;@YR
M2>".W- %R'QOHT\\RQRW!BMGN$FE,#B.,P@;PS'[N/?KBK5OXHM+F;[.(;F*
MY> SP0S1[#.@_B3GGZ=1D9'-<SI&@ZG-X6\3Z<]N]E<W]]<W%OO*D%7;*@X)
MZ]Q[U/<V&I>)?$WAO4S97&FQZ4)Y;E)R,NSA0%7!.Y<J>>F"/I0!<T?QO#=^
M'[*_O$:.XOGQ:P)$V9<\A5R>2%ZG(&?2M"#Q=I5UI%OJ,4SL)Y?L\400^8TH
M)4IM]<C'H/6N.L+;Q%8^'?#FFRZ/<1QV=P(;QH'C,SH%P&B).54G&>C #BLR
M/2K[2= TRT?3IQJEMK<US;"%T9S&9"S,BDX<8;!R1_6@#T*W\9:1<V=W.99H
M_LCK'*DD+J0['"J.,,2>P)_K21^,=-:UN;B7[3;?99U@GCG@8-&S8V@XSC.X
M8.<'-<9+I%QJUC<O8Z=?Q:I;ZE#JUQ;:@L<1NQM9 B["5 P" 3W&3GK5W4H;
MN^\/3_8_"TMCYUU:LL#H@E<QSJ[%MI/RX&!GGJ: .HN/$-A<:;J3/)=V:VB$
MW#/$4DA3!(D (.1U(X/2DN/$5MI=E:K(]Q<3- LQ"1EV$8 S(^!@#^?8&L74
M[2\N)_%I33IGCO=-BMXSQ\S@2@C_ ,?6F,-6T768=231+J^M;ZP@MYH8@A>V
M,9;J"1D$-SCTH [*?5+.WTHZG+<HMIL#B4_=*G&#^.1^=9)\667V6\FE:6U:
MS?RYXYX64H2 5]>""#NZ?2C65U >#YQ! KW0C4+#"@; !&X(&&"< XR .G2N
M1U/2-0;2_%<-MI5ZQOA;F(SL&9\*,C.2=W'_ ->@#N;?Q#87MU?6BM-$]BHD
ME,L31@IDC<N0,KE6YZ<5CVOB![[QOI\<)G%E=:?/-$KIA6"M%AUR,\AC^&/7
M-4M?T>_UC4-8CMK:6W^W:$+>*;( 63>[%3[_ ##\Z=;75]>>*-%OY/#M[:K%
M93VKY"[8V)C/0'&W]V0"/;B@#IM3URUTZXM[1F9[RY!,5O&I9W4?>(^GOBJ,
M_C+2HX=-;[3\NI FV;RVPPV[LYQ].#SSTJGXG34WU_2UALIY]-\N3SY+/:)0
M_&%9CT0]\')KC+/2];AM/ ,$ND2BYTJYE$X."!'M*ALCMR#^% 'H4GBO2[>T
M6=Y953R([B4M$[>1&XR&DP/EX!ZXQCFMR-]R@CD,,@^HK@M3LY;'Q/J1N/#]
MUJUKJ'E26[0%-J$($9)"S A3C/<<UW-D"MK$C(D;(@4HGW5QV'M0!/UHS0<]
MJ8<^E #\THIK=*5>E "TE+24 %%%% "B@T"@T %%%% !1110 4E+24 +WJ"X
M^]'_ +X_G4_>H+C[T?\ OC^= $]%%% !1110 4444 %%%% !1110 4444 %)
M2TE "TPL0>G%.'6ANAH 861-S$X &234?VJ(.!GECMP>N:Y?5].L-2\=+97J
M1R176D2I+&Q_U@\V/ Q^9_"N7LA8ZG<W7]O:FUIKMCJCO''%M\\IOS$(\C++
MLXX]_3- 'J >%6V*%X'W!UQGJ!Z5*KJY91U'!!X->037MM-J&F:C972PF/7V
M25IW'GOR4<-G&V/T7GUJY',UKXCM+B1(]0^VWEP^G7L+,DT;D,?*G3'*KT!S
MC@<4 >HAD^:-6YYSST_SF@-&A5-RC=]T$X)KS&!YEU'P;<12-OU&PD75XXVV
M[CY&\O)CHP?C/7)QFL[P\MM!H_@+5EE+W=U>FWEE+ECY1CFRG7A<A?QH ]?>
M1-Q4X+CD+GK6/X:\21^([.YN$MS (+N2UVN^22AP3^=>;6^JVSZSX?O+"[E*
M3:[-$SS2?Z1(N'+K( %PH(50I!Z YJK#8VK>"M>U!'>#7+;5KD64B.0Z.905
M7;G&&/!R.ASV% 'K-IK/VO7=3TW[.R-8)$Y?=G>) Q&!VQM_6M.( IT/S<\B
MO/=9N;JSU7QK=63NLR:=9NIB)WX'FAB,<[@#GZXJ[X:32$U^.[TO68[E;VU
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M(QSD\]\T >P9'0TT;-W& >E></?7F=#UA#.+^XUV>RFAW-B2$23*%(Z84(K
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M;@D.LWE,SD;N<9"_B3BI8WNH(=!@FU.XF.MXEE>2YV ,L.X1(1R QZXY)]*
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M[\46\>I2/]ETR.^M971-T3,9<K@  K^[!R<GGK4^I7^IVDVDV?\ :,K3:S.
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ML0#TR>N*R+GQC':B*.YTZZBEENS8X.TA9-A<<@]".A]^E0W?C:WL[<2W%I-
M\*>=<P2LBO;ISC=EN6.,A1G@4 ;%AX:T;3IKB>TTRVMYKD8F>) "_.><>_I5
MZTM8+.U@M+6)8H+>-8XT7HJ@8 'T%<UJGC[3M.B>=$:ZBB@CN)/*=%*(XRO#
M,">.> > ?I4MQXSBM[J_MX-.NKEK*!+F385 9'&1MR1DX[<4 =!>6=MJ-I):
MWD$<T$@PR2*&!_ U3LO#^F:<RR6EHJNBE4+.S^6#P=NXG;^&*IZ?XHBO;^SM
M?L=Q&M["TUO-(% F5<9P,Y'# \@9&:@A\8VUQ?6MJMO*BWP8VDS,F)]BEB
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MJ6#P-?7ME=26\J1"2.:%MI49'?TQ0!I7V@V.HWL-Y.KK=6RM'!/%(R-&& #
M$'O@=?2JLGA+2LV)6!HQ8N9(=DS*-QZD@'YB<\DY)I(?%VEM=:A;O.4^PV_V
MJ61D(0Q<_O%/\2\$9'<&EC\6:9):75Q*9H5M8%N95DB8,(SG:^,9(.UNW8T
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MLURR&1YE,G&U6P/OKC&!P>E>C03PW=M'/;2I)&_S+)$VY6]P1UJ8CYQ\Q^E
M'"+!>)H7@^'^RK@-:S0-<H(N8%CC*'*Y]3D8IFH6][<:/XRC&F71>_F#VZ+%
MN+@P1Q\'I]Y"?85WI9"YCS\V,X[XH3;CY01CB@#!\002:OX&U6&&VE6:ZLID
MCA8$,69" ,'H<XKFK6RU*'7= UJ;3KI+.WT\V5Q;E TD#\?O  22IZ9'.!DB
MO1,J$Z' ]:0[6&U@<-UR* .<\)6,UC9:E<3V\ELMW?2SQ0N,%(SC;\H)P3@G
M'O67H%A'=>)_$$M]HS".ZF@DAENK;@A(43^(?WE/\Z[5QDD') ['TJG::C9Z
MEYWV.3?]FE,,AP1AQC(Y^M &!>64]SJ_B**UB> W6EQ6\4Y4A ZF?OTX$B_Y
M!K'TZTOKC0O!VFR6-U%?:1<1?:G9/E411,C8<95@_'0]QG%>AJJ<D#D]0:IZ
MCJUAI*J;^YCMDDZ22,%7/ID]Z .%MUU"U\/BU_LB^1H=:F>0K:B0B*2>5Q)&
M#G) *G(!P3ZBFSV\UEX>U(2V&HQRKKD%S"A0RL^98SN S^\QR2.Y&*[RRU/3
M]5B#VEY%+_?5) 2OU /%/OM/M;YH1<QL[1-OB979&1L$9#*01P30!YS<W@U&
MSU=+6VOWU>YN(+YK.XM&MVGC@,0=$#<'*)C)/5NPJ6^0:SI.J7-CX7O[9KBW
MB0O>PE)I)%D'R;#DE0HSNZ5W\6F6MK=+= .90I022R-(P4\XW,20,^]7 D:H
M% ^7.>M '"7=M(_C2^O!970MIO#ZPYC@=1Y@=V"#C[VUL8Z]JQ-!34-'A\*7
MMYH=_+:PZ0;.:)+=FDMY..2F,X.,9Q^E>K>7&><9I< ]^* .?T:\^R_8+*/0
MKBSBN3*RA$7; !DCS-IPK-^/)Q71DX&:;A20^.15:\U"VLI;:.>54>XD$4:D
M@;B?2@#C_&(F?QOX0GBM;B>*SN97G>*%G$8>(H"2 1R3^E3Z^&7XA^%YA;S/
M%!!=K)*D3,D9<1A<D# ^ZU=BT2MD$<'J*-@)YP<>U 'CEC8ZC'9VFI"PU%[:
MSU^^N)[2"-TE,,I;8Z@X)V[MW%7]3MH#-H=SI^@WT-M)K<=Q,TL#F1AA=TK#
MDJ.W."<9KU18U&2.">O&*7 (H \]UQ(+'Q!J'V^QU2>RU&UBBM_[-20QD@N&
M1MG0G<#D^IJS$BV?C310+*6WA72'MQB-F6!BT95&8 C@#')[5VNQ6 [;3QQT
MIY5&;H,COB@#R73]*O?^$%MM!FTJ6/6X-268N(B 668L;C=C!!7/?OCUK3LM
M-FN-%\>6UK:2QW5Q<7#6CM$RE]\6U60D#OD9%>C.JJP?;\W3=WI^U1T '':@
M#SW3M?TBVW:R-)UBW:VM/)GDNHI/W"AU&P*?O $[LKD *>1FNI\1LK^'M2B*
M&1I+1U557<7)4XP!UK1N+2"XMWMYD#Q2Y$B=-PQSG'6HK6[L=0,@@F@F^SOL
M;RW#;&QG:<="/2@#BK>&.7Q!X/G\AR(-,FA=_*;:CE4 !..#D-QUK0^&JS0>
M&)8;F*6&87UP=DD;)A3(2N 0.,8Q76^7"K* B#)S@"H;Z]M-,@:XN)(HE]78
M+G\_:@"Y2#/>H;:Z@NHEE@F66-QE'4@AAZ@]Q4B2JXSTYQ0 ^D.:"??%,+[7
M"=<T .Y%+T%!.!4*7,+W$ENLT;RQJK.@8%E!S@D=NAH F I:0'-+0 4444 )
M112T  H-%)0 M%%% !1110 4E+24 +WJ"X^]'_OC^=3]Z@N/O1_[X_G0!/11
M10 4444 %%%% !1110 4444 %%%% "4"B@4 +2-Z^E+0: .&\9W+>;?QPR7+
M3P:9+-Y<4WE)!P2LI(.2<K@#^5+I=RVOZQ:V]W/.ABTF&X,22N@F=V.6.T@D
MKL'!_O\ TKI+_0=+U6Z2YO;*.:9(VB#L2/D;JO!Y!]#5)_!^A[;5!I<&+7_4
M8X,8[@$<XSC(Z<4 <%X-NGETWPKI#7TEK:L;Z>7RI"OGLL[@(6!R.#OZ]O2K
M"H-/\/:J;/4I8UC\3 !Q,?W@:2+*DYY !QSGI7<R>$= :QCM/[(MC C[XTVX
MV,>K*>JGW%(WA/0XX)H1IL1@FD$TB#/S2#&&^HQUH XR],MAX6\=W5K.\%['
M?2LDBSL",+&<CGCOT]<5OF0ZOXGO=.N;J>*"UTVWD7RY&3>\I?<^01G;L7V^
M:M5O"^C3"[>2PB=KQ0+L$D^;@=QFIY_#VG74MO/);9F@C\J-_,8,J=UR#DCZ
MT <!X9UG5?$=IX7^V:C<VSS+=13%'(-P(BJJQ]SR<CGTKI?A[>3W/AZ]BENG
MN3:ZA<01RR,6<H&RH)/.0& Y]*VCH6G*;18K>*-[0?Z,$4+Y2\<*!VZ5/IND
M6.E+.MC;+ )Y/-D"DX=SU;'K0!P<]S<:)IGC"_CEE6X&J>3"X=FV(Z09."<?
M*"3D],>E:T=W<:5X\TW3HKR>ZL]0M9&?S)&DV.F,."2< @D8&!702>'M*EN[
MRX>PB:6\39<.2?W@QC!'3H!^5.L]%L[&5)H8,2*@C#%V<A!T4%B2!WP* ,7Q
M'+YVNP6BW5V'%C+,8(G\M%&5'FLX8$$= ,'EO:L*"6[UB]\)I)J]U'%?:1YT
MZ0/@RR;8\L6'0_-U%=IJ.@Z=JEY#-=6JR31 JKEV'R'JI /(]CD5%;^&=,LY
M;=K:V\LVT)A@*RO\BGJ.O?C\AZ"@#@],N]:N_ NA^(Y=4N7_ +,O)OMZI*2+
MBW29D)('5E501]".]=CX7N)=2;4M4:29H+BX86Z.Q*A$PNY<] QR>/:F3Z&]
MCI!TCP_:VEO9S^8DIFD8B N#EE7!W9+,<$@9^IK?L+2*QLK>TMP%@@B6) HP
M %  Q^ H X!]0U#5;#QE??VC=6MQHT\L5I%&^U5$48<.5Z,')/WLC XJQ9_O
MM4UK4&>;S9-&M9]C2-M!=9LC:3@=.GO747?AK2;FZDN)K/?).H6<JS 2@= X
M!PP^N:?/X=TVXU!+V2VS<+#Y.]79?EY&, @=&89Z\F@#C_#BWVGR>#B-1NI(
M[[3=LMM(^8QLB5AM7'!X//O4OAVXU"_@T+7SJL4=O=1?OH7N&99&D&0B(1A"
MAX&.PP<UT\/AO3;?^S_+@D'V $6H\]_W0( (^]SQ@4RT\(Z/8:A-?6MJ8[B4
MLY(E?:KM]YE7.%8YZ@ T 4O!L-U=:;9:M=:I<W4K6QA,;,/+^]PV,?>XQG/?
MI5%A>W?C76+8:M>QVUA%97R1Q$#<29MT9R#E&V#/?WKJ=,TNVTJW%O9HT5NI
M.$+EOYDXIL.BVD.IS:B@D^TSQB.5C*Q#*"2HP3@8W-CCN: .9\//JU_;:%K<
MVI(D-Y;>;=1M-E7:1,A47: I5B.^2 0:RM/N=5&C^&;Z36[J6;4+A[642X*%
M"LASM_O#8,'MZ5UEGX.T2QOFNK6R,4A+,,3/M5V!!9%SM4\GD 4Y/">G1VMA
M;JLWEV$QF@!G?Y6.>?O<\,W7U- '/B]O?[1M=!AO+AW+7K>>\H6218W0!-Y4
MX.),Y S\E/M+G5?M^A^'[[5<RF.>2>XMVPTHC90J%B/O?,=VW'3M6S?^#](U
M*%H+J&64B8W".)W5XI#U96#!AGT!Q3I?"&F26]I$D<D1M2S12I-(LBLWWFWA
MMQ)[Y/- '#&\U#2?#<\]M?-'(/%30S. "9$:<*0<],CTK3GO=>UZ\UB?3=16
MT_LR^,*K+(J1HL9RQ=2IR& ^\>@R170R>"]*FMI+:2*4V[W0NRHN),F4'.XG
M=Z\U)=>#='N]4?47@D6XE&)S%/)&)QV#A6 8#WS0!SZZM>V_BE;?5KBXMOM%
M\XLI82K6\\11ML9(^Z_.[YN3MX-6?B/ )--T='N)(D?5[1&V'ELR#!_ X-;/
M_")Z>UV)95DFC6X^U)%([%$EYPP&>,9/'2K>N:):Z]IZVETK!4D25&1V1E93
MD$%2"/SH X'6'O[?6?&ES9ZA<6[V&D6UPKQA<R.B3L-V005)'(Q^-:'B/6]0
M&E7%[;7DD<T.EK=)!;X 1\$[I&;Y<' PO4C/'>MZ3PK9W2ZA^_N"NH0BWN1N
MSOB&0$Z\<,PR.?FIEQX'TJYB>.19RLMHMI.1.X\Y%&$WC/S;<G!.>IH IV'V
MFY\<QSM=.K'2(96B!&PEG<-V]AZ5-XEN+U?$V@V-I?-:17_GI(R(K'*Q%@>1
MZBM"/PY917UK>K-.)K: 6X(G8!D!R W.6Y.>?6IKW1+;4=6T_4Y'D\VR+& H
MV%&X88$=\C(H X6XUG6['P^-5DU4RG3]9>P"&%!YT8N3%ESCJ5],<@'FM2YU
MF]CU[!U&26--5@MC%!$/(B1MJ['9AEG))/RDX('3I6M-X(TN73I+&1KMK>2]
M^VLHF.3*6W9SV&[G%)+X'L)YKF1[O4%$\XN3''<E$28$'S% Z-D4 8M_JNKZ
M?JNM:++=2/=SQ1RZ1,8TQF1A&%/RX.USSG/R\FMOQ3#(OP^U."Z?SY5LF#N^
M!N;;UXP.M2+I]YJ/B"RO+RVAA336E,3>?YCR;UVY(VC:,<]3S^=;5Y:17]I-
M:SQAHI5*LK="#0!Y_INJZGH%IX9NKB\:?2[S3L-9^2,PF.V\T,K#DY"$8/<U
MHZ!?>(-0N-&U66:-]/O82TR,R!5W#*&/&3Z @GU-;=AX9MK-X TUS<1V\/DP
M1W$F]8QC'R\#MQDY/O4&F^"]/TJ\6>VGO?)B=I(+22<O! 2?X$/3J?IGB@!?
M$<\L5[IT$5TT/VB1PZP#,\F$) 3(PHSR6/' '>N>_M[4H_#6@:]<7[+9"Y:'
M4B(TRT9D9%?('&&"YQQ@FNKU7P_;:I?6=Z9;BWN[3>$FMY-I*.!N0^H.%/KP
M,$57@\):?%X<N]#?SI;&Y5U:.20O@,2<#/N?\<T 8LVHZE<3J(M3:&VO+RX6
M/RT#S,J!539Q@)N#L68]U&3FGZ9K6H:AIGA&>:<!=1D:*Z1%!5P(9&]R/F0=
M#6TWA>Q;^RFA>XMSIL1@B,$FS=&P7<C>H.Q3ZY YJ#3O"%EIT6G6T$]YY>G3
M--"'D! R&&WITPQ'&/K0!ST-S-IL?BRZANX;1VUH)YTB[B 4C&%7!W,0>!@Y
M/:J.O:G>7GA7Q##<2M,UAJMC' TJA796>VD&[''5SV!]>:ZZ?P9:3I>@W5TC
M75TMX75ES%*N-K1\<$ #KFHF\#64B7ZRW-[-]L\LR&:8'+ILQ)C& W[M>>G'
M0"@#._M/4K3Q9J7A_4;A;NWETLW\3"$(8SNV%..HXX)Y^M9_A_6[^YTK0M!T
MX2131Z#;74DJ"/(RBJH&_@C@Y_#UKKU\-6[+<2/=7;W=Q$(6NW<&58P<[0<8
M SD].]4IO!%A+9:=#%<WT$NGQFWAN890LODX \MCC#+PO4=@>M &II3:G)H,
M0U%8X]2" 2^205W#T[?AVKC/#^I7]OX=\-V O/\ 3M8>7,[1+^[5%=V(XP6)
M"]<]2>U=]9V26%C%:VY;:F?F=MS$G)))[DDDU@Q>!=/CTN"R6YOA]FF,UM-Y
MPWP,<@A,C 7#,,$'(/- ">'-8O+G7-=T.\82RZ8Z;+D+M,J2*'7<   PR0<
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MLHA/$A'G13R(!D$G!P6'7MVK0\0>(]6\/FY9FLS%;0)*B$$O<98[C@-^[4#
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M5M;3B&Z2":Y-K]H,)\M)0Y3:Q."I+#'3J14VJVU_/XITB^M;)VAM5F267>H
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M G.G+/)9M&P5$W??QMSGJ,9S@=*O6_B"QN[#3+E9'*:CC[*RQM\_RELXQD<
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M];M]MIXBAB)%@-4L9;8Q\KEI(O-V8Z8[^F37I&EZ;8Z7:&"PMH[:W9VDV(,
MDG)/XT 7CTH%!Y% Z4 +1110 E%%% "T4"@T )2T44 %%%% !24M)0 O>H+C
M[T?^^/YU/WJ"X^]'_OC^= $]%%% !1110 4444 %%%% !1110 4444 %%%%
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M(PB!&#Y8+83@D?+BEB\.:;;?V>((F0:='Y=IB1OW2D;2HYY&..<UL9!'K2T
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MR.6.0=HZYZ=JV<"@@=30!A_\(GIGDP1_Z1NMY9)89!.P="^=P# @X.>13O\
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M3J P"MC<K*>"" /?C@BMG(]:1B IH Y>_P#"2ZAH=_IYOG\[4'5KJY$:DMM
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MI3#G)S\IQGC\^:=#X$E33A:G4\E=7;51)]G',A??M W=,D\]:[?(((XI<\T
M<9=>")#9:KIEGJHM=,U$M*\'D!VCD;ERK%NC'G!'4\8J:X\-ZDFH27^GZ[)9
M/=;6O(C DGFLJ! ZY^ZVU0/3@<5UI/(Z4CD =LT 8.FZ-/9ZY<:I+>B1I[>*
MW,3)R%CW$$MGECN.>*WE(I.&7WH Q0 I7)IP&*** "@T4&@!**** %HHHH #
M2444 +WHI*6@ HHHH *2EI* %[U!<?>C_P!\?SJ?O4%Q]Z/_ 'Q_.@">BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ I#Z4M)WH YS5+:ZC\7:=J$.GFZA
M6VFAD=2@,99XB#\Q&0-K=,GVKC;7P_JUGX>M+0Z3(;F/7&U)V#QDB(RLV<[N
MN"./>O4W4E@V>!VI<8 YX'6@#@;S2+J[N_$_FZ3=F&\FM9H1!*B.^Q$!(.[A
ME8%AG&<8[UM>#8-5@L+I-6_>/]H+1W+Q+%+.NT?-(BD@,#E<CK@' KH]O)<'
MD_RIP(;D4 <=<Z+<:W_;MQ?&ZM4NHS:K;@1-NA4, 0<'[Q);@@CY>F*Q&N-8
MN/A]#;:M92Q:O97-LMN-Z_Z4Z2J5. V.0,E21P#SW'I17A0#@"L_5]'L-<MD
MBOHC(D4@EC(=D9)!P&5E((.">_>@#@7DNM0L_%$4NE7<.IZI9#RH)(HU1U3*
M_*P<@G+\DX]LUIZU87TEQI&M66ESSVEO ZRVL,RPSHQ"@."3@D $8R.#^%=;
M8Z7:6+M-&)7E<;3+-,\K$>F7)Q5_[J]30!YLVA7&F&QU+3] O3:(]Q)-9QWH
M^T[Y?*Q*#NP6Q&PVAOXNO:FW&B2K?^&I+70[F""'4);JXCEF621 Z8#D[L9W
M8^52<5Z4QV\GI]*5CCG)Q]* /,KC3M0DT;QE'_9<OVC4;YFLR N9(RL84YSQ
M@JQYQ5O4--OCJNH0WVE:AJ=IJA5H6M;D1)& H'ERY8$8/(89Z\<]?0C\RDAB
M,CCVI"RJ55N2/:@#SJ?3[O[1XV"VC_\ $QLDBM<#[Y$;IM_-AR:U].AO8_%%
MA>-8R-#)I2V[2%P!'(K D$$Y/'H#TKK]P.?:@E3C/7J.* *NG7,EUI\-S-:R
MVLD@RT,N-Z>QQWJV#FF1\H :DH :32 XIQ&:7% #-O.:6G48H ;FDS3\4F*
M$!XHZT[%&* &YXQ2@8I:* $S24ZB@!O?-!&ZG44 (*&&12T4 -!QQ2^]+BB@
M!,9IFS:V:DHZT - SS2FEI#0 @-.P*,44 -/I2 ;3FGXYHH 0>M*:** &A><
MT;<<TZDSS0 AZ&D44^@#% "8XI .].HH 3-(QIU&,T ,V9YIQ&>M+10 @Z4P
MCG-244 -(W"CIQ3J,4 -X'XT@ '2GT4 -*[J14VT^B@!H3YLTI7-+10 T+BA
MEW#%.HH :%P,4ZBB@"-E.:=C(IPZ4@ZF@ QQBC;2T4 -*YH5<4ZB@!I!- 7
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MXZ4H.:89$#?>'''XTX-D@KR#W% ".Q%*IIU,8D$X% #B<"A3D4U6XYIW0$T
M+3 <,?>DR>IZDXI67D$=J ' YI:0G'2@GD8H ,TT-S2N<8Q0QQB@ W4F_GI2
M9PO-*&!( YQ0 _-%)D>M!(% "TUA3LT@.>U #1P*<*"1D9I: "BBB@ H-%(:
M "BBB@!:*** $HQ2T4 )12FDH *6DI: "BBB@ I*6DH 7O4-Q_RS_P!\?SJ:
MH9^1'_OC^= $J]**%Z44 +1110 4444 %%%% !1110 4444 %%%% "&@TIIG
M>@ R1VIV>*7VJ-N,#/)H 0N=U/4GO4>UP>V<U+QUH 6D!S2$DG II)49/K0
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M<*,GY.A]>M &ZGC2UEMH;N"RNYK=X89G**"\0E^YN7.<'!.1G&*-5\96.EW
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M#QIH^GW5]!,;EI+!0]P(H';RT(R6.!]T#DGD5M><MU9QW%NP>.0!E8=U/?\
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M$YQ\N01GKTH Z;4/%&CZ;/+;W.HQ13P@22I@LR(>AP.<5)=>)-*L[)+I[U!
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M!!'O7H1!"?(.] #CUHS0N<<]::XXXH =FDIJ'*DTX4 %+2T4 %%%% !1244
M*:2BB@ [TM)2T %%%% !24II* %/2H9ND?\ O#^=3'I4,W2/_>'\Z )5Z44+
MTHH 6BBB@ HHHH **** "BBB@ HHHH **** "D-+36.&'I0!@:SXFCT;6M/L
M)+269[]C' T>W <#)!R1QC)XS6Z9(QC>RA@<=>]<-XWN(H_&?@PO.L2Q7LK/
MNSSF)@/ZUC7]PC1^,;S^U+DR64ZO:?OW4(VT'H#@C.1@C'M0!WNJZTUE=BSM
MK5KN]>%IDA5U3*+@'YFX!R0!_DUH6ERMW:QR!#&9(P_EOPRY]17)#["?B#:%
MIV,DNE[U'GLNYO,!&!G]!Z]*PH=2NYO#]CJOVZ>+Q +\1W%J6/[PF49A(Z!5
M0YX]/>@#U!& XR,XH+(00Q''7FO,;F5X_"&NZTFLW@F@O+FU1A,Y15%U\O&>
MH&!GT..E7[B%&\=C3_[5O197.F"YDB2=QF0/C>I!RF0W1<=!0!W[.H7+, #T
MW<54N[ZWMIK:VN)%66Y<QPIW9@"Q_0&O,M$U[^U?#VB0ZCJS/(;*Y,HDG: 2
M,CJH;S!SO <87'/)ZBJ.F:F-3/P[U76=0#2AKN.:X%RRC(1@N2",-C /0G..
M] 'KEG<2SRW,4UHT*I(51F8'S5P/G&.@))&#SQ5E2FS"[2A_NG->?7VLW=II
MWBQK>]FG^SZC''O)):UB:.(N5ST"[G(^E&I3W&EW&LV^G7MP;(Z&]VK^:[^3
M, VT@DDC<,GCIMXH ]#!1?E&![5F:QK-OICVMLZ/+=7CLEO#&!N=@-QZD
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M/F!/8_2@#:35M.DO/L:7=J]QT\E) 77GNO45$=?T>*Y\IK^U\YW$2HLH)+=
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MQV6%;B:%;9O,@C;."ZGD=#QR>.E.NO%%C:QPLK/=^;!]H7[-&7)BQG?@=O\
M(STH TH;&UMK9[:&VMXX'R/+2,!3GKD#BF6^D:=:6[VUK8VL%N^=\4,*HK$]
M<@<&J-]XHTVT"DR-*/LXN6$:DE8CG#8_ \=>#P:AO?$=HUD@LI#<M<VQN$,
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M5W?VMC \\\D4*+_%*P0$^F3WJ&SUS3KVX%M!<*9]NX1$%6V\<[3@XY'..XH
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MWB6%&>)MK89K96&?H34OC#6]7T*UUR2TUB21["SCDACCA4^60/F>8E,'<2
M.<=AUKJ)/!VG-#?0EKD17MP+J0)*0PE#*VX'MRJ_E5>Y\!:1?27+737TJW=N
M+>X1KEL2@="W/)'J: ,J?4]8O/&NIZ='J_V2TBTJ*YB"1H620ELG+*<CCH<^
MV*K:7J.IZQ<>#KJ:_G4WFGS/,T80(90$P<%3SR?SXQ731^#M.AO);H/<//+9
MBR+R2%CY8]2>I]ZC7P;I<-KI5K']I6+3%9( DS*<,.0Q!!(- #-9GU9?$^CV
M<&HM;VERDZSA8T+,53*D%E..2/;CI6!8Z[K1TR6_GU@3"SUT:;M\A%\Z/[4L
M19\#KM)QMQ^-=C<Z'#?:G8Z@T]PDEB&6)%?"'(P=P[Y!Q5'_ (0G3/L5S9$S
MM%<W@O7)?YO.#;\_G0!AZUXCU*QUF?R[\R0QZC;PF*.%3#%$S!65W(R7).<*
M>*=J?B'5]%UW6;.6XEN%EM%FT@+&GSNQ6,IG;RPD>/ .>&%:LW@;3KB>YDFG
MOP+B=+AXX[AE02+@[@!T)(SFH_L=SK'B33Q/I+V]IHLTCI<SLI,[%&0;,$G;
MAMV3CE1Z4 :-^)HO!T_VR=IY1:-YLC #<VWDX  Z^@KE_#&HZA96GA:S^W)(
MEUH!F*2(%1'1( G(YP [9R?_ *W<ZC91:II\]C/O$,R['"'!(^M8Z^#-/2&R
MC+2N+.U:RC5R"IA954H1CD81??CK0!BZ9K&LWFOV4!OIGMKK3IG+K BQF=&3
MYHB5W%<,0-P((YYJSHFM:G>V^DVMU=$:A'=W":@-B@ND08' QP"S1$8YY'O6
MAIW@VRTV^L+F.ZU!WL8FBB,ER2"A_A(Z$=/R%7K'0+/3]?U+5X%?[1J C$N6
MRHVC'RCMGOZX'I0!S>B:MXDUB/1]8B95L;QR\\3O%L6)B=JK@;MZ\9R<$@\5
MO^)+NZ@@M([6Z>!I;C8YBC5Y6&UB%12""2=N2>@R>*K6'@O3])OFN;2XOEA,
MC2+9-.3;1N3G<L?0'/(]#5_6="CU>6QE-Q<6\MI-YJR6[[6(VE64G'0@XH X
M_2-?UZ]C\/Z9<W8BNKV:]CNKHQH) +:0K@+@KN/&>H')%6WU?7+;6].\,7.H
M0F[N$N)GOD50WE1D; %(V[V##/&!S@5</P^T\6$=O#=W\4D%S)<6MT)R9K=I
M"2^UCV.3G(.>^:GN?!%A<VUL@N;^*ZMY#)'?QS?Z2'(PQ+D'(8 9&,>PH R;
MC5_$5KJFF^'FN8[B]>*>XGGM516:)6"H 'XW?,I;@]#C%5]5UOQ7I<.G?VD[
M6ENR3I=WMG LXBDW 0M(,-M4CDX'K6]J'@:QOXK-EO+^VO;21GAOH9\3C<<N
M"Q!!#=QC'L*D?P? NQH-1U&*3RFAFD\Q6,ZL227W*<G).",8H RKOQ'<V^M6
M5O=WTMG;7"PFUNEMU>&X8_?5WP=C'[JCCJ#6QXQDNH_"-Y/97!AN BE9 .<%
MAD#\*1/"%K':_98[N[2V98E>'<I4^7C')4D9P,X(_/FM+5=,AUC1[G3KC>(Y
ME*$H<$>XH Y][_5KOQ2^A6NH)!+:6 N)Y/*4^8[L0G48"C!R  >:U?"FJW>L
M>'(+G48EBOD>2"Y5!A?,CD:-B!V!*DCZU4_X1(QZG#J,6H70OU@>"2X8H3*C
M-D C;C@], 8K7T?2HM&TR*QA=Y$3<S/(<L[,Q9B<8Y))H \T\/7.K:Q;^&+Z
MZU!9-1N+G4-D\D8)B&'7@# .,# X' K:C\4:FUA;Z<LIGU2;5;BP-S'&@.R(
MNQ<(2%SL3'7J<X/2M;2_ UIH]S:R6MY=>7:SRS01ML*IY@(8?=SCGUSSUJ.Y
M\"VTVF36_P!NO4N/MYU"&ZBV))%*<Y*X&,<G@CO0!J>'GUF2RF77(@DZ7+I$
M<KF6+/RN0I(!(ZCVKC;O28]0U/QG9V.FV\UW.84CE<JHA8P##\\\'GCGBNXT
M723I-D\)NIKF61M[SSXWL< #., 8  P!VJOI^@RZ?KE_J?VZ25KTJ98VC0+A
M5VKC SP* .?6[\0V4W_"/VD\ES=:?80N]P561IY'W@ EV&!^[R3R>>U*NM>*
M[KQ%9Z45LM/FN-*:\FC=?-\B02(I7(.&')&??/-:VK>%!JFM1ZM:ZE>Z==K%
M]GE>V<8ECR2%*L",C<<'&1FI+7PK!9^(+;5HKJY:2&T>T"2,&#JS[R6)&XG<
M <YH PX?&,\6M7\-[<Q0&Q%S)<6$\11_)3<4EC;^,$!2<=-U2PZ_K44.B:E=
MFU6WU:98)+=!DVSN"8\-_%R #GUXK3C\(I)>6DFH7DE]';/</&DJKQYRLK*3
MU*;78 ?3KBH[+P:EB+"V6_GDTW3I?,M+1P#L/.T%NK!<\9]!UH RX_$&O0V:
MW]U-8F--8_L]XHXF!=6N!"&!+<$9SCG.*MZAXCO[#6XHI)X?+;4HK,P1Q&3]
MVX&&=P<(Q)SCTQQWJROA!O[,DL6U&8J^H_V@7,29\SS1*!Z;=XSZXXI+CP=Y
M]Q.S:E=+"VH)J$<(5-L;J0QP2I)R1GVS0!6\)!%\2^*A%A5%ZF%7@#]RM07]
MI9/\7=.,MO"T@TB61<H,[Q*@#?7!//O6]H^@G2]6U*]$^Y;Z02M&5'RD+M&#
MUZ#O^?:H+KPY<S^+;?75O]DD-NUND?E J$9@Q![DY YSQZ&@#FK3Q3X@ELI]
M5FO;$6MIK36$EO' <RIYZP\$M\I&=W?//3I5G4^?$^NG6'LI]-MM(BEF@EC+
M Q;[@L.3P2$&3[#BKD/@B6/1[C3H]1=$N-0-_*YB4MO,GF<=L;@/PXSWK6'A
M^1]9O;^YN4EBO+5+2:W\H8**7(YSU_>-GZ_C0!@MXFU;26\/S7R02V^L7"0&
M*)2IM6D4N@S_ !<<'..1D52M_%GB6?PSKNO,=-2#3S>HD91B6,7W6Z\#@\<U
MK6O@>2.WTJWO-4ENK;29EFLHGC4%2JE$WL.6VJ>.G/7-+;>")K7PGJ^A_P!J
MM(NIO,\DIMUROFYWA1G'.3C/3WH 'UG73XBET:*6Q#S:<M[!*T;'ROGV,",_
M/G*D<KWJN_BG4[S3M*NK2:UA2_M26=EW,DX PJ1[@6R<^N !6W_PC\Z^((]8
M%\HD2Q^Q;/(&,;@V[.[KD#BLFS\#W%F=-\C6)HVL;=[8O]G0^;&S XYSM;C[
MP[4 )IVOZAJFH>&94N8([>_TJ:ZFB*$DR*8>ASV\PX_&J?A_7;I_#N@6MC%9
MP3WT<LC,D6V*WC0C)"@\GY@ ,]ZU+'P;-IT>D^5JLC2:;!+;1L\* -$^P[6
M'8QIR.>OK4$/@FXL-+T>"#4F%UI1D$,ZP##(_P!Y74MR#@=^V: *,GB_7H+:
M^M9(+5M2L-5MK2;:#LDBF= C+Z</@\'H:Z/0=1OY]7U73M2:V:>T\IU:V5E7
M:ZG ^8DD@J>??I6?=^#9[M+E_P"T1'<WEU!=7,@ASO:$J8P!N& "@^O-;%CI
M$]GKM_J<ERL@O$C0Q"/&S9NP<YY^\>PH S[K4]8O=7O+'27MXOL*([M-&7\Q
MF!(0 $8& ,GD\]*Y#5/$5QXEB\#7UM+&MGJ%YMEMG&[=(J29#]-RAEQCCD5V
ML^@7*:]<ZKIEZ+:2YB2*>.6/>K%<[77D8(SWR#Z50?P.D4'AZWL;CR+?191+
M$K1AB[X()8Y'7<3P.IH Z'3-,MM(T\6UI$D4:EF")D*I)R<#L.>E7L;E&:"O
MRD$]:4=*    8% 4#I2T4 %!HHH ;2T@I: %HHHH #24II* %[T4=Z* "BBB
M@ -)2FDH 6H;CA4_ZZ+_ #J;O4-Q]U/]]?YT 2+10O2B@!U%%% !1110 444
M4 %%%% !1110 4444 %,<?,*?32.0: ..\8:S?Z7KN@VMOJ M8-2GD@D+QHP
M7:A8$$CKG YJKI7C)[9-5_MB=+FUT^ZBMXKVUAPLN_/! )&0< G..1Q5KQ?I
MEY?>(_#UU#8M=6UG.[RC<H!#(5XR1SSWP*M^+-.N+OPFUCIMJ68M$RQ(1@!)
M%<@DD=E(^M $K^*X'1!';7PG9W58'@V.57JV&(^7G@YY[5E7_CRT2+09M.MK
MBZ&J7)@3&%*84E@P)^\".E6)K?4K?Q;9ZY!8F:VFLS:30(RAXL/N##<0,=CS
MGZUSC^$M8L8M)OU@\R2/Q!/JEQ;HP_=K(' "Y(R!D9^IZT =I:^*[*YU*&Q:
M.X1[AY8X69!MD:+/F $$],=\>U5!X]T@R6Q NF@N[AK6WE6+*R2KG<!@Y/0\
MXQP:YIM.U4^,M$UR339$BLKN\%U/+<JX$;HVPH-W" 8XP#GKZUG:1!-:Z/I<
M]WX<U-M+L;V2_M5BDB>.'YFP_P S[R,,S 8SD_A0!W]UXQTJVNDA<SF)[D69
MN%CS$DQZ*S9X]/3/'7%5YO'&G0O<H8+\BSN5M;B3[.0D;MMQN)/ .]?SK#T[
M0+[2+V\L_P"P(+^*>]EO(=0>1, 2/O.]6(8,N3C .>.G--U#2=4DTSQ3:QZ5
M)F_U&&ZMDW1\H%A5B3NX.8VXZ]* .HCU6"/Q'JT<M]A;.RAEEA>/8D0)D^??
MWSM/';;[T^R\16NH73VL)FCN&@\^(2QXS'G&\>HR1[U@ZGHVH:QJ'B)((FB@
MU+1H+:&<D#]ZAF)4C.1]]><8]ZTO#UUKMX]NNHZ/'8K!$$DD9U<N?1=KG [Y
M/Y4 )INMWVEZ18KXC<R:G>3-' D404R=2HP"5!V@G[WXUMZ=?0ZA8)>1B54<
M;L2H48?4'ITK$\76C:C'8VCZ;)<PM*7:X@E$<MHP!Q(AR.<^_P"!J;P]::P_
MA1K76)6-XZR1K*Q!<J20C-CC=MP3CO0 YO&&E?:+:'S)0+LE;:1HRJ3,.H0G
M&X_S[57B\?:#+%;2I-.+:Y=HX9V@=49QG*9(^]P>.O!K"T&PU.T@T_2[GPI:
M++IQ -[(T<BE%Z/'SD.>G.,>O:JMAH^KV>AZ+#-ILWFV>N37,HW1G,;B7#?>
M_P"F@H ZF7QUHMM927-W+-;K%,L$RS1%6C=CA=P_A![&HF\7V^J:9K*:5++#
MJ&GVSRE;FV9.-I*L P&Y3CJ*X3QK;W4-OXCO)[&:.WNM1T^2"1MH$H20# ^;
MCDC&<5V.H6]YJ=WJ-_;V,\6-)>SC1P \KN<\#/08ZGUH TX-?6+2-,:8R2ZC
M>VZS+##&69OE!8[1T SU_"I#XLTP_P!G+&\TAU$E;8K"Y#,.2&X^4@ D@X/!
M]*P;2RO=,U;1;][*ZG1=)6RN$0 R0."K XS@@E><$]!527P=*O@[5!<W4D-T
M=2EUJVQUMFSN"9'J-P/7[YH ZQO%.E137L<DLL;6<R6\@>)AND<#:J<?.3GM
M2)XITF:Q>YCG=MDYMWB$;>:)AU39C=GCTZ GH*YC4='U%/#&D:E:Z<FH7BW?
M]HW=G(P&]I0Q8 MQE-^%_P!T5!J-I?QV=IJ]GX16-(;X23V :,3W*/%)&[L
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M&D3WT,2/::VS3S64+^7*ODR#S0N"1DL..:BNIC+H?C+3KA"=6N+EIK1"&W3
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MQ<6%K%::C=36:;9F9UD02X;I@J?*QSSS^%:WA*[OKZ75YKUD)BOI8%5,X 7
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MI:O<>(]2M[N&W5+73K:62W64D N)BP#;>>5 SCIZT =.L%JT!DRCQL-RN<$
M=<BG*EI>1E]L4Z,2>5!'H?KTKSS6;V2[\+>"9-/MHX;*_OK)3;,^%"-&7$>
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M^O-/QITOV;4)C%#*KERHP2LC+M^56XP<GKSBNQ7..:  >E+2=#2T )BEHHH
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MEMK>GWD<LMO>0ND+;9BK@^6<9^;'3IWHM=:LKU9)+>Z@DCC4F0K(#Y>/[_\
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M:KI%QJ][;7:Z67>&6.,H\KE=NYAG ..P[UT_F1F+>)!LZ[\\8Z]?2G%D9>6
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M/W=H  Z9X_&NV VKBJ]E>V]_9Q75M('@E4,CCHP-6,@DCO0 W.:<*:1BE!H
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MA36]25FQGAED*@8]>,#OD5);ZC9+JFFL'BM8H]=N(WM74M*&82(7D<YQN)X
M && R:]+N3:VZF6Y=(X^K.[!5'N2:(IK>[5)+>=)5(R&C8,#^(]Z /)M<73[
M;PKKEY$T"7D6M^9'*&!>-?-1OD/TSP.#76Z!<VD7Q!\1P!D\^Y-M+%QR\8A
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MY0$QX+]Z .5\<&VCG\,W5XB"W35T$KR8VHIAE'.>,9(_'%8FOI:S:=XONC%
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MTZQC*I';1(R@A<(,@'KCZ]_6@#A?!LQL?$L>D7<=E<73::);?4[$ )<0*_\
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MG4]077^K3_KHO\Z )AT%%"_=%% "T444 %%%% !1110 4444 %%%% !1110
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MMKNW$Y%M+ A0F((I&]3T?);(XQ5)O!$\EBB77B+5;F\BDCDCN28U*['#A=H
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M1F-KD-T,HZ<<=/\ ZU)IOA?5;&[T*>;4+9XM'MY;552(J9(R$5>YPV$&>>M
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MN?N\YQ@]C6CI7B2+59H1%:S)#/'))!.=K(ZH5!R5)VGYL@'L#7*0^'-8BL_
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M5A;^);(6GS85=^PR[>V-QZ#CK0![3]K@^\9$ VDY)Z =2?05*)8]RJ'3<PW
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M(09R57]WN)&P,3@D8P#2SW5_9Z-KUM S1FWU6W58X;ABP@;R&DCC=L'<=S@
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MWI7A1W5W5<H<J<<C\:X>Y\=WT'AN\U)M,1Y-.O'M;^-9C^Z53@R [.0!ST'
M/TK7U#Q2FGW-\HMS.MI% H*2#]Y-,Q"Q\\#HISGHPH WVCCCP[;<CH2.G?\
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MK03F"-!E@JJ7<98 +\PQDY.1@9XK8TG6[/7M(@U:P+R6\BED^0ACCJ,'OVH
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MOO'MDECI-S90S7?]I7RV<8C7!1P<L&!.0<!N/6@#JK6"&VM8[:!=L42"-!Z
M# _05F'PYIC7#71ME,S7"W+?.VUI   Y7."P &#CM44_BJP@N7MU$KI'+'!-
M.D>8XI),;58]>=R]!CGDBFZGXML-(N+A;E9S%:A3<RQ0EU@W<C=CGISP#UH
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M#%O1F5MWWS\V5&?Y5U!O8([N*V>5%DE1G52<$A2H./\ OH?G4Q=2P 8\\<4
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MELY^;&,4^]\)ZE=77BR59+=?[<L([55WL?*94==Q.WD?/T'I7:&505#.%)(
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M+ 8W8Y_.G?9H NT0H!NW8"]_6@#S[Q9)OUV^M;R=FCETE?L'ES[#!.68;CR
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MJ6G6^J6;VMS%%+&Q!VR(&7@YZ&JB>&]&B2Y4:9:%+A0LR>0NV0#&,C'L/R%
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M^._,>F2-'!?Q&-?XRP1@Q&0-Y0'V)-=W:^&=+LH);6WMC'#)&T80.P6-#U5
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MN.>V*%P%!H <5SZ_@:!TQ_.C<,XSS0<=Z &%,/G)IP3!8Y/-* !2$@$ GDT
M(L>W^(]<TX@'(SUH.,9S2!0<$4 *5R,9-(5!7;DT[(SCO28&?>@!<4F.,9I
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MSGZU<37--EU(6"W4)G&\A,G)V?>QQ@X[@'(KFX)+FX\1>';N33[N#[-:317
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MCJ: .\NM3LK+2WU":XB%HB[S+O&W'KGI52P\0:?=Z%:ZD;N$131J_,@SEEW
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MI!'#<7CV003;I490Q#L ,8.W@>]/\(HD.M>+8T 6,:L"H XR;>$G]30!U 0
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MX'2NC\/:M+JD5P)K9K>6VE\DY)991M#!T8@94AO08(([4 ;+#OQ[YII'S Y
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MVXX(!P3CBDO?!VEWS7SRI+&M\@%T(IY%$QQC+ $#..,]:TK/5[&]C<P7D3E
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MB_E6@LJ,V ^>=OUIXEC93M<-@X^7F@#G[CPVO]KW.I6=]-9R7B*+D*H97*X
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MH 6BBB@ HHHH #2"E-(* %J&X_U:_P"^H_6IJBN/]6/]X?SH D7H**%^Z**
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M7=*O;V'QK:VNF7GEW)M);-5M\)(8PF\)VSD'TS7IZX=!N5<^AI57:,8&/YT
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M6NK0VC375Y;W5D28+N"0)+&<8ZXQ@CJ,8/I0!2EUO74O-)L#;V4=Q=1S"3S
M2HD09'1CP0<^OTJ"R\67DC6^E7*0+JKZ@]@[(I$.]8S*2ASG&Q< D9R1QCFH
M]1T8VNN^'H;:6_<69N)7NF!D8NZ8!=BI')^@],5K_P#"+6;6J0EYA,+G[:)\
MKYHF/5ON[>AQC&,=J ,67QK>V]W?:>T$/VZRO+.*5]A\IH[AU52IW;BPW<Y'
M&#UJY/=ZZGBG1+*Y>TV3?:Y7\G=@HFP+U_BPY]LU9N/!]M=6TRRS7/VBZNH[
MF>9=FYGC*E/X< #RUX ]?6M'4-#@O[K3[N:699K,,JF(@;E;;N!R#P=HZ8-
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M;@94=F;'^T/E/KWH ]%CN[9KN2U2>-KA &= X+*#TR,Y I!J-D]ZUB;J#[0
M#Y/F+OYY^[G->9Z:ESY.B6[@Q^)[?4Y_M8'WG1E<EC_L$>7STX%6?"=U87&E
MZ?:ZI&9?%-E<SO)&,ADG9FW,Q_ND'.3P1TSTH ]!34[%KM[5+NW:9.L:R*7_
M .^0<T^/4;.:X:WANH'F0 M&L@+ 'U .17DWAQM-O;+3(Y;B]D\4:9N!MXH@
MC+.R'S&<A<E"Q+9)YSWZ4WPH^G:AIFCQ_:KYO%>GV[#[*\ 22.8J=_FL5W$'
M.>3SGC)H ]*U/Q#!8WEE;Q%)Y+F=8-B2#<F[/)'7'%30:DHGOFG$4,$,P5)3
M,I#@J#D_W3DXP>>]>=:->:7_ ,(WX6:5E&J0ZF@O1(P$J7!#>;E<Y +<_0YI
M=46P;1?%\;>7L.LV[LN\?)GRAGKQWH ]02ZM[CS/+GB;RB-Y5P=O?GTID6H6
MLQ*0W$+L#MPK@Y_*O/\ 5$TN"\\8V=E<16,,NA02AH".H%QF0 <D[=O3T%0^
M')M"O/$T&NI=Z1#<V^FBW:SL[A9'X.=P'WL!>G?UH ]0&0N6(XK$N?$2V6EW
MM_=PK#%;LX4^:'W@' Z=">..U7-)U2RUW1X=1L[A;BSG0LKCHPK@M4:S_P"%
M?^(/+%N NI/LQ("!NF&#GZ&@#M]'U&YNA<?:['[*D3XCD$PD5UQUS@8]"/U/
M6K46IV<ZN8+F!PA^<I(#MY(YP?8_E52\6SA\-WYA(AMOL\C%X #M7:>5'0\=
M*\]N+>:/PMXJT^XBL[NY&@EX;ZQC*+<Q*)/+W+T#@Y/!(.<T >J+*IG,7F)O
MV[MH/./7'I5>;4(_)N#;M'<2PKEHDD7=TSZ\?C7"7VO6ESXHFETF\AGN9M F
M2!X90P,H<$*"#U]NM3>'[WPS?+IL^F7(DO$LY$N/+D;Y?E&[SAGAMP.-PZDX
MH Z_0]8BUG2K*]"B)[JVCN!$S L%=01D?C3]9U:#1=->]N>50@!01EBQ"J!G
MN20/QKS707BAN/AM<^7%'//I[12RN_S,/*C 7).3SG _*NI^(BVW_".(UPD+
MD7UF!YN!@?:(\XS[4 :>FZQJ%U/<I<:0]MY:%XV%RDBR^@7!SSZD"DL?$,FI
M:5IFI6VG2M'?.JLID4&$$XW'GGZ"LN-[6W^)GD(8H\Z.A"@@  2/T'TQ^%<G
M%(B>'OAW.719!J:("&X*$-D9^N#^5 'K(GA\SR_,CWC^'(SGZ?C^M DB+K&9
M4,G4*#R1]*\LMH;*WU._N+?8&C\6Q)$^[[H>)-P]@<M]?P%5DMK35-1NK"XO
MK#^T8->,OVAIU1_)#_ZK#88X'R\ CC@T >K7C"TLKJZ@MC<.L;2+$C &1@.%
M!/ )Z9J9;A=D9=T1G (5CS_]>N;\>[(_ .NP@%4^P3%=OJ$X _&L'Q=,XE:>
M-+2_LDT^(WUI(=LL46YOWD#="QY!!Z[10!Z%OCCAW\*">33_ # 6X8'(R.]<
M]XS\NY^'NMG)C5M/E92>"#L)7\>E9$FF6$'C&TMXU4I>:/*US'YA(G*/$%+<
M_-@.W7/!- '9^;$1YS.FQ,G=Z>M/4J$_=%3R3QWKR33+^SGT[P]9W<A,C:A>
MQ0P/,/LI6/<!YV<YVK@J/4=JJ^']6632_!-E>7Y^PS7UXMPZOE2ZN1#$V<X0
M[N >H5: /5-)\00:M=ZC!'#+$;&80R&0+\S%0W&"<C!%:BN&^8,"IZ$5XQ;7
M=IIUOXHAA:.&PDUZ&*Z=#N$$)5,D@'A3@J>F!FN_\(V-C87FJ1Z?J,=U!*8Y
MO*MT @@)!X3!/)QDC/<'O0!U=)030#0 M%%% "4HI*44 )1110 4M)2T %%%
M%  :04II!0 M0R]1_OK_ #J:H9>&'^\O\Z )**** '4444 %%%% !1110 44
M44 %%%% !0:** &TIS1CF@GY@/6@"I=6<%];/:W2"2-Q\R'OZ<]1ST(Y!JR-
MJ!8^>F!WKFM=U*]L?%_AVUMY%^SZ@T\4Z%1GY(F<$'J#D#\,US$GBGQ##I^/
MMMJLO_"12Z6'DB',6XA.F.<#DT >@SZ=:3:C#>W""6:(8AWKD(?4>A]^M2I=
MP2WDEH&5I8P&90<D ]#BN)?Q'J6E1:U:75W'=W5O=6]I9RB()\\Y"KN4<<%O
MR%-EDG\.>)-=U6ZF6<Q:+;N7*!2S^9+C.T#C/Z&@#OMJ \ 9)]*3RU)^7&/:
MN'U'5/$VE:9>W+O"(DF@:WEFC7>Z22*KJ55L#!88/7!YYYKJ-)M]2M;.==1O
M([J8R,Z.D(BVJ>BD D$CU]Z -$*D9)  +=<=Z1]CC:PSG\:\^T[QC??V??W6
MH^=!>V=DTT^EW4'E.LF0%9' YB)!R<G&>O%:1U'Q#8W3/*(&M);5I(YKEHXU
M2?:2% 5LF/'4GD8ZT =<I"(=\@VIU8]*CM)[>[B6>W:-XVY22,AE8>Q%<98:
MQ<W=UJ^F3SO>6QTI;Q)9+<1 EBZM@ #*_*,$CL>36I\/YE/@'16>3<6@QN)Z
MG)H Z945<X &3G\:QDT:UMM8?5#=.CNHA=7.%92>%YX^\W'?FMK@#/I7!>.I
M9]3NVT>UEN0+>V^U2_9X9)#YN3Y .P'&'4-SV6@#N'16P,=.V.M/90V&[CD5
MR5IXO^V^!K?7((PMU+Y<'EN.%G,@C8$#L&)S["H-=UO6?#$1^TO;3I<W-O;6
M,N2C>9(2'W@#!  R/7]: .SV1JC;5&.IP.II/*C9#E5;?][CK7&ZKK6O^'TD
MANVM91=W=O9Z=,B8.Z1L,9!TPO'2H=:U_7?#\&LP-/9NUM8?;;2:2$C< <.K
M '!.<8( Z\B@#NEP6)'([55^WV822?[5 5B;RW8N,(Q(X)['IQ7*B_\ $,5W
M8::]_;-/J9,\3+!M\B!%!=3UW-E@ ?TKD5>YTKP[XM<V]A<2?\)0JRI/!N1D
M8PJ#MZ9&X'/J* /8B/F!SP.U 7@Y/'IBN&NM;\0W.N^)=/L9[.WCTZUCF@:2
M(NQ9E9AQG';DYX]*LW/B*]DN;&UCN+:U\[26O_-G0D,Z[/EZ] &)/>@#K#-#
M$41I$C>4_(I."Q]A4B*JC Z#IQTK@8KJ[U?4/ FH:BL,4]SY\QB12-A:W) Y
M)Y%$?B?7RM[IKB :Q;:I#:#$7RM#)\RR8R<_*')Z?<- '>^4A!4@%?0C\:9+
M=06Y/G2I$O\ >=@H_6G1G=#Q(';NPZ9KROQ%YMYX6\4SZA=+<K#?.D41&1$5
M9=I'I]/4YH ]3$<;*0 !O'.!U%/\L$<]Q@\=17$W7BNZ\/7.MQZFT-S#9V\%
MS 8(]A FD9%C/)SAE'/'!K5T6[\02:G<1ZG"IL/*WPW C$9W9 V%=S>O!'IS
M0!O>?")?+,B;AV':G_+@G-<1K]I9CXA:*TFFQWADT^]#0B-26(>'!^8@'&2.
M3_%570[?7?#FESR7]Q#;VM]J$C0QS2^8+"!@Q2,#/SMG:H4' SQF@#O]L98#
M;G;R/EZ4&*)@-RJ0#NP1W]:\]C\;:O)I&A3)!;_:;_5VTV8,K +M9AN Z@?+
MG!S]:V;.;6'\3?9KR]M"T>G([I%&P5Y&=QD9.1RJ^O&1WS0!T\;131,ZLDB,
M?O*<@U(BC:O'0<#TKAM-\072>'=$CMK*&&:_$[LMM"SI"B$YVH""221WZGFG
M7?BW4["SMDU:"/26DFEA>\N4+0;EQL/#?(K\XW'C:1UQ0!VRX8EAP1D=*0?=
M8 X([U4LY;BXT2*7?"MS+"'WQMOCW$=0>Z_TKDM'U[4/[ \/V]S>137VLABL
M_EY$:*A=F(R,]@/=A0!W 5=A+@'/7(ZTA9(XV<OL7J21TK'T'5[C4I]0L[I$
M2YTZY^SS;,[7^575P#T!5AQSTZUQ/BBXU"[TOXB07=[%):VUJ$BBP?W8,9<=
M\9YY/L* /3H3O3._<.JM@4D4L=S#F)UD4Y^=#D$]^:Y#PWJ6K1R:39SBU>RN
MM+\ZW\M3O5X_+!#$G'._L.,=34">)_[&\,:3-,++2X+B>6*:?RV-O 0S<>VX
M]SQGK0!W!VB3_;QC=BD*H@0*=N>%4=ZI:3<37VG0W,PCW2KNWQ/N1O0J>X/4
M?6O/?&WB:YM]1N+ZQOL+H1BQ:)G=<2$9E'N/+8#'8YH ]27:Q)'3IC%#!7!5
MER*YR^\03->:+;:9Y6-422:.>8,8_+5 V.,<G=D<C@'K6;9>*=8O=&L;D6UN
M)[G4)+':KG"E&==QRO0E,_0]Z .TV!E..#TSBE*A4"Y.,@#BN(N/%/B$&\L;
M33;>?4["%'N%C+LDDC[B(TP,CA<[FXY'%%_XPU8BY33M)8W5G;133V\H=F:5
MX]_D@J,*V,<GCD<4 =Q@KDY)'I35B5<<<COBN+_X2_5;K6+K3;6Q@@N(M/M[
MW;>.P";R0RL ,Y&"/U]JDTGQ9?WUSH#W%O!#9ZS;&:W <F5,1^8=_;&/3F@#
ML-F&R6)].*58U7&!@#H,=*Y&S\4ZE<7UFZ:=YEA>[]K*DNZ( '8SL5V[6P.1
MTW#K46G>,-2O!H=W-86\5CJ<[VW$Q:17"R,"!@ K^[/OS^% '9LJN-C+D8QR
M*8)$1_+R=WICH*P/"M[J-ZFH3WUW',$OKF"-(UQL$<A0?^@_K7,7VJ:AI'C/
MQG?VD(N!9V%I.ZS3$(J*LC-M SR1GVXH ](#;@<9.. <4UHPV58YW=3BN/U[
MQ?>:9ICZE;0VZ6::<MZOVF0JTQ.2T:8!^957/?[XJ[)XDEA\4KI<\<4=I)I[
M7<$[.=TC(?G7&,?+E3UZ,* .F"8&,\>F*0QH-IQRO(KBX_&>I2V]K''I\/VV
M:R:\P6=D"[ML8^52V7!STXK=T75+G5_#,6I2V4UC=R0DO;W"G=&X[$>E &MB
M+ 7*A#QMXP:%A2/[HP.I]S7F-EKFJ:EX6\':E,PFN[K4E"B%RBN#%*<-QT!
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M$FIP+!( HPJJI4$<9SS]/:N;UJ+[!K-A9RZIJ%C;6%HL,-Q%8"Y6X9NJM\C
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M*8_+/.[@XP>XS74R7ELL!E:5/)!P7W< ]\GMBF37]G;6T]S+,BQ0(6D<M\H
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ML.!ZUKZ#_;)1WU6WM+0$!8K:W?S-N,[F+X&2V1QCC'O6N^'0KDK]*DQQB@!
M<XI330,4^@ HHHH 2ES244 +1110 &DI324 %+24M !1110 &D%*:04 +4,W
M4?[Z_P ZFJ&7J/\ ?7^= $E%%% #J*** "BBB@ HHHH **** "BBB@ HHHH
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MWBN*280RF71D)2<*1P>3@\?=/Z5F>'K^U0>!QJ,\:6::(5C>1P$^T@Q @G.
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MOWAC^\O\Z )**** '4444 %%%% !1110 4444 %%%% !1110 4A."*6D/44
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M86GE?89?-95S&I'SA2W//8U!X/OYVO[W3GM=.P@%PUUITSRQRR.QW!F89WC
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M[:Z3)<F2S>2.P=8[HI("X8A2=B8S(%# D\8]Z+C3?$MY8V=Q<?8#J-G>1S+
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MCU749;.:QT43Z9=28%T+E5*)G!9D(!Y R N:V7M[9]/,"HAMTCVJH/RX'O7
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MO#=_9XM5AMQ=H^Q&=9E5QC.2N<C/0\UT%[XST^TO)H''FPV]PD$\R.H$3L0
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M&A)$9C4@9ZG&.]6'M\VA@4#R\;=N!C;Z5S/@"1KC1+V3=<-G4[L W#;G $I
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MVYL$XX'7@\5DMX[T;[%/*[S!K:=8;B"2(I) 6.%WKVSZT :\6A:;!=27BV4
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M"JJDC,Q8*.BDYR1]:Z$G S35;<#Q0!E6V@65OJAU6.$+=LOEEP[<QC[JXSC
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MG0!)1110 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ !HIA)'2E4D]:
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M/OVGD $+RO!]ZJ>'_$^NOXWTO3WO7NDOM&:X9'($;W"D@R1\;A&Q'&<<#(%
M'K#.L?WC@>I-+@ [J\FTG6_$&HW>B1&^NEO;JZN4U:U"*5M40G!PRG: 0!GO
M^-6]+\1>)=;U&[NM.1Y+:VUQ[*52T8B6U3Y&R"0V_/SY]#CIQ0!W?B#7M-\/
M::+[5;E;>V\Q8RY!/+' '%:*%?+!CY4\CFN"^+FJ7VC^#!>6-PD4PNXD8/&K
MHZMD$%6!!%4]4\0ZAI_Q#&G:C/<VVFSS6XTZY1%,4@&T20MQG);.#VXY H [
MG7-=LO#VEOJ.I2B&U1E5W/;)P/U-:*2)(BNIX90PY[5P/Q=OIM.\#-?P2*LZ
M31@!T5T.3W5@0?6L'4/$FMIXS\0Z;!JK06MKX?.I(JQ(?WH4="5.!STY]L4
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MC(^M;("XP/K0 N2?7K0!F_\ "/Z6MQ;W*V2>=;1>5"P)RB8QM'H*J#PAHO\
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M:(-.T^R2R6*'3I/-M525E,+?[+ Y_6GMX1T=]3DU)87CO9(A&\T4S(64#&&
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MDH **** "BBB@ HHHH *6DI: "BBB@ I*6DH 6H)?OK_ +P_G4_>H)?]8O\
MO#^= $QHH[44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !BC%%% !BC%%% !BC%%% !BBBB@ H-%% "44M% "9HS2T4 )1FEHH ;2XI:
M*  =**** "BBB@ HHHH **** "BBB@ S24M% "4F:=10 T4M+10 E+FBB@ I
M,TM% "9I*=10 E%+10 E%+10 48HHH 2BEHH 2EQ110 8I"*6B@!*6BB@ HH
MHH 0T"EHH **** "DQ2T4 )BC%+10 4444 )BBEHH 3-%+10 4444 )12T4
M)FBEHH 2BEHH 2C-+10 E%+10 E%+10 E%+10 E%+10 E%+10 E+110 4444
M %)2T@H 7O4$O^L7_>'\ZF[U%/\ >3ZT 344@Z"B@!:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H .]13_>3ZU+WJ
M*?[R?6@"4=!10.@HH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *04M(* #O44_P!Y/K4O>HI_O)]: )1T%% Z"B@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@
MH .]0S_>3ZU-WJ*?[R?6@"4=!10.@HH 6BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *04M(* #O4,_WD^M3U!-UC^M $PZ"
MB@=!10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4@I:04 *>E02]8_K4U0S]8_K0!-V%% Z"B@!:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H .]0S_>3ZU/4,
MW5/K0!*/NBBCL** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "D%+2"@!3TJ&3EHQ[U-43\/&?>@"6BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:AE_@
M^M3'I4,G+QCWH F'2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB@4 %%(3SBEH **0G%
M)NH =12 YH)Q0 M%(&R:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %(*6D% !WJ*7_71?6I>]12_P"NB^M $HHH%% "T444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +WJ*7
M_71?6I>]12?ZV+ZT 2BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II;#8Q3J9_%0
M ^C% Z44  HI.E&: %HIN<TM "T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %(*6D% "]ZBE_UT7UJ7O4
M,O\ KHOK0!,**044 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3<<TZB@!!2TAHH *,4
MM% " 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4@I:04 +WJ&7_71?6I>]12_ZZ+ZT 2BB@=Z*
M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *04M% "#K44O^NB^M2]ZCD'[V/ZT 24444 +1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!29H-'>@ I:2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***!0 4QAET]J?33UH =1
%110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex10-2_009.jpg
<TEXT>
begin 644 ex10-2_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "C-%&* #-&:,48H ,TF:7%&* $S12XHQ0 E%&** "BBB
M@ HHHH **** "BBB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH .]1G_7+4G>HS_KEH >:*#10 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%&: "BC-&: "BC-&: "BC-&: "DI<TE !12XI* "BBB@ HHHH **** %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ [U$?]<M2]ZB/
M^O6@"0T444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% "&B@T4 %%%% !1110 4444 %+
M24M !0:** $HI<44 )1110 4444 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% "=ZC;_7K4G>HV_UZT 244M% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% "&BEHQ0 E%+BC% "44N*,4 )1110 4M%)0 M%)FB@!:*2B@ HI:*
M "DHHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $
M[U&W^O6I.]1'_CX6@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDHH 6BBB@ HHHH *
M*** "@444 %)2TE !1110 4444 +1110 E%%+0 "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***04 +WJ%O^/A:FJ!O^/A: )Z*!10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %)2T4 -S2YI<48H 04M%% !1110 4444 %%%% !24M)0 44N**
M $HI:2@!:**3- !WI:2B@!:*!10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %(*4T@H 6H'XGC/K4_:H)/];%]: )A10.]% "T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +1110
M4444 %%%% !12&EH **** #-%)2T !I!2T4 %%&:* "BBB@ H%%% !24II*
M"BBB@!110** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2"EI!0 M02_P"OB^M3]Z@E_P"/B+Z'^5 $QZ44'I10 M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F:,T +
M2&EIK=* %%-=BH.!D]J=_#7GWQ:U+4-)\'?VAIM[/:7*31HK1,>0S8.1T/Y4
M =XKD@?*1W.13WD$>">A[UQ^F13R:C:36>LW=U"A\F[1Y_,C.8BP8 Y(8-MX
MSW/%<G=ZSJO@_P"(LEMX@OKZZ\/WJ,+(^;@JW7!/&3U')&.M 'KA?D!1DTN_
MC(!/K7D/Q$OM?\)?#W3KR+6+M-1EO!YT@;=M#1R/Y8[8!4 '_$UI>*M:ECU7
MPI;:7KK>5>7L5O.L$P8R+\N22#D9SUH ]+\P$X&2,X--\QB<8QG[M>>75[J$
M7QJL=+CU"Y&GR63SM:[CM9@.,GKC/;I6+<Z[J \6^,]/D\1W%BFFP"2R)9>'
M**P4;\[N3T[T >N*THC^9<O[=*D!; R.37C6N>)/$T7P=L];FNKFPU@RJCE%
MV[D9B 2N  2,'I6]?_\ "11^&;S7/[9NDABT=)8%0@%YMI+,PP>G&.F<T >C
M;B5'&#WIQR%..HK@?A\=8U7PSH&L7.K7,YD\PW*2$;7'S <8SD$ ]:[+4;^+
M3+&YO[@G[-!$7?:,L<=@.Y]!ZT 65+-&<C#4]<[1GK7&_#_Q.^OZ3>+=,1J%
MI?3QS1MPR L608] K*/PKL<_,,T .HHHH *2EI* "BBB@!:*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *04M(* %[U!+_Q\1?0_P J
MG[U!)_Q]0_C_ "H F/2B@]** %HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** $(I!UIU-/WJ '4A&12.<"E'(% !CY<5Q
MWQ \,7_BOP^-+LYHH/WJ.TKD\8.>F.?S%=E36#;3MQN]Z .:L[+6[6YMU2VT
M^"%Y5:[F29G=MJ[<JI0 ;L 'G@5C^)O!EYXMLK]-4E@CG (T^.*9BD1S]\Y4
M?,<8) Z$UWJYV_-UII1B6/&?X: /,/$_@OQ7XJ\ V&B7T^FKJ%M,)'G,K[)%
M",@_ASN^;)^GO6QXE\.:KK5QX>N+2&UMVTR[2ZE$DK#>5Q\JG:>N.IQ7;?O2
M!]W-/<-@;<9SWH X6Y\/:Q+\2;7Q*J0BV@M6A,7FG>VX8R!MQQZ9JC!X/UJ/
MQ=XFUF6STVYM]5B2*.":9^P4?-A.GR]J])YW#IBF?O/,/39CB@#RRZ^'.L'X
M:KX6BU&*29;L3B>5F6-%_N+PQVYZ=.O;I777^E:E=?#R;1XXX_MS61M<ER%S
MMQNSC./PKI</Y6#C?].*?\V!TSWH YKP+I-WH/A.RTB]\MY+52#-&Q*/EB>,
M@'OZ5+XCLKW4_LUA#B.S:59)I4?$I*G<H4;2,;@I))Z \5OD'@#&.]*0#CVH
M \VT[P;J_AWXE7FL:<Z7&FZA$!>>>Y$K/W9<+M/.#V[UZ,"Q()&/8TX[_,&"
M-M./2@!.M!H'2E)H 04&EHH 2BBB@!:*2B@!:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I!2T@H 7O4$O_ !\1'V/\JG[U!+_Q\1#V/\J
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M75R;I[/>OE^:3DG[NX#/.,XJQX<\(6WAZ_U.\BN)YI=1N#<3>:5P'[XP!@4
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MG/O2YI<T -9 T93)QZT!,=SC%.HH 0#'K2]J** $%+110 G>EI*7- !1110
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M\T=K+:7#$0X5OW$L9^4$=<_[- 'IJ\J,TM Z44 %%%% !1110 4444 %%%%
M"44M% !1110 4444 (*7%%% !1110 AZTM-HS0 AI5I.M** %/2F8I_:DQ0
M@%+BEQ2T %%%% "4444 +24M)0 4444 ***!10 4444 %%%% !1110 4444
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M #%V'D-GC\Z!+&RJ1(N#T.>M  3AUI[=*C=X]_S.H91G&>:5F7>H+;?8\9H
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MW.3FI?$NIV0U75K=]7LU-UIR&PDN+CR5M96W ,O(S_"V5Y[5V,N@"4H[:OJ
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M44 %%%% !2TE+0 4444 %(*6D% "]Z@E_P!=%]3_ "-3]Z@F_P!=%]3_ "-
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M$GQ'ND^Q1W?F:,@,;D ']ZWKZYQ70:9I*:?-/</-)=7<X7S+B4*&8+G:N%
M49./J:8^B1'Q FK_ &F<7'D^25R-C)G.,8]?>@#B=.?6_!$/ASPQ)+;7<^I7
M,X\YRQ$*A"Z@="V"!GVX]ZW6UK6[V:[BLH+??I[)%<*S@+(^T,_)(*+@\'!Y
M%:NK^&;36=4TW4)YKB.?3Y#) 8F  )&#G(.<CCM534?!MM?ZS)J27M[:F9 E
MS!;S;8[@#H'&#V..,'!- #8=;O\ 59]1;3_LT,>FW0MY5N21OPJL[ C[HPV
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MW0Y; RF ETE615W;71PZ\9&>5'>@#E(YKJT^)&LS6=LK7']B6[M')*54D22
M'(4GH!V[5I67CHZB;:&RTR6:>33H;^0;CM19!E5W!22?PJS'X9N+;79M<_M2
M26ZGLX[-_,A!7:I+;L CNQX]*SE^'\MI%ILND:PUE?V-H+$W+6ZR+/"N,!T)
MZC P01TH Z?3[R:[TN.\FLY;2=@<P2D;E] <5S/@W2[?Q#X7MM=U>-;R^U!3
M/OF);R02=J(/X-HXXP:ZS3;$6>GQV[2O.P'S22<ESW/MGTK#T[PUJ>AA[72M
M5B73'9F2WN;;S#;Y.2$8,,C). V<4 )871T6\L_#$+->7@ADN=\TA7;!O(7/
M!)/(7\,TB^+9"EBHTTK)/J3Z;+&9P?+E4,<YQRI"D] >>E2S^%V74[+5K*[Q
MJ=M$T+S7"EQ.C$DJV", $EACH?:H?^$2>-8)?M@\^/4FU)W\D_/(P8%0-WRC
M#8&<]* &W?B^XM[#6+F32TVZ3.L5UMN3RI5'RGR\G:Z\';S5J?7[K^UM3L+3
M3!.UA#%-N>X\L,KAL#H>?D;].E5;WPH]U9>)+4WBQQZQ*LQ/D$^20B1_WOFX
MC'IUJA"+JZ\;:W;6M[9"26PM$D:122<&;<54-U'<>XYH E3XA1S:&FKQ:<_V
M.33VNU::<(2R]80!DLX )STXJXWB]I=:_L^UTTR,VG+?I-)/L4H21M( )SQU
M -92_#J2SLQ866J;;632FTV0RP[Y%!W$R(<@*6+'/!J[9>%+F/48;M[X,\&E
M#3E7R"N[J0^=QP03TYZ4 3V'C 7T'A^[CT]ET_61A)VF ,+E68*PQSG:0#ZD
M>M37:/XGT:YMTCDMT%X4AF20_-Y;X#\=MRGY>X'O6!>Z;8:/X1L?!,NHB35U
MBC^PF.,JS,)<HX'.-K $\]!FNYTO3X]+TNVL(N4@C"9]<=Z ,>[\5QP:[)I
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MC2>WECU@0_-IQ1C(7QC  '.?7I^5<G%H:>%K?P#ILY$CVLS/=-L+!08VY/'
MW''- '1P>*=6F\ZT^R::-5M8DEFM_M'RN'=PJJW8E(RQZXXXK>T[46&EP7>J
M7%DDDH^9H)MT(//"L<9KG;*]MH_'?B9G<>5)9VH1F4[3L\W>H[<!ER/>N?\
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M&B<(!COZT+CTIXP.E #2N\LK %3V/>A(PB!%"JH&%"C %*QP.*4YQQ0!$MO
MJ%5C0)_= P,_2EP,L,+N'Z_6G#BD<=2.M &+J^B2:A?Z;/%-"BV,S3(CIN#,
M4:,YY]'/XXK6%K D>S8H4XX/08]/2I$!X.:>0#U% $'V6 ;LQ1?/U&W@U5U2
MQGGLB-.N197? 2X$0DVC(R""1D'O6CU-&/EQ0!G:5I4>G6K0;C*6=I))6 W2
MNWWF;&!^G3%7HHTA18XT5$48"H, ?04YLA>*7M0 M%,[T\4 %%)2T %%%% !
M1110 =Z*** "D/-+24 +112&@!:*92T +2TREYH =12"EH **** "DZ&BDH
M=124E #J::6EH 0"EHI#0 M(*44&@ H-,.:49H .].HI.<T +1110 44AH%
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M_P#>/_H)H G-%%% "T444 %%%% !1110 4444 %%%% !1110 4R0;D(I:44
M<9X]\(2^)K&Q%E.L.H6<XGMY9/NY!!VM[' K2@U'7KE8XI-$%G<C&^6:Y1XP
M!U("'+9YZ@5T!4,>:7 SGO0!Y7J?@C5!:>+M)L8A<Q:Y+%+%.\RX@Y&X."<\
M8R, YZ<5?F\-ZK!XV?48K4362>'_ .SHW\Y0[2@DYP3D# QGWKT$HHRHR-W.
M0:<OW!D4 >66/A/6H/$O@S4)+5%M=(TMK:Y(N$8JVQE!'/(]Q7*>%='U+Q+\
M-UT:RM-T<FN-)/=%U58U5E)XSNW=.@/U%>]7,*W%O) X;;(NTX../3BJ6CZ#
MI^@QRPZ9;F"&4[V0.2-W<\D\G^E '!S^$+ZP\6ZS<#18-7L=6E69'GD7%O)@
MYWACRG/ &3TZ5+J?AG69[[QL\=HH&K:=':V1,RCYECV'//RC)SSZ5Z2#M49S
M2<#U.?>@#RC6/"6HWOAO2(9--F34].TN&*SN+:<!X;A!AMQ# -&<*>O&#ZU+
MXI\/^*=9.HVSV<$L;:2D23K*(\S=6W8Y8>@/RC)KU3 Z<TW..S'% 'E^H^%]
M<;4? 6J16!D;1X?)NX1,@*Y0+N!S@\C/&344_@W6KR'QW;M!Y+:M)%=6[^:O
MS[#N"8!R,D8YQUKU7'<[N/>@ $]^G7- 'G4V@:KJ>O:OK8L98/,\/_V9;P2L
MH:24EF)."0 ,XY-4?#?A/6]/7P/]HL"ITA+D71$J'&^,JH&#SR<\9Z5ZH/F7
MN*$[]>#W- #$'[UCZ@4]ER11TYIU " 8I:** "BBB@ -%%% !VI,\TM)CF@!
M:3/-+2$4 (U /%!Y%'2@!<T4E*!0 M%%% !1110 4444 %%)D"@,#0 IIF:<
MQP*9C- #P>*6D4<4M !129I: "BBDH *6DI: "BBCK0 "@T=*3K0 4M)2T %
M)2TE  :*,4M  **2E'(H ***#0 E)2XHQ0 M%)FEH ***0'-  32TT]:=TH
M*0TM)G- "4[M28H/2@ HHQ1B@ -%!%% "TAI:3&:  4M)B@T &:6FBG4 %%%
M% !1110 E%%% "TAI:0T %%%% !2TE+0 4444 %(*6D% !WJ"7_7V_\ O'_T
M$U/WJ"7_ %]O_O'_ -!- $]%+10 4444 %%%% !1110 4444 %%%% !1110
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M*"H/4GBD;!'ZT .XQFCJ*;QL(YP*0-AD'8B@!YP*, 4'KS02,<4 !(Q2]:3
M/% ((X(- "T4FX8SD>E 8'//3K0 !LG% H.U03TH) % "%J4'(I"!Q1N4-MR
M,T *3BDW4N0<^U(NTC(H .]+NS2;E"[NWK2@#M0 A/.*4\4<'FCK0 448HQ0
M M)11B@!:0TM)0 4444 %+24M !1110 4@I:04 +WJ"7_7V_^\?_ $$U/WJ"
M7_7V_P#O'_T$T 3T444 %%%% !1110 4444 %%%% !1110 4444 %,?_ %BT
M[/-!&2#Z4 <3\1D672M.8QK(!JMHI7'+ S("/Q!(_&JMU9ZEI,_B+7[*T@TZ
M./3/]'M68,KR)N8R%5X'  '.3W]^D\1>'T\000PR7DMND,R3J(@N3(C!E)W
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MQR#D$-@XY^6@#/\ #VK7GB>31-]S)'$=&2ZNEA8IOED(53D8.!LDXSW[UH>
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MVMYVTNWN#;37H4!$<-L)*D[MH;@MC'![<T^7QA&FL7>F0:7>W%Q:/%',(@O
MDSM;D_= 7GZUSUKX9U>#PKJOA4P0SP7<TWDWID&U8Y7+$LGWMRD^G/7(K<TB
MPO+/QEKM[<6I2SNX;=8YBPSF)6!)&<C.>_I0!9T_Q?9ZCHD&JVMM<O#/<_94
MCVJ'#[BIR-V!@@YY[5T0/ KAM+T&%/'%V8)3_9]M)_:(B4G"W$JLI!'3&/G
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M/- '9:3XABO;22:Y:*WVWDUJ@DE \PQR,F1G'7;G'O6O(T,:M+(X15&YF9L
M =S[5Y;HM];VOB*V?5;5);:34;V*S? (M+GSY"?IN0KAO8CO73^/C+'I5A,R
M%K2/48)+X*"?]'#9.0.HW;"?8&@#I(]5L9[87,%Y;RVY./-20%!^(.*<=2M
M+@FZ@ MO]<?,&(^,_-_=_&O-/%9M)5\5W%A*KZ=_9<)E,!!5KC>V""/XMF,]
M^GM5_4+**X\13R:0D0LI-#F2\\@9!<D>5NQU?[W7F@#J[76XM4T[3KW3Y+=H
MKS8_[V?8P#*#@  Y8 CY>/K5]KZV$RP/<1"8C<J%@'/T7J:\N6XTNXT3X<RP
M")O(NK>-RF-P;R &W?0E<^^*=<-YG@[Q%:7[QQ>)EO9'MD)'FF0N/LY3/)&
MHXZ<^] 'I\]_:0_>N8$(8*V]P-I/(!]Z?+?VUN\4<UQ#&TGW5>0*3CTSUKSK
M4[/2YY?'YEA@DF2UCD!<!BK& \C/0[AVJ37IUCN#?6=W97</V.!+JQN\9:+D
MAX&!SOZDCD$@#KB@#T#4M0@TO3+F_N"1#;1M*^!DD 9X]ZRI?$1M-3@L;JU:
M.YN;=[B.-6W9V8RN<8W<].GO4/C4-_PC?F-@1I/;M*F>"@F0MGVVAJZ$HA^7
MVXXZ?YXH XV?XBV<&E:9J;0,]A?,VZ>'<WV<+C)=2H^4$@$^_2NAN-5==8L]
M/CM@Z74$DXF$G"JA0'C'/^L%9NK);-XFT>TE,+126US$8'P-X;R\C'H0#6-H
M.GW^B>,X=#N6:;3K:RN)-,N"066(O#F)NY*XP#W H V8_%;W.B-K=GIXGLP[
M(=LW[T!7*DE-N.,$XSG';-7)->676I-'LH5NKJ"%9IFW[4B!.%#$ X9L' QT
M!SBO/-1>QTO3Y?&'A74HK*Z<[KO2"WF17,A/W/+ZB3/0@5T'AVTDT#XA^(TO
M"%36#%=VLCGA@H*NF?5<@X].: .DTW7H;_4[[2+FW^SWUHBR21,0RM&W1U;N
M..X!'>DUK7%T?1Y]0LX(KT0D&5%G"''J"<[F]!U/2N0U1X;[Q3KVII<R6UCI
M^B36=S=0X/SD[L@]"5 )]B!5_P '0>5K6JVE]8V<5ZL=LS361S%.O[P1R;?X
M6P#D9/04 ;4OB.YANM1A&EM*+%$D9HYE)=#G)QV(P3M)R1TK<MKF.[MHKB%@
MT<J!U8="#3?LMM$LI\M0)#ND/J>Y-<WX!,O_  @&E-*Q),)(]EW'&/PH Z.6
M]MX8Y)7GB$48)=BPPN.N31:7T%_:I<V[AX7&0PKRG1Y=.U*#5XH&CF@O/#R3
M1Q.P>1VW39+D_>DP5R<#'3MFO0?"\MFWA/3FL2GD_9X^80#ERHSG'4YZT ;*
M7,$C,J31L5^\%8''UI%GC,F!*IST&>?>O+_#MW8'Q/X=N8)+6*.]L;H#]Z&F
M=<Q%1,W>3KQVYQFJWAZVMH-&\&7J86\DOI%:4G+R+Y<F1D]N!P.* /7&<1C+
M$ >O8?6F"9"NX2H<KN!!SQ7*?$"^6PM]&^TSK;V$VHK'=S,NY54QR;=PZ;?,
MV9SQ6%<Z#X<FT+7(1J[7BSW".OV0#;;S-T$>,CD]5STR#Q0!Z1YP8#8<\X/'
M2G[PRY4\8R#BO'C??8_ NM/;%H]:^WQQ^(6CY>(;@LCJ!_!M!VX[9J7Q+9:5
M%X6\1WFFZQ#="6VADV6I$<5NR,-I!4G#,&/7KCO0!ZTLB$;@PZ<X[5%)-<?:
M;=(H \+EO,D+;?+ '!QWR>/QS7"W%MH^C^*;&TO6@ATR^BFNF>YES'<W68QE
MM^1G:"0/?BI#'86^K>"H[&YEFM(Y;F"&1Y-QD40R8QV8<<-Z8]: .[:11N(Z
MCVYI0W<D$'VKS*.2_P!/O \5K;WMY-;W<^EW\+[3<,?F\N92,[AZCCCM5KPM
M%83W.CZI:ZW#+)+9LKQV\>'G)4$^=\Q.5*GD\Y)% 'HCLN,;@"?6FF1 @=W
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M>2%4?S+:]A.X*@/1648)!P>.] '9Z-K%MKND0:E:;_(G!9=ZX.,D=/PJ]N!
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MJ5K&U)A<V\1:#_5$QJ2GTXX_"N?7QE')I5C<B!()[N22-(;B78JLA(;<^#@
MJ1TY.*T]!UH:[I+7<49C=9'B9#R RG! /\0]QUH FATG3K>Y>Z@M(([CG]XD
M2A@3UZ"ELM)TRRN9[BTL[:*><YFDCB56<]RQ S7.>&K%?$<%WKNI%IWN;B:*
M")V)CAA1S& J] 3M))Z\U=B,?AL6FEH9+J>]NI?LX9R=JX+MO8Y. ._/4"@!
MFK:#=:IXJL+V6"UFTZWBEC>.4G>2^WD#&!C;Z]ZV7TO32L"FP@/V<?N?W*_N
M_9>./PK$_P"$SC^Q!Y;"<3IJ*Z;<6ZD%HY&(VX.>005(Z<$=*HW7Q _L^#5T
MET:Y%QI*B6YC,J[5B8$JP8$@D@'Y1SQ0!URV5L+HW9@C^U,NWS=@W;>PSZ>U
M1V>C:98O-)96-O;-,Q:0Q1A-Y/4G Y-8,_C%QJ)L+'2KB\G^PK?(J.%RA(&.
M>_-2Q>,4O+"TN[&RFF\ZW>=@V$$6PX96;D!L\8]CS0!LV.D:;ITLLEE8P6[R
M,6D:*,)O/J<#DTNI:3I^KQ)'J-E!=QJ=RI/$' /KR.M8</C*.[.DQV]A=3/J
M5B;Z$+M'R?(=I); /[P>WO2IXQ1H-)G;3IU2_NGM&.X8MY%=D(;U^92* )]>
M\/6>H:7+'!9VPO5@:&UEE3_59&!AL$@?2DTGP["OAG2-/U:SM;BXTZ!(D;;N
M"LJA=RDC(.!UX-0ZW9GQ3:O91326UQ97R%9HG^ZRJ&SCH<!R-IXSUJ1_$F-5
MGTN"U^TFT:%+IA* X\S'S!<<@ Y)XH T5T/1E6&(:?:A86+1KY8^5CU8>AY/
M/6I$T;2H4A"65NJP,7BP@^1CU(]"><GOFN=^)NY?AUK,T<CQS00[T=&VE<$=
MZR'NHX=9\-VND7%VM].1]K6XWK%)"(SO8!P%+YQC;\W7J* ._O+"TU.U>UOK
M6*YMGQF*:,.IQ[&JUSH.DW<L4L^G6TK1+L0M$ORK_=Z=/;I63J/C*VTU;VXE
MMYWLK"98KFX0#9&>-QZ]%)&?ZTZ[\86]G/,WV2XEM8I((WN%P%S+C9MR?FY8
M9(Z9H Z*&-8(A&B[5084 < =JSAH>D1HL:Z=;*$<R1JL0&&/4CC@^XK/'BQ)
MM;N=)CTZ\EEMIHTE=5 55?!W9SR #D]_:L'7=;_M:\\,7%G;W$5HVM1QQW1<
M!95 ;(V@YP2.,CH* .Q?0M):&X@.G6QBNCF=#$I$I_VACD^]/TO2=.T*U6ST
MVRBM(,D[(D &?ZTFJZFFE6JRM')*SR)#'%&,L[L< #L/J>*P[OQ4'M=9LTM9
MH=3L;<RM;N5R%VDB0,"0P]<<YXH WO[+L!?2W0MH_M$X"RR;>64= 3Z>U4HO
M"F@07"SP:9!'.@8)(JG*YZX_.L/P#I\<^D:?KN9Q=7>F0+<%Y,I*Q0,7 SQU
M^H'%,\/Z,EU=>((KF\OC):7PMX7CO)5,*>3$Q"_-TW.QP<]>] '2)X>T>-;2
M-;"%5LV+VPP?W3'.2/KD_G5V[M+>\M&M;J$30N,,C#@BN)CUG;HVMZ9KLEQ>
MMIE]%;>?!A'D638\1.,#(W*&('KQ702^(X4U6[L([6XFN+1H!-M7 6.0MA^3
MRHVDDT 6UT'3&G@N391B>)2D;\Y53U%0MX4T-HTC&EP;(I&EC&#\KL<L1[G)
MK/L_'.DWE]96VYMMX'-O<;EV2[022 &)'"DC('%31>+;-[RTA6WNF2],@LYO
M+_=S%03USQD#C(YZT 68O"^C6JPK#IL*);R-+"J@_([9!8>^"13I?#NEW+7,
MD]C$[7D?E7.0?WJ#HI]A61X=\82ZIX:M]4O+.96NYF2WB11NDR[;57GDA5.2
M<=#5F?QCI]OIMU=3V]S"]I/'!-;R#$D;/MV;@"< [EYSWH N7'A31KJXL99]
M,@D:SSY1;.$_#H?QJRVAZ=_:IU06B?;3@F;)SP,#CIG'&:I2^(D@2X$EC>#R
M9S&25 P-VT/R?NDYP><@$UNC<%;(Y[4 5KVQM=2A^S7L"SQ[D?:PXW*=RG\"
M :IW_AO2M2N(+J[L4FN;=2B2Y*ML(P5R",J1V/%0:QXIT_2&G6?S66VVF>1%
M^6'=ZG//!!(&2!S4%SXPL;35+NPG2Y%Q;QK((Q"29E9PBM'S\V691@=S0!=@
M\+Z/:I:+!811K9.SVP0D>66&#CZC(Q5:7PAI$][/<O8J6N)EG<M*Y!D4Y#;<
M[0<CJ ,U+JOB:TT@RBX$I,,'VF58TW&*+YOG;!SCY&Z9/!J%O&6F-=K;Q?:)
M]\,4\;PPEPZ.VT,,<D>IQ@=Z '2^#M#N-;35YK(->J!N?S' 8CH2H.TD=B16
MKJ-E;:E8R6US$L\+D$J>F0<C]164/%-F=3ALP)3YUP]LDWEGRGE0,6C!]1L;
MVX(ZU'8:Q8V]I/,CW4GGZ@]NL<H;=YN>44$# &#C/&!UH OVF@V5G#<1JDC_
M &B,),TDSNS+@C&YB6[GOWJ>QTZUTC3HK.QA\FVA&V.%22%'H,]JRCXMM!!:
MDQW NKEIECM#'^];RB0YZXXQZX/8FN>U+Q1"WBKPEJ5A>74NDZA;7A:"%&)F
M**-OR ;B<D\'TH Z >!_#Z2PS+89E@E,\&97(C<]2HS@9R>.GM6OJ>F6NLV3
M6EXC26[XW(KLN<<]5(KE-:UU-9T/2=2T?4+B-%UBUMYU4&,MNF5'C=2,C!;D
M>QK<OO$^GZ7,Z77G!("JS2JA,<.<8WGMD$'VSS0!L(HA1(P"< #).?UJC'HU
ME;ZK-J:1O]LE4([^8Y!4$D#!.."2>G>I-2U:VTJP>^NRXMHS\[JI;8,XR0.<
M56N?$EA:7-Y!<.\;V<2SR@QL?W9) 88'/*G\J )3HUHVI3:@PE6ZEB\II$E<
M93J  #@<D\CFJJ^'=/M]*DTN"%DLKAG\V-I&8N')WY8G=\V>>:2V\3Z?>70A
MB9RTEK]JM\J0)HQC<5)&#C<H//>L.S\46^O^&--U"ZGNK W.H*D?E*V)")6"
MQDX(P0 #T[\B@#J;#2K/2+!;&TC<6P^ZCRLX4=E&XG ]!TJBOA72Q=PS^5*7
MMW,ENK2NRPN<Y903C.&-0:1-*WC'Q!;O<22Q0);,BOCY=X8G& ..!UR:S=;G
MOV^(6BZ3!J$\%I=V\TTR)M.2FW&"5..M &U#X2T>&U2TCMV^RQAU2%I'*@.,
M.#D\@C(YS3(/"&CP3+-%'<^?';M;+(]U*2L9Q\O+=!@8].U4H-5N]"UZ?3]4
MOEGTUK*6\@NI%"O'Y3*)%;: " '4@X!Z]>M::>(-.+W/VB1[:6UB\Z=)T*%8
M_P"_SVH CE\(Z-<^'AH=Q:&6P3 CB=V)CQ]W:Q.01V(-9]]X,MO[(2PL4F#^
M>DS7$EW(7#*1M8G.7P!PI(%:%KXIL+N.^#M+;26D(GD2>)D81'.U\'L=I]^*
M)_%VE6<%X]S)- UFB/,DD+AE5L[6Q@G!(//L: -#5-,MM9L+G3[V/S+:X3:R
MY(_(CD5G3^$M-EFMYD\^*[@B:-;@7$A<JQRRD[OFR<GG.,\4K^+M*\R6%3=2
M3*,B)+67?(#D90;<L,@\CCWK U'Q&K>)/#5[::C*=+U".9WC0$B0!$*'&-V<
MD\?I0!V6F:;:Z79):V<>R%<G!)))/4DGDGW-9<?A/2H9W>))XH7?S)+9)W$+
M-G);:#C)/7L?2I;;Q7I%YIKWT%R6B27R'!C9767IL*D;MV?:HAXMT=+>1IIG
MB,4RV\T;QN&CE8 JI&,C((YZ<T -N_"&EZEJ9U*99TN6($WE3NB3@?=$B@@-
M@=,UT"H$15'11@50TC5;75K4SVA<QB1XSOC9""IP>& -:!.* %HH'2B@!***
M6@ I**!0 4444 %+24M !1110 4@I:04 +WJ"7_7V_\ O'^1J?O4$W^NM_\
M>/\ (T 344'I10 M%%% !1110 4444 %%%% !1110 4444 ,'WJ<?O"C'-+0
M!P?Q$>1=2\*^3,D4B:H'RX)&/+<=OK5^]\+WVH6U\SWELMW?O"9'$)VHD9RJ
MJ-W)Y/)]>E;VJS_9--N9Q"9C%$TFT;<G:,\;N.W>LV7Q-%:^%;+6)HBTUU'
M([=7 +RR@84$^YZ^@)H ??Z+=2ZG;:K:W,,5Y%;-;R>;&62520<<$$8(SGZ^
MM<5XETB72=2\)PQ7:?;;K7I+II2F%+O&Q8[<G Z8&:[C2]:EN]2O=+OK=+>\
MMD24A'WI)&^0&&0".5(((]/6KTKPQ6IN9EW"%68D+N(P,\"@#F?^$+>&[L-2
MBNC_ &K:W,]R967]U(9OOJPZA<8 QW /M4K>&+R)[JYCNX'GN[HW-VD\.8)E
M,8C$>T'@ *IR<G(/K4NE^*9I[V]L]5TV33Y;6V%X&:42+)"2><@<$8Y':C3O
M%4L][807U@UJNHPR3VC-)EF1 "0RXX;# @#/&: ,NU\!W>B6U@="U-+2XM7E
M+"6'?"\4C!C%MW9"AE!!!R.?6M"3PWJR:I!J]GJRG4HX6@G:ZAW13J6# ;5(
M*8(XP?YU-9>);RXUZ*PO='N+&"[C=[2:1P2^TC<'7'R'!R.33'\8PBXN9883
M)IMI>)93W0D "2,47@8Y4%U!.>#GC@T 6?"?A^?P]IMU:W-XMVUQ=S7181;
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MT2 #Y<],@D9(&>: -"[AOKC0);5I(?MDL)B,G*H&(P2.#^58\6@WZ7V@SI+
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M^%=D6P"<'CVHR!G/7O0!P=[X7U0^&M2,J0W&K:E=PW=P(&*QKY;(512>2 J
M9QSUQ5ZVTW4)O%&LRW5EY5KJ-E%")UF7*E/,S\HYY#CGVKKACMGGWH(&X?XT
M >>Z/X?UVVT:'P]?Z=8^1;P/;#4XY06>/:5&U-N5;!YR1]35_P +VWB?3-*L
M-!O+&V6.P583J'G@B>-1@;4 R&( '/3KD]*[,L ,D<4C9].10!YSHWAG7M.T
M+0TEMT:ZT*\>2,"<8ND?S%;CHIQ(,9/8],T_6M!U.\&O7L-B6N-3FM%C@:5
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M6\IC8+A4)*%>,@@L3G/>JUSX;E-EJ'V2_DCU"]>-GN<B-EV8QT'(P.1WSUH
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M:7.)H0<9VLN#[@@5J#I3& +CU[4^@ HH-% !24M)0 4444 +2&EI#0 4444
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M34('\^6;3462XCB@=BJL"=W3[N >1FG3^,-+M[N.S1II[F:U%Y''# [M+&2
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M0",Y &.N3TKI=+U.VU?3X;ZTD\R&5=RDJ5/7&"#R"#D<^E %PT4M% "4M%%
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MP;8V]P([:\T]FD*QC?E8^""<]STQVJQ8:YJDNG:!-->@M<:O/8RGRD'F*C3
M'IP<1#IZGB@#NLBFJ%8 JV0#CCM[5Q-GKFH3^*Y-,GNOLEUOG9;.2 !9H@IV
M/#)CYCT+<^O JEI%_J]CX=T!X+];AK_59(9C/'S@M,6.01GE<X/Z4 =J="TI
MM5;5#90F_9=AG*Y;'IGM6CD=,'\J\YO=7\1VNC>*62]MOM&B3DB8P#]^#"DH
M4J" /O@9'I4USXEUS5+R^M-'CQ<6-E;W(1%0^;)*K,%8LV0GRCE1GGKVH [Q
ME5BQ&5<<;@*6/:JJO0^_K7GUYJ_B>YUJ\T[S[73FCT2*_.(1*8I"S!TP6P>4
MQGT_.D@U74];O?"-_'<M MYITUX\00$%U$0(&>F0[#/;- 'HA4$Y/--2)%7:
M!CGBN,\.>(;S4M>-C>21VUV@E>YTZ9-DL'S+Y90_\M$*[LL,\_E5GQ9J^I:;
M=(MO+;0VWV>6;<5\R:210-J+'Z'#$GL!VZT =40C.!@Y'0^E.V@<GG'2O-)O
M'6J2:)H]^3#IMKJ&F>>+V2%GA%T0-L3M_ IY^8_G7=7UW<0Z'+=61@><0%XC
M.^U"V.,GTH O8C3Y@F/PI2D9P2!P/TKBK'Q9="U\1.TB7\>FVL=S!*L)C$H9
M&)X],KP1U'KUJ.'7M6;6X='BN],O$GTPW8N4A?:"#MQD-]TG&,DF@#NU*CA?
MK3756#*PRO4BO/M)\3ZU/X9TO6IUL]NJ1PP6T$4+LR2,26)^;!7:I( P<\9J
MZGB/6K:V>"\L'6>6[CMK.=K<CS59=[$QAL@KM<8R =HZ9H [/Y  Q' Y''3%
M0VUW;WBLUK+')&CE&,;!AD=1D5R-OXAUV;48=&GMX[>XGF=8;F:(IYD"H&=@
M@8X8$A<9P>M:7@[>UKK/F[3*-5N59E! )#=1G- '1IMV@#C'&/2EX+$@_E7"
MC6[[2/\ A+-0FFBN/L^HI;P1/&1\S0P[!NW=,OSQZUH6NNW6G>+K?PY?QP.+
MRV:Z@N(@R$D?>0H2<8[')XXH Z)[^U34([)IHQ=.I81[AOVCJ<=<=LU9!YQ7
M!>(H[C_A:.B&R2#[2VFW9WS E1\T>,@$$_A2V_C._FMK>R:U6'6#<36UPD4;
M3QQ^5G+*%P2"=N!D8#<GB@#NMJ)M (4=A2E1@\\5Y\VKZW?ZWX72[MUL99KJ
MY61'B?#B.-\, 2#M8%3@\@CO4]_XKU/3]-U9YH[))],U!;<JT;X>%PN' #$Y
MVL3Z<'TS0!W(QR^>HH("*!G(-<M>Z]=:?<7K*D4MLD]M:6Y5&9FEDQDG!.Y0
M&!X&>M5O^$HU"V@N5N+"0LMQ%;V<WV9XXYQ)@9V$ELJ<@@=<<=: .TV@KMSQ
M31$ #@\]CZ5Q#>)?$-KILT\^G0AX+V&UC>5'B6X221$#*K<@C<0<GJ*V]'U/
M4)M?U+2M0CM5>UAAG1[;=AED+C!#=P8SS0!KK=6TEXUJL\1N(U#M&&!=1ZD=
M0#ZU*X0C:1T.>G0UQ>HKJ$/Q#O&T:VM6O6T>,AKAB$_USYSCDYP!3]-\7WGB
M*STU-.M8HKJ[CF>?SSN6W\I]A&%(+98$ Y'3- '8LR_*2?I445W!<RNL$\<O
MEMLD$;!MC8S@XZ'!''O7G%YXOU359=%6T$-I.NNOIU[&69QYL:O@ C&4.T'D
M9P:M2:GJ7A^Y\6W]C;6C6]K?PR7"2%@2GV:'(3;T/?)XYH [#6M$TW5[)(=0
M3,<+^;$ZRM$T3X(#*RD$$ GGWJ/2]-TJT#&UN6NI" OFS7)G=0>@!8G ^E6M
M0C2XT:Z29 X\ELJ>F<&O,].TFZU*S\!7&BV$UO)9);SWMW]Q6BV+YB;L_/N]
M.?PH ]8. W7Y0,XH&UCOQVQS7&6?BC5'NVANK.UAG>WGE%L7S*AB*[-Y!(&Y
M26QVXZU3U/Q!XBN=*T:ZMXK*T@U.>S57#NSCS,$@XQQ].U '=&>.69K=9D\Y
M4#%,C<%)(R1Z'!Y]JEQ&B[0!@\<"N7N]<&E:MK<UY90*-/TJ*\>XB/SR@F7Y
M<'H 4; R>M0Q>*-2"7<D^EO(D5BUXC00R ;UX,1W#EN<C'49X&* .M:-)"#P
M<<'Z4A&TG>_R@9R<#%8OAK5Y=6MY[D2V5Q: )Y%Q9L2LAVY8$$D@@\8//%:>
MH-)%IMU+&D<CK$S!)<A3@'@X!H 1O)O;;>)!-#.N Z'AT/H1V/J*M0PQ01)'
M"BI&BA551@ #H*X2+Q1J,%MX/MM/TFS"ZW!O\O>52 "'S JX[ <?A6[X1\12
M^(+&^>X@CAFLKV2SD6)B5RF.03[$4 =%11FD- "T444 )112T %)12B@!***
M* "EI*6@ HHHH *04M(* %[U!-_KH?\ >/\ *I^]03?ZV#_>/\C0!,W2BANE
M% "TE%% !1110 4O:DI>U "4M)2T %)2TE !2TE H 6DP"0?2EI": *6I:59
M:M''#?6L=Q&C"15<9VL#D$>],.AZ65NE:SBQ>1B*<<XD0# 4^V">/<T[4=6M
MM,MQ+</MWN(HAM+%W)PJ@#DDD@5FQ>*=*NA<2M<M%]C(6Y1XG#1.>BD$<D]@
M.O:@"Q=^%M"O9[>:YTR"22!/+C<CY@G]W/<>QXK495AB5(E"*.  .!5!=;L9
M5N-\IA:U02W"S(R%$.<,00#C@_E3;#7;'4;LV:>;',$\U$FB>,O%G&\;@,C)
M ]N/6@!;?0M.A00I9JL&X2"+<?+W9SG9G'7!Z4LVA:7=7-S)+:(S7*!+CD@3
M*!@!P#AQC(YS6)9:V;[QS'!;7$ILY=-><1LA"L1(BJZD@9!4]B1R*7QAK,NF
M7>C:?!YZ'4;SRI9(D8L(PCN0I .&.P#UY)'K0!OOHVGO<3W+6R&6>(0R-D_-
M&.BGVY-5Y="T^.*SDBL@9=/!^QC>W[HXQA>>,CCZ&LC2==M=(\O2-2UE[ZY-
MX;99VB;AGRT<3,!@OMQSQ3[OQ%9Z7'XDU);J6[_L^(2S6X7_ %15"<# ],$]
M<=Z *OA+P>=%T8V>JI%<W$=P]S&RNS("S;AP0!D?2MI?"VB,Z2G38=PD\\$9
M&V3^\HSP3WQU[UD2ZV8?%,4TMQ<#3Y=,GF,#0,"K))$ 0NW>2=S>OL*Z;3-1
ML]6TZ*^T^=9[249CD7H1T/Z@T 5VT#2OL]S!]C40W4OFSH&($CG')YYZ#\A6
M3-H%]JGB&QGU@V4EGILQGLA"I,A?& 7SP,#/W>IQTQ47CO4KO2AHD]O?-:PR
M:I#;W PN'C;)/)&1]WL16G!XMT6[L[J[AO5\NUD$4Q=&0HYZ*58 Y/&..>U
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M*G>Q(.,'</2L30=%O(=7\+'6+6>YEAT>:WO)C 7CW$@HK-C!. >OM7JPY"'
M![TYLDD8Z]Z /+;6QBA\/:1<1Z7.D\6OR21@6I#Q6YN6([9">65]L<47&GV%
MYINNV%G:L=3.JO)9E(#^[8.I#!PN%7@YY'>O4 2<GH2,50T?1X]*6["2RRBZ
MG:X?S2"%9NH& ,#\Z .(U@7+:AJ(32[U3%K%G,66T:4SA7B)D5^@4*I&U>1C
MGK536+".ZL/''DV$DEW<!/LLAM&.YO)13LXY.X$9%>IJ.3\H'O2;%&W/5>E
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MTH5E<97Z4 .I!S2;A\W/3K0G(H =BC%%% "4N*** $HHI10 E%%% !2TE+0
M4444 %(*6D% "U!-]^#_ '_Z&IZ@F^_!_O\ ]#0!,>E%!Z44 %%%% !1110
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MK9SRB"6"":2/!\MYBH7*]<?,,GH*P-?\(ZWJFF>(-*MI[(6>J3B</('$B-A
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M:73TD,F!D,8\D],=?:N2G\*ZI:(R6MC;_9Y]+GL#;0L$2!G?<KC)R<@D''<
MXKK-)L;N'PE!I]TB1SQ6BVY"-N&0FW.: ,'P9XOM+C0='@U"_!U"Y@W*6C8>
M<1G(4XP3@9P/RK:MO%FEW6BR:K'([6Z7!@;$+Y1]VW!&,]<9XXKD]-\(:H+#
MPUIMU9QVZZ)=),UU&RMYJJ1@+SN^;^+(%:+:!')XT-M9L$TJ7;J-U$G0W"-M
M4>P;EC[H/4T =!XHUE-!T62^DCD?&(PL:%OF8A5R0..2.M9+>(I+3QA/]IN9
M!IATU9D@:W82*_F."0NW><@#CGIQ6AXQTJ?6?"T]G:()9RT4D:.^T,R2*X!/
M;.VJ$5CJ1\6/JEUIT<=O]@$ 'F*^'#NV#SZ,.<=<]J -J37K!;*RO$E,T=V@
M>W$4;,TH(SPH!;H<GCCOBLJ\US3;T:)-;ZZD,-Q>A(S$F[[0P)S$1CY>A!S@
MC':N='AC7]+L] N+>PAOI+&"6">S-R8\JQ#!D;H#QCGM4C>$;\QZ#)!HUK9_
M8]7^WS6L,@PB;&!RQ/S,2V>* .N@\5:1<Z@EC#<B2X:5H2JJ3M=0"03T'45K
M*2I/IFN:\+:%/I.H^('GMT2*_OVNX'5LY# #D=B,?K738#'CH* )**** $%+
M2"EH 2E%)2B@!**** "EI*6@ HHHH *04M(* %J";[\'^_\ T-3U!-]^#_?_
M *&@"8]**#THH **** "BBB@ H[T4=Z %I*6DH *!12B@ HHHH ;CFG44UCA
MA0 I(')/M6+I^N_:]7U*RFB2$69C ?S0PD+@G(QTZ=^:RO'E^]E'I9F\Q-+D
MO$2]FB)S&G49_P!EB I]F-<M>I8B/QD=,NHV\G[+<*T4K'8!G."#T'/ XXH
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MW.0&V\@=#C(YK.;4GN+W1$COKRSA.MW5O<E;@R(!Y.<(XP67.,-@$9/2@#V
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MP R !R0.M 'H:R)DY(!/K2AE'U;GI7)^)[B"+7]-M9[D0I-;7#%9+DP([#8
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M2;2;&4();2"3R\^67C!" ]E]/PIXL;?[7]H%M"LH&%E$8#@>F>M6@<]L4$T
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MRPP!UH Z/)/3%*?N^]<='XQNCJ9TE= N5U 6@NS'YT6-A)'7/7*GBNDTJ_\
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M_C0 X49I:;0 ZB@=** "BDI: "BBB@ Q1110 4444 %%%% !1110 F*6BB@
MI,4M% !12=Z6@ Q1110 4A.!FE-)U'- ''_$'3+J^\.QSV5H+R>VNH;AK7_G
MNJ-G:/>KR^*-,O+>..WS=74@Q]C12) 3V93]WW)Q70E=P [4*NU<9SCIF@#A
M_#SIX;UW7;74R+9;W49+V"YF&(Y0ZK\H?. RX*X/4#BL74;*YN-7\8>(U#KI
M=QI@M+9B,>>ZKRZCKC.5![]1D5Z@462,A@#GL>E+M^78.%QC.>: /-O&VEW-
MIH>K:]X=;S8M0MI%U&U!_P!>I0H)DXX=1@G'4+CK5_Q#!X?O/%B?VE<2Z7J5
MG:)+::FLAC)#,X92WW"!MY5O[U=N$WQ-&V#V/N*4(OEX(!SP0>AH \]O9K[4
M/ SW4EPVI"SU:WG2Z2$*;B".>-BP51@X ;D#!P<5N:AK6GZO)I]GI]W#=RM>
M0S,(&W;(U?<2V/N\#OBNHV@84<*<Y%-,$;#  'T[_6@#B+;5=.TGXBZZ;R\C
M@5K:W0%SQD+S716VNVNIV%Y<0-NM(F*I<?PN-H)8>P)(^JFMC"CT&:8\*,PR
M,CICM0!POPSNX=.^%6G2W+;5M8W\TGJ/F)K/U*UU#6O#ESXJMY+=)T<:C:!D
M)D18@?+C!!QAE+ @CJ[5Z85Y P*7;E<.%.>O'% '!R7NC^.!H?FC=:7]E=*\
M;':ZL#%D9XPP/ZBJ^D0:E9_$J"RU%I9[>STN<VE[,P9YHG>'Y7Q_&I!!/<8-
M>A&.,C! XY_&D\I2,L 3MVYQSB@#B/,'_"[001L;1%C R/O":1C^AKN&&4R/
MK3%@C&'"CCH>]38XQ0 +]VEH'%% !24II* %HHHH **** "BBB@ HHHH ***
M* "BBDH 6BDHS0 M%)2T %%)FC- "T&DS10 444N*  TE+10 4AHHH ****
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M .I/:HH[NUFDV17,+O\ W5D!- $U%+BJ=AJFGZIY_P!@O8+H6\ABE,+A@C@
ME3CO@B@"W2BC%% !FBBC% !11BC% !1110 4444 %%%% !1129H 6BDHH 6B
MDHH 6@TE** $HI:* "DHHH **** "BBB@ I:2EH **** "DI:2@!>]0R_P"N
MB^M3=ZAE_P!=%]: )110** "BBB@ HHHH ***.] "TE+24 %%%% "BBBB@!*
M6F]Z=0 44AY%'\- "T4@_"@'/I0 @[_6F!B<EA\H[YZ5CZ[-XBCDC30K2RF5
M@0[W4C+Y;'H0!]X=<CKTK.B\*ZIJUN4\4:V]Y&Q^:TL@;:$CT8@[V'U('M0
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M@ HS29'K2\4 %%%% !1110 449HR/6@!,T9I>#28% !FC-&*,"@ ZT4'B@4
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MH *6DI: "BBB@ I*6DH 7O4,O^NB^M3=ZAE_UT7UH E%% HH **** "BBB@
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M1TI:** "BBB@ I*6DH **** "E%)2B@ -)0:* "BBB@ HHHH **** "BBB@
MI:2EH **** "DI:2@!>]0R_ZZ+ZU-WJ&7_71?6@"444"B@!:3%+10 F*,4M%
M "48I:* "BBB@!,4M%% "9HS0:2@!U)2T4 (.1S3(V7)1!@"G@8J*-")6- $
MGS8 .*7H>E(>HI2: $P,;<#'I2[0%QCBDI: $ XY S[4F,?= YY-.HH ;M[$
M KVI64EAPN/?K2XI: &L&(^7;^-)L(;< N2,&GT4 ($4'.!FD"XX  7TIU%
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MFT .S12"EH *6@44 %%%% "8HQ2T4 )BC%+10 F*,4M% "48I:* $Q1BEHH
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M?V9!_?N__ N7_P"*H M[Q[_E1O'O^55/[,@_YZ7?_@7+_P#%4?V9!_STN_\
MP+E_^*H M>8/?\J4,'X&15/^S(?^>EW_ .!<O_Q5!TN$CB6\'_;W+_\ %4 7
M-ON:-ON:H_V7#WDO3_V]R_\ Q5']EP#HUX/^WN7_ .+H O8]S1CW-4O[,A_O
MWG_@7+_\72?V9!_?O?\ P+E_^+H O8]S1CW-4O[,A[O=GZ7<O_Q=']F0?WKS
M_P "Y?\ XN@"[CW-#+N'4U1.F0'^*\_\"Y?_ (NE33( <[KO\;N7_P"+H MA
M=IQUJ0=*C11$H0%B/]IB3^9J2@ HHHH **** "BBB@ HHHH 2EI*6@!&H'2E
MI"* .6^(T;W/P_UNUABFFGFM72**&,NSL1P  *S=7DN]9\#)H%A8W9OKJT6V
ME,D#Q1P J Q9F Z#/ R37<X&X CGUH*C&.0?6@#Q;Q5IM_;6>L>'K;3KG='H
ML-M!/;VI9KX1J.7DZ*%^;Y>"??I6U<6U[+XBD:TLKI#J'AUK.VE$)"QRX& Y
M.-O3OS7IWDKD')W]-PZX]*01(JC:H&TX&.U ' >%Q92G19&\.WT%_IMJ8)O-
M#K%:C9M81DG;("0H 7(QS77:+=V^IZ5!=VUM-:Q2#<(98C&R>VT]*TRBA<$9
M'<>M1RK\A1<J-N 5X(^E $H;*YPWY4;_ &;\JSDTHE%)O]0!]#-_]:@Z1G_F
M(7__ '^_^M0!F^/8);WP#KMO!&[RM9R;4VGYL#./TKF]4\4:)XEG\)66BZC:
MWMTVHPW+16\BN\,:(S,6 SM].<=:[;^R3_T$+_\ [_?_ %JHV7@W2=-NIKJQ
MB-K<3',LL"HCR=_F(7)_&A:/\?N!ZK[_ ,3DO&>M^&]>M+NUOO$MSH=YI<DJ
M-82SQ)]I8 %=\+;O-C/! [@^M;>@WEWK>JZ3<7]M]GGLM*2:>$+@)/-@8 [8
M5&_[[K3N?!^F7E_%?70DN+N'_532JC/'_NL5R/SJPN@I'+++'?WR22D&1E=
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M HHHH **** "BBB@ HHHH *#THHH C(YH ^84_%&* &R(6 Q0O3%.I /F)H
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M6DQ0* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*2EI* %J&;[\/^__ $J;O4,O^LB_W_Z4 2BB@44 +1110 4444 %%%% !111
M0 4444 %%%% !1110 F*4444 %&:2B@ %+110 E%+BB@!**7%&* $%+110 4
M444 %%%% !1110 4444 %%%% "44M% "44M% "44M% "44M% "4"EHH ****
M "BBB@ HHHH **** "BBB@ HHHH 0TM%% !28I:* $Q1BEHH **** "BBB@
MHHHH ****  T444 %%%%  :2EHH **** "BBB@ I*6C% ""EHHH **** $HH
MQ10 "BEHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "DI:2@!>]0R_ZR+_?_I4W>H9?]9%_O_TH E%% HH 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 2C%+10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 44F:7- !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 +WJ&7_6
M1?[_ /2IN]0R_P"LB_W_ .E $HHH%% "T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !0:** $HHQ2T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !24M(* %[U#+_K(O]_\ I4W>H9?]
M;%_O_P!* )>E%!Z44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %)2TE "]ZAE_P!;%_O_ -*F[U#+_K(O]_\ I0!*>:*!
M10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4E+24 +WJ&7_61?[_]*F[U#+_K(O\ ?_I0!***!10 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 +WJ&7_61?[_
M /2IN]0R_P"LB_W_ .E $HHH%% "T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !24M)0 O>H9?\ 61?[_P#2IN]0R_ZR+_?_
M *4 2BB@44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %)2T@H 7O4,O\ K(O]_P#I4W>H)?\ 6Q?[_P#2@":BANE% "T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2"E
MI!0 M03?ZR'_ '_Z5/4$WWX/]_\ H: )FZ44'I10 M%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +4$W^L@_W_P"A
MJ>H)OOP?[_\ 0T 3-THH/2B@!:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ I!2T@H 6H)N9;<?[?]#4U02_ZZW_ -X_^@F@
M"<T444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %(*6D%  :KR_ZVW_W_ .AJS5>7_7P?4_RH L"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:KR_Z^
M#ZG^56*KR_Z^#ZG^5 %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "D%+2"@!:KR_Z^#ZG^56*KR_Z^#ZG^5 %BBDH
MH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *04M(*  U!+_KX/J?Y5.:@E_P!?;_4_RH GHI/7ZT4 .HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@ -5Y?]?;_4
MU8-5Y?\ 7V_U- $_K]:*7U^M% "T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !2"EI!0 O>J\O\ Q\PU8[U!+_Q\0_6@":BE
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I!2T@H 7O4$O\ Q\P_C4_>H)?^/B'\: )A12T4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +WJ"7_7P_6I^]
M02_\?$/UH G-%!HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I!2T@H 7O4$O^OA^M3]Z@E_U\/UH G-%!HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H 7O
M4$O^OA^M3]Z@E_U\/UH G-%!HH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I!2T@H 7O4$O\ Q\0_6IZ@E_X^(OK0!.:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH #2#K2FD% "U!+_ *Z+ZU/4#<W">U $]%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %(*6B@ J%O\ CX6I>]1-_P ?
M"T 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 -SS49_X^%I_\5,/^O6@":BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!@^]33_KUIX^]33_KE
MH DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
< "BBB@ HHHH 2FX_> TX]*3M0 X44#I10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>34
<FILENAME>ptix-20201231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:PTIX="http://protagenic.com/20201231">
    <link:schemaRef xlink:href="ptix-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="From2016-01-01to2016-12-31_custom_DebtSettlementMember_custom_StrategicBioPartnersMember_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DebtSettlementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PTIX:StrategicBioPartnersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_DebtSettlementMember_custom_StrategicBioPartnersMember_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DebtSettlementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">PTIX:StrategicBioPartnersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_UniversityOfTorontoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:UniversityOfTorontoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_UniversityOfTorontoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:UniversityOfTorontoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ConversionFeatureSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PTIX:ConversionFeatureSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-23</xbrli:startDate>
        <xbrli:endDate>2019-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember_custom_VestBiWeeklyOverTwoMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:VestBiWeeklyOverTwoMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-23</xbrli:startDate>
        <xbrli:endDate>2019-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-16to2019-06-17_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-16</xbrli:startDate>
        <xbrli:endDate>2019-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PTIX:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-10-02_custom_ConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:ConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-10-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_FederalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:FederalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FederalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:FederalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_StateAndLocalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:StateAndLocalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_StateAndLocalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:StateAndLocalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_StateAndLocalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:StateAndLocalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ToxicologyStudiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ToxicologyStudiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ToxicologyStudiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ToxicologyStudiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ConversionFeatureSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PTIX:ConversionFeatureSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">PTIX:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ToxicologyStudiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ToxicologyStudiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ToxicologyStudiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ToxicologyStudiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NonEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:NonEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SixteenIndividualsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:SixteenIndividualsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_TwelveRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:TwelveRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SettlementOfAccruedCompensationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:SettlementOfAccruedCompensationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedImmediatelyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:OptionsVestedImmediatelyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverTwelveMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:OptionsVestedOverTwelveMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverTwentyFourMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:OptionsVestedOverTwentyFourMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverThirtySixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:OptionsVestedOverThirtySixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverFourtyEightMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">PTIX:OptionsVestedOverFourtyEightMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-20</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">PTIX:ProtagenicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">PTIX:ProtagenicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:AdditionalIssuanceOfWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">PTIX:ProtagenicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:AdditionalIssuanceOfWarrantsDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsForAccruedInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">PTIX:ProtagenicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:AdditionalIssuanceOfWarrantsForAccruedInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PrivatePlacementMember_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-21_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-15to2020-02-21_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-15</xbrli:startDate>
        <xbrli:endDate>2020-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ResearchAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ResearchAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-08to2020-02-13_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-08</xbrli:startDate>
        <xbrli:endDate>2020-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-13_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_NonEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:NonEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:ConvertibleNotesPayableRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:ConvertibleNotesPayableRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-12to2020-02-13_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-12</xbrli:startDate>
        <xbrli:endDate>2020-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-13_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-01to2020-06-30_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-18_custom_OptionsToRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:OptionsToRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_custom_OptionsToRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:OptionsToRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-18_custom_DrBuellMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DrBuellMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_custom_DrBuellMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DrBuellMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_custom_DrBuellMember_custom_RecognitionUpcomingServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DrBuellMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:RecognitionUpcomingServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-18_custom_DrBuellMember_custom_RecognitionUpcomingServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DrBuellMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:RecognitionUpcomingServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PlacementAgentKatalystSecuritiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:PlacementAgentKatalystSecuritiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ResearchAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">PTIX:ResearchAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">PTIX:DrDavidLovejoyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LossesIncurredAfter2017Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:LossesIncurredAfter2017Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LossesIncurredPriorTo2018Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">PTIX:LossesIncurredPriorTo2018Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FederalGeneratedPriorTo2018Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">PTIX:FederalGeneratedPriorTo2018Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PlacementAgentKatalystSecuritiesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">PTIX:PlacementAgentKatalystSecuritiesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-01to2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-18_custom_StockOptionToConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:StockOptionToConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_custom_StockOptionToConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:StockOptionToConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PlacementAgentWarrantsMember_us-gaap_SeriesBPreferredStockMember1221750593">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:PlacementAgentWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-29to2020-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-29to2020-06-30_custom_BlackScholesModelMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:BlackScholesModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-29</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_BlackScholesModelTwoMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">PTIX:BlackScholesModelTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-02_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandSixteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">PTIX:TwoThousandSixteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_us-gaap_EmployeeStockOptionMember_custom_OptionsToRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:OptionsToRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-17to2020-07-18_us-gaap_EmployeeStockOptionMember_custom_DrBuellMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">PTIX:DrBuellMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-17</xbrli:startDate>
        <xbrli:endDate>2020-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">PTIX:UnsecuredConvertibleNotesWithRelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-24</xbrli:startDate>
        <xbrli:endDate>2021-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-24</xbrli:startDate>
        <xbrli:endDate>2021-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-24</xbrli:startDate>
        <xbrli:endDate>2021-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SeriesBConvertiblePreferredStockMember258690250">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember346823546">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember3166156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">PTIX:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001022899</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">Protagenic Therapeutics, Inc.\new</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">699797</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">807947</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31_custom_ResearchAgreementsMember" unitRef="USD" decimals="0">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31_custom_ResearchAgreementsMember" unitRef="USD" decimals="0">63905</us-gaap:ResearchAndDevelopmentExpense>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" decimals="0">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2548735</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1750911</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1750911</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-2548735</us-gaap:NetIncomeLoss>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">18000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">18000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">872766</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10261419</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">10360480</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10261419</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">10360480</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001022899</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">1.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">1.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-02-13_custom_RelatedPartyMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-02-13_srt_ChiefFinancialOfficerMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-07-18_custom_OptionsToRelatedPartyMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-07-18_custom_DrBuellMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">1.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-07-18_custom_StockOptionToConsultantsMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31">P6Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-06-16to2019-06-17_us-gaap_EmployeeStockOptionMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-02-08to2020-02-13_custom_RelatedPartyMember">P48M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-02-12to2020-02-13_srt_ChiefFinancialOfficerMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2020-01-01to2020-12-31_us-gaap_ConvertibleNotesPayableMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Maturity Date of Notes for Twelve Months Ending December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount due&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,597,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2025&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,597,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Maturity Date of Notes for Twelve Months Ending December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount due&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2025&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">842273</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">879247</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-172364</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-171586</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-15150201</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-17698936</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">14687172</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">16719749</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1026</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1036</us-gaap:CommonStockValue>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1476639</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2028983</us-gaap:Liabilities>
    <PTIX:ConvertibleLongTermNotesPayableRelatedParty contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">104549</PTIX:ConvertibleLongTermNotesPayableRelatedParty>
    <PTIX:ConvertibleLongTermNotesPayableRelatedParty contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">292412</PTIX:ConvertibleLongTermNotesPayableRelatedParty>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">174821</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1081384</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1197269</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">655187</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">332222</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">83670</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">865047</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">571517</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">842273</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">879247</us-gaap:Assets>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">296</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">841977</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">879247</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">43354</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">208156</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">798623</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">671091</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">10339071</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">10261419</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2547957</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1757558</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">778</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-6647</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2548735</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1750911</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2876</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">335219</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">246178</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">15886</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncome contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">502</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2813</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2551611</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-2086130</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2551611</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2086130</us-gaap:OperatingExpenses>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1851814</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1278183</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">798623</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">362486</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">671091</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-127532</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">436137</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 - GOING CONCERN&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As shown in the accompanying&#13;consolidated financial statements, the Company has incurred significant reoccurring losses resulting in an accumulated deficit.&#13;The Company anticipates further losses in the development of its business. The Company had negative cash flows used in operations.&#13;These factors raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Based on its current forecast&#13;and budget, management believes that its cash resources will be sufficient to fund its operations at least until the end of the&#13;third quarter of 2021. Absent generation of sufficient revenue from the execution of the Company&amp;#8217;s business plan and sales&#13;revenue is not anticipated before 2024, the Company will need to obtain debt or equity financing by the third quarter of 2021.&#13;Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to&#13;continue as a going concern, however, management cannot be certain that such plans can be achieved. The accompanying financial&#13;statements have been prepared assuming the Company will continue as a going concern; no adjustments to the financial statements&#13;have been made to account for this uncertainty.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued&#13;expenses consist of the following at:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Accounting&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,161&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,161&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Research and development&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;393,496&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;650,584&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,273&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;141,860&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;163,029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,517&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;865,047&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On October 1, 2019, the&#13;Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment of approximately&#13;$988,000 as an estimate for the study. 50% of the total price was paid upon the signing of the agreement, 35% of the total price&#13;is to be paid upon completion of the in-life study, and the remaining 15% of the total price is to be paid upon the issuance of&#13;the report. If the Company cancels the study the Company will be required to pay a cancelation fee. If the cancelation happens&#13;prior to the arrival of the test animals then the Company will need to pay between 20% and 50% of the animal fees depending on&#13;when the cancellation happens. If the cancellation occurs after the animals arrive but before the study begins then the Company&#13;will be responsible for paying 50% of the protocol price plus a fee of $7,000 per room/week for animal husbandry until the animals&#13;can be relocated or disposed of. If the Company cancels the study after it has begun then the Company will need to pay any fees&#13;for procured items for the study and any nonrecoverable expenses incurred by the consultant. As of December 31, 2020 and December&#13;31, 2019, the Company has paid $174,106 and $0 and there is a balance of $319,799 and $493,905 due, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 13, 2020,&#13;the Company issued 187,497 options to the Company&amp;#8217;s CFO to settle $93,950 in accrued compensations. The difference between&#13;the fair value of the options and the liability settled of $163,036 was charged to stock compensation expense during the year&#13;ended December 31, 2020. The options are fully vested on issuance, have an exercise price of $1.75, and expire in 10 years from&#13;issuance.&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 - DERIVATIVE LIABILITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Upon closing of the private&#13;placement transactions in 2016, the Company issued 127,346 and 295,945 warrants, respectively, to the placement agent of the 2016&#13;Offering and to Strategic Bio Partners, a holder of the Company&amp;#8217;s debt, for debt cancellation, respectively, to purchase&#13;the Company&amp;#8217;s Series B Preferred Stock with an exercise price of $1.25 and a five-year term. Upon the effectiveness of our&#13;reverse stock split in July 2016, these became warrants to purchase our common stock on the same terms and conditions. The warrants,&#13;if exercised under the cashless provision, do not have an explicit limit on the number of shares that will be issued. The warrants&#13;have a cashless exercise feature that requires the Company to classify the warrants as a derivative liability.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 - COLLABORATIVE AGREEMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company and the University&#13;of Toronto (the &amp;#8220;University&amp;#8221;) entered into an agreement effective April 1, 2014 (the &amp;#8220;New Research Agreement&amp;#8221;)&#13;for the performance of a research project titled &amp;#8220;Teneurin C-terminal Associated Peptide (&amp;#8220;TCAP&amp;#8221;) mediated stress&#13;attenuation in vertebrates: Establishing the role of organismal and intracellular energy and glucose regulation and metabolism&amp;#8221;&#13;(the &amp;#8220;New Project&amp;#8221;). The New Project is to perform research related to work done by Dr. David A. Lovejoy, a professor&#13;at the University and stockholder of the Company, in regard to TCAP mediated stress attenuation in vertebrates: Establishing the&#13;role of organismal and intracellular energy and glucose regulation and metabolism. In addition to the New Research Agreement, Dr.&#13;Lovejoy entered into an agreement with the University in order to commercialize certain technologies. The New Research Agreement&#13;expired on March 30, 2016. In February 2017, the New Research Agreement was extended to December 31, 2017. The extension allowed&#13;for further development of the technologies and use of their applications. On April 10, 2018, the agreement was amended and the&#13;research agreement has been further extended to December 31, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Prior to January 1, 2016,&#13;the University has been granted 25,000 stock options which are fully vested at the exercise price of $1.00 exercisable over a ten&#13;year period which ends on April 1, 2022. As of December 31, 2020, Dr. David Lovejoy of the University has been granted 553,299&#13;stock options, of which 527,570 are fully vested. These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over&#13;ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027&#13;or on February 13, 2030.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The sponsorship research&#13;and development expenses pertaining to the Research Agreements were $0 and $63,905 for the years ended December 31, 2020 and 2019,&#13;respectively.&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 - LICENSING AGREEMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 31, 2005, the Company&#13;had entered into a Technology License Agreement (&amp;#8220;License Agreement&amp;#8221;) with the University pursuant to which the University&#13;agreed to license to the Company patent rights and other intellectual property, among other things (the &amp;#8220;Technologies&amp;#8221;).&#13;The Technology License Agreement was amended on February 18, 2015 and currently does not provide for an expiration date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to the License&#13;Agreement and its amendment, the Company obtained an exclusive worldwide license to make, have made, use, sell and import products&#13;based upon the Technologies, or to sublicense the Technologies in accordance with the terms of the License Agreement and amendment.&#13;In consideration, the Company agreed to pay to the University a royalty payment of 2.5% of net sales of any product based on the&#13;Technologies. If the Company elects to sublicense any rights under the License Agreement and amendment, the Company agrees to pay&#13;to the University 10% of any up-front sub-license fees for any sub-licenses that occurred on or after September 9, 2006, and, on&#13;behalf of the sub-licensee, 2.5% of net sales by the sub-licensee of all products based on the Technologies. The Company had no&#13;sales revenue for the years ended December 31, 2020 and 2019 and therefore was not subject to paying any royalties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the event the Company&#13;fails to provide the University with semi-annual reports on the progress or fails to continue to make reasonable commercial efforts&#13;towards obtaining regulatory approval for products based on the Technologies, the University may convert our exclusive license&#13;into a non-exclusive arrangement. Interest on any amounts owed under the License Agreement and amendment will be at 3% per annum.&#13;All intellectual property rights resulting from the Technologies or improvements thereon will remain the property of the other&#13;inventors and/or Dr. Lovejoy, and/or the University, as the case may be. The Company has agreed to pay all out-of- pocket filing,&#13;prosecution and maintenance expenses in connection with any patents relating to the Technologies. In the case of infringement upon&#13;any patents relating to the Technologies, the Company may elect, at its own expense, to bring a cause of action asserting such&#13;infringement. In such a case, after deducting any legal expenses the Company may incur, any settlement proceeds will be subject&#13;to the 2.5% royalty payment owed to the University under the License Agreement and amendment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The patent applications&#13;were made in the name of Dr. Lovejoy and other inventors, but the Company&amp;#8217;s exclusive, worldwide rights to such patent applications&#13;are included in the License Agreement and its amendment with the University. The Company maintains exclusive licensing agreements&#13;and it currently controls the five intellectual patent properties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Legal Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;From time to time we may&#13;be named in claims arising in the ordinary course of business. Currently, no legal proceedings, government actions, administrative&#13;actions, investigations or claims are pending against us or involve us that, in the opinion of our management, could reasonably&#13;be expected to have a material adverse effect on our business and financial condition.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company is provided&#13;free office space consisting of a conference room by the Company Executive Chairman, Dr. Armen. The Company does not pay any rent&#13;for the use of this space. This space is used for quarterly board meetings and our annual shareholder meeting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 13, 2020,&#13;the Company issued 50,000 options to purchase common stock to a related party. These options had an exercise price of $1.75 and&#13;a term of 48 months. (See Note 7)&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basis of presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"&gt;The Company&amp;#8217;s consolidated&#13;financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America&#13;(&amp;#8220;U.S. GAAP&amp;#8221;) and the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Principles of consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial&#13;statements include the accounts of Protagenic Therapeutics, Inc., and its wholly owned Canadian subsidiary, PTI Canada. All significant&#13;intercompany balances and transactions have been eliminated in the consolidated financial statements.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of consolidated&#13;financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported&#13;amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial&#13;statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those&#13;estimates. Significant estimates underlying the consolidated financial statements include income tax provisions, valuation of&#13;stock options and warrants and assessment of deferred tax asset valuation allowance.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company maintains&#13;its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company&#13;may have deposits in excess of federally insured limits. The Company has not experienced losses on these accounts and management&#13;believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers&#13;all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. While the&#13;Company&amp;#8217;s marketable securities are cash equivalents it is the Company&amp;#8217;s policy to present them separately on the&#13;balance sheet. As of December 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Equipment is stated at&#13;cost less accumulated depreciation. Cost includes expenditures for computer equipment. Maintenance and repairs are charged to&#13;expense as incurred. When assets are sold, retired, or otherwise disposed of, the cost and accumulated depreciation are removed&#13;from the accounts and any resulting gain or loss is reflected in operations. The cost of equipment is depreciated using the straight-line&#13;method over the estimated useful lives of the related assets which is three years. Depreciation expense was nominal for the years&#13;ended December 31, 2020 and 2019.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Marketable Securities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;marketable debt securities, the only type of securities it owns, in accordance with sub-topic 320-10 of the FASB Accounting Standards&#13;Codification (&amp;#8220;Sub-topic 320-10&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to Paragraph 320-10-35-1,&#13;investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the consolidated&#13;balance sheets at each balance sheet date. Unrealized holding gains and losses for available-for-sale debt securities (including&#13;those classified as current assets) shall be excluded from earnings and reported in other comprehensive income until realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company purchased $0 and sold $250,000 in marketable securities, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company owned marketable securities with a total value of $0 and $0, respectively. The Company recorded&#13;a realized gain on marketable securities of $0 and $4,435 for the years ended December 31, 2020 and 2019, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company held no marketable securities.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;ASC 820, &amp;#8220;Fair Value&#13;Measurements and Disclosure,&amp;#8221; defines fair value as the price that would be received to sell an asset or paid to transfer&#13;a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs.&#13;ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value&#13;into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level&#13;1) and the lowest priority to unobservable inputs (Level 3).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The three levels are described below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 1 Inputs &amp;#8211;&#13;Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 2 Inputs &amp;#8211;&#13;Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly&#13;or indirectly;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 3 Inputs &amp;#8211;&#13;Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The carrying amount of&#13;the Company&amp;#8217;s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair&#13;value because of the short term maturity of those instruments. The carrying value of long-term debt approximates fair value since&#13;the related rates of interest approximate current market rates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Transactions involving&#13;related parties cannot be presumed to be carried out on an arm&amp;#8217;s-length basis, as the requisite conditions of competitive,&#13;free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the&#13;related party transactions were consummated on terms equivalent to those that prevail in arm&amp;#8217;s-length transactions unless&#13;such representations can be substantiated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The assets or liability&amp;#8217;s&#13;fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair&#13;value measurement. The following table provides a summary of financial instruments that are measured at fair value on a recurring&#13;basis as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides&#13;a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The table below provides&#13;a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured&#13;at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and&#13;the year ended December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value Measurement&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Using Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Inputs Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;676,079&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(343,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(248,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the derivative&#13;feature of the 127,346 and 295,945 warrants issued to the placement agent of the Company&amp;#8217;s 2016 private offering (the &amp;#8220;2016&#13;Offering&amp;#8221;) and to a holder of its debt for debt cancellation in connection with the Merger, respectively on the issuance&#13;dates and at the balance sheet dates were calculated using a Black-Scholes option model valued with the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;169&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Contractual term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.15 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.14 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Risk-free interest rate:&#13;The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Dividend yield: The Company&#13;uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in&#13;the near future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Volatility: The Company&#13;calculates the expected volatility of the stock price based on the corresponding volatility of the Company&amp;#8217;s peer group stock&#13;price for a period consistent with the warrants&amp;#8217; expected term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Expected term: The Company&amp;#8217;s&#13;expected term is based on the remaining contractual maturity of the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a gain of $248,552&#13;and a gain of $343,857 relating to the change in fair value, respectively.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Derivative Liability&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its&#13;options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify&#13;as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment&#13;is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or&#13;a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated&#13;statements of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the&#13;instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified&#13;to equity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The classification of&#13;derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the&#13;end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification&#13;are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities&#13;will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative&#13;instrument is expected within 12 months of the balance sheet date.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;stock based compensation costs under the provisions of ASC 718, &amp;#8220;Compensation&amp;#8212;Stock Compensation&amp;#8221;, which requires&#13;the measurement and recognition of compensation expense related to the fair value of stock based compensation awards that are ultimately&#13;expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock based payments granted&#13;to employees, officers, non-employees, and directors based on the grant date fair value estimated in accordance with the provisions&#13;of ASC 718. ASC. 718 is also applied to awards modified, repurchased, or canceled during the periods reported.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;If any award granted under&#13;the Company&amp;#8217;s 2016 Equity Compensation Plan (the &amp;#8220;2016 Plan&amp;#8221;) payable in shares of common stock is forfeited,&#13;cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being made, or if shares&#13;of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of common stock as to&#13;which such option or award was forfeited, or which were withheld, will be available for future grants under the 2016 Plan. The&#13;Company recognizes the impact of forfeitures when they occur.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Net (Loss) per Common&#13;Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic (loss) per common&#13;share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period.&#13;Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding&#13;plus the dilutive effect of shares issuable through the common stock equivalents. The effect of dilution on net loss becomes anti-dilutive&#13;and therefore is not reflected on the consolidated statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Potentially Outstanding&lt;br /&gt;&#13;Dilutive Common Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;For the Year&lt;br /&gt;&#13;Ended&lt;br /&gt;&#13;December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;For the Year&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ended&lt;br /&gt;&#13;        December 31, 2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Conversion Feature Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Common shares issuable under the conversion feature of preferred shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,597,861&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,835,366&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,007,058&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,598,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;536,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total potentially outstanding dilutive common shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,075,685&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,070,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Research and Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Research and development&#13;expenses are charged to operations as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows Section&#13;830-10-45 of the FASB Accounting Standards Codification (&amp;#8220;Section 830-10-45&amp;#8221;) for foreign currency translation to translate&#13;the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars.&#13;Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity&#13;(including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes&#13;transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall&#13;be measured using the functional currency of that entity. An entity&amp;#8217;s functional currency is the currency of the primary&#13;economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which&#13;an entity primarily generates and expends cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The functional currency&#13;of each foreign subsidiary is determined based on management&amp;#8217;s judgment and involves consideration of all relevant economic&#13;facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions,&#13;including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency&#13;upon the parent and the nature of the subsidiary&amp;#8217;s operations must also be considered. If a subsidiary&amp;#8217;s functional&#13;currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary&amp;#8217;s financial&#13;statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S.&#13;Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional&#13;currency would be included in the consolidated statements of operations and comprehensive income (loss). If the Company disposes&#13;of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of&#13;operations and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of&#13;a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the&#13;consolidated statements of operations and comprehensive income (loss).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Based on an assessment&#13;of the factors discussed above, the management of the Company determined its subsidiary&amp;#8217;s local currency (i.e. the Canadian&#13;dollar) to be the functional currency for its foreign subsidiary.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2016, FASB&#13;issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2016-02: Leases (Topic 842). The new guidance generally requires an entity&#13;to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The standard&#13;will be effective for the first interim period within annual reporting periods beginning after December 15, 2018 and early adoption&#13;is permitted. The new standard requires a modified retrospective transition for existing leases to each prior reporting period&#13;presented or entered into after, the beginning of the earliest comparative period presented in the financial statements. This&#13;standard was adopted by the Company on January 1, 2018. The Company elected the package of practical expedients permitted under&#13;the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical&#13;lease classification. The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated financial&#13;statements and related disclosures.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe&#13;that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&amp;#8217;s&#13;financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides&#13;a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides&#13;a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The table below provides&#13;a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured&#13;at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and&#13;the year ended December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value Measurement&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Using Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Inputs Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;676,079&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(343,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(248,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Contractual term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.15 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The effect of dilution&#13;on net loss becomes anti-dilutive and therefore is not reflected on the consolidated statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Potentially Outstanding&lt;br /&gt;&#13;Dilutive Common Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;For the Year&lt;br /&gt;&#13;Ended&lt;br /&gt;&#13;December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;For the Year&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ended&lt;br /&gt;&#13;        December 31, 2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Conversion Feature Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Common shares issuable under the conversion feature of preferred shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,597,861&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,835,366&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,007,058&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,598,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;536,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total potentially outstanding dilutive common shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,075,685&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,070,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued&#13;expenses consist of the following at:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Accounting&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,161&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,161&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Research and development&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;393,496&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;650,584&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,273&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;141,860&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;163,029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,517&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;865,047&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;There were 5,597,861 options&#13;outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes assumptions&#13;and or factors as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.64%-1.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;140%-146&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;There were 3,835,366 options&#13;outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the Black-Scholes assumptions&#13;and or factors as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - $1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.09%-2.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;137%-140&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is an analysis&#13;of the stock option grant activity under the Plan:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 49%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,846,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;126,567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(137,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,835,366&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,762,495&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,597,861&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the status&#13;of the Company&amp;#8217;s nonvested options as of December 31, 2020, and changes during the year ended December 31, 2020, is presented&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Nonvested Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;br /&gt;&#13;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;800,210&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;126,567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(584,895&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(137,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;204,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,762,495&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,104,044&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;862,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of warrant issuances&#13;are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 49%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;180,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,007,058&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:NatureOfOperations contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 1 &amp;#8211; ORGANIZATION AND NATURE OF&#13;BUSINESS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Company Background&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Protagenic Therapeutics,&#13;Inc. (&amp;#8220;we,&amp;#8221; &amp;#8220;our,&amp;#8221; &amp;#8220;Protagenic&amp;#8221; or &amp;#8220;the Company&amp;#8221;), is a Delaware corporation with&#13;one subsidiary named Protagenic Therapeutics Canada (2006) Inc. (&amp;#8220;PTI Canada&amp;#8221;), a corporation formed in 2006 under&#13;the laws of the Province of Ontario, Canada.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company was previously&#13;known as Atrinsic, Inc., a company that was once a reporting company under the Securities Exchange Act of 1934, but that, in 2012&#13;and 2013, reorganized under Chapter 11 of the United States Bankruptcy Code and emerged from bankruptcy. On February 12, 2016,&#13;the Company acquired Protagenic Therapeutics, Inc. (&amp;#8220;Prior Protagenic&amp;#8221;) through a reverse merger.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 12, 2016,&#13;Protagenic Acquisition Corp., a wholly-owned subsidiary of the Company, merged (the &amp;#8220;Merger&amp;#8221;) with and into Prior&#13;Protagenic. Prior Protagenic was the surviving corporation of the Merger. As a result of the Merger, the Company acquired the&#13;business of Prior Protagenic and has continued the existing business operations of Prior Protagenic as a wholly-owned subsidiary.&#13;On June 17, 2016, Prior Protagenic merged with and into the Company with the Company as the surviving corporation in the merger.&#13;Immediately thereafter, the Company changed its name from Atrinsic, Inc. to Protagenic Therapeutics, Inc.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 - SUMMARY OF SIGNFICANT ACCOUNTING&#13;POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basis of presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"&gt;The Company&amp;#8217;s consolidated&#13;financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America&#13;(&amp;#8220;U.S. GAAP&amp;#8221;) and the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Principles of consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial&#13;statements include the accounts of Protagenic Therapeutics, Inc., and its wholly owned Canadian subsidiary, PTI Canada. All significant&#13;intercompany balances and transactions have been eliminated in the consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reclassifications:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Reclassifications of prior&#13;periods have been made to conform with current year presentation&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of consolidated&#13;financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported&#13;amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial&#13;statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those&#13;estimates. Significant estimates underlying the consolidated financial statements include income tax provisions, valuation of stock&#13;options and warrants and assessment of deferred tax asset valuation allowance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company maintains its&#13;cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may&#13;have deposits in excess of federally insured limits. The Company has not experienced losses on these accounts and management believes,&#13;based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company considers all&#13;highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. While the Company&amp;#8217;s&#13;marketable securities are cash equivalents it is the Company&amp;#8217;s policy to present them separately on the balance sheet. As&#13;of December 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Equipment is stated at&#13;cost less accumulated depreciation. Cost includes expenditures for computer equipment. Maintenance and repairs are charged to expense&#13;as incurred. When assets are sold, retired, or otherwise disposed of, the cost and accumulated depreciation are removed from the&#13;accounts and any resulting gain or loss is reflected in operations. The cost of equipment is depreciated using the straight-line&#13;method over the estimated useful lives of the related assets which is three years. Depreciation expense was nominal for the years&#13;ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Marketable Securities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;marketable debt securities, the only type of securities it owns, in accordance with sub-topic 320-10 of the FASB Accounting Standards&#13;Codification (&amp;#8220;Sub-topic 320-10&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to Paragraph 320-10-35-1,&#13;investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the consolidated&#13;balance sheets at each balance sheet date. Unrealized holding gains and losses for available-for-sale debt securities (including&#13;those classified as current assets) shall be excluded from earnings and reported in other comprehensive income until realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company purchased $0 and sold $250,000 in marketable securities, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company owned marketable securities with a total value of $0 and $0, respectively. The Company recorded&#13;a realized gain on marketable securities of $0 and $4,435 for the years ended December 31, 2020 and 2019, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company held no marketable securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;ASC 820, &amp;#8220;Fair Value&#13;Measurements and Disclosure,&amp;#8221; defines fair value as the price that would be received to sell an asset or paid to transfer&#13;a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs.&#13;ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value&#13;into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level&#13;1) and the lowest priority to unobservable inputs (Level 3).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The three levels are described below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 1 Inputs &amp;#8211;&#13;Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 2 Inputs &amp;#8211;&#13;Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly&#13;or indirectly;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 3 Inputs &amp;#8211;&#13;Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The carrying amount of&#13;the Company&amp;#8217;s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair&#13;value because of the short term maturity of those instruments. The carrying value of long-term debt approximates fair value since&#13;the related rates of interest approximate current market rates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Transactions involving&#13;related parties cannot be presumed to be carried out on an arm&amp;#8217;s-length basis, as the requisite conditions of competitive,&#13;free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the&#13;related party transactions were consummated on terms equivalent to those that prevail in arm&amp;#8217;s-length transactions unless&#13;such representations can be substantiated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The assets or liability&amp;#8217;s&#13;fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair&#13;value measurement. The following table provides a summary of financial instruments that are measured at fair value on a recurring&#13;basis as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table provides&#13;a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value Measurement Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 40%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The table below provides&#13;a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured&#13;at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and&#13;the year ended December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value Measurement&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Using Level 3&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Inputs Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;676,079&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(343,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;332,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Change in fair value of derivative warrants liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(248,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;83,670&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the derivative&#13;feature of the 127,346 and 295,945 warrants issued to the placement agent of the Company&amp;#8217;s 2016 private offering (the &amp;#8220;2016&#13;Offering&amp;#8221;) and to a holder of its debt for debt cancellation in connection with the Merger, respectively on the issuance&#13;dates and at the balance sheet dates were calculated using a Black-Scholes option model valued with the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31, 2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December 31 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;169&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Contractual term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.15 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.14 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Risk-free interest rate:&#13;The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Dividend yield: The Company&#13;uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in&#13;the near future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Volatility: The Company&#13;calculates the expected volatility of the stock price based on the corresponding volatility of the Company&amp;#8217;s peer group stock&#13;price for a period consistent with the warrants&amp;#8217; expected term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Expected term: The Company&amp;#8217;s&#13;expected term is based on the remaining contractual maturity of the warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a gain of $248,552&#13;and a gain of $343,857 relating to the change in fair value, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Derivative Liability&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates its&#13;options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify&#13;as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment&#13;is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or&#13;a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated&#13;statements of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the&#13;instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified&#13;to equity.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The classification of derivative&#13;instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each&#13;reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified&#13;to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified&#13;in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected&#13;within 12 months of the balance sheet date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;stock based compensation costs under the provisions of ASC 718, &amp;#8220;Compensation&amp;#8212;Stock Compensation&amp;#8221;, which requires&#13;the measurement and recognition of compensation expense related to the fair value of stock based compensation awards that are ultimately&#13;expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock based payments granted&#13;to employees, officers, non-employees, and directors based on the grant date fair value estimated in accordance with the provisions&#13;of ASC 718. ASC. 718 is also applied to awards modified, repurchased, or canceled during the periods reported.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;If any award granted under&#13;the Company&amp;#8217;s 2016 Equity Compensation Plan (the &amp;#8220;2016 Plan&amp;#8221;) payable in shares of common stock is forfeited,&#13;cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being made, or if shares&#13;of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of common stock as to&#13;which such option or award was forfeited, or which were withheld, will be available for future grants under the 2016 Plan. The&#13;Company recognizes the impact of forfeitures when they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted Net (Loss) per Common&#13;Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic (loss) per common&#13;share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period.&#13;Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding&#13;plus the dilutive effect of shares issuable through the common stock equivalents. The effect of dilution on net loss becomes anti-dilutive&#13;and therefore is not reflected on the consolidated statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Potentially Outstanding&lt;br /&gt;&#13;Dilutive Common Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For the Year&lt;br /&gt;&#13;Ended&lt;br /&gt;&#13;December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;For the Year&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Ended&lt;br /&gt;&#13;        December 31, 2019&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Conversion Feature Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Common shares issuable under the conversion feature of preferred shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;872,766&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,597,861&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,835,366&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,007,058&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,598,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;536,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total potentially outstanding dilutive common shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12,075,685&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,070,790&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Research and Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Research and development&#13;expenses are charged to operations as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows Section&#13;830-10-45 of the FASB Accounting Standards Codification (&amp;#8220;Section 830-10-45&amp;#8221;) for foreign currency translation to translate&#13;the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars.&#13;Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity&#13;(including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes&#13;transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall&#13;be measured using the functional currency of that entity. An entity&amp;#8217;s functional currency is the currency of the primary&#13;economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which&#13;an entity primarily generates and expends cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The functional currency&#13;of each foreign subsidiary is determined based on management&amp;#8217;s judgment and involves consideration of all relevant economic&#13;facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions,&#13;including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency&#13;upon the parent and the nature of the subsidiary&amp;#8217;s operations must also be considered. If a subsidiary&amp;#8217;s functional&#13;currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary&amp;#8217;s financial&#13;statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S.&#13;Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional&#13;currency would be included in the consolidated statements of operations and comprehensive income (loss). If the Company disposes&#13;of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of&#13;operations and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of&#13;a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the&#13;consolidated statements of operations and comprehensive income (loss).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Based on an assessment&#13;of the factors discussed above, the management of the Company determined its subsidiary&amp;#8217;s local currency (i.e. the Canadian&#13;dollar) to be the functional currency for its foreign subsidiary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2016, FASB&#13;issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2016-02: Leases (Topic 842). The new guidance generally requires an entity&#13;to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The standard&#13;will be effective for the first interim period within annual reporting periods beginning after December 15, 2018 and early adoption&#13;is permitted. The new standard requires a modified retrospective transition for existing leases to each prior reporting period&#13;presented or entered into after, the beginning of the earliest comparative period presented in the financial statements. This standard&#13;was adopted by the Company on January 1, 2018. The Company elected the package of practical expedients permitted under the transition&#13;guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification.&#13;The adoption of this standard did not have a material impact on the Company&amp;#8217;s consolidated financial statements and related&#13;disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management does not believe&#13;that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&amp;#8217;s&#13;financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reclassifications:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Reclassifications of prior&#13;periods have been made to conform with current year presentation&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &amp;#8211; CONVERTIBLE NOTE PAYABLE&#13;(PIK NOTES)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Convertible Notes Payable&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the fourth quarter&#13;of 2019, the Company entered into a series of unsecured convertible notes (the &amp;#8220;Convertible Notes&amp;#8221;). The Convertible&#13;Notes have a total principal amount of $420,000. The Convertible Notes accrue 6% interest per year payable on October 31, 2020&#13;and on the end of each calendar year thereafter, payable by a corresponding increase in the principal amount of each Convertible&#13;Note that increases to 12% per year (the Default Rate&amp;#8221;) in the case a default. The Company will pay (a &amp;#8220;PIK Payment&amp;#8221;)&#13;the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding principal amount of the&#13;Convertible Notes on each interest payment date and on the maturity date. Each PIK Payment will be preceded by written notice from&#13;the Company to the Convertible Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal&#13;amount of the Convertible Note following such PIK Payment. The Convertible Notes are due on November 6, 2023. The Convertible Notes&#13;are convertible into shares of the Company&amp;#8217;s common stock with a conversion price of $1.25 per share, subject to adjustment&#13;in certain circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the second quarter&#13;of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $850,000. The notes accrue&#13;6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase&#13;in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will&#13;pay (a &amp;#8220;PIK Payment&amp;#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding&#13;principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written&#13;notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal&#13;amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of&#13;the Company&amp;#8217;s common stock with an exercise price of $1.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the third quarter&#13;of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $327,500. The notes accrue&#13;6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase&#13;in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will&#13;pay (a &amp;#8220;PIK Payment&amp;#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding&#13;principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written&#13;notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal&#13;amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of&#13;the Company&amp;#8217;s common stock with an exercise price of $1.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has evaluated&#13;the terms of the Convertible Notes and determined that there are no derivative features in the Convertible Notes. These Convertible&#13;Notes do have a beneficial conversion feature and recorded a total debt discount of $356,204 with $104,204 being recorded in the&#13;year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Katalyst Securities LLC&#13;acted as the Company&amp;#8217;s placement agent (the &amp;#8220;Placement Agent&amp;#8221;) for the sale of the Convertible Notes. The Company&#13;paid the Placement Agent, including its sub-agents, a commission of 10% of the funds raised from the investors introduced by the&#13;Placement Agent. In addition, the Placement Agent will receive warrants to purchase a number of shares of Common Stock equal to&#13;10% of the shares of Common Stock issuable upon conversion of the Notes sold to the investors who were introduced to us by the&#13;Placement Agent (See note 7). The Company recognized $104,090 in expenses related to the Placement Agent commission for this offering&#13;which were recorded as a debt discount. This debt discount and the fair value of the warrants issued to the placement agent of&#13;$179,679 are being amortized over the life of the notes from the private placement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company amortized $117,036 and $6,821 of the debt discount, respectively. At December 31, 2020&#13;and December 31, 2019, the Company had an unamortized debt discount of $516,116 and $245,179, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company owes $1,597,500 and $420,000 on the outstanding Convertible Notes, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Maturity Date of Notes for Twelve Months Ending December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount due&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,597,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2025&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,597,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Convertible Notes Payable &amp;#8211; Related&#13;Party&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the fourth quarter&#13;of 2019, the Company issued unsecured Convertible Notes in the aggregate principal amount of $250,000 to related parties. The notes&#13;accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding&#13;increase in the principal amount of each Convertible Note that increases to 12% per year in the case of the notes entering default.&#13;The Company will pay (a &amp;#8220;PIK Payment&amp;#8221;) the interest due by adding such interest (including interest at the Default&#13;Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment&#13;will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK&#13;Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible&#13;into shares of the Company&amp;#8217;s common stock with an exercise price of $1.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the second quarter&#13;of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $50,000. The notes accrue&#13;6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase&#13;in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will&#13;pay (a &amp;#8220;PIK Payment&amp;#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding&#13;principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written&#13;notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal&#13;amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of&#13;the Company&amp;#8217;s common stock with an exercise price of $1.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the third quarter&#13;of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $100,000. The notes accrue&#13;6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase&#13;in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will&#13;pay (a &amp;#8220;PIK Payment&amp;#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding&#13;principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written&#13;notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal&#13;amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of&#13;the Company&amp;#8217;s common stock with an exercise price of $1.25 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has evaluated&#13;the terms of the notes and determined that there are no derivative features in the note. The Convertible Notes issued to related&#13;parties have a beneficial conversion feature and, accordingly, the Company recorded a debt discount of $150,000 during the year&#13;ended December 31, 2019. No debt discount was recorded during the year ended December 31, 2020. During the year ended December&#13;31, 2020 and 2019, the Company amortized $37,863 and $4,549 of the debt discount, respectively, on Convertible Notes issued to&#13;related parties. Additionally, a fee of $9,000 was expensed related to the notes. At December 31, 2020 and December 31, 2019, the&#13;Company had an unamortized debt discount of $107,588 and $145,451, respectively, on Convertible Notes issued to related parties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and December 31, 2019, the Company owes $400,000 and $250,000 on the outstanding notes, respectively, held by related parties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Maturity Date of Notes for Twelve Months Ending December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount due&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;2025&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 - STOCKHOLDERS&amp;#8217; DEFICIT&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the&#13;consummation of the Merger completed on February 12, 2016, we adopted Prior Protagenic&amp;#8217;s 2006 Employee, Director and Consultant&#13;Stock Plan (the &amp;#8220;2006 Plan&amp;#8221;). On June 17, 2016, our stockholders adopted the 2016 Plan and, as a result, we terminated&#13;the 2006 Plan. We will not grant any further awards under the 2006 Plan. All outstanding grants under the 2006 Plan will continue&#13;in effect in accordance with the terms of the particular grant and the 2006 Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to the 2016 Plan,&#13;the Company&amp;#8217;s Compensation Committee may grant awards to any employee, officer, director, consultant, advisor or other individual&#13;service provider of the Company or any subsidiary. On each of January 1, 2017, January 1, 2019 and January 1, 2020, pursuant to&#13;an annual &amp;#8220;evergreen&amp;#8221; provision contained in the 2016 Plan, the number of shares reserved for future grants was increased&#13;by 564,378 shares, or a total of 1,693,134 shares. As a result of these increases, as of December 31, 2019 and December 31, 2020,&#13;the aggregate number of shares of common stock available for awards under the 2016 Plan was 4,304,245 shares and 4,868,623 shares,&#13;respectively. Options issued under the 2016 Plan are exercisable for up to ten years from the date of issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;There were 5,597,861 options&#13;outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes assumptions&#13;and or factors as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.64%-1.61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;140%-146&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;There were 3,835,366 options&#13;outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the Black-Scholes assumptions&#13;and or factors as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.00 - $1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.09%-2.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137%-140&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is an analysis&#13;of the stock option grant activity under the Plan:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 49%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,846,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;126,567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9.20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(137,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,835,366&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,762,495&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,597,861&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.48&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the status&#13;of the Company&amp;#8217;s nonvested options as of December 31, 2020, and changes during the year ended December 31, 2020, is presented&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Nonvested Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted-Average&lt;br /&gt;&#13;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;800,210&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.63&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;126,567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.15&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(584,895&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(137,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;204,382&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,762,495&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,104,044&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;862,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the Company had 5,597,861 shares issuable under options outstanding at a weighted average exercise price of $1.47 and an intrinsic&#13;value of $38,328.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2019,&#13;the Company had 3,835,366 shares issuable under options outstanding at a weighted average exercise price of $1.34 and an intrinsic&#13;value of $635,536.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The total number of options&#13;granted during the years ended December 31, 2020 and 2019 was 1,762,495 and 126,567, respectively. The exercise price for these&#13;options was $1.00 per share or $1.75 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognized&#13;compensation expense related to options issued of $1,427,084 and $797,761 during the years ended December 31, 2020 and 2019, respectively,&#13;in which $1,354,750 and $698,293 is included in general and administrative expenses and $72,334 and $99,468 in research and development&#13;expenses, respectively. For the year ended December 31, 2020, $1,046,795 of the stock compensation was related to employees and&#13;$380,289 was related to non-employees.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the unamortized stock option expense was $898,665 with $305,527 being related to employees and $593,138 being related to non-employees.&#13;As of December 31, 2020, the weighted average period for the unamortized stock compensation to be recognized is 2.99 years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2019, the&#13;Company granted 101,567 options with an exercise price of $1.00 and a ten year term. 59,900 of these options vest immediately and&#13;41,667 vest bi-weekly over two months. These options have a Black-Scholes value of $199,807. The Company issued 59,900 options&#13;for settlement of accounts payable totaling $29,850 and recorded a loss of $99,541 on the settlement of the accounts payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On June 17, 2019, the Company&#13;granted 25,000 options with an exercise price of $1.75 and a ten year term. These options vest immediately and have a Black-Scholes&#13;value of $36,374.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 21, 2020, the&#13;Company issued a total of 1,387,497 options to purchase shares of the Company&amp;#8217;s common stock to sixteen individuals with&#13;1,362,497 option going to twelve related parties. These options had a grant date fair value of $1,901,724. From these options,&#13;187,497 options were used to settle $93,950 in accrued compensations. These options have an exercise price of $1.75. 187,497 of&#13;the options vest immediately, 510,000 of the options vest monthly over 12 months, 5,000 of the options vest monthly over 24 months,&#13;420,000 of the options vest monthly over 36 months, and 265,000 of the options vest monthly over 48 months. These options were&#13;approved by the board of directors on February 13, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 18, 2020, the Company&#13;issued 124,998 options to a related party. These options have an exercise price of $1.75 and a term of ten years. These options&#13;vest immediately and the grant date fair value of these options was $142,607.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 18, 2020, the Company&#13;issued 105,000 options to consultants. These options have an exercise price of $1.75 and a term of ten years. These options vest&#13;monthly over four years and the grant date fair value of these options was $119,792.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 18, 2020, the Board&#13;of Directors increased the size of the Board from five directors to six directors and appointed Jennifer Buell, Ph.D. as a member&#13;of the Board, effective immediately, to fill the vacancy created by such increase and to serve until the next annual meeting of&#13;shareholders. Dr. Buell was issued options to purchase 100,000 shares of the Company&amp;#8217;s common stock at an exercise price&#13;of $1.75 per share. The options vest as follows: monthly over 48 months. In recognition of her upcoming service as a Director of&#13;the Company, Dr. Buell was issued 45,000 options that vest monthly over 12 months. In each case the vesting commenced on the date&#13;of grant, July 18, 2020. These options had a grant date fair value of $165,426.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Warrants:&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In connection with the&#13;Merger, all of the issued and outstanding warrants to purchase shares of Prior Protagenic common stock converted, on a 1 for 1&#13;basis, into new warrants (the &amp;#8220;&lt;b&gt;New Warrants&lt;/b&gt;&amp;#8221;) to purchase shares of our Series B Preferred Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Simultaneously with the&#13;Merger and the 2016 Offering, New Warrants to purchase 3,403,367 shares of Series B Preferred Stock at an average exercise price&#13;of approximately $1.05 per share were issued to holders of Prior Protagenic warrants; additionally, the holder of $665,000 of our&#13;debt and $35,000 of accrued interest exchanged such debt for five-year warrants to purchase 295,945 shares of Series B Preferred&#13;Stock at $1.25 per share. Warrants to purchase 127,346 shares of Series B Preferred Stock at an exercise price of $1.25 per share&#13;were issued to the placement agent in connection with the 2016 Offering. These warrants to purchase 423,291 shares of Series B&#13;Preferred Stock have been recorded as derivative liabilities. All of these warrants automatically converted into warrants to purchase&#13;our common stock upon the effectiveness of our reverse stock split in July 2016. See Note 5.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of warrant issuances&#13;are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 49%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,826,658&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;180,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,007,058&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the Company had 4,007,058 shares issuable under warrants outstanding at a weighted average exercise price of $1.06 and an intrinsic&#13;value of $782,668.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2019,&#13;the Company had 3,826,658 shares issuable under warrants outstanding at a weighted average exercise price of $1.05 and an intrinsic&#13;value of $1,375,990.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 21, 2020, the&#13;Company extended the expiration date for 100,000 warrants to purchase shares of the Company&amp;#8217;s common stock. The expiration&#13;date was extended by two years from January 2, 2020 to January 2, 2022. These warrants have an exercise price of $1.25 and are&#13;fully vested. The Company recognized $95,187 in stock compensation as part of this modification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On June 30, 2020, the Company&#13;issued 81,600 warrants to purchase shares of the Company&amp;#8217;s common stock. These warrants vest immediately, had an exercise&#13;price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $86,968, which is being amortized over the life&#13;of the notes from the private placement. These warrants were issued as compensation to the placement agents in connection with&#13;the Company&amp;#8217;s private placement offering of debt in which $6,643 was recorded as stock compensation expense and $80,325 recorded&#13;as a debt discount.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the third quarter&#13;of 2020, the Company issued 98,800 warrants to purchase shares of the Company&amp;#8217;s common stock. These warrants vest immediately,&#13;had an exercise price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $105,194 which is being amortized&#13;over the life of the notes from the private placement. These warrants were issued as compensation to the placement agents in connection&#13;with the Company&amp;#8217;s private placement offering in which $5,840 was recorded as stock compensation expense and $99,354 recorded&#13;as a debt discount.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-634366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-210883</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-1149736</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_custom_SeriesBConvertiblePreferredStockMember258690250" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember346823546" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1026</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1026</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">13357920</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14687172</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-13399290</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-15150201</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-170540</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-172364</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember3166156" unitRef="USD" decimals="0">1</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1036</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">16719749</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-17698936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-171586</us-gaap:StockholdersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 11 &amp;#8211; INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The components of loss&#13;before income taxes are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Domestic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,542,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,698,689&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,307&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(52,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Loss before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,548,735&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,750,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company had no income&#13;tax expense due to operating losses incurred for the years ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December&#13;31, 2020 and 2019, a reconciliation of the Company&amp;#8217;s effective tax rate to the statutory U.S. Federal rate is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Income taxes at Federal statutory rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;State income taxes, net of Federal income tax effect&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Perm difference&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign tax rate differential&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Income tax provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The tax effects of temporary&#13;differences that give rise to the Company&amp;#8217;s deferred tax assets and liabilities are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;U.S. net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,907,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,894,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,217,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;784,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Canadian Provincial income tax losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Canadian Provincial scientific investment tax credits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(10,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,121,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,121,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"&gt;As of December 31, 2020&#13;and 2019, the Company had federal net operating loss carryforwards (&amp;#8220;NOL&amp;#8221;) of approximately $7,550,000 and $7,161,000,&#13;respectively. The 2017 Tax Cuts and Jobs Act (&amp;#8220; TCJA&amp;#8221;) will generally allow losses incurred after 2017 to be carried&#13;over indefinitely, but will generally limit the net operating loss deduction to the lesser of the net operating loss carryover&#13;or 80% of a corporation&amp;#8217;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as amended). Also,&#13;there will be no carryback for losses incurred after 2017. Losses incurred prior to 2018 will generally be deductible to the extent&#13;of the lesser of a corporation&amp;#8217;s net operating loss carryover or 100% of a corporation&amp;#8217;s taxable income and be available&#13;for twenty years from the period the loss was generated. The federal net operating losses generated prior to 2018 of $0.1 million&#13;will expire at various dates through 2037. The CARES Act temporarily allows the Company to carryback net operating losses arising&#13;in 2018, 2019 and 2020 to the five prior tax years. In addition, net operating losses generated in these years could fully offset&#13;prior year taxable income without the 80% of the taxable income limitation under the TCJA which was enacted on December 22, 2017.&#13;The Company has been generating losses since its inception, as such the net operating loss carryback provision under the CARES&#13;Act is not applicable to the Company. As of December 31, 2020 and 2019, the Company had state and local net operating loss carryforwards&#13;of approximately $7,540,000 and $7,153,000, respectively, to reduce future state tax liabilities also through 2035.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020&#13;and 2019, the Company had Canadian NOL of approximately $1,115,000 and $1,111,000, respectively. The Canadian losses expire in&#13;stages beginning in 2026. As of December 31, 2020 and 2019, the Company also has unclaimed Canadian federal scientific research&#13;and development investment tax credits, which are available to reduce future federal taxes payable of approximately $0 and $0 respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As a result of losses and&#13;uncertainty of future profit, the net deferred tax asset has been fully reserved. The net change in the valuation allowance during&#13;the years ended December 31, 2020 and 2019 was an increase of $418,000 and $661,000, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Foreign earnings are assumed&#13;to be permanently reinvested. U.S. Federal income taxes have not been provided on undistributed earnings of our foreign subsidiary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;interest and penalties related to uncertain tax positions in selling, general and administrative expenses. The Company has not&#13;identified any uncertain tax positions requiring a reserve as of December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company is required&#13;to file U.S. federal and state income tax returns. These returns are subject to audit by tax authorities beginning with the year&#13;ended December 31, 2017.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 - SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2021, the&#13;Company issued 366,000 options to purchase share of the Company&amp;#8217;s common stock. 350,000 of these options vest over 48 months&#13;and have a term of ten years and the remaining 16,000 options vest immediately and have a term of five years. All of these options&#13;have an exercise price of $5.60.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the first quarter&#13;of 2021, a total of 268,233 warrants were exercised for a total of 161,026 shares of the Company&amp;#8217;s common stock.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The components of loss&#13;before income taxes are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Domestic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,542,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,698,689&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,307&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(52,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Loss before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,548,735&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,750,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December&#13;31, 2020 and 2019, a reconciliation of the Company&amp;#8217;s effective tax rate to the statutory U.S. Federal rate is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Income taxes at Federal statutory rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(21.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;State income taxes, net of Federal income tax effect&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Perm difference&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign tax rate differential&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Income tax provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The tax effects of temporary&#13;differences that give rise to the Company&amp;#8217;s deferred tax assets and liabilities are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;U.S. net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,907,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,894,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,217,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;784,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Canadian Provincial income tax losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Canadian Provincial scientific investment tax credits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(10,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,121,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,121,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" unitRef="USD" decimals="0">12005860</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-03-17" unitRef="Shares" decimals="INF">10521506</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">4435</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">248552</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">343857</us-gaap:DerivativeGainLossOnDerivativeNet>
    <PTIX:DebtDiscountFromWarrantsIssuedToPlacementAgents contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">179679</PTIX:DebtDiscountFromWarrantsIssuedToPlacementAgents>
    <PTIX:DebtDiscountFromWarrantsIssuedToPlacementAgents contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">179679</PTIX:DebtDiscountFromWarrantsIssuedToPlacementAgents>
    <us-gaap:Depreciation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">286</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">339</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1654754</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">797761</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">154899</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">117036</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">6821</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">4549</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">11370</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">356204</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">37863</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-06-29to2020-06-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">80325</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-07-01to2020-09-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">99354</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-99541</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">164802</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-40044</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-196629</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">662158</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1348779</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-487990</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">250000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">250000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">104090</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1177500</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">420000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">150000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">250000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1223410</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">670000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2163</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">4127</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">104204</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">252000</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2020-01-01to2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">104204</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <PTIX:DebtDiscountFromBeneficialConversionFeature contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <PTIX:DebtDiscountFromBeneficialConversionFeature contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">150000</PTIX:DebtDiscountFromBeneficialConversionFeature>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-01to2020-12-31_us-gaap_EquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:AvailableForSaleSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">0</us-gaap:AvailableForSaleSecuritiesCurrent>
    <PTIX:ClassOfWarrantOrRightIssued contextRef="From2016-01-01to2016-12-31_custom_DebtSettlementMember_custom_StrategicBioPartnersMember_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">295945</PTIX:ClassOfWarrantOrRightIssued>
    <PTIX:ClassOfWarrantOrRightIssued contextRef="From2016-01-01to2016-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">127346</PTIX:ClassOfWarrantOrRightIssued>
    <PTIX:ClassOfWarrantOrRightIssued contextRef="From2020-01-01to2020-12-31_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">295945</PTIX:ClassOfWarrantOrRightIssued>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-12-31_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="0">-332222</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="0">-332222</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2019-12-31_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="0">-332222</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-12-31_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="0">-83670</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="0">-83670</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2020-12-31_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="0">-83670</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">332222</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">676079</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">83670</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">248552</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">343857</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:SharePrice contextRef="AsOf2019-12-31_us-gaap_MeasurementInputExercisePriceMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExercisePriceMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:SharePrice>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember" unitRef="Pure" decimals="INF">0.09</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Pure" decimals="INF">0.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Pure" decimals="INF">169</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2019-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember" unitRef="Pure" decimals="INF">1.59</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2019-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Pure" decimals="INF">0.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput contextRef="AsOf2019-12-31_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Pure" decimals="INF">133</us-gaap:DerivativeLiabilityMeasurementInput>
    <PTIX:DerivativeLiabilityMeasurementInputContractualTerm contextRef="From2019-01-01to2019-12-31_us-gaap_MeasurementInputExpectedTermMember">P1Y1M24D</PTIX:DerivativeLiabilityMeasurementInputContractualTerm>
    <PTIX:DerivativeLiabilityMeasurementInputContractualTerm contextRef="From2020-01-01to2020-12-31_us-gaap_MeasurementInputExpectedTermMember">P0Y1M20D</PTIX:DerivativeLiabilityMeasurementInputContractualTerm>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">12075685</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_custom_ConversionFeatureSharesMember" unitRef="Shares" decimals="INF">872766</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">3835366</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">3826658</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_custom_ConvertibleNotesMember" unitRef="Shares" decimals="INF">536000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">9070790</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_custom_ConversionFeatureSharesMember" unitRef="Shares" decimals="INF">872766</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">5597861</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">4007058</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_custom_ConvertibleNotesMember" unitRef="Shares" decimals="INF">1598000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <PTIX:EstimateCommitmentAmount contextRef="AsOf2019-10-02_custom_ConsultantMember" unitRef="USD" decimals="0">988000</PTIX:EstimateCommitmentAmount>
    <us-gaap:RegistrationPaymentArrangementEventToTransferConsideration contextRef="From2020-01-01to2020-12-31_custom_ToxicologyStudiesMember">On October 1, 2019, the Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment of approximately $988,000 as an estimate for the study. 50% of the total price was paid upon the signing of the agreement, 35% of the total price is to be paid upon completion of the in-life study, and the remaining 15% of the total price is to be paid upon the issuance of the report. If the Company cancels the study the Company will be required to pay a cancelation fee. If the cancelation happens prior to the arrival of the test animals then the Company will need to pay between 20% and 50% of the animal fees depending on when the cancellation happens. If the cancellation occurs after the animals arrive but before the study begins then the Company will be responsible for paying 50% of the protocol price plus a fee of $7,000 per room/week for animal husbandry until the animals can be relocated or disposed of. If the Company cancels the study after it has begun then the Company will need to pay any fees for procured items for the study and any nonrecoverable expenses incurred by the consultant.</us-gaap:RegistrationPaymentArrangementEventToTransferConsideration>
    <us-gaap:RegistrationPaymentArrangementGainsAndLosses contextRef="From2019-01-01to2019-12-31_custom_ToxicologyStudiesMember" unitRef="USD" decimals="0">0</us-gaap:RegistrationPaymentArrangementGainsAndLosses>
    <us-gaap:RegistrationPaymentArrangementGainsAndLosses contextRef="From2020-01-01to2020-12-31_custom_ToxicologyStudiesMember" unitRef="USD" decimals="0">174106</us-gaap:RegistrationPaymentArrangementGainsAndLosses>
    <us-gaap:RegistrationPaymentArrangementAccrualCarryingValue contextRef="AsOf2019-12-31_custom_ToxicologyStudiesMember" unitRef="USD" decimals="0">493905</us-gaap:RegistrationPaymentArrangementAccrualCarryingValue>
    <us-gaap:RegistrationPaymentArrangementAccrualCarryingValue contextRef="AsOf2020-12-31_custom_ToxicologyStudiesMember" unitRef="USD" decimals="0">319799</us-gaap:RegistrationPaymentArrangementAccrualCarryingValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2020-02-12to2020-02-13_srt_ChiefFinancialOfficerMember" unitRef="Shares" decimals="INF">187497</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-02-12to2020-02-13_srt_ChiefFinancialOfficerMember" unitRef="USD" decimals="0">93950</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <PTIX:SettlementOfLiabilityChargedToStockCompensationExpense contextRef="From2020-02-12to2020-02-13_srt_ChiefFinancialOfficerMember" unitRef="USD" decimals="0">163036</PTIX:SettlementOfLiabilityChargedToStockCompensationExpense>
    <PTIX:AccruedAccountingFeesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">36161</PTIX:AccruedAccountingFeesCurrent>
    <PTIX:AccruedAccountingFeesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">36161</PTIX:AccruedAccountingFeesCurrent>
    <PTIX:AccruedResearchAndDevelopmentCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">650584</PTIX:AccruedResearchAndDevelopmentCurrent>
    <PTIX:AccruedResearchAndDevelopmentCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">393496</PTIX:AccruedResearchAndDevelopmentCurrent>
    <PTIX:AccruedLegalFeesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15273</PTIX:AccruedLegalFeesCurrent>
    <PTIX:AccruedLegalFeesCurrent contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">163029</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">141860</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-12-31_custom_DebtSettlementMember_custom_StrategicBioPartnersMember_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember" unitRef="USDPShares" decimals="INF">1.05</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-21_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-06-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_PlacementAgentWarrantsMember_us-gaap_SeriesBPreferredStockMember1221750593" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-12-31_custom_DebtSettlementMember_custom_StrategicBioPartnersMember_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-06-30_us-gaap_WarrantMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-09-30_us-gaap_WarrantMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">327500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsDebtMember" unitRef="USD" decimals="0">665000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-06-30_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">850000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">420000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">50000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-06-30_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2020-04-01to2020-06-30_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2020-10-01to2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="Pure" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-04-01to2020-06-30_custom_UnsecuredConvertibleNotesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-10-01to2019-12-31_custom_UnsecuredConvertibleNotesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-10-01to2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-07-01to2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember">2023-11-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-06-30_custom_UnsecuredConvertibleNotesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-09-30_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <PTIX:CommissionPercentageTerms contextRef="From2020-01-01to2020-12-31_custom_PlacementAgentKatalystSecuritiesLLCMember">The Company paid the Placement Agent, including its sub-agents, a commission of 10% of the funds raised from the investors introduced by the Placement Agent. In addition, the Placement Agent will receive warrants to purchase a number of shares of Common Stock equal to 10% of the shares of Common Stock issuable upon conversion of the Notes sold to the investors who were introduced to us by the Placement Agent (See note 7). The Company recognized $104,090 in expenses related to the Placement Agent commission for this offering which were recorded as a debt discount.</PTIX:CommissionPercentageTerms>
    <us-gaap:PaymentsForCommissions contextRef="From2020-01-01to2020-12-31_custom_PlacementAgentKatalystSecuritiesLLCMember" unitRef="USD" decimals="0">104090</us-gaap:PaymentsForCommissions>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-12-31_custom_PlacementAgentKatalystSecuritiesLLCMember" unitRef="USD" decimals="0">179679</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="AsOf2020-12-31_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">127346</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">516116</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">145451</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">107588</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">245179</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">1597500</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">250000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesMember" unitRef="USD" decimals="0">420000</us-gaap:ConvertibleNotesPayable>
    <PTIX:BeneficialConversionFeatureAndDebtDiscount contextRef="AsOf2019-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">150000</PTIX:BeneficialConversionFeatureAndDebtDiscount>
    <PTIX:BeneficialConversionFeatureAndDebtDiscount contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" xsi:nil="true" />
    <PTIX:AdditionalNotesRelatedFee contextRef="AsOf2020-12-31_custom_UnsecuredConvertibleNotesWithRelatedPartiesMember" unitRef="USD" decimals="0">9000</PTIX:AdditionalNotesRelatedFee>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">1597500</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" decimals="0">400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebt contextRef="AsOf2020-12-31_us-gaap_ConvertibleNotesPayableMember" unitRef="USD" decimals="0">1597500</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2020-12-31_custom_ConvertibleNotesPayableRelatedPartyMember" unitRef="USD" decimals="0">400000</us-gaap:LongTermDebt>
    <PTIX:IssuanceOfOptionsForSettlementOfAccountsPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">93950</PTIX:IssuanceOfOptionsForSettlementOfAccountsPayable>
    <PTIX:IssuanceOfOptionsForSettlementOfAccountsPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">29950</PTIX:IssuanceOfOptionsForSettlementOfAccountsPayable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2017-01-01to2017-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">564378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2019-01-01to2019-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">564378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="From2020-01-01to2020-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">564378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2017-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1693134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2019-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1693134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2020-01-02_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">1693134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2019-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">4304245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2020-12-31_custom_TwoThousandSixteenPlanMember" unitRef="Shares" decimals="INF">4868623</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2015-01-01to2015-12-31_custom_UniversityOfTorontoMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-07-17to2020-07-18_custom_OptionsToRelatedPartyMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-07-17to2020-07-18_custom_DrBuellMember">P48M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-07-17to2020-07-18_custom_DrBuellMember_custom_RecognitionUpcomingServiceMember">P12M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MinimumMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MaximumMember">P13Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-07-17to2020-07-18_custom_StockOptionToConsultantsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSixteenPlanMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">3835366</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">3846299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-07-18_custom_OptionsToRelatedPartyMember" unitRef="Shares" decimals="INF">124998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-07-18_custom_DrBuellMember" unitRef="Shares" decimals="INF">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-07-18_custom_DrBuellMember_custom_RecognitionUpcomingServiceMember" unitRef="Shares" decimals="INF">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">5597861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-07-18_custom_StockOptionToConsultantsMember" unitRef="Shares" decimals="INF">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">635536</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">38328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">1762495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">126567</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">101567</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-06-16to2019-06-17_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">126567</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SixteenIndividualsMember" unitRef="Shares" decimals="INF">1387497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_TwelveRelatedPartiesMember" unitRef="Shares" decimals="INF">1362497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SettlementOfAccruedCompensationMember" unitRef="Shares" decimals="INF">187497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-02-08to2020-02-13_custom_RelatedPartyMember" unitRef="Shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">1762495</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">366000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Shares" decimals="INF">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Shares" decimals="INF">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-06-16to2019-06-17_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">1.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SixteenIndividualsMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_TwelveRelatedPartiesMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">797761</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SettlementOfAccruedCompensationMember" unitRef="USD" decimals="0">93950</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-02-15to2020-02-21_us-gaap_WarrantMember" unitRef="USD" decimals="0">95187</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_custom_NonEmployeesMember" unitRef="USD" decimals="0">380289</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_custom_EmployeesMember" unitRef="USD" decimals="0">1046795</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">1427084</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">1354750</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">698293</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">72334</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">99468</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-06-29to2020-06-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">6643</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-07-01to2020-09-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">5840</us-gaap:AllocatedShareBasedCompensationExpense>
    <PTIX:UnamortizedStockOptionExpense contextRef="AsOf2020-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="0">898665</PTIX:UnamortizedStockOptionExpense>
    <PTIX:UnamortizedStockOptionExpense contextRef="AsOf2020-12-31_custom_EmployeesMember" unitRef="USD" decimals="0">305527</PTIX:UnamortizedStockOptionExpense>
    <PTIX:UnamortizedStockOptionExpense contextRef="AsOf2020-12-31_custom_NonEmployeesMember" unitRef="USD" decimals="0">593138</PTIX:UnamortizedStockOptionExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">P2Y11M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">1104044</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">59900</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember_custom_VestBiWeeklyOverTwoMonthsMember" unitRef="Shares" decimals="INF">41667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">584895</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedImmediatelyMember" unitRef="Shares" decimals="INF">187497</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverTwelveMonthsMember" unitRef="Shares" decimals="INF">510000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverTwentyFourMonthsMember" unitRef="Shares" decimals="INF">5000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverThirtySixMonthsMember" unitRef="Shares" decimals="INF">420000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_OptionsVestedOverFourtyEightMonthsMember" unitRef="Shares" decimals="INF">265000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">527570</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">199807</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2019-06-16to2019-06-17_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">36374</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2020-02-20to2020-02-21_us-gaap_EmployeeStockOptionMember_custom_SettlementOfAccruedCompensationMember" unitRef="USD" decimals="0">1901724</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <PTIX:NumberOfOptionsSharesIssuedForSettlement contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">59900</PTIX:NumberOfOptionsSharesIssuedForSettlement>
    <PTIX:NumberOfOptionsSharesIssuedForSettlementValue contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">29850</PTIX:NumberOfOptionsSharesIssuedForSettlementValue>
    <PTIX:LossOnSettlementOfAccountsPayable contextRef="From2019-02-23to2019-02-25_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="0">99541</PTIX:LossOnSettlementOfAccountsPayable>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription contextRef="From2020-07-17to2020-07-18_custom_StockOptionToConsultantsMember">These options vest monthly over four years</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription contextRef="From2020-07-17to2020-07-18_us-gaap_EmployeeStockOptionMember_custom_OptionsToRelatedPartyMember">These options vest immediately</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">1.46</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-07-17to2020-07-18_custom_StockOptionToConsultantsMember" unitRef="USDPShares" decimals="INF">119792</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-07-17to2020-07-18_us-gaap_EmployeeStockOptionMember_custom_OptionsToRelatedPartyMember" unitRef="USDPShares" decimals="INF">142607</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-07-17to2020-07-18_us-gaap_EmployeeStockOptionMember_custom_DrBuellMember" unitRef="USDPShares" decimals="INF">165426</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember" unitRef="Shares" decimals="INF">3403367</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsMember" unitRef="Shares" decimals="INF">295945</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_us-gaap_PrivatePlacementMember_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">423291</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-21_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-06-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">81600</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_custom_PlacementAgentWarrantsMember_us-gaap_SeriesBPreferredStockMember1221750593" unitRef="Shares" decimals="INF">127346</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">98800</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2021-03-31_srt_ScenarioForecastMember" unitRef="Shares" decimals="INF">268233</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember_us-gaap_PrivatePlacementMember_custom_ProtagenicWarrantsMember_custom_AdditionalIssuanceOfWarrantsForAccruedInterestMember" unitRef="USD" decimals="0">35000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <PTIX:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue contextRef="From2020-06-29to2020-06-30_custom_BlackScholesModelMember_us-gaap_WarrantMember" unitRef="USD" decimals="0">86968</PTIX:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue>
    <PTIX:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue contextRef="From2020-07-01to2020-09-30_custom_BlackScholesModelTwoMember_us-gaap_WarrantMember" unitRef="USD" decimals="0">105194</PTIX:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">3826658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">3826658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">4007058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">3826658</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">4007058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.06</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.05</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">782668</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">1375990</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding>
    <PTIX:ClassOfWarrantOrRightExpirationPeriodDescription contextRef="From2020-02-15to2020-02-21_us-gaap_WarrantMember">The expiration date was extended by two years from January 2, 2020 to January 2, 2022.</PTIX:ClassOfWarrantOrRightExpirationPeriodDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2019-12-31_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2019-12-31_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2019-01-01to2019-12-31_srt_MinimumMember" unitRef="Pure" decimals="INF">0.0209</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2019-01-01to2019-12-31_srt_MaximumMember" unitRef="Pure" decimals="INF">0.0270</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2020-01-01to2020-12-31_srt_MinimumMember" unitRef="Pure" decimals="INF">0.0064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2020-01-01to2020-12-31_srt_MaximumMember" unitRef="Pure" decimals="INF">0.0161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-01to2020-12-31">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-12-31">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2019-01-01to2019-12-31_srt_MinimumMember" unitRef="Pure" decimals="INF">1.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2019-01-01to2019-12-31_srt_MaximumMember" unitRef="Pure" decimals="INF">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2020-01-01to2020-12-31_srt_MinimumMember" unitRef="Pure" decimals="INF">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2020-01-01to2020-12-31_srt_MaximumMember" unitRef="Pure" decimals="INF">1.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">204382</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">800210</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">862833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2020-01-01to2020-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">137500</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">1.74</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">1.63</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">180400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2019-01-01to2019-12-31" unitRef="Shares" xsi:nil="true" />
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">1.05</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">1.05</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">1.06</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">1.25</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" xsi:nil="true" />
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning contextRef="From2020-01-01to2020-12-31">P2Y8M9D</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning contextRef="From2019-01-01to2019-12-31">P3Y8M9D</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning>
    <PTIX:NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted contextRef="From2020-01-01to2020-12-31">P4Y6M10D</PTIX:NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted>
    <PTIX:NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted contextRef="From2019-01-01to2019-12-31">P0Y</PTIX:NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding contextRef="From2020-01-01to2020-12-31">P1Y10M10D</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding>
    <PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding contextRef="From2019-01-01to2019-12-31">P2Y8M9D</PTIX:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2015-01-01to2015-12-31_custom_UniversityOfTorontoMember" unitRef="Shares" decimals="INF">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">553299</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2015-12-31_custom_UniversityOfTorontoMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <PTIX:OptionsExpirationDateDescription contextRef="From2015-01-01to2015-12-31_custom_UniversityOfTorontoMember">Exercisable over a ten year period which ends on April 1, 2022.</PTIX:OptionsExpirationDateDescription>
    <PTIX:OptionsExpirationDateDescription contextRef="From2020-01-01to2020-12-31_custom_DrDavidLovejoyMember_us-gaap_EmployeeStockOptionMember">These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027 or on February 13, 2030.</PTIX:OptionsExpirationDateDescription>
    <PTIX:RoyaltyPaymentPercentage contextRef="AsOf2020-12-31_us-gaap_LicensingAgreementsMember" unitRef="Pure" decimals="INF">0.025</PTIX:RoyaltyPaymentPercentage>
    <PTIX:UpFrontSubLicenseFeesPercentage contextRef="AsOf2020-12-31_us-gaap_LicensingAgreementsMember" unitRef="Pure" decimals="INF">0.10</PTIX:UpFrontSubLicenseFeesPercentage>
    <PTIX:RoyaltyPaymentOnBehalfOfSublicenseePercentage contextRef="AsOf2020-12-31" unitRef="Pure" decimals="INF">0.025</PTIX:RoyaltyPaymentOnBehalfOfSublicenseePercentage>
    <us-gaap:Revenues contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <PTIX:InterestOnAmountsOwedUnderLicenseAgreementRate contextRef="AsOf2020-12-31" unitRef="Pure" decimals="INF">0.03</PTIX:InterestOnAmountsOwedUnderLicenseAgreementRate>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31_custom_FederalMember" unitRef="USD" decimals="0">7161000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_custom_FederalMember" unitRef="USD" decimals="0">7550000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31_custom_StateAndLocalMember" unitRef="USD" decimals="0">7153000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_custom_StateAndLocalMember" unitRef="USD" decimals="0">7540000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31_country_CA" unitRef="USD" decimals="0">1111000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_country_CA" unitRef="USD" decimals="0">1115000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31_custom_FederalGeneratedPriorTo2018Member" unitRef="USD" decimals="0">100000</us-gaap:OperatingLossCarryforwards>
    <PTIX:PercentageOfCorporationsTaxableIncome contextRef="AsOf2020-12-31_custom_LossesIncurredAfter2017Member" unitRef="Pure" decimals="INF">0.80</PTIX:PercentageOfCorporationsTaxableIncome>
    <PTIX:PercentageOfCorporationsTaxableIncome contextRef="AsOf2020-12-31_custom_LossesIncurredPriorTo2018Member" unitRef="Pure" decimals="INF">1.00</PTIX:PercentageOfCorporationsTaxableIncome>
    <PTIX:OperatingLossCarryforwardsExpirationDescription contextRef="From2020-01-01to2020-12-31">The federal net operating losses generated prior to 2018 of $0.1 million will expire at various dates through 2037.</PTIX:OperatingLossCarryforwardsExpirationDescription>
    <PTIX:OperatingLossCarryforwardsExpirationDescription contextRef="From2020-01-01to2020-12-31_custom_StateAndLocalMember">State tax liabilities also through 2035.</PTIX:OperatingLossCarryforwardsExpirationDescription>
    <PTIX:OperatingLossCarryforwardsExpirationDescription contextRef="From2020-01-01to2020-12-31_country_CA">The Canadian losses expire in stages beginning in 2026.</PTIX:OperatingLossCarryforwardsExpirationDescription>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">418000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">661000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2542428</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1698689</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-6307</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-52222</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.086</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.086</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <PTIX:EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.00</PTIX:EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent>
    <PTIX:EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.00</PTIX:EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.300</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.302</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2020-01-01to2020-12-31" unitRef="Pure" decimals="INF">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2019-01-01to2019-12-31" unitRef="Pure" decimals="INF">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2894000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2907000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <PTIX:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">784000</PTIX:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet>
    <PTIX:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1217000</PTIX:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet>
    <PTIX:DeferredTaxAssetsIncomeTaxLoss contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">29000</PTIX:DeferredTaxAssetsIncomeTaxLoss>
    <PTIX:DeferredTaxAssetsIncomeTaxLoss contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">7000</PTIX:DeferredTaxAssetsIncomeTaxLoss>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">4000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">10000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3703000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">4121000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3703000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">4121000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2020-01-01to2020-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">137500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31">P9Y2M19D</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-12-31">P8Y4D</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31">P6Y5M23D</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-12-31">P6Y7D</PTIX:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2021-02-24to2021-02-25_us-gaap_SubsequentEventMember" unitRef="USDPShares" decimals="INF">5.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-01-01to2021-03-31_srt_ScenarioForecastMember" unitRef="Shares" decimals="INF">161026</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">4823</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_custom_SeriesBConvertiblePreferredStockMember258690250" unitRef="Shares" decimals="INF">872766</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_custom_SeriesBConvertiblePreferredStockMember346823546" unitRef="Shares" decimals="INF">872766</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10261419</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10261419</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_custom_SeriesBConvertiblePreferredStockMember3166156" unitRef="Shares" decimals="INF">872766</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10360480</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">4823</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">4823</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">778</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-6647</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-6647</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="From2020-01-01to2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">778</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1427084</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">797761</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">797761</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1427084</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">104204</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">104204</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">129491</PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions>
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_custom_SeriesBConvertiblePreferredStockMember" unitRef="USD" xsi:nil="true" />
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">129491</PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions>
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <PTIX:AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions contextRef="From2019-01-01to2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">107670</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">107670</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <PTIX:IssuanceOfOptionsForSettlementOfAccruedPayroll contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">93950</PTIX:IssuanceOfOptionsForSettlementOfAccruedPayroll>
    <PTIX:IssuanceOfOptionsForSettlementOfAccruedPayroll contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">93950</PTIX:IssuanceOfOptionsForSettlementOfAccruedPayroll>
    <PTIX:IssuanceOfOptionsForSettlementOfAccruedPayroll contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">120000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">119990</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">99061</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>35
<FILENAME>ptix-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeKebP9z5Z8yekhvWBybSmKzy8vjrqDQyihl/EmgVsC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:PTIX="http://protagenic.com/20201231" elementFormDefault="qualified" targetNamespace="http://protagenic.com/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://protagenic.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" id="StatementsOfChangesInStockholdersDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/OrganizationAndNatureOfBusiness" id="OrganizationAndNatureOfBusiness">
	  <link:definition>00000007 - Disclosure - Organization and Nature of Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000008 - Disclosure - Going Concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" id="AccountsPayableAndAccruedExpenses">
	  <link:definition>00000010 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/DerivativeLiabilities" id="DerivativeLiabilities">
	  <link:definition>00000011 - Disclosure - Derivative Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes" id="ConvertibleNotePayablePikNotes">
	  <link:definition>00000012 - Disclosure - Convertible Note Payable (PIK Notes)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficit" id="StockholdersDeficit">
	  <link:definition>00000013 - Disclosure - Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/CollaborativeAgreements" id="CollaborativeAgreements">
	  <link:definition>00000014 - Disclosure - Collaborative Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/LicensingAgreements" id="LicensingAgreements">
	  <link:definition>00000015 - Disclosure - Licensing Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000016 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000017 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000018 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000020 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" id="AccountsPayableAndAccruedExpensesTables">
	  <link:definition>00000021 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" id="ConvertibleNotePayablePikNotesTables">
	  <link:definition>00000022 - Disclosure - Convertible Note Payable (PIK Notes) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficitTables" id="StockholdersDeficitTables">
	  <link:definition>00000023 - Disclosure - Stockholders' Deficit (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000024 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
	  <link:definition>00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails">
	  <link:definition>00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails">
	  <link:definition>00000028 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails">
	  <link:definition>00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" id="AccountsPayableAndAccruedExpensesDetailsNarrative">
	  <link:definition>00000030 - Disclosure - Accounts Payable and Accrued Expenses (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" id="AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails">
	  <link:definition>00000031 - Disclosure - Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" id="DerivativeLiabilitiesDetailsNarrative">
	  <link:definition>00000032 - Disclosure - Derivative Liabilities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" id="ConvertibleNotePayablePikNotesDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Convertible Note Payable (PIK Notes) (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" id="ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails">
	  <link:definition>00000034 - Disclosure - Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
	  <link:definition>00000035 - Disclosure - Stockholders' Deficit (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" id="StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails">
	  <link:definition>00000036 - Disclosure - Stockholders' Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" id="StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails">
	  <link:definition>00000037 - Disclosure - Stockholders' Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" id="StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails">
	  <link:definition>00000038 - Disclosure - Stockholders' Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" id="StockholdersDeficit-SummaryOfWarrantIssuancesDetails">
	  <link:definition>00000039 - Disclosure - Stockholders' Deficit - Summary of Warrant Issuances (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" id="CollaborativeAgreementsDetailsNarrative">
	  <link:definition>00000040 - Disclosure - Collaborative Agreements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" id="LicensingAgreementsDetailsNarrative">
	  <link:definition>00000041 - Disclosure - Licensing Agreements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000042 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000043 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" id="IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails">
	  <link:definition>00000044 - Disclosure - Income Taxes - Schedule of Loss Before Income Tax (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" id="IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails">
	  <link:definition>00000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
	  <link:definition>00000046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://protagenic.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ptix-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ptix-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ptix-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ptix-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="PTIX_ConvertibleLongTermNotesPayableRelatedParty" name="ConvertibleLongTermNotesPayableRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" name="DebtDiscountFromWarrantsIssuedToPlacementAgents" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DebtDiscountFromBeneficialConversionFeature" name="DebtDiscountFromBeneficialConversionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DerivativeLiabilityMeasurementInputContractualTerm" name="DerivativeLiabilityMeasurementInputContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_EstimateCommitmentAmount" name="EstimateCommitmentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" name="SettlementOfLiabilityChargedToStockCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AccruedAccountingFeesCurrent" name="AccruedAccountingFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AccruedResearchAndDevelopmentCurrent" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AccruedLegalFeesCurrent" name="AccruedLegalFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_CommissionPercentageTerms" name="CommissionPercentageTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_BeneficialConversionFeatureAndDebtDiscount" name="BeneficialConversionFeatureAndDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AdditionalNotesRelatedFee" name="AdditionalNotesRelatedFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" name="IssuanceOfOptionsForSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_UnamortizedStockOptionExpense" name="UnamortizedStockOptionExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_NumberOfOptionsSharesIssuedForSettlement" name="NumberOfOptionsSharesIssuedForSettlement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_NumberOfOptionsSharesIssuedForSettlementValue" name="NumberOfOptionsSharesIssuedForSettlementValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_LossOnSettlementOfAccountsPayable" name="LossOnSettlementOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" name="ClassOfWarrantOrRightExpirationPeriodDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" name="NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsExpirationDateDescription" name="OptionsExpirationDateDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_RoyaltyPaymentPercentage" name="RoyaltyPaymentPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_UpFrontSubLicenseFeesPercentage" name="UpFrontSubLicenseFeesPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" name="RoyaltyPaymentOnBehalfOfSublicenseePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" name="InterestOnAmountsOwedUnderLicenseAgreementRate" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_PercentageOfCorporationsTaxableIncome" name="PercentageOfCorporationsTaxableIncome" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OperatingLossCarryforwardsExpirationDescription" name="OperatingLossCarryforwardsExpirationDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" name="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DeferredTaxAssetsIncomeTaxLoss" name="DeferredTaxAssetsIncomeTaxLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" name="IssuanceOfOptionsForSettlementOfAccruedPayroll" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DebtSettlementMember" name="DebtSettlementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_StrategicBioPartnersMember" name="StrategicBioPartnersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_UniversityOfTorontoMember" name="UniversityOfTorontoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ConversionFeatureSharesMember" name="ConversionFeatureSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_VestBiWeeklyOverTwoMonthsMember" name="VestBiWeeklyOverTwoMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ConsultantMember" name="ConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_UnsecuredConvertibleNotesMember" name="UnsecuredConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" name="UnsecuredConvertibleNotesWithRelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_FederalMember" name="FederalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_StateAndLocalMember" name="StateAndLocalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ToxicologyStudiesMember" name="ToxicologyStudiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_NonEmployeesMember" name="NonEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SixteenIndividualsMember" name="SixteenIndividualsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_TwelveRelatedPartiesMember" name="TwelveRelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_SettlementOfAccruedCompensationMember" name="SettlementOfAccruedCompensationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsVestedImmediatelyMember" name="OptionsVestedImmediatelyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsVestedOverTwelveMonthsMember" name="OptionsVestedOverTwelveMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsVestedOverTwentyFourMonthsMember" name="OptionsVestedOverTwentyFourMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsVestedOverThirtySixMonthsMember" name="OptionsVestedOverThirtySixMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsVestedOverFourtyEightMonthsMember" name="OptionsVestedOverFourtyEightMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ProtagenicWarrantsMember" name="ProtagenicWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AdditionalIssuanceOfWarrantsMember" name="AdditionalIssuanceOfWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AdditionalIssuanceOfWarrantsDebtMember" name="AdditionalIssuanceOfWarrantsDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" name="AdditionalIssuanceOfWarrantsForAccruedInterestMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DrDavidLovejoyMember" name="DrDavidLovejoyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ResearchAgreementsMember" name="ResearchAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_RelatedPartyMember" name="RelatedPartyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_ConvertibleNotesPayableRelatedPartyMember" name="ConvertibleNotesPayableRelatedPartyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_OptionsToRelatedPartyMember" name="OptionsToRelatedPartyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_DrBuellMember" name="DrBuellMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_RecognitionUpcomingServiceMember" name="RecognitionUpcomingServiceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_PlacementAgentKatalystSecuritiesLLCMember" name="PlacementAgentKatalystSecuritiesLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_LossesIncurredAfter2017Member" name="LossesIncurredAfter2017Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_LossesIncurredPriorTo2018Member" name="LossesIncurredPriorTo2018Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_FederalGeneratedPriorTo2018Member" name="FederalGeneratedPriorTo2018Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_StockOptionToConsultantsMember" name="StockOptionToConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_PlacementAgentWarrantsMember" name="PlacementAgentWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_BlackScholesModelMember" name="BlackScholesModelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_BlackScholesModelTwoMember" name="BlackScholesModelTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="PTIX_TwoThousandSixteenPlanMember" name="TwoThousandSixteenPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>36
<FILENAME>ptix-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://protagenic.com/role/DocumentAndEntityInformation" xlink:href="ptix-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheets" xlink:href="ptix-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:href="ptix-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ptix-20201231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ptix-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfCashFlows" xlink:href="ptix-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:href="ptix-20201231.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/GoingConcern" xlink:href="ptix-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilities" xlink:href="ptix-20201231.xsd#DerivativeLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit" xlink:href="ptix-20201231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreements" xlink:href="ptix-20201231.xsd#CollaborativeAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreements" xlink:href="ptix-20201231.xsd#LicensingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactions" xlink:href="ptix-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes" xlink:href="ptix-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEvents" xlink:href="ptix-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitTables" xlink:href="ptix-20201231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesTables" xlink:href="ptix-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:href="ptix-20201231.xsd#DerivativeLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ptix-20201231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#CollaborativeAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#LicensingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ptix-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:href="ptix-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:href="ptix-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:label="loc_PTIXConvertibleLongTermNotesPayableRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_PTIXConvertibleLongTermNotesPayableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - Organization and Nature of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/GoingConcern" xlink:title="00000008 - Disclosure - Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000010 - Disclosure - Accounts Payable and Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilities" xlink:title="00000011 - Disclosure - Derivative Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:title="00000012 - Disclosure - Convertible Note Payable (PIK Notes)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit" xlink:title="00000013 - Disclosure - Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreements" xlink:title="00000014 - Disclosure - Collaborative Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreements" xlink:title="00000015 - Disclosure - Licensing Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000021 - Disclosure - Accounts Payable and Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:title="00000022 - Disclosure - Convertible Note Payable (PIK Notes) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitTables" xlink:title="00000023 - Disclosure - Stockholders&apos; Deficit (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000030 - Disclosure - Accounts Payable and Accrued Expenses (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedAccountingFeesCurrent" xlink:label="loc_PTIXAccruedAccountingFeesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_PTIXAccruedAccountingFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedResearchAndDevelopmentCurrent" xlink:label="loc_PTIXAccruedResearchAndDevelopmentCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_PTIXAccruedResearchAndDevelopmentCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedLegalFeesCurrent" xlink:label="loc_PTIXAccruedLegalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_PTIXAccruedLegalFeesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:title="00000032 - Disclosure - Derivative Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:title="00000033 - Disclosure - Convertible Note Payable (PIK Notes) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:title="00000034 - Disclosure - Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000035 - Disclosure - Stockholders&apos; Deficit (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000036 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:title="00000037 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:title="00000038 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:title="00000039 - Disclosure - Stockholders&apos; Deficit - Summary of Warrant Issuances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:title="00000040 - Disclosure - Collaborative Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:title="00000041 - Disclosure - Licensing Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:title="00000044 - Disclosure - Income Taxes - Schedule of Loss Before Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:label="loc_PTIXDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PTIXDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsIncomeTaxLoss" xlink:label="loc_PTIXDeferredTaxAssetsIncomeTaxLoss" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_PTIXDeferredTaxAssetsIncomeTaxLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>37
<FILENAME>ptix-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://protagenic.com/role/DocumentAndEntityInformation" xlink:href="ptix-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheets" xlink:href="ptix-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:href="ptix-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ptix-20201231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ptix-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfCashFlows" xlink:href="ptix-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:href="ptix-20201231.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/GoingConcern" xlink:href="ptix-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilities" xlink:href="ptix-20201231.xsd#DerivativeLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit" xlink:href="ptix-20201231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreements" xlink:href="ptix-20201231.xsd#CollaborativeAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreements" xlink:href="ptix-20201231.xsd#LicensingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactions" xlink:href="ptix-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes" xlink:href="ptix-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEvents" xlink:href="ptix-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitTables" xlink:href="ptix-20201231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesTables" xlink:href="ptix-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:href="ptix-20201231.xsd#DerivativeLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ptix-20201231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#CollaborativeAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#LicensingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ptix-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:href="ptix-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:href="ptix-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssetsCurrentAbstract_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapPrepaidExpenseCurrent_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapAssetsCurrent_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssets_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrent_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:label="loc_PTIXConvertibleLongTermNotesPayableRelatedParty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_PTIXConvertibleLongTermNotesPayableRelatedParty_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilities_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquityAbstract_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapPreferredStockValue_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapCommonStockValue_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapAdditionalPaidInCapital_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_50" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:label="loc_PTIXIssuanceOfOptionsForSettlementOfAccruedPayroll_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXIssuanceOfOptionsForSettlementOfAccruedPayroll_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:label="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:label="loc_PTIXAdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXAdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - Organization and Nature of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/GoingConcern" xlink:title="00000008 - Disclosure - Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000010 - Disclosure - Accounts Payable and Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilities" xlink:title="00000011 - Disclosure - Derivative Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:title="00000012 - Disclosure - Convertible Note Payable (PIK Notes)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit" xlink:title="00000013 - Disclosure - Stockholders&apos; Deficit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreements" xlink:title="00000014 - Disclosure - Collaborative Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreements" xlink:title="00000015 - Disclosure - Licensing Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000021 - Disclosure - Accounts Payable and Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:title="00000022 - Disclosure - Convertible Note Payable (PIK Notes) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:label="loc_PTIXConvertibleNotesPayableRelatedPartyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXConvertibleNotesPayableRelatedPartyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitTables" xlink:title="00000023 - Disclosure - Stockholders&apos; Deficit (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesCurrent_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightIssued" xlink:label="loc_PTIXClassOfWarrantOrRightIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightIssued_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DerivativeLiabilityMeasurementInputContractualTerm" xlink:label="loc_PTIXDerivativeLiabilityMeasurementInputContractualTerm_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXDerivativeLiabilityMeasurementInputContractualTerm_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConversionFeatureSharesMember" xlink:label="loc_PTIXConversionFeatureSharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PTIXConversionFeatureSharesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesMember" xlink:label="loc_PTIXConvertibleNotesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PTIXConvertibleNotesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000030 - Disclosure - Accounts Payable and Accrued Expenses (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConsultantMember" xlink:label="loc_PTIXConsultantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXConsultantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ToxicologyStudiesMember" xlink:label="loc_PTIXToxicologyStudiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PTIXToxicologyStudiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EstimateCommitmentAmount" xlink:label="loc_PTIXEstimateCommitmentAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXEstimateCommitmentAmount_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementEventToTransferConsideration" xlink:label="loc_us-gaapRegistrationPaymentArrangementEventToTransferConsideration_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementEventToTransferConsideration_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementGainsAndLosses" xlink:label="loc_us-gaapRegistrationPaymentArrangementGainsAndLosses_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementGainsAndLosses_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementAccrualCarryingValue" xlink:label="loc_us-gaapRegistrationPaymentArrangementAccrualCarryingValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementAccrualCarryingValue_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" xlink:label="loc_PTIXSettlementOfLiabilityChargedToStockCompensationExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXSettlementOfLiabilityChargedToStockCompensationExpense_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:title="00000032 - Disclosure - Derivative Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtSettlementMember" xlink:label="loc_PTIXDebtSettlementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXDebtSettlementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StrategicBioPartnersMember" xlink:label="loc_PTIXStrategicBioPartnersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PTIXStrategicBioPartnersMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightIssued" xlink:label="loc_PTIXClassOfWarrantOrRightIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightIssued_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:title="00000033 - Disclosure - Convertible Note Payable (PIK Notes) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesMember" xlink:label="loc_PTIXUnsecuredConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXUnsecuredConvertibleNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:label="loc_PTIXUnsecuredConvertibleNotesWithRelatedPartiesMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXUnsecuredConvertibleNotesWithRelatedPartiesMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentKatalystSecuritiesLLCMember" xlink:label="loc_PTIXPlacementAgentKatalystSecuritiesLLCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXPlacementAgentKatalystSecuritiesLLCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_CommissionPercentageTerms" xlink:label="loc_PTIXCommissionPercentageTerms_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXCommissionPercentageTerms_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForCommissions_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_210" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BeneficialConversionFeatureAndDebtDiscount" xlink:label="loc_PTIXBeneficialConversionFeatureAndDebtDiscount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXBeneficialConversionFeatureAndDebtDiscount_210" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalNotesRelatedFee" xlink:label="loc_PTIXAdditionalNotesRelatedFee_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXAdditionalNotesRelatedFee_210" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:title="00000034 - Disclosure - Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:label="loc_PTIXConvertibleNotesPayableRelatedPartyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXConvertibleNotesPayableRelatedPartyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebt_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000035 - Disclosure - Stockholders&apos; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwoThousandSixteenPlanMember" xlink:label="loc_PTIXTwoThousandSixteenPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_PTIXTwoThousandSixteenPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StockOptionToConsultantsMember" xlink:label="loc_PTIXStockOptionToConsultantsMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXStockOptionToConsultantsMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RecognitionUpcomingServiceMember" xlink:label="loc_PTIXRecognitionUpcomingServiceMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXRecognitionUpcomingServiceMember_400" xlink:type="arc" order="402" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentWarrantsMember" xlink:label="loc_PTIXPlacementAgentWarrantsMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXPlacementAgentWarrantsMember_470" xlink:type="arc" order="471" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelMember" xlink:label="loc_PTIXBlackScholesModelMember_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXBlackScholesModelMember_550" xlink:type="arc" order="551" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelTwoMember" xlink:label="loc_PTIXBlackScholesModelTwoMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXBlackScholesModelTwoMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EmployeesMember" xlink:label="loc_PTIXEmployeesMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXEmployeesMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NonEmployeesMember" xlink:label="loc_PTIXNonEmployeesMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXNonEmployeesMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SixteenIndividualsMember" xlink:label="loc_PTIXSixteenIndividualsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXSixteenIndividualsMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwelveRelatedPartiesMember" xlink:label="loc_PTIXTwelveRelatedPartiesMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXTwelveRelatedPartiesMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_VestBiWeeklyOverTwoMonthsMember" xlink:label="loc_PTIXVestBiWeeklyOverTwoMonthsMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXVestBiWeeklyOverTwoMonthsMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedImmediatelyMember" xlink:label="loc_PTIXOptionsVestedImmediatelyMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedImmediatelyMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwelveMonthsMember" xlink:label="loc_PTIXOptionsVestedOverTwelveMonthsMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverTwelveMonthsMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwentyFourMonthsMember" xlink:label="loc_PTIXOptionsVestedOverTwentyFourMonthsMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverTwentyFourMonthsMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverThirtySixMonthsMember" xlink:label="loc_PTIXOptionsVestedOverThirtySixMonthsMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverThirtySixMonthsMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverFourtyEightMonthsMember" xlink:label="loc_PTIXOptionsVestedOverFourtyEightMonthsMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverFourtyEightMonthsMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfAccruedCompensationMember" xlink:label="loc_PTIXSettlementOfAccruedCompensationMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXSettlementOfAccruedCompensationMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsDebtMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsDebtMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsDebtMember_440" xlink:type="arc" order="444" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsForAccruedInterestMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsForAccruedInterestMember_450" xlink:type="arc" order="454" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsMember_460" xlink:type="arc" order="464" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsToRelatedPartyMember" xlink:label="loc_PTIXOptionsToRelatedPartyMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXOptionsToRelatedPartyMember_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrBuellMember" xlink:label="loc_PTIXDrBuellMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXDrBuellMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_430" xlink:type="arc" order="431" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_430" xlink:type="arc" order="432" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ProtagenicWarrantsMember" xlink:label="loc_PTIXProtagenicWarrantsMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_PTIXProtagenicWarrantsMember_430" xlink:type="arc" order="433" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember_490" xlink:type="arc" order="491" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_600" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_600" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_600" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_600" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_600" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_600" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_600" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_600" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_600" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnamortizedStockOptionExpense" xlink:label="loc_PTIXUnamortizedStockOptionExpense_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXUnamortizedStockOptionExpense_600" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_600" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_600" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_600" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_600" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlement" xlink:label="loc_PTIXNumberOfOptionsSharesIssuedForSettlement_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXNumberOfOptionsSharesIssuedForSettlement_600" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlementValue" xlink:label="loc_PTIXNumberOfOptionsSharesIssuedForSettlementValue_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXNumberOfOptionsSharesIssuedForSettlementValue_600" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossOnSettlementOfAccountsPayable" xlink:label="loc_PTIXLossOnSettlementOfAccountsPayable_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXLossOnSettlementOfAccountsPayable_600" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_600" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_600" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_600" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_600" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_600" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_600" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_600" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:label="loc_PTIXClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_600" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_600" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_600" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_600" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" xlink:label="loc_PTIXClassOfWarrantOrRightExpirationPeriodDescription_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightExpirationPeriodDescription_600" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_600" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000036 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_100" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:title="00000037 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:title="00000038 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:title="00000039 - Disclosure - Stockholders&apos; Deficit - Summary of Warrant Issuances (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:title="00000040 - Disclosure - Collaborative Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UniversityOfTorontoMember" xlink:label="loc_PTIXUniversityOfTorontoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_PTIXUniversityOfTorontoMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrDavidLovejoyMember" xlink:label="loc_PTIXDrDavidLovejoyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_PTIXDrDavidLovejoyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ResearchAgreementsMember" xlink:label="loc_PTIXResearchAgreementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PTIXResearchAgreementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsExpirationDateDescription" xlink:label="loc_PTIXOptionsExpirationDateDescription_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXOptionsExpirationDateDescription_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_110" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:title="00000041 - Disclosure - Licensing Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentPercentage" xlink:label="loc_PTIXRoyaltyPaymentPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXRoyaltyPaymentPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UpFrontSubLicenseFeesPercentage" xlink:label="loc_PTIXUpFrontSubLicenseFeesPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXUpFrontSubLicenseFeesPercentage_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:label="loc_PTIXRoyaltyPaymentOnBehalfOfSublicenseePercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXRoyaltyPaymentOnBehalfOfSublicenseePercentage_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" xlink:label="loc_PTIXInterestOnAmountsOwedUnderLicenseAgreementRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXInterestOnAmountsOwedUnderLicenseAgreementRate_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RelatedPartyMember" xlink:label="loc_PTIXRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalMember" xlink:label="loc_PTIXFederalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXFederalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalGeneratedPriorTo2018Member" xlink:label="loc_PTIXFederalGeneratedPriorTo2018Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXFederalGeneratedPriorTo2018Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StateAndLocalMember" xlink:label="loc_PTIXStateAndLocalMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXStateAndLocalMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:label="loc_countryCA_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryCA_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredAfter2017Member" xlink:label="loc_PTIXLossesIncurredAfter2017Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXLossesIncurredAfter2017Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredPriorTo2018Member" xlink:label="loc_PTIXLossesIncurredPriorTo2018Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXLossesIncurredPriorTo2018Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PercentageOfCorporationsTaxableIncome" xlink:label="loc_PTIXPercentageOfCorporationsTaxableIncome_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXPercentageOfCorporationsTaxableIncome_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OperatingLossCarryforwardsExpirationDescription" xlink:label="loc_PTIXOperatingLossCarryforwardsExpirationDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXOperatingLossCarryforwardsExpirationDescription_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense_140" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:title="00000044 - Disclosure - Income Taxes - Schedule of Loss Before Income Tax (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="5" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>38
<FILENAME>ptix-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtSettlementMember" xlink:label="PTIX_DebtSettlementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtSettlementMember" xlink:to="PTIX_DebtSettlementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DebtSettlementMember_lbl" xml:lang="en-US">Debt Settlement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StrategicBioPartnersMember" xlink:label="PTIX_StrategicBioPartnersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StrategicBioPartnersMember" xlink:to="PTIX_StrategicBioPartnersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_StrategicBioPartnersMember_lbl" xml:lang="en-US">Strategic Bio Partners [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UniversityOfTorontoMember" xlink:label="PTIX_UniversityOfTorontoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UniversityOfTorontoMember" xlink:to="PTIX_UniversityOfTorontoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_UniversityOfTorontoMember_lbl" xml:lang="en-US">University of Toronto [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="PTIX_SeriesBConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SeriesBConvertiblePreferredStockMember" xlink:to="PTIX_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Contractual Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConversionFeatureSharesMember" xlink:label="PTIX_ConversionFeatureSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConversionFeatureSharesMember" xlink:to="PTIX_ConversionFeatureSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ConversionFeatureSharesMember_lbl" xml:lang="en-US">Conversion Feature Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_VestBiWeeklyOverTwoMonthsMember" xlink:label="PTIX_VestBiWeeklyOverTwoMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_VestBiWeeklyOverTwoMonthsMember" xlink:to="PTIX_VestBiWeeklyOverTwoMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_VestBiWeeklyOverTwoMonthsMember_lbl" xml:lang="en-US">Vest bi-Weekly Over Two Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesMember" xlink:label="PTIX_ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleNotesMember" xlink:to="PTIX_ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConsultantMember" xlink:label="PTIX_ConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConsultantMember" xlink:to="PTIX_ConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ConsultantMember_lbl" xml:lang="en-US">Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesMember" xlink:label="PTIX_UnsecuredConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnsecuredConvertibleNotesMember" xlink:to="PTIX_UnsecuredConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_UnsecuredConvertibleNotesMember_lbl" xml:lang="en-US">Unsecured Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:label="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:to="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember_lbl" xml:lang="en-US">Unsecured Convertible Notes with Related Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalMember" xlink:label="PTIX_FederalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_FederalMember" xlink:to="PTIX_FederalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_FederalMember_lbl" xml:lang="en-US">Federal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StateAndLocalMember" xlink:label="PTIX_StateAndLocalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StateAndLocalMember" xlink:to="PTIX_StateAndLocalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_StateAndLocalMember_lbl" xml:lang="en-US">State and Local [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">Canadian [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ToxicologyStudiesMember" xlink:label="PTIX_ToxicologyStudiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ToxicologyStudiesMember" xlink:to="PTIX_ToxicologyStudiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ToxicologyStudiesMember_lbl" xml:lang="en-US">Toxicology Studies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EmployeesMember" xlink:label="PTIX_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EmployeesMember" xlink:to="PTIX_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NonEmployeesMember" xlink:label="PTIX_NonEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NonEmployeesMember" xlink:to="PTIX_NonEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_NonEmployeesMember_lbl" xml:lang="en-US">Non-Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SixteenIndividualsMember" xlink:label="PTIX_SixteenIndividualsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SixteenIndividualsMember" xlink:to="PTIX_SixteenIndividualsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SixteenIndividualsMember_lbl" xml:lang="en-US">Sixteen Individuals [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwelveRelatedPartiesMember" xlink:label="PTIX_TwelveRelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_TwelveRelatedPartiesMember" xlink:to="PTIX_TwelveRelatedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_TwelveRelatedPartiesMember_lbl" xml:lang="en-US">Twelve Related Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfAccruedCompensationMember" xlink:label="PTIX_SettlementOfAccruedCompensationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SettlementOfAccruedCompensationMember" xlink:to="PTIX_SettlementOfAccruedCompensationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SettlementOfAccruedCompensationMember_lbl" xml:lang="en-US">Settlement of Accrued Compensation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedImmediatelyMember" xlink:label="PTIX_OptionsVestedImmediatelyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedImmediatelyMember" xlink:to="PTIX_OptionsVestedImmediatelyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsVestedImmediatelyMember_lbl" xml:lang="en-US">Options Vested Immediately [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwelveMonthsMember" xlink:label="PTIX_OptionsVestedOverTwelveMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverTwelveMonthsMember" xlink:to="PTIX_OptionsVestedOverTwelveMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsVestedOverTwelveMonthsMember_lbl" xml:lang="en-US">Options Vested Over 12 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwentyFourMonthsMember" xlink:label="PTIX_OptionsVestedOverTwentyFourMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverTwentyFourMonthsMember" xlink:to="PTIX_OptionsVestedOverTwentyFourMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsVestedOverTwentyFourMonthsMember_lbl" xml:lang="en-US">Options Vested Over 24 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverThirtySixMonthsMember" xlink:label="PTIX_OptionsVestedOverThirtySixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverThirtySixMonthsMember" xlink:to="PTIX_OptionsVestedOverThirtySixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsVestedOverThirtySixMonthsMember_lbl" xml:lang="en-US">Options Vested Over 36 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverFourtyEightMonthsMember" xlink:label="PTIX_OptionsVestedOverFourtyEightMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverFourtyEightMonthsMember" xlink:to="PTIX_OptionsVestedOverFourtyEightMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsVestedOverFourtyEightMonthsMember_lbl" xml:lang="en-US">Options Vested Over 48 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ProtagenicWarrantsMember" xlink:label="PTIX_ProtagenicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ProtagenicWarrantsMember" xlink:to="PTIX_ProtagenicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ProtagenicWarrantsMember_lbl" xml:lang="en-US">Protagenic Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsMember" xlink:label="PTIX_AdditionalIssuanceOfWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AdditionalIssuanceOfWarrantsMember_lbl" xml:lang="en-US">Additional Issuance of Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsDebtMember" xlink:label="PTIX_AdditionalIssuanceOfWarrantsDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsDebtMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AdditionalIssuanceOfWarrantsDebtMember_lbl" xml:lang="en-US">Additional Issuance of Warrants for Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:label="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember_lbl" xml:lang="en-US">Additional Issuance of Warrants for Accrued Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrDavidLovejoyMember" xlink:label="PTIX_DrDavidLovejoyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DrDavidLovejoyMember" xlink:to="PTIX_DrDavidLovejoyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DrDavidLovejoyMember_lbl" xml:lang="en-US">Dr. David Lovejoy [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ResearchAgreementsMember" xlink:label="PTIX_ResearchAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ResearchAgreementsMember" xlink:to="PTIX_ResearchAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ResearchAgreementsMember_lbl" xml:lang="en-US">Research Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US">Licensing Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RelatedPartyMember" xlink:label="PTIX_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RelatedPartyMember" xlink:to="PTIX_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Dividend Yield [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Expected Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:label="PTIX_ConvertibleNotesPayableRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:to="PTIX_ConvertibleNotesPayableRelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ConvertibleNotesPayableRelatedPartyMember_lbl" xml:lang="en-US">Convertible Notes Payable - Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">CFO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsToRelatedPartyMember" xlink:label="PTIX_OptionsToRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsToRelatedPartyMember" xlink:to="PTIX_OptionsToRelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsToRelatedPartyMember_lbl" xml:lang="en-US">Options to Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrBuellMember" xlink:label="PTIX_DrBuellMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DrBuellMember" xlink:to="PTIX_DrBuellMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DrBuellMember_lbl" xml:lang="en-US">Dr. Buell [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RecognitionUpcomingServiceMember" xlink:label="PTIX_RecognitionUpcomingServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RecognitionUpcomingServiceMember" xlink:to="PTIX_RecognitionUpcomingServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_RecognitionUpcomingServiceMember_lbl" xml:lang="en-US">Recognition Upcoming Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentKatalystSecuritiesLLCMember" xlink:label="PTIX_PlacementAgentKatalystSecuritiesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PlacementAgentKatalystSecuritiesLLCMember" xlink:to="PTIX_PlacementAgentKatalystSecuritiesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_PlacementAgentKatalystSecuritiesLLCMember_lbl" xml:lang="en-US">Placement Agent - Katalyst Securities LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredAfter2017Member" xlink:label="PTIX_LossesIncurredAfter2017Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossesIncurredAfter2017Member" xlink:to="PTIX_LossesIncurredAfter2017Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_LossesIncurredAfter2017Member_lbl" xml:lang="en-US">Losses incurred after 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredPriorTo2018Member" xlink:label="PTIX_LossesIncurredPriorTo2018Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossesIncurredPriorTo2018Member" xlink:to="PTIX_LossesIncurredPriorTo2018Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_LossesIncurredPriorTo2018Member_lbl" xml:lang="en-US">Losses incurred prior to 2018 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalGeneratedPriorTo2018Member" xlink:label="PTIX_FederalGeneratedPriorTo2018Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_FederalGeneratedPriorTo2018Member" xlink:to="PTIX_FederalGeneratedPriorTo2018Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_FederalGeneratedPriorTo2018Member_lbl" xml:lang="en-US">Federal Generated Prior to 2018 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StockOptionToConsultantsMember" xlink:label="PTIX_StockOptionToConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StockOptionToConsultantsMember" xlink:to="PTIX_StockOptionToConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_StockOptionToConsultantsMember_lbl" xml:lang="en-US">Stock Options to Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentWarrantsMember" xlink:label="PTIX_PlacementAgentWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PlacementAgentWarrantsMember" xlink:to="PTIX_PlacementAgentWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_PlacementAgentWarrantsMember_lbl" xml:lang="en-US">Placement Agent Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelMember" xlink:label="PTIX_BlackScholesModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BlackScholesModelMember" xlink:to="PTIX_BlackScholesModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_BlackScholesModelMember_lbl" xml:lang="en-US">Black-Scholes Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelTwoMember" xlink:label="PTIX_BlackScholesModelTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BlackScholesModelTwoMember" xlink:to="PTIX_BlackScholesModelTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_BlackScholesModelTwoMember_lbl" xml:lang="en-US">Black-Scholes Model Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwoThousandSixteenPlanMember" xlink:label="PTIX_TwoThousandSixteenPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_TwoThousandSixteenPlanMember" xlink:to="PTIX_TwoThousandSixteenPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_TwoThousandSixteenPlanMember_lbl" xml:lang="en-US">2016 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Vesting Over 48 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Vest Immediately [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Other Comprehensive Loss [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TreasuryStockMember_2_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Equipment - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US">PIK convertible notes payable, net of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:label="PTIX_ConvertibleLongTermNotesPayableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:to="PTIX_ConvertibleLongTermNotesPayableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ConvertibleLongTermNotesPayableRelatedParty_lbl" xml:lang="en-US">PIK convertible notes payable, net of debt discount - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.0001 par value, 100,000,000 shares authorized, 10,360,480 and 10,261,419 shares issued and outstanding at December 31, 2020, and December 31, 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">OPERATING AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">TOTAL OPERATING AND ADMINISTRATIVE EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">LOSS FROM OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER (EXPENSE) INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xml:lang="en-US">Realized gain on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">TOTAL OTHER INCOME (EXPENSES)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">LOSS BEFORE INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">INCOME TAX EXPENSE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US">COMPREHENSIVE LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other Comprehensive Loss - net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign exchange translation gain (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">TOTAL COMPREHENSIVE LOSS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per common share - Basic and Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average common shares - Basic and Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_lbl" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_lbl" xml:lang="en-US">Foreign currency translation gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock compensation - stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Stock compensation - warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US">Debt discount from beneficial conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:to="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll_lbl" xml:lang="en-US">Issuance of options for settlement of accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:label="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:to="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_lbl" xml:lang="en-US">Debt discount from warrants issued to placement agents- offering cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:label="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:to="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_lbl" xml:lang="en-US">Issuance of options for settlement of accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Change in fair value of the derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_lbl" xml:lang="en-US">Gain on sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payment of debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from convertible notes - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effect of exchange rate on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH, BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH, END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">NONCASH FINANCING AND INVESTING TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized (gain) loss on marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xml:lang="en-US">Debt discount from beneficial conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromBeneficialConversionFeature" xlink:label="PTIX_DebtDiscountFromBeneficialConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtDiscountFromBeneficialConversionFeature" xlink:to="PTIX_DebtDiscountFromBeneficialConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DebtDiscountFromBeneficialConversionFeature_lbl" xml:lang="en-US">Debt discount from beneficial conversion feature - related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:to="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_2_lbl" xml:lang="en-US">Debt discount from warrants issued to placement agents</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" xlink:to="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_lbl" xml:lang="en-US">Issuance of options for settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Organization and Nature of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Derivative Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Note Payable (PIK Notes)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xml:lang="en-US">Collaborative Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Licensing Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturity Date of Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation Nonvested Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Summary of Warrant Issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Loss Before Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_lbl" xml:lang="en-US">Payments to acquire marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_2_lbl" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_lbl" xml:lang="en-US">Marketable securities, gross realized gain (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Fair value of derivative feature</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightIssued" xlink:label="PTIX_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightIssued" xlink:to="PTIX_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Class of warrant or right, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US">Derivative liability measurement input</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_3_lbl" xml:lang="en-US">Derivative, gain (loss) on derivative, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Derivative warrants liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in fair value of derivative warrants liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Balance at end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DerivativeLiabilityMeasurementInputContractualTerm" xlink:label="PTIX_DerivativeLiabilityMeasurementInputContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DerivativeLiabilityMeasurementInputContractualTerm" xlink:to="PTIX_DerivativeLiabilityMeasurementInputContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DerivativeLiabilityMeasurementInputContractualTerm_lbl" xml:lang="en-US">Derivative liability measurement input, contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total potentially outstanding dilutive common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_2_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EstimateCommitmentAmount" xlink:label="PTIX_EstimateCommitmentAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EstimateCommitmentAmount" xlink:to="PTIX_EstimateCommitmentAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_EstimateCommitmentAmount_lbl" xml:lang="en-US">Estimate commitment amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementEventToTransferConsideration" xlink:label="us-gaap_RegistrationPaymentArrangementEventToTransferConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementEventToTransferConsideration" xlink:to="us-gaap_RegistrationPaymentArrangementEventToTransferConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegistrationPaymentArrangementEventToTransferConsideration_lbl" xml:lang="en-US">Estimate for study description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementGainsAndLosses" xlink:label="us-gaap_RegistrationPaymentArrangementGainsAndLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementGainsAndLosses" xlink:to="us-gaap_RegistrationPaymentArrangementGainsAndLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegistrationPaymentArrangementGainsAndLosses_lbl" xml:lang="en-US">Commitment cost paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementAccrualCarryingValue" xlink:label="us-gaap_RegistrationPaymentArrangementAccrualCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementAccrualCarryingValue" xlink:to="us-gaap_RegistrationPaymentArrangementAccrualCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegistrationPaymentArrangementAccrualCarryingValue_lbl" xml:lang="en-US">Balance due amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Issuance of stock option share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" xlink:label="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" xlink:to="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense_lbl" xml:lang="en-US">Settlement of liability charged to stock compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Stock option, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Option term</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedAccountingFeesCurrent" xlink:label="PTIX_AccruedAccountingFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedAccountingFeesCurrent" xlink:to="PTIX_AccruedAccountingFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AccruedAccountingFeesCurrent_lbl" xml:lang="en-US">Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedResearchAndDevelopmentCurrent" xlink:label="PTIX_AccruedResearchAndDevelopmentCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedResearchAndDevelopmentCurrent" xlink:to="PTIX_AccruedResearchAndDevelopmentCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PTIX_AccruedResearchAndDevelopmentCurrent_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedLegalFeesCurrent" xlink:label="PTIX_AccruedLegalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedLegalFeesCurrent" xlink:to="PTIX_AccruedLegalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AccruedLegalFeesCurrent_lbl" xml:lang="en-US">Legal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightIssued" xlink:to="PTIX_ClassOfWarrantOrRightIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PTIX_ClassOfWarrantOrRightIssued_2_lbl" xml:lang="en-US">Class of warrant or right, issued during period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Class of warrant or right, exercise price of warrants or rights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Class of warrant or right, expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Convertible note principle amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US">Increase in interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Debt amortized debt discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_2_lbl" xml:lang="en-US">Debt beneficial conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_CommissionPercentageTerms" xlink:label="PTIX_CommissionPercentageTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_CommissionPercentageTerms" xlink:to="PTIX_CommissionPercentageTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_CommissionPercentageTerms_lbl" xml:lang="en-US">Commission percentage terms</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForCommissions" xlink:label="us-gaap_PaymentsForCommissions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForCommissions" xlink:to="us-gaap_PaymentsForCommissions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForCommissions_lbl" xml:lang="en-US">Commission</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_2_lbl" xml:lang="en-US">Fair value of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Debt unamortized debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible notes payable outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BeneficialConversionFeatureAndDebtDiscount" xlink:label="PTIX_BeneficialConversionFeatureAndDebtDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BeneficialConversionFeatureAndDebtDiscount" xlink:to="PTIX_BeneficialConversionFeatureAndDebtDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_BeneficialConversionFeatureAndDebtDiscount_lbl" xml:lang="en-US">Beneficial conversion feature and debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalNotesRelatedFee" xlink:label="PTIX_AdditionalNotesRelatedFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalNotesRelatedFee" xlink:to="PTIX_AdditionalNotesRelatedFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AdditionalNotesRelatedFee_lbl" xml:lang="en-US">Additional notes related fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Number of additional shares grants for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for grant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Share-based payment award, expiration period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock options outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Stock options outstanding weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Stock options intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Stock option weighted average exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnamortizedStockOptionExpense" xlink:label="PTIX_UnamortizedStockOptionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnamortizedStockOptionExpense" xlink:to="PTIX_UnamortizedStockOptionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_UnamortizedStockOptionExpense_lbl" xml:lang="en-US">Unamortized stock option expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Stock options granted, term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Stock options fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlement" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfOptionsSharesIssuedForSettlement" xlink:to="PTIX_NumberOfOptionsSharesIssuedForSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlement_lbl" xml:lang="en-US">Number of options shares issued for settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlementValue" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlementValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfOptionsSharesIssuedForSettlementValue" xlink:to="PTIX_NumberOfOptionsSharesIssuedForSettlementValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlementValue_lbl" xml:lang="en-US">Number of options shares issued for settlement, value</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossOnSettlementOfAccountsPayable" xlink:label="PTIX_LossOnSettlementOfAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossOnSettlementOfAccountsPayable" xlink:to="PTIX_LossOnSettlementOfAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_LossOnSettlementOfAccountsPayable_lbl" xml:lang="en-US">Loss on settlement of accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_lbl" xml:lang="en-US">Vesting period, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Stock options vest and grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:label="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:to="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_lbl" xml:lang="en-US">Warrants to purchase shares value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Class of warrant or right, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant or right, outstanding, weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Class of warrant or right, outstanding, intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" xlink:label="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" xlink:to="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription_lbl" xml:lang="en-US">Class of warrant or right, expiration period, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_3_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Stock Options Outstanding, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Stock Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Stock Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Stock Options Outstanding, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted Average Exercisable Price, Stock Options Outstanding, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercisable Price, Stock Options Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercisable Price, Stock Options Outstanding, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">Weighted Average Exercisable Price, Stock Options Outstanding, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3_lbl" xml:lang="en-US">Weighted Average Remaining Life, Stock Options Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Life, Stock Options Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Life, Stock Options Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Nonvested Options, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Nonvested Options, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Nonvested Options, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Nonvested Options, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Nonvested Options, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Warrants Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of Warrants Outstanding, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Number of Warrants Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Exercise Price, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Exercise Price, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Exercise Price, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Remaining Life</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" xlink:label="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" xlink:to="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Remaining Life Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_lbl" xml:lang="en-US">Number of Warrants Outstanding, Weighted Average Remaining Life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Share-based compensation stock options, grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-based compensation weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsExpirationDateDescription" xlink:label="PTIX_OptionsExpirationDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsExpirationDateDescription" xlink:to="PTIX_OptionsExpirationDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OptionsExpirationDateDescription_lbl" xml:lang="en-US">Options expiration date, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentPercentage" xlink:label="PTIX_RoyaltyPaymentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RoyaltyPaymentPercentage" xlink:to="PTIX_RoyaltyPaymentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_RoyaltyPaymentPercentage_lbl" xml:lang="en-US">Royalty payment, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UpFrontSubLicenseFeesPercentage" xlink:label="PTIX_UpFrontSubLicenseFeesPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UpFrontSubLicenseFeesPercentage" xlink:to="PTIX_UpFrontSubLicenseFeesPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_UpFrontSubLicenseFeesPercentage_lbl" xml:lang="en-US">Up-front sub-license fees, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:label="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:to="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage_lbl" xml:lang="en-US">Royalty payment on behalf of sub-licensee, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Sales revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" xlink:label="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" xlink:to="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate_lbl" xml:lang="en-US">Interest on amounts owed under license agreement, rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PercentageOfCorporationsTaxableIncome" xlink:label="PTIX_PercentageOfCorporationsTaxableIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PercentageOfCorporationsTaxableIncome" xlink:to="PTIX_PercentageOfCorporationsTaxableIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_PercentageOfCorporationsTaxableIncome_lbl" xml:lang="en-US">Percentage of corporations taxable income</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OperatingLossCarryforwardsExpirationDescription" xlink:label="PTIX_OperatingLossCarryforwardsExpirationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OperatingLossCarryforwardsExpirationDescription" xlink:to="PTIX_OperatingLossCarryforwardsExpirationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_OperatingLossCarryforwardsExpirationDescription_lbl" xml:lang="en-US">Operating loss carryforwards expiration description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xml:lang="en-US">Reconciliation, tax credit, research, amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Net change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income tax interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Domestic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income taxes at Federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income taxes, net of Federal income tax effect</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" xlink:label="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" xlink:to="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent_lbl" xml:lang="en-US">Perm difference</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign tax rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">U.S. net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:label="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:to="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet_lbl" xml:lang="en-US">Stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsIncomeTaxLoss" xlink:label="PTIX_DeferredTaxAssetsIncomeTaxLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DeferredTaxAssetsIncomeTaxLoss" xlink:to="PTIX_DeferredTaxAssetsIncomeTaxLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_DeferredTaxAssetsIncomeTaxLoss_lbl" xml:lang="en-US">Canadian Provincial income tax losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Canadian Provincial scientific investment tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Gross deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4_lbl" xml:lang="en-US">Option to purchase shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2_lbl" xml:lang="en-US">Option term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedAccountingFeesCurrent" xlink:to="PTIX_AccruedAccountingFeesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AccruedAccountingFeesCurrent_doc" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedLegalFeesCurrent" xlink:to="PTIX_AccruedLegalFeesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AccruedLegalFeesCurrent_doc" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedResearchAndDevelopmentCurrent" xlink:to="PTIX_AccruedResearchAndDevelopmentCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AccruedResearchAndDevelopmentCurrent_doc" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BeneficialConversionFeatureAndDebtDiscount" xlink:to="PTIX_BeneficialConversionFeatureAndDebtDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_BeneficialConversionFeatureAndDebtDiscount_doc" xml:lang="en-US">Beneficial conversion feature and debt discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightIssued" xlink:to="PTIX_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">The number of warrants or rights issued during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConsultantMember" xlink:to="PTIX_ConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ConsultantMember_doc" xml:lang="en-US">Consultant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConversionFeatureSharesMember" xlink:to="PTIX_ConversionFeatureSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ConversionFeatureSharesMember_doc" xml:lang="en-US">Conversion Feature Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:to="PTIX_ConvertibleLongTermNotesPayableRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ConvertibleLongTermNotesPayableRelatedParty_doc" xml:lang="en-US">Convertible long term notes payable related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleNotesMember" xlink:to="PTIX_ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ConvertibleNotesMember_doc" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtSettlementMember" xlink:to="PTIX_DebtSettlementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DebtSettlementMember_doc" xml:lang="en-US">Transaction related to the cancellation of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EmployeesMember" xlink:to="PTIX_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EstimateCommitmentAmount" xlink:to="PTIX_EstimateCommitmentAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_EstimateCommitmentAmount_doc" xml:lang="en-US">Estimate commitment amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_FederalMember" xlink:to="PTIX_FederalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_FederalMember_doc" xml:lang="en-US">Federal [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NonEmployeesMember" xlink:to="PTIX_NonEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_NonEmployeesMember_doc" xml:lang="en-US">Non-Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PlacementAgentWarrantsMember" xlink:to="PTIX_PlacementAgentWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_PlacementAgentWarrantsMember_doc" xml:lang="en-US">Information pertaining to Placement Agent Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ProtagenicWarrantsMember" xlink:to="PTIX_ProtagenicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ProtagenicWarrantsMember_doc" xml:lang="en-US">Protagenic Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SeriesBConvertiblePreferredStockMember" xlink:to="PTIX_SeriesBConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SeriesBConvertiblePreferredStockMember_doc" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StateAndLocalMember" xlink:to="PTIX_StateAndLocalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_StateAndLocalMember_doc" xml:lang="en-US">State and Local [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StrategicBioPartnersMember" xlink:to="PTIX_StrategicBioPartnersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_StrategicBioPartnersMember_doc" xml:lang="en-US">Represents Strategic Bio Partners.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ToxicologyStudiesMember" xlink:to="PTIX_ToxicologyStudiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ToxicologyStudiesMember_doc" xml:lang="en-US">Toxicology Studies [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UniversityOfTorontoMember" xlink:to="PTIX_UniversityOfTorontoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_UniversityOfTorontoMember_doc" xml:lang="en-US">University of Toronto [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnsecuredConvertibleNotesMember" xlink:to="PTIX_UnsecuredConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_UnsecuredConvertibleNotesMember_doc" xml:lang="en-US">Unsecured Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:to="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember_doc" xml:lang="en-US">Unsecured Convertible Notes with Rekated Parties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_VestBiWeeklyOverTwoMonthsMember" xlink:to="PTIX_VestBiWeeklyOverTwoMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_VestBiWeeklyOverTwoMonthsMember_doc" xml:lang="en-US">Vest bi-Weekly Over Two Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SettlementOfAccruedCompensationMember" xlink:to="PTIX_SettlementOfAccruedCompensationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SettlementOfAccruedCompensationMember_doc" xml:lang="en-US">Settlement of Accrued Compensation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedImmediatelyMember" xlink:to="PTIX_OptionsVestedImmediatelyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsVestedImmediatelyMember_doc" xml:lang="en-US">Options Vested Immediately [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverTwelveMonthsMember" xlink:to="PTIX_OptionsVestedOverTwelveMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsVestedOverTwelveMonthsMember_doc" xml:lang="en-US">Options Vested Over 12 Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverTwentyFourMonthsMember" xlink:to="PTIX_OptionsVestedOverTwentyFourMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsVestedOverTwentyFourMonthsMember_doc" xml:lang="en-US">Options Vested Over 24 Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverThirtySixMonthsMember" xlink:to="PTIX_OptionsVestedOverThirtySixMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsVestedOverThirtySixMonthsMember_doc" xml:lang="en-US">Options Vested Over 36 Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsVestedOverFourtyEightMonthsMember" xlink:to="PTIX_OptionsVestedOverFourtyEightMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsVestedOverFourtyEightMonthsMember_doc" xml:lang="en-US">Options Vested Over 48 Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AdditionalIssuanceOfWarrantsMember_doc" xml:lang="en-US">Additional Issuance of Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsDebtMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsDebtMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AdditionalIssuanceOfWarrantsDebtMember_doc" xml:lang="en-US">Additional Issuance of Warrants For Debt [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:to="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember_doc" xml:lang="en-US">Additional Issuance of Warrants For Accrued Interest [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DerivativeLiabilityMeasurementInputContractualTerm" xlink:to="PTIX_DerivativeLiabilityMeasurementInputContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DerivativeLiabilityMeasurementInputContractualTerm_doc" xml:lang="en-US">Derivative liability measurement input, contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DrDavidLovejoyMember" xlink:to="PTIX_DrDavidLovejoyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DrDavidLovejoyMember_doc" xml:lang="en-US">Dr. David Lovejoy [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ResearchAgreementsMember" xlink:to="PTIX_ResearchAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ResearchAgreementsMember_doc" xml:lang="en-US">Research Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RelatedPartyMember" xlink:to="PTIX_RelatedPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_RelatedPartyMember_doc" xml:lang="en-US">Related Party [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdditionalNotesRelatedFee" xlink:to="PTIX_AdditionalNotesRelatedFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AdditionalNotesRelatedFee_doc" xml:lang="en-US">Additional Notes Related Fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DrBuellMember" xlink:to="PTIX_DrBuellMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DrBuellMember_doc" xml:lang="en-US">Dr Buell Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:to="PTIX_ConvertibleNotesPayableRelatedPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ConvertibleNotesPayableRelatedPartyMember_doc" xml:lang="en-US">Convertible Notes Payable - Related Party [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SixteenIndividualsMember" xlink:to="PTIX_SixteenIndividualsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SixteenIndividualsMember_doc" xml:lang="en-US">Sixteen Individuals [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_TwelveRelatedPartiesMember" xlink:to="PTIX_TwelveRelatedPartiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_TwelveRelatedPartiesMember_doc" xml:lang="en-US">Twelve Related Parties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsToRelatedPartyMember" xlink:to="PTIX_OptionsToRelatedPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsToRelatedPartyMember_doc" xml:lang="en-US">Options To Related Party Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RecognitionUpcomingServiceMember" xlink:to="PTIX_RecognitionUpcomingServiceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_RecognitionUpcomingServiceMember_doc" xml:lang="en-US">Recognition Upcoming Service Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BlackScholesModelMember" xlink:to="PTIX_BlackScholesModelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_BlackScholesModelMember_doc" xml:lang="en-US">Black Scholes Model Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_BlackScholesModelTwoMember" xlink:to="PTIX_BlackScholesModelTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_BlackScholesModelTwoMember_doc" xml:lang="en-US">Black Scholes Model Two Member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:to="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents_doc" xml:lang="en-US">Debt discount from warrants issued to placement agents.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_CommissionPercentageTerms" xlink:to="PTIX_CommissionPercentageTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_CommissionPercentageTerms_doc" xml:lang="en-US">Commission percentage terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PlacementAgentKatalystSecuritiesLLCMember" xlink:to="PTIX_PlacementAgentKatalystSecuritiesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_PlacementAgentKatalystSecuritiesLLCMember_doc" xml:lang="en-US">Placement Agent - Katalyst Securities LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DebtDiscountFromBeneficialConversionFeature" xlink:to="PTIX_DebtDiscountFromBeneficialConversionFeature_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DebtDiscountFromBeneficialConversionFeature_doc" xml:lang="en-US">Debt discount from beneficial conversion feature - related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossesIncurredAfter2017Member" xlink:to="PTIX_LossesIncurredAfter2017Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_LossesIncurredAfter2017Member_doc" xml:lang="en-US">Losses Incurred After 2017.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossesIncurredPriorTo2018Member" xlink:to="PTIX_LossesIncurredPriorTo2018Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_LossesIncurredPriorTo2018Member_doc" xml:lang="en-US">Losses Incurred Prior To 2018.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_FederalGeneratedPriorTo2018Member" xlink:to="PTIX_FederalGeneratedPriorTo2018Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_FederalGeneratedPriorTo2018Member_doc" xml:lang="en-US">Federal Generated Prior To 2018.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" xlink:to="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SettlementOfLiabilityChargedToStockCompensationExpense_doc" xml:lang="en-US">Settlement of liability charged to stock compensation expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_StockOptionToConsultantsMember" xlink:to="PTIX_StockOptionToConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_StockOptionToConsultantsMember_doc" xml:lang="en-US">Stock Options to Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" xlink:to="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_doc" xml:lang="en-US">Issuance of options for settlement of accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_TwoThousandSixteenPlanMember" xlink:to="PTIX_TwoThousandSixteenPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_TwoThousandSixteenPlanMember_doc" xml:lang="en-US">2016 Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UnamortizedStockOptionExpense" xlink:to="PTIX_UnamortizedStockOptionExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_UnamortizedStockOptionExpense_doc" xml:lang="en-US">Unamortized stock option expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfOptionsSharesIssuedForSettlement" xlink:to="PTIX_NumberOfOptionsSharesIssuedForSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlement_doc" xml:lang="en-US">Number of options shares issued for settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfOptionsSharesIssuedForSettlementValue" xlink:to="PTIX_NumberOfOptionsSharesIssuedForSettlementValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_NumberOfOptionsSharesIssuedForSettlementValue_doc" xml:lang="en-US">Number of options shares issued for settlement, value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_LossOnSettlementOfAccountsPayable" xlink:to="PTIX_LossOnSettlementOfAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_LossOnSettlementOfAccountsPayable_doc" xml:lang="en-US">Loss on settlement of accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription_doc" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:to="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue_doc" xml:lang="en-US">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right, outstanding, weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding_doc" xml:lang="en-US">Class of warrant or right, outstanding, intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" xlink:to="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ClassOfWarrantOrRightExpirationPeriodDescription_doc" xml:lang="en-US">Class of warrant or right, expiration period, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average remaining life, stock options outstanding, ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_doc" xml:lang="en-US">Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" xlink:to="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted_doc" xml:lang="en-US">Number of warrants outstanding, weighted average remaining life granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_doc" xml:lang="en-US">Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OptionsExpirationDateDescription" xlink:to="PTIX_OptionsExpirationDateDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OptionsExpirationDateDescription_doc" xml:lang="en-US">Options expiration date, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RoyaltyPaymentPercentage" xlink:to="PTIX_RoyaltyPaymentPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_RoyaltyPaymentPercentage_doc" xml:lang="en-US">The percentage of royalty payment of net sales.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_UpFrontSubLicenseFeesPercentage" xlink:to="PTIX_UpFrontSubLicenseFeesPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_UpFrontSubLicenseFeesPercentage_doc" xml:lang="en-US">The percentage of Up-front sub-license fees, for any sub-licenses that occur on or after September 9, 2006, the company agree to pay under an agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:to="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage_doc" xml:lang="en-US">The percentage of royalty payment of net sales made on behalf of a sub-licensee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" xlink:to="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate_doc" xml:lang="en-US">The interest rate charged per annum on any amounts owed under the license agreement and amendment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_PercentageOfCorporationsTaxableIncome" xlink:to="PTIX_PercentageOfCorporationsTaxableIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_PercentageOfCorporationsTaxableIncome_doc" xml:lang="en-US">Percentage of corporations taxable income.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_OperatingLossCarryforwardsExpirationDescription" xlink:to="PTIX_OperatingLossCarryforwardsExpirationDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_OperatingLossCarryforwardsExpirationDescription_doc" xml:lang="en-US">Operating loss carryforwards expiration description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" xlink:to="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent_doc" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:to="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet_doc" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation, net of forfeitures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_DeferredTaxAssetsIncomeTaxLoss" xlink:to="PTIX_DeferredTaxAssetsIncomeTaxLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_DeferredTaxAssetsIncomeTaxLoss_doc" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from income tax loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:to="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll_doc" xml:lang="en-US">Issuance of options for settlement of accrued payroll.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:to="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions_doc" xml:lang="en-US">Adjustments to additional paid in capital issuance of options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_2_lbl" xml:lang="en-US">Other Nonoperating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" xlink:to="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable_3_lbl" xml:lang="en-US">IssuanceOfOptionsForSettlementOfAccountsPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_2_lbl" xml:lang="en-US">Derivative Liability [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_AccruedResearchAndDevelopmentCurrent" xlink:to="PTIX_AccruedResearchAndDevelopmentCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_AccruedResearchAndDevelopmentCurrent_3_lbl" xml:lang="en-US">OPERATING AND ADMINISTRATIVE EXPENSES [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:to="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>39
<FILENAME>ptix-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: PTIX 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D25T07:58:13Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://protagenic.com/role/DocumentAndEntityInformation" xlink:href="ptix-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheets" xlink:href="ptix-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:href="ptix-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:href="ptix-20201231.xsd#StatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="ptix-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StatementsOfCashFlows" xlink:href="ptix-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:href="ptix-20201231.xsd#OrganizationAndNatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/GoingConcern" xlink:href="ptix-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilities" xlink:href="ptix-20201231.xsd#DerivativeLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit" xlink:href="ptix-20201231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreements" xlink:href="ptix-20201231.xsd#CollaborativeAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreements" xlink:href="ptix-20201231.xsd#LicensingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactions" xlink:href="ptix-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes" xlink:href="ptix-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEvents" xlink:href="ptix-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitTables" xlink:href="ptix-20201231.xsd#StockholdersDeficitTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesTables" xlink:href="ptix-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ptix-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:href="ptix-20201231.xsd#AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:href="ptix-20201231.xsd#DerivativeLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:href="ptix-20201231.xsd#ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:href="ptix-20201231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:href="ptix-20201231.xsd#StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#CollaborativeAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:href="ptix-20201231.xsd#LicensingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ptix-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:href="ptix-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ptix-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:href="ptix-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleLongTermNotesPayableRelatedParty" xlink:label="loc_PTIXConvertibleLongTermNotesPayableRelatedParty" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_PTIXConvertibleLongTermNotesPayableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SeriesBConvertiblePreferredStockMember" xlink:label="loc_PTIXSeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_PTIXSeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:label="loc_PTIXIssuanceOfOptionsForSettlementOfAccruedPayroll" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXIssuanceOfOptionsForSettlementOfAccruedPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:label="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:label="loc_PTIXAdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXAdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromBeneficialConversionFeature" xlink:label="loc_PTIXDebtDiscountFromBeneficialConversionFeature" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PTIXDebtDiscountFromBeneficialConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:label="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PTIXDebtDiscountFromWarrantsIssuedToPlacementAgents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable" xlink:label="loc_PTIXIssuanceOfOptionsForSettlementOfAccountsPayable" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_PTIXIssuanceOfOptionsForSettlementOfAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/OrganizationAndNatureOfBusiness" xlink:title="00000007 - Disclosure - Organization and Nature of Business">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/GoingConcern" xlink:title="00000008 - Disclosure - Going Concern">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses" xlink:title="00000010 - Disclosure - Accounts Payable and Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilities" xlink:title="00000011 - Disclosure - Derivative Liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes" xlink:title="00000012 - Disclosure - Convertible Note Payable (PIK Notes)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit" xlink:title="00000013 - Disclosure - Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreements" xlink:title="00000014 - Disclosure - Collaborative Agreements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="loc_us-gaapCollaborativeArrangementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCollaborativeArrangementDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreements" xlink:title="00000015 - Disclosure - Licensing Agreements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="00000021 - Disclosure - Accounts Payable and Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesTables" xlink:title="00000022 - Disclosure - Convertible Note Payable (PIK Notes) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:label="loc_PTIXConvertibleNotesPayableRelatedPartyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXConvertibleNotesPayableRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitTables" xlink:title="00000023 - Disclosure - Stockholders&apos; Deficit (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesTables" xlink:title="00000024 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightIssued" xlink:label="loc_PTIXClassOfWarrantOrRightIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:title="00000028 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DerivativeLiabilityMeasurementInputContractualTerm" xlink:label="loc_PTIXDerivativeLiabilityMeasurementInputContractualTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXDerivativeLiabilityMeasurementInputContractualTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConversionFeatureSharesMember" xlink:label="loc_PTIXConversionFeatureSharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PTIXConversionFeatureSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesMember" xlink:label="loc_PTIXConvertibleNotesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_PTIXConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative" xlink:title="00000030 - Disclosure - Accounts Payable and Accrued Expenses (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConsultantMember" xlink:label="loc_PTIXConsultantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ToxicologyStudiesMember" xlink:label="loc_PTIXToxicologyStudiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PTIXToxicologyStudiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EstimateCommitmentAmount" xlink:label="loc_PTIXEstimateCommitmentAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXEstimateCommitmentAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementEventToTransferConsideration" xlink:label="loc_us-gaapRegistrationPaymentArrangementEventToTransferConsideration" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementEventToTransferConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementGainsAndLosses" xlink:label="loc_us-gaapRegistrationPaymentArrangementGainsAndLosses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementGainsAndLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegistrationPaymentArrangementAccrualCarryingValue" xlink:label="loc_us-gaapRegistrationPaymentArrangementAccrualCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRegistrationPaymentArrangementAccrualCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfLiabilityChargedToStockCompensationExpense" xlink:label="loc_PTIXSettlementOfLiabilityChargedToStockCompensationExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXSettlementOfLiabilityChargedToStockCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedAccountingFeesCurrent" xlink:label="loc_PTIXAccruedAccountingFeesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_PTIXAccruedAccountingFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedResearchAndDevelopmentCurrent" xlink:label="loc_PTIXAccruedResearchAndDevelopmentCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_PTIXAccruedResearchAndDevelopmentCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AccruedLegalFeesCurrent" xlink:label="loc_PTIXAccruedLegalFeesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_PTIXAccruedLegalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:title="00000032 - Disclosure - Derivative Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DebtSettlementMember" xlink:label="loc_PTIXDebtSettlementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXDebtSettlementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StrategicBioPartnersMember" xlink:label="loc_PTIXStrategicBioPartnersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_PTIXStrategicBioPartnersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightIssued" xlink:label="loc_PTIXClassOfWarrantOrRightIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative" xlink:title="00000033 - Disclosure - Convertible Note Payable (PIK Notes) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesMember" xlink:label="loc_PTIXUnsecuredConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXUnsecuredConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:label="loc_PTIXUnsecuredConvertibleNotesWithRelatedPartiesMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXUnsecuredConvertibleNotesWithRelatedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentKatalystSecuritiesLLCMember" xlink:label="loc_PTIXPlacementAgentKatalystSecuritiesLLCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXPlacementAgentKatalystSecuritiesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_CommissionPercentageTerms" xlink:label="loc_PTIXCommissionPercentageTerms" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXCommissionPercentageTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForCommissions" xlink:label="loc_us-gaapPaymentsForCommissions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForCommissions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BeneficialConversionFeatureAndDebtDiscount" xlink:label="loc_PTIXBeneficialConversionFeatureAndDebtDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXBeneficialConversionFeatureAndDebtDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalNotesRelatedFee" xlink:label="loc_PTIXAdditionalNotesRelatedFee" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXAdditionalNotesRelatedFee" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails" xlink:title="00000034 - Disclosure - Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ConvertibleNotesPayableRelatedPartyMember" xlink:label="loc_PTIXConvertibleNotesPayableRelatedPartyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_PTIXConvertibleNotesPayableRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000035 - Disclosure - Stockholders&apos; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwoThousandSixteenPlanMember" xlink:label="loc_PTIXTwoThousandSixteenPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_PTIXTwoThousandSixteenPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StockOptionToConsultantsMember" xlink:label="loc_PTIXStockOptionToConsultantsMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXStockOptionToConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RecognitionUpcomingServiceMember" xlink:label="loc_PTIXRecognitionUpcomingServiceMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXRecognitionUpcomingServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PlacementAgentWarrantsMember" xlink:label="loc_PTIXPlacementAgentWarrantsMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXPlacementAgentWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelMember" xlink:label="loc_PTIXBlackScholesModelMember" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXBlackScholesModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_BlackScholesModelTwoMember" xlink:label="loc_PTIXBlackScholesModelTwoMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_PTIXBlackScholesModelTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EmployeesMember" xlink:label="loc_PTIXEmployeesMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NonEmployeesMember" xlink:label="loc_PTIXNonEmployeesMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXNonEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SixteenIndividualsMember" xlink:label="loc_PTIXSixteenIndividualsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXSixteenIndividualsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_TwelveRelatedPartiesMember" xlink:label="loc_PTIXTwelveRelatedPartiesMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXTwelveRelatedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_VestBiWeeklyOverTwoMonthsMember" xlink:label="loc_PTIXVestBiWeeklyOverTwoMonthsMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXVestBiWeeklyOverTwoMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedImmediatelyMember" xlink:label="loc_PTIXOptionsVestedImmediatelyMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedImmediatelyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwelveMonthsMember" xlink:label="loc_PTIXOptionsVestedOverTwelveMonthsMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverTwelveMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverTwentyFourMonthsMember" xlink:label="loc_PTIXOptionsVestedOverTwentyFourMonthsMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverTwentyFourMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverThirtySixMonthsMember" xlink:label="loc_PTIXOptionsVestedOverThirtySixMonthsMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverThirtySixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsVestedOverFourtyEightMonthsMember" xlink:label="loc_PTIXOptionsVestedOverFourtyEightMonthsMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_PTIXOptionsVestedOverFourtyEightMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SettlementOfAccruedCompensationMember" xlink:label="loc_PTIXSettlementOfAccruedCompensationMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXSettlementOfAccruedCompensationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsDebtMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsDebtMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsForAccruedInterestMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsForAccruedInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_AdditionalIssuanceOfWarrantsMember" xlink:label="loc_PTIXAdditionalIssuanceOfWarrantsMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXAdditionalIssuanceOfWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsToRelatedPartyMember" xlink:label="loc_PTIXOptionsToRelatedPartyMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXOptionsToRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrBuellMember" xlink:label="loc_PTIXDrBuellMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_PTIXDrBuellMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ProtagenicWarrantsMember" xlink:label="loc_PTIXProtagenicWarrantsMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_PTIXProtagenicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UnamortizedStockOptionExpense" xlink:label="loc_PTIXUnamortizedStockOptionExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXUnamortizedStockOptionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlement" xlink:label="loc_PTIXNumberOfOptionsSharesIssuedForSettlement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXNumberOfOptionsSharesIssuedForSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfOptionsSharesIssuedForSettlementValue" xlink:label="loc_PTIXNumberOfOptionsSharesIssuedForSettlementValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXNumberOfOptionsSharesIssuedForSettlementValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossOnSettlementOfAccountsPayable" xlink:label="loc_PTIXLossOnSettlementOfAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXLossOnSettlementOfAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:label="loc_PTIXClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ClassOfWarrantOrRightExpirationPeriodDescription" xlink:label="loc_PTIXClassOfWarrantOrRightExpirationPeriodDescription" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXClassOfWarrantOrRightExpirationPeriodDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000036 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:title="00000037 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails" xlink:title="00000038 - Disclosure - Stockholders&apos; Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails" xlink:title="00000039 - Disclosure - Stockholders&apos; Deficit - Summary of Warrant Issuances (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" xlink:label="loc_PTIXNumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXNumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:label="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_PTIXShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative" xlink:title="00000040 - Disclosure - Collaborative Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UniversityOfTorontoMember" xlink:label="loc_PTIXUniversityOfTorontoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_PTIXUniversityOfTorontoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DrDavidLovejoyMember" xlink:label="loc_PTIXDrDavidLovejoyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_PTIXDrDavidLovejoyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_ResearchAgreementsMember" xlink:label="loc_PTIXResearchAgreementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_PTIXResearchAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OptionsExpirationDateDescription" xlink:label="loc_PTIXOptionsExpirationDateDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXOptionsExpirationDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/LicensingAgreementsDetailsNarrative" xlink:title="00000041 - Disclosure - Licensing Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentPercentage" xlink:label="loc_PTIXRoyaltyPaymentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXRoyaltyPaymentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_UpFrontSubLicenseFeesPercentage" xlink:label="loc_PTIXUpFrontSubLicenseFeesPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXUpFrontSubLicenseFeesPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:label="loc_PTIXRoyaltyPaymentOnBehalfOfSublicenseePercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXRoyaltyPaymentOnBehalfOfSublicenseePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate" xlink:label="loc_PTIXInterestOnAmountsOwedUnderLicenseAgreementRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXInterestOnAmountsOwedUnderLicenseAgreementRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_RelatedPartyMember" xlink:label="loc_PTIXRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_PTIXRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalMember" xlink:label="loc_PTIXFederalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXFederalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_FederalGeneratedPriorTo2018Member" xlink:label="loc_PTIXFederalGeneratedPriorTo2018Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXFederalGeneratedPriorTo2018Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_StateAndLocalMember" xlink:label="loc_PTIXStateAndLocalMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_PTIXStateAndLocalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredAfter2017Member" xlink:label="loc_PTIXLossesIncurredAfter2017Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXLossesIncurredAfter2017Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_LossesIncurredPriorTo2018Member" xlink:label="loc_PTIXLossesIncurredPriorTo2018Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_PTIXLossesIncurredPriorTo2018Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_PercentageOfCorporationsTaxableIncome" xlink:label="loc_PTIXPercentageOfCorporationsTaxableIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXPercentageOfCorporationsTaxableIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_OperatingLossCarryforwardsExpirationDescription" xlink:label="loc_PTIXOperatingLossCarryforwardsExpirationDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_PTIXOperatingLossCarryforwardsExpirationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails" xlink:title="00000044 - Disclosure - Income Taxes - Schedule of Loss Before Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" xlink:label="loc_PTIXEffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PTIXEffectiveIncomeTaxRateReconciliationPermanentDifferencePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:label="loc_PTIXDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PTIXDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ptix-20201231.xsd#PTIX_DeferredTaxAssetsIncomeTaxLoss" xlink:label="loc_PTIXDeferredTaxAssetsIncomeTaxLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_PTIXDeferredTaxAssetsIncomeTaxLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://protagenic.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153283664488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 17, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Protagenic Therapeutics, Inc.\new<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,005,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,521,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153289175416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 671,091<span></span>
</td>
<td class="nump">$ 798,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">208,156<span></span>
</td>
<td class="nump">43,354<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">879,247<span></span>
</td>
<td class="nump">841,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Equipment - net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">879,247<span></span>
</td>
<td class="nump">842,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">571,517<span></span>
</td>
<td class="nump">865,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liability</a></td>
<td class="nump">83,670<span></span>
</td>
<td class="nump">332,222<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">655,187<span></span>
</td>
<td class="nump">1,197,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">PIK convertible notes payable, net of debt discount</a></td>
<td class="nump">1,081,384<span></span>
</td>
<td class="nump">174,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ConvertibleLongTermNotesPayableRelatedParty', window );">PIK convertible notes payable, net of debt discount - related parties</a></td>
<td class="nump">292,412<span></span>
</td>
<td class="nump">104,549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,028,983<span></span>
</td>
<td class="nump">1,476,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.0001 par value, 100,000,000 shares authorized, 10,360,480 and 10,261,419 shares issued and outstanding at December 31, 2020, and December 31, 2019</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">16,719,749<span></span>
</td>
<td class="nump">14,687,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(17,698,936)<span></span>
</td>
<td class="num">(15,150,201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(171,586)<span></span>
</td>
<td class="num">(172,364)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS' DEFICIT</a></td>
<td class="num">(1,149,736)<span></span>
</td>
<td class="num">(634,366)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</a></td>
<td class="nump">879,247<span></span>
</td>
<td class="nump">842,273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ConvertibleLongTermNotesPayableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible long term notes payable related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ConvertibleLongTermNotesPayableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153283415832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ .0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">10,360,480<span></span>
</td>
<td class="nump">10,261,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">10,360,480<span></span>
</td>
<td class="nump">10,261,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">872,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">872,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=PTIX_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153282271784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING AND ADMINISTRATIVE EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 699,797<span></span>
</td>
<td class="nump">$ 807,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,851,814<span></span>
</td>
<td class="nump">1,278,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING AND ADMINISTRATIVE EXPENSES</a></td>
<td class="nump">2,551,611<span></span>
</td>
<td class="nump">2,086,130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(2,551,611)<span></span>
</td>
<td class="num">(2,086,130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER (EXPENSE) INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Interest income</a></td>
<td class="nump">502<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Interest expense</a></td>
<td class="num">(246,178)<span></span>
</td>
<td class="num">(15,886)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet', window );">Realized gain on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of derivative liability</a></td>
<td class="nump">248,552<span></span>
</td>
<td class="nump">343,857<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER INCOME (EXPENSES)</a></td>
<td class="nump">2,876<span></span>
</td>
<td class="nump">335,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE INCOME TAX</a></td>
<td class="num">(2,548,735)<span></span>
</td>
<td class="num">(1,750,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">INCOME TAX EXPENSE</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
<td class="num">(2,548,735)<span></span>
</td>
<td class="num">(1,750,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Loss - net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange translation gain (loss)</a></td>
<td class="nump">778<span></span>
</td>
<td class="num">(6,647)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">TOTAL COMPREHENSIVE LOSS</a></td>
<td class="num">$ (2,547,957)<span></span>
</td>
<td class="num">$ (1,757,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share - Basic and Diluted</a></td>
<td class="num">$ (0.25)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares - Basic and Diluted</a></td>
<td class="nump">10,339,071<span></span>
</td>
<td class="nump">10,261,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280821096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Series B Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1,026<span></span>
</td>
<td class="nump">$ 13,357,920<span></span>
</td>
<td class="num">$ (13,399,290)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (170,540)<span></span>
</td>
<td class="num">$ (210,883)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">10,261,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,823<span></span>
</td>
<td class="nump">4,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation gain</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,647)<span></span>
</td>
<td class="num">(6,647)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation - stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">797,761<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">797,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Debt discount from beneficial conversion feature</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions', window );">Issuance of options for settlement of accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,491<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">129,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,750,911)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,750,911)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1,026<span></span>
</td>
<td class="nump">14,687,172<span></span>
</td>
<td class="num">(15,150,201)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(172,364)<span></span>
</td>
<td class="num">(634,366)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">10,261,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation - stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Stock compensation - warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Debt discount from beneficial conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll', window );">Issuance of options for settlement of accrued payroll</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">119,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents', window );">Debt discount from warrants issued to placement agents- offering cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,548,735)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,548,735)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1,036<span></span>
</td>
<td class="nump">$ 16,719,749<span></span>
</td>
<td class="num">$ (17,698,936)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (171,586)<span></span>
</td>
<td class="num">$ (1,149,736)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">10,360,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital issuance of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_AdjustmentsToAdditionalPaidInCapitalIssuanceOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt discount from warrants issued to placement agents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of options for settlement of accrued payroll.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_IssuanceOfOptionsForSettlementOfAccruedPayroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153283453192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (2,548,735)<span></span>
</td>
<td class="num">$ (1,750,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">1,654,754<span></span>
</td>
<td class="nump">797,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of the derivative liability</a></td>
<td class="num">(248,552)<span></span>
</td>
<td class="num">(343,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet', window );">Gain on sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4,435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">154,899<span></span>
</td>
<td class="nump">11,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of accounts payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">99,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(164,802)<span></span>
</td>
<td class="nump">40,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(196,629)<span></span>
</td>
<td class="nump">662,158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH USED IN OPERATING ACTIVITIES</a></td>
<td class="num">(1,348,779)<span></span>
</td>
<td class="num">(487,990)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH PROVIDED BY INVESTING ACTIVITIES</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(104,090)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes</a></td>
<td class="nump">1,177,500<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from convertible notes - related party</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">1,223,410<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate on cash and cash equivalents</a></td>
<td class="num">(2,163)<span></span>
</td>
<td class="nump">4,127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="num">(127,532)<span></span>
</td>
<td class="nump">436,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH, BEGINNING OF YEAR</a></td>
<td class="nump">798,623<span></span>
</td>
<td class="nump">362,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH, END OF YEAR</a></td>
<td class="nump">671,091<span></span>
</td>
<td class="nump">798,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>NONCASH FINANCING AND INVESTING TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized (gain) loss on marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt discount from beneficial conversion feature</a></td>
<td class="nump">104,204<span></span>
</td>
<td class="nump">252,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DebtDiscountFromBeneficialConversionFeature', window );">Debt discount from beneficial conversion feature - related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents', window );">Debt discount from warrants issued to placement agents</a></td>
<td class="nump">179,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable', window );">Issuance of options for settlement of accounts payable</a></td>
<td class="nump">$ 93,950<span></span>
</td>
<td class="nump">$ 29,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DebtDiscountFromBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt discount from beneficial conversion feature - related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DebtDiscountFromBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt discount from warrants issued to placement agents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DebtDiscountFromWarrantsIssuedToPlacementAgents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of options for settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_IssuanceOfOptionsForSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153287836488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Nature of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Organization and Nature of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 &#8211; ORGANIZATION AND NATURE OF
BUSINESS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Company Background</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Protagenic Therapeutics,
Inc. (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;Protagenic&#8221; or &#8220;the Company&#8221;), is a Delaware corporation with
one subsidiary named Protagenic Therapeutics Canada (2006) Inc. (&#8220;PTI Canada&#8221;), a corporation formed in 2006 under
the laws of the Province of Ontario, Canada.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company was previously
known as Atrinsic, Inc., a company that was once a reporting company under the Securities Exchange Act of 1934, but that, in 2012
and 2013, reorganized under Chapter 11 of the United States Bankruptcy Code and emerged from bankruptcy. On February 12, 2016,
the Company acquired Protagenic Therapeutics, Inc. (&#8220;Prior Protagenic&#8221;) through a reverse merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 12, 2016,
Protagenic Acquisition Corp., a wholly-owned subsidiary of the Company, merged (the &#8220;Merger&#8221;) with and into Prior
Protagenic. Prior Protagenic was the surviving corporation of the Merger. As a result of the Merger, the Company acquired the
business of Prior Protagenic and has continued the existing business operations of Prior Protagenic as a wholly-owned subsidiary.
On June 17, 2016, Prior Protagenic merged with and into the Company with the Company as the surviving corporation in the merger.
Immediately thereafter, the Company changed its name from Atrinsic, Inc. to Protagenic Therapeutics, Inc.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285084712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - GOING CONCERN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As shown in the accompanying
consolidated financial statements, the Company has incurred significant reoccurring losses resulting in an accumulated deficit.
The Company anticipates further losses in the development of its business. The Company had negative cash flows used in operations.
These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Based on its current forecast
and budget, management believes that its cash resources will be sufficient to fund its operations at least until the end of the
third quarter of 2021. Absent generation of sufficient revenue from the execution of the Company&#8217;s business plan and sales
revenue is not anticipated before 2024, the Company will need to obtain debt or equity financing by the third quarter of 2021.
Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to
continue as a going concern, however, management cannot be certain that such plans can be achieved. The accompanying financial
statements have been prepared assuming the Company will continue as a going concern; no adjustments to the financial statements
have been made to account for this uncertainty.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153287743880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 - SUMMARY OF SIGNFICANT ACCOUNTING
POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basis of presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">The Company&#8217;s consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America
(&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Principles of consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements include the accounts of Protagenic Therapeutics, Inc., and its wholly owned Canadian subsidiary, PTI Canada. All significant
intercompany balances and transactions have been eliminated in the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Reclassifications:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Reclassifications of prior
periods have been made to conform with current year presentation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those
estimates. Significant estimates underlying the consolidated financial statements include income tax provisions, valuation of stock
options and warrants and assessment of deferred tax asset valuation allowance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company maintains its
cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may
have deposits in excess of federally insured limits. The Company has not experienced losses on these accounts and management believes,
based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company considers all
highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. While the Company&#8217;s
marketable securities are cash equivalents it is the Company&#8217;s policy to present them separately on the balance sheet. As
of December 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Equipment</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Equipment is stated at
cost less accumulated depreciation. Cost includes expenditures for computer equipment. Maintenance and repairs are charged to expense
as incurred. When assets are sold, retired, or otherwise disposed of, the cost and accumulated depreciation are removed from the
accounts and any resulting gain or loss is reflected in operations. The cost of equipment is depreciated using the straight-line
method over the estimated useful lives of the related assets which is three years. Depreciation expense was nominal for the years
ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Marketable Securities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
marketable debt securities, the only type of securities it owns, in accordance with sub-topic 320-10 of the FASB Accounting Standards
Codification (&#8220;Sub-topic 320-10&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to Paragraph 320-10-35-1,
investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the consolidated
balance sheets at each balance sheet date. Unrealized holding gains and losses for available-for-sale debt securities (including
those classified as current assets) shall be excluded from earnings and reported in other comprehensive income until realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company purchased $0 and sold $250,000 in marketable securities, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company owned marketable securities with a total value of $0 and $0, respectively. The Company recorded
a realized gain on marketable securities of $0 and $4,435 for the years ended December 31, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company held no marketable securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Fair Value Measurements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">ASC 820, &#8220;Fair Value
Measurements and Disclosure,&#8221; defines fair value as the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs.
ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value
into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level
1) and the lowest priority to unobservable inputs (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The three levels are described below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 1 Inputs &#8211;
Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 2 Inputs &#8211;
Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly
or indirectly;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 3 Inputs &#8211;
Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying amount of
the Company&#8217;s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair
value because of the short term maturity of those instruments. The carrying value of long-term debt approximates fair value since
the related rates of interest approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Transactions involving
related parties cannot be presumed to be carried out on an arm&#8217;s-length basis, as the requisite conditions of competitive,
free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the
related party transactions were consummated on terms equivalent to those that prevail in arm&#8217;s-length transactions unless
such representations can be substantiated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The assets or liability&#8217;s
fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair
value measurement. The following table provides a summary of financial instruments that are measured at fair value on a recurring
basis as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value Measurement Using</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value Measurement Using</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The table below provides
a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured
at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and
the year ended December 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value Measurement</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Using Level 3</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Inputs Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">676,079</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value of derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(343,857</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2019</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value of derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(248,552</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of the derivative
feature of the 127,346 and 295,945 warrants issued to the placement agent of the Company&#8217;s 2016 private offering (the &#8220;2016
Offering&#8221;) and to a holder of its debt for debt cancellation in connection with the Merger, respectively on the issuance
dates and at the balance sheet dates were calculated using a Black-Scholes option model valued with the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31 2020</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.59</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.09</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">169</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Contractual term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15 Years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.14 Years</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Risk-free interest rate:
The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Dividend yield: The Company
uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in
the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Volatility: The Company
calculates the expected volatility of the stock price based on the corresponding volatility of the Company&#8217;s peer group stock
price for a period consistent with the warrants&#8217; expected term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Expected term: The Company&#8217;s
expected term is based on the remaining contractual maturity of the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a gain of $248,552
and a gain of $343,857 relating to the change in fair value, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Derivative Liability</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates its
options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify
as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment
is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or
a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated
statements of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the
instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified
to equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The classification of derivative
instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each
reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified
to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified
in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected
within 12 months of the balance sheet date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
stock based compensation costs under the provisions of ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which requires
the measurement and recognition of compensation expense related to the fair value of stock based compensation awards that are ultimately
expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock based payments granted
to employees, officers, non-employees, and directors based on the grant date fair value estimated in accordance with the provisions
of ASC 718. ASC. 718 is also applied to awards modified, repurchased, or canceled during the periods reported.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If any award granted under
the Company&#8217;s 2016 Equity Compensation Plan (the &#8220;2016 Plan&#8221;) payable in shares of common stock is forfeited,
cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being made, or if shares
of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of common stock as to
which such option or award was forfeited, or which were withheld, will be available for future grants under the 2016 Plan. The
Company recognizes the impact of forfeitures when they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basic and Diluted Net (Loss) per Common
Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic (loss) per common
share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period.
Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding
plus the dilutive effect of shares issuable through the common stock equivalents. The effect of dilution on net loss becomes anti-dilutive
and therefore is not reflected on the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Potentially Outstanding<br />
Dilutive Common Shares</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">For the Year<br />
Ended<br />
December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Year</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Ended<br />
        December 31, 2019</p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Conversion Feature Shares</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Common shares issuable under the conversion feature of preferred shares</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">872,766</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">872,766</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,597,861</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,835,366</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrants</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,007,058</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,826,658</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b>Convertible Notes</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,598,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">536,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Total potentially outstanding dilutive common shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">12,075,685</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,070,790</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Research and development
expenses are charged to operations as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Foreign Currency Translation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows Section
830-10-45 of the FASB Accounting Standards Codification (&#8220;Section 830-10-45&#8221;) for foreign currency translation to translate
the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars.
Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity
(including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes
transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall
be measured using the functional currency of that entity. An entity&#8217;s functional currency is the currency of the primary
economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which
an entity primarily generates and expends cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The functional currency
of each foreign subsidiary is determined based on management&#8217;s judgment and involves consideration of all relevant economic
facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions,
including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency
upon the parent and the nature of the subsidiary&#8217;s operations must also be considered. If a subsidiary&#8217;s functional
currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary&#8217;s financial
statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S.
Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional
currency would be included in the consolidated statements of operations and comprehensive income (loss). If the Company disposes
of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of
operations and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of
a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the
consolidated statements of operations and comprehensive income (loss).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Based on an assessment
of the factors discussed above, the management of the Company determined its subsidiary&#8217;s local currency (i.e. the Canadian
dollar) to be the functional currency for its foreign subsidiary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2016, FASB
issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02: Leases (Topic 842). The new guidance generally requires an entity
to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The standard
will be effective for the first interim period within annual reporting periods beginning after December 15, 2018 and early adoption
is permitted. The new standard requires a modified retrospective transition for existing leases to each prior reporting period
presented or entered into after, the beginning of the earliest comparative period presented in the financial statements. This standard
was adopted by the Company on January 1, 2018. The Company elected the package of practical expedients permitted under the transition
guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification.
The adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements and related
disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s
financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285067416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued
expenses consist of the following at:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Accounting</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">36,161</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">36,161</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Research and development</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">393,496</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">650,584</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Legal</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,273</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">141,860</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">163,029</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">571,517</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">865,047</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On October 1, 2019, the
Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment of approximately
$988,000 as an estimate for the study. 50% of the total price was paid upon the signing of the agreement, 35% of the total price
is to be paid upon completion of the in-life study, and the remaining 15% of the total price is to be paid upon the issuance of
the report. If the Company cancels the study the Company will be required to pay a cancelation fee. If the cancelation happens
prior to the arrival of the test animals then the Company will need to pay between 20% and 50% of the animal fees depending on
when the cancellation happens. If the cancellation occurs after the animals arrive but before the study begins then the Company
will be responsible for paying 50% of the protocol price plus a fee of $7,000 per room/week for animal husbandry until the animals
can be relocated or disposed of. If the Company cancels the study after it has begun then the Company will need to pay any fees
for procured items for the study and any nonrecoverable expenses incurred by the consultant. As of December 31, 2020 and December
31, 2019, the Company has paid $174,106 and $0 and there is a balance of $319,799 and $493,905 due, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 13, 2020,
the Company issued 187,497 options to the Company&#8217;s CFO to settle $93,950 in accrued compensations. The difference between
the fair value of the options and the liability settled of $163,036 was charged to stock compensation expense during the year
ended December 31, 2020. The options are fully vested on issuance, have an exercise price of $1.75, and expire in 10 years from
issuance.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153287758152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - DERIVATIVE LIABILITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon closing of the private
placement transactions in 2016, the Company issued 127,346 and 295,945 warrants, respectively, to the placement agent of the 2016
Offering and to Strategic Bio Partners, a holder of the Company&#8217;s debt, for debt cancellation, respectively, to purchase
the Company&#8217;s Series B Preferred Stock with an exercise price of $1.25 and a five-year term. Upon the effectiveness of our
reverse stock split in July 2016, these became warrants to purchase our common stock on the same terms and conditions. The warrants,
if exercised under the cashless provision, do not have an explicit limit on the number of shares that will be issued. The warrants
have a cashless exercise feature that requires the Company to classify the warrants as a derivative liability.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153386027000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Note Payable (PIK Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Note Payable (PIK Notes)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; CONVERTIBLE NOTE PAYABLE
(PIK NOTES)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Convertible Notes Payable</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the fourth quarter
of 2019, the Company entered into a series of unsecured convertible notes (the &#8220;Convertible Notes&#8221;). The Convertible
Notes have a total principal amount of $420,000. The Convertible Notes accrue 6% interest per year payable on October 31, 2020
and on the end of each calendar year thereafter, payable by a corresponding increase in the principal amount of each Convertible
Note that increases to 12% per year (the Default Rate&#8221;) in the case a default. The Company will pay (a &#8220;PIK Payment&#8221;)
the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding principal amount of the
Convertible Notes on each interest payment date and on the maturity date. Each PIK Payment will be preceded by written notice from
the Company to the Convertible Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal
amount of the Convertible Note following such PIK Payment. The Convertible Notes are due on November 6, 2023. The Convertible Notes
are convertible into shares of the Company&#8217;s common stock with a conversion price of $1.25 per share, subject to adjustment
in certain circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the second quarter
of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $850,000. The notes accrue
6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase
in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will
pay (a &#8220;PIK Payment&#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding
principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written
notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal
amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of
the Company&#8217;s common stock with an exercise price of $1.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the third quarter
of 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $327,500. The notes accrue
6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase
in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will
pay (a &#8220;PIK Payment&#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding
principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written
notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal
amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of
the Company&#8217;s common stock with an exercise price of $1.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has evaluated
the terms of the Convertible Notes and determined that there are no derivative features in the Convertible Notes. These Convertible
Notes do have a beneficial conversion feature and recorded a total debt discount of $356,204 with $104,204 being recorded in the
year ended December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Katalyst Securities LLC
acted as the Company&#8217;s placement agent (the &#8220;Placement Agent&#8221;) for the sale of the Convertible Notes. The Company
paid the Placement Agent, including its sub-agents, a commission of 10% of the funds raised from the investors introduced by the
Placement Agent. In addition, the Placement Agent will receive warrants to purchase a number of shares of Common Stock equal to
10% of the shares of Common Stock issuable upon conversion of the Notes sold to the investors who were introduced to us by the
Placement Agent (See note 7). The Company recognized $104,090 in expenses related to the Placement Agent commission for this offering
which were recorded as a debt discount. This debt discount and the fair value of the warrants issued to the placement agent of
$179,679 are being amortized over the life of the notes from the private placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company amortized $117,036 and $6,821 of the debt discount, respectively. At December 31, 2020
and December 31, 2019, the Company had an unamortized debt discount of $516,116 and $245,179, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company owes $1,597,500 and $420,000 on the outstanding Convertible Notes, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Maturity Date of Notes for Twelve Months Ending December 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount due</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font-size: 10pt">2023</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,597,500</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">2025</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,597,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Convertible Notes Payable &#8211; Related
Party</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the fourth quarter
of 2019, the Company issued unsecured Convertible Notes in the aggregate principal amount of $250,000 to related parties. The notes
accrue 6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding
increase in the principal amount of each Convertible Note that increases to 12% per year in the case of the notes entering default.
The Company will pay (a &#8220;PIK Payment&#8221;) the interest due by adding such interest (including interest at the Default
Rate) to the then-outstanding principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment
will be preceded by written notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK
Payment and the principal amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible
into shares of the Company&#8217;s common stock with an exercise price of $1.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the second quarter
of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $50,000. The notes accrue
6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase
in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will
pay (a &#8220;PIK Payment&#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding
principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written
notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal
amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of
the Company&#8217;s common stock with an exercise price of $1.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the third quarter
of, 2020, the Company issued additional unsecured Convertible Notes in the aggregate principal amount of $100,000. The notes accrue
6% interest per year payable on October 31, 2020 and on the end of each calendar year thereafter, payable by a corresponding increase
in the principal amount of each note that increases to 12% per year in the case of the notes entering default. The Company will
pay (a &#8220;PIK Payment&#8221;) the interest due by adding such interest (including interest at the Default Rate) to the then-outstanding
principal amount of the Notes on each interest payment date and on the Maturity Date. Each PIK Payment will be preceded by written
notice from the Company to the Note holder setting forth in reasonable detail the amount of such PIK Payment and the principal
amount of the Note following such PIK Payment. The notes are due on November 6, 2023. The notes are convertible into shares of
the Company&#8217;s common stock with an exercise price of $1.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has evaluated
the terms of the notes and determined that there are no derivative features in the note. The Convertible Notes issued to related
parties have a beneficial conversion feature and, accordingly, the Company recorded a debt discount of $150,000 during the year
ended December 31, 2019. No debt discount was recorded during the year ended December 31, 2020. During the year ended December
31, 2020 and 2019, the Company amortized $37,863 and $4,549 of the debt discount, respectively, on Convertible Notes issued to
related parties. Additionally, a fee of $9,000 was expensed related to the notes. At December 31, 2020 and December 31, 2019, the
Company had an unamortized debt discount of $107,588 and $145,451, respectively, on Convertible Notes issued to related parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company owes $400,000 and $250,000 on the outstanding notes, respectively, held by related parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Maturity Date of Notes for Twelve Months Ending December 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount due</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font-size: 10pt">2023</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">2025</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153370710328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Deficit</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - STOCKHOLDERS&#8217; DEFICIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the
consummation of the Merger completed on February 12, 2016, we adopted Prior Protagenic&#8217;s 2006 Employee, Director and Consultant
Stock Plan (the &#8220;2006 Plan&#8221;). On June 17, 2016, our stockholders adopted the 2016 Plan and, as a result, we terminated
the 2006 Plan. We will not grant any further awards under the 2006 Plan. All outstanding grants under the 2006 Plan will continue
in effect in accordance with the terms of the particular grant and the 2006 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the 2016 Plan,
the Company&#8217;s Compensation Committee may grant awards to any employee, officer, director, consultant, advisor or other individual
service provider of the Company or any subsidiary. On each of January 1, 2017, January 1, 2019 and January 1, 2020, pursuant to
an annual &#8220;evergreen&#8221; provision contained in the 2016 Plan, the number of shares reserved for future grants was increased
by 564,378 shares, or a total of 1,693,134 shares. As a result of these increases, as of December 31, 2019 and December 31, 2020,
the aggregate number of shares of common stock available for awards under the 2016 Plan was 4,304,245 shares and 4,868,623 shares,
respectively. Options issued under the 2016 Plan are exercisable for up to ten years from the date of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There were 5,597,861 options
outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes assumptions
and or factors as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.64%-1.61</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">140%-146</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There were 3,835,366 options
outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the Black-Scholes assumptions
and or factors as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.00 - $1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.09%-2.70</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">137%-140</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is an analysis
of the stock option grant activity under the Plan:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average </b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining Life</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Stock Options</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,846,299</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.36</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.20</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">126,567</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9.20</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(137,500</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,835,366</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.34</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.02</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,762,495</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.01</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,597,861</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.48</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the status
of the Company&#8217;s nonvested options as of December 31, 2020, and changes during the year ended December 31, 2020, is presented
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nonvested Options</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted-Average<br />
Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">800,210</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.63</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">126,567</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(584,895</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.46</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(137,500</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">204,382</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.74</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,762,495</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,104,044</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">862,833</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the Company had 5,597,861 shares issuable under options outstanding at a weighted average exercise price of $1.47 and an intrinsic
value of $38,328.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2019,
the Company had 3,835,366 shares issuable under options outstanding at a weighted average exercise price of $1.34 and an intrinsic
value of $635,536.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The total number of options
granted during the years ended December 31, 2020 and 2019 was 1,762,495 and 126,567, respectively. The exercise price for these
options was $1.00 per share or $1.75 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognized
compensation expense related to options issued of $1,427,084 and $797,761 during the years ended December 31, 2020 and 2019, respectively,
in which $1,354,750 and $698,293 is included in general and administrative expenses and $72,334 and $99,468 in research and development
expenses, respectively. For the year ended December 31, 2020, $1,046,795 of the stock compensation was related to employees and
$380,289 was related to non-employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the unamortized stock option expense was $898,665 with $305,527 being related to employees and $593,138 being related to non-employees.
As of December 31, 2020, the weighted average period for the unamortized stock compensation to be recognized is 2.99 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2019, the
Company granted 101,567 options with an exercise price of $1.00 and a ten year term. 59,900 of these options vest immediately and
41,667 vest bi-weekly over two months. These options have a Black-Scholes value of $199,807. The Company issued 59,900 options
for settlement of accounts payable totaling $29,850 and recorded a loss of $99,541 on the settlement of the accounts payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 17, 2019, the Company
granted 25,000 options with an exercise price of $1.75 and a ten year term. These options vest immediately and have a Black-Scholes
value of $36,374.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 21, 2020, the
Company issued a total of 1,387,497 options to purchase shares of the Company&#8217;s common stock to sixteen individuals with
1,362,497 option going to twelve related parties. These options had a grant date fair value of $1,901,724. From these options,
187,497 options were used to settle $93,950 in accrued compensations. These options have an exercise price of $1.75. 187,497 of
the options vest immediately, 510,000 of the options vest monthly over 12 months, 5,000 of the options vest monthly over 24 months,
420,000 of the options vest monthly over 36 months, and 265,000 of the options vest monthly over 48 months. These options were
approved by the board of directors on February 13, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 18, 2020, the Company
issued 124,998 options to a related party. These options have an exercise price of $1.75 and a term of ten years. These options
vest immediately and the grant date fair value of these options was $142,607.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 18, 2020, the Company
issued 105,000 options to consultants. These options have an exercise price of $1.75 and a term of ten years. These options vest
monthly over four years and the grant date fair value of these options was $119,792.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 18, 2020, the Board
of Directors increased the size of the Board from five directors to six directors and appointed Jennifer Buell, Ph.D. as a member
of the Board, effective immediately, to fill the vacancy created by such increase and to serve until the next annual meeting of
shareholders. Dr. Buell was issued options to purchase 100,000 shares of the Company&#8217;s common stock at an exercise price
of $1.75 per share. The options vest as follows: monthly over 48 months. In recognition of her upcoming service as a Director of
the Company, Dr. Buell was issued 45,000 options that vest monthly over 12 months. In each case the vesting commenced on the date
of grant, July 18, 2020. These options had a grant date fair value of $165,426.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Warrants:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the
Merger, all of the issued and outstanding warrants to purchase shares of Prior Protagenic common stock converted, on a 1 for 1
basis, into new warrants (the &#8220;<b>New Warrants</b>&#8221;) to purchase shares of our Series B Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Simultaneously with the
Merger and the 2016 Offering, New Warrants to purchase 3,403,367 shares of Series B Preferred Stock at an average exercise price
of approximately $1.05 per share were issued to holders of Prior Protagenic warrants; additionally, the holder of $665,000 of our
debt and $35,000 of accrued interest exchanged such debt for five-year warrants to purchase 295,945 shares of Series B Preferred
Stock at $1.25 per share. Warrants to purchase 127,346 shares of Series B Preferred Stock at an exercise price of $1.25 per share
were issued to the placement agent in connection with the 2016 Offering. These warrants to purchase 423,291 shares of Series B
Preferred Stock have been recorded as derivative liabilities. All of these warrants automatically converted into warrants to purchase
our common stock upon the effectiveness of our reverse stock split in July 2016. See Note 5.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of warrant issuances
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining Life</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif"><b><i>Warrants</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 49%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,826,658</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.05</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.69</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,826,658</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.05</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.69</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">180,400</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.53</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,007,058</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.06</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.86</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the Company had 4,007,058 shares issuable under warrants outstanding at a weighted average exercise price of $1.06 and an intrinsic
value of $782,668.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2019,
the Company had 3,826,658 shares issuable under warrants outstanding at a weighted average exercise price of $1.05 and an intrinsic
value of $1,375,990.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 21, 2020, the
Company extended the expiration date for 100,000 warrants to purchase shares of the Company&#8217;s common stock. The expiration
date was extended by two years from January 2, 2020 to January 2, 2022. These warrants have an exercise price of $1.25 and are
fully vested. The Company recognized $95,187 in stock compensation as part of this modification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 30, 2020, the Company
issued 81,600 warrants to purchase shares of the Company&#8217;s common stock. These warrants vest immediately, had an exercise
price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $86,968, which is being amortized over the life
of the notes from the private placement. These warrants were issued as compensation to the placement agents in connection with
the Company&#8217;s private placement offering of debt in which $6,643 was recorded as stock compensation expense and $80,325 recorded
as a debt discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the third quarter
of 2020, the Company issued 98,800 warrants to purchase shares of the Company&#8217;s common stock. These warrants vest immediately,
had an exercise price of $1.25 and a term of 5 years. These warrants have a Black-Scholes value of $105,194 which is being amortized
over the life of the notes from the private placement. These warrants were issued as compensation to the placement agents in connection
with the Company&#8217;s private placement offering in which $5,840 was recorded as stock compensation expense and $99,354 recorded
as a debt discount.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153287738728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Agreements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - COLLABORATIVE AGREEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company and the University
of Toronto (the &#8220;University&#8221;) entered into an agreement effective April 1, 2014 (the &#8220;New Research Agreement&#8221;)
for the performance of a research project titled &#8220;Teneurin C-terminal Associated Peptide (&#8220;TCAP&#8221;) mediated stress
attenuation in vertebrates: Establishing the role of organismal and intracellular energy and glucose regulation and metabolism&#8221;
(the &#8220;New Project&#8221;). The New Project is to perform research related to work done by Dr. David A. Lovejoy, a professor
at the University and stockholder of the Company, in regard to TCAP mediated stress attenuation in vertebrates: Establishing the
role of organismal and intracellular energy and glucose regulation and metabolism. In addition to the New Research Agreement, Dr.
Lovejoy entered into an agreement with the University in order to commercialize certain technologies. The New Research Agreement
expired on March 30, 2016. In February 2017, the New Research Agreement was extended to December 31, 2017. The extension allowed
for further development of the technologies and use of their applications. On April 10, 2018, the agreement was amended and the
research agreement has been further extended to December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Prior to January 1, 2016,
the University has been granted 25,000 stock options which are fully vested at the exercise price of $1.00 exercisable over a ten
year period which ends on April 1, 2022. As of December 31, 2020, Dr. David Lovejoy of the University has been granted 553,299
stock options, of which 527,570 are fully vested. These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over
ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027
or on February 13, 2030.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The sponsorship research
and development expenses pertaining to the Research Agreements were $0 and $63,905 for the years ended December 31, 2020 and 2019,
respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153370690616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licensing Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Licensing Agreements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 - LICENSING AGREEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 31, 2005, the Company
had entered into a Technology License Agreement (&#8220;License Agreement&#8221;) with the University pursuant to which the University
agreed to license to the Company patent rights and other intellectual property, among other things (the &#8220;Technologies&#8221;).
The Technology License Agreement was amended on February 18, 2015 and currently does not provide for an expiration date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the License
Agreement and its amendment, the Company obtained an exclusive worldwide license to make, have made, use, sell and import products
based upon the Technologies, or to sublicense the Technologies in accordance with the terms of the License Agreement and amendment.
In consideration, the Company agreed to pay to the University a royalty payment of 2.5% of net sales of any product based on the
Technologies. If the Company elects to sublicense any rights under the License Agreement and amendment, the Company agrees to pay
to the University 10% of any up-front sub-license fees for any sub-licenses that occurred on or after September 9, 2006, and, on
behalf of the sub-licensee, 2.5% of net sales by the sub-licensee of all products based on the Technologies. The Company had no
sales revenue for the years ended December 31, 2020 and 2019 and therefore was not subject to paying any royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the event the Company
fails to provide the University with semi-annual reports on the progress or fails to continue to make reasonable commercial efforts
towards obtaining regulatory approval for products based on the Technologies, the University may convert our exclusive license
into a non-exclusive arrangement. Interest on any amounts owed under the License Agreement and amendment will be at 3% per annum.
All intellectual property rights resulting from the Technologies or improvements thereon will remain the property of the other
inventors and/or Dr. Lovejoy, and/or the University, as the case may be. The Company has agreed to pay all out-of- pocket filing,
prosecution and maintenance expenses in connection with any patents relating to the Technologies. In the case of infringement upon
any patents relating to the Technologies, the Company may elect, at its own expense, to bring a cause of action asserting such
infringement. In such a case, after deducting any legal expenses the Company may incur, any settlement proceeds will be subject
to the 2.5% royalty payment owed to the University under the License Agreement and amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The patent applications
were made in the name of Dr. Lovejoy and other inventors, but the Company&#8217;s exclusive, worldwide rights to such patent applications
are included in the License Agreement and its amendment with the University. The Company maintains exclusive licensing agreements
and it currently controls the five intellectual patent properties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Legal Proceedings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">From time to time we may
be named in claims arising in the ordinary course of business. Currently, no legal proceedings, government actions, administrative
actions, investigations or claims are pending against us or involve us that, in the opinion of our management, could reasonably
be expected to have a material adverse effect on our business and financial condition.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153287882776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 &#8211; RELATED PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is provided
free office space consisting of a conference room by the Company Executive Chairman, Dr. Armen. The Company does not pay any rent
for the use of this space. This space is used for quarterly board meetings and our annual shareholder meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 13, 2020,
the Company issued 50,000 options to purchase common stock to a related party. These options had an exercise price of $1.75 and
a term of 48 months. (See Note 7)</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285354408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 &#8211; INCOME TAXES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The components of loss
before income taxes are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Domestic</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(2,542,428</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(1,698,689</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Foreign</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(6,307</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(52,222</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Loss before income taxes</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(2,548,735</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(1,750,911</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company had no income
tax expense due to operating losses incurred for the years ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2020 and 2019, a reconciliation of the Company&#8217;s effective tax rate to the statutory U.S. Federal rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Income taxes at Federal statutory rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(21.0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(21.0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">State income taxes, net of Federal income tax effect</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(8.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(8.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Perm difference</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign tax rate differential</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(0.4</font></td>
    <td><font style="font-size: 10pt">)%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(0.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">30.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">30.2</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Other</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Income tax provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The tax effects of temporary
differences that give rise to the Company&#8217;s deferred tax assets and liabilities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">U.S. net operating loss carryforwards</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,907,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,894,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,217,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">784,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Canadian Provincial income tax losses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Canadian Provincial scientific investment tax credits</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(10,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,121,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,703,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,121,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,703,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net deferred tax assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">As of December 31, 2020
and 2019, the Company had federal net operating loss carryforwards (&#8220;NOL&#8221;) of approximately $7,550,000 and $7,161,000,
respectively. The 2017 Tax Cuts and Jobs Act (&#8220; TCJA&#8221;) will generally allow losses incurred after 2017 to be carried
over indefinitely, but will generally limit the net operating loss deduction to the lesser of the net operating loss carryover
or 80% of a corporation&#8217;s taxable income (subject to Section 382 of the Internal Revenue Code of 1986, as amended). Also,
there will be no carryback for losses incurred after 2017. Losses incurred prior to 2018 will generally be deductible to the extent
of the lesser of a corporation&#8217;s net operating loss carryover or 100% of a corporation&#8217;s taxable income and be available
for twenty years from the period the loss was generated. The federal net operating losses generated prior to 2018 of $0.1 million
will expire at various dates through 2037. The CARES Act temporarily allows the Company to carryback net operating losses arising
in 2018, 2019 and 2020 to the five prior tax years. In addition, net operating losses generated in these years could fully offset
prior year taxable income without the 80% of the taxable income limitation under the TCJA which was enacted on December 22, 2017.
The Company has been generating losses since its inception, as such the net operating loss carryback provision under the CARES
Act is not applicable to the Company. As of December 31, 2020 and 2019, the Company had state and local net operating loss carryforwards
of approximately $7,540,000 and $7,153,000, respectively, to reduce future state tax liabilities also through 2035.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and 2019, the Company had Canadian NOL of approximately $1,115,000 and $1,111,000, respectively. The Canadian losses expire in
stages beginning in 2026. As of December 31, 2020 and 2019, the Company also has unclaimed Canadian federal scientific research
and development investment tax credits, which are available to reduce future federal taxes payable of approximately $0 and $0 respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As a result of losses and
uncertainty of future profit, the net deferred tax asset has been fully reserved. The net change in the valuation allowance during
the years ended December 31, 2020 and 2019 was an increase of $418,000 and $661,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Foreign earnings are assumed
to be permanently reinvested. U.S. Federal income taxes have not been provided on undistributed earnings of our foreign subsidiary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
interest and penalties related to uncertain tax positions in selling, general and administrative expenses. The Company has not
identified any uncertain tax positions requiring a reserve as of December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is required
to file U.S. federal and state income tax returns. These returns are subject to audit by tax authorities beginning with the year
ended December 31, 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285237848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2021, the
Company issued 366,000 options to purchase share of the Company&#8217;s common stock. 350,000 of these options vest over 48 months
and have a term of ten years and the remaining 16,000 options vest immediately and have a term of five years. All of these options
have an exercise price of $5.60.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the first quarter
of 2021, a total of 268,233 warrants were exercised for a total of 161,026 shares of the Company&#8217;s common stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153281592568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basis of presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">The Company&#8217;s consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America
(&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Principles of consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements include the accounts of Protagenic Therapeutics, Inc., and its wholly owned Canadian subsidiary, PTI Canada. All significant
intercompany balances and transactions have been eliminated in the consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Reclassifications:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Reclassifications of prior
periods have been made to conform with current year presentation</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Use of estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those
estimates. Significant estimates underlying the consolidated financial statements include income tax provisions, valuation of
stock options and warrants and assessment of deferred tax asset valuation allowance.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company maintains
its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company
may have deposits in excess of federally insured limits. The Company has not experienced losses on these accounts and management
believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company considers
all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. While the
Company&#8217;s marketable securities are cash equivalents it is the Company&#8217;s policy to present them separately on the
balance sheet. As of December 31, 2020 and December 31, 2019, the Company did not have any cash equivalents.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Equipment</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Equipment is stated at
cost less accumulated depreciation. Cost includes expenditures for computer equipment. Maintenance and repairs are charged to
expense as incurred. When assets are sold, retired, or otherwise disposed of, the cost and accumulated depreciation are removed
from the accounts and any resulting gain or loss is reflected in operations. The cost of equipment is depreciated using the straight-line
method over the estimated useful lives of the related assets which is three years. Depreciation expense was nominal for the years
ended December 31, 2020 and 2019.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Marketable Securities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
marketable debt securities, the only type of securities it owns, in accordance with sub-topic 320-10 of the FASB Accounting Standards
Codification (&#8220;Sub-topic 320-10&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to Paragraph 320-10-35-1,
investments in debt securities that are classified as available for sale shall be measured subsequently at fair value in the consolidated
balance sheets at each balance sheet date. Unrealized holding gains and losses for available-for-sale debt securities (including
those classified as current assets) shall be excluded from earnings and reported in other comprehensive income until realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company purchased $0 and sold $250,000 in marketable securities, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company owned marketable securities with a total value of $0 and $0, respectively. The Company recorded
a realized gain on marketable securities of $0 and $4,435 for the years ended December 31, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020
and December 31, 2019, the Company held no marketable securities.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Fair Value Measurements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">ASC 820, &#8220;Fair Value
Measurements and Disclosure,&#8221; defines fair value as the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs.
ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value
into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level
1) and the lowest priority to unobservable inputs (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The three levels are described below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 1 Inputs &#8211;
Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 2 Inputs &#8211;
Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly
or indirectly;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 3 Inputs &#8211;
Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying amount of
the Company&#8217;s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair
value because of the short term maturity of those instruments. The carrying value of long-term debt approximates fair value since
the related rates of interest approximate current market rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Transactions involving
related parties cannot be presumed to be carried out on an arm&#8217;s-length basis, as the requisite conditions of competitive,
free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the
related party transactions were consummated on terms equivalent to those that prevail in arm&#8217;s-length transactions unless
such representations can be substantiated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The assets or liability&#8217;s
fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair
value measurement. The following table provides a summary of financial instruments that are measured at fair value on a recurring
basis as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value Measurement Using</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value Measurement Using</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8212;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The table below provides
a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured
at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and
the year ended December 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value Measurement</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Using Level 3</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Inputs Total</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">676,079</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value of derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(343,857</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2019</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">332,222</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value of derivative warrants liabilities</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(248,552</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">83,670</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of the derivative
feature of the 127,346 and 295,945 warrants issued to the placement agent of the Company&#8217;s 2016 private offering (the &#8220;2016
Offering&#8221;) and to a holder of its debt for debt cancellation in connection with the Merger, respectively on the issuance
dates and at the balance sheet dates were calculated using a Black-Scholes option model valued with the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31 2020</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.59</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.09</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">169</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Contractual term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15 Years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.14 Years</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Risk-free interest rate:
The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar expected term on the date of measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Dividend yield: The Company
uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in
the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Volatility: The Company
calculates the expected volatility of the stock price based on the corresponding volatility of the Company&#8217;s peer group stock
price for a period consistent with the warrants&#8217; expected term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Expected term: The Company&#8217;s
expected term is based on the remaining contractual maturity of the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company marked the derivative feature of the warrants to fair value and recorded a gain of $248,552
and a gain of $343,857 relating to the change in fair value, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Liability</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Derivative Liability</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates its
options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify
as derivatives to be separately accounted for in accordance with ASC 815-10-05-4 and 815-40-25. The result of this accounting treatment
is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or
a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated
statements of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the
instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified
to equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The classification of
derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the
end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification
are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities
will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative
instrument is expected within 12 months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
stock based compensation costs under the provisions of ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;, which requires
the measurement and recognition of compensation expense related to the fair value of stock based compensation awards that are ultimately
expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock based payments granted
to employees, officers, non-employees, and directors based on the grant date fair value estimated in accordance with the provisions
of ASC 718. ASC. 718 is also applied to awards modified, repurchased, or canceled during the periods reported.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If any award granted under
the Company&#8217;s 2016 Equity Compensation Plan (the &#8220;2016 Plan&#8221;) payable in shares of common stock is forfeited,
cancelled, or returned for failure to satisfy vesting requirements, otherwise terminates without payment being made, or if shares
of common stock are withheld to cover withholding taxes on options or other awards, the number of shares of common stock as to
which such option or award was forfeited, or which were withheld, will be available for future grants under the 2016 Plan. The
Company recognizes the impact of forfeitures when they occur.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net (Loss) Per Common Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Basic and Diluted Net (Loss) per Common
Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic (loss) per common
share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period.
Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding
plus the dilutive effect of shares issuable through the common stock equivalents. The effect of dilution on net loss becomes anti-dilutive
and therefore is not reflected on the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Potentially Outstanding<br />
Dilutive Common Shares</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the Year<br />
Ended<br />
December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Year</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Ended<br />
        December 31, 2019</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Conversion Feature Shares</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Common shares issuable under the conversion feature of preferred shares</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">872,766</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">872,766</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Stock Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,597,861</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,835,366</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Warrants</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,007,058</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,826,658</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt"><b>Convertible Notes</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,598,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">536,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total potentially outstanding dilutive common shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">12,075,685</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,070,790</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Research and development
expenses are charged to operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Foreign Currency Translation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows Section
830-10-45 of the FASB Accounting Standards Codification (&#8220;Section 830-10-45&#8221;) for foreign currency translation to translate
the financial statements of the foreign subsidiary from the functional currency, generally the local currency, into U.S. Dollars.
Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity
(including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes
transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall
be measured using the functional currency of that entity. An entity&#8217;s functional currency is the currency of the primary
economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which
an entity primarily generates and expends cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The functional currency
of each foreign subsidiary is determined based on management&#8217;s judgment and involves consideration of all relevant economic
facts and circumstances affecting the subsidiary. Generally, the currency in which the subsidiary transacts a majority of its transactions,
including billings, financing, payroll and other expenditures, would be considered the functional currency, but any dependency
upon the parent and the nature of the subsidiary&#8217;s operations must also be considered. If a subsidiary&#8217;s functional
currency is deemed to be the local currency, then any gain or loss associated with the translation of that subsidiary&#8217;s financial
statements is included in accumulated other comprehensive income. However, if the functional currency is deemed to be the U.S.
Dollar, then any gain or loss associated with the re-measurement of these financial statements from the local currency to the functional
currency would be included in the consolidated statements of operations and comprehensive income (loss). If the Company disposes
of foreign subsidiaries, then any cumulative translation gains or losses would be recorded into the consolidated statements of
operations and comprehensive income (loss). If the Company determines that there has been a change in the functional currency of
a subsidiary to the U.S. Dollar, any translation gains or losses arising after the date of change would be included within the
consolidated statements of operations and comprehensive income (loss).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Based on an assessment
of the factors discussed above, the management of the Company determined its subsidiary&#8217;s local currency (i.e. the Canadian
dollar) to be the functional currency for its foreign subsidiary.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2016, FASB
issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-02: Leases (Topic 842). The new guidance generally requires an entity
to recognize on its balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The standard
will be effective for the first interim period within annual reporting periods beginning after December 15, 2018 and early adoption
is permitted. The new standard requires a modified retrospective transition for existing leases to each prior reporting period
presented or entered into after, the beginning of the earliest comparative period presented in the financial statements. This
standard was adopted by the Company on January 1, 2018. The Company elected the package of practical expedients permitted under
the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical
lease classification. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial
statements and related disclosures.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management does not believe
that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s
financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153290236120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Carrying</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Fair Value Measurement Using</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 1</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 2</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 3</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Derivative warrants liabilities</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">83,670</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">83,670</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">83,670</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table provides
a summary of financial instruments that are measured at fair value on a recurring basis as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Carrying</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Fair Value Measurement Using</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 1</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 2</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Level 3</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Derivative warrants liabilities</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">332,222</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">332,222</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">332,222</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The table below provides
a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured
at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2020 and
the year ended December 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value Measurement</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Using Level 3</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Inputs Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">Balance, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">676,079</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value of derivative warrants liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(343,857</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Balance, December 31, 2019</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">332,222</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Change in fair value of derivative warrants liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(248,552</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">83,670</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.59</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.09</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">133</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">169</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Contractual term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.15 Years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.14 Years</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The effect of dilution
on net loss becomes anti-dilutive and therefore is not reflected on the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Potentially Outstanding<br />
Dilutive Common Shares</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the Year<br />
Ended<br />
December 31, 2020</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Year</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Ended<br />
        December 31, 2019</p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Conversion Feature Shares</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Common shares issuable under the conversion feature of preferred shares</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">872,766</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">872,766</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Stock Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,597,861</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,835,366</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Warrants</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,007,058</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,826,658</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt"><b>Convertible Notes</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,598,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">536,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total potentially outstanding dilutive common shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">12,075,685</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,070,790</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285126408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued
expenses consist of the following at:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Accounting</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">36,161</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">36,161</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Research and development</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">393,496</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">650,584</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Legal</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,273</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">141,860</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">163,029</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">571,517</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">865,047</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285110888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Note Payable (PIK Notes) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturity Date of Notes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Maturity Date of Notes for Twelve Months Ending December 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount due</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font-size: 10pt">2023</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,597,500</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">2025</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,597,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember', window );">Convertible Notes Payable - Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturity Date of Notes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Maturity Date of Notes for Twelve Months Ending December 31,</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount due</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2022</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font-size: 10pt">2023</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">2024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">2025</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153290423448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There were 5,597,861 options
outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes assumptions
and or factors as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1.75</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.64%-1.61</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected life in years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">140%-146</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There were 3,835,366 options
outstanding as of December 31, 2019. The fair value of each stock option granted was estimated using the Black-Scholes assumptions
and or factors as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercise price</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 - $1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 82%"><font style="font-size: 10pt">Expected dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Risk free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.09%-2.70</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected life in years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">137%-140</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is an analysis
of the stock option grant activity under the Plan:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted Average </b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b><i>Stock Options</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 49%"><font style="font-size: 10pt">Outstanding December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3,846,299</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.36</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">7.20</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">126,567</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.15</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.20</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(137,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.75</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Outstanding December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,835,366</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.34</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.02</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,762,495</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.01</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,597,861</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1.47</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6.48</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Share-based Compensation Nonvested Shares</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the status
of the Company&#8217;s nonvested options as of December 31, 2020, and changes during the year ended December 31, 2020, is presented
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nonvested Options</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted-Average<br />
Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">800,210</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.63</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">126,567</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.15</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(584,895</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.46</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(137,500</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">204,382</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.74</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,762,495</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,104,044</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested at December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">862,833</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.75</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Warrant Issuances</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of warrant issuances
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b><i>Warrants</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 49%"><font style="font-size: 10pt">Outstanding December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3,826,658</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.05</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3.69</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Granted</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,826,658</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.05</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.69</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Granted</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">180,400</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4.53</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,007,058</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1.06</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1.86</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153290415032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Loss Before Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The components of loss
before income taxes are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Domestic</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(2,542,428</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(1,698,689</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Foreign</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(6,307</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(52,222</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Loss before income taxes</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(2,548,735</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(1,750,911</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2020 and 2019, a reconciliation of the Company&#8217;s effective tax rate to the statutory U.S. Federal rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Income taxes at Federal statutory rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(21.0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(21.0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">State income taxes, net of Federal income tax effect</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(8.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(8.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Perm difference</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign tax rate differential</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(0.4</font></td>
    <td><font style="font-size: 10pt">)%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(0.6</font></td>
    <td><font style="font-size: 10pt">)%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">30.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">30.2</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Other</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Income tax provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The tax effects of temporary
differences that give rise to the Company&#8217;s deferred tax assets and liabilities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">U.S. net operating loss carryforwards</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,907,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,894,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,217,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">784,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Canadian Provincial income tax losses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Canadian Provincial scientific investment tax credits</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(10,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,121,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,703,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,121,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,703,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net deferred tax assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280716696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Payments to acquire marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet', window );">Marketable securities, gross realized gain (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, gain (loss) on derivative, net</a></td>
<td class="nump">$ 248,552<span></span>
</td>
<td class="nump">$ 343,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of derivative feature</a></td>
<td class="nump">$ 127,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightIssued', window );">Class of warrant or right, issued | shares</a></td>
<td class="nump">295,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of warrants or rights issued during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280723112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative warrants liabilities</a></td>
<td class="nump">$ 83,670<span></span>
</td>
<td class="nump">$ 332,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative warrants liabilities</a></td>
<td class="nump">83,670<span></span>
</td>
<td class="nump">332,222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative warrants liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative warrants liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative warrants liabilities</a></td>
<td class="nump">$ 83,670<span></span>
</td>
<td class="nump">$ 332,222<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285110888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at beginning</a></td>
<td class="nump">$ 332,222<span></span>
</td>
<td class="nump">$ 676,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative warrants liabilities</a></td>
<td class="num">(248,552)<span></span>
</td>
<td class="num">(343,857)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at end</a></td>
<td class="nump">$ 83,670<span></span>
</td>
<td class="nump">$ 332,222<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153289278632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">0.09<span></span>
</td>
<td class="nump">1.59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability measurement input</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Contractual Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DerivativeLiabilityMeasurementInputContractualTerm', window );">Derivative liability measurement input, contractual term</a></td>
<td class="text">1 month 20 days<span></span>
</td>
<td class="text">1 year 1 month 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DerivativeLiabilityMeasurementInputContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative liability measurement input, contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DerivativeLiabilityMeasurementInputContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280824104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially outstanding dilutive common shares</a></td>
<td class="nump">12,075,685<span></span>
</td>
<td class="nump">9,070,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConversionFeatureSharesMember', window );">Conversion Feature Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially outstanding dilutive common shares</a></td>
<td class="nump">872,766<span></span>
</td>
<td class="nump">872,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially outstanding dilutive common shares</a></td>
<td class="nump">5,597,861<span></span>
</td>
<td class="nump">3,835,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially outstanding dilutive common shares</a></td>
<td class="nump">4,007,058<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially outstanding dilutive common shares</a></td>
<td class="nump">1,598,000<span></span>
</td>
<td class="nump">536,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConversionFeatureSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConversionFeatureSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=PTIX_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153282581688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Oct. 02, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock option, exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PTIX_ToxicologyStudiesMember', window );">Toxicology Studies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementEventToTransferConsideration', window );">Estimate for study description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On October 1, 2019, the Company entered into an agreement with a consultant for toxicology studies. The consultant quoted a commitment of approximately $988,000 as an estimate for the study. 50% of the total price was paid upon the signing of the agreement, 35% of the total price is to be paid upon completion of the in-life study, and the remaining 15% of the total price is to be paid upon the issuance of the report. If the Company cancels the study the Company will be required to pay a cancelation fee. If the cancelation happens prior to the arrival of the test animals then the Company will need to pay between 20% and 50% of the animal fees depending on when the cancellation happens. If the cancellation occurs after the animals arrive but before the study begins then the Company will be responsible for paying 50% of the protocol price plus a fee of $7,000 per room/week for animal husbandry until the animals can be relocated or disposed of. If the Company cancels the study after it has begun then the Company will need to pay any fees for procured items for the study and any nonrecoverable expenses incurred by the consultant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementGainsAndLosses', window );">Commitment cost paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,106<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegistrationPaymentArrangementAccrualCarryingValue', window );">Balance due amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,799<span></span>
</td>
<td class="nump">$ 493,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PTIX_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_EstimateCommitmentAmount', window );">Estimate commitment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">CFO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of stock option share based compensation</a></td>
<td class="nump">187,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Accrued compensation</a></td>
<td class="nump">$ 93,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_SettlementOfLiabilityChargedToStockCompensationExpense', window );">Settlement of liability charged to stock compensation expense</a></td>
<td class="nump">$ 163,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock option, exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_EstimateCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimate commitment amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_EstimateCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_SettlementOfLiabilityChargedToStockCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Settlement of liability charged to stock compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_SettlementOfLiabilityChargedToStockCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementAccrualCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date of the liability representing the obligation under the registration payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383193&amp;loc=d3e16207-108621<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementAccrualCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementEventToTransferConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the event or circumstance that would trigger the transfer of consideration under the registration payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383193&amp;loc=d3e16207-108621<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementEventToTransferConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegistrationPaymentArrangementGainsAndLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (gain) or increase (loss) in the carrying amount of the registration payment obligation that was recognized in earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383193&amp;loc=d3e16207-108621<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegistrationPaymentArrangementGainsAndLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PTIX_ToxicologyStudiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PTIX_ToxicologyStudiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153283404600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_AccruedAccountingFeesCurrent', window );">Accounting</a></td>
<td class="nump">$ 36,161<span></span>
</td>
<td class="nump">$ 36,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_AccruedResearchAndDevelopmentCurrent', window );">Research and development</a></td>
<td class="nump">393,496<span></span>
</td>
<td class="nump">650,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_AccruedLegalFeesCurrent', window );">Legal</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">141,860<span></span>
</td>
<td class="nump">163,029<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 571,517<span></span>
</td>
<td class="nump">$ 865,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_AccruedAccountingFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_AccruedAccountingFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_AccruedLegalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_AccruedLegalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280676920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Details Narrative) - Private Placement [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightIssued', window );">Class of warrant or right, issued during period</a></td>
<td class="nump">295,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightIssued', window );">Class of warrant or right, issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrant or right, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Debt Settlement [Member] | Strategic Bio Partners [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightIssued', window );">Class of warrant or right, issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrant or right, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of warrants or rights issued during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=PTIX_DebtSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=PTIX_DebtSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PTIX_StrategicBioPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PTIX_StrategicBioPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280267880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Note Payable (PIK Notes) (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt amortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,899<span></span>
</td>
<td class="nump">$ 11,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt beneficial conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,204<span></span>
</td>
<td class="nump">252,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PTIX_PlacementAgentKatalystSecuritiesLLCMember', window );">Placement Agent - Katalyst Securities LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_CommissionPercentageTerms', window );">Commission percentage terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company paid the Placement Agent, including its sub-agents, a commission of 10% of the funds raised from the investors introduced by the Placement Agent. In addition, the Placement Agent will receive warrants to purchase a number of shares of Common Stock equal to 10% of the shares of Common Stock issuable upon conversion of the Notes sold to the investors who were introduced to us by the Placement Agent (See note 7). The Company recognized $104,090 in expenses related to the Placement Agent commission for this offering which were recorded as a debt discount.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForCommissions', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of warrants issued</a></td>
<td class="nump">$ 179,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesMember', window );">Unsecured Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible note principle amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,500<span></span>
</td>
<td class="nump">$ 850,000<span></span>
</td>
<td class="nump">$ 420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Increase in interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt amortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,036<span></span>
</td>
<td class="nump">$ 6,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt unamortized debt discount</a></td>
<td class="nump">516,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,179<span></span>
</td>
<td class="nump">516,116<span></span>
</td>
<td class="nump">245,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable outstanding</a></td>
<td class="nump">1,597,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
<td class="nump">1,597,500<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt amortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt beneficial conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember', window );">Unsecured Convertible Notes with Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible note principle amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Increase in interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion exercise price</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt amortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,863<span></span>
</td>
<td class="nump">$ 4,549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt unamortized debt discount</a></td>
<td class="nump">$ 107,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,451<span></span>
</td>
<td class="nump">107,588<span></span>
</td>
<td class="nump">145,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable outstanding</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_BeneficialConversionFeatureAndDebtDiscount', window );">Beneficial conversion feature and debt discount</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_AdditionalNotesRelatedFee', window );">Additional notes related fee</a></td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_AdditionalNotesRelatedFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Notes Related Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_AdditionalNotesRelatedFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_BeneficialConversionFeatureAndDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Beneficial conversion feature and debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_BeneficialConversionFeatureAndDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_CommissionPercentageTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission percentage terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_CommissionPercentageTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_PlacementAgentKatalystSecuritiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_PlacementAgentKatalystSecuritiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PTIX_UnsecuredConvertibleNotesWithRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153283507928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">1,597,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">1,597,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember', window );">Convertible Notes Payable - Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=PTIX_ConvertibleNotesPayableRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153270256216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Feb. 21, 2020</div></th>
<th class="th"><div>Feb. 21, 2020</div></th>
<th class="th"><div>Jan. 02, 2020</div></th>
<th class="th"><div>Jun. 17, 2019</div></th>
<th class="th"><div>Feb. 25, 2019</div></th>
<th class="th"><div>Jan. 02, 2019</div></th>
<th class="th"><div>Jan. 02, 2017</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,597,861<span></span>
</td>
<td class="nump">3,835,366<span></span>
</td>
<td class="nump">3,846,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock options intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,328<span></span>
</td>
<td class="nump">$ 635,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock option weighted average exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock options granted, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,104,044<span></span>
</td>
<td class="nump">584,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Stock options vest and grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Class of warrant or right, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,007,058<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,899<span></span>
</td>
<td class="nump">$ 11,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,600<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrant or right, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Class of warrant or right, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,007,058<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice', window );">Class of warrant or right, outstanding, weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding', window );">Class of warrant or right, outstanding, intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 782,668<span></span>
</td>
<td class="nump">$ 1,375,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightExpirationPeriodDescription', window );">Class of warrant or right, expiration period, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The expiration date was extended by two years from January 2, 2020 to January 2, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrant or right, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,403,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=PTIX_OptionsToRelatedPartyMember', window );">Options to Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">124,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=PTIX_DrBuellMember', window );">Dr. Buell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsDebtMember', window );">Additional Issuance of Warrants for Debt [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember', window );">Additional Issuance of Warrants for Accrued Interest [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsMember', window );">Additional Issuance of Warrants [Member] | Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrant or right, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PTIX_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,046,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_UnamortizedStockOptionExpense', window );">Unamortized stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PTIX_NonEmployeesMember', window );">Non-Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_UnamortizedStockOptionExpense', window );">Unamortized stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 593,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">101,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock option weighted average exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,427,084<span></span>
</td>
<td class="nump">$ 797,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock options granted, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Stock options fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,374<span></span>
</td>
<td class="nump">$ 199,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_NumberOfOptionsSharesIssuedForSettlement', window );">Number of options shares issued for settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_NumberOfOptionsSharesIssuedForSettlementValue', window );">Number of options shares issued for settlement, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_LossOnSettlementOfAccountsPayable', window );">Loss on settlement of accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options to Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription', window );">Vesting period, description</a></td>
<td class="text">These options vest immediately<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Stock options vest and grant date fair value</a></td>
<td class="nump">$ 142,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Dr. Buell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Stock options vest and grant date fair value</a></td>
<td class="nump">$ 165,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Settlement of Accrued Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Stock options fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,901,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Vest bi-Weekly Over Two Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options Vested Immediately [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options Vested Over 12 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options Vested Over 24 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options Vested Over 36 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Options Vested Over 48 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Sixteen Individuals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,387,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock option weighted average exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Twelve Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,362,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock option weighted average exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,354,750<span></span>
</td>
<td class="nump">698,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Research and Development Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,334<span></span>
</td>
<td class="nump">$ 99,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_UnamortizedStockOptionExpense', window );">Unamortized stock option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 898,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PTIX_StockOptionToConsultantsMember', window );">Stock Options to Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription', window );">Vesting period, description</a></td>
<td class="text">These options vest monthly over four years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Stock options vest and grant date fair value</a></td>
<td class="nump">$ 119,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PTIX_RecognitionUpcomingServiceMember', window );">Recognition Upcoming Service [Member] | Dr. Buell [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PTIX_PlacementAgentWarrantsMember', window );">Placement Agent Warrants [Member] | Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PTIX_BlackScholesModelMember', window );">Black-Scholes Model [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue', window );">Warrants to purchase shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=PTIX_BlackScholesModelTwoMember', window );">Black-Scholes Model Two [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue', window );">Warrants to purchase shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=PTIX_TwoThousandSixteenPlanMember', window );">2016 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares grants for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">564,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">564,378<span></span>
</td>
<td class="nump">564,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,693,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,693,134<span></span>
</td>
<td class="nump">1,693,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868,623<span></span>
</td>
<td class="nump">4,304,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ClassOfWarrantOrRightExpirationPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, expiration period, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ClassOfWarrantOrRightExpirationPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_LossOnSettlementOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss on settlement of accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_LossOnSettlementOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_NumberOfOptionsSharesIssuedForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options shares issued for settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_NumberOfOptionsSharesIssuedForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_NumberOfOptionsSharesIssuedForSettlementValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options shares issued for settlement, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_NumberOfOptionsSharesIssuedForSettlementValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, award vesting period, description</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, outstanding, weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, outstanding, intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_UnamortizedStockOptionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized stock option expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_UnamortizedStockOptionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=PTIX_ProtagenicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=PTIX_ProtagenicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=PTIX_OptionsToRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=PTIX_OptionsToRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=PTIX_DrBuellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=PTIX_DrBuellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsForAccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_AdditionalIssuanceOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_NonEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_NonEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_SettlementOfAccruedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_SettlementOfAccruedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_VestBiWeeklyOverTwoMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_VestBiWeeklyOverTwoMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_OptionsVestedImmediatelyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_OptionsVestedImmediatelyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_OptionsVestedOverTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_OptionsVestedOverTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_OptionsVestedOverTwentyFourMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_OptionsVestedOverTwentyFourMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_OptionsVestedOverThirtySixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_OptionsVestedOverThirtySixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=PTIX_OptionsVestedOverFourtyEightMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=PTIX_OptionsVestedOverFourtyEightMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_SixteenIndividualsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_SixteenIndividualsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_TwelveRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_TwelveRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PTIX_StockOptionToConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PTIX_StockOptionToConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PTIX_RecognitionUpcomingServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PTIX_RecognitionUpcomingServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PTIX_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PTIX_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PTIX_BlackScholesModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PTIX_BlackScholesModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=PTIX_BlackScholesModelTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=PTIX_BlackScholesModelTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=PTIX_TwoThousandSixteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=PTIX_TwoThousandSixteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153289261816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life in years</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">0.64%<span></span>
</td>
<td class="nump">2.09%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">140.00%<span></span>
</td>
<td class="nump">137.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">1.61%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">146.00%<span></span>
</td>
<td class="nump">140.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153289262952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options Outstanding, Beginning</a></td>
<td class="nump">3,835,366<span></span>
</td>
<td class="nump">3,846,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock Options, Granted</a></td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Stock Options, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(137,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock Options Outstanding, Ending</a></td>
<td class="nump">5,597,861<span></span>
</td>
<td class="nump">3,835,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercisable Price, Stock Options Outstanding, Beginning</a></td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercisable Price, Stock Options Outstanding, Granted</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="nump">1.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercisable Price, Stock Options Outstanding, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercisable Price, Stock Options Outstanding, Ending</a></td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Life, Stock Options Outstanding, Beginning</a></td>
<td class="text">6 years 7 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Life, Stock Options Outstanding, Granted</a></td>
<td class="text">9 years 2 months 19 days<span></span>
</td>
<td class="text">8 years 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Life, Stock Options Outstanding, Ending</a></td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">6 years 7 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards granted during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining life, stock options outstanding, ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153370408184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Schedule of Share-based Compensation Nonvested Shares (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested Options, Beginning Balance</a></td>
<td class="nump">204,382<span></span>
</td>
<td class="nump">800,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Nonvested Options, Granted</a></td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Nonvested Options, Vested</a></td>
<td class="num">(1,104,044)<span></span>
</td>
<td class="num">(584,895)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Nonvested Options, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(137,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested Options, Ending Balance</a></td>
<td class="nump">862,833<span></span>
</td>
<td class="nump">204,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="nump">$ 1.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="nump">1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Vested</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="nump">1.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153282573432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit - Summary of Warrant Issuances (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants Outstanding, Beginning</a></td>
<td class="nump">3,826,658<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of Warrants Outstanding, Granted</a></td>
<td class="nump">180,400<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants Outstanding, Ending</a></td>
<td class="nump">4,007,058<span></span>
</td>
<td class="nump">3,826,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Number of Warrants Outstanding, Weighted Average Exercise Price, Beginning</a></td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Number of Warrants Outstanding, Weighted Average Exercise Price, Granted</a></td>
<td class="nump">1.25<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Number of Warrants Outstanding, Weighted Average Exercise Price, Ending</a></td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning', window );">Number of Warrants Outstanding, Weighted Average Remaining Life</a></td>
<td class="text">2 years 8 months 9 days<span></span>
</td>
<td class="text">3 years 8 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted', window );">Number of Warrants Outstanding, Weighted Average Remaining Life Granted</a></td>
<td class="text">4 years 6 months 10 days<span></span>
</td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding', window );">Number of Warrants Outstanding, Weighted Average Remaining Life</a></td>
<td class="text">1 year 10 months 10 days<span></span>
</td>
<td class="text">2 years 8 months 9 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants outstanding, weighted average remaining life granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_NumberOfWarrantsOutstandingWeightedAverageRemainingLifeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153270128584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Agreements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 25, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,104,044<span></span>
</td>
<td class="nump">584,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 699,797<span></span>
</td>
<td class="nump">$ 807,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=PTIX_ResearchAgreementsMember', window );">Research Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 63,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="nump">59,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=PTIX_UniversityOfTorontoMember', window );">University of Toronto [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based compensation stock options, grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_OptionsExpirationDateDescription', window );">Options expiration date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Exercisable over a ten year period which ends on April 1, 2022.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=PTIX_DrDavidLovejoyMember', window );">Dr. David Lovejoy [Member] | Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based compensation stock options, grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">553,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_OptionsExpirationDateDescription', window );">Options expiration date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">These have an exercise price of $1.00, $1.25 or 1.75 and are exercisable over ten or thirteen year periods which end either on March 30, 2021, December 1, 2022, April 15, 2026, March 1, 2027, October 16, 2027 or on February 13, 2030.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=PTIX_DrDavidLovejoyMember', window );">Dr. David Lovejoy [Member] | Stock Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=PTIX_DrDavidLovejoyMember', window );">Dr. David Lovejoy [Member] | Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Share-based compensation weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_OptionsExpirationDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options expiration date, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_OptionsExpirationDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=PTIX_ResearchAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=PTIX_ResearchAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=PTIX_UniversityOfTorontoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=PTIX_UniversityOfTorontoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=PTIX_DrDavidLovejoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=PTIX_DrDavidLovejoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153363672504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licensing Agreements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage', window );">Royalty payment on behalf of sub-licensee, percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate', window );">Interest on amounts owed under license agreement, rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_RoyaltyPaymentPercentage', window );">Royalty payment, percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_UpFrontSubLicenseFeesPercentage', window );">Up-front sub-license fees, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate charged per annum on any amounts owed under the license agreement and amendment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_InterestOnAmountsOwedUnderLicenseAgreementRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty payment of net sales made on behalf of a sub-licensee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_RoyaltyPaymentOnBehalfOfSublicenseePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_RoyaltyPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty payment of net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_RoyaltyPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_UpFrontSubLicenseFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of Up-front sub-license fees, for any sub-licenses that occur on or after September 9, 2006, the company agree to pay under an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_UpFrontSubLicenseFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153282517928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=PTIX_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options granted</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding weighted average exercise price</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option term</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=PTIX_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=PTIX_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280556888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_OperatingLossCarryforwardsExpirationDescription', window );">Operating loss carryforwards expiration description</a></td>
<td class="text">The federal net operating losses generated prior to 2018 of $0.1 million will expire at various dates through 2037.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Reconciliation, tax credit, research, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Net change in valuation allowance</a></td>
<td class="nump">418,000<span></span>
</td>
<td class="nump">661,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax interest and penalties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=PTIX_LossesIncurredAfter2017Member', window );">Losses incurred after 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_PercentageOfCorporationsTaxableIncome', window );">Percentage of corporations taxable income</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=PTIX_LossesIncurredPriorTo2018Member', window );">Losses incurred prior to 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_PercentageOfCorporationsTaxableIncome', window );">Percentage of corporations taxable income</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,550,000<span></span>
</td>
<td class="nump">7,161,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalGeneratedPriorTo2018Member', window );">Federal Generated Prior to 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_StateAndLocalMember', window );">State and Local [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,540,000<span></span>
</td>
<td class="nump">7,153,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_OperatingLossCarryforwardsExpirationDescription', window );">Operating loss carryforwards expiration description</a></td>
<td class="text">State tax liabilities also through 2035.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_CA', window );">Canadian [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 1,115,000<span></span>
</td>
<td class="nump">$ 1,111,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_OperatingLossCarryforwardsExpirationDescription', window );">Operating loss carryforwards expiration description</a></td>
<td class="text">The Canadian losses expire in stages beginning in 2026.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_OperatingLossCarryforwardsExpirationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_OperatingLossCarryforwardsExpirationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_PercentageOfCorporationsTaxableIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of corporations taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_PercentageOfCorporationsTaxableIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_LossesIncurredAfter2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_LossesIncurredAfter2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=PTIX_LossesIncurredPriorTo2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=PTIX_LossesIncurredPriorTo2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalGeneratedPriorTo2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=PTIX_FederalGeneratedPriorTo2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=PTIX_StateAndLocalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=PTIX_StateAndLocalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153285105304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Loss Before Income Tax (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (2,542,428)<span></span>
</td>
<td class="num">$ (1,698,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(6,307)<span></span>
</td>
<td class="num">(52,222)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (2,548,735)<span></span>
</td>
<td class="num">$ (1,750,911)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280701160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income taxes at Federal statutory rate</a></td>
<td class="num">(21.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of Federal income tax effect</a></td>
<td class="num">(8.60%)<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent', window );">Perm difference</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_EffectiveIncomeTaxRateReconciliationPermanentDifferencePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153387740104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. net operating loss carryforwards</a></td>
<td class="nump">$ 2,907,000<span></span>
</td>
<td class="nump">$ 2,894,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet', window );">Stock compensation</a></td>
<td class="nump">1,217,000<span></span>
</td>
<td class="nump">784,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_PTIX_DeferredTaxAssetsIncomeTaxLoss', window );">Canadian Provincial income tax losses</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Canadian Provincial scientific investment tax credits</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax asset</a></td>
<td class="nump">4,121,000<span></span>
</td>
<td class="nump">3,703,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(4,121,000)<span></span>
</td>
<td class="num">(3,703,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DeferredTaxAssetsIncomeTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from income tax loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DeferredTaxAssetsIncomeTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation, net of forfeitures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">PTIX_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>PTIX_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140153280183416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 25, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,762,495<span></span>
</td>
<td class="nump">126,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option to purchase shares of common stock</a></td>
<td class="nump">366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option exercise price</a></td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Vesting Over 48 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option to purchase shares of common stock</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Vest Immediately [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option to purchase shares of common stock</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>87
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M_OL]=D)"1\%P W&2\^:Q??S:9[(3\DG% )J\9"E7TTZL=?[!\U080\943^3
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MR'MG$%F&Y]"5%N'3!0X0DZ#(UT(KC2=6G,6V8V"E/#JD\H<!'?JC=JJ@L?;
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M6H.9AU X4)]1 RXZ:Q7>+V]NE_?+]?+.MA3C)FIL3?DF2=BA4'2UQ]_P)B,
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M4#GSZJ2ENI%L7QY6;)B4+"\O=P2GA&L#]7[+5!M4W^CSC^:\:_8?4$L#!!0
M   ( (DP>5(T;ZC0)P,  (4,   8    >&PO=V]R:W-H965T<R]S:&5E=#,N
M>&ULK9=1;YLP$,>_BH7ZL$EMP"0!4B5(:ZII>Z@4-=KV,.W!@4NP"IC93M+M
MT\\&2B EA$3+0[#-W?GW!Y_/3/>,OX@(0*+7)$[%S(BDS.Y-4P01)$0,6 :I
MNK-F/"%2=?G&%!D'$N9.26S:EN68":&IX4_SL07WIVPK8YK"@B.Q31+"_SQ
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M:]N>&K!1L9_1SGY32)P()8+Q @$YQQ!@MB,9A:0."0O7\H;X$$8'?CT7%&-
M;M^_Q*;?&==EJ1;##0$W*EXTVGGQAYP,@1?)$>ZS4"F7/K!/.U&G-JR;IJ^[
MUW<OI:3A8*O6E[6+,3"FV59.QPSP'1*>SU'EUW("'\BY\^K[$";S?(ZNS.1C
M_0O)MB$,A!'=@$G]SH4*R?)).5_P="^'S=>4P^@J7W>4 +,* ?A]DZ;\O! ;
ME/^OZ/\-4$L#!!0    ( (DP>5(2,T,;808  $8A   8    >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&ULK5IM;]LV$/XKA#%@+=#4HMY5. 8:OQ9HMZ!9MP_#
M/M R;0N11(^DDV:_?D=9L2V)INQ67V++NGONCO>0O",S>&;\46PHE>A[EN;B
MMK>1<ONAWQ?QAF9$O&=;FL.;%>,9D?#(UWVQY90L"Z4L[=N6Y?<SDN2]X:#X
M[9X/!VPGTR2G]QR)7981_G)'4_9\V\.]UQ^^)NN-5#_TAX,M6=,'*K]M[SD\
M]0\HRR2CN4A8CCA=W?8^X@]SVU8*A<2?"7T6)]^1"F7!V*-Z^+2\[5G*(YK2
M6"H( A]/=$335"&!'_^6H+V#3:5X^OT5?5H$#\$LB* CEOZ5+.7FMA?VT)*N
MR"Z57]GSG)8!>0HO9JDH_J+GO6Q@]5"\$Y)EI3)XD"7Y_I-\+P?B1,'USRC8
MI8)=4X"1T2LXI8)34W#.67!+!;=N(3JCX)4*7EW!/:/@EPK^I4$'I4)04\#.
M&86P5 B+[.[34>1R3"09#CA[1EQ) YKZ4A"BT(84)KGB[H/D\#8!/3D<L5RP
M-%D229?H0<('$%,*Q%9HM"'YF@J4Y/""Q8\;EBXI%[^B,5TE<2+1#?KV,$9O
M?GD[Z$MP10'VX]+LW=ZL?<;L ^4)0-\AL/]$N4P6*47W0%O*>>$(V$-_?Z'9
M@O)_-/ C,_R(91G+VV'&9IB/RV6B9AA)T3U)EC<P$B.R320\&T G+:!QO,MV
M:3'@KR-I0)N:T?Z !4OL^$M[K+/+W?I=;BB'U&2P'&[4.O5$T6<FA E^WN(G
M@U&KJO6!J@>^V@>^V@6.>P;GCJ0DCRDB$@8O?H\<_ [9%@YU%-PC>0626L.?
MAGC0?SIED4;"LOVJT%@CY#A>$-E657#2%+P!R2BRHYKDU!BCVJX^B"V)Z6T/
M$B H?Z*](=*E5&<QL#RW9F^ND;.Q%8;.0:Z2#.>0#.>29+Q#8D/ T8N2LD?T
M3UP) SOP:X,^:HJIS& 71[6A-'IXT5!60G</H;O&T+_E,/'2Y#^8+6NH$-";
M%.;'6P2+#I0 CU02M: )&N\XK"!4Z$;":.!R$HPZPAEWA#/I"&?:$<[,;5#)
M#6VG-D-:A"H<\0X<\8P<@>(*2J<<MG'8U/+X!4E.<@%+K"K:%&MTK#!"7L&*
MCG#&'>%,.L*9=H0S\QH)O_%]-ZC1HDVJP@O_P O?R(O]5AW#]@I[ZYX--T@4
M/[*M>M0N%T;,*XC1$<[8;PQ-$ 6!7]MB)QV9FW:$,^L(9]X:?H4:P8$:@9$:
M8[J0:)F(F.URB5:<96A!\Z)*A*(S+HKEHFU<42)WG.J(8K1P!5$ZPAD'S:75
M@M:Z7CUU9&[:$<ZL(YQY:_@5HH0'HH1&HGP28E<4PM"HE8L&6C$.)8>4:='#
MJ3<D+H@DT):\J(I$1Q>CG2OHTA'..&Q6?G;D1O5UI2-STXYP9AWAS%O#K] E
M.M E,M+E-RJ1JE!U!#!J7D& CG#&'>%,HN;>C0//BG"-2M..#,XZPIE?X'B%
M!-@Z'O98/](]1]H#'*NU?=:)-/OG4JI":=</ QS8M3FMD;S!'O9@O:SGS!SH
M%4G3V@QLQW=KI:!.T'=<YZ1UK6;EY @._TP;K<\.OJR/ULB=::3-3E[?2>/C
MD0XVG^G\2)\T*S$K!5@0UG-F%JKZ>SSUP.9CCQ^JW\=8<Z3AVH$5-HC6+EAU
M_'AF@<V'%EK'GPF'X99ZGYMM,;8"/ZB?+[7+53T^=M#8W$)W4 ^/<;.)PY9K
M6XUQ;Y6K!G%L]["YW[NX5N,[NE2E&F=IJHVDV71$3N353Q?-[ERQ$;7:JP[(
ML<G!YBYGS\,$A@7BW8\$?TIB[3'9J,2J;C+U+:999&,<1?5SU[E.3M7BYR(Z
M5N/87(Z?C>AU4==&UJSUP.5S+20^UGK87.QI)LWK)']U43*T38$"!?G(6EWY
MW  )5Y0G^1KFE9!:_C4K$QQ$?A#5A[E5KGKV?ZQ?;'/]8BAC)[9F?[8]-PP<
MKWX:?H%DU<'C5FY?M)77MG!U4Z"YGL#M]Q,:$<MI7%!HI/P 1X%;2\Q$(PG%
MCA^%41UT:@[TFCL*K4WLA7X]+3I![$:!<Z;"LD\NC2ZZ-3I389U)3[-VT%98
M&CF5(\L-&[<^/W_MLX^_?W+?J_[#X OAZP0VE92N -EZ'\ 8\OVE_?Y!LFUQ
M!;Q@4K*L^+JA9$FY$H#W*\;DZX.Z53[\Z\3P?U!+ P04    " "),'E2D<FZ
MK ,'  #%&P  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;*U9;6_:.A3^
M*Q:Z'S9I&[&=%S*UE2C07:0V(&@W[:.;&,A=B+FQ:;O]^FL[:0+$\8KN]F%-
MPO'Q<UY\GF/[XID5/_B&4@%>MEG.+WL;(7:?^WT>;^B6\$]L1W/YRXH56R+D
M:['N\UU!2:(';;,^<AR_OR5IWKNZT-_FQ=4%VXLLS>F\ 'R_W9+BYS7-V/-E
M#_9>/RS2]4:H#_VKBQU9TR45#[MY(=_ZM98DW=*<IRP'!5U=]H;P\PC[:H"6
M^)K29W[P#)0ICXS]4"_3Y++G*$0TH[%0*HC\\T1'-,N4)HGCWTIIKYY3#3Q\
M?M5^HXV7QCP23D<L^Y8F8G/9&_1 0E=DGXD%>_Z;5@9Y2E_,,J[_!\^E;.#U
M0+SG@FVKP1+!-LW+O^2E<L3! .AW#$#5 '0ZP.T8@*L!6!M:(M-FC8D@5Q<%
M>P:%DI;:U(/VC1XMK4ES%<:E*.2OJ1PGKD8LYRQ+$R)H I9"_I$Q$ARP%1@1
MO@$W,LX<? 0/RS%X]]?[B[Z0DZJA_;B:X+J< '5, !&X8[G8<##)$YH<*^A+
MM#5D] KY&EDUCFG\"6#X 2 '.09 HS</AZ$%#JX]B+4^W.7!X?)O<',[^[8$
M-XO9'9C-)XOA_33Z H:C^^G7Z?UTLK1,X];3N'H:MV.:2"[I6\:Y*0+E2$^/
M5.OVZ>HC\MQ!@+V+_M.A9PR",/"<$,):\ B<5X/SK#X8)O_(5"TS1S"YO&.6
MQVE&02Y19Q*U^JJ>8Y53>RYS+<V!K$4%$6F^+A=S*E+*+9[R:S"^U5-C*@M:
MG!)=)NB++'B<FKQ6:O$/G($&_HG#VC(8AV9?!36\P IO*5C\0Y>>!,1LJ^!I
MJ":(06MZZ'MNX+DG,-MR01@$?D=4!S72@17I:$/R-5616I&T $\DVU-5&,2&
MRDI9I$]$E6"0I>0QS5+QTV3!H(7L(W('GH=.+##(81</O,!L0EB;$%I-^$)4
MGN6 DTQ#EU3U@PKR*-\XC?>%(>=*W%:UBEL_\QV)Z65/YAJGQ1/M70%3+0K;
M=KGNP;H\L@HZ3=5VK'8-MZP0Z:\RQZ5="7T4($EYS/:Y,!9IIYU*LD2$X4D<
M3'(0!TX'X .:@5; JG3I0% A,LTQ"C:)-6 .=N2G"HH1N57Q&:&H%!V:%H:>
MV[%((&I,0W8"T,N$GU0T+BWE@.1)O3[LU0TV? .QU97S@NY(FKR6-F/Z5BJ.
M\@[Z[L Y77<&0==Q7+?#*0U;03M=#4\BJSTAPUWLZ6^0NP;DH>^C5J:V!:44
M] 8=T!LN@YZ=:2?W0)/ZPW(R!M/H#8Q>0?<,T+'DX:"%W2 IY<*P:YTUW ?]
ML[J1:?1ULGQ[-P(;%H._H;%S*ZI=WSGKN,UVR'/DOP[?-70'[7Q7!WZ^F'V=
MCF7PK[^_P8&5>5;=YYC7ID*K>0T5PO"LU+B91L-H].;40 TY(3LYS<G/UP*O
M>2GE?$_RF,IVAPMC;J VZWR$CNL<K(>JM;?._"8O'QO5$!BR$]B\8#&E"0>K
M@FVE)?D3E0RLTCYGPISQJ$TX$ :RWVY9U19T47?(44--"/T?T')?5]!,;_UV
MI# W<-4,QXW#$;;*AK:<+6U10W?(3G?&5?G[W*W0M^D-(H1=V(+?%O0#"_R&
M")&="">K%8WU6J O<=E0RQ:!JEY(;X84+^H'^N]>=M29VD,9+3'P(H(^/K6C
M+>9"U-%%HX83T>\Y<1J-%I/A<@+>C2?ETWO%CBHV1L F-D2!AT];$(.@BWW9
M=': ;K@0V3>""MD'<#WY,HTBE2JS&_!],EP8P;8W>D$X\%'+O88-H2\W-'X'
MUH9.D9U.2ZR3:&Q%V68^/X!R^WZ*TK0?/++F&&7#D&A@I9#EPWQ^.[F;1/?#
M6S">+D>WL^7#8K)4H&MZD4EQ,UO<R8YI%ME*;T-<R+Z)TP=1NN5=L4*VV8+*
MVBYL6WN[PC/(^ \H.CY4:D@4VTGTU.B8;2D0Y,5,-79E9QC\!Q0=&]P0+(;6
MW(IF49E"36F/Q@?MU_UB&"U5M9]%MC8%-^2([>3XD!>49.DOR7[OUB3-WY<G
M5;(PO[FGM<]PCMO;[.D.NM8K/CB:M'/G^/!8H&P"'FE.5VF<DJSJ!_2!_(H2
ML2^,:PD;*-21[<GI&91!#GFHDT%QPZ#8SJ#G&G'2U72%SCKI.:%K,RZT-#ZX
MX5QLYUR#W<^D*(C:5:N66MHG&-AE$J1NM\FZJW? ;8:%0>@''2>9N&%8;&?8
MZ6MG+]L;ME.'45R7J_-/>:J)#H^F0QQZIVV:00R%AV*E(?V#"Y$M+=;ZGH@#
M#:.\:*B_UG=10WT#<_+]&GX>E3=*C9KR@NN.%.M4FIO1E53I?%(W0D5Y9U2^
M"+;3URZ/3 BVU8\;2A):* 'Y^XK)%KQZ41/4-W=7_P%02P,$%     @ B3!Y
M4N&1).Y0!   + H  !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6RM5FUO
MXC@0_LZO&.6D4ROE" G=E]NE2$#;/4XJ5*6]D^YT'TPR$*N)G;4=TNZOW[$3
M K0+V@_W!6S/S#//O'CB0275DTX1#3SGF="77FI,\2D(=)QBSG17%BA(LI(J
M9X:V:AWH0B%+G%&>!5&O]S[(&1?><.#.[M1P($N3<8%W"G29YTR]C#&3U:47
M>MN#>[Y.C3T(AH."K7&!YK&X4[0+6I2$YR@TEP(4KBZ]4?AI?&'UG<)?'"N]
MMP8;R5+*)[N9)I=>SQ+"#&-C$1C];7""66:!B,;7!M-K75K#_?46_<;%3K$L
MF<:)S/[FB4DOO8\>)+AB96;N9?4'-O&\LWBQS+3[A:K1[7D0E]K(O#$F!CD7
M]3][;O+P,P918Q YWK4CQ_**&38<*%F!LMJ$9A<N5&=-Y+BP15D815).=F8X
M5VLF^#=6IT@D,&.F5 AR!>-2D[+6@\"0(ZL>Q WHN :-CH"&$=Q*85(-UR+!
MY! @((8MS6A+<QR=1+S"N O]T(>H%_5.X/7;L/L.K_\38?LPD4++C">[+-PI
MU"A,?4"YN.&"B9BS#!9TB-251L._HZ4VBOKJOQ.,+EI&%X[1Q?];B-.@L_G#
M-83PZR\?HS#\#//[+Z/9])_1PW0^@]'L"F:CA\?[:YC?=,:/B^GL>K&@7.0%
M$R\P9O'36LG2)4,:NJ""Q_"0HF(%EH;'VN],!57ES*)'O<\5^FY%?IH36:K7
M1SNHK4"JK<RDN/7>",]]X!H87&'&*D;)B*4JI*IS5'&3=J1 FB=+S1-.(P4$
MR_$H7Y@PP1(&9W9@G<,!^;N':2/>N68'[NS\(VPNP)H#Y055QU(F:MI6R:[)
M\X:+V%5M3NVCN/0;W*[ETF:W8AIHB&ZX+'7VTGD2LJ*J:Q@9Q6G@Q;ZC5W.H
M+4S*C#.3%I_10"1JAHMUJ^$H.1H+C$O%#4>Z@,]QRL0:810;RRK\O7_AP[(T
M#M"OXPFCCNTX6O1] I9U*U*T->0D986A_S#<QODHN"&QNPN:6D4\J;(P\0O%
MEZ#K7KHB:DTJ*R5S&IM;A2ZE!6YPJ4I;KC"R%SI\[W?V:D^#^FO)U?$Z^J]*
M1TE6\*:QSHDHM>\Z=;G:H-((CI,ZQF'/W<A2T-P5?D)-X"I1I3++7GZC2A&W
MO:9K<M+0]Z&)_,P>-AQOG>.6F6U=ER4NC 07P)[W+KP.R=7=PNE2;?BF+OJN
M-1L"MTUT(^U"UO1=.A3Y\,,TTV%GV8P8:_#&NV6:$H.89CH796T"^,RUZ[^=
M;8$UHR,P^G@2NQVJR9\EW>;P0U./MP!-8@^SMQ^2DQS$>"IMU/I6V#1%9YK3
M_>;4T)F];$@OG)5YG;/Z+I%GFOYVUM3M?7AIP97T1.?^Z&,1['W!'2'[3K$9
M+X6I/^;M:?L4&M4O@)UZ_8ZZ96I-="##%9GVNA_>>:#JMTF],;)P[X&E-/2Z
M<,N4GG.HK +)5U*:[<8Z:!^(P^]02P,$%     @ B3!Y4AOW 0XV!   50D
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M%-Q3=)VCRLT54 S%7=XKNU:VGU?Z"BJ>")<0>=<X:HYKJY(O<PQ-B\P5 ]D
M4OD*./%U=)<!I8AD""O*TN3*9=MY1TSG%2-8^>RPS@":$OW"">^;;\IF6*CD
M-'(ZGBWH?X(Z&P@\.@"%* DN+I[*O\G)> +_B-<:_0J<;Z\Q+89?)WP1_H&U
MMUR'!" %O"0P/)W/X8;I!3Y\8RIJO6-3B2#>=#Q=R']00C\93\_=1Z1D=$S)
M,Q%7%-K:)8)V^&YR5=SR^VS)L/?R ^0<OHI1ZU(7Z!@\S420DZ?ON?6"=O_H
MS^+ZAB!J4CGY6[=>WN=4VBO2ARX+Y>;^5DIG:6_J%QK%]R#:P62@08O+@&B4
M>_>,KLC-5>CF5BU:X5C^$@30IS-H'5.C!@3F<3RVU9R2,!0ROMYGT000O")N
M/WKPJ VA0/O6UK1;UZKC-:FTYSJ-W(J!K-0A,UK'NPNW4%]08_DF_OIL:,A!
M]$4;()T[!X@UU5CPHU:L5\M^SM)1\4^7]@C-YP=N4QZXS> B00_BP@\5)+F"
M!DSCPME*_N!\.!6QHI]]""$83S2;*/0?1OY^G2R")C^'A#:V.\7E%L7]3M=V
M33K*?3,D<)4S#G@T(>U6* Q=*?S1%6O]C?@L\C+'8V(^9"KE6M>'=U(_<;7'
M-DW'S=IE95&'R^6WKA8U4+ZG6M1T@;7TR6)T3JS&[^>3T6S!0)T;+TP%USI\
M3;\!QT)E=Z'KKG=Y'"?#H2+)Z]JIQ*@Q/M4[42L_D'_MJQA1C2\NZ8WE.]9P
M;/<W@W11TZA;+WHX.:DIO8>&:O]1_Q[.W?6A"%$3P:YH;JPO+8SEERW5!:M[
M )MP<P)77'S"/EX<ELF?QPP,0)]H%MWWCK>'=M2?J/A3V[I"G?<9'+&/N!+Z
M#0)[B) )-ZX WA^3Z2.SB.0Z1N"[C2)V41H<YS/U)JKW!NG%L Z=:NT(2)BV
M$4] J !),"9A0Q"431S/?+RA9X?3*'"7D'?C $&_P<+[\7U+13*&-/TWFI,Q
M$7NRN-_9YUE7/3MI19& @PL_6)D[2Z^'E*3'IIWF!E!$@Q[HA<?-(^!L9:J1
M_QI"B1<676\P>QI1TQOLLBE4&2':0=U%&?DX)5Q58CH+ P6K$R!R+.\PEHY>
M$1GHF\&<CL;]^MU/CNA,>!8_065Y'M)Q#08_:D,3>N A+Z=7H8\1;^924J)%
M'EX ^)VXZJR?MQ*'30/OV=:5[D:[(M)\D]@;7E17Z93CY,'2'39<._W%_GE)
M@2'"!D9B\]0Q=&B5C@:B\P]R?V[T@)W@ 2\9VV!!.EIRF^[9FM88)YVC*+>%
MV2LLRD%& ZC(U@EI672!)\>P0&WL 8*AE=B;10SI^O0#X:XO7M&)=XP?QOB)
MZOG8F4FWVT(SAQPC2^I<*YI]"*W*I'.9&.$ZE.0' 7TK%>(2E\UH-<\'UKO!
M8C:E?,X?]53\%LSA*/6C7T/:Y^O9P(-ZDUH_WUF"83FQ:+**E<*!U$0XG^^.
M8Q6@LLJA!N!M@1@-6VNP?[W:D\;@,9U>.P_>#8$PQN%D#]B.A5DG?_ Z^" 7
M8!&2K!Q]XI ^5%A\F-J/-#V)DQCTBVN7-^DW'LKRPV\!>[&\.)97+<%3LSK%
M",Q,C&!#I9#C,D_CUJ$)C8Y5,O1<*(_U)";!J?;G"C@C86G'3B:(C.*DB!O%
M9&2NRP>_9N1!'0$TX[-S\1A0>@8.>4R#SYGKI!8M:M4'<)2/?S9U_03UD.:
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MZ(TD<X+!_/;E@#T?J/=C/0;#I"7<RYDB)RX^B>QO2 [4;^#*VT&(&LN?P>J
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M#Y/Y\/'S6S$3)^+J\\<W?_OAXT\7;S]=_?E/D>?.7HB+M^_>OWG_6?!9)^<
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MJ:HJ581VVDW-?$U=WU;><8SEF$?&/?9 MG%#4G9!H)<BS4NV+7G3-'!I ,-
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M<T%"\^MZ"Q9(4C.]9M6WEQM-Y&S8ML?%#_:\80U!'@B=S J/Q):D*#89S<#
M!*E#94M]3V-&G:0"QK4]A.F3,Q3":."A5?LB"YY</S]TDZ1OC1!\T]08SF1M
MFK[U^LA=0^I QMZ_3!K:>TG=>P&(VB2N%"Y7M*ZUD&6"T \'09U,M[SFD/Z%
MDOB -T82<95L./JHO"ZAHCU)>A<J;B@^PH6H_;*')/H2^';@^"@89CU9KK )
MG\XAC@(!FC==]6 [WD.3[3COW/*($ZQ19=P#LRX$&NV"!7/S-:8\HX<7:.%B
M1C$,=*>CE=ZG6_(N72) 6K%:Z!NE8[]];LJ+=MJI;O6,*M:A@O?P30<BS0D7
MBJ.6]N93>]Y=!HQJR6JU!-&]@1^/ZMY%P^P'X>,U/YI7^@=9>SKF.S?4L;K\
M)N7R/=V()PP!8QQN5!6!YZ/Q=D?8MO;9YH2XH"JUZQ-*Z+Q(;G1+GB9R05-D
M+D//6B?L'RWK*J>KWB5!H/,D[31C#%J4+ ?N5V^;(-/FE$SI7H66%G1[5IJ.
MO-R"'5(21R#2R@3R*?$A1YQ!I3F8GS;'M_<SI45 [T_J?Z<)ML'/MX?77FB'
MTTA?"4R%/PGG[?SQA/[[]E!Z2,'K4W C!_'"$8RZ8#+UOS&"#N"&,]LQU$+\
MB<+'3R>[[>/SOM;ZOW+@!X8>&/C-(E2*X1/GDXWR_B!^IP_QB[YOAB U=Q[3
MFZ("TL,J=@NZ5= C%)U.*3DU5<TW\MZW2ATSKS0'6'P 7X89#JA)V>7]JT]S
M^>TU,,+1PT?>O0#U8.GM-7I#@%S5%$7T*/W0^!/MZ=1&1TE18&3*)$ON<K3T
M28E:)TY6"$_TLAME^,X#;47DH@?Y?73;5\+]=I<KI4XKUIA6VH9D.FQ']G1[
M<,H4A?8\1*6FQ[10B!X!=I,Z/<1:*[Y.-%5^AGC:N^G><DKH9:M[7/13FRSO
M#?Y&4ETYDNM&?T-R[W#Z<0@G0FZ:J43HQM!P\,!OIK!=3AO!B1FJ<D6"P.E#
MX6:+Q<4W4XZ3DL=AZ#BZ63F A2[K%T"^THW1/2@95<PC._IO0,G:@]*H@_U6
M*%&[[<Z#@U"R!E 2_S,H66W9] 0H=1":VE'@/!E"\SE=@#P(H;'?_9WV?D"Y
MH2:!?B9*0F.#_BUE^[3])>J9_@%FMUS_C/5G65PCZXA4K;#50:]Z) K]TU#]
MI<JW_'/,15ZA:../:R61^F@!WJ]RF*KY0@>TO\]]_1]02P,$%     @ B3!Y
M4M;G;VE+!0  ?0P  !D   !X;"]W;W)K<VAE971S+W-H965T,30N>&ULK5==
M;]LV%'WWKR"\8N@ U9;E.!]M$L!)W*U#VP1)VCT,>Z"E:XLM16HD'<?]]3LD
M9=EQ5F,#^A*+Y.7E.>=^D#E=:O/5ED2./592V;-NZ5S]NM^W>4D5MSU=D\+*
M3)N*.PS-O&]K0[P(FRK9S]+TL%]QH;KGIV'NQIR?ZH630M&-87915=RL+DCJ
MY5EWT%U/W(IYZ?Q$__RTYG.Z(_>IOC$8]5LOA:A(6:$5,S0[ZXX'KR\.O'TP
M^"QH:;>^F6<RU?JK'[PKSKJI!T22<N<]</P\T"5)Z1T!QM^-SVY[I-^X_;WV
M_C9P!Y<IMW2IY1^B<.59][C+"IKQA72W>OD;-7Q&WE^NI0U_V;*Q3;LL7UBG
MJV8S$%1"Q5_^V.CP7S9DS88LX(X'!917W/'S4Z.7S'AK>/,?@6K8#7!"^:#<
M.8-5@7WN'&PDGVK#O3AL/#=$D-S9T[Z#=V_3SQM/%]%3]AU/@XQ]T,J5EDU4
M0<53!WW :K%E:VP7V5Z/5Y3WV'"0L"S-TCW^ABW78? W_(Z_:S/G2GSC/AT2
M=JF5U5(4/&:'*MB-(0ON<4+/V%NAN,H%E^P.DU$7]N=X:IU!,OVU!]%!B^@@
M(#KX >KO]_3Q^G["CMDK=GG]_OWXXOIV?/_N\X2-?[V=3#Y,/M[?L?N2P+FJ
MN5H%M@[C3PKG&BO<J@.^]]H@@)J]]$L__W2<9>F;C468&+SYA0$@&2J8\+8<
MTJUA,YK-*(]4:B,D"Z$;'#QQ^!&%>@N=N<G+#>.U\P[:3$!6DPD=1^7D0\&9
M6>^IC?Z"4Y@33@)%X_:>%"V,4.SR%="A4!"UL;4:X7.PNJ':B8+8R[7YY?BF
M)511$:T06+*VPYTCM8AI (_@[VB*&)%]S2;6\:D4MA1J'H :+0-"'9++5CC7
MJPMQD"1H-@O)#20C,X^RS^4BUQ;[:(ZE-O<J@E^DHZT:6)U=T6XB[S7J7@CH
MU@(3EB$@C7 ;O0S)0 YKOD&R0BMBTQ6[,CUVQ1]$P<8]]EX_T!>]2B T])U!
M!6V@PTZ2!*1H2?G74LN"C.?M-FF5>+7 BYMPFM=X5UOV?[3M_'!M>^P=IHI"
MA#5@=(V&SS,R\0)U&EWVY/Q2N')7)A#3QNL#XUQ7%1G?1<0W8CGXXJ9DCO)2
M::GG@NPFDL]1=.BQ%OY@P/T0EH9I**K#0.4MM%O@+O4S1\D>-FS)+:-':%_$
M5$!OI6H*B+&_#HXBBF 2+EPN<5]3$0IRMC!P;7#;/> 6KX/#)O3;1(+8"TO-
MFC",U[44>8@$:%ZK=5^('(XC8OX$)*\BQJ9%==H\WIB5,)L2J1;7'F+9L(<"
M$3K$XG>N@EJ1\F'2V8E;ZWANN/))FXV2-$UCRC-=!QYL60H/QQ#.EW*%'+;>
MMJD6>O31A@A@&GO7BT$//IIY)#@F<2 J#: [*Y#S-2MTT3@&$^O#O=5"LZR'
M9N9][;)+DZTZ7B=K$YI]Q$:C89*=G'2>,$O\S@ABE!TEHZ/T&<N0)2!7<C1Y
MU,%WV";^)QNA"MB@=S0*P?2N=D7H0 (6.KY '\#WEAQVHP<C$>*\4P09-&@%
M:81*UKJ-PO@P:7;$9=3(=>YTL#^,,QT=_+:5-!CZ^6$:Z\'6_I5@T)+JMJ-V
M/)OM4D"-HFB0_W6L[M"^8F]Y7HF@A4["7J1!E!>'P^0D';'UM>?Y6Q:3^5FL
MPPXD[DGBJZ*.5ZU<]?[M(=+?>A*B_\S#P]>B&RV4BZ_#=K9]6X_CDW)C'A_F
M$' ND/>29MB:(IY=9N)C-PZ<KL,#<ZH=GJOAL\3_!V2\ =9G6KOUP!_0_L=Q
M_@]02P,$%     @ B3!Y4I76[W4(!P  (!$  !D   !X;"]W;W)K<VAE971S
M+W-H965T,34N>&ULI5C;;MPV$'W75Q!;I&@!>6^.VZ2Q#3B.D[I(4B-VVX>B
M#UR)6K&12)6DLMF_[YFAI-6N'3= 'Y+5A9S+F3-G*)]NK/OH2Z6"^%Q7QI]-
MRA":GV8SGY6JEGYJ&V7PIK"NE@&W;CWSC5,RYTUU-5O.YS_,:JG-Y/R4G]VX
M\U/;ADH;=>.$;^M:NNU+5=G-V60QZ1]\T.LRT(/9^6DCU^I6A=^:&X>[V6 E
MU[4R7ELCG"K.)A>+GUX^I?6\X'>M-GYT+2B3E;4?Z>8Z/YO,*2!5J2R0!8F?
M3^I251490AC_=#8G@TO:.+[NK;_FW)'+2GIU::L_=![*L\FSB<A5(=LJ?+";
MGU67SPG9RVSE^7^QB6M/CB<B:WVP=;<9$=3:Q%_YN<-AM.'9_ L;EMV&)<<=
M'7&4KV20YZ?.;H2CU;!&%YPJ[T9PVE!1;H/#6XU]X?RMS@AALQ87:Z<4X [^
M=!9@F=[/LL[*RVAE^04KBZ5X9TTHO;@RN<KW#<P0TA#7LH_KY?)1BZ]4-A7'
MBU0LY\OY(_:.ASR/V=[Q%^R]L3;?Z*H2TN3BV@1IUGI5*7'AO0I>O-(^JZQO
MG1)_7JQ\<&#+7X^X?3JX?<ING_Y/>!^W\O[7NROQ7!R)M]>75^]OK]^_$1=O
M/EQ=O;MZ?W<K?C7BE[;:=FC-3U(12B4N;=U(LTU*F0MX54[E0IM@A11W*BN-
MK>QZ*V)\:A>=^.[;;YXME_,7]][P\\6+[T'04+*+WPP:RGD=MJ)IG6\EML/!
MIM39X8)$DIF<7E>=85R.XA2-#.3>41=YKI+%:T<QHV71PZVL1..@1BYL4R%K
M"U#CDE "8"^^(W-=]$.*6OD^\&ERAP6/)K^1<(TK<%A ,EZKE6LA56+QC*!=
MG'!<6>L<%@/QW"HOC T4UR>=*P&1Q!*A/C?:25:='&E-Q<T('HJR\YSL/)-A
M'3KO]&2OBL*N @064;'UK&H]D"7!J\!J.!Z!6LN/*A6EQ/M:YKAL/?Z##D;N
MZ[JQCB/.VRSXA"0M%VV#6,,8'@"7"J0#B[Y=#?8/EJ \$-;,NER:3.VH ;[5
M7MABG*W8SW;(=)I<&Y%9M$FN(FK[N>^HT\AMC^"(>U(XNY45L5!NV3S\+J<G
M3^C78*YY62D.AGD6$Q<Q[YAU,DYI*JZ+/?\\0?P!$/2BXVH+NKBO2?2!M'R7
M5G(_K<7\21]SVQP5#OI* 1SU$12T.Q)N.WX!DZ4$!AGSE%.D105*(FY5$U2]
MPM5SUHH?4HH0=3;)2I6R*OJ2C>R!//?!7&WO+>-@JVI@UA["8A_ANQ$.)%#&
M)M&N4Y^4:6,CT;:MDLZ+V) 8"3'V?BPPNFC+YWQ!4J"P3W$74U<BNK]1N@YB
M$F&N&I,E%CK&1C[#GF@64E>Q-%UC']2&>>Y5K8^D,21,3E%7^3Y;;$-UO2?D
M!UN@>-"47->DV"2]-9+&4&;K6KE,PY0J"C(%1FRDRWW7^A2]4^NVDL%"D&1#
MD6$U ?7?B*>'"=3H),2#6S"E=2--Z<J9=+/"6'.T>RF=P^!D:A-Z-%5\((=,
MZ-JVAC#8D*!\;5,(GLHKV [B^(F O O"M)XF%WC^H/KWC0?G.'L1,NB.^KXV
M 1JH'7"*<S<R!,&R1Z?HR-I7*]KMR,]3!0 0+:SC832#K5=N*M["V-]VF_;/
M]F'%8_8B,A2",5ZI0[+[ SVCEL%A^<@61Z*QV4>T6*%Q %BG">+R*FOCZ168
M4< 8DJRT&#&QV35KI^D.N4S,W3@EC, 8@J@3F .E,[MPD;PVA=-=?7DD)%]K
M:E_:*'-6S92JJID3I@\YI?TKQ^T(SVUT+;M#.HYCCIWX-BN3<4 <+3WE;60G
M:AJD >3ON[M2:^JA'IW#J+2!*J91,E4(54P50&<HB1^XV"E'K\JL?_>&S"86
M\:"SOIKXD1C=L0?]C,;CX>>3#6C*LUMT!#781""-&+AW0NJ(FHI5NZ=C=/)9
M_/C"[]H['9T9NB[BN094'XI$.HH!>W,^/3Z2UM[9Y:$CXGX?,)7QS]]3'B[D
M<%9.HNW1F8M4U-DJEK:@??L:$;/H6II)_I8I<1-KS"?%URP7^+;D^M'OAML5
M0Y"QYERS2FJ<8:33'%.7/4XZVM"1,(-L1NJN$+Z!V$_%91]E"MWLJ-CL_*9B
MC>(Y$T%CPN.9S/%9I^F3@[Y/D^$YE=4'O8ZE(#$;(@)M@'1$BD!$LT:U,Y]L
M!43:> 9(AZ ;>*!S0,%B7TLC8T^EE$:5[R810T#=DX7(;CY'2FQ!J]%TDCG5
M4]&4HM%*1F&QAX"I4&B2*%J,6N6:PI\^]"DU&WVU8OBM^=O<4T0FQ _8X>GP
M^7\1OWIWR^/?#MY)MR8R5:K UOGTQY-)I'=_$VS#W\ K&_!%S9>E0H<Y6H#W
MA;6AOR$'PQ]%SO\%4$L#!!0    ( (DP>5)=^"%*  ,  $8&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;*U5;8_3, S^?K_"*@B!=%I?MH,3;)-V
MNR&0X&[:!@@A/F2MNT;7),5)V>W?XZ3;V$EP$A)?FMBQ'S]V8G>X-71G*T0'
M]ZK6=A15SC6OX]CF%2IA>Z9!S2>E(24<B[2);4,HBN"DZCA+DI>Q$E)'XV'0
MS6D\-*VKI<8Y@6V5$K2[PMIL1U$:'10+N:F<5\3C82,VN$3WJ9D32_$1I9 *
MM95& V$YBB;IZZN!MP\&GR5N[<D>?"9K8^Z\\+X818DGA#7FSB,(7G[B%.O:
M S&-'WO,Z!C2.Y[N#^AO0^Z<RUI8G)KZBRQ<-8HN(RBP%&WM%F;[#O?Y7'B\
MW-0V?&';V?;9.&^M,VKOS R4U-TJ[O=U.'&X3/[BD.T=LL"["Q187@LGQD,R
M6R!OS6A^$U(-WDQ.:G\I2T=\*MG/C1=8"X<%S 6Y':Q(:"M"O>PP=HSOK>)\
MCW75865_P4HS^&BTJRS,=('%0X"8B1W990=V5]FCB->8]Z"?GD.69,DC>/UC
MMOV U__G;.';9&T=L?3]D3B#8YQ!B#/X+U5]'.OF=C6#-(%G3RZS-'T#B]F'
MR6IV#?/)8O455HO)S7(R7;V_O5G"JD*8&M4(O0-IH2'S4_)%G)6$"*8L98Y@
M&\'?G*E(ZZ3>L!Z$ETLDU'Q$QBA8[\"=@,WN,6]]^\"T$I*;09_#-?5@0MR?
MO0=Q"X,6M''0B!UX!:.Z,YX> ;"UG@AOF5Y@XIT/>\^9#0KPUC]:KAU2O8.U
M$52 XA?.="UC%F!:XE6WH@9;"<+*U 72P:8'MQK>XIH88@=IOWL^YV?N07EL
MRY$NDO,D2< TW2-P!IJ6\HK;G$NB%(\-[L#\SA\(SJ2[U<;?:LC:9[-WK43!
ME #OD7+)^H9\M3G7IVGOU85G?2: $U)>-[@$%3JE!\^7?#<WQB&\>O&GEQ>?
M]+9"VH0)9IE=JUW7YD?M<4A.NMGPV[R;L!\%;213K;%DUX1I14#=U.H$9YHP
M*=;&\=P)VXH'/9(WX//2,,^]X ,<?QWC7U!+ P04    " "),'E2??H/92L(
M  "I%   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6R=6&MOVS@6_:Y?
M07C;10)H;$FV8Z=- Z1I!YM!'T&3F5E@L1]HB;:YE44/2<7)_OH]]U*2G<1.
M9Q8!8CW(^SSWW$N=;8S][I9*>7&_*BOWKK?T?OUF,'#Y4JVDZYNUJO!F;NQ*
M>MS:Q<"MK9(%;UJ5@RQ)3@8KJ:O>^1D_N[;G9Z;VI:[4M16N7JVD?7BO2K-Y
MUTM[[8-O>K'T]&!P?K:6"W6C_*_K:XN[02>ET"M5.6TJ8=7\7>\B??-^1.MY
MP6]:;=S.M2!/9L9\IYNKXETO(8-4J7)/$B1^[M2E*DL2!#/^:&3V.I6T<?>Z
ME?XS^PY?9M*I2U/^K@N_?->;]D2AYK(N_3>S^8=J_!F3O-R4CO^+35@['/9$
M7CMO5LUF6+#25?B5]TT<=C9,DP,;LF9#QG8'16SE!^GE^9DU&V%I-:31!;O*
MNV&<KB@I-][BK<8^?WY5Y6:EQ*V\5^YLX"&1G@_R9O?[L#L[L#O-Q&=3^:43
M'ZM"%8\%#&!*9T_6VO,^>U'B!Y7WQ3"-199DR0ORAIU_0Y8W_*%_XH-V>6E<
M;97XU\7,>0M$_/L%%:-.Q8A5C/[/$+Z\^\O7VX\B3<7?_S;-TO2MN/IR^?7S
M1W%[\<^/-^)VJ02$KTVE*N^$F0LXX**90C4JH8-B3XJ%Q /IQ-R4J#/W)J+X
M(8CI:?0!BYS7N3C*XO$HBT?95!R+HS0^.9W&)]-3<1P!X(!O)8Y.XF$RH;?C
M+,ZR#*\^0:'8IY"E3>/)<!RD3<9)? I'CMGJ2U@MJP>QE(6H3+,SPDZA[D$H
M3HFBAB0C0"]6>ETMV#7(Q=+:6E7 %2L\1#TH:9U0!# !>*C53-D.(D)6!;O9
M%S^_L#YZMCX6$J22FRK7I9;,$ BOWYK."9F\A:3Y7#%WD.,"QK+=M-)YZ6MO
M[(/XM7\# U0!7\JP1+L#Z;AZE#7?[=H*X_U'6=I/Q/'K[B*Z\2QW9WLL*M V
MS&YE;%\V5HNC:?^$I83?Z%K9E2@T7EI5Y4HDD/V:_^-E"X/.SW:AUQ!^E/1'
M+"H)HBZ7LEJ00>).EG4(H21W)0D>!LGXR<3KZ"O"97>4O=X)@UA;<Z>9Y7<6
M,(JVCC#XO4(I6/2.:.N!0R80Q07EQVK7Y>9I%L'4BF%%,B60!I&$!21_!@1X
M_6(-<7XYV(_@*G)I[0. NI&V<"*+3Y-)G"38%$]/1W2%K)G\.Q<Q4!^"E,8P
MB9=-IF'1I:QDH64EKBD4@.3C7#:5T8@^/;C%Y9IR-4>MZ^H.18_NZ5E"#L\U
M/#Y*$Q:"BAV%BV@4IUG*U\-XD@Q9^&][$GJT78C=W5I(^(*X[ OO3_B[X,0]
M*]MH6X;^"5O,&RS_,-I'E-LL>?OEZR>^2M\>DRZY!I[N-1JV*A_$JTD\'@>?
M225NTQ-V(HZL<NM0V.5#G^$&@R;<*B[K!AV_F)D3%U1'C3)Q>_G+1:=NH\M2
M+%1%!D,9!^L9C\FYA^<L&]B<*79#JR(R=WBNP5-S76FR-A:SVC\56NJ5]ARE
M/1$!Q]5AO&E@7RHHMRV5'8HA:8Y E]/D-8<,^+14622IJQAD4L[*CG&.7#W[
M#U$*--TT,]5PFK6JKBIX62%OW]2=JFK*::'H97HZ/8FIK.2*.?FX+RY*9^*(
M*$$%;Q$4- DV;291+D3]A\/8%Y^>O%M;3>1OZ/7T:0 AO D3>=/$2=U[U$;4
M&+^-VOY0O!1' <UI\A<"2;B"3?).ZI*>1]SH-C#GH>E=<VM6;!=4:E,$$TGI
M!F$,CGE5!,P>+A>UL_9)A&#JJZ2?8J L2U@:<<30F#41H >?8W4-=&$K\:LU
M]6*)G<-)T'EY\0W#"95%R\BZ1;][5,]^-ZE[+<16A]L(780LBYD4FB8-\FVR
M-2=V;UQ >7*4^H"<D 5H#1[$/_(?\B'(M=-!;NH25%,3/LQ\#KJ*@GAZ_31A
M&^V7.,^P)4W%^-"<=E=QG0;2K('S,(L06XC-4N=+SIVJ,'/"&JSI*#'+XH#J
MZ/'<1%.7JEH7=IQ"O$#'Q.9TL0[N8[FKH>6EJN<L;)OMUDK.9T3YQ-12&4\<
M6NI<[M1+8U?_$*&+PX3N>&[A7FOR/T'LT5X2'STF\3$WGUCLDGA,QEHJ=2"F
M]C3H!]W<0W?[//AG%];C@VZ]T*>Z!HS^LZ?OI'&:CK<FTVWZW.2FGEI138:;
M2M15!/L7BI"PT%5%X>(ZR4[^:A[88\)47>6EQ*EZQ_Z607:F!YB(.LB7['X!
M0B_-FF>)_6-%W$"<YZ>6UIXGHU441M^U?.!EST/7A"QY$BEX3".[PWF[/0DI
M[M(1G%+62TT,BC>-.LB<:Q]W)?%\1-E666 "<MO>M<Q*>_)NQB4I^^;<HK;$
M7W_^H,)$@+"C>*V2C@/P:@3JZ[!R<K(7*>UT#BT$A79<=36R&87) E6UDG16
M9&="LLB=1\>31Z>XI;Q37/(<!B:'(A 4Z$'CD*PQDN!!IQ36FMI2AV9C,!0X
M#1C9%LH-X.AHM:CT?Y4#M:-QPQ!V#E.P++D(K2J9F6%YE[]P'#"..9WX33B%
M#E4MXK:?LQ!9K# QT0F>CV7-B=+UQ5,&A6,1_&%4TPB!QX=T6?5'K2F5 62$
M R+5%VOLL4+="@GIF&N FP/?XIZVN2>'.&P!6*M@.\#0W')N=P8N6:/.Q.PA
M8+=&/[*!RK;,0%VJ._]&>U&()K/O>\=@Y_/12MD%?R3C'EGY\"6I>]I]A[L(
MGY^VR\-'O,_2PAZ'@6J.K4E_,N[A5,8?QL*--VO^&#4SWIL57RZ51'QH =[/
MC?'M#2GHODZ>_P]02P,$%     @ B3!Y4F+S )+5 @  + 8  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&ULI95+<]HP$,?O?(H=M],3Q<8\0E-@!A(R
M[2&/AB0]='H0]H(UL21'DB%\^ZYD<,DT83+3BZW'_G_[L+0>;I1^-!FBA6>1
M2S,*,FN+TS T28:"F98J4-+.4FG!+$WU*C2%1I9ZD<C#.(KZH6!<!N.A7[O1
MXZ$J;<XEWF@PI1!,;Z>8J\TH: ?[A5N^RJQ;",?#@JUPCO:^N-$T"VM*R@5*
MPY4$C<M1,&F?3KO.WAL\<-R8@S&X3!9*/;K)]W041"X@S#&QCL#HM<8SS','
MHC">=LR@=NF$A^,]_<+G3KDLF,$SE?_DJ<U&P2" %)>LS.VMVGS#73X]QTM4
M;OP3-I5M_"6 I#16B9V8(A!<5F_VO*O#@6 0O2&(=X+8QUTY\E&>,\O&0ZTV
MH)TUT=S I^K5%!R7[J/,K:9=3CH[GI<+@T\E2@NS-3W-,+2$=9MALD-,*T3\
M!J(=PZ62-C,PDRFF+P$AQ5,'%>^#FL9'B>>8M*#3;D(<Q=$17J=.LN-YG?<F
M";\F"V,U'8G?1_#=&M_U^.[_U/ XXNKZ;@94R,\POY_.9S_N9U=W,'N@YQRN
M)5S@0I=T9R#N^:)0:6R&C3,E"B:WP(TI,85.O]^,H@A4X0Z\ :N@*'62T:$%
MDS&-H)9.!SO=IP^#N'WRU4"BA* ;0H<M>:3"]Z(*XXU)N^>MT5A0:]30'8#P
MG[S!9 H96R,PL*B%%Z&$+3)MP&TZ?QI=>^!R!>V7$7HB%P)3SBSF6W@%MZ1;
M6_%:,,GS?\)J5/82\!EUPFFCT#SQN7[LM?I1"\Y+[7R[2)9<D\<GJB7A&V12
M%9.\*<L\.^X/FG&G QNF-7-'98-4N#T[!>J#A^;M?KL9Q?VJON9=!7[MQ(4'
M-UB@7OD^Y72EM-5EKE?K5CBI.L!?\ZJ/7C*]XE3;')<DC5HGO0!TU9NJB56%
M[P<+9:F[^&%&[1RU,Z#]I5)V/W$.ZA_$^ ]02P,$%     @ B3!Y4A=70;W2
M&   D4T  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULO5Q;D]LVEG[G
MKT#U9K;:591:4K?ZXEN5W;9GLA5/>MUVIK:V]H$B(8DQ22@ V;+RZ_=<<*.:
MDATG-0^)I28!')SK=PX.]'RK]&>SEK(57^JJ,2].UFV[>7IV9O*UK#,S5AO9
MP).ETG76PE>].C,;+;."!M75V6PRN3RKL[(Y>?F<_G:G7SY775N5C;S3PG1U
MG>G=:UFI[8N3Z8G[PX=RM6[Q#V<OGV^RE;R7[:?-G89O9WZ6HJQE8TK5""V7
M+TY>39^^GM[@ 'KCEU)N3?19X%862GW&+S\6+TXF2)&L9-[B%!G\\R!O957A
M3$#';W;2$[\F#HP_N]G?T>9A,XO,R%M5_:LLVO6+D^L34<AEUE7M![7]A[0;
MFN-\N:H,_5]L^=WYQ8G(.].JV@X&"NJRX7^S+Y81T8#KR8$!,SM@1G3S0D3E
MFZS-7C[7:BLTO@VSX0?:*HT&XLH&I7+?:GA:PKCVY3U+0ZBEN"]73;DL\ZQI
MQ:L\5UW3ELU*W*FJS$MIQ*G[].3Y60M+XP1GN5WF-2\S.[#,=";>JZ9=&_&V
M*631G^ ,:/:$SQSAKV='9WPC\[$XGZ9B-IE-CLQW[AEQ3O.='YAO:,?_^VIA
M6@V*\W]'%KCP"US0 A<'%GB=F=(@G^^T-+)I,]3*(4Y^XS2;:!KQ<2W%K:HW
M6;/[S_^XGDVOGAF1J\; 3HJLE46R+)NLR<NL$@:&2+"KUHAU]B#%0LH&)]MD
M6A:B1$/)E2[@;0FZV*[IN^7,1I<PR:8"WJQD(W5653M\+C<MCVV!CD]-B=_N
M<1VB]%4M-:A5<HJDS2;//HWOQ^+OKU[=T??ILR<B:PH:JCN<&K]IN>HJVAM-
M@0_O9=[ILBWM&V^_Y.NL6=&^Z]*0FW KW+^]=7./CXAN[D4W/\KSN[!MH.76
M\_6  /_(9'D\&8DQ%IOP8DLBL<'XJBLD,<4*QRJ6:L&3-F6.$^EL([NVS$TJ
M?FSR<4I,*^'-[5JAV-2V@05NLR8KRJP!M[PP)7S2NU3<??R1'V1C\:H"E0F>
M(2F;5NJ<50W\885ZP@(!2VE,EK/,@FK)J@2_E44*,KS#2#&/R>S2R^SR*)L_
MR+S*0"N0;")I2%)_<(JGXM&?V!)+I9,-*+DJXIW7&0I)X7XQ?+(U@0YKV*/8
MR4SW;/C(GJ_\GJ^.$OS)2*3GK6G+&HUO:,O?-(-T,Y!&LG-@#>VI["&_ G*V
M>R[;'6_;VSQ8]F]="?L&]C2@K3@"F51GGV6T+BH4,+JK-\SF=IVU(ELN(9BS
MIY ;I9& K/;Z#^_+EH=69;8HJ^ LBM+DE3*=EG8'Z,YPY4-C>!7<HW,_7[=+
M[\4L;2*B3<L'V722WI%? %,!HPMP9^!4PQ!RL:1&8'=YVP%7@5& +]"9=Q5N
M SB@Q5*K&H8I(Q//L7$O?@=&=A!O=;5S"WW5]KQW@7]5#?J;?0$%4 \E.ECP
M)0]9U3E5@,VK_+-05D:XMVVFP0VT7H#2&)(PL "PDM088W!*XGLT&402M45?
M<LSVK[T=7!_58O#0.2RJ@XG>PKIE*SZ4YO.04?R)Z>+0*Q &M_"?2=#1YIE9
M!P<-*A7X#:^T9=OQA-MUF<.+&GF.*EJ(Q8Z$]4X6&&/%&] . ^O]B(\I,-\J
M#0I#!(&J@+("4@;AM(&6I,YV[(L*'DUF*;^ MZ8M+'EN" 1N4?33X'M[&UIG
M1C2J)975I82EX3V%8A6*G+F)0A"*/!AUL@#/#UH/9"%L+D2WX2'B-U!L= S6
ML(:YDK+)D\XRMS5RFYP)@(-,%^@UF(*P0Z8VBE?'U.G&J]/-<?F3'!L,EO#A
M+;@OT%NTE2%5^LZI>EQ'(RU!/"8! 8DU)!8@IJJ$MS&& DM;-E6&9V")NEP!
M$RO@?HL0R;)62REJ1MU*BPH%OUTCV.LT0"<4"7!P(5E/9:!E+/ZU+BO"%\D^
MJ(1DX;-LLP4\-A$>TX]G :R!\F@'D.D& ?8.5[<!$-^J84(*,Q+!"6E*8O&%
MH/P&%)TT%Y"_K!?@!AWZ)X;N_75ZT[,&\)P%J099!/%X?]-'%&4Z"=G4Y*A\
M4:(;%,Y@BO2-8T7X! PDUPR^M$UR95H6(YA<5R,^A@>@_%J"^; ON,5WK LW
M'&G =CJ,MQ"/!0*W#@ <[9R6&(OWZ+1D0XQFZ+W)2FV%NL[TBA0E<5$KHQ"!
M**9 10%]<C$4WH?84J0P0PL1'C[ B@JDH+<E6FEIP$QA,K5,;2P"6BE.'-@.
M3:EEK1X0:7#0V_,W*$J.D1CA5K 5TG5P4<@[R/ Q_6?HJ<"%L0L?6Z!M*"[)
MF-M^>718QD5-S (QO1^AS)):0NR%;3P '_&I"[8X0BZ["DSU0?JT14O>F.42
M.WLR#+1/A(% SYMXUX[36W*^-5DV"@]GH_<3B4GT 4- W3^JS%%I8'I4(=\'
M6P^YUZ!B?\<\/8?G10K;3"(74\A%&_D95AO5@(-H=QM"9I$3 G\#.0V\-)##
M0G8S:M4&,J/SV60TG3CAO'MU_SHN=D#2VA006PPXOL*C_)!7[DWCDTQQUVG3
M90QE[\"+K2#]6MNW1N?ST31-8L\-).[MS2)<M#F;89#.B.PA*RMB!JJ R=#Q
MKC$L@..N9<:A&Y,W4&.8&O-Q !I@P 2NY%#.U7>KA$QD!DK9^S-AWS$D\UI"
MM/X=%H&TL7!&9A$S(P$DS),Y@F\C(G-_@Z?LEF"*A+#KWD9=8L1V\B3L$C +
M>K."82_H?P-3N"J!1=IHWNAHR,%IN<:RX8/'L"A<A-*\$;"V +S)G@394W+8
MGOJQ),3/'_@5]'KBA]E\DDXF$Z1E,$JB7S0;267(:G<PFB7?$,TX=Q^.Q0P*
M0 ];<!NL [",I?2'R3X5L1F""P*KP:3*,\NZU -;BF>^2"_.YWT_);[FI_Y"
MEJQEA1%^F,ZC_G 6_.'LJ!][AU;U"W'T/5M>?0@%?M],XM7]K;B>@8RLOPGO
M);WWB!\^I4VM&\(,"Q8RL?EGC, VNLPENY@M99(+#$RY!+X3"C02;"VSH1PC
M*$  !MA8U(&\#53"Y<<[<K 89RFSC.L^,&V[Y=('2@%F@:0V+S>938"0E#IL
MA'Q,2K@L*W[M#.6DJ$#1C!BES3BQG($\T2@,N"#@$OP4S!KO=EU"B ?CW/%6
MJ3 #"O"[9"Z4#8 ?@]L*B6<K\W4#T!I390N)+871Q%CU4C9B+[3*P/5!9E,9
ML2H?G"=!F Z$N44)WO[6*=P3<=]P7$)5M^QASPE ']Q3#L9J$0+BEZ@4<?H3
M+I5,0Y44,N7]A;I&0030#Z3W=IL\4)P_82-GZBW=&&< (.:Z7&"ZB8<S3P6_
M/X4TD\837)\^2SXU7CA_Q7Y(,B5A6("R)1)LTUUKRL\L(;-]0OY[?W6WK ^=
MI$E,$JS:3RQUQ[:#--J,NU_:='S#B0(W4R%+BBP%0-H<XFN">VS<-T?L^6.N
M/9:(<X[>RF*3LK&Q1U%< ;.(Q4,F4 8.>0.V9@%NIC45?K@.A06;H6PLL&FX
M&)8"O$!N<4$C#6!MD^UH=Q;"ZT[ZVA9,LMEH]85P,=(-EH3FE+"=+F2>=<:7
MULP:HCA8HJ[W,EA$"9'L]K;E@UNEFM6(AA/FB);N^4* \[E,8DRNW1$%5;71
MJ&*R'2*Q#-9<9OL8E[D!TZD*74#BIB0Q2.15@]JXH/(I2#'*MK5&R*.Z%N,J
M.EU=.V&,(!==M0C%3 F,M]Z;2J:F; G&03KG] '!#J1:J.\IY$=2CBRI!49O
M!$E8!.+Z36D@U?L@XXHS"&F!5/0*][; TML,0.HE5;-3B\IPRK+>5#M?I.GM
M?[<WI=0,0/&L$=\AMZMK$^7?7,Q!>5O/+1%0DHMYS)W>[%V#*7%".JKW]@="
M0)8C/ 9@WU):QTKTV#=Y@T@BE8F#%7+&HNG!D ,^;:_091TU^5PJ4#<[=@7>
M"<;&SN6LV$RBU9GJI<(R*44<LCPJS!84!4TXR!WV>]Y)^JRAGRB@+B(F *5'
M?28-1 4< F3CY-89X3"4$9\P=T[X[RZN.+?N/.9'A*B NC7H /EL7SR.X\4/
MXOH\O;R:P >2T.Q9[Y-_:#\<8U/RE[-)'&$3I.'_5C:=G\_2V6QV@$_AJ?M$
MH(#X0_'_ )<H>:2#5@JY@1-I%+,:V7JDR+B@*<ZP^-.U*2D^^(ROA1G/\.0;
M&,ZEF=AZCB*@^*B%#MZ.)";)\9>F-T^38\)T8DLL'F#IO>;4.GTTVS4(Y/+J
M,IU<W22W?)[=XS(?G!P7_>GYQ7EZ/;\23PZO<Q,$__WKS"ZNT_E\=F2=V;XE
M]A:@(S6_2+*4&.S]D^GL*CV_N.3D\&:>WES, QTE("'I2OYB4V4Y\SQ;V=.E
M(60#^[Y$N/C QWB@G"B@4WS5)ECX1O*S?=)O1U"@=ECR@+TA0&@-@PO$</0A
M1P94W*-@3SP;VVI$,117>2_U2NI^EFMKV[0CG"(IPH$G9TB/ZS NAF95;LND
M; "9> V<^#RZSX%21#*$%46M"FES_R(0$[QB!"N?[E<]0%.BOW#Z_?:+U#F6
M<#F-G(YG<_I?0@=@"#P"@$*4! _G-^)O8C*>P#_)FQ+]"NQO5V*2#G^=\$/X
M!^;><(46@!3PDL#P]/P<7IA>XN!;U5 +#AZ&$L2;CJ=S\3]47IB,IQ?V(U(R
M>DS)TR2N;W3&)H)Z^&UR57Q4_5&38>_$/R'G<#454]9EA8[!T4P$67FZL^)>
MT.YO_6E<;4F(FDQ,_A;F*_J<RGK')_XPCG)S]RJEL[0VG7,KR>\@VL%DH$6+
MRX%HE'L84S;DYAIT<\L.K7 L?O$"Z-/IM8ZID0,"<SB>CH-921@**5=]U&@"
M"%X1MS\:^.B 2(+VK;3J-CQGPG-2H=&>D/,A&62E%IG1/,Y=V(GZ@AJ+M_'7
MIT--4TE?M![2V7V 6+,2RX_40N#4LI^S!"K^=*&1T'RQYS;%GMOT+A+T("[\
M4'F4ZWG -"[C+<4/UH=322WZLPLA!..)9A6%_OW(WZO:':NMA>Z[Z?G1BE@$
M;WYR@'RPL/;'I^F5."57?NBXP"2V<R$-3'0G5E[ G/S T)0,3:)>P*+X1UO%
M=B_B6!1K@1S'U$PUTG9_[+]))^#+79*92+#&)HC1,:A-M6U9;.!<@\IBTSD>
M,DSFHPN2.GZ_F(QF<\X9^'2,J>"RBSOL:,''T7E$4IIPVOXX9/M-14I8VJ/@
M8M0JEW4>.$384T7C"BI1N3&N+H[%CVQLV#'3#M)%)WMAOFAP>E!I>X.&#D6B
M%AC8=S@L)'!/!-O3!*5=E6,L/FVH1-D\ .Z%EU-X8D,E'K;&"(%"2\Q GW,0
MS4GX'GB[;]+]IJ1O6M;6#)W[8O#PB"O^(":!%3$I;^W)0+_;#2M(@ULP<3*P
M74MB%V7D<6IEUE'IV4LO1ICHWXTE(&7:1MQ$)!TZPK-/.K7-.-_?:YMZ2V.'
M,SKPW&U)+2_]DR=>C]];2)*QZ1:_4JN9BMC#3$CX4#J: EX*A;R#5A0)V$>3
M/?;RD=N;(0[';$JV)9^,1318C>Y;7W2J!IQM5#-R7WU4<\*BYRTF<B/JC "[
M;"M91^ Z NY]7?4ATQ9(IC/?=;(\@&>/QHS04#T]W@I]C]!@])JV@OX=3/)@
M3^YW3G7XE)JQ#O,QCT?0@06WW=FC%]<\1[W0X+"OIM?^A"=>S";K1(O8?P")
M26KKUJZ#,MD_3G&.=M64H5DS(LTU%C@_$%6<@JX>W%BVQ8/Q8$[8<U%3G(I0
MDQ)XR#T6]X=F"300G;^3[MIV%?;)>[QDU(>E^FC*3;9CXUYAV+9^J]Y4:B>Q
M7 FY'N!%;5)2^N@!]X)BZ5[I/6Q',[%SC1@2>CL&HF]?O$D0[Q@_C/$3G73@
MF56VV53665A&UM1A(*E?QA\II\&#8\ -^-&U%[LC;PB37%"DV1P?6.\&R_R4
M#%OWV%/Q.[#.1TDQ_=4GQ*[2#SPPZTR[UO4:[-R*I22K6$IL_4\3&X+L=K0$
MO-I8$ .\K1"]XJ$CK&^6.](8W*;5:QM00N,00RY.@X'M6+*V\@<GB .Y-(T(
M:6GI2_;I0X7%P71,3#W9V+U#?[%M#6WVA;L:73NKAX(L+X8634? 72T/,0)S
M-I6PH5($M#FYLO-05T]@E?"G493A.Q+!U*V/[_=_<*[&THZ=C!<9A6W7M1>,
MS)Y_PE]S<NB6 .H+VUIX /E+#O'AJ&\.-R:FQV\YX#65W)Y35QUJYC_!]Y_^
MI(QY(NZ ZEMFVCUR<=!A'YT?+ZL]-; ;^>*$2O[Z09X<7W3C%TUH4<%OGU;^
M*<LQ(<&B0MMF.6K'I=39V2*6.^TX>W2YI=M?""= K;+5-^@):#&>2="<*%G"
M,Q;%)([\B+A_.U7)INI8;0JD!N&(Y/[[,)QJ6 MJ%85D?;5V'CQ,V&LKQ6 :
MYN!I%767(.W4M,?XRU#]8N063BR*U1(X)5V7;VCN4P/W2@[!^7%RI[!HP$#P
MYVB_[^SI+!:4>E_XSAI6HBS>%N]L"G[/SL;J\CY3@GD&J!YG[Z"XMB/>CKR^
MFJ57EY?NWX2#Z,_6'\W3^<U5>GTY%9"JG\_3<WCC7RYOO4@GDZMT,K_&A[/+
M]')^;0ENZ8@=RUA&3&&*:VI2FI]?XK\)E:?%)F))K)A>\GEOA]-9.KF:IY?7
M<W$#GR;IU<U$'',;X=+.]&M7;HS$TS3;TOL@*W6XG?;[IA*]!T5XD(2SZU[G
MZUXNZ)M?CVTXW-B9'K]P WH&1MJ(6P+F^8Z/EZO#./;[I^MA62X&&VS(I*3F
M^IPZ%2_F7^V,%,.=D;;T[>?QV('"EB4K=V2U$5FNRP@Q*2&7P6LI[K* G2E<
M5Q.^,7C9-40$#'0+I=$]13Z1S7M/J:^'"KYO@"'8BIL\VHG@D^*.$[M55S("
MC"ME:Q![%F6C:$P LWRUR!RBC\L";E,\+ F-DD./"8BZ2P%ELV0N(B/ =3:J
MWCU!0#FR>0&OC+>B[34D1+#B%(!2(['_!L8]85B,"@_H "+0[YA:1"U8^PV?
M_6[71_Q*0X\+@*9>(PDUK01K&MH=-1@D<7-K:,,^P$#*2'@X &\W4^AO&1AE
M+R;T9Z'S#3SW3)B3@ YD\U!JU7"JVUBD1L4III8W(\TSB$BZ1C5+_=G^T +1
M?"DWJN_K(Z\!$<\MP325(&Q697=8Q+W]W)1CNP,>;S1QE9(!NZ%N=ZN@1<B%
MP@T>S\%?NV+E$TQN>9'&WU()]:T*FVPK^4 WT"P+DR55/$G#2IUW-087NC)*
M0,!WV'NZQN+OSF33/@][ H@VXG05*X%U]JMRM7@\LXM;1; %VQD6Z"1UR*3.
MVS2K%+,*K:@1TO56Q1<HTM ZZ;9NB_.#CF?1M92?%1*G(&'XQA"\:VW92<BM
M5] /._,"B&RF[K!+"3/*'AV<#@Z-#<0EL?H74H:>I"'72%5#W$#O4@68M;+7
M(WP*'#MS9XY#A S>9?87#EV&[6^"'&[H'HM_J"T$;IUR&7[8,PQM$EU]PJ[^
MC^PP^-.H(F8.1"H?C_H<]=66 7EXQ8IY\<V0EHUKJ/&=TP'2C?A<R=[$H2SY
MD6-P]RR8-58<.&<L9@X)EF680SZJ[-J.V6-;2/[,%N+0RC57L" \(:6KUUET
M!G X<B19SXTHKR+"J0@N=6S?P"X^B%^V%NK[ZCRO_UBRH8TL^8ND^]JY;GNB
MPE=N$X>8,BYVX17HC@OI"_4@V;=&=[#5 0;SCP8,V/.>>I^68S!,FL+^ID!2
M$!>?1/8W) <ZVN*JZEZ(.@JQPV7@Z?'KNS^!Y1ZXM_0M _$XZIU<Z YU!.LL
M*6'CQ':D#$+D3QM2 P>.7]U_\G 89QA-9MAM3;.??J3[1-<7,]NGW<AM )D!
MO?IK\QX9)'PXP04>%#\RL5]KMUJ$"MH4(=*)"M=^=$F^?TJOZ<*;6HXZX] <
M$VCL-OTQ!*?T=#1ML^9EJ>D:(J+)VAW86\7/FH8OMO>/;M!P5V73!&ORI^33
MN6V5(MB3X9V#K."R&IY<;E!/6]_9B?QS)$9<\^56+$=JY<ZOV;JY7$YE&&R4
M]2RB(UFNS&"S_2.B$]MNBN:'_6*MU,[UT1[8R,+&' J$/938=$*_HZ'9O5HN
MA1F=ZQKZ@0S8:6D2OTVL*1)+PMUQ?U6H$?^5-:2\MN.L?^='VAH*PY+\,Y:)
MJ#:!H D-'"%049)?\IR.RLP1_[S61IVRL33<^456*^0%A7=\$5$8W?^W9#C2
ML$R+_9,H&"J=XD/8-[@SI"QA+>Z?H=GNWL)57>VIM^=4_QXPMFX V[$%U)9&
MF\%^E&_[[0=WK!)^;.+XQ:-P_WQZ_-;X!XF_/]#[429((N!S?N0&TI^;4KP/
MD<$W%=D;_0D? 7%]F>\<LC-DT$O]YLXEI''#@9,"]U38LTAGS3B<H^6^;%S)
M<% V@[] ,LCVL^A7LFILS,/? J-?UFA:_L$L_U?_>V.O^%>VPNO\8V7O,[U"
M(%#))0R=C*_F)^POW9=6;>@WMQ:J;55-']<R YO!%^#Y4JG6?<$%_*^PO?Q_
M4$L#!!0    ( (DP>5*,@#C\=@4  *X.   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;,U766_;.!!^UZ\8> ^T@#;68<EV-@F0JVB!'D&2ME@L]H&6
M*)L(1;HD92?_?F<H67&VL3?HPV)?)!YS?'.2/%IK<V<7G#NXKZ6RQX.%<\O#
MX= 6"UXS>Z"77.%.I4W-'$[-?&B7AK/2,]5RF$11/JR94(.3([]V94Z.=..D
M4/S*@&WJFIF',R[U^G@0#S8+UV*^<+0P/#E:LCF_X>[S\LK@;-A+*47-E15:
M@>'5\> T/CP;$[TG^"+XVFZ-@2R9:7U'DW?E\2 B0%SRPI$$AK\5/^=2DB"$
M\:V3.>A5$N/V>"/]C;<=;9DQR\^U_"I*MS@>3 90\HHUTEWK]5O>V9.1O$)+
MZ[^P[FBC 12-=;KNF!%!+53[9_>='U["D'0,B<?=*O(H+YAC)T=&K\$0-4JC
M@3?5<R,XH2@H-\[@KD ^=W+3!@-T!3=BKD0E"J8<G!:%;I03:@Y76HI"< NO
M;ME,<OOZ:.A0,;$/BT[)6:LDV:$D3N"#5FYAX5*5O'PJ8(B(>]C)!O99LE?B
M!2\.((U#2*(DVB,O[=V0>GGI#GG/V?OGZ<PZ@VGSUQX%HU[!R"L8[?(S5E/9
M2$Z.?L.$@2],-CR$4VNYL\!4">\%FPDI'.G^P)EM#"\!$_>:%XTQ!.V,66&?
M<_]>W537AW;)"GX\P,*UW*SXX.1VP:'2$HN2)#L*+2R-7HF2VX!MBI3@5D(Q
M50@F02AT2(,EB8C=@CE@AD.]@8KSBBQ;D64$G&'5;J#/"#HP2P(Q>+R><=,'
M\" X9\8\$-VC;S8^('7PV>)FT*Z_YRLN(>[^2?=/X58[)H,+;L2*4:G#&H4R
MPBJW//LS3-(P'T<X^/6G21(GOS\9]9O=X/_CIGCZW[HI39,P29(=?GK<W8SV
M%$G6%TGV0T7RPLH(X;/2,\IO'Z9W:MDXHM$8%K2-3H'GBF<OIMW%T^;"C(ZU
M'1GAD*I8,#5'V$)M13W$:2&;DI K/'BQRRA;<>/)L!4,M0$\0$,2PJ3<2BWV
MV"ZVH[5)KN %R=50CH#=:O;-MM<$>0V;?9<NKZ%L/#,9\\"9 4XM_/L:)DS!
M?J)X>ACL2]Q-B@;O6@QMIIXQB<:CS_XI;8+)EX_S,!I/@W/OYJ=>)N^5_Y+F
MK])1&DZR,;S>K6?ZF.0_KB<93<(L2_;H2;:ZSIY:ROM:RG^@EK:=CO7R6$"4
M41^UZI,E]/2^9N"6%PLEOC7\V;-G+XSGR^=[#V^M>%<$E_?<%,)2LQ4%A_@@
MR?PGN!;V#BK#*0B.HT@'ACFBR*;P"T0'$?Z""T'UB#8]""Y+6HW:3?RA["7>
M"3$_5UJBA1BB!XC3% GBG)C/\:Y"YWZ#!8<J:I0=9_ 'YK5%$?&H&^X)TK@/
MTOC%03K%ZT<I9..3Z(;BT*;.Y3VU"D1;&5W#N:ZQ-MJX(-,E,PJC9>$*?7>S
MP(/FN1#M!;&[P_&J0C_Y]/:XM I0*S4LJ:W%UE?HFE,S<N*W'CDE$K8!O%MK
M//6PWRCMZ/8N6Y>C -\6M;)XSRH9K5FTI\U(TH7O#>/MLP?!E7:XC(U//L G
M; D.I=,)AQ=R+X8"\6327C I@BMLI^2D-YPY3/C6.19WZAI7K9\A/-OXKM<@
MF]D@V[!6'2N"0L=@?Z9CI^.<C)-PG.>;?W#C='$'GY8>.&1A-AV'DSP&["YI
M%J9(\773%T9A%(W#*)O09I*'>3;I #M!6#ZBT19B%#%!R@BR-*=_X-LA++=<
MHA]= GT BB<6Q@GVQRS,)QE,<12%X^GS[66X]8:HN9G[EY(%?RUNGQ/]:O\8
M.VW?((_D[4ON S-SO .!Y!6R1@=C/&%-^SIJ)TXO_8MDIAV^;_QP@0]*;H@
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M96G)^6M!?Q74SH'L:T4M:05'T/VGTE]02P,$%     @ B3!Y4N?_*"H$!0
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M7#%82EXP> *!GR4XNL2:1?22KWG)4'S+65T"@0OGCJL'J"1CP-$<B9: 1$N
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ME:57@V^NZ)F&VAG0_$(I>^RX -7#;_PO4$L#!!0    ( (DP>5(0XC<9R ,
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M,NB?F7(HRY&DW&B1NZZ^$=K,"&Z9FC$.I34P[[="Z./&!J@'P_EO4$L#!!0
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MXHQLV8<N'\Y=)2FH=OL;3/7QYG.YM-9""H61?$'EI@K<3Q)<$-:"ET6!'EI
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M9^M8)-M)Q:M.C 156;=O^M#5X4C@!B\(O$[@O5;@=P+?)-J2F;065-$T$?Q
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MDL79X8Z2@')E />W#*)5G*@!RO]YN/D/4$L#!!0    ( (DP>5+O>.\#L@(
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M\HYZQ-&^HT5G5:1?=OICQP<]%I]5E'[9&43[SHC]K?%873:RPT^A'YE?^Y>
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MC'0,UL@A2FB@-YCN#:;.T1T:.V M7"N64:X-.]7T?=!U0B<$B=Z%8.]",&*
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M@-WA@2-"@N?K/FCW%=T<ZRNR\PTA;W1617#<Q47"Y\#A__+7 2;2&9#&TAS
MA9UA>V6>[WYRZ/(_RF,'6$AOL,]D!Y%[+V)_I[_(4"Y<VZ4@$LM<EQ_;>K5N
M[2Y<0_-J_=*V?*YO>:8I^\4;*A?,] H<$T,9&&]X(,L6K)QH4;@NYD%HTQ.Y
M86K:5I3V!?,\$4(_36R NA&>_@%02P,$%     @ B3!Y4J!^QG:W P  )PX
M !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULM5=M;^(X$/XK5G32W4JT
M>4](!4A N[<KW6JKHMW]<+H/)AF(U23.V@;:?[^V$P*$D+:WZA<2FYEGGF<\
M=L:C'66// 40Z"G/"CXV4B'*&]/D<0HYYM>TA$+^LZ(LQT(.V=KD)0.<:*<\
M,QW+"LP<D\*8C/3</9N,Z$9DI(![AO@FSS%[GD%&=V/#-O83#V2="C5A3D8E
M7L,"Q+?RGLF1V: D)(>"$UH@!JNQ,;5OYK:G'+3%=P([?O2.E)0EI8]J\#D9
M&Y9B!!G$0D%@^=C"'+),(4D>/VM0HXFI'(_?]^@?M7@I9HDYS&GV@R0B'1M#
M R6PPIM,/-#=)Z@%^0HOIAG7OVA7VUH&BC=<T+QVE@QR4E1/_%0GXLC!\2\X
M.+6#\UH'MW9PM="*F99UBP6>C!C=(::L)9IZT;G1WE(-*=0R+@23_Q+I)R8+
M0>/'E&8),/XGNH45B8E 5V@AZR799(#H"BU2S.!*)2M!<YK+"N)8K<$ :6_T
MM50C/D!3M29$/*._;D%@DO$/$ND/9"*N$/C(%)*QBFO&-;M9Q<ZYP,YVT!=:
MB)2CNR*!Y!3 E%(;O<Y>[\SI1;R%^!JY]@ YEF-U$)J_VMV.>NBX3?I=C>=>
MP+O[N5'Y^G>ZY(+)DOZO!]-K,#V-Z?4MZ7Y1T->-X (7"2G6 S2#-2D*^=JU
M%!5JH%'5[M].W*'KNT$P,K?'&>JR\P(GBAJ[$]I^0]M_/>T!^IOA0K27O"+J
MGQ&PP\#Q(K]%M,/."?P@[.89-#R#M_"\>RH)Z^;9BZ/.YQM>XAC&ACR .; M
M&!/459+!F8XKVPU]R^H6$C9"PO];)W?ZV:4I/./B^U$X#.Q6[L_MVL5TPGG8
M<![V<OZACV5Y#DVWP.1G1J8?6$PX7LJCZIZ1&%J'TAOJOXH<'9?+M>NU='4:
M71 5-:*B]Q35LU.JN+9U0C=L[Y-.*]OO%F5;AR^+]9ZR>C96?^ W[*P:Z'*"
M3J4??53M=Y5^<?O5<4_KSPM;"]II=53*IZJ<@RKG;:H>0#6*DBKZAZQ^8^>]
M$#= SX 91R%*\'-7%S%_ 2"L 1R45]V$["O.H4ZS<OB"V^Z[9:5GZ[X0-3J3
M%%W.3C_4L(;R7LS)H0.Q^UN0W\E)3_'W!]V7B;]/B>->3LGKH+HJKDJ)>=1R
MY\#6^B;"44PWA:BZT6:VN>U,=8_?FI^I6Y!NY0\PU17J"V9RSW"4P4I"6O)8
M,A"K;B750-!2-_9+*N0U0;^F\B8'3!G(_U>4BOU !6CNAI-?4$L#!!0    (
M (DP>5)*C)P[:0,  .T+   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM
M;*66WV^;,!#'_Q4+3=HFK04,(:1*(C5I]^-A6[5HV\.T!Q<NP2K8F>TDW7\_
MVU!""*2+^A*PN?OZ<_9=?.,=%P\R U#HL<B9G#B94NLKUY5)!@61EWP-3']9
M<E$0I8=BY<JU )):IR)WL>=%;D$H<Z9C.W<GIF.^43EE<">0W!0%$7]GD//=
MQ/&=IXEO=)4I,^%.QVNR@@6H[^L[H4=NK9+2 IBDG"$!RXES[5_-_< X6(L?
M%':R\8Y,*/></YC!IW3B>(8(<DB4D2#ZL84YY+E1TAQ_*E&G7M,X-M^?U-_;
MX'4P]T3"G.<_::JRB1,[*(4EV>3J&]]]A"J@@=%+>"[M+]I5MIZ#DHU4O*B<
M-4%!6?DDC]5&-!S\J,<!5PZX[1#V. 25@]TYMR2S8=T01:9CP7=(&&NM9E[L
MWEAO'0UEYA@72NBO5/NIZ4+QY"'C>0I"OD8WL*0)5>@"+72^I)L<$%^B148$
M7)C-2M&<%SJ#)+%G\(6S+4BEIZV)1&]N0!&:R[=:X15RD;338U=I4K.>FU14
MLY(*]U#Y&'WF3&42W;(4TD,!5X=8QXF?XISADXHWD%RBP'^'L(>]#J#Y?[O[
MHQ,X0;WM@=4+>O1N_VRH^HM^7=]+)70J_SZA&=::H=4,>S3WI_%U;8Y'OD,S
M6%'&*%NA&<D)2Z#K*$K5R*J:JM].L1<&,1Z[V^8&'9O%GH=]KS8[@![4T(-S
MH3\(PE3[T$O4P1&#/XQP.!JT6#OL<#2(AMVL4<T:G<OZPXZ[4*,CA O?]T(O
M#%NL'8:#.(P;,1W #FO8X;FP^G]O";2']Z2:N4RNY)HD,''T;2%!;,&9HJXZ
M&G;$'0P'7D^>Q'4X\;GAZ+^&9S([/D[9",=!T#J!8[-6 1P0CVKBT4GBG_8&
MT<#76Q#Z1D2WCR 2*@'="9K ?Q9GN<:HF<F7PW8*=1E%03>^[^UO!N]E 9PH
MU$K:/)K@[3KM-O-[4M]O7&K^R]#[Z[92?I:\TRR,>LCQGAR_C/QD$9\6/Z.*
M*Z'^73@,;W_M^<'+PGN^J*L51L^<3Z=5V.)W&XU3 6)E^TF)$KYAJNPMZMFZ
M9[VVG5IK?F9Z6=N0[67*1O@S$;K,)<IAJ24]3>H@4?:6Y4#QM6W/[KG2S9Y]
MS70_#L(8Z.]+SM73P"Q0=_C3?U!+ P04    " "),'E2S=LE %4#  "F#
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MD,B_2>0+Q=?FI7O!%;S"F\N8DH@*?0#VEYRKPT*_QY=?AJ;_ 5!+ P04
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M,J71B])<H.^Q$'J_,0;:81[\!E!+ P04    " "),'E2?*I&U\@"  #'"
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MM-)]<B^Y>DH53L[OL" 2,U@1+@_PA9-*$%-" :^7* DM!-P2SHFNYQMX!Z_
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ML9TL'S/L^$&["?A]J91]?'$+-/]#F/\'4$L#!!0    ( (DP>5+N2=$CA0(
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M)%V6V+)CU:ZH4FMEL>85S2V^2D [ QS/E+*O'5?XZG=.\AM02P,$%     @
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M-;[_D53G\[/Q]OK+\KK98^>"<X"?B.^_4$L#!!0    ( (DP>5)EX9FUMP$
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MY5__^&KO::W+YI#/NK^+TT]02P$"% ,4    " "),'E2!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M (DP>5*N#HQ/[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( (DP>5*97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ B3!Y4HFX
M9U$D!   ,P\  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( (DP>5)XA^FG'@4  /L2   8
M  " @6<,  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " ")
M,'E2-&^HT"<#  "%#   &               @(&[$0  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ B3!Y4D@H%6'I!   NQ   !@
M         ("!&!4  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( (DP>5(2,T,;808  $8A   8              " @3<:  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "),'E2D<FZK ,'  #%&P
M&               @('.(   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ B3!Y4N&1).Y0!   + H  !@              ("!!R@  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (DP>5(;]P$.-@0
M %4)   8              " @8TL  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " "),'E2P==U7>X7  !S10  &               @('Y
M,   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ B3!Y4@Z6
MM3-W!0  ,PP  !D              ("!'4D  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " "),'E2;6?Y?)T#  "E!P  &0
M    @('+3@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M (DP>5*>Y;=2@P@  +HH   9              " @9]2  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ B3!Y4HC8)&L(#@  JRL  !D
M             ("!65L  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " "),'E2UN=O:4L%  !]#   &0              @(&8:0  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( (DP>5*5UN]U" <
M " 1   9              " @1IO  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ B3!Y4EWX(4H  P  1@8  !D              ("!
M678  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "),'E2
M??H/92L(  "I%   &0              @(&0>0  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( (DP>5)B\P"2U0(  "P&   9
M      " @?*!  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ B3!Y4A=70;W2&   D4T  !D              ("!_H0  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "),'E2C( X_'8%  "N#@
M&0              @($'G@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( (DP>5+_?@9PE (  ((%   9              " @;2C  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ B3!Y4C;3$@][
M @  LP8  !D              ("!?Z8  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " "),'E2Y_\H*@0%   0#@  &0
M@($QJ0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( (DP
M>5+G)'>@.@0   0*   9              " @6RN  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ B3!Y4A#B-QG( P  6PP  !D
M         ("!W;(  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " "),'E2N61G4-D"  !#"@  &0              @('<M@  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (DP>5+,SJ=OU0(  .,&
M   9              " @>RY  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ B3!Y4E-][1U& P  ) H  !D              ("!^+P
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "),'E2!L$E
M"",#  "\"0  &0              @(%UP   >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( (DP>5*7/ /1<@4  !81   9
M  " @<_#  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
MB3!Y4J1]&T"6 @  (0<  !D              ("!>,D  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " "),'E2.J?Y5^\"  ";"0  &0
M            @(%%S   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( (DP>5+HDO6D%P<  /\@   9              " @6O/  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ B3!Y4N]X[P.R @
M. H  !D              ("!N=8  'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " "),'E2-2"[B"H-  #/3@  &0              @(&B
MV0  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( (DP>5):
M/FH^*P,  !0+   9              " @0/G  !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ B3!Y4J!^QG:W P  )PX  !D
M     ("!9>H  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (DP>5)\JD;7R (  ,<(   9              "
M@3/]  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ B3!Y
M4HH%B 9>!   3Q   !D              ("!,@ ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " "),'E2[DG1(X4"  !;!@  &0
M        @(''! $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( (DP>5*=6GA"_ (  "H*   9              " @8,' 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ B3!Y4H8" 'T) P  \P@
M !D              ("!M@H! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " "),'E2YLMGUBX#  "4"P  &0              @('V#0$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( (DP>5)--7?Y
M'0,  #H2   -              "  5L1 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ B3!Y4I>*NQS     $P(   L              ( !HQ0! %]R96QS
M+RYR96QS4$L! A0#%     @ B3!Y4CG4X3/^ P  PA\   \
M ( !C!4! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (DP>5*Y(]HWL@$
M %0<   :              "  ;<9 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( (DP>5)EX9FUMP$  &4<   3              "
M :$; 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     W #< ^ X  (D= 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>195</ContextCount>
  <ElementCount>337</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Organization and Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/OrganizationAndNatureOfBusiness</Role>
      <ShortName>Organization and Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/GoingConcern</Role>
      <ShortName>Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/AccountsPayableAndAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Derivative Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/DerivativeLiabilities</Role>
      <ShortName>Derivative Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Convertible Note Payable (PIK Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://protagenic.com/role/ConvertibleNotePayablePikNotes</Role>
      <ShortName>Convertible Note Payable (PIK Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficit</Role>
      <ShortName>Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Collaborative Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/CollaborativeAgreements</Role>
      <ShortName>Collaborative Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Licensing Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/LicensingAgreements</Role>
      <ShortName>Licensing Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://protagenic.com/role/AccountsPayableAndAccruedExpenses</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Convertible Note Payable (PIK Notes) (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://protagenic.com/role/ConvertibleNotePayablePikNotesTables</Role>
      <ShortName>Convertible Note Payable (PIK Notes) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://protagenic.com/role/ConvertibleNotePayablePikNotes</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Stockholders' Deficit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficitTables</Role>
      <ShortName>Stockholders' Deficit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://protagenic.com/role/StockholdersDeficit</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://protagenic.com/role/IncomeTaxes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Accounts Payable and Accrued Expenses (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/AccountsPayableAndAccruedExpensesDetailsNarrative</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/AccountsPayableAndAccruedExpensesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/AccountsPayableAndAccruedExpenses-ScheduleOfAccountsPayableAndAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Derivative Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/DerivativeLiabilitiesDetailsNarrative</Role>
      <ShortName>Derivative Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/DerivativeLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Convertible Note Payable (PIK Notes) (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://protagenic.com/role/ConvertibleNotePayablePikNotesDetailsNarrative</Role>
      <ShortName>Convertible Note Payable (PIK Notes) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/ConvertibleNotePayablePikNotesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://protagenic.com/role/ConvertibleNotePayablePikNotes-ScheduleOfMaturityDateOfNotesDetails</Role>
      <ShortName>Convertible Note Payable (PIK Notes) - Schedule of Maturity Date of Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/ConvertibleNotePayablePikNotesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Stockholders' Deficit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>Stockholders' Deficit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/StockholdersDeficitTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Stockholders' Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' Deficit - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Stockholders' Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationStockOptionsActivityDetails</Role>
      <ShortName>Stockholders' Deficit - Schedule of Share-based Compensation, Stock Options, Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Stockholders' Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficit-ScheduleOfShare-basedCompensationNonvestedSharesDetails</Role>
      <ShortName>Stockholders' Deficit - Schedule of Share-based Compensation Nonvested Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Stockholders' Deficit - Summary of Warrant Issuances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/StockholdersDeficit-SummaryOfWarrantIssuancesDetails</Role>
      <ShortName>Stockholders' Deficit - Summary of Warrant Issuances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Collaborative Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/CollaborativeAgreementsDetailsNarrative</Role>
      <ShortName>Collaborative Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/CollaborativeAgreements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Licensing Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/LicensingAgreementsDetailsNarrative</Role>
      <ShortName>Licensing Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/LicensingAgreements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/RelatedPartyTransactions</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/IncomeTaxesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Income Taxes - Schedule of Loss Before Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxes-ScheduleOfLossBeforeIncomeTaxDetails</Role>
      <ShortName>Income Taxes - Schedule of Loss Before Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ptix-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://protagenic.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://protagenic.com/role/SubsequentEvents</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ptix-20201231.xml</File>
    <File>ptix-20201231.xsd</File>
    <File>ptix-20201231_cal.xml</File>
    <File>ptix-20201231_def.xml</File>
    <File>ptix-20201231_lab.xml</File>
    <File>ptix-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>92
<FILENAME>0001493152-21-006756-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-006756-xbrl.zip
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M;H=-*+KVXBYWPNFM@X7O"J[4%2_\N,-;R]J$R"N&V@&\Z+;AP1.&DB*7?R8
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MG-_9<)EJ?/.WFS"(G7OF\X%U!SSJ3%@2\T%D6\"@]?_/9X]_>;=H#AV&3\&
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MHJ_6['4:9\WF%N=?CQ36W9$5:WSL<O;ED;Y=0K(@/+!OPEGF?-SI1I7V2NQ
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M&PU>VXJ FL0D8XS7XG:YR4#ZF_ITRSL-\^H49%O"$(N2?CK'S",R_ $'"SI
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M?7S0#40AA4S8>IK<EM:%'_BU[ $G,T_1_R%KK)*[9XJ*FVYFH]NBO)1(0P7
MP.V?*2\#<3L6XO(<?BNT$Y0TRLJ\I"4N<H(;4 3J / ES7IB%0"89A5)0FKG
MQ+@J2(T/2D0@J6!1%H#['8R'9]K,?R>^RZ/8QE"$C*HPPG>?S7)_-"/L488$
M25P+AC5K H8[R)PAQ\JPMDP""B)5N8-\:UA1@?FDCK2T#MQ8GU'(3X6RE $6
M"<^D=NR940-^!C)6MO&'&+\3.X9Z4QZJR@V7E_V( 5(KMB4KI6!1( DV!>WZ
M(E8(LTO?E0A;8AD+3!&&W[!2AMR/##""FFIH4"@)QA)"'V0F,(42>Q[>_<FP
M- L9)</80J=0 @(M&?-K8'OT*BXD4G7510IB3B,_BDV=X;K2#/&*93-RB#PM
MZ%Y+D?Z%YW&J,B(YUL>H)WJ=,G;,'2XDU]J4:;8H#IR*-ENS-*5H(0L( R0+
M('(HX0.+FXF*3HOW-F?U%IVT\L*!>-O!1+A9T4P4G?HH4C<'5BU/CRNRJ'0D
M*[<\L!D!*E8CY=VKL 7R7@C\P/$#70G$: [R.9XS"2">NB!>N3/B,^E3/A;G
M>?SO(^DR:383_Q'=#SR'8^I!R"-9;HT4J*QU#O28A$*F9X72+A2UVEAQ2,CG
M2;81MG6/SE=?,-! ^GZ=7$U90?SJ-V1W6,Z]K*<%&CF%"F.?(IG5N4>F FTF
MS +_(?" .Q)Q>K!3P"<PB\@O1NLHJ^%DXU(\-S/?4E2@:AG(F)],;,!LZ1#-
M.L<5B1\BKDM'$Q@UK;"%[)N55TI3-PH]A27<??.=7[-FBEIGAH/P%#8;J<^G
MV?Q@?;_\<GYW^<FZ.?]^][MU]_W\V^WYQ=W5];=]N X/(L2DZQ0>J3.-#"F&
M='0=8E $:PXQ52])9I71[0*5TXF)TNKLJP:\%(7D@-@O1@X/"6I4Q><A\$I>
MGV4.-)G('*KHJCKKI@%+ ).@P0'49X2=JB;BT[(@')9V"S#F/68L)A\AJ?Y$
M'!ZP4!DF(\F(N7S&!"!?GC_<H9[U>OIPFI66RTBC,Z/*@)B@U%$!.?4J^CT6
M9]/B-@K)3KXU_/[DU(+QXQ&HC;>W0+38\M3J_5(D(%>0=K."$ML]1=?#K/S+
M30 FUU3\NY(R,K5C"'3$E"Q[2#K0V#)(Z[T"49BS__4"M$(B%90Z+*JO6. 0
M=E+:0:*&02;HUA.E.3% #;^C+S(]*X#Y'U/>*96;A?T['\,B!X[(2M)SR.JW
M=>O7\YG,JO2F4^+)M(\L_2;U2=^"D Y%NVM\0I5@1ER,@;71SM%GNKV\R,=3
M"IBL'*<4]$B6B(8Y#X&K;K(M!%P.=/ -;\U:&<5UG&4"1\I&\K L$HY4'4=
M+AS!8LPBYP/4%:$S86!8# "P*W]0M],3]".H<V"CX!&#1!=@EKO<\:E&,H=/
M(9PE;NZNQ \.V"&>IY>(5CY-T#I2L\D+2/(>BIXJG[$[PU1GW]&8]MF*U0MB
M_(NI?Y93?D3L>G@I+UR6;K.R4][X(<PU=2O4')SGO5BD)]**S.74C'#?8C9I
M&FM(17^6"J\5%58!A70CA"<12_\J0XW*(HNC)RD+BE=((%*'_9#\K#(X[V47
MCT3=KM1XDBM!F4\'\P7OB)EPK4H+E1,/V=5= :.EP:>"8_*NU>Q]+_$*:5Y*
MRP+V%]XN$1Z(Y,E=7%-3D8) 1CI2[-6M6ZVF?(94<MUZ4S79LR(@%71<]+**
MG:?L6@60%]Z&4Z0QG^1&:\SN-(@-95&DPKVNNK""P](>: -2UNC"RV9YT5*@
MHK%JIZ#:[SSZXP)FX3%^JJ04RL%+5"( MA!B(Y(6>0)2[[)0B:IL?:J0G5@C
M:O27\3B9S2^%KQ/M^O!GAND,GO4)V#""#;C"G\DPO@C"22!V"'@R)C]B-)_6
MA&$8TKJN&(%D(7L:R$M40S&^-TTGIBM(<Q%UX65 ^1!R=%RXJGF#"(M&FMDA
M8FA*DDI'GJ@E;ULSR2)_@B3A66BP&#NVD+4D( 09AL@X),6S_'P!1;9*&:W/
MQ,XB\V$19Y;K'7X(!O<%4:&/IAU\T( WK+R(E54FD8P$@<4[XO<C8!./ _I<
MZ167^:SR8F,0\GNZR3/&>W8I6:,[4+A9T#=.5_*HZ(-R\[BR6@;)"I9M3MWZ
MQXA[+$TM*CIDPTK_8*+$>:2=1\/YT3"2Q7,1VMQ $R)CD9]!K@Y\<@R#DJW%
M\'"0)3FI @/1B+&290VLXI(&+G?UBY#3>204,FT93IQEWQN9AG #L,?P-KY)
MZ<N'P,$IL(9C=8Y-T8*D358BWLD@0 9!% MFR[<G O+&2W:D-2_P&6E11L+X
M!=F?A#(5#H^S">8\,#5-W?JJ)8<(Q]#$X:%DN;26@KK?)!+\LJ(@R-+,3\U[
M> ?,71=O6L=X%8K2)2G(_HC^6ZWVB2W-XRA671D*ET1#AFP</*2Q")FYD]/.
M(E"@LGLP=$>2"9N@<DP^&7HBYI;OI20K'HF^#TS'? H"JO9(&?,83L1P?\WC
MOI ;8P9' U=<A:%,,6DOT[6J8>*!<'U@J8--^;HEMH2)1"(,)2KE\-71+LI6
MKS N4O7$K<I<SI_8EV?R_@I%3EGI,2MUOJ8".O,7BE<J*6<R<#7_II$Y"R\M
M*ZX:RCNFFCZF@@J94A8<'/B@2>/IA,[OFL;&2_^/(MH^Y_S&E-@XF/"!U4:B
M:"C^^'Q^^]'*?,7H[?9=S&V4UH)+=F\\YXB>&6Z!5]K$\?+)]S=@!]V'SF0D
MT59K=VI-.TUC5+:@:K^E[:UP%*%^$*45.,DTRWEPN.>H4EN8J(R159$0-V:.
M.(RA"Q9$K4@_PN-C5O*GP&LZ;YS1F9,Y(#AS7XM;%=8//V1T@=>E4B%*&4C'
MDSC?44ZX K4&?]4(U-E%ON6J%Z6,<^*EY?R"50,X(<]_R59+J5@HDTE;@9SV
MT[!SZK!"54399ZB40S;"C*V'U TDZHFIQ1@JSL'R*5^\22:^$R!+;MCE[QFE
M1Q5Y;0_-%NNGEHQ=<[_X(+*O(F.5VX(%)Z0TR_"94Y*(RQ2?]63!2E%_,2T&
MIFY7-F:V(.?5P?IUH2(%)V4?:1 NV%-]]!/[I+WRU4U3>&YK=#)B'AZGBS>N
MT*Q=;)[.&K*?0?/\AN3U5>BFS/8]A/,S0F\1^)8&O[%L\]1W>V&=8FD!S5K,
M$$< Z<@3_ITTA&5KAB2U ?;1>LCL%7EO0R0EB4I6%#FBBI\#!N) 5"$45PUE
M^(6*D'+AW\4X\E#>''&TTH:B"3%5)D'C.@LWIS59!3]0TA1U5)6^> 1GG"V(
MC");M%ZE1ITR+TX?$8^_LJNPQ);E>%& )UE1ZX51/=1LU2,.YV=0GE.Q9"HX
M"USV;WE9@ON31.3#9X$FJCG"P>B3N7D8BA10:@-G%XG$<;@?!@[8;'@I/[+N
M^8/2^.BUQ(M$<F+R\,E2Q;03\OXE91L*- F3CR-Q8/UX=?Q&!X$6BGS[!:<B
M*)I9P@S659F9+/$#,&'#!Y)&<KGB9:N]P_/&7A/D4>F*;9(;A*<!ET6#D/>I
MN2_@K7*-,W<G=P0U-*TK01U:9C(!\\-/V7$3E"M:2I-;D$6BUG$^_[8"&*G>
M[K06[<[_F=T2M1?IL9<$JM@GO+N9"_')VH"T<3(&FD\N4B(#!\H$B:TJPK@<
M=$<LKPO0S0/U304P5[U=;"_FL7DIK>SZ5!/K*E<>]G-;I6?'Y$NI:;?'"G3Q
M\6N!Y1E^3AB*>^24E*.7QR^*U&4,5)PE9,M;FR+YP,Y\E 5MG;.;FUJ? EG<
M#&T- D08,E@]-2M^9D4CK -!B>3Y:"?Z?33.EE$#M<3T@.H%_CV5/A2>)&WZ
MG-$8 :5EY6951"!4:;U<W9/6P5=^)DEI]/!K)K%\J6*\F:6\=/IM E2-P,4H
MK/N49 >\K(6FPQ"]>$$BKZ2#/![K5%GSF'\?HY<QXE%Z1YL2ZR(>,ZUPKLAT
M&T]8S%$EV.F5F9K<+Q?=$.C_P\P5D73"H[AN?6=Z$CY0+':SSV>7RHR0W*)L
MBP]E*1/A<,0A^7CB3=.LDCE<3&>&Q?NQ5,=_+*)59*1C>9(L4"TR4(*(*3N?
MH<^43)1B3.5F2'Q/5? DY@UGUBH[(Z W&#L)4*3M-9.TTDHYXRXG)@5998)$
M/^<AF4CO>>%)C4>S:4KR7$/6NRJC0EHRM29U/2AOJ,\(4 T"(12' 684TD&-
MY+*\1(8'2**TD"1JL;V4&E=II" ?'$ FQ6,UB$+%[,2:R)E%'J;*$9- "59$
MQ8MJL(:_OFF\H;]EKR3Z.P];$V"[@-GZ(;>MOS/O@>$Y . "3JM)X%2/WT;C
MYP^6; 4UP#)QDXB]M]2GK!L:P?*"7N5%?=_TQNU;:B'^LF:&SW24+[/M>;_;
MA=3W,UZU/?2'37'3/*D*<HI]D=:/:+,(\^9[A!E"7G6OA.>S.E1<&<1(GXU!
MS2+4M QJ%J&F;5 SCYJL3>K>Q/^+FL-*@^JD\7-I?3#S:G,/;Y[]O+#)YV$L
MP"S=+-TLO6)+WY#,?:X!^SKZ)FO-E%V$U)S'&];'2W5KN7;/I5>VWS[0I<$\
M;=O=7F-?=H_9CSD#3#D-6WLS1LVFF$TY@$TQDNLH]Z/ :'E'WO?<5Z\CJ+0H
M)"-S#C<<EK&6A&1RU]!,2,:$9$Q(QH1D#"'?FY","<F8D(P)R9B0S&*]8$(R
MQD-]*&^:I9NEFY","<GLTY'6;K?L5JNU+\/';(AQ_YM-,9MB1)?9D'U'90[B
M+BM=IZ=@!-V<7Q*EH0)9U):#KB9GD1A;N\**/8A5<0EQJ5PT'@V2V%8MB)^[
M=)D&? 0,SP=]1)E$_=;0TD()>D5VK+.SK,P.@;#\P>;95LH-F$#2QB6LYA7+
M_:P>V1S7S;C/EL1%"-S,)3;9 V 4F;&*?9>3#<K< R*/BCA-98&!BOI.EYSC
M9[P*IZV?U\?*1U%TT9Z3OZ<K6C,;\]7LT@134W<6>WO6 :?;Z]J-WMD6,+DA
M8EOHJ%][Z1>BU5C.I!$-3"KC2M(DSLHTNYH(VQ YO6V?M.W33F\5)*TSWR\+
M)]J^K-N>8"O+CBMIPET*K<,Z$QJQ=/1BJ75R:G<Z*U&/$4OS)51W2&.OT_-E
MTI$WGXZ<DZ+4^B^5I 32D&'MK?379JMGMT^ZHM;R6<<^.^ED E>VFY;%:29
M%2+)T;F7W>\6%1P#K=[%^GX/HNW@D)$GZBT^KIYK-3[@4P33M7PB_2WMJ(L-
MK&7?<*S=%4>B]A?6F:,/ ^1=3[39E1T;?2;JKE)E)YSQ*POO69@O(BU;$]$*
M'54OS,V:-HI*K_,%\%5E)\<;R%XJPBOG6!^19VJW X 6"XU133MK'+A,EMAV
M,X"RE'$G*W]GO&LO=Y^\ A])L=%LLN\6(2G3X ?J3.INPIET^<3" ?:%HEJK
M^W(@O>#-[G;\/TTP:0X("Z\%?Y4_I5+77:PXF94/Q1JA^Y*\V_,[@*Q>R1VS
MSEP_'Q_Z&O5&!=!W *?N3QS#[V!I3SGSW*,DA)7.M8:/*HB^RJNERZ>)Z+KY
M$. 1F K:'ATM--OM_9/"X6*O:Q12J3A$@!W=!W'B>%2H^P@IH=[L6+]32]O]
MK*T".&C4FR<;PD$!3;]*IS,>C6KS1Z/W!(K>.C")9 .KL/@-RINT?M1OZ]9=
M2)EC4^M;$#/5KC#B8^YA=J)2>M0*0OIQ73F 7C%]_[BITC[E+>[W>E='@H:V
MQ[$:/V<(=G.OJ X-:>= ZI@=BV9KZE'J2T:;@6YT-V#B&6Q @)U;8@Q'#& 7
MT?F=O</]- '5QP3488(A"K.!.5A^2VV\^<U+XQ%BB]B\79@V88FQWZ+HJ"<Z
M%@2J*7"( 1)LNH%-5^9>+ KS3!@++=31$S$NP2+&IA[ \$#( Y<:8? H5HT4
M:#P59-(&S+.VV?X<+)<Z;O(4H&T) 9:7D&EK"KG1(!T=CNV2J>NFLGGR'7FR
M[3&[D)>BZS=&IIXU[DQHUIH)RZ8A6!"G>D-,ZF\M6O ">XFNNT/K)Y7P@7!0
M_#+[2::HB1XW!'N@W7&8O>*PH-%NUOVU=$_7V6:PV975Z!"ZOVHW;+^DS6(0
M'Z;UJY9MH&B:B5:D>&4F%C)(!,!ADI22\7J,;,<NQ([HLP2OVV0T,)16W&?X
MI>P%KQ[$=Y&W7"1[[ 05^%0[+9A_\D\09@"UX(1(X[!(]J6*V,1!<].;JC9G
MLF<KM89$UJ*0/^DIZM?:[-2:0(Z=V@FQ'_Y]TJBU.J(C#S:]\F0NA.@0B4,2
MGX$1&]/=!X2%1VGOJ((<C71QFD3@D105M3A0C:Z8,Q@59"7,R(5(M3K4>N(*
MA&2-C^K6E5 '[(%:417 !@#H8VHOVPLE2.XEKBP+GX*_F"Y!8$0Q?!RK'0S
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M2A-JK4 F">.>ZE%7AZZVS[G&ZQ;>M<]706;.8 2+P(6+T:Q[3/QCKO4(HS
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MD3H\%O,X$1A^'/$!/!@BN:.4<*T^^6^LS\S%@YKU"9@S@@VXPI_I='>1.8*
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MA\X@3AR/"G4?(274FQWK=^IENY^U50 'C7KS9$,X**#I5^ETQJ-1;?YH])Y
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M4[D4$#I#Z(A,*^W9:=NN[+L,S[-R-LZ=*DI-+1O:*B4KLD/FL./!IO AE]B
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M&XOZ0P?AS$&:1A,V@H886! 7+3\+C,K\M@MC.=WZ.GZHXR?J->Y% ?:H];C
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M, >5><X21EW>SZ(SJC& )3OPG7,*5HR^!EX,C[,MSHRJV/<Y@U6EJ!1$B($
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MOPGGUY]_O?QR]^']QTN!?GQS]OL9_,+N.VX^_)O^]?;[-V2S:Y;,4G:@<,.
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M\Q:9KPG&,76V-.&VSDJS"+NII19V9J7Y,5VEI6YKF3\EEOFBM66F9.2L<_F
M*Z%FM]:XD07VFEG=[+%Z*UOV2>LLK9<A_=<9VGVB\^W%%D:/3K G4Z@J$U$?
M3>%H"D=3^&9,X>'&C_EEB0DO28^D62IZ3% (ZW8F(<_X3[,8<ODS.+6>7]$Z
M++6D2V^CFA'6'2?,_.1$X9YX9.[0X_(*3*52[S%V_# C]Q'-SL@,M6Z(BJ0Q
MU7DG2QK]C:&,E[H#42*HQ:-=U,IHB(IT_.#9M1KT;QO$^PI6\!8=)[LT__CQ
MG%D/>F-:;,=96,,+UY[R1@\/^._RT=--^OG90]DE)/?IH>V26OT\7>I 2;N
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MG2+JFB)JRI9%=@V&:MKP\PB$*HO8"<4PMRS\VDJH':VSVJ3K!NN_ ?U7$ T
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M5\2F?26[B;8*9XJ;T-$3+QOX5J5@^ ?$2T\GPEW.7N7]9_?:5[<0.AB^_=T
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M8A55/0;O"W\\<F"-H=]1"N;"H'+.&02T8GFCR%QC@YH@YH5)Q]=*^B2XOXA
M*8#8!!^01Z6C9^U!^EQTN,LA]2X'K*;XO0?&,KOXT^ IBT#XYF@K%>#ZP;N\
M;6O@DC"S_8.]P,+Z)R2NB7EFLTIZ.\K.2M[WL)3Q%MI0/-#I3 46C)W<"M)
MLK0(TNR(;L5T^4.<R]0U#W/A" RB!':4CSW=0Q,+KH&YIKA1Z18$O@*T.0PK
M?3Z?4V7ZUUP[8226I7Y7!Z 142HH&TYB6_1G^A<48!PQ^[+IC?7PK',D\-K8
MZW=*ESS^1'6$9[J3.R/7A,B^+_3K\I'0*V!VU=(AVP^PM(<%UNR"N0/R1#R^
MT&#E(JZ"W7%1;\D4>]4&+*G>58',@"+UO'9/A*-3,U.B1T691$/5 .M.$TK?
MQ]L"\Y;IV3A6,IE'TC3"6-MF/WDD<5V3>L">"4O#>!3<+?9""\".RA2=O=$_
M%V$VJ*^Y2$\!N2L[D:3-T78V9OL*$L%"BOY!TD=J<[/B*J =M2ZL[!^)B(T4
M')P+@LV,P2(Q&\"W':G69=7<56XJ7X2TLTZK]\&'K$9'K0.XJY&;,<]E_BCJ
MA5XX30WHY3(!21^--_]^)=+<939R#(AT!%T$0H2![L^BWO;D7+K"C#P_N0O=
MQYY'W,MEE&@( 66FPVR)UL[VH[6=X(ZS<! 9^DH/[?HG-[\1+36L(R# @6CM
MZ@4"-RK)O: .V=CMUFFQ_K04Z)?Y<UUM&-B6=@MGR8NR%NZV7/WPS>_F09\P
M/X G$^$OIE,!4;XB-TQW&$D=XV0IG60TW4;K.QH,E/9E"&%HT/4J!\HU\-H>
M C?O9 4?^+=W\PTXV(5NOUW9/P6Y\-#96C) (R8:=X'=-T*U SZ0.:8L^'&H
M=(KWDDPI8_DQ>9>X:C\#'453<>RT6IY;.B'&&9-MA8VIM*^(G?"-JV((L3,L
MM6^B, I*)G]]B[\D9*@!UW:(\,"7V%/+T&A)BC42P5*_YO2J"6PC7[6X%N @
M(_\QN I$=+Z[R/]JL';%R.IWR"[)#'L36%3ZCU[ ,%EEE-5([8H(:P0BB 0^
M@SU#.7PF[E?F$A&:)+[!I<^UQZG5IECM"IGH>SCI<['@X6\!C_%+\-"F/N\=
MR587N%V1PA\TAAF22]F'"74YX4*/ZND!K6S0:XK6]AA8YV8'F&R.&: -*$ +
M @O5T(KQ%OFF5-8-E;=D[L)%!W-S*2@+,_R9V9^YP6:6DN49ACZ7ZH[$ZOEY
MY'<TSU 0./:+X'?**]22A]I1Z=;.*H4Q41AQ5ZPBJV+ C7-:F[;>?NRYJ>C-
M ^]M*7VMEMM7^(7[NR_-D2<YYLG6]CVFX#]]O* *>X5]X&0K?#WDG=TIJ+'C
MK4^@@/D%][P&^^19K)V57Q_12#C_0G2Z(7UZLZ2N^;S.F9[:7:Y[Q3:&#.A3
MBDRI<TFY/C;,B)!9SJT0K?/_E5%S5$8MAY,QU\LYGF7?!M Z]R-HB\C+U*GN
M>Q%.^N8,1<X2=:%;EZMP@"DX1I 59Q50ZU+H#>Q+^HV0[]YR"*R.G_D7\)]9
M3H[58*U+DGOXLM00);6[P+?T/1W"%CC.E[?.ZU=8I3CZ5RGLREX-MKN2?*-J
MEKIB0FO+9D%L7=IKXD*@Z64ER1>VSN5(@?+T\P+<R?-:7M4ZQV/^0AWN\>ER
MI'RWX"O5U:US?C5?>'Q)\AP7BUOG](ZS"F9+:UKG=T1?%"'L!A9Z3]2%E5P^
MUJRN;YWW\3/QGHAM^+-"M,Y_R9HJO5;/AYKU@%N7*GK=USQ[>3.?PP(/M.\M
ML^*LA-HM.8(H4CM36;Q9#W0G)6)J><U]45>J<O =E&Q&A5K"X%5/L KHW9-+
M*U\MKW0^KI9DU?"MRW8?OQ04'?_(RF*I;YWW)#>8Y,K*I:@%N=/RZ#Q9?9DR
MT#LMUS47X3P:;5[7E]*"V[K, S' $*K=\B?R.\_-NA5UK?,<7_",7X?-\FVI
MWP'>DQ<>\ER7U+3.;SX34/)0A3T994-H7;IP!ASS:GGL(*U+,!"7/O&\?,?-
M%K;.I3XI,0T>M?JZ</B<LNF(B"?JD'P?6 G7NBS95TH^8X6]I53)1:';VWXN
M-&F T+IT^F0"T0<5].UR]V("\]7I2>]M5J)50#LFQ3TT+,8<6'QGDZ,,K'5)
MPD3F)\+TR2N++'4 6Y<F=;%XS)--@,*.Y0JHUN7(=NF*%8D=IG49+H&_[R-G
MQCTBOW"7Y.:0ZNK=XUSOV-F93T.TSC\P,YYQ7V+FA@E3\)5< F\%S+]1A@_=
MX#DU^/@O4$L#!!0    ( (DP>5*]_%1<#A$  *;/   5    <'1I>"TR,#(P
M,3(S,5]C86PN>&UL[5WK<]LV$O]^,_<_X-RYFW8FBBT[:1JWN8[B1T93Q_+8
M3A_WI4.3D(4+1:@@Y4?_^EN #X$O$)1( NF</]@6A5WL[@]8++ @\,./3TL?
M/6 6$AJ\VQN_/-A#.'"I1X+[=WN?;D:3FY/I= ^%D1-XCD\#_&XOH'L__OOO
M?T/P\\,_1B-T3K#O':-3ZHZFP9Q^CRZ=)3Y&'W" F1-1]CWZV?'7_ D])SYF
MZ(0N5SZ.,'P15WR,7K]\XZ#12(/MSSCP*/MT/<W8+J)H=;R___CX^#*@#\XC
M99_#ERY=ZO&[H6OFXHS9U>WT5W1X<'@P/CP:H_'!3^C\-W1Z?OGR:0Z*G#H1
ME(&OQ_\\/#TX@E^'KV\/WAR__NYX?/0?S0HC)UJ'684'3P?)3TS^@T^"S\?\
MUYT38@3P!.'Q4TC>[4EZ/AZ]I.Q^__#@8+S_Z\>+&W>!E\Z(!!PF%^^E5)Q+
M%=WX[=NW^^+;M&BIY-,=\],ZCO93<3+.\"U1E)<D"<EQ*,2[H*X3B5;66 VJ
M+<$_C=)B(_YH-#X<'8U?/H7>7FI\84%&?7R-YXC_A=:2U;IB-'+N<4!<WD;V
M^=?[ -%ZB8-H$GAG042B9XX76PIQ007!;\'P_-W>*B)/H[1Y\$J_TJ&-GE?0
M;T+"F_T>VM]:SO>.SZUZL\ X"IL$JRS<BR17#@,#+'!$7,=O)58E95<R\HZ&
M.33A;#Y;<5\$D(2 $_<_#"]P$)('?$'#1E.VY]2'#B<+)[C'X32XB:C[>4%]
M#[SG*9X3ET1M--#ATXO\3K@X]^EC*W.7B+J2;,;NG8#\*: $)"_!*3,\F[]?
MAR3 S4U"D[PK:3]0&)!/*'0<UNB1JLIVAN=ZN738\VQ^0^X# DW& <_GNG0-
MKB^XOZ(^-"+<#' K+EW)GM0 3N?9N?,QH 9/V!I[9T\KZ,'-8FLSZ$KB4\S(
M S0Q\"W$N2,^B32,JR3J2C)H7A T1@3,<$DCG%CDBGSFGQI%U*/NS@=MX2Y[
M]XPGU/>=.\H$4I-[AF./UVPZ)5E7TET0EP]JP;V^9 J2KJ2ZQCZ,#!Y$#='S
M+7."T''%2-PD6A-=5_)-8>:TQ+?.4W,7J"C:G8^^"_$?:P#@[$$'N+KRPXX9
MW8X=?8TA>K7?<G?6D29Y7H.-A7HJM&0SS.BC)WH;'CV.1)I-I8FP!P^F)UDM
MP; ][A1'#O'#2X?%(V,W?:^.Z["ZC?CRCK?V87IQ[A FUHTF80C39^AO4HSW
M$3LA3$*\67"-W35CP.*]$Y)4BVY,TK$PYBVI(?.G@,((R1YX^YX&JW4$7\/T
M"JC$]*]W^W8NHGFK)WJ(*#'3A,^C:<#2C[R@D/X6NXN 0(32?U/N1BYC]IW
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M(S"]"M@6LP;-[4>J<="HIS"]\+<S5LV1E^$Q?A.OQ"]$\Y>IUR#X9E99>'6
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MOM5Q3)7EL%7=9_9%09.0Q"F*4(.DR^I?OP!(293$Q(4B"="E?JBNL@$P,S\
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MDW%5NTH H_H@]L.IR8N=7A@Z*3V$_)A=*,Z.2I5PU1C%?F!UF;'SS $3G94
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M1//<@I+'/VZ]Z5JS]*RM4;RO-_UZL+32LGDE]:87H1"Q>VRCU?"XF\6C2]D
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M8(!EY5;<U4\&]&^QZ_$@M<S@U![(S&E6# [>C25+#ZRF,+;2"FA^'K3J;7]
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M&Q"."@_1Y3]G?S U1W_R_P%02P,$%     @ B3!Y4JE#321A7@  &&8% !4
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M!L!X_NR]ZON\^7MK?2Y3J^KS^B]A]+E$(Z'/.0VP?9#/V,NV*5L*7<6;;?Y
M/JC9!E&3VUR[=BE=7[VJ:)WCQE!! 49[<L3H$64 M1=R[J7I+HQ7=WB3I#D.
M9FNZJ+KTPI1=.[P(,S]*J!':39+>4FPB<*")=6#V% $&K\/T%H\].3>_B8KJ
MJ(;E("O#SG;57_\<XI2T_M/N&C\3B*G=I2FS3>CV,ZB.6#-.,$#MI6X;GY2#
M8_,$54R@O&QE$YL%,F;0>ZU'U7(X@:!:=2GN1')X8%/JJ$,89SI!C V]!^8"
MYUD>KKT<+Y:5E7TG\WXB;&)QB'%U</;A!X/6 4JWX5N*H+NA>R@?PT1>&Z$?
M>OO+#U#\Y8=^_O(#, 1VZVCN+S\< =(^]D;:1RA(^]@/:1^/ &D?!R+M(S"D
MM?<.YJ\X]<,,WZ:AKY^0C3A=[NEH3-%M[TC8P"#17-?.39\35#(CQ@T>EQOL
M\Q=.\JWF/HQN4:DR1 _*-A=@3"I4%2]*Q'GJ^?G6BQ E!H; 69R'01AM\_ 9
MWV-_FX9YB+/YJQ]M QQ<DDZF#\&W.7L5O%C.O30.XU5VB]/[)R_%9SNY ,U>
MSZ1?M(EY"TU7'RP3?@[,*)O>QO;PK#.@/<>TMYGXU06:5.$2>SEQ*TQ[S1N3
M#@9KEU.,%*_NI&BIG6/.6$6)1R]X4,&$.!<PU\ZNPBPV=*CHWP6(=':?F"C4
M;#XM:1$YAT^79N(K)7HQB1-"0\HO7IIZ'7>Q6S0V$2)5KXZ.!@$89,BT:J.B
MH($&B-F+EP8=5QQ:-%8C+YEZC5BI3@ &$#*MA'B$TL"[JC!?;Z)DA['IG**A
MMWIHT:5VXX1"16P50"2T>$RJ]";]&O<(IYZO.,M)"*_Q,PT*F^"1J%:'2^W7
M8#R,J%,;"P7%M.L;^I&S\!>,?XMV"P+HAY?D<Q+G3YH53B>+M36.H?+5*J>#
MWCDV>B@I PMZ#$\Y'Z*,B' BSCKUHX[:!?^;).]>'HN4EM?%*E5;"^(V&0R$
M:'63+X'YVPM&#>"&]D.8TZ>Q5W$0/H?!UI/=-]/0V;JQK56SO+DM)7*.DR[-
MVBAAM/3>PYYZ\GVU;!OEJJ6L@L:FEY"J5_</#0+G/:[32N(3"C)@(29-<745
M9WFZI:<WFDA31F@SX%0K6H\[12KG,.E439IU;$\Y]=OAC.[KX\ \H.ADL?B.
MV$CYVFMB+;USJ/104GQ97'"AZ<*/OA#Z)<R?:@G,PD&@4@MQ#[,N [N!IY(
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MNEFM8M73(@F,SE;JU>YO&J=:Z_/[\#7'.-X?,NN*=2AI[>UK=*B[W]Q0$,+
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MV)4,I]U\B],P">9Q<$'"1HTQ+3K;'2]5LXV !A$H*,@T4V*"$Z,Y?>="R)W
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M82-5L8F6!@D@D,CT4F"#D:*2UB$B[M=>%)UMLS#&F7IJ:E'91814Q28B&B2
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M_8OYDL6R?C!UF^)UN%VK6JN;SVI0;6I& [5=3&"F"E--A=BUQL=S"]>.#&$
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MZ]144=NNY#@A$Y,/JQ!C60>M6*86E;UG<7!#.KE9X+S5&$:<-F>8'J;4X6?
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MTBYBIYAM**R%)J.$=2U&JV,;9NQW*"A8&)8\R@042<8[R>!VAP?N^(+9Q3W
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M*J?PGV=YN&8/_M;KD%T[YG5SQ!97$ )K>KV60A\4Y.PD@M,7Z<&=H+[($:3
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MS]1_=$W^1GY<_HC\A^X?DI_\_U!+ P04    " "),'E2R?*!Z2-   #,6 0
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M%I4[,J=BFRM$5[VRU-"OBV>A4DFA5#.2"D>&<M$6K>46;9\Q1Q.9VU]P8U
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M@6/"[&/4.MEJQ)V1@&EBV$9AS10JJ0#.KD6[%UG19$Z#4YJ(S\4D5=^84G7
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MN\]HCBSTC&,$J+$MV3S95AR4*4X1#89P?2VW)WP L>! DR_2G,S_5$\8U0<
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M$' 0R=E*Y>>?_G(?/'&9L$])2"(E7M+6T#"[O1N9!X)*(Z]#H<3WP69 -3I
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M0-[<]5ET3]UKQ@ETLL!A\H:]*K['?M7P.Z_^O7&E?%^'[E199V)]<E-6'DR
MZQLK!U,W0T@0Z6&?RZV;1QU YFN83[B^BF+_=6>96"T=1>R\T"'N(Y\3%J2T
M^(W$^=!W<QXZTR(%X^-5S-7QU;A$\EBV_3J7#M5I[63'X3EY)E&R%#R(=[UC
MIG <--U<7U4! PQB?_0Y@]?<XX@9C>>F^8+OVOF"ZY'PY@I^3)+P*XTB#ND5
MEV \I]P7FS!&.--K5O0Y@8;#8$@E&V7N7R^XCCE^R.*@A\OQ,T;ADL8T(]?<
M*NTHV.GJD__O)#V+?,;4D6JC04:$FQ%?5I('A\1S0S D \1X(!RX]M!G..C=
MC*/(ZNAP8G3G%HHNK@-2/;6XA:16)I8B!G?)RH^R5;7CN25I(&0WEUU5EC='
M'X56DV]5R)^7ER(=]3Y_+&$FEX0PK:RUO5QK/DSF0.8/HM_3^)0\^=&,[^#S
MQZ@DAQ@JO78,_%'-'DSABG0\DSA7!;LV+? '+G=(MCH?KD1J-V$<\,E"Y'FS
MZ5<2?HZY$*K9N5Y_[CCAD@EA.@C^*&$?KJ0X'3XL=$<B\>#(K4C9;Q[)PV)#
M[]NQH6HXKQC/:PZ(+$(DXUL?%-+WQ!!N&&4<" K*,?2#+(2 ['KG@S!2T]E5
M'-)G&N9^)$_\EC0=@^SEU+N[X;E#T,\T>RJFM9C'3W3YD%S$? U9J>YY&@_B
M/K%<J7$JP'2LV4HQW!A:37+A;D.7USQ[ZM=V2J&,=QQ[E&&3W1 _H>I\XV11
MTJ]#E?H7)QQ(PD-7>1U_;N&A*KN^FI=\S(M%O=?H\Z&)P1\5="D=1+&4JYC_
ME3SX+P08/OG0#I^4(WC%$,@")FOF3!)HE)TP;,U'&28!0'&,D&#9I>-/CEFK
MTR3/GI)4U'-4YL'(VH\(#1D+.+);=JG3I;'(>^  1:UB6G#L!D,N"1_5CY1Q
MD%8;UV>#.@UIQCLZV;-T1EA]ZR.)^7]$D(5OC-.'A#?["T2\JGZNWPSN(7*]
M&&Q5418V<!*'U[R/6J\[6[JN<VXB:@6K0\1@6&W-&0F^G2?/;P)QOINN2F->
M_:-MQZL?_W(VZ9!Z]4OQ.VC0PEK4 BKH!LT6PUN@ X;U\GX?D-CG\TI^M"-I
MBF-%U![M2*BW4J8-)OF*CL\Q6Y* SB@)58<XBN;NCVN46M0$0<Z$'5_D.F&,
M,#XO<Q&IF\PRDO(FWRMMN*:/R_I 6IUIFG(0[Y96S.UO0]T6;2^7!83VD+TU
M?V7@_5%U1^^4^UDS"@E#M3N,Y:1*P_'XH_S3I?"4Q5,C7!'/_#1=S9)4A(85
M<0A5G]&<!^D9MV3Q-BFZT]E9DBZ3\MX[XTHF/))2XR1V#]@7_\&% 3-6P9!K
M0:,B : 8@^$HKL,8T-H,O82#;*VZ(T$2!S2B!;W\!V?<2-.,U;?/ :N7?@C\
MZ=+F/(T S;,G<<)YQ;6P7'O%CKJXQO63'^6E\*,H^>K'JER)(<8>3<V%X02)
M3#$N7OP%C:NZ/;$?992P\EI[<4- 6U3#>"#7CW#V\6%-1(3M9/_D/G@B82ZR
M$,5Z=$KX8D0V)[+ED7WW<?^?E,?])UX]LI?,/#&V5P[>:+;."3AF @S*C)#V
M)==LD5Y"XYS[&I73P?W %L*$\5TT5U,:Z)CM.:CC/:EY<L$ (L1DQ(T8N>3_
MI'/MR6R_,5UO8@^B"BT)CE83+EZX8#@B?&5+5\4Z>,,=&Y&NED2<OGF]O VJ
M*O"/NMZ+'T273#'H'3?+N(L0.2_IU>V57,QF)!#9@AL?FWMHVWZVTDWYSL!-
M67^LZ:2([WG;'SPZ+D,S X%YDE69",))SSDAJZW&<J8'&7QTCLR (C6W+#^4
M<SHF<Y$QXCXB#Q'&5O)%PQKMIUCR4<?G$ TA19>Z)(E70]BZ)>G"C[E0SREO
MS:4;U&5!).'K?0<=D8LS!+N8_&4(+Y6CO]6B9BNC?K2?T="/[OJPPX[Q@$IU
M/'HR2#!]\ ^Y/EFQHSVCC;=#F)MF3R2=A/_.6594Q=M/6W9'<WW88D<E9%(;
M?XY)-_==@0533>D>P_7)S%#ZH9(0XM.9'9LF7&SJ/W)%%R=.RA#(GPU"(/5W
MBM!'^27/CT.O\:UC]&-H9G; E2>)Z(]K>@TVNNC&'B*SE/6T0U%Q@%K^K#H%
MWKI('H=5WB/KOFE^EK#LALBVE]:^-J*HA%4Y'%97UEQ?=Q>XZ62UU6ED$0.8
M#' XZ%U:5J9V;5D:??:;\4#CV^?WE-7X8\P[C&NJ5<G:CV]SKN9\T'-)#+B:
MA&Y&D>@X .*@$,MKF=C=;IE,-"9N%:+MLXKKD:<:W.>/C/R:\P$OG@GXZ;#O
MV]OHS3!>.0ZR(D=M-O4;9'D/#'5U1EG>2 ?"L;81EFOJ"O*1U#9JZ=(#_YZZ
MN)&TPYCPD/& H[Q1!WFZ^D:*+DAP4>N9'B!4SVRUZ-,]L25I[CHNIM4S-2H8
M;[Z+MX3%2U]*$[;5",GT@)BM+;JMU#GI*V^=>6HUPR'S#EWI%C@NT]-='UD$
MP,2+(,$3F<9$:Y!,!G$=!.[4,5C5:)54<!@L/>$/7Y/]X6P,XCK\.PR<.U(Y
M5MQR7''KP['BUK@K;NV/@\BU#'PF]X<;]+?;.CNB,*D$I:!_!(O*\844=*]5
MP%Y(,0N(+Q-&19SX@:08L@I[BZCXH_(62OF\LZ"%G5]QOC.WKG\*X2*R87W>
MRMC4/"KYTNC,,)]PO4>R_P2)3*SC3WO6SB&F,>+UPT)K.V[I+:B!Z7"]$1S.
MR%D!"(<9/(M\QJ:SG\7A;YQ-TSM!^$TN?,[I[)X$>5HD4)_Y443"TU75CE4-
M%6[;W@.[SBD"J\] (GP%ABY+@B]7C.5\>\.9KA?^8NJP&_*U^)7R%!;6WW7N
M$=RP& G$Z"I']1OQAUA*^4_^/U!+ 0(4 Q0    ( (DP>5)>P9L2V;H  #\[
M"0 1              "  0    !P=&EX+3(P,C Q,C,Q+GAM;%!+ 0(4 Q0
M   ( (DP>5+77S_AY!   (RM   1              "  0B[  !P=&EX+3(P
M,C Q,C,Q+GAS9%!+ 0(4 Q0    ( (DP>5*]_%1<#A$  *;/   5
M      "  1O,  !P=&EX+3(P,C Q,C,Q7V-A;"YX;6Q02P$"% ,4    " ")
M,'E2?3L3_:$O  #Y%P, %0              @ %<W0  <'1I>"TR,#(P,3(S
M,5]D968N>&UL4$L! A0#%     @ B3!Y4JE#321A7@  &&8% !4
M     ( !, T! '!T:7@M,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( (DP
M>5+)\H'I(T   ,Q8!  5              "  <1K 0!P=&EX+3(P,C Q,C,Q
>7W!R92YX;6Q02P4&      8 !@"* 0  &JP!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
